>ACN58946.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|macB|antibiotic target protection|0
MAEPVLSVKDLDIRFTTPDGNVHAVKKVSFDIAPGECLGVVGESGSGKSQLFMACIGLLA
GNGKATGSVTYRGQELLGQPAAKLNAIRGAKITMIFQDPLTSLTPHMRIGDQIVESLRTH
SKLSKGEAEKRAIQALELVRIPEAKRRMRQYPHELSGGMRQRVMIAMATACGPDLLIADE
PTTALDVTVQAQILDIMRDLRKELGTSIALISHDMGVIASICDRVQVMRYGEFVETGPAD
DIFYHPQHPYTRMLLEAMPRIDQPVREGRAALKPLAPQEARTTLLEVDNVKVHFPIQMGG
VFFGKYKPLRAVDGVSFTLHQGETIGIVGESGCGKSTLARAVLELLPKTTGGVVWMGRDL
GALPPAELRRARKDFQIVFQDPLASLDPRMTIGQSIAEPLQSLEPELSKHEVQSRVRAIM
EKVGLDPDWINRYPHEFSGGQNQRVGIARAMILKPKLIVCDEAVSALDVSIQAQIVDLIL
SLQAEFGMSIIFISHDLSVVRQVSHRVMVLYLGRVVELASRDAIYEDARHPYTKALISAV
TVPDPRAERLKKRRELPGELPSPLDTRSALMFLKSKRIDDPDAEQYVPKLIEVAPGHFVA
EHDPFEVVEMTG
>ACN58871.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MADYLLEMKNIVKEFGGVRALNGIDIKLKAGECAGLCGENGAGKSTLMKVLSAVYPHGTW
DGEILWDGKPLRAQSIRETEAAGIVIIHQELMLVPELSVAENIFLGNEIKLPGGRMDYAA
MNRRAEELLAELDIRDVNVVLPVKQYGGGYQQLIEIAKALNKNARLLILDEPSSSLTASE
IKVLLRIIHSLKAKGVTCVYISHKLDEVADICDTIVVIRDGQHIATTPMADMNIERIIAQ
MVGREMNQLYPERSHVPGEVIFEARNVSCYDADNPQRKRVDNISFKLRKGEILGIAGLVG
AGRTELVSALFGAYPGPSEAEVWLNGVKLDTRTPLKAIRAGLAMVPEDRKQHGIVPDLGV
GHNMTLAVLNDFVRATRIDQQAELATIHKEIKSVKLKTATPFLPITSLSGGNQQKAVLSK
MLLTKPKILILDEPTRGVDVGAKFEIYQLMFDLAAQGMSIIMVSSELAEVLGISDRVLVV
GEGKLRGDFVNDNLSQETVLAAALDHTQPALH
>ACN58991.1|FEATURES|NCBI|multidrug|cmeB|antibiotic efflux|0
MKNDRGEMVPFSAFMTIKKKQGANEINRYNMYNTAAIRGGPATGYSSGEAIKAVQEVAAK
NLPNGFDIDWAALSYDETRRGNEAVYIFLIVLAFVYLVLAAQYESFIIPLAVVFSLPAGV
FGSFLLIKGMGLANDIYAQVGLVMLVGLLGKNAVLIVEFAVQKQQQGATVFEAAIEGARV
RFRPILMTSFAFIAGLIPLVFAHGAGAIGNKTIGSSALGGMFFGTVFGVIVVPGLYYVFG
SWAEGRKLIRGEDHDPLTENLVHQMDNFPQSDDK
>ACN58776.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|macA|antibiotic efflux|0
MGNLPRPTLSPSLSGIRPTMNRETTTRVDSSTPAARLGMRVPSTSRAALVGVAALVVILG
GWYGIKRWRAHVASEGQYIFAAIQKGDIEDLVTATGSLQPRDYVDVGAQVSGQLDKILVE
VGSDVKEGDLLAEIDADVAAARVDASRAQLRSQQAQLVQQQANLTKAERDLTRQQNLMKE
DATTAEQVQNAETTLDTTKAQINALKAQMEQLRASMRVDESNLNYTKILAPMSGTVVSIS
AKQGQTLNTNQQAPTILRIADLSTMTVQTQVSEADVSKLRSGMQAYFTTLGSAGKRWYGQ
LKKIEPTPTVTNNVVLYNALFEVPNDNKQLLPQMTAQVFFVAAAAHDVLVVPMSAVSLQR
TPPGGIPNAAAAQAAGARGAGAQGAGAQGAQGASAQGAGAQSGQGGQGAAALTPEQIARR
EARRQQRMQSNGGSATGGAIEGGPPRGGFGASMAARGPRHATVRVQAADGKIEERQITIG
VTNRVHAEVLSGLKEGERVVAGTKEPEKAPATAGGQQGAGGQRNNIGGFPGGGLGGGFGR
>ACN58740.1|FEATURES|NCBI|pleuromutilin|TaeA|antibiotic efflux|0
MRQAVMQGVGDAFKKLVRFNEISEKFAEPMSDDEMNALLEEQAKLQDAIDAANGWELERK
LDIAADALRLPDWDAIIGKLSGGEKRRVALCQLLLSAPDMLLLDEPTNHLDAESVAWLER
YLEEYPSTVIAVTHDRYFLDNVAEWILELDRGHGIPWQGNYSSWLEQKDKRLEQEERSQE
GLRKMLERELEWVRSNPKARQSKSKARMQRFEELSSQEFQKRNETNEIYIPPGERLGDVV
IEVKNLTKGFGDRLLIDNFSFSLPRGGIVGIIGPNGAGKTTLFRMLTDQEKPDSGEIRIG
PSVKLAYVDQSRQQLNDKNSVFQEISGGQEIIKVGNYETSSRGYVGRFNFKGTQQQQLIG
ELSGGERNRVHLAKVLKTGGNLLLLDEPTNDLDIETLRALEEALVAFPGCAVVISHDRWF
LDRIATHILAFEGDSQVVFFEGNYQEYAADYERRHGDSQPHRIKYKKLTR
>ACT97463.1|FEATURES|NCBI|multidrug|MexB|antibiotic efflux|0
MALLVAFLVLAAQYESWTSPVAAVMGLPVALLGAMLGCYVMGTPVSIYTQIGIILLVALS
AKNGILIVEFARDFRAQGNSIRDAAFQAGHIRLRPILMTSLAFVFGVMPLLFATGAGAGS
RIALGAAVVFGMALNTLLATVYIPNFYELMQKLQEKFSKKQ
>ADI87846.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MEKNQHISLHKVSTNNLKQIDVTIPLNQLTVVTGVSGSGKSSLVFDTLYAEAYRRFVDSL
SSYARQYLKTLPKPDLQSVSNLPPAVAVKQGRSPANQRSTVGTLTELTHLIQTLFMHLGK
IQCYKCGRPVQKDHARSIVDNLLQDISTDTQLAIMAPLKGWSGLKGSALKKQLQEQGFVR
VSLDSEIFSLEDIDLKKIHSSNVIIDRLKCKPDEKTRLTEAVELALKVGRGLCLVGLPKE
ELRFSNALECTHCRINYLPASMVLFSFNHPLGACDSCHGYGRIANLDWDKVIPDKNSSIA
QDGIAPLNFGSHAEYYSEIKKSAKKLRIDLKKAFHQYTEREWQWLREGSGADFGGMKAYF
EWLNSKKYKAHYRIHAAKYNKYEICPSCNGRRYCRDALVYKIEGKNISDVHEMAIKDFKT
WLSVFNNAQEASKSSPEPIAGLSEALEEIESRIRYLVKVGLSYLNLNRVSGTLSGGELQR
IHMASCIGSSLTDTMYCLDEPTAGLHARDSQNLLDVICELRDQGNTVVIVEHDKQIMNGS
DFLIEIGPGSGHLGGHISYEGKAKSRSSAMPYPERPARKFGSYLKLEGAKTHNLKNIGVE
FPMGGLSVVCGVSGSGKTSLIQHTLFPMLESALGNRPMETIPAKSIGPKSVLDKIAQVLF
IDQKTLARSSRSNIATYLGIFEAIRKLFSSQERAKELKLGPGSFSFNVPGGRCETCKGLG
TVIEDLSFLGEVQVTCPQCEGKRFSSQVLSVTVRGQNLLQILSLTVHQAFELFYDHGEIR
DVLKPIIDLGLGYLTLGQSTNSFSGGEAQRLKLLSLLKETHSKSKSMLLIFDEPTTGLSD
KDVYNLWKHLDFLTQKGHTVIVIEHHLDMIRHADWLIEIGPDAADLGGQVVYQGSPGGIF
SAPLSKTAPFLKS
>AET35489.1|FEATURES|NCBI|multidrug|MexB|antibiotic efflux|0
VAAVMGLPVALLGAMLGCYVMGTPVSIYTQIGIILLVALSAKNGILIVEFARDFRAQGNS
IRDAAFQAGHIRLRPILMTSLAFVFGVMPLLFATGAGAGSRIALGAAVVFGMALNTLLAT
VYIPNFYELMQKLQEKFSKKQ
>AIA15373.1|FEATURES|NCBI|tetracycline|tcr3|antibiotic efflux|0
MEPIKSKEIISFSSYQKLVIALLAIMQFTVVLDFMVLSPLGDILMKSMDITPSRFGLVVS
SYAFSAGISGIFAAGFADKFDRKKLLLFFYSGFILGTFCCAMADSFAVLLAARIVTGLFG
GVIGSISMAIITDLFTINQRGRVMGFVQMAFAASQVLGIPTGLFFADIWGWHSSFLMIVI
LALTTALTIYWKLRPVNAHLQLQTDKAPLLHLWHTLTNKHYQIGFVATAFLSVGGFILMP
FGSSFLINNIGIHQEQLKLVFMLTGVSSVIIMPIVGKLSDKFDKFVLFTCGSVISIIMII
IYTNLSTIPLWEVVGINMLLFMGIMSRMVPAMALASAVPEMKDRGAFMSVNSSLQQMAGG
FAALVAGMIVVQKTKTSPLEHYDTLGLVVSGVAVVCLFFVYRVSELVKKKTAERELAGIN
QALALKNQLPAEESILQ
>AIA11224.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MTVISNIEVRGARVHNLANIDVSLPRNQLIVITGLSGSGKSSLAFDTIYAEGQRRYVESL
SSYARQFLQLQDKPDVDLIEGLSPAISIEQKTTSKNPRSTVATITEIYDYLRLLFARIGM
PHCYHCHKPITQKSATAITDEIMSLGQGVRISILAPIVRAKKGEHKLELSKLSKEGFVRV
RVDGELRYLEEDIELNPKTKHSIDLVVDRLVVDIQERPRLSDAVELSLKKSGGLVLVLKH
LADDTMVEELFSEHFGCVDCGTSFPEIEPRMFSFNAPQGACQTCNGLGNFLHFTEEKVIK
NQSLSLDQGAISPYAANQKGYYYSQINSVAKAYDAPLDLPWKKLSKKVRDFILFGSDKRI
NFVFKSEKSGRTHRASRVYEGLINQLKRRYEETDNDTIRLELETYMSRDFCPDCQGARLN
LFARSVKIEGKAIYELTDMAIKESVQFFNDLKVLERQQKIADPILKEIRARLSFLEAVGL
DYLTLSRAARTLSGGEAQRIRLATQIGSALVGVLYVLDEPSIGLHQRDNEKLLNTLKNLR
DLGNTVLVVEHDEDTILASDYVVDMGPGAGALGGQVVAVGSPKAIMKNKASLTGRYLSRE
LAIKTPKTRRTGTGKVLSIKNAKGNNLAGVDLNIPLGVMTAITGVSGSGKSSLIIDTLYA
ELASQLYASSIDVLP
>AIA19084.1|FEATURES|NCBI|multidrug|salA|antibiotic efflux|0
MIADISISEKSFGPKSLMTNVRFTINDAEKIGVIGRNGVGKSTLFGVLAGTDKDFSGEVN
YKPGTVVVATQQEYHDVGDKTVLQYILQGLPEYTDLSHIIETYPETMGDNLKKINEYTEA
LQRFDDKGFYQIEEQIERELNNFQLDGIAHREFTTLSGGQKRLVEVVKIMHSDAHLALID
EPTNHMDYIAKQQFIDWIKQAREAVLVITHDRDVLREVDRIIELKDGGSASFKGNYDGRY
>AIA18737.1|FEATURES|NCBI|tetracycline|tet(30)|antibiotic efflux|0
MNKALTIILAAVTLDAIGIGLIFPILPRLLEDVTHTGEVTVIIGVMLALYSAMQFLFSPV
LGVLSDRYGRRPVLLVSLAGAAIDYLVMAFAPELWMLVLGRAIAGITSANMAVATAYITD
ISAEEERA
>AIA17432.1|FEATURES|NCBI|elfamycin|facT|antibiotic efflux|0
MAQTTHLSAQEHAAGFTHRARTIALIIVALAFIMDLLDNTIVNIAIPSIQSNLGASYATI
QWLIAGYALTFATLLITGGRMGDVYGYKKVFMAGVGGFTLASLLCGVSWNSHVLIAARLL
QGAFAALMVPQVMSLMQVMFKPHERGGIMGIFGALAGVAATLGPVIGGILIHFNIAGLDW
RPIFLINIPVGLFALFAGAKYLPDGKSPHPLKLDVFGTVLITAALFLLVFPLIQGRELGW
PTWSFVLMALAIPILPFICMVAANKRA
>AIA16964.1|FEATURES|NCBI|tetracycline|tetZ|antibiotic efflux|0
MIGTVQRKVRAHADARLKGKLTVLMITAFVDMLGLVMVLPLLPFYATKLGGSATMVGGLI
AAFSLAQLASAPFWGSFSDRYGRRPALLSGLILSAIAYVIFAFASTLWLLLLSRIVQGFG
GGTIGVVQAYVTDVSDPKERAKSLGWLSAVTSLGAVIGPAIGSALVQLWGRHAPGLAAAA
FSLLVSLFAWEFLRESKQAPTTDEMALPPAPASAVMWNVLVHPGEAAPRLIWIYTIAIGA
FYGMAPTLPLVLQRYLPITESNVGYFVMYLGGIGFLVRSLILGRMIEVLGEARLARLGLI
LLGLGLALVSAIR
>AIA15464.1|FEATURES|NCBI|multidrug|mexN|antibiotic efflux|0
MGGVVGRLFNEFGMVVALAIVASAVVSLTVTPMLGSRLSGAEHHPGLMVRIFDAGFSRTL
RGYDRAVGWCLRNRAIILLVFLASVGASVYLFRTLPTSFFPQEDIGRLTISTRAREDISY
PAMRDLQAQVAAAVQKNPAVKHVTSIVGSNGRSSLNNGTIWVELKDRGERPPLDQTLREL
RQATSKFAGMKTFITPQQSLRFGGRATASQYQLVVQALNASQTSEWSDKIQTAMRADRTH
FTDVTSDAQNDAIEANIKVDPEKAASFGITDDELRKTLQMAFGGYTAAEIQSTGDSYDVI
TEFEQWNDQMLQGVRVMSSNGSLVPLSNFATIVRQTAPITINQTGQLVSTTVSFNLPAGV
SLSDATAAIDQIKANLQMPNDVFTSYGGTAQIFQQSQGNTPLLILAAVLTIYVVLGVLYE
SFIHPLTILSGLPAAAFGALLALKLFGFDLSIIALIGLLMLIGIVKKNAIMMIDVAVETM
RSKGETAAAAIHEACVRRFRPIMMTTFCALLGALPIALGTGASSELRQPLGVAVVGGLIV
SQALTLFITPVIFVEMDRFGRFLGRLWTKKDKDLHEANDDAPTQIAAE
>AIA15197.1|FEATURES|NCBI|tetracycline|tet41|antibiotic efflux|0
MNKALVVILAAVMLDAVGIGLIFPILPALLRDVGHTSDISVLLGIMLALYSACQFLFSPI
LGVLSDRFGRRPVLLVSLAGAAVDYLIMALAPHLWMLVIGRAIAGVTSANMAVATAYITD
ITTEEERAQRFGLFHAMFGVGFIIGPVIGGILGDWWLHAPFLAAAMLNGVNFALALFVLP
ESRKGQADTRFAWTVS
>AIA13517.1|FEATURES|NCBI|tetracycline|tet41|antibiotic efflux|0
MALFLLPETRKIGAEAESQEFSPLAHFRWLLGYRLLLPLAGAYFVLALVGEVGGTIWVLY
GQDKFSWSPMMVGISLAAFGFFHAVVQAFIAGPISERWGEHRTLLIGIIADSAAYIIIAL
LTEGWMAFLLMPLFCLGGIGAPALQSLVTGRVDNAHQGRAQGMLASMTSLASIIGPLAIS
TIYFASRDVFPGLVWVLGAAFYALCLPIAFTRRPKDATA
>AIA11748.1|FEATURES|NCBI|tetracycline|tet(30)|antibiotic efflux|0
WNFKALLPLVVVAVVFGLVAAVPGTVWVLYGAERFGWDPVHIGLSLSVFGISGAISQMFL
VGPLTKRFGDLGTLMIGVVFDTLAYVLMAFASQGWMGYALAPLFALGGVAMPALQSLLTS
RVSDEHQGQLQGVLASLMGLAGIVGPVLTTAVFFSTKSLWLGTIWIVGAGLYILAFPLFA
TVRRPQPAAA
>AMJ38548.1|FEATURES|NCBI|multidrug|mdtG|antibiotic efflux|0
MTGEKTMTQQSDGEAEPERYWRRNLWVCMAGSFTTLIAMTLLLPFLPLYVAELGVSEPAA
VARWSGVAYGATFFTAALTAPLWGRLGDRYGRKLMLIRASLGMAIAMSLIGMASAPWQLV
ALRLLAGLLGGYASGATIFIAAQTPKAHTGWALGMLSSGVMAGNVVGPLIGGLLPPLIGI
RATFWLAGGVIFLAFLATSLLLKEAPRPAPQQRQRETAALSLRQGMLPVMLLSGMLLIFA
NMSVEPIITLYVAQFVHQPHQVTLMAGVTMSAAALGSILSAAWLGRRY
>AMJ38429.1|FEATURES|NCBI|multidrug|mdtG|antibiotic efflux|0
MTGEKTMTQQSDGEAEPERYWRRNLWVCMAGSFTTLIAMTLLLPFLPLYVAELGVSEPAA
VARWSGVAYGATFFTAALTAPLWGRLGDRYGRKLMLIRASLGMAIAMSLIGMASAPWQLV
ALRLLAGLLGGYASGATIFIAAQTPKAHTGWALGMLSSGVMAGNVVGPLIGGLLPPLIGI
RATFWLAGGVIFLAFLATSLLLKEAPRPAPQQRQRETAALSLRQGML
>AMJ38206.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
LDVTVQAQILQLLRELRDELNMSLLFITHNLSIVKKLADAVAVMQNGRCVEQNRASALLS
APQHPYTQRLLDSEPAGDPVPLNADSAPLLRVERLSVSFPIRKGILRRVVDHNHVLKDMS
FALRPGESLGLVGESGSGKSTTGLALLRLIASQGSIVFDGMPLQNLNRRMMLPVRPRMQV
VFQDPNSSLNPRLSVLQIIEEGLRVHQPTMTAQQREIDVMRVMAEVGLDPETRHRYPAEF
SGGQRQRIAIARALILKPELIVLDEPTSSLDRTVQAQILALLKGLQEKHRLAYIFISHDL
QVVRALCHQVVVLRQGEVVEQGECQRVFTAPTQDYTRQLLSAD
>AMJ37632.1|FEATURES|NCBI|multidrug|acrB|antibiotic efflux|0
MFSRFFVRRPVFAWVIAILIMLAGVLAIRTLPVGQYPDVAPPAVKISATYTGASAETLEN
SVTQVIEQQLTGLDHLLYFSSTSSSDGSVSITVTFEQGTDPDTAQVQVQNKVQQAESRLP
SEVQQSGVTVEKSQSSFLLILAVYDKTNRATSSDISDWLVSNMQDPLARVEGVGSLQVFG
AEYAMRVWMDPTKLASYSLMPSDVQSAIEAQNVQVSAGKIGALPSSNAQQLTATVRAQSR
LQTPDQFKAIIVKSQADGSVVRLSDVARVEMGSEDYTATANLNGHPAAGIAVMMAPGANA
LDTATLVKSKIAEFQRQMPQGYDIAYPKDSTEFIKISVEDVIQTLFEAIILVVCVMYLFL
QNFRATLIPAVAVPVVLLGTFGVLALFGYSINTLTLFAMVLAIGLLVDDAIVVVENVERI
MRDEGLPAREATEKSMGEISGALVAIALVLSAVFLPMAFFGGSTGVIYRQFSVTIISAMM
LSVVVALTLTPALCGALLSHSKPHTKGFFGAFNRLWGRTEAGYQRRVLGGLRRGAVMMGA
YALICGAMALAMWKLPGSFLPVEDQGEIMVQYTLPAGATAVRTAEVRRQVTDWFLTKEKA
NTDVIFTVDG
>AMJ36754.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|tlrC|antibiotic target protection|0
MCIQVQQITYIHPDKEVLFRNLSFTVGKGRQLALIGNNGCGKSTLLQIMAGKLQPSSGNV
LRPDDLYYVPQHFGQYDEMSIAQALGIDRKQKALHEILNGNASIDHFNILDDDWNIEEKA
LAALNGWGLGNRSLSESMHTLSGGEKTRVFLAGLELQEPPAVLMDEPT
>AMJ36428.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
TVPEKRLNDYPHQLSGGERQRIMIAMAILTRPKLLIADEPTTALDVSVQAQILELLAELK
QELNMGMLFITHNLNIVKRLADRVAVMRYGEIVETGECQALFSAPQHPYTQQLLDAIPSG
DPVALPQPTQTLLEVKDLSVRFPIRQGILRRTVGYSHIVDRLNFTLQRGESLGLVGESGS
GKSTTGLALLRLIPALGEIWFEGTALHLLNLKQLQPYRSQIQVVFQDPYSALNPRLNVLQ
IIAEGLQVHQKLNEQQREERVISAMNEVGLDPETRYRYPTEFSGGQRQRIAIARALILEP
RLLILDEPTSSLDRSVQAQILTLLKTLQQRHQLSYLFISHDLQVVRSLCHQVMVMRNGKV
IEHGNCAEVFANPTQDYTRQLLAFAD
>AMJ35756.1|FEATURES|NCBI|multidrug|mdtG|antibiotic efflux|0
MTTYTRPVLLLLCGLLLLTLAIAVLNTLVPLWLAHENLPTWQVGMVSSSFFTGNLLGTLL
TGSLIKRFGFNRSYYLASLIFAVGCAGLGLMVGFWSWMVWRFIAGVGCAMIWVVVESALM
CSGTSRNRGRLLAAYMMVYYVGTVLGQLMVSKFPTDLMSVLPWVTGMVLAAILPLLFTRI
VNQSSEHQEATHVWPMLRLRQARLGINGCIISGIVLGSLYGLMPLYLNHQGVSDSGIGFW
MAVMVSAGIVGQWPIGRLADRFGRLLVLRVQVFVVIMGCLAMLSNAAMAPALFILGAAGF
TLYPVAMAWACEKVEHHQLVAMNQALLLSYTIGSLLGPTFTAMLMQNYSDNLLFIMIASV
SFIYLLMLLRKAGEHPTPVAHA
>AMJ34484.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
ILNCLDRVGIRQAAKRLTDYPHQLSGGERQRVMIAMALLTRPELLIADEPTTALDVSVQA
QILQLLRELQGELNMGMLFITHNLSIVRKLAHRVAVMQNGRCVEQNNAATLFASPTHPYT
QKLLNSEPSGDPVPLPEPASTLLDVEQLQVAFPIRKGILKRIVDHNVVVKNISFTLRAGE
TLGLVGESGSGKSTTGLALLRLINSQGSIIFDGQPLQNLNRRQLLPIRHRIQVVFQDPNS
SLNPRLNVLQIIEEGLRVHQPTLSAAQREQQVIAVMHEVGLDPETRHRYPAEFSGGQRQR
IAIARALILKPSLIILDEPTSSLDKTVQAQILTLLKSLQQKHQLAYLFISHDLHVVRALC
HQVIVLRQGEVVEQGPCARVFAAPQQEYTRQLLALS
>AMJ33780.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|tlrC|antibiotic efflux|0
MHRVGKVVPPKRHILKNISLSFFPGAKIGVLGLNGAGKSTLLRIMAGIDT
>AMJ33545.1|FEATURES|NCBI|pleuromutilin|TaeA|antibiotic efflux|0
LEKPDMLLLDEPTNHLDAESVAWLERFLHDFEGTVVAITHDRYFLDNVAGWILELDRGEG
IPWEGNYSSWLEQKDQRLA
>AMJ32925.1|FEATURES|NCBI|quinolone|oqxB|antibiotic efflux|0
PDDMKWAAPYDPTVFVRDSIRAVVQTLLEAVVLVVLVVILFLQTWRASIIPLIAVPVSVV
GTFSILYLLGFSLNTLSLFGLVLAIGIVVDDAIVVVENVERNIEEGLAPLAAAHQAMREV
SGPIIAIALVLCAVFVPMAFLSGVTGQFYKQFAVTIAISTVISAINSLTLSPALAALLLK
PHGAPKDFPTRLIDILSSVRLDFPPV
>CAH19071|FEATURES|argannot|aminoglycoside|AAC(6')-IIa|antibiotic inactivation|1
MPSHDHPVTLRLMTEQDLPMLHEWLNRPHIVEWWGGEEQRPTLADVLEHYRPRILAHESV
TPYIAMLGEEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQSLANPTQLNMGLGTELVRA
LVDRLFSDPTVTKIQTDPAPNNRRAIRCYEKAGFVQERVITTPDGQAVYMTQSRQAYERA
RGAA
>AAA03550|FEATURES|argannot|aminoglycoside|AAC(2')-Ia|antibiotic inactivation|1
MGIEYRSLHTSQLTLSEKEALYDLLIEGFEGDFSHDDFAHTLGGMHVMAFDQQKLVGHVA
IIQRHMALDNTPISVGYVEAMVVEQSYRRQGIGRQLMLQTNKIIASCYQLGLLSASDDGQ
KLYHSVGWQIWKGKLFELKQGSYIRSIEEEGGVMGWKADGEVDFTASLYCDFRGGDQW
>AAC44793|FEATURES|argannot|aminoglycoside|AAC(2')-Ib|antibiotic inactivation|1
VPFQDVSAPVRGGILHTARLVHTSDLDQETREGARRMVIEAFEGDFSDADWEHALGGMHA
FICHHGALIAHAAVVQRRLLYRDTALRCGYVEAVAVREDWRGQGLATAVMDAVEQVLRGA
YQLGALSASDTARGMYLSRGWLPWQGPTSVLQPAGVTRTPEDDEGLFVLPVGLPAGMELD
TTAEITCDWRDGDVW
>AAB17563|FEATURES|argannot|aminoglycoside|AAC(2')-Ic|antibiotic inactivation|1
VHTQVHTARLVHTADLDSETRQDIRQMVTGAFAGDFTETDWEHTLGGMHALIWHHGAIIA
HAAVIQRRLIYRGNALRCGYVEGVAVRADWRGQRLVSALLDAVEQVMRGAYQLGALSSSA
RARRLYASRGWLPWHGPTSVLAPTGPVRTPDDDGTVFVLPIDISLDTSAELMCDWRAGDV
W
>AAB41701|FEATURES|argannot|aminoglycoside|AAC(2')-Id|antibiotic inactivation|1
VLTQHVSEARTRGAIHTARLIHTSDLDQETRDGARRMVIEAFRDPSGDSDFTDDFTDDDW
DHALGGMHALISHHGALIAHGAVVQRRLMYRGPDGRGHALRCGYVEAVAVREDRRGDGLG
TAVLDALEQVIRGAYQIGALSASDIARPMYIARGWLSWEGPTSVLTPTEGIVRTPEDDRS
LFVLPVDLPDGLELDTAREITCDWRSGDPW
>WP_010908954|FEATURES|argannot|aminoglycoside|AAC(2')-Ic|antibiotic inactivation|1
MDTHHVHTARLVHTADLDGETLRRLQQMVTDAFAGDFDETDWEHALGGMHALIWRHGTII
AHAAVVQRRLFYHGNALRCGYLEGVAVRKDCRGRGLVHALLDAIEQVIRGAYQFGALSSS
DRARRVYMSRGWLPWLGPTSVLAPTGVIRTPDDDGSVFVLPVGINPDTSSGLMCDWRAGN
VW
>CAA39184|FEATURES|argannot|aminoglycoside|AAC(3)-IIIa|antibiotic inactivation|1
MTDLNIPHTHAHLVDAFQALGIRAGQALMLHASVKAVGAVMGGPNVILQALMDALTPDGT
LMMYAGWQDIPDFIDSLPDALKAVYLEQHPPFDPATARAVRENSVLAEFLRTWPCVHRSA
NPEASMVAVGRQAALLTANHALDYGYGVESPLAKLVAIEGYVLMLGAPLDTITLLHHAEY
LAKMRHKNVVRYPCPILRDGRKVWVTVEDYDTGDPHDDYSFEQIARDYVAQGGGTRGKVG
DADAYLFAAQDLTRFAVQWLESRFGDSASYG
>AAA25682|FEATURES|argannot|aminoglycoside|AAC(3)-IIIb|antibiotic inactivation|1
MVHAAVSRVGRLLDGPDTIIAALRDTVGPGGTVLAYADWEARYEDLVDDAGRVPPEWREH
VPPFDPQRSRAIRDNGVLPEFLRTTPGTLRSGNPGASLVALGAKAEWFTADHPLDYGYGE
GSPLAKLVEAGGKVLMLGAPLDTLTLLHHAEHLADIPGKRIKRIEVPFATPTGTQWRMIE
EFDTGDPIVAGLAEDYFAGIVTEFLASGQGRQGLIGAAPSVLVDAAAITAFGVTWLEKRF
GTPSP
>AAA25683|FEATURES|argannot|aminoglycoside|AAC(3)-IIIc|antibiotic inactivation|1
MFSRWSKPLVLAAVTRASLAADLAALGLAAGDAVMVHAAVSKVGRLLDGPDTIIAALSDA
GRPAGTILAYADWEARYEDLVDEDGRVPQEWREHIPPFDPRRSRAIRDNGVLPEFLRTTP
GALRSGNPGASMVGLGARAEWFTADHPLDYGYGEGSPLARLVEAGGKVLMLGAPLDTLTL
LHHAEHLADIPGKRIRRIEVPLATPTGTQWRMIEEFDTGDPIVEGLAEDYFAEIVTAFLA
GGRGRQGLIGTAPSVLVDAAAITAFGVAWLESRFGSPSS
>CAA35913.1|FEATURES|argannot|aminoglycoside|AAC(3)-IIc|antibiotic inactivation|1
MHTRKAITEAIRKLGVQTGDLLMVHASLKAIGPVEGGAETVVAALRSAVGPTGTVMGYAS
WDRSPYEETLNGARLDDKARRTWPPFDPATAGTYRGFGLLNQFLVQAPGARRSAHPDASM
VAVGPLAETLTEPHELGHALGEGSPVERFVRLGGKALLLGAPLNSVTALHYAEAVADIPN
KRWVTYEMPMLGRNGEVAWKTASEYDSNGILDCFAIEGKPDAVETIANAYVKLGRHREGV
VGFAQCYLFDAQDIVTFGVTYLEKHFGATPIVPAHEAAQRSCEPSG
>CAA38525|FEATURES|argannot|aminoglycoside|AAC(3)-IIc|antibiotic inactivation|1
MHTRKAITEALQKLGVQTGDLLMVHASLKAIGPVEGGAETVVAALRSAVGPTGTVMGYAS
WDRSPYEETRNGARLDDKTRRTWPPFDPATAGTYRGFGLLNQFLVQAPGARRSAHPDASM
VAVGPLAETLTEPHKLGHALGEGSPVERFVRLGGKALLLGAPLNSVTALHYAEAVADIPN
KRRVTYEMPMLGSNGEVAWKTASDYDSNGILDCFAIEGKPDAVETIANAYVKLGRHREGV
VGFAQCYLFDAQDIVTFGVTYLEKHFGTTPIVPAHEVAECSCEPSG
>ABS70977.1|FEATURES|argannot|aminoglycoside|AAC(3)-IIa|antibiotic inactivation|1
MHTRKAITEALQKLGVQTGDLLMVHASLKAIGPVEGGAETVVAALRSAVGPTGTVMGYAS
WDRSPYEETLNGARLDDEARRTWLPFDPATAGTYRGFGLLNQFLVQAPGARRSAHPDASM
VAVGPLAETLTEPHELGHALGEGSPVERFVRLGGKALLLGAPLNSVTALHYAEAVADIPN
KRWVTYEMPMLGRDGEVAWKTASDYDSNGILDCFAIEGKPDAVETIANAYVKLGRHREGV
VGFAQCYLFDAQDIVTFGVTYLEKHFGTTPIVPPHEAVERSCEPSG
>ABS70978|FEATURES|argannot|aminoglycoside|AAC(3)-IIc|antibiotic inactivation|1
MHTRKAITEAIRKFGVQTGDLLMVHASLKAIGPVEGGAETVVAALRSAVGPTGTVMGYAS
WDRSPYEETLNGARLDDKARRTWPPFDPATAGTYRGFGLLNQFLVQAPGARRSAHPDASM
VAVGPLAETLTEPHELGHALGEGSPVERFVRLGGKALLLGAPLNSVTALHYAEAVADIPN
KRWVTYEMPMLGRNGEVAWKTASEYDSNGILDCFAIEGKPDAVETIANAYVKLGRHREGV
VGFAQCYLFDAQDIVTFGVTYLEKHFGATPIVPAQKAAQRSCEPSG
>CAA25642|FEATURES|argannot|aminoglycoside|AAC(3)-IVa|antibiotic inactivation|1
VQYEWRKAELIGQLLNLGVTPGGVLLVHSSFRSVRPLEDGPLGLIEALRAALGPGGTLVM
PSWSGLDDEPFDPATSPVTPDLGVVSDTFWRLPNVKRSAHPFAFAAAGPQAEQIISDPLP
LPPHSPASPVARVHELDGQVLLLGVGHDANTTLHLAELMAKVPYGVPRHCTILQDGKLVR
VDYLENDHCCERFALADRWLKEKSLQKEGPVGHAFARLIRSRDIVATALGQLGRDPLIFL
HPPEGGMRRMRCRSPVDWLSS
>AAA25334|FEATURES|argannot|aminoglycoside|AAC(3)-IXa|antibiotic inactivation|1
MEEMSLLNHSGGPVTRSRIKHDLADLGLKDGDVVIFHTRMSAIGYVAGGTQTIIGALLDV
VGARGTLMVPCGWNNAPPYDFLDWPRDWQDALRAEHPAYDPDLSEADYNNGRLPEALPRW
PGAIRSRHPDASFAALGPAAAELMAEHPWDHPHGPDTPLARLIAHSGRVLLLGAPLDTMT
LLHHAEALADVRSKRFVTYEQPILVNGQRVWRQFRDIDSEEGAFDYSTVRRGVEPFEAIA
RDMLSAGIGRQGRVGAADSYLFDAGPVFNFAINWIEAKLKR
>CAA33850|FEATURES|argannot|aminoglycoside|AAC(3)-Ia|antibiotic inactivation|1
MLRSSNDVTQQGSRPKTKLGGSSMGIIRTCRLGPDQVKSMRAALDLFGREFGDVATYSQH
QPDSDYLGNLLRSKTFIALAAFDQEAVVGALAAYVLPRFEQPRSEIYIYDLAVSGEHRRQ
GIATALINLLKHEANALGAYVIYVQADYGDDPAVALYTKLGIREEVMHFDIDPSTAT
>AAA88422|FEATURES|argannot|aminoglycoside|AAC(3)-Ib|antibiotic inactivation|1
MLWSSNDVTQQGSRPKTKLGGSMSIIATVKIGPDEISAMRAVLDLFGKEFEDIPTYSDRQ
PTNEYLANLLHSETFIALAAFDRGTAIGGLAAYVLPKFEQARSEIYIYDLAVASSHRRLG
VATALISHLKRVAVELGAYVIYVQADYGDDPAVALYTKLGVREDVMHFDIDPRTAT
>AAL82588|FEATURES|argannot|aminoglycoside|AAC(3)-Ib/AAC(6')-Ib''|antibiotic inactivation|1
MSIIATVKIGPDEISAMRAVLDLFGKEFEDIPTYSDRQPTNEYLANLLHSETFIALAAFD
RGTAIGGLAAYVLPKFEQARSEIYIYDLAVASSHRRLGVATALISHLKRVAVELGAYVIY
VQADYGDDPAVALYTKLGVREDVMHFDIDPLTNSNDSVTLRLMTEHDLAMLYEWVNRSHI
VEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGGGDGWWEE
ETDPGVRGIDQSLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYE
KAGFERQGTVTTPDGPAVYMVQTRQAFERTRSDA
>CAD53575|FEATURES|argannot|aminoglycoside|AAC(3)-Ic|antibiotic inactivation|1
MISTQTKITRLNSQDVGVMRAMLGMFGEAFEDAENYCRAQPSDSYLQDLLCGSGFIAIAA
LQGQEVIGGLAAYVLPKFEQQRKEIYIYDLGVQGAYRRRGIATALINELQRIAHDIGAYV
IFVQADYGDDPAVALYTKLGIREDVMHFDIEPQPAA
>BAD00738|FEATURES|argannot|aminoglycoside|AAC(3)-Id|antibiotic inactivation|1
VSVEIIHLTGNDVALLQSINAMFGEAFNDQDSYARNKPSSSYLQKLLSTSSFIALAAVDE
QKVIGAIAAYELQKFEQQRSEIYIYDLAVAATRRREGIATALIKKLKAIGAARGAYVIYV
QADKGVEDQPAIELYKKLGTIEDVFHFDIAVEQSKNHA
>AAX16011|FEATURES|argannot|aminoglycoside|AAC(3)-Ib|antibiotic inactivation|1
MSITATIRIGPDEIPAMRAVLDLFGREFEDMSAYSDRQPTNDYLAKLLRSETFIALAAFD
QGTAIGGLAAYVLPKFEQARSEIYIYDLAVASSYRRQGIATSLISHLKREAIKIGAYVIY
VQADYGDDPAVALYTKLGVREDVMHFDIDPGTAT
>ABD81100|FEATURES|argannot|aminoglycoside|AAC(3)-Id|antibiotic inactivation|1
MPLEIKQITENELSQMEALSAVFGEVFSDKETYTENKPSADYVRSLLSSDYFIALAALDE
SKVIGGLAAYELKKFEQERSEIYIYDLAVIAAHRRKGVAIALIERLKIIAAERGAYVIYV
QADTGPEDKPAIELYSKLGVQEEVLHFDIEVKGNHGVT
>ABL71428|FEATURES|argannot|aminoglycoside|AAC(3)-Id|antibiotic inactivation|1
MSVSIRCLGRSDVSVLRQMNALFGDAFDDPDTYLGEPPDDAYLSGLLAGDHLIALAAMDG
AVVVGGLIAYELEKFERARSEIYIYDLAVAETHRRQGIATALIGTLQRIAAERGAWVVYV
QADYGDEPAIALYTGLGKREDVLHFDIPVDAG
>ABF52347|FEATURES|argannot|aminoglycoside|AAC(3)-Ib|antibiotic inactivation|1
MIVRRLGPGDIAAVRALNAVYGAAFDDPETYRADRPDDAWLARQLGREGVIVLVAELDGN
IVGGLTAYELPKLEAARSEIYLYDLAVDAAHRRCGIATALIGELQHIAAETGAWAVFVQA
DHGDDPAVALYTGLGAREDVMHFDLPPRPRGA
>AAA26685|FEATURES|argannot|aminoglycoside|AAC(3)-VIIIa|antibiotic inactivation|1
VDEKELIERAGGPVTRGRLVRDLEALGVGAGDTVMVHTRMSAIGYVVGGPQTVIDAVRDA
VGADGTLMAYCGWNDAPPYDLAEWPPAWREAARAEWPAYDPLLSEADRGNGRVPEALRHQ
PGAVRSRHPDASFVAVGPAAHPLMDDHPWDDPHGPDSPLARLAGAGGRVLLLGAPLDTLT
LLHHAEARAEAPGKRFVAYEQPVTVGGRRVWRRFRDVDTSRGVPYGRVVPEGVVPFTVIA
QDMLAAGIGRTGRVAAAPVHLFEAADVVRFGVEWIESRMGGAAGGA
>AAA88552|FEATURES|argannot|aminoglycoside|AAC(3)-VIIa|antibiotic inactivation|1
MDELALLKRSDGPVTRTRLARDLTALGLGDGDTVMFHTRMSAVGYVAGGPETVIGALRDV
VGERGTLMVTCGWNDAPPYDFTDWPQTWQDARRAEHPAYDPVLSEADHNNGRLPEALRRR
PGAVRSRHPDASFAALGAAATALTADHPWDDPHGPDSPLARLVAMGGRVLLLGAPLEALT
LLHHAEALADAPGKRFVDYEQPILVDGERVWRRFHDIDSEDGAFDYSALVPEGTEAFEII
GRDMRAAGIGRRGTVGAADSHLFEARDVVDFGVAWMEEKLGRERGPGG
>AAA16194|FEATURES|argannot|aminoglycoside|AAC(3)-VIa|antibiotic inactivation|1
MTDPRKNGDLHEPATAPATPWSKSELVRQLRDLGVRSGDMVMPHVSLRAVGPLADGPQTL
VDALIEAVGPTGNILAFVSWRDSPYEQTLGHDAPPAAIAQSWPAFDPDHAPAYPGFGAIN
EFIRTYPGCRRTAHPDASMAAIGPDAAWLVAPHEMGAAYGPRSPIARFLAHAGKILSIGA
GPDAVTALHYAEAVARIEGKRRVTYSMPLLREGKRVWVTTSDWDSNGILDEYAAPDGPDA
VERIARDYLARTRVAQGPVGGAQSRLIDAADIVSFGIEWLEARHAAPAAAALKPKQRRD
>BAA78619|FEATURES|argannot|aminoglycoside|AAC(3)-Xa|antibiotic inactivation|1
MDETELLRRSDGPVTRDRIRHDLAALGLVPGDTVMFHTRLSAIGYVSGGPQTVIDALLDV
VGPTGTLLVTCGWNDAPPYDFTDWPPAWQEAVRAHHPAFDPRTSEAEHANGRLPEALRRR
PGAVRSRHPDVSLAALGASAPALMDAHPWDDPHGPGSPLARLVALGGRVLLLGAPRDTMT
LLHHAEALAQAPGKRFVTYEQPIEVAGERVWRTFRDIDSEHGAFDYSSAVPEGQDPFAVI
VGSMLAAGIGREGFVGAARSRLFDAAPAVEFGVRWIEEHLNRDR
>ABC17631|FEATURES|argannot|aminoglycoside|AAC(6')-29b|antibiotic inactivation|1
MKYSLNPIRPEESHDWLRLRDLLWEADDHAIEIARFFTGELEETVEVLIARDLEGRAVGH
VELSIREDIDGLNGVKTGYIEGLYVDVLHRSSGLVRQFLRASEQWAKDQGCSAFASDRQD
RVIIHRRFSGGSA
>CAG26810|FEATURES|argannot|aminoglycoside|AAC(6')-31|antibiotic inactivation|1
MTEHDLPMLHDWLNRPHIVEWWGGEETRPTLAEVLEQYLPSALAKESVTPYIAMLDEEPI
GYAQSYIALGSGDGWWEDETDPGVRGIDQSLANPSQLGKGLGTKLVCALVEMLFKDAEVT
KIQTDPSPNNLRAIRCYEKAGFVAQRTINTPDGPAVYMVQTRQAFEQARSAV
>ABR10839|FEATURES|argannot|aminoglycoside|AAC(6')-32|antibiotic inactivation|1
MSPSKTPVTLRLMTERDLPMLHAWLNRPHIVEWWGGEEERPTLHEVVKHYLPRVLAEEAV
TPYIAMLGDEPIGYAQSYVALGSGDGWWEDETDPGVRGIDQFLSNHTQLNQGLGTKLVQA
LVELLFSDPTVTKIQTDPAPNNHRAIRCYEKAGFVQQNVITTPDGPAVYMVQTRQAFERV
RSAA
>ACT99627|FEATURES|argannot|aminoglycoside|AAC(6')-33|antibiotic inactivation|1
MAYEFCEIGESNEYIILAARILTKSFLDIGNNSWPDMKSATKEVEECIEKPNICLGIHEN
EKLLGWIGLRPMYKLTWELHPLVISTQYQNKGIGRLLINELEKKAKQIGIIGIVLGTDDE
YFKTSLSAVDLYGENILDEIRTIKNIKNHPYEFYQKCGYSIVGVIPDANGKRKPDIWMWK
KIND
>AAA25688.1|FEATURES|argannot|aminoglycoside|AAC(6')-IIa|antibiotic inactivation|1
MSASTPPITLRLMTERDLPMLHDWLNRPHIVEWWGGDEERPTLDEVLEHYLPRAMAEESV
TPYIAMLGEEPIGYAQSYVALGSGDGWWEDETDPGVRGIDQSLADPTQLNKGLGTRLVRA
LVELLFSDPTVTKIQTDPTPNNHRAIRCYEKAGFVREKIITTPDGPAVYMVQTRQAFERK
RGVA
>AAA25680|FEATURES|argannot|aminoglycoside|AAC(6')-IIb|antibiotic inactivation|1
MHPGVVTLRPMTEDDIGMLHEWLNRPHIVEWWGGERPSLEEVKEDYRPSALAEEGVTPYI
GLLDGTPFAFAQSYVALGSGGGWWEEETDPGVRGIDQSIADSGLLGRGYGTRLVQALVDL
LFADPQVSKVQTDPSPNNMRAIRCYEKAGFRKVKVVSTPDGPAMYMLHERPLVNGLRSAA
>NP_460578|FEATURES|argannot|aminoglycoside|AAC(6')-Iaa|antibiotic inactivation|0
MDIRQMNRTHLDHWRGLRKQLWPGHPDDAHLADGEEILQADHLASFIAMADGVAIGFADA
SIRHDYVNGCDSSPVVFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTSPEN
TISQKVHQALGFEETERVIFYRKRC
>BAD12078|FEATURES|argannot|aminoglycoside|AAC(6')-Iad|antibiotic inactivation|1
MIRKATVQDPPLLARLAMNVWKESSLKELVAEFEQMTKSNDAVAFILFIEDQAVGFAQCQ
LRHDYVEGTNTSPVGYLEGIFVEKEFRHRGYASELLLKCEDWVKTKGCLQFASDCELDNI
DSLAFHLKVGFTEANRMICFTKQL
>BAD14386|FEATURES|argannot|aminoglycoside|AAC(6')-Iae|antibiotic inactivation|1
MKYNIVNIKDSEKYITQAAEILFDVFSHINFDSWPSLQKATETVIECISAENICIGILIN
DELCGWVGLREMYKKTWELHPMVIKKKHQNKGFGKILIFETEKKAKERNLEGIVLGTDDE
TFRTTLSMSELNNENIFHEIKNIKNLKNHPFEFYEKCGYSIIGVIPNANGKNKPDILMWK
NIM
>ACI28880|FEATURES|argannot|aminoglycoside|AAC(6')-Iai|antibiotic inactivation|1
MKYTIIDIKDSETYITQAAEILFDVFSEISPESWPTLQKAKEDVIECIEGENICIGIIIN
KELIGWIGLREMYKKTWELHPMVIKKTHHNMGFGKILINEIEKKARERNLEGIVLGTDDE
TYRTSLSMIELNNENILQEIKNIRNLENHPYEFYKKCGYCIIGVIPNANGKNKPDILMWK
NIMEENCG
>AAA69747.1|FEATURES|argannot|aminoglycoside|AAC(6')-Ib|antibiotic inactivation|1
MSIQHFQTKLGITKYSIVTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTL
ADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQLL
ANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTP
DGPAVYMVQTRQAFERTRSVA
>AAA26549|FEATURES|argannot|aminoglycoside|AAC(6')-Ic|antibiotic inactivation|1
MIVICDHDNLDAWLALRTALWPSGSPEDHRAEMREILASPHHTAFMARGLDGAFVAFAEV
ALRYDYVNGCESSPVAFLEGIYTAERARRQGWAARLIAQVQEWAKQQGCSELASDTDIAN
LDSQRLHAALGFAETERVVFYRKTLG
>CAA31139.1|FEATURES|argannot|aminoglycoside|VN23_18795|antibiotic inactivation|1
MIEACHSVECPGWLQLRFLLWPQDSADEHLAEMAIFVAEPNRFAQFIAYDEANKPLGFVE
AALRSDYVNGTNSSPVAFLEGVYVLPEARRRGIAHALVGAVEIWARNRACTEFASDASTD
NPESHRFHQSLGFKETERVVYFRKMLAPE
>CAA39038|FEATURES|argannot|aminoglycoside|AAC(6')-If|antibiotic inactivation|1
MDEASLSMWVGLRSQLWPDHSYEDHILDSQHILSCPDKYVSFLAINNQSQAIAFADAAVR
HDYVNGCESSPVVYLEGIFVIPEQRGHGVAKLLVAAVQDWGVAKGCTEMASDAALDNHIS
YQMHQALGFEETERVVFFRKRIAG
>AAA21889|FEATURES|argannot|aminoglycoside|AAC(6')-Ig|antibiotic inactivation|1
MNIKPASEASLKDWLELRNKLWSDSEASHLQEMHQLLAEKYALQLLAYSDHQAIAMLEAS
IRFEYVNGTETSPVGFLEGIYVLPAHRRSGVATMLIRQAEVWAKQFSCTEFASDAALDNV
ISHAMHRSLGFQETEKVVYFSKKID
>AAC41391|FEATURES|argannot|aminoglycoside|AAC(6')-Ih|antibiotic inactivation|1
MNIMPISESQLSDWLALRCLLWPDHEDVHLQEMRQLITQAHRLQLLAYTDTQQAIAMLEA
SIRYEYVNGTQTSPVAFLEGIFVLPEYRRSGIATGLVQQVEIWAKQFACTEFASDAALDN
QISHAMHQALGFHETERVVYFKKNIG
>AAB63533|FEATURES|argannot|aminoglycoside|AAC(6')-Ii|antibiotic inactivation|1
MIISEFDRNNPVLKDQLSDLLRLTWPEEYGDSSAEEVEEMMNPERIAVAAVDQDELVGFI
GAIPQYGITGWELHPLVVESSRRKNQIGTRLVNYLEKEVASRGGITIYLGTDDLDHGTTL
SQTDLYVHTFDKVASIQNLREHPYEFYEKLGYKIVGVLPNANGWDKPDIWMAKTIIPRPD
SQ
>AAC41392|FEATURES|argannot|aminoglycoside|AAC(6')-Ij|antibiotic inactivation|1
MNIMPVSESLMADWLGLRKLLWPDHDEAHLQEMQRLLQQTQSLQLLAYSDTQQAIAMLEA
SIRYEYVNGTQTSPVAFLEGIYVLPDYRRSGIATHLVQQVEAWAKPFGCIEFASDAALDN
RISHAMHQALGFHETERVVYFKKHIG
>AAA87229|FEATURES|argannot|aminoglycoside|AAC(6')-Ik|antibiotic inactivation|1
MNIKPASEASLKDWLKLRIKLWNDLEESHLQEMHQLLAEKHALQLLVYSDDHAVGMLEAS
IRYEYVNGTETSPVAFLEGIYVLPEYRRLGVATLLVRQVEAWAKQFSCTEFASDAALDNV
ISHAMHRALGFQETERVVYFSKKID
>CAA91010|FEATURES|argannot|aminoglycoside|AAC(6')-Ip|antibiotic inactivation|1
MLKKSFLDAGNESWGDIKNAIEEVEECIEHPNICLGICLDDKLIGWTGLRPMYDKTWELH
PMVIKTEYQGKGFGKVLLRELETRAKSRGIIGIALGTDDEYQKTSLSMIDINERNIFDEI
GNIKNVNNHPYEFYKKCGYMIVGIIPNANGKRKPDIWMWQILARKNSPTIAST
>AAK63041|FEATURES|argannot|aminoglycoside|AAC(6')-Ip|antibiotic inactivation|1
MLEKKRVSFRPMNEDDLVLMLKWLTDDRVLEFYDGRDKKHTQKTIREHYTEQWADEIYRV
IIEYDTIPIGYAQIYRIQGELFDEYNYHETEEKIYAMDQFIGEPEYWNMGIGAEYCRVVC
QYLRTEMDADAVILDPRKNNLRAVRAYQKAGFKIIKELPEHELHEGKKEDCVLMEWRV
>AAC25500|FEATURES|argannot|aminoglycoside|AAC(6')-Iq|antibiotic inactivation|1
LDYSICDIAESNELILEAAKILRKSFLDAGNESWVDIKKAIEEVEDCIEHPNLCLGICLD
DKLIGWTGLRPMYDKTWELHPMVIKTEYQCRGIGKVLIKELEKRAKGRGIIGIALGTDDE
YQKTSLSMIDINERNIFDEIGNIKNVTNHPYEFYKKCGYMIVGIIPNANGKRKPDIWMWK
DIS
>AAD03490|FEATURES|argannot|aminoglycoside|AAC(6')-Ir|antibiotic inactivation|1
MKIMPVSEPFLADWLQLRILLWPDHEDAHLLEMRQLLEQPHTLQLLSYNDQQQAVAMLEA
SIRYEYVNGQQSSPVAFLEGIYVLPEYRRLGVASTLVQQVEHWAKQFACTEFASDAALDN
TISHAMHRALGFQETECVVYFKKNIS
>AAD03491|FEATURES|argannot|aminoglycoside|AAC(6')-Is|antibiotic inactivation|1
MNIMPISESQLSDWLALRSLLWPDHEDAHLLEMRHVLKQTDTLQLLVYSETQLAIAMLEA
SIRHEYVNGTQTSPVAFLEGIYVLPEYRRSGIATQLVQCVEEWAKQFACTEFASDAALEN
TISHAMHRALGFHETERVVYFKKNIG
>AAD03492|FEATURES|argannot|aminoglycoside|AAC(6')-It|antibiotic inactivation|1
MHIMPITESQLSDWLVLRCLLWPDHEDADLQEMRQLITQAHCLQLLAYTNTQKAIGMLEA
SIRYEYVNGTQTSPVAFLEGIYVLPEYRRSGIATGLVQHVEIWAKQFACTEFASDATLDN
QISHAMHRALGFHETERVVYFKKNIG
>AAD03493|FEATURES|argannot|aminoglycoside|AAC(6')-Iu|antibiotic inactivation|1
MNILPISESQLSDWLALRSLLWPDHEEAHLQEMRQLLKQTDTLQLLAYSETQHAIAMLEA
SIRHEYVNGTQTSPVAFLEGIYVLPEYRRSGIATQLVQCVEEWAKQFACTEFASDAALDN
TISHAMHRALGFHETERVVYFKKNIS
>AAD03494|FEATURES|argannot|aminoglycoside|AAC(6')-Iv|antibiotic inactivation|1
MKIMPISESQLSDWLVLRCLLWPDHEEQHLQEMRQLITQAHCLQLLAYTDTQQAIAMLEA
SIRYEYVNGTQTSPVAFLEGIYVLPEYRRSGIATGLVQHVEIWAKQFSCTEFASDAALDN
QITHAMHQALGFQETERVVYFKKNIG
>AAD03495|FEATURES|argannot|aminoglycoside|AAC(6')-Iw|antibiotic inactivation|1
MKIMPISEALLADWLQLRILLWPDHEDAHLLEMRQLLTRTDSLQLLAYSETQQPIAMLEA
SIRHEYVNGTQTSPVAFLEGIYVLPEHRRSGIATQLVQQVEQWAKQYACTEFASDAAIDN
TISHAMHQALGFHETERVVYFKKNIS
>AAF03531|FEATURES|argannot|aminoglycoside|AAC(6')-Iy|antibiotic inactivation|0
MDIRQMNKTHLEHWRGLRKQLWPGHPDDAHLADGEEILQADHLASFIAMADGVAIGFADA
SIRHDYVNGCDSSPVVFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTSPEN
TISQKVHQALGFEETERVIFYRKRC
>AAD52985|FEATURES|argannot|aminoglycoside|AAC(6')-Iz|antibiotic inactivation|1
VIASAPTIRQATPADAAAWAQLRLGLWPDADDPLEELTQSLADAEGAVFLACAADGETVG
FAEVRLRHDYVNGTESSPVGFLEGWYVQPQWQGSGVGRALLAAVQAWTRDAGCRELASDS
RVEDVQAHAAHRACGFEETERVVYFRMPLEPSA
>ABV25540|FEATURES|argannot|aminoglycoside|aac(6')-ib-cr|antibiotic inactivation|1
MTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPI
GYAQSYVALGSGDGRWEEETDPGVRGIDQLLANASQLGKGLGTKLVRALVELLFNDPEVT
KIQTDPSPSNLRAIRCYEKAGFERQGTVTTPYGPAVYMVQTRQAFERTRSDA
>AAL10408|FEATURES|argannot|aminoglycoside|AAC(6')-Ib8|antibiotic inactivation|1
MYSIVTNSTDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLA
QESVTPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQSLANASQLGKGLGTK
LVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQA
FERTRSDA
>AAN41429|FEATURES|argannot|aminoglycoside|AAC(6')-29b|antibiotic inactivation|1
VKEQDAADWLALRNLLWLADDHASEIEQYFSGGLEEPVEVLIARDATGAAVGHVELSIRH
DLEELQGIKTGYIEGLYVAPSHRSTDLVKRFLRESEKWALEQGCSAFASDRSDRVITHRK
FAGSAV
>AEA07977|FEATURES|argannot|aminoglycoside|AAC(6')-Iaf|antibiotic inactivation|1
MIYNIINIADSEKNKEDAARILYSAFRGKGKDAWPTLDSAREEIAECIASPNICLGITLD
DRLVGWGGLRPMYETTWELHPLVIDPDYQGNGLGRLLLSKIESTATTNRIIGIMLGTDDE
TLSTSLSMTDIDESNIFQEIKNIINIKNHPFEFYKKCGYIIVGIVPNANGYRKPDIWMWK
NLEKKSG
>AFK93816|FEATURES|argannot|aminoglycoside|Ant3Ia|antibiotic inactivation|1
VRASLVAKTKLNIMREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSD
IDLLVTVTVRLDETTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKREL
QFGEWQRNDILAGIFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALN
ETLTLWNSPPDWAGDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEA
RQAYLGQEEDRLASRADQLEEFVHYVKGEITKVVGK
>AAB59083.4|FEATURES|argannot|aminoglycoside|Ant3Ia|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGRIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>AAL36430|FEATURES|argannot|aminoglycoside|aadA6/aadA10|antibiotic inactivation|1
MRNTVPAEISVQLSQALNVIEHHLGSTLLAMHLYGSALDGGLKPYSDIDLLVTVTARLDE
SVRQALFVDLLGVSVFPGQSRVLRALEVTIVVHSDIVPWRYPARRELQFGEWQRKDILAG
IFEPATTDVDLAILLTKARQHSLALAGSAAEDFFNPVPESDLFKALADTLKLWNSQPDWI
GDERNVVLTLSRIWYSAATGKIAPKDVAANWVMERLPVQHQPVLLEARQAYLGQGEDCLA
SLTDQLEAFVHFVKHEATKLLGATPMMSKTKLDALST
>CAD99015|FEATURES|argannot|aminoglycoside|aadA11|antibiotic inactivation|1
MREAVTAEISTQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVTVRLNE
ATRQALLNDLLEASAFPGESETLRAIEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
ISEPAMIDVDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLKLWNSQPDWA
GDERNVVLTLSRIWYTEVTGKIVPKDVAADWAMERLPAQHQPVLLEARQAYLGQKEDRLA
SRADQLEEFVHFVKGEITKVVGK
>AAV49760|FEATURES|argannot|aminoglycoside|aadA12|antibiotic inactivation|1
MRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADHLEEFIRFVKGEIIKSVGK
>AAV49321|FEATURES|argannot|aminoglycoside|aadA13|antibiotic inactivation|1
MRDSVTAEISTQLSKVLSVIEHHLEPTLLAVHLYGSAVDGGLKPYSDIDLLVTVTARLDD
TTRRALFNDLLEVSAFPGESEILRAIEVTIVVHEDIMPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLIKALNETLKLWNSQPDWA
GDERNVVLTLSRIWYSAATGKIAPKDVAANWAMEHLPAQHQSVLLEARQAYLGQEEDRSV
LRADKLEEFIHFMKSEITKVLGNDV
>CAI57696|FEATURES|argannot|aminoglycoside|aadA14|antibiotic inactivation|1
MTNKPPESIAEQVSEARSILENHLETIQAIHLFGSAVDGGLKPFSDIDLLVTVGTPLNES
TRAALMSDLLAVSAFPGTDSKRRALEVTVLTQEDVVPWRYPAKRQMQFGEWLRDDINARI
FEPALMDHDLAILLTKVRRHSVALYGPAAHEFFDEIPVVDVQRSLLETLTLWTTEADWKG
DERNIVLALVRIWYTAMTGEITSKVAAADWALQRLPREIKSVVIAARDAYLGLEAADLAA
YPKERADLRNHIHSSVTAKLQ
>ABD58917|FEATURES|argannot|aminoglycoside|aadA15|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADHLEEFIRFVKGEIIKSVGK
>ACK43806|FEATURES|argannot|aminoglycoside|aadA17|antibiotic inactivation|1
MRVAVTIEISNQLSEVLSVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADHLEEFIRFVKGEIIKSVGK
>CAA48308.1|FEATURES|argannot|aminoglycoside|aadA|antibiotic inactivation|1
VTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRR
ALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
AMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDER
NVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRAD
HLEEFIRFVKGEIIKSVGK
>AAN87151|FEATURES|argannot|aminoglycoside|aadA21|antibiotic inactivation|1
MRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGKIAPKDVARDWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>CAK12750|FEATURES|argannot|aminoglycoside|HMPREF9349_04665|antibiotic inactivation|1
MRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVIGK
>ADM53774.1|FEATURES|argannot|aminoglycoside|aadA24|antibiotic inactivation|1
VIAEISTQLLEVLSVIERHLEPTLLAVHLYGSAVNGGLKPYSDIDLLVTVTVRLNETTRR
ALLNDLLEVSTFPGESEALRAIEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
ATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLKLWNSQPDWAGDER
NVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVLLEARQAYLGQEEDRLALHAD
QLEEFVHYVKGESTKVVGK
>AAD54217|FEATURES|argannot|aminoglycoside|aadA6|antibiotic inactivation|1
MSNAVPAEISVQLSLALNAIERHLESTLLAVHLYGSALDGGLKPYSDIDLLVTVAARLDE
TVRQALVVDLLEISASPGQSEALRALEVTIVVHGDVVPWRYPARRELQFGEWQRKDILAG
IFEPATTDVDLAILLTKVRQHSLALAGSAAEDFFNPVPEGDLFKALSDTLKLWNSQPDWE
GDERNVVLTLSRIWYSAATGKIAPKDIVANWAMERLPDQHKPVLLEARQAYLGQGEDCLA
SRADQLAAFVHFVKHEATKLLSAMPVMSNNSFKPTPLRGAA
>AAF44098|FEATURES|argannot|aminoglycoside|aadA7|antibiotic inactivation|1
MSEKVPAEISVQLSQALNVIGRHLESTLLAVHLYGSALDGGLKPYSDIDLLVTVAAPLND
AVRQALLVDLLEVSASPGQNKALRALEVTIVVHSDIVPWRYPARRELQFGEWQRKDILAG
IFEPATTDSDLAILLTKAKQHSVVLAGSAAKDLFSSVPESDLFKALADTLKLWNSPPDWA
GDERNVVLTLSRIWYTAATGKIAPKDVAATWAMARLPAQHQPILLNAKRAYLGQEEDYLP
ARADQVAALIKFVKYEAVKLLGASQ
>AAK69614|FEATURES|argannot|aminoglycoside|aadA8|antibiotic inactivation|1
MRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSVVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKDEITKVVGK
>CAJ13568|FEATURES|argannot|aminoglycoside|aadA8b|antibiotic inactivation|1
MREAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>CAA24595|FEATURES|argannot|bacitracin|uppP|antibiotic inactivation|0
MKERYGTVYKGSQRLIDEESGEVIEVDKLYRKQTSGNFVKAYIVQLISMLDMIGGKKLKI
VNYILDNVHLSNNTMIATVREIAEGTNTSTKTVNTTLKILEEGNIIKRRTGALMLNPELL
MRGDDQKQKYLLLEFGNFEQEDDQKQENALSEYYSFKE
>CAD12230.1|FEATURES|argannot|aminoglycoside|aadA9|antibiotic inactivation|1
MSNSIHTGISRQLSQARDVIKRHLASTLKAIHLYGSAIDGGLKPYSDIDLLVTVDARLDE
ATRRSLMLDFLNISAPPCESSILRPLEVTVVACNEVVPWRYPARRELQFGEWLREDILEG
VFEPAALDADLAILITKARQHSIALVGPVAQKVFMPVPEHDFLQVLSDTLKLWNTHEDWE
NEERNIVLTLARIWYSTETGGIVPKDVAAEWVLERLPAEHKPILVEARQAYLGLCKDSLA
LRADETSAFIGYAKSAVADLLEKRKSQTSHICDGAKNV
>AAA16527.1|FEATURES|argannot|aminoglycoside|aad9|antibiotic inactivation|1
MRRIYLNTYEQINKVKKILRKHLKNNLIGTYMFGSGVESGLKPNSDLDFLVVVSEPLTDQ
SKEILIQKIRPISKKIGDKSNLRYIELTIIIQQEMVPWNHPPKQEFIYGEWLQELYEQGY
IPQKELNSDLTIMLYQAKRKNKRIYGNYDLEELLPDIPFSDVRRAIMDSSEELIDNYQDD
ETNSILTLCRMILTMDTGKIIPKDIAGNAVAESSPLEHRERILLAVRSYLGENIEWTNEN
VNLTINYLNNRLKKL
>AAF85647.1|FEATURES|argannot|aminoglycoside|AadD|antibiotic inactivation|1
MRIVNGPIIMTREERMKIVHEIKERILDKYGDDVKAIGVYGSLGRQTDGPYSDIEMMCVM
STEEAEFSHEWTTGEWKVEVNFDSEEILLDYASQVESDWPLTHGQFFSILPIYDSGGYLE
KVYQTAKSVEAQTFHDAICALIVEELFEYAGKWRNIRVQGPTTFLPSLTVQVAMAGAMLI
GLHHRICYTTSASVLTEAVKQSDLPSGYDHLCQFVMSGQLSDSEKLLESLENFWNGIQEW
TERHGYIVDVSKRIPF
>CCC83993.1|FEATURES|argannot|aminoglycoside|aadE|antibiotic inactivation|1
MRSEPEMMNMLVKFAMNDKRIRLVTMEGSRTNFNVPPDSFQDYDISYFVTDMDSFKESDQ
WLNVFGDRLMMQKPEDMELFPSELGNWFSYIILFEDGNKLDLTLIPINEVEDYFTNSDGL
VEVLLDKDVLIQEEVIANDHQYWIKKPTAREFDDCCNEFWMVSTYIVKGLARKEILFAID
HLNEIARPNLLRMMAWKIGSEQGYTFSVGKNYKFINQYLPNEDWKSLLSTYSENGYQEMW
QSLLTCYSLFRTYAKAVASSLKYEYPEYDEAITRYTVNIYNSLN
>AEI42793|FEATURES|argannot|aminoglycoside|aadK|antibiotic inactivation|1
MKPVGTEEYCLRSEHEMMSTIINFAKNDDRIRLATLEGSRTNKNIPVDTFRDYDISYFVT
DIESFKETDQWLEFFGNRLMMQKPEDMELFPSELGNWFSYIILFEDGNKLDLTLIPINEV
GDYFTKNDGLVEVLLDKDTLINNEVIADDRQYWIKKPTARAFDDCCNEFWMVSTYVVKGL
ARKEILFAIDHLNEIGRPNLLRMMAWQIGSEHGYTFSVGKNYKFINRYLPNEDWEKLLST
YSENGYQEMWQSLLTCYELFRKYSKAVSESLGYTYPDYDEAITKYTENIYSSLVI
>AAA25717|FEATURES|argannot|aminoglycoside|ANT(4')-IIa|antibiotic inactivation|1
MHLTITYWIDRLREAYPHAVAILLKGSYARGEASAWSDIDFDVLVSDEEVEEYRTWIEPV
GERLVHISVAVEWVTGWERDSADPSSWSYGLPTQETTQLLWAADENIRRRLDRPFKVHPA
AEPEVEDTVEALGKIRNAMVRGDDLAVYQAAQVVGKLIPTLLVPINPPTYARFAREAIDR
ILAFPNVPEGFAADWLTCMGLVDRRTHDPQPTRPNEWCAARSRFCRRMRTSSVRISRGCW
KQDWYLRISART
>AAM76670|FEATURES|argannot|aminoglycoside|ANT(4')-IIb|antibiotic inactivation|1
VQHTIARWVDRLREEYADAVAILLKGSYARGDAATWSDIDFDVLVSTQDVEDYRTWIEPV
GDRLVHISAAVEWVTGWERDTVDPSSWSYGLPTQETTRLMWAINDETRRRMDRPYKTHPA
AEPEVENTVEALGKIRNAIARGDDLGVYQSAQTVAKLVPTLLIPINPPVTVSHARQAIEA
ILAFPRVPVGFAADWLTCLGLVEERSARSTAAAAERMVRGVLEMLPTDPDLLGEDIARLM
NAGLLEKYVQQ
>CAD44606.1|FEATURES|argannot|aminoglycoside|ANT(4')-Ia|antibiotic inactivation|1
MNMNGPASMAQKERLQTCQEIAKRLHEVYGNDVLAIGVYGSVSRGTDGPFSDIEMFCVLR
DSAETVDKSYEWSAGPWKAEVNVCSASILLKDAATVEDRWPLTHGPYFSPLRLYDPEGFF
QRLRLAAESPTKEDFRQAIHEILVGEMYEYVGKLRNVNRNGPSTYLPSLALRFAHYGAML
IGLHNQTLFSTGAMVLPEALKLPHRPKGFDHVAELAMSGDLAQPAKIVSACEDFWKGLVA
WAAEHDYVIHSKRIPF
>AAK62560|FEATURES|argannot|aminoglycoside|aad(6)|antibiotic inactivation|1
MRSEKEMMDLVLSLAEQDERIRIVTLEGSRANINIPKDEFQDYDITYFVSDIEPFISNDD
WLNQFGNIIMMQKPEDMELFPPEEKGFSYLMLFDDYNKIDLTLLPLEELDNYLKGDKLIK
VLIDKDCRIKRDIVPTDIDYHVRKPSAREYDDCCNEFWNVTPYVIKGLCRKEILFAIDHF
NQIVRHELLRMISWKVGIETGFKLSVGKNYKFIERYISEDLWEKLLSTYRMDSYENIWEA
LFLCHQLFRAVSGEVAERLHYAYPEYDRNITKYTRDMYKKYTGKTGCLDSTYAADIEERR
EQ
>AAG13458|FEATURES|argannot|aminoglycoside|APH(2'')-IIa|antibiotic inactivation|1
MVNLDAEIYEHLNKQIKINELRYLSSGDDSDTFLCNEQYVVKVPKRDSVRISQKREFELY
RFLENCKLSYQIPAVVYQSDRFNIMKYIKGERITYEQYHKLSEKEKDALAYDEATFLKEL
HSIEIDCSVSLFSDALVNKKDKFLQDKKLLISILEKEQLLTDEMLEHIETIYENILNNAV
LFKYTPCLVHNDFSANNMIFRNNRLFGVIDFGDFNVGDPDNDFLCLLDCSTDDFGKEFGR
KVLKYYQHKAPEVAERKAELNDVYWSIDQIIYGYERKDREMLIKGVSELLQTQAEMFIF
>AAB49832|FEATURES|argannot|aminoglycoside|APH(2'')-IIIa|antibiotic inactivation|1
MKQNKLHYTTMIMTQFPDISIQSVESLGEGFRNYAILVNGDWVFRFPKSQQGADELNKEI
QLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMAVFPDDAKDRLALQL
AEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYM
THPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISDPDYDYVYLLEDCGE
LFTRQVMAYRGEVDLDTHIRKVSLFVTFDQVSYLLEGLRARDQDWISEGLELLEEDKANN
FGANSA
>AAX38178|FEATURES|argannot|aminoglycoside|APH(2'')-Ie|antibiotic inactivation|1
MTTYTFDQVEEAIEQLYPDFTINTIEISGEGNDCIAYEINGNFIFKFPKHSRASINLLNE
VTVLKTIHNELSLPIPEVVFTGMPSEMCQMSFAGFTKIKGVPLTPLLLKNLPKQSQDQAA
KDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGHQMKKVDDFYRDI
LDNEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEY
GMEFVSKILNHYKHKDIPTVLEKYMMKEKYWSFEKIIYGKEYGYMDWYEEGLNEIRSIKI
K
>ACN81017|FEATURES|argannot|aminoglycoside|APH(3')-Ia|antibiotic inactivation|1
MSHIQRETSCSRPRLNSNLDADLYGYRWARDNVGQSGATIYRLYGKPNAPELFLKHGKGS
VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENI
VDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK
EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFS
PSLQKRLFQKYGIDNPDMNKLQFHLMLDEFF
>BAF93086|FEATURES|argannot|aminoglycoside|strA|antibiotic inactivation|1
LNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKG
RGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLSVDQC
PFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDMVV
CHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAV
LFNVLGIEAPDRERLAFYLRLDPLTWG
>CAA24789.1|FEATURES|argannot|aminoglycoside|APH(3')-IIIa|antibiotic inactivation|1
MAKMRISPELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVERE
KDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIR
LFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKP
EEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRADKWYDIAFCVRSIREDIGEEQYVEL
FFDLLGIKPDWEKIKYYILLDELF
>CAA62365|FEATURES|argannot|aminoglycoside|APH(3')-IIb|antibiotic inactivation|1
MHDAATSMPPQAPSTWADYLAGYRWRGQGEGCSAATVHRLEAARRPTLFVKQEVLSAHAE
LPAEIARLRWLHGAGIDCPQVLNETQSDGRQWLLMSAMPGDTLSALAQRDELEPERLVRL
VAAALRRLHDLDPAACPFDHRLERRLDTVRQRVEAGLVDEADFDDDHRGRSATELYRLLL
DRRPAVEDLVVAHGDACLPNLLAEGRRFSGFIDCGRLGVADRHQDLALAARDIEAELGAA
WAEAFLVEYGGDIDGERLAYFRLLDEFF
>ADQ43421|FEATURES|argannot|aminoglycoside|APH(3')-IIc|antibiotic inactivation|1
MEASNPFTDGLRLPRAWQEALADAHIERQSIGVSRADVARVHRPGQTDAFLKSEVIDAFS
ELGDEIARLRWLQAQGQSAPTVIATTEEGGRRWLLMSALPGRDLASSPELAPRRVAELLA
DALRGLHAVPVANCPFDQQLASRLQAAQARVEAGLVDADDFDDERLGQSPQQVFAELRAT
RPAHEDLVVSQGDACLPNLTVTDGRFTGFIDCGRLGVADRYQDLALAARSLVHNFGESRC
VAALFQRYGAVPDERRLAFYRLLDEFF
>CAA27061|FEATURES|argannot|aminoglycoside|APH(3')-IVa|antibiotic inactivation|1
MNESTRNWPEELLELLGQTELTVNKIGYSGDHVYHVKEYRGTPAFLKIAPSVWWRTLRPE
IEALAWLDGKLPVPKILYTAEHGGMDYLLMEALGGKDGSHETIQAKRKLFVKLYAEGLRS
VHGLDIRECPLSNGLEKKLRDAKRIVDESLVDPADIKEEYDCTPEELYGLLLESKPVTED
LVFAHGDYCAPNLIIDGEKLSGFIDLGRAGVADRYQDISLAIRSLRHDYGDDRYKALFLE
LYGLDGLDEDKVRYYIRLDEFF
>AES85952|FEATURES|argannot|aminoglycoside|APH(3')-Ia|antibiotic inactivation|1
MSHIQRETSCSRPRLNSNMDADLYGYKWARDNVGQSGATIYRLYGKPDAPELFLKHGKGS
VANDVTDEMVRLNWLTEFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENI
VDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK
EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFS
PSLQKRLFQKYGIDNPDMNKLQFHLMLDEFF
>CAA88266.1|FEATURES|argannot|aminoglycoside|Aph3Ic|antibiotic inactivation|1
MSEWRRQQVCAPIPMPASMATSLEGYQWAPITIGESGSNVYRLYGKPKAPDLFLKRGKYD
VADDVTDEMVRLRWLAERIPVPTVVNFVRTLDEAWLLTTAMPGRTVYEELEANPDACLAI
ADALADFLRRLHEIPTIECPFNSNHIYRLALARKRIEAGMVEVDDFDDERKGWAAEQVWD
AMHNLLPFTPDPVTTHGDSALENLFVREGKVTGCIDVGRSGVADRYQDIAILWNRLGEFG
SLPQERFVEQYGIADVDRRKLSFHLMLDELF
>AAG11411|FEATURES|argannot|aminoglycoside|AC230_04535|antibiotic inactivation|1
MDDALRALRGRYPGCEWVVVEDGASGAGVYRLRGGGRELFVKVAALGAGVGLLGEAERLV
WLAEVGIPVPRVVEGGGDERVAWLVTEAVPGRPASARWPREQRLDVAVALAGLARSLHAL
DWERCPFDRSLAVTVPQAARAVAEGSVDLEDLDEERKGWSGERLLAELERTRPADEDLAV
CHGDLCPDNVLLDPRTCEVTGLIDVGRVGRADRHSDLALVLRELAHEEDPWFGPECSAAF
LREYGRGWDGAVSEEKLAFYRLLDEFF
>AAA76822|FEATURES|argannot|aminoglycoside|APH(3')-VIIa|antibiotic inactivation|1
MKYIDEIQILGKCSEGMSPAEVYKCQLKNTVCYLKKIDDIFSKTTYSVKREAEMMMWLSD
KLKVPDVIEYGVREHSEYLIMSELRGKHIDCFIDHPIKYIECLVNALHQLQAIDIRNCPF
SSKIDVRLKELKYLLDNRIADIDVSNWEDTTEFDDPMTLYQWLCENQPQEELCLSHGDMS
ANFFVSHDGIYFYDLARCGVADKWLDIAFCVREIREYYPDSDYEKFFFNMLGLEPDYKKI
NYYILLDEMF
>AEK25612|FEATURES|argannot|aminoglycoside|T630_4108|antibiotic inactivation|1
MELPNIIQQFIGNSVLEPNKIGQSPSDVYSFNRNNETFFLKRSSTLYTETTYSVSREAKM
LSWLSEKLKVPELIMTFQDEQFEFMITKAINAKPISALFLTDQELLAIYKEALNLLNSIA
IIDCPFISNIDHRLKESKFFIDNQLLDDIDQDDLDTELWGDHKTYLSLWNELTETRVEER
LVFSHGDITDSNIFIDKFNEIYFLDLGRAGLADEFVDISFVERCLREDASEETAKIFLKH
LKNDRPDKRNYFLKLDELN
>AAB03856|FEATURES|argannot|aminoglycoside|AC230_04535|antibiotic inactivation|0
MSPPSPVLKNFEAWTMRCVHCGVGIPVVSGLLWRMGPRGLVFIGFGVVGGSCLSRWQLWG
PGWAWVRLSGWCGWRRWGFPYLVLWRVVGTRGSPGWSPKRFRGVRPVRGGRGSSGWTWRW
RSRGSLVRCTALDWERCPFDRSLAVTVPQARAVAEGSVDLEDLTRSGRGGRGSGFSPSWS
GLGLRTRISVCHGDLCPDNVLLDPRTCEVTGLIDWGGSAVRTGTPISRGAGVARAARVGR
GRCNRRKSCVYRLLDEFF
>AAC32025|FEATURES|argannot|aminoglycoside|APH(3')-Vb|antibiotic inactivation|1
MESTLRRTYPHHTWHLVNEGDSGAFVYRLTGHGPELYAKIAPRTPENSAFHLDGEADRLD
WLARHGISVPRVVERGADDTTAWLVTEAVPGAAASEEWPEDERAAVVDAIAEMARTLHEL
PVSECPFDRRLDVTGEARHNVREGLVDLDDLQEEPAGWTGDQLLAELDLTRPEKEDLVVC
HGDLCPNNVLLDPETHRITGLIDVGRLRLATCHADLALAARELAIDEDPWFGPAYAERFL
ERYGAHHVDQEKMAFYQLLDEFF
>AAB21326|FEATURES|argannot|aminoglycoside|APH(3')-Vc|antibiotic inactivation|1
MYAMLRRKYQHYEWTSVNEGDSGASVYRLAGQQPELYVKFAPREPENSAFDLAGEADRLT
WLTRHGIPVPCIVECGGDDTSVFLVTEAVTGVSAAEEWPEHQRFAVVEAMADLARTLHEL
PVGGCPFDRSLAVTVAEARHNLREGLVDLDDLQEEHANWSGDQLLAELDRTRPEKEDLVL
CHGDLCPNNVLLDPETCRVTGMIDVGRLGRADRHADLALAARELEIDEDPWFGPEYAQRF
LERYGAHHVDENKMAFYQLLDEFF
>CAD91341|FEATURES|argannot|aminoglycoside|APH(3')-IIa|antibiotic inactivation|1
MTVALDEVSELKNLLSPLLDECTFEEVEYGQSDARVIRVLFPDRNTAYLKYASGSSAQEI
LQEHQRTRWLRTRALVPEVISYVSTSTVTILLTKALIGHNAADAADADPVIVVAEMARAL
RDLHSISPDDCPFDERLHLRLKLASGRLEAGLVDEEDFDHARQGMLARDVYEQLFIQMPG
AEQLVVTHGDACPENFIFQGNAFVGFIDCGRVGLADKYQDLALASRNIDAVFGPELTNQF
FIEYGEPNPNIAKIEYYRILDEFF
>AAX82592|FEATURES|argannot|aminoglycoside|APH(6)-Ia|antibiotic inactivation|1
MSSSDHIHVPDGLAESYSRSGGEEGRAWIAGLPALVARCVDRWELKRDGGVRSGEASLVV
PVLRADGTRAALKLQMPREETTAALIGLRAWGGDGMVRLLDHDEESSTMLLERLDGSRTL
ASVEDDDEAMGVLAGLLNRLHSVPAPPGLRGLGEIAGAMVEEVPSAVDSLADPEDRSRLR
GWASAVAELVGEPGDRVLHWDLHYENVLAAEREPWLAIDPEPLVGDPGFDLWPALDTGWE
RIEATGDARRVVRRRFDLLTEALELDRGRAAGWTLARLLQNTLWDIEDGLTAIAPSQIAV
AEALAKP
>CAA29136|FEATURES|argannot|aminoglycoside|APH(6)-Ib|antibiotic inactivation|1
MSTSKLVEIPEPLAASYARAFGEEGQAWIAALPALVEELLDRWELTADGASASGEASLVL
PVLRTDGTRAVLKLQLPREETSAAITGLRTWNGHGVVRLLDHDPRSSTMLLERLDASRTL
ASVEDDDAAMGVLAGLLARLVSVPAPRGLRGLGDIAGAMLEEVPRAVAALADPADRRLLN
DWASAVAELVGEPGDRMLHWDLHYGNVLAAEREPWLAIDPEPLAGDPGFDLWPALDSRWD
DIVAQRDVVRVVRRRFDLLTEVLGLDRARAAGWTYGRLLQNALWDIEDGSAALDPAAVTL
AQALRGH
>EFI05284|FEATURES|argannot|aminoglycoside|APH(4)-Ia|antibiotic inactivation|0
MKSDYSKESITEFLSRKYGEDIRLFPIKEGQESQAYWFSRGGREYVVRINSNMEGFKKDK
YAYEHFRSDRVPIPEVVETGNFDGTHYFCISVKADGITYEDSDEETVVRLLGDITDVTEA
ISRTDISGTSGCGVFDSDTGNAPFYSWREYLAEVFERDWTAVSRSYVNLSLIDELLAAYR
ELISYCPEERALFHGDFGSNNVIVGKKSRISGVIDWDCAAYGDFLYDIATAYFWRTWLMC
MEKTAAYWERKYSHLPRYTERILCYELRIGLTEIYENAVENDTETTEWLQNRCREILREY
RQRKA
>AAD45541|FEATURES|argannot|aminoglycoside|APH(6)-Ib|antibiotic inactivation|0
MDTSKAIEVPEHLAASYSRGFGEEGRAWIAALPTLAAAFLDRWELRRDGAARAGEASLVL
PVLRQDGTRAVLKLQMPREETTAALIGLCTWNGAGTVRLLDHDPHSSTMLLERLDSARTL
ASLEDDDVAMGILAELLARLVSVPAPRELRRLKDIAADMLERVPRAVTALADPADRQLLR
GWAAAVAELIEEPGDQMLHWDLHYDNVLAAEREPWLAIDPEPLAGDPGFDLWPALDSRWD
DIVATGDTRRVVRRRFDLLTGVLGLDRGRAAGWTLGRLLQNELWDIEGGGSALAPSSVAM
AEALQNR
>AAP50754|FEATURES|argannot|aminoglycoside|rmtB|antibiotic target alteration|1
MDKNDVVKKILESKKYENLDSDIVEKVVSISEKKYKLKEVENYSKKKLHQIWGSYYSAYP
NWDKLLKKYNQGQLSIEDLLKIHSSTNERVATLNDFYTYVFGNIKHVSSILDFGCGFNPL
ALYQWNENEKIIYHAYDIDRAEIAFLSSIIGKLKTTIKYRFLNKESDVYKGTYDVVFLLK
MLPVLKQQDVNILDFLQLFHTQNFVISFPIKSLSGKEKGMEENYQLWFESFTKGWIKILD
SKVIGNELVYITSGFQK
>BAU61743|FEATURES|argannot|aminoglycoside|npmA|antibiotic target alteration|1
LLILKGTKTVDLSKDELTEIIGQFDRVHIDLGTGDGRNIYKLAINDQNTFYIGIDPVKEN
LFDISKKIIKKPSKGGLSNVVFVIAAAESLPFELKNIADSISILFPWGTLLEYVIKPNRD
ILSNVADLAKKEAHFEFVTTYSDSYEEAEIKKRGLPLLSKAYFLSEQYKAELSNSGFRID
DVKELDNEYVKQFNSLWAKRLAFGRKRSFFRVSGHVSKH
>BAD12551|FEATURES|argannot|aminoglycoside|rmtA|antibiotic target alteration|1
MSFDDALASILSSKKYRSLCPDTVRRILDQEWGRHKSPKLAVEATRTRLHGICGAYVTPE
SLKAAAAALSVGDVQKALSLHASTKERLAELDCLYDFIFSGGVPHRVLDIACGLNPLALF
IRDITSVWACDIHQGLGDVITPFAHHQGLDFTFALQDVMCTPPTETGDLALVFKLLPLLE
REQAGAAMALLQALATPRIAVSFPTRSLGGRGKGMEANYSAWFEGALPDEFEIEDTKTIG
IELVYMIKRNK
>BAC81971.1|FEATURES|argannot|aminoglycoside|rmtB|antibiotic target alteration|1
MNINDALTSILASKKYRALCPDTVRRILTEEWGRHKSPKQTVEAARTRLHGICGAYVTPE
SLKAAAAALSAGDVKKALSLHASTKERLAELDTLYDFIFSAETPRRVLDIACGLNPLALY
ERGIASVWGCDIHQGLGDVITPFAREKDWDFTFALQDVLCAPPAEAGDLALIFKLLPLLE
REQAGSAMALLQSLNTPRMAVSFPTRSLGGRGKGMEANYAAWFEGGLPAEFEIEDKKTIG
TELIYLIKKNG
>AFC75738|FEATURES|argannot|aminoglycoside|rmtB|antibiotic target alteration|1
MNINDALTSILASKKYRALCPDTVRRILTEEWGRHKSPKQAVEAARTRLHGICGAYVTPE
SLKAAAAALSAGDVKKALSLHASTKERLAELDTLYDFIFSAETPRRVLDIACGLNPLALY
ERGVASVWGCDVHQGLGDVITPFAREKDWDFTFALQDVLCAPPAETGDLALIFKLLPLLE
REQAGSAMALLQSINTPRMAVSFPTRSLGGRGKGMEANYAAWFEGGLPTEFEIEDKKTIG
TELIYLIKKNG
>BAE48305|FEATURES|argannot|aminoglycoside|rmtC|antibiotic target alteration|1
MKTNDNYIEEVTAKVLTSGKYSTLYPPTVRRVTERLFDRYPPKQLEKEVRKKLHQAYGAY
IGGIDGKRLEKKIEKIIHEIPNPTTDEATRTEWEKEICLKILNLHTSTNERTVAYDELYQ
KIFEVTGVPTSITDAGCALNPFSFPFFTEAGMLGQYIGFDLDKGMIEAIEHSLRTLNAPE
GIVVKQGDILSDPSGESDLLLMFKLYTLLDRQEEASGLKILQEWKYKNAVISFPIKTISG
RDVGMEENYTVKFENDLVGSDLRIMQKLKLGNEMYFIVSRL
>ABJ53409|FEATURES|argannot|aminoglycoside|rmtD|antibiotic target alteration|1
MSELKEKLLASKKYRDVCPDTIERIWRECSAKFKKEKDVDKAAREALHGVTGAFMTEREY
KRAMEMAAARDWEALLGMHASTRERLPVESMDRVFDQLFEASGTPARILDLACGLNPVYL
AHRLPNAAITGVDISGQCVNVIRAFGGAEARLGDLLCEIPEDEANAALLFKVLPLLERQR
AGAAMDALMRVNAEWIVASFPTRSLGGRNVGMEKHYSEWMEAHVPENRAIAARLTGENEL
FYVLKRK
>ADW66527|FEATURES|argannot|aminoglycoside|rmtD|antibiotic target alteration|1
MSELKEKLLASKKYRDVCPDTIERIWRECSAKFKKEKDADKAAREALHGVTGAFMTEREY
KRAMELAATRDWEALLGMHASTRERLPVESMDRVFDQLFEAIGTPARILDLACGLNPVYL
AHRLPNAAIAGVDISGQCVNVIRAFGGAEARLGDLLCEIPEDEADAALMFKVLPLLERQR
TGAAMEALMRVNAEWIVASFPTRSLGGRNVGMEKHYSEWMEAHVPENRAIAARLTGENEL
FYVLKRK
>ADA63498|FEATURES|argannot|aminoglycoside|rmtB|antibiotic target alteration|1
MNIDEMVAEVLSSKKYTSVDPAVVRRVCMETAPKYPKKKEAIKAVKNELHIIHEVFLQNE
CYKNALSFLSQLSLDFNNAQLIDITMQIMQSHTSTKERLGDIEAVCSFLSTHISKEGSVM
DIGCGFNPFALPLLHEFPATYYAYDICSEGINILNKYFSILKKGEYRAELLDAVSVTPKE
KVDVALLFKLLPLLQQQKKGRGFSILEELDFDKAIVSFPIKSLGGKQKGMETFYSNLFEE
NLPSSLEIIEKQTFSNEMFYVIQNKTKNGGNQS
>AFJ11385|FEATURES|argannot|aminoglycoside|rmtF|antibiotic target alteration|1
MDERAQAALDALLSAKNLRDVCPETVRRVFMELLPRYRKPKDAEKAARTHLHQITGAFMT
ADAQKKARALLARWNEGDESALAAALSLHASTRERLPGADEWMRRVSPFLGADARVLDLA
CGLNPILLGSMGVTNALGMDIHLGCVRLVNETARARGWHTRARACDLLSEIPAEEADAAL
LMKLLPVLEAQKTGRAAELLASLRAPRLVVTFPTRTLGGRGVGMEKHYADWFERILPDTL
SVRDRFTVSDELVYLVERT
>AGE00988|FEATURES|argannot|aminoglycoside|rmtG|antibiotic target alteration|1
MRDPLFEKLAASKKYRDVCPDTIARILTECRAKYRREKEIDKAAREKLHGITAAFMTDAE
YRRAMEIAVRGGELAELMECHASTRERLPLEETDAVYARLLGAPDESALDLACGLNPAYL
QNRYPEMRVTGIDISGQCVRVLRALGVDARLGDLLAENAIPRARYSVALLFKILPLLDRQ
SAGAARRILEAVNADALICSFPTRSLSGRNVGMAVHYAAWMRDQLPEKWRIERTVETDNE
LYYVLKEKQDGEAVRGGDSHRESE
>AGH19769|FEATURES|argannot|aminoglycoside|rmtH|antibiotic target alteration|1
MTIEQAAADILSSKKYQLLCPDTVVRILTQEWGRHKKPKQAVERTRERLHGICGAYLAPQ
VEKQASTALAAGDVQKALALHASTRERLDTYPQLYQFVFENNLPARVLDIACGLNPLMLH
RQGVASVWGCDIHQGLGNVLTPYAQKHGWDFTFALHDVLCAPVAASGDMALVFKLLPLLE
REQPGAALALLRTLDAPVICVSFPTRSLGGRGKGMHQHYATWFEGLVAPHFTVQHHTLIG
DELLYRIQPNPA
>CAA35921.1|FEATURES|argannot|streptothricin|sat-1|antibiotic inactivation|1
MKISVIPEQVAETLDAENHFIVREVFDVHLSDQGFELSTRSVSPYRKDYISDDDSDEDSA
CYGAFIDQELVGKIELNSTWNDLASIEHIVVSHTHRGKGVAHSLIEFAKKWALSRQLLGI
RLETQTNNVPACNLYAKCGFTLGGIDLFTYKTRPQVSNETAMYWYWFSGAQDDA
>CAC29201|FEATURES|argannot|aminoglycoside|sat-4|antibiotic inactivation|1
VITEMKAGHLKDIDKPSEPFEVIGKIIPRYENENWTFTELLYEAPYLKSYQDEEDEEDEE
ADCLEYIDNTDKIIYLYYQDDKCVGKVKLRKNWNRYAYIEDIAVCKDFRGQGIGSALINI
SIEWAKHKNLHGLMLETQDNNLIACKFYHNCGFKIGSVDTMLYANFENNFEKAVFWYLRF
>CAA26428.1|FEATURES|argannot|aminoglycoside|aad9Ib|antibiotic inactivation|1
MSNLINGKIPNQAIQTLKIVKDLFGSSIVGVYLFGSAVNGGLRINSDVDVLVVVNHSLPQ
LTRKKLTERLMTISGKIGNTDSVRPLEVTVINRSEVVPWQYPPKREFIYGEWLRGEFENG
QIQEPSYDPDLAIVLAQARKNSISLFGPDSSSILVSVPLTDIRRAIKDSLPELIEGIKGD
ERNVILTLARMWQTVTTGEITSKDVAAEWAIPLLPKEHVTLLDIARKGYRGECDDKWEGL
YSKVKALVKYMKNSIETSLN
>AAK68631|FEATURES|argannot|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSVSSRFPPEVTAWMERWRLLRDGELLTTHSSWILPVRQGDMPAMLKVARIPDEEAGYRL
LTWWDGQGAARVFASAAGALLMERASGAGDLAQIAWSGQDDEACRILCDTAARLHAPRSG
PPPDLHPLQEWFQPLFRLAAEHAALAPAASVARQLLAAPREVCPLHGDLHHENVLDFGDR
GWLAIDPHGLLGERTFDYANIFTNPDLSDPGRPLAILPGRLEARLSIVVATTGFEPERLL
RWIIAWTGLSAAWFIGDGDGEGEGAAIDLAVNAMARRLLD
>CAA63519.1|FEATURES|argannot|aminoglycoside|str|antibiotic inactivation|1
MRTEKEILNLVSEFAYQRSNVKIIALEGSRTNENIKKDKFQDYDFAFFVSDIECFTHEES
WLSLFGELLFIQKPEDMELFPPDLDYGYSYIMYFKDGIKMDITLINLKDLNRYFSDSDGL
VKILVDKDNLVIQEIVPDDSNYWLKKPTEREFYDCCNEFWSVSTYVAKGVFRREILFALD
HFNNILRPELLRMISWYIGFNRGFDFSLGKNYKFINKYLTDKEFNMFLATFEMNGYRKTY
QSFKLCCELFKYYSNKVSCLGNYNYPNYEKNIENFIRNNYEN
>X57709|FEATURES|argannot|aminoglycoside|APH(3')-IIa|antibiotic inactivation|1
MIEQDGLHAGSPAAWVERLFGYDWAQQTIGCSDGAVFRLSAQGRPVLFVKTDLSGALNEL
QDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSHLAPAEKVSIMADAM
RRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPD
GEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVADRYQDIALATRDIAEELGGEWADRF
LVLYGIAAPDSQRIAFYRLLDEFF
>AAA26412|FEATURES|argannot|aminoglycoside|APH(3')-Ib|antibiotic inactivation|1
VNDIDREEPCAAAAVPESMAAHVMGYKWARDKVGQSGCAVYRLHSKSGGSDLFLKHGKDA
FADDVTDEMVRLRWLAGHISVPSVVSFVRTPNQAWLLTTAIHGKTAYQVLKSDFGARLVV
VDALAAFMRRLHAIPVSECSVQQWTTHAGLPERGSIEAGVVDVDDFDKEREGWTAEQVWE
AMHRLLPLAPDPVVTHGDFSLDNLLIVEGKVVGCIDVGRAGIADRYQDLAVLWNCLEEFE
PSLQERLVAQYGIADPDRRKLQFHLLLDELF
>CCJ25600|FEATURES|argannot|aminoglycoside|APH(9)-Ib|antibiotic inactivation|0
VDELEQFYQLGWTLDSAGGASGEAYMAEQDGQKLFLKRNSNPFIAALSAEGIVPKLVWTK
RIETGEVVTAQHWKNGRELSSNEMKQTRVAHLLKKIHNSRPLLSMLKRMEMEPITPEIML
NKINASLSREVLTHHIVRKSLTYLEEHIPSLDSRFFTVVHGDVNHNNWLLSDRDELFLVD
WEGAMIADPAIDIGMLLYNYVPQQQWSEWLETYGVQESLNLNKRMKWYTVIQSIGLVQWY
EEQKRYKDMNTWLKFLNEVMNSNMFI
>AKP24019.1|FEATURES|argannot|aminoglycoside|aph(3')-Ic|antibiotic inactivation|1
MSHIQRETSCSRPRLNSNLDADLYGYRWARDNVGQSGATIYRLYGKPNAPELFLKHGKDS
VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENI
VDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK
EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFS
PSLQKRLFQKYGIDNPDMNKLQFHLMLDEFF
>AKP24021.1|FEATURES|argannot|aminoglycoside|aph(3'')-Ib|antibiotic inactivation|1
MGQQLGAVHSLSVDQCPFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVE
RELPVRLDQERTDMVVCHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANA
EENWAAPDEAERAFAVLFNVLGIEAPDRERLAFYLRLDPLTWG
>AKP24022.1|FEATURES|argannot|aminoglycoside|APH(6)-Id|antibiotic inactivation|1
MFMPPVFPAHWHVSQPVLIADTFSSLVWKVSLPDGTPAIVKGLKPIEDIADELRGADYLV
WRNGRGAVRLLGRENNLMLLEYAGERMLSHIVAEHGDYQATEIAAELMAKLYAASEEPLP
SALLPIWDRFAALFQRARDDQNAGCQTDYVHAAIIADQMMSNASELRGLHGDLHHENIMF
SSRGWLVIDPVGLVGEVGFGAANMFYDPADRDDLCLDPRRIAQMADAFSRALDVDPRRLL
DQAYAYGCLSAAWNADGEEEQRDLAIAAAIKQVRQTSY
>BAJ42218.1|FEATURES|argannot|beta_lactam|CMY-34|antibiotic inactivation|0
LKRSLLFSAVLCAASLTSVHAAQPITEPEFASDIVDRYADHIFYGSGATGMALVVIDGNQ
RVFRSYGETRPGNNVRPQLDSVVRIASLTKLMTSEMLVKLLDQGTVKLNDPLSKYAPPGA
RVPTYNGTPITLVNLATHTSALPREQPGGAAHRPVFVWPTREQRWKYLSTAKLKAAPGSQ
AAYSNLAFDLLADALANASGKPYTQLFEEQITRPLGMKDTTYTPSPDQCRRLMVAERGAS
PCNNTLAAIGSGGVYSTPGDMMRWMQQYLSSDFYQRSNQADRMQTLIYQRAQFTKVIGMD
VPGKADALGLGWVYMAPKEGRPGIIQKTGGGGGFITYMAMIPQKNIGAFVVVTRSPLTRF
KNMSDGINDLVTELSGNKPLVIPAS
>AFC91828|FEATURES|argannot|beta_lactam|pbp1a|antibiotic target alteration|0
MNKPTILHLIKYLSISFLSLVIAAIVLGGGVFFYYVSKAPSLSESKLVATTSSKIYDNKN
QLIADLGSERRVNAQANDIPTDLVKAIVSIEDHRFFDHRGIDTIRILGAFLRNLQSNSLQ
GGSTLTQQLIKLTYFSTSTSDQTISRKTQEAWLAIQLEQKATKQEILTYYINKVYMSNGN
YGMQTAAQNYYGKDLNNLSLPQLALLAGMPQAPNQYDPYSHPEAAQDRRNLVLSEMKNQG
YISAEQYEKAVNTPITDGLQSLKSASNYPAYMDNYLKEVINQVEKETGYNLLTTGMDVYT
NVDQEAQKHLWDIYNTDEYVAYPDDELQVASTIVDVSNGKVIAQLGARHQSSNVSFGINQ
AVETNRDWGSTMKPITDYAPALEYGVYDSTATIVHDEPYNYPGTNTPVYNWDRGYFGNIT
LQYALQQSRNVPAVETLNKVGLNRAKTFLNGLGIDYPSIHYSNAISSNTTESDKKYGASS
EKMAAAYAAFANGGTYYKPMYIHKVVFSDGSEKEFSNVGTRAMKETTAYMMTDMMKTVLS
YGTGRNAYLAWLPQAGKTGTSNYTDEEIENHIKTSQFVAPDELFAGYTRKYSMAVWTGYS
NRLTPLVGNGLTVAAKVYRSMMTYLSEGSNPEDWNIPEGLYRNGEFVFKNGARSTWTQPA
PQQPPSTESSSSSSDSSTSQSSSTTPSTNNSTTTDPNNNTQQSNTTPDQQNQNPQPAQP
>AAF04736|FEATURES|argannot|beta_lactam|pbp1b|antibiotic target alteration|0
MQNQLNELKRKMLEFFQQKQKNKKSARPGKKGSSTKKSKTLDKSAIFPAILLSIKALFNL
LFVLGFLGGMLGAGIALGYGVALFDKVRVPQTEELVNQVKDISSISEITYSDGTVIASIE
SDLLRTSISSEQISENLKKAIIATEDEHFKEHKGVVPKAVIRATLGKFVGLGSSSGGSTL
TQQLIKQQVVGDAPTLARKAAEIVDALALERAMNKDEILTTYLNVAPFGRNNKGQNIAGA
RQAAEGIFGVDASQLTVPQAAFLAGLPQSPITYSPYENTGELKSDEDLEIGLRRAKAVLY
SMYRTGALSKDEYSQYKDYDLKQDFLPSGTVTGISRDYLYFTTLAEAQERMYDYLAQRDN
VSAKELKNEATQKFYRDLAAKEIENGGYKITTTIDQKIHSAMQSAVADYGYLLDDGTGRV
EVGNVLMDNQTGAILGFVGGRNYQENQNNHAFDTKRSPASTTKPLLAYGIAIDQGLMGSE
TILSNYPTNFANGNPIMYANSKGTGMMTLGEALNYSWNIPAYWTYRMLRENGVDVKGYME
KMGYEIPEYGIESLPMGGGIEVTVAQHTNGYQTLANNGVYHQKHVISKIEAADGRVVYEY
QDKPVQVYSKATATIMQGLLREVLSSRVTTTFKSNLTSLNPTLANADWIGKTGTTNQDEN
MWLMLSTPRLTLGGWIGHDDNHSLSRRAGYSNNSNYMAHLVNAIQQASPSIWGNERFALD
PSVVKSEVLKSTGQKPGKVSVEGKEVEVTGSTVTSYWANKSGAPATSYRFAIGGSDADYQ
NAWSSIVGSLPTPSSSSSSSSSSSDSSNSSTTRPSSSRARR
>AFG41385|FEATURES|argannot|beta_lactam|mrdA|antibiotic target replacement|0
MKLQNSFRDYTAESALFVRRALVAFLGILLLTGVLIANLYNLQIVRFTDYQTRSNENRIK
LVPIAPSRGIIYDRNGIPLALNRTIYQIEMMPEKVDNVQQTLDALRSVVDLTDDDIAAFR
KERARSHRFTSIPVKTNLTEVQVARFAVNQYRFPGVEVKGYKRRYYPYGSALTHVIGYVS
KINDKDVERLNNDGKLANYAATHDIGKLGIERYYEDVLHGQTGYEEVEVNNRGRVIRQLK
EVPPQAGHDIYLTLDLKLQQYIETLLAGSRAAVVVTDPRTGGVLALVSTPSYDPNLFVDG
ISSKDYSALLNDPNTPLVNRATQGVYPPASTVKPYVAVSALSAGVITRNTTLFDPGWWQL
PGSEKRYRDWKKWGHGRLNVTRSLEESADTFFYQVAYDMGIDRLSEWMGKFGYGHYTGID
LAEERSGNMPTREWKQKRFKKPWYQGDTIPVGIGQGYWTATPIQMSKALMILINDGIVKV
PHLLMSTAEDGKQVPWVQPHEPPVGDIHSGYWELAKDGMYGVANRPNGTAHKYFASAPYK
IAAKSGTAQVFGLKANETYNAHKIAERLRDHKLMTAFAPYNNPQVAVAMILENGGAGPAV
GTLMRQILDHIMLGDNNTDLPAENPAVAAAEDH
>CBJ02047.1|FEATURES|argannot|beta_lactam|ampC|antibiotic inactivation|0
MKRTMLYLSLLAVSCSVSAAKYPVLTESSPEKAGFNVERLNQMDRWISQQVDVGYPSVNL
LIIKDNQIVYRKAWGAAKKYDGSVLMEQPVKATTGTLYDLASNTKMYATNFALQKLMSEG
KLHPDDRIAKYIPGFADSPNDTIKGKNTLRISDLLHHSGGFPADPQYPNKAVAGALYSQD
KGQTLEMIKRTPLEYQPGSKHIYSDVDYMLLGFIVESVTGQPLDRYVEESIYRPLGLTHT
VFNPLLKGFKPQQIAATELNGNTRDGVIHFPNIRTSTLWGQVHDEKAFYSMGGVSGHAGL
FSNTGDIAVLMQTMLNGGGYGDVQLFNAETVKMFTTSSKEDATFGLGWRVNGNATMTPTF
GTLASPQTYGHTGWTGTVTVIDPVNHMTIVMLSNKPHSPVADPQKNPNMFESGQLPIATY
GWVVDQVYAALKQK
>AFH19307|FEATURES|argannot|beta_lactam|BL1_ec|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVDAAWQILNALQ
>AFQ67211|FEATURES|argannot|beta_lactam|ampC|antibiotic inactivation|0
LKRSLLIFAALCAASWTSVQAAQPTVDPVFASDVVDRYANHIYYGSGATGMALVVIDGNQ
RVFRSFGETRPGNNQHPQLDSVIRIASLSKLMTSEMLVKLLDQGVVKLNDPLSKYAPPGA
RVPDWQGKPITLVNLATHTSALPREQPGGAAHRPVFVWPTRQQRWNWLSTATLKAAPGSQ
AAYSNLAFDLLADALATAAGKPYPQLFEEQITRPLGMKDTTFTPSPDQCQRLMIPEKGAS
PCNNTLAAIGSGGVYSTPGDMMRWMQQFLSSDFYTRSQQADRMQTLIYQRNQLTRVIGMD
VPGRADALGLGWVYMKPKNGHPGIIQKTGGGGGFITYMAMNPQANVGAFVVVTRSPLTRF
NNMSDGINDLVSELSGAQPNMQTASQ
>WP_013544541.1|FEATURES|argannot|aminoglycoside|ampS|antibiotic target alteration|0
MRFDIDEMISPEMLDRLAEVAIKVGLNLQEGQDLVLTAPVKALPLVRRITYYAYKAGAGV
ITPLFGDEALSLIRFENAHSASFDCAPSWLYEGMAKAFENGAARLAIVGDDPLLFSNQDL
DKISRLNKATSMAYQPALNKISNFTINWSIIAYPTPEWAIAMFSDLPLDKAVQKLAEAIF
SASRVTQDNAVYEWHAHNANLKQRSSWLNEQRFAALHFIGPGTNLTVGLADEHEWHGGTS
IAQNGVVCNPNIPTEEVFTTPHAYKVDGFVRSTKPLSYQGTLIDNIEVRFEEGRIINASA
SKGQEVLQRVLQSDEGASRLGEVALVPHSSPISKSGLLFYNTLFDENAACHIALGQCYSK
CFLNGAALTAEDIAMRGGNKSIIHIDWMIGSNEINIDGIMQDGAKIPVFRRGEWV
>AFB78806|FEATURES|argannot|beta_lactam|blaA|antibiotic inactivation|1
MKKIITLIIGIIFITFSFATTKIDTQVTNDIQNIEKKHGGKIGVYTINRNDWSNFAVNAS
FYFPICSTYKFLVVGAILKQSMTDNKLLNQKIKISKNQIVEYSPITRRHINQIMTVKQLC
QASMQGDNTATNILIEKLGGLKNLNKFILSLADHATKVANLEPKVNHVSLTTNENKTTPK
IMARDINKLAFSDDILDKKHRLMFKQWLIASNTSNNRIAAEVPDEWEVGDKTGTCQYGTT
NDVAIIWPDDNRAVIMAIFYTQSQKNAKPNSKIVREVTKILLNRLQLNNTTKNA
>AAF86696|FEATURES|argannot|beta_lactam|ACC-3|antibiotic inactivation|1
MRKKMQNTLKMLSVITCLALTAQGAMASEMDQAKIKDTVDSLIQPLMQKNNIPGMSVAVT
LNGKNYIYNYGLASKQPQQPVTDNTLFEVGSLSKTFAATLASYAQVSGKLSLDKSISHYV
PELRGSSFDHISVLNAGTHTTGLALFMPEEVKNTDQLMAYLKAWKPADPAGTHRVYSNIG
TGLLGMIAAQSMGMTYEDAIEKTLLPKLGMTHTYLNVPADQAENYAWGYNKKNEPIHVNM
EVLGNEAYGIRTNASDLIRYVQANMGQLKLDGNSTLQKALTDTHIGYFKSGKITQDLMWE
QLPYPVSLPDLLTGNDMAMTKSVATPIVPPLPPQENVWINKTGSTNGFGAYIAFVPAKKM
GIVMLANKNYSIDQRVT
>ABP49606|FEATURES|argannot|beta_lactam|blaACC-6|antibiotic inactivation|1
MQNTLKLLSVITCLAATVQGALAANIDESKIKDTVDDLIQPLMQKNNIPGMSVAVTVNGK
NYIYNYGLAAKQPQQPVTENTLFEVGSLSKTFAATLASYAQVSGKLSLDQSVSHYVPELR
GSSFDHVSVLNVGTHTSGLQLFMPEDIKNTTQLMAYLKAWKPADAAGTHRVYSNIGTGLL
GMIAAKSLGVSYEDAIEKTLLPQLGMHHSYLKVPADQMENYAWGYNKKDEPVHGNMEILG
NEAYGIKTTSSDLLRYVQANMGQLKLDANAKMQQALTATHTGYFKSGEITQDLMWEQLPY
PVSLPNLLTGNDMAMTKSVATPIVPPLPPQENVWINKTGSTNGFGAYIAFVPAKKMGIVM
LANKNYSIDQRVTVAYKILSSLEGNK
>AAC45086|FEATURES|argannot|beta_lactam|ACT-1|antibiotic inactivation|1
MMMTKSLCCALLLSTSCSVLATPMSEKQLAEVVERTVTPLMKAQAIPGMAVAVIYEGQPH
YFTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGK
QWQGIRMLDLATYTAGGLPLQVPDEVKDNASLLRFYQNWQPQWKPGTTRLYANASIGLFG
ALAVKPSGMSYEQAITTRVFKPLKLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAE
AYGVKTNVQDMASWVMVNMKPDSLQDNSLRKGLTLAQSRYWRVGAMYQGLGWEMLNWPVD
AKTVVEGSDNKVALAPLPAREVNPPAPPVNASWVHKTGSTGGFGSYVAFIPEKQLGIVML
ANKSYPNPARVEAAYRILSAL
>CAJ28994|FEATURES|argannot|beta_lactam|ACT-2|antibiotic inactivation|1
MMMTKSLCCALLLSTSCSVLATPMSEKQLAEVVERTVTPLMKAQAIPGMAVAVIYEGQPH
YFTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGK
QWQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFG
ALAVKPSGMSYEQAITTRVFKPLKLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAE
AYGVKTNVQDMASWVMVNMKPDSLQDNSLRKGLTLAQSRYWRVGAMYQGLGWEMLNWPVD
AKTVVEGSDNKVALAPLPAREVNPPAPPVNASWVHKTGSTGGFGSYVAFIPEKQLGIVML
ANKSYPNPARVEAAYRILSAL
>ABZ81086|FEATURES|argannot|beta_lactam|ACT-4|antibiotic inactivation|1
MMTKSLCCALLLSTSCSVLAAPMSEKQLAEVVERTVTPLMKAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVADNASLLRFYQNWQPQWKPGTTRLYANTSIGLFGA
LAVKPSGMSYEQAITTRVFKPLKLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVQDMASWVMVNMKPDSLQDNSLRQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVEGSDNKVALAPLPAREVNPPAPPVNASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILSAL
>ACJ05689|FEATURES|argannot|beta_lactam|ACT-5|antibiotic inactivation|1
MMKKSLCCALLLGISCSALAAPVSEKQLAEVVANTVTPLMKAQSIPGMAVAVIYQGKPHY
YTFGKADIAASKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNAALLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPFEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGMKTNVQDMANWVMANMAPENVADASLKQGISLAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVIEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYPILDALQ
>ACJ05686|FEATURES|argannot|beta_lactam|ACT-6|antibiotic inactivation|1
MMTKSLCCALLLSTSCSVLAAPMSEKQLAEVVERTVTPLMKAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAITTRVFKPLKLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVKDMANWVMVNMKPDSLQDSSLKEGITLAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVEGSDNKVALAPLPAREVNPPAPPVNASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>ACJ05688|FEATURES|argannot|beta_lactam|ACT-7|antibiotic inactivation|1
MMRKSLCCALLLGISCSALATPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPENVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NTSYPNPARVEAAYHILEALQ
>CBI75448|FEATURES|argannot|beta_lactam|blaACT-8|antibiotic inactivation|1
MMMTKSLCCALLLSTSCSVLATPMSEKQLAEVVERTVTPLMKAQAIPGMAVAVIYQGQPH
YFTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGK
QWQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFG
ALAVKPSGMSYEQAITTRVFKPLKLDHTWINVPKAEESHYAWGYRDGKAVHVSPGMLDAE
AYGVKTNVQDMANWVMVNMKPDSLQDSSLRKGITLAQSRYWRVGAMYQGLGWEMLNWPVD
AKTVVEGSDNKVALAPLPAREVNPPAPPVNASWVHKTGSTGGFGSYVAFIPEKQLGIVML
ANKSYPNPARVEAAYRILSAL
>AEI70575|FEATURES|argannot|beta_lactam|ACT-9|antibiotic inactivation|1
MKTKSLCCALLLSTSCSVLAAPMSEKQLSDVVERTVTPLMKAQAIPGMAVAVIYQGQPHY
FTFGKADVTANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNTSLLRFYQHWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMNFEQAMTKRVFKPLKLDHTWINVPKEEEAHYAWGYRDGKAIHVSPGMLDAEA
YGVKTNIQDMASWLKANMNPDALSDSTLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVEA
KTVVEGSDNKVALAPLLVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKELGIVMLA
NKSYPNPARVEAAYRILSAL
>AEV91214|FEATURES|argannot|beta_lactam|ACT-10|antibiotic inactivation|1
MMKKSVCCALLLSTSCSVLAAPMSEKQLAEVVERTVTPLMKAQAIPGIAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQ
WKGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAITTRVFKPLKLDHTWINVPKTEEAHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVKDMASWVMVNMKPDSLEDSSLRKGFTLAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVEGSDNKVALAPLPAREVNPPAPPVNASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>AFU25650|FEATURES|argannot|beta_lactam|ACT-12|antibiotic inactivation|1
MMKKSLCCALLLSTSCAALAAPLSETQLAKVVERTVTPLMKAQSIPGMAVAVIYQGQPHY
FTFGKADVAANTPVTAQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQ
WQGVRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQSWQPQWAPGTTRLYANASIGLFGA
LAVKPSGMRFEQAMTERVLKPLNLNHTWINVPKAEEQHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVKDMASWVVANMAPDGVQDASLKQGMVLAQSRYWRTGSMYQGLGWEMLNWPVEA
KTVVEGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKELGIVMLA
NKSYPNPARVEAAYRILSALQ
>AFU25647|FEATURES|argannot|beta_lactam|ACT-14|antibiotic inactivation|1
MMKKSLCCALLLGISCSALAAPVSEKQLAEVVANTVTPLMKAQSIPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNAALLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMGYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPEKVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVIEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYLAFIPEKQIGIVMLA
NKSYPNPARVEAAYHILDALQ
>AFU25653|FEATURES|argannot|beta_lactam|ACT-15|antibiotic inactivation|1
MMKKSLCCALLLGISCSALATPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKSGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPENVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVVEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NTSYPNPARVEAAYHILEALQ
>BAM34463|FEATURES|argannot|beta_lactam|ACT-16|antibiotic inactivation|1
MMKKSLCCALLLGLSCSALAAPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKSHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPEKVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYHILEAL
>AKS43590|FEATURES|argannot|beta_lactam|ACT-38|antibiotic inactivation|1
MMTKSLCCALLLSTSCSVLAAPMSEKQLAEVVERTVTPLMKAQAIPGMAVAVIYQGQPHY
FTFGKADVAANNPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQ
WLGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAITMRVFKPLKLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVKDMANWVMVNMKPDSLQDSSLKEGITLAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVEGSDNKVALAPLPAREVNPPAPPVNASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>AAC09015|FEATURES|argannot|beta_lactam|AER-1|antibiotic inactivation|1
MYVLSVEKPTLRNKFAAGIGVVLVCVVASFIPTPVFALDTTKLIQAVQSEESALHARVGM
TVFDSNTGTTWNYRGDERFPLNSTHKTFSCAALLAKVDGKSLSLGQSVSISKEMLVTYSP
ITEKSLSPETVTFGKICQAAVSYSDNTAANVVFDAIGGATGFNAYMRSIGDEETQLDRKE
PELNEGTPGDVRDTTTPNAMVNSLRKILLGDALSASSRSQLTQWMLDDQVAGALLRASLP
SDWKIADKTGAGGYGSRSIVAVIWPPSKQPLVVGIYITQTKASMQASNQAIARIGVVLKD
TVAP
>CAG25812|FEATURES|argannot|beta_lactam|OKP-A-1|antibiotic inactivation|1
MRYVRLCLISLIAALPLAVFASPPPLEQITRSESQLAGRVGYVEMDLVSGRTLAAWRANE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMAATLRKLLTSHTLSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIAEKTGAGERGSRG
IVALLGPNGKAERIVVIYLRDTPASMAERNQQIARIGAALIEHWQR
>CAG25815|FEATURES|argannot|beta_lactam|OKP-A-2|antibiotic inactivation|1
MRYVRLCLFSLIAALPLAVFASPQPLEQVTRSESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMAATLRKLLTSHTLSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPNGKAERIVVIYLRDTPATMAERNQQIARIGAALIEHWQR
>CAJ19599|FEATURES|argannot|beta_lactam|OKP-A-3|antibiotic inactivation|1
MRYVRLCLISLIAALPLAVFASPPPLEQITRSESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMAATLRKLLTSHALSDRSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPNGKAERIVVIYLRDTPATMAERNQQIAKIGAALIEHWQR
>CAJ19601|FEATURES|argannot|beta_lactam|OKP-A-4|antibiotic inactivation|1
MRYVRLCLFSLIAALPLAVFASPPPLEQITRSESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMAATLRKLLTSHTLSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPNGKAERIVVIYLRDTPATMAERNQQIARIGAALIEHWQR
>CAJ19602|FEATURES|argannot|beta_lactam|OKP-A-5|antibiotic inactivation|1
MRYVRLCLISLIAALPLAVFASPQPLEQITLSESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDERLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMAATLRKLLTSHALSDRSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPNGKAERIVVIYLRDTPATMAERNQQIARIGAALIEHWQR
>CAJ19603|FEATURES|argannot|beta_lactam|OKP-A-6|antibiotic inactivation|1
MRYVRLCLISLIAALPLAAFASPQPLEQVTRSESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDERLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKRVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMAATLRKLLTSHALSDRSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPNGKAERIVVIYLRDTPATMAERNQQIAKIGAALIEHWQR
>CAJ19604|FEATURES|argannot|beta_lactam|OKP-A-7|antibiotic inactivation|1
MRCVRLCLISLIAALPLAVFASPQPLEQITLSESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDERLDRRIRYPQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMAATLRKLLTSHALSDRSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPNGKAERIVVIYLRDTPAAMAERNQQIAKIGAALIEHWQR
>CAJ19606|FEATURES|argannot|beta_lactam|OKP-A-8|antibiotic inactivation|1
MRYVRLCLISLIAALPLAAFASPPPLEQVTRSESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMAATLRKLLTSHTLSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPNGKAERIVVIYLRDTPATMAERNQQIARIGAALIEHWQR
>CAJ19607|FEATURES|argannot|beta_lactam|OKP-A-9|antibiotic inactivation|1
MRYVRLCLISLIAALPLAVFASPPPLEQITRSESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKALLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMAATLRKLLTSHALSDRSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPNGKAERIVVIYLRDTPATMAERNQQIAKIGAALIEHWQR
>CAJ19608|FEATURES|argannot|beta_lactam|OKP-A-10|antibiotic inactivation|1
MRCVRLCLIPLIAALPLAVFASPPPLEQITLSESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMAATLRKLLTSHALSDRSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPNGKAERIVMIYLRDTPATMAERNQQIAKIGAALIEHWQR
>CAP12353|FEATURES|argannot|beta_lactam|OKP-A-11|antibiotic inactivation|1
MRYVRLCLISLIAALPLAAFASPPPLEQVTRSESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMAATLRKLLTSHALSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPNGKAERIVVIYLRDTPATMAERNQQIARIGAALIEHWQR
>ACL68096|FEATURES|argannot|beta_lactam|OKP-A-13|antibiotic inactivation|1
MRYIRLCLFSLIAALPLAVFASPPPLEQITRSESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMAATLRKLLTSHTLSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPNGKAERIVVIYLRDTPATMAERNQQIARIGAALIEHWQR
>ACL68095|FEATURES|argannot|beta_lactam|OKP-A-14|antibiotic inactivation|1
MRYIRLCLFSLIAALPLAVFASPPPLEQITRSESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTSHTLSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPNGKAERIVVIYLRDTPATIAERNQQIARIGAALIEHWQR
>ACN65419|FEATURES|argannot|beta_lactam|OKP-A-15|antibiotic inactivation|1
MRYVRLCLFSLIAALPLAVFASPPPLEQITRSESQLAGRVGYVEMDLLAAWRASERFPLM
STFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCAAAITM
SDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPASMAAT
LRKLLTSHTLSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRGIVALL
GPNGKAERIVVIYLRDTPATMAERNQQIARIGAALIEHWQR
>ACN65418|FEATURES|argannot|beta_lactam|OKP-A-16|antibiotic inactivation|1
MRYVRLCLISLIAALPLVAFASPQPLEQVTRSESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMAATLRKLLTSHALSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPNGKAERIVVIYLRDTPATMAERNQQIARIGAALIEHWQR
>CAG25813|FEATURES|argannot|beta_lactam|OKP-B-1|antibiotic inactivation|1
MRYVRLCLISLIAALPLAVFASPQPLEQIKISEGQLAGRVGYVEMDLASGRMLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTAATMAERNQQIAGIGAALIEHWQR
>CAJ19610|FEATURES|argannot|beta_lactam|OKP-B-2|antibiotic inactivation|1
MRYVRLCLISLIAALPLAVFASPQPLEQIKISEGQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTAATMAERNQQIAGIGAALIEHWQR
>CAJ19611|FEATURES|argannot|beta_lactam|OKP-B-3|antibiotic inactivation|1
MRYVRLCLISLIAALPLAVFASPQPLEQIKISESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKIVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTAATMVERNQQIAGIGAALIEHWQR
>CAJ19612|FEATURES|argannot|beta_lactam|OKP-B-4|antibiotic inactivation|1
MRYVRLCLISLIAALPLAVFASPQPLEQIKISESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTPATMVERNQQIAGIGAALIEHWQR
>AAS13468|FEATURES|argannot|beta_lactam|OKP-B-5|antibiotic inactivation|1
MRYVRLCLISLIAALPLAVFASPQPLEQIKISESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNTAGNLLLKIVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTPATMVERNQQIAGIGAALIEHWQR
>CAJ19615|FEATURES|argannot|beta_lactam|OKP-B-7|antibiotic inactivation|1
MRYVRLCLISLIAALPLAVFASPQPLEQIKISESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKIVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTAATMAERNQQIAGIGAALIEHWQR
>CAJ19616|FEATURES|argannot|beta_lactam|OKP-B-8|antibiotic inactivation|1
MRYVRLCLISLIAALPLAVFASPQPLEQIKISESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNTAGNLLLKIVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTAATMAERNQQIAGIGAALIEHWQR
>CAJ19618|FEATURES|argannot|beta_lactam|OKP-B-9|antibiotic inactivation|1
MRYVRLCLISLIAALPLAVFASPQPLEQIKISESQLAGRVGYIEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRRLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTAATMVERNQQIAGIGAALIEHWQR
>CAJ19619|FEATURES|argannot|beta_lactam|OKP-B-10|antibiotic inactivation|1
MRYVRLCLISLIAALPLAVFASPQPLEQIKISESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNTAGNLLLKIVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
NMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTAATMAERNQQIAVIGAALIEHWQR
>CAJ19620|FEATURES|argannot|beta_lactam|OKP-B-11|antibiotic inactivation|1
MRYVRLCLISLITALPLAVFASPQPLEQIKISESQLAGRVGYVEMDLASGRTLATWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKIVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTPATMVERNQQIAGIGAALIEHWQR
>CAG25831|FEATURES|argannot|beta_lactam|OKP-B-12|antibiotic inactivation|1
TALPLAVFASPQPLEQIKISEGQLAGRVGYVEMDLASGRMLAAWRASERFPLMSTFKVLL
CGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAGN
LLLKSVGGPAGLTTFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPASMATTLRKLLTT
PSLSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRGIVALLGPDGKAE
RIVVIYLRDTAATMAERNQQIAG
>AAV80715|FEATURES|argannot|beta_lactam|OKP-B-13|antibiotic inactivation|1
MRYIRLCLISLIAALPLAVFASPQPLEQIKISESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNTAGNLLLKIVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTAATMAERNQQIAVIGAALIEHWQR
>AAZ79403|FEATURES|argannot|beta_lactam|blaOKP-B-14|antibiotic inactivation|1
MRYVCLCLISLVAALPLAVFASPQPLEQIKISEGQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTAATMAERNEQIAGIGAALIEHWQR
>CAP12357|FEATURES|argannot|beta_lactam|OKP-B-17|antibiotic inactivation|1
MRYVRLCLISLIAALPLAVFASPQPLEQIKISEGQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTPATMVERNQQIAGIGAALIEHWQR
>CAP12358|FEATURES|argannot|beta_lactam|OKP-B-18|antibiotic inactivation|1
MRYVRLCLISLIAALPLAVFASPQPLEQIKISEGQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKIVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTAATMAERNQQIAGIGAALIEHWQR
>CAP12359|FEATURES|argannot|beta_lactam|OKP-B-19|antibiotic inactivation|1
MRYVRLCLISLIAALPLAVFASPQPLEQIKISEGQLAGRVGYVEMDLASGRMLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNTAGNLLLKIVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTPATMVERNQQIAGIGAALIEHWQR
>CAP12360|FEATURES|argannot|beta_lactam|OKP-B-20|antibiotic inactivation|1
MRYVRLCLISLIAALPLAVFASPQPLEQIKISESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNTAGNLLLKIVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTAATMVERNQQIAGIGAALIEHWQR
>AFD53816|FEATURES|argannot|beta_lactam|NDM-1|antibiotic inactivation|1
MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQ
HTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTH
AHQDKMGGMDALHAAGIATYANALSNQLAPQEGMVAAQHSLTFAANGWVEPATAPNFGPL
KVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAF
PKASMIVMSHSAPDSRAAITHTARMADKLR
>AET86558|FEATURES|argannot|beta_lactam|NDM-2|antibiotic inactivation|1
MELPNIMHPVAKLSTALAAALMLSGCMAGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQ
HTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTH
AHQDKMGGMDALHAAGIATYANALSNQLAPQEGMVAAQHSLTFAANGWVEPATAPNFGPL
KVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAF
PKASMIVMSHSAPDSRAAITHTARMADKLR
>AFK80349|FEATURES|argannot|beta_lactam|NDM-3|antibiotic inactivation|1
MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQ
HTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTNDQTAQILNWIKQEINLPVALAVVTH
AHQDKMGGMDALHAAGIATYANALSNQLAPQEGMVAAQHSLTFAANGWVEPATAPNFGPL
KVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAF
PKASMIVMSHSAPDSRAAITHTARMADKLR
>AFB82585|FEATURES|argannot|beta_lactam|NDM-4|antibiotic inactivation|1
MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQ
HTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTH
AHQDKMGGMDALHAAGIATYANALSNQLAPQEGLVAAQHSLTFAANGWVEPATAPNFGPL
KVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAF
PKASMIVMSHSAPDSRAAITHTARMADKLR
>AEN03071|FEATURES|argannot|beta_lactam|NDM-5|antibiotic inactivation|1
MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQ
HTSYLDMPGFGAVASNGLIVRDGGRVLLVDTAWTDDQTAQILNWIKQEINLPVALAVVTH
AHQDKMGGMDALHAAGIATYANALSNQLAPQEGLVAAQHSLTFAANGWVEPATAPNFGPL
KVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAF
PKASMIVMSHSAPDSRAAITHTARMADKLR
>AEX08599|FEATURES|argannot|beta_lactam|NDM-6|antibiotic inactivation|1
MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQ
HTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTH
AHQDKMGGMDALHAAGIATYANALSNQLAPQEGMVAAQHSLTFAANGWVEPATAPNFGPL
KVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASVRAFGAAF
PKASMIVMSHSAPDSRAAITHTARMADKLR
>AFS33103|FEATURES|argannot|beta_lactam|NDM-7|antibiotic inactivation|1
MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQ
HTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTH
AHQDKMGGMNALHAAGIATYANALSNQLAPQEGLVAAQHSLTFAANGWVEPATAPNFGPL
KVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAF
PKASMIVMSHSAPDSRAAITHTARMADKLR
>BAM84089|FEATURES|argannot|beta_lactam|NDM-8|antibiotic inactivation|1
MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQ
HTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTH
AHQDKMGGMGALHAAGIATYANALSNQLAPQEGLVAAQHSLTFAANGWVEPATAPNFGPL
KVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAF
PKASMIVMSHSAPDSRAAITHTARMADKLR
>AGU91756|FEATURES|argannot|beta_lactam|NDM-9|antibiotic inactivation|1
MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQ
HTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTH
AHQDKMGGMDALHAAGIATYANALSNQLAPQKGMVAAQHSLTFAANGWVEPATAPNFGPL
KVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAF
PKASMIVMSHSAPDSRAAITHTARMADKLR
>AGT37351|FEATURES|argannot|beta_lactam|NDM-10|antibiotic inactivation|1
MELPNIMHPVAKLSTALAAALMLSGCMPGEISPTIDQQMETGDQRFGDLVFRQLAPNVWQ
HTSYLDMPSFGAVTSNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTH
AHQDKMGGMDALHAAGIATYANALSNQLAPQEGMVAAQHSLTFAANGWVEPATAPNFGPL
KVFYPGPGHTSDNITVGIDRTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAF
PKASMIVMSHSAPDSRAAITHTARMADKLR
>BAO79439|FEATURES|argannot|beta_lactam|NDM-12|antibiotic inactivation|1
MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQ
HTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTH
AHQDKMGGMDALHAAGIATYANALSNQLAPQEGLVAAQHSLTFAANGWVEPATAPNFGPL
KVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLDDADTEHYAASARAFGAAF
PKASMIVMSHSAPDSRAAITHTARMADKLR
>BAQ02518|FEATURES|argannot|beta_lactam|NDM-13|antibiotic inactivation|1
MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQ
HTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTNDQTAQILNWIKQEINLPVALAVVTH
AHQDKMGGMDALHAAGIATYANALSNQLAPQEGLVAAQHSLTFAANGWVEPATAPNFGPL
KVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAF
PKASMIVMSHSAPDSRAAITHTARMADKLR
>AKF43458|FEATURES|argannot|beta_lactam|NDM-6|antibiotic inactivation|1
MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQ
HTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTH
AHQDKMGGMDALHAAGIATYANALSNQLAPQEGLVAAQHSLTFAANGWVEPATAPNFGPL
KVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASVRAFGAAF
PKASMIVMSHSAPDSRAAITHTARMADKLR
>AKZ20823|FEATURES|argannot|beta_lactam|NDM-1|antibiotic inactivation|1
MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQ
HTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTH
AHQDKMGGMDALHAAGIATYANALSNQLAPQEGMVAAQHSLTFAANGWVEPATAPNFGPL
KVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAF
PKASMIVMSHSAPDSRAAITHTAHMADKLR
>AAU10324|FEATURES|argannot|beta_lactam|CF70_016075|antibiotic inactivation|1
MNVILNRRTFLLASAVVSASYSLGTLAGANRDDASFQDRLAKLEQQLNGRLGVCAIDTAN
GAQLGYRANERFAMNSTFKVMLASAFLARSQDEPGLLEERLTYTRADLVTYSPVTEKHVS
TGMTVAELCAAGIQYSDNTAANVLMKKLGGPEAVTAFARSIGDTHFRLDRWETELNSAIP
GDPRDTSTPQAMAMSLQRLALGDMLAADKQHQLQAWLKGNTTGGKRIRAGVPAGWQVGDK
TGTGDYGSANDVAILWPPRRAPVVLALYSALENQQAEARNDVLADAARIVAEWVTG
>CAC33434|FEATURES|argannot|beta_lactam|bla|antibiotic inactivation|1
MRNEEVISMWQRMKWGLCVLAALSGSAMAAPLTAQYVSTIATQEEQRLHARIGIAVLDTA
TNSITHYRGEERFPLNSTHKPLLCAALLREVDRKALALSASTQFESSQLVEYSPITEKHV
APDAMSWAQLCSAAVSYSDNTAANLIARKLNGPQAVTQFLRDSGDTITRLDRYEPELNSA
IPGDERDSTTPVAIAQTLNTLLLGNVLQPSSREQLMQWMRDDKVADGLLRSVLPDGWKIA
DKTGAGDNGSRSIVSVVWPTSQKPLLVVIYITQTPATMAQRDAAIVRIGESLFSTLAVYD
>AAD22636|FEATURES|argannot|beta_lactam|MIR-1|antibiotic inactivation|1
MMTKSLSCALLLSVASSAFAAPMSEKQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEIALGDPVAKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHFAWGYREGKAVHVSPGMLDAEA
YGVKTNVKDMASWLIANMKPDSLQAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>AAO42602|FEATURES|argannot|beta_lactam|MIR-2|antibiotic inactivation|1
MMTKSLSCALLLSVASAAFAAPMSETQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEIALGDPVAKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYREGKAVHVSPGMLDAEA
YGVKTNVKDMASWVIANMKPDSLQAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYHILDALQ
>AAU95779|FEATURES|argannot|beta_lactam|MIR-3|antibiotic inactivation|1
MMTKSLSCALLLSVASAAFAAPMSEKQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEIALGDPVAKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYREGKAVHVSPGMLDAEA
YGVKTNVKDMASWLIANMKPDSLHAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>ABQ57390|FEATURES|argannot|beta_lactam|MIR-2|antibiotic inactivation|1
LSCALLLSVTSAAFAAPMSETQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHYFTFGK
ADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEIALGDPVAKYWPELTGKQWQSIR
MLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKP
SGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYREGKAVHVSPGMLDAEAYGVKT
NVKDMASWVIANMKPDSLQAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDAKTVVG
GSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLANKSYP
NPARVEA
>AFJ79785|FEATURES|argannot|beta_lactam|MIR-6|antibiotic inactivation|1
MMTKSLSCALLLSVTSAAFAAPMSETQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTSTGVLGGDAIARGEIALGDPVAKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYREGKAVHVSPGMLDAEA
YGVKTNVKDMASWLIANMKPDSLQAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>ACJ05687|FEATURES|argannot|beta_lactam|MIR-5|antibiotic inactivation|1
MMTKSLSCALLLSVASSAFAAPMSEKQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEIALGDPVAKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYREGKAVHVSPGMLDAEA
YGVKTNVKDMASWLIANMKPDSLQAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>CAA71326|FEATURES|argannot|beta_lactam|DHA-21|antibiotic inactivation|1
MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYF
NYGFADVQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMTLNDPAEKYQPELALPQW
KGITLLDLATYTAGGLPLQVPDAVKSRADLLHFYQQWQPSRKPGDMRLYANSSIGLFGAL
TANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESY
GVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKD
MIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>AAO84036|FEATURES|argannot|beta_lactam|ampC|antibiotic inactivation|1
MTKSVSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYF
NYGFADVQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMTLNDPAEKYQPELALPQW
KGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGAL
TANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESY
GVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKD
MIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>BAA02563|FEATURES|argannot|beta_lactam|MOX-1|antibiotic inactivation|1
MQQRQSILWGAVATLMWAGLAHAGEASPVDPLRPVVDASIQPLLKEHRIPGMAVAVLKDG
KAHYFNYGVANRESGASVSEQTLFEIGSVSKTLTATLGAYAVVKGAMQLDDKASRHAPWL
KGSVFDSITMGELATYSAGGLPLQFPEEVDSSEKMRAYYRQWAPVYSPGSHRQYSNPSIG
LFGHLAASSLKQPFAQLMEQTLLPGLGMHHTYVNVPKQAMASYAYGYSKEDKPIRVNPGM
LADEAYGIKTSSADLLAFVKANIGGVDDKALQQAISLTHKGHYSVGGMTQGLGWESYAYP
VTEQTLLAGNSAKVILEANPTAAPRESGSQVLFNKTGSSNGFGAYVAFVPARGIGIVMLA
NRNYPIPARVKAAHAILAQLAG
>CAB82578|FEATURES|argannot|beta_lactam|MOX-2|antibiotic inactivation|1
MQQRQSILWGALATLMWAGLAHAGETSPVDPLRPVVDASIRPLLKEHRIPGMAVAVLKDG
KAHYFNYGVADRERAVGVSEQTLFEIGSVSKPLTATLGAYAVVKGAMQLDDKASRHAPWL
KGSAFDSITMGELATYSAGGLPLQFPEEVDSLEKMQAYYRQWTPAYSPGSHRQYSNPSIG
LFGHLAASSMKQPFAQLMEQTLLPGLGLHHTYVNVPKQAMASYAYGYSKEDKPIRVSPGM
LADEAYGIKTSSADLLRFVKANISGVHDKALQQAISLTHKGHYSVGGMTQGLGWESYAYP
VSEQTLLAGNSAKVILEANPTAAPRESGSQMLFNKTGSTSGFGAYVAFVPAKGIGIVMLA
NRNYPIPARVKAAHAILTQLAR
>ACA30419|FEATURES|argannot|beta_lactam|MOX-3|antibiotic inactivation|1
MQQRQSILWGAVATLMWAGLAHAGETSPVDPLRPVVDASIQPLLKEHRIPGMAVAVLKDG
KAHYFNYGVADRERAVGVSEQTLFEIGSVSKPLTATLGAYAVVKGAMQLDDKASRHAPWL
KGSAFDSITMGELATYSAGGLPLQFPEEVDSLEKMQAYYRQWTPAYSPGSHRQYSNPSIG
LFGHLAASSLKQPFAQLMEQTLLPGLGLHHTYVNVPKQAMASYAYGYSKEDKPIRVSPGM
LADEAYGIKTSSADLLRFVKANISGVDDKALQQAISLTHKGHYSVGGMTQGLGWERYAYP
VSEQTLLAGNSAKVILEANPTAAPRESGSQMLFNKTGSTSGFGAYVAFVPAKGIGIVMLA
NRNYPIPARVKAAHAILTQLAR
>ACI89425|FEATURES|argannot|beta_lactam|MOX-4|antibiotic inactivation|1
MQQRQSILWGALATLMWAGLAHAGDTSAVDPLRPVVDASIRPLLKEHRIPGMAVAVLKDG
KAHYFNYGVADRERAVGVSEQTLFEIGSVSKPLTATLGAYAVVKGAMQLDDKASRHAPWL
KGSAFDSITMGELATYSAGGLPLQFPEEVDSLEKMQAYYRQWTPAYSPGSHRQYSNPSIG
LFGHLAASSMKQPFAQLMEQTLLPGLGLHHTYVNVPKQAMASYAYGYSKEDKPIRVSPGM
LADEAYGIKTSSADLLRFVKANISGVDDKALQQAISLTHKGHYSVGGMTQGLGWESYAYP
VSEQTLLAGNSAEVILEANPTAAPRESGNLMLFNKTGSTSGFGAYVAFVPAKGIGIVMLA
NRNYPIPARVKAAHAILTQLAR
>ACS44783|FEATURES|argannot|beta_lactam|MOX-5|antibiotic inactivation|1
MQQRQSILWGALATLMWAGLAHAGDKAATDPLRPVVDASIRPLLKEHRIPGMAVAVLKDG
KAHYFNYGVADRERAVGVSEQTLFEIGSVSKTLTATLGAYAVVQGGFELDDKASLFAPWL
KGSAFDNITMGELATYSAGGLPLQFPEEVDSLEKMQAYYRQWTPAYSRGSHRQYANPSIG
LFGYLAASSMKQPFDRLMEQTMLPGLGLYHTYLNVPEQPMGHYAYGYWKEDKPFRVTPAM
LAEEPYGIKTSSADLLRFVKANISGVDNAAMQQAIDLTHQGQYAVGEMTQGLGWERYPYP
VSEQTLLAGNSPAMIYNANPAAPAPAAAGHPVLFKKTGSTNGFGAYVAFVPAKGIGVVML
ANRNYPNEGTLKAGHAILTQLAR
>ACS44784|FEATURES|argannot|beta_lactam|MOX-6|antibiotic inactivation|1
MQQRQSILWGVLPTLMWAGLAHAGDRAATDPLRPVVDASIRPLLKEHRIPGMAVAVLKDG
KAHYFNYGVADRERAVGVSEQTLFEIGSVSKTLTATLGAYAVVQGSFELDDKASLFAPWL
KGSVFDNITMGELATYSAGGLPLQFPEEVDSLEKMQAYYRQWTPAYSPGSHRQYANPSIG
LFGYLAASSMKQPFDRLMEQTILPGLGLYHTYLNVPEQAMGHYAYGYSKEDKPIRVTPGM
LADEAYGIKTSSADLLRFVKANISGVDNAAMQQAIDLTHQGQYAVGEMTQGLGWERYAYP
VSEQTLLAGNSAAMIYNANPAAPAPAARGHPVLFNKTGSTNGFGAYVAFVPAKGIGIVML
ANRNSPIEGTLKAGHAILTQLAR
>ACS44785|FEATURES|argannot|beta_lactam|MOX-7|antibiotic inactivation|1
MQQRQSILWGALATLMWAGLVHAGDKAATDPLRPVVDASIRPLLKEHRIPGMAVAVLKDG
KAHYFNYGVADRERAVGVSEQTLFEIGSVSKTLTATLGAYAVVQGSFELDDKASLFAPWL
KGSVFDNITMGELATYSAGGLPLQFPEEVDSLEKMQAYYRQWTPAYSPGSHRQYANPSIG
LFGYLAASSMKQPFDRLMEQTMLPGLGLYHTYLTVPEQAMGHYAYGYSKEDKPIRVTPGM
LADEAYGIKTSSADLLRFVKANIGGVDNAAMQQAIDLTHQGQYAVGEMTQGLGWERYAYP
VSEQTLLAGNSPAMIYNAIPAVPAPAAAGHPVLFNKTGSTNGFGAYVAFVPAKGIGIVML
ANRNSPIEARIKAAHAILTQLAR
>AGH56079|FEATURES|argannot|beta_lactam|MOX-8|antibiotic inactivation|1
MQQRQSILWGALATLMWAGLAHAGDKAATDPLRPVVDASIRPLLKEHRIPGMAVAVLKDG
KAHYFNYGVADRERAVGVSEQTLFEIGSVSKPLTATLGAYAVVKGAMQLDDKASRHAPWL
KGSAFDSITMGELATYSAGGLPLQFPEEVDSLEKMQAYYRQWTPAYSPGSHRQYSNPSIG
LFGHLAASSMKQPFAQLMEQTLLPGLGLHHTYVNVPKQAMASYAYGYSKEDKPIRVSPGM
LADEAYGIKTSSADLLRFVKANISGVDDKALQQAISLTHKGHYSVGGMTQGLGWESYAYP
VSEQTLLAGNSPAMIYNANPAAPAPAAAGHPVLFNKTGSTSGFGAYVAFVPAKGIGIVML
ANRNYPIPARVKAAHAILTQLAR
>AAN63648|FEATURES|argannot|beta_lactam|TUS-1|antibiotic inactivation|1
MYHYFSSLFVLIFSTLVYPQSDKLKIEPLNDHMYVYTTYQVFQGVEYSSNALYVVTDEGV
ILIDTPWDKDQYAPLVEHIRREHNKEIKWVITTHFHEDRSGGLDYFNKAGAETYTYALTN
EILKQRNEPQATFTFGSTKQFNLGKEKIEVYFLGEGHSKDNTVVWFPEEAILYGGCLIKS
AEATTIGNIVDGNVEAWPTTIKAVKRKFKKAKVIIPGHDAWNQSGHLENTARILSAYQAQ
KLKNNKQL
>AAN63647|FEATURES|argannot|beta_lactam|MUS-1|antibiotic inactivation|1
MHRILSVITMLICTTLVHAQSDKLKIKQLNDNMYIYTTYQEFQGVTYSSNSMYVLTDEGV
ILIDTPWDKDQYEPLLEYIRSNHNKEVKWVITTHFHEDRSGGLGYFNSIGAQTYTYALTN
EILKERNEPQAQHSFNKEKQFTFGNEKLAVYFLGEGHSLDNTVVWFPKEEVLYGGCLIKS
AEATTIGNIADGNVIAWPKTIEAVKQKFKNAKVIIPGHDEWDMTGHIENTERILSAYNQQ
HSTKND
>ADM26831|FEATURES|argannot|beta_lactam|TLA-1|antibiotic inactivation|1
MKKHLVVIAFCVLFASASAFAAKGTDSLKSSIEKYLKDKKAKVGVAVLGIEDNFKLNVNE
KHHYPMQSTYKFHLALAVLDKLDKENISIDKKLFVKKSELLPNTWSPLRDKYPDGNVDLS
ISEILKATVSRSDNNGCDILFRFVGGTNKVHNFISKLGVKNISIKATEEEMHKAWNVQYT
NWTTPDATVQLLKKFYKNEILSKNSYDYLLNTMIETTTGPKRLKGLLPDGTVVAHKTGSS
DTNDKGITAATNDIGIITLPNGKHFAIAVYVSDSSEKSDVNEKIIAEICKSVWDYLVKDG
K
>ABW05394|FEATURES|argannot|beta_lactam|ampC|antibiotic inactivation|1
MKQRIALSLLALGPLLLVPRVYAAADEPMANIVEKAVQPLLEEYRIPGMAVAVLKEGKPH
YFNYGVANRESGRRISERTLFEIGSVSKTFTATLGTYAVVKGGFRLDDKVSQHAPWLQNS
AFDRVTMAQLATYSAGGLPLQFPDAVDSNERMRQYYRQWSPLYAAGTHREYSNPSIGLFG
HLAASTLGQPFRQLMSQTLLPKLDLQHTYLEVPDAAMVDYAYGYSKEDKPVRVNPGVLAD
EAYGIKTSAADLIKFVGANMTGSGDKAVQQALAMTRTGFYSVGEMTQGLGWESYAYPVTE
QALLAGNSPAVSFKANPVKPFVAPRVMGNERLYNKTGSTNGFGAYVVFVPARGVGIVMLA
NRNYPIEARVKAAYAIMRHLAP
>AAT90846|FEATURES|argannot|beta_lactam|SLB-1|antibiotic inactivation|1
MLSLPSYSHEVEPTSTTIQSVTSSLEGQLSISKLADGVYLHHSYKNVSNFGLVEANGLVV
IKDKQAFIIDTPWTDNDTQKLVDWITQQGFIPVASISTHSHQDRAGGIGYLNRQGITTTV
SETTQQILTENDKTTAKSTFTGMQYIMKTDLVEVYDLGAGHTKDNLVVWLPTQQILFGGC
LIKSLNSSTLGYTGEADLQQWPLTIAKVQAQFPQVKIVVPGHGQVGDKALLEHTIELLIP
KNETVNSSS
>AAT90847|FEATURES|argannot|beta_lactam|SFB-1|antibiotic inactivation|1
MISAPSFAHENEQQTDQSNTDAVKKPQQQPTELFLSPLVPDVYLHQSYKQVSGFGLVESN
GLVVVQNKQAFIIDTPWTDSDTAKLVDWITQQGLTVTASISTHSHQDRAGGIGYLNSQGI
ATWVSDKTQRLLTANKLSTASHTFRTKQHTLQQQLIEVYDLGAGHTVDNLLVWLPKQQIL
FGGCLIKSLSSRTLGYTGEADLEQWPLTVAKVQAQFIQAKIVVPGHGKIGDTSLLSHTID
LLTQ
>BAL14456|FEATURES|argannot|beta_lactam|SMB-1|antibiotic inactivation|1
MKIIASLILAAFASVAQAQDRDWSSPQQPFTIYGNTHYVGTGGISAVLLSSPQGHILVDG
TTEKGAQVVAANIRAMGFKLSDVKYILSTHSHEDHAGGISAMQKLTGATVLAGAANVDTL
RTGVSPKSDPQFGSLSNFPGSAKVRAVADGELVKLGPLAVKAHATPGHTEGGITWTWQSC
EQGKCKDVVFADSLTAVSADSYRFSDHPEVVASLRGSFEAVEKLSCDIAIAAHPEVNDMW
TRQQRAAKEGNSAYVDNGACRAIAAAGRKRLETRLASEKR
>BAA23130|FEATURES|argannot|beta_lactam|SRT-1|antibiotic inactivation|1
MTKMNRLAAALIAALILPTAQAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
VASKQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQGKLSFNDPASRYLPELRGSAFDGV
SLLNLATHTSGLPLFVPDDVTNDAQLMAYYRAWQPKHPAGSYRVYSNLGIVMLGMIAAKS
LDQPFIQAMEQGMLPALGMSHTYVQVPAAQMANYAQGYSKDDKPVRVNPGPLDAKSYGIK
SNARDLIRYLDANLQQVKVAHAWRDALAATHVGYYKAGAFTQDLMWENYPYPVKLSRLIE
GNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFP
NDDRVEAAYHIVQALEKR
>WP_024531368|FEATURES|argannot|beta_lactam|Sfh-1|antibiotic inactivation|1
IILNIKYLFTAVTFLLIACESMASEKNLTLTHFKGPLYIVEDKEYVQENSMVYIGTDGIT
IIGATWTPETAETLYKEIRKVSPLPINEVINTNYHTDRAGGNAYWKTLGAKIVATQMTYD
LQKSQWGSIVNFTRQGNNKYPNLEKSLPDTVFPGDFNLQNGSIRAMYLGEAHTKDGIFVY
FPAERVLYGNCILKENLGNMSFANRTEYPKTLEKLKGLIEQGELKVDSIIAGHDTPIHDV
GLIDHYLTLLEKAPK
>ACO57220|FEATURES|argannot|beta_lactam|NmcR|antibiotic inactivation|0
MRSNPPLNALRAFEASARHLSFTRAALELYVTQAAVSQQVRLLEERLGMVLFKRLPRGLE
MTEESRALFAVLTDAFGHIEKAFRQFEGGQFQEVLTVAAVGTFAVGWLLPRLDRFRQEHP
FVKLRLRTNNNVVNLAAEGLDFAIRFGTGLWPSTHNEMLFNAPLTVLCTPATAKRLVTPA
DLLQEDLLRSYRAEEWENWFAAAGLQAVRVNGAIFDSSRLMIESAIHSGGVALAPAKMFV
RELTTAQLVRPFATEINMGSYWLTHLKSKAMTPAMEIFSEWLLKEAAEDNT
>AAK63223|FEATURES|argannot|beta_lactam|Sed1|antibiotic inactivation|1
MLKERFRQTVFIAAAVMPFIFSSTSLHAQATSDVQQVQKKLAALEKQSGGRLGVALINTA
DNSQVLYRADERFAMCSTSKVMTAAAVLKQSETHDGILQQKMTIKKADLTNWNPVTEKYV
GNTMTLAELSAATLQYSDNTAMNKLLAHLGGPGNVTAFARSIGDTTFRLDRKEPELNTAI
PGDERDTTSPLAMAKSLRKLTLGDALAGPQRAQLVDWLKGNTTGGQSIRAGLPAHWVVGD
KTGAGDYGTTNDIAVIWPEDRAPLVLVTYFTQPQQDAKWRKDVLAAAAKIVTEGK
>AAB72007|FEATURES|argannot|beta_lactam|ROB-1|antibiotic inactivation|1
MLNKLKIGTLLLLTLTACSPNSVHSVTSNPQPASAPVQQSATQATFQQTLANLEQQYQAR
IGVYVWDTETGHSLSYRADERFAYASTFKALLAGAVLQSLPEKDLNRTISYSQKDLVSYS
PETQKYVGKGMTIAQLCEAAVRFSDNSATNLLLKELGGVEQYQRILRQLGDNVTHTNRLE
PDLNQAKPNDIRDTSTPKQMAMNLNAYLLGNTLTESQKTILWNWLDNNATGNPLIRAATP
TSWKVYDKSGAGKYGVRNDIAVVRIPNRKPIVMAIMSTQFTEEAKFNNKLVEDAAKQVFH
TLQLN
>AAK83220|FEATURES|argannot|beta_lactam|blaRAHN-1|antibiotic inactivation|1
MMKNTLRKTALMAAAVVPMLAFSAASWAQTATKMTSVQQQLTALEKESGGRLGVMLIDTA
DNSQIAYRADERFAMCSTSKFMAASAILKESEVKKNLLTQHVALKQSDLVNYNPITEKHL
NDGMTIGELAAAALQYSDNAAMNKLIEHLGGPHKVTDYARTLGDKTFRLDRTEPTLNTAI
PGDDRDTTSPRAMALSLQHATLGSALAEPQRAQLVEWMKGNTTGAMSIRAGLPATWVVGD
KTGSGDYGTTNDIAVIWPENKAPLVLVTYFTQPEKDAKSRRDVLASAAKIVTQGY
>ADO51656|FEATURES|argannot|beta_lactam|BL2be_ctxm|antibiotic inactivation|1
MMKNTLRKTVLMAAAVVPMLAFSAVSWAQTATKMTSVQQQLTALEKESGGRLGVMLINTE
DNSQIAYRADERFAMCSTSKFMAASAILKQSETQTELLNRRVSLTRSDLVNYNPITEKHL
DTGMTVGELAAAALQYSDNTAMNKLIEQLGGPQKVTEYARTLGDKTFRLDRTEPTLNTAI
PGDDRDTTSPRAMALSLQHVTLGSALAEPQRAQLVEWMKGNTTGAMSIRAGLPATWVVGD
KTGSGDYGTTNDIAVIWPDNKAPLILITYFTQPQKDAKSRRDVLASAAKIVTPGY
>ADW20349|FEATURES|argannot|beta_lactam|LRA-1|antibiotic inactivation|1
MFLYFTQIRAWPLAALLLFMLAACAGAPRAPDDATDTASDALAALELRNGGRLGVFALDA
GSGRSLGWREDERFGMCSTFKLLLAATVLDAARQGRLDGTAPIHFSDDDLVPHSPVLREH
LALGSSTLTAPELARATQLTSDNAAANLLIRKLGGPEAVTALWRASGDEVSRLDRLEPDM
NLLPPGDLRDSTSPRAMAQHVARLFTSEMLVPEDRERLREWMVETGTGLARLRAATPPHW
QAGDKTGSAIAPLMPNKTHDVAVFWPPGRAPVIVAAYYESDAHHAGRIRAQDEAVLAQVG
RIAVAWAGD
>ABQ10556|FEATURES|argannot|beta_lactam|PER-1|antibiotic inactivation|1
MNVIIKAVVTASTLLMVSFSSFETSAQSPLLKEQIESIVIGKKATVGVAVWGPDDLEPLL
INPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWAPIMKAYQGDEF
SVPVQQLLQYSVSHSDNVACDLLFELVGGPAALHDYIQSMGIKETAVVANEAQMHADDQV
QYQNWTSMKGAAEILKKFEQKTQLSETSQALLWKWMVETTTGPERLKGLLPAGTVVAHKT
GTSGIKAGKTAATNDLGIILLPDGRPLLVAVFVKDSAESSRTNEAIIAQVAQTAYQFELK
KLSALSPN
>CAA63714|FEATURES|argannot|beta_lactam|PER-2|antibiotic inactivation|1
MNVITKCVFTASALLMLGLSSFVVSAQSPLLKEQIETIVTGKKATVGVAVWGPDDLEPLL
LNPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQSVTVNRAAVLQNTWSPMMKDHQGDEF
TVAVQQLLQYSVSHSDNVACDLLFELVGGPQALHAYIQSLGVKEAAVVANEAQMHADDQV
QYQNWTSMKAAAQVLQKFEQKKQLSETSQALLWKWMVETTTGPQRLKGLLPAGTIVAHKT
GTSGVRAGKTAATNDAGVIMLPDGRPLLVAVFVKDSAESERTNEAIIAQVAQAAYQFELK
KLSAVSPD
>AAU89132|FEATURES|argannot|beta_lactam|PER-3|antibiotic inactivation|1
MNVIIKAVVTASTLLMVSFSSFETSAQSPLLKEQIESIVIGKKATVGVAVWGPDDLEPLL
INPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWAPIMKAYQGDEF
SVPVQQLLQYSVSLSDNVACDLLFELVGGPAALHDYIQSMGIKETAVVANEAQMHADDQV
QYQNWTSMKGAAEILKKFEQKTQLSETSQALLWKWMVETTTGPERLKGLLPAGTVVAHKT
GTSGIKAGKTAATNDLGIILLPDGRPLLVAVFVKDSAESSRTNEAIIAQVAQTAYQFELK
KLSALSPN
>ACE77058|FEATURES|argannot|beta_lactam|PER-4|antibiotic inactivation|1
MNVIIKAVVTASTLLMVSFSSFETSAQSPLLKEQIESIVIGKKATVGVAVWGPDDLEPLL
INPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWAPIMKAYQGDEF
SVPVQQLLQYSVSHTDNVACDLLFELVGGPAALHDYIQSMGIKETAVVANEAQMHADDQV
QYQNWTSMKGAAEILKKFEQKTQLSETSQALLWKWMVETTTGPERLKGLLPAGTVVAHKT
GTSGIKAGKTAATNDLGIILLPDGRPLLVAVFVKDSAESSRTNEAIIAQVAQTAYQFELK
KLSALSPN
>ACN22483|FEATURES|argannot|beta_lactam|PER-5|antibiotic inactivation|1
MNVIIKAVVTASTLLMVSFSSFETSAQSPLLKGQIESIVIGKKATVGVAVWGPDDLEPLL
INPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWAPIMKAYQGDEF
SVPVQQLLQYSVSHSDNVACDLLFELVGGPAALHDYIQSMGIKETAVVANEAQMHADDQV
QYQNWTSMKGAAEILKKFEQKTQLSETSQALLWKWMVETTTGPERLKGLLPAGTVVAHKT
GTSGIKAGKTAATNDLGIILLPDGRPLLVAVFVKDSAESSRTNEAIIAQVAQTAYQFELK
KLSALSPN
>ADU79020|FEATURES|argannot|beta_lactam|PER-6|antibiotic inactivation|1
MNVIAKGVFTTTALLMLSLSSWVVSAQSPLLKEQIETIVTGKKATVGVAVWGPDDLEPLL
VNPFEKFPMQSVFKMHLAMLVLHQVDQGKLDLNKTVAVNRAAVLQNTWSPMMKDHQGDEF
TVTVQQLLQYSVSHSDNVACDLLFELVGGPAALHAYIQSLGIKETEVVANEAQMHADDQV
QYKNWTSMKAAAQLLRKFEQKKQLSETSQALLWKWMVETTTGPQRLKGLLPAGTVVAHKT
GTSGVRAGKTAATNDIGVIMLPDGRPLLVAVFVKDSAESARTNEAIIAQVAQAAYQFELK
KLSAVSPD
>AFE02728.1|FEATURES|argannot|beta_lactam|PER-7|antibiotic inactivation|1
MNVIIKAVVTASTLLMVSFSSFETSAQSPLLKEQIESIVIGKKATVGVAVWGPDDLEPLL
INPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWAPIMKAYQGDQF
SVPVQQLLQYSVSHSDNVACDLLFELVGGPAALHDYIQSMGIKETAVVANEAQMHADDQV
QYQNWTSMKGAAEILKKFEQKTQLSETSQALLWKWMVETTTGPERLKGLLPAGTVVAHKT
GTSGVRAGKTAATNDLGIILLPDGRPLLVAVFVKDSAESSRTNEAIIAQVAQAAYQFELK
KLSALSPN
>BAP39824|FEATURES|argannot|beta_lactam|blaPER-8|antibiotic inactivation|1
MNVIIKAVVTASTLLMVSFSSFETSAQSPLLKEQIESIVIEKKATVGVAVWGPDDLEPLL
INPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWAPIMKAYQGDQF
SVPVQQLLQYSVSHSDNVACDLLFELVGGPAALHDYIQSMGIKETAVVANEAQMHADDQV
QYQNWTSMKGAAEILKKFEQKTQLSETSQALLWKWMVETTTGPERLKGLLPAGTVVAHKT
GTSGVRAGKTAATNDLGIILLPDGRPLLVAVFVKDSAESSRTNEAIIAQVAQAAYQFELK
KLSALSPN
>AEN02811|FEATURES|argannot|beta_lactam|blaKPC-18|antibiotic inactivation|1
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ
>AEN02506|FEATURES|argannot|beta_lactam|KPC-3|antibiotic inactivation|1
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKYSEAVIAAAARLALEGLGVNGQ
>ACL01102|FEATURES|argannot|beta_lactam|KPC-4|antibiotic inactivation|1
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVRWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGGY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ
>ABY91240|FEATURES|argannot|beta_lactam|KPC-5|antibiotic inactivation|1
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVRWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ
>ACB71165|FEATURES|argannot|beta_lactam|KPC-6|antibiotic inactivation|1
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGGY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ
>ACE62798|FEATURES|argannot|beta_lactam|KPC-7|antibiotic inactivation|1
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAIDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKYSEAVIAAAARLALEGLGVNGQ
>ACI95258|FEATURES|argannot|beta_lactam|KPC-8|antibiotic inactivation|1
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGGY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKYSEAVIAAAARLALEGLGVNGQ
>ACM91559|FEATURES|argannot|beta_lactam|KPC-9|antibiotic inactivation|1
RLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYRAEERF
PLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAELSAAA
VQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTSSPRAV
TESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGAYGTAND
YAVVWPTGRAPIVLAVYTRAPNKDDKYSEAVIAAAARLALEGLG
>ACS35345|FEATURES|argannot|beta_lactam|KPC-10|antibiotic inactivation|1
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVRWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKYSEAVIAAAARLALEGLGVNGQ
>ADH95186|FEATURES|argannot|beta_lactam|KPC-11|antibiotic inactivation|1
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVLWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ
>AEA73284|FEATURES|argannot|beta_lactam|KPC-13|antibiotic inactivation|1
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLGTPIRYGKNALVPWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKYSEAVIAAAARLALEGLGVNGQ
>AEA73285|FEATURES|argannot|beta_lactam|KPC-13|antibiotic inactivation|1
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLGTPIRYGKNALVPWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDCWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKYSEAVIAAAAGLALEGLGVNGQ
>AFV48348|FEATURES|argannot|beta_lactam|KPC-14|antibiotic inactivation|1
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
ANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ
>AGF70638|FEATURES|argannot|beta_lactam|KPC-15|antibiotic inactivation|1
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVRWSPISEKYLTTGMTVLE
LSAAAVQYSDNAAANLLLKELGGPAKLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGGY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKYSEAVIAAAARLALEGLGVNGQ
>AGJ01153|FEATURES|argannot|beta_lactam|KPC-16|antibiotic inactivation|1
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAASQRQQLVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ
>AGJ01154|FEATURES|argannot|beta_lactam|KPC-17|antibiotic inactivation|1
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQLVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ
>AIH07017|FEATURES|argannot|beta_lactam|KPC-19|antibiotic inactivation|1
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKYSEAVIAAAARLALEGLGVTGQ
>AIX87991|FEATURES|argannot|beta_lactam|KPC-22|antibiotic inactivation|1
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPGSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQLVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ
>AKQ06274|FEATURES|argannot|beta_lactam|blaKPC-24|antibiotic inactivation|1
MSLYRPLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ
>CAB75346|FEATURES|argannot|beta_lactam|L1|antibiotic inactivation|1
MRSTLLAFALSSLALAATLFTFDGAAADASLPQLQAYTVDPSWLQTMAPLQIADHTWQIG
THDLTALLVQTADGLVLIDGGMPQMASYLLTNMKARGTNTGPLRMVLLSHAHTDHAGPVA
EIKRRTGAQVVVNAETAVLLARGGSDDLHFGDEITFPPVNADRIVMDREVVKLGGIAFTA
HFMPGHTPGSTAWTWTDTRDGKPVRIAYADSLSAPGYQLQGNARYPRLVEDYRRSFATVR
GLPCDLLLTPHPGASNWNYAAGSNASEKVLSCKAYADAAEKKFDAQLAKETAGAR
>CAA55007|FEATURES|argannot|beta_lactam|LAT-1|antibiotic inactivation|1
MMKKSLCSALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDCIARGEIKLSDPVTKYWPELTGKK
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGRLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>CAA40146|FEATURES|argannot|beta_lactam|LCR-1|antibiotic inactivation|1
MLKSTLLAFGLFIALSARAENQAIAKLFLRAGVDGTIVIESLTTGQRLVHNDPRAQQRYP
AASTFKVLNTLIALEEGAISGENQIFHWNGTQYSIANWNQDQTLDSAFKVSCVWCYQQIA
LRVGALKYPAYIQQTNYGHLLEPFNGTEFWLDGSLTISAEEQVAFLRQVVERKLPFKASS
YDSLKKVMFADENAQYRLYAKTGWATRMTPSVGWYVGYVEAKDDVWLFALNLATRDANDL
PLRTQIAKDALKAIGAFPTK
>BAF91108|FEATURES|argannot|beta_lactam|KHM-1|antibiotic inactivation|1
MKIALVISFGLLLFTNMVCADDSLPELDIQKIEDGVYLYTAYEKIEGWGLVGSNGLVVLD
NKNAYLIDTPISATDTEKLVKWIDAQGFTAKASISTHFHTDSTGGIAFLNSKSIPTYASK
LTNQLLKNKGEEQATHSFGKNPYWLLKNKIEAFYPGAGHTPDNLVVWLPKQKILFGGCFV
KPEGLGNLSHAVIAEWPASAEKLIARYSNATMVVPGHGKVGDASLLEKTRQRAVEALAAK
K
>AAK96394|FEATURES|argannot|beta_lactam|CARB-1|antibiotic inactivation|1
MKFLLAFSLLIPSVVFASSSKFQQVEQDVKAIEVSLSARIGVSVLDTQNGEYWDYNGNQR
FPLTSTFKTIACAKLLYDAEQGKVNPNSTVEIKKADLVTYSPVIEKQVGQAITLDDACFA
TMTTSDNTAANIILSAVGGPKGVTDFLRQIGDKETRLDRIEPDLNEGKLGDLRDTTTPKA
IASTLNKFLFGSALSEMNQKKLESWMVNNQVTGNLLRSVLPAGWNIADRSGAGGFGARSI
TAVVWSEHQAPIIVSIYLAQTQASMEERNDAIVKIGHSIFDVYTSQSR
>CAP72547|FEATURES|argannot|beta_lactam|CARB-10|antibiotic inactivation|1
MTRSALLIPLTTAAIALNAISPVYASDTHSIDDTVKQVETTLGAKVGIAVLDTGSQRAWF
HRADDRFPMASTSKALTCAALLDKGQSFMNKEALIKKADLDEYAPVTSGIVGKKVSAADL
CSITMRTSDNTAVNKVLEILGGPQAVTAYLRKTGDNITRLDRNEPDLNEGTPGDVRDTTT
PRAILETLNKLVLGPTLGSDERKQLTTWLESNEVGDPLLRAGVPSDWRVADRTGAGGNGT
RGVIAVMWPPKHAPIIAAIYITQTKATMEERNAAIASIGKAIAAEVLE
>ABO21411|FEATURES|argannot|beta_lactam|IND-7|antibiotic inactivation|1
MKKSIRFFIVSILLSPFASAQVKDFVIEPPIKNNLHIYKTFGVFGGKEYSANSMYLVTKK
GVVLFDVPWEKVQYQSLMDTIKKRHNLPVVAVFATHSHDDRAGDLSFFNNKGIKTYATAK
TNEFLKKDGKATSTEIIKIGKPYRIGGEEFVVDFLGEGHTADNVVVWFPKYNVLDGGCLV
KSNSATDLGYIKEANVEQWPKTINKLKAKYSKATLIIPGHDEWKGGGHVEHTLELLNKK
>ABO21414|FEATURES|argannot|beta_lactam|IND-2|antibiotic inactivation|1
MKKSIQLLMMSMFFSPLINAQVKDFVIEPPVKPNLYLYKSFGVFGGKEYSANAVYLTTKK
GVVLFDVPWQKEQYQTLMDTIQKRHHLPVIAVFATHSHDDRAGDLSFYNQKGIKTYATAK
TNELLKKDGKATSTEIIKTGKPYKIGGEEFMVDFLGEGHTVDNVVVWFPKYKVLDGGCLV
KSRTATDLGYTGEANVKQWPETMRKLKTKYAQATLVIPGHDEWKGGGHVQHTLDLLDKNK
KPE
>AAG29763|FEATURES|argannot|beta_lactam|IND-3|antibiotic inactivation|1
MKKRIQFFMVSMMLSSLFSAQVKDFVIEPPIKKNLHIYKTFGVFGGKEYSANSVYLVTQK
GVVLFDVPWEKVQYQSLMDTIQKRHNLPVIAVFATHSHDDRAGDLSFFNNKGIKTYATSK
TNEFLKKDGKATSTEIIKTGKPYRIGGEEFVVDFLGEGHTADNVVVWFPKYNVLDGGCLV
KSKAATDLGYIKEANVEQWPKTINKLKSKYSKASLVIPGHDEWKGGGHVKHTLELLNKK
>AAG29765|FEATURES|argannot|beta_lactam|IND-4|antibiotic inactivation|1
MRKNVRIFTVLSLFLINFFNAQARDFVIEQPFGKQLYLYKTFGVFDGKEYSTNALYLVTK
KGVVLFDVPWQKTQYQSLMDTIKKRHNLPVIAVFATHSHSDRAGDLSFYNKKGIPTYATA
KTNELLKKEGKATSSKLTKIGKKYKIGGEEFTVDFLGEGHTADNVVVWFPKYNVLDGGCL
VKSSAAVDLGYTGEANVEQWPATMKKLQAKYPSTAKVIPGHDEWKGNDHVKHTLELLDQQ
KQ
>AAS78754|FEATURES|argannot|beta_lactam|IND-5|antibiotic inactivation|1
MKKRIQFFMVSMMLAPMFNAQVKDFVIEPPIKNNLHIYKTFGVFGGKEYSANSVYLVTKK
GVVLFDVPWEKAQYQSLMDTIKKRHNLPVIAVFATHSHDDRAGDLSFFNNKGIKTYATSK
TNEFLKKDGKATSTEIIKTGKPYRIGGEEFTVDFLGEGHTADNVVVWFPKYNVLDGGCLV
KSNSATDLGYIKEANVEQWPITIDKLKAKYSKATLIIPGHDDWKGGGHVEHTLELLNKK
>CAJ32373|FEATURES|argannot|beta_lactam|IND-6|antibiotic inactivation|1
MKRRIQFFMVSMMLTPLFSAQVKDFVIEPPIKKNLYIYKTFGVFGGKEYSANSVYLVTKT
GVVLFDVPWEKAQYQSLMDTIKKRHNLPVVAVFATHSHDDRAGDLSFFNNKGIKTYATPK
TNQFLKRDGKATSTELIKPGKPYRFGGEEFVVDFLGEGHTADNVVVWFPKYKVLDGGCLV
KSNSATDLGYIKEANLEQWPKTMHKLKTKYSEAVLIIPGHDEWKGGGHVEHTLELLDKK
>BAJ05825|FEATURES|argannot|beta_lactam|IND-7|antibiotic inactivation|1
MKKSIRFFIVSILLSPFASAQVKDFVIEPPIKNNLHIYKTFGVFGGKEYSANSMYLVTKK
GVVLFDVPWEKVQYQSLMDTIKKRHNLPVVAVFATHSHDDRAGDLSFFNNKGIKTYATAK
TNEFLKKDGKATSTEIIKTGKPYRIGGEEFVVDFLGEGHTADNVVVWFPKYNVLDGGCLV
KSNSATDLGYIKEANVEQWPKTINKLKAKYSKATLIIPGHDEWKGGGHVEHTLELLNKK
>ACZ65152|FEATURES|argannot|beta_lactam|IND-8|antibiotic inactivation|1
MKKSIQFFIVSMLLSPFANSQVKDFVIEPPIKSNLYIYKTFGVFGGKEYSANAAYLKTKK
GVILFDVPWEKVQYQSLMDTIKKRHNLPVIAVFATHSHDDRAGDLSFFNNKGIKTYATLK
TNEFLKKDGKATSTEIIQTGKPYHIGGEEFVVDFLGEGHTADNVVVWFPKYNVLDGGCLV
KSNSATDLGYIKEANVEQWPKTMNKLKTKYSKATLIIPGHDEWKGGGHVEHTLELLNKK
>ACZ65153|FEATURES|argannot|beta_lactam|IND-9|antibiotic inactivation|1
MKKSIQFFIVSLLLSPFANAQVKDFVIEPPISKNLYIYKTFGVFGGKEYSANAVYLVTKK
GVVLFDVPWEKVQYQSLMDTIKKRHNLPVVAVFATHSHDDRAGDLSFFNKKGIKTYATAK
TNELLKKEGKAVSSNIINTGKAYHIGGEEFVVDFIGEGHTVDNVVVWFPKYKVLDGGCLV
KSTSATDLGYIKEANVEQWPQTMNTLKSKYSQATLIIPGHDEWKGGGHVEHTLELLNKK
>ADA13241|FEATURES|argannot|beta_lactam|IND-10|antibiotic inactivation|1
MKKSIQFFIVSMLLSPFANAQVKDFVIEPPIKSNLYIYKTFGVFGGKEYSANAAYLKTKK
GVILFDVPWEKVQYQSLMDTIKKRHNLPVIAVFATHSHDDRAGDLSFFNNKGIKKYATLK
TNEFLKKDGKATSTEIIQTGKPYHIGGEEFVVDFLGEGHTADNVVVWFPKYNVLDGGCLV
KSNSATDLGYIKEANVEQWPKTMNKLKTKYSKATLIIPGHDEWKGGGHVEHTLELLNKK
>ADK25050|FEATURES|argannot|beta_lactam|IND-11|antibiotic inactivation|1
MKKSIQLLMMSMFLSPLINAQVKDFVIEPPVKPNLYLYKSFGVFGGKEYSANAVYLTTKK
GVVLFDVPWQKEQYQTLMDTIQKRHHLPVIAVFATHSHDDRAGDLSFYNQKGIKTYATAK
TNELLKKDGKATSTEIIKTGKPYKIGGEEFMVDFLGEGHTVDNVVVWFPKYKVLDGGCLV
KSRTATDLGYTGEANVKQWPETMRKLKTKYAHATLVIPGHDEWKGGGHVQHTLDLLDKNK
KPE
>ADK25051|FEATURES|argannot|beta_lactam|IND-12|antibiotic inactivation|1
MKKSIQLLMMSMFLSPLINAQVKDFVIEPPVKPNLYLYKSFGVFGGKEYSANAVYLTTKK
GVVLFDVPWQKEQYQTLMDTIQKRHHLPVIAVFATHSHDDRAGDLSFYNQKGIKTYATAK
TNELLKKDGKATSTEIIKTGKPYKIGGEEFMVDFLGEGHTVDNVVVWFPKYKVLDGGCLV
KSRTATDLGYTGEANVKQWPETMRKLKTKYAQATLVIPGHDEWKGGGHVQHSLDLLDKNK
KPE
>ADK25052|FEATURES|argannot|beta_lactam|IND-2a|antibiotic inactivation|1
MKKSIQLLMMSMFLSPLINAQVKDFVIEPPVKPNLYLYKSFGVFGGKEYSANAVYLTTKK
GVVLFDVPWQKEQYQTLMDTIQKRHHLPVIAVFATHSHDDRAGDLSFYNQKGIKTYATAK
TNELLKKDGKATSTEIIKTGKPYKIGGEEFMVDFLGEGHTVDNVVVWFPKYKVLDGGCLV
KSRTATDLGYTGEANVKQWPETMRKLKTKYAQATLVIPGHEEWKGGGHVQHTLDLLDKNK
KPE
>ADK38716|FEATURES|argannot|beta_lactam|IND-14|antibiotic inactivation|1
MKKRIQFFMVSMMLSPLFSAQVKDFVIEPPIKKNLHIYKTFGVFGGKEYSANSVYLVTQK
GVVLFDVPWEKVQYQSLMDTIQKRHNLPVIAVFATHSHDDRAGDLSFFNNKGIKTYATAK
TNEFLKKDGKATSTEIIKTGKPYRIGGEEFVVDFLGEGHTADNVVVWFPKYNVLDGGCLV
KSKAATDLGYIKEANVEQWPKTINKLKSKYSKASLVIPGHDEWKGGGHIEHTLELLNKK
>BAJ14288|FEATURES|argannot|beta_lactam|IND-15|antibiotic inactivation|1
MKKSIQLLMMSMFLSPLINAQVKDFVIEPPVKPNLYLYKSFGVFGGKEYSANAVYLTTKK
GVVLFDVPWQKEQYQTLMDTIQKRHHLPVIAVFATHSHDDRAGDLSFYNQKGIKTYATAK
TNELLKKDGKATSTEIIKTGKPYKIGGEEFMVDFLGEGHTVDNVVVRFPKYKVLDGGCLV
KSRTATDLGYTGEANVKQWPETMRKLKMKYAQATLVIPGHDEWKGGGHVQHTLDLLDKNK
KPE
>ADH03007|FEATURES|argannot|beta_lactam|IMP-14|antibiotic inactivation|1
MKKLFVLCVFFFCNIAVAEESLPDLKIEKLEEGVYVHTSFEEVKGWSVVTKHGLVVLVKN
DAYLIDTPITAKDTEKLVNWFVERGYKIKGSISTHFHGDSTAGIEWLNSQSIPTYASELT
NELLKKDNKVQAKHSFNGVSYSLIKNKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFVKP
DGLGYLGDANLEAWPKSAKILMSKYGKAKLVVSSHSDIGDVSLLKRTWEQAVKGLNESKK
SSQPSD
>BAD26594|FEATURES|argannot|beta_lactam|IMP-2|antibiotic inactivation|1
MKKLFVLCVCFLCSITAAGARLPDLKIEKLEEGVYVHTSFEEVNGWGVVSKHGLVVLVNT
DAYLIDTPFTATDTEKLVNWFVERGYKIKGTISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKNSFSGVSYWLVKNKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFVKP
DGLGNLGDANLEAWPKSAKILMSKYVKAKLVVSSHSEIGDASLLKRTWEQAVKGLNESKK
PSQPSN
>BAA77393|FEATURES|argannot|beta_lactam|IMP-3|antibiotic inactivation|1
MSKLSVFFIFLFCSIATAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIGWLNSRSIPTYASELT
NELLKKDGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILFGGCFIKP
YGLGNLGDANIEAWPKSAKLLKSKYGKAKLVVPGHSEVGDASLLKLTLEQAVKGLNESKK
PSKPSN
>ABC24668|FEATURES|argannot|beta_lactam|IMP-26|antibiotic inactivation|1
MSKLSVFFIFLFCSIATAAEPLPDLKIEKLDEGVYVHTSFEEVNGWGVFPKHGLVVLVDA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKNSFGGVNYWLVKNKIEVFYPGPGHTPDNLVVWLPERKILFGGCFIKP
YGLGNLGDANLEAWPKSAKLLISKYGKAKLVVPSHSEAGDASLLKLTLEQAVKGLNESKK
PSKLSN
>AAK27847|FEATURES|argannot|beta_lactam|IMP-5|antibiotic inactivation|1
MSKLFVFFMFLFCSITAAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNT
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKNSFSGASYWLVKKKIEVFYPGPGHTPDNVVVWLPENRVLFGGCFVKP
YGLGNLGDANVEAWPKSAKLLMSKYGKAKLVVPSHSEVGDASLLKRTLEQAVKGLNESKK
PSKPSN
>BAL45798|FEATURES|argannot|beta_lactam|IMP-6|antibiotic inactivation|1
MSKLSVFFIFLFCSIATAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSRSIPTYASELT
NELLKKDGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILFGGCFIKP
YGLGNLGDANIEAWPKSAKLLKSKYGKAKLVVPGHSEVGDASLLKLTLEQAVKGLNESKK
PSKPSN
>AAT48071|FEATURES|argannot|beta_lactam|IMP-7|antibiotic inactivation|1
MKKLSVFFMFLFCSIAASGEALPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNT
DAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKNSFSGASYWLVKKKIEIFYPGPGHTPDNVVVWLPEHRVLFGGCFVKP
YGLGNLGDANLEAWPKSAKLLVSKYGKAKLVVPSHSEVGDASLLKRTLEQAVKGLNESKK
LSKPSN
>AEI54179|FEATURES|argannot|beta_lactam|IMP-24|antibiotic inactivation|1
MKKLFVLCVCFLCSITAAGAALPDLKIEKLEEGVYVHTSFEEVNGWGVVSKHGLVVLVNT
DAYLIDTPFTATDTEKLVNWFVERGYKIKGTISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKNSFSGVSYWLVKNKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFVKP
DGLGNLGDANLEAWPKSAKILMSKYGKAKLVVSSHSEIGDASLLKRTWEQAVKGLNESKK
PSQPSN
>ADI49236|FEATURES|argannot|beta_lactam|IMP-9|antibiotic inactivation|1
MSKLFVFFMFLFCSITAAGESLPDLKIEKLDEGVYVHTSFEEVNGWGVIPKHGLVVLVNT
DAYLIDTPFTAKDTENLVNWFVERGYRIKGSISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKYSFSGVSYWLVKKKIEVFYPGPGHAPDNVVVWLPENRVLFGGCFVKP
YGLGNLGDANLEAWPKSAKLLMSKYSKAKLVVPSHSDIGDSSLLKLTWEQTVKGFNESKK
STTAH
>BAB72072|FEATURES|argannot|beta_lactam|IMP-11|antibiotic inactivation|1
MKKLFVLCIFLFCSITAAGASLPDLKIEKLEEGVYVHTSFEEVNGWGVVSKHGLVVLVNT
DAYLIDTPFTAKDTEKLVNWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASVLT
NELLKKDGKVQAKNSFSGVSYWLVKNKIEVFYPGPGHTQDNVVVWLPKNKILFGGCFVKP
YGLGNLDDANVEAWPHSAEKLISKYGNAKLVVPSHSDIGDASLLKLTWEQAVKGLNESKK
SNTVH
>AER27704|FEATURES|argannot|beta_lactam|IMP-13|antibiotic inactivation|1
MKKLFVLCVCFFCSITAAGAALPDLKIEKLEEGVFVHTSFEEVNGWGVVTKHGLVVLVNT
DAYLIDTPFTATDTEKLVNWFVERGYEIKGTISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKSGKVQAKYSFSEVSYWLVKNKIEVFYPGPGHTQDNLVVWLPESKILFGGCFIKP
HGLGNLGDANLEAWPKSAKILMSKYGKAKLVVSSHSEKGDASLMKRTWEQALKGLKESKK
TSSPSN
>AAT49070|FEATURES|argannot|beta_lactam|IMP-15|antibiotic inactivation|1
MNKLSVFFMFMFCSITAAGESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNT
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKNSFSGGSYWLVNNKIEVFYPGPGHTPDNVVVWLPENRVLFGGCFVKP
YGLGNLGDANLEAWPKSAKILMSKYGKAKLVVSSHSETGNASLLKLTWEQAVKGLKESKK
PSLPSN
>CAE48334|FEATURES|argannot|beta_lactam|IMP-16|antibiotic inactivation|1
MKKLFVLCIFLFCSITAAGESLPDLKIEKLEDGVYVHTSFEEVNGWGVVTKHGLVFLVNT
DAYLIDTPFAAKDTEKLVNWFVERGYKIKGSISSHFHSDSSGGIEWLNSQSIPTYASELT
NELLKKNGKVQAKNSFSGVSYWLLKNKIEIFYPGPGHTQDNVVVWLPEKKILFGGCFVKP
YGLGNLDDANVEAWPHSAEILMSRYGNAKLVVPSHSDVGDASLLKLTWEQAVKGLKESKK
PSQPSN
>BAJ19094.1|FEATURES|argannot|beta_lactam|IMP-18|antibiotic inactivation|1
MKKLFVLCVFFLCNIAAADDSLPDLKIEKLEKGVYVHTSFEEVKGWGVVTKHGLVVLVKN
DAYLIDTPITAKDTEKLVNWFIEHGYRIKGSISTHFHGDSTAGIEWLNSQSISTYASELT
NELLKKDNKVQATNSFSGVSYSLIKNKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFVKP
DGLGNLGDANLEAWPKSAKILMSKYGKAKLVVSSHSEIGNASLLQRTWEQAVKGLNESKK
PLQPSS
>BAD89185|FEATURES|argannot|beta_lactam|IMP-19|antibiotic inactivation|1
MKKLFVLCVCFLCSITAAGAALPDLKIEKLEEGVYVHTSFEEVNGWGVVSKHGLVVLVNT
DAYLIDTPFTATDTEKLVNWFVERGYKIKGTISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKNSFSGVSYWLVKNKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFVKP
DGLGNLGDANLEAWPKSAKILMSKYVKAKLVVSSHSEIGDASLLKRTWEQAVKGLNESKK
PSQPSN
>BAD81061|FEATURES|argannot|beta_lactam|IMP-20|antibiotic inactivation|1
MKKLFVLCVCFLCSITAAGAALPDLKIEKLEEGVYVHTSFEEVNGWGVFSKHGLVVLVNT
DAYLIDTPFTATDTEKLVNWFVERGYKIKGTISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKNSFSGVSYWLVKNKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFVKP
DGLGNLGDANLEAWPKSAKILMSKYVKAKLVVSSHSEIGDASLLKRTWEQAVKGLNESKK
PSQPSN
>BAD89802|FEATURES|argannot|beta_lactam|IMP-21|antibiotic inactivation|1
MKKLFVLCIFLFCSITAAGASLPDLKIEKLEEGVYVHTSFEEVNGWGVASKHGLVVLVNT
DAYLIDTPFTAKDTEKLVNWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASVLT
NELLKKDGKVQAKNSFSGVSYWLVKNKIEVFYPGPGHTQDNVVVWLPKNKILFGGCFVKP
YGLGNLDDANVEAWPHSAEKLISKYGNAKLVVPSHSDIGDASLLKLTWEQAVKGLNESKK
SNTVH
>CAS92952|FEATURES|argannot|beta_lactam|IMP-22|antibiotic inactivation|1
MKKLFVLCVFLFCSITAAGESLPDLKIEKLEEGVYVHTSFEEVNGWGVVSKHGLVILVNT
DAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELT
NDLLKQNGKVQAKNSFSGVSYWLVKNKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFVKP
YGLGNLDDANVVAWPHSAEILMSRYGNAKLVVPSHSDIGDASLLKLTWEQAVKGLKESKK
PSEPSN
>ABM68358|FEATURES|argannot|beta_lactam|IMP-24|antibiotic inactivation|1
MKKLFVLCVCFLCSITAAGAALPDLKIEKLEEGVYVHTSFEEVNGWGVVSKHGLVVLVNT
DAYLIDTPFTATDTEKLVNWFVERGYKIKGTISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKNSFSGVSYWLVKNKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFVKP
DGLGNLGDANLEAWPKSAKILMSKYGKAKLVVSSHSEIGDASLLKRTWEQAVKGLNESRK
PSQPSN
>ABY60377|FEATURES|argannot|beta_lactam|IMP-45|antibiotic inactivation|1
MSKLFVFFMFLFCSITAAGESLPDLKIEKLDEGVYVHTSFEEVNGWGVIPKHGLVVLVNT
DAYLIDTPFTAKDTENLVNWFVERGYRIKGSISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKYSFSGVSYWLVKKKIEVFYPGPGHAPDNVVVWLPENRVLFGGCFVKP
YGLGNLGDANLEAWPKSAKLLMSKYSKAKLVVPGHSDIGDSSLLKLTWEQTVKGFNESKK
STTAH
>AEH41427|FEATURES|argannot|beta_lactam|IMP-27|antibiotic inactivation|1
MKKLFVLCVFVFCSITVAGETLPNLRVEKLEEGVYVHTSYEEVKGWGVVTKHGLVVLIGA
DAYLIDTPFTAKDTEKLVNWFVERGYKIKGTVSSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKNSFDGVSYWLAKDKIEVFYPGPGHTQDNVVVWLPEKEILFGGCFVKP
HGLGNLGDANLEAWPESAKILMEKYGKAKLVVSGHSETGDATHLKRTWEQAVKGLKESKK
TLQPSN
>ADU33210|FEATURES|argannot|beta_lactam|IMP-28|antibiotic inactivation|1
MSKLFVFFMFLFCSITAAAESLPDLKIERLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNT
EAYLIDTPFTAKDTEKLVTWFVGRGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKNSFGGVSYWLVKNKIEVFYPGPGHTPDNVVVWLPENRVLFGGCFVKP
YGLGNLGDANLEAWPKSAKLLMSKYGKAKLVVPSHSEVGDASLLKRTLEHAVKGLNESKK
PSKPSN
>ADT63777|FEATURES|argannot|beta_lactam|IMP-29|antibiotic inactivation|1
MSKLFVFLIFLFCSITAAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNT
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKGGKVQAKNSFSGVSYWLVKKKIEVFYPGPGHTPDNVVVWLPENRVLFGGCFVKP
YGLGNLDDANVEAWPHSAEILMSRYGNAKLVVPSHSDIGNASLLKLTWEQAVKGLKESKK
PSQPSN
>AEN75249|FEATURES|argannot|beta_lactam|IMP-38|antibiotic inactivation|1
MSKLSVFFIFLFCSIATAAEPLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVDA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKNSFGGVNYWLVKNKIEVFYPGPGHTPDNLVVWLPERKILFGGCFIKP
YGLGNLGDANLEAWPKSAKLLISKYGKAKLVVPGHSEAGDASLLKLTLEQAVKGLNESKK
PSKLSN
>AFR33816|FEATURES|argannot|beta_lactam|IMP-32|antibiotic inactivation|1
MKKLFVLCVFFFCNIAVAEESLPDLKIEKLEEGVYVHTSFEEVKGWSVVTKHGLVVLVKN
DAYLIDTPITAKDTEKLVNWFVERGYKIKGSISTHFHGDSTAGIEWLNSQSIPTYASELT
NELLKKDNKVQAKHSFYGVSYSLIKNKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFVKP
DGLGYLGDANLEAWPKSAKILMSKYGKAKLVVSSHSDIGDVSLLKRTWEQAVKGLNESKK
SSQPSD
>AEU17778|FEATURES|argannot|beta_lactam|IMP-33|antibiotic inactivation|1
MKKLFVLCVCFFCSITAAGSSLPDLKIEKLEEGVFVHTSFEEVNGWGVVTKHGLVVLVNT
DAYLIDTPFTATDTEKLVNWFVERGYKIKGTISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKSGKVQAKYSFSEVSYWLVKNKIEVFYPGPGHTQDNLVVWLPESKILFGGCFVKP
HGLGNLGDANLEAWPKSAKILMSKYGKAKLVVSSHSEKGDASLLKRTWEQALKGLKESKK
TSSPSN
>BAP75826|FEATURES|argannot|beta_lactam|IMP-34|antibiotic inactivation|1
MSKLSVFFIFLFCSIATAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIGWLNSRSIPTYASELT
NELLKKDGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILFGGCFIKP
YGLGNLGDANIEAWPKSAKLLKSKYGKAKLVVPSHSEVGDASLLKLTLEQAVKGLNESKK
PSKPSN
>AFO59566|FEATURES|argannot|beta_lactam|IMP-35|antibiotic inactivation|1
MKKIFVLFVFLFCSITAAGESLPDIKIEKLDEDVYVHTSFEEDNGWGVITKHGLVVLVNT
DAYIIDTPFTAKDTEKLVRWFVGRGYKIKGSISSHFHSDSAGGIEWLNSQSIPTYASKLT
NELLKKNGNAQAENSFSGVSYWLVKHKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFIKP
DGLGYLGDANLEAWPKSAETLMSKYGNAKLVVSSHSEIGGASLLKRTWEQAVKGLKESKK
PSQPNN
>AFP97028|FEATURES|argannot|beta_lactam|IMP-37|antibiotic inactivation|1
MKKLFVLCVCFFCSITAAGAALPDLKIEKLEEGVFVHTSFEEVNGWGVVTKHGLVVLVNT
DAYLIDTPFTATDTEKLVNWFVERGYEIKGTISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKSGKVQAKYSFSEVSYWLVKNKIEVFYPGPGHTQDNLVVWLPESKILFGGCFIKP
HGLGNLGDANLEAWPKSAKILMSKYGKAKLVVSSHSEKGDASLMKRTWEQALKGLKESKK
TSSQSTAS
>BAA08930.1|FEATURES|argannot|beta_lactam|IMP-1|antibiotic inactivation|1
MSKLSVFFIFLFCSIATAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSRSIPTYASELT
NELLKKDGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILFGGCFIKP
YGLGNLGDANIEAWPKSAKLLKSKYGKAKLVVPSHSEVGDASLLKLTLEQAVKGLNESKK
PSKPSN
>BAM62794|FEATURES|argannot|beta_lactam|IMP-40|antibiotic inactivation|1
MSKLSVFFIFLFCSIATAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVFPKHGLVVLVNA
EAYLIDTPSTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSRSIPTYASELT
NELLKKDGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILFGGCFIKP
YGLGNLGDANIEAWPKSAKLLKSKYGKAKLVVPSHSEVGDASLLKLTLEQAVKGLNESKK
PSKPSN
>BAM62795|FEATURES|argannot|beta_lactam|IMP-41|antibiotic inactivation|1
MKKLFVLCIFLFCSITAAGASLPDLKIEKLEEGVYVHTSFEEVNGWGVFSKHGLVVLVNT
DAYLIDTPFTAKDTEKLVNWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASVLT
NELLKKDGKVQAKNSFSGVSYWLVKNKIEVFYPGPGHTQDNVVVWLPKNKILFGGCFVKP
YGLGNLDDANVEAWPHSAEKLISKYGNAKLVVPSHSDIGDASLLKLTWEQAVKGLNESKK
SNTVH
>BAM62793|FEATURES|argannot|beta_lactam|IMP-42|antibiotic inactivation|1
MSKLSVFFIFLFCSIATAAESLPDLKIEKLDEGVYVHTSFEEVNRWGVVPKHGLVVLVNA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSRSIPTYASELT
NELLKKDGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILFGGCFIKP
YGLGNLGDANIEAWPKSAKLLKSKYGKAKLVVPSHSEVGDASLLKLTLEQAVKGLNESKK
PSKPSN
>BAM98935|FEATURES|argannot|beta_lactam|IMP-43|antibiotic inactivation|1
MKKLSVFFMFLFCSIAASGEALPDLKIEKLDEGVYVHTSFEEVNGWGVFPKHGLVVLVNT
DAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKNSFSGASYWLVKKKIEIFYPGPGHTPDNVVVWLPEHRVLFGGCFVKP
YGLGNLGDANLEAWPKSAKLLVSKYGKAKLVVPSHSEVGDASLLKRTLEQAVKGLNESKK
LSKPSN
>BAM98942|FEATURES|argannot|beta_lactam|IMP-44|antibiotic inactivation|1
MKKLFVLCIFLFCSITAAGASLPDLKIEKLEEGVYVHTSFEEVNGWGVFSKHGLVVLVNT
DAYLIDTPSTAKDTEKLVNWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASVLT
NELLKKDGKVQAKNSFSGVSYWLVKNKIEVFYPGPGHTQDNVVVWLPKNKILFGGCFVKP
YGLGNLDDANVEAWPHSAEKLISKYGNAKLVVPSHSDIGDASLLKLTWEQAVKGLNESKK
SNTVH
>AKO63210|FEATURES|argannot|beta_lactam|IMP-18|antibiotic inactivation|1
MKKLFVLCVFFLCNIAAADDSLPDLKIEKLEKGVYVHTSFEEVKGWGVFTKHGLVVLVKN
DAYLIDTPITAKDTEKLVNWFIEHGYRIKGSISTHFHGDSTAGIEWLNSQSISTYASELT
NELLKKDNKVQATNSFSGVSYSLIKNKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFVKP
DGLGNLGDANLEAWPKSAKILMSKYGKAKLVVSSHSEIGNASLLQRTWEQAVKGLNESKK
PLQPSS
>BAQ56016|FEATURES|argannot|beta_lactam|IMP-51|antibiotic inactivation|1
MKKLSVFFMFLFCSIAASGEALPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNT
DAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKNSFSGASYWLVKKKIEIFYPGPGHTPDNVVVWLPEHRVLFGGCFVKP
YGLGNLGDANLEAWPKSAKLLVSKYGKAKLVVPGHSEVGDASLLKRTLEQAVKGLNESKK
LSKPSN
>BAR80870|FEATURES|argannot|beta_lactam|blaIMP-52|antibiotic inactivation|1
MSKLSVFFIFLFCSIATAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNA
EAYIIDTPFTAKDTEKLGTWFVERGYKIKGSISSHFHSDSTGGIEWLNSRSIPTYASELT
NELLKKDGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILFGGCFIKP
YGLGNLGDANIEAWPKSAKLLKSKYGKAKLVVPSHSEVGDASLLKLTLEQAVKGLNESKK
PSKPSN
>AEU10762|FEATURES|argannot|beta_lactam|IMI-2|antibiotic inactivation|1
MSLNVKPSRIAILFSSCLVSISFFSQANTKGIDEIKNLETDFNGRIGVYALDTGSGKSFS
YKANERFPLCSSFKGFLAAAVLKGSQDNQLNLNQIVNYNTRSLEFYSPITTKYKDNGMSL
GDMAAAALQYSDNGATNIILERYIGGPEGMTKFMRSIGDKDFRLDRWELDLNTAIPGDER
DTSTPAAVAKSLKTLALGNILNEREKETYQTWLKGNTTGAARIRASVPSDWVVGDKTGSC
GAYGTANDYAVVWPKNRAPLIISVYTTKNEKEAKHEDKVIAEASRIAIDNLK
>ACX71212|FEATURES|argannot|beta_lactam|IMI-3|antibiotic inactivation|1
MSLNVKQSRIAILFISCLFSISFFSQANTKGIDEIKNLETDFNGRVGVYALDTGSGKSFS
YKANERFPLCSSFKGFLAAAVLKGSQDNQLNLNQIVNYNTRSLEFHSPITTKYKDNGMSL
GDMAAAALQYSDNGATNIILERYIGGPEGMTKFMRSIGDEDFRLDRWELDLNTAIPGDER
DTSTPAAVAKSLKTLALGNILSEREKETYQTWLKGNTTGAARIRASVPSDWVVGDKTGSC
GAYGTANDYAVVWPKNRAPLIISVYTTKNEKEAKHEDKVIAEASRIAIDNLK
>AHE78014|FEATURES|argannot|beta_lactam|IMI-4|antibiotic inactivation|1
MSLNVKPSRIAILFSSCLVSISFFSQANTKGIDEIKDLETDFNGRIGVYALDTGSGKSFS
YKANERFPLCSSFKGFLAAAVLKGSQDNQLNLNQIVNYNTRSLEFHSPITTKYKDNGMSL
GDMAAAALQYSDNGATNIILERYIGGPEGMTKFMRSIGDKDFRLDRWELDLNTAIPGDER
DTSTPAAVAKSLKTLALGNILNEREKETYQTWLKGNTTGAARIRASVPSDWVVGDKTGSC
GAYGTANDYAVVWPKNRAPLIISVYTTKYEKEAKHEDKVIAEASRIAIDNLK
>AIS19858|FEATURES|argannot|beta_lactam|IMI-7|antibiotic inactivation|1
MSLNVKPSRIAILFSSCLVSISFFSQANTKGIDEIKDLEKDFNGRIGVYALDTGSGKSFS
YKANERFPLCSSFKGFLAAAVLKGSQDNQLNLNQIVNYNTRSLEFHSPITTKYKDNGMSL
GDMAAAALQYSDNGATNIILERYIGGPEGMTKFMRSIGDKDFRLDRWELDLNTAIPGDER
DTSTPAAVAKSLKTLALGNILNEREKETYQTWLKGNTTGAARIRASVPSDWVVGDKTGSC
GAYGTANDYAVVWPKNRAPLIISVYTTKNEKEAKHEDKVIAEASRIAIDNLK
>AIY69088|FEATURES|argannot|beta_lactam|bla(IMI-8)|antibiotic inactivation|1
MSINAKKSKAAVFLSYFLIPISFYSQADTNAMDEIKKLETGFGGRVGVYALDTGSGKSFS
YRANERFPLCSSFKGFLAAAVLKGSQDNQLNINEIVNYNKRSLEPHSPITQKYKENGMSL
GDMAAAALQYSDNGAANIILERYIGGPEGMTNFMRSIGDEDFRLDRWELDLNTAIPGDER
DTSTPAAVGKSLKNLALGNILNDHEKETYQTWLKGNTTGAARIRASVPSDWVVGDKTGTC
GAYGTANDYAVVWPKNRAPLIISVYTTKSEKEAKHDEKVIEEASRIAITHLK
>AAL26797|FEATURES|argannot|beta_lactam|dsx2_1119|antibiotic inactivation|1
MKKITPLFVIAFLTLIALLAPAQASVTPDMTDFLRQQEQRLHARIGMAVVNAQGETVFGY
RQDERFPLTSTFKTLACAALLERLQKNGGSLDEQVTIPPDALLDYAPVTKNYLAPATISL
RMLCAAAVSYSDNTAGNRILTYLGGPDAVTQFMRGIGDHVTRLDRTEPTLNEATPGDARD
TSSPQKMAAGLQKILTSPPLISANRATLAQWMRDDKVGDALLRAALPKGWAIADKTGAGG
YGSRAIIAAVYPPERPPFYVAIFITQTEASMKMANETIAEIGKQLFAGQP
>AAL26995|FEATURES|argannot|beta_lactam|dsx2_1119|antibiotic inactivation|1
MKKITPLFAIAFLTLIALLAPAQASVTPDMTDFLRQQEQRLHARIGMAVVNAQGETVFGY
RQDERFPLTSTFKTLACAALLERLQKNGGSLDEQVTIPPDALLDYAPVTKNYLAPATISL
RMLCAAAVSYSDNTAGNRILTYLGGPDAVTQFMRGIGDHVTRVDRTEPTLNEATPGDARD
TSSPQKMAAGLQKILTAPPLTPANRAVLAQWMRDDKVGDALLRAALPKGWAIADKTGAGG
YGSRAIIAAVYPPERPPFYVAIFITQTEASMKMANETIAEIGKQLFAGQP
>AAL26996|FEATURES|argannot|beta_lactam|dsx2_1119|antibiotic inactivation|1
MKKITPLFAIAFLTLIALLAPAQASVTPDMTDFLRQQEQRLHARIGMAVVNAQGETVFGY
RQDERFPLTSTFKTLACAALLERLQKNGGSLDEQVTIPPDALLDYAPVTKNYLAPATISL
RMLCAAAVSYSDNTAGNRILTYLGGPDAVTQFMRGIGDHVTRLDRTEPTLNEATPGDARD
TSSPQKMAAGLQKILTAPPLTPANRAVLAQWMRDDKVGDALLRAALPKGWAIADKTGAGG
YGSRAIIAAVYPPERPPFYVAIFITQTEASMKMANETIAEIGKQLFAGQP
>CAD60968|FEATURES|argannot|beta_lactam|dsx2_1119|antibiotic inactivation|1
MKKITPLFVIAFLTLIALLAPAQASVTPDMTDFLRQQEQRLHARIGMAVVNAQGETVFGY
RQDERFPLTSTFKTLACAALLERLQKNGGSLDEQVTIPPDALLDYAPVTKNYLAPATISL
RMLCAAAVSYSDNTAGNRILTYLAGPDAVTQFMRGIGDHVTRLDRTEPTLNEATPGDARD
TSSPQKMAAGLQKILTSPPLISANRATLAQWMRDDKVGDALLRAALPKGWAIADKTGAGG
YGSRAIIAAVYPPERPPFYVAIFITQTEASMKMANETTAEIGKQLFAGQP
>CAD60969|FEATURES|argannot|beta_lactam|dsx2_1119|antibiotic inactivation|1
MKKITPLFAIAFLTLIALLAPAQASVTPDMTDFLRQQEQRLHARIGMAVVNAQGETVFGY
RQDERFPLTSTFKTLACAALLERLQKNGGSLDEQVTIPPDALLDYAPVTKNYLAPATISL
RMLCAAAVSYSDNTAGNRILTYLGGPDAVTQFMRGIGEHVTRLDRTEPTLNEATPGDARD
TSSPQKMAAGLQKILTAPPLTPANRATLAQWMRDDKVGDALLRAALPKGWAIADKTGAGG
YGSRAIIAAVYPPERPPFYVAIFITQTEASMKMANETIAEIGKQLFAGQP
>CAD60970|FEATURES|argannot|beta_lactam|dsx2_1119|antibiotic inactivation|1
MKKITPLFAIAFLTLIALLAPAQASVTPDMTDFLRQQEQRLHARIGMAVVNAQGETVFGY
RQDERFPLTSTFKTLACAALLERLQKNGGSLDEQVTIPPDALLDYAPVTKNYLAPATISL
RMLCAAAVSYSDNTAGNRILTYLGGPDAVTQFMRGIGDHVTRLDRTEPTLNEATPGDARD
TSSPQKMAAGLQKILTAPPLTPANRATLAQWMRDDKVGDALLRAALPKGWAIADKTGAGG
YGSRAIIAAVYPPERPPFYVAIFITQTEASMKMANEAIAAIGKQLFAGQP
>CAD60972|FEATURES|argannot|beta_lactam|dsx2_1119|antibiotic inactivation|1
MKKITPLFAIAFLTLIALLAPAQASVTPDMTDFLRQQEQRLHARIGMAVVNAQGETVFGY
RQDERFPLTSTFKTLACAALLERLQKNGGSLDEQVTIPPDALLDYAPVTKNYLAPATISL
RMLCAAAVSYSDNTAGNRILTYLGGPDAVTQFMRGIGDPVTRLDRTEPTLNEATPGDARD
TSSPQKMAAGLQKILTAPPLTPANRAVLAQWMRDDKVGDALLRAALPKGWAIADKTGAGG
YGSRAIIAAVYPPERPPFYVAIFITQTEASMKMANEAIPAIGKQLFAGQP
>AAF04458|FEATURES|argannot|beta_lactam|GOB-1|antibiotic inactivation|1
MRNFATLFFMFICLGLNAQVVKEPENMPKEWNQAYEPFRIAGNLYYVGTYDLASYLIVTD
KGNILINTGTAESLPIIKANIQKLGFNYKDIKILLLTQAHYDHTGALQDFKTETAAKFYA
DKADVDVLRTGGKSDYEMGKYGVTFKPVTPDKTLKDQDKIKLGNITLTLLHHPGHTKGSC
SFIFETKDEKRKYRVLIANMPSVIVDKKFSEVTAYPNIQSDYAYTFGVMKKLDFDIWVAS
HASQFDLHEKRKEGDPYNPQLFMDKQSYFQNLNDLEKSYLDKIKKDSQDK
>AAF89152|FEATURES|argannot|beta_lactam|GOB-1|antibiotic inactivation|1
KEPENMPNEWNQAYEPFRIAGNLYYLGTYDLASYLIVTDKGNILINTGTAESLPIIKANI
QKLGFNYKDIKILLLTQAHYDHTGALQDFKTETAAKFYADKADVDVLRTGGKSDYEMGKY
GVTFKPVTPDKTLKDQDKIKLGNITLTLLHHPGHTKGSCSFIFETKDEKRKYRVLIANMP
SVIVDKKFSEVTAYPNIQSDYAYTFGVMKKLDFDIWVASHASQFDLHEKRKEGDPYNPQL
FMDKQSYFQNLN
>AAF89147|FEATURES|argannot|beta_lactam|GOB-1|antibiotic inactivation|1
KEPENMPKEWNQTYEPFRIAGNLYYVGTYDLASYLIVTDKGNILINTGTAESLPIIKANI
QKLGFNYKDIKILLLTQAHYDHTGALQDLKTETGAKFYADKADADVLRTGGNSDYEMGKY
GVTFKPVTPDKTLKDQDKITLGNTILTLLHHPGHTKGSCSFIFETKDEKRKYRVLIANMP
SIIVDKKFSEVTAYLNIQSDYAYTFKAMKNLDFDLWVASHASQFDLHEKRKEGDPYNPQL
FMDKQSYFQNLN
>AAF89149|FEATURES|argannot|beta_lactam|GOB-1|antibiotic inactivation|1
KEPENMPKEWNQTYEPFRIAGNLYYVGTYDLASYLIVTDKGNILINTGTAESLPIIKANI
QKLGFNYKDIKILLLTQAHYDHTGALQDLKTETAAKFYADKADADVLRTGGNSDYEMGKY
GVTFKPVTPDKTLKDQDKITLGNTILTLLHHPGHTKGSCSFIFETKDEKRKYRVLIANMP
SVIVDKKFSEVTAYPNIQSDYAYTFKAMKNLDFDLWVASHASQFDLHEKRKEGDPYNPQL
FMDKQSYFQNLN
>AAF89146|FEATURES|argannot|beta_lactam|GOB-1|antibiotic inactivation|1
KEPENMPKEWNQTYEPFRIAGNLYYVGTYDLASYLIVTDKGNILINTGTAESLPIIKANI
QKLGFNYKDIKILLLTQAHYDHTGALQDLKTETAAKFYADKEDADVLRTGGKSDYEMGKY
GVTFKPVTPDKTLKDQDKIKLGNTILTLLHHPGHTKGSCSFIFETKDEKRKYRVLIANMP
SVIVDKKFSEVTAYPNIQSDYAYTFKAMKNLDFDLWVASHASQFDLHEKRKEGDPYNPQL
FMDKQSYFQNLN
>AAF89148|FEATURES|argannot|beta_lactam|GOB-1|antibiotic inactivation|1
KEPENMPKEWNQTYEPFRIAGNLYYVGTYDLASYLIVTDKGNILINTGTAESLPIIKANI
QKLGFNYKDIKILLLTQAHYDHTGALQDLKTETAAKFYADKADADVLRTGGNSDYEMGKY
GVTFKPVTPDKTLKDQDKIKLGNITLTLLHHPGHTKGSCSFIFETKDEKRKYRVLIANMP
SVIVDKKFSEVTAYPNIQSDYAYTFKAMKNLDFDLWVASHASQFDLHEKRKEGDPYNPQL
FMDKQSYFQNLN
>AAF89153|FEATURES|argannot|beta_lactam|GOB-1|antibiotic inactivation|1
KEPENMPKEWNQTYEPFRIAGNLYYVGTYDLASYLIVTDKGNILINTGTAESFPIIKGNI
QKLGFNYKDIKILLLTQAHYDHTGALQDFKTETGAKFYADKADADVLRTGGKSDYELGKY
GVTFKPVTPDKTLKDQDKITLGNTTLTLLHHPGHTKGSCSFIFETKDENRKYKILIANMP
SIIVDKKFSEVTAYPGIQSDYAYTFKAMKNLDFDIWVASHASQFDLHTKRKEGDSYNPQL
FMDKENYFKRLE
>AAQ54756|FEATURES|argannot|beta_lactam|GOB-1|antibiotic inactivation|1
MRNFVILFFMFICLGLNAQVVKEPENMPKEWNQTYEPFRIAGNLYYVGTYDLASYLIVTD
KGNILINTGTAESLPIIKANIQKLGFNYKDIKILLLTQAHYDHTGALQDLKTETGAKFYA
DKEDADVLRTGGKSDYEMGKYGVTFKPVTPDKTLKDQDKITLGNTILTLLHHPGHTKGSC
SFIFETKDEKRKYRVLIANMPSVIVDKKFSEVTAYPNIQSDYAYTFKAMKNLDFDIWVAS
HASQFDLHEKRKEGDPYNPQLFMDKQSYFQNLNDLEKSYLNKRKKDSQDK
>AAT68576|FEATURES|argannot|beta_lactam|GOB-1|antibiotic inactivation|1
MRNFVILFFMFICLGLNAQVVKEPENMPKEWNQTYEPFRIAGNLYYVGTYDLASYLIVTD
KGNILINTGTAESLPIIKANIQKLGFNYKDIKILLLTQAHYDHTGALQDLKTETGAKFYA
DKEDADVLRTGGKSDYEMGKYGVTFKPVTPDKTLKDQDKITLGNTILSLLHHPGHTKGSC
SFIFETKDEKRKYRVLIANMPSVIVDKKFSEVTAYPNIQSDYAYTFKAMKNLDFDIWVAS
HASQFDLHEKRKEGDPYNPQLFMDKQSYFQNLNDLEKSYLNKIKKDSQDK
>AAT68577|FEATURES|argannot|beta_lactam|GOB-1|antibiotic inactivation|1
MRNFVILFFMFICLGLNAQVVKEPENMPKEWNQTYEPFRIAGNLYYVGTYDLASYLIVTD
KGNILINTGTAESLPIIKANIQKLGFNYKDIKILLLTQAHYDHTGALQDLKTETGAKFYA
DKEDADVLRTGGKSDYEMGKYGVTFKPVTPDKTLKDQDKITLGNTILTLLHHPGHTKGSC
SFIFETKDEKRKYRVLIANMPSVIVDKKFSEVTAYPNIQSDYAYTFKAMKNLDFDIWVAS
HASQFDLHEKRKEGDPYNPQLFMDKQSYFQNLNDLEKSYLDKIKKDSQDK
>AAT68578|FEATURES|argannot|beta_lactam|GOB-1|antibiotic inactivation|1
MRNFATLFFLSACLSLSLNAQVVKEPENMPKEWNQTYEPFRIAGNLYYVGTYDLASYLIV
TDKGNILINTGTAESLTIIKGNIQKLGFNYKDIKVLLLTQAHYDHTGALEDFKTETGAKF
YADKADADVLKTGGKSDYELGKYGVTFKPITPDRTLKDQDKITLGNTTLTLLHHPGHTKG
SCSFIFETKDEKRKYRVLIANMPSIIVDKKFSEVAAYPNIQSDYAYTFGAMKKLDFDLWV
ASHASQFDLHEKRKEGDPYNPQLFMDKQSYFQNLNDLEKSYLDKIKKDSQDK
>AAT68579|FEATURES|argannot|beta_lactam|GOB-1|antibiotic inactivation|1
MRNFATLFFMFVCLGLNAQVVKEPENMPKEWNQTYEPFRIAGNLYYVGTYDLASYLIVTD
KGNILINTGTAESLPIIKANIQKLGFNYKDIKILLLTQAHYDHTGALQDLKTETAAKFYA
DKADADVLRTGGKSDYEMGKYGVTFKPITPDRTLKDQDKITLGNTTLTLLHHPGHTKGSC
SFIFETKDEKRKYRVLIANMPSIIVDKKFSEVTAYPNIQSDYAYTFGAMKKLDFDLWVAS
HASQFDLHEKRKEGDPYNPQLFMDKQSYFQNLNDLEKSYLDKIKKDSQDK
>AAT68580|FEATURES|argannot|beta_lactam|GOB-1|antibiotic inactivation|1
MRNFATLFFLSVCLNLNLNAQVVKEPENMPKEWNQTYEPFRIAGNLYYVGTYDLASYLIV
TDKGNILINTGTAESLPIIKGNIQKLGFNYKDIKILLLTQAHYDHTGALQDFKTETGAKF
YTDKADADVLKTGGKSDYELGKYGVTFKPITPDRTLKDQDKITLGNTTLTLLHHPGHTKG
SCSFIFDTKDEKRKYRVLIANMPSIIVDKKFSEVTAYPNIQSDYAYTFGAMKKLDFDLWV
ASHASQFDLHEKRKEGDPYNPQLFMDKQNYFQSLNNLEKSYLDKIKKDSQDK
>AAT68582|FEATURES|argannot|beta_lactam|GOB-1|antibiotic inactivation|1
MRNFATLFFLSVCLDLNLNAQVVKEPENMPKEWNQTYEPFRIAGNLYYVGTYDLASYLIV
TDKGNILINTGTAESLPIIKGNIQKLGFNYKDIKILLLTQAHYDHTGALQDFKTETGAKF
YTDKADADVLKTGGKSDYELGKYGVTFKPITPDRTLKDQDKITLGNTTLTLLHHPGHTKG
SCSFIFDTKDEKRKYRVLIANMPSIIVDKKFSEVTAYPNIQSDYAYTFGAMKKLDFDLWV
ASHASQFDLHEKRKEGDPYNPQLFMDKQNYFQSLNNLEKSYLDKIKKDSQDK
>AAV65595|FEATURES|argannot|beta_lactam|GOB-1|antibiotic inactivation|1
MRNFATLFFLSVCLNLNLNAQVVKEPENMPKEWNQTYEPFRIAGNLYYVGTYDLASYLIV
TDKGNILINTGTAEPLPIIKGNIQKLGFNYKDIKILLLTQAHYDHTGALQDFKTETGAKF
YTDKADADVLKTGGKSDYELGKYGVTFKPITPDRTLKDQDKITLGNTTLTLLHHPGHTKG
SCSFIFDTKDEKRKYRVLIANMPSIIVDKKFSEVTAYPNIQSDYAYTFGAMKKLDFDLWV
ASHASQFDLHEKRKEGDPYNPQLFMDKQNYFQSLNNLEKSYLDKIKKDSQDK
>ACZ72746|FEATURES|argannot|beta_lactam|GOB-1|antibiotic inactivation|1
MRNFAILFFLLITFSWKAQVVKEPENTNEEWSRSYEPFRIAGNLYYVGTYDLASYLIVTD
KGNILINTGLAGSLPMIKENIKKLGFNYKDIKILLLTQAHYDHTGALKDLQTETGAKFYA
DSADADVLKTGGKSDYEMGKYGATFKPIKPDILLKDQDKIKLGNTTLTLLHHPGHTKGSC
SFIFETKDENRNYKVLIANMPSVIVDRKFSEIKDYPNIQADYAYTFKAMKKLDFDLWVAS
HASQFDLHTKHKEGDPYNPQVFMDKANYFAFLNSLETDYLEKIKNDSQKK
>AAY53478|FEATURES|argannot|beta_lactam|GOB-1|antibiotic inactivation|1
MRNFATLFFMFICLGLSAQVVKEPENMPKEWNQAYEPFRIAGNLYYVGTYDLASYLIVTD
KGNILINTGTAESFPIIKANIQKLGFNYKDIKILLLTQAHYDHTGALQDFKTETAAKFYV
DKADVDVLRTGGKSDYEMGKYGVTFKPVTPDKTLKDQDKIKLGNITLTLLHHPGHTKGSC
SFIFETKDEKRKYRVLIANMPSVIVDKKFSEVTAYPNIQSDYAYTFGVMKKLDFDIWVAS
HASQFDLHEKRKEGDPYNPQLFMDKQSYFQNLNDLEKSYLNKIKKDSQDK
>AEX25999|FEATURES|argannot|beta_lactam|GIM-1|antibiotic inactivation|1
MKNVLVFLILLVALPALAQGHKPLEVIKIEDGVYLHTSFKNIEGYGLVDSNGLVVLDNNQ
AYIIDTPWSEEDTKLLLSWATDRGYQVMASISTHSHEDRTAGIKLLNSKSIPTYTSELTK
KLLAREGKPVPTHYFKDDEFTLGNGLIELYYPGAGHTEDNIVAWLPKSKILFGGCLVRSH
EWEGLGYVGDASISSWADSIKNIVSKKYPIQMVVPGHGKVGSSDILDHTIDLAESASNKL
MQPTAEASAD
>AIY26289|FEATURES|argannot|beta_lactam|GIM-2|antibiotic inactivation|1
MKNVLVFLILLVALPALAQGHKPLEVIKIEDGVYLHTSFKNIEGYGLVDSNGLVVLDNNQ
AYIIDTPWSEEDTKLLLSWATDRGYQVMASISTHSHGDRTAGIKLLNSKSIPTYTSELTK
KLLAREGKPVPTHYFKDDEFTLGNGLIELYYPGAGHTEDNIVAWLPKSKILFGGCLVRSH
EWEGLGYVGDASISSWADSIKNIVSKKYPIQMVVPGHGKVGSSDILDHTIDLAESASNKL
MQPTAEASAD
>CAQ53840|FEATURES|argannot|beta_lactam|AIM-1|antibiotic inactivation|1
MKRRFTLLGSVVALALSSTALASDAPASRGCADDAGWNDPAMPLKVYGNTWYVGTCGISA
LLVTSDAGHILVDAATPQAGPQILANIRALGFRPEDVRAIVFSHEHFDHAGSLAELQKAT
GAPVYARAPAIDTLKRGLPDRTDPQFEVAEPVAPVANIVTLADDGVVSVGPLALTAVASP
GHTPGGTSWTWRSCEGDDCRQMVYADSLTAISDDVFRYSDDAAHPGYLAAFRNTLARVAA
LDCDILVTPHPSASGLWNRIGPRAAAPLMDTTACRRYAQGARQRLEKRLAEEAATSPSSG
ARP
>ADN96169|FEATURES|argannot|beta_lactam|GES-1|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMGDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>AAK58421|FEATURES|argannot|beta_lactam|GES-2|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMNDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>BAD08689|FEATURES|argannot|beta_lactam|GES-4|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRTAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVKWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMSDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>AAR97271|FEATURES|argannot|beta_lactam|GES-6|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVKWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMSDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>AAK18183|FEATURES|argannot|beta_lactam|GES-8|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQL
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMGDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>AAY43207|FEATURES|argannot|beta_lactam|GES-9|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMGDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGSRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>ACS73598|FEATURES|argannot|beta_lactam|GES-10|antibiotic inactivation|1
MRFIHALLLAGTAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRTAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLCDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMGDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>AEO12975|FEATURES|argannot|beta_lactam|GES-11|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMGDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGARND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>CBG22732|FEATURES|argannot|beta_lactam|GES-12|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMGDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGACANGARND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>ACZ54536|FEATURES|argannot|beta_lactam|GES-13|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVKWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMNDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>ACZ98826|FEATURES|argannot|beta_lactam|GES-15|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKESEMSDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>ADJ94120|FEATURES|argannot|beta_lactam|GES-16|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAEIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMSDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>ADZ48685|FEATURES|argannot|beta_lactam|GES-17|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVKWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMGDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGARND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>AEX59144|FEATURES|argannot|beta_lactam|GES-18|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALIFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMSDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>AFK80745|FEATURES|argannot|beta_lactam|GES-21|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVLERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMSDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>AFU25739|FEATURES|argannot|beta_lactam|GES-22|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPELGDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGARND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>AGT20529|FEATURES|argannot|beta_lactam|GES-23|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGELVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMGDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>BAP75641|FEATURES|argannot|beta_lactam|GES-24|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRTAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMSDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>AJP67510|FEATURES|argannot|beta_lactam|GES-26|antibiotic inactivation|1
MRFIHALLLAAIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMGDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>CAA54602|FEATURES|argannot|beta_lactam|FOX-1|antibiotic inactivation|1
MQQRRAFALLTLGSLLLAPCTYARGEAPLTAAVDGIIQPMLKEYRIPGMAVAVLKDGKAH
YFNYGVANRESGQRVSEQTLFEIGSVSKTLTATLGAYAAVKGGFELDDKVSQHAPWLKGS
AFDGVTMAELATYSAGGLPLQFPDEVDSNDKMRTYYRHWSPVYPAGTHRQYSNPSIGLFG
HLAANSLGQPFEQLMSQTLLPKLGLHHTYIQVPESAIANYAYGYSKEDKPVRVTPGVLAA
EAYGIKTGSADLLKFTEANMGYQGDAALKTRIALTHTGFYSVGDMTQGLGWESYAYPLTE
QALLAGNSPAVSFQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPARGIAIVMLA
NRNYPIEARVKAAHAILSQLAE
>CAA71325|FEATURES|argannot|beta_lactam|FOX-2|antibiotic inactivation|1
MQQRRALALLTLGSLLLAPCTYASGEAPLTAAVDGIIQPMLKEYRIPGMAVAVLKDGKAH
YFNYGVANRESGQRVSEQTLFEIGSVSKTLTATLGAYAAVKGGFELDDKVSHHAPWLKGS
AFDGVTMAELATYSAGGLPLQFPDEVDSNDKMQTYYRSWSPVYPAGTHRQYSNPSIGLFG
HLAANSLGQPFEKLMSQTLLPKLGLHHTYIQVPESAMANYAYGYSKEDKPIRVTPGVLAA
EAYGIKTGSADLLKFVEANMGYQGDAALKSAIALTHTGFYSVGDMTQGLGWESYAYPVTE
QALLAGNSPAVSFQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPARGIAIVMLA
NRNYPIEARVKAAHAILSQLAE
>CAA71947|FEATURES|argannot|beta_lactam|FOX-3|antibiotic inactivation|1
MQQRRAFALLTLGSLLLAPCTYASGEAPLTATVDGIIQPMLKEYRIPGIAVAVLKDGKAH
YFNYGVANRESGQRVSEQTLFEIGSVSKTLTATLGAYAAVKGGFVLDDKVSQHAPWLKGS
ALDGVTMAELATYSAGGLPLQFPDKVDSNDKMQTYYRSWSPVYPAGTHRQYSNPSIGLFG
HLAANSLGQPFEQLMSQTLLPKLGLHHTYIQVPESAMANYAYGYSKEDKPIRVTPGVLAA
EAYGIKTGSADLLKFAEANMGYQGDALVKSAIALTHTGFYSVGEMTQGLGWESYDYPVTE
QVLLAGNSPAVSFQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPARGIAIVMLA
NRNYPIEARVKAAHAILSQLAE
>CAB89086|FEATURES|argannot|beta_lactam|FOX-4|antibiotic inactivation|1
MQQRRALALLMLGSLLLAPCTYASGEAPLTATVDGIIQPMLKAYRIPGMAVAVLKDGKAH
YFNYGVANRESGQRVSEQTLFEIGSVSKTLTATLGAYAAVKGGFELDDKVSQHAPWLKGS
AFDGVTMAELATYSAGGLPLQFPDEVDSNDKMQTYYRSWSPVYPAGTHRQYSNPSIGLFG
HLAANSLGQPFEQLMSQTLLPKLGLHHTYIQVPESAMANYAYGYSKEDKPIRATPGVLAA
EAYGIKTGSADLLKFVEANMGYQGDAALKSAIALTHTGFHSVGEMTQGLGWESYDYPVTE
QVLLAGNSPAVSFQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPARGIAIVMLA
NRNYPIEARVKAAHAILSQLAE
>AAG12974|FEATURES|argannot|beta_lactam|FOX-5|antibiotic inactivation|1
MQQRRAFALLTLGSLLLAPCTYASGEAPLTAAVDGIIQPMLKAYRIPGMAVAVLKDGKAH
YFNYGVANRESGQRVSEQTLFEIGSVSKTLTATLGAYAAVKGGFELDDKVSQHAPWLKGS
ALDGVTMAELATYSAGGLPLQFPDEVDSNDKMRTYYRSWSPVYPAGTHRQYSNPSIGLFG
HLAANSLGQPFEQLMSQTLLPKLGLHHTYIQVPESAMVNYAYGYSKEDKPVRVTPGVLAA
EAYGIKTGSADLLKFAEANMGYQGDAAVKSAIALTHTGFYSVGDMTQGLGWESYAYPVTE
QTLLAGNAPAVSFQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPARGIAIVMLA
NRNYPIEARVKAAHAILSQLAE
>CAG28257|FEATURES|argannot|beta_lactam|FOX-7|antibiotic inactivation|1
MQQRRAFALLTLGSLLLAPCTYARGEAPLTAAVDGIIQPMLKEYRIPGMAVAVLKDGKAH
YFNYGVANRESGQRVSEQTLFEIGSVSKTLTATLGAYAAVKGGFELDDKVSQHAPWLKGS
AFDGVTMAELATYSAGGLPLQFPDEVDSNDKMRTYYRHWSPVYPAGTHRQYSNPSIGLFG
HLAANSLGQPFEQLMSQTLLPKLGLHHTYIQVPESAIANYAYGYSKEDKPVRATPGVLAA
EAYGIKTGSADLLKFTEANMGYQGDAALKSAIALTHTGFYSVGDMTQGLGWESYAYPLTE
QALLAGNSPAVSFQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPARGIAIVMLA
NRNYPIEARVKAAHAILSQLAE
>ADK73994|FEATURES|argannot|beta_lactam|FOX-8|antibiotic inactivation|1
MQQRRAFALLTLGSLLLAPCTYASGEAPLTATVDGIIQPMLKEYRIPGIAVAVLKDGKAH
YFNYGVANRESGQRVSEQTLFEIGSVSKTLTATLGAYAAVKGGFVLDDKVSQHAPWLKGS
ALDGVTMAELATYSAGGLPLQFPDKVDSNDKMQTYYRSWSPVYPAGTHRQYSNPSIGLFG
HLAANSLGQPFEQLMSQTLLPKLGLHHTYIQVPESAMANYAYGYSKEDKPIRVTPGVLAA
EAYGIKTGSADLLKFAEANMGYQGDALVKSAIALTHTGFYSVGEMTQGLGWESYDYPVTE
QVLLAGNSPAVSLQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPARGIAIVMLA
NRNYPIEARVKAAHAILSQLAE
>AEK78851|FEATURES|argannot|beta_lactam|FOX-9|antibiotic inactivation|1
MQQRRAFALLTLGSLLLAPCTYASGEAPLTVTVDGIIQPMLKAYRIPGMAVAVLKDGKAH
YFNYGVANRESGQRVSEQTLFEIGSVSKTLTATLGAYAAVKGGFELDDKVSQHAPWLKGS
AFDGVTMAELATYSAGGLPLQFPEEVDSNDKMRTYYRSWSPVYPAGTHRQYANTSIGLFG
YLAANSLGQSFEQLMSQTLLPKLGLHHTYIQVPESAMANYAYGYSKEEKPIRVTPGMLAA
EAYGIKTGSADLLKFAEANMGYQGDAAVKSAIALTHTGFYSVGDMTQGLGWESYDYPVTE
QVLLADNSPAVSFQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPARGIAIVMLA
NRNYPIEARVKAAHAILSQLAE
>AGE45503|FEATURES|argannot|beta_lactam|FOX-10|antibiotic inactivation|1
MQQRRAFALLTLGSLLLAPCTYASGEAPLTAAVDGIIQPMLKAYRIPGMAVAVLKDGKAH
YFNYGVANRESGQRVSEQTLFEIGSVSKTLTATLGAYAAVKGGFELDDKVSQHAPWLKGS
ALDGVTMAELATYSAGGLPLQFPDEVDSNDKMRTYYRSWSPVYPAGTHRQYSNPSISLFG
HLAANSLGQPFEQLMSQTLLPKLGLHHTYIQVPESAMVNYAYGYSKEDKPVRVTPGVLAA
EAYGIKTGSADLLKFAEANMGYQGDAAVKSAIALTHTGFYSVGDMTQGLGWESYAYPVTE
QTLLAGNAPAVSFQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPARGIAIVMLA
NRNYPIEARVKAAHAILSQLAE
>CAB61635|FEATURES|argannot|beta_lactam|fonA-1|antibiotic inactivation|1
MIKNTLRKTTLMVATVMPLLFGSAPLWAQTANAKANIQQQLSELEKSSGGRLGVALIDTA
DNSQILYRGDERFPMCSTSKVMAVSALLKQSETDKNLLAKRMEIKQSDLVNYNPIAEKHL
DTGMTLAEFSAATIQYSDNTAMNKILEHLGGPAKVTEFARTIGDKTFRLDRTEPTLNTAI
PGDERDTSSPLAMAKSLQNLTLGKALGEPQRAQLVEWMKGNTTGGASIRAGLPTTWIVGD
KTGSGDYGTTNDIAVIWPANHAPLVLVTYFTQPQQNAEARKDVLAAAAKIVTEGL
>CAB61637|FEATURES|argannot|beta_lactam|fonA-2|antibiotic inactivation|1
MVKNTLRKTTLMVATVMPLLFSSAPLWAQTANAKANIQQQLSELEKNSGGRLGVALIDTA
DNSQILYRGDERFPMCSTSKVMAVSALLKQSETDKNLLAKRMEIKQSDLVNYNPIAEKHL
DTGMTLAEFSAATIQYSDNTAMNKILEHLGGPAKVTEFARTIGDKTFRLDRTEPTLNTAI
PGDPRDTSSPLAMAKSLQNLTLGKALGEPQRAQLVEWMKGNTTGGASIRAGLPTTWIVGD
KTGSGDYGTTNDIAVIWPANHAPLVLVTYFTQPQQNAEARKDVLAAAAKIVTEGL
>CAB61639|FEATURES|argannot|beta_lactam|fonA-3|antibiotic inactivation|1
MVKNILRKTTLMVTTVMPLLFGSAPLWAQTANAKANIQQQLSELEKNSGGRLGVALIDTA
DNSQILYRGDERFPMCSTSKVMAVSALLKQSETDKNLLAKRMEIKQSDLVNYNPIAEKHL
DTGMTLAEFSAATIQYSDNTAMNKILEHLGGPAKVTEFARTIGDKTFRLDRTEPTLNTAI
PGDKRDTTSPLAMAKSLQNLTLGKALGEPQRAQLVEWMKGNTTGGASIRAGLPTTWVVGD
KTGSGDYGTTNDIAVIWPANHAPLVLVTYFTQPQQNAEARKDVLAAAAKIVTEGL
>CAB61641|FEATURES|argannot|beta_lactam|fonA-4|antibiotic inactivation|1
MVKNTLRKTTLMVATVMPLLFGSAPLWAQTANAKANIQQQLSELEKSSGGRLGVALIDTA
DNSQILYRGDERFPMCSTSKVMAVSALLKQSETDKNLLAKRMEIKQSDLVNYNPIAEKHL
DTGMTLAEFSAATIQYSDNTAMNKILEHLGGPAKVTEFARTIGDKTFRLDRTEPTLNTAI
PGDERDTSSPLAMAKSLQNLTLGKALGEPQRAQLVEWMKGNTTGGASIRAGLPTTWIVGD
KTGSGDYGTTNDIAVIWPANHAPLVLVTYFTQPQQNAEARKDVLAAAAKIVTEGL
>CAB61643|FEATURES|argannot|beta_lactam|fonA-5|antibiotic inactivation|1
MVRNTLRQTTLMVATVMPLLFGSAPLWAQPANAKANIQQQLSELEKNSGGRLGVALIDTA
DNSQILYRGDERFPMCSTSKVMAVSALLKQSETDKNLLAKRMEIKQSDLVNYNPIAEKHL
DTGMTLAEFSAATIQYSDNTAMNKILEHLGGPAKVTEFARTIGDKTFRLDRTEPTLNTAI
PGDKRDTTSPQAMAISLQNLTLGKALAEPQRAQLVEWMKGNTTGGASIRAGLPTTWVVGD
KTGSGDYGTTNDIAVIWPANHAPLVLVTYFTQPQQNAEARKDVLAAAAKIVTEGL
>AAB81957|FEATURES|argannot|beta_lactam|BSONL12_02412|antibiotic inactivation|1
MAAAAAIALLGGCGADAGSEPATTAASTTAPSTATDAATAEFAALEQRSGARLGVYAVDT
TSGAEVAYRADERFGMASTFKGLACGALLREHPLSSGYFDQVVRYSREEVVSYSPVTETR
VDTGMTVAELCHATITVSDNTAGNQILKLLGGPAGFTAFLRSLGDEVSRLDRWETELNEV
PPGEERDTTTPAAVAANYRALVLGDVLAEPERAQLRDWLVANTTGDQRIRAGVPAGWTVG
DKTGGGSHGGNNDVAVAWTETGDPIVIALLSHRTDPAAKADNALLAEATRAVVTALR
>AAL86999|FEATURES|argannot|beta_lactam|CTX-M-105|antibiotic inactivation|1
MTILLQRRQLLVAGAALALTASLTPLNVFAAGDSLQRQLAALETEVNGRIGLSLIDSASQ
QAWSYRGDERFPLCSTFKLLLVAAVLKRSESQPALMQQTLHWTPADHLSYMPVTAKHPQG
MTVSDLCAAALQYSDNLAANVLLTLLGGPASVTRLARSLGDSVTQLDRNEPTLNTAIPGD
PRDTTTPLHMSHSVQQLLVKSGLQTAQQQQLIAWLKGNTTGKNAIAAALPAGWEIGDKTG
SGGYGTTNDVAILWPPGKAPLILAIYFTQHAPEAKSRQDVLAKAAAIALKSVI
>AAN32638|FEATURES|argannot|beta_lactam|EBR-1|antibiotic inactivation|1
MKKLFSLIALIGSFAFGQIKPIQIDPINNNLFVYQTFNSFNGVEYNANGMYLVTNKGIVL
FDVPWQKSQYQELNDMLQEKYNLPVIAVFATHSHDDRAGDLSFYNELNIPTYATSLTNSK
LKKEGKATSKFEIELGKTYKFGNEKFVFEYFGEGHTSDNVVVWFPKYKVLNGGCLIKGAD
AVNLGYTGEANVVEWPKTVHKLVAKHPTIKQVIPGHDNWKATGHIENTFKLLEKK
>ADD91577|FEATURES|argannot|beta_lactam|DIM-1|antibiotic inactivation|1
MRTHFTALLLLFSLSSLANDEVPELRIEKVKENIFLHTSYSRVNGFGLVSSNGLVVIDKG
NAFIVDTPWSDRDTETLVHWIRKNGYELLGSVSTHWHEDRTAGIKWLNDQSISTYATTST
NHLLKENKKEPAKYTLKGNESTLVDGLIEVFYPGGGHTIDNVVVWLPKSKILFGGCFVRS
LDSEGLGYTGEAHIDQWSRSAQNALSRYSEAQIVIPGHGKIGDIALLKHTKSLAETASNK
SIQPNANASAD
>ADM51921|FEATURES|argannot|beta_lactam|DHA-1|antibiotic inactivation|1
MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYF
NYGFADIQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQW
KGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGAL
TANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESY
GVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKD
MIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>AAG36927|FEATURES|argannot|beta_lactam|DHA-2|antibiotic inactivation|1
MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYF
NYGFADVQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMMLNDPAEKYQPELALPQW
KGITLLDLATYTTGGLPLQVPDAVKNRAELLHFYQQWQPSRKPGDMRLYANSSIGLFGAL
TANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESY
GVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKD
MIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>AAR87489|FEATURES|argannot|beta_lactam|DHA-3|antibiotic inactivation|1
MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYF
NYGFADIQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQW
KGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGAL
TANAAGMPYEQLLTARILAPLGLSHTFITVPDSAQSQYAYGYKNKKPVRVSPGQLDAESY
GVKSASKDMLRWAEMNIEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKD
MIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>AEL22919|FEATURES|argannot|beta_lactam|DHA-5|antibiotic inactivation|1
MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGRPYYF
NYGFADVQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQW
KGITLLDLATYTAGGLPLQVPDAVKSRADLLHFYQQWQPSRKPGDMRLYANSSIGLFGAL
TANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESY
GVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKD
MIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>ADT91161|FEATURES|argannot|beta_lactam|DHA-6|antibiotic inactivation|1
MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYF
NYGFADIQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQW
KGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGAL
TANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESY
GVKSTSKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKD
MIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>ADQ00385|FEATURES|argannot|beta_lactam|DHA-7|antibiotic inactivation|1
MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYF
NYGFADIQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQW
KGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGAL
TANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESY
GVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKD
MIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGSGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>AHL39320|FEATURES|argannot|beta_lactam|blaDHA-9|antibiotic inactivation|1
MTKSVSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYF
NYGFADIQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQW
KGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGAL
TANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSHYAYGYKNKKPVRVSPGQLDAESY
GVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKD
MIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>ALE30770|FEATURES|argannot|beta_lactam|bla(IMI-8)|antibiotic inactivation|1
MFFFKKGASTFIFLLCLPLNSFASQVINSVEEMRELETSFGGRIGVYILNPKNGKEFAYR
QDERFPLCSSFKAFLAASVLKRTQEKSVSLDDMVEYSGRVMEKHSPVSEKYRKTGASVQT
LAKAAIQYSDNGASNLLMERYIGGPEGLTAFMRSTGDTDFRLDRWELELNTAIPGDERDT
STPKAVAMSLKNIAFGSVLDAKNKSLLQEWLKGNTTGNARIRAAVPDKWVVGDKTGTCGF
YGTANDVAILWTDANSPAVMAVYTTRPNQNDKHDEAVIKNAAKIAIKAVYGSYK
>BAX00166|FEATURES|argannot|beta_lactam|bla(IMI-8)|antibiotic inactivation|1
MFFFKKSASTFIFLLCLPLNSFASQESNGVEQMRELETSFGGRIGVYILNTKNGKEFSYR
QDERFPLCSSFKAFLAASVLKRTQDKSVSLDDMMEYSGRVMEKHSPVSEKYRETGASVQT
LAKAAIQYSDNGASNLLMERYIGGPEGLTAFMRSTGDTDFRLDRWELELNSAIPGDERDT
STPKAVAISLNNIAFGSVLDAKNKSLLQDWLKGNTTGNARIRAAVPDKWVVGDKTGTCGL
YGTANDIAILWPDANSPAVMAVYTTRPNQNDKHDETVIKNAAKIAINAVYGSTK
>AQS23610|FEATURES|argannot|beta_lactam|bla(IMI-8)|antibiotic inactivation|1
MFFLKKAQVHLFFFLCLPLNSFASQESNSIEQMRELEAAFGGRIGVYILNTKNGKEFSYR
QDERFPLCSSFKAFLAASVLKKTQDKSVSLDDMMEYSGRVMEKHSPVSEKYRKTGASVRT
LAKAAIQYSDNGASNLLMERYIGGPEGLTAFMRSTGDTDFRLDRWELELNSAIPGDERDT
STPKAVAMSLKNIAFGSVLDAKNKSLLQEWLKGNTTGNARIRAAVPDKWDVGDKTGTCGF
YGTANDVAILWPDANSPAVMAVYTTRPNQNDKHDEAVIKNSAKIAINAVYGSYK
>WP_063865149|FEATURES|argannot|beta_lactam|VCC-1|antibiotic inactivation|1
MKRIAMYVALSISTSTAFADEHNKNMADIEAAFEGRVGVYAINTGSGKAYSYRANERFPL
CSSFKAFLAAAVLKMDQDSPGVLLEKVNYHNRTMEPHSPITEKFQSQGMAVGELAAATLQ
YSDNGAANLLMEKYIKGPEGMTQFMNSIGDTKFRLDRWELDLNSAIPGDERDTSTPKAVA
ESLNKLISNTVLDNYHQEIFKKWMIGNTTGDNRIRAAVPDGWVVGDKTGTCGKYGTANDH
AFILQGNNAAPLILSIYTTRKGEHMKHDDEVIAKAARIAIENVK
>CAA90890|FEATURES|argannot|beta_lactam|BL2c_pse3|antibiotic inactivation|1
MMQRRHFLQKTLLALPIIFSGNLLTGCKTNLSDDYLPDDKITNNPNLLQNKLKEILPIWE
NKFNAKIGMTIIADNGELSSHRGNEYFPVNSTIKAFIASHILLLVDKEKLDLNEKIIIKE
SDLIEYSPVCKKYFDENKPISISELCEATITLSDNGSANILLDKIGGLTAFNQFLKEIGA
DMVLANNEPLLNRSHYGETSDTAKPIPYTKSLKALIVGNILSNQSKEQLITWLINDKVAD
NLLRKYLPKNWRIGDKTGTGSESKNIIAVIWNENNKPYFISLFITQPHDGKSLDFKNQKD
EIMAQIGKEIYPFL
>CAA90891|FEATURES|argannot|beta_lactam|BL2c_pse3|antibiotic inactivation|1
MMQRRHFLQKTLLALPIIFSGNLLTGCKTNLSDDYLPDDKITNNPNLLQNKLKEILPIWE
NKFNAKIGMTIIADNGELSSHRGNEYFPVNSTIKAFIASHILLLVDKEKLDLNEKIIIKE
SDLIEYSPVCKKYFDENKPISISELCEATITLSDNGSANILLDKIGGLTAFNQFLKEIGA
DMVLANNEPLLNRSHYGETSDTAKPIPYTKSLKALIVGNILSNQSKEQLITWLINDKVAD
NLLRKYLPKNWRIGDKTGTGSESKNIIAVIWNENNKPYFISLFITQPHDGKSLGFKNQKD
EIMAQIGKEIYPFL
>AFI56422|FEATURES|argannot|beta_lactam|blaCMH-1|antibiotic inactivation|1
MMTKSLSCALLLSVACSAFAAPMSEKQLADVVERTVTPLMKAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSVSKTFTGVLGGDAIARKEISLADPVTKYWPELTGKQ
WQGIRLLDLATYTAGGLPLQVPDDVTDNASLLRFYQSWQPKWAPGTTRLYANTSIGLFGS
LAVKPSGMCFEQAMAERVFKPLKLNHTWINVPHAEEPHYAWGYREGKAVHVSPGMLDAEA
YGVKSNVKDMASWVMANMAPETLPQSTLQQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVDGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPVRVETAYRILDALQ
>AAL55262|FEATURES|argannot|beta_lactam|TLA-2|antibiotic inactivation|1
MKKTTLLFLLISAFSLAQTSLLEQKINSIIKNKKATVGVSVLGFENGFKYDKNGDKKLPM
QSVFKFHIAAAVLNAVDQGKLSLDQKIMLNQSNLLENTWSPLRDKYPAGNIEIPLSEVIE
YTVAKSDNNGCDILLRLLGGTQVVQKFMDSKGVKGFQIKYNEEDMHKDWNVQYENYSTTK
SAADVLKKLYDGKLLSKKSTDYLMKVMLSTSTGLNKMVEQLPKNTPVARKTGASGKNNAG
LTGAENEIGIVTLPNGKHYALAVFVSNSMETDAVNCRMISDISKEVWEYFNK
>BAL40892|FEATURES|argannot|beta_lactam|TLA-3|antibiotic inactivation|1
MKKITFLLLMVSAFATAQKSVLDEKISAVIKDKKATVGVSVLGFENAFKYSKNGDKKLPL
LSVFKFHLACAVLDMADKGKFSTDQKFLIKKSDLLENTWSPLREKFPEGNIELSLGEIIT
YTVAQSDNNTCDFLLRLIGGPQVVQHFMDSKGAKDLQIKYNEDDMHRDWKNQYGNESSTN
ATVSLLKKFYDGKLLTKKSTDFLMQIMLGTTTGTNKIVEQLPKSTPVAHKTGSSGKPDNI
LTVAENDMGIITLPNGKHYAIAVFVSNSTETEKVNTRMVSDISKIVWDNFNK
>BAL40893|FEATURES|argannot|beta_lactam|TLA-3|antibiotic inactivation|1
MKKITFLILMVSAFATAQKSVLDEKISAVIKDKKATVGVSVLGFENAFKYSKNGDEKLPL
LSVFKFHLACAVLDMADKGKFSTDQKFLIKKSDLLENTWSPLREKFPEGNIELSLGEIIT
YTVAQSDNNTCDFLLRLIGGPQVVQHFMDSKGAKDLQIKYNEDDMHRDWKNQYGNESSTN
ATVSLLKKFYDGKLLTKKSTDFLMQIMLGTTTGTNKIVEQLPKGTPVAHKTGSSGKPDNI
LAVAENDMGIITLPNGKHYAIAVFVSNSTETEKVNTRMVSDISKIVWDNFNK
>BAL40894|FEATURES|argannot|beta_lactam|TLA-3|antibiotic inactivation|1
MKKITFLLLMVSAFATAQKSVLDEKISAVIKDKKATVGVSVLGFENAFKYSKNGDEKLPL
LSVFKFHLACAVLDMADKGKFSTYQKFLIKKSDLLENTWSPLREKFPEGNIELSLGEIIT
YTVAQSDNNTCDFLLRLIGGPQVVQHFMDSKGAKDLQIKYNEDDMHRDWKNQYGNESSTN
ATVSLLKKFYDGKLLTKKSTDFLMQIMLATTTGTNKIVEQLPKGTPVAHKTGSSGKPDNI
LTVAENDMGIITLPNGKHYAIAVFVSNSTETEKVNTRMVSDISKIVWDNFNK
>BAL40895|FEATURES|argannot|beta_lactam|TLA-3|antibiotic inactivation|1
MKKITFLILMVSAFATAQKSVLDEKISAVIKDKKATVGVSVLGFENAFKYSKNGDEKLPL
LSVFKFHLACAVLDMADKGKFSTDQKFLIKKSDLLENTWSPLREKFPEGNIELSLGEIIT
YTVAQSDNNTCDFLLRLIGGPQVVQHFMDSKGAKDLQIKYNEDDMHRDWKNQYGNESSTN
ATVSLLKKFYDGKLLTKKSTDFLMQIMLGTTTGTNKIVEQLPKGTPVAHKTGSSGKPDNI
LTVAENDMGIITLPNGKHYAIAVFVSNSTETEKVNTRMVSDISKIVWDNFNK
>AAR06587|FEATURES|argannot|beta_lactam|SME-2|antibiotic inactivation|1
MSRTGRLSVFFSAIFPLLTLTNMAEAASQPPQVTVDKLKRLENDFGGRIGVYAIDTGSNK
TFGYRANERFPLCSSFKGFLAAAVLSKSQQQEGLLNQRIRYDNRVMEPHSPVTEKQITTG
MTVAELSAATLQYSDNGAANLLLEKLIGGPEGMTSFMRSIGDNVFRLDRWELELNSAIPG
DDRDTSTPKAVAESMQKLAFGNVLGLTERHQLMDWFKGNTTGGARIRASVPANWVVGDKT
GTCGVYGTANDYAVIWPVGHAPIVLAVYTSKPDKNSKHSDAVIADASRIVLESFNIDALR
MATGKSIGF
>AFV91534|FEATURES|argannot|beta_lactam|NDM-6|antibiotic inactivation|1
MRPLPHSYLKSLVICLLTAFAALTPVVNSGVQAAQPKDVPVTFTAITQGVWMHTSMKHME
NWGHVPSNGLIVEKGDFSILVDTAWDDPQTAQIIEWSKDTLKKPIRWAVFTHAHDDKMGG
VAALRQQGIVTYAAADSNRMAPQNGLTPAEHDLIFDSEHSTSVLHPLVIFDPGPGHTRDN
IVVGLPEQGIVFGGCLIRPSGSTSLGNTADADLAHWKTAVLAVAQRFAEAQQIIPSHGPM
AGRELFELTAQLAEKASIPSTP
>ABK58097|FEATURES|argannot|beta_lactam|blaLAP-1|antibiotic inactivation|1
MKKIRLIIISLLAGMCTPALSTPVNVTDTIQSTEDHIKGRVGFTEIDFLSGKVLSSHRRE
ERFPMMSTFKVLLCGAILVRVDKGLEQLERRITYNKHDLDDYSPLTSQHIADGMTVSELC
NAAITTSDNTAANLLLSTIGGPEGLTHFLRSTGDSYTRLDRHEPSLNEAKPGDERDTTTP
AAMAQTLQKLLNGSVLTEKSRKKLISWMQEDKVGGPLFRSVLPAGWMIADKTGAGDHGSR
GIVALLGPGGKPSRIVVLYITNTHSSMNELNEHIAGIGDSVIKNW
>ABV89601.1|FEATURES|argannot|beta_lactam|bla|antibiotic inactivation|1
MKKIRLIIISLLAGMCTPALSTPVNVTDTIQSTEDHIKGRVGFTEIDFLSGKVLSSHRRE
ERFPMMSTFKVLLCGAILVRVDKGLEQLERRITYNKHDLDDYSPLTSQHIADGMTVSELC
NAAITTSDNTAANLLLSTIGGPEGLTHFLRSTGDSYTRLDRHEPSLNEAKPGDERDTTTP
AAMAQTLQKLLNESVLTEKSRKKLISWMQEDKVGGPLFRSVLPAGWMIADKTGAGDHGSR
GIVALLGPGGKPSRIVVLYITNTHSSMNELNEHIAGIGDSVIKNW
>AKD43328|FEATURES|argannot|beta_lactam|bla|antibiotic inactivation|1
MTITFSRRQAIAGALLAVPAVSTLAASAGALLAVPAVSTLAASAGAATGGPLEKRLAELE
GRHKGRIGVAIHNLATGARIGHRADERFLMCSTFKALLAAHILARVDRKEETLDRRIVVG
KSDLVDWSPVVETRVGGEGISIAELCEAAITLSDNAAANLLLSASGGPKAVTQFLRGFGD
DVTRLDRTEPTLNYRETPDDERDTTTPAAMAETLRKLIIGDVLARGSKAQLAAWLVMNKT
GDTRLRAGFPVDWTTGDKTGTNGDRHGNANDVAIAWSPDRGAVVVTAFCEIPGISGDERN
AVIAEIGRIAAEA
>ABY56045|FEATURES|argannot|beta_lactam|BL3_l|antibiotic inactivation|1
VRTLTTLGLALLLAQPAVAAQAVLPQLQPYTAPAAWLTPVAPLRIADNTWHIGTASITAL
LVKTPEGAVLLDGGMPQVADHLLANMRELGVAPGDLKLILHSHAHIDHVGPLAAIKKATG
AQLVSNAESAVLLQRGDSQDIHFGDDMVFAPVQVDRLVQDGETVELGGMTFTAHFTPGHT
PGSLSWTWTDRRDGKPLRIAYSDSLSAPGYSLWMNPRFPKIAEAFRSGFAAVRALPCDLL
ITPHAEASGWDYTNAEHPNPSPMSCKAYADKAEAAFDAQLKKQRGG
>AAP79046|FEATURES|argannot|beta_lactam|blaPLA-6A|antibiotic inactivation|1
MRQYRFALLPLLAALALPGWAHQATVTTVKQAESQLQGRVGYAELDLASGQLLAGYRSDE
RFPMMSTFKVLLCGAVLSRVDAGEEQLDRRIHYRQQDLVEYSPVTEKHLTDGLTVGELCA
AAITLSDNTAANLLLTTLGGPQGLTSFLRHSGDQTSRLDRWETELNEARPGDVRDTTTPQ
AMARTLRNLLTGRVLSSASQQQLQRWMVEDKVAGPLLRSVLPAGWFIADKTGAGNRGSRG
IIAALGPDGKAARIVVIYLTGTPATMDERNKQIAAIGATLIRHWSADENRP
>AAP79049|FEATURES|argannot|beta_lactam|blaPLA2a|antibiotic inactivation|1
MRQYRFALLPLLAALALPGWAHQATVTTVKQAESQLQGRVGYAELDLASGQLLAGYRSDE
RFPMMSTFKVLLCGAVLSRVDAGEEQLDRRIHYRQQDLVEYSPVTEKHLTDGLTVGELCA
AAITLSDNTAANLLLTTLGGPQGLTSFLRHSGDQTSRLDRWETELNEARPGDVRDTTTPQ
AMARTLRNLLTGRVLSSASQQQLQRWMVEDKVAGPLLRSVLPAGWFIADKTGAGNRGSRG
IIAALGPDGKAARIVVIYLTGTPATMDERNKQIAAIGATLVTHWSADENRP
>ADK47391|FEATURES|argannot|beta_lactam|TLA-2|antibiotic inactivation|1
MKKYFSFCLLGIFIFCFSQQNLKRDITKIIQGKNALVAVSVMNSKGKTEVNINGNKKVPM
LSVFKFHIALAVLDLVDRGILDLEQNIFVKKSELLENTWSPIRDKYPNGNVNIPLREIIE
HTVSQSDNNGCDILLRLIGGVDTVQKFIESKGIKDFAIKYNEEEMNKNGKSIYSNYTTAN
ASSRLLQKFYNGEIISESSRDFLFRIMYETSTGADRLISLLPPDVIVAHKTGTSGIVSGI
QAATNDVGIIILPDDEYYTISVFVINSKENTSTNEKIIADISKTVWDYYFQNK
>AAF23816|FEATURES|argannot|beta_lactam|vhw-1|antibiotic inactivation|1
MKKLFLLLGLLACSSATYAAKLNEDISAIEEHISGRIGVSVWDTQTDEHWDYRGDERFPM
MSTFKTLACATMLSDMDNEKLDKNATAKVEERNMVVWSPVMDRMAGQTTRFEHACEAAML
MSDNSAAHIVLRSIWGVHAGGTSFLRSIGDKATRLDRFEPRLNEANPGDKRDTTTPNAMV
NTLHTLLEGDALSYESRIQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGGFGSRGITA
MIWKENHKPVYISIYITETDLSLQARDQVIAQVSQLILDEVQYYLALAKY
>AAF23817|FEATURES|argannot|beta_lactam|vhh-1|antibiotic inactivation|1
MKKLFLLLGLLACSSATYAANLMKTSPRLKKHISGRIGVSVWDTQTDEHWDYRGDERFPM
MSTFKTLACATMLSDMDNEKLDKNATAKVEERNMVVWSPVMDRMASQTTRIEHACEAAML
MSDNTAANIVLRSIGGPRGVTTFLRSIGDKATRLDRFEPRLNEANPGDKRDTTTPNAMVN
TLHTLLEGDALSYESRIQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGGFGSRGITAM
IWKENHKPVYISIYITETDLSLQARDQVIAQVSQLILDEYNTI
>BAA23131|FEATURES|argannot|beta_lactam|classC|antibiotic inactivation|1
MTKMNRLAAALIAALILPTAHAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
VASKQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQGKLSFNDPASRYLPELRGSAFDGV
SLLNLATHTSGLPLFVPDDVTDNAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKS
LDQPFTQAMEQGMLPALGMRHTYVQVPAAQMANYAQGYNKDDKPVRVNPGPLDAESYGIK
SNARDLIRYLDANLQQVKVAHAWREALTATHVGYYKAGAFTQDLMWENYPYPVKLSRLIE
GNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFP
NDDRVEAAYRIVQALDKR
>CAA79967|FEATURES|argannot|beta_lactam|NmcA|antibiotic inactivation|1
MSLNVKQSRIAILFSSCLISISFFSQANTKGIDEIKNLETDFNGRIGVYALDTGSGKSFS
YRANERFPLCSSFKGFLAAAVLKGSQDNRLNLNQIVNYNTRSLEFHSPITTKYKDNGMSL
GDMAAAALQYSDNGATNIILERYIGGPEGMTKFMRSIGDEDFRLDRWELDLNTAIPGDER
DTSTPAAVAKSLKTLALGNILSEHEKETYQTWLKGNTTGAARIRASVPSDWVVGDKTGSC
GAYGTANDYAVVWPKNRAPLIISVYTTKNEKEAKHEDKVIAEASRIAIDNLK
>AAP93850|FEATURES|argannot|beta_lactam|blaCMG|antibiotic inactivation|1
LSCALLLSVASAAFAAPMSEKQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHYFTFGK
ADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEITLGDPVTKYWPELTGKQWQGIR
MLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPKWKPGTTRLYANTSIGLFGALAVKP
SGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAEAYGVKT
NVQDMASWVMVNMMPDSLQDSPLKHGIALAQSRYWRVGAMYQGLGWEMLNWPVDAQTVVG
GSDNKVALAPLPAREVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGI
>AIG20028|FEATURES|argannot|beta_lactam|MIR-5|antibiotic inactivation|1
MMTKSLSCALLLSVASSAFAAPMSEKQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEIALGDPVAKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYREGKAVHVSPGMLDAEA
YGVKTNVKDMASWLIANMKPDSLQASSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>CAB55427|FEATURES|argannot|beta_lactam|TLA-3|antibiotic inactivation|1
MKKIILLFILTSQLVLAQHTSILNDINAVTKDKKATVAVSVLGIENDFQFSNANGNLKMP
MLSVFKFHIALAVLNQVDKGNLTLDQKILIKKSDLLENTWSPLREKYPDGNVELPLSEII
TYTVAQSDNNGCDILLRLIGGTKTVQKLMDVNGIKNFQIKYNEEEMHKNDVKTLYANYTT
TASMVKTLKAFYKGMFLSKRSTIFLMDIMTKTNTGMSKLPGLLPKVRMARKTGSSGKMKN
GLTIAENDSGIVTLANGKHYAIAVFVKDSMESEEVNCGMIAQVSKIVWDALNKKK
>AAL85333|FEATURES|argannot|beta_lactam|bla|antibiotic inactivation|1
MRNEEVISMWQRMKWGLCVLAALSGSAMAAPLTAQYVSAIAMQEEQRLHARIGIAVLDTA
TNSITHYRGEERFPLNSTHKPLLCAALLREVDRKALALSASMQFEPSQLVEYSPITEKHV
APDAMSWAQLCSAAVSYSDNTAANLIARKLNGPQAVTQFLRDSGDTITRLDRYEPELNSA
IPGDERDSTTPVAIAQTLNTLLLGNVLQPSSREQLMQWMRDDKVADGLLRSVLPDGWKIA
DKTGAGDNGSRSIVSVVWPTSQKPLLVVIYITQTPATMAQRDAAIVRIGESLFSTLAVYD
>CAC87665|FEATURES|argannot|beta_lactam|CAU-1|antibiotic inactivation|1
MKRLILAAAASLLALASAAHADDMPANWTKPTKPYRVVGNIYYVGTEGISSWLITSSEGH
VVLDGGPNAETGKLVERNITALGFQLADVKILINTHAHYDHAGGLAQLKADTGAKLWISR
DDAPAMAAGHHIGDNIYGPTPMPAAKPDRSFGDQTKLKLGEIAMVAHLTPGHTIGCTSWT
TAVVEKGRPLTVTFPCSLSVAGNVLVGNKTHRTIVADYRASFAKLRAIPTDVMLPAHEEQ
GNLLAKRQKQLRGDPNAFVDPGELARFVDASEAAFNKELARQQAAGPNR
>ABS29619|FEATURES|argannot|beta_lactam|CGB-1|antibiotic inactivation|1
MKKSIPFFIISMLLSPLANAQDTQVRDFVIEPQIQPNFYIYKTFGVFGGKEYSTNAVYLV
TKKGVVLFDVPWQKTQYQSLMDTIQKRHHLPVIAVFATHSHEDRAGDLSFYNKKGIKTYA
TAKTNEILKKEGKATSTEIIKTGKPYRIGGEEFVVDFLGEGHTADNVVVWFPKYKILDGG
CLVKSKAAADLGYTGEANVAQWPKTMEKLKSKYAQATLIIPGHDEWKGGGHVEHTLDLLN
KK
>BAC76072|FEATURES|argannot|beta_lactam|CFE-1|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYQGKPYY
FTWGKADIANNRPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTQYWPELTGKQ
WQGISLLHLATYTAGGLPLQVPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTTRVLQPLKLAHTWITVPQSEQKDYALGYREGKPVHVSPGQLDAEA
YGVKSSVVDMTRWVQANMDASQVQEKTLQQGIKLAQSRYWRIGDMYQGLGWEMLNWPVKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>AAA22904|FEATURES|argannot|beta_lactam|CcrA|antibiotic inactivation|1
MKTVFILISMLFPVAVMAQKSVKISDDISITQLSDKVYTYVSLAEIEGWGMVPSNGMIVI
NNHQAALLDTPINDAQTEMLVNWVTDSLHAKVTTFIPNHWHGDCIGGLGYLQRKGVQSYA
NQMTIDLAKEKGLPVPEHGFTDSLTVSLDGMPLQCYYLGGGHATDNIVVWLPTENILFGG
CMLKDNQATSIGNISDADVTAWPKTLDKVKAKFPSARYVVPGHGDYGGTELIEHTKQIVN
QYIESTSKP
>AAM63403|FEATURES|argannot|beta_lactam|CEPH-A3|antibiotic inactivation|1
MMKGWIKCTLAGAVVLMASFWGGSVRAAGIELKQVSGPVYVVEDNYYVKENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVRAFYAGPAHTPDGIF
VYFPDEQVLYGNCILKEKLGNLSFANVKAYPQTIERLKAMKLPIKTVIGGHDSPLHGPEL
IDHYEELIKAVPQS
>AAA21535|FEATURES|argannot|beta_lactam|cepA|antibiotic inactivation|1
MQKRLIHLSIIFFLLCPALVVAQNSPLETQLKKAIEGKKAEIGIAVIIDGQDTITVNNDI
HYPMMSVFKFHQALALADYMHHQKQPLETRLLIKKSDLKPDTYSPLRETYPQGGIEMSIA
DLLKYTLQQSDNNACDILFNYQGGPDAVNKYLHSLGIRECAVIHTENDMHKNLEFCYQNW
TTPLAAAKLLEIFRNENLFDKEYKNFIYQTMVECQTGQDRLIAPLLDKKVTMGHKTGTGD
RNAKGQQIGCNDIGFILLPDGHVYSIAVFVKDSEADNRENSEIIAEISHIVYEYVTQQID
>AAA21534|FEATURES|argannot|beta_lactam|cepA|antibiotic inactivation|1
MQKRLIHLSIIFFLLCPALVVAQNSPLETQLKKAIEGKKAEIGIAVIIDGQDTITINNDI
HYPMMSVFKFHQALALADYMHHQKQPLKTRLLIKKSDLKPDTYSPLRETYPQGGIEMSIA
DLLKYTLQQSDNNACDILFNYQGGPDAVNKYLHSLGIRECAVIHTENDMHENLEFCYQNW
TTPLAAAKLLEIFRNENLFDKEYKNFIYQTMVECQTGQDRLIAPLLDKKVTMGHKTGTGD
RNAKGQQIGCNDIGFILLPDGHAYSIAVFVKDSEADNRENSEIIAEISRIVYEYVKQQID
>AAA21533|FEATURES|argannot|beta_lactam|cepA|antibiotic inactivation|1
MQKRLIHLSIIFFLLCPALVVAQNSPLETQLKKAIEGKKAEIGIAVIIDGQDTITVNNDI
HYPMMSVFKFHQALALADYMHHQKQPLKTRLLIKKSDLKPDTYSPLREIYPQGGIEMSIA
DLLKYTLQQSDNNACDILFNYQGGPDAVNKYLHSLGIRECAVIHTENDMHENLEFCYQNW
TTPLAAAKLLEIFRNENLFDKEYKNFIYQTMVECQTGQDRLIAPLLDKKVTMGHKTGTGD
RNAKGQQIGCNDIGFILLPDRHAYSIAVFVKDSEADNRENSEIIAEISRIVYEYVTQQID
>CBX07044|FEATURES|argannot|beta_lactam|cepA|antibiotic inactivation|1
MQKRLIHLSIIFFLLCPALVVAQNSPLETQLKKAIEGKKAEIGIAVIIDGQDTITVNNDI
HYPMMSVFKFHQALALADYMHHQKQPLKTRLLIKKSDLKPDTYSPLRETYPQGGIEMSIA
DLLKYTLQQSDNNACDILFNYQGGPDAVNKYLHSLGIRECAVIHTENDMHENLEFCYQNW
TTPLAAAKLLEIFRNENLFDKEYKNFIYQTMVECQTGQDRLIAPLLDKKVTMGHKTGTGD
RNAKGQQIGCNDIGFILLPDGHVYSIAVFVKDSEADNRENSEIIAEISRIVYEYVTQQID
>AAO83986|FEATURES|argannot|beta_lactam|bcl1|antibiotic inactivation|1
MKRSFFMLKTKITSSILVGACLLIGCSNGNEQPVSNEPEPEESVETGEAVFKALEEEYAA
RLGVFALDTGTGQTVSYRSDERFTYASAHKPLAVAVLLQQKSIEELEQLITYSADDLVNY
NPITENHVETGMTLRELSDASIRYSDNTAANFIFDEIGGPEGFKEGLRAIGDTVTEPERI
EPELNHVEPGEIQDTSTPEALAKSLQEFALGEALPADKQELLIDWLIGNTTGDALIRAGV
PEGWEVGDKTGAGSYGTRNDIAILWPPEKEPIILAVLSSKDEKDAEYDDELIAKATEEVI
NLLAQTE
>ADB56658|FEATURES|argannot|beta_lactam|SME-2|antibiotic inactivation|1
MARPSKLALSFSLLLPFLPFTSFAETWPQGDIARQKIVKLEKDFGGRIGVSAIDTGANRT
FDFRADERFPLCSSFKGFLAGAVLSHSQQQEGLLEKRIDYKNRVMEPHSPISAQHSSTGM
TVAQLAAAALQYSDNGATNLLLENVLGGPAGMTTFMRTLGDTTFRLDRWELELNSAIPGD
DRDTSTPHAIARSLQKIALGEALQTAPRQQLVDWLIGNTTGGARIRAGVPVEWVVGDKTG
TCGVYGTANDYAVIWPKTSAPIVLAIYTAKPNKEDKHSDAVIAEVTRAVLESFE
>AAF61147|FEATURES|argannot|beta_lactam|KS18_02580|antibiotic inactivation|1
MWQWLGKVRWLLVVIALLGGKVMAASELDSALARLEQQHHGRLGLAYIDSGSGESYSYRG
EERFAFCSTFKAVLAGAVLQRSVSQPGLLDKRVHYAATDLLAYAPITKTHLDKGMRIGEL
AAAAVQYSDNTAANLLLQEIGGVQALNRFVQGLGDPAFRLDRIEPHLNSAEPGDVRDTTT
PLAMAHTLQAMTLGKGLPQAQQAQLVSWLKGNTTGAQRIQAGVPAGWQVGDKTGTGGYGT
TNDIAILWPEQGAPKVLAIYFTQPAADAEANRAILAEATRLVLQDKSINKIK
>AAR20595|FEATURES|argannot|beta_lactam|BLA1|antibiotic inactivation|1
MIVLKNKKMLKIGMCVGILGLSITSLVTFTGGALQVEAKEKTGQVKHKNQATHKEFSQLE
KKFDARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTKKLDEVITYTKE
DLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRQMGDRVT
MSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTAGNALPNHKRNILTKWMKGNATGDKL
IRAGVPTNWVVADKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKGATYDNQLIAEA
AEVIVNAFR
>ADB27941|FEATURES|argannot|beta_lactam|BEL-1|antibiotic inactivation|1
MKLLLYPLLLFLVIPAFAQADFEHAISDLEAHNQAKIGVALVSENGNLIQGYRANERFAM
CSTFKLPLAALVLSRIDAGEENPERKLHYDSAFLEEYAPAAKRYVATGYMTVTEAIQSAL
QLSDNAAANLLLKEVGGPPLLTKYFRSLGDKVSRLDRIEPTLNTNTPGDERDTTTPMSMA
QTVSKLIFGDTLTYKSKGQLRRLLIGNQTGDKTIRAGLPDSWVTGDKTGSCANGGRNDVA
FFITTAGKKYVLSVYTNAPELQGEERALLIASVAKLARQYVVH
>ACV69996|FEATURES|argannot|beta_lactam|BEL-2|antibiotic inactivation|1
MKLLLYPLLLFLVIPAFAQADFEHAISDLEAHNQAKIGVALVSENGNLIQGYRANERFAM
CSTFKLPLAALVLSRIDAGEENPERKLHYDSAFLEEYAPAAKRYVATGYMTVTEAIQSAL
QLSDNAAANLLLKEVGGPPLLTKYFRSLGDKVSRFDRIEPTLNTNTPGDERDTTTPMSMA
QTVSKLIFGDTLTYKSKGQLRRLLIGNQTGDKTIRAGLPDSWVTGDKTGSCANGGRNDVA
FFITTAGKKYVLSVYTNAPELQGEERALLIASVAKLARQYVVH
>ACT09140|FEATURES|argannot|beta_lactam|BEL-3|antibiotic inactivation|1
MKLLLYPLLLFLVIPAFAQADFEHAISDLEAHNQAKIGVALVSENGNLIQGYRANERFAM
CSTFKLPLAALVLSRIDAGEENPERKLHYDSAFLEEYAPAAKRYVATGYMTVTEAIQSAL
QLSDNAAANLLLKEVGGPPLLTKYFRSLGDKVSRLDRIESTLNTNTPGDERDTTTPMSMA
QTVSKLIFGDTLTYKSKGQLRRLLIGNQTGDKTIRAGLPDSWVTGDKTGSCANGGRNDVA
FFITTAGKKYVLSVYTNAPELQGEERALLIASVAKLARQYVVH
>AAG44836|FEATURES|argannot|beta_lactam|penP|antibiotic inactivation|1
VTFSALPFRRADRRRLLAAALAACALTLTAACDSGTVTVPVTDSVTTSAVADPRFAELET
TSGARLGVFAVDTGSGRTVAHRADERFPMASTFKGLACGALLREHPLSTGYFDQVIHYSA
AELVEYSPVTETRVETGMTVRELCDAAITVSDNTAGNQLLKLLGGPEGFTASLRSLGDAT
SRLDRWETDLNTAIPGDERDTTTPAALAADYRALVVGDVLGAPERDQLKAWLVANTTGAT
RIRAGLPADWTVGDKTGSPAYGSALDVAVAWPPGRAPIVIAVLSTKSEQDAEPDNALLAE
ATRVVVDALG
>CAB96921|FEATURES|argannot|beta_lactam|FEZ-1|antibiotic inactivation|1
MKKVLSLTALMMVLNHSSFAYPMPNPFPPFRIAGNLYYVGTDDLASYLIVTPRGNILINS
DLEANVPMIKASIKKLGFKFSDTKILLISHAHFDHAAGSELIKQQTKAKYMVMDEDVSVI
LSGGKSDFHYANDSSTYFTQSTVDKVLHDGERVELGGTVLTAHLTPGHTRGCTTWTMKLK
DHGKQYQAVIIGSIGVNPGYKLVDNITYPKIAEDYKHSIKVLESMRCDIFLGSHAGMFDL
KNKYVLLQKGQNNPFVDPTGCKNYIEQKANDFYTELKKQETA
>BAI66131|FEATURES|argannot|beta_lactam|pbp2b|antibiotic target alteration|0
MLIKSEYKPRMLPKEEQVKKPMTSNGRISFVLMAMAVLFACLIARGLYLQTVTYNFLKEQ
GDNRIVRTQALPATRGTVSDRNGAVLALSAPTESLFAVPKEMKEMPSAAQLERLSELVDV
PVDVLRNKLEQKGKSFIWIKRQLDPKVAEEVKALGLENFAFEKELKRHYPMGSLFAHVIG
FTDIDGKGQEGLELSLEDSLHAGEGAEVVLRDREGNIVDSLDSPRNKAPQNGKDIILSLD
QRIQTLAYEELNKAVEYHQAKAGTVVVLDARTGEILALVNTPAYEPNKPGQADSEQRRNR
AVTDMIEPGSAMKPFTIAKALDSGKVDATDTFNTLPYKIGSATVQXDTHVYPTLDVRGIM
QKSSNVGTSKLSAMFTPKEMYDFYHDLGVGVRMHSGFPGETAGLLRSWRRWQKIEQATMS
FGYGLQLSLLQLARAYTVLTHDGELLPVSFEKQAVAPKGKRVIKASTAKKVRELMVSVTE
AGGTGTAGAVDGFDVGAKTGTARKLVNGRYVDYKHVATFIGFAPAKNPRVIVAVTIDEPT
ANGYYSGVVTGPVFKQVMGGSLNILGVSPTKPLTNVAAVKTPS
>CAA71441|FEATURES|argannot|beta_lactam|imiS|antibiotic inactivation|1
MMKGWIKCGLAGAVVLMASFWGGSVRAAGMSLTQQVSGPVYVVEDNYYVQENSMVYFGAK
GVTVVGATWTPDTARELHKLIKRVSRKPVLEVINTNYHTDRAGGNAYWKSIGAKVISTRQ
TRDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHEGDFTLQEGKLRAFYLGPAHSPDGI
FVYFPDQQVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKTVVGGHDSPLHGPE
LIDHYEALIKAASQS
>CAD69003|FEATURES|argannot|beta_lactam|imiH|antibiotic inactivation|1
MMKGWMKCGLAGAVVLMASFWGGSVRAAGMSLTQVSGPVYVVEDNYYVQENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSRQPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKLRAFYAGPAHTPDGIF
VYFPDQLVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKTVVGGHDSPLHGPEL
IDHYEALIKAAPQS
>BAE75889|FEATURES|argannot|beta_lactam|mecC|antibiotic target replacement|1
MKKIKIVPLILIVVVVGFGIYFYASKDKEINNTIDAIEDKNFKQVYKDSSYISKSDNGEV
EMTERPIKIYNSLGVKDINIQDRKIKKVSKNKKRVDAQYKIKTNYGNIDRNVQFNFVKED
GMWKLDWDHSVIIPGMQKDQSIHIENLKSERGKILDRNNVELANTGTAYEIGIVPKNVSK
KDYKAIAKELSISEDYIKQQMDQNWVQDDTFVPLKTVKKMDEYLSDFAKKFHLTTNETES
RNYPLGKATSHLLGYVGPINSEELKQKEYKGYKDDAVIGKKGLEKLYDKKLQHEDGYRVT
IVDDNSNTIAHTLIEKKKKDGKDIQLTIDAKVQKSIYNNMKNDYGSGTAIHPQTGELLAL
VSTPSYDVYPFMYGMSNEEYNKLTEDKKEPLLNKFQITTSPGSTQKILTAMIGLNNKTLD
DKTSYKIDGKGWQKDKSWGGYNVTRYEVVNGNIDLKQAIESSDNIFFARVALELGSKKFE
KGMKKLGVGEDIPSDYPFYNAQISNKNLDNEILLADSGYGQGEILINPVQILSIYSALEN
NGNINAPHLLKDTKNKVWKKNIISKENINLLTDGMQQVVNKTHKEDIYRSYANLIGKSGT
AELKMKQGETGRQIGWFISYDKDNPNMMMAINVKDVQDKGMASYNAKISGKVYDELYENG
NKKYDIDE
>CDH98053|FEATURES|argannot|beta_lactam|mecC|antibiotic target replacement|1
MKKIYISVLVLLLIMIIITWLFKDDDIEKTISSIAKGNYNEVYKNSSEKSKLAYGEEEII
DRNKKIYKDLSVNNLKITNHEIKKTGKDKKQVDVKYNIYTKYGTIRRNTQLNFIYEDKHW
KLDWRPDVIVPGLKNGQKINIETLKSERGKIKDRNGIELAKTGNTYEIGIVPNKTPEEKY
DDIAHDLQIDKKAIINKVNQKWVQPSSFVPIKKINQKDESIDKLIKLHNLQINTIKSRVY
PLNKATAHLLGYVGPINSEELQSKQFKNYSKTSVIGKKGLERLYDKQLQNTDGFRISISN
IYDNKPLDTLLEKKANNGKDLHLTIDARVQESIYKHMKNDYGSGTALQPKTGEILALVST
PSYDVYPFMNGLSNNDYRKLTNNKKEPLLNKFQITTSPGSTQKIFTSIIALKENKLDENT
NFDIYGKGWQKDASWGDYNITRFKVVDGNIDLKQAIESSDNIFFARIALALGAKKFEQGM
QDLGIGENIPSDYPFYKAQISNSNLKNEILLADSGYGQGEILVNPIQILSIYSALENNGN
IQNPHVLRKTKSQVWKKDIISKKDIDILTNGMERVVNKTHRDDIYKNYARIIGKSGTAEL
KMNQGETGRQIGWFVSYNKNNPNMLMAINVKDVQNKGMASYNATISGKVYDDLYDNGKTQ
FDIDQ
>CAC33832|FEATURES|argannot|beta_lactam|THIN-B|antibiotic inactivation|1
MTLLAKLMLATVATMSAATVQAKTPAPKPDTPVDCDSCKAWNGEVTPFNVFGNTWYVGTA
GLSAVLVTSPQGHVLLDGALPQSAPLIIANIAALGFRIEDVKFILNSHAHWDHAGGIAAL
QAASGATVVASASGALGLQSGTNGKDDPQFQAKPVVHVAKVEKVKVVGEGDAIKLGPLNL
TAHMTPGHTPGATTWTWTSCEGQRCLDVVYADSLNPYSSGDFTYTGKGDGPDISASFAAS
IAKVAALPCDIILSVHPDSTGVLDKAAKRSGEHNPFIDANACRAYAATADAMLTKRLAKE
RGVALPAAAPAAQHAH
>AAP97132|FEATURES|argannot|beta_lactam|CEPH-A3|antibiotic inactivation|1
MMKGWIKCTLAGAVVLMASFWGGSVRAAGISLKQVSGPVYVVEDNYYVKENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQT
WDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVRAFFAGPAHTPDGIF
VYFPDEQVLYGNCILKEKLGNLSFANVKAYPQTIERLKAMKLPIKTVVGGHDSPLHGPEL
IDHYEALIKASPHS
>NP_214233.1|FEATURES|argannot|beta_lactam|cphA1|antibiotic inactivation|0
MGGFLFFFLLVLFSFSSEYPKHVKETLRKITDRIYGVFGVYEQVSYENRGFISNAYFYVA
DDGVLVVDALSTYKLGKELIESIRSVTNKPIRFLVVTHYHTDHFYGAKAFREVGAEVIAH
EWAFDYISQPSSYNFFLARKKILKEHLEGTELTPPTITLTKNLNVYLQVGKEYKRFEVLH
LCRAHTNGDIVVWIPDEKVLFSGDIVFDGRLPFLGSGNSRTWLVCLDEILKMKPRILLPG
HGEALIGEKKIKEAVSWTRKYIKDLRETIRKLYEEGCDVECVRERINEELIKIDPSYAQV
PVFFNVNPVNAYYVYFEIENEILMGE
>NP_213666.1|FEATURES|argannot|beta_lactam|cphA2|antibiotic inactivation|0
VGGAVMLKTLFVLLLIISTAFSMTLKKVEENLYMVRGNDGLPSKENKGFISNAYAVLTEE
GWVVIDTLTTPELSEEFLNLLKKVSNKPVIYAIVTHYHLDHWYGAKTFKDKGAKVIAHEK
LKEFYDSGEALQVLEAQKKRFKGVLDSVELVPPDEVVKDKKVLKVGKDVFEIYAMPPAHT
NSDLVIYWKNRKVLFVGDLVYINRIPFMGDRNASSKGWLEVLERLKEFDARMLLGGHNYP
MNKDAIDWTYNYIKFVRDTVKKLKDEGYFIDEIKEAFKGNPYEKVKMYEVFHNTNVWKVY
NELDLEL
>AAP69912|FEATURES|argannot|beta_lactam|cphA4|antibiotic inactivation|1
MMKGWMKCTLAGAVVLMASFWGGSVRAAGISLKQVSGPVYVVEDNYYVKENSVVYFGAKG
VTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRVGGNAYWKSIGAKVVATRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVRAFYAGPAHTPDGIF
VYFPDEQVLYGNCILKEKLGNLSFANVKAYPQTIERLKAMKLPIKTVIGGHDSPLHGPEL
IDHYEELIKAAAAV
>AAP69913|FEATURES|argannot|beta_lactam|cphA5|antibiotic inactivation|1
MMKGWIKCGLAGAVVLVASFWGGSVHAAAISLTQVSGPVYVVEDNYYVKENSMVYFGAKG
VTIVGATWTPDTARELHKLIKRVNNKPVLEVINTNYHTGQAGGNAYWKSIGAKVVSTRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFNLQEGKVRAFYAGPAHTPDGIF
VYFPDQQVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKIVVGGHDSPLHGPEL
IDHYQALIKAATHS
>AAP69914|FEATURES|argannot|beta_lactam|cphA6|antibiotic inactivation|1
MMKSWMKCTLAGAVVLMASFWGGSVRAAGISLKQVSGPVYVVEDNYYVKENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVRAFYAGPAHTPDGIF
VYFPDEQVLYGNCILKEKLGNLSFANVKAYPQTIERLKAMKLPIKTVIGGHDSPLHGPEL
IDHYEELIKAAAHS
>AAP97129|FEATURES|argannot|beta_lactam|cphA8|antibiotic inactivation|1
MMKGWIKCTLAGAVVLMASFWGGSVRAAGMSLMQVSGPVYVVEDNYYVKENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFKLQEGKVRAFYAGPAHTPDGIF
VYFPDQQVFYGNCILKEKLGNLSFANVKEYPQTIERLKAMKLPIKTVIGGHDSPLHGPEL
IDHYEELIKAATHS
>ADF36549|FEATURES|argannot|beta_lactam|SPM-1|antibiotic inactivation|1
MNSPKSRALLGFMGAFCLLLVAGAPLSAKSSDHVDLPYNLTATKIDSDVFVVTDRDFYSS
NVLVAKMLDGTVVIVSSPFENLGTQTLMDWVAKTMKPKKVVAINTHFHLDGTGGNEIYKK
MGAETWSSDLTKQLRLEENKKDRIKAAEFYKNEDLKRRILSSHPVPADNVFDLKQGKVFS
FSNELVEVSFPGPAHSPDNVVVYFPKKKLLFGGCMIKPKELGYLGDANVKAWPDSARRLK
KFDAKIVIPGHGEWGGPEMVNKTIKVAEKAVGEMRL
>ACT66697|FEATURES|argannot|beta_lactam|SIM-1|antibiotic inactivation|1
MRTLLILCLFGTLNTAFAEEAQPDLKIEKIEEGIYLHTSFQEYKGFGIVKKQGLVVLDNH
KAYLIDTPASAGDTEKLVNWLEKNDFTVNGSISTHFHDDSTAGIEWLNTKSIPTYASKLT
NELLNKNGKTQAKHSFDKESFWLVKNKIEIFYPGPGHTQDNEVVWIPNKKILFGGCFIKP
NGLGNLSDANLEAWPGSAKKMISKYSKAKLVIPSHSEIGDASLLKLTWEQAIKGLNESKS
KPPLIN
>AFI61435|FEATURES|argannot|beta_lactam|blaTEM-169|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTDGESGNYG
>AAS38487|FEATURES|argannot|beta_lactam|TEM-2|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>CAA45828|FEATURES|argannot|beta_lactam|TEM-3|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>CAA41038|FEATURES|argannot|beta_lactam|TEM-6|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAO33760|FEATURES|argannot|beta_lactam|TEM-7|antibiotic inactivation|1
FFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRPEERFPMMSTFKV
LLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTA
ANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTMPAAMATTLRKLL
TGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGK
PSRIVVIYTTGSQATMDERNR
>CAA46344|FEATURES|argannot|beta_lactam|TEM-8|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAB59975.1|FEATURES|argannot|beta_lactam|TEM-10|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGKRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMD
>AAW66604|FEATURES|argannot|beta_lactam|TEM-11|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAA25053|FEATURES|argannot|beta_lactam|TEM-12|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>CAA46346|FEATURES|argannot|beta_lactam|TEM-16|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>CAA74912|FEATURES|argannot|beta_lactam|TEM-17|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ACB22021|FEATURES|argannot|beta_lactam|TEM-20|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAN61404.1|FEATURES|argannot|beta_lactam|TEM-21|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLRNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>CAA76795|FEATURES|argannot|beta_lactam|TEM-22|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGGSERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ADC80822|FEATURES|argannot|beta_lactam|TEM-24|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGTGKRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAC36883|FEATURES|argannot|beta_lactam|TEM-26|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMD
>CAC43180|FEATURES|argannot|beta_lactam|TEM-29|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>CAD24670|FEATURES|argannot|beta_lactam|TEM-30|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
SGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ADL13944|FEATURES|argannot|beta_lactam|TEM-33|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMLSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AGE11905|FEATURES|argannot|beta_lactam|TEM-34|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMVSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>CAA66659|FEATURES|argannot|beta_lactam|TEM-42|antibiotic inactivation|1
QHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGVRVGYIELDLNSGKILESFRPEER
FPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSA
AITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAA
MATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASKRGSRGI
IAALGPDGKPSRIVVIYMTGSQATMDERNRQIAEIGASLIK
>AAC32889|FEATURES|argannot|beta_lactam|TEM-43|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>CAA71322|FEATURES|argannot|beta_lactam|TEM-47|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASKRGS
RGIIAALGPDGKPSRIVVIYMTGSQATMDERNRQIAEIGASLIKHW
>CAA71323|FEATURES|argannot|beta_lactam|TEM-48|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASKRGS
RGIIAALGPDGKPSRIVVIYMTGSQATMDERNRQIAEIGASLIKHW
>CAA71324|FEATURES|argannot|beta_lactam|TEM-49|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASKRGS
RGIIAALGPDGKPSRIVVIYMTGGQATMDERNRQIAEIGASLIKHW
>CAA73933|FEATURES|argannot|beta_lactam|TEM-52|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAD22538|FEATURES|argannot|beta_lactam|TEM-53|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAD22539|FEATURES|argannot|beta_lactam|TEM-54|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
LGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ABB97007|FEATURES|argannot|beta_lactam|TEM-55|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAEPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ACJ43254|FEATURES|argannot|beta_lactam|TEM-57|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLDRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAD45935|FEATURES|argannot|beta_lactam|TEM-59|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMGDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAE
>AAC05975|FEATURES|argannot|beta_lactam|TEM-60|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDPNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMRTTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRCALPAGWLIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAK17194|FEATURES|argannot|beta_lactam|TEM-63|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAD33116|FEATURES|argannot|beta_lactam|TEM-67|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCIPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
CGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>CAB92324|FEATURES|argannot|beta_lactam|TEM-68|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASKRGS
RGIIAALGPDGKPSRIVVIYMTGSQATMDELNRQIAEIGASLIKHW
>AAF01046|FEATURES|argannot|beta_lactam|TEM-70|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASQQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAL03985|FEATURES|argannot|beta_lactam|TEM-71|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASKRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAF19151|FEATURES|argannot|beta_lactam|TEM-72|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASKRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAN05028|FEATURES|argannot|beta_lactam|TEM-75|antibiotic inactivation|1
FFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKV
LLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTA
ANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAIPNDERDTTMPAAMATTLRKLL
TGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGK
PSRIVVIYMTGSQATMDERNR
>AAF05613|FEATURES|argannot|beta_lactam|TEM-76|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMGDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAF05614|FEATURES|argannot|beta_lactam|TEM-73|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMLSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
SGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAF05612|FEATURES|argannot|beta_lactam|TEM-78|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMVSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRREPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERDRQIAEIGASLIKHW
>AAF05611|FEATURES|argannot|beta_lactam|TEM-79|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
GGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAM15527|FEATURES|argannot|beta_lactam|TEM-80|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMLSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAVTMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERDRQIAEIGASLIKHW
>AAL29433|FEATURES|argannot|beta_lactam|TEM-81|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMLSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAVTMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAL29434|FEATURES|argannot|beta_lactam|TEM-82|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMVSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDEQNRQIAEIGASLIKHW
>AAL29435|FEATURES|argannot|beta_lactam|TEM-83|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMLSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRCEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDEQNRQIAEIGASLIKHW
>AAL29436|FEATURES|argannot|beta_lactam|TEM-84|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERDRQIAEIGASLIKHW
>CAC43229|FEATURES|argannot|beta_lactam|TEM-85|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGKRGS
RGIIAALGPDGKPSRIVVIYMTGSQATMDERNRQIAEIGASLIKHW
>CAC43230|FEATURES|argannot|beta_lactam|TEM-86|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGTGKRGS
RGIIAALGPDGKPSRIVVIYMTGSQATMDERNRQIAEIGASLIKHW
>AAG44570|FEATURES|argannot|beta_lactam|TEM-87|antibiotic inactivation|1
MSIKHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLHCWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAK14792|FEATURES|argannot|beta_lactam|TEM-88|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTT
PAAMATTLRKLLTDELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAK71474|FEATURES|argannot|beta_lactam|TEM-89|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMGDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEI
>AAK30619|FEATURES|argannot|beta_lactam|TEM-90|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTGGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>BAB16308|FEATURES|argannot|beta_lactam|TEM-91|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDCWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGKRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAF66653|FEATURES|argannot|beta_lactam|TEM-92|antibiotic inactivation|1
MSIKHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>CAC85660|FEATURES|argannot|beta_lactam|TEM-93|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASKRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>CAC85661|FEATURES|argannot|beta_lactam|TEM-94|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYMTGSQATMDERNRQIAEIGASLIKHW
>CAC67290|FEATURES|argannot|beta_lactam|TEM-95|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGAKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAM22276|FEATURES|argannot|beta_lactam|TEM-96|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLGRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAK85244|FEATURES|argannot|beta_lactam|TEM-34|antibiotic inactivation|1
MDPQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMVSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKLW
>AAK85245|FEATURES|argannot|beta_lactam|TEM-163|antibiotic inactivation|1
MDPQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKLW
>AAK85243|FEATURES|argannot|beta_lactam|TEM-30|antibiotic inactivation|1
MDPQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
SGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKLW
>AAM18924|FEATURES|argannot|beta_lactam|TEM-101|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASKRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIVEIGASLIKHW
>AAK33121|FEATURES|argannot|beta_lactam|TEM-85|antibiotic inactivation|1
MDPQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYMTGSQATMDERNRQIAE
>AAM61952|FEATURES|argannot|beta_lactam|TEM-104|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIVEIGASLIKHW
>AAM61953|FEATURES|argannot|beta_lactam|TEM-105|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CNAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAM52207|FEATURES|argannot|beta_lactam|TEM-106|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAM52215|FEATURES|argannot|beta_lactam|TEM-107|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAM28884|FEATURES|argannot|beta_lactam|TEM-108|antibiotic inactivation|1
MDPQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAELSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTSELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERSRQIAEIGASLIKHW
>AAT46413|FEATURES|argannot|beta_lactam|TEM-109|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMLSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAN05027|FEATURES|argannot|beta_lactam|TEM-110|antibiotic inactivation|1
FFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKV
LLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTA
ANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLL
TGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGK
PSRIVVIYMTGSQATMDERNR
>AAL77062|FEATURES|argannot|beta_lactam|TEM-111|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGADERGS
RGIIAALGPDGKPSRIVVIYMTGSQATMDERNRQIAEIGASLIKHW
>AAS89982|FEATURES|argannot|beta_lactam|TEM-112|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLRNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAS89983|FEATURES|argannot|beta_lactam|TEM-113|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAS89984|FEATURES|argannot|beta_lactam|TEM-114|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGTGKRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAN04881|FEATURES|argannot|beta_lactam|TEM-115|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAN05026|FEATURES|argannot|beta_lactam|BL2b_tem1|antibiotic inactivation|1
FFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKV
LLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTA
ANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLL
TGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGK
PSRIVVIYTTGSQA
>AAN05029|FEATURES|argannot|beta_lactam|TEM-118|antibiotic inactivation|1
FFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKV
LLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTA
ANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAIPNDERDTTMPAAMATTLRKLL
TGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGK
PSRIVVIYMTGSQATMDERNR
>AAO85882|FEATURES|argannot|beta_lactam|TEM-120|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAQ75087|FEATURES|argannot|beta_lactam|TEM-121|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGTGKRGS
SGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAQ98890|FEATURES|argannot|beta_lactam|TEM-122|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDEQNRQIAEIGASLIKHW
>AAQ93490|FEATURES|argannot|beta_lactam|TEM-123|antibiotic inactivation|1
MSIKHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIALGPDGKPSRIVVIYTTGSQATMDEANRQIAEIGASLIKHW
>AAQ93491|FEATURES|argannot|beta_lactam|TEM-124|antibiotic inactivation|1
MSIKHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIALGPDGKPSRIVVIYTTGSQATMDEANRQIAEIGASLIKHW
>AAT46414|FEATURES|argannot|beta_lactam|TEM-125|antibiotic inactivation|1
MSIQHFRVALIPFLAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMLSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSREPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERDRQIAEIGASLIKHW
>AAT45742|FEATURES|argannot|beta_lactam|TEM-126|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERETTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAR89358|FEATURES|argannot|beta_lactam|TEM-127|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDNVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAQ57123|FEATURES|argannot|beta_lactam|TEM-1|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGTSLIKHW
>AAR21068|FEATURES|argannot|beta_lactam|TEM-1|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAIATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>CAI29263|FEATURES|argannot|beta_lactam|TEM-130|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKPAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGTGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAR10958|FEATURES|argannot|beta_lactam|TEM-131|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGTGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAR84298|FEATURES|argannot|beta_lactam|TEM-132|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAVPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGKRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAS19171|FEATURES|argannot|beta_lactam|TEM-133|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAS79107|FEATURES|argannot|beta_lactam|TEM-134|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AEY16488|FEATURES|argannot|beta_lactam|TEM-135|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAV83795|FEATURES|argannot|beta_lactam|TEM-136|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGTGKRGS
RGIIAALGPDGKPSRIVVIYTTGGQATMDERNRQIAEIGASLIKHW
>CAL08007|FEATURES|argannot|beta_lactam|TEM-137|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGRRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAW47922|FEATURES|argannot|beta_lactam|TEM-138|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPIDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAZ23494|FEATURES|argannot|beta_lactam|TEM-139|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIEMDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAX56615|FEATURES|argannot|beta_lactam|TEM-141|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVEDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ABD60314|FEATURES|argannot|beta_lactam|TEM-142|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGANERGS
RGIIAALGPDGKPSRIVVIYMTGSQATMDERNRQIAEIGASLIKHW
>AAY85632|FEATURES|argannot|beta_lactam|TEM-143|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDCWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ABB72432|FEATURES|argannot|beta_lactam|TEM-54|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALLAGWFIADKSGAGERGS
LGIIEALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAZ14083|FEATURES|argannot|beta_lactam|TEM-145|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLMRSALPAGWFIADKSGAGERGS
HGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAZ14084|FEATURES|argannot|beta_lactam|TEM-146|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLPDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
HGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ABB84515|FEATURES|argannot|beta_lactam|TEM-147|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSVLPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>CAJ32372|FEATURES|argannot|beta_lactam|TEM-148|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMAKTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ABC96711|FEATURES|argannot|beta_lactam|TEM-149|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGVRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>CAJ66089|FEATURES|argannot|beta_lactam|TEM-150|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPDTLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ABI74448|FEATURES|argannot|beta_lactam|TEM-151|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMVSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERDRQIAEIGGSLIKHW
>ABI74447|FEATURES|argannot|beta_lactam|TEM-152|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMVSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGKRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERDRQIAEIGASLIKHW
>AGA83484|FEATURES|argannot|beta_lactam|TEM-153|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTVSQATMDERNRQIAEIGASLIKHW
>ACO07310|FEATURES|argannot|beta_lactam|TEM-154|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMLSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ABG77582|FEATURES|argannot|beta_lactam|TEM-155|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGKRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>CAJ39390.1|FEATURES|argannot|beta_lactam|TEM-156|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNIGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ABI81768|FEATURES|argannot|beta_lactam|TEM-157|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQSDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ABQ00181|FEATURES|argannot|beta_lactam|TEM-158|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMLSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERDRQIAEIGASLIKHW
>ABM54869|FEATURES|argannot|beta_lactam|TEM-159|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMISTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ABM54870|FEATURES|argannot|beta_lactam|TEM-160|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMVSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ABO64442|FEATURES|argannot|beta_lactam|TEM-162|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPKTLVKVKDAENQLGARVGYIELDLNSGKILESFRP
EKRFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQSDVVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ACF32746|FEATURES|argannot|beta_lactam|TEM-163|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDEQNRQIAEIGASLIKLW
>ABX71157|FEATURES|argannot|beta_lactam|TEM-164|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQVGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQTAEIGASLIKHW
>ACI25375|FEATURES|argannot|beta_lactam|TEM-166|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVGEL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ACJ04051|FEATURES|argannot|beta_lactam|TEM-167|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSVLPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYMTGSQATMDERNRQIAEIGASLIKHW
>ACR22829|FEATURES|argannot|beta_lactam|TEM-168|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYMTGSQATMDERNRQIAEIGASLIKHW
>ACP18864|FEATURES|argannot|beta_lactam|TEM-169|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMLSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRGEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ADA79631|FEATURES|argannot|beta_lactam|TEM-171|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ADB90239|FEATURES|argannot|beta_lactam|TEM-176|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSVLPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>CBJ06718|FEATURES|argannot|beta_lactam|TEM-177|antibiotic inactivation|1
MSIKHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGTGKRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>CAA65888|FEATURES|argannot|beta_lactam|TEM-178|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGSTSGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGSQELTAFLHNMGDHVTRLDRWEPELNEAIPNDEADTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMADKVAGPLLRSALPAGWFIADKSGARERGSR
GIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ADP20705|FEATURES|argannot|beta_lactam|TEM-182|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMISTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRLEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDELNRQIAEIGASLIKHW
>ADR71220|FEATURES|argannot|beta_lactam|TEM-183|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWLIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AEG64812|FEATURES|argannot|beta_lactam|TEM-185|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMLSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRREPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AET99222|FEATURES|argannot|beta_lactam|TEM-186|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNNERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ADM61585|FEATURES|argannot|beta_lactam|TEM-187|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYMTGSQATMDERNRQIAEIGASLIKH
>AEL17198|FEATURES|argannot|beta_lactam|TEM-188|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASKRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AEL79515|FEATURES|argannot|beta_lactam|TEM-189|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMLSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGKRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AEL88240|FEATURES|argannot|beta_lactam|TEM-190|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMLSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRGEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERDRQIAEIGASLIKHW
>AFC75523|FEATURES|argannot|beta_lactam|TEM-193|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAAHLFLTTIGGPKELTAFLHNMGDHVTRLDCWGPKLTEAIPHDERDTTM
PAAVANTLRKLLTGELLTLASRQQLIDWMEADKVAGPILRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AFC75524|FEATURES|argannot|beta_lactam|TEM-194|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSRNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANILLTTIGGPKELTAFLHNMRDHVTRLDRWEPELNEAIPHDERDTTM
PAPVATTLRTLLTVELLTLASRPRLIDWMEADKVAGPILRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AFC75525|FEATURES|argannot|beta_lactam|TEM-195|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSRNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDCWEPELNEAIPHDERDTTM
PAAVATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AEK48085|FEATURES|argannot|beta_lactam|TEM-197|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>BAL68178|FEATURES|argannot|beta_lactam|TEM-198|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQAIMDERNRQIAEIGASLIKHW
>AFN69127|FEATURES|argannot|beta_lactam|TEM-199|antibiotic inactivation|1
QHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRPEER
FPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVRELCSA
AITMSDNTAANLLLTTIGGPKELTAFLHNIGDHVTRLDRWEPELNEAIPNDERDTTMPAA
MATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGSRGI
IAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AFS44742|FEATURES|argannot|beta_lactam|TEM-201|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETVVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGGQATMDERNRQIAEIGASLIKHW
>AGZ20205|FEATURES|argannot|beta_lactam|TEM-205|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTT
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AGK82336|FEATURES|argannot|beta_lactam|TEM-206|antibiotic inactivation|1
MSIQHFRVTLIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AGK40892|FEATURES|argannot|beta_lactam|TEM-207|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGGRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AGL39384|FEATURES|argannot|beta_lactam|TEM-208|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDFVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AGW25367|FEATURES|argannot|beta_lactam|TEM-209|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLDARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AHA80960|FEATURES|argannot|beta_lactam|TEM-211|antibiotic inactivation|1
MSIKHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMTDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDELNRQIAEIGASLIKHW
>AHA58207|FEATURES|argannot|beta_lactam|TEM-213|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEFSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AJO16044|FEATURES|argannot|beta_lactam|TEM-214|antibiotic inactivation|1
MSIQHFRVALFPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AJO16045|FEATURES|argannot|beta_lactam|TEM-215|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLRNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AHJ78622|FEATURES|argannot|beta_lactam|TEM-216|antibiotic inactivation|1
MSIQHFRVSLIPFFAAFCLPVFAHPETLVKVKDAEDQLGAPVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>CDN33426|FEATURES|argannot|beta_lactam|TEM-217|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVMYTTGSQATMDERNRQIAEIGASLIKHW
>AIS39742|FEATURES|argannot|beta_lactam|TEM-219|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVFIYTTGSQATMDERNRQIAEIGASLIKHW
>AIW68620|FEATURES|argannot|beta_lactam|SHV-186|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTT
PATMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>BAE94459|FEATURES|argannot|beta_lactam|PC1|antibiotic inactivation|1
LKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKALIEASMTY
SDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKENKKFLLDLMLNNKSGDTLIKDGVPKDYKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>AAP93849|FEATURES|argannot|beta_lactam|blaZEG|antibiotic inactivation|1
APMSDKQLADVVKRTITPLMKAQTIPGMAVAVIYQGQPHYFTFGNADVAANKPVTPQTLF
ELGSISKTFTGVLGGDAIARGEISLTDPATKYWPELSGKQWQGIRMLDLATYTAGGLPLQ
VPDEVTDSASLLRFYQNWQPQWKPSTTRLYANASIGLFGALAVKPSGMSYAQAMTERVFK
PLKLGHTWINVPKTEEEHYAWGYRDGKPVHVSPGALDAEAYGVKSNVQDMASWVMANIAP
EHVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVDAKTVVGGSDNNVALAPLPARE
VTPPVPPVKASWVHKTGSTGGFGGYVAFIPEKNLGIV
>CAA63264|FEATURES|argannot|beta_lactam|CMY-1|antibiotic inactivation|1
MQQRQSILWGAVATLMWAGLAHAGEASPVDPLRPVVDASIQPLLKEHRIPGMAVAVLKDG
KAHYFNYGVANRESGAGVSEQTLFEIGSVSKTLTATLGAYAVVKGAMQLDDKASRHAPWL
KGSAFDSITMGELATYSAGGLPLQFPEEVDSSEKMRAYYRQWAPVYSPGSHRQYSNPSIG
LFGHLAASSLKQPFAPLMEQTLLPGLGMHHTYVNVPKQAMASYAYGYSKEDKPIRVNPGM
LADEAYGIKTSSADLLRFVKANIGGVDDKALQQAISLTHQGHYSVGGMTQGLGWESYAYP
VTEQTLLAGNSAKVILEANPTAAPRESGSQVLFNKTGSTNGFGAYVAFVPARGIGIVMLA
NRNYPNEARIKAAHAILAQLAG
>CAO91853|FEATURES|argannot|beta_lactam|blaCMY-2|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGLGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AAL16928|FEATURES|argannot|beta_lactam|BL1_cmy2|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYARGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>CAB50867|FEATURES|argannot|beta_lactam|CMY-5|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKFSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>CAB36902|FEATURES|argannot|beta_lactam|CMY-6|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYALGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>CAB36900|FEATURES|argannot|beta_lactam|CMY-7|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGE
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AAD50818|FEATURES|argannot|beta_lactam|CMY-8|antibiotic inactivation|1
MQQRQSILWGAVATLMWAGLAHAGEASPVDPLRPVVDASIQPLLKEHRIPGMAVAVLKDG
KAHYFNYGVANRESGASVSEQTLFEIGSVSKTLTATLGAYAVVKGAMQLDDKASRHAPWL
KGSVFDSITMGELATYSAGGLPLQFPEEVDSSEKMRAYYRQWAPVYSPGSHRQYSNPSIG
LFGHLAASSLKQPFAQLMEQTLLPGLGMHHTYVNVPKQAMASYAYGYSKEDKPIRVNPGM
LADEAYGIKTSSADLLAFVKANIGGVDDKALQQAISLTHKGHYSVGGMTQGLGWESYAYP
VTEQTLLAGNSAKVILEANPTAAPRESGSQVLFNKTGSTNGFGAYVAFVPARGIGIVMLA
NRNYPIPARVKAAHAILAQLAG
>BAB72158|FEATURES|argannot|beta_lactam|CMY-9|antibiotic inactivation|1
MQQRQSILWGAVATLMWAGLAHAGEASPVDPLRPVVDASIQPLLKEHRIPGMAVAVLKDG
KAHYFNYGVANRESGASVSEQTLFDIGSVSKTLTATLGAYAVVKGAMQLDDKASRHAPWL
KGSVFDSITMGELATYSAGGLPLQFPEEVDSSEKMRAYYRQWAPVYSPGSHRQYSNPSIG
LFGHLAASSLKQPFAQLMEQTLLPGLGMHHTYVNVPKQAMASYAYGYSKEDKPIRVNPGM
LADEAYGIKTSSADLLAFVKANIGGVDDKALQQAISLTHKGHYSVGGMTQGLGWESYAYP
VTEQTLLAGNSAKVILEANPTAAPRESGSQVLFNKTGSTNGFGAYVAFVPARGIGIVMLA
NRNYPIPARVKAAHAILAQLAG
>AAM90334|FEATURES|argannot|beta_lactam|CMY-10|antibiotic inactivation|1
MQQRQSILWGAVATLMWAGLAHAGEASPVDPLRPVVDASIQPLLKEHRIPGMAVAVLKDG
KAHYFNYGVANRESGAGVSEQTLFEIGSVSKTLTATLGAYAVVKGAMQLDDKASRHAPWL
KGSAFDSITMGELATYSAGGLPLQFPEEVDSSEKMRAYYRQWAPVYSPGSHRQYSNPSIG
LFGHLAASSLKQPFAPLMEQTLLPGLGMHHTYVNVPKQAMASYAYGYSKEDKPIRVNPGM
LADEAYGIKTSSADLLRFVKANIGGVDDKALQQAISLTHQGHYSVGGMTQGLGWESYAYP
VTEQTLLAGNSAKVILEANPTAAPRESGSQVLFNKTGSTNGFGAYVAFVPARGIGIVMLA
NRNYPIEARIKAAHAILAQLAG
>AAK59980|FEATURES|argannot|beta_lactam|CMY-11|antibiotic inactivation|1
MQQRQSILWGAVATLMWAGLAHAGEASPVDPLRPVVDASIQPLLKEHRIPGMAVAVLKDG
KAHYFNYGVANRESGAGVSEQTLFEIGSVSKTLTATLGAYAVVKGAMQLDDKASRHAPWL
KGSAFDSITMGELATYSAGGLPLQFPEEVDSSEKMRAYYRQWAPVYSPGSHRQYSNPSIG
LFGHLAASSLKQPFAPLMEQTLLPGLGMHHTYVNVPKQAMASYAYGYSKEDKPIRVNPGM
LADEAYGIKTSSADLLRFVKANIGGVDDKALQQAISLTHQGHYSVGGMTQGLGWESYAYP
VTEQTLLAGNSAKVSLEANPTAAPRESGSQVLFNKTGSTNGFGAYVAFVPARGIGIVMLA
NRNYPIEARIKAAHAILAQLAG
>CBX51207|FEATURES|argannot|beta_lactam|CMY-12|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYSNSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYARGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKNYPNPVRVEAAWRILEKLQ
>AAQ16660|FEATURES|argannot|beta_lactam|CMY-13|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFASAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSNVTDMARWVQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ACC60954|FEATURES|argannot|beta_lactam|BL1_cmy2|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYARGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEINPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>CAD88477|FEATURES|argannot|beta_lactam|CMY-15|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYARGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKNYPNPVRVEAAWRILEKLQ
>CAX33921|FEATURES|argannot|beta_lactam|BL1_cmy2|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYSNSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYARGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AAS13399|FEATURES|argannot|beta_lactam|CMY-17|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVAFAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AAU95778|FEATURES|argannot|beta_lactam|CMY-18|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGNGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVM
LANKSYPNPVRVEAAWRILEKLQ
>BAE48233|FEATURES|argannot|beta_lactam|CMY-19|antibiotic inactivation|1
MQQRQSILWGAVATLMWAGLAHAGEASPVDPLRPVVDASIQPLLKEHRIPGMAVAVLKDG
KAHYFNYGVANRESGASVSEQTLFDIGSVSKTLTATLGAYAVVKGAMQLDDKASRHAPWL
KGSVFDSITMGELATYSAGGLPLQFPEEVDSSEKMRAYYRQWAPVYSPGSHRQYSNPSIG
LFGHLAASSLKQPFAQLMEQTLLPGLGMHHTYVNVPKQAMASYAYGYSKEDKPIRVNPGM
LADEAYGIKTSSADLLAFVKANIGGVDDKALQQAISLTHKGHYSVGGMTQGLGWESYAYP
VTEQTLLAGNSAKVSLEANPTAAPRESGSQVLFNKTGSTNGFGAYVAFVPARGIGIVMLA
NRNYPIPARVKAAHAILAQLAG
>AAX58682|FEATURES|argannot|beta_lactam|CMY-20|antibiotic inactivation|1
MKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYYF
TWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQW
QGISLLHLATYTAGGLPLQIPDDVTDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGAL
AVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEAY
GVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKAD
SIINGSDNKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLAN
KSYPNPVRVEAAWRILEKLQ
>AAZ66866|FEATURES|argannot|beta_lactam|CMY-21|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGE
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGKLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ABB72431|FEATURES|argannot|beta_lactam|CMY-22|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAYWRILEKLQ
>ABD94117|FEATURES|argannot|beta_lactam|CMY-23|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAGA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ABN69070|FEATURES|argannot|beta_lactam|CMY-24|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVYVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ACA30420|FEATURES|argannot|beta_lactam|CMY-25|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVTDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>BAF56185|FEATURES|argannot|beta_lactam|CMY-26|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFASAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKTYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQDISLLHLATYTAGGLPLQIPDDVTDKTALLHFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSNVTDMARWVQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ACA30421|FEATURES|argannot|beta_lactam|CMY-27|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYACGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ABQ51091|FEATURES|argannot|beta_lactam|CMY-28|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGE
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDNKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ABS12248|FEATURES|argannot|beta_lactam|CMY-29|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQFPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGE
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ABS12249|FEATURES|argannot|beta_lactam|CMY-30|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHGSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ABR18736|FEATURES|argannot|beta_lactam|CMY-31|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGRLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ACA97846|FEATURES|argannot|beta_lactam|CMY-32|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPEQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ACA97847|FEATURES|argannot|beta_lactam|CMY-33|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANK
SYPNPVRVEAAWRILEKLQ
>ABN51006|FEATURES|argannot|beta_lactam|CMY-34|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ABN51007|FEATURES|argannot|beta_lactam|CMY-35|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKAVHVSPGQLDAEA
YGVKSSVIDMARWVQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ABY58049|FEATURES|argannot|beta_lactam|CMY-2|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDCIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPENEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>BAF36388|FEATURES|argannot|beta_lactam|CMY-37|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWSELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKTALLHFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAAIPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPIRVEAAWRILEKLQ
>CAP60699|FEATURES|argannot|beta_lactam|CMY-38|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYARGYREGKPVHVSPGQLNAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKNYPNPVRVEAAWRILEKLQ
>BAF95726|FEATURES|argannot|beta_lactam|CMY-39|antibiotic inactivation|1
MMKKSLCCALLLTAPLSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADITNNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWIKVPQSEQKDYAWGYREGKAVHVSPGQLDAEA
YGVKSSVIDMARWVQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ACA30422|FEATURES|argannot|beta_lactam|CMY-40|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGT
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMAHWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGYTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>BAG14343|FEATURES|argannot|beta_lactam|CMY-41|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAATKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEEKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDEVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>ADM21467|FEATURES|argannot|beta_lactam|CMY-42|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHSSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ACJ05361|FEATURES|argannot|beta_lactam|CMY-43|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFAA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ACJ65711|FEATURES|argannot|beta_lactam|CMY-44|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVAPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSY
PNPVRVEAAWRILEKLQ
>CBB16411|FEATURES|argannot|beta_lactam|CMY-45|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLKIPDDVRDKAALLHFYQNWQPQWTPGAKRLYSNSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYARGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTVGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>CBH19182|FEATURES|argannot|beta_lactam|CMY-46|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADITNNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPKNEQKDYAWGYREGKAVHVSPGQLDAEA
YGVKSSVIDMARWVQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ADH82410|FEATURES|argannot|beta_lactam|CMY-47|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDEVTDKAELLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LVVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>ADP02979|FEATURES|argannot|beta_lactam|CMY-48|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>ACV32310|FEATURES|argannot|beta_lactam|CMY-49|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVTPGQLDAEA
YGVKSNVTDMARWIQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALHTVEVNPPAPAVKASWVHKTGSTGGFGSYVAFIPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>CBI75447|FEATURES|argannot|beta_lactam|CMY-50|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDEVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVQPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWCIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AFK73431|FEATURES|argannot|beta_lactam|CMY-51|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLNDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVQPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>ADQ38362|FEATURES|argannot|beta_lactam|CMY-53|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGICLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>ADK55604|FEATURES|argannot|beta_lactam|CMY-54|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLELDA
EAYGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPL
KADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVM
LANKSYPNPVRVEAAWRILEKLQ
>ADK55605|FEATURES|argannot|beta_lactam|CMY-55|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGEAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ADT91162|FEATURES|argannot|beta_lactam|CMY-56|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKT
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ADP37961|FEATURES|argannot|beta_lactam|CMY-57|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQFDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ADY19254|FEATURES|argannot|beta_lactam|CMY-58|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YCVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AEM97672|FEATURES|argannot|beta_lactam|CMY-60|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFIGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AEM97673|FEATURES|argannot|beta_lactam|CMY-61|antibiotic inactivation|1
MMNRYAAALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYYF
TWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQW
QGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGAL
AVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEAY
GVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKAD
SIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLAN
KSYPNPVRVEAAWRILEKLQ
>AEM97674|FEATURES|argannot|beta_lactam|CMY-62|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFSA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AET07387|FEATURES|argannot|beta_lactam|CMY-63|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADITNNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKAVHVSPGQLDAEA
YGVKSSVIDMARWVQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKKLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ADW84690|FEATURES|argannot|beta_lactam|CMY-64|antibiotic inactivation|1
MMKKSLCCALLLTASLSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAIAVIYQGKPYY
FTWGKADITNNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKAVHVSPGQLDAEA
YGVKSSVIDMARWVQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AEZ49852|FEATURES|argannot|beta_lactam|CMY-65|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDVTDKAELLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LVVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>AFK08541|FEATURES|argannot|beta_lactam|CMY-67|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDEVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVQPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEVAWRILEKLQ
>AEZ49855|FEATURES|argannot|beta_lactam|CMY-68|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGIAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDEVTDKAELLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LVVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AGE45504|FEATURES|argannot|beta_lactam|CMY-69|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALPALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AFU25635|FEATURES|argannot|beta_lactam|CMY-70|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYQGKPYY
FTWGKADIANNRPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTQYWPELTGKQ
WQGISLLHLATYTAGGLPLQVPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMSKRVLHPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMTRWVQANMDASQVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPVKA
DSIISGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AFK08538|FEATURES|argannot|beta_lactam|CMY-71|antibiotic inactivation|1
MMKKSLCCALLLTAPFSTFAAAKTEQQIADTVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADITNNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKAVHVSPGQLDAEA
YGVKSSVIDMARWVQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKKLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AFU25641|FEATURES|argannot|beta_lactam|CMY-72|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDVTDKAELLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKSSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYLEGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>ACU00152|FEATURES|argannot|beta_lactam|CMY-73|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVLYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYLPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVTPGQLDAEA
YGVKSNVTDMARWIQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPTVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AFU25632|FEATURES|argannot|beta_lactam|CMY-74|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYQGKPYY
FTWGKADIANNRPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTHYWPELTGKQ
WQGISLLHLATYTAGGLPLQVPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTKRVLHPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMTRWVQANMDASQVQEKTLQQGIELAQSRYWRVGDMYQGLGWEMLNWPVKA
DSIISGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AFK73434|FEATURES|argannot|beta_lactam|CMY-75|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDVTDKAELLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LVVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AFK73437|FEATURES|argannot|beta_lactam|CMY-76|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEEKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVQPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AFU25644|FEATURES|argannot|beta_lactam|CMY-77|antibiotic inactivation|1
MMKKSLCCALLLTAPLSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADITNNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKAVHVSPGQLDAEA
YGVKSSVIDMARWVQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AFK73443|FEATURES|argannot|beta_lactam|CMY-78|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPGDVTDKAELLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKSSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYLEGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>AFK73446|FEATURES|argannot|beta_lactam|CMY-79|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDITDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQDKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPVPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AFK73449|FEATURES|argannot|beta_lactam|CMY-80|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEPQIADIVNRTITPLMQEQAIPGMAVAVIYQGKSYY
FTWGKADITNNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWIKVPQSEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AFK73452|FEATURES|argannot|beta_lactam|CMY-81|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIVNNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDYVTDKAELLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LVVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>AFU25638|FEATURES|argannot|beta_lactam|CMY-83|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYQGKPYY
FTWGKADIANNRPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTHYWPELTGKQ
WQGISLLHLATYTAGGLPLQVPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVNPSGMSYEEAMTKRVLRPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMTRWVQANMDASQVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPVKA
DSIISGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AFK73455|FEATURES|argannot|beta_lactam|CMY-84|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPALTGKQ
WRGISLLHLATYTAGGLPLQIPDDITDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>BAL63057|FEATURES|argannot|beta_lactam|CMY-87|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLNDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVQPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>AGC54798|FEATURES|argannot|beta_lactam|CMY-94|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVASAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AGC54799|FEATURES|argannot|beta_lactam|CMY-95|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHASPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVASAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AGR82311|FEATURES|argannot|beta_lactam|CMY-104|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNHTITPLMQKQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPSTKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASQVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVDAAWRILEKLQ
>AHL39330|FEATURES|argannot|beta_lactam|CMY-105|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDEVTDKAELLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LVVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AJH76980|FEATURES|argannot|beta_lactam|blaCMY-106|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVTPGQLDAEA
YGVKSNVTDMARWIQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPTPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AGZ20169|FEATURES|argannot|beta_lactam|CMY-108|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWHILEKLQ
>BAO05497|FEATURES|argannot|beta_lactam|CMY-110|antibiotic inactivation|1
MMKKSICCALLLTASFSKFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWGIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>AHW47897|FEATURES|argannot|beta_lactam|CMY-111|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDVEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AIT76090|FEATURES|argannot|beta_lactam|CMY-112|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEEKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDEVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>AIT76089|FEATURES|argannot|beta_lactam|CMY-113|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDVTDKAELLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LVVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASLVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>AIT76099|FEATURES|argannot|beta_lactam|CMY-114|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDYVTDKAELLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LVVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>AIT76092|FEATURES|argannot|beta_lactam|CMY-115|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYKGKPYY
FTWGKADIANNHPVTQHTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDITDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMAHWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>AIT76093|FEATURES|argannot|beta_lactam|CMY-116|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDITDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPVPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AIT76097|FEATURES|argannot|beta_lactam|CMY-117|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDITDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHAQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPVPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>AIT76091|FEATURES|argannot|beta_lactam|CMY-118|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>AIT76098|FEATURES|argannot|beta_lactam|CMY-119|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFASAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWIQVNMDASRVQEKMLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAAEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AKG51729|FEATURES|argannot|beta_lactam|blaCMY-131|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGE
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPRQLGAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AKZ20822|FEATURES|argannot|beta_lactam|blaCMY-132|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKKLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AKZ20821|FEATURES|argannot|beta_lactam|blaCMY-133|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGNDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AKP17985|FEATURES|argannot|beta_lactam|blaCMY-135|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHLVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDITDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>CAA82281|FEATURES|argannot|beta_lactam|SME-1|antibiotic inactivation|1
MSNKVNFKTASFLFSVCLALSAFNAHANKSDAAAKQIKKLEEDFDGRIGVFAIDTGSGNT
FGYRSDERFPLCSSFKGFLAAAVLERVQQKKLDINQKVKYESRDLEYHSPITTKYKGSGM
TLGDMASAALQYSDNGATNIIMERFLGGPEGMTKFMRSIGDNEFRLDRWELELNTAIPGD
KRDTSTPKAVANSLNKLALGNVLNAKVKAIYQNWLKGNTTGDARIRASVPADWVVGDKTG
SCGAIGTANDYAVIWPKNRAPLIVSIYTTRKSKDDKHSDKTIAEASRIAIQAID
>AAG29813|FEATURES|argannot|beta_lactam|SME-2|antibiotic inactivation|1
MSNKVNFKTASFLFSVCLALSAFNAHANKSDAAAKQIKKLEEDFDGRIGVFAIDTGSGNT
FGYRSDERFPLCSSFKGFLAAAVLERVQQKKLDINQKVKYESRDLEYHSPITTKYKGSGM
TLGDMASAALQYSDNGATNIIMERFLGGPEGMTKFMRSIGDNEFRLDRWELELNTAIPGD
KRDTSTPKAVANSLNKLALGNVLNAKEKAIYQNWLKGNTTGDARIRASVPADWVVGDKTG
SCGAYGTANDYAVIWPKNRAPLIVSIYTTRKSKDDKHSDKTIAEASRIAIQAID
>AAS92558|FEATURES|argannot|beta_lactam|SME-3|antibiotic inactivation|1
MSNKVNFKTASFLFSVCLALSAFNAHANKSDAAAKQIKKLEEDFDGRIGVFAIDTGSGNT
FGYRSDERFPLCSSFKGFLAAAVLERVQQKKLDINQKVKYESRDLEYYSPITTKYKGSGM
TLGDMASAALQYSDNGATNIIMERFLGGPEGMTKFMRSIGDNEFRLDRWELELNTAIPGD
KRDTSTPKAVANSLNKLALGNVLNAKVKAIYQNWLKGNTTGDARIRASVPADWVVGDKTG
SCGAYGTANDYAVIWPKNRAPLIVSIYTTRKSKDDKHSDKTIAEASRIAIQAID
>AHA49908|FEATURES|argannot|beta_lactam|SME-4|antibiotic inactivation|1
MSNKVNFKTASFLFSVCLALSAFNAHANKSDAAAKQIKKLEEDFDGRIGVFAIDTGSGNT
FGYRSDERFPLCSSFKGFLAAAVLERVQQKKLDINQKVKYESRDLEYHSPITTKYKGSGM
TLGDMASAALQYSDNGATNIIMERFLGGPEGMTKFMRSIGDNEFRLDRWELELNTAIPGD
KRDTSTPKAVANSLNKLALGNVLNAKVKAIYQNWLKGNTTGDARIRASVPADWVVGDKTG
SCGAYGTANDYAVIWPKNRAPLIVSIYTTRKSKDDKHSDKTIAEASRIAIQAID
>AHV85514|FEATURES|argannot|beta_lactam|SME-5|antibiotic inactivation|1
MSNKVNFKTASFLFSVCLALSAFNAHANKSDAAAKQIKKLEEDFDGRIGVFAIDTGSGNT
FGYRSDERFPLCSSFKGFLAAAVLERVQQKKLDINQKVKYESRDLEYHSPITPKYKGSGM
TLGDMASAALQYSDNGATNIIMERFLGGPEGMTKFMRSIGDNEFRLDRWELELNTAIPGD
KRDTSTPKAVANSLNKLALGNVLNAKVKAIYQNWLKGNTTGDARIRASVPADWVVGDKTG
SCGAYGTANDYAVIWPKNRAPLIVSIYTTRKSKDDKHSDKTIAEASRIAIQAID
>AAD37413|FEATURES|argannot|beta_lactam|SHV-2|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAA66730|FEATURES|argannot|beta_lactam|SHV-2A|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAA39164|FEATURES|argannot|beta_lactam|SHV-5|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAA87176|FEATURES|argannot|beta_lactam|SHV-7|antibiotic inactivation|1
MRYFRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGSVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAB51384|FEATURES|argannot|beta_lactam|SHV-8|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARNTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ACO07066|FEATURES|argannot|beta_lactam|SHV-66|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAD43815|FEATURES|argannot|beta_lactam|SHV-13|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAAERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAG17550|FEATURES|argannot|beta_lactam|SHV-14|antibiotic inactivation|1
MRYFRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGSVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAB37325|FEATURES|argannot|beta_lactam|SHV-15|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAMLARVDAGDKQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAC98092|FEATURES|argannot|beta_lactam|SHV-16|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKITHRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETDRWETELNEALPGDARD
TTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGE
RGARGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ACG63555|FEATURES|argannot|beta_lactam|SHV-18|antibiotic inactivation|1
MRYFRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGSVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAAKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>BAA84973|FEATURES|argannot|beta_lactam|SHV-24|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARGTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAF37209|FEATURES|argannot|beta_lactam|SHV-25|antibiotic inactivation|1
MRYIRLCIISLLAALPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITVSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ACO07068|FEATURES|argannot|beta_lactam|SHV-27|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIDDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ACA09611|FEATURES|argannot|beta_lactam|SHV-28|antibiotic inactivation|1
MRFIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAG49894|FEATURES|argannot|beta_lactam|SHV-29|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGSVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAAERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAT75225|FEATURES|argannot|beta_lactam|SHV-30|antibiotic inactivation|1
MRYFRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGSVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ACY68243|FEATURES|argannot|beta_lactam|SHV-31|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAK69828|FEATURES|argannot|beta_lactam|SHV-32|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AVITMSDNSAANLLLATVGGPAGLTAFLRQIDDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAK69829|FEATURES|argannot|beta_lactam|SHV-33|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLSAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAK64187|FEATURES|argannot|beta_lactam|SHV-34|antibiotic inactivation|1
MRYFRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGSVGMIEMDLASGRTLTAWRADG
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAL68926|FEATURES|argannot|beta_lactam|SHV-35|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDKQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGGRG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAL82592|FEATURES|argannot|beta_lactam|SHV-36|antibiotic inactivation|1
MRYVRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAL82593|FEATURES|argannot|beta_lactam|SHV-37|antibiotic inactivation|1
MRYIRLCIISLLAALPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITVSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQHIAGIGAALIEHWQR
>ACV33211|FEATURES|argannot|beta_lactam|SHV-38|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPVGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAN77730|FEATURES|argannot|beta_lactam|SHV-39|antibiotic inactivation|0
ALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFI
ADKTGASERGARGIVALLGPNNKAERIVVIYLRDS
>AAN04883|FEATURES|argannot|beta_lactam|SHV-41|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATFGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAN04884|FEATURES|argannot|beta_lactam|SHV-42|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHSSPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITVSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAL40899|FEATURES|argannot|beta_lactam|SHV-43|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHFADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLSAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAP82228|FEATURES|argannot|beta_lactam|SHV-44|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQLQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AEK48091|FEATURES|argannot|beta_lactam|SHV-45|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIDDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGA
>AAO53445|FEATURES|argannot|beta_lactam|SHV-46|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLNSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAP03063|FEATURES|argannot|beta_lactam|UUU_18620|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTIGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAS98184|FEATURES|argannot|beta_lactam|UUU_18620|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMISTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAP41108|FEATURES|argannot|beta_lactam|SHV-50|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMTATLRKLLTSQRLSARSQRHLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAP41944|FEATURES|argannot|beta_lactam|SHV-51|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGLAGLTAFLRQIGDNVTRLDRWETELNEALPADARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AEJ08681|FEATURES|argannot|beta_lactam|SHV-52|antibiotic inactivation|1
MRYIRLCIISLLAALPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMISTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLAIVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAT01223|FEATURES|argannot|beta_lactam|SHV-53|antibiotic inactivation|1
IISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMST
FKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSD
NSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLR
KLLISQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGP
NN
>AEK48092|FEATURES|argannot|beta_lactam|SHV-55|antibiotic inactivation|1
MRFIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGA
>AAQ55480|FEATURES|argannot|beta_lactam|SHV-66|antibiotic inactivation|1
MRYIRLCIIYLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAO66446|FEATURES|argannot|beta_lactam|SHV-57|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETERNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAV66328|FEATURES|argannot|beta_lactam|SHV-59|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSVANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTLASMAERNQQIAGIGAALIEHWQR
>CAI30649|FEATURES|argannot|beta_lactam|SHV-60|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMTATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAI30650|FEATURES|argannot|beta_lactam|SHV-61|antibiotic inactivation|1
MRYIRRCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ABY56290|FEATURES|argannot|beta_lactam|SHV-63|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGENVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTNQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ABA06586|FEATURES|argannot|beta_lactam|SHV-64|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVLLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ABA06587|FEATURES|argannot|beta_lactam|SHV-65|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCT
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ABA06588|FEATURES|argannot|beta_lactam|SHV-66|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADQ
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ABA06589|FEATURES|argannot|beta_lactam|SHV-67|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWCADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ABA06590|FEATURES|argannot|beta_lactam|SHV-69|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLTDGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAY42633|FEATURES|argannot|beta_lactam|SHV-70|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGVTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAJ47126|FEATURES|argannot|beta_lactam|SHV-71|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKYLADGMTVGELCA
AAITMSDNSAANLLLATVGGPVGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAJ47127|FEATURES|argannot|beta_lactam|SHV-72|antibiotic inactivation|1
MRYFRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPVGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADRTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAJ47128|FEATURES|argannot|beta_lactam|SHV-73|antibiotic inactivation|1
MRIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADER
FPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAA
AITMSDNSAANLLLATVGGPVGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPAS
MAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADRTGAGERGARGI
VALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAJ47129|FEATURES|argannot|beta_lactam|SHV-74|antibiotic inactivation|1
MRYIRLCIISLLATLPLTVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAJ47130|FEATURES|argannot|beta_lactam|SHV-75|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPHNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAJ47131|FEATURES|argannot|beta_lactam|SHV-76|antibiotic inactivation|1
MRYIRLCIISLLAALPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVEDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAJ47132|FEATURES|argannot|beta_lactam|SHV-77|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVALCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ACO07070|FEATURES|argannot|beta_lactam|SHV-78|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASSRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAJ47134|FEATURES|argannot|beta_lactam|SHV-79|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEVLPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAJ47135|FEATURES|argannot|beta_lactam|SHV-80|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPTGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAJ47136|FEATURES|argannot|beta_lactam|SHV-81|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGSPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAJ47137|FEATURES|argannot|beta_lactam|SHV-82|antibiotic inactivation|1
MRYVRLCIISLLATLPLAVHTSPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAJ32371|FEATURES|argannot|beta_lactam|SHV-84|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADRTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIG
>ABC54571|FEATURES|argannot|beta_lactam|SHV-85|antibiotic inactivation|1
MRYIRLCIISLLATMPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ABC58727|FEATURES|argannot|beta_lactam|SHV-86|antibiotic inactivation|1
MRFIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASRRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ABA60809|FEATURES|argannot|beta_lactam|SHV-89|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITVSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ABH04327|FEATURES|argannot|beta_lactam|SHV-92|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMISTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLAIVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ABN49110|FEATURES|argannot|beta_lactam|SHV-93|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGTVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIDDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ABN49111|FEATURES|argannot|beta_lactam|SHV-94|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQHLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ABN49113|FEATURES|argannot|beta_lactam|SHV-95|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARLQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ABN49112|FEATURES|argannot|beta_lactam|SHV-96|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDARVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ABN49114|FEATURES|argannot|beta_lactam|SHV-97|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGKRGARG
IVALLGPNNKAERIVVIYLRDSPASMAERNQQIAGIGAALIEHWQR
>CAP58287|FEATURES|argannot|beta_lactam|SHV-98|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPAIMAERNQQIAGIGAALIEHWQR
>CAP58288|FEATURES|argannot|beta_lactam|SHV-99|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVGYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAP58289|FEATURES|argannot|beta_lactam|SHV-100|antibiotic inactivation|1
MRFIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIESESQLSGRVGMIEMDL
ASGRTLTAWRADERFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEK
HLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNE
ALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFI
ADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ABV72593|FEATURES|argannot|beta_lactam|SHV-101|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDGRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ABS72342|FEATURES|argannot|beta_lactam|SHV-102|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAAERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ABS72351|FEATURES|argannot|beta_lactam|UUU_18620|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNRAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ACI22621|FEATURES|argannot|beta_lactam|SHV-105|antibiotic inactivation|1
MRYFRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGSVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIDDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAQ03506|FEATURES|argannot|beta_lactam|SHV-106|antibiotic inactivation|1
MRFIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAQ03507|FEATURES|argannot|beta_lactam|SHV-107|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKAGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAQ03508|FEATURES|argannot|beta_lactam|SHV-108|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLAIVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ACM04459|FEATURES|argannot|beta_lactam|SHV-109|antibiotic inactivation|1
MRYIRRCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDMPASMAERNQQIAGIGAALIEHWQR
>AEK48093|FEATURES|argannot|beta_lactam|SHV-110|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIDDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AEG79634|FEATURES|argannot|beta_lactam|SHV-120|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>BAI65841|FEATURES|argannot|beta_lactam|SHV-121|antibiotic inactivation|1
MRYIRLCIISLLAALPLVVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITVSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ACY70943|FEATURES|argannot|beta_lactam|SHV-122|antibiotic inactivation|1
ARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLAT
VGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSA
RSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVSLLGPN
>ADE58494|FEATURES|argannot|beta_lactam|SHV-128|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELRA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGTGAAPIEHWQR
>ADU15837|FEATURES|argannot|beta_lactam|UUU_18620|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMLSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>BAI94487|FEATURES|argannot|beta_lactam|SHV-133|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDGVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ADM25824|FEATURES|argannot|beta_lactam|SHV-134|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLREIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ADR66517|FEATURES|argannot|beta_lactam|SHV-135|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLKQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMTATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AEI83430|FEATURES|argannot|beta_lactam|SHV-137|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAALTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPHNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AEK80394|FEATURES|argannot|beta_lactam|SHV-140|antibiotic inactivation|1
KRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYSQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AFC60795|FEATURES|argannot|beta_lactam|SHV-141|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGSVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AEX99752|FEATURES|argannot|beta_lactam|SHV-142|antibiotic inactivation|1
MRYIRLCIISLLAALPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AFQ32277|FEATURES|argannot|beta_lactam|SHV-143|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDLWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AFK93491|FEATURES|argannot|beta_lactam|SHV-144|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPVGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AFN88952|FEATURES|argannot|beta_lactam|SHV-145|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGERCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AFQ23953|FEATURES|argannot|beta_lactam|SHV-147|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSAFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTSASMAERNQQIAGIGAALIEHWQR
>AFQ23954|FEATURES|argannot|beta_lactam|SHV-148|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQQ
>AFQ23955|FEATURES|argannot|beta_lactam|SHV-149|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESRLSGSVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTASLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AFQ23956|FEATURES|argannot|beta_lactam|SHV-150|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVVLLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AFQ23957|FEATURES|argannot|beta_lactam|SHV-151|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQPSGSVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AFQ23958|FEATURES|argannot|beta_lactam|SHV-152|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTARRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AFQ23959|FEATURES|argannot|beta_lactam|SHV-153|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASERGARG
IVALLGPNNKAERIVVIYLRDTPASMVERNQQIAGIGAALIEHWQR
>AFQ23960|FEATURES|argannot|beta_lactam|SHV-154|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGSVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AFQ23961|FEATURES|argannot|beta_lactam|SHV-155|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQQ
>AFQ23962|FEATURES|argannot|beta_lactam|SHV-156|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQPERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTTFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AFQ23963|FEATURES|argannot|beta_lactam|SHV-157|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVMLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AFQ23964|FEATURES|argannot|beta_lactam|SHV-158|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLAAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AFQ23965|FEATURES|argannot|beta_lactam|SHV-159|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVGDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AFQ23966|FEATURES|argannot|beta_lactam|SHV-160|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSEGQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AFQ23967|FEATURES|argannot|beta_lactam|SHV-161|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGSVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AFQ23968|FEATURES|argannot|beta_lactam|SHV-162|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGSVGMVEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AFQ23969|FEATURES|argannot|beta_lactam|SHV-163|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGSVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQQ
>AFQ23970|FEATURES|argannot|beta_lactam|SHV-165|antibiotic inactivation|1
MRYIRLCIISLLAPLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>BAM28879|FEATURES|argannot|beta_lactam|SHV-167|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDADDEQLERKIHYRQQDLVDYSPVSEKYLADGMTVGELCA
AAITMSDNSAANLLLATVGGPVGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIE
>AFW16978|FEATURES|argannot|beta_lactam|SHV-168|antibiotic inactivation|1
MRYFRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPVGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AHA80958|FEATURES|argannot|beta_lactam|SHV-172|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKADRIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AHA80959|FEATURES|argannot|beta_lactam|SHV-173|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDQASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AHA80963|FEATURES|argannot|beta_lactam|SHV-178|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWVVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AHA80962|FEATURES|argannot|beta_lactam|SHV-179|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMNTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AJO16040|FEATURES|argannot|beta_lactam|SHV-180|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGHVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMTATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AJO16042|FEATURES|argannot|beta_lactam|SHV-182|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYTPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CDN33427|FEATURES|argannot|beta_lactam|SHV-183|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGAR
GIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AIS67768|FEATURES|argannot|beta_lactam|SHV-185|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVMIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AIS67769|FEATURES|argannot|beta_lactam|SHV-186|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMTATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERCARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CEA29751|FEATURES|argannot|beta_lactam|SHV-188|antibiotic inactivation|1
VVKRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRA
DERFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGEL
CAAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELKLNEALPGDARDT
TTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGER
GARGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AJO16047|FEATURES|argannot|beta_lactam|SHV-189|antibiotic inactivation|1
MRYFRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGSVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AKK23732|FEATURES|argannot|beta_lactam|SHV-190|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALLEHWQR
>AKK23733|FEATURES|argannot|beta_lactam|SHV-191|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLVSGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIDDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ALI16958|FEATURES|argannot|beta_lactam|blaSHV-193|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
LFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAA82916|FEATURES|argannot|beta_lactam|OXY-1-1|antibiotic inactivation|1
MLKSSWRKTALMAAAAVPLLLASGSLWASADAIQQKLADLEKRSGGRLGVALINTADDSQ
TLYRGDERFAMCSTGKVMAAAAVLKQSESNPEVVNKRLEIKKSDLVVWSPITEKHLQSGM
TLAELSAAALQYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDK
RDTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGA
GDYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL
>AAL78275|FEATURES|argannot|beta_lactam|OXY-1-3|antibiotic inactivation|1
MLKSSWRKTALMAAAAVPLLLASGSLWASADAIQQKLADLEKRSGGRLGVALINTADDSQ
TLYRGDERFAMCSTGKVMAAAAVLKQSESNPEVVNKRLEIKKSDLVVWSPITEKHLQSGM
TLAELSAAALQYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDK
RDTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGG
GDYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL
>AAL78276|FEATURES|argannot|beta_lactam|OXY-1-4|antibiotic inactivation|1
MLKSSWRKTALMAAAVPLLLASGSLWASADAIQQKLADLEKRSGGRLGVALINTADDSQT
LYRGDERFAMCSTGKVMAAAAVLKQSESNPEVVNKRLEIKKSDLVVWSPITEKHLQSGMT
LAELSAAALQYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDKR
DTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWVVGDKTGAG
DYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL
>CAB42615|FEATURES|argannot|beta_lactam|OXY-1-6|antibiotic inactivation|1
MLKSSWRKTALMAAAAVPLLLASGSLWASADAIQQKLADLEKRSGGRLGVALINTADDSQ
TLYRGDERFAMCSTGKVMAAAAVLKQSESNPEVVNKRLEIKKSDLVVWSPITEKHLQSGM
TLAELSAAALQYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDK
RDTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGA
GDYGTTNDIAVIWPENHAPLVPVTYFTQPQQDAKSRKKVLAAAAKIVTEGL
>CAI43414|FEATURES|argannot|beta_lactam|OXY-2-1|antibiotic inactivation|1
MIKSSWRKIAMLAAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
LYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMT
LAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFAHSIGDATFRLDRTEPTLNTAIPGDER
DTSTPLAMAESLRKLTLGDALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAG
DYGTTNDIAVIWPEDHAPLVLVTYFTQPQQDAKNRKEVLAAAAKIVTEGL
>CAI43415|FEATURES|argannot|beta_lactam|OXY-2-2|antibiotic inactivation|1
MIKSSWRKIAMLAAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
LYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMT
LAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDER
DTSTPLAMAESLRKLTLGDALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAG
DYGTTNDIAVIWPEDHAPLILVTYFTQPQQDAKNRKEVLAAAAKIVTEGL
>AAL78281|FEATURES|argannot|beta_lactam|OXY-2-3|antibiotic inactivation|1
MIKSSWRKIAMLAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQIL
YRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMTL
AELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDERD
TSTPLAMAESLRKLTLGDALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGGGD
YGTTNDIAVIWPEDHAPLVLVTYFTQPQQDAKNRKEVLAAAAKIVTEGL
>AAL78278|FEATURES|argannot|beta_lactam|OXY-2-6|antibiotic inactivation|1
MIKSSWRKIAMLAAAVPLLLASSALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
LYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMT
LAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDER
DTSTPLAMAESLRKLTLGDALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAG
DYGTTNDIAVIWPEDHAPLVLVTYFTQPQQDAKNRKEVLAAAAKIVTEGL
>CAA88908|FEATURES|argannot|beta_lactam|OXY-2-7|antibiotic inactivation|1
MIKSSWRKIAMLAAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
LYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMT
LAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDER
DTSTPLAMAESLRKLTLGDALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAG
DYGTTNDIAVIWPEDHAPLVLVTYFTQPQQDAKNRKEVLAAAAKIVTEGL
>AAL17873|FEATURES|argannot|beta_lactam|OXY-2-8|antibiotic inactivation|1
MIKSSWRKIAMLAAAVPLLLASSALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
LYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMT
LAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDER
DTSTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAG
DYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKNRKEVLAAAAKIVTEGL
>ACV44455|FEATURES|argannot|beta_lactam|OXY-2-9|antibiotic inactivation|1
MIKSSWRKIAMLAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQIL
YRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMTL
AELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDERD
TSTPLAMAESLRKLTLGDALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGTGD
YGTTNDIAVIWPEDHAPLVLVTYFTQPQQDAKNRKEVLAAAAKIVTEGL
>ACV44456|FEATURES|argannot|beta_lactam|OXY-2-10|antibiotic inactivation|1
MIKSSWRKIAMLAAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
LYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMT
LAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDER
DTSTPLAMAESLRKLTLGDALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAG
DYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKNRKEVLAAATKIVTEGL
>AAN28732|FEATURES|argannot|beta_lactam|OXY-3-1|antibiotic inactivation|1
MIKTSWRKSALIAAALPLLLCSSSLWANAIQQKLADLEKSTGGRLGVALIDTTDNSQILY
RGDERFAMCSTGKVMAAAAVLKQSESNKDVVNKRLEIKASDLVVWSPVTEKHLQSGMTLA
ELSAAALQYSDNTAMNKMIGYLGGPEKVTAFARSIGDVTFRLDRTEPALNTAIPGDERDT
TTPLAMAESLHKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWVVGDKTGAGDY
GTTNDIAVIWPENHAPLVLVTYFTQPLQDAKSRKDVLAAAAKIVTEGL
>AAL78161|FEATURES|argannot|beta_lactam|OXY-4-1|antibiotic inactivation|1
MLKSSWRKSALMAAAVPLLLASGSLWASADTLQQKLADLEKRSGGRLGVALINTADDSQT
LYRGDERFAMCSTGKVMAAAAVLKQSESHPDVVNKRLEIKKSDLVVWSPITEKHLQSGMT
LAELSAAALQYSDNTAMNKIIGYLGGPEKVTAFAQSIGDVTFRLDRMEPALNSAIPGDKR
DTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGGG
DYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL
>CAI43416|FEATURES|argannot|beta_lactam|OXY-5-1|antibiotic inactivation|1
MLKSSWRKTALMAAAVPLLLASGSLWASADAIQQKLADLEKHSGGRLGVALINTADDSQT
LYRGDERFAMCSTGKVMAAAAVLKQSESNPEVVNKRLEIKKADLVVWSPITEKHLQSGMT
LAELSAAALQYSDNTAMNKIIGYLGGPEKVTAFAQSIGDVTFRLDRMEPALNSAIPGDKR
DTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGAG
DYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL
>CAI43419|FEATURES|argannot|beta_lactam|OXY-5-2|antibiotic inactivation|1
MLKSSWRKTALMAAAVPLLLASGSLWASADAIQQKLADLEKRSGGRLGVALINTADDSQT
LYRGDERFAMCSTGKVMAAAAVLKQSESNPEVVNKRLEIKKADLVVWSPITEKHLQSGMT
LAELSAAALQYSDNTAMNKIIGYLGGPEKVTAFALSIGDVTFRLDRMEPALNSAIPGDKR
DTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGAG
DYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL
>CAI43421|FEATURES|argannot|beta_lactam|OXY-6-1|antibiotic inactivation|1
MLKSSWRKSALMAAAAVPLLLASGSLWASADAIQQKLADLEKRSGGRLGVALINTADDSQ
TLYRGDERFAMCSTGKVMAAAAVLKQSESHPDVVNKRLEIKKSDLVVWSPITEKHLQSGM
TLAELSAAALQYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDK
RDTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGA
GDYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL
>CAI43424|FEATURES|argannot|beta_lactam|OXY-6-3|antibiotic inactivation|1
MLKSSWRKSALMAAAAVPLLLASGSLWASADAIQQKLADLEKRSGGRLGVALINTTDDSQ
TLYRGDERFAMCSTGKVMAAAAVLKQSESHPDVVNKRLEIKKSDLVVWSPITEKHLQSGM
TLAELSAAALQYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDK
RDTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGA
GDYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL
>AFJ92668.1|FEATURES|argannot|beta_lactam|OXA-1|antibiotic inactivation|1
MKNTIHINFAIFLIIANIIYSSASASTDISTVASPLFEGTEGCFLLYDASTNAEIAQFNK
AKCATQMAPDSTFKIALSLMAFDAEIIDQKTIFKWDKTPKGMEIWNSNHTPKTWMQFSVV
WVSQEITQKIGLNKIKNYLKDFDYGNQDFSGDKERNNGLTEAWLESSLKISPEEQIQFLR
KIINHNLPVKNSAIENTIENMYLQDLDNSTKLYGKTGAGFTANRTLQNGWFEGFIISKSG
HKYVFVSALTGNLGSNLTSSIKAKKNAITILNTLNL
>ADI82851.1|FEATURES|argannot|beta_lactam|OXA-2|antibiotic inactivation|1
MAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFD
PVRSKKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNS
TVWVYELFAKEIGDDKARRYLKKIDYGNADPSTSNGDYWIEGSLAISAQEQIAFLRKLYR
NELPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGRMGWWVGWVEWPTGSVFFALNIDTP
NRMDDLFKREAIVRAILRSIEALPPNPAVNSDAAR
>AAC41449|FEATURES|argannot|beta_lactam|OXA-3|antibiotic inactivation|1
MAIRIFAILFSTFVFGTFAHAQEGMRERSDWRKFFSEFQAKGTIVVADERQTDRVILVFD
QVRSEKRYSPASTFKIPHTLFALDAGAARDEFQVFRWDGIKRSFAAHNQDQDLRSAMRNS
TVWIYELFAKEIGEDKARRYLKQIDYGNADPSTSNGDYWIDGNLAIAAQEQIAFLRKLYH
NELPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGRIGWWVGWVEWPTGPVFFALNIDTP
NRMDDLFKREAIVRAILRSIEALPPNPAVNSDAAR
>CAA41211|FEATURES|argannot|beta_lactam|OXA-5|antibiotic inactivation|1
MKTIAAYLVLVFYASTALSESISENLAWNKEFSSESVHGVFVLCKSSSNSCTTNNAARAS
TAYIPASTFKIPNALIGLETGAIKDERQVFKWDGKPRAMKQWEKDLKLRGAIQVSAVPVF
QQIAREVGEIRMQKYLNLFSYGNANIGGGIDKFWLEGQLRISAFNQVKFLESLYLNNLPA
SKANQLIVKEAIVTEATPEYIVHSKTGYSGVGTESSPGVAWWVGWVEKGTEVYFFAFNMD
IDNESKLPSRKSISTKIMASEGIIIGG
>CAA53242|FEATURES|argannot|beta_lactam|OXA-7|antibiotic inactivation|1
MKTFAAYVITACLSSTALASSITENTFWNKEFSAEAVNGVFVLCKSSSKLACATNNLARA
SKEYLPASTFKIPNAIIGLETGVIKNEHQIFKWDGKPRAMKQWERDLSLRGAIQVSAVPV
FQQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLFLNKLS
ASKENQLIVKEALVTEAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKGAEVYFFAFNMD
IDNENKLPLRKSIPTKIMASEGIIGG
>YP_004455304|FEATURES|argannot|beta_lactam|OXA-9|antibiotic inactivation|1
MKDTLMKKILLLHMLVFVSATLPISSVASDEVETLKCTIIADAITGNTLYETGECARRVS
PCSSFKLPLAIMGFDSGILQSPKSPTWELKPEYNPSPRDRTYKQVYPALWQSDSVVWFSQ
QLTSRLGVDRFTEYVKKFEYGNQDVSGDSGKHNGLTQSWLMSSLTISPKEQIQFLLRFVA
HKLPVSEAAYDMAYATIPQYQAAEGWAVHGKSGSGWLRDNNGKINESRPQGWFVGWAEKN
GRQVVFARLEIGKEKSDIPGGSKAREDILVELPVLMGNK
>AEH57056.1|FEATURES|argannot|beta_lactam|OXA-10|antibiotic inactivation|1
MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARAS
KEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLYLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMD
IDNESKLPLRKSIPTKIMESEGIIGG
>CAA80304|FEATURES|argannot|beta_lactam|OXA-11|antibiotic inactivation|1
MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARAS
KEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGSQNISGGIDKFWLEDQLRISAVNQVEFLESLYLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMD
IDNESKLPLRKSIPTKIMESEGIIGG
>AAA83417|FEATURES|argannot|beta_lactam|OXA-12|antibiotic inactivation|1
MSRLLLSGLLATGLLCAVPASAASGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALM
GYDSGFLVNEEHPALPYKPSYDGWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQ
YVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPEEQARFLGKMVSGKLPVSAQTLQYT
ANILKVSEVEGWQIHGKTGMGYPKKLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKP
GKQFASIKAKEEVLAALPAQLKKL
>AAC46344|FEATURES|argannot|beta_lactam|OXA-13|antibiotic inactivation|1
MKTFAAYVITACLSSTALASSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNNLARAS
KEYLPASTFKIPSAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLSLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLFLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKGTEVYFFAFNMD
IDNENKLPLRKSIPTKIMASEGIIGG
>AAA93528|FEATURES|argannot|beta_lactam|blaOXA-10|antibiotic inactivation|1
IACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARASKEYLPASTF
KIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVFQQIAREVGE
VRMQKYLKKFSYGNQNISGGIDKFWLEDQLRISAVNQVEFLESLYLNKLSASKENQLIVK
EALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMDIDNESKLPL
RKSIPTKIMESEGIIGG
>AAB05874|FEATURES|argannot|beta_lactam|OXA-15|antibiotic inactivation|1
MAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFD
PVRSKKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNS
TVWVYELFAKEIGDDKARRYLKKIDYGNAGPSTSNGDYWIEGSLAISAQEQIAFLRKLYR
NELPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGRMGWWVGWVEWPTGSVFFALNIDTP
NRMDDLFKREAIVRAILRSIEALPPNPAVNSDAAR
>AAB97924|FEATURES|argannot|beta_lactam|OXA-16|antibiotic inactivation|1
IACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARASKEYLPASTF
KIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVFQQITREVGE
VRMQKYLKKFSYGNQNISGGIDKFWLEDQLRISAVNQVEFLESLYLNKLSASKENQLIVK
EALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMDIDNESKLPL
RKSIPTKIMESEGIIGG
>ABI63579|FEATURES|argannot|beta_lactam|OXA-256|antibiotic inactivation|1
MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARAS
KEYLPASTFKIPSAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLYLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMD
IDNESKLPLRKSIPTKIMESEGIIGG
>ACJ05191|FEATURES|argannot|beta_lactam|OXA-18|antibiotic inactivation|1
MQRSLSMSGKRHFIFAVSFVISTVCLTFSPANAAQKLSCTLVIDEASGDLLHREGSCDKA
FAPMSTFKLPLAIMGYDADILLDATTPRWDYKPEFNGYKSQQKPTDPTIWLKDSIVWYSQ
ELTRRLGESRFSDYVQRFDYGNKDVSGDPGKHNGLTHAWLASSLKISPEEQVRFLRRFLR
GELPVSEDALEMTKAVVPHFEAGDWDVQGKTGTGSLSDAKGGKAPIGWFIGWATRDDRRV
VFARLTVGARKGEQPAGPAARDEFLNTLPALSENF
>ACQ77169|FEATURES|argannot|beta_lactam|OXA-19|antibiotic inactivation|1
MKTFAAYVITACLSSTALASSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNNLARAS
KEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLSLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEDQLRISAVNQVEFLESLFLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKGTEVYFFAFNMD
IDNENKLPLRKSIPTKIMASEGIIGG
>AAC23554|FEATURES|argannot|beta_lactam|OXA-20|antibiotic inactivation|1
LIIRFLALLFSAVVLVSLGHAQEKTHESSNWGKYFSDFNAKGTIVVVDERTNGNSTSVYN
ESRAQQRYSPASTFKIPHTLFALDAGAVRDEFHVFRWDGAKRSFAGHNQDQNLRSAMRNS
TVWVYQLFAKEIGENKARSYLEKLNYGNADPSTKSGDYWIDGNLAISANEQISILKKLYR
NELPFRVEHQRLVKDLMIVEAKRDWILRAKTGWDGQMGWWVGWVEWPTGPVFFALNIDTP
NRMEDLHKREAIARAILQSVNALPPN
>ABF70511|FEATURES|argannot|beta_lactam|OXA-21|antibiotic inactivation|1
MAIRIFAILFSTFVFGTFAHAQEGMRERSDWRKFFSEFQAKGTIVVADERQTDRVILVFD
QVRSEKRYSPASTFKIPHTLFALDAGAARDEFQVFRWDGIKRSFAAHNQDQDLRSAMRNS
TVWIYELFAKEIGEDKARRYLKQIDYGNADPSTSNGDYWIDGNLAIAAQEQIAFLRKLYH
NELPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGRMGWWVGWVEWPTGPVFFALNIDTP
NRMDDLFKREAIVRAILRSIEALPPNPAVNSDAAR
>AAD12233|FEATURES|argannot|beta_lactam|OXA-22|antibiotic inactivation|1
MKRRHAAIGALLAALATFAHAEHPICTIVADAATGKAVLHEGKCDERVTPASTFKLALAV
MGFDHGFLKDEHTPVEHFRHGDPDWGGEAWHQPIDPALWLKYSVVWYSQRITHAMGAQTF
QAYVRKLGYGNMDVSGDPGKNNGMDRSWITSSLKISPEEQVGLMRRIVNRQLPVSAHTYE
MLDRTVQTWQVPGGWAVQGKTGTAGPAPGNTSPDGTWDQAHAYGWFVGWARKGDKTYVFA
NLIQDDKVEPTSGGIRSRDALFARLSEVLAFAGH
>ABL67479|FEATURES|argannot|beta_lactam|OXA-23|antibiotic inactivation|1
MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGK
IVAFALNMEMRSEMPASIRNELLMKSLKQLNII
>CAB92323|FEATURES|argannot|beta_lactam|OXA-24|antibiotic inactivation|1
MKKFILPIFSISILVSLSACSSIKTKSEDNFHISSQQHEKAIKSYFDEAQTQGVIIIKEG
KNLSTYGNALARANKEYVPASTFKMLNALIGLENHKATTNEIFKWDGKKRTYPMWEKDMT
LGEAMALSAVPVYQELARRTGLELMQKEVKRVNFGNTNIGTQVDNFWLVGPLKITPVQEV
NFADDLAHNRLPFKLETQEEVKKMLLIKEVNGSKIYAKSGWGMGVTPQVGWLTGWVEQAN
GKKIPFSLNLEMKEGMSGSIRNEITYKSLENLGII
>AAG35607|FEATURES|argannot|beta_lactam|OXA-25|antibiotic inactivation|1
MKKFILPIFSISILVSLSACSSIKTKSEDNFHISSQQHEKAIKSYFDEAQTQGVIIIKEG
KNLSTYGNALARANKEYVPASTFKMLNALIGLENHKATTNEIFKWDGKKRTYPMWEKDMT
LGEAMALSAVPVYQELARRTGLELMQKEVKRVNFGNTNIGTQVDNFWLVGPLKITPVQEV
NFADDLAHNRLPFKLETQEEVEKMLLIKEVNGSKIYAKSGWGMGVTPQVGWLTGWVEQAN
GKKIPFSLNLEMKEGMSGSIRNEITYKLLENLGII
>AAG35608|FEATURES|argannot|beta_lactam|OXA-26|antibiotic inactivation|1
MKKFILPIFSISILVSLSACSSIKTKSEDNFHISSQQHEKAIKSYFDEAQTQGVIIIKEG
KNLSTYGNALARANKEYVPASTFKMLNALIGLENHKATTNEIFKWDGKKRTYPMWEKDMT
LGEAMALSAVPVYQELARRTGLELMQKEVKRVNFGNTNIGTQVDNFWLVGPLKITPVQEV
NFADDLAHNRLPFKLETQEEVKKMLLIKEVNGSKIYAKSGWGMGVTPQVGWLTGWVEQAN
GKKIPFSLNLEMKEGMTGSIRNEITYKSLENLGII
>AAG35609|FEATURES|argannot|beta_lactam|OXA-27|antibiotic inactivation|1
MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKADINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGK
IVAFALKMEMRSEMPASIRNELLMKSLKQLNII
>ACJ12495|FEATURES|argannot|beta_lactam|OXA-28|antibiotic inactivation|1
MKTFAAYVITACLSSTALASSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNNLARAS
KEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLSLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFGLEGQLRISAVNQVEFLESLFLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKGTEVYFFAFNMD
IDNENKLPLRKSIPTKIMASEGIIGG
>CAC35728|FEATURES|argannot|beta_lactam|OXA-29|antibiotic inactivation|1
MKKLSVLLWLTLFYCGTIWAQSTCFLVQENQTVLKHEGKDCNKRFAPESTFKIALSLMGF
DSGILKDTLNPEWPYKKEYELYLNVWKYPHNPRTWIRDSCVWYSQVLTQQLGMTRFKNYV
DAFHYGNQDISGDKGQNNGLTHSWLSSSLAISPSEQIQFLQKIVNKKLSVNPKAFTMTKD
ILYIQELAGGWKLYGKTGNGRQLTKDKSQKLSLQHGWFIGWIEKDGRVITFTKHIADSKK
HVTFASFRAKNETLNQLFYLINELEK
>AAK52604|FEATURES|argannot|beta_lactam|OXA-31|antibiotic inactivation|1
MKNTIHINFAIFLIIANIIYSSASASTDISTVASPLFEGTEGCFLLYDVSTNAEIAQFNK
AKCATQMPPDSTFKIALSLMAFDAEIIDQKTIFKWDKTPKGMEIWNSNHTPKTWMQFSVV
WVSQEITQKIGLNKIKNYLKDFDYGNQDFSGDKERNNGLTEAWLESSLKISPEEQIQFLR
KIINHNLPVKNSAIENTIENMYLQDLENSTKLYGKTGAGFTANRTLQNGWFEGFIISKSG
HKYVFVSALTGNLGSNLTSSIKAKKNAITILNTLNL
>AAK58418|FEATURES|argannot|beta_lactam|OXA-32|antibiotic inactivation|1
MAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFD
PVRSKKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNS
TVWVYELFAKEIGDDKARRYLKKIDYGNADPSTSNGDYWIEGSIAISAQEQIAFLRKLYR
NELPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGRMGWWVGWVEWPTGSVFFALNIDTP
NRMDDLFKREAIVRAILRSIEALPPNPAVNSDAAR
>AAK15582|FEATURES|argannot|beta_lactam|OXA-34|antibiotic inactivation|1
MAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFD
PVRSKKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNS
TVWVYELFAKEIGDDKARRYLKKIDYGNADPSTSNGDYCIEGSLAISAQEQIAFLRKLYR
NELPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGRMGWWVGWVEWPTGSVFFALNIDTP
NRMDDLFKREAIVRAIL
>ACR33071|FEATURES|argannot|beta_lactam|OXA-35|antibiotic inactivation|1
MKTFAAYVITACLSSTALASSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNNLARAS
KEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLSLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLFLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKGTEVYFFAFNMD
IDNENKLPLRKSIPTKIMASEGIIGG
>AAG24866|FEATURES|argannot|beta_lactam|oxa-2-related|antibiotic inactivation|1
IFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFDPVRSKKRYSPA
STFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNSTVWVYELFAKE
IGDDKARRYLKKIDYGNAYPSTSNGDYWIEGSLAISAQEQIAFLRKLYRNELPFRVEHQR
LVKDLMIVEAGRNWILRAKTGWEGRMGWWVGWVEWPTGSVFFALNIDTPNRMDDLFKREA
IVRAIL
>CAD32564|FEATURES|argannot|beta_lactam|OXA-42|antibiotic inactivation|1
MKFRHALSSAFVLLGCIAASAHAKTICTAIADAGTGKLLVQDGDCGRRASPASTFKIAIS
LMGYDAGFLRNEHDPVLPYRDSYIAWGGEAWKQPTDPTRWLKYSVVWYSQQVAHHLGAQR
FAQYAKAFGYGNADVSGDPGQNNGLDRAWIGSSLQISPLEQLEFLGKMLNRKLPVSPTAV
DMTERIVESTTLADGTVVHGKTGVSYPLLADGTRDWARGSGWFVGWIVRGNQTLVFARLT
QDERKQPVSAGIRTREAFLRDLPRLLAAR
>CAD32565|FEATURES|argannot|beta_lactam|OXA-43|antibiotic inactivation|1
MKFRHALSSAFVLLGCIAASAHAKTICTAIADAGTGKLLVQDGDCGRRASPASTFKIAIS
LMGYDAGFLRNEHDPVLPYRDSYIAWGGEAWKQPTDPTRWLKYPVVWYSQQVAHHLGAQR
FAQYAKAFGYGNADVSGDPGQNNGLDRAWIGSSLQISPLEQLEFLGKMLNRKLPVSPTAV
DMTERIVESTTLADGTVVHGKTGVSYPLLADGTRDWARGSGWFVGWIVRGKQTLVFARLT
QDERKQPVSAGIRTREAFLRDLPRLLAAR
>CAO91943|FEATURES|argannot|beta_lactam|OXA-45|antibiotic inactivation|1
MRGKHTVILGAALSALFAGAAGAQMLECTLVADAASGQELYRKGACDKAFAPMSTFKVPL
AVMGYDAGILVDAHNPRWDYKPEFNGYKFQQKTTDPTIWEKDSIVWYSQQLTRKMGQKRF
AAYVAGFGYGNGDISGEPGKSNGLTHSWLGSSLKISPEGQVRFVRDLLSAKLPASKDAQQ
MTVSILPHFAAGDWAVQGKTGTGSFIDARGAKAPLGWFIGWATHEERRVVFARMTAGGKK
GEQPAGPAARDAFLKALPDLAKRF
>AAN63499.1|FEATURES|argannot|beta_lactam|OXA-46|antibiotic inactivation|1
MAIRFFTILLSTFFLTSFVYAQEHVVIRSDWKKFFSDLQAEGAIVIADERQAKHTLSVFD
QERAAKRYSPASTFKIPHTLFALDADAVRDEFQVFRWDGVNRSFAGHNQDQDLRSAMRNS
TVWVYELFAKDIGEDKARRYLKQIDYGNVDPSTIKGDYWIDGNLKISAHEQILFLRKLYR
NQLPFKVEHQRLVKDLMITEAGRSWILRAKTGWEGRFGWWVGWIEWPTGPVFFALNIDTP
NRTDDLFKREAIARAILRSIDALPPN
>AAP69225|FEATURES|argannot|beta_lactam|OXA-47|antibiotic inactivation|1
MKNTIHINFAIFLIIANIIYSSASASTDISTVASQLFEGTEGCFLLYDASTNAEIAQFNK
AKCAAQMAPDSTFKIALSLMAFDAEIIDQKTIFKWDKIPKGMEIWNSNHTPKTWMQFSVV
WVSQEITQKIGLNKIKNYLKDFDYGNQDFSGDKERNNGLTEAWLESSLKISPEEQIQFLR
KIINHNLPVRNSAIENTIDNMYLQDLENSTKLYGKTGAGFTANRTLQNGWFEGFIISKSG
HKYVFVSALTGSLGSNLTSSIKAKKNAITILNTLNL
>AAP70012|FEATURES|argannot|beta_lactam|OXA-48|antibiotic inactivation|1
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVV
PVYQEFARQIGEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNK
LHVSERSQRIVKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMD
MPTSDGLGLRQAITKEVLKQEKIIP
>AAP40270|FEATURES|argannot|beta_lactam|OXA-49|antibiotic inactivation|1
MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVERIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAAMDIKPQVGWLTGWVEQPDG
KIVAFALNMEMRSEMPASIRNELLMKSLKQLNII
>CAJ40948|FEATURES|argannot|beta_lactam|OXA-50|antibiotic inactivation|1
MRPLLFSALLLLSGHTQASEWNDSQAVDKLFGAAGVKGTFVLYDVQRQRYVGHDRERAET
RFVPASTYKVANSLIGLSTGAVRSADEVLPYGGKPQRFKAWEHDMSLREAIKASNVPVYQ
ELARRIGLERMRANVSRLGYGNAEIGQVVDNFWLVGPLKISAMEQTHFLLRLAQGELPFP
APVQSTVRAMTLLESGPGWELHGKTGWCFDCTPELGWWVGWVKRNERLYGFALNIDMPGG
EADIGKRVELGKASLKALGILP
>ABD47672|FEATURES|argannot|beta_lactam|OXA-51|antibiotic inactivation|1
MNIKTLLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEVHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AAR89917|FEATURES|argannot|beta_lactam|OXA-54|antibiotic inactivation|1
MRVLALSAVLVVASIVGMPAMANEWQEKPSWNTHFSEHKAQGVIVLWNENKQQGFTNNLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIAAWNRDHDLITAMKYSVV
PVYQEFARQIGQARMSKMLHAFDYGNEDISGNLDSFWLDGGIRISATEQVAFLRKLYHNK
LHVSERSQRIVKQAMLTEANSDYIIRAKTGYSTRIEPQIGWWVGWVELDDNVWFFAMNMD
MPTADGLGLRQAITKEVLKQEKIIP
>AAR03105|FEATURES|argannot|beta_lactam|OXA-55|antibiotic inactivation|1
MNKGLHRKRLSKRLLLPMLLCLLAQQTQAVAAEQTKVSDVCSEVTAEGWQEVRRWDKLFE
SAGVKGSLLLWDQKRSLGLSNNLSRAAEGFIPASTFKLPSSLIALETGAVRDETSRFSWD
GKVREIAVWNRDQSFRTAMKYSVVPVYQQLAREIGPKVMAAMVRQLEYGNQDIGGQADSF
WLDGQLRITAFQQVDFLRQLHDNKLPVSERSQRIVKQMMLTEASTDYIIRAKTGYGVRRT
PAIGWWVGWLELDDNTVYFAVNLDLASASQLPLRQQLVKQVLKQEQLLP
>CAF74882|FEATURES|argannot|beta_lactam|oxa|antibiotic inactivation|1
MKFRHALSSAFVLLGCIAASAHAKTICTAIADAGTGKLLVQDGDCGRRASPASTFKIAIS
LMGYDAGFLRNEHDPVLPYRDSYIAWGGEAWKQPTDPTRWLKYSVVWYSQQVAHHLGAQR
FAQYAKAFGYGNADVSGDPGQNNGLDRAWIGSSLQISPLEQLEFLGKMLDRKLPVSPTAV
DMTERIVESTTLADGTVVHGKTGVSYPLLADGTRDWARGSGWFVGWIVRGKQTLVFARLT
QDERKQPVSAGIRTREAFLRDLPRLLAAR
>AAW57529|FEATURES|argannot|beta_lactam|OXA-58|antibiotic inactivation|1
MKLLKILSLVCLSISIGACAEHSMSRAKTSTIPQVNNSIIDQNVQALFNEISADAVFVTY
DGQNIKKYGTHLDRAKTAYIPASTFKIANALIGLENHKATSTEIFKWDGKPRFFKAWDKD
FTLGEAMQASTVPVYQELARRIGPSLMQSELQRIGYGNMQIGTEVDQFWLKGPLTITPIQ
EVKFVYDLAQGQLPFKPEVQQQVKEMLYVERRGENRLYAKSGWGMAVDPQVGWYVGFVEK
ADGQVVAFALNMQMKAGDDIALRKQLSLDVLDKLGVFHYL
>CAG15145|FEATURES|argannot|beta_lactam|OXA-59|antibiotic inactivation|1
MKFRHALSSAFVLLGCIAASAHAKTICTAIADAGTGKLLVQDGDCGRRASPASTFKIAIS
LMGYDAGFLRNEHDPVLPYRDSYIAWGGEAWKQPTDPTRWLKYSVVWYSQQVAHHLGAQR
FAQYAKAFGYGNADVSGDPGQNNGLDRAWIGSSLQISPLEQLEFLGKMLNRKLPVSPTAV
DMTERIVESTTLADGTVVHGKTGVSYPLLADGTRDWARGSGWFVGWIVRGKQTLVFARLT
QDERKQPVSAGIRTREAFLRDLPRLLAAR
>AAT71317|FEATURES|argannot|beta_lactam|blaOXA-60c|antibiotic inactivation|1
MFSRWSKTFAFGLAACAVALSTATAHAELVVRNDLKRVFDDAGVSGTFVLMDISADRTYV
VDPARAARHIHPASTFKIPNSLIAFDTGAVRDDQEVLPYGGKPQPYKQWEHDMALPEAIR
LSAVPIYQEVARRVGFERMQAYVDAFDYGNRQLGSVIDQFWLRGPLEISAFEEARFTSRM
ALKQLPVKPRTWDMVHRMLLIEQQGDAALYAKTGVATEYQPQIGWWVGWVERAGRIYAFA
LNIDMPREGDMAKRIPLGKQLMQALAVWPAP
>AAR32134|FEATURES|argannot|beta_lactam|OXA-62|antibiotic inactivation|1
MNTIISRRWRAGLWRRLVGAVVLPATLAATPAAYAADVPKAALGRITERADWGKLFAAEG
VKGTIVVLDARTQTYQAYDAARAEKRMSPASTYKIFNSLLALDSGALDNERAIIPWDGKP
RRIKNWNAAMDLRTAFRVSCLPCYQVVSHKIGRRYAQAKLNEVGYGNRTIGGAPDAYWVD
DSLQISAREQVDFVQRLARGTLPFSARSQDIVRQMSIVEATPDYVLHGKTGWFVDKKPDI
GWWVGWIERDGNITSVAINIDMLSEADAPKRARIVKAVLKDLKLI
>AAU88145|FEATURES|argannot|beta_lactam|OXA-63|antibiotic inactivation|1
MSKKNFILIFIFVILISCKNTEKISNETTLIDNIFTNSNAEGTLVIYNLNDDKYIIHNKE
RAEQRFYPASTFKIYNSLIGLNEKAVKDVDEVFYKLMAKSFLESWAKDSNLRYAIKNSQV
PAYKELARRIGIKKMKENIEKLDFGNKSIGDSVDTFWLEGPLEISAMEQVKLLTKLAQNE
LQYPIEIQKAISDITITRANLHITLHGKTGLADSKNMTTEPIGWFVGWLEENDNIYVFAL
NIDNINSDDLAKRINIVKESLKALNLLK
>AAW81336|FEATURES|argannot|beta_lactam|OXA-64|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKGEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AAW81337|FEATURES|argannot|beta_lactam|OXA-65|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABK40505|FEATURES|argannot|beta_lactam|OXA-66|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABF50983|FEATURES|argannot|beta_lactam|OXA-67|antibiotic inactivation|1
MNIKALLLITSTIFISACSPYIVTANPNHSTSKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEIFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSLKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AAW81339|FEATURES|argannot|beta_lactam|OXA-68|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQEVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AAW81340.1|FEATURES|argannot|beta_lactam|OXA-69|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDDKAEKIKNLFNEAHTTGVLVIHQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGEKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AAW81341|FEATURES|argannot|beta_lactam|OXA-70|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDKKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWNGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQHEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AAW81342|FEATURES|argannot|beta_lactam|OXA-71|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKTTTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AAU86900|FEATURES|argannot|beta_lactam|OXA-72|antibiotic inactivation|1
MKKFILPIFSISILVSLSACSSIKTKSEDNFHISSQQHEKAIKSYFDEAQTQGVIIIKEG
KNLSTYGNALARANKEYVPASTFKMLNALIGLENHKATTNEIFKWDGKKRTYPMWEKDMT
LGEAMALSAVPVYQELARRTGLELMQKEVKRVNFGNTNIGTQVDNFWLVGPLKITPVQEV
NFADDLAHNRLPFKLETQEEVKKMLLIKEVNGSKIYAKSGWGMDVTPQVGWLTGWVEQAN
GKKIPFSLNLEMKEGMSGSIRNEITYKSLENLGII
>AAW22056|FEATURES|argannot|beta_lactam|OXA-73|antibiotic inactivation|1
MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGK
IVAFALKMEMRSEMPASIRNELLMKSLKQLNII
>CAH69530|FEATURES|argannot|beta_lactam|OXA-74|antibiotic inactivation|1
MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARAS
KEYLPVSTFKIPSAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLYLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMD
IDNESKLPLRKSIPTKIMESEGIIGG
>AAW51373|FEATURES|argannot|beta_lactam|OXA-75|antibiotic inactivation|1
MNIQALLLITSAIFISACSPYIVTANPNYSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRIGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGISSSVRKEITYRGLEQLGIL
>AAX51234|FEATURES|argannot|beta_lactam|OXA-76|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEKLGIL
>AAX51233|FEATURES|argannot|beta_lactam|OXA-77|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTL
GDAMKASAIPVYQDLPRRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AAW81358|FEATURES|argannot|beta_lactam|OXA-78|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTAVFKWDGQKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGTPSSVRKEITYKSLEQLGIL
>ABV71246|FEATURES|argannot|beta_lactam|OXA-79|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGGDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AEI69286|FEATURES|argannot|beta_lactam|OXA-80|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAILVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ACU00283|FEATURES|argannot|beta_lactam|OXA-82|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWVVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABC26007|FEATURES|argannot|beta_lactam|OXA-83|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASALPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABC26006|FEATURES|argannot|beta_lactam|OXA-84|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAISVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLAGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AAP69916|FEATURES|argannot|beta_lactam|OXA-85|antibiotic inactivation|1
MLLFMFSIISFGNENQFMKEIFERKGLNGTFVVYDLKNDKIDYYNLDRANERFYPASSFK
IFNTLIGLENGIVKNVDEMFYYYDGSKVFLDSWAKDSNLRYAIKVSQVPAYKKLARELGK
ERMQEGLNKLNYGNKEIGSEIDKFWLEGPLKISAMEQVKLLNLLSQSKLPFKLENQEQVK
DITILEKKDDFILHGKTGWATDNIVVPIGWFVGWIETSDNIYSFAINLDISDSKFLPKRE
EIVREYFKNINVIK
>AAZ78361|FEATURES|argannot|beta_lactam|OXA-86|antibiotic inactivation|1
MNIKTLLLITSTIFISACSPYIVTANPNHSTSKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASIEYVPASTFKMLNALIGLEHHKATTTEIFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSLKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABC84263|FEATURES|argannot|beta_lactam|OXA-87|antibiotic inactivation|1
MNIKTLLLITSTIFISACSPYIVTANPNHSTSKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASIEYVPASTFKMLNALIGLEHHKATTTEIFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSLKAQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABD48715|FEATURES|argannot|beta_lactam|OXA-88|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDKKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABE03012|FEATURES|argannot|beta_lactam|OXA-89|antibiotic inactivation|1
MNIKTLLLITSAIFISACSHYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FTYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ACD84986|FEATURES|argannot|beta_lactam|OXA-90|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABF47914|FEATURES|argannot|beta_lactam|OXA-91|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABC61637|FEATURES|argannot|beta_lactam|OXA-92|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDDKAEKIKNLFNEAHTTGVLVIHQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGEKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGSVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABF47916|FEATURES|argannot|beta_lactam|OXA-93|antibiotic inactivation|1
MNIKALLLITSTIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALISLEHHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABF47917|FEATURES|argannot|beta_lactam|OXA-94|antibiotic inactivation|1
MNIQALLLITSAIFISACSPYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPHG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABF47918|FEATURES|argannot|beta_lactam|OXA-95|antibiotic inactivation|1
MNIKALFLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABF47919|FEATURES|argannot|beta_lactam|OXA-96|antibiotic inactivation|1
MKLLKILSLVCLSISIGACAEHSMSRAKTSTIPQVNNSIIDQNVQALFNEISADAVFVTY
DGQNIKKYGTHLDRAKTAYIPASTFKIANALIGLENHKATSTEIFKWDGKPRFFKAWDKD
FTLGEAMQASTVPVYQELARRIGPSLMQSELQRIGYGNMQMGTEVDQFWLKGPLTITPIQ
EVKFVYDLAQGQLPFKPEVQQQVKEMLYVERRGENRLYAKSGWGMAVDPQVGWYVGFVEK
ADGQVVAFALNMQMKAGDDIALRKQLSLDVLDKLGVFHYL
>ABO33299|FEATURES|argannot|beta_lactam|OXA-97|antibiotic inactivation|1
MKLLKILSLVCLSISIGACAEHSMSRAKTSTIPQVNNSIIDQNVQALFNEISGDAVFVTY
DGQNIKKYGTHLDRAKTAYIPASTFKIANALIGLENHKATSTEIFKWDGKPRFFKAWDKD
FTLGEAMQASTVPVYQELARRIGPSLMQSELQRIGYGNMQIGTEVDQFWLKGPLTITPIQ
EVKFVYDLAQGQLPFKPEVQQQVKEMLYVERRGENRLYAKSGWGMAVDPQVGWYVGFVEK
ADGQVVAFALNMQMKAGDDIALRKQLSLDVLDKLGVFHYL
>CAK50801|FEATURES|argannot|beta_lactam|OXA-98|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABI53716|FEATURES|argannot|beta_lactam|OXA-99|antibiotic inactivation|1
MNIKTLLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEVHTTGVLVIRQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEMNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>CAJ77817|FEATURES|argannot|beta_lactam|OXA-100|antibiotic inactivation|1
MNIKALLLITSTIFISACSPYIVTANPNHSTSKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEIFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>CAL85435|FEATURES|argannot|beta_lactam|OXA-101|antibiotic inactivation|1
MKTFAAYVITACLSSTALASSITENTFWNKEFSAEAVNGVFVLCKSSSKSCATNNLARAS
KEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLSLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLFLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKGTEVYFFAFNMD
IDNENKLPLRKSIPTKIMASEGIIGG
>ABQ52429|FEATURES|argannot|beta_lactam|OXA-104|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABV31686|FEATURES|argannot|beta_lactam|OXA-106|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDKKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWNGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABV31687|FEATURES|argannot|beta_lactam|OXA-107|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDDKAEKIKNLFNEAHTTGVLVIHQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGEKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWVVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABV31688|FEATURES|argannot|beta_lactam|OXA-108|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTTNPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNTDIGTQVDNFWVVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ACH99105|FEATURES|argannot|beta_lactam|OXA-109|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIQVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABV31690|FEATURES|argannot|beta_lactam|OXA-110|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDDKAEKIKNLFNEAHTTGVLVIHQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGEKRLFPEWEKNMTL
GDAMKASALPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABV31691|FEATURES|argannot|beta_lactam|OXA-111|antibiotic inactivation|1
MNIKTLLLITSAIFISACSPYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEMNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABV31692|FEATURES|argannot|beta_lactam|OXA-112|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDDKAEKIKNLFNEAHTTGVLVIHQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGEKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFPLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABW70410|FEATURES|argannot|beta_lactam|OXA-113|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKTTTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWVVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABX38721|FEATURES|argannot|beta_lactam|OXA-114a|antibiotic inactivation|1
MTVRRLSCALGAALSLSALGGGPVQAAVLCTVVADAADGRILFQQGTQQACAERYTPAST
FKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAK
ALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPLEQLAFLRKLVNRQLP
VKAAAYELAENLFEAGQADGWRLYGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVY
ARLLQDERATRPNAGLRARDELVRDWPAMAGAWRP
>ABS71123|FEATURES|argannot|beta_lactam|OXA-115|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAILVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWVVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABW95047|FEATURES|argannot|beta_lactam|OXA-116|antibiotic inactivation|1
LLITSAIFISACSPYIVSANPNHSASKSDDKAEKIKNLFNEAHTTGVLVIQQGQTQQSYG
NDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTLGDAMKA
SAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQFAYKLA
NKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQGNIVAFS
LNLEMKKGIPSSVRKEITYKSL
>ACV49885|FEATURES|argannot|beta_lactam|OXA-98|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTEWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AAK55330|FEATURES|argannot|beta_lactam|OXA-118|antibiotic inactivation|1
MAIRFLTILLSTFFLTSFVHAQEHVLERSDWKKFFSDLRAEGAIVISDERQAEHALLVFG
QERAAKRYSPASTFKLPHTLFALDADAVRDEFQVFRWDGVKRSFAGHNQDQDLRSAMRNS
AVWVYELFAKEIGKDKARHYLKQIDYGNADPSTIKGDYWIDGNLEISAHEQISFLRKLYR
NQLPFQVEHQRLVKDLMITEAGRNWILRAKTGWEGRFGWWVGWVEWPTGPVFFALNIDTP
NRTDDLFKREAIARAILRSIDALPPN
>AAN41427|FEATURES|argannot|beta_lactam|OXA-119|antibiotic inactivation|1
MAIRFLTILLSTFFLTSFVHAQEHVLERSDWKKFFSDLRAEGAIVISDERQAEHALLVFG
QERAAKRYSPASTFKLPHTLFALDADAVRDEFQVFRWDGVKRSFAGHNQDQDLRSAMRNS
AVWVYELFAKEIGEDKARRYLKQIDYGNADPSTIKGDYWIDGNLEISAHEQISFLRKLYR
NQLPFQVEHQRLVKDLMITEAGRNWILRAKTGWEGRFGWWVGWVEWPTGPVFFALNIDTP
NRTDDLFKREAIARAILRSIDALPPN
>CCJ32595|FEATURES|argannot|beta_lactam|OXA-120|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDDKAEKIKNLFNEAHTTGVLVIHQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEIFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABY77907|FEATURES|argannot|beta_lactam|OXA-128|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNVLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQEVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>CAP69660|FEATURES|argannot|beta_lactam|OXA-129|antibiotic inactivation|1
MKTIAAYLVLVFFAGTALSESISENLAWNKEFSSESVHGVFVLCKSSSNSCTTNNATRAS
TAYIPASTFKIPNALIGLETGAIKDARQVFKWDGKPRAMKQWEKDLTLRGAIQVSAVPVF
QQIARDIGKKRMQKYLNLFSYGNANIGGGIDKFWLEGQLRISAVNQVKFLESLYLNNLPA
SKANQLIVKEAIVTEATPEYIVHSKTGYSGVGTESNPGVAWWVGWVEKGTEVYFFAFNMD
IDNESKLPSRKSIPTKIMASEGIIIGG
>ACD84988|FEATURES|argannot|beta_lactam|OXA-130|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTTNPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNTDIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ACD84989|FEATURES|argannot|beta_lactam|OXA-131|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAVPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNQQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ACD84990|FEATURES|argannot|beta_lactam|OXA-132|antibiotic inactivation|1
MNIKTLLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEVHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEMTYKSLEQLGIL
>ACE63186|FEATURES|argannot|beta_lactam|OXA-133|antibiotic inactivation|1
MNKYFTCYVVASLFFSGCTVQHNLINETQSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTTWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVERIDFGNAEIGQQVDNFWLIGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEENNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGK
IVAFALNMEMRSEMPASIRNELLMKSLKQLNII
>ACI26264|FEATURES|argannot|beta_lactam|OXA-23|antibiotic inactivation|1
MNKYFTCYVFASLFLSGCTVQHNLINETPSQIAQGHNQVIHQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGK
IVAFALNMEMRSEMPASIRNELLMKSLKQLNII
>ABW76134|FEATURES|argannot|beta_lactam|OXA-136|antibiotic inactivation|1
MSKKNFILIFIFVILISCKNTEKISNETTLIDNIFTNSNAEGTLVIYNLNDDKYIIHNKE
RAEQRFYPASTFKIYNSLIGLNEKAVKDVDEVFYKYNGEKVFLESWAKDSNLRYAIKNSQ
VPAYKELARRIGLKKMKENIEKLDFGNKSIGDSVDTFWLEGPLEISAMEQVKLLTKLAQN
ELPYPIEIQKAVSDITILEQTYNYTLHGKTGLADSKNMTTEPIGWFVGWLEENDNIYVFA
LNIDNINSDDLAKRINIVKESLKALNLLK
>ABW76139|FEATURES|argannot|beta_lactam|OXA-137|antibiotic inactivation|1
MSKKNFILIFIFVILTSCKNTEKISNETTLIDNIFTNSNAEGTLVIYNLNDDKYIIHNKE
RAEQRFYPASTFKIYNSLIGLNEKAVKDVDEVFYKYNGEKVFLESWAKDSNLRYAIKNSQ
VPAYKELARRIGLKKMKENIEKLDFGNKSIGDSVDTFWLEGPLEISAMEQIKLLTKLAQN
ELPYPIEIQKAVSDITILEQTYNYTLHGKTGLADSKNMTTEPIGWFVGWLEENDNIYVFA
LNIDNINSDDLAKRINIVKESLKALNLLK
>ACD45467|FEATURES|argannot|beta_lactam|OXA-138|antibiotic inactivation|1
MNIKTLLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWVVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>CAQ51348|FEATURES|argannot|beta_lactam|OXA-139|antibiotic inactivation|1
MKKFILPIFSISILVSLSACSSIKTKSEDNFHISSQQHEKAIKSYFDEAQTQGVIIIKEG
KNLSTYGNALARANKEYVPASTFKMLIALIGLENHKATTNEIFKWDGKKRTYPMWEKDMT
LGEAMALSAVPVYQELARRTGLELMQKEVKRVNFGNTNIGTQVDNFWLVGPLKITPVQEV
NFADDLAHNRLPFKLETQEEVKKMLLIKEVNGSKIYAKSGWGMGVTPQVGWLTGWVEQAN
GKKIPFSLNLEMKEGMSGSIRNEITYKSLENLGII
>ABQ15112|FEATURES|argannot|beta_lactam|OXA-141|antibiotic inactivation|1
MAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFD
PVRSKKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNS
TVWVYELFAKEIGDDKARRYLKKIDYGNADPSTSNGDYWIESSLAISAQEQIAFLRKLYR
NELPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGRMGWWVGWVEWPTGSVFFALNIDTP
NRMDDLFKREAIVRAILRSIEALPPNPAVNSDAAR
>ABY79006|FEATURES|argannot|beta_lactam|OXA-142|antibiotic inactivation|1
MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARAS
KEYLPASTFKIPSAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEDQLRISAVNQVEFLESLYLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMD
IDNESKLPLRKSIPTKIMESEGIIGG
>ACX70402|FEATURES|argannot|beta_lactam|OXA-143|antibiotic inactivation|1
MKKFILPILSISTLLSVSACSSIQTKFEDTFHTSNQQHEKAIKSYFDEAQTQGVIIIKKG
KNISTYGNNLTRAHTEYVPASTFKMLNALIGLENHKATTTEIFKWDGKKRSYPMWEKDMT
LGDAMALSAVPVYQELARRTGLDLMQKEVKRVGFGNMNIGTQVDNFWLVGPLKITPIQEV
NFADDFANNRLPFKLETQEEVKKMLLIKEFNGSKIYAKSGWGMDVTPQVGWLTGWVEKSN
GEKVAFSLNIEMKQGMPGSIRNEITYKSLENLGII
>ACY56711|FEATURES|argannot|beta_lactam|OXA-144|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQEVQDEVQSILFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ACN85419|FEATURES|argannot|beta_lactam|OXA-145|antibiotic inactivation|1
MKTFAAYVITACLSSTALASSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNNLARAS
KEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLSLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWEGQLRISAVNQVEFLESLFLNKLSAS
KENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKGTEVYFFAFNMDI
DNENKLPLRKSIPTKIMASEGIIGG
>ACI22666|FEATURES|argannot|beta_lactam|OXA-146|antibiotic inactivation|1
MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAAMDIKPQVGWLTGWVEQPDG
KIVAFALNMEMRSEMPASIRNELLMKSLKQLNII
>ACO72579|FEATURES|argannot|beta_lactam|OXA-147|antibiotic inactivation|1
MKTFAAYVITACLSSTALASSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNNLARAS
KEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLSLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFLLEGQLRISAVNQVEFLESLFLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKGTEVYFFAFNMD
IDNENKLPLRKSIPTKIMASEGIIGG
>ACX31140|FEATURES|argannot|beta_lactam|OXA-148|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDKKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKASTTEVFKWNGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVKSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ACX31141|FEATURES|argannot|beta_lactam|OXA-149|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKHVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ACX31142|FEATURES|argannot|beta_lactam|OXA-150|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKHVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ADB28891|FEATURES|argannot|beta_lactam|OXA-160|antibiotic inactivation|1
MKKFILPIFSISILVSLSACSSIKTKSEDNFHISSQQHEKAIKSYFDEAQTQGVIIIKEG
KNLSTYGNALARANKEYVPASTFKMLNALIGLENHKATTNEIFKWDGKKRTYPMWEKDMT
LGEAMALSAVPVYQELARRTGLELMQKEVKRVNFGNTNIGTQVDNFWLVGPLKITPVQEV
NFADDLAHNRLPFKLETQEEVKKMLLIKEVNGSKIYAKSGWGMGVTSQVGWLTGWVEQAN
GKKIPFSLNLEMKEGMSGSIRNEITYKSLENLGII
>ACT09125|FEATURES|argannot|beta_lactam|OXA-161|antibiotic inactivation|1
MAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFD
PVRSKKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNS
TVWVYELFAKEIGDDKARRYLKKIDYGDADPSTSNGDYWIEGSLAISAQEQIAFLRKLYR
NELPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGRMGWWVGWVEWPTGSVFFALNIDTP
NRMDDLFKREAIVRAILRSIEALPPNPAVNSDAAR
>ACZ73269|FEATURES|argannot|beta_lactam|OXA-162|antibiotic inactivation|1
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVV
PVYQEFARQIGEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNK
LHVSERSQRIVKQAMLTEANGDYIIRAKTGYSARIEPKIGWWVGWVELDDNVWFFAMNMD
MPTSDGLGLRQAITKEVLKQEKIIP
>ADY06444|FEATURES|argannot|beta_lactam|OXA-163|antibiotic inactivation|1
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVV
PVYQEFARQIGEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNK
LHVSERSQRIVKQAMLTEANGDYIIRAKTGYDTKIGWWVGWVELDDNVWFFAMNMDMPTS
DGLGLRQAITKEVLKQEKIIP
>ADK34116|FEATURES|argannot|beta_lactam|OXA-164|antibiotic inactivation|1
MKLLKILSLVCLSISIGACAEHSMSRAKTSTIPQVNNSIIDQNVQALFNEISADAVFVTY
DGQNIKKYGTHLDRAKTAYIPASTFKIANALIGLENHKATSTEIFKWDGKPRFLKAWDKD
FTLGEAMQASTVPVYQELARRIGPSLMQSELQRIGYGNMQIGTEVDQFWLKGPLTITPIQ
EVKFVYDLAQGQLPFKPEVQQQVKEMLYVERRGENRLYAKSGWGMAVDPQVGWYVGFVEK
ADGQVVAFALNMQMKAGDDIALRKQLSLDVLDKLGVFHYL
>ADK35869|FEATURES|argannot|beta_lactam|OXA-165|antibiotic inactivation|1
MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDVKPQVGWLTGWVEQPDGK
IVAFALNMEMRSEMPASIRNELLMKSLKQLNII
>ADK35870|FEATURES|argannot|beta_lactam|OXA-166|antibiotic inactivation|1
MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGALVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGK
IVAFALNMEMRSEMPASIRNELLMKSLKQLNII
>ADK35871|FEATURES|argannot|beta_lactam|OXA-167|antibiotic inactivation|1
MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGK
IVAFALNMEMRSEMPASIRNELMMKSLKQLNII
>ADK35872|FEATURES|argannot|beta_lactam|OXA-168|antibiotic inactivation|1
MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLAGWVEQPDGK
IVAFALNMEMRSEMPASIRNELLMKSLKQLNII
>ADK35873|FEATURES|argannot|beta_lactam|OXA-169|antibiotic inactivation|1
MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDERNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGK
IVAFALNMEMRSEMPASIRNELLMKSLKQLNII
>ADK35874|FEATURES|argannot|beta_lactam|OXA-170|antibiotic inactivation|1
MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEKSNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGK
IVAFALNMEMRSEMPASIRNELLMKSLKQLNII
>ADK35875|FEATURES|argannot|beta_lactam|OXA-171|antibiotic inactivation|1
MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGK
IVAFALNMEMRSEMPASTRNELLMKSLKQLNII
>ADI58616|FEATURES|argannot|beta_lactam|OXA-172|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAVPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGLDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ADI58617|FEATURES|argannot|beta_lactam|OXA-173|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAVPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGLDVNLQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ADI58618|FEATURES|argannot|beta_lactam|OXA-174|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWVVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEKLGIL
>ADI58619|FEATURES|argannot|beta_lactam|OXA-175|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIRNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWVVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ADI58620|FEATURES|argannot|beta_lactam|OXA-176|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDSKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWVVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ADI58621|FEATURES|argannot|beta_lactam|OXA-177|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWVVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDGVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ADI58622|FEATURES|argannot|beta_lactam|OXA-178|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDSKKRLFPEWEKDMTL
GDAMKASAILVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ADM26744|FEATURES|argannot|beta_lactam|OXA-179|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIAVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ADM26745|FEATURES|argannot|beta_lactam|OXA-180|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAIKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ADM26760|FEATURES|argannot|beta_lactam|OXA-181|antibiotic inactivation|1
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIAAWNRDHDLITAMKYSVV
PVYQEFARQIGEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATQQIAFLRKLYHNK
LHVSERSQRIVKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMD
MPTSDGLGLRQAITKEVLKQEKIIP
>ADK92148|FEATURES|argannot|beta_lactam|OXA-182|antibiotic inactivation|1
MKKFILPIFSISILLSLSACSSIQTKFEDTFHISNQKHEKAIKSYFDEAQTQGVIIIKEG
KNISSYGNNLVRAHTEYVPASTFKMLNALIGLENHKATTNEIFKWDGKKRSYPMWEKDMT
LGEAMALSAVPVYQDLARRIGLNLMQKEVKRVGFGNMNIGTQVDNFWLIGPLKITPIQEV
NFADDLANNRLPFKLETQEEVKKMLLIKEVNGSKIYAKSGWGMDVSPQVGWLTGWVEKSN
GEKVSFSLNIEMKQGMSGSIRNEITYKSLENLGII
>ADV41666|FEATURES|argannot|beta_lactam|OXA-183|antibiotic inactivation|1
MKTFAAYVITACLSSTALASSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNNLARAS
KEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLSLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGNQNISGGTDKFWLEDQLRISAVNQVEFLESLFLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKGTEVYFFAFNMD
IDNENKLPLRKSIPTKIMASEGIIGG
>ADZ54048|FEATURES|argannot|beta_lactam|OXA-192|antibiotic inactivation|1
MSKKNFILIFIFVILISCKNTEKTSNETTLIDNIFTNSNAEGTLVIYNLNDDKYIIHNKE
RAEQRFYPASTFKIYNSLIGLNEKAVKDVDEVFYKYNGEKVFLESWAKDSNLRYAIKNSQ
VPAYKELARRIGLEKMKENIEKLDFGNKNIGDSVDTFWLEGPLEISAMEQVKLLTKLAQN
ELPYPIEIQKAVSDITILEQTDNYTLHGKTGLADSENMTTEPIGWLVGWLEENNNIYVFA
LNIDNINSDDLAKRINIVKESLKALNLLK
>AEB98920|FEATURES|argannot|beta_lactam|OXA-194|antibiotic inactivation|1
MNIKALFLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWVVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AEB98921|FEATURES|argannot|beta_lactam|OXA-195|antibiotic inactivation|1
MNIKALFLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWVVGPLKITPQQEAQ
FAYKLANKTLPSSQKVQDEVQSMLFIEEKNGNKMYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AEB98922|FEATURES|argannot|beta_lactam|OXA-196|antibiotic inactivation|1
MNIQALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDHARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWVVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AEB98923|FEATURES|argannot|beta_lactam|OXA-197|antibiotic inactivation|1
MNIKALFLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWVVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEIAYKSLEQLGIL
>ADT70779|FEATURES|argannot|beta_lactam|OXA-198|antibiotic inactivation|1
MHKHMSKLFIAFLAFLLSVPAAAEDQTLAELFAQQGIDGTIVISSLHNGKTFIHNDPRAK
QRFSTASTFKILNTLISLEEKAISGKDDVLKWDGHIYDFPDWNRDQTLESAFKVSCVWCY
QALARQVGAEKYRNYLRKSVYGELREPFEETTFWLDGSLQISAIEQVNFLKKVHLRTLPF
SASSYETLRQIMLIEQTPAFTLRAKTGWATRVKPQVGWYVGHVETPTDVWFFATNIEVRD
EKDLPLRQKLTRKALQAKGIIE
>AEI69285|FEATURES|argannot|beta_lactam|OXA-109|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIRVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ADX07745|FEATURES|argannot|beta_lactam|OXA-200|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAILVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGLDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ADX07746|FEATURES|argannot|beta_lactam|OXA-201|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIQVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWVVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ADX07747|FEATURES|argannot|beta_lactam|OXA-202|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAMPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ADX07748|FEATURES|argannot|beta_lactam|OXA-203|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEVHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AFU91598|FEATURES|argannot|beta_lactam|OXA-204|antibiotic inactivation|1
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGHRRDIATWNRDHNLITAMKYSVV
PVYQEFARQIGEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNK
LHVSERSQRIVKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMD
MPTSDGLGLRQAITKEVLKQEKIIP
>AEO92079|FEATURES|argannot|beta_lactam|OXA-205|antibiotic inactivation|1
MAIRFLTILLSTFFLTSFVHAQEHVVVRSDWKKFFSDLQAEGAIVIADERQAEHALLVFG
QERAAKRYSPASTFKLPHTLFALDAGAVRDEFQVFRWDGVKRSFAGHNQDQDLRSAMRNS
AVWVYELFAKEIGEDNARRYLKQIDYGNADPSTIKGNYWIDGNLEISAHEQISFLRKLYR
NQLPFQVEHQRLVKYLMITEAGRNWILRAKTGWEGRFGWWIGWVEWPTGPVFFALNIDTP
NRTDDLFKREAIARAILRSIDALPPN
>BAL15076|FEATURES|argannot|beta_lactam|OXA-206|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAISVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AFK28473|FEATURES|argannot|beta_lactam|OXA-207|antibiotic inactivation|1
MKKFILPIFSISILVSLSACSSIKTKSEDNFHISSQQHEKAIKSYFDEAQTQGVIIIKEG
KNLSTYGNALARANKEYVPASTFKMLNALIGLENHKATTNEIFKWDGKKRTYPMWEKDMT
LGEAMALSAVPVYQELARRTGLELMQKEVKRVNFGNTNIGTQVDNFWLVGPLKITPVQEV
NFADDLAHNRLPFKLETQEEVKKMLLIKEVNGSKIYAKSGWVMGVTPQVGWLTGWVEQAN
GKKIPFSLNLEMKEGMSGSIRNEITYKSLENLGII
>CCA94644|FEATURES|argannot|beta_lactam|OXA-208|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDDKAEKIKNLFNEAHTTGVLVIHQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWNGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AEM66528|FEATURES|argannot|beta_lactam|OXA-209|antibiotic inactivation|1
MKKTFILLNLILLVNLNGYCQTKSLKSNEIVKPEFRNILDSLKVKGAILIYDVKNKTYYS
NDFSWTKTGIIPASTFKIPNSIIALETGIIKNDSTIFKWNGEKRKFKNWEEDLTFKKAFQ
VSCVPCYQEIARKIGVKRMKRYLKKLNYRGMVFDTLTIDQFWLEGESKITQMQQIDFLER
LYFSKFPISDRTIKIVKNIMEIERTENYILSGKTGLSSIEEKYNGWFVGYVETKSNVYFF
ATNVIPTDGLNVDDFISSRINVTKNALKQMNIMK
>AEE61368|FEATURES|argannot|beta_lactam|OXA-210|antibiotic inactivation|1
MAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFD
PVRSKKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNS
TVWVYELFAKEIGDDKARRYLKKIDYGNADPSTSNGDCWIEGSLAISAQEQIAFLRKLYR
NELPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGRMGWWVGWVEWPTGSVFFALNIDTP
NRMDDLFKREAIVRAILRSIEALPPNPAVNSDAAR
>AEV91550|FEATURES|argannot|beta_lactam|OXA-211|antibiotic inactivation|1
MKTLQLALIALITTFGSACTTIPPSVETAKNHQQQSAQQQIQQAFDQLQTTGVIVIKDKH
GLHSYGNDLSRAQTPYVPASTFKMLNALIGLEHGKATSTEVFKWDGQKRSFPAWEKDMTL
GQAMQASAVPVYQELARRIGLDLMKKEVQRIGYGNQQIGTVVDNFWLVGPLQITPVQEVL
FVEKLANTQLAFKPDVQHTVQDMLLIEQKPNYKLYAKSGWGMDLEPQVGWWTGWVETATS
EKVYFALNMHMKTGISASVREQLVKQSLTALGII
>AEV91551|FEATURES|argannot|beta_lactam|OXA-212|antibiotic inactivation|1
MKTLQSGLIALITTFGSACTTISPSVETAKNQQQQSAQQQIQQAFDQLQTTGVIVVKDKH
SLHSYGNDLSRAQTPYIPASTFKMLNALIGLEHGKATSTEVFKWDGQKRSFPTWEKDMTL
GQAMQASAVPVYQELARRIGLDLMKKEVQRIGYGNQQIGTVVDNFWLVGPLQITPVQEVL
FVEKLANTQLAFKPDVQHAVQDMLLIEQKPNYKLYAKSGWGMDLEPQVGWWAGWVETSTG
EKVYFALNMHMKTGISASVREQLVKQSLTALGII
>AEV91552|FEATURES|argannot|beta_lactam|OXA-213|antibiotic inactivation|1
MYKKALIVATSILFLSACSSNMVKQHQIHSISANKNSEEIKSLFDQAQTTGVLVIKRGQT
EEIYGNDFKRASTDYVPASTFKMLNALIGLEHHKATTTEVFKWNGQKRLFPDWEKDMTLG
DAMKASAIPVYQELARRIGLDLMSKEVKRVGFGNANIGSKVDNFWLVGPLKITPQQETQF
AYQLAHKTLPFSKDVQEQVQSMVFIEEKNGSKIYAKSGWGWDVEPQVGWLTGWVVQPQGE
IVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGIL
>AEV91553|FEATURES|argannot|beta_lactam|OXA-214|antibiotic inactivation|1
MKLSKLYTLTVLIGFGLSGVACQHIHTPVSFNQIENDQTKQIASLFENVQTTGVLITFDG
QAYKAYGNDLNRAKTAYIPASTFKILNALIGIEHDKTSPNEVFKWDGQKRAFESWEKDLT
LAEAMQASAVPVYQALAQRIGLDLMAKEVKRVGFGNTRIGTQVDNFWLIGPLKITPIEEA
QFAYRLAKQELPFTPKTQQQVIDMLLVDEIRGTKVYAKSGWGMDITPQVGWWTGWIEDPN
GKVIAFSLNMEMNQPAHAAARKEIVYQALTQLKLL
>AEV91554|FEATURES|argannot|beta_lactam|OXA-215|antibiotic inactivation|1
MKLSKLYTLTVLIGFGLSGVACQHIHTPVSFNQIENDQTKQIASLFENVQTTGVLITFDG
QAYKAYGNDLNRAKTAYIPASTFKILNALIGIEHDKTSPNEVFKWDGQKRAFESWEKDLT
LAEAMQASAVPVYQALAQRIGLDLMAKEVKRVGFGNTRIGTQVDNFWLIGPLKITPIEEA
QFAYRLAKQELPFTPKTQQQVIDMLLVDEIRGTKVYAKSGWGMDITPQVGWWTGWIEDPN
GKVIAFSLNMEMNQPTHAAARKEIVYQALTQLKLL
>CCA94649|FEATURES|argannot|beta_lactam|OXA-216|antibiotic inactivation|1
MNIKALLLITSAISISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAIKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AEO44980|FEATURES|argannot|beta_lactam|OXA-217|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTAVFKWDGQKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AEL17179|FEATURES|argannot|beta_lactam|OXA-219|antibiotic inactivation|1
MNIKTLLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEVHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWVVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AEL88491|FEATURES|argannot|beta_lactam|OXA-223|antibiotic inactivation|1
MNIKTLLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEVHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEYHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AEQ73520|FEATURES|argannot|beta_lactam|OXA-224|antibiotic inactivation|1
MKNTIHINFAIFLIIANIIYSSASASTDISTVASPLFEGTEGCFLLYDVSTNTEIAQFNK
AKCATQMAPDSTFKIALSLMAFDAEIIDQKTIFKWDKTPKGMEIWNSNHTPKTWMQFSVV
WVSQEITQKIGLNKIKNYLKDFDYGNQDFSGDKERNNGLTEAWLESSLKISPEEQIQFLR
KIINHNLPVKNSAIENTIENMYLQDLENSTKLYGKTGAGFTANRTLQNGWFEGFIISKSG
HKYVFVSALTGNLGSNLTSSIKAKKNAITILNTLNL
>AEP43731|FEATURES|argannot|beta_lactam|OXA-225|antibiotic inactivation|1
MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKSQVGWLTGWVEQPDGK
IVAFALNMEMRSEMPASIRNELLMKSLKQLNII
>AFM55001|FEATURES|argannot|beta_lactam|OXA-228|antibiotic inactivation|1
MKFKMKGLFCVILSSLAFSGCVYDSKLQRPVISERVTEIPLLFNQAQTQAVFVTYDGIHL
KSYGNDLSRAKTEYIPASTFKMLNALIGLQNAKATNTEVFHWNGEKRAFSAWEKDMTLAE
AMQASAVPVYQELARRIGLELMREEVKRVGFGNAEIGQQVDNFWLVGPLKISPEQEVQFA
YQLAMKQLPFDSNVQQQVKDMLYIERRGDSKLYAKSGWGMDVEPQVGWYTGWVEQPNGKV
TAFALNMNMQAGNDPAERKQLTLSILDKLGLFFYLR
>AFM55000|FEATURES|argannot|beta_lactam|OXA-229|antibiotic inactivation|1
MKFKMKGLFCVILSSLAFSGCVYDSKLQRPVISERETEIPLLFDQAQTQAVFVTYDGIHL
KSYGNDLSRAKTEYIPASTFKMLNALIGLQNAKATNTEVFHWNGEKRAFSAWEKDMTLAE
AMQASAVPVYQELARRIGLELMREEVKRVGFGNAEIGQQVDNFWLVGPLKISPEQEVQFA
YQLAMKQLPFDSNVQQQVKDMLYIERRGDSKLYAKSGWGMDVEPQVGWYTGWVEQPNGKV
TAFALNMNMQAGDDPTERKQLTLSILDKLGLFFYLR
>AFM55002|FEATURES|argannot|beta_lactam|OXA-230|antibiotic inactivation|1
MKFKMKGLFCVILSSLAFSGCVYDSKLQRPVISERETEIPLLFNQAQTQAVFVTYDGIHL
KSYGNDLSRAKTEYIPASTFKMLNALIGLQNGKATNTEVFQWNGEKRAFSAWEKDMTLAE
AMQASAVPVYQELARRIGLELMREEVKRVGFGNAEIGQQVDNFWLVGPLKISPEQEVQFA
YQLAMKQLPFDRNVQQQVKDMLYIERRGDSKLYAKSGWGMDVEPQVGWYTGWVEQPNGKV
TAFALNMNMQAGNDPAERKQLTLSILDKLGLFFYLR
>AFG29918|FEATURES|argannot|beta_lactam|OXA-231|antibiotic inactivation|1
MKKFILPILSISTLLSVSACSSIQTKFEDTFHTSNQQHEKAIKSYFDEAQTQGVIIIKKG
KNISTYGNNLTRAHTEYVPASTFKMLNALIGLENHKATTTEIFKWDGKKRSYPMWEKDMT
LGDAMALSAVPVYQELARRTGLDLMQKEVKRVGFGNMNIGTQVDNFWLVGPLKITPIQEV
NFADDFANNRLPFKLETQEEVKKMLLIKEFNGSKIYAKSGWGMAVTPQVGWLTGWVEKSN
GEKVAFSLNIEMKQGMPGSIRNEITYKSLENLGII
>AFH36331|FEATURES|argannot|beta_lactam|OXA-237|antibiotic inactivation|1
MKTLILLPLLSCLSLTACSLPVSNSSSQITSTQSIQTIAKLFDQAQSSGVLVIQRGPHLQ
VYGNDLSRAHTEYIPASTFKILNALIGLQHGKATTNEIFKWDGKKRSFAAWEKDMTLGQA
MQASAVPVYQELARRIGLELMQQEVQRIRFGNQQIGQHIDNFWLVGPLKITPEQEVEFAS
ALAQEQLAFDPQVQQQVKAMLLLQERQGYRLYAKSGWGMDVEPQVGWLTGWIETPQDEIV
AFSLNMQMQSNMDPAIRLKILQQALAELALYPKAEG
>AFH36332|FEATURES|argannot|beta_lactam|OXA-236|antibiotic inactivation|1
MKTLILLPLLSCLSLTACSLPVSNSSSQITSTQSIQTIAKLFDQAQSSGVLVIQRGPHLQ
VYGNDLSRAHTEYIPASTFKILNALIGLQHGKATTNEIFKWDGKKRSFAAWEKDMTLGQA
MQASAVPVYQELARRIGLELMQQEVQRIRFGNQQIGQHIDNFWLVGPLKITPVQEVEFAS
ALAQEQLAFDPQVQQQVKAMLLLQERQDYRLYAKSGWGMDVEPQVGWLTGWIETPQDEIV
AFSLNMQMQSNMDPAIRLKILQQALAELALYPKAEG
>AFH36330|FEATURES|argannot|beta_lactam|OXA-235|antibiotic inactivation|1
MKTLILLPLLSCLSLTACSLPVSNSSSQITSTQSIQTIAKLFDQAQSSGVLVIQRGPHLQ
VYGNDLSRAHTEYIPASTFKILNALIGLQHGKATTNEIFKWDGKKRSFAAWEKDMTLGQA
MQASAVPVYQELARRIGLELMQQEVQRIRFGNQQIGQHIDNFWLVGPLKITPEQEVEFAS
ALAQEQLAFDPQVQQQVKAMLLLQERQDYRLYAKSGWGMDVEPQVGWLTGWIETPQDEIV
AFSLNMQMQSNMDPAIRLKILQQALAELALYPKAEG
>AFN65709|FEATURES|argannot|beta_lactam|OXA-239|antibiotic inactivation|1
MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRLFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMNIKSQVGWLTGWVEQPDGK
IVAFALNMEMRSEMPASIRNELLMKSLKQLNII
>AFN20670|FEATURES|argannot|beta_lactam|OXA-240|antibiotic inactivation|1
MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARAS
KEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMNQWERDLTLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLYLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMD
IDNESKLPLRKSIPTKIMESEGIIGG
>AFO55201|FEATURES|argannot|beta_lactam|OXA-241|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVIANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLAHASTEYVPASTFKMLNALIGLEHHKTTTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AFO55202|FEATURES|argannot|beta_lactam|OXA-242|antibiotic inactivation|1
MNIKTLLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEVHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQR
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AFQ90085|FEATURES|argannot|beta_lactam|OXA-243|antibiotic inactivation|1
MTVRLSSTALGAALSLSALAGAPAQAAVLCTVVADAADGRIVYQQGTQQACAARYTPAST
FKLPIALMGADAGILTGPHAPVWNYQPGYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAR
ALGQERFQRYASAFHYGNEDVSGEPGKHNGLDGAWINSSLRISPLEQLAFLRKLVNRQLP
LKAAAYDLAENLFEVGEAGGWHLYGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVF
ARLVQDEQATKPNAGLRARDDLMRDWPAMADAPRK
>AGC60012|FEATURES|argannot|beta_lactam|OXA-244|antibiotic inactivation|1
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVV
PVYQEFARQIGEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNK
LHVSERSQRIVKQAMLTEANGDYIIRAKTGYSTGIEPKIGWWVGWVELDDNVWFFAMNMD
MPTSDGLGLRQAITKEVLKQEKIIP
>AGC60013|FEATURES|argannot|beta_lactam|OXA-245|antibiotic inactivation|1
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVV
PVYQYFARQIGEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNK
LHVSERSQRIVKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMD
MPTSDGLGLRQAITKEVLKQEKIIP
>AGC70814|FEATURES|argannot|beta_lactam|OXA-247|antibiotic inactivation|1
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVV
PVYQEFARQIGEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNK
LHVSERSQRIVKQAMLTEANGDYIIRAKTGSNTKIGWWVGWVELDDNVWFFAMNMDMPTS
DGLGLRQAITKEVLKQEKIIP
>CCJ32596|FEATURES|argannot|beta_lactam|OXA-248|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDDKAEKIKNLFNEAHTTGVLVIHQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGEKRLFPEWEKNMTL
GDAMKASAMPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>CCJ32597|FEATURES|argannot|beta_lactam|OXA-249|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTTNPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIQVYQDLARRIGLELMSKEVKRVGYGNTDIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>CCJ32598|FEATURES|argannot|beta_lactam|OXA-250|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDDKAEKIKNLFNEAHTTGVLVIHQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGEKRLFPEWEKNMTL
GDAMKASAILVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGLDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AER57903|FEATURES|argannot|beta_lactam|OXA-251|antibiotic inactivation|1
MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARAS
KEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVF
QQIAREVDEVRMQKYLKNFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLYLNKLSA
SKENQLTVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMD
IDNESKLPLRKSIPTKIMESEGIIGG
>CCE94500|FEATURES|argannot|beta_lactam|OXA-256|antibiotic inactivation|1
MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARAS
KEYLPASTFKIPDAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLYLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMD
IDNESKLPLRKSIPTKIMESEGIIGG
>CCE73593|FEATURES|argannot|beta_lactam|OXA-258|antibiotic inactivation|1
MTVRLVSRALGAVLFASALTLPARADVLCTLVADAADGRILFQQGTRQDCTQRYTPASTF
KLPIALMGADAGILQGPHQPVWNYQPAYPDWGGEAWRQPTDPARWIKYSVVWYSQLTARA
LGQERFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPFEQVDFLRKFVNRQLPV
KAAAYDLAENLFEVGEADGWRLYGKTGTGSPGSHGVYTPANAYGWFVGWARKDDRQLVFA
RLLQDEGATQPNAGLRARDGLMRDWAAMVAAPRK
>AGI65307|FEATURES|argannot|beta_lactam|OXA-278|antibiotic inactivation|1
MKILILWPLLSYLSLTACSFPVSNSPSQITSTQSIQAIAKLFDQAQSSGVLVIQRGPHLQ
VYGNDLSRAHTEYVPASTFKIFNALIGLQHGKATTNEIFKWDGKKRSFAAWEKDMTLGQA
MQASAVPVYQELARRIGLELMEQEVRRIQFGNQHIGQQVDNFWLVGPLKITPKQEVEFVS
ALAQEQLAFDPQVQQQVKAMLLLQEQQAYRLYAKSGWGMDVEPQVGWLTGWVETPQAEIV
AFSLNMQMQSNMDPAIRLKILQQALAELGLYPKAEG
>CCW28916|FEATURES|argannot|beta_lactam|OXA-309|antibiotic inactivation|1
MKTLQLALIALITTFGSACTTISPSVETAKNHQQQSAQQQIQQAFDQLQTTGVIVIKDKH
GLHSYGNDLSRAQTPYVPASTFKMLNALIGLEHGKATRTEVFKWDGQKRSFPAWEKDMTL
GQAMQASAVPVYQELARRIGVDLMQKEVQRIGYGNQQIGTVVDNFWLVGPLQITPVQEVL
FVEKLANTQLAFKPDVQHTVQDMLLIEQKPNYKLYAKSGWGMDLEPQVGWWAGWVETSTG
EKAYFALNMQMKTGISASVREQLVKQSLTALGII
>AGR55864|FEATURES|argannot|beta_lactam|OXA-320|antibiotic inactivation|1
MKNTIHINFAIFLIIANIIYSSASASTDISTVASPLFEGTEGCFLLYDASTNAEIAQFNK
AKCATQMAPDSTFKIALSLMAFDAEIIDQKTIFKWDKTPKGMEIWNSNHTPKTWMQFSVV
WVSQEITQKIGLNKIKNYLKDFDYGNQDFSGDKERNNGLTEAWLESSLKISPEEQIQFLR
KIINHNLPVKNSAIENTIENMYLQDLDNSTKLYGKTGAGFTANRTLQNGWFEGFIISKSG
HKYVFVSALTGNLGSNLTSSIKAKKIAITILNTLNL
>ABK34773|FEATURES|argannot|beta_lactam|J532_3674|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>AEL30572|FEATURES|argannot|beta_lactam|blaADC-30|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>AEL30570|FEATURES|argannot|beta_lactam|adc56|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYQQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>AFG25594|FEATURES|argannot|beta_lactam|ADC-2|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANFNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYVVLNAIKK
>AFG25595|FEATURES|argannot|beta_lactam|ADC-2|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKIIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYVVLNAIKK
>AFH53180|FEATURES|argannot|beta_lactam|ADC-2|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRANPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYVVLNAIKK
>AFI56570|FEATURES|argannot|beta_lactam|blaADC-61|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPLDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>AFK24475|FEATURES|argannot|beta_lactam|ADC-2|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRINSGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYVVLNAIKK
>AGL39360|FEATURES|argannot|beta_lactam|blaADC-68|antibiotic inactivation|1
MRFKKISCLLLSPLFIFNTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGAYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKIIFPALGLKHSYVNVAKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>AFP89364|FEATURES|argannot|beta_lactam|blaADC-57|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYVVLNAIKK
>ALA14808|FEATURES|argannot|beta_lactam|ampC|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYSVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>ALA14809|FEATURES|argannot|beta_lactam|adc74|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNRSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWQPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRANPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGFYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLDAIKK
>ALA14810|FEATURES|argannot|beta_lactam|adc75|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGFYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>ALA14811|FEATURES|argannot|beta_lactam|adc76|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKVL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGESRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPTDIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>ALA14812|FEATURES|argannot|beta_lactam|adc77|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFINANLNPQKYPTDIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>ALA14813|FEATURES|argannot|beta_lactam|adc78|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLDAIKK
>CAC17622|FEATURES|argannot|beta_lactam|OCH-2|antibiotic inactivation|1
MRTSTTLLIGFLTTAAVIPNNGALAASKVNDGDLRRIVDETVRPLMAEQKIPGMAVAITI
DGKSHFFGYGVASKESGQKVTEDTIFEIGSVSKTFTAMLGGYGLATGAFSLSDPATKWAP
ELAGSSFDKITMLDLGTYTPGGLPLQFPDAVTDDSSMLAYFKNWKPDYPAGTQRRYSNPS
IGLFGYLAARSMDKPFDVLMEQKLLPAFGLKNTFINVPESQMKNYAYGYSKANKPIRVSG
GALDAQAYGIKTTALDLARFVELNIDSSSLELDFQKAVAATHTGYYHVGANNQGLGWEFY
NYPTALKTLLAGNSSDMALKSHKIEKFDTPRQPSADVWLNKTGSTNGFGAYAAFIPAKKT
GIVLLANRNYPIDERIKAAYRILQALDNKQ
>CAC17623|FEATURES|argannot|beta_lactam|OCH-3|antibiotic inactivation|1
MRKSTTLLIGFLTTAAIIPNNGALAASKANDGDLRRIVDETVRPLMAEQKIPGMAVAITI
DGKSHFFGYGVASKESGQKVTEDTIFEIGSVSKTFTAMLGGYGLATGAFTLSDPATKWAP
ELADSSFDKITMLDLGTYTPGGLPLQFPDAVSDDSSMLAYFKKWKPDYPAGTQRRYSNPS
IGLFGYLAARSMDKPFDVLMEQKLLPAFGLKNTFINVPESQMKNYAYGYSKANKPIRVSG
GALDAQAYGIKTTALDLARFVELNIDSSSLEPDFQKAVAATHTGYYRVDANNQGLGWEFY
NYPTALKTLLEGNSSDMALKSHKIEKFDTPSQPSADVWLNKTGSTNGFGAYAAFIPAKKI
GIVLLANRNYPIDERVKAAYRILQALDNKQ
>CAC17624|FEATURES|argannot|beta_lactam|OCH-4|antibiotic inactivation|1
MRKSTTLLIGFLTTAAIIPNNGALATSKANDGDLRRIVDETVRPLMAEQKIPGMAVAITI
DGKSHFFGYGVASKESGQKVTEDTIFEIGSVSKTFTAMLGGYGLATGAFSLSDPATKWAP
ELAGSSFDKITMRDLGTYTPGGLPLQFPDAVTDDSSMLAYFKKWKPDYPAGTQRRYSNPS
IGLFGYLAARSMDKPFDVLMEQKLLPAFGLKNTFINVPASQMKNYAYGYSKANKPIRVSG
GALDAQAYGIKTTALDLARFVELNIDSSSLEPDFQKAVAATHTGYYHVGANNQGLGWEFY
NYPTALKTLLAGNSSDMALKSHKIEKFDTPRQPSADVLINKTGSTNGFGAYAAFIPAKKI
GIVLLANRNYPIDERVKAAYRILQALDNKQ
>CAC17625|FEATURES|argannot|beta_lactam|OCH-5|antibiotic inactivation|1
MRKSTTLLIGFLTTAAIIPNNGALAASKANDGDLRRIVDETVRPLMAEQKIPGMAVAITI
DGKSHFFGYGVASKESGQKVTEDTIFEIGSVSKTFTAMLGGYGLATGAFSLSDPATKWAP
ELAGSSFDKITMLDLGTYTPGGLPLQFPDAVTDDSSMLAYFKKWRPDYPAGTQHRYSNPS
IGLFGYLAARSMDKPFDVLMEQKLLPAFGLKNTFINVPESQMKNYAYGYSKANKPIRVSG
GTLDAQAYGIKTTALDLARFVELNIDSSSLEPDFQKAVAATHTGYYHVDANNQGLGWEFY
NYPTALKTLLAGNSSDMALKSHKIEKFDTPRQPSADVLINKTGSTNGFGAYAAFIPAKKI
GIVVLANRNYPIDERVKAAYRILQALDNKQ
>CAC17626|FEATURES|argannot|beta_lactam|OCH-6|antibiotic inactivation|1
MRKSTTLLIGFLTTAAIIPNNGALAASKANDGDLRRIVDETVRPLMAEQKIPGMAVAITI
DGKSHFFGYGVASKESGQKVTEDTIFEIGSVSKTFTAMLGGYGLATGAFSLSDPATKWAP
ELAGSSFDKITMRDLGTYTPGGLPLQFPDAVTDDSSMLAYFKKWKPDYPAGTQRRYSNPS
IGLFGYLAARSMDKPFDVLMEQKLLPAFGLKNTFINVPESQMKNYAYGYSKANKPIRVSG
GALDAQAYGIKTTALDLARFVELNIDSSSLEPDFQKAVAATHTGYYHVGANNQGLGWEFY
NYPTALKTLLAGNSSDMALKSHKIEKFDTPRQPSADVWLNKTGSTNGFGAYAAFIPAKKT
GIVLLANRNYPIDERVKAAYRILQALDNKQ
>CAC17627|FEATURES|argannot|beta_lactam|OCH-7|antibiotic inactivation|1
MRKSTTLLIGFLTTAAIIPNSGALAASKVNDGDLRRIVDETVRPLMAEQKIPGMAVAITI
DGKSHFFGYGVASKESGQKVTEDTIFEIGSVSKTFTAMLGGYGLATGAFSLSDPATKWAP
ELAGSSFDKITMRDLGTYTPGGLPLQFPDAVTDDSSMLAYFKKWKPDYPAGTQRRYSNPS
IGLFGYLAARSMDKPFDVLMEQKLLPAFGLKNTFINVPASQMKNYAYGYSKANKPIRVSG
GALDAQAYGIKTTALDLARFVELNIDSSSLEPDFQKAVAATHTGYYHVGANNQGLGWEFY
NYPTALKTLLAGNSSDMALKSHKIEKFDTPRQPSADVWLNKTGSTNGFGAYAAFIPAKKT
GIVLLANRNYPIDERVKAAYRILQALDNKQ
>ABF50909|FEATURES|argannot|beta_lactam|OCH-8|antibiotic inactivation|1
MRKSTTLLIGFLTTAAIIPNNGALATSKANDGDLRRIVDETVRPLMAEQKIPGMAVAITI
DGKSHFFGYGVASKESGQKVTEDTIFEIGSVSKTFTAMLGGYGLATGAFSLSDPATKWAP
ELAGSSFDKITMLDLGTYTPGGLPLQFPDAVTDDSSMLAYFKKWKPDYPAGTQRRYSNPS
IGLFGYLAARSMDKPFDVLMEQKLLPAFGLKNTFINVPESQMKNYAYGYSKANKPIRVSG
GALDAQAYGIKTTALDLARFVELNIDSSSLEPDFQKAVAATHTGYYHVGANNQGLGWEFY
NYPTALKTLLAGNSSDMALKSHKIEKFDTPRQPSADVLINKTGSTNGFGAYAAFIPAKKI
GIVLLANRNYPIDERVKAAYRILQALDNKQ
>BAA24531|FEATURES|argannot|beta_lactam|CARB-12|antibiotic inactivation|1
MKFLLVFSLLIPSVVFASSSKFRQVEQDVKAIEVSLSARIGVSVLDTQNGEYWDYNGNQR
FPLTSTFKTIACAKLLYDAEQGKVNPNSTVEIKKADLVTYSPVIEKQVGQAITLDDACFA
TMTTSDNTAANIILSAVGGSKGVTDFLRQIGDKETRLDRIEPDLNEGKLGDLRDTTTPKA
IASTLNKFLFGSALSEMNKKKLESWMVNNQVTGNLLRSVLPAGWNIADRSGAGGFGARSI
TAVVWSEHQAPIIVSIYLAQTQASMAERNDAIVKIGRSIFDVYTSQSR
>ADW23164.1|FEATURES|argannot|beta_lactam|CARB-3|antibiotic inactivation|1
MKFLLAFSLLIPSVVFASSSKFQQVEQDVKAIEVSLSARIGVSVLDTQNGEYWDYNGNQR
FPLTSTFKTIACAKLLYDAEQGKVNPNSTVEIKKADLVTYSPVIEKQVGQAITLDDACFA
TMTTSDNTAANIILSAVGGPKGVTDFLRQIGDKETRLDRIEPDLNEGKLGDLRDTTTPKA
IASTLNKFLFGSALSEMNQKKLESWMVNNQVTGNLLRSVLPAGWNIADRSGAGGFGARSI
TAVVWSEHQAPIIVSIYLAQTQASMAERNDAIVKIGHSIFDVYTSQSR
>AAB19430|FEATURES|argannot|beta_lactam|CARB-3|antibiotic inactivation|1
MLLYKMCDNQNYGVTYMKFLLAFSLLIPSVVFASSSKFQQVEQDVKAIEVSLSARIGVSV
LDTQNGEYWDYNGNQRFPLTSTFKTIACAKLLYDAEQGKVNPNSTVEIKKADLVTYSPVI
EKQVGQAITLDDACFATMTTSDNTAANIILSAVGGPKGVTDFLRQIGDKETRLDRIEPDL
NEGKLGDLRDTTTPKAIASTLNKLLFGSALSEMNQKKLESWMVNNQVTGNLLRSVLPAGW
NIADRSGAGGFGARSITAVVWSEHQAPIIVSIYLAQTQASMAERNDAIVKIGHSIFDVYT
SQSR
>AAX93315|FEATURES|argannot|beta_lactam|CARB-4|antibiotic inactivation|1
MKLLLVFSLLIPSMVFANSSKFQQVEQDAKVIEASLSAHIGISVLDTQTGEYWDYNGNQR
FPLTSTFKTIACAKLLYDAEQGEINPKSTIEIKKADLVTYSPVIEKQVGQAITLDDACFA
TMTTSDNAAANIILNALGGPESVTDFLRQIGDKETRLDRIEPELNEGKLGDLRDTTTPNA
IVNTLNELLFGSTLSQDGQKKLEYWMVNNQVTGNLLRSVLPEGWNIADRSGAGGFGARSI
TAVVWSEAQSPIIVSIYLAQTEASIADRNDAIVKIGRSIFEVYSSQSR
>AAF61417|FEATURES|argannot|beta_lactam|CARB-5|antibiotic inactivation|1
MNVRKHKASFFSVVITFLCLTLSLNANATDSVLEAVTNAETELGARIGLAVHDLETGKRW
EHKSNERFPLSSTFKTLACANVLQRVDLGKERIDRVVRFSESNLVTYSPVTEKHVGKKGM
SLAELCQATLSTSDNSAANFILQAIGGPKALTKFLRSIGDDTTRLDRWETELNEAVPGDK
RDTTTPIAMVTTLEKLLIDETLSIKSRQQLESWLKGNEVGDALFRKGVPSDWIVADRTGA
GGYGSRAITAVMWPPNRKPIVAALYITETDASFEERNAVIAKIGEQIAKTVLMENSRN
>AAD19217|FEATURES|argannot|beta_lactam|CARB-6|antibiotic inactivation|1
MKFLLAFSLLIPSVVFASSSKFQQVEQDVKAIEVSLSARIGVSVLDTQNGEYWDYNGNQR
FPLTSTFKTIACAKLLYDAEQGKVNPNSTVEIKKADLVTYSPVIEKQVGQAITLDDACFA
TMTTSDNTAANIILSAVGGPKGVTDFLRQIGDKETRLDRIEPDLNEGKLGDLRDTTTPKA
IASTLNQLLFGSTLSEASQKKLESWMVNNQVTGNLLRSVLPVKWSIADRSGAGGFGARSI
TAIVWSEEKKTIIVSIYLAQTEASMAERNDAIVKIGRSIFEVYTSQSR
>AAM74565|FEATURES|argannot|beta_lactam|CARB-7|antibiotic inactivation|1
MKSLLVFALLMPSVVFASSSKFQSVEQEIKGIESSLSARIGVAILDTQNGESWDYNGDQR
FPLTSTFKTIACAKLLYDAEHGKVNLNSTVEIKKADLVTYSPVLEKQVGKPITLSDACLA
TMTTSDNTAANIVINAVGDPKSITDFLRQIGDKETRLDRVEPELNEGKLGDLRDTTTPNA
ITSTLNQLLFGSTLSEASQKKLESWMVNNQVTGNLLRSVLPVKWSIADRSGAGGFGARSI
TAIVWSEEKKPIIVSIYLAQTEASMAERNDAIVKIGRSIFEVYTSQSR
>YP_009077556|FEATURES|argannot|beta_lactam|CARB-12|antibiotic inactivation|1
MKFLLVFSLLIPSVVFASSSKFRQVEQDVKAIEVSLSARIGVSVLDTQNGEYWDYNGNQR
FPLTSTFKTIACAKLLYDAEQGKVNPNSTIEIKKADLVTYSPVIEKQVGQAITLDDACFA
TMTTSDNTAANIILSAVGGSKGVTDFLRQIGDKETRLDRIEPDLNEGKLGDLRDTTTPKA
IASTLNKFLFGSALSEMNKKKLESWMVNNQVTGNLLRSVLPAGWNIADRSGAGGFGARSI
TAVVWSEHQAPIIVSIYLAQTQASMAERNDAIVKIGRSIFDVYTSQSR
>AAO59455|FEATURES|argannot|beta_lactam|CARB-8|antibiotic inactivation|1
MDVRKHKASFFSVVITFLCLTLSLNANATDSVLEAVTNAETELGARIGLAVHDLETGKRW
EHKSNERFPLSSTFKTLACANVLQRVDLGKERIDRVVRFSESNLVTYSPVTEKHVGKKGM
SLAELCQATLSTSDNSAANFILQAIGGPKALTKFLRSIGDDTTRLDRWETELNEAVPGDK
RDTTTPIAMVTTLEKLLIDETLSIKSRQQLESWLKGNEVGDALFRKGVPSDWIVADRTGA
GGYGSRAITAVMWPPNRKPIVAALYITETDASFEERNAVIAKIGEQIAKTILMENSRN
>AAP22374|FEATURES|argannot|beta_lactam|CARB-9|antibiotic inactivation|1
MKSLLVFALLMPSVVFASSSKFQSVEQEIKGIESSLSARIGVAILDTQNGESWDYNGDQR
FPLTSTFKTIACAKLLYDAEHGKVNLNSTVEVKKADLVTYSPVLEKQVGKPITLSDACFA
TMTTSDNTAANIVINAVGDPKSITDFLRQIGDKETRLDRVEPELNEGKLGDLRDTTTPNA
ITSTLNQLLFGSTLSEASQKKLESWMVNNQVTGNLLRSVLPVTWSIADRSGAGGFGARSI
TAIVWSEEKKPIIVSIYLAQTEASMAERNDAIVKIGRSIFEVYTSQSR
>ACJ61335|FEATURES|argannot|beta_lactam|CARB-10|antibiotic inactivation|1
MDVRQHKASFFSVVITFLCLTLSLNANATDSVLEAVTNAETELGARIGLAAHDLETGKRW
EHKSNERFPLTSTFKTLACANVLQRVDLGKERIDRVVRFSESNLVTYSPVTEKHVGKKGM
SLAELCQATLSTSDNSAANFILQAIGGPKALTKFLRSIGDDTTRLDRWETELNEAVPGDK
RDTTTPIAMVTTLEKLLIDETLSIKSRQQLESWLKGNEVGDALFRKGVPSDWIVADRTGA
GGYGSRAITAVMWPPNRKPIVAALYITETDASFEERNAVIAKIGEQIAKTVLMENSRN
>AAG23870|FEATURES|argannot|beta_lactam|CARB-3|antibiotic inactivation|1
MKFLLAFSLLIPSVVFASSSKFQQVEQDVKAIEVSLSARIGVSVLDTQNGEYWDYNGNQR
FPLTSTFKTIACAKLLYDAEQGKVNSNSTVEIKKADLVTYSPVIEKQVGQAITLDDACFA
TMTTSDNTAANIILSAVGGPKGVTDFLRQIGDKETRLDRIEPDLNEGKLGDLRDTTTPKA
IASTLNKFLFGSALSEMNQKKLESWMVNNQVTGNLLRSVLPAGWNIADRSGAGGFGARSI
TAVVWSEHQAPIIVSIYLAQTQASMAERNDAIVKIGHSIFDVYTSQSR
>AAF89154|FEATURES|argannot|beta_lactam|BD94_2866|antibiotic inactivation|1
MLKKIKISLILALGLTSLQAFGQENPDVKIEKLKDNLYVYTTYNTFNGTKYAANAVYLVT
DKGVVVIDCPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKIGAKTYST
KMTDSILAKENKPRAQYTFDNNKSFKVGKSEFQVYYPGKGHTADNVVVWFPKEKVLVGGC
IIKSADSKDLGYIGEAYVNDWTQSVHNIQQKFSGAQYVVAGHDDWKDQRSIQHTLDLINE
YQQKQKASN
>AAF89156|FEATURES|argannot|beta_lactam|BD94_2866|antibiotic inactivation|1
MLKKIKISLILALGLTSLQAFGQENPDVKIDKLKDNLYVYTTYNTFNGTKYAANAVYLVT
DKGVVVIDCPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKIGAKTYST
KMTDSILAKENKPRAQYTFDNNKSFKVGKSEFQVYYPGKGHTADNVVVWFPKEKVLVGGC
IIKSADSKDLGYIGEAYVNDWTQSVHNIQQKFSGAQYVVAGHDDWKDQRSIQRTLDLINE
YQQKQKASN
>AAD43582|FEATURES|argannot|beta_lactam|blaB-15|antibiotic inactivation|1
MMKKMKWALVLALGLTGLNAFGQETPEVKIEKLKDNLYVYTTYNTFNGTKYAANAVYLVT
SKGVVVIDSPWGEEKFKNFTDEIYKRHGKKVIMNIATHSHDDRAGGLEYFKSLGAKTYST
KMTDSILAKDNKPRAQYTFDNNKSFKVGKDEFQVYYPGKGHTADHVVVWFPKDKVLVGGC
IIKSGDSKDLGFLGEAYVNDWTQSVHNIQKKFPNVQYVVAGHDDWKDQTAIQHTLDLISE
YQQKQKASN
>AAF89159|FEATURES|argannot|beta_lactam|blaB-15|antibiotic inactivation|1
MLKRLKGLLVLALGFTGLQVFGQQNPDIKIEKLKDNLYVYTTYNTFKGTKYAANAVYMVT
DKGVVVIDSPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKLGAKTYST
KMTDSILAKENKPRAKYTFDNNKSFKVGNTEFQVYYPGKGHTADNVVVWFPKDKVLVGGC
IVKSGDSKDLGYIGEAYVNDWTQSIHNIQQKFPDVQYVVAGHDDWKDQTSIQHTLDLISD
YQQKQKASN
>AAF89158|FEATURES|argannot|beta_lactam|KS04_10900|antibiotic inactivation|1
MKRLKGLLVLALGFTGLQVFGQQNPDIKIEKLKDNLYVYTTYNTFKGTKYAANAVYMVTD
KGVVVIDSPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKLGAKTYSTK
MTDSILAKENKPRAKYTFDNNKSFKVGNTEFQVYYPGKGHTADNVVVWFPKDKVLVGGCI
VKSGDSKDLGFIGEAYVNDWTQSIHNIQQKFPDVQYVVAGHDDWKDQTSIQHTLDLISEY
QQKQKASN
>AAF89160|FEATURES|argannot|beta_lactam|KS04_10900|antibiotic inactivation|1
MKGLKGLLVLALGFTGLQVFGQQNPDIKIEKLKDNLYVYTTYNTFKGTKYAANAVYMVTD
KGIVVIDSPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKLGAKTYSTK
MTDSILAKENKPRAKYTFDNNKSFKVGKTEFQVYYPGKGHTADNVVVWFPKDKVLVGGCI
VKSGDSKDLGFIGEAYVNDWTQSIHNIQQKFPDVQYVVAGHDDWKDQTSIQHTLDLISEY
QQKQKASN
>AAF89161|FEATURES|argannot|beta_lactam|KS04_10900|antibiotic inactivation|1
MKGLKGLLVLALGFTGLQVFGQQNPDIKIEKLKDNLYVYTTYNTFKGTKYAANAVYMVTD
KGVVVIDSPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKLGAKTYSTK
MTDSILAKENKPRAKYTFDNNKSFKVGKTEFQVYYPGKGHTADNVVVWFPKDKVLVGGCI
VKSGDSKDLGFIGEAYVNDWTQSIHNIQQKFPDVQYVVAGHDDWKDQTSIQHTLDLISEY
QQKQKASN
>AAQ54753|FEATURES|argannot|beta_lactam|KS04_10900|antibiotic inactivation|1
MKGLKGLLVLALGFTGLQVFGQQNPDIKIEKLKDNLYVYTTYNTFKGTKYAANAVYMVTD
KGVVVIDSPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKLGAKTYSTK
MTDSILAKENKPRAKYTFDNNKSFKVGNTEFQVYYPGKGHTADNVVVWFPKDKVLVGGCI
VKSGDSKDLGFIGEAYVNDWTQSIHNIQQKFPDVQYVVAGHDDWKDQTSIQHTLDLISEY
QQKQKASN
>AAQ54754|FEATURES|argannot|beta_lactam|blaB1|antibiotic inactivation|1
MKGLKGLLVLALGFTGLQVFGQQNPDIKIEKLKDNLYVYTTYNTFKGTKYAANAVYMVTD
KGVVVIDSPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKLGAKTYSTK
MTDSILAKENKPRAKYTFDNNKSFKVGKTEFQVYYPGKGHTADNVVVWFPKDKVLVGGCI
VKSGDSKDLGFIGEAYVNDWTQSIHNIQQKFPYVQYVVAGHDDWKDQTSIQHTLDLISEY
QQKQKASN
>AAQ54755|FEATURES|argannot|beta_lactam|BD94_2866|antibiotic inactivation|1
MLKKIKISLILALGLTSLQAFGQENPDVKIEKLKDNLYVYTTYNTFNGTKYAANAVYLVT
DKGVVVIDCPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKIGAKTYST
KMTDSILAKENKPRAQYTFDNNKSFKVGKSEFQVYYPGKGHTADNVVVWFPKEKVLVGGC
IIKSADSKDLGYIGEAYVNDWTQSVHNIQQKFSGAQYVVAGHDDWKDQRSIQRTLDLINE
YQQKQKASN
>ABQ84947|FEATURES|argannot|beta_lactam|blaB-15|antibiotic inactivation|1
MMKKMKWALVLALGLTGLNAFGQETPEVKIEKLKDNLYVYTTYNTFNGTKYAANAVYLVT
SKGVVVIDSPWGEEKFKNFTDEIYKRHGKKVIMNIATHSHDDRAGGLEYFKSLGVKTYST
KMTDSILAKDNKPRAQYTFDNNKSFKVGKDEFQVYYPGKGHTADNVVVWFPKDKVLVGGC
IIKSGDSKDLGFLGEAYVNDWTQSVHNIQKKFPNVQYVVAGHDDWKDQTAIQHTLDLISE
YQQKQKASN
>ABQ84948|FEATURES|argannot|beta_lactam|blaB-15|antibiotic inactivation|1
MMKKMKWALVLALGLTGLNAFGQETPEVKIEKLKDNLYVYTTYNTFNGTKYAANAVYLVT
SKGVVVIDSPWGEEKFKNFTDEIYKRHGKKVIMNIATHSHDDRAGGLEYFKSLGVKTYST
KMTDSILAKDNKPRAQYTFDNNKSFKVGKDEFQVYYPGKGHTADNVVVWFPKDKVLVGGC
IIKSGDSKNLGFLGEAYVNDWTQSVHNIQKKFPNVQYVVAGHDDWKDQTAIQHTLDLISE
YQQKQKASN
>AEY68295|FEATURES|argannot|beta_lactam|BlaB|antibiotic inactivation|1
MKNIMRALILVFGFMSFFMFGQENPDVKIEKLRDNLYVYTTYNTFNGTKYAANAVYLVTD
KGVVVIDCPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKIGAKTYSTK
MTDSILAKENKPRAQYTFDNNKSFKVGKSEFQVYYPGKGHTADNVVVWFPKEKVLVGGCI
IKSADSKDLGYIGEAYVNDWTQSVHNIQQKFSGAQYVVAGHDDWKDQRSIQRTLDLINEY
QQKQKASN
>ABD49192.1|FEATURES|argannot|beta_lactam|VEB-1|antibiotic inactivation|1
MKIVKRILLVLLSLFFTIVYSNAQTDNLTLKIENVLKAKNARIGVAIFNSNEKDTLKINN
DFHFPMQSVMKFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKTWSPIKEEFPNGTTLTI
EQILNYTVSESDNIGCDILLKLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQN
WATPTAMNKLLIDTYNNKNQLLSKKSYDFIWKIMRETTTGSNRLKGQLPKNTIVAHKTGT
SGINNGIAAATNDVGVITLPNGQLIFISVFVAESKETSEINEKIISDIAKITWNYYLNK
>AAK29174|FEATURES|argannot|beta_lactam|VEB-2|antibiotic inactivation|1
MKIVKRILLVLLSLFFTIVYSNAQADNLTLKIENVLKAKNARIGVAIFNSNEKDTLKINN
DFHFPMQSVMKFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKTWSPIKEEFPNGTTLTI
EQILNYTVSESDNIGCDILLKLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQN
WATPTAMNKLLIDTYNNKNQLLSKKSYDFIWKIMRETTTGSNRLKGQLPKNTIVAHKTGT
SGINNGIAAATNDVGVITLPNGQLIFISVFVAESKETSEINEKIISDIAKITWNYYLNK
>AAS48620|FEATURES|argannot|beta_lactam|VEB-3|antibiotic inactivation|1
MKIVKRILLVLLSLFFTVVYSNAQTDNLTLKIENVLKAKNARIGVAIFNSNEKDTFKINN
DFHFPMQSVMKFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKTWSPIKEEFPNGTTLTI
EQILNYTVSESDNIGCDILLKLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQN
WATPTAMNKLLIDTYNNKNQLLSKKSYDFIWKIMRETTTGSNRLKGQLPKNTIVAHKTGT
SGINNGIAAATNDVGVITLPNGQLIFISVFVAESKETSEINEKIISDIAKITWNYYLNK
>ABM54868|FEATURES|argannot|beta_lactam|VEB-4|antibiotic inactivation|1
MKIVKRILLVLLSLFFTIVYSNAQADNLTLKIENVLKAKNARIGVAIFNSNEKDTLKINN
DFHFPMQSVMKFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKMWSPIKEEFPNGTTLTI
EQILNYTVSESDNIGCDILLKLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQN
WATPTAMNKLLIDTYNNKNQLLSKKSYDFIWKIMRETTTGSNRLKGQLPKNTIVAHKTGT
SGINNGIAAATNDVGVITLPNGQLIFISVFVAESKETSEINEKIISDIAKITWNYYLNK
>ABN80430|FEATURES|argannot|beta_lactam|VEB-5|antibiotic inactivation|1
MKIVKRILLVLLSLFFTVEYSNAQTDNLTLKIENVLKAKNARIGVAIFNSNEKDTLKINN
DFHFPMQSVMKFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKMWSPIKEEFPNGTTLTI
EQILNYTVSESDNIGCDILLKLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQN
WATPTAMNKLLIDTYNNKNQLLSKKSYDFIWKIMRETTTGSNRLKGQLPKNTIVAHKTGT
SGINNGIAAATNDVGVITLPNGQLIFISVFVAESKETSEINEKIISDIAKITWNYYLNK
>ACA34904|FEATURES|argannot|beta_lactam|VEB-6|antibiotic inactivation|1
MKIVKRILLVLLSLFFTVVYSNAQADNLTLKIENVLKAKNARIGVAIFNSNEKDTLKINN
DFHFPMQSVMKFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKMWSPIKEEFPNGTTLTI
EQILNYTVSESDNIGCDILLKLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQN
WATPTAMNKLLIDTYNNKNQLLSKKSYDFIWKIMRETTTGSNRLKGQLPKNTIVAHKTGT
SGINNGIAAATNDVGVITLPNGQLIFISVFVAESKETSEINEKIISDIAKITWNYYLNK
>ACO56763|FEATURES|argannot|beta_lactam|VEB-7|antibiotic inactivation|1
MKIVKRILLVLLSLFFTVEYSNAQTDNLTLKIENVLKAKNARIGVAIFNSNEKDTLKINN
DFHFPMQSVMKFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKTWSPIKEEFPNGTTLTI
EQILNYTVSESDNIGCDILLKLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQN
WATPTAMNKLLIDTYNNKNQLLSKKSYDFIWKIMRETTTGSNRLKGQLPKNTIVAHKTGT
SGINNGITAATNDVGVITLPNGQLIFISVFVAESKETSEINEKIISDIAKITWNYYLNK
>AGH33739|FEATURES|argannot|beta_lactam|VEB-8|antibiotic inactivation|1
MKIVKRILLVLLSLFFTVEYSNAQTDNLTLKIENVLKAKNARIGVAIFNSNEKDTLKINN
DFHFPMQSVMKFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKMWSPIKEEFPNGTTLTI
EQILNYTVSESDNIGCDILLKLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQN
WATPTAMNKLLIDTYNNKNQLLSKKSYDFIWKIMRETTAGSNRLKGQLPKNTIVAHKTGT
SGINNGIAAATNDVGVITLPNGQLIFISVFVAESKETSEINEKIISDIAKITWNYYLNK
>AAK14293|FEATURES|argannot|beta_lactam|VEB-1a|antibiotic inactivation|1
MKIVKRILLVLLSLFFTVVYSNAQTDNLTLKIENVLKAKNARIGVAIFNSNEKDTLKINN
DFHFPMQSVMKFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKTWSPIKEEFPNGTTLTI
EQILNYTVSESDNIGCDILLKLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQN
WATPTAMNKLLIDTYNNKNQLLSKKSYDFIWKIMRETTTGSNRLKGQLPKNTIVAHKTGT
SGINNGIAAATNDVGVITLPNGQLIFISVFVAESKETSEINEKIISDIAKITWNYYLNK
>AAK14294|FEATURES|argannot|beta_lactam|VEB-1b|antibiotic inactivation|1
MKIVKRILLVLLSLFFTVEYSNAQTDNLTLKIENVLKAKNARIGVAIFNSNEKDTLKINN
DFHFPMQSVMKFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKTWSPIKEEFPNGTTLTI
EQILNYTVSESDNIGCDILLKLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQN
WATPTAMNKLLIDTYNNKNQLLSKKSYDFIWKIMRETTTGSNRLKGQLPKNTIVAHKTGT
SGINNGIAAATNDVGVITLPNGQLIFISVFVAESKETSEINEKIISDIAKITWNYYLNK
>AKO63208|FEATURES|argannot|beta_lactam|blaVEB-11|antibiotic inactivation|1
MKIVKRILLVLLSLFFTIVYSNAQTDNLTLKIENVLKEKNARIGVAIFNSNEKDTLKINN
DFHFPMQSVMKFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKTWSPIKEEFPNGTTLTI
EQILNYTVSESDNIGCDILLKLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQN
WATPTAMNKLLIDTYNNKNQLLSKKSYDFIWKIMRETTTGSNRLKGQLPKNTIVAHKTGT
SGINNGIAAATNDVGVITLPNGQLIFISVFVAESKETSEINEKIISDIAKITWNYYLNK
>AKO63209|FEATURES|argannot|beta_lactam|blaVEB-12|antibiotic inactivation|1
MKIVKRILLVLLSLFFTVEYSNAQTDNLTLKIENVLKAKNARIGVAIFNSNEKDTLKINN
DFHFPMQSVMKFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKTWSPIKEEFPNGTTLTI
EQILNYTVSESDNIGCDILLKLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQN
WATPTAMNKLLIDTYNNKNQLLSKKSYDFIWKIMRETTAGSNRLKGQLPKNTIVAHKTGT
SGINNGIAAATNDVGVITLPNGQLIFISVFVAESKETSEINEKIISDIAKITWNYYLNK
>ADE18863|FEATURES|argannot|beta_lactam|VIM-1|antibiotic inactivation|1
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVHELSSTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGH
GLPGGLDLLQHTANVVKAHKNRSVAE
>AAX16004.1|FEATURES|argannot|beta_lactam|VIM-2|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>ADF48906|FEATURES|argannot|beta_lactam|VIM-3|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATK
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGSEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>AEO50497|FEATURES|argannot|beta_lactam|VIM-4|antibiotic inactivation|1
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVHELSRTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGH
GLPGGLDLLQHTANVVKAHKNRSVAE
>AAY44598|FEATURES|argannot|beta_lactam|VIM-5|antibiotic inactivation|1
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRKAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVLALSRTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGH
GLPGGLDLLQHTANVVTAHKNRSVAE
>AAN84550|FEATURES|argannot|beta_lactam|VIM-6|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATR
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGSEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>CAD61201|FEATURES|argannot|beta_lactam|VIM-7|antibiotic inactivation|1
MFQIRSFLVGISAFVMAVLGSAAYSAQPGGEYPTVDDIPVGEVRLYKIGDGVWSHIATQK
LGDTVYSSNGLIVRDADELLLIDTAWGAKNTVALLAEIEKQIGLPVTRSISTHFHDDRVG
GVDVLRAAGVATYTSPLTRQLAEAAGNEVPAHSLKALSSSGDVVRFGPVEVFYPGAAHSG
DNLVVYVPAVRVLFGGCAVHEASRESAGNVADANLAEWPATIKRIQQRYPEAEVVIPGHG
LPGGLELLQHTTNVVKTHKVRPVAE
>AAS13759|FEATURES|argannot|beta_lactam|VIM-8|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSARRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>AAS13760|FEATURES|argannot|beta_lactam|VIM-9|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSIRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>AAS13761|FEATURES|argannot|beta_lactam|VIM-10|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQYVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>ABL61511|FEATURES|argannot|beta_lactam|VIM-11|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGSEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>AAZ73123|FEATURES|argannot|beta_lactam|VIM-12|antibiotic inactivation|1
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVHELSSTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>ABC94518|FEATURES|argannot|beta_lactam|VIM-13|antibiotic inactivation|1
MLKVISSLLFYMTASLMAVASPLAHSGESRGEYPTVSEIPVGEVRLYQIDDGVWSHIATH
TFDGVVYPSNGLIVRDGDELLLIDTAWGTKNTVALLAEIEKQIGLPVTRSVSTHFHDDRV
GGVDALRAAGVATYASPSTRRLAEAEGNEVPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVLELSRTSAGNVADADLAEWPGSVERIQQHYPEAEVVIPGH
GLPGGLDLLQHTANVVKAHTNRSVAE
>ACB54702|FEATURES|argannot|beta_lactam|VIM-15|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLFGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>ACB54703|FEATURES|argannot|beta_lactam|VIM-16|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWLHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>ABW90721|FEATURES|argannot|beta_lactam|VIM-17|antibiotic inactivation|1
MFKLLSKLLVYLTASMMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>CAO83029|FEATURES|argannot|beta_lactam|VIM-18|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATR
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLANEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHSTDNL
VVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGHGLPG
GLDLLKHTTNVVKAHTNRSVVE
>ACQ77171|FEATURES|argannot|beta_lactam|VIM-19|antibiotic inactivation|1
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSAKVLYGGCAVHELSRTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGH
GLPGGLDLLQHTANVVKAHKNRSVAE
>ACV13198|FEATURES|argannot|beta_lactam|VIM-20|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQRYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>ACT33323|FEATURES|argannot|beta_lactam|VIM-23|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSSTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>ADL27533|FEATURES|argannot|beta_lactam|VIM-24|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSLTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>ADO50679|FEATURES|argannot|beta_lactam|VIM-25|antibiotic inactivation|1
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRKAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVLALSRTSAGNVADADLAEWPTSVERIQKHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>CBY80143|FEATURES|argannot|beta_lactam|VIM-26|antibiotic inactivation|1
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVLELSSTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGH
GLPGGLDLLQHTANVVKAHKNRSVAE
>ADX78234|FEATURES|argannot|beta_lactam|VIM-27|antibiotic inactivation|1
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHISTQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVHELSSTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGH
GLPGGLDLLQHTANVVKAHKNRSVAE
>AEI25539|FEATURES|argannot|beta_lactam|VIM-28|antibiotic inactivation|1
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVLELSRTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGH
GLPGGLDLLQHTANVVKAHKNRSVAE
>AFP99885|FEATURES|argannot|beta_lactam|VIM-29|antibiotic inactivation|1
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSAKVLYGGCAVHELSSTSAGNVADADLAEWPTSVERIQKRYPEAEVVIPGH
GLPGGLDLLQHTANVVKAHKNRSVAE
>AFK24647|FEATURES|argannot|beta_lactam|VIM-31|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIHELSRTSAGNVADADLAEWPTSIERIQQRYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>AEZ49857|FEATURES|argannot|beta_lactam|VIM-32|antibiotic inactivation|1
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAAGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVHELSSTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGH
GLPGGLDLLQHTANVVKAHKNRSVAE
>AFP99175|FEATURES|argannot|beta_lactam|VIM-33|antibiotic inactivation|1
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLFGGCAVHELSSTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGH
GLPGGLDLLQHTANVVKAHKNRSVAE
>AFN88953|FEATURES|argannot|beta_lactam|VIM-34|antibiotic inactivation|1
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAISTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVHELSSTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGH
GLPGGLDLLQHTANVVKAHKNRSVAE
>AGC50805|FEATURES|argannot|beta_lactam|VIM-35|antibiotic inactivation|1
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVHELSSTSAGNVTDADLAEWPTSVERIQKHYPEAEVVIPGH
GLPGGLDLLQHTANVVKAHKNRSVAE
>AGC50806|FEATURES|argannot|beta_lactam|VIM-36|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATR
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>AGC50807|FEATURES|argannot|beta_lactam|VIM-37|antibiotic inactivation|1
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHISTQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVHELSRTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGH
GLPGGLDLLQHTANVVKAHKNRSVAE
>AGE83081|FEATURES|argannot|beta_lactam|VIM-38|antibiotic inactivation|1
MLKVISSLLVYLTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRKAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVLALSRTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGH
GLPGGLDLLQHTANVVTAHKNRSVVE
>AGS82586|FEATURES|argannot|beta_lactam|VIM-39|antibiotic inactivation|1
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPAVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVLELSSTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGH
GLPGGLDLLQHTANVVKAHKNRSVAE
>AJP08641|FEATURES|argannot|beta_lactam|VIM-42|antibiotic inactivation|1
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVHELSSTSAGNVADADLAEWPTSIERIQKHYPEAEVVIPGH
GLPGGLDLLQHTANVVKAHKNRSVAE
>AJP67511|FEATURES|argannot|beta_lactam|VIM-43|antibiotic inactivation|1
MLKVISSLLVYMTASVMAVASPLVHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVHELSRTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGH
GLPGGLDLLQHTANVVKAHKNRSVAE
>AKO63212|FEATURES|argannot|beta_lactam|VIM-2|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVNAHTNRSVVE
>AKO63211|FEATURES|argannot|beta_lactam|VIM-2|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPIVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>AKQ98357|FEATURES|argannot|beta_lactam|VIM-2|antibiotic inactivation|1
MFKFLSKLLVYLTASIMAIASPLAFSVDSSGEYPTASEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>BAC06845|FEATURES|argannot|beta_lactam|CcrA|antibiotic inactivation|1
MKTVFILISMLFPVAVMAQKSVKISDDISITQLSDKVYTYVSLAEIEGWGMVPSNGMIVI
NNHQAALLDTPINDAQTETLVNWVTDSLHAKVTTFIPNHWHGDCIGGLGYLQKKGVQSYA
NQMTIDLAKEKGLPVPEHGFTDSLTVSLDGMPLQCYYLGGGHATDNIVVWLPTENILFGG
CMLKDNQTTSIGNISDADVTAWPKTLDKVKAKFPSARYVVPGHGNYGGTELIEHTKQIVN
QYIESTSKP
>BAC06849|FEATURES|argannot|beta_lactam|CcrA|antibiotic inactivation|1
MKTVFILISMLFPVAVMAQKSVKISDDISITQLSDKVYTYVSLAEIEGWGMVPSNGMIVI
NNHQAALLDTPINDAQTETLVNWVADSLHAKVTTFIPNHWHGDCIGGLGYLQKKGVQSYA
NQMTIDLAKEKGLPVPEHGFTDSLTVSLDGMPLQCYYLGGGHATDNIVVWLPTENILFGG
CMLKDNQATSIGNISDADVTAWPKTLDKVKAKFPSARYVVPGHGDYGGTELIEHTKQIVN
QYIESTLKP
>BAC06850|FEATURES|argannot|beta_lactam|CcrA|antibiotic inactivation|1
MKTVFILISMLFPVAVMAQKSVKISDDISITQLSDKVYTYVSLAEIEGWGMVPSNGMIVI
NNYQAALLDTPINDAQTETLVNWVADSLHAKVTTFIPNHWHGDCIGGLGYLQKKGVQSYA
NQMTIDLAKEKGLPVPEHGFTDSLTVSLDGMPLQCYYLGGGHATDNIVVWLPTENILFGG
CMLKDNQATSIGNISDADVTAWPKTLDKVKAKFPSARYVVPGHGDYGGTELIEHTKQIVN
QYIESTSKP
>BAC06843|FEATURES|argannot|beta_lactam|CcrA|antibiotic inactivation|1
MKTVFILISMLFPVAVMAQKSVKISDDISITQLSDKVYTYVSLAEIEGWGMVPSNGMIVI
NNHQAALLDTPINDAQTETLVNWVADSLHAKVTTFIPNHWHGDCIGGLGYLQKKGVQSYA
NQMTIDLAKEKGLPVPEHGFTDSLTVSLDGMPLQCYYLGGGHATDNIVVWLPTENILFGG
CMLKDNQATSIGNISDADVTAWPKTLDKVKAKFPSARYVVPGHGDYGGTELIEHPKQIVN
QYIESTSKP
>CAQ87576|FEATURES|argannot|beta_lactam|CcrA|antibiotic inactivation|1
MKTVFILISMLFPVAVMAQKSVKISDDISITQLSDKVYTYVSLAEIEGWGMVPSNGMIVI
NNHQAALLDTPINDAQTETLVNWVTDSLHAKVTTFIPNHWHGDCIGGLGYLQKKGVQSYA
NQMTIDLAKEKGLPVPEHGFTDSLTVSLDGMPLQCYYLGGGHATDNIVVWLPTENILFGG
CMLKDNQATSIGNISDADVTAWPKTLDKVKAKFPSARYVVPGHGDYGGTELIEHTKQIVN
QYIESTSKP
>AAB17891|FEATURES|argannot|beta_lactam|CfxA|antibiotic inactivation|1
MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIG
VAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTW
SPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQI
AYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIA
APLLDKEGVVIAHKTGSGYVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNKSQAS
QYVAHISAVVYSLLMQTSVKS
>AAV37205|FEATURES|argannot|beta_lactam|CfxA4|antibiotic inactivation|1
MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIG
VAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTW
SPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQI
AYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIA
APLLDKEGVVIAHKTGSGNVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQAS
QYVAHISAVVYSLLMQTSVKS
>AAV37206|FEATURES|argannot|beta_lactam|CfxA5|antibiotic inactivation|1
MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIG
VAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTW
SPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQI
AYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIA
APLLDKEGVVIAHKTGSGCVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQAS
QYVAHISAVVYSLLMQTSVKS
>CAA63262|FEATURES|argannot|beta_lactam|CTX-M-1|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLISHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>ABQ96621.1|FEATURES|argannot|beta_lactam|CTX-M-2|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDILAAAAKIVTHGF
>CAA74573|FEATURES|argannot|beta_lactam|CTX-M-4|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVAQINTADNSQ
ILYVADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIRASDLVNYNPIAEKHVNGTM
TLAELGAGALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNSAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGMPKSWGVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDILAAAAKIVTHGF
>AEM36716|FEATURES|argannot|beta_lactam|CTX-M-5|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQTNSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWGVGDKTGS
GDYGTTNDIAVIWPANHAPLVLVTYFTQPEQKAESRRDVLAAAAKIVTHGF
>CAA06311|FEATURES|argannot|beta_lactam|CTX-M-6|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYLADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKASDLVNYNPIAEKHVNGTM
TLAELGAGALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNSAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKCWVVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDVLAAAAKIVTHGF
>CAA06312|FEATURES|argannot|beta_lactam|CTX-M-7|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYVADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIRASDLVNYNPIAEKHVNGTM
TLAQLGAGALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNSAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWGVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDVLAAAAKIVTHGF
>AAF04388|FEATURES|argannot|beta_lactam|CTX-M-8|antibiotic inactivation|1
MMRHRVKRMMLMTTACISLLLGSAPLYAQANDVQQKLAALEKSSGGRLGVALIDTADNAQ
TLYRADERFAMCSTSKVMAAAAVLKQSETQKKVLSQKVEIKSSDLINYNPITEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAHLGGPDKVTAFARAIGDNTFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLRNLTLGSALGETQRAQLVTWLKGNTTGAASIQAGLPTSWVVGDKTGS
GDYGTTNDIAVIWPEGRAPLILVTYFTQPEQKAESRRDVLAAAAKIVTDGY
>AAF65843|FEATURES|argannot|beta_lactam|CTX-M-10|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTVDVQQKLAELEQQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>AAF93177|FEATURES|argannot|beta_lactam|CTX-M-11|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAGLERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SPAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRHVLAS
>AAP43783|FEATURES|argannot|beta_lactam|CTX-M-12|antibiotic inactivation|1
MVKKSLRQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPSLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDILASAAKIVTDGL
>AAF72530|FEATURES|argannot|beta_lactam|CTX-M-14|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>AAK32961|FEATURES|argannot|beta_lactam|CTX-M-16|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTAGDKTGS
GGYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>AAK71471|FEATURES|argannot|beta_lactam|CTX-M-17|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAKGL
>AAK55534|FEATURES|argannot|beta_lactam|CTX-M-19|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTESTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>CAC95175|FEATURES|argannot|beta_lactam|CTX-M-20|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDFLAAAAKIVTHGF
>CAD08929|FEATURES|argannot|beta_lactam|CTX-M-21|antibiotic inactivation|1
MVTKRVQRMMFAGGAGIPLLLGSAPFYAQTSAGQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>AAL86924|FEATURES|argannot|beta_lactam|CTX-M-22|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>AAL99990|FEATURES|argannot|beta_lactam|CTX-M-23|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTETTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>AAN38836|FEATURES|argannot|beta_lactam|CTX-M-24|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAERRRDVLASAARIIAEGL
>AAM70498|FEATURES|argannot|beta_lactam|CTX-M-25|antibiotic inactivation|1
MMRKSVRRAMLMTTACVSLLLASVPLCAQANDVQQKLAALEKSSGGRLGVALINTADNTQ
TLYRADERFAMCSTSKVMAVAAVLKQSETQKGLLSQRVEIKPSDLINYNPIAEKHVNGTM
TFGELSAAALQYSDNTAMNKLIAHLGGPDKVTAFARTIGDDTFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQALRNLTLGNALGDTQRAQLVMWLKGNTTGAASIQAGLPTSWVVGDKTGS
GGYGTTNDIAVIWPEGRAPLVLVTYFTQSEPKAESRRDVLAAAARIVTDGY
>AAN75444|FEATURES|argannot|beta_lactam|CTX-M-26|antibiotic inactivation|1
MMRKSVRRAMLMTTACVSLLLASVPLCAQANDVQQKLAALEKSSGGRLGVALINTADNTQ
TLYRADERFAMCSTSKVMAAAAVLKQSETQKGLLSQRVEIKPSDLINYNPIAEKHVNGTM
TFGELSAAALQYSDNTAMNKLIAHLGGPDKVTAFARTIGDDTFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQALRNLTLGNALGDTQRAQLVMWLKGNTTGAASIRAGLPTSWVVGDKTGS
GDYGTTNDIAVIWPEGRAPLVLVTYFTQSEPKAESRRDVLAAAARIVTDGY
>AAO61597|FEATURES|argannot|beta_lactam|CTX-M-27|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GGYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>CAD70280|FEATURES|argannot|beta_lactam|CTX-M-28|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>AAP22736|FEATURES|argannot|beta_lactam|CTX-M-29|antibiotic inactivation|1
MVKKSLRQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>AAP43508|FEATURES|argannot|beta_lactam|CTX-M-30|antibiotic inactivation|1
MVKKSLRQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>CAD99182|FEATURES|argannot|beta_lactam|CTX-M-31|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDESFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDILAAAAKIVTHGF
>CAD89606|FEATURES|argannot|beta_lactam|CTX-M-32|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLISHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>AAO88912|FEATURES|argannot|beta_lactam|CTX-M-33|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYSPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>AAR99493|FEATURES|argannot|beta_lactam|CTX-M-34|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTVDVQQKLAELEQQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
CDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>BAD83775|FEATURES|argannot|beta_lactam|CTX-M-35|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTESTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDILAAAAKIVTHGF
>BAD16611|FEATURES|argannot|beta_lactam|CTX-M-36|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLISHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>AAT70415|FEATURES|argannot|beta_lactam|CTX-M-37|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLHAQTADVQQKLAELEQQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>AAX54694|FEATURES|argannot|beta_lactam|CTX-M-39|antibiotic inactivation|1
MMRKSVRRAMLMTTACVSLLLASVPLCAQANDVQQKLAALEKSSGGRLGVALINTADNTQ
TLYRADERFAMCSTSKVMAAAAVLKQSETQKGLLSQRVEIKPSDLINYNPIAEKHVNGTM
TFGELSAAALQYSDNTAMNKLIAHLGGPDKVTAFARTIGDDTFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQALRNLTLGNALGDTQRAQLVMWLKGNTTGAASIQAGLPTSWVVGDKTGS
GDYGTTNDIAVIWPEGRAPLVLVTYFTQSEPKAESRRDVLAAAARIVTDGY
>AAV28215|FEATURES|argannot|beta_lactam|CTX-M-40|antibiotic inactivation|1
MRHRVKRMMLMTTACISLLLGSAPLYAQANDVQQKLAALEKSSGGRLGVALIDTADNAQT
LYRADERFAMCSTSKVMAAAAVLKQSETQKNVLSQKVEIKSSDLINYNPIAEKHVNGTMT
LAELSAAALQYSDNTAMNKLIAHLGGPDKVTAFARAIGDDTFRLDRTEPTLNTAIPGDPR
DTTTPLAMAQTLRHLTLGSALGETQRAQLVTWLKGNTTGAASIQAGLPTSWVVGDKTGSG
DYGTTNDIAVIWPEGRAPLILVTYFTQPEQKAESRRDVLAAAAKIVTDGY
>AAY43008|FEATURES|argannot|beta_lactam|CTX-M-41|antibiotic inactivation|1
MMRKSVRRAMLMTTACVSLLLASVPLCAQANDVQQKLAALEKSSGGRLGVALINTADNTQ
TLYRADERFAMCSTSKVMAAAAVLKQSETQKGLLSQRVEIKPSDLVNYNPIAEKHVNGTM
TFGELIAAALQYSDNTAMNKLIAHLGGPDKVTAFARTIGDDTFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQALRNLTLGNALGDTQRAQLVMWLKGNTTGAASIQAGLPTSWVVGDKTGS
GGYGTTNDIAVIWPEGRAPLVLVTYFTQSEPKAESRRDVLAAAARIVTDGY
>AAY84742|FEATURES|argannot|beta_lactam|CTX-M-42|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTETTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>AEL20766|FEATURES|argannot|beta_lactam|blaCTX-M-131|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYGDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGS
GGYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDILAAAAKIVTHGF
>BAA07082|FEATURES|argannot|beta_lactam|CTX-M-44|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAERRRDILAAAAKIVTHGF
>BAA28282|FEATURES|argannot|beta_lactam|CTX-M-45|antibiotic inactivation|1
MVTKRVQRMMSAAAACIPLLLGSPTLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTARAGADVASLRWVMRWAKPSGAVGDVAQRQYDRAAGIRAGLPTSWTVGDKTGSGD
YGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>AAV97956|FEATURES|argannot|beta_lactam|CTX-M-46|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTNAVQQKLAALEKSSGGRLGVPLIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>AAV97952|FEATURES|argannot|beta_lactam|CTX-M-47|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGRRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>AAV97953|FEATURES|argannot|beta_lactam|CTX-M-48|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTNAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>AAV97954|FEATURES|argannot|beta_lactam|CTX-M-49|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGRRLGVPLIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>AAV97955|FEATURES|argannot|beta_lactam|CTX-M-50|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVPLIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>ABA62022|FEATURES|argannot|beta_lactam|CTX-M-51|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAVAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTAGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>ADA62518|FEATURES|argannot|beta_lactam|CTX-M-52|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTESTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>YP_002332251|FEATURES|argannot|beta_lactam|CTX-M-53|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTVDVQQKLAELEQQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVIYFTQPQPKAESRRDVLASAAKIVTDGL
>ABC18328|FEATURES|argannot|beta_lactam|CTX-M-54|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEQTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>ADL27910|FEATURES|argannot|beta_lactam|CTX-M-55|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>ABN48311|FEATURES|argannot|beta_lactam|CTX-M-56|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAENRRDILAAAAKIVTHGF
>AEL20760|FEATURES|argannot|beta_lactam|CTX-M-58|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYGDNVAMNKLISHVGGPASVTAFARQLGDETFRLDRTESTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>ACC95405|FEATURES|argannot|beta_lactam|CTX-M-59|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKLLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDILAAAAKIVTHGF
>CAL80726|FEATURES|argannot|beta_lactam|CTX-M-60|antibiotic inactivation|1
MVKKSLRQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPSLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDILASAAKIVTDGL
>ADA62534|FEATURES|argannot|beta_lactam|CTX-M-61|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>ADA62520|FEATURES|argannot|beta_lactam|CTX-M-62|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLISHVGGPASVTAFARQLGDETFRLDRTESTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>BAD90119|FEATURES|argannot|beta_lactam|CTX-M-63|antibiotic inactivation|1
MRHRVKRMMLMTTACISLLLGSAPLYAQANDVQQKLAALEKSSGGRLGVALIDTADNAQT
LYRADERFAMCSTSKVMAAAAVLKQSETQKNVLSQKVEIKSSDLINYNPIAEKHVNGTMT
LAELSAAALQYSDNTAMNKLIAHLGGPDKVTAFARAIGDDTFRLDRTEPTLNTAIPGDPR
DTTTPLAMAQTLRHLTLGSALGETQRAQLVTWLKGNTTGAASIQAGLPTSWVVGDKTGSG
DYGTTNDIAVIWPEGRAPLILVTYFTQPEQKAENRRDVLAAAAKIVTDGY
>ACU87985|FEATURES|argannot|beta_lactam|CTX-M-64|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>ABN69105|FEATURES|argannot|beta_lactam|CTX-M-65|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAVAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAERRRDVLASAARIIAEGL
>ABQ45409|FEATURES|argannot|beta_lactam|CTX-M-66|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGNVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>ABS90365|FEATURES|argannot|beta_lactam|CTX-M-67|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYSPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>ABV81082|FEATURES|argannot|beta_lactam|CTX-M-68|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLHAQTVDVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDDTFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>ABY91281|FEATURES|argannot|beta_lactam|CTX-M-69|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPNAESRRDVLASAAKIVTNGL
>ACV92002|FEATURES|argannot|beta_lactam|CTX-M-71|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
CGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>AAV97957|FEATURES|argannot|beta_lactam|CTX-M-72|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDGTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>ACS32293|FEATURES|argannot|beta_lactam|CTX-M-74|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTETTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDILAAAAKIVTHGF
>ACS32294|FEATURES|argannot|beta_lactam|CTX-M-75|antibiotic inactivation|1
MMTQSIRRSMLTVMATLSLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDILAAAAKIVTHGF
>CAQ42486|FEATURES|argannot|beta_lactam|CTX-M-76|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQTNSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWGVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDVLAAAAKIVTHGF
>CAQ42480|FEATURES|argannot|beta_lactam|CTX-M-77|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQTNSVQQQLKALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIQAGLPKSWVVGDKTGS
GDYGTTNDIAIIWPENHAPLVLVTYFTQPEQKAESRRDVLAAAAKIVTRGF
>CAQ42481|FEATURES|argannot|beta_lactam|CTX-M-78|antibiotic inactivation|1
MMRKSVRRAILMTTACVSLLLASVPLYAQANDIQQKLAALEKSSGGRLGVALINTADNTQ
TLYRADERFAMCSTSKVMAAAAVLKQSETQKDLLSQRVEIKSSDLINYNPIAEKHVNGTM
TLGELSAAALQYSDNTAMNKLIAHLGGPGKVTAFARVIGDDTFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLRNLTLGNALGDTQRAQLVTWLKGNTTGAASIQAGLPTSWVVGDKTGS
GDYGTTNDIAVIWPEGRAPLVLVTYFTQPEPKAESRRDVLAAAARIVTDGY
>ADA62553|FEATURES|argannot|beta_lactam|CTX-M-79|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLISHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>ABW86620|FEATURES|argannot|beta_lactam|CTX-M-80|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTVDVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>ABV57756|FEATURES|argannot|beta_lactam|CTX-M-81|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLEQSETQKQLLNQPVEIQPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDHTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>ACB41777|FEATURES|argannot|beta_lactam|CTX-M-87|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAVAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTELTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>ACI29345|FEATURES|argannot|beta_lactam|CTX-M-83|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTH
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>ACI29346|FEATURES|argannot|beta_lactam|CTX-M-84|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVAWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>ACI29347|FEATURES|argannot|beta_lactam|CTX-M-85|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TPAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>ACI29348|FEATURES|argannot|beta_lactam|CTX-M-86|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPFAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>ACP18863|FEATURES|argannot|beta_lactam|CTX-M-88|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRHDVLASAAKIVTDGL
>ACR56321|FEATURES|argannot|beta_lactam|CTX-M-89|antibiotic inactivation|1
MMRKSVRRAMLMTTACVSLLLASVPLCAQANDVQQKLAALEKSSGGRLGVALINTADNTQ
TLYRADERFAMCSTSKVMAVAAVLKQSETQKGLLSQRVEIKPSDLINYNPIAEKHVNGTM
TFGELSAAALQYSDNTAMNKLIAHLGGPDKVTAFARTIGDDTFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQALRNLTLGNALGDTQRAQLVMWLKGNTTGAASIQAGLPTSWVVGDKTGS
GDYGTTNDIAVIWPEGRAPLVLVTYFTQSEPKAESRRDVLAAAARIVTDGY
>ACQ99521|FEATURES|argannot|beta_lactam|CTX-M-90|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAVAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>ACX34099|FEATURES|argannot|beta_lactam|CTX-M-91|antibiotic inactivation|1
MMRKSVRRAMLMTTACVSLLLASVPLCAQANDVQQKLAALEKSSGGRLGVALINTADNTQ
TLYRADERFAMCSTSKVMAVAAVLKQSETQKGLLSQRVEIKPSDLINYNPIAEKHVNGTM
TFGELSAAALQYSDNTAMNKLIAHLGGPDKVTAFARTIGDDTFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQSLRNLTLGNALGDTQRAQLVMWLKGNTTGAASIQAGLPTSWVVGDKTGS
GDYGTTNDIAVIWPEGRAPLVLVTYFTQSEPKAESRRDVLAAAARIVTDGY
>ACY74743|FEATURES|argannot|beta_lactam|CTX-M-92|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRTQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDILAAAAKIVTHGF
>ADN26580|FEATURES|argannot|beta_lactam|CTX-M-93|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTQNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GGYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>ADK11041|FEATURES|argannot|beta_lactam|CTX-M-94|antibiotic inactivation|1
MMRKSVRRAMLMTTACVSLLLASVPLCAQANDVQQKLAALEKSSGGRLGVALINTADNTQ
TLYRADERFAMCSTSKVMAAAAVLKQSETQKGLLSQRVEIKPSDLINYNPIAEKHVNGTM
TLGELSAAALQYSDNTAMNKLIAHLGGPDKVTAFARTIGDDTFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQALRNLTLGNALGDTQRAQLVMWLKGNTTGAASIQAGLPTSWVVGDKTGS
GGYGTTNDIAVIWPEGRAPLVLVTYFTQSEPKAESRRDVLAAAARIVTDGY
>CBL80615|FEATURES|argannot|beta_lactam|CTX-M-95|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQTNSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAALLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIQAGLPKSWVVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDVLAAAAKIVTHGF
>CAG28417|FEATURES|argannot|beta_lactam|CTX-M-96|antibiotic inactivation|1
MVKKSLRQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPSLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDILASAAKIVTDGL
>ADM08178|FEATURES|argannot|beta_lactam|CTX-M-2|antibiotic inactivation|1
MMTQSIGRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDILAAAAKIVTHGF
>ADR66516|FEATURES|argannot|beta_lactam|CTX-M-98|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAVAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GGYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>ADL27532|FEATURES|argannot|beta_lactam|CTX-M-99|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTESTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAERRRDVLASAARIIAEGL
>CBW46935|FEATURES|argannot|beta_lactam|CTX-M-100|antibiotic inactivation|1
MMRKSVRRAMLMTTACVSLLLASVPLCAQANDVQQKLAALEKSSGGRLGVALINTADNTQ
TLYRADERFAMCSTSKVMAAAAVLKQSETQKGLLSQRVEIKPSDLINYNPIAEKHVNGTM
TFGELSAAALQYSDNTAMNKLIAHLGGPDKVTAFARTIGDDTFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQALRNLTLGNALGDTQRAQLVMWLKGNTTGAASIQAGLPTSWVVGDKTGS
GGYGTTNDIAVIWPEGRAPLVLVTYFTQSEPKAESRRDVLAAAARIVTDGY
>ADY02545|FEATURES|argannot|beta_lactam|CTX-M-101|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELIAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>ADY02546|FEATURES|argannot|beta_lactam|CTX-M-102|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQREQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GGYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>ADY02555|FEATURES|argannot|beta_lactam|CTX-M-104|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAENRRDVLASAARIIAEGL
>ADY02554|FEATURES|argannot|beta_lactam|CTX-M-105|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAVAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQREQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GGYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>ADZ31262|FEATURES|argannot|beta_lactam|CTX-M-106|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDRTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRHDVLASAARIIAEG
>AEM44650|FEATURES|argannot|beta_lactam|CTX-M-107|antibiotic inactivation|1
VKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQI
LYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMS
LAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPR
DTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDRTGSG
GYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVT
>AEM44651|FEATURES|argannot|beta_lactam|CTX-M-108|antibiotic inactivation|1
VKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQI
LYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRAEIKKSDLVNYNPIAEKHVNGTMS
LAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPR
DTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSG
GYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVT
>AEM44654|FEATURES|argannot|beta_lactam|CTX-M-109|antibiotic inactivation|1
VKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSRI
LYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMS
LAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPR
DTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSG
GYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTK
>AEM44648|FEATURES|argannot|beta_lactam|CTX-M-110|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEEHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGNL
>AEM44649|FEATURES|argannot|beta_lactam|CTX-M-111|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGQGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>AEM44652|FEATURES|argannot|beta_lactam|CTX-M-112|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>AEM44653|FEATURES|argannot|beta_lactam|CTX-M-113|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKRSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>ACU00153|FEATURES|argannot|beta_lactam|CTX-M-114|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKAMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>AEI70324|FEATURES|argannot|beta_lactam|CTX-M-116|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>AET99223|FEATURES|argannot|beta_lactam|CTX-M-117|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIQGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>AFA51699|FEATURES|argannot|beta_lactam|CTX-M-121|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPITEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GGYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>AFA51700|FEATURES|argannot|beta_lactam|CTX-M-122|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARSIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAERRRDVLASAARIIAEGL
>AFA51701|FEATURES|argannot|beta_lactam|CTX-M-123|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>AFH88134|FEATURES|argannot|beta_lactam|CTX-M-124|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGS
GDYGTTNDIAIIWPENHAPLVLVTYFTQPEQKAESRRDVLAAAAKIVTHGF
>AFO69261|FEATURES|argannot|beta_lactam|CTX-M-125|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAEHRRDVLASAARIIAEGL
>BAL72196|FEATURES|argannot|beta_lactam|CTX-M-126|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEATLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>AFJ59956|FEATURES|argannot|beta_lactam|CTX-M-129|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLRGNTTGAASIRAGLPTSWTVGDKTGS
GGYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>AFJ59957|FEATURES|argannot|beta_lactam|CTX-M-130|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAERRHDVLASAARIIAEGL
>AEW46676|FEATURES|argannot|beta_lactam|blaCTX-M-131|antibiotic inactivation|1
MTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQI
LYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTMT
LAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDPR
DTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGSG
GYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDILAAAAKIVTHGF
>AFQ94051|FEATURES|argannot|beta_lactam|CTX-M-132|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>AFX60298|FEATURES|argannot|beta_lactam|CTX-M-134|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GSYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>AGG08693|FEATURES|argannot|beta_lactam|CTX-M-136|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>AFY98865|FEATURES|argannot|beta_lactam|CTX-M-139|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLFAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>AAM45855|FEATURES|argannot|beta_lactam|bla|antibiotic inactivation|1
MHSRSSYSRRYVLAGLCALPFASLSAGLIFNSSADAASLAAINGKTLQKKLAELEAASGG
RLGVAARSSNGGKSLSYRGDERFPMCSTFKVLAVAALLRDKPGILEQRIHFAQIDIQPWS
PVTEKHLEDGMTVAELCAAMLQHSDNTAANLVLAKLGGPQGLTSLARSFGDTTFRLDRWE
VELNTAIPGDARDTTTPLAMCNTLNGLLCGNLLKAPARERLTGWMLGCATGAGRIPAGIP
QGWRSAHKSGSGENGTANDVGVLLPPSNPGKATKPGKNKGKPLTVALYLTGSRLTGPEND
KILASATRLVCAAEGLAMPLDNMY
>CAA28198|FEATURES|argannot|beta_lactam|LEN-1|antibiotic inactivation|1
MRYVRLCVISLLATLPLVVYAGPQPLEQIKQSESQLSGRVGMVEMDLANGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLVDGMTIGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPASMAERNQHIAGIGQR
>AAK69830|FEATURES|argannot|beta_lactam|LEN-2|antibiotic inactivation|1
MRYVRLCVISLLATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGVEQLDRRIHYRQQDLVDYSPVSEKHLVDGMTIGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPASMAERNQHIAGIGAALIEHWQR
>AAN05030|FEATURES|argannot|beta_lactam|LEN-3|antibiotic inactivation|1
VISLLATLPLVVYAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADERFPMVST
FKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLVDGMTIGELCAAAITLSD
NSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPASMAATLR
KLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARGIVALLGP
DGKPERIVVIYLRDTPASMAERNQQIAGIGAALI
>AAN05031|FEATURES|argannot|beta_lactam|LEN-4|antibiotic inactivation|1
VISLLATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADERFPMVST
FKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLTDGMTIGELCAAAITLSD
NSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPASMAATLR
KLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARGIVALLGP
DGKPERIVVIYLRDTPASMAERNQQIAGIGAALI
>AAU25807|FEATURES|argannot|beta_lactam|LEN-5|antibiotic inactivation|1
MRYIRLCVISLLATLPLAVYAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLTDGMTIGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPASMAERNQHIAGIGAALIEHWQR
>CAG25836|FEATURES|argannot|beta_lactam|LEN-7|antibiotic inactivation|1
ATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADERFPMVSTFKVLL
CGAVLARVDAGVEQLDRRIHYRQQDLVDYSPVSEKHLTDGMTIGELCAAAITLSDNSAGN
LLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPASMAATLRKLLTA
QHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARGIVALLGPDGKPE
RIVVIYLRDTPASMAERNQHIAG
>CAG25835|FEATURES|argannot|beta_lactam|LEN-8|antibiotic inactivation|1
ATLPLVVYAGPQPLEQIKQSESQLPGRVGMVEMDLASGRTLAAWRADERFPMVSTFKVLL
CGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLVDGMTIGELCAAAITLSDNSAGN
LLLATVGGPAGLTAFLRQIGDNVTHLDRWETALNEALPGDARDTTTPASMAATLRKLLTA
QHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARGIVALLGPDGKPE
RIVVIYLRDTPASMAERNQHIAG
>CAG25834|FEATURES|argannot|beta_lactam|LEN-9|antibiotic inactivation|1
ATLPLVVYAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADERFPMVSTFKVLL
CGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLVDGMTIGELCAAAITLSDNSAGN
LLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPASMAATLRKLLTA
QHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARGIVALLGPDGKPE
RIVVIYLRDTPASMAERNQHIAG
>CAG25830|FEATURES|argannot|beta_lactam|LEN-10|antibiotic inactivation|1
ATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADERFPMVSTFKVLL
CGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLTDGMTIGELCAAAITLSDNSAGN
LLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPASMAATLRKLLTA
QHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARGIVALLGPDGKPE
RIVVLYLRDTPASMAERNQHIAG
>CAG25828|FEATURES|argannot|beta_lactam|LEN-11|antibiotic inactivation|1
ATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADERFPMVSTFKVLL
CGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLVDGMTIGELCAAAITLSDNSAGN
LLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPASMAATLRKLLTA
QHLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGARGIVALLGPDGKPE
RIVVIYLRDTPASMAERNQHIAG
>CAG25817|FEATURES|argannot|beta_lactam|LEN-12|antibiotic inactivation|1
ATLPLAVYAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADERFPMVSTFKVLL
CGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLVDGMTIGELCAAAITLSDNSAGN
LLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPASMAATLRKLLTA
QHLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGARGIVALLGPDGKPE
RIVVIYLRDTPASMAERNQHIAG
>CAG25814|FEATURES|argannot|beta_lactam|LEN-13|antibiotic inactivation|1
ATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADERFPMVSTFKVLL
CGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLVDGMTIGELCAAAITLSDNSAGN
LLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPASMAATLRKLLTA
QHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARGIVALLGPDGKPE
RIVVLYLRDTPASMAERNQHIAG
>AAL50725|FEATURES|argannot|beta_lactam|LEN-15|antibiotic inactivation|1
MRYVRLCVISLLATLPLVVYAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLVDGMTIGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSPRSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPASMAERNQHIAGIGQR
>AAU89706|FEATURES|argannot|beta_lactam|LEN-16|antibiotic inactivation|1
MRYVRLCVISLLATLPLAVYAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLTDGMTIGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPASMAERNQHIAGIGAALIEHWQR
>CAP12346|FEATURES|argannot|beta_lactam|LEN-18|antibiotic inactivation|1
MRYVRLCVISLLATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLTDGMTVGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVLYLRDTPASMAERNQHIAGIGAALIEHWQR
>CAP12347|FEATURES|argannot|beta_lactam|LEN-19|antibiotic inactivation|1
MRYVRLCVISLLATLPLAVYAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLTDGMTVGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPASMAERNQHIAGIGAALIEHWQR
>CAP12348|FEATURES|argannot|beta_lactam|LEN-20|antibiotic inactivation|1
MRYVRLCVISLLATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLTDGMTVGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPVSMAERNQHIAGIGAALIEHWQR
>CAP12349|FEATURES|argannot|beta_lactam|LEN-21|antibiotic inactivation|1
MRYVRLCVISLLATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGVEQLVRRIHYRQQDLVDYSPVSEKHLVDGMTIGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPASMAERNQHIAGIGAALIEHWQR
>CAP12350|FEATURES|argannot|beta_lactam|LEN-22|antibiotic inactivation|1
MRYVRLCVISLLATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLVDGMTIGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSPRSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPASMAERNQHIAGIGAALIEHWQR
>CAP12351|FEATURES|argannot|beta_lactam|LEN-23|antibiotic inactivation|1
MRYVRLCVISLLATLPLAVYAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLTDGMTIGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVLYLRDTPASMAERNQHIAGIGAALIEHWQR
>ADW77562|FEATURES|argannot|beta_lactam|LEN-25|antibiotic inactivation|1
MRYVRLCVISLLATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLVDGMAIGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVLYLRDTPASMAERNQHIAGIGAALIEHWQR
>AGB34168|FEATURES|argannot|beta_lactam|LEN-26|antibiotic inactivation|1
MRYVRLCVISLLANLPLAVYAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGVEQLDRRIHYRQQDLVDYSPVSEKHLTDGMTIGELCA
AAITMSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDMRDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGARG
IVALLGPDGKAERIVVIYMRDTPATIAERNQQIAAIGAALIEHWQR
>ALK01318|FEATURES|argannot|beta_lactam|blaLEN|antibiotic inactivation|1
MRYIRLCVISLLATLPLAVYAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLTDGMTVGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPASMAERNQHIAGIGAALIEHWHD
>ALK01319|FEATURES|argannot|beta_lactam|blaLEN|antibiotic inactivation|1
MRYVRLCVISLLATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGHTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGVEQLDRRIHYRQQDLVDYSPVSEKHLTDGMTVGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPASMAERNQHIAGIGAALIEHWQR
>ALK01320|FEATURES|argannot|beta_lactam|blaLEN|antibiotic inactivation|1
MRYVRLCVISLLATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGVEQLDRRIHYRQQDLVDYSPVSEKHLVDGMTIGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMSATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPASMAERNQHIAGIGAALIEHWQR
>BAM76830|FEATURES|argannot|beta_lactam|AQU-1|antibiotic inactivation|1
MKQTSPLSSLALSALLLSPLTQAAPADPLVGVVDEVIRPLVKEHRIPGMAVAVFKEGQPH
YFNYGVAELATGKKVSEQTLFEIGSVSKTYTATLGAYAVVKGSIGLDDKVSRHAPWLKGS
AFDGITMAELATYSAGGLPLQFPDEVESLEQMQAYYRQWTPAYQPGSHRQYSNPSIGLFG
YLAASSLQQPFAQLMEQTLLPGLGLHHTYINVPKQAMANYAYGYSKEDKPIRVTPGVLAD
EAYGIKTSSADLLAFVKANINGVDDKGLQQAIALTHQGRYSVGEMTQGLGWESYPYPVSE
QTLLAGNSVQVIMKANPTTAAPKEMGSQRLFNKTGSTNGFGAYVAFVPAKGVGIVMLANR
NYPIQERVKAAHSILSKLAP
>AHF82023|FEATURES|argannot|beta_lactam|blaAQU-2|antibiotic inactivation|1
MKQTSPLSLLALSALLLSPLTQAAPADPLVGVVDDVIRPLVKEHRIPGMAVAVFKEGQPH
YFNYGVAELATGKKVSEQTLFEIGSVSKTLTATLGAYAVVKGSIGLDDKVSRHAPWLKGS
AFDGITMAELATYSAGGLPLQFPDEVESLEQMQAYYRQWTPAYQPGSHRQYSNPSIGLFG
YLAASSLQQPFAQLMEQTLLPGLGLHHTYINVPKQAMANYAYGYSKEDKPIRVNPGMLAD
EAYGIKTSSADLLAFVQANINGVDDKGLQQAIALTHQGHYSVGGMTQGLGWESYPYPVSE
QTLLAGNSAQVIMKANPTTAAPXEMGSQRLFNKTGSTNGFGAYVAFVPAKGVGIVMLANR
NYPIQERVKAAHAILSKLAP
>AHF82024|FEATURES|argannot|beta_lactam|blaAQU-3|antibiotic inactivation|1
MKQTSPLSLLALSALLLSPLTQAAPADPLVGVVDDVIRPLVKEHRIPGMAVAVLKGGQAH
YFNYGVAELATGKKVSEQTLFEIGSVSKTLTATLGAYAVVKGSIGLDDKVSRHAPWLKGS
AFDGITMAELATYSAGGLPLQFPDEVESLEQMQAYYRQWTPAYQPGSHRQYSNPSIGLFG
YLAASSLQQPFAQLMEQTLLPGLGLHHTYINVPKQAMANYAYGYSKEDKPIRVTPGVLAD
EAYGIKTSSADLLAFVKANINGVDDKGLQQAIALTHQGHYSVGGMTQGLGWESYPYPVSE
QTLQVGNSREVSFKGNPVKGFKAPVTFGEARLYNKTGSTNGFGAYVAFVXAKGVGIVMLA
NRNYPIQERVKAAHAILSKLAP
>WP_000732912.1|FEATURES|argannot|beta_lactam|LRA-9|antibiotic inactivation|0
MKKLFVALGLIMGSLHISYAEPASAQQVPGYYHHQFGNYRITSLLDGTIYLDPKLFKNLS
QAEKTKILTKYAAVNEKGIQTSVNAFLVDDGKSLTLVDSGAASCFGPQLGSIAKNLELAG
YQLANVKTVLLTHLHPDHVCGIAQNGKAVFPNATIYAHEREADYWLNPANEKTVPADKKE
NYLGTVKNVKAALAPYQAKKAFKTFKDGDVIQGFEVINTHGHTPGHHSFRLKSKGQQIVF
VGDIVHSHSLQFDAPKTGVDFDVNSEQAINTRLKMFAEISNKQQWVAAPHLPFPGIGHVY
KVNAEQYQWIPLYFNNSLDK
>WP_001211205.1|FEATURES|argannot|beta_lactam|blaADC-30|antibiotic inactivation|1
MSYLFLSCTEELIMRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKY
DVPGMAVGVIQNNKKYEMYYGLQSVQDKKAVNRSTIFELGSVSKLFTATAGGYAKNKGKI
SFDDTPGKYWKELKNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWQPKNP
IGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGY
NQENQPIRVNPGPLDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGFYQVN
TMYQALGWEEFSYPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYV
VFIPKENIGLVMLTNKRIPNEERIKAAYAVLDAIKK
>WP_000155957.1|FEATURES|argannot|beta_lactam|MBL-fold|antibiotic inactivation|0
MTISNTTDLPAPLMPSQQHNGKFRNTRPNQHKPSFGKTLQLMWKFLFNKPKNTVPNREIP
VLSLSKEQLLSAPDRSLFRLGHSTILLKLQDEFWLTDPVFSERASPFQWLGPKRFHQPPI
SIAELPPIKGVILSHNHYDHLDYHAVMQLNDKVEHFLTPLGVGDTLIKWGIPAEKVQQLD
WWGTTQVDGLKLVATPAHHFSGRGMGDSNATLWASWVIIDNDLRVFFSGDTGYFDGFKEI
GLRYGPFDLTMLETGAYDPEWPDVHMQPEQTLQAHIDLKGRHLLPVHNGTFDLALHAWDD
PFERIVALAQQNNLAISTPQMGQILNLNEPNVENYWWRS
>WP_000465449.1|FEATURES|argannot|beta_lactam|BL3_l|antibiotic inactivation|0
MFFKQFFEKESSTYTYMLGCEETRGAVLIDPVASDIEIYAKELEQHQFTLIYTLDTHVHA
DHITAADLLRERFHCKSVLHRNSEVSCGDILITDGCMLKVGNLSIEARYTPGHTNACTSY
LVGNMIFTGDALLIDGCGRTDFQQGNAGTLYDSIHKQLFSLPDNTIVYPGHDYKGRLSST
IGYERLNNSRLGQNRSREDFIELMNNLNLPYPKQIDKALPANQACGSISQL
>WP_002017666.1|FEATURES|argannot|beta_lactam|BN977_05631|antibiotic inactivation|0
MNLNIRGHLMKNFLTKKMYATRALFFAVGVTALNVSPIVISTTHAATEQKMDNLSTTLSL
IFADKPIEASLFSPQFLGQVPITQIQKIVDDLKVSLGALKNINVSNGSGTIDFEKGELPV
SISLNEQEQISTLWFSAPHFKTISLDEMVKGLHENAIGKTSLLVIVDNKPVVVENDKTPM
AVGSTFKLLVLKAYEDAIKKGELKRETIVSLKEKNRSLPTGVLQNLPAGTPINLELLAQL
MIQISDNTATDSLIDVLKKPRIEALSPRNSPLLTTRELFQLIDSSNEKLRNKFKTGTKSA
RLEALSELDKLPLPSVSSIGKSATWQDAEWYMSAHEICPLLESVQDAPALNSSLNPLFKN
LNWQKIGFKGGSEYGVINFSVIGKTQKGHNVCAVFTANGNEPQPESKLAILFTGILQAVD
SMSH
>BAO01151|FEATURES|argannot|beta_lactam|BL3_l|antibiotic inactivation|1
MRFLASLALPLFAANLAVAAPKPLPQLEAYEGLQAWLVPVEPLRISDHVWQIGTASISAL
LVKTDAGAVLIDGGMPQVADHLLANMKKLGVQPQDLRLILHSHAHIDHVGPLAAIKRATG
AVLVSNAESAVLLQRGGADDIHFGSGMLFAPLTPERLVQDGEAVTLGDTTFTVHFTPGHT
PGSMSWTWTDTQDGKPLRIAYADSLSAPGYQLRDNARYPHLVDAFRASFAAVRALPCDLL
LTPHAEGSGWDYTNAEKPHPAPVSCKAYADKAEQKLDQMLAEQAKSR
>CBY88906|FEATURES|argannot|beta_lactam|tmb1|antibiotic inactivation|1
MRPFLFLIIFISHFAFANEEIPGLEVEEIDNGVFLHKSYSRVEGWGLVSSNGLVVISGGK
AFIIDTPWSESDTEKLVDWIRSKKYELAGSISTHSHEDKTAGIKWLNGKSITTYASALTN
EILKREGKEQARSSFKGNEFSLMDGFLEVYYPGGGHTIDNLVVWIPSSKILYGGCFIRSL
ESSGLGYTGEAKIDQWPQSARNTISKYPEAKIVVPGHGKIGDFELLKHTKVLAEKASNKA
NHGDR
>BAM73613|FEATURES|argannot|beta_lactam|DIM-1|antibiotic inactivation|1
MRPFLFLIIFISHFAFANEEIPGLEVEEIDNGVFLHKSYSRVEGWGLVSSNGLVVISGGK
AFIIDTPWSESDTEKLVDWIRSKKYELAGSISTHSHEDKTAGIKWLNGKSITTYASALTN
EILKREGKEQARSSFKGNEFSLMDGFLEVYYPGGGHTIDNLVVWIPSSKILYGGCFIRSL
EPSGLGYTGEAKIDQWPQSARNTISKYPEAKIVVPGHGKIGDFELLKHTKVLAEKASNKA
NHGDR
>AAL60061|FEATURES|argannot|quinolone|QnrA1|antibiotic target protection|1
MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLQDASFEDCSFIESGAVEGCHFS
YADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQVSHKMYFCSAYIS
GCNLAYTNLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLT
FADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD
>AAT79355|FEATURES|argannot|quinolone|QnrA2|antibiotic target protection|1
MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFS
YADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQVSHKMYFCAAYIS
GCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLT
FADLDGLDPRRVNLEGVKICAWQQEQLLEPLGIIVLPD
>AAZ04782|FEATURES|argannot|quinolone|QnrA3|antibiotic target protection|1
MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFS
YADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYIS
GCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLT
FADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD
>AAZ04783|FEATURES|argannot|quinolone|QnrA4|antibiotic target protection|1
MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFS
YADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYIS
GCNLAYANLNGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLT
FADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD
>AAZ04784|FEATURES|argannot|quinolone|QnrA5|antibiotic target protection|1
MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFS
YADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYIS
GCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSCGTFSRDCWQQVNLRGCDLT
FADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD
>AAZ78355|FEATURES|argannot|quinolone|QnrA6|antibiotic target protection|1
MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAIEGCHFS
YADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYIS
GCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCWQQVNLRGCDLT
FADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD
>ACV83303|FEATURES|argannot|quinolone|QnrA7|antibiotic target protection|1
MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFS
YADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYIS
GCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCWQQVNLRGCDLT
FADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD
>CAQ79275|FEATURES|argannot|quinolone|QnrVC1|antibiotic target protection|1
MAKYNEIFDNVDFSKQDLRESYFEGCKFYRCDFNRTNLRDSRFVDCVFIEQGAIEGCHFD
YSDLRDASFKRCRLTMSNFKGANCFGVEFRECDLKGANFVQASFVNQISHQMYFCSAYIT
GCNLSYANFERLCIEKCDLFENKWNGANLQGASFKGSDLSRGAFSEDSWGQFRMQDANLC
HCELDGLDPRRIDLTGVKICAWQQEQLLEPLGLVVLPD
>ABC86904.2|FEATURES|argannot|quinolone|QnrB1|antibiotic target protection|1
MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>CAO82104|FEATURES|argannot|quinolone|QnrB12|antibiotic target protection|1
MMTLALVGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRA
ILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNT
NLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNS
ELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG
>ABX72043|FEATURES|argannot|quinolone|QnrB13|antibiotic target protection|1
MTPLLYKKTSTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG
>CAP45902|FEATURES|argannot|quinolone|QnrB17|antibiotic target protection|1
MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>CAP45903|FEATURES|argannot|quinolone|QnrB18|antibiotic target protection|1
MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIDNSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>ACA28712|FEATURES|argannot|quinolone|QnrB19|antibiotic target protection|1
MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDSYQASLLMERLGIAVIG
>ABC86905.1|FEATURES|argannot|quinolone|QnrB20|antibiotic target protection|1
MALALVGEKINRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG
>BAG55487|FEATURES|argannot|quinolone|QnrB20|antibiotic target protection|1
MTPLLYKKTGTNMALALVGEKINRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAVIG
>ACM50952|FEATURES|argannot|quinolone|QnrB21|antibiotic target protection|1
MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAI
LKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSE
LGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG
>ACS71747|FEATURES|argannot|quinolone|QnrB23|antibiotic target protection|1
MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFYCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG
>ADI46626|FEATURES|argannot|quinolone|QnrB24|antibiotic target protection|1
MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADMSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMVDFRNASALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>ADN94685|FEATURES|argannot|quinolone|QnrB25|antibiotic target protection|1
MALALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAI
LKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITSTN
LSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSE
LGDLDIRGVDLQGVKLDSYQAALLMERLGIAIIG
>AEH59666|FEATURES|argannot|quinolone|QnrB26|antibiotic target protection|1
MTPLLYKKTGTNMALALVGVKIDRNRFTGEKIENGTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>ADM52186|FEATURES|argannot|quinolone|QnrB27|antibiotic target protection|1
MTLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG
>ADM52188|FEATURES|argannot|quinolone|QnrB28|antibiotic target protection|1
MTLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG
>ADM52193|FEATURES|argannot|quinolone|QnrB29|antibiotic target protection|1
MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMVDFRNASALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>ABC17629.2|FEATURES|argannot|quinolone|QnrB3|antibiotic target protection|1
MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCKFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>ADM52194|FEATURES|argannot|quinolone|QnrB30|antibiotic target protection|1
MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSSDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>ADQ43424|FEATURES|argannot|quinolone|QnrB31|antibiotic target protection|1
MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFLCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEISHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG
>AEL00451|FEATURES|argannot|quinolone|QnrB33|antibiotic target protection|1
MTLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSSTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG
>AEL00456|FEATURES|argannot|quinolone|QnrB35|antibiotic target protection|1
MALALIGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAI
LKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKAVLEKCELWENRWMGTQMLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSE
LGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG
>AEL00458|FEATURES|argannot|quinolone|QnrB36|antibiotic target protection|1
MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDTIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>AEL00459|FEATURES|argannot|quinolone|QnrB37|antibiotic target protection|1
MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAI
LKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSE
LGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG
>AEL00461|FEATURES|argannot|quinolone|QnrB38|antibiotic target protection|1
MALALIGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAI
LKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSE
LGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG
>AEL31271|FEATURES|argannot|quinolone|QnrB40|antibiotic target protection|1
NTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCN
FSRAMLRDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAY
ITNTNLSYANFSKVVLEKCELWENRWMGTQVLGTTFSGSDLSGGEFSTFDWRAANFTHCD
LTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>AEL31272|FEATURES|argannot|quinolone|QnrB41|antibiotic target protection|1
MTPLLYKKTGTNMALALVGDKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIGS
>AEQ94272|FEATURES|argannot|quinolone|QnrB42|antibiotic target protection|1
MALVLVGEKIDRNCFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG
>AFA52643|FEATURES|argannot|quinolone|QnrB43|antibiotic target protection|1
MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLAGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>AFA52645|FEATURES|argannot|quinolone|QnrB44|antibiotic target protection|1
MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFTTFDWRA
ANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>AFA52644|FEATURES|argannot|quinolone|QnrB45|antibiotic target protection|1
MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRTMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>AFA52646|FEATURES|argannot|quinolone|QnrB62|antibiotic target protection|1
MTPLLYKKTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLRDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDTRGVDLQGVKLDNYQASLLMERLGIAVIG
>AFA52647|FEATURES|argannot|quinolone|QnrB62|antibiotic target protection|1
MTPLLYKKTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLRDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>AFH88686|FEATURES|argannot|quinolone|QnrB48|antibiotic target protection|1
MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGGLDIRGVDLQGVKLDNYQASLLMERLGIAIIG
>AFD54601|FEATURES|argannot|quinolone|QnrB49|antibiotic target protection|1
MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG
>ABC17628.2|FEATURES|argannot|quinolone|QnrB5|antibiotic target protection|1
MTPLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLMERLGIAIIG
>ABP87778|FEATURES|argannot|quinolone|QnrB6|antibiotic target protection|1
MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>ABW03157|FEATURES|argannot|quinolone|QnrB8|antibiotic target protection|1
MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAI
LKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSE
LGDLDIRGVDLQGVKLDNYQAALLMERLGIAVIG
>AGN92479|FEATURES|argannot|quinolone|QnrB72|antibiotic target protection|1
MTLALVCEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITMRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>ACG70184|FEATURES|argannot|quinolone|QnrD1|antibiotic target protection|1
MEKHFINEKFSRDQFTGNRVKNIAFSNCDFSGVDLTDTEFVDCSFYDRNSLEGCDFNRAK
LKNASFKSCDLSMSNFKNISALGLEISECLAQGADFRGANFMNMITTRSWFCSAYITKTN
LSYANFSRVILEKCELWENRWNGTVITGAVFRGSDLSCGEFSSFDWSLADFTGCDLTGGA
LGELDARRINLDGVKLDGEQALQLVESLGVIVHR
>BAD88776.1|FEATURES|argannot|quinolone|QnrS1|antibiotic target protection|1
METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFD
VADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFIS
GCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLC
HAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD
>ABF47470|FEATURES|argannot|quinolone|QnrS2|antibiotic target protection|1
METYRHTYRHHSFSHQDLSDITFTACTFIRCDFRRANLRDATFINCKFIEQGDIEGCHFD
VADLRDASFQQCQLAMANFSNANCYGIELRECDLKGANFSRANFANQVSNRMYFCSAFIT
GCNLSYANMERVCLEKCELFENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLC
HAELDGLDPRKVDTSGIKIASWQQEQLLEALGIVVFPD
>ABU52984|FEATURES|argannot|quinolone|QnrS3|antibiotic target protection|1
ETYNHTYRHRNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDV
ADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISG
CNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCH
AELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD
>ACJ24509|FEATURES|argannot|quinolone|QnrS4|antibiotic target protection|1
METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFD
AADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFIS
GCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLC
HAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD
>AEG74319|FEATURES|argannot|quinolone|QnrS5|antibiotic target protection|1
METYRHTYRHHNFSHKDLSALTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFD
VADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFIT
GCTLSYANMERVCLERCELFENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLC
HAELDGLDPRKVDTSGIKIAAWQQEQLLEALGIVVFPD
>AFZ85132|FEATURES|argannot|quinolone|QnrVC1|antibiotic target protection|1
MEKSKQLYNQVNFSHQDLQEHIFSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFS
YADLRDASFKNCQLSMSHFKGANCFGIELRDCDLKGANFSQVSFVNQVSNKMYFCSAYIT
GCNLSYANFEQQLIEKCDLFENRWIGANLRGASFKESDLSRGVFSEDCWEQFRVQGCDLS
HSELYGLDPRKIDLTGVKICSWQQEQLLEQLGVIIVPD
>YP_008047252|FEATURES|argannot|quinolone|QnrVC5|antibiotic target protection|1
MDKTDQLYVQADFSHQDMSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFS
YSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFSQASFMNQVSNRMYFCSAYIT
GCNLSYANFERQCIEKCDLFENRWIGANLSGASFKESDLSRGVFSEGCWSQCRLQGCDLS
HSELYGLDPRKVDLTGVKICSWQQEQLLEQLGLIVVPD
>AGH56075|FEATURES|argannot|quinolone|QnrVC4|antibiotic target protection|1
MDKTDQLYVQADFSHQDMSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFS
YSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQASFMNQVSNRMYFCSAYIT
GCNLSYANFERQCIEKCDLFENRWIGANLSGASFKESDLSRGVFSEGCWSQCRLQGCDLS
HSELYGLDPRKVDLTGVKICSWQQEQLLEQLGLIVVPD
>AGH08253|FEATURES|argannot|quinolone|QnrVC6|antibiotic target protection|1
MEKSKQLYNQVNFSHQDLQEHIFSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFS
YADLRDASFKDCQLSMSHFKGANCFGIELRDCDLKGANFSQVSFVNQVSNKMYFCSAYIT
GCNLSYANFEQQLIEKCDLFENRWIGANLRGASFKESDLSRGVFSEDCWEQFRVQGCDLS
HSELYGLDPRKIDLTGVKICSWQQEQLLEQLGVIIVPD
>AJA36815|FEATURES|argannot|quinolone|QnrVC7|antibiotic target protection|1
MDKTDQLYVQADFSHQDLSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFS
YSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQASFMNQVSNRMYFCSAYIT
GCNLSYANFERQCIEKCDLFENRWIGANLSGTSFKESDLSRGVFSEGCWSQCRLQGCDLS
HSELYGLDPRKVDLTGVKICSWQQEQLLEQLGLIVVPD
>BAF63419|FEATURES|argannot|multidrug|qepA|antibiotic efflux|1
MSATLHDTAADRRKATRREWIGLAVVALPCLVYAMDLTVLNLALPVLSRELQPSSAQLLW
ILDIYGFFVAGFLITMGTLGDRIGRRRLLLIGAAFFAFASVLAALADTAALLIAARALLG
LAGATIAPSTMALVRNMFHDPRQRQFAIGVWIAAFSLGSAIGPLVGGVLLEFFHWGAVFW
LNVPVMLLTLALGPRFLPEYRDPDAGHLDLASVLLSLAAVLLTIYGLKQLAEHGAGLASM
AALLAGLAVGALFLRRQGHIAYPLLDLRLFAHAPFRAALAAYALAALAMFGVYIFMTQYL
QLVLGLSPLQAGLATLPWSLCFVIGSLLSPQLAARWPAARILVVGLSAAAFGFAVLGLGQ
GLWWLVPATIVMGLGLAPVFTIGNEIIITSAPSERAGAASALSETVSEFSGALGIALFGS
VGLVVYRQALTSAALPGLPADALQAAGASLGGAVHLADTLPAWQGAALLAAARAGFTDAL
QATAWAGAVLVLVAAGLVARLLRKRPALASG
>ACF70723|FEATURES|argannot|multidrug|qepA|antibiotic efflux|1
MSATLHDTAADRRKATRREWIGLAVVALPCLVYAMDLTVLNLALPVLSRELQPSSAQLLW
ILDIYGFFVAGFLITMGTLGDRIGRRRLLLIGAAFFAFGSVLAALADTAALLIAARALLG
LAGATIAPSTMALIRNMFHDPRQRQFAIGVWIAAFSLGSAIGPLVGGVLLEFFHWGAVFW
LNVPVMLLTLALGPRFLPEYRDPDAGHLDLASVLLSLAAVLLTIYGLKQLAEHGAGLASM
AALLAGLAVGALFLRRQGHIAYPLLDLRLFAHAPFRAALAAYALAALAMFGVYIFMTQYL
QLVLGLSPLQAGLATLPWSLCFVIGSLLSPQLAARWPAARILVVGLSAAAFGFAVLGLGQ
GLWWLVPATIVMGLGLAPVFTIGNEIIITSAPSERAGAASALSETVSEFSGALGIALFGS
VGLVVYRQALTSAALPGLPADALQAAGASLGGAVHLADTLPAWQGAALLAAARAGFTDAL
QATAWAGAVLVLVAAGLVARLLRKRPALASG
>BAA14147.1|FEATURES|argannot|multidrug|NorA|antibiotic efflux|0
MNKQIFVLYFNIFLIFLGIGLVIPVLPVYLKDLGLTGSDLGLLVAAFALSQMIISPFGGT
LADKLGKKLIICIGLILFSVSEFMFAVGHNFSVLMLSRVIGGMSAGMVMPGVTGLIADIS
PSHQKAKNFGYMSAIINSGFILGPGIGGFMAEVSHRMPFYFAGALGILAFIMSIVLIHDP
KKSTTSGFQKLEPQLLTKINWKVFITPVILTLVLSFGLSAFETLYSLYTADKVNYSPKDI
SIAITGGGIFGALFQIYFFDKFMKYFSELTFIAWSLLYSVVVLILLVFANGYWSIMLISF
VVFIGFDMIRPAITNYFSNIAGERQGFAGGLNSTFTSMGNFIGPLIAGALFDVHIEAPIY
MAIGVSLAGVVIVLIEKQHRAKLKEQNM
>AAP43109.1|FEATURES|argannot|quinolone|oqxA|antibiotic efflux|1
MSLQKTWGNIHLTALGAMMLSFLLVGCDDSVAQNAAPPAPTVSAAKVLVKSISQWDSFNG
RIEAVESVQLRPRVSGYIDKVNYTDGQEVKKGQVLFTIDDRTYRAALEQAQAALARAKTQ
ASLAQSEANRTDKLVHTNLVSREEWEQRRSAAVQAQADIRAAQAAVDAAQLNLDFTKVTA
PIDGRASRALITSGNLVTAGDTASVLTTLVSQKTVYVYFDVDESTYLHYQNLARRGQGAS
SDNQALPVEIGLVGEEGYPHQGKVDFLDNQLTPSTGTIRMRALLDNSQRLFTPGLFARVR
LPGSAEFKATLIDDKAVLTDQDRKYVYIVDKDGKAQRRDITPGRLADGLRIVQKGLNPGD
SVIVDGLQKVFMPGMPVNAKTVAMTSSATLN
>AAP43110.2|FEATURES|argannot|quinolone|oqxB|antibiotic efflux|1
MDFSRFFIDRPIFAAVLSILIFITGLIAIPLLPVSEYPDVVPPSVQVRAEYPGANPKVIA
ETVATPLEEAINGVENMMYMKSVAGSDGVLVTTVTFRPGTDPDQAQVQVQNRVAQAEARL
PEDVRRLGITTQKQSPTLTLVVHLFSPGGKYDSLYMRNYATLKVKDELARLPGVGQIQIF
GSGEYAMRVWLDPNKVAARGLTASDVVTAMQEQNVQVSAGQLGAEPLPQESDFLISINAQ
GRLHTEEEFGNIILKTAQDGSLVRLRDVARIEMGSGSYALRSQLNNKDAVGIGIFQSPGA
NAIDLSNAVRAKMAELATRFPEDMQWAAPYDPTVFVRDSIRAVVQTLLEAVVLVVLVVIL
FLQTWRASIIPLIAVPVSVVGTFSILYLLGFSLNTLSLFGLVLAIGIVVDDAIVVVENVE
RNIEEGLAPLAAAHQAMREVSGPIIAIALVLCAVFVPMAFLSGVTGQFYKQFAVTIAIST
VISAINSLTLSPALAALLLKPHGAKKDLPTRLIDRLFGWIFRPFNRFFLRSSNGYQGLVG
KTLGRRGAVFAVYLLLLCAAGVMFKVVPGGFIPTQDKLYLIGGVKMPEGSSLARTDAVIR
KMSEIGMNTEGVDYAVAFPGLNALQFTNTPNTGTVFFGLKPFDQRKHTAAEINAEINAKI
AQIQQGFGFSILPPPILGLGQGSGYSLYIQDRGGLGYGALQSAVNAMSGAIMQTPGMHFP
ISTYQANVPQLDVQVDRDKAKAQGVSLTDLFGTLQTYLGSSYVNDFNQFGRTWRVMAQAD
GPYRESVEDIANLRTRNNQGEMVPIGSMVNISTTYGPDPVIRYNGYPAADLIGDADPRVL
SSSQAMTHLEELSKQILPNGMNIEWTDLSFQQATQGNTALIVFPVAVLLAFLVLAALYES
WTLPLAVILIVPMTMLSALFGVWLTGGDNNVFVQVGLVVLMGLACKNAILIVEFARELEI
QGKGIMEAALEACRLRLRPIVMTSIAFIAGTIPLILGHGAGAEVRGVTGITVFSGMLGVT
LFGLFLTPVFYVTLRKLVTRRKPVQEDLPA
>AFH89470|FEATURES|argannot|fosfomycin|FosA3|antibiotic inactivation|1
MLQGLNHLTLAVSDLASSLAFYQQLPGMRLHASWDSGAYLSCGALWLCLSLDEQRRKTPP
QESDYTHYAFSVAEEEFAGVVALLAQAGAEVWKDNRSEGASYYFLDPDGHKLELHVGNLA
QRLAACRERPYKGMVFFD
>EHS19134.1|FEATURES|argannot|fosfomycin|FosB|antibiotic inactivation|1
MLKSINHICFSVRNLNDSIHFYRDILLGKLLLTGKKTAYFELAGLWIALNEEKDIPRNEI
HFSYTHIAFTIDDSEFKYWHQRLKDNNVNILEGRVRDIRDRQSIYFTDPDGHKLELHTGT
LENRLNYYKEAKPHMTFYK
>CAA83855|FEATURES|argannot|fosfomycin|FosC|antibiotic inactivation|1
MMTSIMFSMLSDITRIFVEQGLRVYPFQSSALLGVDEEGRVTLHARQLATAMASGYMPLL
TGDLLLRGEQEAQVFSSDNIAPLLAADFEVRRVLYYSDVAGVYDQGNALVPWVGNANAAC
MEACVGASSMTDLTGGMRNKFMQQRQLARLGVVSEVLSFECFDRVHLSLCGLRQFGTVFL
SE
>BAH75037|FEATURES|argannot|fosfomycin|fosX|antibiotic inactivation|1
MITGLSHITFICRDLDRMEAVLTGVLGARRVYDSGEATFSLSRERFYLVGGEGDDGLWLA
VMEGEPLAEPTYNHVAFAVDEADFEACLARVQALGLTFRPPRLRVAGEGRSLYFYDHDNH
LFELHTGTLPERLARYRQGRAAAPAPTPDNPETP
>NP_932197|FEATURES|argannot|fusidic_acid|fusB|antibiotic inactivation|1
MKTMIYPHQYNYIRSVILRLKNVYKTVNDKETVKVIQSETYNDINEIFGHIDDDIEESLK
VLMNIRLSNKEIEAILNKFLEYVVPFELPSPQKLQKVFKKVKKIKIPQFEEYDLKVSSFV
GWNELASNRKYIIYYDEKKQLKGLYGEISNQVVKGFCTICNKESNVSLFMKKSKTNSDGQ
YVKKGDYICRDSIHCNKQLTDINQFYNFIDKLD
>ABB53368.1|FEATURES|argannot|glycopeptide|vanRB|antibiotic target alteration|1
MSIRILLVEDDDHICNTVRAFLAEAGYQVDACTDGNEAYTKFYENTYQLVILDIMLPGMN
GHELLREFRAKNDTPILMMTALSDDENQIRAFDAEADDYVTKPFKMQILLKRVEALLRRS
GALAKEIRVGRLTLLPEDFTVLCDGTELPLTRKEFEILLLLVQNKGRTLTHEIILSRIWG
YDFEGDGSTVHTHIKNLRAKLPENIIKTIRGVGYRLEES
>ABB53369.1|FEATURES|argannot|glycopeptide|vanSB|antibiotic target alteration|1
MERKGIFIKVFSYTIIVLLLLVGVTATLFAQQFVSYFRVMELQQTVKSYQPLVELIQNSD
RLDIQEVAGLFHYNNQSFEFYIEDKEGSVLYATPNANTSNSFRPDFLYVVHRDDNISIVA
QSKAGVGLLYQGLTIRGIVMIAIMVVFSLLCAYIFARQMTTPIKALADSANKMANLKDVP
PPLERKDELGALAHDMHSMYVRLKETIARLEDEIAREHELEETQRYFFAAASHELKTPIA
ATSVLLEGMLENIGDYKDHSKYLRECIKMMDRQGKIISEILELVSLNDGRIVPIAEPLDI
GRTVAELLPDFQTLAEANNQRFVTDIPAGQIVLSDPRLLQKALSNVILNAVQNTPQGGEV
RIWSEPGAEKCRLFVLNMGVHIDDTALPRLFTPFYRIDQARSRKSGRSGLGLAIVQKTLD
AMSLQYALENTSDGVLFWLDLPLTSTL
>ABX79408|FEATURES|argannot|glycopeptide|vanC|antibiotic target alteration|1
MKKIAIIFGGNSPEYTVSLASATSAIEALQSSPYDYDLSLIGIAPDAMDWYLYTGELENI
RQDTWLLDTKHTQKIQPLFEGNGFWISEAQQTLVPDVLFPIMHGKYGEDGSIQGMFELMK
LPYVGCGVAASALCMNKWLLHQAAAAIGVQSAPTILLTNQANQQRQIEAFIQTHGFPVFF
KPNEAGSSKGITKVTCVEEIAPALKEAFAYCSAVLLQKNIAGVEIGCGILGNDSLTVGAC
DAISLVDGFFDFEEKYQLISAKITVPAPLPETIETKVKEQAQLLYHSLGLKGLARIDFFV
TDQGELYLNEINTMPGFTSHSRYPAMMAAVGLSYQELLQKLLVLAKEEGK
>ABB53370.1|FEATURES|argannot|glycopeptide|vanYB|antibiotic target alteration|1
MEKSNYHSNADHHKRHMKQSVEKRAFLCAFIISFTVCTLFLGWRLASVLEATQIPPIPAT
HTGSSTDVVENLEENALATAKEQGDEQEWSLILVNRQNPIPAQYDVELEQLSNGERIDIR
ISPYLQDLFDAARTDGVYPIVASGYRTTEKQQEIMDEKIAEYKAKGYTSAQAKAEAETWV
AVPGTSEHQLGLAVDINADGIHSTGNEVYRWLDENSYRFGFIRRYPPDKTEITGVSNEPW
HYRYVGIEAATEMYNQGVCLEEYLKPEK
>ABB53373.1|FEATURES|argannot|glycopeptide|vanXB|antibiotic target alteration|1
MENGFLFLDEMLHGVRWDAKYATWDNFTGKPVDGYEVNRIIGTKAVAFALREAQIHAAAL
GYGLLLWDGYRPRTAVDCFLRWAAQPEDNLTKEKFYPNIERAELITKGYVASQSSHSRGS
AIDLTLYHLDTGELVSMGSNFDFMDERSHHTAKGIGDAEAQNRRCLRKIMESSGFQSYRF
EWWHYKLIDEPYPDTYFNFAVS
>ABB53371.1|FEATURES|argannot|glycopeptide|vanWB|antibiotic target alteration|1
MDRKRLTQRFPFLLPMRRAQRKMCFYAGMRFDGCRYAQTIGEKSLSHLLFETDCALYNHN
TGFDMIYQENKVFNLKLAAKTLNGLLIRPGETFSFWWLVRHADKDTPYKDGLTVTNGKLT
TMSGGGMCQMSNLLFWMFLHTPLTIIQRRGHEVKEFPEPNSDEIKGVDATISEGWIDLKV
RNDTDCTYQIWVTLDDEKIIGQVSADKEPQALYKITNGSIQYVRESGGIYEYAQVKRMQV
ALGTGEIIDCKLLYTNKCKICYPLPESVDIQEENQ
>BAE96113.1|FEATURES|argannot|glycopeptide|vanRD|antibiotic target alteration|1
MNEKILVVDDEKELADLVEVYLKNDGYTVYKFYNGRDALNCIESVELDLAILDIMLPDID
GFQICQKIREKFYFPVIMLTAKVEDGDKIMGLSVADDYITKPFNPLEVVARVKAQLRQYM
RYKQPCIKQEAERTEYDIRGMTISKSSHKCILFGKEIQLTPTEFSILWYLCERQGTVVST
EELFEAVWGERYFDSNNTVMAHIGRLREKMKEPSRNPKFIKTVWGVGYTIEK
>BAE96114.1|FEATURES|argannot|glycopeptide|vanSD|antibiotic target alteration|1
MKNKNMTSYEDDYLLFKNRLSVKILLMMACSILIISVVYLFVLKDNFANVVVAILDRFIY
HDRDEAVAVYLRTFKAYEIWLFLIAVMGVFFVIFRRYLDSISKYFKEINRGIDTLVHEDT
NDIALPPELASTERKINSIRHTLTKRKTDAELAEQRKNDLVMYLAHDLKIPLSSVIGYLN
LLRDEKQISEELREKYLSISLDKAERLEELINEFFEITRFNLSNITLVYSKINLTMMLEQ
LGHEFKPMLAGKNLKCEFDIQPDMLLSCDANKLQRVFDNLLRNAVSYCYENTTIQVNARQ
AEDHVLIKIINEGDTIPRERLERIFEQFYRLDMSRSSSTGGAGLGLAIAREIVELHHGQI
TARSENGITSFEVTLPTVGKS
>BAE96118.1|FEATURES|argannot|glycopeptide|vanXD|antibiotic target alteration|1
MEKNFVFLDEMLPGIRWDAKYATWDNFTGKPVDGYEVNRIVGTKELGAALRKAQKAAEKL
GYGLLLWDGYRPQCAVDCFLTWASLPENNLTKKRYYPNIKRNEMITKGYVASQSSHSRGS
AIDLTIFRLDTGMLVPMGGDFDFMDVRSHHAASGLSEEEAGNRERLRDIMERSGFEAYRY
EWWHYVLADEPYPDTYFDFCIA
>ABB88462.1|FEATURES|argannot|glycopeptide|vanHO|antibiotic target alteration|1
MLPTMSAMTYSEPARSEASRSRSLASAPSSADEARGITIYGCGQDEAVLFKEMAPRFGIM
PTIAEAPVSEATIELASGNRCISVGHKTPISNSILLALREAGVEYISTRSIGFNHIDVKY
AESIGITVGNVAYSPDSVADFTLMLMLMVIRDAKSIIRRTEVHDYRLNAVRGKELRDLTV
GVVGTGRIGVAVMDRLKGFGCRVLAYDTIPNASADYVPLDDLLQQSDIVTLHVPLNTDTY
HLLDRRNIEEMKGGAYIINTGRGPLIETEALISALESGNLGGAALDVLEGEEGIFYADCR
DKAIDGNKPLLRLQELSNVIISPHTAYYTDHALSDTVENSIINCLEFESGK
>AAV74561|FEATURES|argannot|glycopeptide|vanB|antibiotic target alteration|1
MNRIKVAIIFGGCSEEHDVSVKSAIEIAANIDTEKFDPHYIGITKNGVWKLCKKPCTEWE
ADSLPAILSPDRKTHGLLVMKESEYETRRIDVAFPVLHGKCGEDGAIQGLFVLSGIPYVG
CDIQSSAACMDKSLAYILTKNAGIAVPEFQMIDKGDKPEAGALTYPVFVKPARSGSSFGV
TKVNGTEELNAAIEAAGQYDGKILIEQAISGCEVGCAVMGNEDDLIVGEVDQIRLSHGIF
RIHQENEPEKGSENAMITVPADIPVEERNRVQETAKKVYRVLGCRGLARVDLFLQEDGGI
VLNEVNTLPGFTSYSRYPRMMAAAGITLPALIDSLITLALKR
>ABX79431|FEATURES|argannot|glycopeptide|VanXYC|antibiotic target alteration|1
MNPYLQLVSKEFPLEKNQEPPHLVLAAFSEDEVYLQPEAAKQWERLVKALKLENEICLLD
GYRTEKQQRYLWEYSLKENGLAYTKQFVALPGCSEHQLGLAIDVGLKGSQDDLICPRFRD
SAAADLFTQEMMNYGFILRYPADKQEITGIGYEPWHFRYVGLPHSQIIASQQWTLEEYHQ
YLEQTARQFA
>ABX79420|FEATURES|argannot|glycopeptide|vanC|antibiotic target alteration|1
MKKIAIIFGGNSPEYTVSLASATSAIEALQSSPYDYDLSLIGIAPDAMDWYLYTGELENI
RQDTWLLDTKHTQKIKPLFEGNGFWLSEEQQTLVPDVLFPIMHGKYGEDGSIQGLFELMK
LPYVGCGVAGSALCMNKWLLHQAAAAIGVQSAPTILLTNQANQQEQIEAFIQTHGFPVFF
KPNEAGSSKGITKVTCVEEIASALKEAFTYCSAVLLQKNIAGVEIGCGILGNDSLTVGAC
DAISLVDGFFDFEEKYQLISAKITVPAPLPETIETKVKEQAQLLYRSLGLKGLARIDFFV
TDQGELYLNEINTMPGFTSHSRYPAMMAAVGLSYQELLQKLLVLAKEEVK
>AAK58490.1|FEATURES|argannot|glycopeptide|VanXYC|antibiotic target alteration|1
MNPYLQLVSKEFPLEKNQEPPHLVLAAFSEDEVYLQPEAAKQWKRLVKALKLEDEICLLD
GYRTEKQQRYLWEYSLKENGLAYTKQFVALPGCSEHQLGLAIDVGLKGSQDDLICPRFRD
SAAADLFTQEMMNYGFILRYPADKQEITGIGYEPWHFRYVGLPHSQIIASQQWTLEEYHQ
YLEQTARQFA
>AAK58491.1|FEATURES|argannot|glycopeptide|vanTC|antibiotic target alteration|1
MKKNQGIEQFRVILAMMVVAIHCLPLHHLWPDGDTLITLTLFRIAVPFFFMISGYYVFSD
LATQNSYPARHRVWQFIKKQLQVYLIATLLFLPLAWYSGMLGLNMPLGTFIQTLLVNGIL
YHLWYFPAIITGSLLVMGLLTRLSFKQVFFTAVGLYVVGLGGDSWSGLAAQTPITPLYSR
IFQLLDGTRNGIFFAPLFLILGVLARRFAKKPASPHRYSYLLISLICLLLESYLLHHFTT
PKHDSMYIFLPFVLLFLFPIIQQWQAPIIWKQAGRLSLWLYLLHPYTIAVTHFLSQKLPL
LQNNLINFFVVLGLTIGVVHGLFALQKLFPFPKKTPPHLQRATKEFSAPALLHNLQEIKR
LIPATTKVMAVVKADAYGCDAKTVASTLERAGVDFFAVATLEEAIELRRAGIKSRLLILG
YTSAQRAKELKHYSLIQTIVSEAHGHALAQTSIPIECHLAVDTGMHRLGVAPDLETVTGL
YALPSLKITRIFSHLGSSDQLDTASILRTQAQITCFDDLLAGLSARNIAYGLTHLQSSYG
ILNYPEKHYDYVRPGILLTGSLSVPNEPTKQKINVQPILTLKALLVDKKTVAAGEAIGYG
LGTVFDRPATIGIVSIGYCDGVPRALSNQGFQLSYQGALLPQIGLVCMDMLLIDLTDYPE
LAVESSLEVISDWTTTAYQAQTITNELISRLGSRITSSSK
>AAK58492.1|FEATURES|argannot|glycopeptide|VanRC|antibiotic target alteration|1
MAEKIIVVDDEKEIAELVTTFLRNEGFQVEPFYDGTSALAYLEKETVDVAVLDVMLPDID
GFQLLQQIRKTHFFPVLMLTAKGEDLDKITGLSLGADDYVTKPFNPLEVVARVKTQLRRY
QRYNQSANPQKIEEYEKEGLLLKINSHQCFLYGKEVFLTPIEFKILLYLFEHQGSVVASE
TLFEAVWKEKYLDNNNTVMAHIARLREKLNEQPRKPKLIKTVWGVGYIIEK
>ABX79414.1|FEATURES|argannot|glycopeptide|VanXYC|antibiotic target alteration|1
MNPYLQLVSKEFPLEKNQEPPHLVLAAFSEEEVYLQPEAAKQWERLVKALKLENEICLLD
GYRTEKQQRHLWEYSLKENGLAYTKQFVALPDCSEHQLGLAIDVGLKGQQGDLICPRFRD
SVAADLFTQEMMNYGFILRYPADKQEITGIGYEPWHFRYVGLPHSQIIASQQWTLEEYYQ
YLEQTARQFA
>ABX79415.1|FEATURES|argannot|glycopeptide|vanTC|antibiotic target alteration|1
MKKNQGIEQFRVILAMMVVAIHCLPLHRLWPNGDILITLTLFRIAVPFFFMISGYYVFSD
LATQNSYPARQRIWLFIKKQLQVYLIATLLFLPLAWYSGILGLNMPLDTFIQTLLVNGIL
YHLWYFPAIITGGLLVMGLLTRLSFKQVFFIAVGLYVVGLGGDSWSGLAAQTPITPLYSL
IFQLLDGTRNGIFFAPLFLILGVLARRFAKKPASPHRYSYLMISLICLLLESYLLHHFTT
PKHDSMYVFLPFVLLFLFPIIQQWQAPMIWKQAGRLSLWLYLLHPYTIAVTHFLSQKLPL
LQNNLINFLVVLGLTIGVVHGLFALQKLLPFPKKTPLHLQRAAKEFSAPALLHNLQEIKR
VIPSTTKVMAVVKADAYGCDAQLVARTLERVGVDFFAVATIEEAIELRRAGIKSRLLILG
YTSAQRAKELNRYSLIQTIVSEAHGQALARTGLPIECHLAVDTGMHRLGVAPDLETVRRL
YALPSLKITGIFSHLGSSDQLDTASILRTQAQIICFDDLLAGLSARNIAYGLTHLQSSYG
ILNYPEKHYDYVRPGILLTGSLSVPNEPTKQKINVQPILTLKALLVDKKTVAAGEAIGYG
LATVFDRPTTIGIVSIGYCDGVPRALSNQGFQLSYQGVLLPQVGLICMDMLLIDLTDYPE
LAVESWLEVISDWTNTADQAQTIPNELISRLGSRVPSMSK
>ABX79416.1|FEATURES|argannot|glycopeptide|VanRC|antibiotic target alteration|1
MAEKIIVVDDEKEIAELVTTFLRNEGFQVEPFYDGTSALAYLEKETVDVAVLDVMLPDID
GFQLLQTIRKTHFFPVLMLTAKGEDLDKITGLSLGADDYVTKPFNPLEVVARVKTQLRRY
QRYNQSAVPQKIEEYEKEGLLLKINSHQCFLYGKEVFLTPIEFKILLYLFEHQGSVVASE
TLFEAVWKEKYLDNNNTVMAHIARLREKLNEQPRKPKLIKTVWGVGYIIEK
>ABX79417.1|FEATURES|argannot|glycopeptide|VanSC|antibiotic target alteration|1
MLLLILIPLTVRFVAGLRVWYGYEPIYQILRLFADYWLVCLAIGALLIWVSTTIYYMSKA
ISYLNETIQATNQLIAEPTKRIVLSSNLIDVQEEMNQLREKNLQDQRAAKEAEQRKNDLI
VYLAHDLRTPLTSVIGYLTLLEEEPQLSSELRARYTKIALQKAQRLELLISEFFEITRFN
LTTIALQTETTDLSLMLEQLTFEFLPLLEEKNLHWQLQLQKKVYATVDTEKMERVFDNLI
RNAINYSYADSPLHLAISTSDDILIRLTNHGKTIPAEKIGLIFEPFYRMDASRATATGGT
GLGLPIAKEIVEALGGKIWAESRDETIVFSIRLPKVAMEKNEQRSKPHPSEPTA
>AAY52004.1|FEATURES|argannot|glycopeptide|vanHA|antibiotic target alteration|1
MKNIGITVYGCEQDEADAFRALSPRFGIMPTIINAAVSEANAISAPCNQCISVGHKSEVS
ASILLALKRAGVKYISTRSIGCNHIDTTAAKRMGIAVGNVAYSPDSVADYTMMLMLMAVR
NAKSIVRSVEKHDFRLDSVRGKVLRDMTVGVVGTGHIGKAVIERLRGFGCHVLAYDRSQK
IEANYVPFDALLQNSDIVTLHVPLNADTRHIIGHEQIKRMKQGAFIINTGRGPLVDTDAL
VKALENGKLGGAALDVLEGEEEFFYSDCSQKPIDNQFLLKLQRMPNVIITPHTAYYTEQA
LRDTVEKTIKNCLDFERSQEHE
>AAX19283.1|FEATURES|argannot|glycopeptide|vanHA|antibiotic target alteration|1
MNNIGITVYGCEQDEADAFCALSPRFGVMPSIINANVSESNAKSAPFNQCISVGHKSEVS
ASILLALKRAGVKYISTRSIGCNHIDTTAAKRMGITVGNVAYSPDSVADYTMMLMLMAVR
NAKSIVRSVEKHDFRLDSVRGKVLSDMTVGVVGTGHIGKAVIERLRGFGCKVLAYSRSQS
IEANYVPFDELLQNSDIVTLHVPLNADTRHIISHEQIQRMKQGAFIINTGRGPLVYTNEL
VKALENGKLGGAALDVLEGEEEFFYSDCSQKPIDNQFLLKLQRMPNVIITPHTAFYTEQA
LRDTVEKTNINCLDFERSQEHE
>AEI58860.1|FEATURES|argannot|glycopeptide|vanO|antibiotic target alteration|1
MGRLKIGILFGGLSEEHPISIKSAREVQKHLDLEKYEPYYIGITQSGSWMLCDGPAEDWE
NGDVRPAVLSPDRGVHGLLVLDEGKYETIALDVVLPVLHGKFGEDGAMQGLLEISGIPYV
GCDLPSSVMCIDKSLTYSVVRGAGIATPTFHIVTPDNDVDPDALNYPVFVKPARSGSSFG
VSKVSSKEELPAALAEARQYDAKILIEEAVIGSEIGCSILGDGEDLFAGEVDRVALTHGF
FKIHQEKSPETGSENSSFIVPADIPDASRDLVQETAKVIYRALGCSGLARVDLFLKEDGS
VVLNEVNTLPGLTSYSRYPRMMNAAGLSLGDVIDRLVKLTLAGVTNEG
>AAF72363.1|FEATURES|argannot|glycopeptide|vanB|antibiotic target alteration|1
MNRIKVAIIFGGCSEEHDVSVKSAIEIAANINTEKFDPHYIGITKNGVWKLCKKPCTEWE
ADSLPAILSPDRKTHGLLVMKESEYETRRIDVAFPVLHGKCGEDGAIQGLFELSGIPYVG
CDIQSSAACMDKSLAYILTKNAGIAVPEFQMIDKGDKPEAGALTYPVFVKPARSGSSFGV
TKVNGTEELNAAIEAAGQYDGKILIEQAISGCEVGCAVMGNEDDLIVGEVDQIRLSHGIF
RIHQENEPEKGSENAMITVPADIPVEERNRVQETAKKVYRVLGCRGLARVDLFLQEDGGI
VLNEVNTLPGFTSYSRYPRMVAAAGITLPALIDSLITLALKR
>AAQ16248|FEATURES|argannot|glycopeptide|vanG|antibiotic inactivation|0
MTLKGVTYTEKADAGEMLLAICKDYPMSAPTEIGSYRGFRMEIYYDTVNAHYCMNLCGKA
KHKVDLGADALGNLTRIENELSKLPARLEDAKTKKAETIAQLETAKEEIKKPFAFEDELK
EKTERLNALNIDMDLYHIGGNNEYLITVS
>ACP19235|FEATURES|argannot|glycopeptide|vanHA|antibiotic target alteration|1
MNNIGITVYGCEQDEADAFHALSPRFGVMATIINANVSESNAKSAPFNQCISVGHKSEIS
ASILLALKRAGVKYISTRSIGCNHIDTTAAKRMGITVDNVAYSPDSVADYTMMLILMAVR
NVKSIVRSVEKHDFRLDSDRGKVLSDMTVGVVGTGQIGKAVIERLRGFGCKVLAYSRSRS
IEVNYVPFDELLQNSDIVTLHVPLNTDTHYIISHEQIQRMKQGAFLINTGRGPLVDTYEL
VKALENGKLGGAALDVLEGEEEFFYSDCTQKPIDNQFLLKLQRMPNVIITPHTAYYTEQA
LRDTVEKTIKNCLDFERRQEHE
>AAT38880.1|FEATURES|argannot|glycopeptide|vanHO|antibiotic target alteration|1
HIDVEYAESIGITVGNVAYSPDSVADFTLMLMLMVIRDAKSIIRRTEVHDYRLNAVRGKE
LRDLTVGVVGTGRIGVAVMDRLKGFGCRVLAYDTIPNASADYVPLDDLLQQSDIVTLHVP
LNTDTYHLLDRRNIEEMKGGAYIINTGRGPLIETEALISALESGNLGGAALDVLEGEEGI
FYADCRDKAIDGNKPLLRLQELSNVIISPHTAYYTDHALSDTVENSIINCLEFESGK
>AAD19834.1|FEATURES|argannot|glycopeptide|vanH|antibiotic target alteration|1
MTYSEPARSAAPRTGSPASASSSAVLARGITIYGCGSDEAALFREMAPRFGVMPNIVDEP
VSEANIGLVSGNRCISIGHKTKVTNSILLALAEAGVEYISTRSIGFNHIDVEYAASVGIT
VGNVAYSPDSVADFTLMLMLMAVRDAKSIIRRTEVHDYRLNEVRGKELRDLTVGVVGTGR
IGVAVLDRLRGFGCRVLAYDTLLTASADYVPLDELLQQSDIVTLHVPLNNDTYHLLDRKN
IERMKDGAYIINTGRGPLIETEALISALEDGKLGGAALDVVEGEEGIFYADCRNKPLESE
TLLRLEKLPNVLISPHTAYYTDHALSDTVENSIINCLQFRKREVVWVG
>AEI58859.1|FEATURES|argannot|glycopeptide|vanHO|antibiotic target alteration|1
MTYSEPARSAAPRTGSPASASSSAVLARGITIYGCGSDEAALFREMAPRFGVMPTIVDEP
VSEANIGLVSGNRCISIGHKTKVTNSILLALAEAGVEYISTRSIGFNHIDVEYAASVGIT
VGNVAYSPDSVADFTLMLMLMAVRDAKSIIRRTEVHDYRLNEVRGKELRDLTVGVVGTGR
IGVAVLDRLRGFGCRVLAYDTLLTASADYVPLDELLQQSDIVTLHVPLNNDTYHLLDRKN
IERMKDGAYIINTGRGPLIETEALISALEDGKLGGAALDVVEGEEGIFYADCRNKPLESE
TLLRLEKLPNVLISPHTAYYTDHALSDTVENSIINCLQFESGK
>AAF72362.1|FEATURES|argannot|glycopeptide|vanHB|antibiotic target alteration|1
MRKSMGITVFGCEQDEANAFRALSPDFHIIPTLISDAISADNAKLAAGNQCVSEGHKSEV
SEATILALRKVGVKYISTRSIGCDHIDTTAAERMGISVGTVAYSPDSVADYALMLMLMAI
RGAKPTMHAVAQQDFRLDRIRGKELGDMTVRVIGTGHIGQAVVKRLRGFGCHVLAYDNSR
KMDADYVQLDELLKNSGIVTLHVPLCADTRHLIGQKQIGEMKQGAFLINTGRGALVDTGA
LVEALESGKLGGAALDVLEGEDQFVYTDCSQKVLDHPFLSQLLRMPNVIITPHTAYYTER
VLQDTTEKTIRNCLNFERSLQHE
>AAY52009.1|FEATURES|argannot|glycopeptide|vanRA|antibiotic target alteration|1
MSDKILVVDDEHEIADLVELYLKNENYTVFKYYTAKEALECIDKTDLDLAILDIMLPGAS
GLAICQKIRDKHTYPIITLTAKDTEVDKITGLTIGADDYITKPFRPLELIARVKAQLRRY
KKYNGVTEQNENVIVHSGLVININTHECFLNEKQLSLTPTEFSILRILCENKGNVVSSEQ
LFHEIWGDEYFSKSNNTITVHIRHLREKMNDTIDNPKYIKTVWGVGYKIEK
>AAY67972.1|FEATURES|argannot|glycopeptide|vanSC|antibiotic target alteration|1
MKNRNPLIRKLLTQYFVTTGILLAFLVMIPLVIRFIAGTRTWYGTEPIYYILRFFADRWL
FCVAIGALLIWFGTTIYYMTKAIGYLNETIQATTQLIEEPTKRITLSSHLVDVQEEMNQL
REKSLQDQRAAKEAEQRKNDLIVYLAHDLRTPLTSVIGYLTLLKEEPQLSNAMRNRYTEI
ALQKAQRLELLISEFFEITRFNLTTIVLQTETTDLSLMLEQLTFEFLPLLEEKNLNWQLN
LQKNVLATVDTEKIARVFDNLIRNAINYSYPDSPLLLELVESDSIHIRLTNRGKTIPEEM
IGRLFEPFYRMDSSRATATGGTGLGLPIAKEILLASGGDISAESKDETIIFNVRLPKPAN
S
>AAY52003.1|FEATURES|argannot|glycopeptide|VanSA|antibiotic target alteration|1
MAIKLKNKNKKTDYSKLKRKLYQYIVVIVMAAVVFVLFLRLFIKGTLGEWIVRFLENSYH
LERQDAMKIYQYTIRNNIEIFIYVAIAISILILCRVMLSKFAKYFDEINTGIDILIQNED
KQIELSAEMEFMEQKLNTLKRTLEKREQDAKLAEQRKNDVVMYLAHDIKTPLTSVIGYLS
LLDEAPDMPVEQKAKYVHITLDKAYRLEQLIDEFFEITRYNLQTITLTKKHIDLYYMLVQ
MTDEFYPQLAANGKQAVIHASEDLTVSGDPDKLARVFNNILKNAAAYSEDNSVIDITAGL
SGDVVSIVFKNAGSIPKDKLAAIFEKFYRLDDARSSDTGGAGLGLAIAKEIIVQHGGQIY
AESNDNYTTFTVELPALPDLVDKRSS
>AAX19282.1|FEATURES|argannot|glycopeptide|vanSA|antibiotic target alteration|1
MAIKLKNKNKKTDYSKLKRKLYQYIVVIVMAAVVFVLFLRLFIKGTLGEWIVRFLENSYH
LDRLDAMKLYQYSIRNNIDIFIYVAIVISILILCRVMLSKFAKYFDEINTGIDVLIQNED
KQIELSAEMDVMEQKLNTLKRTLEKREQDAKLAEQRKNDVVMYLAHDIKTPLTSIIGYLS
LLDEAPDMPVDQKAKYVHITLDKAYRLEQLIDEFFEITRYNLQTITLTKTHIDLYYMLVQ
MTDEFYPQLSAHGKQAVIHAPEDLTVSGDPDKLARVFNNILENAAAYSEDNSVIDITAGL
SGDVVSIVFKNAGSIPKDKLAAIFEKFYRLDDARSSDTGGAGLGLAIAKEIIVQHGGQIY
AESNDNYTTFTVELPALPDLVDKRSS
>AAY67970.1|FEATURES|argannot|glycopeptide|vanTC|antibiotic target alteration|1
MKNKGIDQFRVIAAMMVVAIHCLPLHYLWPEGDILITLTIFRVAVPFFFMISGYYVFAEL
AVANSYPSRQRVFNFIKKQLKVYLLATLMFLPLALYSQTIGFDLPVGTLVQSLLVNGILY
HLWYFPALITGSLLLTSLLIHVSFKKVFWLAAGLYLIGLGGDSWFGLIQQTPIEPFYTAV
FHLLDGTRNGIFFTPLFLCLGVLVRKQSVKRSLSKTALFFLISLIGLLIESAYLHGFSIP
KHDSMYLFLPVVLFFLFPLILRWHPHRTWKHPGQLSLWLYLLHPYTIAGTHFLSQKISIL
QNNLINYLVVLILTIGFICLFLRQQHSWFRHKQTTPVKRVVKEFSKTALLHNLQEIQRII
SPKTKVMAVVKADAYGCGAKEVAPVLEQAGIDFFAVATIDEGIQLRKNAVKSPILVLGYT
SPKRIKELRRYSLTQSIISEGHAVALSQRKVAIDCHLAIDTGMHRLGVTPTIDSILSIFD
LPFLTISGVYSHLGSADRLNPDSMIRTQKQIACFDQILLELDQRQISYGITHLQSSYGIL
NYPDLNYDYVRPGILLTGSLSDTNEPTKQRVSLQPILTLKAQLITKRVVAKGEAIGYGQT
AVANQETTVGVVSIGYCDGLPRSLSNQEFCLSYRGQSLPQIGLICMDMLLIDLSHCPTIP
IESEIEILTDWSDTAEQVQTITNELICRIGPRVSARIK
>AAY67969.1|FEATURES|argannot|glycopeptide|vanXYC|antibiotic target alteration|1
MNTLQLINKNHPLKKNQEPPHLVLAPFSDHDVYLQPEVAKQWERLVRATGLEKDIRLVDG
YRTEKEQRRLWEYSLKENGLAYTKQFVALPGCSEHQIGLAIDVGLKKQEDDDLICPHFRD
SAAADLFMQQMMNYGFILRYPEDKQEITGISYEPWHFRYVGLPHSQVITAQKWTLEEYHD
YLAQTVRQFA
>AAY52011.1|FEATURES|argannot|glycopeptide|vanWB|antibiotic target alteration|1
MTQIFPFLLPVRVMQRKMCFYAGMRFDGRRYAETIDGKQLPYKLFEAGCALYNGNTGFDM
AYQENKVFNLKLAAKTLNGLLIRPGETFSFWRLVRHADKHIPYKDGLTVTNGKLTTAPGG
GLCQMSNLLFWMFLHTPLTVTERSGHEVKEFPEPNSDEIKGVDATISEGWIDLKARNGTD
CTYQISVAFDDENIIGTVFVDKRPQVLYRVANGGIEYSRESGGIYESVKVERAEIDSDTG
EITGQKPLYTNKCKICYPLPENVEIKEAKKV
>ABB88464.1|FEATURES|argannot|glycopeptide|vanXO|antibiotic target alteration|1
MKDDFVFVDEVVPGIRWDAKYATWDNFTGKPVDGYLVNRVVGTRAFCAALEKAREKAESL
GFGLLLWDVYRPQRAVDCFMRWAEQPEDGRKKLRHYPNIDRPQMFEKGYVATKSGHSRGS
TVDLTLYHLDTGELADMGGDHDVMDVVSHHGAAGITPEQEKNREHLCSIMVDSGFGSYEF
EWWHYNLKNEPYPDTYFDFPIAGS
>AAT38882.1|FEATURES|argannot|glycopeptide|vanXO|antibiotic target alteration|1
MKDDFVFVDEVVPGIRWDAKYATWDNFTGKPVDGYLVNRVVGTRAFCAALEKAREKAESL
GFGLLLWDVYRPQRAVDCFMRWAEQPEDGRKKLRHYPNIDRPQMFEKGYVATKSGHSRGS
TVDLTLYHLDTGELADMGGDHDVMDVVSHHGAAGITPEQEKNREHLCSIMVDSGFGSYEF
EWWHYTL
>AAD19836.1|FEATURES|argannot|glycopeptide|vanX|antibiotic target alteration|1
MRDDFVFVDEVVSGIRWDAKYATWDNFTGKPVDGYLVNRVVGTRAFCAALEKARDKAAEL
GFGLLLWDVYRPQRAVDRFMRWAEEPEDGRKKARHYPNIERPQMFEQGYVATKSGHSRGS
TVDLTLYRLDTGELADMGGDHDLMDVVSHHGADGVPEEAAKNRAHLCAIMEGSGFSSYEC
EWWHYNLKDEPYPDTYLDFPIE
>AEI58861.1|FEATURES|argannot|glycopeptide|vanXI|antibiotic target alteration|1
MRDDFVFVDEVVSGIRWDAKYATWDNFTGKPVDGYLVNRVVGTRAFCAALEKARDKAAEL
GFGLLLWDVYRPQRAVDRFMRWAEEPEDGRKKARHYPNIERPQMFEQGYVATKSGHSRGS
TVDLTLYRLDTGELADMGGDHDLMDVVSHHGADGVPEEAAKNRAHLCAIMEGSGFSSYEC
EWWHYNLKDEPYPDTYFDFPIE
>AAY52006.1|FEATURES|argannot|glycopeptide|vanXA|antibiotic target alteration|1
MKIGFTFLDEILHGVRWDAKYATWDNFTGKPVDGYEVNRIVGTYELADALLKVKELAATQ
GYGLLLWDGYRPQRAVNCFLQWAAQPEDDLTKERYYPNIDRTEMVSKGYVASKSSHSRGS
AIDLTLYRLDTGELVPMGSGFDFMDERSHHAAKGISGNEAQNRRRLRSIMEDSGFEAYSF
EWWHYVLRNEPYPNSYFDFPVK
>AAX19285.1|FEATURES|argannot|glycopeptide|vanXA|antibiotic target alteration|1
MKKGFTFLDEILHGVRWDAKYATWDNFTGKPVDGYEVNRIAGTYELADALLKVKELAAAQ
GYGLLLWDGYRPQRAVNCFVQWAAQPEDGLTKERYYPNIDRTEMVSKGYVASKSSHSRGS
AIDLTLYRLDTGELVPMGSGFDFMDERSHHAAKGISGNEAQNRRCLRSIMENSGFEAYSF
EWWHYVLRNEPYPNSYFDFPVK
>CAB45463|FEATURES|argannot|glycopeptide|vanX|antibiotic target alteration|1
MTGDFAFVDELVSGIRWDAKYATWDNFTGKPVDGYLANRIVGTKALCAALGRAQERAEDL
GFGLLLWDGYRPQRAVDCFLRWSQQPEDGRTKARHYPNIGRAEMFDRGYVAARSGHSRGA
TVDLTLYHLTTGELAAMGGGHDLMDPISHHDARDVPRAEAANRRHLRSIMAACGFASYAC
EWWHYTLKEEPHPDTYFDFPIA
>AAY52013.1|FEATURES|argannot|glycopeptide|VanYA|antibiotic target alteration|1
MKKWGFLLLFLLCLGFAFINKALFFQDKVEIQKYDQNHKDNIDNIENIGTPLSIQKNEIV
KEQIYQGNLLLINSKYPIRQESVKSDIVNLSKHNELINGYGLLNTNIYLSKGIAQKFSEM
INDAVKEGVSQFFINSGYRDFDEQSVLYQEMGADYALPAGYSEHNSGLSLDVGSSLTKME
RAPEGKWLKENAWKYGFILRYPKDKTDVTGIQYEPWHIRYVGFPHSAIMKEKNFALEEYM
DFLKEQKSITTTIDHQVYKIFYYPISQNTTIPVPANGQYEISGNNMDGVIVTVYSGKRD
>ACV60627.1|FEATURES|argannot|glycopeptide|VanYA|antibiotic target alteration|1
MKKWGFLFLLCLGFVFINKALFFQEKVAVEIENYDQNPKDHLDNRGTSESTQTKTITNEQ
IYQGNLLLFNSKYPVRQESVKSDIVNLSKHNELINGYGLLDTNIYMSKGIAQKFSEMVND
ALKEGVSHFIINSGYRDFDEQSVLYQEMGADYALPAGYSEHNSGLSLDVGSSLTKMERAP
EGKWLKENAWKYGFILRYPKDKTDVTGIQYEPWHIRYVGFPHSAIMKEKNFALEEYMDFL
KEQKSITTTIDHQVYKIFYYPISQNTTIHVPANGQYEISGNNMDGVIVTVYSGKRD
>AAY52015.1|FEATURES|argannot|glycopeptide|VanZ|antibiotic target alteration|1
MNGGSRLKNWVVRAFFASYMYALFKIIVLKFGPTDVEFLWVRLMRNSTNPECIAARLHAG
NLIPLKEISRASDSMSGHSLLNLLGNVGIFVPLGIFLGVLAKSGKLTLAGSFWSSLGVSL
VLECTQVLFSIGTFDVDDLILNSIGGSIGFVVYALCALG
>ABX79438|FEATURES|argannot|glycopeptide|vanC|antibiotic target alteration|1
MKKIAVLFGGNSPEYSVSLTSAASVIQAIDPLKYEVMTIGIAPTMDWYWYQGNLANVRND
TWLEDHKNCHQLTFSSQGFILGEKRIVPDVLFPVLHGKYGEDGCIQGLLELMNLPYVGCH
VAASALCMNKWLLHQLADTMGIASAPTLLLSRYENDPATIDRFIQDHGFPIFIKPNEAGS
SKGITKVTDKTALQSALTTAFAYGSTVLIQKAIAGIEIGCGILGNEQLTIGACDAISLVD
GFFDFEEKYQLISATITVPAPLPLALESQIKEQAQLLYRNLGLTGLARIDFFVTNQGAIY
LNEINTMPGFTGHSRYPAMMAEVGLSYEILVEKLIALAEEDKR
>AAA60990|FEATURES|argannot|glycopeptide|vanC|antibiotic target alteration|1
MKKIAIIFGGNSPEYTVSLASATSAIEALQSSPYDYDLSLIGIAPDAMDWYLYTGELENI
RQDTWLLDTKHKQKIQPLFEGNGFWLSEEQQTLVPDVLFPIMHGKYGEDGSIQGLFELMK
LPYVGCGVAGSALCMNKWLLHQAAAAIGVQSAPTILLTNQANQQEQIEAFIQTHGFPVFF
KPNEAGSSKGITKVTCVEEIASALKEAFTYCSAVLLQKNIAGVEIGCGILGNDSLTVGAC
DAISLVDGFFDFEEKYQLISAKITVPAPLPETIETKVKEQAQLLYRSLGLKGLARIDFFV
TERGELYLNEINTMPGFTSHSRYPAMMAAVGLSYQELLQKLLVLAKEEVK
>AAK58489.1|FEATURES|argannot|glycopeptide|vanC|antibiotic target alteration|1
MKKIAIIFGGNSPEYTVSLASATSAIEALQSSPYDYDLSLIGIAPDAMDWYLYTGELENI
RQDTWLLDTKQKQKIQPLFEGNGFWLSEEQQTLVPDVLFPIMHGKYGEDGSIQGMFELMK
LPYVGCGVAGSALCMNKWLLHQAAAAIGVQSAPTILLTNHANQQEQIEAFIQTHGFPVFF
KPNEAGSSKGITKVTCVEEIASALKEAFTYCSAVLLQKNIAGVEIGCGILGNDSLTVGAC
DAISLVDGFFDFEEKYQLISAKITVPAPLPETIETKVKEQAQLLYRSLGLKGLARIDFFV
TDQGELYLNEINTMPGFTSHSRYPAMMAAVGLSYQELLQKLLVLAKEEVK
>AAV74562.1|FEATURES|argannot|glycopeptide|vanB|antibiotic target alteration|1
MNRIKVAIIFGGCSEEHDVSVKSAIEIAANIDTEKFDPHYIGITKNGVWKLCKKPCTEWE
ADSLPAILSPDRKTHGLLVMKESEYETRRIDVAFPVLHGKCGEDGAIQGLFVLSGIPYVG
CDIQSSAACMDKSLAYILTKNAGIAVPEFQIIDKGDKPEAGALTYPVFVKPARSGSSFGV
TKVNGTEELNAAIEAAGQYDGKILIEQAISGCEVGCAVMGNEDDLIVGEVDQIRLSHGIF
RIHQENEPEKGSENAMITVPADIPVEERNRVQETAKKVYRVLGCRGLARVDLFLQEDGGI
VLNEVNTMPGFTSYSRYPRMVAAAGITLPALIDSLITLALKR
>AAL27442|FEATURES|argannot|glycopeptide|vanE|antibiotic target alteration|1
MKTVAIIFGGVSSEYEVSLKSAVAIIKNMESIDYNVMKIGITEEGHWYLFEGTTDKIKKD
RWFLDESCEEIVVDFAKKSFVLKNSKKIIKPDILFPVLHGGYGENGAMQGVFELLDIPYV
GCGIGAAAISMNKIMLHQFAEAIGVKSTPSMIIEKGQDLQKVDAFAKIHGFPLYIKPNEA
GSSKGISKVERKSDLYKAIDEASKYDSRILIQKEVKGVEIGCGILGNEQLVVGECDQISL
VDGFFDYEEKYNLVTAEILLPAKLSIDKKEDIQMKAKKLYRLLGCKGLARIDFFLTDDGE
ILLNEINTMPGFTEHSRFPMMMNEIGMDYKEIIENLLVLAVENHEKKLSTID
>CAL64019.1|FEATURES|argannot|multidrug|cfr|antibiotic target alteration|1
MNFNNKTKYGKIQEFLRSNNEPDYRIKQITNAIFKQRISRFEDMKVLPKLLREDLINNFG
ETVLNIKLLAEQNSEQVTKVLFEVSKNERVETVNMKYKAGWESFCISSQCGCNFGCKFCA
TGDIGLKKNLTVDEITDQVLYFHLLGHQIDSISFMGMGEALANRQVFDALDSFTDPNLFA
LSPRRLSISTIGIIPSIKKITQEYPQVNLTFSLHSPYSEERSKLMPINDRYPIDEVMNIL
DEHIRLTSRKVYIAYIMLPGVNDSLEHANEVVSLLKSRYKSGKLYHVNLIRYNPTISAPE
MYGEANEGQVEAFYKVLKSAGIHVTIRSQFGIDIDAACGQLYGNYQNSQ
>AAO38246|FEATURES|argannot|macrolide-lincosamide-streptogramin|EreA|antibiotic inactivation|1
MTWRTTRTLLQPQKLDFNEFEILTSVIEGARIVGIGEGAHFVAEFSLARASLIRYLVERH
EFNAIGLECGAIQASRLSEWLNSTAGAHELERFSDTLTFSVYGSVLIWLKSYLRESGRKL
QLVGIDLPNTLNPRDDLAQLAEIIQLIDHLMKPHVDMLTHLLASIDGQSAVISSAKWGEL
ETARQEKAISGVTRLKLRLASLAPVLKKHVNSDLFRKASDRIESIEYTLETLRIMKTFFD
GTSLEGDTSVRDSYMAGVVDGMVRANPDVKIILLAHNNHLQKTPVSFSGELTAVPMGQHL
AERVNYRAIAFTHLGPTVPEMHFPSPKSPLGFSVVTTPADAIREDSMEQYVIDACGTENS
CLTLTDAPMEAKRMRSQSASVETKLSEAFDAIVCVTSAGKDSLVAL
>AID65165|FEATURES|argannot|macrolide-lincosamide-streptogramin|EreA2|antibiotic inactivation|1
MTWRTTRTLLQPQKLEFNEFEILNPVVEGARIVGIGEGAHFVAEFSLARASLIRYFVERH
DFNAIGLECGAIQASRLSEWLNSTAGAHELERFSDTLTFSLYGSVLIWVKSYLRESGRKL
QLVGIDLPNTLNPRDDLAQLAEIIQVIDHLMKPHVDALTQLLTSIDGQSAVISSAKWGEL
ETAQQEKAISGVTRLKLRLASLAPVLKNHVNSDFFRKASDRIESIEYTLETLRVMKAFFD
GTSLEGDTSVRDSYMAGVVDGMVRANPDVRIILLAHNNHLQKTPVSFSGELTAVPMGQHL
AEREEGDYRAIAFTHLGLTVPEMHFPSPDSPLGFSVVTTPADAIREDSVEQYVIDACGKE
DSCLTLTDDPMEAKRMRSQSASVETNLSEAFDAIVCVPSAGKDSLVAL
>CAA27626|FEATURES|argannot|macrolide-lincosamide-streptogramin|EreB|antibiotic inactivation|1
MRFEEWVKDKHIPFKLNHPDDNYDDFKPLRKIIGDTRVVALGENSHFIKEFFLLRHTLLR
FFIEDLGFTTFAFEFGFAEGQIINNWIHGQGTDDEIGRFLKHFYYPEELKTTFLWLREYN
KAAKEKITFLGIDIPRNGGSYLPNMEIVHDFFRTADKEALHIIDDAFNIAKKIDYFSTSQ
AALNLHELTDSEKCRLTSQLARVKVRLEAMAPIHIEKYGIDKYETILHYANGMIYLDYNI
QAMSGFISGGGMQGDMGAKDKYMADSVLWHLKNPQSEQKVIVVAHNAHIQKTPILYDGFL
SCLPMGQRLKNAIGDDYMSLGITSYSGHTAALYPEVDTKYGFRVDNFQLQEPNEGSVEKA
ISGCGVTNSFVFFRNIPEDLQSIPNMIRFDSIYMKAELEKAFDGIFQIEKSSVSEVVYE
>CAB37345|FEATURES|argannot|macrolide-lincosamide-streptogramin|tlrB|antibiotic target alteration|1
MRKNVVRYLRCPHCAAPLRSSDRTLRCENGHTFDVARQGYVNLLRRPTKLAADTTDMVAA
RAALLDSGHYAPLTERLAGTARRAAGAGAPDCVVDIGGGTGHHLARVLEEFEDAEGLLLD
MSKPAVRRAARAHPRASSAVADVWDTLPLRDGAAAMALNVFAPRNPPEIRRILRPGGTLL
VVTPQQDHLAELVDALGLLRVRDHKEGRLAEQLAPHFEAVGQERLRTTLRLDHDALGRVV
AMGPSSWHQDPDELARRIAELPGIHEVTLSVTFTVCRPLP
>CAC86410.1|FEATURES|argannot|macrolide-lincosamide-streptogramin|Erm(33)|antibiotic target alteration|1
MNKKNIKDSQNFITSKRNIDKIMTNISLNEHDNIFEIGSGKGHFTLELVQRCNFVTAIEI
DHKLCKTTENKLVDHDNFQVLNKDILQFKFPKNQSYNIFGNIPYNISTDIVKRITFESQA
KYSYLIVEKGFAKRLQNLQRALGLLLMVEMDIKMLKKVPPLYFHPKPSVDSVLIVLERHQ
PLISKKDYKKYRSFVYKWVNREYRVLFTKNQFRQALKHANVTNINKLSKEQFLSIFNSYK
LFH
>AAP74657|FEATURES|argannot|macrolide-lincosamide-streptogramin|Erm(34)|antibiotic target alteration|1
MTKKMNKYNGKKLSRGEPPNFSGQHFMHNKRLLKEIVDKADVSVRDTVLELGAGKGALTT
ILSERADRVLAVEYDQKCIEALQWKLVGSKNVSILHQDIMKVALPTEPFVVVSNIPYSIT
TAIMKMLLNNPKNKLQRGAIVMEKGAAKRFTSVSPKDAYVMAWHMWFDIHYERGISRSSF
SPPPKVDSALVRIVRKQHPLFPYKEAKAMHDFLSYALNNPRAPLDQVLRGIFTAPQAKKV
RQAIGVKPETPVAMLHARQWAMVCDAMVRHVPKVYWPRRKR
>AAK07612|FEATURES|argannot|macrolide-lincosamide-streptogramin|Erm(35)|antibiotic target alteration|1
MTKKKLPVRFTGQHFTIDKVLIKDAIKESNINQHDTVLDIGAGKGFLTVHLLKNVDKVIA
IENDVALSQHLRKKFIHAQNVQVVSCDYRNFVVPKVPFKVVSNIPFGITSDIFSSLMFEN
VEYFLCGSIILQSEPAKKLFSSKVYNPLTVLYHTYYDLKFLYEINPESFLPPPTVKSALL
RIERKQISLDIGLKVKYLNFVSYMLQKPDLTVKTAMKSIFRKKQVRSISEKFGVDLNSKI
VCLTPNQWKNCFLEMLEVVPEKFHPS
>AAL68827|FEATURES|argannot|macrolide-lincosamide-streptogramin|Erm(36)|antibiotic target alteration|1
MPTYRGGRHEHGQNFLTDHTTIDRLSRLVGDSTGPIVEIGPGQGRLTRELQKLGRSLTAV
EIDSRLADRLASASQFREQKHVTVVNADFLHWPLPTTPYVVVGNVPFHLTTAILRRLLHD
GAWTQVVLLVQWEVARRRAGIGGSSMMTAQWWPWIDFSLHGRVPRSAFKPAPSVDGGLLE
MTRRPDPLLSPDARESYRQFVHDVFTSRGRGIGEILANVSSSLGKRGALQLLKSEGIRSS
SLPKDLSAEQWARLFTSASPTKSAKTGRNAHPAHSARRQGR
>ACH43059|FEATURES|argannot|macrolide-lincosamide-streptogramin|Erm(41)|antibiotic target alteration|0
VSGQRSRRQWGWYPLTDDWAARIVAESGVRSGEFVVDLGAGHGALTAHLVAAGARVLAVE
LHPGRARHLRSRFAEEDVRIAEADLLAFRWPRRPFRVVASPPYQVTSALIRSLLTPESRL
LAADLVLQRGAVHKHAKRALVRHWTLRAGITLPRSAFHHPPQVDSSVLVIRRR
>CBY77552|FEATURES|argannot|macrolide-lincosamide-streptogramin|Erm(42)|antibiotic target alteration|1
MNKNTKIKNKNFNIKDSQNFLHNTKLVEDLLFKSNITKEDFVVEIGPGKGIITKALSKIC
KAVNAIEFDSVLADKLSHEFKSSNVSIIEADFLKYNLPDHNYKVFSNIPFNITASILNKL
LDSENPPLDTFLIMQYEPFLKYAGAPSYKESYKSLLYKPFFKTNILHSFSKFDFKPAPNA
NIILGQFSYKDFTDINLEDRHAWKDFLAFVFLEKGVTFKEKTKRIFSYKQQKIILKESRI
NDDSNISNWSYEFWLKMFKLYNSNMVSKDKKVLVNNSYKRMLEHESSLEKIHRNRKQNNR
K
>CAA26967.1|FEATURES|argannot|macrolide-lincosamide-streptogramin|ErmA|antibiotic target alteration|1
MNQKNPKDTQNFITSKKHVKEILNHTNISKQDNVIEIGSGKGHFTKELVKMSRSVTAIEI
DGGLCQVTKEAVNPSENIKVIQTDILKFSFPKHINYKIYGNIPYNISTDIVKRITFESQA
KYSYLIVEKGFAKRLQNLQRALGLLLMVEMDIKMLKKVPPLYFHPKPSVDSVLIVLERHQ
PLISKKDYKKYRSFVYKWVNREYRVLFTKNQFRQALKHANVTNINKLSKEQFLSIFNSYK
LFH
>AAA27452.2|FEATURES|argannot|macrolide-lincosamide-streptogramin|ErmB|antibiotic target alteration|1
MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNLSSEKLKLNIRVTLIHQDILQFQFPNKQRYKIVGNIPYHLSTQIIKKVVFESHAS
DIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTT
DVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTVTYEQVLSIFNSYLL
FNGRK
>AAA20192|FEATURES|argannot|macrolide-lincosamide-streptogramin|ErmC|antibiotic target alteration|1
MNEKNIKHSQNFITSKHNIDKIMTNIRLNEHDNIFEIGSGKGHFTLELVQRCNFVTAIEI
DHKLCKTTENKLVDHDNFQVLNKDILQFKFPKNQSYKIFGNIPYNISTDIIRKIVFDSIA
DEIYLIVEYGFAKRLLNTKRSLALLLMAEVDISILSMVPREYFHPKPKVNSSLIRLNRKK
SRISHKDKQKYNYFVMKWVNKEYKKIFTKNQFNNSLKHAGIDDLNNISFEQFLSLFNSYK
LFNK
>AAA22599|FEATURES|argannot|macrolide-lincosamide-streptogramin|ErmD|antibiotic target alteration|1
MKKKNHKYRGKKLNRGESPNFSGQHLMHNKKLIEEIVDRANISIDDTVLELGAGKGALTT
VLSQKAGKVLAVENDSKFVDILTRKTAQHSNTKIIHQDIMKIHLPKEKFVVVSNIPYAIT
TPIMKMLLNNPASGFQKGIIVMEKGAAKRFTSKFIKNSYVLAWRMWFDIGIVREISKEHF
SPPPKVDSAMVRITRKKDAPLSHKHYIAFRGLAEYALKEPNIPLCVALRGIFTPRQMKHL
RKSLKINNEKTVGTLTENQWAVIFNTMTQYVMHHKWPRANKRKPGEI
>AAA98217|FEATURES|argannot|macrolide-lincosamide-streptogramin|ErmF|antibiotic target alteration|1
MTKKKLPVRFTGQHFTIDKVLIKDAIRQANISNQDTVLDIGAGKGFLTVHLLKIANNVVA
IENDTALVEHLRKLFSDARNVQVVGCDFRNFAVPKFPFKVVSNIPYGITSDIFKILMFES
LGNFLGGSIVLQLEPTQKLFSRKLYNPYTVFYHTFFDLKLVYEVGPESFLPPPTVKSALL
NIKRKHLFFDFKFKAKYLAFISYLLEKPDLSVKTALKSIFRKSQVRSISEKFGLNLNAQI
VCLSPSQWLNCFLEMLEVVPEKFHPS
>AAA22419|FEATURES|argannot|macrolide-lincosamide-streptogramin|ErmG|antibiotic target alteration|1
MNKVNIKDSQNFITSKYHIEKIMNCISLDEKDNIFEIGAGKGHFTAELVKRCNFVTAIEI
DSKLCEVTRNKLLNYPNYQIVNDDILKFTFPSHNPYKIFGSIPYNISTNIIRKIVFESSA
TISYLIVEYGFAKRLLDTNRSLALLLMAEVDISILAKIPRYYFHPKPKVDSALIVLKRKP
AKMAFKERKKYETFVMKWVNKEYEKLFTKNQFNKALKHARIYDINNISFEQFVSLFNSYK
IFNG
>AAC32026|FEATURES|argannot|macrolide-lincosamide-streptogramin|ErmH|antibiotic target alteration|1
MAALLKRILRRRMAEKRSGRGRMAAARTTGAQSRKTAQRSGRSEADRRRRVHGQNFLVDR
ETVQRFVRFADPDPGEVVLEVGAGNGAITRELARLCRRVVAYEIDRHFADRLREATAEDP
RIEVVAGDFLKTSQPKVPFSVVGNIPFGNTADIVDWCLNARRLRTTTLVTQLEYARKRTG
GYRRWSRLTVATWPEVEWRMGERISRRWFRPVPAVDSAVLRLERRPVPLIPPGLMHDFRD
LVETGFTGKGGSLDASLRRRFPARRVAAGFRRARLEQGVVVAYVTPGQWITLFEELHGR
>CAA66307|FEATURES|argannot|macrolide-lincosamide-streptogramin|ErmN|antibiotic target alteration|1
MPSRPRTDSPHRHEGPAGPARLDRDEARRVWGQNFFRSAGSARRFARQLTGAESAGNDSV
TVEVGPGAGRITKELVRDGHPIVAVEVDPHWADRLAELELPNLTVVNDDFTTWPLPDGPL
RFIGNLPFGTGTRMLRRCLALGPDRCREGVFLLQKQYTRKRTGAYGGNLFNAQWEPWYTF
RRGLGFPRQEFAPVPGSDTETLLVRSRPRPLAPWSRHAAYQRFVEDVFNTSRLTIGEAAR
ALDRRAGPGWLRGARVPPGLRVKDITAEQWADLFHACTPPPARRISPQRRR
>AAA26779|FEATURES|argannot|macrolide-lincosamide-streptogramin|ErmO|antibiotic target alteration|1
MARPTQRARTLSQNFLADRATAERVARLAVPDRGRPPLLLEVGAGNGALTEPLARRSREL
HAYEIDPRLVPGLRARFARSPHVHVVAGDFLTARPPRTPFAVAGNVPFSRTADIVDWCLT
APGLTDATLLTQLEYARKRTGDYGRWTLLTVLTWPRHEWRLVGRVGRSRFCPAPRVDAGI
LRIERRPTALLTGAAARRDWADLVELGFSGVGGSLHASLRRAHSRRRVDAAFRAARLDPG
VLVGEVAPDRWLRLHEELTA
>AAC36915|FEATURES|argannot|macrolide-lincosamide-streptogramin|ErmQ|antibiotic target alteration|1
MKAKSNNYRGKVDISVSQNFITSKNTIYKLIKKTNISKNDFVIEIGPGKGHITEALCEKS
YWVTAIELDRSLYGNLINKFKSKNNVTLINKDFLNWKLPKKREYKVFSNIPFYITTKIIK
KLLLEELNSPTDMWLVMEKGSAKRFMGIPRESKLSLLLKTKFDIKIVHYFNREDFHPMPS
VDCVLVYFKRKYKYDISKDEWNEYTSFISKSINNLRDVFTKNQIHAVIKYLGINLNNISE
VSYNDWIQLFRYKQKID
>AAA22075|FEATURES|argannot|macrolide-lincosamide-streptogramin|ErmR|antibiotic target alteration|1
MAGPQDRPRGRGPSSGRPQRPVGGRSQRDRDRRVLGQNFLRDPATIRRIADAADVDPDGL
VVEAGPGEGLLTRELARRAGRVRTYELDQRLARRLSTDLAQETSIEVVHADFLTAPHPEE
PFQFVGAIPYGITSAIVDWCLTAPTLTSATLVTQQEFARKRTGDYGRWTALTVTTWPTFE
WQYVAKVDRTLFTPVPRVHSAIMRLRRRPQPLLRDAAARSRFADMVEIGFVGKGGSLYRS
LTREWPRSKVDSAFARADVHHDEIVAFVHPDQWITLFQLLDGSRGGAARGPGDQRGRRGR
PGGGPRPDGRAGGGPRRDAGGRRTGDGRGGRPRPPRGGQA
>AAA26742|FEATURES|argannot|macrolide-lincosamide-streptogramin|ErmS|antibiotic target alteration|1
VARAPRSPHPARSRETSRAHPPYGTRADRAPGRGRDRDRSPDSPGNTSSRDGGRSPDRAR
RELSQNFLARRAVAERVARLVRPAPGGLLLEVGAGRGVLTEALAPYCGRLVAHEIDPRLL
PALRDRFGGPHHAHVRISGGDFLAAPVPREPFALAGNIPYSRTAGIVDWALRARTLTSAT
FVTQLEYARKRTGDYGRWSLLTVRTWPRHEWRLLGRVSRREFRPVPRVDSGILRIERRER
PLLPSAALGDYHRMVELGFSGVGGSLYASLRRAHRAGPLDAAFRAARLDRSVVVAYVTPE
QWLTVFRTLRPVRSRPAGR
>AAA98096|FEATURES|argannot|macrolide-lincosamide-streptogramin|ErmT|antibiotic target alteration|1
MNKKNIKDSQNFITSKHHINEILRNVHLNTNDNIIEIGSGKGHFSFELAKRCNYVTAIEI
DPKLCRITKNKLIEYENFQVINKDILQFKFPKNKSYKIFGNIPYNISTDIIRKIVFESTA
TESYLIVEYGFAKRLLNTNRSLALFLMTEVDISILSKIPREYFHPKPRVNSSLIVLKRHP
SKISLKDRKQYENFVMKWVNKEYIKLFSKNQFYQALKYARIDDLNNISFEQFLSLFNSYK
LFNR
>AAB51440|FEATURES|argannot|macrolide-lincosamide-streptogramin|ErmV|antibiotic target alteration|1
MARPSRVSRALSQNFLADRAAAGQLARLAAPHGLPVPLLLEVGAGKGALTELLAPRCRSL
LAYEIDPRLVPVLRSRFADAPHVRVLGEDFLRARAPRTPFSVAGNVPFSRTAAVVAWCLR
APHLTDATLLTQLEYARRRTGDYGSWTRLTVLTWPRHEWRLAGRVGRRSFRPVPRVDAGI
VRIERRRTPLLAPGADAGWRELVDLGFSGAGGSLHASLRRARPRRRVDAAFRAAGLDRDV
LVGEVPPWTWLRLHEVLGS
>BAA03402|FEATURES|argannot|macrolide-lincosamide-streptogramin|ErmW|antibiotic target alteration|1
MSSIRRRHAAASLDTPAVGGRHELGQNFLVDRGVCTRIAEVVSSTTAHPVLELGAGDGAI
TRALVAANLPVTALELDPRRVRRLQRTFADGVTVVHGDMLRYDFGPYPHHVVSTVPFSIT
TPLLRRLIGQRFWHTAVLLVQWEVARKRAGVGGTTMLTAASWPWYEFTLVERVPKTSFDP
VPSVDGGILVIERRSAPLLDDRCVGDYQNLVREVYTGPGRGLAAILRTRLPGREVDAWLR
RERVDPAALPRDLKAGHWASLYRLYREVGTRPAPAGRSVRARPGSVGPDRSLPPRGLRSG
PPRARRRGGGA
>BAB20748|FEATURES|argannot|macrolide-lincosamide-streptogramin|ErmY|antibiotic target alteration|1
MNKKDIKFSQNFITSKRHINKIMSNLELNRNDNVFEIGSGKGHFTLELVQKCNYVTVIEI
DSNLCIQTQNKVTNYDNFRIINKDILQFKFPNNKAYKIYGNIPYYISTDIVRKIVFESEA
TVSYLIVEEGFAKRLLNTNRSLALLLMTEVDISILSKIPKEYFHPKPKINSSLIILKRHP
SKISYKDKKMYNNFVMKWVNQEYSKLFTKNQFNKALNYAKIKDLKNINFEQFLSVFNSYK
LFNN
>AAG03357|FEATURES|argannot|macrolide-lincosamide-streptogramin|ErmX|antibiotic target alteration|1
MSAYGHGRHEHGQNFLTNHKIINSIIDLVKQTSGPIIEIGPGSGALTHPMAHLGRAITAV
EVDAKLAAKITQETSSAAVEVVHDDFLNFRLPATPCVIVGNIPFHLTTAILRKLLHAPAW
TDAVLLMQWEVARRRAGVGASTMMTAQWSPWFTFHLGSRVPRPAFRPQPNVDGGILVIRR
VGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRQGCFHHVQKHNHGCAREESTPRPYL
PDCTPTTGSISSR
>AGI42804|FEATURES|argannot|macrolide-lincosamide-streptogramin|lnuB|antibiotic inactivation|1
MLKQKELIANVKNLTESDERITACMMYGSFTKGEGDQYSDIEFYIFLKDSITSNFDSSNW
LFDVAPYLMLYKNEYGTEVVIFDNLIRGEFHFLSEKDMNIIPSFKDSGYIPDTKAMLIYD
ETGQLENYLSEISGARPNRLTEENANFLLCNFSNLWLMGINVLKRGEYARSLELLSQLQK
NTLQLIRMAEKNADNWLNMSKNLEKEISLENYKKFAKTTARLDKVELFEAYKNSLLLVMD
LQSHLIEQYNLKVTHDILERLLNYISE
>CAA42550.1|FEATURES|argannot|macrolide-lincosamide-streptogramin|LmrA|antibiotic efflux|0
MSVFARATSLFSRAARTRAADEAARSRSRWVTLVFLAVLQLLIAVDVTVVNIALPAIRDS
FHVDTRQLTWVVTGYTVVGGGLLMVGGRIADLFGRRRTLLFGAFLFGASSLAAGLAPNLE
LLVLARFGQGAGEALSLPAAMSLIACSSRTAPFQGVERLASVASVGLVLGFLLSGVITQL
FSWRWIFLINIPLVSLVLVAVLLLVKKDETTARNPVDLPGALLFTAAPLLLIFGVNELGE
DEPRLPLAVGSLLAAAVCAAAFVAVERRTAHPLVPLTFFGNRVRLVANGATVLLSAALST
SFFLLTMHLQEERDLSPIEAGLSFLPLGLSLILACVLVRGLIERIGTTGAAVLGMALAGP
RHRLFALLPSDNSLLTSVFPGMILLLRMATGLVALQNAALHAVTEADAGVASGVQRCADQ
LGGASGIAVYVSIGFSPHLGGDWDPFTVAYSLAGIGLIAAVLAVLALSPDRRLAAPREQE
D
>CAA55745|FEATURES|argannot|macrolide-lincosamide-streptogramin|ErmU|antibiotic target alteration|1
VPSRYGSRQELGQNFLVDPDIIKLIRRAAERTEGPIVDLGAGDGALTLPLSRLGRPVTAV
ELDPRRVKRLSARAPENVKVVGEDILRFRLPTVPHTVVGNIPFHVTTATMRRILVAPAWV
SAVLVVQWEVARRRAGIGGCSLVTAESWPWFDFSVLKRVPRFAFRPAPSVDGGILVIERR
PEPLVRERREYQDFVRQVFTGRGHGLREILQRIGRVQDSDLSAWFRAHGVSPQALPKDLT
AEQWASLWGMARGGRSVPRTRRPRGLPPRTSRGPRRNSG
>AAA26652|FEATURES|argannot|macrolide-lincosamide-streptogramin|linA|antibiotic inactivation|1
MKNNNVTEKELFYILDLFEHMKVTYWLDGGWGVDVLTGKQQREHRDIDIDFDAQHTQKVI
QKLEDIGYKIEVHWMPSRMELKHEEYGYLDIHPINLNDDGSITQANPEGGNYVFQNDWFS
ETNYKDRKIPCISKEAQLLFHSGYDLTETDHFDIKNLKSIT
>CAB41414|FEATURES|argannot|macrolide-lincosamide-streptogramin|linB|antibiotic inactivation|1
MLKQKELIANVKNLTESDERITACMMYGSFTKGEGDQYSDIEFYIFLKHSITSNFDSSNW
LFDVAPYLMLYKNEYGTEVVIFDNLIRGEFHFLSEKDMNIIPSFKDSGYIPDTKAMLIYD
ETGQLENYLSEISGARPNRLTEENANFLLCNFSNLWLMGINVLKRGEYARSLELLSQLQK
NTLQLIRMAEKNADNWLNMSKNLEKEISLENYKKFAKTTARLDKVELFEAYKNSLLLVMD
LQSHLIEQYNLKVTHDILERLLNYISE
>AAY32951|FEATURES|argannot|macrolide-lincosamide-streptogramin|lnuC|antibiotic inactivation|1
MVNITDVNQIFQFAIDAEIKVFLDGGWGVDALLGYQSRAHNDIDIFVEKNDYQNFIEIMK
ANGFYEIKMEYTTLNHTVWEDLKNRIIDLHCFEYTDEGEILYDGDCFPVETLSGKGRIEE
IEVSCIEPYSQVMFHLGYEFDENDAHDVKLLCETLHIEIPNEYR
>ABR14060|FEATURES|argannot|macrolide-lincosamide-streptogramin|lnuD|antibiotic inactivation|1
MVNKADAIEIILYAEENEIDIWLDGGWGVDALLGEETRSHNDIDLFVEEKNGKTFIEILK
EKGFTEVIEAYTTTDHTVWKDDKDRIIDLHVFEFNEQGDLVFEGESYPSNVFSGIGKIGN
KVVKCIDAENQVLFHLGYEHDENDVHDVRLLCERYNIPVPSEYK
>ABV04087|FEATURES|argannot|macrolide-lincosamide-streptogramin|linG|antibiotic inactivation|1
MLQLKMIELFKEGCHEDARIIAALMFGSFAIGEGDEFSDIEFAVFIQDDHFENFDQRSWL
NAVSPVAAYFPDDFGHHTALFENGIRGEFHFMRKSDIPVISTWQGYGWFPSLEAAVLLDR
SGELSRYASALVGGPPIREGAPLVEGLVLNLISLMLFGANLLNRGEYARAWALLSKAHEN
LLKLVRLHEGATDHWPTPSRALEKDISEDSYNRYLACTSSAEPRALCAAYHQTWTWSLEL
FKSVTEPLNIELPRTVIAQAKRLLNESATPHNK
>CAE18145|FEATURES|argannot|multidrug|lsaB|antibiotic target protection|1
MSMIHVQNLTFSYPSSFDNIFEDVSFQIDTDWKLGFIGRNGRGKTTLFNLLLDKFEYRGK
IISSVDFNYFPYPVEDKSKYTHEILEEICPQAEDWEFLREIAYLNVDAEAMYRPFETLSN
GEQTKVLLVALFLNEGQFLLIDEPTNHLDTEARKTVSNYLRKKKGNILISHDRNFLDGSV
DHILSINRADIEVQSGNYSSWKLNFDRQQGHEQATNERLQKDIGRLEQSTKRSAGWSNRV
EASKNGTTNSGSKLDKGFVGHKAAKMMKRSKNLEARQQKSIEEKSKLLKNIEKTESLQFE
PVEYKSKELIQLTDVSVIYDGQVVNKPISFNVEQGDRIVLDGKNGSGKSSILKLILGDPI
QYTGTLNTGSNLITSYVQQDTSHLKGMLADFIEENEIDESLFKAILRKLDFDRVQFEKDI
SHYSGGQKKKLLIAKSLCEKAHLYIWDEPLNFIDIYSRMQIEELIQTFNPTMVFVEHDQT
FQETISTKIIKI
>AEA37904|FEATURES|argannot|multidrug|lsaC|antibiotic target protection|1
MSTIKIENLTFSYYGYVKPVFENVSFSFDTNWKTGLIGRNGIGKSTLFKLLLNQEVYKGK
ISKSVDFIKFPPNLSDTSKLGIELYRELISDEEEWKLFRELHLLKVDESLIYRKFETLSK
GEQTKILLAILFTREDGFLLIDEPTNHLDMDGRKIVSEYLKNKKGFLLISHDRDFLDGCI
NHIISINRNSIDVQSGNFTSWYENKLMKDQFEISQNEKLRKDIKRLKEAARQSQIWSDKV
ENTKNGVKVSGVKPDKGHIGHQSAKMMKKSKNLENRQNKAIEEKQNLLKDIETKESLLLH
PLHHHKNPLISVCDLSSYYGKKQILSNISFDIKQGDIVAIYGGNGSGKSTLIKILLGLNH
EYSGDVKLASNLKISYVPQDTSNLTGSLNEYIHKQGVDETLCKTILRKLDFARELFEIDM
KNYSDGQKKKVLIAVSLSKSAHIFIWDEPLNYLDVISRIQIEEIIKEANPTLIFVEHDKS
FVEDIANKIIRL
>ABE02099.1|FEATURES|argannot|macrolide-lincosamide-streptogramin|mphA|antibiotic inactivation|1
MTVVTTADTSQLYALAARHGLKLHGPLTVNELGLDYRIVIATVDDGRRWVLRIPRRAEVS
AKVEPEARVLAMLKNRLPFAVPDWRVANAELVAYPMLEDSTAMVIQPGSSTPDWVVPQDS
EVFAESFATALAALHAVPISAAVDAGMLIRTPTQARQKVADDVDRVRREFVVNDKRLHRW
QRWLDDDSSWPDFSVVVHGDLYVGHVLIDNTERVSGMIDWSEARVDDPAIDMAAHLMVFG
EEGLAKLLLTYEAAGGRVWPRLAHHIAERLAFGAVTYALFALDSGNEEYLAAAKAQLAAA
E
>BAA12910|FEATURES|argannot|macrolide-lincosamide-streptogramin|mphB|antibiotic inactivation|1
MSKDIKQVIEIAKKHNLFLKEETIQFNESGLDFQAVFAQDNNGIDWVLRLPRREDVMPRT
KVEKQALDLVNKYAISFQAPNWIIYTEELIAYKKLDGVPAGTIDHNIGNYIWEIDINNVP
ELFHKSLGRVLAELHSIPSNKAAALDLVVHTPEEARMSMKQRMDAVRAKFGVGENLWNRW
QAWLNDDDMWPKKTGLIHGDVHAGHTMIDKDANVTGLIDWTEAKVTDVSHDFIFNYRAFG
EEGLEALILAYKEIGGYYWPKMKEHIIELNAAYPVSIAEFALVSGIEEYEQMAKEALEVQ
GS
>AAF99569|FEATURES|argannot|macrolide-lincosamide-streptogramin|mphC|antibiotic inactivation|1
MTRHNEIIKCAEKYQLHIQPQTISLNESGLDFQVAFGKDKHGVEWVLRLPRRPDVYKRTK
PEKQTVDFLQKNVSFEIPKWKVHAKDLIAYPKLTGKPAATIDPEIQNYVWEIEHKPLPEN
FINTLAETLVDLHNIPEENINVQHINIKTIQEIKNDFQRRMNKVKETYGVSDELWNRWKQ
WLENDELWPRHATMIHGDLHPGHIMVDNQANVTGLIDWTEATHSDPSMDFIGHHRVFDDE
GLEQLITAYGKAGGEIWPRMKEHIIELNAVFPMFIAEFAMESGESAYETMALKELGMKE
>WP_033591432.1|FEATURES|argannot|macrolide-lincosamide-streptogramin|MphD|antibiotic efflux|0
MMTKTSKTKTENLITKKELNQVFWRSFQMEFSWNYERQMNMAYVYAMIPILKKLYPQKEE
MAAALKRHLAFFNTTPHIVTFILGINAAMEEENVLDENFEVGTIDSIKTSLMGPLAGLGD
SFFWGTLRLIATGVGTSLALQGNVLGPILFLLIFNVPHVIVRYLLNRWGYKLGTGFLKNI
QANGMMESLTLGASIIGLMVVGAMTASMIDLTIPITISGSGKNAVTVQSIFDDIMPKLLP
LASFGFVFYLLKKEVKPLAILGGMAIVGILGSLIGLF
>AEG42377.1|FEATURES|argannot|macrolide-lincosamide-streptogramin|mphD|antibiotic inactivation|1
MTIQDIQSLAEAHGLLITDKMNFNEMGIDFKVVFALDTKGQQWLLRIPRRDGMREQIKKE
KRILELVKKHLSVEVPDWRISSTELVAYPILKDNPVLNLDAETYEIIWNMDKDSPKYITS
LAKTLFEIHSIPEKEVRENDLKIMKPSDLRPEIANNLQLVKSEIGISEQLETRYRKWLDN
DVLWADFTQFIHGDLYAGHVLASKDGAVSGVIDWSTAHIDDPAIDFAGHVTLFGEESLKT
LIIEYEKLGGKVWNKLYEQTLERAAASPLMYGLFALETQNESLIVGAKAQLGVI
>AAA26832|FEATURES|argannot|macrolide-lincosamide-streptogramin|tlrC|antibiotic target protection|1
MRTSPSSQLSLHGVTKRYDDRVVLSQVSLAISPGEKAGIIGDNGAGKSTLLRLLAGEERP
DAGEVTVIAPGGVGYLPQTLGLPPRATVQDAIDLAMTELRVLEAELRRTEAALAEAATDE
ALQDALTAYARLTEQYEVRDGYGADARVDAALHGLGLPGLPRDRRLGTLSGGERSRLALA
ATLASQPELLLLDEPTNDLDDRAVHWLEEHLSGHRGTVVTVTHDRVFLDRLTATVLEVDG
RGVSRHGDGYAGYLAAKAAERRRRQQQYDEWRAELDRNRRLAEANVARLDGIPRKMGKAA
FGHGAFRARGRDHGAMSRVRNAKERVERLTANPVAPPADRLSLTARIATADGPGEAPAAE
LDGVVVGSRLRVPKLRLGAAERLLITGPNGAGKSTLLSVLAGELSPDAGAVSVPGRVGHL
RQEETPWPAKLTVLEAFAHNRPGDRDEQADRRLSLGLFEPEALRLRVGELSYGQRRRIEL
ARLVSEPVGLLLLDEPTNHLSPALVEELEEALTGYGGALVLVTHDRRMRSRFTGSHLELR
EGVVSGAR
>AAF91071|FEATURES|argannot|macrolide-lincosamide-streptogramin|msrC|antibiotic target protection|1
MENLAVNITNLQVSFGNQLELSIDSLRVYQQDRIGIIGENGVGKSTLLKLIAGELFPDHG
KIQTEITFNYLPQLTYLAEAKDLNLELASHFQLRLEETSERKWSGGEERKIELIRLLSSY
EQGMLLDEPTTHLDRKSIDRLIEELRYYYGTLVFVSHDRYFLDELASKIWEVKDGEIREF
SGNYSAYLTQKELEKKTQLREAESIMKEKKRLEKSIQEKKKQAEKLEKVSSKKKKQQIRP
DRLSSSKQKDSVQKAIQKNAKTLERRLQKIGETTKPQQMKQIRFPVPKSLELHSRYPIMG
QNVQLERSGRTLLVNGDFQFSLGKKIAIVGENGSGKTTLLEHIRKQGEGILLSPKVSFQV
YQQKDYQMTSEESVIRFVMRQTEFSESLVRSLLNHLGFAQETLAKPLCTLSGGEATRLMI
ALLFTKPSNVLLLDEPTNFIDMATIEALEKLMQVYPGTILFTSHDSYFVERTADEVYEIK
GQKIKKVLTRNF
>AAK69028|FEATURES|argannot|macrolide-lincosamide-streptogramin|mel|antibiotic target protection|1
MELILKAKDIRVEFKGRDVLDINELEVYDYDRIGLVGANGAGKSTLLRVLLGELTPPGCK
MNRLGELAYIPQLDEVTLQEEKDFALVGKLGVEQLNIQTMSGGEETRLKIAQALSAQVHG
ILADEPTSHLDREGIDFLIGQLKYFTGALLVISHDRYFLDEIVDKIWELKDGKITEYWGN
YSDYLRQKEEERKSQAAEYEQFIAERARLERAAEEKRKQARKIEQKAKGSSKKKSTEDGG
RLAHQKSIGSKEKKMYNAAKTLEHRIAALGKVEAPEGIRRIRFRQSKALELHNPYPIVGA
EINKVFGDKALFENASFQIPLGAKVALTGGNGIGKTTLIQMILNHEEGISISPKAKIGYF
AQNGYKYNSNQNVMEFMQKDCDYNISEIRSVLASMGFKQNDIGKSLSVLSGGEIIKLLLA
KMLMGRYNILIMDEPSNFLDIPSLEALEILMKEYTGTIVFITHDKRLLENVADVVYEIRD
KKINLKH
>AEG42376.1|FEATURES|argannot|macrolide-lincosamide-streptogramin|msrE|antibiotic target protection|1
MSLIIKARNIRLDYAGRDVLDIDELEIHSYDRIGLVGDNGAGKSSLLKVLNGEIVLAEAT
LQRFGDFAHISQLGGIEIETVEDRAMLSRLGVSNVQNDTMSGGEETRAKIAAAFSQQVHG
ILADEPTSHLDLNGIDLLIGQLKAFDGALLVISHDRYFLDMVVDKIWELKDGKITEYWGG
YSDYLRQKEEERQHQAVEYELMMKERERLESAVQEKRQQANRLDNKKKGEKSKNSTESAG
RLGHAKMTGTKQRKLYQAAKSMEKRLAALEDIQAPEHLRSIRFRQSSALELHNKFPITAD
GLSLKFGSRTIFDDANFIIPLGAKVAITGSNGTGKTSLLKMISERADGLTISPKAEIGYF
TQTGYKFNTHKSVLSFMQEECEYTVAEIRAVLASMGIGANDIQKNLSDLSGGEIIKLLLS
KMLLGKYNILLMDEPGNYLDLKSIAALETMMKSYAGTIIFVSHDKQLVDNIADIIYEIKD
HKIIKTFERDC
>AAA50325|FEATURES|argannot|macrolide-lincosamide-streptogramin|oleB|antibiotic target protection|1
MQNAHRSDTGAAALTGTPEKLLPTQPETGSFQVVLDDVVRAPGGRPLLDGVNQSVALGER
VGIIGENGSGKSTLLRMLAGVDRPDGGQVLVRAPGGCGYLPQTPDLPPEDTVQDAIDHAL
AELRSLERGLREAEQALAGAEPEELEGLLGAYGDLLEAFEARDGYAADARVDAAMHGLGL
AGITGDRRLGSLSGGEQARLNLACLLAASPQLMLLDEPTNHLDVGALEWLEERLRAHRGS
VLVVSHDRVFLERVATALWEVDGERRTVNRHGGGYAGYLQAKAAARRRWEQAYQDWLEDL
ARQRELARSAADHLATGPRRNTERSNQRHQRNVEKQISARVRNAKERVRRLEENPVPRPP
QPMRFRARVEGGGTVGRGGALAELYKVTVGTRLDVPSFTVDPGERILITGHNGAGKSTLL
RVLAGDLAPDQGECERPERIGWLPQETEITDRQQSLLAAFAAGLPGIAEEHRGALLGFGL
FRPSALGTAVGDLSTGQLRRLALARLLRDPADLLLLDEPTNHLSPALVEDLEEALAHYRG
ALVVVSHDRMFAQRFTGRRMHMEGGRFVE
>AAA86871|FEATURES|argannot|macrolide-lincosamide-streptogramin|vatB|antibiotic inactivation|1
MKYGPDPNSIYPHEEIKSVCFIKNTITNPNIIVGDYTYYSDVNGAEKFEEHVTHHYEFRG
DKLVIGKFCAIAEGIEFIMNGANHRMNSITTYPFNIMGNGWEKATPSLEDLPFKGDTVVG
NDVWIGQNVTVMPGIQIGDGAIVAANSVVTKDVPPYRIIGGNPSRIIKKRFEDELIDYLL
QIKWWDWSAQKIFSNLETLCSSDLEKIKSIRD
>AAA24783|FEATURES|argannot|macrolide-lincosamide-streptogramin|vatD|antibiotic inactivation|1
MGPNPMKMYPIEGNKSVQFIKPILEKLENVEVGEYSYYDSKNGETFDKQILYHYPILNDK
LKIGKFCSIGPGVTIIMNGANHRMDGSTYPFNLFGNGWEKHMPKLDQLPIKGDTIIGNDV
WIGKDVVIMPGVKIGDGAIVAANSVVVKDIAPYMLAGGNPANEIKQRFDQDTINQLLDIK
WWNWPIDIINENIDKILDNSIIREVIWKK
>AAD44719|FEATURES|argannot|macrolide-lincosamide-streptogramin|vatE|antibiotic inactivation|1
MTIPDANAIYPNSAIKEVVFIKNVIKSPNIEIGDYTYYDDPVNPTDFEKHVTHHYEFLGD
KLIIGKFCSIASGIEFIMNGANHVMKGISTYPFNILGGDWQQYTPELTDLPLKGDTVVGN
DVWFGQNVTVLPGVKIGDGAIIGANSVVTKDVAPYTIVGGNPIQLIGPRFEPEVIQALEN
LAWWNKDIEWITANVPKLMQTTPTLELINSLMEK
>ABH10964|FEATURES|argannot|macrolide-lincosamide-streptogramin|vgaALC|antibiotic target protection|1
MKILLEGLHIKHYVQDRLLLNINRLKIYQNDRIGLIGKNGSGKTTLLHILYKKIVPEEGI
VKQFSHCELIPQLKLIESTKSGGEVTRNYIRQALDKNPELLLADEPTTNLDNNYIEKLEQ
DLKNWHGAFIIVSHDRAFLDNLCTTIWEIDEGRITEYKGNYSNYVEQKELERHREELEYE
KYEKEKKRLEKAINIKEQKAQRATKKPKNLSSSEGKIKVTKPYFASKQKKLRKTVKSLET
RLEKLERVEKRNELPPLKMDLVNLESVKNRTIIRGEDVSGTIEGRVLWKAKSFSIRGGDK
MAIIGSNGTGKTTFIKKIVHGNPGISLSPSVKIGYFSQKIDTLELDKSILENVQSSSQQN
ETLIRTILARMHFFRDDVYKPISVLSGGERVKVALTKVFLSEVNTLVLDEPTNFLDMEAI
EAFESLLKEYNGSIIFVSHDRKFIEKVATRIMTIDNKEIKIFDGTYEQFKQAEKPTRNIK
EDKKLLLETKITEVLSRLSIEPSEELEQEFQNLINEKRNLDK
>AAB95639|FEATURES|argannot|multidrug|vgaB|antibiotic target protection|1
MLKIDMKNVKKYYADKLILNIKELKIYSGDKIGIVGKNGVGKTTLLKIIKGLIEIDEGNI
IISEKTTIKYISQLEEPHSKIIDGKYASIFQVENKWNDNMSGGEKTRFKLAEGFQDQCSL
MLVDEPTSNLDIEGIELITNTFKEYRDTFLVVSHDRIFLDQVCTKIFEIENGYIREFIGN
YTNYIEQKEMLLRKQQEEYEKYNSKRKQLEQAIKLKENKAQGMIKPPSKTMGTSESRIWK
MQHATKQKKMHRNTKSLETRIDKLNHVEKIKELPSIKMDLPNREQFHGRNVISLKNLSIK
FNNQFLWRDASFVIKGGEKVAIIGNNGVGKTTLLKLILEKVESVIISPSVKIGYVSQNLD
VLQSHKSILENVMSTSIQDETIARIVLARLHFYRNDVHKEINVLSGGEQIKVAFAKLFVS
DCNTLILDEPTNYLDIDAVEALEELLITYEGVVLFASHDKKFIQNLAEQLLIIENNKVKK
FEGTYIEYLKIKDKPKLNTNEKELKEKKMILEMQISSLLSKISMEENEEKNKELDEKYKL
KLKELKSLNKNI
>ACX92986|FEATURES|argannot|multidrug|vgaD|antibiotic target protection|1
MLILEANHIEKSINDRKLLDVTHLQIHYEDRIGVVGRNGSGKTTLLSILAGEIEADKGEV
KTSASRYFLPQLKETDTFRSGGEITKSYIDKALAMKAEILFADEPTTNLDTHNIKELEKH
FSRYRGAIILVSHNRYFLDQICTKIWEIEDGEVKEIHGNYTSYVKQKELLRRQQQEEYEK
YITKKKQLERAVTMKEQKAQKMIKPPSKQMGTSESRIWKMQHATKQKKMHQNIKALETRV
EKLERVKKPKDYPAVKMKLSNQDQIQGRNVLRVKDLSVSFGNHVLWTDASFTIKGGEKAA
IIGNNGVGKTTLLKQILERVPAVTISPAAKIGYFSQNLDTLDTHVSILENVMSTAIQDET
TVRTVLARLHFYREDVYKEVQVLSGGERVKVAFAKLFVSDYNTLILDEPTNYLDIDAIEA
LEELLINYEGAVLFVSHDCRFVQNIASKIIELSDQKVIEFLGSYKAFRERSQETERDYMK
EELLKIEIKLTQMISEMNDEASNELEKEFQMLIHERNQLRNQVNN
>CBY88983|FEATURES|argannot|macrolide-lincosamide-streptogramin|vgaE|antibiotic target protection|1
MLLFEGTSLKKHIQDRLLFDIDLIQVHEHQRIGLVGRNGTGKTSLLKIITGEELVDGGNV
NHFTSVKLVPQFKETRSEKSGGEITQQYLQLAFNEKPGLLILDEPTTHLDTQRIDWLEKK
LANYQGAFVVVSHDRTFLNNVCTEIWEIEDGSLNAFKGDYNAYAEQKELIKTQQQIAFEK
YEREKKQLEKAIRQKEERAQRATKKPKNLSSSEARITGAKTHYANIQKKLRGSAKALETR
LEQLDRIDKVKELPEIKMDILNKESLTNQSVLRAENIKGEVDGRKLWNPFSLYLYGGDKV
AIIGKNGTGKTTLLKKIVERDERIAIPEKVRIGYFSQHLTILDDDKTIIENIQLTSSQDE
TLIRTVLARMHFWDEDVYKKVGILSGGEKVKVALAKLFLSDVNMLVLDEPTNFLDIESLE
ALETLMKSYHGTILFVTHDRTLVTNIATKIIDIKDGKITVFDGSYEAYEEWLENQTKSNN
DDQLLLIETKISDVLGRLSLEPSRELEDEFQRLLKEKKELTKKL
>AAF24087|FEATURES|argannot|macrolide-lincosamide-streptogramin|VgbA|antibiotic inactivation|1
MEFKLQELNLTNQDTGPYGITVSDKGKVWITQHKANMISCINLDGKITEYPLPTPDAKVM
CLTISSDGEVWFTENAANKIGRITKKGIIKEYTLPNPDSAPYGITEGPNGDIWFTEMNGN
RIGRITDDGKIREYELPNKGSYPSFITLGSDNALWFTENQNNAIGRITESGDITEFKIPT
PASGPVGITKGNDDALWFVEIIGNKIGRITPLGEITEFKIPTPNARPHAITAGAGIDLWF
TEWGANKIGRLTSNNIIEEYPIQIKSAEPHGICFDGETIWFAMECDKIGKLTLIKDNME
>WP_041823632|FEATURES|argannot|macrolide-lincosamide-streptogramin|carA|antibiotic target protection|0
MPTQITALAVTKAYQGQVVLDSVTCSLTEGERTGIIGENGSGKTTLLRLLAGPEQPDSGE
IVLHATGGVGYFAQDGELPPHVTVAQVVDHALGELRAVEARLRDLEARMADGDTSSLAEY
GDLLTVFELRGGYEADARLERALHGLGLGHLPRDRVVGGLSGGEQARLRLACVLASGPEV
LLLDEPTNHLDASALTWLETYLSTRRGTTVAVSHDRAFLEHVTTTLLEVDADRRQVFRYG
NGYAGYLAEKAAARQRWAQAYDEWRAETDRLRETAATTARRVAPGRAMTDRNKMAYGRAA
GRVQQSVASRVRNAEERLRRLLADPVPAPPEPLRFTAAPRPAGDPQGAVLDAAAITVTGR
LAATDLTVTAGERVLITGANGAGKTTLLRVLAGELAPDGGRVSRRGRIGYLSQEPPPGRP
GETLLAAFARGRAGTAEEHAERLLALGLFTADRFDTPVTRLSTGQRQRLALARLVTAPAD
VLLLDEPTNHLSPALVEELEEALAGFPGALVVVSHDRRLRERWRGSRVELADSGTAALRM
>CAA50578|FEATURES|argannot|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MFREMRRKRQLLPTEESVAILERMTNGTLALHGDDGYPYAVPISYVYADGKIYFHSAMKG
HKVDAILQNDKVSFCVVEQDDIRPSEFTTYFRSVIVFGKAHILTDELEKRVALGLLADKY
SYGEAGMEAEIAKGFNHLLIVKIAIEHITGKEAIELTKNRNDRP
>AAQ63644|FEATURES|argannot|chloramphenicol|cat|antibiotic inactivation|0
MEILTLLIRDTMGSKRIFLNPYFQQQPTFSLTNEINITILMKNLKKKHYKLYPAFIFMVT
KIVNAHREFRINFNSEGNLGYWTEICPLYTIFDNKSHTFSGIWSPNLTIFSEFHSKYEND
AERYNGTRRLFPKKPIPDNPIPISMIPWSSFTAFNLNINNGGDFLLPIITGGKYSQVNDE
LFLPVSIQNASCLFVMATMQSVFINDLQNLVDESEDWIYLVVSDEWYY
>CAA26367|FEATURES|argannot|chloramphenicol|IO48_10670|antibiotic inactivation|1
MTFNIIKLENWDRKEYFEHYFNQQTTYSITKEIDITLFKDMIKKKGYEIYPSLIYAIMEV
VNKNKVFRTGINSENKLGYWDKLNPLYTVFNKQTEKFTNIWTESDNNFTSFYNNYKNDLL
EYKDKEEMFPKKPIPENTIPISMIPWIDFSSFNLNIGNNSNFLLPIITIGKFYSENNKIY
IPVALQLHHAVCDGYHASLFMNEFQDIIHKVDDWI
>AAQ55242|FEATURES|argannot|chloramphenicol|cat|antibiotic inactivation|1
MTFNIINLETWDRKEYFNHYFNQQTTYSVTKELDITLLKSMIKDKGYELYPALIHAIVSV
INRNKVFRTGINSEGNLGYWDKLEPLYTVFNKETEKFSNIWTESNASFNSFYNSYKNDLF
KYKDKNEMFPKKPIPENTVPISMIPWIDFSSFNLNIGNNSRFLLPIITIGKFYSKDDKIY
LPFSLQVHHAVCDGYHVSLFMNEFQNIIDNVNEWI
>AAA22289|FEATURES|argannot|chloramphenicol|cat86|antibiotic inactivation|1
LFKQIDENYLRKEHFHHYMTLTRCSYSLVINLDITKLHAILKEKKLKVYPVQIYLLARAV
QKIPEFRMDQVNDELGYWEILHPSYTILNKETKTFSSIWTPFDENFAQFYKSCVADIETF
SKSSNLFPKPHMPENMFNISSLPWIDFTSFNLNVSTDEAYLLPIFTIGKFKVEEGKIILP
VAIQVHHAVCDGYHAGQYVEYLRWLIEHCDEWLNDSLHIT
>CAA37805|FEATURES|argannot|chloramphenicol|catII|antibiotic inactivation|1
MNFTRIDLNTWNRREHFALYRQQIKCGFSLTTKLDITALRTALAETGYKFYPLMIYLISR
AVNQFPEFRMALKDNELIYWDQSDPVFTVFHKETETFSALSCRYFPDLSEFMAGYNAVTA
EYQHDTRLFPQGNLPENHLNISSLPWVSFDGFNLNITGNDDYFAPVFTMAKFQQEGDRVL
LPVSVQVHHAVCDGFHAARFINTLQLMCDNILK
>CAA30695|FEATURES|argannot|chloramphenicol|catIII|antibiotic inactivation|1
MNYTKFDVKNWVRREHFEFYRHRLPCGFSLTSKIDITTLKKSLDDSAYKFYPVMIYLIAQ
AVNQFDELRMAIKDDELIVWDSVDPQFTVFHQETETFSALSCPYSSDIDQFMVNYLSVME
RYKSDTKLFPQGVTPENHLNISALPWVNFDSFNLNVANFTDYFAPIITMAKYQQEGDRLL
LPLSVQVHHAVCDGFHVARFINRLQELCNSKLK
>AAA26615|FEATURES|argannot|chloramphenicol|cat|antibiotic inactivation|1
MTFNIIKLENWDRKEYFEHYFNQQTTYSITKEIDITLFKDMIKKKGYEIYPSLIYAIMEV
VNKNKVFRTGINSENKLGYWDKLNPLYTVFNKQTEKFTNIWTESDNNFTSFYNNYKNDLF
EYKDKEEMFPKKPIPENTIPISMIPWIDFSSFNLNIGNNSSFLLPIITIGKFYSENNKIY
IPVALQLHHAVCDGYHASLFINEFQDIIKKVDDWI
>YP_001429534|FEATURES|argannot|chloramphenicol|cat|antibiotic inactivation|1
MTFNIINLETWDRKEYFNHYFNQQTTYSVTKEFDITLLKSMIKNKGYELYPALIYTIVNI
INQNKVFRTGINSEGNLGYWEKLNPLYTVFNKETEKFSNIWTESNVSFNSFYNSYKSDLL
EYKDKNEMFPKKPIPENTVPISMIPWIDFSSFNLNIGNNSRFLLPIITIGKFYSKNNKIY
LPVSLQVHHAVCDGYHVSLFMSEFQNIVDSVNEWI
>AAA92251|FEATURES|argannot|chloramphenicol|JP30_06285|antibiotic inactivation|1
MNFNKIDLDNWKRKEIFNHYLNQQTTFSITTEIDISVLYRNIKQEGYKFYPAFIFLVTRV
INSNTAFRTGYNSDGELGYWDKLEPLYTIFDGVSKTFSGIWTPVKNDFKEFYDLYLSDVE
KYNGSGKLFPKTPIPENAFSLSIIPWTSFTGFNLNINNNSNYLLPIITAGKFINKGNSIY
LPLSLQVHHSVCDGYHAGLFMNSIQELSDRPNDWLL
>AAA22081|FEATURES|argannot|chloramphenicol|cat|antibiotic inactivation|1
MENYFESPFRGITLDKQVKSPNLVVGKYSYYSGYYHGHSFEDCARYLLPDEGADRLVIGS
FCSIGSGAAFIMAGNQGHRNEWISTFPFFFMPEVPEFENAANGYLPAGDTVIGNDVWIGS
EAIIMPGITVGDGAVIGTRALVTKDVEPYAIVGGNPAKTIRKRFDDDSIALLLEMKWWGW
PAERLKAAMPLMTSGNVAALYRFWRSDSL
>AAC14737.2|FEATURES|argannot|chloramphenicol|catB2|antibiotic inactivation|1
MTNYFESPFKGKLLTEQVKNPNIKVGRYSYYSGYYHGHSFDDCARYLLPDRDDVDQLIIG
SFCSIGSGAAFIMAGNQGHRYDWVSSFPFFYMNEEPAFAKSVDAFQRAGDTVIGSDVWIG
SEAMIMPGIKIGHGAVIGSRALVAKDVEPYTIVGGNPAKSIRKRFSEEEISMLLDMAWWD
WPLEQIKEAMPFLCSSGIASLYRRWQGTSA
>CAA08841.1|FEATURES|argannot|chloramphenicol|catB3|antibiotic inactivation|1
MTNYFDSPFKGKLLSEQVKNPNIKVGRYSYYSGYYHGHSFDDCARYLFPDRDDVDKLIIG
SFCSIGSGASFIMAGNQGHRYDWASSFPFFYMQEEPAFSSALDAFQKAGNTVIGNDVWIG
SEAMVMPGIKIGHGAVIGSRSLVTKDVEPYAIVGSNPAKKIKKRFTDEEISLLLEMEWWN
WSLEKIKAAMPMLCSSNIVGLHKYWLEFAV
>ACQ42045|FEATURES|argannot|chloramphenicol|catB3|antibiotic inactivation|1
MTNYFDSPFKGKLLSEQVKNPNIKVGRYSYYSGYYHGHSFDDCARYLFPDRDDVDKLIIG
SFCSIGSGASFIMAGNQGHRYDWASSFPFFYMQEEPAFSSALDAFQKAGNTVIGNDVWIG
SEAMVMPGIKIGHGAVIGSRSLVTKDVGHCCKVSDEAAFCLIQRPYISKTLLTRRISPRG
SP
>EDL73619|FEATURES|argannot|chloramphenicol|catB9|antibiotic inactivation|1
MNFFTSPFSGIPLDQQVTNPNIIVGKHSYYSGYYHGHSFDDCVRYLHPERDDVDKLVIGS
FCSIGSGAVFMMAGNQGHRSDWISTFPFFYQDNDNFADARDGFTRSGDTIIGHDVWIGTE
AMIMPGVKIGHGAIIASRSVVTKDVAPYEVVGSNPAKHIKFRFSDVEIAMLLEMAWWNWP
ESWLKESMQSLCSSDIEGLYLYWQSKART
>CAA11474|FEATURES|argannot|glycopeptide|vanO|antibiotic efflux|0
MDVDLQSIGIQTVQEALEKGSLIFNEKTKTDDFNRACDHILVLLVDAFQCFDRGSWGTSV
FLSITAIEEVAKAEVGLYRREGKIGKAKRGKDKLFNHQEKHRMAILPTVFMSKRLEEALG
KEKCAELLKEAAHGEFRNLRESSLYFSNENGQFVTPANVVSQNRAKEFLLLALEAADDRL
VGYTNHTGILEAKINEIFSVVAHS
>AAD02068.1|FEATURES|argannot|chloramphenicol|catB7|antibiotic inactivation|1
MGNYFESPFRGKLLSEQVSNPNIRVGRYSYYSGYYHGHSFDDCARYLMPDRDDVDKLVIG
SFCSIGSGAAFIMAGNQGHRAEWASTFPFHFMHEEPVFAGAVNGYQPAGDTLIGHDVWIG
TEAMFMPGVRVGHGAIIGSRALVTGDVEPYAIVGGNPARTIRKRFSDGDIQNLLEMAWWD
WPLADIEAAMPLLCTGDIPALYRHWKQRQATA
>AAF61918.1|FEATURES|argannot|chloramphenicol|catB8|antibiotic inactivation|1
MKNYFNSPFKGELLSEQVKNPNIRVGRYSYYSGYYHGHSFDECARYLLPDRDDVDKLIIG
SFCSIGSGASFIMAGNQGHRHDWASSFPFFYMQEEPAFSRALDAFQRAGDTVIGNDVWIG
SEAMIMPGIKIGDGAVIGSRSLVTKDVEPYAIIGGNPAKQIKKRFSDEEISLLMEMEWWN
WPLDKIKTAMPLLCSSNIFGLHKYWREFAV
>AAL68645|FEATURES|argannot|chloramphenicol|catB9|antibiotic inactivation|1
MNFFTSPFSGIPLDQQVTNPNIIVGKHSYYSGYYHGHSFDDCVRYLHPERDDVDKLVIGS
FCSIGSGAVFMMAGNQGHRSDWISTFPFFYQDNDNFADARDGFTRSGDTIIGHDVWIGTE
AMIMPGVKIGHGAIIASRSVVTKDVAPYEVVGSNPAKHIKFRFSDVEIAMLLEMAWWNWP
ESWLKESMQSLCSSDIEGLYLNWQSKART
>CAI47810|FEATURES|argannot|chloramphenicol|catB10|antibiotic inactivation|1
MTNYFESPFKGKLLADQVKNPNIKVGRYSYYSGYYHGHSFDECARFLLPDRDDIDQLIVG
SFCSIGTGASFIMAGNQGHRYDWASSFPFFYMKEEPAFSGALDAFQKAGDTVIGSDVWIG
SEAMIMPGINVGHGAVIGSRALVTKDVEPYTIVGGNPAKPIKKRFSDEEIAMLLKMNWWD
WPTEKIEEAMPLLCSSNIVGLHRYWQGFAV
>AAB51421|FEATURES|argannot|chloramphenicol|catD|antibiotic inactivation|1
MVFEKIDKNSWNRKEYFDHYFASVPCTYSMTVKVDITQIKEKGMKLYPAMLYYIAMIVNR
HSEFRTAINQDGELGIYDEMIPSYTIFHNDTETFSSLWTECKSDFKSFLADYESDTQRYG
NNHRMEGKPNAPENIFNVSMIPWSTFDGFNLNLQKGYDYLIPIFTMGKYYKEDNKIILPL
AIQVHHAVCDGFHICRFVNELQELINS
>AAA23215|FEATURES|argannot|chloramphenicol|catQ|antibiotic inactivation|1
MKFNLIDIEDWNRKPYFEHYLNAVRCTYSMTANIEITGLLREIKLKGLKLYPTLIYIITT
VVNRHKEFRTCFDQKGKLGYWDSMNPSYTVFHKDNETFSSIWTEYDENFPRFYYNYLEDI
RNYSDVLNFMPKTGEPANTINVSSIPWVNFTGFNLNIYNDATYLIPIFTLGKYFQQDNKI
LLPMSVQVHHAVCDGYHISRFFNEAQELASNYETWLGEK
>CAA52904|FEATURES|argannot|chloramphenicol|catS|antibiotic inactivation|0
FTNIPCTYSMTVKLDITQIKKKRMKLYPAMLYYLATIVNRHSEFRTAINQEGELGIYDEM
IPSYTIFHEDTETFSNLWTPYIPDFEAFSMAYANDMQRYGSNYGMIGKPDIPENVFNVSM
IPWSTFDSFNLNLQKGYDYLIPIFTMGKYYRDDEKIILPLAIQV
>CAA42594|FEATURES|argannot|chloramphenicol|cml|antibiotic efflux|1
MPLPLYLLAVAVCAMGTSEFMLAGLVPDIASDLGVTVGTAGTLTSAFATGMIVGAPLVAA
LARTWPRRSSLLGFILAFAAAHAVGAGTTSFPVLVACRVVAALANAGFLAVALTTAAALV
PADKQGRALAVLLSGTTVATVAGVPGGSLLGTWLGWRATFWAVAVCCLPAAFGVLKAIPA
GRATAAATGGPPLRVELAALKTPRLLLAMLLGALVNAATFASFTFLAPVVTDTAGLGDLW
ISVALVLFGAGSFAGVTVAGRLSDRRPAQVLAVAGPLLLVGWPALAMLADRPVALLTLVF
VQGALSFALGSTLITRVLYEAAGAPTMAGSYATAALNVGAAAGPLVAATTLGHTTGNLGP
LWASGLLVAVALLVAFPFRTVITTAAPADATR
>ADV91378.1|FEATURES|argannot|chloramphenicol|cmlA5|antibiotic efflux|1
VRSKNFSWRYSLAATVLLLSPFDLLASLGMDMYLPAVPFMPNALGTTASTIQLTLTTYLV
MIGAGQLLFGPLSDRLGRRPVLLGGGLAYVVASMGLALTSSAEVFLGLRILQACGASACL
VSTFATVRDIYAGREESNVIYGILGSMLAMVPAVGPLLGALVDMWLGWRAIFAFLGLGMI
AASAAAWRFWPETRVQRVAGLQWSQLLLPVKCLNFWLYTLCYAAGMGSFFVFFSIAPGLM
MGRQGVSQLGFSLLFATVAIAMVFTARFMGRVIPKWGSPSVLRMGMGCLIAGAVLLAITE
IWASQSVLGFIAPMWLVGIGVATAVSVSPNGALRGFDHVAGTVTAVYFCLGGVLLGSIGT
LIISLLPRNTAWPVVVYCLTLATVVLGLSCVSRVKGSRGQGEHDVVALQSAESTSNPNR
>YP_009080793|FEATURES|argannot|chloramphenicol|cmlA5|antibiotic efflux|1
VRSKDFSWRYSLAATLLLLSPFDLLASLGMDMYLPVVPFMAGALGAGAGTIQLTLTVYLV
LLGAGQLLFGPLSDLLGRRPVLLGGGITYILASFGLAAASSPEVFLSFRILQACGASACL
VSTFATVRDIYSGSEESNVIYGLLGSMLAMVPAIGPLLGALVDAWLGWRAIFGLLGIAMI
GAVTAAWRFWPETRRQRTADLQWSQLLLPVKCLNFWLYTLCYSAGMGSFFVFFSTAPWLM
MGRQALSQLSFSLLFATVAIAMMATARIMGRLIPRWGSLNTLRVGMGCLVVGALLLAVGE
TLIPNSVLGFIAPMWLVGVGIATAASVAPNGALRGFDHIAGTATAVYFCLGGLLLGGIGT
FIIALLPSDTTWPIIAYCLILAIAVLCLSCFNPNRHHPSDDEHDSLATQDIGRSQSGHGH
D
>AAB36568|FEATURES|argannot|chloramphenicol|cmlv|antibiotic inactivation|1
MPSPSAEPTTSTPTPDAGPAASPRMPLAVYILGLSAFALGTSEFMLSGLVPPIAEDMNVS
IPRAGLLISAFAIGMVVGAPLLAVATLRLPRKTTLIALITVFGLRQMAGALAPNYAVLFA
SRVISALPCAGFWAVGAAVAIAMVPVGSRARALAVMIGGLSIANVLRVPAGAFLGEHLGW
ASAFWAVGLASAIALVGVVTRIPRIPLPETRPRPLKNEVAIYRDRQVLLSIAVTALAAGG
VFCAFSYLAPLLTDVSGLDEAWVSGVLGLFGIGAVVGTTIGGRVADAHLFGVLLTGISAS
TVFLVALALFASNPAATIVLTFLLGVSAFYTAPALNARMFNVAGAAPTLAGATTTAAFNL
GNTGGPWLGGTVIDANLGFASTAWAGAAMTVLGLGTAALALRLTKRPAPGHVVARSRGAG
GTTPSEPARGKATSSC
>AEX07579|FEATURES|argannot|multidrug|fexA|antibiotic efflux|1
MKKDSKSKEMIQSEKRGSTRLLMMVLSLSVLVGAITADLVNPVLPLISKDLEASKSQVSW
IVSGIALVLAIGVPIYGRISDFFELRKLYIFAIMILASGSLLCAIAPNLPLLVLGRMVQG
AGMSAIPVLSVIAISKVFPQGKRGGALGIIAGSIGVGTAAGPIFGGVVGQYLGWNALFWF
TFLLAIMIVIGAYYALPTIKPAESVGSNKNFDFIGGLFLGLTVGLLLFGITQGETSGFSS
FSSLTSLIGSVVALVGFIWRIVTAENPFVPPVLFNNKDYVNTVIIAFFSMFAYFAVLVFV
PLLVVEVNGLSSGQAGMILLPGGVAVAILSPFVGRLSDRFGDKRLIITGMTLMGLSTLFL
STYASGASPLLVSVGVLGVGIAFAFTNSPANNAAVSALDADKVGVGMGIFQGALYLGAGT
GAGMIGALLSARRDATEPINPLYILDAMSYSDAFLAATGAILIALIAGLGLKKRG
>EIN87433|FEATURES|argannot|multidrug|floR|antibiotic efflux|1
MTTTRPAWAYTLPAALLLMAPFDILASLAMDIYLPVVPAMPGILNTTPAMIQLTLSLYMV
MLGVGQVIFGPLSDRIGRRPILLAGATAFVIASLGAAWSSTAPAFVAFRLLQAVGASAML
VATFATVRDVYANRPEGVVIYGLFSSMLAFVPALGPIAGALIGEFLGWQAIFITLAILAM
LALLNAGFRWHETRPLDQVKTRRSVLPIFASPAFWVYTVGFSAGMGTYFVFFSTATRVLI
GQAEYSEIGFSFAFATVALVMIVTTRFAKSFVARWGIAGCVARGMALLVCGAVLLGIGEL
YGSPSFLTFILPMWVVAVGIVFTVSVTANGALAEFDDIAGSAVAFYFCVQSLIVSIVGTL
AVALLNGDTAWPVICYATAMAVLVSLGLVLLRLRGAATEKSPVV
>AAB46601|FEATURES|argannot|chloramphenicol|cmx|antibiotic efflux|1
MPFALYMLALAVFVMGTSEFMLAGLLPAIATELDVSVGTAGLLTSAFAVGMVVGAPVIAA
FARRWPPRLTLIVCLLVFAGSHVIGAMTPVFSLLLITRVLSALANAGFLAVALSTATTLV
PANQKGRALSILLSGTTIATVVGVPAGALLGTALGWRTTFWAIAILCIPAAVGVIRGVTN
NVGRSETSATSPRLRVELSQLATPRLILAMALGALINGGTFAAFTFLAPIVTETAGLAEA
WVSVALVMFGIGSFLGVTIAGRLSDQRPGLVLAVGGPLLLTGWIVLAVVASHPVALIVLV
LVQGFLSFGVGSTLITRVLYAASGAPTMGGSYATAALNIGAAAGPVLGALGLATGLGLLA
PVWVASVLTAIALVIMLLTRRALTKTAAEAN
>BAB43543.1|FEATURES|argannot|chloramphenicol|cmx|antibiotic efflux|0
MSIMRLFTFILSIFIVGMVEMMVAGIMNLMSQDLHVSEAVVGQLVTMYALTFAICGPILV
KLTNRFSSRPVLLWTLLIFIIGNGIIAVAPNFSILVVGRIISSAAAALIIVKVLAITAML
SAPKNRGKMIGLVYTGFSGANVFGVPIGTVIGDLVGWRYTFLFLIIVSIIVGFLMMIYLP
KDQEIQRGPVNHEAPSHENHVTSKILRPAEVAKYLIITFLVLIANSVTFVFINPLILSNG
HDMSFVSLALLVNGIAGVIGTSLGGIFSDKITSKRWLMISVSIFIVMMLLMNLILPGSGL
LLAGLFIWNIMQWSTNPAVQSGVIQHVEGDTSQVMSWNMSSLNAGIGVGGIIGGLVMTHV
SVQAITYTSAIIGALGLIVVFTLKNNHYAKTFKSS
>AFE02723.1|FEATURES|argannot|rifampin|arr-2|antibiotic inactivation|1
MVKDWIPISHDNYKQVQGPFYHGTKANLAIGDLLTTGFISHFEDGRILKHIYFSALMEPA
VWGAELAMSLSGLEGRGYIYIVEPTGPFEDDPNLTNKKFPGNPTQSYRTCEPLRIVGVVE
DWEGHPVELIRGMLDSLEDLKRRGLHVIED
>AEP16488|FEATURES|argannot|rifampin|arr-3|antibiotic inactivation|1
MVKDWIPISHDNYKQVQGPFYHGTKANLAIGDLLTTGFISHFEDGRILKHIYFSALMEPA
VWGAELAMSLSGLEGRGYIYIVEPTGPFEDDPNLTNKRFPGNPTQSYRTCEPLRIVGVVE
DWEGHPVELIRGMLDSLEDLKRRGLHVIED
>ABV26705|FEATURES|argannot|rifampin|arr-4|antibiotic inactivation|1
MTNDWIPTSHDNCSQVAGPFYHGTKAKLTVGDLLSPGHPSHFEQGRKLKHIYFAALMEPA
IWGAELAMSLSSLEGRGHIYIVEPLGPFEDDPNLTNKKFPGNPTKSYRTTEPLRIVGIVE
DWQGHSPEVLQGMLASLEDLQRRGLAIIED
>ABV26707|FEATURES|argannot|rifampin|arr-5|antibiotic inactivation|1
MTVDWIPISHDNYHQVRGPFYHGTKAELAIGDLISTGFISHFERDRALKHVYFSALMEPA
IWGAELAVALSGSDGPGHIYIIEPTGPFEDDPNLTNKRFPGNPTQSYRTCHPLKIVGILR
EWERHSPEALKTMLDSLADLKRRGLAIIEE
>CAZ48628|FEATURES|argannot|rifampin|arr-7|antibiotic inactivation|1
MPNDWIPTSHENCSLVPGPFYHGTKAKLAIGDLLSPGHPSHFEQGRRLKHIYFAALMEPA
IWGAELAMSLSRQEGRGYIYIVEPLGPFEDDPNLTNKKFPGNPTKSYRTSESLRIVEVVE
DWQGHSPDVLQGMLASLEDLQRRGLAIIED
>ABR68540|FEATURES|argannot|rifampin|rif|antibiotic inactivation|0
MELTTFNTNHPFIHSAYPKTFSYVPKNENDIYSVNVTDVRVEAISSPEIKLILPEIKGKG
RVSYLKNYQFLLLDYFEIWLKNKDEHPFLFHKAKSEEIFSTYIINEYHSLNYFTNKDDFL
TTKEGTHADCIIFPKKEISIPLDSLLSAFKIFKDTEIIFNFKFHNIEEIIAYDVEFRRHS
LEQLKKNFSETSLNIRFQFLNVPIISSAELTATNVITKKDVIGKDNTQMMNTSDFSNTIA
VSFHSKSDIFNHENRYIINPGVDYSEDVLVQKWVLNILKDLLIVTTKDMSLSENKKALGF
KDEAVFHEITKNTMTFNKLEKRFCKITIENIPEDHKLYYHTNILSFTRRFQHTKALNVST
LFKKITGVYLPNQKVINFLDIDHSIDIKIVSLPISIWDHELNSHPGDLRSNAMKERDFFF
KNRFLLGMDFNCKDRGYERISLKGGKDIFENLLRERKPFLRKLPIIEFDPAMQRGISLYT
TFISPSLMIYADPSINFTNFLVEIQWKEYDECDPLNLLKRFPCVDLYEMQKITQNPDTQR
ISIESI
>AAB41059|FEATURES|argannot|rifampin|iri|antibiotic inactivation|1
MSDVIIVGAGPTGLMLAGELRLQGVDVVVVDKDEEPTQFVRALGIHVRSIEIMEQRGLLD
KFLAHGRKYPLGGFFAGISKPAPAHLDTAHGYVLGIPQPEIDRILAEHATEVGADIQRGK
RVVAIRQDTDNVAAELSDGTTLHARYLVGCDGGRSTVRKLRSTSVFPASRTSADTLIGEM
DVTMPADELAAVVAEIRETHKRFGVGPAGNGAFRVVVPAAEVADGRATPTTLDDIKQQLL
AIAGTDFGVHSPRWLSRFGDATRLADDYRRDRVFLAGDAAHIHPPMGGQGLNLGVQDAFN
LGWKLAAEINGWAPVGLLDTYESERRPVAADVLDNTRAQAELISTAAGPQAVRRLISELM
EFEDVKRYLTEKITAISIRYDFGEGDDLLGRRLRNIALTRGNLYDLMRSGRGLLLDQGGQ
LSVDGWSDRADHIVDTSTELEAPAVLLRPDGHVAWIGDAQAELDTQLSTWFGRSARDRA
>ABZ82584.1|FEATURES|argannot|sulfonamide|sul2|antibiotic target replacement|1
MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVS
SDTEIARIAPVLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDAAFYPQLAK
SSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFF
LGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAAA
GGADFIRTHEPRPLRDGLAVLAALKETARIR
>AEK32510|FEATURES|argannot|sulfonamide|sul3|antibiotic target replacement|1
MSKIFGIVNITTDSFSDGGLYLDTDKAIEHALHLVEDGADVIDLGAASSNPDTTEVGVVE
EIKRLKPVIKALKEKGISISVDTFKPEVQSFCIEQKVDFINDIQGFPYPEIYSGLAKSDC
KLVLMHSVQRIGAATKVETNPEEVFTSMMEFFKERIAALVEAGVKRERIILDPGMGFFLG
SNPETSILVLKRFPEIQEAFNLQVMIAVSRKSFLGKITGTDVKSRLAPTLAAEMYAYKKG
ADYLRTHDVKSLSDALKISKALG
>CAA37477|FEATURES|argannot|tetracycline|otrA|antibiotic target protection|1
MNKLNLGILAHVDAGKTSLTERLLHRTGVIDEVGSVDAGTTTTDSMELERQRGITIRSAV
ATFVLDDLKVNLIDTPGHSDFISEVERALGVLDGAVLVVSAVEGVQPQTRILMRTLRRLG
IPTLVFVNKIDRGGARPDGVLREIRDRLTPAAVALSAVADAGTPRARAIALGPDTDPDFA
VRVGELLADHDDAFLTAYLDEEHVLTEKEYAEELAAQTARGLVHPVYFGSALTGEGLDHL
VHGIRELLPSVHASQDAPLRATVFKVDRGARGEAVAYLRLVSGTLGTRDSVTLHRVDHTG
RVTEHAGRITALRVFEHGSATSETRATAGDIAQAWGLKDVRVGDRAGHLDGPPPRNFFAP
PSLETVIRPERPEEAGRLHAALRMLDEQDPSIDLRQDEENAAGAVVRLYGEVQKEILGST
LAESFGVRVRFDPTRTVCIEKPVGTGEALIELDTRTHNYFWGAPWVCASDRPSPARAITF
RLAVELGSLPLAFHKAIEETVHTTLRHGLYGWQVTDCAVTLTRTGVRSPVSAADDFRKAN
ARLVLMDALGRAGTEVHEPVSSFELEVPAARLSPVLAKLAELGATPGVPTAEGDVFRLEG
TMPTSLVHDFNQRVPGLTQGEGVFLAEHRGYRPAVGQPPVRPRPEGPNPLNRDEYILHVL
KRV
>AAR96051|FEATURES|argannot|tetracycline|otrC|antibiotic efflux|0
MTRKTISNGARNAVEVRGLVKHFGEVKAVDGVDLDVREGTVLGVLGPXGAAXXRGALPAH
VXGPDAGRRPWRFXTWCANRRALRRTIGXHRPVRXGRRESFSGRENLYMIGRXLDLSRKD
ARARADELLERFSLTEAAGRAAAKYSGGMRRRLDLAASMIGRPAVLYLDEPTTGLDPRTR
NEVWDEVRSMVRDGATVLLTTQYMEEAEQLAHELTVIDRGRVIADGKVDELKTKVGGRTL
QIRPAHAAELDRMVGAIAQAGLDGIAGATADHEDGVVNVPIVSDEQLSAVVGMLGERGFT
ISGHQHPSAQLXEVFLAITGQKTSEAADGGPQDGPQDQQGVQDKQYEEVPA
>BAA07390|FEATURES|argannot|tetracycline|tcr3|antibiotic efflux|1
MGMANATSQTGEAVADEAGGPAGFTHRQIITALSGLLLAVLLAALDQTIVSTALRTIGDQ
LHGQTVQAWVITGYLVSSTIAMPFYGKLSDIYGRKPLYLAAIAVFIVGSAACAMANSMET
LAIARVLQGFGGAGLMSLPTAVIADLAPVRERGRYFSYLMMAWVAASVLGPLVGGLFAGA
GEILGVTGWRWAFLINVPLGLVALLSVRKALNLPHRRVDHPIDFRGALTLALCLVPLLIV
AEEGLDWGWGSARSLTLFAVSLIGLVLFVLAERARGLEAMVPLRLFRRGGITMATAVNFT
IGVGIFGTVSTLPLFLQLVQGRSATVAGLVIIPVMTGAIVSQTICAKIIKKWNRYKKPAI
VGLGSMAGALLSLSAAGADTPLAVIVVIAAWLGFGIGLSQTVITLAIQSSAPKSELGVAN
AASGLFRQLGGTSGAAVFMSVLFGVAAGRLDGADPDEAVRRALSDPGSTGGLSASAVDAF
TSGFDTMFLVGGLILAVGFLLTFPLRELRDEE
>AAD09860|FEATURES|argannot|tetracycline|tet(30)|antibiotic efflux|1
MNKALIVILSTVALDAIGAGLIFPILPDILVEVTGGGDIGFLYGVMLGVFAVMQFVFSPI
LGALSDRFGRRPVLLLSLAGTLLDYLVMAFSPLGWVLVVGRAMAGITSANMAVASAYITD
ITPAEQRAQRFGTVGAVMSLGFIIGPVIGGVIGAWWLRAPFLVAALFNGLNLFVALFVLP
ESRKAGPGKFAFKELNPLAPLVWLWNFKPLLPLVTVSVVFGLVAAIPGTIWVLYGAERFG
WDSVHMGLSLSVFGVSGALAQAFLVGPLSRRFGDLGTLMIGVGFDMLAYMLMAFANQSWM
GYAVAPLFALGGVAMPALQSLVTSRVSDDQQGQLQGVLASLMSLAGIIGPVLTTAVFFST
KSIWIGTIWLVGAALYLLALPLFATVKTPKAVAA
>CAC80727|FEATURES|argannot|tetracycline|tet31|antibiotic efflux|1
MIGKLIMMNRYITIALLITFLDATGMGLIMPVLPTLLEEFSVKESIATHYGFILAIYALM
QVIFAPILGQLSDKFGRKPVLILSLIGAVCDYTLLSFSSALWMLYLGRMIAGISAATGAV
AASMVADHTKKAERTKWFGKLGAAFGAGLIAGPAIGGFIGQYSAHFPFIIAAILNAIALI
MVIILFPKEQSRPKEIEQDQSKIHEKTTINAPLIHILKPVLLLLMLFFTVQLIGQIPAST
WVLFTEYRFEWNTFNIGLSLAGLGLMHIIFQAFVAGYIASRWKNETVFILGFILDASAFL
LLAFISQVWLVIPTLILLAGGGIALPALQGLISIKTADEHQGKIQGIMVSLTNITGIIGP
PIFAFSFAKTVTNWDGTLWLIGAVLYSILLGLYFLYQKIRAYKQLKSQTA
>BAB59035|FEATURES|argannot|tetracycline|tet34|antibiotic target alteration|1
MSKKFIITWDAMQNYCRQLAEKQMPAEQWKGIWAVSRGGLVPGAILARELGIRHVDTICI
SSYDHDHQRDMTVLKAPEGDGEGYLIVEDLVDSGDTARKLREMYPKAKLIAVCAKPSGAT
LLDDYVVDIAQDTWIEQPWDTTVQFVEPINRKQK
>AAK37619|FEATURES|argannot|tetracycline|tet35|antibiotic efflux|1
MCVIMPASSWGAYIITIIGGILVSHGITEYSALGAYVRLIPMNFYAVFALLMVFAVAWFG
LDIGKMREHEIAASQGRGFDKDKENDSQEAHDLNEELDIRESEKGKVSDLILPIVTLIVA
TIASMLYTGGQALAADGKEFVLLGAFENTDVGTSLIYGSLLGLAVALFTVIKQGLPMVEI
ARTLWIGAKSMFGAILILVFAWTIGSVIGDMKTGSYLSTMAQGNINPHWLPVILFLLSGL
MAFSTGTSWGTFGIMLPIAGDMAGATDVALMLPMLSAVLAGAVFGDHCSPISDTTILSST
GARCNHIDHVSTQLPYALSVAFVSCIGFITLGMTASIAFSFIAASITFVIVCAILSWLSK
SKMASCQNA
>CAD55718|FEATURES|argannot|tetracycline|tet36|antibiotic target protection|1
MRTINIGILAHIDAGKTSITENLLFASGATIVRGSVDKGNTTTDSMDIEKRRGITVRAST
TSIQWNDTKINIIDTPGHMDFLAEVERTFRMLDGAILVVSAKEGIQAQTRLLFNVLQQLE
IPTILFVNKIDREGVNLNQLYLEIQNSLSKDIIFMQSVEGKELTSSCTIHYISEKNRETI
LEKDDLLLEKYLSDTQLSNLDYWNSMVRLVQAAKLHPIYHGSAMYGIGIEDLLNSITTFI
ETSLPQENALSAYVYKIEHNKKEQKRAYLKIIGGTLKSRKLYSLNGSDENLKIRGLKTFY
SGDEIDVDEVFTNDIAIADHADNLMVGDYLGIMPNLFDKLNIPSPALKSSIHPAKVENRS
KLISAMNVLSVEDPSLAFSINADNNELEVSLYGATQREVILTLLEERFSVDAYFEEVKTI
YKERLKTKSEYTIHIEVPPNPYWASIGLIIEPLPIGAGLVMESEISLGYLNRSFQNAVFD
GVKKACESGLYGWEVTDLKVTFSHGIYYSPVSTPADFRSLAPYVFRLALQQADVELLEPI
LDFKLQIPLAVNARAITDINKMQGEISTITSDGDWTTILGNIPLDTSKEYSAEVSSYTQG
LGVFVTRFSGYRPTNKKVSRSVELNEKDKLMYMFEKESIK
>AAN28721|FEATURES|argannot|tetracycline|tet37|antibiotic inactivation|1
MVRYYSNIVGKYGIPVQNALKKLAGIHIDYICSTHGPVWHENVEKVVNLYDRMSKYETDP
GLVICYGTMYGNTEDRTPSMYEYIWIKENREAKVVSSFAANIYLGWGR
>ACD35503|FEATURES|argannot|tetracycline|tet42|antibiotic efflux|1
MTSPTSLTRRDQNRAWIMLIVLTMLTVIGMTVVLPVLPFVVLQYVSHESDLAIWVGVLEA
INGLCAFLVAPFLGRLSDRFGRRPVIIVAAFGAAFSMALFGFGGALWVLVLARVIQGLTA
GDLPALFAYLADITPPEQRAKRFGLLGALSGIGTMIGPAIGGLLAAISIQLPVFLTAAVA
LTIAILSIFLLPESLKPGNRITAIKLRDVQPFAVFKEAFGRKELRGLMIGFGLLALPFGF
FVNNFSVLALDSIQWGPTQIGLLTAAVGIIDILIQGVLLGILLPRIGERGVIVSGIVAQM
IGLAALAVVASVFAQPWVFIVGALMLAAGQGASQAAMDGAMSNAVGDDEQGWLGGATQSL
NAAMGTAAPLIAGALYALVSHAAPYWLGVALMIVAVTVVSRAHIANTAKRPAGETTGDAP
AALVETAG
>CCN79972|FEATURES|argannot|multidrug|mtrR|antibiotic efflux|0
MTKLQPNTVIRAALDLLNEVGVDGLTTRKLAERLGVQQPALYWHFRNKRALLDALAEAML
AENHTHSVPRADDDWRSFLIGNARSFRQALLAYRDGARIHAGTRPGAPQMETADAQLRFL
CEAGFSAGDAVNALMTISYFTVGAVLEEQAGDSDAGERGGTVEQAPLSPLLRAAIDAFDE
AGPDAAFEQGLAVIVDGLAKRRLVVRNVEGPRKGDD
>AAB24797|FEATURES|argannot|multidrug|mtrR|antibiotic efflux|0
MTKLDKGTVIAAGLELLNEVGMDSLTTRKLAERLKVQQPALYWHFQNKRALLDALPEAML
RERHTRSLPEENEDWRVFLKENALSFRTALLSYRDGARIHAGTRPTEPNFGTAETQIRFL
CAEGFCPKRAVWALRAVSHYVVGSVLEQQASDADERVPDRPDVSEQAPSSFLHVLFHELE
TDGMDAAFNFGLDSLIAGFERLRAAVLATD
>ACE95681|FEATURES|argannot|tetracycline|tetC|antibiotic efflux|1
MKSNNALIVILGTVTLDAVGIGLVMPVLPGLLRDIVHSDSIASHYGVLLALYALMQFLCA
PVLGALSDRFGRRPVLLASLLGATIDYAIMATTPVLWILYAGRIVAGITGATGAVAGAYI
ADITDGEDRARHFGLMSACFGVGMVAGPVAGGLLGAISLHAPFLAAAVLNGLNLLLGCFL
MQESHKGERRPMPLRAFNPVSSFRWARGMTIVAALMTVFFIMQLVGQVPAALWVIFGEDR
FRWSATMIGLSLAVFGILHALAQAFVTGPATKRFGEKQAIIAGMAADALGYVLLAFATRG
WMAFPIMILLASGGIGMPALQAMLSRQVDDDHQGQLQGSLAALTSLTSIIGPLIVTAIYA
ASASTWNGLAWIVGAALYLVCLPALRRGAWSRATST
>ABP38225.1|FEATURES|argannot|tetracycline|tetH|antibiotic inactivation|0
MPLDNVLAIRRLYIMIKRYYAIGIAVTATLLIPTEALASITPVLQPGNPFDPDSPFARLY
LPQNAPKGKDKVGPAEWTHAYGSPTHNAGFSVSAHAPAWVRRGVQWNFPEARAWPLTDPT
PFGAQVDGVKEALPVQTQFYGNALGVSMVRGVVYAESDDMFAYAINARTGKLIWRTSPVG
NNLMGNPLVIGNRVFLSAGSVSFNFANVVEFKTDPDKAGRGKDISYNGIYCLNSKTGMLE
WYFPTAGDAMPTPAYAYHSLYISTGDGNVYRINASDGKQIWKTHVGGIANMSSPAVWHGR
VYVGMSVVPGLYALNARTGSVDWKGEIPGAVNTGMGDVSPAVAHGIVVMDAVANPKIVDG
KPTMVTLVRGFNAKTGTALWTDNMGRGAKIPAFKGGVPMIHGNVVYVGSPVTSDYDAINL
DTGKVLWTWHVPHPGPAGAARGAPTYYQHMLYISTGPDLYVLNPKNGQEVGHYHVGGRFG
IVNPTIVGGTIYLGNSWDWVNAVPVKDVYSGFNTAKD
>AAD12753|FEATURES|argannot|tetracycline|tetJ|antibiotic efflux|1
MNKSIIIILLVTVLDAIGIGLIMPVLPTLLNEFVSENRLANHYGILLALYATMQVIFAPI
LGKLSDKYGRKPILLISLLGAALDYLLMACPTSLWMLYIGRIIAGITGATGAVCASAMTD
VTHPHERTRYFGFLGGAFGVGLIIGPMLGGLLGEISAHTPFIFAAISHSLLFIFSLLCFQ
ETQTTKISTEISALNQDTAPHSTTGFIKKSLFFWLIAYFIIQLIGQIPATIWVLFTQVRF
AWHTTEVGLSLAFLGVLHIFFQAVLAGKLAQKWGERNTVIISMSIDAFGCLLLAWISHVW
VMLPALICLAAGGMGQPALQGYLSKSVDHHVQGQLQGTLVSLTNITGIVGPLLFSFIYSY
SVEYWDGLLWFIGAMLYSGLLVASYFKQKSPILKKFPS
>AAA19179|FEATURES|argannot|tetracycline|tetK|antibiotic efflux|1
MFSLYKKFKGLFYSVLFWLCILSFFSVLNEMVLNVSLPDIANHFNTTPGITNWVNTAYML
TFSIGTAVYGKLSDYINIKKLLIIGISLSCLGSLIAFIGHNHFFILIFGRLVQGVGSAAF
PSLIMVVVARNITRKKQGKAFGFIGSIVALGEGLGPSIGGIIAHYIHWSYLLILPMITIV
TIPFLIKVMVPGKSTKNTLDIVGIVLMSISIICFMLFTTNYNWTFLILFTIFFVIFIKHI
SRVSNPFINPKLGKNIPFMLGLFSGGLIFSIVAGFISMVPYMMKTIYHVNVATIGNSVIF
PGTMSVIVFGYFGGFLVDRKGSLFVFILGSLSISISFLTIAFFVEFSMWLTTFMFIFVMG
GLSFTKTVISKIVSSSLSEEEVASGMSLLNFTSFLSEGTGIAIVGGLLSLQLINRKLVLE
FINYSSGVYSNILVAMAILIILCCLLTIIVFKRSEKQFE
>CBA13543.1|FEATURES|argannot|tetracycline|tetL|antibiotic efflux|1
MNTSYSQSNLRHNQILIWLCILSFFSVLNEMVLNVSLPDIANDFNKPPASTNWVNTAFML
TFSIGTAVYGKLSDQLGIKRLLLFGIIINCFGSVIGFVGHSFFSLLIMARFIQGAGAAAF
PALVMVVVARYIPKENRGKAFGLIGSIVAMGEGVGPAIGGMIAHYIHWSYLLLIPMITII
TVPFLMKLLKKEVRIKGHFDIKGIILMSVGIVFFMLFTTSYSISFLIVSVLSFLIFVKHI
RKVTDPFVDPGLGKNIPFMIGVLCGGIIFGTVAGFVSMVPYMMKDVHQLSTAEIGSVIIF
PGTMSVIIFGYIGGILVDRRGPLYVLNIGVTFLSVSFLTASFLLETTSWFMTIIIVFVLG
GLSFTKTVISTIVSSSLKQQEAGAGMSLLNFTSFLSEGTGIAIVGGLLSIPLLDQRLLPM
EVDQSTYLYSNLLLLFSGIIVISWLVTLNVYKHSQRDF
>AAA23033|FEATURES|argannot|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMK
IPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGTRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMYVPTNG
ELYSSDTACSGDIVILPNDVLQLNSILGNEILLPQRKFIENPLPMIQTTIAVKKSEQREI
LLGALTEISDCDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>AAA25293|FEATURES|argannot|tetracycline|tetS|antibiotic target protection|1
LKIINIGILAHVDAGKTTLTESLLYSSGAIKELGSVDSGTTKTDTMFLERQRGITIQTAI
TSFQRENVKVNIVDTPGHMDFLADVYRSLSVLDGAILLISAKDGVQSQTRILFHALRKMN
IPIIFFINKIDQNGINLPDVYQDIKDKLSDDIIIKQTVNLNLKPYVIDYTEPEQWETVIV
GNDYLLEKYTIGKTLNIAELEKEENERIQSCSLYPVYHGSAKNNIGIKQLIEVITSKLFS
PTQLNSDKLCGNVFKVEYSDDGQRLVYVRLYSGTLHLRDSVNISEKEKIKVTEMYTSING
ELRQIDKAEPGEIIILKNELLKLNNVLGDKKRLPHREILENPLPMLQTTIEPCKSVQREK
LLDALFEISDSDPLLQYYVDTVTHEIVLSFLGEVQMEVTCTLIQEKYHIEIETRKPTVIY
MERPLKKSEFTIDIEVPPNPFWASIGLSVTPLPLGSGIQYESLVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWKLTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQAFRKSGTELLEPYL
SFEIYVPQEYLSRAYNDASKYCANILNTKLKGNEVILIGEIPARCIQEYRNSLTFFTNGR
SVCLTELKGYQVTNIKSAFQPRRPNNRIDKVRHMFNKINLH
>AAF01499|FEATURES|argannot|tetracycline|tetT|antibiotic target protection|1
MKIINIGILAHVDAGKTTVTEGLLYKSGAINKIGRVDNATTTTDSMELERDRGITIRAST
VSFNYNDTKVNIIDTPGHMDFIAEVERTLKVLDGAILVISAKEGIQVQTKVIFNTLVKLN
IPTLIFVNKIDRKGVCLDEIYTQIQEKLTSNLAIMQSVKIKDKGDFELTNVRDDKVIQSQ
IIEKLLDINDYLAEKYINGDVIAEKEYNDVFLDEINNCNLYPVFHGSALKNIGIDELLFA
ITKYLPTKSYNTEDLLSAYVYKIDRDEKSRKMTFLRVFSGNIRTRQDVYINGTEETFKIK
SLESIMNGEIVKVGQVNSGDIAIISNANSLKIGDYIGKKYDGILDIKIAQPALRASIKPC
DLSKRSKLIEALFELTEEDPFLDCEINGDTGEIILRLFGNIQMEVIESLLKSRYKIDARF
GELKTIYKERPKRNSKAVIHIEVPPNPYWASIGLSIEPLPIGSGLLYKTEVSYGYLNNSF
QNAVKDAVEKACKEGLYGWEVTDLKVTFDYGLYYSPVSTPSDFRNLTPYVFWEALRKAGT
EILEPYLKYTVQVPNDFCGRVMSDLRKMRASIEDIIAKGEETTLSGKIPVDTSKSYQSEL
LSYSNGKGIFITEPYGYDIYNDKPIINDIGNDNNDSNKEGLRYLFQKQDEN
>AAB08924|FEATURES|argannot|glycopeptide|vanE|antibiotic target alteration|0
MQLRRGKATDWHAMVQESLDSFASPHFLPIDIKPIDKIVIEGLIAEPSNWSIIARHTKYK
YRNLLKQESQNDELTNHLRETFKESADELKKELDTWLLGLDVTEK
>AAB84282|FEATURES|argannot|tetracycline|tetV|antibiotic efflux|1
VRSPRPVAGWRVLAPFRIREYRLLIAAVTLSIFAEGMWSVVMALQVIAIDNDPASLSLVA
TCLGVGLVAFVLVGGITADRINQRTIIIAVEVVNFVTVAVISALALLGVLKIWHMAVAAG
ILGIAAAFFFPAYSAILPRILPPEQLLAANGVEGVVRPVFQRSVGPAVAGMVIGATMPSI
GAVVVAVLFALGLALLVATRPPAQPASEHHERPHVLRDLREGFAFVLKTPWLLWTVLFAS
MFVLVVLGPIEVLLPFIAQDRFADGARAYGFILAFFGIGSAMGALTVSSRRMPRRYLTTM
MLMWGLGSIPLVIVGYTSSFPLMAAATFVIGVTDGAGMVIWGTLLQRRVPTEMLGRVSSL
DFFVSLAFMPLSFAIVGPLSKVVSMEVIFATAGLVPVAIAAVAFTAARMHRDEVANPLL
>AAA27471|FEATURES|argannot|tetracycline|tetX|antibiotic inactivation|1
MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTL
DLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADKKGNILSTKNVKPENRFDNPEINRNDL
RAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKVRKFVTD
TEVEETGTFNIQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNNGALHFGISFK
TPDEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIHTTLSFVGLATRIFPLEKPWKS
KRPLPITMIGDAAHLMPPFAGQGVNSGLVDALILSDNLADGKFNSIEEAVKNYEQQMFMY
GKEAQEESTQNEIEMFKPDFTFQQLLNV
>AAC72341|FEATURES|argannot|tetracycline|tetY|antibiotic efflux|1
MSKSLITALIVVALDAIGLGLIMPVVPALLNEFVPAEQTAFHYGVFLSLYAFMQVFCAPV
LGRLSDRYGRRIILLVSFLGATIDYSIMAAAPVLWVLYIGRIISGVTGATGAIAASIIAD
TTKQEERARWFGFMGACFGAGMIAGPAIGGVLGDISVHAPFVAGALLNAIAFCLVAFLLP
KTPSQPPEGQPAKINLFEGFRFNFAVQGLASFFALFFLMQLIGQAPAALWVIYGEQRLNW
DIGTAGVSLAVFGAAHTFVQAVLTGTLSKRLGDRGVLLLGMGADMCGFLLLAFITQSWMV
LPAIFMLATGGIGMPALQAIISGLVCDEKQGALQGTLTGLTNITSIIGPVGFTTLYGLTA
GQWDGWVWLVAASLYLIAIPLLRQSASLLRS
>AAD25063|FEATURES|argannot|tetracycline|tetZ|antibiotic efflux|1
VLITATLDAAGLGLVMPILPTLLDQVGAPDDMIPLHVGLLTALYAIMQFLCAPILGRLSD
RFGRRRVLVASLAGATIDYLVLALTDTLWVFYLARAVAGITGATNAVTATVIADITPPDQ
RAKRYGWLGACYGGGMIAGPAIGGLFGGVSPHLPFLVAAALAGITLVLSASLLRETRPPG
SNGSHAQQPGTAKRTAVPGMLILLAVFGIVQFIGQAPGSTWVLFTQQRLDWNPVEVGVSL
SIFGMVQVFVQAALTGRIVSRIGETRAILVGIAADAIGLIGLALIASTWAMLPILAALGL
GSITLPALQTLLSRRAPEQQQGRLQGTLASLNSLTSIIGPVTFTGIFALTRTNADGTLWI
CAAALYVLCALLMIRETCASRRSR
>AFL92279|FEATURES|argannot|trimethoprim|dfrA1|antibiotic target replacement|1
VKLSLMVAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYA
VVTRSSFTSDNENVLIFPSIKDALTNLKKITDHVIVSGGGEIYKSLIDQVDTLHISTIDI
EPEGDVYFPEIPSNFRPVFTQDFASNINYSYQIWQKG
>AAA92749.1|FEATURES|argannot|trimethoprim|dfrA10|antibiotic target replacement|1
MNISLIFANELITRAFGNQGKLPWQFIKEDMQFFQKTTENSVVVMGLNTWRSLPKMKKLG
RDFIVISSTITEHEVLNNNIQIFKSFESFLEAFRDTTKPINVIGGVGLLSEAIEHASTVY
MSSIHMVKPVHADVYVPVELMNKLYSDFKYPENILWVGDPIDSVYSLSIDKFVRPASLVG
VPNDINT
>ADI46759.1|FEATURES|argannot|trimethoprim|dfrA14|antibiotic target replacement|1
LKVSLMAAKAKNGVIGCGPDIPWSAKGEQLLFKALTYNQWLLVGRKTFESMGALPNRKYA
VVTRSGWTSNDDNVVVFQSIEEAMDRLAEFTGHVIVSGGGEIYRETLPMASTLHLSTIDI
EPEGDVFFPSIPNTFEVVFEQHFTSNINYCYQIWKKG
>AEW67113|FEATURES|argannot|trimethoprim|dfrA15|antibiotic target replacement|1
MAAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYAVVTRS
SFTSSDENVLVFPSIDEALNHLKTITDHVIVSGGGEIYKSLIDKVDTLHISTIDIEPEGD
VYFPEIPSSFRPVFSQDFVSNINYSYQIWQKG
>BAD02331.1|FEATURES|argannot|trimethoprim|dfrA17|antibiotic target replacement|1
LKISLISAVSENGVIGSGPDIPWSVKGEQLLFKALTYNQWLLVGRKTFDSMGVLPNRKYA
VVSKNGISSSNENVLVFPSIENALKELSKVTDHVYVSGGGQIYNSLIEKADIIHLSTVHV
EVEGDIKFPIMPENFNLVFEQFFMSNINYTYQIWKKG
>CAC81320|FEATURES|argannot|trimethoprim|dfrA19|antibiotic target replacement|1
MSHPQLELIVAVDSKLGFGKGGKIPWKCKEDMARFTRISKEIRVCVIGKHTYTDMRDMQL
EKDGAEERIKEKGILPERESFVISSTLKQEDVIGATVVPDLRAVINLYENTDQRIAVIGG
EKLYIQALSSATKLHMTIIPREFDCDRFIPVDPIQNNFHIDSSASETVEATVDETQERIH
FATYVRNNQ
>CAE53424|FEATURES|argannot|trimethoprim|dfrA20|antibiotic target replacement|1
MGIKYSLIVAIGKHREMGADNDLLWHLPRDMQFFKETTTGHAVVMGRKSWESIPQKYRPL
PNRLNFVLTRDKNYSAEGATVIYDLKEVAQHLEGKNLTCFIIGGAQIYQLALETGLLNEM
YVTQVHNTFEEADTFFPFVNWGEWEEEDILEQDKDEKHLYSFNIKKFTR
>AAS66087.1|FEATURES|argannot|trimethoprim|dfrA21|antibiotic target replacement|1
MNPESVRIYLVAAMGANRVIGNGPDIPWKIPGEQKIFRRLTESKVVVMGRKTFESIGKPL
PNRHTVVLSRQARYSAPGCAVVSTLSQAIAIAAEHGKELYVAGGAEVYALALPHANGVFL
SEVHQTFEGDAFFPVLNAAEFEVVSSETIQGTITYTHSVYARRNG
>CAF31623.1|FEATURES|argannot|trimethoprim|dfrA22|antibiotic target replacement|1
MNPELVRIYLVAAMGANRVIGNGPDIPWKIPGEQKIFRRLTEGKVVVMGRKTFESIGKPL
PNRRTVVLSRQASYSAAGCAVVSTLSQAIAIAAEHGKELYVAGGAEVYALALPRADGVFL
SEVHQTFEGDAFFPVLDEAEFEVVSAETVQATITYTHSVYARRNG
>CAG34233|FEATURES|argannot|trimethoprim|dfrA23|antibiotic target replacement|1
MPTVEIIVAVDPVGGFGRNGQIPWTCKEDMKRFTTISKEIRVCVMGKNTYKDMLDMQMKK
EGAEERIKEKGILPERESYVVSSTLKPEDVIGATVVPDLRAVLNQYHDSDQRIAVIGGEK
LYVQALASATKVHMTVMHKPYNCDRTLPMSYIDKKFVAGQGSITIQTAVDGETHPVKFIT
YERARP
>CAI99385|FEATURES|argannot|trimethoprim|dfrA24|antibiotic target replacement|1
MTYQLDVSKILSFDLEAIVAATENGGIGYKGDLPWRLQGDLKRFREITQGGIVIMGAGTY
KSLPSPLKDRINIVITKKSEISWTACYDVRVVNSPEDALRMVGRIIDEKEEQGRDRPRVF
VIGGASIYQALMPFVSTLHWTEVHVEQLPEEIGLDTYIEDFLSLRGTSTPKRKSNLVLPP
TPTTP
>ABB71176|FEATURES|argannot|trimethoprim|dfrA25|antibiotic target replacement|1
MAARAKNGVIGCGPDIPWSAKGEQLLFKALTYNQWLLVGRKTFESMGPLPNRKYAVVTRS
NWTAANENVVVFPSIDEAMGRLGEITDHVIVAGGGEIYHETIPMASTLHVSTIDVEPEGD
VFFPNIPGKFDVVFEQQFTSNINYCYQIWQKG
>CAL48457|FEATURES|argannot|trimethoprim|dfrA26|antibiotic target replacement|1
MADEEYDPLLDDDMEDAKVAVIAARAQNGCIGRHGKLPWKLPGDLKYFRERTWGKPIIMG
RKTWESLNGALPGRTNIVVTRQQGYEAEGARVVDSIEEAISLAQSIALIEAVDEIMVLGG
GEIYTQALPQADILYLTEVHASVDGDAFFPDVDLSQYQETQRQDFEPSGGNPYPFSFVVY
QRT
>ACD56152.1|FEATURES|argannot|trimethoprim|dfrA5|antibiotic target replacement|1
MKISLMAAKARNGVIGCGSDIPWNAKGEQLLFKAITYNQWLLVGRKTFEAMGALPNRKYA
VVSRSGSVATNDDVVVFPSIEAAMRELKTLTNHVVVSGGGEIYKSLIAHADTLHISTIDS
EPEGNVFFPEIPKEFNVVFEQEFHSNINYRYQIWQRG
>AM237806_2|FEATURES|argannot|trimethoprim|dfrA17|antibiotic target replacement|1
LKISLIAAQSENGVIGNGPDIPWSAKGEQLLFKALTYNQWLLVGRKTFESMGILPNRKYA
VLSKNGISHLPENVLVFSSIENALYELAKVTDHLYISGGGQIYNSLIESADTIHLSIIHK
EVEGEVRFPKIPPNYKLVFEQYYSSNINYTYQIWQKG
>AAA25550|FEATURES|argannot|trimethoprim|dfrA3|antibiotic target replacement|1
MLISLIAALAHNNLIGKDNLIPWHLPADLRHFKAVTLGKPVVMGRRTFESIGRPLPGRRN
VVVSRNPQWQAEGVEVAPSLDAALALLTDCEEAMIIGGGQLYAEALPRADRLYLTYIDAQ
LNGDTHFPDYLSLGWQELERSTHPADDKNSYACEFVTLSRQR
>BAD88719.1|FEATURES|argannot|trimethoprim|dfrA17|antibiotic target replacement|1
MKISIMAAVSENGVIGSGLDIPWHVQGEQLLFKAMTYNHWLLVGRKTFDSMGKLPNRKYA
VVTRSEMVSNDPDVIYFTSIESALSYLDNTTTHVFVSGGGEIYKALIEQADVIHLSVIHK
HISGDVFFPSVPQSFKQTFEQSFSSNIDYTYQIWAKG
>CAX16467|FEATURES|argannot|trimethoprim|dfrA22|antibiotic target replacement|1
MNPESVRIYLVAAMGANRVIGNGPDIPWNIPGEQKIFRRLTEGKVVVMGRKTFESIGKPL
PNRRTVVLSRQASYSAAGCAVVSTLSQAIAIAAEHGKELYVAGGAEVYALALPRADGVFL
SEVHQTFEGDAFFPALDAAEFDVVSAETVQATITYTHSVYARRNG
>AAN85115|FEATURES|argannot|trimethoprim|dfrA10|antibiotic target replacement|1
MTKQAIFAVAENLAFGLGGGLPWDTLKDDLQFFKRLTEGTDLVMGASTYRTLPLLPTNNR
QFIVVSNTEEPSLNVHVVSPEHFKAFLSKTSRNLTIIGGSSLLTVDILSKMDKIIMTTVY
GSFDADVYLPTEVVSYVTGKASNATLFNNSDAKMAVYYG
>CAA31356|FEATURES|argannot|trimethoprim|dfrA5|antibiotic target replacement|1
VKVSLMAAKAKNGVIGCGPHIPWSAKGEQLLFKALTYNQWLLVGRKTFESMGALPNRKYA
VVTRSAWTADNDNVIVFPSIEEAMYGLAELTDHVIVSGGGEIYRETLPMASTLHISTIDI
EPEGDVFFPNIPNTFEVVFEQHFSSNINYCYQIWQKG
>CAB06660|FEATURES|argannot|trimethoprim|dfrA17|antibiotic target replacement|1
MKISLMAAVSENGVIGSGLDIPWHVQGEQLLFKAMTYNQWLLVGRKTFDSMGKLPNRKYA
VVTRSKIISNDPDVVYFASVESALAYLNNATAHIFVSGGGEIYKALIDQADVIHLSVIHK
HISGDVFFPPVPQGFKQTFEQSFSSNIDYTYQIWAKG
>CAA41326.1|FEATURES|argannot|trimethoprim|dfrA7|antibiotic target replacement|1
LKISLISATSENGVIGNGPDIPWSAKGEQLLFKALTYNQWLLVGRKTFDSMGVLPNRKYA
VVSRKGISSSNENVLVFPSIEIALQELSKITDHLYVSGGGQIYNSLIEKADIIHLSTVHV
EVEGDINFPKIPENFNLVFEQFFLSNINYTYQIWKKG
>AAA68493|FEATURES|argannot|trimethoprim|dfrA8|antibiotic target replacement|1
MIELHAILAATANGCIGKDNALPWPPLKGDLARFKKLTMGKVVIMGRKTYESLPVKLEGR
TCIVMTRQALELPGVRDANGAIFVNNVSDAMRFAQEESVGDVAYVIGGAEIFKRLALMIT
QIELTFVKRLYEGDTYVDLAEMVKDYEQNGMEEHDLHTYFTYRKKELTE
>CAA40897|FEATURES|argannot|trimethoprim|dfrC|antibiotic target replacement|1
MASLNMIVAVNKTGGIGFENQIPWHEPEDLKHFKAVTMNSVLIMGRKTFASLPKVLPGRL
HVVVSKTVPPTQNTDQVVYVSTYQIAVRTASLLVDKPEYSQIFVIGGKSAYENLAAYVDK
LYLTRVQLNTQQDTELDLSLFKSWKLVSEVPTITENKTKLIFQIWINPNPISEEPTC
>AAN41433|FEATURES|argannot|trimethoprim|dfrB1|antibiotic target replacement|1
MQRVVGPHRTPRSSQERSEMERSSNEVSNPVAGNFVFPSNATFGMGDRVRKKSGAAWQGQ
IVGWYCTNLTPEGYAVESEAHPGSVQIYPVAALERIN
>AAN41415|FEATURES|argannot|trimethoprim|dfrB2|antibiotic target replacement|1
MGQSSDEANAPVAGQFALPLSATFGLGDRVRKKSGAAWQGQVVGWYCTKLTPEGYAVESE
SHPGSVQIYPVAALERVA
>ACR57831|FEATURES|argannot|trimethoprim|dfrB3|antibiotic target replacement|1
MDQHNNGVSTLVAGQFALPSHATFGLGDRVRKKSGAAWQGQVVGWYCTKLTPEGYAVESE
SHPGSVQIYPVAALERVA
>CAT00052|FEATURES|argannot|trimethoprim|dfrB3|antibiotic target replacement|1
MNEGKNEVSTSAAGRFAFPSNATFALGDRVRKKSGAAWQGRIVGWYCTTLTPEGYAVESE
SHPGSVQIYPMTALERVA
>AAX46054|FEATURES|argannot|trimethoprim|dfrB6|antibiotic target replacement|1
MDQGRSEVSNPVAGQFAFPSNAAFGMGDRVRKKSGAAWQGQIVGWYCTKLTPEGYAVESE
AHPGSVQIYPVAALERIN
>ABB72057|FEATURES|argannot|trimethoprim|dfrB6|antibiotic target replacement|1
MDQGSNEVINPVAGQFASPSNATFGMGDRVRKKSGAAWQGQIVGWYSTKLTPEGYAVESE
AHPGSVQIYPVAALERVN
>ADB54781|FEATURES|argannot|trimethoprim|dfrB6|antibiotic target replacement|1
MDQGSNEVGNPVAGQFSFPSNAAFSMGDRVRKKSGAAWQGQIVGWYCTKLTPEGYAVESE
AHPGSVQIYPVAALERINGVQG
>CAA88269|FEATURES|argannot|trimethoprim|dfrC|antibiotic target replacement|1
MTLSIIVAHDKQRVIGYQNQLPWHLPNDLKHVKQLTTGNTLVMGRKTFNSIGKPLPNRRN
VVLTNQASFHHEGVDVINSLDEIKELSGHVFIFGGQTLFEAMIDQVDDMYITVIDGKFQG
DTFFPPYTFENWEVESSVEGQLDEKNTIPHTFLHLVRRKGK
>CAA90486.1|FEATURES|argannot|trimethoprim|dfrD|antibiotic target replacement|1
MWSFLKISLIVAMDKKRVIGKDNDIPWRISSDWEYVKNTTKGHAIILGRKNLQSIGRALP
DRRNIILTRDKNFNFKDCEIAHSIEAAFKLCENEEEVFIFGGEQIYVMFLPYVEKMYVTK
IHHEFEGDTFFPVVNFDDWKEVSVEKGIKDEKNPYDYYFHIYERIR
>CAR62505.1|FEATURES|argannot|trimethoprim|dfrK|antibiotic target replacement|1
MKVSLIAAMDKNRVIGKENDIPWRIPEDWEYVKNTTKGYPIILGRKNLESIGRALPGRRN
IILTRDKGFSFNGCEIVHSIEDVFELCNSEEEIFIFGGEQIYNLFLPYVEKMYITKIHYE
FEGDTFFPEVNYEEWNEVSVTQGITNEKNPYTYYFHIYERKAS
>SBV31106|FEATURES|argannot|polymyxin|MCR-1|antibiotic target alteration|1
MTSHHSWYRYSINPFVLMGLVALFLAATANLTFFEKAMAVYPVSDNLGFIISMAVAVMGA
MLLIVVLLSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNAMQTDQAESKDLMN
LAFFVRIIGLGVLPSVLVAVAKVNYPTWGKGLIQRAMTWGVSLVLLLVPIGLFSSQYASF
FRVHKPVRFYINPITPIYSVGKLASIEYKKATAPTDTIYHAKDAVQTTKPSERKPRLVVF
VVGETARADHVQFNGYGRETFPQLAKVDGLANFSQVTSCGTSTAYSVPCMFSYLGQDDYD
VDTAKYQENVLDTLDRLGVGILWRDNNSDSKGVMDKLPATQYFDYKSATNNTICNTNPYN
ECRDVGMLVGLDDYVSANNGKDMLIMLHQMGNHGPAYFKRYDEQFAKFTPVCEGNELAKC
EHQSLINAYDNALLATDDFIAKSIDWLKTHEANYDVAMLYVSDHGESLGENGVYLHGMPN
AFAPKEQRAVPAFFWSNNTTFKPTASDTVLTHDAITPTLLKLFDVTAGKVKDRAAFIQ
>YP_006965431.1|FEATURES|CARD|chloramphenicol|catB3|antibiotic inactivation|1
MTNYFDSPFKGKLLSEQVKNPNIKVGRYSYYSGYYHGHSFDDCARYLFPDRDDVDKLIIG
SFCSIGSGASFIMAGNQGHRYDWASSFPFFYMQEEPAFSSALDAFQKAGNTVIGNDVWIG
SEAMVMPGIKIGHGAVIGSRSLVTKDVEPYAIVGGNPAKKIKKRFTDEEISLLLEMEWWN
WSLEKIKAAMPMLCSSNIVGLHKYWLEFAV
>AAA99931.1|FEATURES|CARD|thiostrepton|tsnR|antibiotic target alteration|1
MANLDVIVDRSDPAVQRIVDVTKHSRSVVRTVLIEDIEPLTQSIRAGVEFTEVYGLDTVP
FPGDLLAACEKRGIRVRLLSAAVANQVFKTEKKPKVFGIAKVPPAGRFADLESLSGDVVL
LDGVKIVGNIGAIVRTRSALGAAGIVLVDSGLGTIADRRLIRASRGYVFSLPIVLATRDE
ALAFFRDGGMRPVVFEADGKLSIGELDGIDERLVLVFGSEKTGPSGEFAGVATESVSIPM
NPAAESLNVSVSAGIALHRRARRNLSRPRG
>AAM77075.1|FEATURES|CARD|chloramphenicol|cmlA5|antibiotic efflux|1
MRSKNFSWRYSLAATVLLLSPFDLLASLGMDMYLPAVPFMPNALGTTASTIQLTLTTYLV
MIGAGQLLFGPLSDRLGRRPVLLGGGLAYVVASMGLALTSSAEVFLGLRILQACGASACL
VSTFATVRDIYAGREESNVIYGILGSMLAMVPAVGPLLGALVDMWLGWRAIFAFLGLGMI
AASAAAWRFWPETRVQRVAGLQWSQLLLPVKCLNFWLYTLCYAAGMGSFFVFFSIAPGLM
MGRQGVSQLGFSLLFATVAIAMVFTARFMGRVIPKWGSPSVLRMGMGCLIAGAVLLAITE
IWASQSVLGFIAPMWLVGIGVATAVSVSPNGALRGFDHVAGTVTAVYFCLGGVLLGSIGT
LIISLLPRNTAWPVVVYCLTLATVVLGLSCVSRVKGSRGQGEHDVVALQSAESTSNPNR
>CAA78046.1|FEATURES|CARD|chloramphenicol|cmx|antibiotic efflux|1
MPFAIYVLGIAVFAQGTSEFMLSGLIPDMAQDLQVSVPTAGLLTSAFAIGMIIGAPLMAI
VSMRWQRRRALLTFLITFMVVHVIGALTDSFGVLLVTRIVGALANAGFLAVALGAAMSMV
PADMKGRATSVLLGGVTIACVVGVPGGALLGELWGWRASFWEVVLISAPAVAAIMASTPA
DSPTDSVPNATRELSSLRQRKLQLILVLGALINGATFCSFTYLAPTLTDVAGFDSRWIPL
LLGLFGLGSFIGVSVGGRLADTRPFQLLVAGSAALLVGWIVFAITASHPVVTLVMLFVQG
TLSFAVGSTLISRVLYVADGAPTLGGSFATAAFNVGAALGPALGGVAIGIGMGYRAPLWT
SAALVALAIVIGAATWTRWREPRPALDTVPP
>YP_108402.1|FEATURES|CARD|multidrug|amrB|antibiotic efflux|0
MARFFIDRPVFAWVISLFIMLGGIFAIRALPVAQYPDIAPPVVSLYATYPGASAQVVEES
VTAVIEREMNGVPGLLYTSATSSAGQASLSLTFKQGVSADLAAVDVQNRLKIVEARLPEP
VRRDGISIEKAADNAQIIVSLTSEDGRLSGVELGEYASANVLQALRRVEGVGKVQFWGAE
YAMRIWPDPVKMAALGLTASDIASAVRAHNARVTIGDVGRSAVPDSAPIAATVLADAPLT
TPDAFGAIALRARADGSTLYLRDVARIEFGGNDYNYPSFVNGKTATGMGIKLAPGSNAVA
TEKRVRATMEELAKFFPPGVKYQIPYETASFVRVSMSKVVTTLVEAGVLVFAVMFLFMQN
FRATLIPTLVVPVALLGTFGAMLAAGFSINVLTMFGMVLAIGILVDDAIVVVENVERLMV
EEKLPPYEATVKAMKQISGAIVGITVVLTSVFVPMAFFGGAVGNIYRQFAFALAVSIGFS
AFLALSLTPALCATLLKPVADDHHEKDGFFGWFNRFVARSTHRYTRRVGRVLERPLRWLV
VYGALTAAAALLITKLPAAFLPDEDQGNFMVMVIRPQGTPLAETMQSVRRVEEYVRTHSP
SAYTFALGGYNLYGEGPNGGMIFVTMKDWKERKRARDQVQAIIAEINAHFAGTPNTMVFA
INMPALPDLGLTGGFDFRLQDRGGLGYGAFVAAREKLLAEGRKDPVLTDLMFAGTQDAPQ
LKLDIDRAKASALGVSMEEINATLAVMFGSDYIGDFMHGSQVRRVIVQADGRHRLDAADV
TKLRVRNAKGEMVPLAAFATLHWTMGPPQLTRYNGFPSFTINGAASAGHSSGEAMAAIER
IASTLPAGTGYAWSGQSYEERLSGAQAPMLFALSVLVVFLALAALYESWSIPFAVMLVVP
LGVIGAVAGVTLRGMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVAQRMSLADAALEA
ARLRLRPIVMTSLAFGVGVLPLAFATGAASGAQIAIGTGVLGGVISATLFAIFLVPLFFV
CVGRVFDVVPRRRGGAQAALEAK
>AAD22144.1|FEATURES|CARD|chloramphenicol|cmlB|antibiotic efflux|1
MRSKNCNWRYSLAVTVLLLSPFDLLASLGMDMYLPAVPFMPHALGTTAGTIQLTLTTYLV
MIGAGQLLFGPLSDRLGRRPVLLAGGAAYVAASIGLVVTSSAGVFLGFRILQACGASACL
VATFATVRDIYAGRKESNVIYGLLGSMLAMVPAIGPLLGAVIDTWFGWRAIFAFLGLGMI
AALTAAWRLWPETRVQRPAALQWSQLLLPIKHLNFWLYTVCYAAGMGSFFVFFSIAPGLM
MGRQGMSQFGFSLLFATVAIAMMLAARFMGRVIAKWGSLSALRMGMGCLIAGAVLLVITE
LWIPQSVLGFIAPMWLVGVGVATAVSVAPNGALRGFDHIAGAVTAVYFCLGGLLLGSVGT
LIISLLPRDTAWPVIAYCLVLATIVLGLSCVSRARDLRGHGEYDAVART
>CAD70268.1|FEATURES|CARD|multidrug|fexA|antibiotic efflux|1
MKKDSKSKEMIQSEKRGSTRLLMMVLSLSVLVGAITADLVNPVLPLISKDLEASKSQVSW
IVSGIALVLAIGVPIYGRISDFFELRKLYIFAIMILASGSLLCAIAPNLPLLVLGRMVQG
AGMSAIPVLSIIAISKVFPQGKRGGALGIIAGSIGVGTAAGPIFGGVVGQYLGWNALFWF
TFLLAIMIVIGAYYALPTIKPAESVGSNKNFDFIGGLFLGLTVGLLLFGITQGETSGFSS
FSSLTSLIGSVVALVGFIWRIVTAENPFVPPVLFNNKDYVNTVIIAFFSMFAYFAVLVFV
PLLVVEVNGLSSGQAGMILLPGGVAVAILSPFVGRLSDRFGDKRLIITGMTLMGLSTLFL
STYASGASPLLVSVGVLGVGIAFAFTNSPANNAAVSALDADKVGVGMGIFQGALYLGAGT
GAGMIGALLSARRDATEPINPLYILDAMSYSDAFLAATGAILIALIAGLGLKKRG
>AAF27726.1|FEATURES|CARD|chloramphenicol|cmlA4|antibiotic efflux|1
MRSKNFSWRYSLAATVLLLSPFDLLASLGMDMYLPAVPFMPNALGTTASTVQLTLATYLV
MIGAGQLLFGPLSDRLGRRPVLLGGGLAYVVASMGLAFTSLAEVFLGLRILQACGASACL
VSTFATVRDIYAGREESNVIYGILGSMLAMVPAVGPLLGALVDMWLGWRAIFAFLGLGMI
AASAAAWRFWPETRVQRVTGLQWSQLLLPVKCLNFWLYTLCYAAGMGSFFVFFFIAPGLI
MGRQGVSQLGFSLLFATVAIAMVFTARFMGRVIPKWGSPSVLRMGMGCLIAGAVLLAITE
IWASQSVLGFIAPMWLVGIGVATAVSVAPNGALQGFDHVAGTVTAVYFCLGGVLLGSIGT
LIISLLPRNTAWPVVVYCLTLATVVLGLSCVSRAKGSRGQGEHDVVALQSAESTSNPNR
>AAL38577.1|FEATURES|CARD|aminoglycoside|AAC(6')-Ib4|antibiotic inactivation|1
MTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESV
TPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRA
LVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERT
RSDA
>AAO15535.1|FEATURES|CARD|chloramphenicol|cmlA1|antibiotic efflux|1
MRSKNFSWRYSLAATVLLLSPFDLLASLGMDMYLPAVPFMPNALGTTASTIQLTLTTYLV
MIGAGQLLFGPLSDRLGRRPVLLGGGLAYVVASMGLALTSSAEVFLGLRILQACGASACL
VSTFATVRDIYAGREESNVIYGILGSMLAMVPAVGPLLGALVDMWLGWRAIFAFLGLGMI
AASAAAWRFWPETRVQRVAGLQWSQLLLPVKCLNFWLYTLCYAAGMGSFFVFFSIAPGLM
MGRQGVSQLGFSLLFATVAIAMVFTARFMGRVIPKWGSPSVLRMGMGCLIAGAVLLAITE
IWASQSVLGFISPMWLVGIGVATAVSVAPNGALRGFDHVAGTVTAVYFCLGGVLLGSIGT
LIISLLPRNTAWPVVVYCLTLATVVLGLSCVSRAEGSRGQGEHDVVALQSAESTSNPNR
>CAL30186.1|FEATURES|CARD|chloramphenicol|cmlB1|antibiotic efflux|1
MRSKDFSWRYSLAATLLLLSPFDLLASLGMDMYLPVVPFMAGALGAGAGTIQLTLTVYLV
LLGAGQLLFGPLSDLLGRRPVLLGGGITYILASFGLAAASSPEVFLSFRILQACGASACL
VSTFATVRDIYSGSEESNVIYGLLGSMLAMVPAIGPLLGALVDAWLGWRAIFGLLGIAMI
GAVTAAWRFWPETRRQRTADLQWSQLLLPVKCLNFWLYTLCYSAGMGSFFVFFSTAPWLM
MGRQALSQLSFSLLFATVAIAMMATARIMGRLIPRWGSLNTLRVGMGCLVVGALLLAVGE
TLIPNSVLGFIAPMWLVGVGIATAASVAPNGALRGFDHIAGTATAVYFCLGGLLLGGIGT
FIIALLPSDTTWPIIAYCLILAIAVLCLSCFNPNRHHPSDDEHDSLATQDIGRSQSGHGH
D
>AAK52606.1|FEATURES|CARD|chloramphenicol|cmlA6|antibiotic efflux|1
MRSKNFSWRYSLAATVLLLSPFDLLASLGMDMYLPAVPFMPNALGTTASTIQLTLTTYLV
MIGAGQLLFGPLSDRLGRRPVLLGGGLAYVVASMGLALTSSAEVFLGLRILQACGASACL
VSTFATVRDIYAGREESNVIYGILGSMLAIVPAVGPLLGALVDMWLGWRAIFAFLGLGMI
AASAAAWRFWPETRVQRVAGLQWSQLLLPVKCLNFWLYTLCYAAGMGSFFVFFSIAPGLM
MGRQGVSQLGFSLLFATVAIAMVFTARFMGRVIPKWGSPSVLRMGMGCLIAGAVLLAITE
IWALQSVLGFIAPMWLVGIGVATAVSVAPNGALRGFDHVAGTVTAVYFCLGGVLLGSIGT
LIISLLPRNTAWPVVVYCLTLATVVLGLSCVSRVKGSRGQGEHDVVALQSAESTSNPNR
>YP_108403.1|FEATURES|CARD|multidrug|amrA|antibiotic efflux|0
MKYEWARTRRLSAALAVAAFVAAGCGKHESEHDAAAPREASVVTVKKTSVPLSVELPGRL
DAYRQAEVRARVAGIVTARTYEEGQEVKRGAVLFRIDPAPFKAARDAAAGALEKARAAHL
AALDKRRRYDELVRDRAVSERDHTEALADERQAKAAVASARAELARAQLQLDYATVTAPI
DGRARRALVTEGALVGQDQATPLTTVEQLDPIYVNFSQPAADVESLRRAVKSGRAAGIAQ
QDVEVTLVRPDGSTYARKGKLLFADLAVDPSTDTVAMRALFPNPERELLPGAYVRIALDR
AVARDAILVPRDALLRTADSATVKVVGQNGKIRDVTVEAAQMKGRDWIVTRGLAGGERVV
VVDAAQFEAGTTVKALERGAAAQPASGAAAASAPGRRST
>AAC45805.1|FEATURES|CARD|chloramphenicol|cmrA|antibiotic efflux|1
MPFAIYVLGLAVFAQGTSEFMLSGLIPDMARDLGVSVPAAGLLTSAFAVGMIIGAPLMAI
ASMRWPRRRALLTFLITFMLVHVIGALTSSFEVLLVTRIVGALANAGFLAVALGAAMAMV
PADMKGRATSVLLGGVTIACVAGVPGGAFLGEIWGWRAAFWAVVVISAPAVVAIMFATPA
EPPAESTPNAKRELSSLRSRKLQLMLVLGALINGATFCSFTYMAPTLTDISGFDSRWIPL
LLGLFGLGSFIGVSVGGRLADTRPFQLLAVGSAALLTGWIVFALTASHPAVTLVMLFVQG
ALSFAVGSTLISQVLYAADAAPTLGGSFATAAFNVGAALGPALGGLAIGMGLSYRAPLWT
SAALVTLAIVIGAATLSLWRRPASVQETVPA
>AKN19287.1|FEATURES|CARD|aminoglycoside|AAC(6')-Ib7|antibiotic inactivation|1
MRSRNWSRTLTERSGGNGAVAVFMACYDCFFVQSMPRASKQQARYAVGRCLMLWSSNDVT
QQGSRPKTKLGITKYSIVTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTL
ADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQLL
ANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTP
DGPAVYMVQTRQAFERTRSDA
>WP_080510927.1|FEATURES|megares|glycopeptide|vanSI|antibiotic target alteration|0
MKSEKSKRKNDYSKLKRKLFLQMLLLVSATAATVILMRSVIQKNFSVGDSIVEFLKNTFY
LRDSDAVIIYRYIFLHNIEVITFIVILIFLVILLGFSISWFTKYFDEISDGMDKLVGEST
AEIALSAELGFMENKLNQIKSNLEKQKKAALEAEQRKNDLVVYLAHDIKTPLTSVIGYLS
LLDEAPDMPPEQKAKYVGITLEKAYRLEQLINEFFEITRFNLQTIVLNKEKINLLFMLQQ
LADEFYPMLTPAQGKQVSVNVPEGLTLWGDADKLARVFNNILKNALAYSYENSVIDISAQ
KQDKNTVITFTNQGNPIPQEKLETIFEKFFRLDTSRSTNTGGSGLGLAIAKEIANAHGGN
IFVQSNSEKTVFTVVLPQKQEKATDRHC
>AAA26793.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|oleC|antibiotic efflux|0
MTVRGLVKHYGETKALDGVDLDVREGTVMGVLGPNGAGKTTLVRILSTLITPDSGQATVA
GYDVVRQPRQLRRVIGLTGQYASVDEKLPGWENLYLIGRLLDLSRKEARARADELLERFS
LTEAARRPAGTYSGGMRRRLDLAASMIGRPAVLYLDEPTTGLDPRTRNEVWDEVKAMVGD
GVTVLLTTQYMEEAEQLASELTVVDRGRVIAKGGIEELKARVGGRTLRVRPVDPLQLRPL
AGMLDELGITGLASTTVDTETGALLVPILSDEQLTAVVGAVTARGITLSSITTELPSLDE
VFLSLTGHRASAPQDAEPARQEVAV
>WP_001033157|FEATURES|CARD|fusidic_acid|fusC|antibiotic inactivation|1
MNKIEVYKFVKVKQLVYQLIKLYRTNDMNSHKTQKDFLLNEINDIFKEKDIDISDFITSI
DDVKLTKKKAEHLLNELKVYIQDFEIPSSSQLEKIFRKVKKLKRPDINLIDTKEISYLGW
NDNSSNRKYIVYKNLDDKFEGIYGEISPNKVKGFCKICNQESDTSLFLNKTKHNKSSGTY
TKKGDYICYDSFKCNQNLDDINNLYEFIVKIK
>AKA86814.1|FEATURES|CARD|multidrug|optrA|antibiotic target protection|1
MSKATFAIASTNAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKT
TLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDM
ENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADYKKPI
SEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRM
FLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFR
YKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTP
LAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMGGVAALSGDFKFGYNVEISYFDQQLAQI
SGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKR
TNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFV
QSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQ
YDEELERLNKIISEPNNSSDYIVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM
>AEY83581|FEATURES|CARD|mupirocin|mupB|antibiotic target alteration|1
MENENIIEEQKILNFWKEENIFKKSIDNRKNDNPFVFYDGPPTANGLPHTGHVLGRVIKD
LFARYKTMQGFYVERKAGWDTHGLPVELGVEKKLGIKDKNEIEKYGIEKFINECKNSVFM
YEKQWREFSELIGYWVDMEKPYKTMDNTYIESIWYILSDFHKKGLLYKGHKVTPYCPSCE
TSLSSHEVAQGYKEVKDISVILKFPILDSDENFLVWTTTPWSLPGNIALAINAEEIYVKV
NYDNEIFIIMESLLQSVFKDEDNIDIVSKHKGKEFVGKEYLAPFPNKSLMNNENSYKVLP
ADFVTNKDGTGIVHIAPAYGEDDYKLVQENNIPFINVIDSRGKYNQDSPIFKGELAKESD
INIIKELTHLNLLFKKEKYEHSYPFCWRCDNPLIYYAMEGWFIKTTAYKNEIKENNQKIE
WYPDHIKNGRFGNFLDNMIDWNIGRKRYWGTPLNIWKCSTCSHEFSPKSINDLIQHSIED
IPSDIELHRPYIDNVKCKCQNCGGDMCREEEVIDVWFDSGSMPFAQNHYPFSGPIQNSYP
ADFIAEGVDQTRGWFYSLLVISTIFKGEAPYKNALSLGHILDSNGQKMSKSKGNVIDPIS
MIKTYGADSLRWTLVSDSVPWTNKRFSENMVAQSKSRVIDTLKNIFNFYNMYQKIDNYDY
TRDTPKQLNLLDNWAISRMNSVIKEVELHLEKYNPTNASRAIGEFINEISNWYIRRSRSR
FWSSEMNEDKKSAYFTLRLILINTCKIIAPFTPFTSEEIHLNLTKKSVHLEDFPQAKEEY
INLKLEEDMNKVLDIVEKSRSIRNNINIKTKQPLSNMYIYDNNNLDNEFLRKYKDIIKDE
INVKKINIVSDLDNFLEYDVKPNFSTLGPKLGKDMKQFQILFKNIKKEEMNKLINDFDKL
QKVFDSLGVTIEEKDFIISKIPKKGFSLSSNDSDRLIILDTNLTQELIREGFVRELIRVI
QQLRKQQNFNIEERINVVIDIDSDGLLSIKNNINILKENVLINNLKFEKRETMKYFKINQ
KEIGIQLMSSFTN
>CAA53189|FEATURES|CARD|mupirocin|mupA|antibiotic target alteration|1
MTKKYLNTQNEISAFWNTQKIFKKSIDNRKGQESFVFYDGPPTANGLPHAGHVLGRVIKD
LVARLKTMQGFYVERKAGWDTHGLPVELEVEKKIGIKGKQDIEKYGIENFINECKKSVFN
YEKEWRDFSKDLGYWVDMDSPYITLENNYIESVWNILSTFHKKGLLYKGHKVTPYCTHDQ
TALSSHEVAQGYKNVKDLSAVVKFQLTNSKDTYFLSWTTTPWTLPANVALAINKDLNYSK
IRVENEYYILATDLINSIITEKYEIIDTFSGSNLINLKYIPPFESDGLVNAYYVVDGEFV
TNSEGTGIVHIAPAHGEDDYQLVLERDLDFLNVITREGVYNDRFPELVGNKAKNSDIEII
KLLSKKQLLYKKQKYEHNYPHCWRCGNPLIYYAMEGWFIKTTNFKNEIINNNNNIEWFPS
HIKEGRMGNFLENMVDWNIGRNRYWGTPLNVWICNDCNHEYAPSSIKDLQNNSINKIDED
IELHRPYVDNITLSCPKCNGKMSRVEEVIDVWFDSGSMPFAQHHYPFDNQKIFNQHFPAD
FIAEGVDQTRGWFYSLLVISTILKGKSSYKRALSLGHILDSNGKKMSKSKGNVINPTELI
NKYGADSLRWALISDSAPWNNKRFSENIVAQTKSKFIDTLDNIYKFYNMYNKIDHYNPNN
EITKSRNTLDNWALSRLNTLIKESNIYVNNYDFTSAARLINEYTNTISNWYIGDSRGRFW
EQGISNDKKDAYNTLYEILTTLSRLVAPFVPFISEKIHYNLTGKSVHLQDYPQYKESFIN
QALEDEMHTVIKIVELSRQARKNADLKIKQPLSKMVIKPNSQLNLSFLPNYYSIIKDELN
IKNIELTDNINDYITYELKLNFSSVGPKLGNKTKNIQTLIDSLSEYDKKSLIESNNFKSL
SSDAELTKDDFIIKTLPKDSYQLSEDNDCVILLDKNLSPELIREGHARELIRLIQQLRKK
KNLPINQRIDIYIGVTGELLESIKTNKNMFKENFVIKNIHLNVIDEYENTIHFNNKEIKI
SLLY
>AAO47226.2|FEATURES|CARD|beta_lactam|XD36_3096|antibiotic target alteration|0
MSTFPAPAAGSRPQDGSDYTARHLMVLDGLEAVRKRPGMYIGSSDSRGLMHCLWEIIDNS
VDEALAGACDHIEVILHDDGSVEVTDNGRGIPVDTEPRTGLSGVELAYTKLHAGGKFGGG
SYAASGGLHGVGASVVNALSARLDIEVDRHGRTHAISFRRGAPGTYSAPGPDAPFTRAQG
LHRTARIPKSRTGTRVRYWADRQIFLKDAKLSLENLHQRARQTAFLVPGLTIVVRDEYGL
GEGGSKGEESFRFDGGISEFCEYLAADKPVCDVLRLTGQGTFKETVPVLDEHGQMTPTEV
TRELGVDVALRWGTGYDTTLRSFVNIIATPKGGTHVAGFEQAVAKTMNEVLRAKKLLRVA
EDDIVKDDALEGLTAVVTVRLAEPQFEGQTKEVLGTSAARRIVNTVISRELKAFLTSTKR
DAAAQARVVMEKAVAAARTRIAARQHKDAQRRKTALESSSLPAKLADCRSDDVERSELFI
VEGDSALGTAKLARNSEFQALLPIRGKILNVQKSSVTDMLKNAECGAIIQVIGAGSGRTF
DIDAARYGKIIMMTDADVDGSHIRTLLLTLFHRYMRPMVESGRVFAAVPPLHRIELVQPK
KGQDRYVYTYSDRELRDRLMEFQSKGVRYKDSIQRYKGLGEMDADQLAETTMDPRHRTLR
RINLSDLEAAEQVFDLLMGNDVAPRKEFISSSAATLDRSRIDI
>ACJ42146.1|FEATURES|CARD|beta_lactam|ampC|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNRSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWQPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGFYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>WP_004714775.1|FEATURES|CARD|beta_lactam|ADC-1|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LGAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNRFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>WP_063857798.1|FEATURES|CARD|beta_lactam|ADC-3|antibiotic inactivation|1
MRFKKISCLLLSPLFFFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIYANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLSAIKK
>WP_063857801.1|FEATURES|CARD|beta_lactam|ADC-4|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIYANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNRFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>WP_017725267.1|FEATURES|CARD|beta_lactam|ADC-6|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTLFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PAMLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>WP_063857816.1|FEATURES|CARD|beta_lactam|ADC-7|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYADNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSNTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPTDIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTSGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYVVLNAIKK
>CAL25116.3|FEATURES|CARD|beta_lactam|ADC-8|antibiotic inactivation|1
MMKDILGNLDNVPFKIMTGCIAGLLSCGTVAQSTVQQSIQQSVDRHFKPLMAQYQISGMA
IAVSINGQHYYQNYGVASKQTEQNVSEHTLFELGSVSKLFNATLTGYAQAQGQLKLSDHP
AQYFPELKNTAVNQATLLNLGTYTAGGFPLQFPEQIKTTQDMTQYFQHWQPKAAPRRIRE
YSNPSIGLMGYVTALAMKNSYSNLIENTLFPALGMHHSYINVPAAQMSNYAWGYQADQAI
RVSPGMFDAEAYGIKSNTADMLKFLDAQINPQNLKPTLRKAIQTTQMGYFRVGQMRQGLG
WEQYTYPVSLTTLLAGNSAKMALQPQPVTGISKPITAPQQALLNKTGATNGFSAYVVVIP
SQKIGLVMLANRNFPNDARVKAAYATLQQILNADIQK
>WP_038405930.1|FEATURES|CARD|beta_lactam|ADC-5|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWQPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLTPQKYPTDIQRAINETHQGFYQVGTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>WP_063857787.1|FEATURES|CARD|beta_lactam|ADC-12|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDREIKKLVDQNFKPLLDKYDVPGMAVGVIQNN
KKYETYYGLQSVQDKKSVSSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKEWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPGLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLKFINANLNPQKYPKDTQRAINETHQGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGSYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>WP_001211223.1|FEATURES|CARD|beta_lactam|ADC-31|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPLDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTSGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>WP_063857800.1|FEATURES|CARD|beta_lactam|ADC-39|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNRSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWQPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGFYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>ALV80601.1|FEATURES|CARD|multidrug|bcr-1|antibiotic efflux|0
MPASASRIQVGSGERRLLLLLSALVAFGPLSIDMYLPSLPAIAADLGASDAQVQRSISGF
LVGFCVGMLFYGPLSDRFGRRPVLLAGIALYLFSSLACALADSAGQLVLLRVLQALGGGA
ASVLARAMVRDLYPLGEAARMLALMHMVTMLAPLAAPLLGGYLMLWAGWRALFVVLALFA
GLCLLAVWRVAESHPPERRGGSLAQAFLAYGRLLGDRRALGYVLCMGLAFAGMFAYISAA
PFVFIEHFGVRAERFGWFFGLNILGVMLATWCSARLVRRHGPRPLLRAGSLLACVSGLFL
LGYAALGERGGLWALVPGLLCFVSVTGLLGANCIASLLALYPGQAGAASAVAVSGQFGLG
CLASLAVGWLALPGVLPMALVMAVCGVGSLLALGLALHGGNR
>WP_002118772.1|FEATURES|CARD|beta_lactam|ADC-18|antibiotic inactivation|1
MRFKKISCLLLPPLFIFSTSIYAGNTPKEQEVKKLVDQNFKPLLDKYDVPGMAVGVIQNN
KKYEIYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKAKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKTKNAIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPPLHLKNSYVNVPKTQMQNYAYGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLTFINANLNPQKYPKDIQRAISETHQGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGSYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>WP_063857793.1|FEATURES|CARD|beta_lactam|ADC-19|antibiotic inactivation|1
MRFKKISCLLLSPLFIFNTSIYAGNTSKEQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKKL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLKFINANLNPQKYPKDIQRAINETHQGFYQVGTMYQALGWEEFSY
PALLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>WP_063857794.1|FEATURES|CARD|beta_lactam|ADC-20|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYADNTPKDQEIKKLVDQNFKPLLDKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKTVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTSGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPGLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLKFINANLNPQKYPKDIQRAINETHQGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>WP_063857795.1|FEATURES|CARD|beta_lactam|ADC-21|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLDKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVSSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKLKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFINANINPQKYPADIQRAINETHQGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSIKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>WP_063857796.1|FEATURES|CARD|beta_lactam|ADC-22|antibiotic inactivation|1
MRFKKISCLLLPPLFIFSTSIYAGNTPKDREIKKLVDQNFKPLLDKYDVPGMAVGVIQNN
KKYETYYGLQSVQDKKAVSSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLKFINANLNTQKYPKDIQRAINETHQGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>WP_063857797.1|FEATURES|CARD|beta_lactam|ADC-23|antibiotic inactivation|1
MRFKKISCLLLPPLFIFSTSIYAGNTPKEQEVKKLVDQNFKPLLDKYDVPGMAVGVIQNN
KKYEIYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKAKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKTKNAIGEYRQYSNPSIG
LFGKIVALSMNKPFDQVLEKTIFPPLHLKNSYVNVPKTQMQNYAYGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLTFINANLNPQKYPKDIQRAINETHQGFYQVGTMYQALGWEEFSY
PASLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>APU52409.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|lnuG|antibiotic inactivation|1
MLKQKELMARVKELVQSDERISACMMYGSFTKGEGDQYSDIEYYVFLKDDTISTFDSAKW
LNEVASYTLLYQNEYGTEVVIFENLIRGEFHFLSENEMNIIPSFKESGYIPDTKAMFIYD
ETGQLELYLSELEGPGPNRLTEENVNFLLNNFSNLWLMGINVLKRGENARSLELLSQLQK
NILQLIRIAEENADNWFNMTKNLEKEISPENYEKFKKTTARLNELELYEAYKNSLLLVME
LRNLVEKQYQLTISDDFLGKLFNYMNE
>CAH14032.1|FEATURES|CARD|multidrug|LpeA|antibiotic efflux|0
MLGIQFNRGQWRSNYYWQIPVLIIAVISILFFISKKLFYSKVTPESIPNKLVEVEPIKSH
NLQQTIHLLGTIHPKHATTLIAKESGMLDTLIPTGQKVTKGTLIAKINNPDLEKNLQLSL
SAVELAKAQYERITPLIKSGYVSTKEVEEKKQAWIDAQKELSKTRIELDNLRFYAPFDGI
IGAYKKREGAQVNAGESVVSIYDPSALVVDFDIPCSNLATLNEGQPVYVLGKRYSLSHLQ
KMLDEDTHMCPADVDIQCDDCLIGATTSVELLVAEKNNTIVIPFQAIFLRNSKPFVYLVK
KGKIVLASVKTGLQQEDKIEIVEGLKAGQQLVTKGQERLYPEMTVDIYHPATSSS
>CAH14033.1|FEATURES|CARD|multidrug|LpeB|antibiotic efflux|0
MKLTSYFIKHPVITIILNAMIVVLGLLCLYNLSVREYPDINFPTITVSASYPNASPDLVE
TAITNVLEDRLAGIEGLETITSQSSAGYAQITLMFRSGTSMDRALSTTQDAVGVAKALLP
PEVRSPTVERQRKSNGLPFIGISLESTSKDFGELTHYANLNLKNVFRSVQGVASVEVWGQ
PYTYNITLQPEKLFSFGVNVDEIVNALAKNRISLPAGNYRNKIPSTLNSELKTREDYENL
LIKANSKHPILLKSLANVALETDNSQMRVRVNGHAGVVLSINKANEANPIEVSKEIRKVI
KGLQQGLPKDLKINTIIDQSDFINASIKNIRSAIGEAIFLVLIIVFLFLRNIKATIIPLI
TIPISLLGSLLFLKLFGFSINLMTLLAMVLAIGLVVDDAIIVLENIWRHIESGLSPLDAA
LKGAREIGFAIIAMTFTLSSVYLPIAFIQGMLGQLFVEFAVALAGSVFISGIVALTLSPL
MCANLLSASSKNWWPQFDNALEKLTKHYSNILQFILKHQKITLLTALISVVACFGFYNLI
SHETAPKEDRGLIGIYIPPVAGEDIGMLDNKTGKLEKKLDAIPEANNRLTFIGDWGGSIV
LPLKPHAQRHRSANQIVEKLRPSFNHFPSMDPHVWSWDTGLPGVDDAGSGSELTLVISTP
DHFRQLFDETEKLKSVLDKSKLFAAVNYDLRLDTMGYNIDLDYNQLAKLGLTANQVAKTI
EVFFSGDKSQTFEKDGVVYNISIKGDSSPWTLNELYLTTNEGKSVSLGAITKMQPKAQPA
TLDHYQQMRSTTLHVQLHKGDSMAKAIEKLWGTTKEVMPQHYKLTWIGAAKAFHESSNSM
LFLFFLSLAFIYAILCTQFENFTDPFIILFTVPLACSGALLFTYLFGQSLNIYTQVGLIT
LIGLISKHGILIVEFANKLHKDGASLPEAIQKSAALRLRPILMTTGAMVFGAIPLVLSHD
AGSESRHAIGTVLISGLGLGTLFTLFVLPAVYNIIKSKLIDMQKTGGKKRCSKE
>WP_063964000.1|FEATURES|CARD|aminoglycoside|kamB|antibiotic target alteration|1
MRRVVGKRVQEFSDAEFEQLRSQYDDVVLDVGTGDGKHPYKVARQNPSRLVVALDADKSR
MEKISAKAAAKPAKGGLPNLLYLWATAERLPPLSGVGELHVLMPWGSLLRGVLGSSPEML
RGMAAVCRPGASFLVALNLHAWRPSVPEVGEHPEPTPDSADEWLAPRYAEAGWKLADCRY
LEPEEVAGLETSWTRRLHSSRDRFDVLALTGTISP
>NP_250963.1|FEATURES|CARD|multidrug|golS|antibiotic efflux|0
MKNSCASRELSVGELARRAGVAVSALHFYETKGLISSQRNAGNQRRFSRETLRRVVVIKV
AQRVGIPLAEIARALQTLPAGRSPSAADWARLSAQWKEDLTERIDKLLLLRDQLDGCIGC
GCLSLQACPLRNPGDQLSAEGPGAHWLDAEGREHDG
>WP_069174570.1|FEATURES|CARD|fosfomycin|FosA6|antibiotic inactivation|1
MLSGLNHLTLAVSQLAPSVAFYQQLLGMTLHARWDSGAYLSCGDLWLCLSLDPQRRVTPP
EESDYTHYAFSISEADFASFAARLEAAGVAIWKLNRSEGASHYFLDPDGHKLELHVGSLA
QRLAACREQQYKGMVFFDQ
>KKE03230.1|FEATURES|CARD|fosfomycin|FosA7|antibiotic inactivation|1
MLQSLNHLTLAVSNLQTSLTFWRDLLGLQLHAEWDTGAYLTCGDLWVCLSYDVSCNYVAP
QECDYTHYAFSIAPEDFEPFSYKLKQAGVTVWKDNKSEGQSFYFLDPDGHKLELHVGDLA
SRLAQCREKPYSGMRFGPGK
>AAP82271|FEATURES|CARD|multidrug|TolC|reduced permeability to antibiotic|0
MNKTLIVAAVAASFATVAHAQSSVTLYGVLDAGITYQSNVATPSGSGKSLWSVGAGVDQS
RFGLRGSEDLGGGLKAIFTLESGFNIGNGRFNNGGGMFNRQAFVGLSSNYGTVTLGRQYD
ATQDYLSPLSATGTWGGTYFAHPLNNDRLNTNGDVAVNNTVKFTSANYAGLQFGGTYSFS
NNSQFANNRAYSAGASYQFQGLKVGAAYSQANNAGANTTGATDPLTGFNIGGTNAASIQG
RSRVYGAGASYAYGPLQGGLLWTQSRLDNLANGAPTIRADNYEANVKYNLTPALGLGVAY
TYTNAKANGESTHWNQVGVQADYALSKRTDVYAQAVYQRSSKNANASIYNGDLSTPFSTS
INQTAATVGLRHRF
>CAA09666|FEATURES|CARD|beta_lactam|KR51_00036950|reduced permeability to antibiotic|0
MKRKVLALVIPALLAAGAAHAAEIYNKDGNKLDLYGKVDGLHYFSSDSKKDGDQTYLRFG
FKGETQINDILTGYGQWEYNVQANNTETSSDQAWTRLAFAGIKVGDYGSFDYGRNYGVLY
DVEGWTDILPEFGGDSYTYADNFMAGRANGVATYRNSDFFGLVEGLNFALQYQGKNEGQN
AQDINVGTNNRSSDSDVRFDNGDGFGLSTSYDFGMGISAAAAYTSSDRTNDQMTQTNARG
DKAEAWTAGLKYDANDIYLATMYSETRNMTPYGNDGVANKTQNFEVTAQYQFDFGLRPAI
SYLQSKGKDLYNNGRYADKDLVKYMDVGATYYFNRNMSTYVDYKINLLDGNDKFYEDNGI
STDNIVALGLVYQF
>ASF81896.1|FEATURES|CARD|polymyxin|MCR-3|antibiotic target alteration|1
MPSLIKIKIVPLMFFLALYFAFMLNWRGVLHFYEILYKLEDFKFGFAISLPILLVAALNF
VFVPFSIRYLIKPFFALLIALSAIVSYTMMKYRVLFDQNMIQNIFETNQNEALAYLSLPI
IVWVTIAGFIPAILLFFVEIEYEEKWFKGILTRALSMFASLIVIAVIAALYYQDYVSVGR
NNSNLQREIVPANFVNSTVKYVYNRYLAEPIPFTTLGDDAKRDTNQSKPTLMFLVVGETA
RGKNFSMNGYEKDTNPFTSKSGGVISFNDVRSCGTATAVSVPCMFSNMGRKEFDDNRARN
SEGLLDVLQKTGISIFWKENDGGCKGVCDRVPNIEIEPKDHPKFCDKNTCYDEVVLQDLD
SEIAQMKGDKLVGFHLIGSHGPTYYKRYPDAHRQFTPDCPRSDIENCTDEELTNTYDNTI
RYTDFVIGEMIAKLKTYEDKYNTALLYVSDHGESLGALGLYLHGTPYQFAPDDQTRVPMQ
VWMSPGFTKEKGVDMACLQQKAADTRYSHDNIFSSVLGIWDVKTSVYEKGLDIFSQCRNV
Q
>EGP45230|FEATURES|CARD|multidrug|OprZ|antibiotic efflux|0
MKPVAMTLLALALSGCSLAPTHERPAAPVPAQYDTPAQPGQAAAPQDWRAYFNDPALQAW
IAAALANNRDLRVAALRIEEARALYGVQQSERLPAIDASGEFSRGRATEPGQPRTPVSNR
YRAAVGITAFELDFFGRVRSLSDAALARYLASEEAHRAATLALVAETATAYFNQRSLAEQ
LRLTDDTLALRETTLKLTQRRYDAGLETAIGLRTAQMLVESSRATRAELTREASLARHAL
GLLAGDFALPLGVDPTPLESQSLTPLAAGLPSELLTRRPDLRQAEQALRAANADIGAARA
AFFPSVQLTTDIGTTADRFSDLFSGGTGGWSFAPRLTLPIFNAGRNRANLSLAETRKHIA
VAQYEGSIQAAFRDVADALSARDALRDQIEAQRKVRDADRERQRLAERRYARGVANYLEM
LEAQRSLFESEQEFIRLQQRRLVNAVDLYKALGGWDDGSSPAS
>EGP45232.2|FEATURES|CARD|multidrug|AxyX|antibiotic efflux|0
MTHRVPFRTLAFASVLVLVSACSKQEAPEAAKAPAEVGVIVARATPTAVASELPGRLEPY
REAEVRARVAGIVTRRLYEEGQEVTRGTPLFQIDPAPLQAAYDSEAAALARAQANLSAAA
DKLRRYADLVSDRAISERDHAESVAQERQARAEVALAKANLQSARLRLEYARVTSPIDGR
ARRALVTEGALVGEGQATPLTVVQQLDPIYVNFSQPAAEVMQLQKQIRAGALQGVAPDKM
RVRLLLPDGSEYGQGGTLSFADLAVDPGTDNVTMRALFANPGRELLPGMYVRVRLEQAVN
RDTFLVPRNALLRNADGAHVLVAGDDGELRSVAVTAHRLLGPNWVVTEGLAGGERVVVEN
AAQLAPGQKIKPVERTAPSAPVATAGNNEKR
>EGP45231.1|FEATURES|CARD|multidrug|AxyY|antibiotic efflux|0
MARFFIDRPVFAWVISLLIALVGLLSIRALPVAQYPDIAPPVVNIGASYPGASAKVVEEA
VTAIIEREMNGAPGLMYTSSSSDSTGWASINLTFKQGTNPDIAAVEVQNRLKAVEPRLPE
SVRRDGVRVEKAADNIQLVVSLKSDGSLDDMQLGELAASNVLQALRRVEGVGKVQSFGAE
AAMRIWPDPAKLTALSLTPGDIVSALRSHNARVTIGELGNQAVPKDAPLNASIVAGESLH
TPEQFANIPLRALPDGATLRLKDVARVELGGTDYMYLSRVNGLTGTGLGIKLAPGSNAVE
TTRRIRETMRELAQYFPPGVTWDIPYETSTFVEISIKKVLMTLLEAVALVFCVMYLFMQN
LRATLIPTLVVPVALLGTLGVMLGLGYSINVLTMFGMVLAIGILVDDAIVVVENVERIMA
EEGLSPHDATVKAMGQISGAIVGITVVLVSVFVPMAFFDGAVGNIYRQFAVTLAVSIAFS
AFLALSLTPALCASLLKPVPAGHHEKRGFFGWFNRAFARLTTRYTARVAGVLARPVRFGL
AYALVIGVAALLFARLPSSFLPDEDQGSFMAMVILPQGSPQAETMAVVKDVERYMMEHEP
VQYVYSVNGFSQYGSGPNSAMFFVTLKDWKERRDASQHVDAVVKRINKAFADRKNLMVFA
LNSPPLPDLGSTSGFDFRLQDRGGLGYEALTQARQKLLAKAAEHPALTDVVFAGQEEAPQ
LQLRVDRDKAQAMGVPIDEINTALAVMYGSDYIGDFMLNGQVRRVMVQADGKRRVDVDDI
SRLHVRNLQGQMVPLSAFATLTWSMGPPQLNRYNGFPSFTINGSAARGHSSGEAMRAMET
LAAELPRGIGFDWSGQSYEERLSGNQAPVLFALSVLIVFLALAALYESWSIPLAVILVVP
LGVIGALLGVTVRGMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVRDGQGILSATLEA
ARLRLRPIVMTSLAFGVGVLPLALATGAASGAQAAIGTGVLGGIITATVLAVFLVPLFFL
IVGRMVGMRARPARPDGREPLETTP
>YP_001255356.1|FEATURES|CARD|multidrug|cfrC|antibiotic target alteration|1
MKQTKTKYGKMKQIASNLKLPDYRYEQLTKAIFHQRIDNFHDMHILPKALRIALVNEFGK
NVSSVTPIFSQDSKQAQKLLFELTDGERIEAVGLKYKQGWESFCISSQCGCSFGCRFCAT
GSAGFKRNLTADEITDQLLYFYFNDHRLNSISFMGMGEAFANPELFDAVKILTDQNLFGL
SQRRITISTIGIIPGIQRLTKEFPQVNLAFSLHSPFESQRSDLMPINKRFPLNEVMKTLD
EHIIHTGRRVFIAYIMLEGINDSKEHAEAIIGLLRNRGSWEHLYHIDLIPYNSTDKTTFK
FQSSSAIKQFCSTLKKASISATVRTQFGSEISAACGQLCYENEL
>AQX82857.1|FEATURES|CARD|beta_lactam|mecD|antibiotic target replacement|1
MKNIKVKILIVCSLCLISFFLYNLLKENEIDKIFSSIENRNVDEINENITFLSRNTFSKK
QRYDRMNHIDNSLGIKKVNITDIKLLEEIVDTRKYSANMHYDSKFGKFTKKGYFEFEKNG
ESKRWELNWTPEVIIPGLTATNEVRVEELKSSRGEIVDRNGIPLAIDGEHYQVGIDPKNY
NKKDSKQIAKLLNINESTLKNKLKQSWVKDGVFVPIKSYVELSDEIKNKIPEYGLSVNKI
KGRTYPLKEASAHLLGYIGEINADELNDPKFKGYDSHSIVGKTGIEYMYDKELQNRDGLI
VYITDDDGLTDSKEILVHKKPKNGKKIVLSIDSRVQNSIYNHLKDDNGSGTAMNPKTGEL
LALVSYPSFNPYDFMFGISNKKYQALLNDKKAPLLNKFQELTSPGSTQKLLTSIIGLNNG
VINESKSYEINGKGWRKDGSWGGYKVTRFEVVNGRIDLEKAIAHSDNIFFARTTLEMGGK
KFVRGMKDLGVGEETPSDYPVRTGQIANKINLERNLNNDILLADSGYGQGEILVNPIHIL
SIYSSLVNEGNMMAPKLNMEHKSKVWKKHITSQKNIDILTSSMRKVVTGTHKLDTERNYA
NFAGKTGTAELKMTQNEGLGTQIGWFVGYDQQNPNMMLAINVKNVEDKGMSSYNAQKFAQ
VMDDLYEHGARTYEPDSE
>BAD59497.1|FEATURES|CARD|rifampin|rpoB|antibiotic target alteration|0
MLEGRIVTVSSRTESPLAAPGVPGAPRRLSFARIREPLAVPGLLDIQTESFGWLIGAPDW
CARAAARGTEPVAGLAEVLAEISPIEDFAGTMSLTLSDPRFEEVKASVEECKDKDLTYAA
PWFVTAEFVNNNTGEIKSQTVFMGDFPMMTAHGTFVVNGTERVVVSQLVRSPGVYFDHAI
DKGSEKDVHSARVIPSRGAWLEFDVDKRDTLGVRIDRKRRQPVTVLLKALGWSAERIAER
FGFAPLIMASLAKDNVAGTDDALLEIHRKLRPGEPPTKESAQNLLANLFFTEKRYDLARV
GRYKIDKKLGLRAPGAPRVLTEDDIAATIEYLVRLHAGERTMIAPGGVEVPVEVDDIDHF
GNRRVRTVGELIQNQIRVGLSRMERVVRERMTTQDVEAITPQSLMNIRPVVAAMKEFFGT
SQLSQFMDQRNPLASLTNKRRLSALGPGGLSRERAGLEVRDVHYSHYGRMCPIETPEGPN
IGLMGYLSVYARVNPFGFVETPYRRVVDGRVTDEVDYLTADEEDRHVVAQANEPLDAEGR
FLAARIPVRRKNSEVELVDSAAVDYMDVSPRQMVSVATAMIPFLEHDDANRALMGANMQR
QAVPLIRSEAPIVGTGMELRAAVDAGDVVVNEKAGVVEEVSADYVTVMADDGTRKSYRMR
KFNRSNQGTCSNQRPIVDEGQRVEAGQVLADGPCTENGEMALGKNLLVAIMPWEGHNYED
AIILSQRLVEQDVLTSIHIEEHEIDARDTKLGAEEITRDIPNVSDEVLADLDERGIVRIG
AEVRDGDILVGKVTPKGETELTPEERLLRAIFGEKAREVRDTSLKVPHGESGKVIGIRVF
SREDDDDLPPGVNELVRVYVAQKRKIQDGDKLAGRHGNKGVIGKILPTEDMPFLPDGTPV
DIILNTHGVPRRMNIGQILETHLGWIGKAGWKVEGNPEWAKDLPEEMWEAPADSNIATPV
FDGAREEELTGLLGSTLPNRDGERMVDDNGKAVLFDGRSGEPFPYPVAVGYMYILKLHHL
VDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMECWAMQAYGAAYTLQELLTIKSDDV
VGRVKVYEAIVKGDNIPEPGVPESFKVLLKELQALCLNVEVLSAGAAVELAHGVDDDHER
TAANLGINLSRAESITETELSG
>CAD31707.1|FEATURES|CARD|chloramphenicol|cmlA5|antibiotic efflux|1
MDMYLPAVPFMPNALGTTASTIQLTLTTYLVMIGAGQLLFGPLSDRLGRRPVLLGGGLAN
VVASMGLALTSSAEVFLGLRILQACGASACLVSTFATVRDIYAGREESNVIYGILGSMLA
MVPAVGPLLGALVDMWLGWRAIFAFLGLGMIAASAAAWRFWPETRVQRVAGLQWSQLLLP
VKCLNFWLYTLCYAAGMGSFFVFFSIAPGLMMGRQGVSQLGFSLLFATVAIAMVFTARFM
GRVIPKWGSPSVLRMGMGCLIAGAVLLAITEIWALQSVLGFIAPMWLVGIGVATAVSVAP
NGALRGFDHVAGTVTAVYFCLGGVLLGSIGTLIISLLPRNTAWPVVVYCLTLATVVLGLS
CVSRVKGSRGQGEHDVVALQSAGSTSNPNR
>AAR20596.1|FEATURES|CARD|beta_lactam|Bla2|antibiotic inactivation|1
MKNTLLKLGVCVSLLGITPFVSTISSVQAERKVEHKVIKNETGTISISQLNKNVWVHTEL
GCFNGEAVPSNGLILNTSKGLVLVDSSWDDKLTKELIEMAEKKFKKSVTDVIITHAHADR
IGGIKTLKERGIKAHSTTLTAELAKKNGYEEPLGDLQAITKLKFGNMKVETFYPGKGHTE
DNIVVWLPQYNMLVGGCLVKSASAKDLGNITDAYVNEWSTSIENVLKRYENINFVVPGHG
EVGDKGLLLHTLDLLK
>AAW34150.1|FEATURES|CARD|aminoglycoside|APH(2'')-If|antibiotic inactivation|1
MDIKKIIEEKCNIVVDSIKLIGEGYDSKAYIVNNEYVFKIKFSANKKKGYEKEKAIYDFL
NKKLNTNIKIPNIEYSYISEELSILGYKEIKGTFLTPEIYFALSKEKQELLKQDIAMFLR
QMHDLDYSEISSYTIDNKQNVLEEYQLLKETIYDSLTDIEKQYVEEFMQRLNSTTIFDGK
KCLCHNDFSCNHLLLDDENRLCGVIDFGDSGIIDEYCDFIYLLEDSEEEIGVSFGEDILR
LYGNIDISKAKEYQDVVEQYYPIETIVYGIKNNRPDFIEKGRKEIYIRTRKDEKLRK
>ANR95875.1|FEATURES|CARD|polymyxin|MCR-1.2|antibiotic target alteration|1
MMLHTSVWYRRSVSPFVLVASVAVFLTATANLTFFDKISQTYPIADNLGFVLTIAVVLFG
AMLLITTLLSSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNALQTDQAETKDL
LNAAFIMRIIGLGVLPSLLVAFVKVDYPTWGKGLMRRLGLIVASLALILLPVVAFSSHYA
SFFRVHKPLRSYVNPIMPIYSVGKLASIEYKKASAPKDTIYHAKDAVQATKPDMRKPRLV
VFVVGETARADHVSFNGYERDTFPQLAKIDGVTNFSNVTSCGTSTAYSVPCMFSYLGADE
YDVDTAKYQENVLDTLDRLGVSILWRDNNSDSKGVMDKLPKAQFADYKSATNNAICNTNP
YNECRDVGMLVGLDDFVAANNGKDMLIMLHQMGNHGPAYFKRYDEKFAKFTPVCEGNELA
KCEHQSLINAYDNALLATDDFIAQSIQWLQTHSNAYDVSMLYVSDHGESLGENGVYLHGM
PNAFAPKEQRSVPAFFWTDKQTGITPMATDTVLTHDAITPTLLKLFDVTADKVKDRTAFI
R
>AAF94716.1|FEATURES|CARD|beta_lactam|Vibrio|antibiotic inactivation|1
MFVSHLSFPHLIEERKMKLSTLALAPITAALLTFNASAKGHDHDNQRAIFFPGETVQDTV
KVEVEPSATQSLKLGQKINNLYERQFDNSQATVQKLGKNTYWIGVNYYNATVVVNEDSVL
LIDPLGDGRIDALFKGVQSITNKPITTIMYSHYHLDHLGGGNQLVDLIKKNYPKVDKIRV
IASQTVADKINQHAEVGENGVKTPKVPAPNDIYDLTKPQTVQFGSMKIKMMAPKGSGHTP
DNTMILIPSDRVLHFADMINPDQLPFYNFAGAEHFHGYEEDLQSLLSKPLSKQWDFINGG
HGNIGSKQDVKDLLEYIADIRTEVGKQLEVAPYTPVLSDGNHFVWFKRWQDEITNNVHTA
LANKYGHMYGFDSGVVETHAAMILADMIDH
>YP_355256.1|FEATURES|CARD|beta_lactam|RSKD131_3983|antibiotic inactivation|1
MKHLSPLSILLMVGALTPALAQDTTPSFESAAAAAFESVIEEHDIPGLVVGVTHGGRHSF
YQTGLASREDQQPVTPDTLFELGSISKIFNVTLAALAEERGALSLDAPVADYLPSLRGSP
AGELTLIDLATHHTGGLPLQVPDEVADVDRLVDWLRSWRPPEPGTRSYSNISIGLLGHIT
AGVLGMSYADASQTVIFPALGLKSTWIDVPTDAMGRYAFGYDRKTDAPTRVTPGVLDDEA
YGVKSSARDMLTLLDLELGTGTASPEVQTAVATTQEGRFQTRLYTQAMIWEAYPWPVDPE
RLVEGNGYDFILQPQPVDEVDTTPDRRVILNKTGSTNGFGGYIAIVPSEDLGVVVLANRN
YPNEARVRATYDLITHILAE
>AAT46346.1|FEATURES|CARD|beta_lactam|ampC|antibiotic inactivation|1
MKKRITPFSRFASKGLFACSAGMLLVTVAHAANTAAAPAGMDAMVQTVMQAHQIPGMAIA
IIQPGKTTYHNYGVASRETGQPVRETTLFEIGSLSKPFTALVAQRAETEGRIDLSAPASR
YVAALRGSAFDRITLRQLGTYSAGGLPLQFPDNVTTPADVLAYYQHWQPVHPAGTTRLYS
NPSIGLMGLAASQATGESFAGLLGTTVLHPLGMNSTYLQVPPEARSRYAMGYTAAGKAVR
VSPGPLDEETYGVKSTTADMAGFLLAHMDPARSKGALQSALQQTRVPVYCAGQTRQGLGW
ESYQDWKNLDVLLAGNSNQMVFEPQPVKACPAGTMNDPDVWVNKTGSTAGFGAYAVFLPA
RQTGIVILANRNFPIADRIRLAHGILTALH
>AAN17791.1|FEATURES|CARD|beta_lactam|BUT-1|antibiotic inactivation|1
MCRTLCHVTYGRFSMMKKTLCCALVLSASFSAFAAQKTLSDKQLEEAVNQTLKPMITAQA
IPGMAVAVIYQGKPHYFTYGVADIAKNQPVTTQTIFELGSVSKTFTGVLGGDIVARGEVK
LSDPAMKYWPELTGKQWQGITLLDLATYTAGGLPLQVPDEVDNQAALLKFYQNWQPDWAP
GTRRQYANSSIGLFGALAVKPSGMTFNDAMRQRVLQPLNLKHTWLTVPASEENHYAWGYR
DGKAMHVGPGMLDTEAYGVKSTIEDMASWVQYNMNPQQVKQPTLQKGLEIAQSRYWRSGS
MYQGLGWEMLNWPVAAATVINGSDNKVALAASPVTAIEPPVAPVKASLVHKTGSTNGFGA
YVAFIPEKQIGIVMLANKMYPNTERVKAANTLLNTLQ
>WP_063857788.1|FEATURES|CARD|beta_lactam|ADC-13|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEIYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKTKGTISFKDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPGLSLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLKFINANLNPQKYPADIQRAINETHQGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>WP_063857789.1|FEATURES|CARD|beta_lactam|ADC-14|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEIYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKTKGTISFKDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPGLSLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLKFINANLNPQKYPADIQRAINETHQGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERFKAAYAVLNAIKK
>WP_063857790.1|FEATURES|CARD|beta_lactam|ADC-15|antibiotic inactivation|1
MRFKKISCLLLSPLFIFNTSIYAGNTPKDQEIKKLVDQNFKPLLDKYDVPGMAVGVIQNN
KKYETYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKTKGTISFKDTTGKYWKEL
KNTPIDQVNLFQLATYTSGNLGLQFPDEVQTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQLLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLKFINANLNPQKYPKDIQRAINETHQGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKIFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>WP_063857792.1|FEATURES|CARD|beta_lactam|ADC-17|antibiotic inactivation|1
MRFKKISCLLLPPLFIFSTSIYAGNTPKDREIKKLVDQNFKPLLDKYDVPGMAVGVIQNN
KKYETYYGLQSVQDKKAVSSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDRQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNRENQPIRVNPGP
LDAPAYGVKSTLPDMLKFINANLNTQKYPKDIQRAINETHQGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>WP_063857791.1|FEATURES|CARD|beta_lactam|ADC-16|antibiotic inactivation|1
MRFKKISCLLLPPLFIFSSSIYAGNTPKEQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSNTIFELGSVSKLFTATAGGYAKTKGTISFNDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKEWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFINANLNPQKYPANIQRAINETHQGFYQVGTMYQALGWEEFSY
PALLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>WP_063857802.1|FEATURES|CARD|beta_lactam|ADC-41|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLDKYDVPGMAVGVIQNN
KKYETYYGLQSVQDKKAVSSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPGLGLKHSYVNVPKNQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLKFINANLNPQKYPADIQRAINETHQGFYQVGIMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>WP_063857803.1|FEATURES|CARD|beta_lactam|ADC-42|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDREIKKLVDQNFKPLLDKYDVPGMAVGVIQNN
KKYETYYGLQSVQDKKSVSSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTSGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKEWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPGLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFINANINPQKYPKDTQRAINETHQGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGSYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>WP_032055358.1|FEATURES|CARD|beta_lactam|ADC-43|antibiotic inactivation|1
MRFKKISCLLLPPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLDKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPGLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFINANLNPLKYPKDIQRAINETHKGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>WP_063857804.1|FEATURES|CARD|beta_lactam|ADC-44|antibiotic inactivation|1
MRFKKISCLLLPPLFIFSTSIYAGNTSKEQEIKKLVDQNFKPLLDKYNVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKTKGTISFKDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLGLQFPDEVQTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPGLSLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLKFINANLNPQKYPKDIQRAINETHQGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSIKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>WP_001159760.1|FEATURES|CARD|beta_lactam|ADC-79|antibiotic inactivation|1
MQFKKISCLLLSPLFIFSTSIYADNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGFYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>WP_029424536.1|FEATURES|CARD|beta_lactam|ADC-80|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKVL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPTDIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYIVFIPKENIGLVML
TNKRIPNEERIKAAYAVLSAIKK
>WP_059262723.1|FEATURES|CARD|beta_lactam|ADC-81|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNRSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWQPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGFYQVNTMYQALGW
EEFSYPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENI
GLVMLTNKRIPNEERIKAAYAVLDAIKK
>WP_001211216.1|FEATURES|CARD|beta_lactam|ADC-82|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDALAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>ASR73329.1|FEATURES|CARD|polymyxin|MCR-4|antibiotic target alteration|1
MISRFKTLSVNQFTFITALFYVAIFNLPLFGIVRKGIEKQPEVDPLFIASMPLFLTFALS
FLFSIFTVKYLLKPFFIVLTLLSSSVFFAAYQYNVVFDYGMIENTFQTHPAEALMYVNLA
SITNLLLTGLLPSYLIYKADIHYQPFFKELLHKLAFMLLMFVGIGIVAFFYYQDYAAFVR
NNSELRRYIVPTYFVSSASKYLNEHYLQTPMEYQQLGLDAKNASRNPNTKPNLLVVVVGE
TARSMSYQYYGYNKPTNAHTQNQGLIAFNDTSSCGTATAVSLPCMFSRMGRADYDPRRAN
AQDTVIDVLSHSGIKVQWFDNDSGCKGVCDQVENLTIDLKSDPKLCSGQYCFDQVLLNKL
DKILAVAPSQDTVIFLHIIGSHGPTYYLRYPPEHRKFIPDCPRSDIQNCSQEELINTYDN
TILYTDFILSEVVNKLKGKQDMFDTAMLYLSDHGESLGEKGMYLHGAPYSIAPKEQTSVP
MLAWVSNDFSQDNQLNMTCVAQRAEQGGFSHDNLFDSLLGLMNVKTTVYQSQLDIFAPCR
Y
>ASK40562.1|FEATURES|CARD|polymyxin|MCR-5|antibiotic target alteration|1
MRLSAFITFLKMRPQVRTEFLTLFISLVFTLLCNGVFWNALLAGRDSLTSGTWLMLLCTG
LLITGLQWLLLLLVATRWSVKPLLILLAVMTPAAVYFMRNYGVYLDKAMLRNLMETDVRE
ASELLQWRMLPYLLVAAVSVWWIARVRVLRTGWKQAVMMRSACLAGALAMISMGLWPVMD
VLIPTLRENKPLRYLITPANYVISGIRVLTEQASSSADEAREVVAADAHRGPQEQGRRPR
ALVLVVGETVRAANWGLSGYERQTTPELAARDVINFSDVTSCGTDTATSLPCMFSLNGRR
DYDERQIRRRESVLHVLNRSDVNILWRDNQSGCKGVCDGLPFENLSSAGHPTLCHGERCL
DEILLEGLAEKITTSRSDMLIVLHMLGNHGPAYFQRYPASYRRWSPTCDTTDLASCSHEA
LVNTYDNAVLYTDHVLARTIDLLSGIRSHDTALLYVSDHGESLGEKGLYLHGIPYVIAPD
EQIKVPMIWWQSSQVYADQACMQTHASRAPVSHDHLFHTLLGMFDVKTAAYTPELDLLAT
CRKGQPQ
>AKR18013.1|FEATURES|CARD|beta_lactam|PDC-73|antibiotic inactivation|1
GEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
EIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQ
FPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNLSIGLFGYLAARSLGQPFERLMEQQVF
PALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANL
HPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIA
RLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSG
LEQQGKVPLKR
>AKR18014.1|FEATURES|CARD|beta_lactam|PDC-74|antibiotic inactivation|1
GEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
EIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQ
FPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQVF
PALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPRPLDAEGYGVKTSAADLLRFVDANL
HPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIA
RLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSG
LEQQGKVPLKR
>AKR18015.1|FEATURES|CARD|beta_lactam|PDC-75|antibiotic inactivation|1
GEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
EIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQ
FPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQVF
PALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPRPLDAEGYGVKTSAADLLRFVDANL
HPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIA
RLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRDLGLVILANRNYPNAERVKIAYAILSG
LEQQGKVPLKR
>AKR18016.1|FEATURES|CARD|beta_lactam|PDC-76|antibiotic inactivation|1
GEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
EIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQ
FPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQVF
PALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANL
HPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIA
RLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPIAERVKIAYAILSG
LEQQGKVPLKR
>AKR18017.1|FEATURES|CARD|beta_lactam|PDC-77|antibiotic inactivation|1
GEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
EIGSVSKTFTATLAGYALTQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQ
FPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQVF
PALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPRPLDAEGYGVKTSAADLLRFVDANL
HPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIA
RLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSG
LEQQGKVPLKR
>AKR18018.1|FEATURES|CARD|beta_lactam|PDC-78|antibiotic inactivation|1
GEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
EIGSVSKTFTATLAGYALTQDKMRLDDRASQHWPALQGSHFDGISLLDLATYTAGGLPLQ
FPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQVF
PALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPRPLDAEGYGVKTSAADLLRFVDANL
HPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIA
RLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSG
LEQQGKVPLKR
>AKR18019.1|FEATURES|CARD|beta_lactam|PDC-79|antibiotic inactivation|1
GEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
EIGSVSKTFTATLAGYALTQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQ
FPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQVF
PALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAKGYGVKTSAADLLRFVDANL
HPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIA
RLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSG
LEQQGKVPLKR
>AKR18020.1|FEATURES|CARD|beta_lactam|PDC-80|antibiotic inactivation|1
GEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
EIGSVSKTFTATLAGYALTQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQ
FPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQVF
PALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAGGYGVKTSAADLLRFVDANL
HPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIA
RLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSG
LEQQGKVPLKR
>AKR18021.1|FEATURES|CARD|beta_lactam|PDC-81|antibiotic inactivation|1
GEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
EIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQ
FPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNLSIGLFGYLAARSLGQPFERLMEQQVF
PALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANL
HPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIA
RLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSG
LEQQAKVPLKR
>AKR18022.1|FEATURES|CARD|beta_lactam|PDC-82|antibiotic inactivation|1
GEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
EIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQ
LPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLLEQQVF
PALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANL
HPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIA
RLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSG
LEQQAKVPLKR
>AKR18023.1|FEATURES|CARD|beta_lactam|PDC-83|antibiotic inactivation|1
GEAPADRLKALVDAAVQPAMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
EIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQ
FPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQVF
PALGLEQTHLDVPEAALAQYAQGYGKDDRPLRAGPGPLDAEGYGVKTSAADLLRFVDANL
HPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIA
RLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSG
LEQQAKVPLKR
>AKR18024.1|FEATURES|CARD|beta_lactam|PDC-84|antibiotic inactivation|1
GEAPADRLKALVDAAVQPAMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
EIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQ
FPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQVF
PALGLEQTHLDVPEAALAQYAQGYGKDDRPLRAGPGPLDAEGYGVKTSAADLLRFVDANL
HPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIA
RLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPIAERVKIAYAILSG
LEQQAKVPLKR
>AKR18025.1|FEATURES|CARD|beta_lactam|PDC-85|antibiotic inactivation|1
GEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
EIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQ
FPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQVF
PALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGHGVKTSAADLLRFVDANL
HPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIA
RLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSG
LEQQAKVPLKR
>AKR18026.1|FEATURES|CARD|beta_lactam|PDC-86|antibiotic inactivation|1
DEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
EIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQ
FPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQLF
PALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAKGYGVKTSAADLLRFVDANL
HPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIA
RLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRDLGLVILANRNYPNAERVKIAYAILSG
LEQQAKVPLKR
>AKR18027.1|FEATURES|CARD|beta_lactam|PDC-87|antibiotic inactivation|1
DEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
EIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQ
FPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQLF
PALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANL
HPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIA
RLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRDLGLVILANRNYPIAERVKIAYAILSG
LEQQAKVPLKR
>AKR18028.1|FEATURES|CARD|beta_lactam|PDC-88|antibiotic inactivation|1
DEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
EIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQ
FPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQLF
PALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANL
HPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSMALQPHRIARL
PAPQALEGQRLLNKTGSTNGFGAYVAFIPGRDLGLVILANRNYPNAERVKIAYAILSGLE
QQAKVPLKR
>AKR18029.1|FEATURES|CARD|beta_lactam|PDC-89|antibiotic inactivation|1
DEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
EIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQ
FPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQLF
PALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANL
HPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSALQPHRIARLP
APQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSGLEQ
QAKVPLKR
>AKR18030.1|FEATURES|CARD|beta_lactam|PDC-90|antibiotic inactivation|1
DEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
EIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQ
FPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQLF
PALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANL
HPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSALQPHRIARLP
APQALEGQRLLNKTGSTNGFGAYVAFIPGRDLGLVILANRNYPNAERVKIAYAILSGLEQ
QAKVPLKR
>AKR18031.1|FEATURES|CARD|beta_lactam|PDC-91|antibiotic inactivation|1
DEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
EIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQ
FPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQLF
PALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANL
HPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSLQPHRIARLPA
PQALEGQRLLNKTGSTNGFGAYVAFIPGRDLGLVILANRNYPNAERVKIAYAILSGLEQQ
AKVPLKR
>AKR18032.1|FEATURES|CARD|beta_lactam|PDC-92|antibiotic inactivation|1
DEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
EIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQ
FPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQLF
PALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANL
HPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMAPHRIARL
PAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSGLE
QQAKVPLKR
>AKR18033.1|FEATURES|CARD|beta_lactam|PDC-93|antibiotic inactivation|1
DEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
EIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQ
FPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQLF
PALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANL
HPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMAPQPHRIA
RLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSG
LEQQAKVPLKR
>CAD09823.1|FEATURES|CARD|multidrug|tetR|antibiotic efflux|0
MMSRLDKSKVINSALELLNEVGIEGLTTRKLAQKLGVEQPTLYWHVKNKRALLDALAIEM
LDRHHTHFCPLEGESWQDFLRNNAKSFRCALLSHRDGAKVHLGTRPTEKQYETLENQLAF
LCQQGFSLENALYALSAVGHFTLGCVLEDQEHQVAKEERETPTTDSMPPLLRQAIELFDH
QGAEPAFLFGLELIICGLEKQLKCESGS
>NP_251182.1|FEATURES|CARD|sulfonamide|MexT|antibiotic efflux|0
MPVSDPMPLRHLARPRPVSHARLDGEPPRLQPLAPGNEERHEPKRPAPRRSEPADRVRDP
DARTQRDPRRRETVPRPAGQPAISAALSRLRTLFDDPLFVRTGRSMEPTARAQEIFAHLS
PALDSISTAMSRASEFDPATSTAVFRIGLSDDVEFGLLPPLLRRLRAEAPGFVLVVRRAN
YLLMPNLLASGEISVGVSYTDELPANAKRKTVRRSKPKILRADSAPGQLTLDDYCARPHA
LVSFAGDLSGFVDEELEKFGRKRKVVLAVPQFNGLGTLLAGTDIIATVPDYAAQALIAAG
GLRAEDPPFETRAFELSMAWRGAQDNDPAERWLRSRISMFIGDPDSL
>AAC77033.1|FEATURES|CARD|multidrug|golS|antibiotic efflux|0
MEKKLPRIKALLTPGEVAKRSGVAVSALHFYESKGLITSIRNSGNQRRYKRDVLRYVAII
KIAQRIGIPLATIGEAFGVLPEGHTLSAKEWKQLSSQWREELDRRIHTLVALRDELDGCI
GCGCLSRSDCPLRNPGDRLGEEGTGARLLEDEQN
>NP_418486.1|FEATURES|CARD|multidrug|robA|antibiotic efflux|0
MSHQKIIQDLIAWIDEHIDQPLNIDVVAKKSGYSKWYLQRMFRTVTHQTLGDYIRQRRLL
LAAVELRTTERPIFDIAMDLGYVSQQTFSRVFRRQFDRTPSDYRHRL
>NP_250710.1|FEATURES|CARD|multidrug|mexZ|antibiotic efflux|0
MARKTKEESQKTRDGILDAAERVFLEKGVGTTAMADLADAAGVSRGAVYGHYKNKIEVCL
AMCDRAFGQIEVPDENARVPALDILLRAGMGFLRQCCEPGSVQRVLEILYLKCERSDENE
PLLRRRELLEKQGQRFGLRQIRRAVERGELPARLDVELASIYLQSLWDGICGTLAWTERL
RDDPWNRAERMFRAGLDSLRSSPYLLLADA
>NP_414997.1|FEATURES|CARD|multidrug|acrS|antibiotic efflux|0
MARKTKQEAQETRQHILDVALRLFSQQGVSSTSLGEIAKAAGVTRGAIYWHFKDKSDLFS
EIWELSESNIGELELEYQAKFPGDPLSVLREILIHVLESTVTEERRRLLMEIIFHKCEFV
GEMAVVQQAQRNLCLESYDRIEQTLKHCIEAKMLPADLMTRRAAIIMRGYISGLMENWLF
APQSFDLKKEARDYVAILLEMYLLCPTLRNPATNE
>NP_252410.1|FEATURES|CARD|multidrug|nalC|antibiotic efflux|0
MNDASPRLTERGRQRRRAMLDAATQAFLEHGFEGTTLDMVIERAGGSRGTLYSSFGGKEG
LFAAVIAHMIGEIFDDSADQPRPAATLSATLEHFGRRFLTSLLDPRCQSLYRLVVAESPR
FPAIGKSFYEQGPQQSYLLLSERLAAVAPHMDEETLYAVACQFLEMLKADLFLKALSVAD
FQPTMALLETRLKLSVDIIACYLEHLSQSPAQG
>NP_249115.1|FEATURES|CARD|multidrug|mexR|antibiotic efflux|0
MNYPVNPDLMPALMAVFQHVRTRIQSELDCQRLDLTPPDVHVLKLIDEQRGLNLQDLGRQ
MCRDKALITRKIRELEGRNLVRRERNPSDQRSFQLFLTDEGLAIHQHAEAIMSRVHDELF
APLTPVEQATLVHLLDQCLAAQPLEDI
>NP_253464.1|FEATURES|CARD|polymyxin|basR|antibiotic target alteration|0
MRILLAEDDLLLGDGIRAGLRLEGDTVEWVTDGVAAENALVTDEFDLLVLDIGLPRRSGL
DILRNLRHQGLLTPVLLLTARDKVADRVAGLDSGADDYLTKPFDLDELQARVRALTRRTT
GRALPQLVHGELRLDPATHQVTLSGQAVELAPREYALLRLLLENSGKVLSRNQLEQSLYG
WSGDVESNAIEVHVHHLRRKLGNQLIRTVRGIGYGIDQPAP
>CAB12062.1|FEATURES|CARD|multidrug|lmrA|antibiotic efflux|0
MSYGDSREKILSAATRLFQLQGYYGTGLNQIIKESGAPKGSLYYHFPGGKEQLAIEAVNE
MKEYIRQKIADCMEACTDPAEGIQAFLKELSCQFSCTEDIEGLPVGLLAAETSLKSEPLR
EACHEAYKEWASVYEEKLRQTGCSESRAKEASTVVNAMIEGGILLSLTAKNSTPLLHISS
CIPDLLKR
>CAC35723.1|FEATURES|CARD|multidrug|acrS|antibiotic efflux|0
MARKTKQQALETRQLILDVALRLFSQQGVSSTSLAAIAKAAGVTRGAIYWHFKNKSDLFN
EIWSLSDASISDLEVEYRAKFPNDPLSVVREILVYILEATVVEERRRLMMEIIFHKCEFV
GEMAVVQQAQRSLWLESYDRIEQTLKDCITAQQLPANLLTRRAAILMRSYLSGLMENWLF
APESFNLHAEARAYVDALIEMYQTCPSLRSSSEVMA
>YP_491362.1|FEATURES|CARD|sulfonamide|sul3|antibiotic target alteration|0
MKLFAQGTSLDLSHPHVMGILNVTPDSFSDGGTHNSLIDAVKHANLMINAGATIIDVGGE
STRPGAAEVSVEEELQRVIPVVEAIAQRFEVWISVDTSKPEVIRESAKVGAHIINDIRSL
SEPGALEAAAETGLPVCLMHMQGNPKTMQEAPKYDDVFAEVNRYFIEQIARCEQAGIAKE
KLLLDPGFGFGKNLSHNYSLLARLAEFHHFNLPLLVGMSRKSMIGQLLNVGPSERLSGSL
ACAVIAAMQGAHIIRVHDVKETVEAMRVVEATLSAKENKRYE
>NP_415449.1|FEATURES|CARD|multidrug|ompF|reduced permeability to antibiotic|0
MMKRNILAVIVPALLVAGTANAAEIYNKDGNKVDLYGKAVGLHYFSKGNGENSYGGNGDM
TYARLGFKGETQINSDLTGYGQWEYNFQGNNSEGADAQTGNKTRLAFAGLKYADVGSFDY
GRNYGVVYDALGYTDMLPEFGGDTAYSDDFFVGRVGGVATYRNSNFFGLVDGLNFAVQYL
GKNERDTARRSNGDGVGGSISYEYEGFGIVGAYGAADRTNLQEAQPLGNGKKAEQWATGL
KYDANNIYLAANYGETRNATPITNKFTNTSGFANKTQDVLLVAQYQFDFGLRPSIAYTKS
KAKDVEGIGDVDLVNYFEVGATYYFNKNMSTYVDYIINQIDSDNKLGVGSDDTVAVGIVY
QF
>YP_039996.1|FEATURES|CARD|multidrug|acrF|antibiotic target alteration|0
MAGQVVQYGRHRKRRNYARISEVLELPNLIEIQTKSYEWFLREGLIEMFRDISPIEDFTG
NLSLEFVDYRLGEPKYDLEESKNRDATYAAPLRVKVRLIIKETGEVKEQEVFMGDFPLMT
DTGTFVINGAERVIVSQLVRSPSVYFNEKIDKNGRENYDATIIPNRGAWLEYETDAKDVV
YVRIDRTRKLPLTVLLRALGFSSDQEIVDLLGDNEYLRNTLEKDGTENTEQALLEIYERL
RPGEPPTVENAKSLLYSRFFDPKRYDLASVGRYKTNKKLHLKHRLFNQKLAEPIVNTETG
EIVVEEGTVLDRRKIDEIMDVLESNANSEVFELHGSVIDEPVEIQSIKVYVPNDDEGRTT
TVIGNAFPDSEVKCITPADIIASMSYFFNLLSGIGYTDDIDHLGNRRLRSVGELLQNQFR
IGLSRMERVVRERMSIQDTESITPQQLINIRPVIASIKEFFGSSQLSQFMDQANPLAELT
HKRRLSALGPGGLTRERAQMEVRDVHYSHYGRMCPIETPEGPNIGLINSLSSYARVNEFG
FIETPYRKVDLDTHAITDQIDYLTADEEDSYVVAQANSKLDENGRFMDDEVVCRFRGNNT
VMAKEKMDYMDVSPKQVVSAATACIPFLENDDSNRALMGANMQRQAVPLMNPEAPFVGTG
MEHVAARDSGAAITAKHRGRVEHVESNEILVRRLVEENGVEHEGELDRYPLAKFKRSNSG
TCYNQRPIVAVGDVVEFNEILADGPSMELGEMALGRNVVVGFMTWDGYNYEDAVIMSERL
VKDDVYTSIHIEEYESEARDTKLGPEEITRDIPNVSESALKNLDDRGIVYIGAEVKDGDI
LVGKVTPKGVTELTAEERLLHAIFGEKAREVRDTSLRVPHGAGGIVLDVKVFNREEGDDT
LSPGVNQLVRVYIVQKRKIHVGDKMCGRHGNKGVISKIVPEEDMPYLPDGRPIDIMLNPL
GVPSRMNIGQVLELHLGMAAKNLGIHVASPVFDGANDDDVWSTIEEAGMARDGKTVLYDG
RTGEPFDNRISVGVMYMLKLAHMVDDKLHARSTGPYSLVTQQPLGGKAQFGGQRFGEMEV
WALEAYGAAYTLQEILTYKSDDTVGRVKTYEAIVKGENISRPSVPESFRVLMKELQSLGL
DVKVMDEQDNEIEMTDVDDDDVVERKVDLQQNDAPETQKEVTD
>BAE77595.1|FEATURES|CARD|fosfomycin|fosB|antibiotic target alteration|0
MSNSYDSSSIKVLKGLDAVRKRPGMYIGDTDDGTGLHHMVFEVVDNAIDEALAGHCKEII
VTIHADNSVSVQDDGRGIPTGIHPEEGVSAAEVIMTVLHAGGKFDDNSYKVSGGLHGVGV
SVVNALSQKLELVIQREGKIHRQIYEHGVPQAPLAVTGETEKTGTMVRFWPSLETFTNVT
EFEYEILAKRLRELSFLNSGVSIRLRDKRDGKEDHFHYEGGIKAFVEYLNKNKTPIHPNI
FYFSTEKDGIGVEVALQWNDGFQENIYCFTNNIPQRDGGTHLAGFRAAMTRTLNAYMDKE
GYSKKAKVSATGDDAREGLIAVVSVKVPDPKFSSQTKDKLVSSEVKSAVEQQMNELLAEY
LLENPTDAKIVVGKIIDAARAREAARRAREMTRRKGALDLAGLPGKLADCQERDPALSEL
YLVEGDSAGGSAKQGRNRKNQAILPLKGKILNVEKARFDKMLSSQEVATLITALGCGIGR
DEYNPDKLRYHSIIIMTDADVDGSHIRTLLLTFFYRQMPEIVERGHVYIAQPPLYKVKKG
KQEQYIKDDEAMDQYQISIALDGATLHTNASAPALAGEALEKLVSEYNATQKMINRMERR
YPKAMLKELIYQPTLTEADLSDEQTVTRWVNALVSELNDKEQHGSQWKFDVHTNAEQNLF
EPIVRVRTHGVDTDYPLDHEFITGGEYRRICTLGEKLRGLLEEDAFIERGERRQPVASFE
QALDWLVKESRRGLSIQRYKGLGEMNPEQLWETTMDPESRRMLRVTVKDAIAADQLFTTL
MGDAVEPRRAFIEENALKAANIDI
>CCP46624.1|FEATURES|CARD|beta_lactam|Sbal223_2079|antibiotic target alteration|0
MTQCASRRKSTPNRAILGAFASARGTRWVATIAGLIGFVLSVATPLLPVVQTTAMLDWPQ
RGQLGSVTAPLISLTPVDFTATVPCDVVRAMPPAGGVVLGTAPKQGKDANLQALFVVVSA
QRVDVTDRNVVILSVPREQVTSPQCQRIEVTSTHAGTFANFVGLKDPSGAPLRSGFPDPN
LRPQIVGVFTDLTGPAPPGLAVSATIDTRFSTRPTTLKLLAIIGAIVATVVALIALWRLD
QLDGRGSIAQLLLRPFRPASSPGGMRRLIPASWRTFTLTDAVVIFGFLLWHVIGANSSDD
GYILGMARVADHAGYMSNYFRWFGSPEDPFGWYYNLLALMTHVSDASLWMRLPDLAAGLV
CWLLLSREVLPRLGPAVEASKPAYWAAAMVLLTAWMPFNNGLRPEGIIALGSLVTYVLIE
RSMRYSRLTPAALAVVTAAFTLGVQPTGLIAVAALVAGGRPMLRILVRRHRLVGTLPLVS
PMLAAGTVILTVVFADQTLSTVLEATRVRAKIGPSQAWYTENLRYYYLILPTVDGSLSRR
FGFLITALCLFTAVFIMLRRKRIPSVARGPAWRLMGVIFGTMFFLMFTPTKWVHHFGLFA
AVGAAMAALTTVLVSPSVLRWSRNRMAFLAALFFLLALCWATTNGWWYVSSYGVPFNSAM
PKIDGITVSTIFFALFAIAAGYAAWLHFAPRGAGEGRLIRALTTAPVPIVAGFMAAVFVA
SMVAGIVRQYPTYSNGWSNVRAFVGGCGLADDVLVEPDTNAGFMKPLDGDSGSWGPLGPL
GGVNPVGFTPNGVPEHTVAEAIVMKPNQPGTDYDWDAPTKLTSPGINGSTVPLPYGLDPA
RVPLAGTYTTGAQQQSTLVSAWYLLPKPDDGHPLVVVTAAGKIAGNSVLHGYTPGQTVVL
EYAMPGPGALVPAGRMVPDDLYGEQPKAWRNLRFARAKMPADAVAVRVVAEDLSLTPEDW
IAVTPPRVPDLRSLQEYVGSTQPVLLDWAVGLAFPCQQPMLHANGIAEIPKFRITPDYSA
KKLDTDTWEDGTNGGLLGITDLLLRAHVMATYLSRDWARDWGSLRKFDTLVDAPPAQLEL
GTATRSGLWSPGKIRIGP
>YP_040771.1|FEATURES|CARD|quinolone|parE|antibiotic target alteration|0
MAMNKQNNYSDDSIQVLEGLEAVRKRPGMYIGSTDKRGLHHLVYEIVDNSVDEVLNGYGN
EIDVTINKDGSISIEDNGRGMPTGIHKSGKPTVEVIFTVLHAGGKFGQGGYKTSGGLHGV
GASVVNALSEWLEVEIHRDGNIYHQSFKNGGSPSSGLVKKGKTKKTGTKVTFKPDDTIFK
ASTSFNFDVLSERLQESAFLLKNLKITLNDLRSGKERQEHYHYEEGIKEFVSYVNEGKEV
LHDVATFSGEANGIEVDVAFQYNDQYSESILSFVNNVRTKDGGTHEVGFKTAMTRVFNDY
ARRINELKTKDKNLDGNDIREGLTAVVSVRIPEELLQFEGQTKSKLGTSEARSAVDSVVA
DKLPFYLEEKGQLSKSLVKKAIKAQQAREAARKAREDARSGKKNKRKDTLLSGKLTPAQS
KNTDKNELYLVEGDSAGGSAKLGRDRKFQAILPLRGKVINTEKARLEDIFKNEEINTIIH
TIGAGVGTDFKIEDSNYNRVIIMTDADTDGAHIQVLLLTFFFKYMKPLVQAGRVFIALPP
LYKLEKGKGKTKRVEYAWTDEELNKLQKELGKGFTLQRYKGLGEMNPEQLWETTMNPETR
TLIRVQVEDEVRSSKRVTTLMGDKVQPRREWIEKHFEFGMQEDQSILDNSEVQVLENDQF
DEEEI
>CCP43072.1|FEATURES|CARD|ethambutol|iniA|antibiotic efflux|0
MVPAGLCAYRDLRRKRARKWGDTVTQPDDPRRVGVIVELIDHTIAIAKLNERGDLVQRLT
RARQRITDPQVRVVIAGLLKQGKSQLLNSLLNLPAARVGDDEATVVITVVSYSAQPSARL
VLAAGPDGTTAAVDIPVDDISTDVRRAPHAGGREVLRVEVGAPSPLLRGGLAFIDTPGVG
GLGQPHLSATLGLLPEADAVLVVSDTSQEFTEPEMWFVRQAHQICPVGAVVATKTDLYPR
WREIVNANAAHLQRARVPMPIIAVSSLLRSHAVTLNDKELNEESNFPAIVKFLSEQVLSR
ATERVRAGVLGEIRSATEQLAVSLGSELSVVNDPNLRDRLASDLERRKREAQQAVQQTAL
WQQVLGDGFNDLTADVDHDLRTRFRTVTEDAERQIDSCDPTAHWAEIGNDVENAIATAVG
DNFVWAYQRSEALADDVARSFADAGLDSVLSAELSPHVMGTDFGRLKALGRMESKPLRRG
HKMIIGMRGSYGGVVMIGMLSSVVGLGLFNPLSVGAGLILGRMAYKEDKQNRLLRVRSEA
KANVRRFVDDISFVVSKQSRDRLKMIQRLLRDHYREIAEEITRSLTESLQATIAAAQVAE
TERDNRIRELQRQLGILSQVNDNLAGLEPTLTPRASLGRA
>WP_001025093|FEATURES|CARD|peptide|pgsA|antibiotic target alteration|0
MNIPNQITVFRVVLIPVFILFALVDFGFGNVSFLGGYEIRIELLISGFIFILASLSDFVD
GYLARKWNLVTNMGKFLDPLADKLLVASALIVLVQLGLTNSVVAIIIIAREFAVTGLRLL
QIEQGFVSAAGQLGKIKTAVTMVAITWLLLGDPLATLIGLSLGQILLYIGVIFTILSGIE
YFYKGRDVFKQK
>CCP46748.1|FEATURES|CARD|aminoglycoside|gidb|antibiotic target alteration|0
MSPIEPAASAIFGPRLGLARRYAEALAGPGVERGLVGPREVGRLWDRHLLNCAVIGELLE
RGDRVVDIGSGAGLPGVPLAIARPDLQVVLLEPLLRRTEFLREMVTDLGVAVEIVRGRAE
ESWVQDQLGGSDAAVSRAVAALDKLTKWSMPLIRPNGRMLAIKGERAHDEVREHRRVMIA
SGAVDVRVVTCGANYLRPPATVVFARRGKQIARGSARMASGGTA
>CCP43073.1|FEATURES|CARD|ethambutol|iniC|antibiotic efflux|0
MSTSDRVRAILHATIQAYRGAPAYRQRGDVFCQLDRIGARLAEPLRIALAGTLKAGKSTL
VNALVGDDIAPTDATEATRIVTWFRHGPTPRVTANHRGGRRANVPITRRGGLSFDLRRIN
PAELIDLEVEWPAEELIDATIVDTPGTSSLACDASERTLRLLVPADGVPRVDAVVFLLRT
LNAADVALLKQIGGLVGGSVGALGIIGVASRADEIGAGRIDAMLSANDVAKRFTRELNQM
GICQAVVPVSGLLALTARTLRQTEFIALRKLAGAERTELNRALLSVDRFVRRDSPLPVDA
GIRAQLLERFGMFGIRMSIAVLAAGVTDSTGLAAELLERSGLVALRNVIDQQFAQRSDML
KAHTALVSLRRFVQTHPVPATPYVIADIDPLLADTHAFEELRMLSLLPSRATTLNDDEIA
SLRRIIGGSGTSAAARLGLDPANSREAPRAALAAAQHWRRRAAHPLNDPFTTRACRAAVR
SAEAMVAEFSARR
>NP_312937.1|FEATURES|CARD|rifampin|rpoB|antibiotic target alteration|0
MVYSYTEKKRIRKDFGKRPQVLDVPYLLSIQLDSFQKFIEQDPEGQYGLEAAFRSVFPIQ
SYSGNSELQYVSYRLGEPVFDVQECQIRGVTYSAPLRVKLRLVIYEREAPEGTVKDIKEQ
EVYMGEIPLMTDNGTFVINGTERVIVSQLHRSPGVFFDSDKGKTHSSGKVLYNARIIPYR
GSWLDFEFDPKDNLFVRIDRRRKLPATIILRALNYTTEQILDLFFEKVIFEIRDNKLQME
LVPERLRGETASFDIEANGKVYVEKGRRITARHIRQLEKDDVKLIEVPVEYIAGKVVAKD
YIDESTGELICAANMELSLDLLAKLSQSGHKRIETLFTNDLDHGPYISETLRVDPTNDRL
SALVEIYRMMRPGEPPTREAAESLFENLFFSEDRYDLSAVGRMKFNRSLLREEIEGSGIL
SKDDIIDVMKKLIDIRNGKGEVDDIDHLGNRRIRSVGEMAENQFRVGLVRVERAVKERLS
LGDLDTLMPQDMINAKPISAAVKEFFGSSQLSQFMDQNNPLSEITHKRRISALGPGGLTR
ERAGFEVRDVHPTHYGRVCPIETPEGPNIGLINSLSVYAQTNEYGFLETPYRKVTDGVVT
DEIHYLSAIEEGNYVIAQANSNLDEEGHFVEDLVTCRSKGESSLFSRDQVDYMDVSTQQV
VSVGASLIPFLEHDDANRALMGANMQRQAVPTLRADKPLVGTGMERAVAVDSGVTAVAKR
GGVVQYVDASRIVIKVNEDEMYPGEAGIDIYNLTKYTRSNQNTCINQMPCVSLGEPVERG
DVLADGPSTDLGELALGQNMRVAFMPWNGYNFEDSILVSERVVQEDRFTTIHIQELACVS
RDTKLGPEEITADIPNVGEAALSKLDESGIVYIGAEVTGGDILVGKVTPKGETQLTPEEK
LLRAIFGEKASDVKDSSLRVPNGVSGTVIDVQVFTRDGVEKDKRALEIEEMQLKQAKKDL
SEELQILEAGLFSRIRAVLVAGGVEAEKLDKLPRDRWLELGLTDEEKQNQLEQLAEQYDE
LKHEFEKKLEAKRRKITQGDDLAPGVLKIVKVYLAVKRRIQPGDKMAGRHGNKGVISKIN
PIEDMPYDENGTPVDIVLNPLGVPSRMNIGQILETHLGMAAKGIGDKINAMLKQQQEVAK
LREFIQRAYDLGADVRQKVDLSTFSDEEVMRLAENLRKGMPIATPVFDGAKEAEIKELLK
LGDLPTSGQIRLYDGRTGEQFERPVTVGYMYMLKLNHLVDDKMHARSTGSYSLVTQQPLG
GKAQFGGQRFGEMEVWALEAYGAAYTLQEMLTVKSDDVNGRTKMYKNIVDGNHQMEPGMP
ESFNVLLKEIRSLGINIELEDE
>AFK58562.1|FEATURES|CARD|multidrug|evgA|antibiotic target alteration|0
MIKVLLVDDHEMVRLGVSSYLSIQEDIEVIGEAENGRQGYEKAMTLRPDVILMDLVMEEM
DGIESTKAILKDWPEAKIIIVTSFIDDEKVYPAIEAGAAGYLLKTSTAHEIADAIRATQR
GERVLEPEVTTKMMEKMSRRNEPVLHEELTNRENEILMLISEGKSNQEIADELFITLKTV
KTHVSNILAKLEVEDRTQAAIYAFKHGLVK
>YP_039997.1|FEATURES|CARD|peptide|rpoC|antibiotic target alteration|0
MIDVNNFHYMKIGLASPEKIRSWSFGEVKKPETINYRTLKPEKDGLFCERIFGPTKDWEC
SCGKYKRVRYKGMVCDRCGVEVTKSKVRRERMGHIELAAPVSHIWYFKGIPSRMGLLLDM
SPRALEEVIYFASYVVVDPGPTGLEKKTLLSEAEFRDYYDKYPGQFVAKMGAEGIKDLLE
EIDLDEELKLLRDELESATGQRLTRAIKRLEVVESFRNSGNKPSWMILDVLPIIPPEIRP
MVQLDGGRFATSDLNDLYRRVINRNNRLKRLLDLGAPGIIVQNEKRMLQEAVDALIDNGR
RGRPVTGPGNRPLKSLSHMLKGKQGRFRQNLLGKRVDYSGRSVIAVGPSLKMYQCGLPKE
MALELFKPFVMKELVQREIATNIKNAKSKIERMDDEVWDVLEEVIREHPVLLNRAPTLHR
LGIQAFEPTLVEGRAIRLHPLVTTAYNADFDGDQMAVHVPLSKEAQAEARMLMLAAQNIL
NPKDGKPVVTPSQDMVLGNYYLTLERKDAVNTGAIFNNTNEVLKAYANGFVHLHTRIGVH
ASSFNNPTFTEEQNKKILATSVGKIIFNEIIPDSFAYINEPTQENLERKTPNRYFIDPTT
LGEGGLKEYFENEELIEPFNKKFLGNIIAEVFNRFSITDTSMMLDRMKDLGFKFSSKAGI
TVGVADIVVLPDKQQILDEHEKLVDRITKQFNRGLITEEERYNAVVEIWTDAKDQIQGEL
MQSLDKTNPIFMMSDSGARGNASNFTQLAGMRGLMAAPSGKIIELPITSSFREGLTVLEY
FISTHGARKGLADTALKTADSGYLTRRLVDVAQDVIVREEDCGTDRGLLVSDIKEGTEMI
EPFIERIEGRYSKETIRHPETDEVIIRPDELITPEIAKKITDAGIEQMYIRSAFTCNARH
GVCEKCYGKNLATGEKVEVGEAVGTIAAQSIGEPGTQLTMRTFHTGGVAGSDITQGLPRI
QEIFEARNPKGQAVITEIEGVVEDIKLAKDRQQEIVVKGANETRSYLASGTSRIIVEIGQ
PVQRGEVLTEGSIEPKNYLSVAGLNATESYLLKEVQKVYRMQGVEIDDKHVEVMVRQMLR
KVRIIEAGDTKLLPGSLVDIHNFTDANREAFKHRKRPATAKPVLLGITKASLETESFLSA
ASFQETTRVLTDAAIKGKRDDLLGLKENVIIGKLIPAGTGMRRYSDVKYEKTAKPVAEVE
SQTEVTE
>CCP44816.1|FEATURES|CARD|beta_lactam|ampC|antibiotic target alteration|0
MRALIIVDVQNDFCEGGSLAVTGGAALARAISDYLAEAADYHHVVATKDFHIDPGDHFSG
TPDYSSSWPPHCVSGTPGADFHPSLDTSAIEAVFYKGAYTGAYSGFEGVDENGTPLLNWL
RQRGVDEVDVVGIATDHCVRQTAEDAVRNGLATRVLVDLTAGVSADTTVAALEEMRTASV
ELVCSS
>AAL82403.1|FEATURES|CARD|quinolone|gyrA|antibiotic target alteration|0
MTDLTRLPEHDVSTGIEPVSIIEEMQCSYLDYAMSVIVSRALPDVRDGLKPVHRRILHAM
NEMGLLFNKPYRKSAGVVGEVMGKFHPHGDASIYDALVRMAQDFSLRNPLIDGQGNFGSV
DGDPPAAMRYTECRLEKVAEELLADIDKDTVDFQDNYDGREHEPIVLPARFPNLLVNGSG
GIAVGMATNIPPHNLGEVIDGCVALIDNPNITIDEMLAIIPGPDFPTGGIILGHSGVRSA
YETGRGSIIMRAKVEIEEIRNQRQAIIVSEIPYQVNKATMVEKMAELVRDKRIEGISDLR
DESDRDGYRVVIELKREAVADVVLNQLYRYTPLQASFGCNMVALNGGKPEQMTLLDMLRA
FVSFREEVVSRRTKYLLRKARERAHVLVGLAIAVANIDEIIELIRKAHDPQTARTQLMER
RWPASEVAALIKLIDDPRHIIHEDNTYNLSEEQARAILELRLQRLTALGRNEIADELNAI
GEDIADYLGILASRSRIMDIVKSELSALRETFATPRRTVFGFGSAEMDCEDLIVPEDMVV
TVSHSGYIKRVPLNTYRAQRRGGKGRSGMATKDQDFVTRLFVANTHTPVLFFSSRGIVYK
EKVWRLPVGTPQSRGRALINMLPLQQGERITTIMPLPEDEASWGKLDIMFATTRGTVRRN
KLSDFIQVNRNGKIAMKLDEEGDEILSVETCTEHDDVVLITANGQCIRFPVTDIRVFSGR
NSMGVRGINMVEGDKVISMTILEHVEATSVERSAYIKRAINERRVAGSDDEDILTVDEDG
EETEVELTDERYAELSAHEQMLLTVSEFGYGKRSSSYDFRISGRGGKGIRATDLSKAAEI
GKLVAAFPVGERDQIMLVSDGGQLIRVPVNCIRIAGRSTKGVTVFNTAKGEKVVSVERIS
ESENDTNQLDIESEEHSGTVSMSEEKKL
>ADJ67256|FEATURES|CARD|peptide|mprF|antibiotic target alteration|0
MNQEVKNKIFSILKITFATALFIFVAITLYRELSGINFKDTLVEFSKINRMSLVLLFIGG
GASLVILSMYDVILSRALKMDISLGKVLRVSYIINALNAIVGFGGFIGAGVRAMVYKNYT
HDKKKLVHFISLILISMLTGLSLLSLLIVFHVFDASLILDKITWVRWVLYVVSFFLPLFI
IYSMVRPPDKNNRFVGLYCTLVSCVEWLAAAVVLYFCGVIVDAHVSFMSFIAIFIIAALS
GLVSFIPGGFGAFDLVVLLGFKTLGVPEEKVLLMLLLYRFAYYFVPVIIALILSSFEFGT
SAKKYIEGSKYFIPAKDVTSFLMSYQKDIIAKIPSLSLAILVFFTSMINLTIVYDALYDG
NHLTYYILLAIHTSACLLLLLNVVGIYKQSRRAIIFAMISILLITVATFFTYASYILITW
LAIIFVLLIVAFRRARRLKRPVRMRNIVAMLLFSLFILYVNHIFIAGTLYALDIYTIEMH
TSVLRYYFWLTILIIAIIIGMIAWLFDYQFSKVRISSKIEDCEEIINQYGGNYLSHLIYS
GDKQFFTNENKTAFLMYRYKASSLVVLGDPLGDENAFDELLEAFYNYAEYLGYDVIFYQV
TDQHMPLYHNFGNQFFKLGEEAIIDLTQFSTSGKKRRGFRATLNKFDELNISFEIIEPPF
STEFINELQHVSDLWLDNRQEMHFSVGEFNEEYLSKAPIGVMRNEENEVIAFCSLMPTYF
NDAISVDLIRWLPELDLPLMDGLYLHMLLWSKEQGYTKFNMGMATLSNVGQLHYSYLRER
LAGRVFEHFNGLYRFQGLRRYKSKYNPNWEPRFLVYRKDNSLWESLSKVMRVIRHK
>AFK58561.1|FEATURES|CARD|multidrug|evgS|antibiotic target alteration|0
MMGKISRAMLAVYSGIAAFLIILFSLFTYFYASNQSHWWGELLRARLLYVPLIFHLLAIS
LGVGLIVFLLLSLIQKTKYGKIEEKLRALSSGNYESKLLLLPIPSASDDLYIKDIDKEIT
KIKEKMIEVSSELQIVTSRPQYVDGQTKEEILELERHRLARELHDSVSQQLFAAMMMMSA
LTEQAEKSETPEMFRKQLKMVAEIINASQSEMRALLLHLRPVNLEEKSLKQGIEQLLKEL
QNKIQISLKWDVEDVKLSSSIEDHLFRIVQELLSNTLRHAKANELEVYLHKIDNNLLLRI
IDDGTGFNMNETKTGSYGLNNIKERVAGIGGTVKIISFKGQGTSVEIKVPLMKEA
>YP_039483.1|FEATURES|CARD|beta_lactam|ampC|antibiotic target alteration|0
MAELPQSRINERNITSEMRESFLDYAMSVIVARALPDVRDGLKPVHRRILYGLNEQGMTP
DKSYKKSARIVGDVMGKYHPHGDLSIYEAMVRMAQDFSYRYPLVDGQGNFGSMDGDGAAA
MRYTEARMTKITLELLRDINKDTIDFIDNYDGNEREPSVLPARFPNLLANGASGIAVGMA
TNIPPHNLTELINGVLSLSKNPDISIAELMEDIEGPDFPTAGLILGKSGIRRAYETGRGS
IQMRSRAVIEERGGGRQRIVVTEIPFQVNKARMIEKIAELVRDKKIDGITDLRDETSLRT
GVRVVIDVRKDANASVILNNLYKQTPLQTSFGVNMIALVNGRPKLINLKEALVHYLEHQK
TVVRRRTQYNLRKAKDRAHILEGLRIALDHIDEIISTIRESETDKVAMESLQQRFKLSEK
QAQAILDMRLRRLTGLERDKIEAEYNELLNYISELEAILADEEVLLQLVRDELTEIRDRF
GDDRRTEIQLGGFEDLEDEDLIPEEQIVITLSHNNYIKRLPVSTYRAQNRGGRGVQGMNT
LEEDFVSQLVTLSTHDHVLFFTNKGRVYKLKGYEVPELSRQSKGIPVVNAIELENDEIIS
TMIAVKDLESEDNFLVFATKRGVVKRSALSNFSRINRNGKIAISFREDDELIAVRLTSGQ
EDILIGTSHASLIRFPESTLRPLGRTATGVKGITLREGDEVVGLDVAHANSVDEVLVVTE
NGYGKRTPVNDYRLSNRGGKGIKTATITERNGNVVCITTVTGEEDLMIVTNAGVIIRLDV
ADISQNGRAAQGVRLIRLGDDQFVSTVAKVKEDADEENEDEQSTVSEDGTEQQREAVVND
ETPGNAIHTEVIDSEVNDEDGRIEVRQDFMDRVEEDIQQSSDDDEE
>ALL09868|FEATURES|CARD|aminoglycoside|HMPREF9710_02755|antibiotic target alteration|0
MVSSIITALYLLNALIALVAILIKPRDVAAIWAWLLVLFALPGVGFVLYLFFGRGLTDKK
KFYLRQSDLKELENFQSFRGDTIEHYDPDMGDKDKQQFVDFFSSLNRMPLTRMNSVTLLT
DGQEKLDSLLQDLKKAKHSIHIEYYAFVTDNIGQQVLHVLEEKAAEGVEVRILYDAFGSH
GTKAKDFNRLIKNGGHVHTFVTSQRALLRFRLNYHDHRKIVVIDGKISYTGGFNIANQYV
NTTKKFGYWRDTHIRIFGAASSLLQLRFLTDWNVSVPEEKKVGYHLNYFFKKADRDESKL
ADTSIQLVSSGPNNEREQIKLSFIKLITSAKKRVWIQTPYLVPDESVIAALKIATASGVD
VKIMIPNKPDHPFIYRATQYYARQLIKENVQILVYENGFLHAKTLIMDDEICMVGSANQD
IRSYRLNFETSAVIYDPEFLEELATQFKEDETHCSSMTTETVKEMSNWLLFKQQISRLFS
PIL
>NP_216424.1|FEATURES|CARD|isoniazid|katG|antibiotic target alteration|0
MPEQHPPITETTTGAASNGCPVVGHMKYPVEGGGNQDWWPNRLNLKVLHQNPAVADPMGA
AFDYAAEVATIDVDALTRDIEEVMTTSQPWWPADYGHYGPLFIRMAWHAAGTYRIHDGRG
GAGGGMQRFAPLNSWPDNASLDKARRLLWPVKKKYGKKLSWADLIVFAGNCALESMGFKT
FGFGFGRVDQWEPDEVYWGKEATWLGDERYSGKRDLENPLAAVQMGLIYVNPEGPNGNPD
PMAAAVDIRETFRRMAMNDVETAALIVGGHTFGKTHGAGPADLVGPEPEAAPLEQMGLGW
KSSYGTGTGKDAITSGIEVVWTNTPTKWDNSFLEILYGYEWELTKSPAGAWQYTAKDGAG
AGTIPDPFGGPGRSPTMLATDLSLRVDPIYERITRRWLEHPEELADEFAKAWYKLIHRDM
GPVARYLGPLVPKQTLLWQDPVPAVSHDLVGEAEIASLKSQIRASGLTVSQLVSTAWAAA
SSFRGSDKRGGANGGRIRLQPQVGWEVNDPDGDLRKVIRTLEEIQESFNSAAPGNIKVSF
ADLVVLGGCAAIEKAAKAAGHNITVPFTPGRTDASQEQTDVESFAVLEPKADGFRNYLGK
GNPLPAEYMLLDKANLLTLSAPEMTVLVGGLRVLGANYKRLPLGVFTEASESLTNDFFVN
LLDMGITWEPSPADDGTYQGKDGSGKVKWTGSRVDLVFGSNSELRALVEVYGADDAQPKF
VQDFVAAWDKVMNLDRFDVR
>AAK44936.1|FEATURES|CARD|aminoglycoside|APH(2'')-Ig|antibiotic target alteration|0
MPTIQQLVRKGRRDKISKVKTAALKGSPQRRGVCTRVYTTTPKKPNSALRKVARVKLTSQ
VEVTAYIPGEGHNLQEHSMVLVRGGRVKDLPGVRYKIIRGSLDTQGVKNRKQARSRYGAK
KEKG
>CCP44620.1|FEATURES|CARD|bacitracin|uppP|antibiotic target alteration|0
MSPQQEPTAQPPRRHRVVIIGSGFGGLNAAKKLKRADVDIKLIARTTHHLFQPLLYQVAT
GIISEGEIAPPTRVVLRKQRNVQVLLGNVTHIDLAGQCVVSELLGHTYQTPYDSLIVAAG
AGQSYFGNDHFAEFAPGMKSIDDALELRGRILSAFEQAERSSDPERRAKLLTFTVVGAGP
TGVEMAGQIAELAEHTLKGAFRHIDSTKARVILLDAAPAVLPPMGAKLGQRAAARLQKLG
VEIQLGAMVTDVDRNGITVKDSDGTVRRIESACKVWSAGVSASRLGRDLAEQSRVELDRA
GRVQVLPDLSIPGYPNVFVVGDMAAVEGVPGVAQGAIQGAKYVASTIKAELAGANPAERE
PFQYFDKGSMATVSRFSAVAKIGPVEFSGFIAWLIWLVLHLAYLIGFKTKITTLLSWTVT
FLSTRRGQLTITDQQAFARTRLEQLAELAAEAQGSAASAKVAS
>CCP43410.1|FEATURES|CARD|polymyxin|arnA|antibiotic target alteration|0
MADSRQSKTAASPSPSRPQSSSNNSVPGAPNRVSFAKLREPLEVPGLLDVQTDSFEWLIG
SPRWRESAAERGDVNPVGGLEEVLYELSPIEDFSGSMSLSFSDPRFDDVKAPVDECKDKD
MTYAAPLFVTAEFINNNTGEIKSQTVFMGDFPMMTEKGTFIINGTERVVVSQLVRSPGVY
FDETIDKSTDKTLHSVKVIPSRGAWLEFDVDKRDTVGVRIDRKRRQPVTVLLKALGWTSE
QIVERFGFSEIMRSTLEKDNTVGTDEALLDIYRKLRPGEPPTKESAQTLLENLFFKEKRY
DLARVGRYKVNKKLGLHVGEPITSSTLTEEDVVATIEYLVRLHEGQTTMTVPGGVEVPVE
TDDIDHFGNRRLRTVGELIQNQIRVGMSRMERVVRERMTTQDVEAITPQTLINIRPVVAA
IKEFFGTSQLSQFMDQNNPLSGLTHKRRLSALGPGGLSRERAGLEVRDVHPSHYGRMCPI
ETPEGPNIGLIGSLSVYARVNPFGFIETPYRKVVDGVVSDEIVYLTADEEDRHVVAQANS
PIDADGRFVEPRVLVRRKAGEVEYVPSSEVDYMDVSPRQMVSVATAMIPFLEHDDANRAL
MGANMQRQAVPLVRSEAPLVGTGMELRAAIDAGDVVVAEESGVIEEVSADYITVMHDNGT
RRTYRMRKFARSNHGTCANQCPIVDAGDRVEAGQVIADGPCTDDGEMALGKNLLVAIMPW
EGHNYEDAIILSNRLVEEDVLTSIHIEEHEIDARDTKLGAEEITRDIPNISDEVLADLDE
RGIVRIGAEVRDGDILVGKVTPKGETELTPEERLLRAIFGEKAREVRDTSLKVPHGESGK
VIGIRVFSREDEDELPAGVNELVRVYVAQKRKISDGDKLAGRHGNKGVIGKILPVEDMPF
LADGTPVDIILNTHGVPRRMNIGQILETHLGWCAHSGWKVDAAKGVPDWAARLPDELLEA
QPNAIVSTPVFDGAQEAELQGLLSCTLPNRDGDVLVDADGKAMLFDGRSGEPFPYPVTVG
YMYIMKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMECWAMQAYGAAYTLQ
ELLTIKSDDTVGRVKVYEAIVKGENIPEPGIPESFKVLLKELQSLCLNVEVLSSDGAAIE
LREGEDEDLERAAANLGINLSRNESASVEDLA
>YP_500802.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|macB|antibiotic target alteration|0
MIELLSIALKHSNIILNSIFIGAFILNLLFAFTIIFMERRSANSIWAWLLVLVFLPLFGF
ILYLLLGRQIQRDQIFKIDKEDKKGLELIVDEQLAALKNENFSNSNYQIVKFKEMIQMLL
YNNAAFLTTDNDLKIYTDGQEKFDDLIQDIRNATDYIHFQYYIIQNDELGRTILNELGKK
AEQGVEVKILYDDMGSRGLRKKGLRPFRNKGGHAEAFFPSKLPLINLRMNNRNHRKIVVI
DGQIGYVGGFNVGDEYLGKSKKFGYWRDTHLRIVGDAVNALQLRFILDWNSQATRDHISY
DDRYFPDVNSGGTIGVQIASSGPDEEWEQIKYGYLKMISSAKKSIYIQSPYFIPDQAFLD
SIKIAALGGVDVNIMIPNKPDHPFVFWATLKNAASLLDAGVKVFHYDNGFLHSKTLVIDD
EIASVGTANMDHRSFTLNFEVNAFIYDQQIAKKLKQAFIDDLAVSSELTKARYAKRSLWI
KFKEGISQLLSPIL
>CDO13981.1|FEATURES|CARD|multidrug|phoQ|antibiotic target alteration|0
MRVLVVEDNALLRHHLKVQLQELGHQVDAAEDAREADYYLGEHLPDIAIVDLGLPDEDGL
SLIRRWRSHDVSLPVLVLTAREGWQDKVEVLSAGADDYVTKPFHIEEVAARMQALLRRNS
GLASQVISLPPFQVDLSRRELSVNDQPIKLTAFEYTIMETLIRNRGKVVSKDSLMLQLYP
DAELRESHTIDVLMGRLRKKIQAEYPQDVITTVRGQGYLFELR
>CCP44023.1|FEATURES|CARD|glycopeptide|vanRI|antibiotic target alteration|0
MAGSATVEKRLDFGLLGPLQMTIDGTPVPSGTPKQRAVLAMLVINRNRPVGVDALITALW
EEWPPSGARASIHSYVSNLRKLLGGAGIDPRVVLAAAPPGYRLSIPDNTCDLGRFVAEKT
AGVHAAAAGRFEQASRHLSAALREWRGPVLDDLRDFQFVEPFATALVEDKVLAHTAKAEA
EIACGRASAVIAELEALTFEHPYREPLWTQLITAYYLSDRQSDALGAYRRVKTTLADDLG
IDPGPTLRALNERILRQQPLDAKKSAKTTAAGTVTVLDQRTMASGQQAVAYLHDIASGRG
YPLQAAATRIGRLHDNDIVLDSANVSRHHAVIVDTGTNYVINDLRSSNGVHVQHERIRSA
VTLNDGDHIRICDHEFTFQISAGTHGGT
>AFN51820.1|FEATURES|CARD|ethambutol|embA|antibiotic target alteration|0
MPHDGNERSHRIARLAAVVSGIAGLLLCGIVPLLPVNQTTATIFWPQGSTADGNITQITA
PLVSGAPRALDISIPCSAIATLPANGGLVLSTLPAGGVDTGKAGLFVRANQDTVVVAFRD
SVAAVAARSTIAAGGCSALHIWADTGGAGADFMGIPGGAGTLPPEKKPQVGGIFTDLKVG
AQPGLSARVDIDTRFITTPGALKKAVMLLGVLAVLVAMVGLAALDRLSRGRTLRDWLTRY
RPRVRVGFASRLADAAVIATLLLWHVIGATSSDDGYLLTVARVAPKAGYVANYYRYFGTT
EAPFDWYTSVLAQLAAVSTAGVWMRLPATLAGIACWLIVSRFVLRRLGPGPGGLASNRVA
VFTAGAVFLSAWLPFNNGLRPEPLIALGVLVTWVLVERSIALGRLAPAAVAIIVATLTAT
LAPQGLIALAPLLTGARAIAQRIRRRRATDGLLAPLAVLAAALSLITVVVFRDQTLATVA
ESARIKYKVGPTIAWYQDFLRYYFLTVESNVEGSMSRRFAVLVLLFCLFGVLFVLLRRGR
VAGLASGPAWRLIGTTAVGLLLLTFTPTKWAVQFGAFAGLAGVLGAVTAFTFARIGLHSR
RNLTLYVTALLFVLAWATSGINGWFYVGNYGVPWYDIQPVIASHPVTSMFLTLSILTGLL
AAWYHFRMDYAGHTEVKDNRRNRILASTPLLVVAVIMVAGEVGSMAKAAVFRYPLYTTAK
ANLTALSTGLSSCAMADDVLAEPDPNAGMLQPVPGQAFGPDGPLGGISPVGFKPEGVGED
LKSDPVVSKPGLVNSDASPNKPNAAITDSAGTAGGKGPVGINGSHAALPFGLDPARTPVM
GSYGENNLAATATSAWYQLPPRSPDRPLVVVSAAGAIWSYKEDGDFIYGQSLKLQWGVTG
PDGRIQPLGQVFPIDIGPQPAWRNLRFPLAWAPPEADVARIVAYDPNLSPEQWFAFTPPR
VPVLESLQRLIGSATPVLMDIATAANFPCQRPFSEHLGIAELPQYRILPDHKQTAASSNL
WQSSSTGGPFLFTQALLRTSTIATYLRGDWYRDWGSVEQYHRLVPADQAPDAVVEEGVIT
VPGWGRPGPIRALP
>WP_005768149.1|FEATURES|CARD|aminocoumarin|gyrB|antibiotic target alteration|0
MSDETTSPTSGDYGAASIKVLKGLDAVRKRPGMYIGDTDDGSGLHHMVYEVVDNAIDEAL
AGYATLVNVTLHADGSCSVCDNGRGIPTDIHPTEHVSAAEVIMTQLHAGGKFDQNSYKVS
GGLHGVGVSVVNALSVWLRLRIKRDGKIHEMSFTHGVADAPLKVVGQCGTESGTEISFLP
SPETFTMVKFDFETLERRLRELAFLNSGVHILLVNQHHADVRSVELYYEGGLIEFIKYID
QSKKPLIDAPIYITSEKDGISVDVALWWNDSYHEKVLCFTNNIPQRDGGTHLAGFRSALT
RQINGYAESSGIAKKEKVNLTGDDCREGLTAILSVKVPDPKFSSQTKDKLVSSEVRPIVE
NLVNEGLSAWLEEHPNEAKILISKVVEAAAAREAARKARELTRRKGALDITSLPGKLADC
QERDPTKSEIFIVEGDSAGGSAKSGRSRQNQAILPLRGKILNVERARFDRMLSSEMIGTL
ITALGTSIGKDEFSPDKLRYHKIIIMTDADVDGAHIRTLLLTFFFRQMPELIERGHLYIA
QPPLYKVSRGKSSQYIKNEAAFEDFLIDSGLEETTLELSSGEVCAGIDLRQFVQDARLLR
QLLNGLHTRYDRNIVEQAAIAGAFNFEAFATPETAQKIADTIAKRLDLIADDMERGWSGQ
YTSDGSLCFERVLRGVKDVITLDAGFINSADARQIGHIAKNLKDIYRDPPLLRRKDKSER
IFGPTSLLESIFINGKKGITLQRYKGLGEMNADQLWETTLDPDARSLLQVKINDATDADS
LFSQLMGDEVEPRRIFIQKNALNVANLDI
>AAB57788.1|FEATURES|CARD|rifampin|rphB|reduced permeability to antibiotic|0
MKKSLIALTLAALPVAATADVTLYGAIKAGVQTYRSVEHTKGKVSKVETGSEIADFGSKI
GFKGQEDLGNGLKAVWQLEQGASVAGTNTGWGNKQSFVGLKGGFGTIRAGSLNSPLKNTG
ANVNAWESGKFTGNVLEISGMAQREHRYLSVRYDSPEFAGFSGSVQYAPKDNSGSNGESY
HVGLNYRNNGFFAQYAGLFQRYGEGTKKIEYEHQVYSIPSLFVEKLQVHRLVGGYDNNAL
YVSVAAQQQDAKLYGARRANSHNSQTEVAATAAYRFGNVTPRVSYAHGFKGTVDSADHDN
TYDQVVVGAEYDFSKRTSALVSAGWLQEGKGADKIVSTASAVVLRHKF
>AFN51819.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|msrE|antibiotic target alteration|0
MATEAAPPRIAVRLPSTSVRDAGANYRIARYVAVVAGLLGAVLAIATPLLPVNQTTAQLN
WPQNGTFASVEAPLIGYVATDLNITVPCQAAAGLAGSQNTGKTVLLSTVPKQAPKAVDRG
LLLQRANDDLVLVVRNVPLVTAPLSQVLGPTCQRLTFTAHADRVAAEFVGLVQGPNAEHP
GAPLRGERSGYDFRPQIVGVFTDLAGPAPPGLSFSASVDTRYSSSPTPLKMAAMILGVAL
TGAALVALHILDTADGMRHRRFLPARWWSTGGLDTLVIAVLVWWHFVGANTSDDGYILTM
ARVSEHAGYMANYYRWFGTPEAPFGWYYDLLALWAHVSTASIWMRLPTLAMALTCWWVIS
REVIPRLGHAVKTSRAAAWTAAGMFLAVWLPLDNGLRPEPIIALGILLTWCSVERAVATS
RLLPVAIACIIGALTLFSGPTGIASIGALLVAIGPLRTILHRRSRRFGVLPLVAPILAAA
TVTAIPIFRDQTFAGEIQANLLKRAVGPSLKWFDEHIRYERLFMASPDGSIARRFAVLAL
VLALAVSVAMSLRKGRIPGTAAGPSRRIIGITIISFLAMMFTPTKWTHHFGVFAGLAGSL
GALAAVAVTGAAMRSRRNRTVFAAVVVFVLALSFASVNGWWYVSNFGVPWSNSFPKWRWS
LTTALLELTVLVLLLAAWFHFVANGDGRRTARPTRFRARLAGIVQSPLAIATWLLVLFEV
VSLTQAMISQYPAWSVGRSNLQALAGKTCGLAEDVLVELDPNAGMLAPVTAPLADALGAG
LSEAFTPNGIPADVTADPVMERPGDRSFLNDDGLITGSEPGTEGGTTAAPGINGSRARLP
YNLDPARTPVLGSWRAGVQVPAMLRSGWYRLPTNEQRDRAPLLVVTAAGRFDSREVRLQW
ATDEQAAAGHHGGSMEFADVGAAPAWRNLRAPLSAIPSTATQVRLVADDQDLAPQHWIAL
TPPRIPRVRTLQNVVGAADPVFLDWLVGLAFPCQRPFGHQYGVDETPKWRILPDRFGAEA
NSPVMDHNGGGPLGITELLMRATTVASYLKDDWFRDWGALQRLTPYYPDAQPADLNLGTV
TRSGLWSPAPLRRG
>CCP44244.1|FEATURES|CARD|beta_lactam|ROB-1|antibiotic target alteration|0
MTGLLDGKRILVSGIITDSSIAFHIARVAQEQGAQLVLTGFDRLRLIQRITDRLPAKAPL
LELDVQNEEHLASLAGRVTEAIGAGNKLDGVVHSIGFMPQTGMGINPFFDAPYADVSKGI
HISAYSYASMAKALLPIMNPGGSIVGMDFDPSRAMPAYNWMTVAKSALESVNRFVAREAG
KYGVRSNLVAAGPIRTLAMSAIVGGALGEEAGAQIQLLEEGWDQRAPIGWNMKDATPVAK
TVCALLSDWLPATTGDIIYADGGAHTQLL
>CAC29513.1|FEATURES|CARD|quinolone|gyrB|antibiotic target alteration|0
MAAQRKAQDEYGAASITILEGLEAVRKRPGMYVGSTGERGLHHLIWEVVDNSVDEAMAGY
ATQVDVRLFDDGSVEVADNGRGIPVAVHATGVPTVDVVMTQLHAGGKFGGKDSGYNVSGG
LHGVGVSVVNALSTRVEVDIKRDGYEWSQFYDKAVPGILKQGEATEATGTTIRFWADPDI
FETTKYDFGTVARRIQEVAFLNKGLTINLVDERVKQDEVVDDVVSDTAEAPVAMTVEEKS
TESSAPHKVRHRTFHYPGGLVDFVKHINRTKTPIQQSIIDFDGKGAGHEVEVAMQWNGGY
SESVHTFANTINTHEGGTHEEGFRSALTSVVNKYAKDKKLLKDKDPNLTGDDIREGLAAV
ISVKVSEPQFEGQTKTKLGNTEVKSFVQRVCNEQLIHWFEANPVDAKAVVNKAISSAQAR
IAARKARELVRRKSATDLGGLPGKLADCRSTDPRSSELYVVEGDSAGGSAKSGRDSMFQA
ILPLRGKIINVEKARIDRVLKNTEVQAIITALGTGIHDEFDISRLRYHKIVLMADADVDG
QHISTLLLTLLFRFMRPLIEHGYVFLAQPPLYKLKWQRMDPEFAYSDSERDGLLETGLKL
GKKINKEDGIQRYKGLGEMDAKELWETTMDPSVRVLRQVTLDDAAAADELFSILMGEDVD
ARRSFITRNAKDVRFLDV
>YP_039482.1|FEATURES|CARD|bacitracin|uppP|antibiotic target alteration|0
MVTALSDVNNTDNYGAGQIQVLEGLEAVRKRPGMYIGSTSERGLHHLVWEIVDNSIDEAL
AGYANQIEVVIEKDNWIKVTDNGRGIPVDIQEKMGRPAVEVILTVLHAGGKFGGGGYKVS
GGLHGVGSSVVNALSQDLEVYVHRNETIYHQAYKKGVPQFDLKEVGTTDKTGTVIRFKAD
GEIFTETTVYNYETLQQRIRELAFLNKGIQITLRDERDEENVREDSYHYEGGIKSYVELL
NENKEPIHDEPIYIHQSKDDIEVEIAIQYNSGYATNLLTYANNIHTYEGGTHEDGFKRAL
TRVLNSYGLSSKIMKEDKDRLSGEDTREGMTAIISIKHGDPQFEGQTKTKLGNSEVRQVV
DKLFSEHFERFLYENPQVARTVVEKGIMAARARVAAKKAREVTRRKSALDVASLPGKLAD
CSSKSPEECEIFLVEGDSAGGSTKSGRDSRTQAILPLRGKILNVEKARLDRILNNNEIRQ
MITAFGTGIGGDFDLAKARYHKIVIMTDADVDGAHIRTLLLTFFYRFMRPLIEAGYVYIA
QPPLYKLTQGKQKYYVYNDRELDKLKSELNPTPKWSIARYKGLGEMNADQLWETTMNPEH
RALLQVKLEDAIEADQTFEMLMGDVVENRRQFIEDNAVYANLDF
>AAK46002.1|FEATURES|CARD|aminoglycoside|tlyA|antibiotic target alteration|0
MARRARVDAELVRRGLARSRQQAAELIGAGKVRIDGLPAVKPATAVSDTTALTVVTDSER
AWVSRGAHKLVGALEAFAIAVAGRRCLDAGASTGGFTEVLLDRGAAHVVAADVGYGQLAW
SLRNDPRVVVLERTNARGLTPEAIGGRVDLVVADLSFISLATVLPALVGCASRDADIVPL
VKPQFEVGKGQVGPGGVVHDPQLRARSVLAVARRAQELGWHSVGVKASPLPGPSGNVEYF
LWLRTQTDRALSAKGLEDAVHRAISEGP
>CCP42728.1|FEATURES|CARD|fosmidomycin|rosa|antibiotic target alteration|0
MTDTTLPPDDSLDRIEPVDIEQEMQRSYIDYAMSVIVGRALPEVRDGLKPVHRRVLYAMF
DSGFRPDRSHAKSARSVAETMGNYHPHGDASIYDSLVRMAQPWSLRYPLVDGQGNFGSPG
NDPPAAMRYTEARLTPLAMEMLREIDEETVDFIPNYDGRVQEPTVLPSRFPNLLANGSGG
IAVGMATNIPPHNLRELADAVFWALENHDADEEETLAAVMGRVKGPDFPTAGLIVGSQGT
ADAYKTGRGSIRMRGVVEVEEDSRGRTSLVITELPYQVNHDNFITSIAEQVRDGKLAGIS
NIEDQSSDRVGLRIVIEIKRDAVAKVVINNLYKHTQLQTSFGANMLAIVDGVPRTLRLDQ
LIRYYVDHQLDVIVRRTTYRLRKANERAHILRGLVKALDALDEVIALIRASETVDIARAG
LIELLDIDEIQAQAILDMQLRRLAALERQRIIDDLAKIEAEIADLEDILAKPERQRGIVR
DELAEIVDRHGDDRRTRIIAADGDVSDEDLIAREDVVVTITETGYAKRTKTDLYRSQKRG
GKGVQGAGLKQDDIVAHFFVCSTHDLILFFTTQGRVYRAKAYDLPEASRTARGQHVANLL
AFQPEERIAQVIQIRGYTDAPYLVLATRNGLVKKSKLTDFDSNRSGGIVAVNLRDNDELV
GAVLCSAGDDLLLVSANGQSIRFSATDEALRPMGRATSGVQGMRFNIDDRLLSLNVVREG
TYLLVATSGGYAKRTAIEEYPVQGRGGKGVLTVMYDRRRGRLVGALIVDDDSELYAVTSG
GGVIRTAARQVRKAGRQTKGVRLMNLGEGDTLLAIARNAEESGDDNAVDANGADQTGN
>CCP45025.1|FEATURES|CARD|isoniazid|kasA|antibiotic target alteration|0
MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKI
GGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAE
RIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAH
AWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFG
EAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGL
SPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVL
TLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY
>CAA55486.1|FEATURES|CARD|quinolone|gyrB|antibiotic target alteration|0
MGKNEARRSALAPDHGTVVCDPLRRLNRMHATPEESIRIVAAQKKKAQDEYGAASITILE
GLEAVRKRPGMYIGSTGERGLHHLIWEVVDNAVDEAMAGYATTVNVVLLEDGGVEVADDG
RGIPVATHASGIPTVDVVMTQLHAGGKFDSDAYAISGGLHGVGVSVVNALSTRLEVEIKR
DGYEWSQVYEKSEPLGLKQGAPTKKTGSTVRFWADPAVFETTEYDFETVARRLQEMAFLN
KGLTINLTDERVTQDEVVDEVVSDVAEAPKSASERAAESTAPHKVKSRTFHYPGGLVDFV
KHINRTKNAIHSSIVDFSGKGTGHEVEIAMQWNAGYSESVHTFANTINTHEGGTHEEGFR
SALTSVVNKYAKDRKLLKDKDPNLTGDDIREGLAAVISVKVSEPQFEGQTKTKLGNTEVK
SFVQKVCNEQLTHWFEANPTDAKVVVNKAVSSAQARIAARKARELVRRKSATDIGGLPGK
LADCRSTDPRKSELYVVEGDSAGGSAKSGRDSMFQAILPLRGKIINVEKARIDRVLKNTE
VQAIITALGTGIHDEFDIGKLRYHKIVLMADADVDGQHISTLLLTLLFRFMRPLIENGHV
FLAQPPLYKLKWQRSDPEFAYSDRERDGLLEAGLKAGKKINKEDGIQRYKGLGEMDAKEL
WETTMDPSVRVLRQVTLDDAAAADELFSILMGEDVDARRSFITRNAKDVRFLDV
>WP_009887863.1|FEATURES|CARD|tetracycline|tetW|antibiotic target alteration|0
MAKAKYERTKPHVNIGTIGHVDHGKTTLTAAITKTLYDRYQLGEAVDFANIDKAPEERER
GITISTAHVEYETPNRHYAHVDCPGHADYVKNMITGAAQMDGAILVCSATDGPMPQTREH
ILLSRQVGVPYIVVFLNKCDMVDDEELLELVEMEVRDLLTEYDFPGDDTPIVRGSALMAL
EDPKSEWGDKIVELFEQIDEYIPAPERDTDKPFLMPVEDVFSITGRGTVATGRVERGVLK
VQDEVELVGLTEAPRKVVVTGVEMFRKLLDQAQAGDNIGALLRGVQRNEIERGQVLAKTG
SVKAHTKFTAEVYVLKKEEGGRHTPFFDGYRPQFYFRTTDVTGACKLPEGIEMVMPGDNV
TMEVDLINSIVVEEGLRFSIREGGRTVASGVVATIIE
>AAA50993.1|FEATURES|CARD|tetracycline|tetW|antibiotic target alteration|0
MSKEKFERTKPHVNVGTIGHVDHGKTTLTAAITTVLAKTYGGAARAFDQIDNAPEEKARG
ITINTSHVEYDTPTRHYAHVDCPGHADYVKNMITGAAQMDGAILVVAATDGPMPQTREHI
LLGRQVGVPYIIVFLNKCDMVDDEELLELVEMEVRELLSQYDFPGDDTPIVRGSALKALE
GDAEWEAKILELAGFLDSYIPEPERAIDKPFLLPIEDVFSISGRGTVVTGRVERGIIKVG
EEVEIVGIKETQKSTCTGVEMFRKLLDEGRAGENVGVLLRGIKREEIERGQVLAKPGTIK
PHTKFESEVYILSKDEGGRHTPFFKGYRPQFYFRTTDVTGTIELPEGVEMVMPGDNIKMV
VTLIHPIAMDDGLRFAIREGGRTVGAGVVAKVLG
>CDO45096.1|FEATURES|CARD|beta_lactam|Sbal223_2079|antibiotic target alteration|0
MTQCASRRKSTPSRAILGAFASARGTRWVATIAGLIGFVLSVATPLLPVVQTTAMLDWPQ
RGQLGSVTAPLISLTPVDFTATVPCDVVRAMPPAGGVVLGTAPKQGKDANLQALFVVVSA
QRVDVTDRNVVILSVPREQVTSPQCQRIEVTSTHAGTFANFVGLKDPSGAPLRSGFPDPN
LRPQIVGVFTDLTGPAPPGLAVSATIDTRFSTRPTTLKLLAIIGAIVATVVALIALWRLD
QLDGRGSIAQLLLRPFRPASSPGGMRRLIPASWRTFTLTDAVVIFGFLLWHVIGANSSDD
GYILGMARVADHAGYMSNYFRWFGSPEDPFGWYYNLLALMTHVSDASLWMRLPDLAAGLV
CWLLLSREVLPRLGPAVAASKPAYWAAAMVLLTAWMPFNNGLRPEGIIALGSLVTYVLIE
RSMRYSRLTPAALAVVTAAFTLGVQPTGLIAVAALVAGGRPMLRILVRRHRLVGTLPLVS
PMLAAGTVILTVVFADQTLSTVLEATRVRAKIGPSQAWYTENLRYYYLILPTVDGSLSRR
FGFLITALCLFTAVFIMLRRKRIPSVARGPAWRLMGVIFGTMFFLMFTPTKWVHHFGLFA
AVGAAMAALTTVLVSPSVLRWSRNRMAFLAALFFLLALCWATTNGWWYVSSYGVPFNSAM
PKIDGITVSTIFFALFAIAAGYAAWLHFAPRGAGEGRLIRALTTAPVPIVAGFMAAVFVA
SMVAGIVRQYPTYSNGWSNVRAFVGGCGLADDVLVEPDTNAGFMKPLDGDSGSWGPLGPL
GGVNPVGFTPNGVPEHTVAEAIVMKPNQPGTDYDWDAPTKLTSPGINGSTVPLPYGLDPA
RVPLAGTYTTGAQQQSTLVSAWYLLPKPDDGHPLVVVTAAGKIAGNSVLHGYTPGQTVVL
EYAMPGPGALVPAGRMVPDDLYGEQPKAWRNLRFARAKMPADAVAVRVVAEDLSLTPEDW
IAVTPPRVPDLRSLQEYVGSTQPVLLDWAVGLAFPCQQPMLHANGIAEIPKFRITPDYSA
KKLDTDTWEDGTNGGLLGITDLLLRAHVMATYLSRDWARDWGSLRKFDTLVDAPPAQLEL
GTATRSGLWSPGKIRIGP
>WP_004025678.1|FEATURES|CARD|quinolone|gyrB|antibiotic target alteration|0
MNDSNKENKYTAESIKVLEGLEAVRKRPGMYIGSTQSEGLHHMIWEIVDNSIDEAMGGFA
TVVKVIIKKDGVIRVEDDGRGIPVGIHEKTGLSGVETVLTVLHAGGKFDNDSYKVSGGLH
GVGASVVNALSKNFKVWVNKNYVQHYVEFINGGHAIEPLKIINDKDIKEKGTTIEFIPDF
EIMEENEWDELKIMARLKQLAYLNKGVNIEFESEMTNRKEKWHYEGGLKEYIADLNAEKE
PLFDAIVYGEEEKEVKVPGHNDQTYNIKCEVAFQYNNSYNNSTHSFCNNINTTEGGTHEE
GFKLAITRLLNKYAIDKKYLKDTDDKITKEDVSEGLTAIISIKHPNPQYEGQTKKKLGNS
EVRPYVNEITSIIFEKFLNENPEESKKIVAKVMQAAEARRRSHEAREATRRKSPFESNSL
PGKLADCSNRDSSVTEIYIVEGDSAGGSAKTGREREFQAILPLRGKIINVEKAKIDKIFA
NEEIQNMITAFGAGIGPEFNIEKLRYSKIIIMTDADVDGSHIRILLLTFFYRYMLPLIQN
GNVYIAQPPLYKVSYGKTIKYAYSDQELEKIKSTLLNTKYNIQRYKGLGEMNPDQLWETT
MDPKNRLLLKVNIEDAAIADKTFSLLMGDDVTPRKEFIEKNAKYVKNIDA
>AAN82549.1|FEATURES|CARD|tetracycline|tetW|antibiotic target alteration|0
MLSPEGESTIVRNIAVSKEKFERTKPHVNVGTIGHVDHGKTTLTAAITTVLAKTYGGAAR
AFDQIDNAPEEKARGITINTSHVEYDTPTRHYAHVDCPGHADYVKNMITGAAQMDGAILV
VAATDGPMPQTREHILLGRQVGVPYIIVFLNKCDMVDDEELLELVEMEVRELLSQYDFPG
DDTPIVRGSALKALEGDAEWEAKILELAGFLDSYIPEPERAIDKPFLLPIEDVFSISGRG
TVVTGRVERGIIKVGEEVEIVGIKETQKSTCTGVEMFRKLLDEGRAGENVGVLLRGIKRE
EIERGQVLAKPGTIKPHTKFESEVYILSKDEGGRHTPFFKGYRPQFYFRTTDVTGTIELP
EGVEMVMPGDNIKMVVTLIHPIAMDDGLRFAIREGGRTVGAGVVAKVLG
>AAK11270.1|FEATURES|CARD|trimethoprim|dfrA5|reduced permeability to antibiotic|0
MKVKVLSLLVPALLVAGAANAAEIYNKDGNKLDLYGKIDGLHYFSSDDSVDGDQTYMRIG
VKGETQINDQLTGYGQWEYNVQANNTESSSDQAWTRLAFAGLKFGDAGSFDYGRNYGVVY
DVTSWTDVLPEFGGDTYGSDNFLQSRANGVATYRNSDFFGLVDGLNFALQYQGKNGSVSG
EDQTNNGRDFQKQNGEGFGTSVTYDIWDGISAGFAYSSSKRTDEQNNSTFVSKTDGGRYG
VLGEGDHAETYTGGLKYDANNIYLATQYTQTYNATRTGNIGFANKAQNFEVVAQYQFDFG
LRPSVAYLQSKGKDMGRYGDQDILKYVDLGATYYFNKNMSTYVDYKINLLDDNKFTKDAS
ISTDNVVALGLVYQF
>AAC75291.1|FEATURES|CARD|beta_lactam|ampC|antibiotic target alteration|0
MSDLAREITPVNIEEELKSSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAMNVLGNDWN
KAYKKSARVVGDVIGKYHPHGDSAVYDTIVRMAQPFSLRYMLVDGQGNFGSIDGDSAAAM
RYTEIRLAKIAHELMADLEKETVDFVDNYDGTEKIPDVMPTKIPNLLVNGSSGIAVGMAT
NIPPHNLTEVINGCLAYIDDEDISIEGLMEHIPGPDFPTAAIINGRRGIEEAYRTGRGKV
YIRARAEVEVDAKTGRETIIVHEIPYQVNKARLIEKIAELVKEKRVEGISALRDESDKDG
MRIVIEVKRDAVGEVVLNNLYSQTQLQVSFGINMVALHHGQPKIMNLKDIIAAFVRHRRE
VVTRRTIFELRKARDRAHILEALAVALANIDPIIELIRHAPTPAEAKTALVANPWQLGNV
AAMLERAGDDAARPEWLEPEFGVRDGLYYLTEQQAQAILDLRLQKLTGLEHEKLLDEYKE
LLDQIAELLRILGSADRLMEVIREELELVREQFGDKRRTEITANSADINLEDLITQEDVV
VTLSHQGYVKYQPLSEYEAQRRGGKGKSAARIKEEDFIDRLLVANTHDHILCFSSRGRVY
SMKVYQLPEATRGARGRPIVNLLPLEQDERITAILPVTEFEEGVKVFMATANGTVKKTVL
TEFNRLRTAGKVAIKLVDGDELIGVDLTSGEDEVMLFSAEGKVVRFKESSVRAMGCNTTG
VRGIRLGEGDKVVSLIVPRGDGAILTATQNGYGKRTAVAEYPTKSRATKGVISIKVTERN
GLVVGAVQVDDCDQIMMITDAGTLVRTRVSEISIVGRNTQGVILIRTAEDENVVGLQRVA
EPVDEEDLDTIDGSAAEGDDEIAPEVDVDDEPEEE
>YP_491222.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|macB|antibiotic target alteration|0
MTQTYNADAIEVLTGLEPVRRRPGMYTDTTRPNHLGQEVIDNSVDEALAGHAKRVDVILH
ADQSLEVIDDGRGMPVDIHPEEGVPAVELILCRLHAGGKFSNKNYQFSGGLHGVGISVVN
ALSKRVEVNVRRDGQVYNIAFENGEKVQDLQVVGTCGKRNTGTSVHFWPDETFFDSPRFS
VSRLTHVLKAKAVLCPGVEITFKDEINNTEQRWCYQDGLNDYLAEAVNGLPTLPEKPFIG
NFAGDTEAVDWALLWLPEGGELLTESYVNLIPTMQGGTHVNGLRQGLLDAMREFCEYRNI
LPRGVKLSAEDIWDRCAYVLSVKMQDPQFAGQTKERLSSRQCAAFVSGVVKDAFILWLNQ
NVQAAELLAEMAISSAQRRMRAAKKVVRKKLTSGPALPGKLADCTAQDLNRTELFLVEGD
SAGGSAKQARDREYQAIMPLKGKILNTWEVSSDEVLASQEVHDISVAIGIDPDSDDLSQL
RYGKICILADADSDGLHIATLLCALFVKHFRALVKHGHVYVALPPLYRIDLGKEVYYALT
EEEKEGVLEQLKRKKGKPNVQRFKGLGEMNPMQLRETTLDPNTRRLVQLTIDDEDDQRTD
AMMDMLLAKKRSEDRRNWLQEKGDMAEIEV
>YP_040772.1|FEATURES|CARD|beta_lactam|CTX-M-101|antibiotic target alteration|0
MSEIIQDLSLEDVLGDRFGRYSKYIIQERALPDVRDGLKPVQRRILYAMYSSGNTHDKNF
RKSAKTVGDVIGQYHPHGDFSVYEAMVRLSQDWKLRHVLIEMHGNNGSIDNDPPAAMRYT
EAKLSLLAEELLRDINKETVSFISNYDDTTLEPMVLPSRFPNLLVNGSTGISAGYATDIP
PHNLAEVIQATLKYIDNPDITVNQLMKYIKGPDFPTGGIIQGIDGIKKAYESGKGRIIVR
SKVEEETLRNGRKQLIITEIPYEVNKSSLVKRIDELRADKKVDGIVEVRDETDRTGLRIA
IELKKDVNSESIKNYLYKNSDLQISYNFNMVAISDGRPKLMGIRQIIDSYLNHQIEVVAN
RTKFELDNAEKRMHIVEGLIKALSILDKVIELIRSSKNKRDAKENLIEVYEFTEEQAEAI
VMLQLYRLTNTDIVALEGEHKELEALIKQLRHILDNHDALLNVIKEELNEIKKKFKSERL
SLIEAEIEEIKIDKEVMVPSEEVILSMTRHGYIKRTSIRSYNASGVEDIGLKDGDSLLKH
QEVNTQDTVLVFTNKGRYLFIPVHKLADIRWKELGQHVSQIVPIEEDEVVINVFNEKDFN
TDAFYVFATQNGMIKKSTVPLFKTTRFNKPLIATKVKENDDLISVMRFEKDQLITIITNK
GMSLTYNTSELSDTGLRAAGVKSINLKAEDFVVMTEGVSENDTILMATQRGSLKRISFKI
LQVAKRAQRGITLLKELKKNPHRIVAAHVVTGEHSQYTLYSKSNEEHGLINDIHKSEQYT
NGSFIVDTDDFGEVIDMYIS
>ABR75897.1|FEATURES|CARD|multidrug|acrS|antibiotic efflux|0
MARKTKQQARETRQLILDVALRLFSQQGVSSTSLATIAKAAGVTRGAIYWHFKNKSDLFN
EIWELSDASISDLEIEYRAKFPNDPLSVIREILVYVLEATVTEERRRLMMEIIYHKCEFV
GEMTVVQQAQRQLSLASYERIEQTLKECIAAKLLPANLLTRRAAVLMRSYLSGLMENWLF
APDSFDLHAEARDYVAILLEMYQFCPTLRGPESLSA
>YP_007503908.1|FEATURES|CARD|fosfomycin|fosB|antibiotic target alteration|0
MSNTYDSSSIKVLKGLDAVRKRPGMYIGDTDDGTGLHHMVFEVVDNAIDEALAGYCKDII
VTIHNDNSVSVQDDGRGIPTGIHEEEGVSAAEVIMTVLHAGGKFDDNSYKVSGGLHGVGV
SVVNALSEKLELVIRRDGKVHEQIYRHGEPQDRLTVVGETDKTGTRVRFWPSMDTFKGET
EFQYDILAKRLRELSFLNSGVSIRLIDKRDGKEDHFHYEGGIKAFVEYLSRAKTSIHNNV
FYFSTEKDDIGVEISMQWNDSFQENVYCFTNNIPQRDGGAHLAGFRAAMTRTLNSYIEKE
GLNKKSKVSTTGDDAREGLVAVISVKVPDPKFSSQTKDKLVSSEVKTAVETLMNEKLSEY
LDENPNDTKIIVGKIIDAARAREAARRAREMTRRKGALDLAGLPGKLADCQERDPAFSEL
YLVEGDSAGGSAKQGRNRKNQAILPLKGKILNVEKARFDKMLASQEVATLITALGCGIGR
DEYNPDKLRYHSIIIMTDADVDGSHIRTLLLTFFYRQMPEIIERGYVYIAQPPLYKVKKG
KQEQYIKDDEAMEQYQVSIALDGAALYVNENAAPIQGEHLEKLLHEYNGAHKIIRRLERL
YPLALLNSLVYQPKLEESALLNKTEVEAWAQSLTERLTRHEEHGSTYSYRIAENKERQLF
EPVLTIRTHGVDTDYNLDFDFVHGSEYARISKLGELIRGLIEEGAYVVRGERRQNVSNFE
QALDWLMKESRRGLAVQRYKGLGEMNPEQLWETTMNPETRRMLQVTVKDAIATDQLFTTL
MGDDVEPRRAFIEENALKAANIDV
>CAC29732.1|FEATURES|CARD|sulfonamide|folp|antibiotic target alteration|0
MSLAPVQVIGVLNVTDNSFSDGGRYLDPDDAVQHGLAMVAEGAAIVDVGGESTRPGAIRT
DPRVELSRIVPVVKELAAQGITVSIDTTRADVARAALQSGARIVNDVSGGRADPAMAPLV
AEAGVAWVLMHWRLMSAERPYEAPNYRDVVAEVRADLLAGVDQAVAAGVDPGSLVIDPGL
GFAKTGQHNWALLNALPELVATGVPILLGASRKRFLGRLLAGADGAVRPPDGRETATAVI
SALAALHGAWGVRVHDVRASVDALKVVGAWLHAGPQIEKVRCDG
>AAK48336.1|FEATURES|CARD|isoniazid|ethA|antibiotic target alteration|0
MTEHLDVVIVGAGISGVSAAWHLQDRCPTKSYAILEKRESMGGTWDLFRYPGIRSDSDMY
TLGFRFRPWTGRQAIADGKPILEYVKSTAAMYGIDRHIRFHHKVISADWSTAENRWTVHI
QSHGTLSALTCEFLFLCSGYYNYDEGYSPRFAGSEDFVGPIIHPQHWPEDLDYDAKNIVV
IGSGATAVTLVPALADSGAKHVTMLQRSPTYIVSQPDRDGIAEKLNRWLPETMAYTAVRW
KNVLRQAAVYSACQKWPRRMRKMFLSLIQRQLPEGYDVRKHFGPHYNPWDQRLCLVPNGD
LFRAIRHGKVEVVTDTIERFTATGIRLNSGRELPADIIITATGLNLQLFGGATATIDGQQ
VDITTTMAYKGMMLSGIPNMAYTVGYTNASWTLKADLVSEFVCRLLNYMDDNGFDTVVVE
RPGSDVEERPFMEFTPGYVLRSLDELPKQGSRTPWRLNQNYLRDIRLIRRGKIDDEGLRF
AKRPAPVGV
>CAC29514.1|FEATURES|CARD|quinolone|gyrA|antibiotic target alteration|0
MTDITLPPGDGSIQRVEPVDIQQEMQRSYIDYAMSVIVGRALPEVRDGLKPVHRRVLYAM
LDSGFRPDRSHAKSARSVAETMGNYHPHGDASIYDTLVRMAQPWSLRYPLVDGQGNFGSP
GNDPPAAMRYCVSGNSLVRLLFGKSIRIGDIVTGAQFNSDNPIDLKVLDRHGNPVVADYL
FHSGEHQTYTVRTTEGYEITGTSNHPLLCLVNVGGIPTLLWKLIGEIRSGDYVVLQRIPP
VEFGPADWYSTMEALLFGAFISGGFVFQDHAGFNSLDRDYFTMVVNAYDTVVGGLRCISS
RITVSGSTLLELDVYNLIEFKKTRLSGLCGQRSADKLVPDWLWHSPSTVKRAFLQALFEG
EGFSSILSRNIIEISYSTLSERLAADVQQMLLEFGVVSERYCHTVNEYKVVIANRAQVEM
FFTQVGFGVTKQAKLIRDVVSMSPCVGMDINCVPGLATFIRKHCDNRWVEEDSFNQHNVD
CVQHWHHHSAEIVGHIADPDIRAIVTDLTDGRFYYARVASVTDTGIQPVFSLHVDTEDHS
FLTNGFISHNTEARLTPLAMEMLREIDEETVDFISNYDGRVQEPMVLPSRFPNLLANGSG
GIAVGMATNIPPHNLYELADAVFWCLENHDADEETMLVAVMERVKGPDFPTAGLIVGSQG
IADAYKTGRGSIRIRGVVEVEEDSRGRTSLVITELPYQVNHDNFITSIAEQVRTGRLAGI
SNVEDQGSDRVGVRIVIEIKRDAVAKVVLNNLYKHTQLQTSFGANMLSIVDGVPRTLRLD
QMICYYVEHQLDVIVRRTTYRLRKANERAHILRGLVKALDALDEVITLIRASQTVDIARV
GVVELLDIDDIQAQAILDMQLRRLAALERQRIIDDLAKIEVEIADLGDILAKPERRRGII
RNELTEIAEKYGDDRRTRIIAVDGDVNDEDLIAREEVVVTITETGYAKRTKTDLYRSQKR
GGKGVQGAGLKQDDIVRHFFVCSTHDWILFFTTQGRVYRAKAYELPEASRTARGQHVANL
LAFQPEERIAQVIQIRSYEDAPYLVLATRAGLVKKSKLTDFDSNRSGGIVAINLRDNDEL
VGAVLCAADGDLLLVSANGQSIRFSATDEALRPMGRATSGVQGMRFNADDRLLSLNVVRE
DTYLLVATSGGYAKRTSIEEYPMQGRGGKGVLTVMYDRRRGSLVGAIVVDEDSELYAITS
GGGVIRTTARQVRQAGRQTKGVRLMNLGEGDTLLAIARNAEESADGGVG
>NP_462735.1|FEATURES|CARD|fosfomycin|fosB|antibiotic target alteration|0
MSNSYDSSSIKVLKGLDAVRKRPGMYIGDTDDGTGLHHMVFEVVDNAIDEALAGHCKDIV
VTIHADNSVSVTDDGRGIPTGIHPEEGVSAAEVIMTVLHAGGKFDDNSYKVSGGLHGVGV
SVVNALSQKLELVIQRDGKIHRQIYEHGVPQAPLAVTGDTDKTGTMVRFWPSHETFTNVT
EFEYEILAKRLRELSFLNSGVSIRLRDKRDGKEDHFHYEGGIKAFVEYLNKNKTPIHPNI
FYFSTEKDGIGVEVALQWNDGFQENIYCFTNNIPQRDGGTHLAGFRAAMTRTLNAYMDKE
GYSKKAKVSATGDDAREGLIAVVSVKVPDPKFSSQTKDKLVSSEVKSAVEQQMNELLSEY
LLENPSDAKIVVGKIIDAARAREAARRAREMTRRKGALDLAGLPGKLADCQERDPALSEL
YLVEGDSAGGSAKQGRNRKNQAILPLKGKILNVEKARFDKMLSSQEVATLITALGCGIGR
DEYNPDKLRYHSIIIMTDADVDGSHIRTLLLTFFYRQMPEIVERGHVYIAQPPLYKVKKG
KQEQYIKDDEAMDQYQISIALDGATLHANAHAPALSGEALEKLVSEYNATQKMIGRMERR
FPKALLKELVYQPTLTEADLSDEQTVTRWVNALITELNEKEQHGSQWKFDVHTNTEQNLF
EPIVRVRTHGVDTDYPLDHEFVTGAEYRRICTLGEKLRGLIEEDAFIERGERRQPVTSFE
QALEWLVKESRRGLAIQRYKGLGEMNPDQLWETTMDPESRRMLRVTVKDAIAADQLFTTL
MGDAVEPRRAFIEENALKAANIDI
>NP_462096.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|macB|antibiotic target alteration|0
MTQTYNADAIEVLTGLEPVRRRPGMYTDTTRPNHLGQEVIDNSVDEALAGHAKRVDVILH
ADQSLEVIDDGRGMPVDIHPEEGVPAVELILCRLHAGGKFSNKNYQFSGGLHGVGISVVN
ALSKRVEVTVRRDGQVYNIAFENGEKVQDLQVVGTCGKRNTGTSVHFWPDESFFDSPRFS
VSRLMHVLKAKAVLCPGVEITFKDEVNNSEQRWCYQDGLNDYLGEAVNGLPTLPEKPFIG
NFNGETEAVDWALLWLPEGGELLTESYVNLIPTMQGGTHVNGLRQGLLDAMREFCEYRNI
LPRGVKLSAEDIWDRCAYVLSVKMQDPQFAGQTKERLSSRQCAAFVSGVVKDAFSLWLNQ
NVQAAEQLAEMAIASAQRRLRAAKKVVRKKLTSGPALPGKLADCTAQDLNRTELFLVEGD
SAGGSAKQARDREYQAIMPLKGKILNTWEVSSDEVLASQEVHDISVAIGIDPDSDDLSQL
RYGKICILADADSDGLHIATLLCALFVRHFRALVKNGHVYVALPPLYRIDLGKEVYYALT
EEEKAGVLEQLKRKKGKPNVQRFKGLGEMNPMQLRETTLDPNTRRLVQLTISDEDDQRTN
AMMDMLLAKKRSEDRRNWLQEKGDLADLDV
>NP_463130.1|FEATURES|CARD|multidrug|robA|antibiotic efflux|0
MSHQQIIQTLIEWIDEHIDQPLNIDVVAKKSGYSKWYLQRMFRTVTHQTLGEYIRQRRLL
LAAVELRTTERPIFDIAMDLGYVSQQTFSRVFRREFDRTPSDYRHRL
>AAO82601.1|FEATURES|CARD|beta_lactam|HMPREF1562_2717|antibiotic target alteration|0
MNNPWRFFIVAEALLFILALWQIVHNPGLAVLLTIGVLLVAYVSRKASKTHFNNFQFVLG
VVFIVIGAMNSTAVWFMLIFGVLFIGLKGFEISGVDIAERAPWRKKQMIMVETAAKEPKN
GKRFKRRWFANERIGNNIYEWDDINIDLISGDTIIDLGNTLLPKEDNIIIIRKGFGRTRI
LVPLGVAILLEHSTFYGTVRFEEEKYQLKNESLKIYSNDYDTNLRRLKIMTNTLVGDVEV
IRV
>BAA11086.1|FEATURES|CARD|aminocoumarin|grlB|antibiotic target alteration|0
MNKQNNYSDDSIQVLEGLEAVRKRPGMYIGSTDKRGLHHLVYEIVDNSVDEVLNGYGNEI
DVTINKDGSISIEDNGRGMPTGIHKSGKPTVEVIFTVLHAGGKFGQGGYKTSGGLHGVGA
SVVNALSEWLEVEIHRDGNIYHQSFKNGGSPSSGLVKKGKTKKTGTKVTFKPDDTIFKAS
TSFNFDVLSERLQESAFLLKNLKITLNDLRSGKERQEHYHYEEGIKEFVSYVNEGKEVLH
DVATFSGEANGIEVDVAFQYNDQYSESILSFVNNVRTKDGGTHEVGFKTAMTRVFNDYAR
RINELKTKDKNLDGNDIREGLTAVVSVRIPEELLQFEGQTKSKLGTSEARSAVDSVVADK
LPFYLEEKGQLSKSLVKKAIKAQQAREAARKAREDARSGKKNKRKDTLLSGKLTPAQSKN
TEKNELYLVEGDSAGGSAKLGRDRKFQAILPLRGKVINTEKARLEDIFKNEEINTIIHTI
GAGVGTDFKIEDSNYNRVIIMTDADTDGAHIQVLLLTFFFKYMKPLVQAGRVFIALPPLY
KLEKGKGKTKRVEYAWTDEELNKLQKELGKGFTLQRYKGLGEMNPEQLWETTMNPETRTL
IRVQVEDEVRSSKRVTTLMGDKVQPRREWIEKHVEFGMQEDQSILDNSEVQVLENDQFDE
EEI
>AAL97684.1|FEATURES|CARD|sulfonamide|folp|antibiotic target alteration|0
MKIGRFVIEGNAAIMGILNVTPDSFSDGGSYTTVQKALDHVEQMIADGAKIIDVGGESTR
PGCQFVSATDEIDRVVPVIKAIKENYDILISIDTYKTETARAALEAGADILNDVWAGLYD
GQMFALAAEYDAPIILMHNQDEEVYQEVTQDVCDFLGNRAQAALDAGVPKNNIWIDPGFG
FAKSVQQNTELLKGLDRVCQLGYPVLFGISRKRVVDALLGGNTKAKERDGATAALSAYAL
GKGCQIVRVHDVKANQDIVAVLSQLM
>NP_251858.1|FEATURES|CARD|beta_lactam|ACT-18|antibiotic target alteration|0
MGELAKEILPVNIEDELKQSYLDYAMSVIVGRALPDARDGLKPVHRRVLYAMSELGNDWN
KPYKKSARVVGDVIGKYHPHGDTAVYDTIVRMAQPFSLRYMLVDGQGNFGSVDGDNAAAM
RYTEVRMAKLAHELLADLEKETVDWVPNYDGTEQIPAVMPTKIPNLLVNGSSGIAVGMAT
NIPPHNLGEVIDGCLALMDNPDLTVDELMQYIPGPDFPTAGIINGRAGIIEAYRTGRGRI
YIRARAVVEEMEKGGGREQIIITELPYQLNKARLIEKIAELVKEKKIEGISELRDESDKD
GMRVVIELRRGEVGEVVLNNLYAQTQLQSVFGINVVALVDGQPRTLNLKDMLEVFVRHRR
EVVTRRTVYELRKARERGHILEGQAVALSNIDPVIELIKSSPTPAEAKERLIATAWESSA
VEAMVERAGADACRPEDLDPQYGLRDGKYYLSPEQAQAILELRLHRLTGLEHEKLLSEYQ
EILNLIGELIRILTNPARLMEVIREELEAVKAEFGDARRTEIVASQVDLTIADLITEEDR
VVTISHGGYAKSQPLAAYQAQRRGGKGKSATGMKDEDYIEHLLVANSHATLLLFSSKGKV
YWLRTFEIPEASRTARGRPLVNLLPLDEGERITAMLQIDLEALQQNGGADDDLDEAEGAV
LEGEVVEAAEVEEVEGETAELVAEPTGAYIFMATAFGTVKKTPLVQFSRPRSSGLIALKL
EEGDTLIAAAITDGAKEVMLFSSAGKVIRFAESVVRIMGRNARGVRGMRLGKGQQLISML
IPESGAQILTASERGFGKRTPLSKFPRRGRGGQGVIAMVTNERNGALIAAVQVQEGEEIM
LISDQGTLVRTRVDEVSLSGRNTQGVTLIKLASDEVLVGLERVQEPSGGDDEDLPEGEEA
AESLGESAESESEPAAEAEGNEE
>AAC76055.1|FEATURES|CARD|beta_lactam|RW25_27295|antibiotic target alteration|0
MSDMAERLALHEFTENAYLNYSMYVIMDRALPFIGDGLKPVQRRIVYAMSELGLNASAKF
KKSARTVGDVLGKYHPHGDSACYEAMVLMAQPFSYRYPLVDGQGNWGAPDDPKSFAAMRY
TESRLSKYSELLLSELGQGTADWVPNFDGTLQEPKMLPARLPNILLNGTTGIAVGMATDI
PPHNLREVAQAAIALIDQPKTTLDQLLDIVQGPDYPTEAEIITSRAEIRKIYENGRGSVR
MRAVWKKEDGAVVISALPHQVSGARVLEQIAAQMRNKKLPMVDDLRDESDHENPTRLVIV
PRSNRVDMDQVMNHLFATTDLEKSYRINLNMIGLDGRPAVKNLLEILSEWLVFRRDTVRR
RLNYRLEKVLKRLHILEGLLVAFLNIDEVIEIIRNEDEPKPALMSRFGLTETQAEAILEL
KLRHLAKLEEMKIRGEQSELEKERDQLQGILASERKMNNLLKKELQADAQAYGDDRRSPL
QEREEAKAMSEHDMLPSEPVTIVLSQMGWVRSAKGHDIDAPGLNYKAGDSFKAAVKGKSN
QPVVFVDSTGRSYAIDPITLPSARGQGEPLTGKLTLPPGATVDHMLMESDDQKLLMASDA
GYGFVCTFNDLVARNRAGKALITLPENAHVMPPVVIEDASDMLLAITQAGRMLMFPVSDL
PQLSKGKGNKIINIPSAEAARGEDGLAQLYVLPPQSTLTIHVGKRKIKLRPEELQKVTGE
RGRRGTLMRGLQRIDRVEIDSPRRASSGDSEE
>AKJ52802.1|FEATURES|CARD|quinolone|parC|antibiotic target alteration|0
MKKDRKEEIQEVTENIIEKNMADIMSDRFGRYSKYIIQQRAIPDARDGLKPVQRRILYSM
WNLHLKNSEPFKKSARIVGDVIGRYHPHGDSSIYEALVRMAQDWKSNFPLIEMHGNKGSI
DDDPAAAMRYTESRLEKISELMLRDLDRKVVKMAPNFDDSEYEPIVLPALFPNLLVNGAK
GIAAGFATEIPPHNLGEVIDATIALIKNPTISIEELSEIVKGPDFPTGAIINGINEIKKA
LSSGQGRITISSKYHYVYDKKDESKIIGIEIIEIPFGVVKSKLVADIDAIAIDKKISGIK
EVLDQTDRNGISIFIQLEDGANADAIIAYLMNKTELSISYSYNMVAIDNNRPVILNLYSA
LIAYLSHLKEVNINGINYDLKKFKLRLEIVEGFIKVAEISDEVIHLIKESDNSKKGVILA
LMNKFKFSELQATAIAELRLYKLSRMDQIEFQEEKKNLEIQIENCNKLLNDKWEFNQYLI
KQLLEIKNQYSKPRLTEISDQKIDKEIDHKLLTKNEDFYLYITKDGYYKKISLKVYTSNE
LNTFKLKEEDNVFYFDKVNSLSKILFFTNLGNYFIIDCHLFKDCNWKDLGQHISSIVALE
SSEKIIRVIEITSFNSYANFILMSKLGYAKKVNLRDFENKSSLKTKTCMSFKDDNDELID
AQISNDEKMLFILLNNGMYHLVSENELKVGISLKARGIRLLLNLYKHPQLQVSGFITVSK
YNNIIYLTQGGYIKCWDTSKLELTTRNTPKMLFTPLKNNILGLQSLAVTLSNLKMLYTDN
NGNLAEYDWKFILKDKTKESKLLKLDYSFTNPGYFITPIKINELIEADEIEQEKIRQEYQ
GYIDKNIELTAEHALIKKSYDQDIQHLNNEEQEELFQISTEDIELPNVSNNVNDNQKDKK
NIATKESVSQKIQEIEKIDLETIMQKIKQIKKK
>NP_458564.1|FEATURES|CARD|multidrug|golS|antibiotic efflux|0
MEKKSPRLKALLTPGEVAKRSGVAVSALHFYESKGLITSIRNSGNQRRYKRDVLRYVAII
KIAQRIGIPLATIGDAFGILPEGHTLSAKEWKQLSSQWREELDRRIHTLVALRDELDGCI
GCGCLSRSDCPLRNPGDRLGEHGTGARLLEDD
>NP_253654.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|macB|antibiotic target alteration|0
MATYNADAIEVLSGLDPVRKRPGMYTDTTRPNHLAQEVIDNSVDEALAGHAKSVQVILHQ
DNSLEVIDDGRGMPVDIHPEEGVPGVELILTKLHAGGKFSNKNYQFSGGLHGVGISVVNA
LSTRVEVRVKRDANEYRMTFADGFKDSDLEVIGTVGKRNTGTSVHFWPDPKYFDSAKFSV
SRLKHVLKAKAVLCPGLSVVFEDKNTGERVEWHFEDGLRSYLTDAVAELPRLPDEPFCGN
LEGSKEAVSWALLWLPEGGESVQESYVNLIPTAQGGTHVNGLRQGLLDAMREFCEFRNLL
PRGVKLAPEDVWERIAFVLSMKMQEPQFSGQTKERLSSREAAAFVSGVVKDAFSLWLNEH
AEIGLQLAELAISNAGRRLKAGKKVERKKITQGPALPGKLADCAGQEPMRAELFLVEGDS
AGGSAKQARDKEFQAIMPLRGKILNTWEVDGGEVLASQEVHDIAVAIGVDPGASDLAQLR
YGKICILADADSDGLHIATLLCALFVRHFRPLVEAGHVYVAMPPLYRIDLGKDIYYALDE
AERDGILERLAAEKKRGKPQVTRFKGLGEMNPLQLRETTMDPNTRRLVQLTLEDATGTLE
IMDMLLAKKRAGDRKSWLESKGNLAEVLV
>AJF82049.1|FEATURES|CARD|chloramphenicol|LpxA|antibiotic target alteration|0
MSNHDLIHSTAIIDPSAVIASDVQIGPYCIIGPQVTIGAGTKLHSHVVVGGFTRIGQNNE
IFQFASVGEVCQDLKYKGEETWLEIGNNNLIREHCSLHRGTVQDNALTKIGSHNLLMVNT
HIAHDCIVGDHNIFANNVGVAGHVHIGDHVIVGGNSGIHQFCKIDSYSMIGGASLILKDV
PAYVMASGNPAHAFGINIEGMRRKGWSKNTIQGLREAYKLIFKSGLTSVQAIDQIKSEIL
PSVPEAQLLIDSLEQSERGIVR
>AJF83452.1|FEATURES|CARD|peptide|lpxC|antibiotic target alteration|0
MVKQRTLNRVVKASGIGLHSGQKVMINFIPHTVDGGIVFRRIDLDPPVDIPANALLIQEA
FMCSNLVTGDIKVGTIEHVMSAIAGLGIDNLIVEVSASEVPIMDGSAGPFIYLLMQGGLR
EQDAPKKFIKILKPVEALIDDKKAIFSPHNGFQLNFTIDFDHPAFAKEYQSATIDFSTET
FVYEVSEARTFGFMKDLDYLKANNLALGASLDNAIGVDDTGVVNEEGLRFADEFVRHKIL
DAVGDLYLLGHQIIAKFDGYKSGHALNNQLLRNVQSDPSNYEIVTFDDEKDCPIPYVSVT
>AAB39605.1|FEATURES|CARD|tetracycline|tetW|antibiotic target alteration|0
MAKAKFERTKPHMNIGTIGHIDHGKTTLTAAITKVLHDRYPELNKATPFDKIDKAPEEKA
RGITISIAHVEYQTEKRHYAHVDCPGHADYVKNMITGAAQMDGAILVVAATAGPMPQTKE
HVLLARQVGVPYIVVALNKADMVDDEEILELVELEVRELLSAQEFPGDDLPVVRVSALKA
LEGDEKWADSIIELMNAVDENIPEPPRDTDKPFLMPIEDVFSITGRGTVVTGRIERGVVK
VNEQVDIIGIKSEKTTTTVTSIEMFNKMLDEGHAGDNAALLLRGIKREQVERGQCIIKPG
TTTPHTEFEAQVYILSKDEGGRHTPFFNNYRPQFYFRTTDVTGVVNLPEGTEMVMPGDNT
EMTVQLIQPIAMEEGLKFAIREGGRTVGAGRVTKILK
>BAA37152.1|FEATURES|CARD|quinolone|parC|antibiotic target alteration|0
MSESLDLSLEGVERRSLAEFTEQAYLNYSMYVIMDRALPHIGDGLKPVQRRIVYAMSELG
LDADSKHKKSARTVGDVLGKFHPHGDSACYEAMVLMAQPFSYRYPLVDGQGNWGAPDDPK
SFAAMRYTEARLSRYSEVLLSELGQGTVDWVPNFDGTLDEPAVLPARLPNLLLNGTTGIA
VGMATDVPPHNLREVASACVRLLDQPGATVAELCEHVPGPDFPTEAEIITPRADLQKVYE
TGRGSVRMRAVYRFEDGDIVIHALPHQVSGSKVLEQIAGQMQAKKLPMVADLRDESDHEN
PTRIVIIPRSNRVDVEELMTHLFATTDLETSYRVNLNIIGLDGKPAVKDLRQLLSEWLQF
RIGTVRRRLQFRLDKVERRLHLLDGLLIAFLNLDEVIHIIRTEDQPKAVLMERFELSEVQ
ADYILDTRLRQLARLEEMKIRGEQEELLKEQKRLQTLLGSEAKLKKLVREELIKDAETYG
DDRRSPIVARAEARALSETELMPTEPVTVVLSEKGWVRCAKGHDIDAAGLSYKAGDGFKA
AAPGRSNQYAVFIDSTGRSYSLPAHSLPSARGQGEPLSGRLTPPPGASFECVLLPDDDAL
FVIASDAGYGFVVKGEDLQAKNKAGKALLSLPNGSAVVAPRPVRDVEQDWLAAVTTEGRL
LLFKVSDLPQLGKGKGNKIIGIPGERVASREEYLTDLAVLPAGATLVLQAGKRTLSLKGD
DLEHYKGERGRRGNKLPRGFQRVDSLLVDIPPQD
>NP_249649.1|FEATURES|CARD|aminoglycoside|APH(3')-Ia|reduced permeability to antibiotic|0
MKVMKWSAIALAVSAGSTQFAVADAFVSDQAEAKGFIEDSSLDLLLRNYYFNRDGKSGSG
DRVDWTQGFLTTYESGFTQGTVGFGVDAFGYLGLKLDGTSDKTGTGNLPVMNDGKPRDDY
SRAGGAVKVRISKTMLKWGEMQPTAPVFAAGGSRLFPQTATGFQLQSSEFEGLDLEAGHF
TEGKEPTTVKSRGELYATYAGETAKSADFIGGRYAITDNLSASLYGAELEDIYRQYYLNS
NYTIPLASDQSLGFDFNIYRTNDEGKAKAGDISNTTWSLAAAYTLDAHTFTLAYQKVHGD
QPFDYIGFGRNGSGAGGDSIFLANSVQYSDFNGPGEKSWQARYDLNLASYGVPGLTFMVR
YINGKDIDGTKMSDNNVGYKNYGYGEDGKHHETNLEAKYVVQSGPAKDLSFRIRQAWHRA
NADQGEGDQNEFRLIVDYPLSIL
>CAA52296.1|FEATURES|CARD|mupirocin|ileS1|antibiotic target alteration|0
MDYKETLLMPKTDFPMRGGLPNKEPQIQEKWDAEDQYHKALEKNKGNETFILHDGPPYAN
GNLHMGHALNKILKDFIVRYKTMQGFYAPYVPGWDTHGLPIEQALTKKGVDRKKMSTAEF
REKCKEFALEQIELQKKDFRRLGVRGDFNDPYITLKPEYEAAQIRIFGEMADKGLIYKGK
KPVYWSPSSESSLAEAEIEYHDKRSASIYVAFNVKDDKGVVDADAKFIIWTTTPWTIPSN
VAITVHPELKYGQYNVNGEKYIIAEALSDAVAEALDWDKASIKLEKEYTGKELEYVVAQH
PFLDRESLVINGDHVTTDAGTGCVHTAPGHGEDDYIVGQKYELPVISPIDDKGVFTEEGG
QFEGMFYDKANKAVTDLLTEKGALLKLDFITHSYPHDWRTKKPVIFRATPQWFASISKVR
QDILDAIENTNFKVNWGKTRIYNMVRDRGEWVISRQRVWGVPLPVFYAENGEIIMTKETV
NHVADLFAEHGSNIWFEREAKDLLPEGFTHPGSPNGTFTKETDIMDVWFDSGSSHRGVLE
TRPELSFPADMYLEGSDQYRGWFNSSITTSVATRGVSPYKFLLSHGFVMDGEGKKMSKSL
GNVIVPDQVVKQKGADIARLWVSSTDYLADVRISDEILKQTSDVYRKIRNTLRFMLGNIN
DFNPDTDSIPESELLEVDRYLLNRLREFTASTINNYENFDYLNIYQEVQNFINVELSNFY
LDYGKDILYIEQRDSHIRRSMQTVLYQILVDMTKLLAPILVHTAEEVWSHTPHVKEESVH
LADMPKVVEVDQALLDKWRTFMNLRDDVNRALETARNEKVIGKSLEAKVTIASNDKFNAS
EFLTSFDALHQLFIVSQVKVVDKLDDQATAYEHGDIVIEHADGEKCERCWNYSEDLGAVD
ELTHLCPRCQQVVKSLV
>AIL15701|FEATURES|CARD|fosfomycin|murA|antibiotic target alteration|0
MDKFRVQGPTKLQGEVTISGAKNAALPILFAALLAEEPVEIQNVPKLKDVDTSMKLLSQL
GAKVERNGSVHIDARDVNVFCAPYDLVKTMRASIWALGPLVARFGQGQVSLPGGCTIGAR
PVDLHISGLEQLGATIKLEEGYVKASVDGRLKGAHIVMDKVSVGATVTIMCAATLAEGTT
IIENAAREPEIVDTANFLITLGAKISGQGTDRIVIEGVERLGGGVYRVLPDRIETGTFLV
AAAISRGKIICRNAQPDTLDAVLAKLRDAGADIEVGEDWISLDMHGKRPKAVNVRTAPHP
AFPTDMQAQFTLLNLVAEGTGFITETVFENRFMHVPELSRMGAHAEIESNTVICHGVEKL
SGAQVMATDLRASASLVLAGCIAEGTTVVDRIYHIDRGYERIEDKLRALGANIERVKGE
>WP_038583059|FEATURES|CARD|bacitracin|uppP|antibiotic target alteration|0
MSHPGATASDRHKVVIIGSGFGGLTAAKTLKRADVDVKLIARTTHHLFQPLLYQVATGII
SEGEIAPATRVILRKQKNAQVLLCDVTHIDLENKTVDSVLLGHTYSTPYDSLIIAAGAGQ
SYFGNDHFAEFAPGMKSIDDALELRGRILGAFEQAERSSDPVRRAKLLTFTVVGAGPTGV
EMAGQIAELADQTLRGSFRHIDPTEARVILLDAAPAVLPPMGEKLGKKARARLEKMGVEV
QLGAMVTDVDRNGITVKDSDGTIRRIESACKVWSAGVSASPLGKDLAEQSGVELDRAGRV
KVQPDLTLPGHPNVFVVGDMAAVEGVPGVAQGAIQGGRYAAKIIKREVSGTSPKIRTPFE
YFDKGSMATVSRFSAVAKVGPVEFAGFFAWLCWLVLHLVYLVGFKTKIVTLLSWGVTFLS
TKRGQLTITEQQAYARTRIEELEEIAAAVQDTEKAAS
>AGQ48857.1|FEATURES|CARD|multidrug|eatAv|antibiotic target protection|1
MSKIEIKNLTFGYDSQGTLLFEQANLNFDTQWKLGLIGRNGRGKTTLLNILQNKLPYQGQ
VIHQQEFAYFPQQTKDKERLTYYVLNDITDFEIWEIERELQLMQTDPEILWREFSTLSGG
EKTKVLLALLFVDDTHFPLIDEPTNHLDISGRKQVAAYLKKKKQGFIVVSHDRGFIDEVV
DHVLAIEKSQLELYQGNFSIYEEQKKLRDEFEMAQNEKLKKEVSRLKKTAAEKAEWSRSR
EGDKTKKQVGFIDTESRRVNKGAVGADAARTMKRSKAIVNRMETQISEKEKLLKDIEYID
SLTMNSQASHHKRLLSVEDLQLGYENLLFEPIHFTIEPHQRVAISGPNGAGKSSIIHYLL
GAFNGKVIGEKYQPKHLSISYASQNYEDNRGTLAEFAEKNQVDYQAFLNNLRKLGMERDV
FHNKIEQMSMGQRKKVELAKSLSQPAELYIWDEPLNYLDVFNQEQLEQLILNVKPAMLLV
EHDQTFLDKVSTEIISLERI
>CAG39573|FEATURES|CARD|tetracycline|tetT|antibiotic target alteration|0
MAREFSLEKTRNIGIMAHIDAGKTTTTERILYYTGRIHKIGETHEGASQMDWMEQEQDRG
ITITSAATTAAWEGHRVNIIDTPGHVDFTVEVERSLRVLDGAVTVLDAQSGVEPQTETVW
RQATTYGVPRIVFVNKMDKLGANFEYSVSTLHDRLQANAAPIQLPIGAEDEFEAIIDLVE
MKCFKYTNDLGTEIEEIEIPEDHLDRAEEARASLIEAVAETSDELMEKYLGDEEISVSEL
KEAIRQATTNVEFYPVLCGTAFKNKGVQLMLDAVIDYLPSPLDVKPIIGHRASNPEEEVI
AKADDSAEFAALAFKVMTDPYVGKLTFFRVYSGTMTSGSYVKNSTKGKRERVGRLLQMHA
NSRQEIDTVYSGDIAAAVGLKDTGTGDTLCGEKNDIILESMEFPEPVIHLSVEPKSKADQ
DKMTQALVKLQEEDPTFHAHTDEETGQVIIGGMGELHLDILVDRMKKEFNVECNVGAPMV
SYRETFKSSAQVQGKFSRQSGGRGQYGDVHIEFTPNETGAGFEFENAIVGGVVPREYIPS
VEAGLKDAMENGVLAGYPLIDVKAKLYDGSYHDVDSSEMAFKIAASLALKEAAKKCDPVI
LEPMMKVTIEMPEEYMGDIMGDVTSRRGRVDGMEPRGNAQVVNAYVPLSEMFGYATSLRS
NTQGRGTYTMYFDHYAEVPKSIAEDIIKKNKGE
>ADL24064|FEATURES|CARD|fusidic_acid|fusE|antibiotic target alteration|0
MSRVGKKIIDIPSDVTVTFDGNHVTVKGPKGELSRTLNERMTFKQEENTIEVVRPSDSKE
DRTNHGTTRALLNNMVQGVSQGYVKVLELVGVGYRAQMQGKDLILNVGYSHPVEIKAEEN
ITFSVEKNTVVKVEGISKEQVGALASNIRSVRPPEPYKGKGIRYQGEYVRRKEGKTGK
>AEA93051.1|FEATURES|CARD|multidrug|OpmD|antibiotic target alteration|0
MILSVLTVIYFINAIIAGITILLKPRDVAAIWAWLLVLIALPVFGFFLYLFFGRGLTDKK
KFYLQQSDLRELENFQNFQEESFELYSQKMPTEEQQQFTDFFSSLNRMPLTKKNDVEIFT
DGTEKFNALMADIKKAQHSIHIEYYAFVTDHIGTKILNLLEEKAAEGVEVRLLYDAFGSK
GTKVHHLNELKKNGGFVQTFITSQKALLKFRLNYHDHRKIVVIDGKVGYIGGFNVADQYA
GTTKKFGYWRDTHLRIQGPATSLLQMRFLMDWNVSSPEKNRVAYQLDYFFKLEALVPEAN
TSIQMIASGPNSDREQIKLAFIKLITSAKKRVWIQTPYLVPDDSVLAALKVAAASGVDVK
IMIPDKPDHPFIYRATQYYGRLLMKENIEILIYNGGFLHAKTMIMDDEVCTVGSANQDIR
SYKLNFEANAVLYDKKIIDQLEAIFLEDRKKCTTMTPEVVRDMSKWLIFKQQISRLFSPI
L
>CAG41169|FEATURES|CARD|fosfomycin|murA|antibiotic target alteration|0
MDKIVIKGGNKLTGEVKVEGAKNAVLPILTASLLASDKPSKLVNVPALSDVETINNVLTT
LNADVTYKKDENAVVVDATKTLNEEAPYEYVSKMRASILVMGPLLARLGHAIVALPGGCA
IGSRPIEQHIKGFEALGAEIHLENGNIYANAKDGLKGTSIHLDFPSVGATQNIIMAASLA
KGKTLIENAAKEPEIVDLANYINEMGGRITGAGTDTITINGVESLHGVEHAIIPDRIEAG
TLLIAGAITRGDIFVRGAIKEHMASLVYKLEEMGVELEYQEDGIRVRAEGDLQPVDIKTL
PHPGFPTDMQSQMMALLLTANGHKVVTETVFENRFMHVAEFKRMNANINVEGRSAKLEGK
SQLQGAQVKATDLRAAAALILAGLVADGKTSVTELTHLDRGYVDLHGKLKQLGADIERIN
D
>CAL71877|FEATURES|CARD|bacitracin|uppP|antibiotic target alteration|0
MSPQQEPTAQPPRRHRVVIIGSGFGGLNAAKKLKRADVDIKLIARTTHHLFQPLLYQVAT
GIISEGEIAPPTRVVLRKQRNVQVLLGNVTHIDLAGQCVVSELLGHTYQTPYDSLIVAAG
AGQSYFGNDHFAEFAPGMKSIDDALELRGRILSAFEQAERSSDPERRAKLLTFTVVGAGP
TGVEMAGQIAELAEHTLKGAFRHIDSTKARVILLDAAPAVLPPMGAKLGQRAAARLQKLG
VEIQLGAMVTDVDRNGITVKDSDGTVRRIESACKVWSAGVSASRLGRDLAEQSRVELDRA
GRVQVLPDLSIPRYPNVFVVGDMAAVEGVPGVAQGAIQGAKYVASTIKAELAGANPAERE
PFQYFDKGSMATVSRFSAVAKIGPVEFSGFIAWLIWLVLHLAYLIGFKTKITTLLSWTVT
FLSTRRGQLTITDQQAFARTRLEQLAELAAEAQGSAASAKVAS
>CAA67349.1|FEATURES|CARD|tetracycline|tetW|antibiotic target alteration|0
MAKAKFERTKPHVNIGTIGHVDHGKTTLTAAITKVLHDAIPDLNPFTPFDEIDKAPEERQ
RGITISIAHVEYQTESRHYAHVDCPGHADYIKNMITGAAQMDGAILVVAATDGPMPQTKE
HVLLARQSGVPYIVVALNKADMVDDEEIMELVELEVRELLSEYEFDGDNCPVVQVSALKA
LEGDKEWGEKLLGLMKAVDENIPQPERDVDKPFLMPIEDVFTITGRGTVVTGRIERGVLK
VNETVDIIGIKTEKTTTTVTGIEMFRKLLDEGQAGENVGLLLRGIKREDVERGQCIIKPG
TVTPHTEFEATAYILSKDEGGRHTPFFNNYRPQFYFRTTDVTGVVTLKEGTEMVMPGDNA
EMTVNLIQPVAMEEGLRFTIREGGRTVGAGQVVKINK
>AJK71171.1|FEATURES|CARD|quinolone|gyrA|antibiotic target alteration|0
MENIFSKDSDIELVDIENSIKSSYLDYSMSVIIGRALPDARDGLKPVHRRILYAMQNDEA
KSRTDFVKSARIVGAVIGRYHPHGDIAVYDALVRMAQDFSMRYPSITGQGNFGSIDGDSA
AAMRYTEAKMSKLSHELLKDIDKDTVDFVPNYDGSESEPDVLPSRVPNLLLNGSSGIAVG
MATNIPPHSLNELIDGLLYLLDSKDASLEEIMQFIKGPDFPTGGIIYGKKGIIEAYRTGR
GRVKVRAKTHIEKKTNKDVIVIDELPYQTNKARLIEQIAELVKEKQIEGISEVRDESNKE
GIRVVIELKREAMSEIVLNNLFKSTTMESTFGVIMLAIYNKEPKIFSLLELLNLFLTHRK
TVIIRRTIFELQKARARAHILEGLKIALDNIDKVIALIKNSSDNNTARDSLVAKFGLSEL
QANAILDMKLGRLTGLEREKIENELAELMKEIARLEEILKSETLLENLIRDELKEIRSKF
DVPRITQIEDDYDDIDIEDLIPNENMVVTITHRGYIKRVPSKQYEKQKRGGKGKLAVTTY
DDDFIESFFTANTHDTLMFVTDRGQLYWLKVYKIPEGSRTAKGKAVVNLINLQAEEKIMA
IIPTTDFDESKSLCFFTKNGIVKRTNLSEYQNIRSVGVRAINLDENDELVTAIIVQRDED
EIFATGGEENLENQEIENLDDENLENEESVSTQGKMLFAVTKKGMCIKFPLAKVREIGRV
SRGVTAIKFKEKNDELVGAVVIENDEQEILSISAKGIGKRTNAGEYRLQSRGGKGVICMK
LTEKTKDLISVVIVDETMDLMALTSSGKMIRVDMQSIRKAGRNTSGVIVVNVENDEVVSI
AKCPKEENDEDELSDENFGLDLQ
>AJF82744.1|FEATURES|CARD|quinolone|gyrA|antibiotic target alteration|0
MSVSEIRPIAIEDELKHSYLDYAMSVIVSRALPDVRDGLKPVHRRVLYAMHELGNDYNKA
YKKSARVVGDVIGKYHPHGDSAVYETIVRMAQDFSLRYLLVDGQGNFGSIDGDSAAAMRY
TEVRMTKLAHELLADLEKDTVDWEDNYDGSERIPEVLPTRVPNLLINGAAGIAVGMATNM
APHNMTEVVNACLAYADNPNISIEGLMEYITGPDFPTGGIIYGKSGIVDAYRTGKGRLHI
RGKYHFEEDEKTGRTTIVFTEIPYQVNKARVIERIAELVKEKKLEGISELRDESDKEGMR
IAIDLKRGENAEVVVNNLFLNTQLENSFSINMVCLDNGQPKLMNLKDIIAAFIRHRQEVV
TRRTMFELRKARERGHILEGLTVALANIDEIIETIKTSANPAEARERLLAGEWAGGGVVA
LLEKAGAISVRPDEIEGEDPNRPFGLSDSIYRLSPTQVGAILELRLHRLTGLEQDKLHAE
YTEILGQIAELTAILNDFNLLMGVIREELAQVLQQYGDARRTEIVESRVDFCREDLIPEE
QVVLTVSQTGYAKTQPLSDYQAQRRGGRGKSATSMKDDDFIQHLIVASNHATVLCFTNVG
KVYRLKVFEVPQASRGAKGRPIVNLLPLDATETVTAILPLTEFPENHYVFMATASGTVKR
VELEQFANIRSNGLRAIELNEEDTLIGVAITDGNQQIMLFSNEGKAIRFAETDVRAMGRT
AKGVRGMRVSFASSTLSEEDADVENDDSDDNDDSTDSSLVSRIVSLVVVPETGEVLCASA
NGYGKRTPVNDFPTKKRGGKGVIAIKTSERNGELVGAVSIDETKELLLISDGGTLVRTRA
AEVAMTGRNAQGVRLIRLSEEETLVGVVSIEAVEDEEELLEGEVDTTETDSEEAVSNNED
TSEE
>WP_002389492|FEATURES|CARD|glycopeptide|vanG|antibiotic target alteration|0
MNYRELMQKKNVRPYVLMARFGLEKENQRSTREGLLATTDHPTVFGNRSYHPYIQTDFSE
TQLELITPVANSGTEMLRFLDAIHDVARRSIPEDEMLWPLSMPPQLPTKDEEIKIAKLDQ
YDAVLYRRYLAKEYGKRKQMVSGIHFNFEYDQALIQQLYDEQSEVTDCKQFKTKVYMKVA
RNFLRYRWLITYLFGASPVSEDGYFRVYDDQPQEPIRSIRNSTYGYRNHDNVKVSYASLE
RYLEDIHRMVENGLLSEEKEFYAPVRLRGGKQMSDLPKTGIRYIELRNLDLNPFSRLGIV
EDTVDFLHYFMLYLLWTDEKEEADEWVKTGDILNEQVALGHPHETIKLIAEGDRIFSEMI
DMLDALGIRKGKEVVGKYYQQLRNPQDTVSGKMWTIIQENSNSELGNIFGNQYQSMAFER
PYQLAGFREMELSTQIFLFDAIQKGLEIEILDEQEQFLKLQHGEHIEYVKNANMTSKDNY
VVPLIMENKTVTKKILSAAGFHVPGGEEFSSFIEAQEAHLRYANKAFVVKPKSTNYGLGI
TIFKEGASLEDFTEALRIAFKEDTAVLIEEFLPGTEYRFFVLDNDVKAIMLRVPANVTGD
GKHTVEELVAAKNSDPLRGTNHRAPLELIQLNDLEKLMLKEQGLTIYSVPEKEQIVYLRE
NSNVSTGGDSIDMTDVIDDSYKQIAIEAVAALGAKICGIDLIIPDKDVKGTRDSLTYGII
EANFNPAMHMHVYPYAGQGRRLTMDVLKLLYPEVVQ
>WP_002356022|FEATURES|CARD|aminoglycoside|sat-3|antibiotic target alteration|0
MQKKRIQKNGFLIVVGLLLVEFLLYFLLTNKWLLLAVIIALDIFLLVVIRLLIRDVEITN
VEKIQEASSIAEQSLDYVVNEVPVGIITYNGETRAVEWLNPYAASIFNKDNQLTLTASQV
TSYLELAERNQDIFTIDENTYRFSVNKEQHTITFEDITKESNLYQEKVEMQTAIGIVSVD
NYDDVTDTMDEKEISYLNSFITTMVSDWMDQYKVFYKRINAERYFFIAQWEDIQKMMDEK
FSILDTIRKESANHEVAITLSMGIAYGGPTLDQTGTTAQTNLDTALVRGGDQVVVKEAKD
EAKPLFFGGKTAVTTKRSQVRSRAMSMAIKGIIAESADIYIMGHRYPDMDALGSAFGVAR
LASFNNRKAWIVLDENEIIPDVKRVLEAIKEYPELEERIISPKEAMKRKKESSLLVMVDY
HKPSLSISQELYERFDKVVIIDHHRRGDEFPAKPLLSYIESSASSASELVTELIEYQSNS
ANKLQAFEATMMLAGIVVDTKSFNTRTTARTFDVASYLRTCGADSSLVQYLLSSDLTSYL
EMNNLISKSEYVTKDTVVVAGSEDKEYDSVTAAKTADTLLSMAGINAAFVITKRTDQQIG
ISARSNGSINVQIIMENLGGGGHFTNAAVQLSNVTVAEVKEQLLDVIRQNINEMYEQE
>NP_212606|FEATURES|CARD|fosfomycin|Borrelia|antibiotic target alteration|0
MHSYIVEGGYKIGGQITASGNKNAALPCILAALLTDEEVILENIPNINDVKVVLDILNDI
GADIAREGNTLKIKVLNIVKTEIDSSFTDLIRASILLLGPFVSRFGKIDMALPGGDVIGK
RRLDTHFYGLCKLGAKLSTKDRRIVLKANKLVGAEMFLDEASVTATENIIMAAVLAEGNT
VIMNAACEPHVQDLCNMLNSMGANILGIGSNVLEIKGVKKLSGTVFRIGADFMQVGSLIS
LAALTGGELEIKKADPQHFRLIRHVYSRLGINFEYDRENVYVRNKQELKVKLDFGGHIPK
IDDGPWPAFPTDLMSIIVVTATQVEGTVLVFEKMFESRMFFVDKLIKMGARIVLCDPHRV
VVTGKSSLKGNVLSSPDVRAGMSLLIAAFVAEGRSEIQNVYQIERGYEDVVNKLINLGAK
IKKVKSQ
>BAA85265|FEATURES|CARD|polymyxin|arnC|antibiotic target alteration|0
MKKELSFHEKLLKLTKQQKKKTNKHVFIAIPIVFVLMFAFMWAGKAETPKVKTYSDDVLS
ASFVGDIMMGRYVEKVTEQKGADSIFQYVEPIFRASDYVAGNFENPVTYQKNYKQADKEI
HLQTNKESVKVLKDMNFTVLNSANNHAMDYGVQGMKDTLGEFAKQNLDIVGAGYSLSDAK
KKISYQKVNGVTIATLGFTDVSGKGFAAKKNTPGVLPADPEIFIPMISEAKKHADIVVVQ
SHWGQEYDNDPNDRQRQLARAMSDAGADIIVGHHPHVLEPIEVYNGTVIFYSLGNFVFDQ
GWTRTRDSALVQYHLKKNGTGRFEVTPIDIHEATPAPVKKDSLKQKTIIRELTKDSNFAW
KVEDGKLTFDIDHSDKLKSK
>CAG39047|FEATURES|CARD|glycopeptide|VanSC|antibiotic target alteration|0
MKWLKQLQSLHTKLVIVYVLLIIIGMQIIGLYFTNNLEKELLDNFKKNITQYAKQLEISI
EKVYDEKGSVNAQKDIQNLLSEYANRQEIGEIRFIDKDQIIIATTKQSNRSLINQKANDS
SVQKALSLGQSNDHLILKDYGGGKDRVWVYNIPVKVDKKVIGNIYIESKINDVYNQLNNI
NQIFIVGTAISLLITVILGFFIARTITKPITDMRNQTVEMSRGNYTQRVKIYGNDEIGEL
ALAFNNLSKRVQEAQANTESEKRRLDSVITHMSDGIIATDRRGRIRIVNDMALKMLGMAK
EDIIGYYMLSVLSLEDEFKLEEIQENNDSFLLDLNEEEGLIARVNFSTIVQETGFVTGYI
AVLHDVTEQQQVERERREFVANVSHELRTPLTSMNSYIEALEEGAWKDEELAPQFLSVTR
EETERMIRLVNDLLQLSKMDNESDQINKEIIDFNMFINKIINRHEMSTKDTTFIRDIPKK
TIFTEFDPDKMTQVFDNVITNAMKYSRGDKRVEFHVKQNPLYNRMTIRIKDNGIGIPINK
VDKIFDRFYRVDKARTRKMGGTGLGLAISKEIVEAHNGRIWANSVEGQGTSIFITLPCEV
IEDGDWDE
>ALJ89624.1|FEATURES|CARD|quinolone|parC|antibiotic target alteration|0
MTSLAHHATENRSVAEFTEQAYLNYAMYVIMDRALPHISDGLKPVQRRIVYAMSELGLKS
SGKPKKSARTVGDVLGKYHPHGDLACYEAMVLMAQPFSYRYPLIEGQGNWGSPDDPKSFA
AMRYTEAKLSAYSELLLSELGQGTSEWQDNFDGSLKEPITLPARVPNILLNGTTGIAVGM
ATDIPPHNLREVVKGTIALIRNPQTSDEKLAEYIPAPDLPTKAEIITPPEELLKIQTTGR
GSYRMRAVYTIEKNEIVITELPYQVSGSKVITQIADQMQAKKLPLVVDVRDESDHENPTR
LVIVLRSNRIDAEAVMSHLFATTDLESSYRVNLNMIGEDGRPQVKSIRRILLEWIEIRKK
TVTRRLQYHLNRIEKRLHILAGLLIAYLDIDTVIRIIREEDQPKPVLMEHFNIDEIQAEA
ILELKLRHLAKLEEMEIRHEQDELSAKAAIIREQLENPESLKNLIISELKEDAKKFGDER
RSPIVARAEAVQIKEQDLMPAETVTVVLSEAGWVRAAKGADVDAENLNYRAGDQYLSHAV
GKTNQRVYFLDETGRSYALPISNLPSARGLGDPLSSKLSPASGVSFIQVYLDDDESELIA
ASSAGYGFKTQTKQLDTNAKAGKTFLTVPDKAKALPLISAQNMTHLAVLSSAGRLLILDL
AELPNLNKGKGNKLIQLEGKEQILSMTTLNLDEIIQVVAGQQHLKLKGDDLQKYMGKRAS
KGQLLPRGYQKANKLLIQR
>CUX99269.1|FEATURES|CARD|glycopeptide|vanTN|antibiotic target alteration|0
MNSSWRFFVVVEALLLLFAVWQIVNNTGLLLLVIFGIFNIYLAMRKYPRTKFQNFQLILG
SLVIFFSLVNSPALWMMVVLAVLFIGLKGVEISGIDLTKNAFWRKKQIMMVQTEQLKTHN
NERKRQQLFGNQRIGNDVYEWDDINIAIISGDTIIDLGNTLLPKDDNIVIVRKGIGRTRI
LVPLGVAIRLEHATLVGNVLFEEEQFSLKNEQIKICSSDYDENPRRLKIITNTLVGDVEV
IRI
>AAO82600.1|FEATURES|CARD|polymyxin|PmrB|antibiotic target alteration|0
MTDRISRRMISLYASLSTFIVILITLFSYFHSIKQNRWLLELLQRKVFYLPLIVHIVLIS
LLIGLLTFLLISLVQKGQYGRIEEKLRLLANGNYESPVLNKPTTSENQDHYLTEVEQDIW
SIKNKLLEMSKELQLLNSRPQLMDGQTKEEILENERHRLARELHDSVSQQLFAAMMMLSA
LNEQAQRTETPEPYRKQLAMVAEIINASQSEMRALLLHLRPISLEGKSLRKGIEQLLKEL
QTKIKIELIWDVEDVHLNSSIEDHLFRIVQELLSNTLRHAKAKELEVYLHQVDKNVLLRI
VDDGVGFDMKEQSNKAGSYGLNNIRERVVGMGGTVKIISFKGQGTSVEIKVPVIKEETAS
DQSNVSG
>NP_816529|FEATURES|CARD|multidrug|evgA|antibiotic target alteration|0
MIKVMLVDDHEMVRLGVSSYLSIQEDIEVVGEAENGKIGYEKALELRPDVILMDLVMEEM
DGIDSTKAILKDWPEAKIIIVTSFIDDEKVYPAIEAGAAGYLLKTSTAHEIADAIRATYR
GERVLEPEVTHKMMERLTKKQEPVLHEDLTNREHEILMLIAQGKSNQEIADELFITLKTV
KTHVSNILAKLDVDDRTQAAIYAFQHGLAK
>CDJ73208|FEATURES|CARD|fosmidomycin|RosA|antibiotic target alteration|0
MLAFLNQVRKPTLDLPLEVRRKMWFKPFMQSYLVVFIGYLTMYLIRKNFNIAQNDMISTY
GLSMTQLGMIGLGFSITYGVGKTLVSYYADGKNTKQFLPFMLILSAICMLGFSASMGSGS
VSLFLMIAFYALSGFFQSTGGSCSYSTITKWTPRRKRGTFLGFWNISHNLGGAGAAGVAL
FGANYLFDGHVIGMFIFPSIIALIVGFIGLRYGSDSPESYGLGKAEELFGEEISEEDKET
ESTDMTKWQIFVEYVLKNKVIWLLCFANIFLYVVRIGIDQWSTVYAFQELKLSKAVAIQG
FTLFEAGALVGTLLWGWLSDLANGRRGLVACIALALIIATLGVYQHASNEYIYLASLFAL
GFLVFGPQLLIGVAAVGFVPKKAIGAADGIKGTFAYLIGDSFAKLGLGMIADGTPVFGLT
GWAGTFAALDIAAIGCICLMAIVAVMEERKIRREKKIQQLTVA
>CDJ72593|FEATURES|CARD|multidrug|EmeA|antibiotic target alteration|0
MLSIFKPAPHKARLPAAEIDPTYRRLRWQIFLGIFFGYAAYYLVRKNFALAMPYLVEQGF
SRGDLGFALSGISIAYGFSKFIMGSVSDRSNPRVFLPAGLILAAAVMLFMGFVPWATSSI
AVMFVLLFLCGWFQGMGWPPCGRTMVHWWSQKERGGIVSVWNCAHNVGGGIPPLLFLLGM
AWFNDWHAALYMPAFCAILVALFAFAMMRDTPQSCGLPPIEEYKNDYPDDYNEKAEQELT
AKQIFMQYVLPNKLLWYIAIANVFVYLLRYGILDWSPTYLKEVKHFALDKSSWAYFLYEY
AGIPGTLLCGWMSDKVFRGNRGATGVFFMTLVTIATIVYWMNPAGNPTVDMICMIVIGFL
IYGPVMLIGLHALELAPKKAAGTAAGFTGLFGYLGGSVAASAIVGYTVDFFGWDGGFMVM
IGGSILAVILLIVVMIGEKRRHEQLLQERNGG
>NP_249871.1|FEATURES|CARD|multidrug|smeS|antibiotic efflux|0
MIRSLRIRLMLGAAALAVLFMLALLPALQRAFGIALENTIEQRLAADVATLVSAARVEKG
RLVMPEHLPVEEFNLPEAKVLGYIYDQNGDLLWRSTSAADESINYTPRYDGRGNEFHTTR
DAKGEEFFVFDVEIDLLRGKQAAYSIVTMQSVSEFESLLKGFREQLYLWLGGALLVLLGL
LWLGLTWGFRAMRGLSSELDQIESGERESLSEEHPRELLRLTHSLNRLLRSEHKQRERYR
HSLGDLAHSLKTPLAVLQGVGDQLAEEPGNREQVRVLQGQIERMSQQIGYQLQRASLRKS
GLVRHREQLAPLVETLCDALDKVYRDKRVSLQRDFSPSFSVPVERGALLELLGNLLENAY
RLCLGRVRVGARLGPGYSELWVEDDGPGVPAEQRARIIRRGERADTQHPGQGIGLAVALD
IIESYDGELSLDDSELGGACFRIRFATV
>AAK74984.1|FEATURES|CARD|aminoglycoside|MB84_23135|antibiotic target alteration|0
MSNIQNMSLEDIMGERFGRYSKYIIQDRALPDIRDGLKPVQRRILYSMNKDSNTFDKSYR
KSAKSVGNIMGNFHPHGDSSIYDAMVRMSQNWKNREILVEMHGNNGSMDGDPPAAMRYTE
ARLSEIAGYLLQDIEKKTVPFAWNFDDTEKEPTVLPAAFPNLLVNGSTGISAGYATDIPP
HNLAEVIDAAVYMIDHPTAKIDKLMEFLPGPDFPTGAIIQGRDEIKKAYETGKGRVVVRS
KTEIEKLKGGKEQIVIIEIPYEINKANLVKKIDDVRVNNKVAGIAEVRDESDRDGLRIAI
ELKKDANTELVLNYLFKYTDLQINYNFNMVAIDNFTPRQVGIVPILSSYIAHRREVILAR
SRFDKEKAEKRLHIVEGLIRVISILDEVIALIRASENKADAKENLKVSYDFTEEQAEAIV
TLQLYRLTNTDVVVLQEEEAELREKIAMLAAIIGDERTMYNLMKKELREVKKKFATPRLS
SLEDTAKAIEIDTASLIAEEDTYVSVTKAGYIKRTSPRSFAASTLEEIGKRDDDRLIFVQ
SAKTTQHLLMFTSLGNVIYRPIHELADIRWKDIGEHLSQTITNFETNEEILYVEVLDQFD
DATTYFAVTRLGQIKRVERKEFTPWRTYRSKSVKYAKLKDDTDQIVAVAPIKLDDVVLVS
QNGYALRFNIEEVPVVGAKAAGVKAMNLKEDDVLQSGFICNTSSFYLLTQRGSLKRVSIE
EILATSRAKRGLQVLRELKNKPHRVFLAGAVAEQGFVGDFFSTEVDVNDQTLLVQSNKGT
IYESRLQDLNLSERTSNGSFISDTISDEEVFDAYLQEVVTEDK
>CDJ73205|FEATURES|CARD|multidrug|evgA|antibiotic target alteration|0
MITVALIDDHLIVRSGFAQLLGLEPDLQVVAEFGSGREALAGLPGRGVQVCICDISMPDI
SGLELLSQLPKGMATIMLSVHDSPALVEQALNAGARGFLSKRCSPDELIAAVHTVATGGC
YLTPDIAIKLASGRQDPLTKRERQVAEKLAQGMAVKEIAAELGLSPKTVHVHRANLMEKL
GVSNDVELARRMFDGW
>YP_207769.1|FEATURES|CARD|beta_lactam|ampC|antibiotic target alteration|0
MTDATIRHDHKFALETLPVSLEDEMRKSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAM
HELKNNWNAAYKKSARIVGDVIGKYHPHGDSAVYDTIVRMAQNFAMRYVLIDGQGNFGSV
DGLAAAAMRYTEIRMAKISHEMLADIEEETVNFGPNYDGSEHEPLVLPTRFPTLLVNGSS
GIAVGMATNIPPHNLTDTINACLRLLDEPKTEIDELIDIIQAPDFPTGATIYGLGGVREG
YKTGRGRVVIRGKTHIEPIGKNGEREAIVIDEIPYQVNKAKLVEKIGDLVREKTLEGISE
LRDESDKSGMRVVIELKRNENAEVVLNQLYKLTPLQDSFGINMVVLVDGQPRLLNLKQIL
SEFLRHRREVVTRRTLFRLKKARHEGHIAEGKAVALSNIDEIIKLIKESPNAAEAKEKLL
ARPWRSSLVEEMLTRSGLDLEMMRPEGLAANIGLKKQGYYLSEIQADAILRMSLRNLTGL
DQKEIIESYKNLMGKIIDFVDILSKPERITQIIRDELEEIKTNYGDERRSEINPFGGDIA
DEDLIPQREMVVTLTHGGYIKTQPTTDYQAQRRGGRGKQAAATKDEDFIETLFVANTHDY
LMCFTNLGKCHWIKVYKLPEGGRNSRGRPINNVIQLEEGEKVSAILAVREFPEDQYVFFA
TAQGMVKKVQLSAFKNVRAQGIKAIALKEGDYLVGAAQTGGADDIMLFSNLGKAIRFNEY
WEKSGNDEAEDADIETEISDDLEDETADNENTLPSGKNGVRPSGRGSGGLRGMRLPADGK
IVSLITFAPETEESGLQVLTATANGYGKRTPIADYSRKNKGGQGSIAINTGERNGDLVAA
TLVGETDDLMLITSGGVLIRTKVEQIRETGRAAAGVKLINLDEGETLVSLERVAEDESEL
SGASVISNVTEPEAEN
>WP_014065640.1|FEATURES|CARD|beta_lactam|ampC|antibiotic target alteration|0
MTDSIHSSITPVNIEEELKSSYLDYAMSVIVGRALPDVRDGLKPVHRRVLFSMDQSGITA
GKKYVKSARVVGDVIGKYHPHGDSAVYDTIVRMAQPFSLRYMLVDGQGNFGSIDGDAPAA
MRYTEVRMQKITQALLTDLDKETVNFSPNYDGELMIPDVLPTRIPALLANGSSGIAVGMA
TNIPPHNLNEVLDGCLAYIDNENITIDELMQYIPGPDFPTAALINGRKGIEEAYRTGRGK
VYVRARASVETTDKGKEQIIVTELPYQVNKAKLVEKIAELIKDKKIEGISNIIDLSNKEG
IRIEIDIKRDAVGEVVLNHLYALTQMQVTFGINMVALDHGQPRLFNLKQIIEAFVMHRRE
VVIRRSLFELRKARERTHILEGLAVATSNIDEIIDIIRQSKERKEAAEKLISRPWKLNNE
ILGLLDAAARPAELAAEFGIKGSDYYLSPEQVDAILELRLHRLTGLATEEVINEYKELLV
KIAELLHIINSPERLMEVIREELEQVRAQFADERRTEITAASGDIDLEDLIAQEDVVVTL
SHEGYVKYQPLTDYEAQRRGGKGKSATKMKDEDFIEKLLVANTHDTILCFSSRGRLYWLK
VYQLPQASRGARGRPIVNILPLQENERITAILPISAYEEDKFVIMATAGGIVKKIALTEF
SRPRSSGIIALNLRDEDELIGVDITDGSNEIMLFSSQGRVVRFAESAVRAMGRLATGVRG
IKLALTNDIADDESAVEIEEVSDDNAEETLDLNIDKVVSLVVPKNDGAILTATQNGYGKR
TQLSEYPTKSRNTKGVISIKVSERNGKVVAATQVEETDQIMLITDAGTLVRTRVSEVSIV
GRNTQGVRLIRTAEDEHVVSLERVCDVDDEDEGTEDVTSEE
>WP_041918279.1|FEATURES|CARD|aminoglycoside|AAC(2')-Ia|antibiotic target alteration|0
MSNINYEGIEQMPLRTFTEKAYLNYSMYVIMDRALPFIGDGLKPVQRRIVYAMSELGLNA
AAKFKKSARTVGDVLGKFHPHGDSACYEAMVLMAQPFSYRYPLVDGQGNWGAPDDPKSFA
AMRYTESRLSKISEILLSELGQGTVDFQPNFDGTLEEPQYLPARLPHILLNGTTGIAVGM
ATDIPPHNINEVADAAVMLLDNPKAGLDDVLNIIQGPDFPTEAEIISPKDDIRKMYETGR
GSIKMRATWHKEDGEIIISALPHQSSPSKIIAQIAEQMTAKKLPMVEDIRDEADYENPVR
IVLVPRSNRVDTDALMAHLFATTDLEKSYRVNMNMIGLDHKPAVKGLLQVLIEWLTFRRT
TVTRRLQHRLDKVLARLHILDGLMIAFLNIDEVIEIIRTEDEPKQVLMARFNLSDEQAEA
ILNLRLRHLAKLEEHQLQAEKDKLEEERSNLELILGSERRLNTLIKKEIQEDAKKYASPR
MSQLVEREEAKAISESEMTPAEPVTVILSEMGWVRCAKGHDIDPEGLSYKAGDKYLAHAC
GKSNQPVIFIDSTGRSYALDPLSLPSARSQGEPLTGKLTLPAGATIEQVIMEPEKQELLM
ASDAGYGFICKFEDLIARNKAGKALISLPENAKVLKPETLSESTSLLVSLTSAGRMLIFP
VRDLPALSKGKGNKIISIPAANAKARSELLVKLFLISEQASLEFHSGKRKITLKPEDLQK
FRAERGRKGSQLPRGLHSNVDIVVVEPEHNS
>NP_461214.1|FEATURES|CARD|multidrug|MexB|antibiotic target alteration|0
MSDLAREITPVNIEEELKSSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAMNVLGNDWN
KAYKKSARVVGDVIGKYHPHGDSAVYDTIVRMAQPFSLRYMLVDGQGNFGSIDGDSAAAM
RYTEIRLAKIAHELMADLEKETVDFVDNYDGTEKIPDVMPTKIPNLLVNGSSGIAVGMAT
NIPPHNLTEVINGCLAYIDNEDISIEGLMEHIPGPDFPTAAIINGRRGIEEAYRTGRGKV
YIRARAEVEADAKTGRETIIVHEIPYQVNKARLIEKIAELVKDKRVEGISALRDESDKDG
MRIVIEVKRDAVGEVVLNNLYSQTQLQVSFGINMVALHHGQPKIMNLKDIISAFVRHRRE
VVTRRTIFELRKARDRAHILEALAIALANIDPIIELIRRAPTPAEAKAALISRPWDLGNV
AAMLERAGDDAARPEWLEPEFGVRDGQYYLTEQQAQAILDLRLQKLTGLEHEKLLDEYKE
LLEQIAELLHILGSADRLMEVIREEMELIRDQFGDERRTEITANSADINIEDLISQEDVV
VTLSHQGYVKYQPLTDYEAQRRGGKGKSAARIKEEDFIDRLLVANTHDTILCFSSRGRLY
WMKVYQLPEASRGARGRPIVNLLPLEANERITAILPVREYEEGVNVFMATASGTVKKTAL
TEFSRPRSAGIIAVNLNDGDELIGVDLTSGSDEVMLFSAAGKVVRFKEDAVRAMGRTATG
VRGIKLAGDDKVVSLIIPRGEGAILTVTQNGYGKRTAADEYPTKSRATQGVISIKVTERN
GSVVGAVQVDDCDQIMMITDAGTLVRTRVSEISVVGRNTQGVILIRTAEDENVVGLQRVA
EPVDDEELDAIDGSVAEGDEDIAPEAESDDDVADDADE
>YP_208330.1|FEATURES|CARD|chloramphenicol|AB432_04625|antibiotic target alteration|0
MNTQPHASHTDSNTLMLGRYAERAYLEYAMSVVKGRALPEVSDGQKPVQRRILFAMRDMG
LTAGAKPVKSARVVGEILGKYHPHGDSSAYEAMVRMAQDFTLRYPLIDGIGNFGSRDGDG
AAAMRYTEARLTPIAELLLSEINQGTVDFMPNYDGAFDEPLHLPARLPMVLLNGASGIAV
GMATEIPSHNLNEVTQAAIALLKKPTLETADLMQYIPAPDFAGGGQIITPADELRRIYET
GKGSVRVRARYEIEKLARGQWRVIVTELPPNANSAKILAEIEEQTNPKPKAGKKQLNQDR
LNTKKLMLDLIDRVRDESDGEHPVRLVFEPKSSRIDTDTFINTLMAQTSLEGNVSMNLVM
MGLDNRPAQKNLKTILQEWLDFRVVTVTRRLKFRLNQVEKRLHILEGRLKVFLHIDEVIK
VIRESDDPKADLMAVFGLTEIQAEDILEIRLRQLARLEGFKLEKELNELREEQGRLNIFL
GDENEKRKLIIKEMQADMKQFGDARRTLVEEAGRAVLTQTAADEPITLILSEKGWIRSRA
GHNLDLSQTAFKEGDRLKQTLEGRTVLPVVILDSSGRTYSIDAAEIPGGRGDGVPVSSLI
ELQNGAKPVAMLTGLPEQHYLLSSSGGYGFIAKLGDMVGRVKAGKVVMTADSGETVLPPV
AVYASSFINPDCKIIAATSQNRALAFPIGELKIMAKGKGLQIIGLNAGESMTHTAVSSEP
EILIESEGRRGAAHKDRLPVALIEAKRGKKGRLLPISGSLKQLSSPK
>YP_208874.1|FEATURES|CARD|beta_lactam|rpsJ|antibiotic target protection|0
MANQKIRIRLKAYDYALIDRSAQEIVETAKRTGAVVKGPIPLPTKIERFNILRSPHVNKT
SREQLEIRTHLRLMDIVDWTDKTTDALMKLDLPAGVDVEIKVQ
>EEK14408.1|FEATURES|CARD|polymyxin|arnA|antibiotic target alteration|0
MVEGEKLIPINIEDQMKTAYIDYSMSVIVSRALPDVRDGLKPVHRRVLFGMHELGVRSNT
AHKKSARIVGEVLGKYHPHGDSSVYDTMVRMAQWWNMRYMLVDGQGNFGSIDGDSPAAMR
YTEARMRKMAEDMLIDIDKETVDHSLNFDDTLLEPTVLPTRIPNLLVNGSSGIAVGMATN
MPPHNLAEVVDGIIAYLGNQDITIDELMEYIKAPDFPTGGIIYGYDGVREAFKTGRGRVV
IRAKAHFEEVNGRDCIVVTEVPYQVNPETMREQTSNLVKEGKLEGLADIVDQTGKGGMRI
VYELKKDAIPNVVLNNLFKHTALQSSFSVNNIALVNGRPQQLNLKDLIYHFVEHRHDVVY
RRTEYELKKAKERIHILEGFMKVMATEDTMGKAIEIIRFHDKPKEDLMTEFELTEIQAEA
ILALQLRRINKLLILQTKEEYEQLLAQIIDLEDILARKERRTEIIKEELLEIKSKYGDER
RSVIEYAGGDISIEDIIPDDQVVITISNAGYIKRTSVNEYKTQARGGVGQKASATRDKDF
IEHLFIGTNHQYMLFFTEKGKCFWLRVYEIPEGGKNTKGRAIQNLINIEPDDLVKAVICT
HDLKEKDYTNSHYVIMATKKGIIKKTSLEQYSRPRQNGIVAITIKEDDELLEARLTSGNS
QIMLAVKSGKAIRFPEDKVRAVGRSGSGVRGISLDSDKDEVIGMIAIENPLEETVLVVSE
NGYGKRTFIDEPETGEAVYRITNRGGKGVKTISITEKTGNLVAIKSVLEEDDLMIINKSG
MAIRLPVSGLRVMGRATQGVRLINIKGNDSIAAVAKVMKEDEDENTTEEIENPTEE
>NP_462089.1|FEATURES|CARD|beta_lactam|RW25_27295|antibiotic target alteration|0
MSDMAERLALHEFTENAYLNYSMYVIMDRALPFIGDGLKPVQRRIVYAMSELGLNATAKF
KKSARTVGDVLGKYHPHGDSACYEAMVLMAQPFSYRYPLVDGQGNWGAPDDPKSFAAMRY
TESRLSKYAELLLSELGQGTADWVPNFDGTMQEPKMLPARLPNILLNGTTGIAVGMATDI
PPHNLREVAKAAITLIEQPKTTLDQLLDIVQGPDYPTEAEIITPRAEIRKIYENGRGSVR
MRAVWTKEDGAVVISALPHQVSGAKVLEQIAAQMRNKKLPMVDDLRDESDHENPTRLVIV
PRSNRVDMEQVMNHLFATTDLEKSYRINLNMIGLDGRPAVKNLLEILTEWLAFRRDTVRR
RLNYRLEKVLKRLHILEGLLVAFLNIDEVIEIIRSEDEPKPALMSRFGISETQAEAILEL
KLRHLAKLEEMKIRGEQDELEKERDQLQGILASERKMNTLLKKELQADADAYGDDRRSPL
REREEAKAMSEHDMLPSEPVTIVLSQMGWVRSAKGHDIDAPGLNYKAGDSFKAAVKGKSN
QPVVFIDTTGRSYAIDPITLPSARGQGEPLTGKLTLPPGATVEHMLMEGDDQKLLMASDA
GYGFVCTFNDLVARNRAGKTLITLPENAHVMPPLVIEDEHDMLLAITQAGRMLMFPVDSL
PQLSKGKGNKIINIPSAEAAKGDDGLAHLYVLPPQSTLTIHVGKRKIKLRPEELQKVVGE
RGRRGTLMRGLQRIDRIEIDSPHRVSHGDSEE
>NP_273462.1|FEATURES|CARD|beta_lactam|pbp2b|antibiotic target alteration|0
MLIKSEYKPRMLPKEEQVKKPMTSNGRISFVLMAIAVLFAGLIARGLYLQTVTYNFLKEQ
GDNRIVRTQTLPATRGTVSDRNGAVLALSAPTESLFAVPKEMKEMPSAAQLERLSELVDV
PVDVLRNKLEQKGKSFIWIKRQLDPKVAEEVKALGLENFVFEKELKRHYPMGNLFAHVIG
FTDIDGKGQEGLELSLEDSLHGEDGAEVVLRDRQGNIVDSLDSPRNKAPKNGKDIILSLD
QRIQTLAYEELNKAVEYHQAKAGTVVVLDARTGEILALANTPAYDPNRPGRADSEQRRNR
AVTDMIEPGSAIKPFVIAKALDAGKTDLNERLNTQPYKIGPSPVRDTHVYPSLDVRGIMQ
KSSNVGTSKLSARFGAEEMYDFYHELGIGVRMHSGFPGETAGLLRNWRRWRPIEQATMSF
GYGLQLSLLQLARAYTALTHDGVLLPVSFEKQAVAPQGKRIFKESTAREVRNLMVSVTEP
GGTGTAGAVDGFDVGAKTGTARKFVNGRYADNKHIATFIGFAPAKNPRVIVAVTIDEPTA
HGYYGGVVAGPPFKKIMGGSLNILGISPTKPLTAAAVKTPS
>NP_359110.1|FEATURES|CARD|beta_lactam|pbp2|antibiotic target alteration|0
MRLICMRKFNSHSIPIRLNLLFSIVILLFMTIIGRLLYMQVLNKDFYEKKLASASQTKIT
SSSARGEIYDASGKPLVENTLKQVVSFTRSNKMTATDLKETAKKLLTYVSISSPNLTERQ
LADYYLADPEIYKKIVEALPSEKRLDSDGNRLSESELYNNAVDSVQTSQLNYTEDEKKEI
YLFSQLNAVGNFATGTIATDPLNDSQVAVIASISKEMPGISISTSWDRKVLETSLSSIVG
SVSSEKAGLPAEEAEAYLKKGYSLNDRVGTSYLEKQYEETLQGKRSVKEIHLDKYGNMES
VDTIEEGSKGNNIKLTIDLAFQDSVDALLKSYFNSELENGGAKYSEGVYAVALNPKTGAV
LSMSGIKHDLKTGELTPDSLGTVTNVFVPGSVVKAATISSGWENGVLSGNQTLTDQSIVF
QGSAPINSWYTQAYGSFPITAVQALEYSSNTYMVQTALGLMGQTYQPNMFVGTSNLESAM
EKLRSTFGEYGLGTATGIDLPDESTGFVPKEYSFANYITNAFGQFDNYTPMQLAQYVATI
ANNGVRVAPRIVEGIYGNNDKGGLGDLIQQLQPTEMNKVNISDSDMSILHQGFYQVAHGT
SGLTTGRAFSNGALVSISGKTGTAESYVADGQQATNTNAVAYAPSDNPQIAVAVVFPHNT
NLTNGVGPSIARDIINLYQKYHPMN
>YP_499533.1|FEATURES|CARD|beta_lactam|blaOXA-1|antibiotic target alteration|0
MSNQYQQYSTVKKYWHLMRPHTLTASVVPVLVGTAASKIYFLGSEDHIKISLFIAMLLAC
LLIQAATNMFNEYYDYKKGLDDHESVGIGGAIVRNGMSPELVLRLAIAFYILAAILGLFL
AANSSFWLLPVGLVCMAVGYLYTGGPFPISWTPFGELFSGVFMGMFIIVIAFFIQTGNIQ
SYVIWLSVPIVITIGLINMANNIRDRVKDKASGRKTLPILLGKNASLTFMAIMYFIAYAF
IVLTIIIKPGGSLFYLLALLSFPMPVKVIRRFKKNDTPPTMMPAMAAAGKTNTFFGLLYA
LGIYISALFAGI
>CAG39357|FEATURES|CARD|multidrug|mdtH|antibiotic target alteration|0
MNFLKPAKHIKPLPENQIDDTYKRLRLQVFLGIFIGYAGYYLLRKNFSLAMPALQEQGFT
KAELGFALSAVSIAYGFSKFFMGTVSDRSNARIFLVLGLVLTAIVNLLMGFVPFFTSGIG
IMFVLLFLNGWFQGMGWPPSGRVLVHWFSVSERGSKTALWNVAHNVGGGIMAPIAAWGIT
TTAFINFGYLKGFEGVFIYPALLALIIAAISYILIRDTPQSQGLPPIEIYKNDFATSDKK
TLETELTTKEILFKYVLNNKWVWAIAFANIFVYFVRYGVLDWAPVYLSEEKHFDLKASGW
AYFLYEWAGIPGTLLCGYISDKLFKGRRGPAGFFFMLGVTVFVLIYWLNPPGNAWLDNVS
LIAIGFLIYGPVMLIGLQALDYVPKKAAGTAAGLTGLFGYLFGAVMANIVLGAVVDKFGW
DVGFILLTAISVFAMLSFILTWNKVGQETVHH
>CDJ73082|FEATURES|CARD|aminoglycoside|B2K_23630|antibiotic target alteration|0
MYLYIETLKQRLDAINQLRVDRALAAMGPAFQQVYSLLPTLLHYHHPLMPGYLDGNVPKG
ICLYTPDETQRHYLNELELYRGMSVQDPPKGELPITGVYTMGSTSSVGQSCSSDLDIWVC
HQSWLDSEERQLLQRKCSLLENWAASLGVEVSFFLIDENRFRHNESGSLGGEDCGSTQHI
LLLDEFYRTAVRLAGKRILWNMVPCDEEEHYDDYVMTLYAQGVLTPNEWLDLGGLSSLSA
EEYFGASLWQLYKSIDSPYKAVLKTLLLEAYSWEYPNPRLLAKDIKQRLHDGEIVSFGLD
PYCMMLERVTEYLTAIEDFTRLDLVRRCFYLKVCEKLSRERACVGWRRAVLSQLVSEWGW
DEARLAMLDNRANWKIDQVREAHNELLDAMMQSYRNLIRFARRNNLSVSASPQDIGVLTR
KLYAAFEALPGKVTLVNPQISPDLSEPNLTFIYVPPGRANRSGWYLYNRAPNIESIISHQ
PLEYNRYLNKLVAWAWFNGLLTSRTRLYIKGNGIVDLPKLQEMVADVSHHFPLRLPAPTP
KALYSPCEIRHLAIIVNLEYDPTAAFRNQVVHFDFRKLDVFSFGENQNCLVGSVDLLYRN
SWNEVRTLHFNGEQSMIEALKTILGKMHQDAAPPDSVEVFCYSQHLRGLIRTRVQQLVSE
CIELRLSSTRQETGRFKALRVSGQTWGLFFERLNVSVQKLENAIEFYGAISHNKLHGLSV
QVETNHVKLPAVVDGFASEGIIQFFFEETQDENGFNIYILDESNRVEVYHHCEGSKEELV
RDVSRFYSSSHDRFTYGSSFINFNLPQFYQIVKVDGREQVIPFRTKSIGNMPPANQDHDT
PLLQQYFS
>CAG39240|FEATURES|CARD|tetracycline|tetL|antibiotic target alteration|0
MNFFDIHKIPNKGIPLSVQRKLWLRNFMQAFFVVFFVYMAMYLIRNNFKAAQPFLKEEIG
LSTLELGYIGLAFSITYGLGKTLLGYFVDGRNTKRIISFLLILSAITVLIMGFVLSYFGS
VMGLLIVLWGLNGVFQSVGGPASYSTISRWAPRTKRGRYLGFWNTSHNIGGAIAGGVALW
GANVFFHGNVIGMFIFPSVIALLIGIATLFIGKDDPEELGWNRAEEIWEEPVDKENIDSQ
GMTKWEIFKKYILGNPVIWILCVSNVFVYIVRIGIDNWAPLYVSEHLHFSKGDAVNTIFY
FEIGALVASLLWGYVSDLLKGRRAIVAIGCMFMITFVVLFYTNATSVMMVNISLFALGAL
IFGPQLLIGVSLTGFVPKNAISVANGMTGSFAYLFGDSMAKVGLAAIADPTRNGLNIFGY
TLSGWTDVFIVFYVALFLGMILLGIVAFYEEKKIRSLKI
>AAN62561.1|FEATURES|CARD|glycopeptide|vanL|antibiotic target alteration|0
MKIILLYGGRSAEHDVSLLSAFSVVNAVYYNYYQVQLVMITRDGQWLKGSLLTEAPTSKE
VLNLTDSAYQGTPIQPGEIKEEDAIVFPLLHGPNGEDGTIQGFLETIGMPYVGAGVLTSA
CGMDKIMTKYILQAAGIPQVPYVPVLKNYWKENPKKVFEQCEGSLLYPMFIKPANMGSSV
GITKAENREELQNALQEAYRYDTRAIVEQGIEAREIEVAVLGNEDVRTTMPGEIVKDVAF
YDYNSKYLDNKIEMQIPAQIPEETQAKAQEFAKKAYTMLGGSGLSRCDFFLTNKNELFLN
ELNTMPGFTEFSMYPLLWEKTGLPYGDLIEELIQLGVNRFKQRQAFLTDVE
>WP_002530866.1|FEATURES|CARD|beta_lactam|ACU52_03190|antibiotic target alteration|0
MADDEKPDEQNQADRQGLVTGRHVGIQPVEIRDEIQNAYLDYAMSVIVGRALPDVRDGLK
PVHRRVIYAMYDGGYRPDRGWNKCSRVVGDVMGKYHPHGDSAIYDTLVRLAQPWAMRYKL
VQGQGNFGSQGNDGAAAMRYTECKMAPLAMEMVRDIDQDTVDFQPNYDNKETEPVVLPSR
FPNLLVNGSSGIAVGMATNIPTHNLREVNEAVQWSLAHPNASHEELLEACMERIKGPDFP
GGALIVGRQGIEDAYRTGRGSVTMRAVIDMEEDKKGRQCLVVTELPYMCNPDNLATKIAD
LVNSGRINGIADIRDDSSARTGQRLVIVLKRDAQPRVVMNNLYKHTALQDTFGCNMLALV
DNVPRTLRLDQFISYWIDHQMEVIRRRTEYRLAQAEKDAHIQRALVKALDMLDEVIALIR
RSPNTEAASTGLQELLDIDEIQARAILDMQLRRLAALERQKIIDRLEELERLIADYKAIL
ASEDRQREIISTELAEIVDKYGDERRTRIIAADGDFSEEDFIPDDDVVVTITRGGYAKRT
RTDLYRVQKRGGKGVRGASLRADDEMAQLFTTTNHQWILFFTNMGRVYRTKVWQLPEAGR
DARGGHVAGLLSFLPDEKIAQVMTLRSYDGAEYLLLATRKGMVKKTALKAYDSSRQAGVI
AVNFRTEDDELIGAEQCSAADDVLLISRKGQAIRFSAGDDQLRPMGRATSGVTGMKFRGD
DELLSMSIIHSDMPEDDRFVFTATGGGYAKRTAVSEYRQQGRGGVGIKAMALSEERGSLV
GGLVVSEADEIIAIKTSGQITRSAVSEVPAKGRSTMGVKFVSVRGGDAVSIIAVNPEHTV
EEEVADESVETVEGDATQAQSGGVVRRSDTVDDDRAVDTAGNDMKPEDNGE
>YP_001086469.1|FEATURES|CARD|aminoglycoside|AAC(1)|antibiotic target alteration|0
MEENNKILPIEIAEEMKKSYIDYSMSVIAGRALPDVRDGLKPVHRRILYSMSELNLTPDK
PYRKSARIVGDVLGKYHPHGDTAVYYAMVRMAQDFSTRALLVDGHGNFGSVDGDSPAAMR
YTEAKMSKLSLELLRDIEKETVDFKPNFDESLKEPSVLPARYPNLLVNGSNGIAVGMATS
IPPHNLAEVIDATVYLIDNPECSVDDLIKFVQGPDFPTAAIIMGKESIAEAYRTGRGKVK
VRSRAFIEELPKGKQQIIVTEIPYQVNKAKLVERIAELVKEKRIEGISDLRDESNRNGMR
IVIELKRDANANIVLNNLYKHSQMEDTFSIIMLALVDGQPRVLNLKQILYHYIKHQEDVV
TRRTKFELNKAEARAHILEGLKIALDNIDAVISLIRASKTGQEAKLGLIEKFKLTEIQAQ
AILDMRLQRLTGLERDKIEAEYEDLIKKINRLKEILADERLLLNVIKDEITIIKENYSDE
RRTEIRHAEGEIDMRDLISDEEIAITLTHFGYIKRLPSDTYKSQKRGGRGISALTTREED
FVRHLVTTTTHSRLLFFTNKGRVFKLNAYEIPEGKRQAKGTAIVNLLQLSADEKIATLIP
IDGNDENEYLLLATKKGIVKKTKREEFKNINKSGLIAIGLRDDDELIGVELTDGKQEVLL
VTKEGMSIRFDENDIRYMGRTAMGVKGITLSKEDFVVSMNLCSKGTDVLVVSKNGFGKRT
NIEEYRSQIRAGKGIKTYNISEKTGTIVGADMVNEDDEIMIINSDGVLIRIRVNEISLFG
RVTSGVKLMKTNDEVNVVSIAKINIEEE
>NP_415804.1|FEATURES|CARD|isoniazid|fabI|antibiotic target alteration|0
MGFLSGKRILVTGVASKLSIAYGIAQAMHREGAELAFTYQNDKLKGRVEEFAAQLGSDIV
LQCDVAEDASIDTMFAELGKVWPKFDGFVHSIGFAPGDQLDGDYVNAVTREGFKIAHDIS
SYSFVAMAKACRSMLNPGSALLTLSYLGAERAIPNYNVMGLAKASLEANVRYMANAMGPE
GVRVNAISAGPIRTLAASGIKDFRKMLAHCEAVTPIRRTVTIEDVGNSAAFLCSDLSAGI
SGEVVHVDGGFSIAAMNELELK
>NP_415611.1|FEATURES|CARD|bacitracin|uppP|antibiotic target alteration|0
MNFEGKIALVTGASRGIGRAIAETLAARGAKVIGTATSENGAQAISDYLGANGKGLMLNV
TDPASIESVLEKIRAEFGEVDILVNNAGITRDNLLMRMKDEEWNDIIETNLSSVFRLSKA
VMRAMMKKRHGRIITIGSVVGTMGNGGQANYAAAKAGLIGFSKSLAREVASRGITVNVVA
PGFIETDMTRALSDDQRAGILAQVPAGRLGGAQEIANAVAFLASDEAAYITGETLHVNGG
MYMV
>NP_415372.1|FEATURES|CARD|multidrug|adeJ|antibiotic target alteration|0
MTPTIELICGHRSIRHFTDEPISEAQREAIINSARATSSSSFLQCSSIIRITDKALREEL
VTLTGGQKHVAQAAEFWVFCADFNRHLQICPDAQLGLAEQLLLGVVDTAMMAQNALIAAE
SLGLGGVYIGGLRNNIEAVTKLLKLPQHVLPLFGLCLGWPADNPDLKPRLPASILVHENS
YQPLDKGALAQYDEQLAEYYLTRGSNNRRDTWSDHIRRTIIKESRPFILDYLHKQGWATR
>YP_006374661.1|FEATURES|CARD|tetracycline|tetW|antibiotic target alteration|0
MGMWCTLCTSYTYQTNKKYIVFLGGHFKMAKEKFDRSKPHVNIGTIGHVDHGKTTLTAAI
TTVLSKKNGGQAMAYDQIDGAPEERERGITISTAHVEYETDTRHYAHVDCPGHADYVKNM
ITGAAQMDGAILVVSAADGPMPQTREHILLSRQVGVPYIVVFLNKVDMVDDEELLELVEM
EVRDLLTEYEFPGDDVPVVAGSALKALEGDASYEEKILELMAAVDEYIPTPERDNDKPFM
MPVEDVFSITGRGTVATGRVERGQVRVGDEVEVVGIAEETSKTTVTGVEMFRKLLDYAEA
GDNIGALLRGVAREDIQRGQVLAKPGTITPHTKFSAEVYVLTKEEGGRHTPFFTNYRPQF
YFRTTDVTGVVELPEGTEMVMPGDNVTMEVELIHPIAIENGTKFSIREGGRTVGAGVVTE
IKA
>CAC30845.1|FEATURES|CARD|rifampin|rpoB|antibiotic target alteration|0
MLEGCILPDFGQSKTDVSPSQSRPQSSPNNSVPGAPNRISFAKLREPLEVPGLLDVQTDS
FEWLIGSPCWRAAAASRGDLKPVGGLEEVLYELSPIEDFSGSMSLSFSDPRFDEVKAPVE
ECKDKDMTYAAPLFVTAEFINNNTGEIKSQTVFMGDFPMMTEKGTFIINGTERVVVSQLV
RSPGVYFDETIDKSTEKTLHSVKVIPSRGAWLEFDVDKRDTVGVRIDRKRRQPVTVLLKA
LGWTSEQITERFGFSEIMRSTLEKDNTVGTDEALLDIYRKLRPGEPPTKESAQTLLENLF
FKEKRYDLARVGRYKVNKKLGLHAGELITSSTLTEEDVVATIEYLVRLHEGQSTMTVPGG
VEVPVETDDIDHFGNRRLRTVGELIQNQIRVGMSRMERVVRERMTTQDVEAITPQTLINI
RPVVAAIKEFFGTSQLSQFMDQNNPLSGLTHKRRLSALGPGGLSRERAGLEVRDVHPSHY
GRMCPIETPEGPNIGLIGSLSVYARVNPFGFIETPYRKVVDGVVSDEIEYLTADEEDRHV
VAQANSPIDEAGRFLEPRVLVRRKAGEVEYVASSEVDYMDVSPRQMVSVATAMIPFLEHD
DANRALMGANMQRQAVPLVRSEAPLVGTGMELRAAIDAGHVVVAEKSGVIEEVSADYITV
MADDGTRRTYRMRKFARSNHGTCANQSPIVDAGDRVEAGQVIADGPCTENGEMALGKNLL
VAIMPWEGHNYEDAIILSNRLVEEDVLTSIHIEEHEIDARDTKLGAEEITRDIPNVSDEV
LADLDERGIVRIGAEVRDGDILVGKVTPKGETELTPEERLLRAIFGEKAREVRDTSLKVP
HGESGKVIGIRVFSHEDDDELPAGVNELVRVYVAQKRKISDGDKLAGRHGNKGVIGKILP
AEDMPFLPDGTPVDIILNTHGVPRRMNVGQILETHLGWVAKSGWKIDVAGGIPDWAVNLP
EELLHAAPNQIVSTPVFDGAKEEELQGLLSSTLPNRDGDVMVGGDGKAVLFDGRSGEPFP
YPVTVGYMYIMKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMECWAMQAYG
AAYTLQELLTIKSDDTVGRVKVYEAIVKGENIPEPGIPESFKVLLKELQSLCLNVEVLSS
DGAAIELREGEDEDLERAAANLGINLSRNESASIEDLA
>NP_249870.1|FEATURES|CARD|polymyxin|basR|antibiotic efflux|0
MKLLVVEDEALLRHHLYTRLGEQGHVVDAVPDAEEALYRVSEYHHDLAVIDLGLPGMSGL
DLIRELRSQGKSFPILILTARGNWQDKVEGLAAGADDYVVKPFQFEELEARLNALLRRSS
GFVQSTIEAGPLVLDLNRKQALVEEQPVALTAYEYRILEYLMRHHQQVVAKERLMEQLYP
DDEERDANVIEVLVGRLRRKLEACGGFKPIDTVRGQGYLFTERCR
>AFC91898.1|FEATURES|CARD|beta_lactam|pbp2b|antibiotic target alteration|0
MKWTKRVIRYATKNRKSPAENRRRVGKSLSLLSVFVFAIFLVNFAVIIGTGTRFGTDLAK
EAKKVHQTTRTVPAKRGTIYDRNGVPIAEDATSYNVYAVIDENYKSATGKILYVEKTQFN
KVAEVFHKYLDMEESYVREQLSQPNLKQVSFGAKGNGITYANMMSIKKELETAEVKGIDF
TTSPNRSYPNGQFASSFIGLAQLHENEDGSKSLLGTSGMESSLNSILAGKDGIITYEKDR
LGNVVPGTEQVSQQTVDGKDVYTTISSTLQSFMETQMNAFQEKVKGKYMTATLVSAKTGE
ILATTQRPTFDADTKEGLTKDFVWRDILYQSNYEPGSPMKVMTLAASIDNNTFPGGEYFN
SSELKIADVTIRDWDVNESLTGGGMMTFSQGFAHSSNVGMTLLEQKMGDATWLDYLNRFK
FGVPTRFGLTDEYAGQLPADNIVNIAQSSFGQGISVTQTQMIRAFTAIANDGVMLEPKFI
SAIYDPNDQTARKSQKEVVGNPVSKDAASLTRTNMILVGTDPVYGTMYNHSTGKPTVTVP
GQNVALKSGTAQIADEKNGGYLVGLTNYIFSAVSMNPAENPDFILYVTVQQPEHYSGIQL
GEFANPILERASAMKDSLNLQTTAKALEQVSQQSPYPMPSVKDISPGDLAEELRRNLVQP
IVVGTGTKIKESSVEEGTNLAPNQQVILLSDKVEEIPDMYGWKKETAEAFAKWLDIELEF
EGSGSVVQKQDVRTNTAIKNIKKITLTLGD
>WP_010891786.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|macB|antibiotic target alteration|0
MSVNHQKIINTPLDNIVGESYAKYAKYIIQDRALPDIRDGLKPVQRRILYAMSELGIFYD
KPYKKSARTVGEVIGKYHPHGDSSIYEAMVRMSQDWKNNLCLLDMHGNKGSIDGDNAAAM
RYTEARLSKIASVMLANLKKDVVKFSPNFDDSEKEPSILPSLFPNLLINGATGIASGYAT
NIPPHNPNEVFDALIYRIDHPDCSVEKLIEICPAPDFPTGGEIHDLNGCANAHKTGEGKF
IIRACIDFKINDNKINQIIISSIPYETNKALIIKEIEDIIYNKEVAGLIEVRDESDAKGI
SIIIDTKKDINLENVKNYLYKKTNLEISYNTKFIAIVHRTPTLVNLSTYLDAQINHSLDV
INKVDLYDLNKILLRIEIVEGLIKCVDLIDEIIKIIRASESRQDAKNTLIQVFNFTNNQA
EAIIMMRLHNLTRTDIFDLKNEWQTLQDEAKTLQERINSLQVRKNYLKQKMIEFKKTFGF
ERKTKLFDELVKVEINEDQMIEKQNLNLVISRDGYIKTVSKKSFESSKYDELGLKTNDIL
FYHNIINSHDKILIITSKAKLINLVAHKITSMRWKDVGEHLNNYVKFDANEKVIAVYIWN
EQFKIDEYQLVLASRLNLIKRIELSELDINKNSKQISIMKLNDNDNLISANLIKKGHNQF
IIAISKLGLALLFLVHEINCLNRLAKGIKIMKLKPNDEVSAILITPNNGYNVQLFLERGS
KCFNISELKLSKRAATPTNLYPITKKVQNVLAAFLVAHENVFYLLDQQQKINPYYLSNPK
PTKLDTKISIYENDQMITDVVKDCFLSDEAISDFKKINMYANEFDNEMLKINKNHDDSQL
ELIDEEEEKK
>AQA08261.1|FEATURES|CARD|multidrug|mexf|antibiotic target alteration|0
MTKDLQKRTLFAVLALAIFLPVLFAGGLLLQIGIGLLAMLGVHELLHMKGLKTMTIEGAL
TLFATFALTVPLENYLTFLPVDGNVVAYSVLITIMLGTTVFSKNYTIEDAAFPIAVSFYV
GFGFNALLDARVAGFDKVLLALFIVWATDSAAYLTGMNFGKHKLAPRVSPNKSIEGFVGG
ILGAVLITVIFMLVDSTVALPYGIYRMSLFAAFFSVAGQFGDLIESAMKRHFGVKDSGKF
IPGHGGVLDRFDSMLIVFPMMHLFGLF
>EGP45233.1|FEATURES|CARD|multidrug|AxyZ|antibiotic efflux|0
MARKTKEESQRTRDRILDAAEHVFLSKGVASTTMSDIADFAGVSRGAVYGHYKNKIDVCI
AMCDRALGEAVSLTRVSTDGEALEALYASMRQYVQIYAEEGSVQRVLEILYLKCERSDEN
APLLRRRDLWERHALRTSEKLLRAAVSREDLPPALDVRLSNVYLHSLVEGVFGTICWSDR
LKGDIWPRVERMLRAAIDTLRLSPQLRLPQAA
>NP_217280.1|FEATURES|CARD|trimethoprim|dfrE|antibiotic target alteration|0
MTPYEDLLRFVLETGTPKSDRTGTGTRSLFGQQMRYDLSAGFPLLTTKKVHFKSVAYELL
WFLRGDSNIGWLHEHGVTIWDEWASDTGELGPIYGVQWRSWPAPSGEHIDQISAALDLLR
TDPDSRRIIVSAWNVGEIERMALPPCHAFFQFYVADGRLSCQLYQRSADLFLGVPFNIAS
YALLTHMMAAQAGLSVGEFIWTGGDCHIYDNHVEQVRLQLSREPRPYPKLLLADRDSIFE
YTYEDIVVKNYDPHPAIKAPVAV
>NP_216963.1|FEATURES|CARD|bacitracin|bacA|antibiotic target alteration|0
MNSTNSGPPDSGSATGVVPTPDEIASLLQVEHLLDQRWPETRIDPSLTRISALMDLLGSP
QRSYPSIHIAGTNGKTSVARMVDALVTALHRRTGRTTSPHLQSPVERISIDGKPISPAQY
VATYREIEPLVALIDQQSQASAGKGGPAMSKFEVLTAMAFAAFADAPVDVAVVEVGMGGR
WDATNVINAPVAVITPISIDHVDYLGADIAGIAGEKAGIITRAPDGSPDTVAVIGRQVPK
VMEVLLAESVRADASVAREDSEFAVLRRQIAVGGQVLQLQGLGGVYSDIYLPLHGEHQAH
NAVLALASVEAFFGAGAQRQLDGDAVRAGFAAVTSPGRLERMRSAPTVFIDAAHNPAGAS
ALAQTLAHEFDFRFLVGVLSVLGDKDVDGILAALEPVFDSVVVTHNGSPRALDVEALALA
AGERFGPDRVRTAENLRDAIDVATSLVDDAAADPDVAGDAFSRTGIVITGSVVTAGAART
LFGRDPQ
>NP_217187.1|FEATURES|CARD|beta_lactam|BN1047_01714|antibiotic target replacement|0
MPDSGQLGAADTPLRLLSSVHYLTDGELPQLYDYPDDGTWLRANFISSLDGGATVDGTSG
AMAGPGDRFVFNLLRELADVIVVGVGTVRIEGYSGVRMGVVQRQHRQARGQSEVPQLAIV
TRSGRLDRDMAVFTRTEMAPLVLTTTAVADDTRQRLAGLAEVIACSGDDPGTVDEAVLVS
QLAARGLRRILTEGGPTLLGTFVERDVLDELCLTIAPYVVGGLARRIVTGPGQVLTRMRC
AHVLTDDSGYLYTRYVKT
>NP_214855.1|FEATURES|CARD|isoniazid|iniB|antibiotic efflux|0
MTSLIDYILSLFRSEDAARSFVAAPGRAMTSAGLIDIAPHQISSVAANVVPGLNLGAGDP
MSGLRQAVAARHGFAQDVANVGFAGDAGAGVASVITTDVGAGLASGLGAGFLGQGGLALA
ASSGGFGGQVGLAAQVGLGFTAVIEAEVGAQVGAGLGIGTGLGAQAGMGFGGGVGLGLGG
QAGGVIGGSAAGAIGAGVGGRLGGNGQIGVAGQGAVGAGVGAGVGGQAGIASQIGVSAGG
GLGGVGNVSGLTGVSSNAVLASNASGQAGLIASEGAALNGAAMPHLSGPLAGVGVGGQAG
AAGGAGLGFGAVGHPTPQPAALGAAGVVAKTEAAAGVVGGVGGATAAGVGGAHGDILGHE
GAALGSVDTVNAGVTPVEHGLVLPSGPLIHGGTGGYGGMNPPVTDAPAPQVPARAQPMTT
AAEHTPAVTQPQHTPVEPPVHDKPPSHSVFDVGHEPPVTHTPPAPIELPSYGLFGLPGF
>CDJ72759|FEATURES|CARD|rifampin|rphB|antibiotic target alteration|0
MISGILASPGIAFGKALLLKEDEIVIDRKKISADQVDQEVERFLSGRAKASAQLETIKTK
AGETFGEEKEAIFEGHIMLLEDEELEQEIIALIKDKHMTADAAAHEVIEGQASALEELDD
EYLKERAADVRDIGKRLLRNILGLKIIDLSAIQDEVILVAADLTPSETAQLNLKKVLGFI
TDAGGRTSHTSIMARSLELPAIVGTGSVTSQVKNDDYLILDAVNNQVYVNPTNEVIDKMR
AVQEQVASEKAELAKLKDLPAITLDGHQVEVCANIGTVRDVEGAERNGAEGVGLYRTEFL
FMDRDALPTEEEQFAAYKAVAEACGSQAVIVRTMDIGGDKELPYMNFPKEENPFLGWRAI
RIAMDRREILRDQLRAILRASAFGKLRIMFPMIISVEEVRALRKEIEIYKQELRDEGKAF
DESIEIGVMVETPAAATIARHLAKEVDFFSIGTNDLTQYTLAVDRGNDMISHLYQPMSPS
VLNLIKQVIDASHAEGKWTGMCGELAGDERATLLLLGMGLDEFSMSAISIPRIKKIIRNT
NFEDAKVLAEQALAQPTTDELMTLVNKFIEEKTIC
>CAO82974.1|FEATURES|ARDB_deepARG|chloramphenicol|catQ|antibiotic inactivation|1
MKFNLIDIEDWNRKPYFEHYLNAVRCTYSMTANLEITSLLREIKLKGLKLYPTLIYIITT
VVNRHKEFRTSFDQNGKLGYWDSMNPSYTIFHKDNETFSSIWTEYDENFPRFYYNYLEDI
RNYSDVMNFMPKAGQPANTINVSSIPWVNFTGFNLNIYNDATYLIPIFTLGKYFQQDNKI
LLPMSVQVHHAVCDGYHTSRFFNEAQELASNFETWLGEK
>AAA26492.1|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|ErmE|antibiotic target alteration|1
MSSSDEQPRPRRRNQDRQHPNQNRPVLGRTERDRNRRQFGQNFLRDRKTIARIAETAELR
PDLPVLEAGPVEGLLTRELADRARQVTSYEIDPRLAKSLREKLSGHPNIEVVNADFLTAE
PPPEPFAFVGAIPYGITSAIVDWCLEAPTIETATMVTQLEFARKRTGDYGRWSRLTVMTW
PLFEWEFVEKVDSAIMRLRRRAEPLLEGAALERYESMVELCFTGVGGNIQASLLRKYPRR
RVEAAFDHAGVGGGAVVAYVRPEQWLRLFERLDQKNEPRGGQPQRGRRTGGRDHGDRRTG
GQDRGDRRTGGRDHRDRQASGHGDRRSSGRNRDDGRTGEREQGDQGGRRGPSGGGRTGGR
PGRRGGPGQR
>ACM47285.1|FEATURES|ARDB_deepARG|glycopeptide|vanYD|antibiotic target alteration|1
MWKGVKRNVERQNNNENQYGRNRRKDKRRKLFFYRAACAMLGLLIVSVIFGAVYFLRESK
DPALPSKENTKTSKDYSFLADVQSEDESPVSEPAISNRANTIDLNIIAANAIVVNKDTDA
VLYQKNGTDRIAPASTAKMITALTVLEYCSPEEEMRVGAEIEMIHSDSSTAWLMKGDTLT
VRQLLIALMLPSGNDAAYTLAVNTGKTIAGDNSLSNQQAIKIFMDKVNEKARELGVTDSN
FVVPDGYDAEGQYTTAYDLAIIAKACLENPIISEIVASNTSYEKWPNGREVTYNNSNELL
DPNSPYYRPEVIGLKTGTSSLGGACVVSAAVIDGETYICVAMGSTKESRFQDSVDILDKI
KAQ
>CAI29521.1|FEATURES|ARDB_deepARG|trimethoprim|dfrA15|antibiotic target replacement|1
MKLSLMAAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYA
VVTRSSFTSSDENVLVFPSIDEALNHLKTITDHVIVSGGGEIYKSLIDKADTLHISTIDI
EPEGDVYFPEIPGSFRPVFSKDFVSNINYSYQIWQKG
>AAA19915.1|FEATURES|ARDB_deepARG|aminoglycoside|AAC(3)-IIa|antibiotic inactivation|1
MHTRKAITEALQKLGVQTGDLLMVHASLKAIGPVEGGAETVVAALRSAVGPTGTVMGYAS
WDRSPYEETLNGARLDDEARRTWLPFDPATAGTYRGFGLLNQFLVQAPGARRSAHPDASM
VAVGPLAETLTEPHELGHALGEGSPVERFVRLGGKALLLGAPLNSVTALHYAEAVADIPN
KRWVTYEMPMLGRDGEVAWKTASDYDSNGILDCFAIEGKPDAVETIANAYVKLGRHREGV
VGFAQCYLFDAQDIVTFGVTYLEKHFGTTPIVPPHEAVEPSCEPSG
>AAL51021.1|FEATURES|ARDB_deepARG|aminoglycoside|ANT(3'')-Ii-AAC(6')-IId|antibiotic inactivation|1
MSNAVPAEISVQLSLALNAIERHLESTLLAVHLYGSALDGGLKPYSDIDLLVTVAAQLDE
TVRQALVVDLLEISASPGQSEALRALEVTIVVHGDVVPWRYPARRELQFGEWQRKDILAG
IFEPATTDVDLAILLTKVRQHSLALAGSAAEDFFNPVPEGDLFKALSDTLKLWNSQPDWE
GDERNVVLTLSRIWYSAATGKIAPKDIVANWAIERLPDQHKPVLLEARQAYLGRGEDCLA
SRADQLAAFVHFVKHEATKLLGAMPVMSKTKLGITKYSIVTNSNDSVTLRLMTEHDLAML
YEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVAL
GSGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPS
NLRAIRCYEKAGFEKQGTVTTPDGPAVYMVQTRQAFERTRSDA
>AAB03644.1|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|mphA|antibiotic inactivation|1
MTVVTTADTSQLYALAARHGLKLHGPLTVNELGLDYRIVIATVDDGRRWVLRIPRRAEVS
AKVEPEARVLAMLKNRLPFAVPDWRVANAELVAYPMLEDSTAMVIQPGSSTPDWVVPQDS
EVFAESFATALAALHAVPISAAVDAGMLIRTPTQARQKVADDVDRVRRQFVVNDKRLHRW
QRWLDDDSSWPDFSVVVHGDLYVGHVLIDNTERVSGMIDWSEARVDDPAIDMAAHLMVFG
EEGLAKLLLTYEAAGGRVWPRLAHHIAERLAFGAVTYALFALDSGNEEYLAAAKAQLPQR
NERTSI
>BAA07922.1|FEATURES|ARDB_deepARG|beta_lactam|ACT-17|antibiotic inactivation|1
MMKKSLCCALLLGISCSALATPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRAVRVSPGMLD
AQAYGVKTNVQDMANWVMANMAPENVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWP
VEANTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIV
MLANTSYPNPARVEAAYHILEALQ
>CAE53427.1|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MIQSINHICFSVANLEKAIEFYQNILQAKLLVKGRKLAYFDLNGLWIALNVEESIPRNEI
QYSYTHIAFTVTNNEFDSLKEILIQNQVNILPGRERDDRDKRSIYFTDPDGHKFEFHTGT
LQDRLQYYKEDKKYMTFY
>AAF27725.1|FEATURES|ARDB_deepARG|trimethoprim|dfrA15|antibiotic target replacement|1
MKLSLMAAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYA
VVTRSSFTSSDENVLVFPSIDEALNHLKTITDHVIVSGGGEIYKSLIDKADTLHISTIDI
EPEGDVYFPEIPGSFRPVFSQDFVSNINYSYQIWQKG
>AAC32186.1|FEATURES|ARDB_deepARG|trimethoprim|dfrA16|antibiotic target replacement|1
MKLSLMAAKSKNGIIGNGPDIPWSAKGQQLLFRAIIYNQWLLVGRKTFESMGALPNRKYA
VVTRSNFSTNDEGVMVFSSIQDALINLEEITDHVIVSGGGEIYKSLISKVDTLHISTVDI
ERDGDIVFPEIPDTFKLVFEQDFESNINYCYQIWQKS
>AAL92527.1|FEATURES|ARDB_deepARG|tetracycline|tetL|antibiotic efflux|1
MNTSYSQSNLRHNQILIWLCILSFFSVLNEMVLNVSLPDIANDFNKPPASTNWVNTAFML
TFSIGTAVYGKLSDQLGIKRLLLFGIIINCFGSLIGFVGHSFFSLLIMARFIQGAGAAAF
PALVMVVVARYIPKENRGKAFGLIGSIVAMGEGVGPAIGGMIAHYIHWSYLLLIPMITII
TVPFLMKLLKKEVRIKGHFDIKGIILMSVGIVFFMLFTTSYSISFLIVSVLSFLIFVKHI
RKVTDPFVDPGLGKNIPFMIGVLCGGIIFGTVAGFVSMVPYMMKDVHQLSTAEIGSVIIF
PGTMSVIIFGYIGGILVDRRGPLYVLNIGVTFLSVSFLTASFLLETTSWFMTIIIVFVLG
GLSFTKTVISTIVSSSLKQQEAGAGMSLLNFTSFLSEGTGIAIVGGLLSIPLLDQRLLPM
EVDQSTYLYSNLLLLFSGIIVISWLVTLNVYKHSQRDF
>AAB59094.1|FEATURES|ARDB_deepARG|tetracycline|tetA|antibiotic efflux|1
MNSSTKIALVITLLDAMGIGLIMPVLPTLLREFIASEDIANHFGVLLALYALMQVIFAPW
LGKMSDRFGRRPVLLLSLIGASLDYLLLAFSSALWMLYLGRLLSGITGATGAVAASVIAD
TTSASQRVKWFGWLGASFGLGLIAGPIIGGFAGEISPHSPFFIAALLNIVTFLVVMFWFR
ETKNTRDNTDTEVGVETQSNSVYITLFKTMPILLIIYFSAQLIGQIPATVWVLFTENRFG
WNSMMVGFSLAGLGLLHSVFQAFVAGRIATKWGEKTAVLLEFIADSSAFAFLAFISEGWL
DFPVLILLAGGGIALPALQGVMSIQTKSHEQGALQGLLVSLTNATGVIGPLLFTVIYNHS
LPIWDGWIWIIGLAFYCIIILLSMTFMLTPQAQGSKQETSA
>ABD49191.1|FEATURES|ARDB_deepARG|trimethoprim|dfrA14|antibiotic target replacement|1
MRTLKVSLMAAKAKNGVIGCGPDIPWSAKGEQLLFKALTYNQWLLVGRKTFESMGALPNR
KYAVVTRSGWTSNDDNVVVFQSIEEAMDRLAEFTGHVIVSGGGEIYRETLPMASTLHLST
IDIEPEGDVFFPSIPNTFEVVFEQHFTSNINYCYQIWKKG
>BAE96115.1|FEATURES|ARDB_deepARG|glycopeptide|vanYD|antibiotic target alteration|1
MERQNNNENQYGRNRRKDKRKKLFFYRAACAMLGLLIVCVIFGAVYFLRESKDPVLPSKE
NTKTGKDYSFLADGQSEDESPISEPAISNRANAIDLNIIAANAIVMNKDTDALLYQKNGT
DRIAPASTAKMITALTVLEYCSPEEEMRVGAEIEMIHSDSSTAWLMKGDTLTVRQLLIAL
MLPSGNDAAYTLAVNTGKVIAGDNSLSNQQAIQIFMDKVNEKARAIGVTDSNFVVPDGYD
AEGQYTTAYDLAIIAKACLEDPIISEIVASNTSYEKWPNGREVTYNNSNELLDPNSPYYR
PEVIGLKTGTSSLGGACVVSAAVIDGETYICVVMGSTKESRFQDSVAILDKIKAQ
>AAF72358.1|FEATURES|ARDB_deepARG|glycopeptide|vanRB|antibiotic target alteration|1
MSIRILLVEDDDHICNTVRGFLAEAGYQVDACTDGNEAYTKFYENTYQLVILDIMLPGMN
GHELLREFRAKNDTPILMMTALSDDENQIRAFDAEADDYVTKPFKMQILLKRVEALLRRS
GALAKEIRVGRLTLLPEDFTVLCDGTELPLTRKEFEILLLLVQNKGRTLTHEIILSRIWG
YDFEGDGSTVHTHIKNLRAKLPENIIKTIRGVGYRLEESL
>AAK58493.1|FEATURES|ARDB_deepARG|glycopeptide|VanSC3|antibiotic target alteration|1
MLIIIPFAVRFVAGMRVWYGYEPIYQILRLFADYWLLCLAIGALLIWVSTTIYYMSKAIS
YLNETIQATNQLIAEPTKRIVLSSNMIDVQEEMNQLREKNLQDQRAAKEAEQRKNDLIVY
LAHDLRTPLTSVIGYLTLLEEEPQLSTELRARYTKIALQKAQRLELLISEFFEITRFNLT
TIALQTETTDLSLMLEQLTFEFLPLLEEKNLHWQLQLQKKVFATVDTEKMERVFDNLIRN
AINYSYPNSPLRLAISESDDILIRLTNQGKTIPAEKIGLIFEPFYRMDASRATATGGTGL
GLPIAKEIVEALGGKIWAESRDETIVFSIRLPKAAMEKNEQLSKPHPSEPTA
>P20074.1|FEATURES|ARDB_deepARG|chloramphenicol|catA5|antibiotic inactivation|1
MDAPIPTPAPIDLDTWPRRQHFDHYRRRVPCTYAMTVEVDVTAFAAALRRSPRKSYLAQV
WALATVVNRHEEFRMCLNSSGDPAVWPVVHPAFTVFNPERETFACLWAPYDPDFGTFHDT
AAPLLAEHSRATDFFPQGNPPPNAFDVSSLPWVSFTGFTLDIRDGWDHLAPIFTLGRYTE
RDTRLLLPLSVQIHHAAADGFHTARLTNELQTLLADPAWL
>AAB51122.1|FEATURES|ARDB_deepARG|tetracycline|tetQ|antibiotic target protection|1
MRFDNASIVVYYCLIQMNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITD
SMDIEKRRGITVRASTTSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEG
IQAQTKLLFNTLQKLQIPTIIFINKIDRDGVNLERLYLDIKTNLSQDVLFMQTVVDGLVY
PICSQTYIKEEYKEFVCNHDDNILERYLADSEISPADYWNTIIDLVAKAKVYPVLHGSAM
FNIGINELLDAISSFILPPESVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDIVRI
NDSEKFIKIKNLKTIYQGRKINVDEVGANDIAIVEDMEDFRIGDYLGTKPCLIQGLSHQH
PALKSSVRPDRSEERSKVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLL
EERFSVKVHFDEIKTIYKERPVKKVNKIIQIEVPPNPYWATIGLTLEPLPLGTGLQIESD
ISYGYLNHSFQNAVFEGIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYV
FRLALQQSGVDILEPMLYFELQIPQAASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPY
NTSKDYASEVSSYTKGLGVFMVKPCGYQITKGDYSDNIRMNEKDKILFMFQKSNVIKIME
RSGNFYKAIQ
>BAH18719.1|FEATURES|ARDB_deepARG|aminoglycoside|AAC(6')-Ie-APH(2'')-Ia|antibiotic inactivation|1
MNIVENEICIRTLIDDDFPLMLKWLTDERVLEFYGGRDKKYTLESLKKHYTEPWEDEVFR
VIIEYNNVPIGYGQIYKMYDELYTDYHYPKTDEIVYGMDQFIGEPNYWSKGIGTRYIKLI
FEFLKKERNANAVILDPHKNNPRAIRAYQKSGFRIIEDLPEHELHEGKKEDCYLMEYRYD
DNATNVKAMKYLIEHYFDNFKVDSIEIIGSGYDSVAYLVNNEYIFKTKFSTNKKKGYAKE
KAIYNFLNTNLETNVKIPNIEYSYISDELSILGYKEIKGTFLTPEIYSTMSEEEQNLLKR
DIASFLRQMHGLDYTDISECTIDNKQNVLEEYILLRETIYNDLTDIEKDYIESFMERLNA
TTVFEGKKCLCHNDFSCNHLLLDGNNRLTGIIDFGDSGIIDEYCDFIYLLEDSEEEIGTN
FGEDILRMYGNIDIEKAKEYQDIVEEYYPIETIVYGIKNIKQEFIENGRKEIYKRTYRGP
ERLREICIDKK
>AAD42182.1|FEATURES|ARDB_deepARG|glycopeptide|VanYD|antibiotic target alteration|1
MMEYQNNNGNYDKRNRRKAKKRKLLFYRAACVTLCLLIVSVIFGVVHFLGESKDPGLLSK
ENTKTDKNYSWLTDDQNEAVPSVPEPAISDQANKISVNITAANAIVMNKDTNEVLYQKKS
TAKIAPASTAKMIMALTALDYCSPEDEMKVGAEIGMIQSDSSTAWLMKGDTLTVRQLLIA
LMLPSGNDAAYTLAVNTGKAIAGDNSLTSQQAIEVFMDKVNEKAVALGATNSKFVAPDGY
DAEGQYTTAYDLAIIAKACLDNPIISEIVASYSSYEKWSNGREVTYNNSNELLDPNSPYY
RPEVIGLKTGTSSLGGACIVSAAVMDGETYICVVMGSTKESRFQDSVDILDKIKAQ
>CAD60196.1|FEATURES|ARDB_deepARG|aminoglycoside|AAC(6')-Ie-APH(2'')-Ia|antibiotic inactivation|1
MNIVENEICIRTLIDDDFPLMLKWLTDERVLEFYGGRDKKYTLESLKKHYTEPWEDEVFR
VIIEYNNVPIGYGQIYKMYDELYTDYHYPKTDEIVYGMDQFIGEPNYWSKGIGTRYIKLI
FEFLKKERNANAVILDPHKNNPRAIRAYQKSGFRIIEDLPEHELHEGKKEDCYLMEYRYD
DIATNVKAMKYLIEHYFDNFKVDSIEIIGSGYDSVAYLVNNEYIFKTKFSTNKKKGYAKE
KAIYNFLNTNLETNVKIPNIEYSYISDELSILGYKEIKGTFLTPEIYSTMSEEEQNLLKR
DIASFLRQMHGLDYTDISECTIDNKQNVLEEYILLRETIYNDLTDIEKDYIESFMERLNA
TTVFEGKKCLCHNDFSCNHLLLDGNNRLTGIIDFGDSGIIDEYCDFIYLLEDSEEEIGTN
FGEDILRMYGNIDIEKAKEYQDIVEEYYPIETIVYGIKNIKQEFIENGRKEIYKRTYKD
>AFG73660.1|FEATURES|megares|aminoglycoside|AAC(6')-Ib9|antibiotic inactivation|1
MTEHDLSMLHEWLNRPHIVEWWGGEDERPTLDEVYEHYLPRVLAQESVTPYIAMLGNEPI
GYAQSYVALGSGDGWWEEETDPGVRGIDQSLANPTKLNKGLGTKLVRALADLLFSDASVT
KIQTDPAPGNHRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSDA
>NP_274611.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MNTQAHAPHTDSNTLMLGRYAERAYLEYAMSVVKGRALPEVSDGQKPVQRRILFAMRDMG
LTAGAKPVKSARVVGEILGKYHPHGDSSAYEAMVRMAQDFTLRYPLIDGIGNFGSRDGDG
AAAMRYTEARLTPIAELLLSEINQGTVDFVPNYDGAFDEPLHLPARLPMVLLNGASGIAV
GMATEIPPHNLNEVTQAAIALLKKPTLETADLMQYIPAPDFAGGGQIITPADELRRIYET
GKGSVRVRARYEIEKLARGQWRVIVTELPPNANSAKILAEIEEQTNPKPKAGKKQLNQDQ
LNTKKLMLDLIDRVRDESDGEHPVRLVFEPKSSRIDTDTFINTLMAQTSLEGNVSMNLVM
MGLDNRPAQKNLKTILQEWLDFRTVTVTRRLKFRLNQVEKRLHILEGRLKVFLHIDEVIK
VIRESDDPKADLMAAFGLTEIQAEDILEIRLRQLARLEGFKLEKELNELREEQGRLNILL
SDENEKRKLIVKEMQADMKQYGDARRTLVEEAGRAVLTQTTADEPITLILSEKGWIRSRA
GHNLDLSQTAFKEGDCLKQTLEGRTVLPVVILDSSGRTYTLDAAEIPGGRGDGVPVSSLI
ELQNGAKPVAMLTGLPEQHYLLSSSSGYGFITKLGDMVGRVKAGKVVMTADSGETVLPPV
AVYASSFINPDCKIIAATSQNRALAFPIGELKIMAKGKGLQIIGLNAGESMTHTAVSSEL
EILIESEGRRGAAHKDRIPISLLEAKRGKKGRLLPISGSLKQLSSPK
>AFO09969.1|FEATURES|megares|beta_lactam|OXA-184|antibiotic inactivation|1
MKKILLLFSLFYSFALANDKLKDFFKDYNTSGVFITFDGKHYASNNFKRAKEPFSPASTF
KIFNALIALDNGVVKDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIG
LKTMQESLNKLSYGNTKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVK
KIILFKEDKIQKIYAKTGFNDGINLAWIVGFIESKNKILSFALNVDIKNIKNIKIREELL
EKYIYSLN
>CAA31895.1|FEATURES|megares|aminoglycoside|AAC(3)-IIa|antibiotic inactivation|1
MHTQKAITEALQKLGVQSGDLLMVHASLKSIGPVEGGAETVVAALRSAVGPTGTVMGYAS
WDRSPYEETLNGARLDDNARRTWPPFDPATAGTYRGFGLLNQFLVQAPGARRSAHPDASM
VAVGPLAETLTEPHELGHALGEGSPNERFVRLGGKALLLGAPLNSVTALHYAEAVADIPN
KRWVTYEMPMPGRDGEVAWKTASDYDSNGILDCFAIEGKQDAVETIANAYVKLGRHREGV
VGFAQCYLFDAQDIVTFGVTYLEKHFGTTPIVPAHEAIERSCEPSG
>AAK44921.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MSLSFSDPRFDDVKAPVDECKDKDMTYAAPLFVTAEFINNNTGEIKSQTVFMGDFPMMTE
KGTFIINGTERVVVSQLVRSPGVYFDETIDKSTDKTLHSVKVIPSRGAWLEFDVDKRDTV
GVRIDRKRRQPVTVLLKALGWTSEQIVERFGFSEIMRSTLEKDNTVGTDEALLDIYRKLR
PGEPPTKESAQTLLENLFFKEKRYDLARVGRYKVNKKLGLHVGEPITSSTLTEEDVVATI
EYLVRLHEGQTTMTVPGGVEVPVETDDIDHFGNRRLRTVGELIQNQIRVGMSRMERVVRE
RMTTQDVEAITPQTLINIRPVVAAIKEFFGTSQLSQFMDQNNPLSGLTHKRRLSALGPGG
LSRERAGLEVRDVHPSHYGRMCPIETPEGPNIGLIGSLSVYARVNPFGFIETPYRKVVDG
VVSDEIVYLTADEEDRHVVAQANSPIDADGRFVEPRVLVRRKAGEVEYVPSSEVDYMDVS
PRQMVSVATAMIPFLEHDDANRALMGANMQRQAVPLVRSEAPLVGTGMELRAAIDAGDVV
VAEESGVIEEVSADYITVMHDNGTRRTYRMRKFARSNHGTCANQCPIVDAGDRVEAGQVI
ADGPCTDDGEMALGKNLLVAIMPWEGHNYEDAIILSNRLVEEDVLTSIHIEEHEIDARDT
KLGAEEITRDIPNISDEVLADLDERGIVRIGAEVRDGDILVGKVTPKGETELTPEERLLR
AIFGEKAREVRDTSLKVPHGESGKVIGIRVFSREDEDELPAGVNELVRVYVAQKRKISDG
DKLAGRHGNKGVIGKILPVEDMPFLADGTPVDIILNTHGVPRRMNIGQILETHLGWCAHS
GWKVDAAKGVPDWAARLPDELLEAQPNAIVSTPVFDGAQEAELQGLLSCTLPNRDGDVLV
DADGKAMLFDGRSGEPFPYPVTVGYMYIMKLHHLVDDKIHARSTGPYSMITQQPLGGKAQ
FGGQRFGEMECWAMQAYGAAYTLQELLTIKSDDTVGRVKVYEAIVKGENIPEPGIPESFK
VLLKELQSLCLNVEVLSSDGAAIELREGEDEDLERAAANLGINLSRNESASVEDLA
>AAC45607.1|FEATURES|megares|macrolide-lincosamide-streptogramin|ErmB|antibiotic target alteration|1
MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGNIPYHLSTQIIKKVVFESRAS
DIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTT
DVPDKYWKLYKYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTITYEQVLSIFNSYLL
FNGRKQLPIF
>AAL78279.1|FEATURES|megares|beta_lactam|OXY-1-2|antibiotic inactivation|1
MLKSSWRKTALMAAAAVPLLLASGSLWASADAIQQKLADLEKRSGGRLGVALINTADDSQ
TLYRGDERFAMCSTGKVMAAAAVLKQSESNPEVVNKRLEIKKSDLVVWSPITEKHLQSGM
TLAELSAAALQYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDK
RDTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWVVGDKTGG
GDYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEG
>ADU82030.1|FEATURES|megares|elfamycin|tufab|antibiotic target alteration|0
MAKEKFNRTKPHVNIGTIGHVDHGKTTLSAAISAVLSLKGLAEMKDYDNIDNAPEEKERG
ITIATSHIEYETENRHYAHVDCPGHADYVKNMITGAAQMDGAILVVSAADGPMPQTREHI
LLSRQVGVPHIVVFLNKQDMVDDQELLELVEMEVRELLSAYEFPGDDTPIVAGSALRALE
EAKAGNVGEWGEKVLKLMAEVDSYIPTPERDTEKTFLMPVEDVFSIAGRGTVVTGRIERG
VVKVGDEVEIVGIRATQKTTVTGVEMFRKELEKGEAGDNVGVLLRGTKKEEVERGMVLCK
PGSITPHKKFEGEIYVLSKEEGGRHTPFFTNYRPQFYVRTTDVTGSITLPEGVEMVMPGD
NVKITVELISPVALELGTKFAIREGGRTVGAGVVSNIIE
>AAK21276.1|FEATURES|megares|multidrug|omp36|reduced permeability to antibiotic|0
MKVKVLSLLVPALLVAGAANAAEIYNKDGNKLDLYGKIDGLHYFSSDDSVDGDQTYMRIG
VKGETQINDQLTGYGQWEYNVQANNTESSSDQAWTRLAFAGLKFGDAGSFDYGRNYGVVY
DVTSWTDVLPEFGGDTYGSDNFLQSRANGVATYRNSDFFGLVDGLNFALQYQGKNGSVSG
EDQTNNGRGFQKQNGEGFGTSVTYEIWDGISAGFAYSSSKRTDEQNNSTYFSKSYQRTYG
VLGEGDHAETYTGGLKYDANNIYLATQYTQTYNATRTGDIGFANKAQNFEVVAQYQFDFG
LRPSVAYLQSKGKDMGRYGDQDILKYVDLGATYYFNKNMSTYVDYKINLLDDNKFTKDAS
ISTDNVVALGLVYQF
>AAB05462.1|FEATURES|megares|sulfonamide|sul2|antibiotic target replacement|1
MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVS
SDTEIARIAPVLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDTAFYPQLAK
SSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFF
LGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAAA
GGADFIRTHEPRPLRDGLAVLAALKETARIR
>AVN57400.1|FEATURES|megares|tetracycline|tetA|antibiotic efflux|1
MPVLPGLLRDLVHSNDVTAHYGILLALYALMQFACAPVLGALSDRFGRRPVLLVSLAGAA
VDYAIMATAPFLWVLYIGRIVAGITGATGAVAGAYIADITDGDERARHFGFMSACFGFGM
VAGPVLGGLMGGFSPHAPFFAAAALNGLNFLTGCFLLPESHKGERRPLRREALNPLASFR
WARGMTVVAALMAVFFIMQLVGQVPAALWVIFGEDRFHWDATTIGISLAAFGILHSLAQA
MITGPVAARLGERRALMLGMIADGTGYILLAFATRGWMAFPIMVLLASGGIGMPALQAML
SRQVDEERQGQLQGSLAALTSLTSIVGPLLFTAIYAASITTWNGWAWIAGAALYLLCLPA
LRRGLWSGAGQRADR
>CAA50581.1|FEATURES|megares|chloramphenicol|ND00_04320|antibiotic inactivation|1
MFREMRRKRQLLPPEESLAILERMTGGTLALHGDNGYPYAVPVSYVYADGKIYFHGAVQG
HKMDAIRQHPEVSFCVVEQDRIVPAEFTTYFRSVIVFGKARILTDEVEKRAALLRLAEKY
SSGESGMQDEIDKGFDHLVMVEITVEHMTGKEAIQLVRRKGNNRWDAFPSKDVFIR
>ACO83422.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MLNEGKILPVDVSKEMKKCYIDYAMSVIAGRALPDVRDGLKPVHRRIIYSMQGLGLAPEK
GYRKCARIVGDVLGKYHPHGDTAVYEALVRMAQNFSIRYTLVDGHGNFGSVDGDGAAAMR
YTEAKMSKISMELIKDINKNTVDFIPNFDGEEEEPSVLPSRFPNLLVNGSSGIAVGMATN
IPPHNLTEVIDGIIMLIENEDVNILDLMTKIKGPDFPTSGLIVGTRGIREAYETGRGKVI
IRAKAEIEEEKGKNKIIVTEIPYQVNKARLIENMANLVKDKKINGISDLRDESDRDGMRI
VIELKRDANPNIVLNQLYKHTKLQDTFGIIMLALVNNQPQILNLKEILVNYVEFQKEVIR
RRTRFDLDKALARAHILEGLRIALDHIDEVIKLIRASKNTAEAKEGLMNNFNLSEKQAQA
ILDMKLQRLTGLEREKIEEEYKELMEKISYFREILDKEELVLSIIKEELIEIKNKYGDER
KTEIVKGEHDIDIEDLIEDKKVIVTLTHGGYIKRLDMDTYSSQKRGGKGIQATSTKQDDF
IENMFVTSTHSTILFFTNRGKVYKLKAYEIPEAGRTAKGTNIVNLIPIENNEKIQTVIGL
KDIDDMKHFVMCTRNGIIKKTEISKYSSIRKGGLNAINLREDDELIDVKMTKGNDEIIVV
TQNGYCIRFNEEDVRPMGRVATGVKAITLRKTDKAVSMDVVIEDETLLSISENGFGKRTD
IEEYPIHRRGGKGVITYKITDKTGPIVGARFVKEDDELMLVNSGDVAIRINVSEISKTSR
NAMGVKLMRTSEEEKIVAIAKIKSEDIIEEEILNEENLNEENLNEENLNEENLNEENLNE
ENLNEE
>AAY52010.1|FEATURES|megares|glycopeptide|VanSA|antibiotic target alteration|1
MAIKLKNKNKNKKTDYSKLKRKLYQYIVVIVMAAAVFVLFLRLFIKGTLGEWIVRFLENS
YHLERQDAMIIYQYTIRNNIEIFIYVAIAISILILCRVMLSKFAKYFDEINTGIDILIQN
EDKQIELSAEMEFMEQKLNTLKRTLEKREQDAKLAEQRKNDVVMYLAHDIKTPLTSVIGY
LSLLDEAPDMPVEQKAKYVHITLDKAYRLEQLIDEFFEITRYNLQTITLTKKHIDLYYML
VQMADEFYPQLAANGKQAVIHASEDLTVTGDSDKLARVFNNILKNAAAYSEDNSVIDITA
GLSGDVVSIVFKNAGSIPKDKLAAIFEKFYRLDDARSSDTGGAGLGLAIAKGIIVQHGGQ
IYAESNDNYTTFTVELPALPDLVDKRSS
>AFK60290.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MKSLAGHVVKYGKHRERRSFARISEVLELPNLIEIQTDSYQWFLDEGLREMFEDILPIDD
FNGNLSLEFVDYELKEPKYTVAEARAHDANYSAPLHVTLRLTNRETGEIKAQEVFFGDFP
LMTEQGTFIINGAERVIVSQLVRSPGVYFHGKVDKNGKEGFGSTVIPNRGAWLEMETDAK
DISYVRIDRTRKIPLTVLVRALGFGSDDTIFEIFGDSETLRNTVEKDLHKNASDSRTEEG
LKDVYERLRPGEPKTADSSRNLLNARFFDPKRYDLANVGRYKVNKKLDLKTRLLNLTLAE
TLVDPETGEIIVEKGTVLTHQVMETLAPFIDNGLNSVTYYPSEDGVVTDPMTVQVIKVFS
PRDPEREVNVIGNGYPEAAVKTVRPADIIASMSYFLNLMEGIGNVDDIDHLGNRRIRSVG
ELLQNQFRIGLARMERVVRERMSIQDTETLTPQQLINIRPVVASIKEFFGSSQLSQFMDQ
TNPLGELTHKRRLSALGPGGLTRDRAGYEVRDVHYSHYGRMCPIETPEGPNIGLINSLSS
YAKVNKFGFIETPYRRVDRETGRVTDQIDYLTADIEDHYIVAQANSPLNEDGTFAQDVVM
ARAQSENLEVSIDKVDYMDVSPKQVVAVATACIPFLENDDSNRALMGANMQRQAVPLINP
QAPWVGTGMEYKSAHDSGAALLCKHDGVVEYVDASEIRVRRDNGALDKYDVTKFRRSNSG
TSYNQRPIVHLGEKVEKGDTLADGPSMEQGEMALGQNVLVGFMTWEGYNYEDAIIMSRRL
VKDDVYTSIHIEEYESEARDTKLGPEEITREIPNVGEDALKDLDEMGIIRIGAEVQDGDL
LVGKVTPKGVTELSAEERLLHAIFGEKAREVRDTSLRVPHGGGGIVHDVKIFTREAGDEL
SPGVNMLVRVYIVQKRKIHEGDKMAGRHGNKGVVSRIMPEEDMPFLPDGTPIDIMLNPLG
VPSRMNIGQVLELHLGMAARQLGIHVATPVFDGASDEDVWETVREAGMASDAKTVLYDGR
TGEPFDGRVSVGVMYMIKLAHMVDDKLHARSIGPYSLVTQQPLGGKAQFGGQRFGEMEVW
ALEAYGAAYTLQEILTYKSDDVVGRVKTYEAIVKGEPIPKPGVPESFRVLVKELQSLGLD
MRVLDIEETEIELRDMDDEDDDLITVDALTKFAEQQTAKELEKKAAEQVEDEKDDVIQNF
ETAEDNLD
>ABX45066.1|FEATURES|megares|beta_lactam|OXA-82|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWQVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>BAB47622.1|FEATURES|megares|beta_lactam|mecC|antibiotic target replacement|1
MKKIKIVPLILIVVVVGFGIYFYASKDKEINNTIDAIEDKNFKQVYKDSSYISKSDNGEV
EMTERPIKIYNSLGVKDINIQDRKIKKVSKNKKRVDAQYKIKTNYGNIDRNVQFNFVKED
GMWKLDWDHSVIIPGMQKDQSIHIENLKSERGKILDRNNVELANTGTAYEIGIVPKNVSK
KDYKAIAKELSISEDYIKQQMDQKWVQDDTFVPLKTVKKMDEYLSDFAKKFHLTTNETES
RNYPLEKATSHLLGYVGPINSEELKQKEYKGYKDDAVIGKKGLEKLYDKKLQHEDGYRVT
IVDDNSNTIAHTLIEKKKKDGKDIQLTIDAKVQKSIYNNMKNDYGSGTAIHPQTGELLAL
VSTPSYDVYPFMYGMSNEEYNKLTEDKKEPLLNKFQITTSPGSTQKILTAMIGLNNKTLD
DKTSYKIDGKGWQKDKSWGGYNVTRYEVVNGNIDLKQAIESSDNIFFARVALELGSKKFE
KGMKKLGVGEDIPSDYPFYNAQISNKNLDNEILLADSGYGQGEILINPVQILSIYSALEN
NGNINAPHLLKDTKNKVWKKNIISKENINLLTDGMQQVVNKTHKEDIYRSYANLIGKSGT
AELKMKQGETGRQIGWFISYDKDNPNMMMAINVKDVQDKGMASYNAKISGKVYDELYENG
NKKYDIDE
>WP_000918667.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MAGQVVQYGRHRKRRNYARISEVLELPNLIEIQTKSYEWFLREGLIEMFRDISPIEDFTG
NLSLEFVDYRLGEPKYDLEESKNRDATYAAPLRVKVRLIIKETGEVKEQEVFMGDFPLMT
DTGTFVINGAERVIVSQLVRSPSVYFNEKIDKNGRENYDATIIPNRGAWLEYETDAKDVV
YVRIDRTRKLPLTVLLRALGFSSDQEIVDLLGDNEYLRNTLEKDGTENTEQALLEIYERL
RPGEPPTVENAKSLLYSRFFDPKRYDLASVGRYKTNKKLHLKHRLFNQKLAEPIVNTETG
EIVVEEGTVLDRRKIDEIMDVLESNANSEVFELHGSVIDEPVEIQSIKVYVPNDDEGRTT
TVIGNAFPDSEVKCITPADIIASMSYFFNLLSGIGYTDDIDHLGNRRLRSVGELLQNQFR
IGLSRMERVVRERMSIQDTESITPQQLINIRPVIASIKEFFGSSQLSQFMDQANPLAELT
HKRRLSALGPGGLTRERAQMEVRDVHYSHYGRMCPIETPEGPNIGLINSLSSYARVNEFG
FIETPYRKVDLDTHAITDQIDYLTADEEDSYVVAQANSKLDENGRFMDDEVVCRFRGNNT
VMAKEKMDYMDVSPKQVVSAATACIPFLENDDSNRALMGANMQRQAVPLMNPEAPFVGTG
MEHVAARDSGAAITAKHRGRVEHVESNEILVRRLVEENGVEHEGELDRYPLAKFKRSNSG
TCYNQRPIVAVGDVVEYNEILADGPSMELGEMALGRNVVVGFMTWDGYNYEDAVIMSERL
VKDDVYTSIHIEEYESEARDTKLGPEEITRDIPNVSESALKNLDDRGIVYIGAEVKDGDI
LVGKVTPKGVTELTAEERLLHAIFGEKAREVRDTSLRVPHGAGGIVLDVKVFNREEGDDT
LSPGVNQLVRVYIVQKRKIHVGDKMCGRHGNKGVISKIVPEEDMPYLPDGRPIDIMLNPL
GVPSRMNIGQVLELHLGMAAKNLGIHVASPVFDGANDDDVWSTIEEAGMARDGKTVLYDG
RTGEPFDNRISVGVMYMLKLAHMVDDKLHARSTGPYSLVTQQPLGGKAQFGGQRFGEMEV
WALEAYGAAYTLQEILTYKSDDTVGRVKTYEAIVKGENISRPSVPESFRVLMKELQSLGL
DVKVMDEQDNEIEMTDVDDDDVVERKVDLQQNDAPETQKEVTD
>ABS18770.1|FEATURES|megares|sulfonamide|sul1|antibiotic target replacement|1
MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPAD
EIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADC
RLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFL
SPAPETSLHVLSNLQKLKSALGLPLNVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGN
GADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA
>CAH17152.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MKKIPNMNEVTEKKPLTEFTEKAYLDYSMYVILDRALPSIADGLKPVQRRIVYAMSELGL
KATAKYKKSARTVGDVLGKFHPHGDSACYEAMVLMAQPFSYRYPFVDGQGNWGSPDDPKS
FAAMRYTEARLSHYADVLLGELLQGTVDWVDNFDGTLQEPALLPARLPNILLNGATGIAV
GMASDILPHNLTEVANACIHLLDNPQADIKTICEYIKGPDFPTEAEIISPSETIRAMYES
GNGSIKMRAIYTQEKQNIVITALPYQVSGARVMEQIALQMQQKKLPMVEDLRDESDHEHP
TRLVIIPRSNRVDIESLMSHLFATTDLERSYRVNFNMIGLDGKPRVKGLLAILTEWLEFR
LATVKRRLQFRLEKVLERIHILEGLLIAYLNIDEVIAIIREHEQPKQGLISRFNLTERQA
EAILEMKLRHLAKLEEIKLRGELDELSDERDTLQKTLASHFLLKELVKEEITKDRDEFGD
PRRSPIITREDSQALKEEDILPNEPITVVLSKNGWVRAAKGHDVDGKELSYKAGDEFKAQ
TLARTNQQVLFFDGEGKVYSLPGHVLPSARGQGEPLTGKLNPAEGVLFEAIVGGEPEQKV
LLATDSGYGFIAKIEDLYVKNRNGKACIKLSEKSHILPPRLIPNREQLFVACATNVGRLL
IFSLEELPELSRGKGNKLISIPAAKAVSREEYIVDIQVLTTNDSLTVHAGKRHFTLKGED
LTHYKGERGRRGNRLPRGLQNVSQLHVTQSE
>NP_274686.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MAKNNQYSESSITVLKGLEPVKERPGMYTRTDSPTHICQEVIDNASDEALGGFATAIDVQ
IHEDGSLSVHDNGRGIPVGLHPEEGVSVVELVFTRLHAGGKFNKKDGGSAYAFSGGLHGV
GVSVTNALSTRLEVTVKREGKIHRIVFAGGDVVEPLAQVGKCAVKDSGTEVRVWPDGKYF
ESPNYSIPELERLLRAKAVLLPGVRVSLTRPVKGEDEAHTQTWHYPDGLKSYLTDLIADA
QEAVPLFSCENYISDEHNGDFSIGEGAAFALTWLEEGSCANESYVNLIPTPLGGTHEAGL
KQAVFNAVNNFINLHNLLPRGVKVQSDDVFGKTAFVLSARVLDPQFQGQTKDKLTNRDAL
KLVATVSGDPLELWLNQNVDFGKKIAELAIRQAQARMRSVKKIEKKKGSGVAVLPGKLTD
CESEDIRENELFLVEGDSAGGSAKLARDKATQAILPLRGKVLNSFEVHPDQLFGNAEIHD
ISVAIGVDPHGINDHPDLSGLRYGKIAILSDADVDGSHIQVLLLTLFYRHFPKLVADGHI
YVAQPPLFRVDVNAQGKSKPARKFYALDQNELDSILERLQKEGVKETAYSISRFKGLGEM
NPDQLKDTTMHPDTRRLLQVQIPEGADDETRDIFVKLMGKGEAAARRAWMEREGDTAELD
I
>ABX45063.1|FEATURES|megares|beta_lactam|OXA-208|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDDKAEKIKNLFNEAHTTGVLVIHQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWNGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNAHIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>CAB45461.1|FEATURES|megares|glycopeptide|vanHO|antibiotic target alteration|1
MTFSSTSSAPPPSPLLPATRITVYGCGRDEAALFRRTAPRFGVEATLTEAAVSEENAEMA
AGNQCISIDHKTPVTPATLRALHRAGVTYISTRSIGYNHIDVTYAAGVGISVENVTYSPA
GVADYTLMLMLMAVRNAKSTVRRAELHDYRLNEIRGKELRDLTVGVIGTGRIGAAVVDRL
RGFGSRVLAYGKRPTIAADYVSLDELLRSSDIVSLHVPLTPDTHHLLDQSRIRRMKSGAF
VINTGRGPLIDTEALVPALESGRLSGAALDVIEGEEGIFYADCRNRTIESTWLPRLQKMP
NVLISPHTAYYTDHALMDTVENSIINCLNFGSRKQHG
>WP_011764849.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MTSKTYDESSFRVLKGLEPVRERPGMYTRTDSPAHIIQEVIDNAADEALGGFAKKIHVTL
HLDGSVTVADDGRGIPVGLHPEEGVPVVVLAYTRLHAGGKFDKREGNGAYAFSGGLHGVG
VAVTNALSTRVEVEVKRDGKIHRIDFSDGGENIGAVRIEGDCGRQTGTRVRVWPDPKYFE
APRVPMNELERLLRSKAVLLSGVSVRLDIEQAAGPALTKTWSYPEGLAGYLKELAGDVEP
VAPIFTAEKYAGKDDASFAPGEGAAWALAWFESAVPSESYVNLIPTVNGGTHESGLRAGV
FEAVKSFIEHHTLLPRGVKLQQEDVCGRMSFLLSARLLDPQFQGQVKEKLNSREAVKLVS
TQLRDPFEIWLNNHVEAGKAIAELSIKQALARQKNAQKVEKKKTSGVAVLPGKLSDCESE
DIAENELFLVEGDSAGGSAKMARNKETQAILPLRGKVQNAWEIDPDRLLANAEIHDIAVA
LGVDAHRADSSPDLSGLRYGKIVIMSDADVDGSHIQTLLLTLFFRHFPKLIENGHIYVAQ
PPLYRVDVPAQGKKRPARRLYALDDGELAAIRDRLAQEGFKPDAIEIGRFKGLGEMNPDQ
LRETTMDPATRRVLPVQVRAEAIEQTLKMFTLLMGKGEASGRRAWMEEKGDTVEADV
>AAL10704.1|FEATURES|megares|sulfonamide|sul1|antibiotic target replacement|1
MLRSRVTVFGILNPTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPV
SPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIA
EADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGM
GFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATAGLPVKDLGPASLAAELH
AIGNGADYVRTHAPGELRSAIAFSETLAKFRSRDARDRGLDHA
>AAO79891.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MSEEIKENIQDVNLTSEMKESFIDYAMSVIVARALPDVRDGLKPVHRRILYGMNELGVTP
DKPHKKSARIVGDVMGKYHPHGDSAIYESMVRMAQPFSYRAMLVDGHGNFGSVDGDGAAA
MRYTEARMSKIALEMLRDINKNTVDFQGNYDDSEQEPVVLPARFPNLLVNGTTGIAVGMA
TNIPPHNLSEVIDATSLLMDNPDVTTNELMEVLPGPDFPTGGLVMGKSGIRRAYETGKGS
ITVRAKVELTEMPNGKERILVTELPYMVNKAKLIERISELHRDKRIEGITDLRDESSREG
MRIVIDVRRDVSASVVLNNLYKMTALQTSFGFNMLAIEKGVPKILSLKRILENYVEHQKE
VITRRTIFDKNKAEARAHILEGLRIALDHIDEIIAIIRGSQSDDEAKATLIERFEFSDRQ
AQAILDMRLRRLTGLERDKIENEYQELLKFIADLEDILARPERVIEIIKTELNDVRTKFG
DARRTELLVGEVLSLEDEDLIEEEEVVITLTNNGYIKRMANSEFRAQRRGGRGVQGMGVH
DDDFVKNLVSCSTHDTLLFFTNTGKVYRAKGYEIPEYGRTAKGIPVINLLGIDSAEKIQA
IISVEGKAEAGKYLFFTTLKGTVKRTAVTAFSNIRSNGLIAISLKEDDELVNVVTTNGNQ
KMIIGTHAGYSVTFDENTVRDMGRTASGVRGIRLRENDYVVGAAILDENKEVLVITENGY
GKRTKASEYPVKGRGGKGIKTANITEKNGPLAGLTTVNGDEDILLITNKGVIIRFNVDSV
SQTGRATLGVRLMRMEDGAKVVTMAVVEPEEVEEEIVEVVETTENETTSETEE
>CAG39069.1|FEATURES|megares|aminoglycoside|aac3|antibiotic inactivation|0
MRTLNKDEHNYIKQIANIHETLLSQAESNYKCTKLSIALRYEMICSRLEHTNDKIYIYEN
EGQLIAFIWGHFSNEKSMVNIELLYVEPQFRKLGIATQLKIALEKWAKTMNAKRISSTIH
KSNLPMISLNKDLGYQVSHVKMYKDID
>AER57902.1|FEATURES|megares|aminoglycoside|AAC(6')-IIa|antibiotic inactivation|1
MSASTPPITLRLMTERDLPMLHDWLNRPHIVEWWGGDEERPTLDEVLEHYLPRAMAEESV
TPYIAMLGEEPIGYAQSYVALGSGGGWWEDETDPGVRGIDQSLADPTQLNKGLGTRLVRA
LVELLFSDPTVTKIQTDPTPNNHRAIRCYEKAGFVREKIITTPDGPAVYMVQTRQAFERK
RGVA
>NP_462206.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|0
MKLFAQGATLDLTHPHVMGILNVTPDSFSDGGAHNTLIEAVKHANLMVNAGATIIDVGGE
STRPGAAEVSVEEELDRVIPVLEAIAQRFEVWISVDTSKPEVIREAARAGAHIINDVRSL
SEPGALEAAAETGLPVSLMHMQGNPKTMQEAPKYDDVFAEVNRYFIEQIARCEKAGIAKE
KLLLDPGFGFGKNLSHNYTLLARLGEFHHFNLPLLVGMSRKTMVGQLLNVGPSDRLNGSL
ACAVIAAMQGAQIIRVHDVKETVEAMRVVEATLSAKGNKRYE
>AAK52605.1|FEATURES|megares|aminoglycoside|ant3-dprime|antibiotic inactivation|1
MTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRR
ALLNDLMEASALPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
AMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDER
NVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRAD
HLEEFIRFVKGEIIKSVGK
>AAW66496.1|FEATURES|megares|tetracycline|tet39|antibiotic efflux|1
MPILPELLRSLAGAEAGGVHYGALLAVYALMQFIFAPILGALSDRFGRRPVLIISIAGAT
ADYLLMAAAPSLLWLYIGRIFAGITGANMAVATAYVSDITPAHERAKRFGLLGAVFGIGF
IAGPVIGGVLGEWNLHAPFFAAAFMNGINLIMTAVLLKESKHSNKMTEKVQEQSILKKLS
YLITQPNMAPLLGIFLIITLVSQVPATLWVIYGQDRYGWSIFIAGVSLASYGICHSIAQA
FAIAPMVKRFGEKNTLLCGIACDAIGLLLLSIAVEEWVPFALLPLFALGGVAVPALQAMM
SRGISDERQGELQGLLSSFNSLGAIIGPVLVTSLYFMTQASAPGMVWALAAILYVITLPL
LLKYRLNKYSGVP
>YP_003610753.1|FEATURES|megares|elfamycin|tufab|antibiotic target alteration|0
MSKEKFERTKPHVNVGTIGHVDHGKTTLTAAITTVLAKTYGGSARAFDQIDNAPEEKARG
ITINTSHVEYDTPTRHYAHVDCPGHADYVKNMITGAAQMDGAILVVAATDGPMPQTREHI
LLGRQVGVPYIIVFLNKCDMVDDEELLELVEMEVRELLSQYDFPGDDTPIVRGSALKALE
GDAEWEAKIIELAGYLDSYIPEPERAIDKPFLLPIEDVFSISGRGTVVTGRVERGIIKVG
EEVEIVGIKETAKSTCTGVEMFRKLLDEGRAGENVGVLLRGIKREEIERGQVLAKPGSIK
PHTKFESEVYILSKDEGGRHTPFFKGYRPQFYFRTTDVTGTIELPEGVEMVMPGDNIKMV
VTLIHPIAMDDGLRFAIREGGRTVGAGVVAKVLG
>AAF89155.1|FEATURES|megares|beta_lactam|BD94_2866|antibiotic inactivation|1
MLKKIKISLILALGLTSLQAFGQENPDVKIEKLKDNLYVYTTYNTFNGTKYAANAVYLVT
DKGVVVIDCPWGEDKFKSFTDEIYKKHGKKVIINIATHSHDDRAGGLEYFGKIGAKTYST
KMTDSILAKENKPRAQYTFDNNKSFKVGKSEFQVYYPGKGHTADNVVVWFPKEKVLVGGC
IIKSADSKDLGYIGEAYVNDWTQSVHNIQQKFSGAQYVVAGHDDWKDQTSIQHTLDLISE
YQQKQKASN
>NP_627789.1|FEATURES|megares|glycopeptide|vanJ|antibiotic target alteration|1
MMLHAEIPNRFGSVGSLVETFLPWFGLFVPVLAAGALWRRSAAAVTALVLPVTVWLSLFG
GLLGDKSGAGGEFTMASHNVGAENPDPAGTARDLAASGVDVLALEEITAQDREVYEKGLA
REYPYHTVQGTVGLWSKLPLSGTRPVDIATDYGPLADTKPADVTMAGNRALRTTVATERG
PLVVYVAHLGSVRLNPRAGFWTDSRDRNAWALGEALAADRSERIALLGDLNGTVDDRALA
GITSQLHSVQEAAGNGFGFTWPAKFPVARIDQILVRGVEPTGSWTLPATGSDHLPVAAGV
SW
>NP_253651.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MSESLDLSLEGVERRSLAEFTEQAYLNYSMYVIMDRALPHIGDGLKPVQRRIVYAMSELG
LDADSKHKKSARTVGDVLGKFHPHGDSACYEAMVLMAQPFSYRYPLVDGQGNWGAPDDPK
SFAAMRYTEARLSRYSEVLLSELGQGTVDWVPNFDGTLDEPAVLPARLPNLLLNGTTGIA
VGMATDVPPHNLREVASACVRLLDQPGATVAELCEHVPGPDFPTEAEIITPRADLQKVYE
TGRGSVRMRAVYRVEDGDIVIHALPHQVSGSKVLEQIAGQMQAKKLPMVADLRDESDHEN
PTRIVIIPRSNRVDVEELMTHLFATTDLETSYRVNLNIIGLDGKPQVKDLRQLLSEWLQF
RIGTVRRRLQFRLDKVERRLHLLDGLLIAFLNLDEVIHIIRTEDQPKAVLMERFELSEVQ
ADYILDTRLRQLARLEEMKIRGEQEELLKEQKRLQTLLGSEAKLKKLVREELIKDAETYG
DDRRSPIVARAEARALSETELMPTEPVTVVLSEKGWVRCAKGHDIDAAGLSYKAGDGFKA
AAPGRSNQYAVFIDSTGRSYSLPAHSLPSARGQGEPLSGRLTPPPGASFECVLLPDDDAL
FVIASDAGYGFVVKGEDLQAKNKAGKALLSLPNGSAVVAPRPVRDVEQDWLAAVTTEGRL
LLFKVSDLPQLGKGKGNKIIGIPGERVASREEYLTDLAVLPAGATLVLQAGKRTLSLKGD
DLEHYKGERGRRGNKLPRGFQRVDSLLVDIPPQD
>AAY43209.1|FEATURES|megares|aminoglycoside|AAC(6')-Ib10|antibiotic inactivation|1
MTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPI
GYAQSYVALGSGDGWWEEETDPGVRGIDQLLANASQLGKGLGTKLVRALVELLFNDPEVT
KIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTCSDA
>CBW28949.1|FEATURES|megares|elfamycin|tufab|antibiotic target alteration|0
MSKEKFERTKPHVNVGTIGHVDHGKTTLTAAITTVLAKHYGGAARAFDQIDNAPEEKARG
ITINTSHVEYDTPTRHYAHVDCPGHADYVKNMITGAAQMDGAILVVAATDGPMPQTREHI
LLGRQVGVPYIIVFLNKCDMVDDEELLELVEMEVRELLSQYDFPGDDTPIVRGSALQALN
GVAEWEEKILELANHLDTYIPEPERAIDQPFLLPIEDVFSISGRGTVVTGRVERGIIRTG
DEVEIVGIKDTAKTTVTGVEMFRKLLDEGRAGENIGALLRGTKREEIERGQVLAKPGSIT
PHTDFESEVYVLSKDEGGRHTPFFKGYRPQFYFRTTDVTGTIELPEGVEMVMPGDNIKMT
VSLIHPIAMDQGLRFAIREGGRTVGAGVVAKIIK
>ACR56004.1|FEATURES|megares|nitroimidazole|nimA|antibiotic inactivation|1
FREMRRKRQLLPTEESITILEKMTNGTLALHGDNGYPYAVPVSYVYADGKIYFHSAVKGH
KVDAILRNNKVSFCVVEQDDVKPAEFTTYFRSVIAFGKARILADEGEKQLAFRLLADKYS
HGEVGMEAEIAKGFNHLLMVEIMVEHMTGKEA
>CAP02766.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MTQYTAQSLEVLSGLDPVRRRPGMYTDTSRPNHLAQEVIDNAVDEALAGHADKICVTVYK
DGSLSVEDNGRGMPVDIHPEYGQSGIEIILTKLHAGGKFSTDNYQFSGGLHGVGISVVNA
LSTRVEVEVQRQGNLYQMAFEQGEPVAPLAVLEGKAPKRATGTTVRFWPEAKYFDSPKFA
LKALKHNLKAKAVLAAGLKITYIDQINDEKIEWQFENGLVDYLMDELQDREILPNPAFVS
SGQADRAACEFAICWNVEGGEQVQESYVNLIPTAQGGTHVNGLRSGVTEALREFCELRNL
LPRNLKLSAEDVWDGVNYILSLKFQEPQFSGQTKERLSSREAANIVLNIAKDAFALWLNQ
HAEIAMQLAEMVISKAGRRLKAAKKVERKKIVSGPALPGKLADCVGQTREESELFIVEGD
SAGGSAKQARDKNFQAIMPIRGKILNTWEVSSDEVLASQEVHDIAIAIGVDPGSDDLSEL
RYGKICILADADSDGLHIATLLCALFVKHFPALVEEGHLYVAMPPLFRIDIGKDVHYALD
DEELETILKNVKGNKNPQITRFKGLGEMNAIQLRETTMDPNTRRLVQLDLDDAHLTAGLL
DKLLAKKRAADRKQWLEQKGNLADITV
>AKF41840.1|FEATURES|megares|beta_lactam|OXA-23|antibiotic inactivation|1
MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGK
IVAVALNMEMRSEMPASIRNELLMKSLKQLNII
>ABX45065.1|FEATURES|megares|beta_lactam|OXA-130|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTTNPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNTDIGTQVDNFWLMGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>WP_000733281.1|FEATURES|megares|beta_lactam|blaZ|antibiotic inactivation|1
LKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDIALKELIEASMKY
SDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKKNKNFLLDLMLNNKNGDTLIKDGIPKDYKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>AAO81397.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MEKRQEVQELTLEEVMGDRFGRYSKYIIQERALPDIRDGLKPVQRRILFSMNKDGNTFDK
GFRKSAKSVGNIMGNYHPHGDSSIYEAMVRLSQDWKLREVLIEMHGNNGSMDGDPPAAMR
YTEARLSQLSGELLKDIDKNTVDFVWNFDDTEKEPTVLPAKYPNLLVNGSTGISAGYATE
IPTHNLAEIIDGTVYLIDHPNASLEKLMEYIPGPDFPTGGILQGKAEIKKAYETGRGKVI
LRAKTKIEPLKGGKQQIVISEIPYEVNKATLVKKMDEIRLNKKVDGIAEVRDESDRTGLQ
IVVELKKDVNAEGILNYLFKNTELQINYNFNMVAIDNMTPQQVGLKRILESYITHRKSVI
INRCQFELDKARKREHIVAGLIKALSILDKVIATIRGSKDKKDAKKNLVSDYAFTEEQAE
AIVTLQLYRLTNTDITDLQEEAKTLEQQIAELLNILNNEKELFSVMKKELREVKKQYGNP
RLTQIEEEIQEIKIETAVLVAQEDVVVTVTHEGYIKRSSIRSYTASKPEEIGMKEGDFLL
YAGEVNTLDHLLLVTNKGNMIYRPVHELPDLRWKEIGEHISQTILNLAIDESIIAVYPYK
ELSPTKTFVFITKAGMIKQTKMADFEPWRTYKSRPTSCMKLKSDQDEITNVYLTNDQDLL
DVFLVSNRGFGLRYPLYEVPVVGSKAAGVKSMNLKEDDYVVNGLLVHSEGDTPIVIVTQR
GGVKRMLAQELTQLGRAKRGLMVLRELKKNPHRVVFMSESTDLDLLVTTQKGTQEVIQSK
NYPISERTSNGSFVIDEQKDGQVMEVHEMHSAVIEEEQTN
>NP_273190.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MNYSFTEKKRIRKSFAKRENVLEVPFLLATQIDSYAKFLQLENAFDKRTDDGLQAAFNSI
FPIVSHNGYARLEFVHYTLGEPLFDIPECQLRGITYAAPLRARIRLVILDKEASKPTVKE
VRENEVYMGEIPLMTPSGSFVINGTERVIVSQLHRSPGVFFEHDKGKTHSSGKLLFSARI
IPYRGSWLDFEFDPKDLLYFRIDRRRKMPVTILLKALGYNNEQILDIFYDKETFYLSSNG
VQTDLVADRLKGETAKVDILDKEGNVLVAKGKRITAKNIRDITNAGLTRLDVEPESLLGK
ALAADLIDSETGEVLASANDEITEELLAKFDINGVKEITTLYINELDQGAYISNTLRTDE
TAGRQAARVAIYRMMRPGEPPTEEAVEQLFNRLFFSEDSYDLSRVGRMKFNTRTYEQKLS
EAQQNSWYGRLLNETFAGAADKGGYVLSVEDIVASIATLVELRNGHGEVDDIDHLGNRRV
RSVGELTENQFRSGLARVERAVKERLNQAESENLMPHDLINAKPVSAAIKEFFGSSQLSQ
FMDQTNPLSEVTHKRRVSALGPGGLTRERAGFEVRDVHPTHYGRVCPIETPEGPNIGLIN
SLSVYARTNDYGFLETPYRRVIDGKVTEEIDYLSAIEEGRYVIAQANADLDSDGNLIGDL
VTCREKGETIMATPDRVQYMDVATGQVVSVAASLIPFLEHDDANRALMGANMQRQAVPCL
RPEKPMVGTGIERSVAVDSATAIVARRGGVVEYVDANRVVIRVHDDEATAGEVGVDIYNL
VKFTRSNQSTNINQRPAVKAGDVLQRGDLVADGASTDFGELALGQNMTIAFMPWNGYNYE
DSILISEKVAADDRYTSIHIEELNVVARDTKLGAEDITRDIPNLSERMQNRLDESGIVYI
GAEVEAGDVLVGKVTPKGETQLTPEEKLLRAIFGEKASDVKDTSLRMPTGMSGTVIDVQV
FTREGIQRDKRAQSIIDSELKRYRLDLNDQLRIFDNDAFDRIERMIVGQKANGGPMKLAK
GSEITTEYLAGLPSRHDWFDIRLTDEDLAKQLELIKVSLQQKREEADELYEIKKKKLTQG
DELQPGVQKMVKVFIAIKRRLQAGDKMAGRHGNKGVVSRILPVEDMPYMADGRPVDIVLN
PLGVPSRMNIGQILEVHLGWAAKGIGERIDRMLKEQRKAGELREFLNRLYNGSGKKEDLD
ALTDEEIIELASNLRKGASFASPVFDGAKESEIREMLNLAYPSDDPEVEKLGFNDSKTQI
TLYDGRSGEAFDRKVTVGVMHYLKLHHLVDEKMHARSTGPYSLVTQQPLGGKAQFGGQRF
GEMEVWALEAYGAAYTLQEMLTVKSDDVNGRTKMYENIVKGEHKIDAGMPESFNVLVKEI
RSLGLDIDLERY
>NP_274400.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MTDATIRHDHKFALETLPVSLEDEMRKSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAM
HELKNNWNAAYKKSARIVGDVIGKYHPHGDTAVYDTIVRMAQNFAMRYVLIDGQGNFGSV
DGLAAAAMRYTEIRMAKISHEMLADIEEETVNFGPNYDGSEHEPLVLPTRFPTLLVNGSS
GIAVGMATNIPPHNLSDTVNACLRLLDAPDTEIDELIDIIQAPDFPTGATIYGLSGVREG
YKTGRGRVVMRGKTHIEPIGRNGEREAIVIDEIPYQVNKAKLVEKIGDLVREKTLEGISE
LRDESDKSGMRVVIELKRNENAEVVLNQLYKLTPLQDSFGINMVVLVDGQPRLLNLKQIL
SEFLRHRREVVTRRTLFRLKKARHEGHIAEGKAVALSNIDEIIKLIKESPNAAEAKDKLL
ARPWRSSLVEEMLTRSGLDLEMMRPEGLAANIGLKEQGYYLSEIQADAILRMSLRNLTGL
DQEEIVESYKNLMGKIIDFVDILSKPERITQIIRDELEEIKTNYGDERRSEINPFGGDIA
DEDLIPQREMVVTLTHGGYIKTQPTTDYQAQRRGGRGKQAAATKDEDFIETLFVANTHDY
LMCFTNLGKCHWIKVYKLPEGGRNSRGRPINNVIQLEEGEKVSAILAVREFPEDQYVFFA
TAQGMVKKVQLSAFKNVRAQGIKAIALKEGDYLVGAAQTGGADDIMLFSNLGKAIRFNEY
WEKSGNDEAEDADIETEISDGIEDETADSENALPSGKHGVRPSGRGSGGLRGMRLPADGK
IVSLITFAPETEESGLQVLTATANGYGKRTPIADYSRKNKGGQGNIAINTGERNGDLVAA
TLVGETDDLMLITSGGVLIRTKVEQIRETGRAAAGVKLINLDEGETLVSLERVAEDESEL
SDASVISNVTEPEVEN
>YP_002344015.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|0
MKFFKINPNTDFNLLCSFINPHKMGQKIMSEKTKIHFIFIKDISTPAANILKQDALRVGA
ELITHKEVITAKITHSNALLMASKEQIQKLVVKEKLQDFGLKNLALFLQKDFLKPKKAEL
MAVINVNEDSFNAKSRVSEEDFEKRLNDFLALKPEYIDIGAVSSRPGSEYCGKEEEFKRL
KKVLDLIYEKNYYEQAIFSLDSFDEYCLEYALNKGFKLINDITSLRNLNLAKLASKYGAK
YCLMHMQNNPNNMQDNPFYEDLLDEMTLFFKEKLELLESFGVKESILDVGIGFGKSAGHN
MILIKHLEHFLQFNKPLLIGASRKSVINAYFQSEIKDRLAGTLYLHLKAFENGASIIRVH
DLYEHKQLFALAQAMDNIGV
>BAE77397.1|FEATURES|megares|multidrug|cpxr|antibiotic efflux|0
MNKILLVDDDRELTSLLKELLEMEGFNVIVAHDGEQALDLLDDSIDLLLLDVMMPKKNGI
DTLKALRQTHQTPVIMLTARGSELDRVLGLELGADDYLPKPFNDRELVARIRAILRRSHW
SEQQQNNDNGSPTLEVDALVLNPGRQEASFDGQTLELTGTEFTLLYLLAQHLGQVVSREH
LSQEVLGKRLTPFDRAIDMHISNLRRKLPDRKDGHPWFKTLRGRGYLMVSAS
>AAQ16273.1|FEATURES|megares|glycopeptide|vanWG|antibiotic target alteration|1
MKFDGNRYAKKTSEKLLPNTVFETSSLMLNENSGFDMKYQINKVHNLKLAAKTINKVIIE
PKETFSFWQLVRWADRHEKYKDGLNLVNGKIVGSYGGGLCQLSNMLFWLFLHTPLVIVER
HGHAVESFPSTTEDLPCGTDATINEGWLDLKLRNDTDNTFQIEISFDDNFMYGRILSQSS
VNIEYTVFNSSVSYFKREEKVYQIASVCRTEKDKMTGSQTEKELYVNQCKIAYKLPDDVK
IEERGV
>WP_007611767.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MARKQQFDYNEDAIQVLEGLEAVRKRPGMYIGSTDARGLHHLVYEIVDNSVDEVLAGYGD
HIIVTIHKDNSISVQDRGRGMPTGMHKLGKPTPEVIFTVLHAGGKFGQGGYKTSGGLHGV
GASVVNALSEWLTVTIERDGYVYKQRFENGGKPVTSLEKIGTTKKTGTLTHFKPDPSMFS
ATVYNFDTLSERLRESAFLLKGLKIELIDERNGVKEVFYYENGIEAFVAYLNEEKDALCE
VVSFEGEHHDIEVDFAFQFNDGYSENMLSFVNNVRTKDGGTHESGAKTAMTRAFNEYARK
VALLKEKDKNLEGADIREGLSAIISVRIPEELLQFEGQTKGKLGTSEARSAADAVISENL
AYFLEENRDTATLLVKKAIKASQAREAARKAREEARSGKKRKKSEATLSGKLTPAGSRNP
AKNELYLVEGDSAGGSAKQGRDRKFQAVLPLRGKVINTEKAKLADIFKNEEINTIIHAIG
GGVGADFEIDDINYDKIIIMTDADTDGAHIQVLLLTFFYRYMKPLIEHGKVFIALPPLYK
VSKGSGKKEIIEYAWSDEEMDGVLKKVGKGYTIQRYKGLGEMNADQLWETTMNPESRTLV
RVKIDDAARVERRVTTLMGDKVEPRRKWIEKNVAFGLDEESNILENENLSVAEEV
>AAY52016.1|FEATURES|megares|glycopeptide|VanA|antibiotic target alteration|1
MYRVKIAILFGGCSEEHDVSVKSAKEIANNINTEKYEPIYIGITRSGVWKMCEKPCMDWD
NENCRSAVLSPDKRMHGLLVMRDKGYQIQRIDAAFSVLHGKSGEDGAIQGLFELSGIPYV
GCDIQSSAVCMDKSLAYIIAKNDGIATPEFWVINKDDRPAAAAFTYPVFVKPARSGSSYG
VKKVNGADELDAAIESARQYDSKILIEQAVLGCEVGCAVLGNSSELIVGEVDQIRLQHGI
FRIHQEAEPEKGSENAVITIPADLSAEERGRIRDTAKKIYKALGCRGLARVDMFLQDNGR
IVLNEVNTLPGFTSYSRYPRMMVAAGITLPELIDRLIVLALKG
>YP_003614297.1|FEATURES|megares|multidrug|acrR|antibiotic efflux|0
MARKTKQQALETRQHILDVAIRLFSQQGVSSTSLAQIAQAAGVTRGAIYWHFKDKSDLFS
EIWELSESSISDLESEYRAKFPDDPLSVLREILVYILEATVVEERRRLMMEIIFHKCEFV
GEMAVVQQAQRSLSLESYDRIEQNLNQCMQAKLLPANLLTRRAAILMRSYISGLMENWLF
APQSFDLKAEARSYVAILLEMLQLCPTLRSDAPSLTA
>CAP70016.1|FEATURES|megares|aminoglycoside|ant6|antibiotic inactivation|1
MRTENEILSLVSEFAYQQSNIKIITLEGSRTNKNIKKDKFQDYDFTFFVSDVDYFTSEES
WLSLFGELLFIQKPEDMELFPPDLDYGYSYIMYFKDGIKMDITLINLKDLNRYFNDSDGL
VKILVDKDNLVTKEIVPDDSNYWLKKPTEREFHDCCNEFWSVSTYVAKGVFRREILFALD
HFNNILRP
>CAC29169.1|FEATURES|megares|aminoglycoside|sat-4|antibiotic inactivation|1
MKAGHLKDIDKPSEPFEVIGKIIPRYENENWTFTELLYEAPYLKSYQDEEDEEDEEADCL
EYIDNTDKIIYLYYQDDKCVGKVKLRKNWNRYAYIEDIAVCKDFRGQGIGSALINISIEW
AKHKNLHGLMLETQDNNLIACKFYHNCGFKIGSVDTMLYANFENNFEKAVFWYLRF
>EGF60091.1|FEATURES|megares|fosfomycin|FosA5|antibiotic inactivation|1
MLSGLNHLTLAVSQLAPSVAFYQQLLGMTLHARWDSGAYLSCGDLWLCLSLDPQRRVTPP
DESDYTHYAFSISEADFASFAVRLEAAGVAMWKLNRSEGASHYFLDPDGHKLELHVGSLA
QRLAACREQPYKGMVFFDQ
>CBA27391.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|0
MFSFIQVHKGMAMKLFAQGSTLELSHPHVMGILNVTPDSFSDGGQHNTLTEAVKHANAMI
NAGATIIDVGGESTRPGAAEVSVEEELSRVVPVVEALAQRFEVWVSVDTSKPEVIRESAR
VGAHIINDIRSLTEPGALEAAAETGLPVCLMHMQGQPKTMQQAPHYEDVFADVTRFFEQQ
IARCEAAGITKEKIILDPGFGFGKNLTHNYQLLARLSEFQRFEMPLLVGMSRKSMIGQLL
NVGPDQRLPGSLACAVMAAMQGAQIIRVHDVKETVEAMRVVEATLSAKDKKCYE
>AGS61252.1|FEATURES|megares|elfamycin|tufab|antibiotic target alteration|0
MSKEKFERSKPHVNVGTIGHVDHGKTTLTAAITTVLAKTYGGAARAFDQIDNAPEEKARG
ITISTSHVEYDTPTRHYAHVDCPGHADYVKNMITGAAQMDGAILVVAATDGPMPQTREHI
LLGRQVGVPYIIVFLNKCDMVDDEELLELVEMEVRELLSQYDFPGDDTPVIRGSALKALE
GEAEWEAKIVELAEALDSYIPEPERAIDKPFLLPIEDVFSISGRGTVVTGRVERGIIKVG
DEVEIVGIKETTKTTCTGVEMFRKLLDEGRAGENVGVLLRGTKREEIERGQVLAKPGSIN
PHNKFESEVYILSKDEGGRHTPFFKGYRPQFYFRTTDVTGTIELPEGVEMVMPGDNVNMI
VELIHPIAMDEGLRFAIREGGRTVGAGVVAKVLG
>CBH29314.1|FEATURES|megares|trimethoprim|dfrA16|antibiotic target replacement|1
MAAKSKNGIIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYAVVTRS
NFSTNDEGVMVFSSIQDALINLEEITDHVIVSGGGEIYKSLISKVDTLHISTVDIERDGD
IVFPEIPDTFELVFEQDFESNINYCYQIWQRVNKRLQSDLRLLSPFFAVELQKCAINLRQ
LRRALDALAHNCSQPTIRSSLL
>CBW29606.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MTDSIQSSITPVNIEEELKSSYLDYAMSVIVGRALPDVRDGLKPVHRRVLFSMDREGNTA
NKKYVKSARVVGDVIGKYHPHGDSAVYDTIVRMAQPFSLRYMLVDGQGNFGSIDGDAPAA
MRYTEVRMQKITQALLTDLDKETVNFSPNYDGELMIPDVLPTRIPALLANGSSGIAVGMA
TNIPPHNLNEVLNGCLAYIDNNEITIDELMQHIPGPDFPTAALINGRKGIEEAYRTGRGK
VYVRARATVETNEKGREQIIVSELPYQVNKAKLVEKIAELIREKKIEGISNITDLSNKEG
IRIEIDIKRDAVGEVVLNHLYSLTQMQVTFGINMVALDHGQPRLFNLKEIIEAFVLHRRE
VVTRRSIFELRKARERTHILEGLAVARSNIDEMIAIIRNSKNREEAATAISSRSWTLHSD
IINLLDASARPDELEENLGIQGEQYYLSPAQVNAILELRLHRLTGIAFEEVIKEYEELLV
KIADLLHILSSAERLMEVIREELEEVKAQFGDDRLTEITAASGDIDLEDLIAQEDVVVTL
SHEGYVKYQPLTDYEAQRRGGKGKSATKMKEEDFIEKLLVANTHDTILCFSSRGRLYWLK
VYQLPQASRGARGRPIVNILPLQENERITAILPVSAYEEDKFVVMATAGGIVKKIALTEF
SRPRSNGIIALNLRDEDELIGVDITNGSNEIMLFSSQGRVVRFAENAVRAMGRLATGVRG
IKLALTNDISDDESAVEIEDISDDNAEASLDLNIDKVVSLVVPKGEGAILTATQNGYGKR
TQLSEYPTKSRNTKGVISIKVSERNGKVVAATQVEETDQIMLITDAGTLVRTRVSEVSIV
GRNTQGVRLIRTADDEHVVSLERVCDADEEDSLEESSSEE
>AFK60084.1|FEATURES|megares|multidrug|adeC|antibiotic efflux|0
MGGTPLETTLRKYIEVASKKKPADLVIKHAKIVNVFTKEIMEKDVAICEGMIVGIGEYEG
KSVHNANGQYLVPGFIDGHVHIESSLLSPSEFSKVSLLHGVTTVVTDPHEIGNIAGSTGL
EFMIEDARQTLMNIFFMLPSCVPVTPFETNGANLNAKKLAPFLQKPEVLGLAEVMNYQAV
ANNETDILEKIQLMHQHKKKIDGHAAGIGMEELNVYPAAGIRTDHEATTAKEAKERLDLG
MYLMVREGTVAKDLASLLPAITPENSRRCFFVTDDKLINDLVKEGSIDHIVRQAIALGID
PLQAIQMATLNAAECFDLKTLGAIAPGYQADFFLTDDLTKLPIHEVFYKGTLVVQSGQLQ
DHLFADHSNSYTCCLPKLNAQPLNPHSLELLLSSSQAHVIEIIPNSLVTKDLVEKVDRQG
ERFIPSIEKDQLKIAVIERHHQTGNIGLGIVKGFQLKQGAIATTIAHDSHNLVVVGTNDE
DMLYAANLLIQKGGGMTVVNKQQEIACVSLPIGGIMTQEPFSIVYEQLNELITKAHQLGA
AKTFDPFLTLSFLTLSVIPELKITDKGLFSFSRFQLIPPCGKTDEINTF
>WP_000331899.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MAYSYTEKKRIRKNFGKLPQVMDAPYLLSIQVDSYRTFLQDGKSPKNREDIGLQAAFRSV
FPIESYSGNAALEFVEYSLGKPEFDVRECILRGSTYAAPMRVKIRLIIKDRETKSIKDVR
EQEVYMGEIPLMTENGTFVINGTERVIVSQLHRSPGVFFDHDKGKTHSSGKVLYSARIIP
YRGSWLDFEFDAKDLVYVRIDRRRKLLATVVLRALGYNNEQILNLFYEKVPVYLDMGSYQ
IDLVPERLRGEMAQFDITDNEGKVIVEQGKRINARHVRQMEAAGLTKLSVPDEYLYERIT
AEDITLRDGEVIAANTLLSHEVMVKLAEGGVKQFNILFTNDIDRGSFVADTLRADLTRDR
EEALVEIYKVMRPGEPPTKEAAENLFNNLFFSSERYDLSPVGRMKFNRRLGRPYEVGTDQ
KSREVEGILSHEDIIDVLRTLVEIRNGKGEVDDIDHLGNRRVRSVGEMTENQFRVGLVRV
ERAVKERLSQAETDNLSPQDLINAKPVAAAIKEFFGSSQLSQFMDQNNPLSEITHKRRVS
ALGPGGLTRERAGFEVRDVHQTHYGRVCPIETPEGPNIGLINSLSVYAKANDFGFLETPY
RKVVDGRVTDDVEYLSAIEEVGTVIAQADSAVDKDGNLTEEFVSVRHQGEFVRMPPEKVT
HMDVSAQQVVSVAASLIPFLEHDDANRALMGSNMQRQAVPTLRADKPLVGTGMEANVARD
SGVCVIANRGGVIEYVDASRIVIRVNEDEMVAGEAGVDIYNLIKYTRSNQNTCINQNVIV
NLGDKVARGDILADGPSTDMGELALGQNMRVAFMTWNGYNYEDSILLSERVLQEDRLTSI
HIQELSCVARDTKLGAEEITADIPNVGEAALSKLDESGIVYIGAEVTAGDILVGKVTPKG
ETQLTPEEKLLRAIFGEKAADVKDSSLRVPSGTKGTVIDVQVFTRDGLEKDDRALAIEKA
QLDSYRKDLKEEYKIFEEAARERVIRLLKGQESNGGGSTKRGDKLSEDLLSGLELVDLLE
IQPADEAIAERLTQIQVFLKEKSAEIDEKFAEKKRKLATGDELTTGVLKVVKVYLAVKRR
IQPGDKMAGRHGNKGVVSNILPVEDMPHDANGVPVDIVLNPLGVPSRMNVGQILETHLGM
AAKGLGDKIEKMLKEQRTVLELREFLDKIYNKVGGEQEDLDSLTDEEILALAGNLRAGVP
LATPVFDGAEESQIKDLLELADISRTGQTVLFDGRTGEQFDRPVTVGYMYMLKLNHLVDD
KMHARSTGSYSLVTQQPLGGKAQFGGQRFGEMEVWALEAYGAAYTLQEMLTVKSDDVEGR
TRIYKNIVDGNHYMDPGMPESFNVLTKEIRSLGINIELKNGD
>YP_003615180.1|FEATURES|megares|elfamycin|tufab|antibiotic target alteration|0
MSKEKFERTKPHVNVGTIGHVDHGKTTLTAAITTVLAKTYGGSARAFDQIDNAPEEKARG
ITINTSHVEYDTPTRHYAHVDCPGHADYVKNMITGAAQMDGAILVVAATDGPMPQTREHI
LLGRQVGVPYIIVFLNKCDMVDDEELLELVEMEVRELLSQYDFPGDDTPIVRGSALKALE
GEAEWEEKIIELAGYLDSYIPEPERAIDKPFLLPIEDVFSISGRGTVVTGRVERGIIKVG
EEVEIVGIKETAKSTCTGVEMFRKLLDEGRAGENVGVLLRGIKREEIERGQVLAKPGYNQ
ATHQVRI
>WP_015891554.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MKETETQQTLTYTEEDIQVLEGLIAVRKRPGMYIGSTGSRGLHHLLWEIVDNAKDEALAG
VNDSIIVTLYKDGSVSVEDHGRGIPTGMHKTGRPVPEVIFTTLHAGGKFGGGGYKKSGGL
HGVGSSVVVALSKWLEVEIHREGKIHKQRFEYVVDANGTEHVGKPVTGLEITGNTKRTGT
TVRFLPDDAVFGNARFDYETIRDRFRETAFLLKKLRMVLIDERGPEKKREEFYFEDGLKS
YVSYLNEGKNSLHPIVYFEGEKDNIYVELAFQYNDGYAETLVSYVNSIVTTDGGTHVTGF
RNGTTRIFNEFARKKGYLKEKDPNLTGNDLREGFLGVLSLQMADVQFESQTKDKLGNEEA
RAIVEQIVSEKLGFFLEENPEIGKLLIDKAVRSAEIREELRKQREALRGDKKGKTAKKRK
SISEKFTPPQYRDSKRNELFLVEGDSAGGSAKQARNSEFQALFSLRGKPLNTEKAKLSEV
LANEEFRTILEVLETDIGEEFSIENCAFDKVIIMSDADVDGSHIQTLLLTFFFRYMRPMI
AAGHLYIAQPPLYQVKKQSKGKQTEAIYCWSDYELEQALKKVGRGAEVQRYKGLGEMNAD
QLWETTMDPETRKLIKVELEDLAHCEKLVTVLMGDKVPPRREWIENHVTFEVGEDE
>ACH58981.1|FEATURES|megares|multidrug|hlyD|antibiotic efflux|0
MNEAATPTAPADVPATGNRRRILLTITFVLLLLAAGWTVLEVLVLSKREKTDDAYVTGNQ
IRVSSQIAGIVVEVFARNTSRVEPGQKLLRLDDADARQALERAAANLAQTVRQVRQQTAQ
SVQFDAQIAGRELELQQAEEDLRQREPLLAEQAVAGEEVRHARNAVALARTALRQSQQQS
AAARALVDHVSLEQNPSVLAAVAAYKDAWLHTQRSIIVAPAGGYIAQRSVQLGQRIAPGE
PLMSIIALQDVWLEANFKEKQLRNLRIGQPAEIETDVYGGDVVFHGRIIGLSAGTGAAFS
LLPPQNASGNWIKITQRVPVKIALDPRELAAHPLRIGLSTTTTIDTHDRDGAVLAVDPVS
DVHESTLSYVHDPVTAEQEALKIIRANSGGN
>ABB82610.1|FEATURES|megares|beta_lactam|blaZ|antibiotic inactivation|1
LKKLIFLIAIALVLSACNSXSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKIHIXKDDIVAYSPILEKYVGKDITLKELIEASMAY
SDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKENKKFLLDLMLNNKSGDTLIKDGVSKDCKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>AAF40441.1|FEATURES|megares|macrolide-lincosamide-streptogramin|lmrB|antibiotic efflux|0
MDSQINTQTSPAAAKLPREVVVVLSILVVSAMIMILNETILSVALPSIMEDFSVPETTAQ
WLTTGFMLTMAVVIPTTGYLLDRFSTKTIFVTALLFFTVGTLTAALAPTFAVLLGARIVQ
AVGTALVMPLLMTVTLTVVPAERRGSMMGIISIVISVAPALGPTLSGVILNSLTWHWLFW
MMLPIVVIALVIGFFLIKNIGETKITPLDVLSVILSVFAFGGLVYGFSSFGAILEGEGTV
GIFAIVVGAIALLIFALRQHQLGKQDKALMDLRAFKVRNFSFSLTTILLAFGAMLGTVMV
LPIYLQTSLGVTALVTGLVVMPGGLLQGLISPFIGRFYDKVGPRPLLIPGAIALAIAASS
MTFLNENSPVWMVVVMHVVFSIGMCLMMTPLMTTALGALPKHLYGHGSAILNTFQQLAGA
AGTAIMIAALSFGTSIAASSGSAHAEAVAAGTKVAFIAGAIIAVIALVVSLFVTRVEEEA
H
>AAA26443.1|FEATURES|megares|aminoglycoside|APH(3'')-Ib|antibiotic inactivation|1
MGQQLGAVHSLSVDQCPFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPLHDLLARVE
RELPVRLDQERTDMVVCHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANA
EENWAAPDEAERAFAVLFNVLGIEAPDRERLAFYLRLDPLTWG
>BAH73495.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MSDLIQIEEELKKSYLEYSLSVIIGRAIPDVRDGLKPVHRRILYAMHDLSNTYNRPYKKS
ARVVGDVIGKYHPHGDQSVYDALVRMAQDFSMRDAIVDGQGNFGSIDGDAAAAMRYTEVR
MSRLAGEFLADIEKETVDFRPNYDNSLEEPAVLPTKVPNLLLNGSSGIAVGMATNIPPHN
LGELCDGLLHLLDTPSCPVTDIIGLVKGPDFPTGAAIYGGKGLTEAYTTGRGTIKIRGRA
EVEERKKDYVSVVIREIPYALNKSSLVEKIAALINDGRIEGVSDLRDESDRKGIRIVLDL
KKGVIPDIVINALYKYTPLETSFGINMLVVADNRPALLNIKQVLEHFLTHRRDVILRRTR
FDLRKSEERAHILEGLRIALDNIDEVVSIIRASKNAVEARERLMERFGLSERQAQAILDM
RLQRLTNLERQKLIDEYNELIKLIEYLRSILENDEVLRGVIRDEIKEIQDRYATPRKTEI
LEDLEGINILDLIPDEDVVITLSRRGYIKRTKIDNYQQQKRGGKGIAGVATAGDDFVQSF
CATTNHQQLLLFTNLGRMFMLPVHQIPEGQRTAKGAHIANLLPMDKEEFVATALSIREFS
EERYFLFVTRKGMVKRTCTDLYKNCRSTGIIAVGLKENDELLTVKEIDDETEVLLATQQG
LSNRFHISGVRPTGRGAAGVKGIALKGNDRVAAGVVITSVSRSEVLTVSANGYGKRTSIE
HYPIRNRGGSGVINMRVTPKTGQVIGAVMVGDDDELLLLTSANKIIRLSVSGISSVGRAT
QGVMLVRMDENDTVMGFDLVDPSDLDRCAPSGE
>CAG34240.1|FEATURES|megares|sulfonamide|sul1|antibiotic target replacement|1
MVTVFGILNLTEDSFFDESRRVDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPAD
EIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADC
RLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFL
SPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGN
GADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA
>CAD11598.1|FEATURES|megares|tetracycline|tetA|antibiotic efflux|1
MPVLPGLLRDLVHSNDVTAHYGILLALYALMQFACAPVLGALSDRFGRRPVLLVSLAGAA
VDYAIMATAPFLWVLYIGRIVAGITGATGAVAGAYIADITDGDERARHFGFMSACFGFGM
VAGPVLGGLMGGFSPHAPFFAAAALNGLNFLTGCFLLPESHIGERRPLRREALNPLASFR
WARGMTVVAALMAVFFIMQLVGQVPAALWVIFGEDRFHWDATTIGISLAAFGILHSLAQA
MITGPVAARLGERRALMLGMIADGTGYILLAFATRGWMAFPIMVLLASGGIGMPALQAML
SRQVDEERQGQLQGSLAALTSLTSIVGPLLFTAIYAASITTWNGWAWIAGAALYLLCLPA
LRRGLWSGAGQRADR
>CAJ13500.1|FEATURES|megares|sulfonamide|sul1|antibiotic target replacement|1
MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPTASHPDARPVSPAD
EIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADC
RLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFL
SPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGN
GADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA
>BAJ45007.1|FEATURES|megares|beta_lactam|ampH|antibiotic inactivation|0
MALVVIDGNQRVFRSYGETRPGNNVRPQLDSVVRIASLTKLMTSEMLVKLLDQGTVKLND
PLSKYAPPGARVPTYNGTPITLVNLATHTSALPREQPGGAAHRPVFVWPTREQRWKYLST
AKLKAAPGSQAAYSNLAFDLLADALANASGKPYTQLFEEQITRPLGMKDTTYTPSPDQCR
RLMVAERGASPCNNTLAAIGSGGVYSTPGDMMRWMQQYLSSDFYQRSNQADRMQTLIYQR
AQFTKVIGMDVPGKADALGLGWVYMAPKEGRPGIIQKTGGGGGFITYMAMIPQKNIGAFV
VVTRSPLTRFKNMSDGINDLVTELSGNKPLVIPAS
>NP_459974.1|FEATURES|megares|multidrug|ompF|reduced permeability to antibiotic|0
MMKRKILAAVIPALLAAATANAAEIYNKDGNKLDLYGKAVGRHVWTTTGDSKNADQTYAQ
IGFKGETQINTDLTGFGQWEYRTKADRAEGEQQNSNLVRLAFAGLKYAEVGSIDYGRNYG
IVYDVESYTDMAPYFSGETWGGAYTDNYMTSRAGGLLTYRNSDFFGLVDGLSFGIQYQGK
NQDNHSINSQNGDGVGYTMAYEFDGFGVTAAYSNSKRTNDQQDRDGNGDRAESWAVGAKY
DANNVYLAAVYAETRNMSIVENTVTDTVEMANKTQNLEVVAQYQFDFGLRPAISYVQSKG
KQLNGAGGSADLAKYIQAGATYYFNKNMNVWVDYRFNLLDENDYSSSYVGTDDQAAVGIT
YQF
>WP_023356657.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MSEQNTPQVREVNISQEMRTSFLDYAMSVIVSRALPDVRDGLKPVHRRILYAMNDLGMTS
DKPYKKSARIVGEVIGKYHPHGDSAVYESMVRMAQDFNYRYMLVDGHGNFGSVDGDSAAA
MRYTEARMSKIAMEILRDITKDTIDYQDNYDGAEREPVVMPSRFPNLLVNGAAGIAVGMA
TNIPPHQLGEVIEGVLAVSENPEITNQELMEYIPGPDFPTAGQILGRSGIRKAYESGRGS
ITIRAKAEIEETSSGKERIIVTELPYQVNKARLIEKIADLVRDKKIEGITDLRDESDRNG
MRIVIEIRRDANAHVILNNLYKQTALQTSFGINLLALVDGQPKVLSLKQCLEHYLDHQKV
VIRRRTAYELRKAEARAHILEGLRIALDHLDAVISLIRNSQTAEIARTGLIEQFSLTEKQ
AQAILDMRLQRLTGLEREKIEEEYQSLVALIAELKDILANEARVLEIIREELNEIKERFN
DERRTEIVTSGLETIEDEDLIERENIVITLTHNGYVKRLPASTYRSQKRGGKGVQGMGTN
EDDFVEHLISTSTHDTILFFSNKGKVYRSKGYEIPEYGRTAKGIPIINLLEVEKGEWINA
IIPVSTFDEEQYLFFTTKQGVSKRTALSQFANIRNNGLIALGLREDDELMAVRLTDGKKQ
IIIGTKNGLLIRFPEEDVRQMGRTAAGVKGITLTDDDVVVGMEILEEDSHVLIVTENGYG
KRTPASEYRVQSRGGKGLKTCKITDSNGPLVTVKATKGEEDLMIITASGVLIRMDINDIS
TTGRVTQGVRLIRMSDQEHVATVALVEKNEEEPEETEEV
>ABX45062.1|FEATURES|megares|beta_lactam|OXA-106|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDKKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWNGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>BAM98943.1|FEATURES|megares|aminoglycoside|AAC(6')-Ib|antibiotic inactivation|1
MTNSTDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESV
TPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRA
LVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERT
RSDA
>NP_252955.1|FEATURES|megares|elfamycin|tufab|antibiotic target alteration|0
MAKEKFERNKPHVNVGTIGHVDHGKTTLTAALTKVCSDTWGGSARAFDQIDNAPEEKARG
ITINTSHVEYDSAVRHYAHVDCPGHADYVKNMITGAAQMDGAILVCSAADGPMPQTREHI
LLSRQVGVPYIVVFLNKADMVDDAELLELVEMEVRDLLNTYDFPGDDTPIIIGSALMALE
GKDDNGIGVSAVQKLVETLDSYIPEPVRAIDQPFLMPIEDVFSISGRGTVVTGRVERGII
KVQEEVEIVGIKATTKTTCTGVEMFRKLLDEGRAGENVGILLRGTKREDVERGQVLAKPG
TIKPHTKFECEVYVLSKEEGGRHTPFFKGYRPQFYFRTTDVTGNCELPEGVEMVMPGDNI
KMVVTLIAPIAMEDGLRFAIREGGRTVGAGVVAKIIE
>BAQ56017.1|FEATURES|megares|aminoglycoside|AAC(6')-IIc|antibiotic inactivation|1
MYTKNAAIVLRLMTESDLPMLHAWLNRPHIVEWWGGEDKRPTLGEVLEHYSPRVLAEQAV
VPYIAMLDDEPIGYAQSYTALGSGDGWWEDETDPGVRGIDQSLANPSQLNKGLGTTLVRS
LVELLFSDPAVSKIQTDPSPNNHRAIRCYEKAGFAQDKIILTPDGPAVYMVQTRQAFESQ
RNAA
>AEL00446.1|FEATURES|megares|quinolone|QnrB13|antibiotic target protection|1
MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG
>WP_000202252.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MTSLAHHATENRSVAEFTEQAYLNYAMYVIMDRALPHISDGLKPVQRRIVYAMSELGLKS
SGKPKKSARTVGDVLGKYHPHGDLACYEAMVLMAQPFSYRYPLIEGQGNWGSPDDPKSFA
AMRYTEAKLSAYSELLLSELGQGTSEWQDNFDGSLKEPITLPARVPNILLNGTTGIAVGM
ATDIPPHNLREVVKGTIALIRNPQTSDEKLAEYIPAPDLPTKAEIITPPEELLKIQTTGR
GSYRMRAVYTIEKNEIVITELPYQVSGSKVITQIADQMQAKKLPLVVDVRDESDHENPTR
LVIVLRSNRIDAEAVMSHLFATTDLESSYRVNLNMIGEDGRPQVKSIRRILLEWIEIRKK
TVTRRLQYHLNRIEKRLHILAGLLIAYLDIDTVIRIIREEDQPKPVLMEHFNIDEIQAEA
ILELKLRHLAKLEEMEIRHEQDELSAKAAIIREQLENPESLKNLIIGELKEDAKKFGDER
RSPIVARAEAVQIKEQDLMPAETVTVVLSEAGWVRAAKGADVDAENLNYRAGDQYLSHAV
GKTNQRVYFLDETGRSYALPISNLPSARGLGDPLSSKLSPASGVSFIQVYLDDDESELIA
ASSAGYGFKTQTKQLDTNAKAGKTFLTVPDKAKALPLISAQNMTHLAVLSSAGRLLILDL
AELPNLNKGKGNKLIQLEGKEQILSMTTLNLDEIIQVVAGQQHLKLKGDDLQKYMGKRAS
KGQLLPRGYQKANKLLIQR
>CBX07047.1|FEATURES|megares|beta_lactam|cepA|antibiotic inactivation|1
MQKRLIHLSIIFFLLCPALVVAQNSPLETQLKKAIEGKKAEIGIAVIIDGQDTITVNNDI
HYPMMSVFKFHQALALADYMHHQKQPLETRLLIKKSDLKPDTYSPLRETYPQGGIEMSIA
DLLKYTLQQSDNNACDILFNYQGGPDAVNKYLHSLGIRECAVIHTENDMHENLEFCYQNW
TTPLAAAKLLEIFRNENLFDKEYKNFIYQTMVECQTGQDRLIAPLLDKKVTMGHKTGTGD
RNAKGQQIGCNDIGFILLPDGHAYSIAVFVKDSEADNRENSEIIAEISRIVYEYVTQQID
>EEM84592.1|FEATURES|megares|macrolide-lincosamide-streptogramin|mph|antibiotic inactivation|1
MEEIKMNTLKVKQLANKEGLNILEDSIEINESGVDFQVAHVKEQNGDKWILRIPRRRESM
RHALREKEALEIMKKHAEFQVPDWSIFSEELIAYKQLSGVPAATIDIEQQGYISTFNEKD
VPTEYYISLGKVLANLHSLPQQKFNSIGVEILTANELRTSMKQRMNRVKEQYHINQNLWD
RWQAWLAEDSFWPSHVGVKHGDIHPGHILIDNKNKVTGLIDWTEVGIGDVSIDFTSHYLL
F
>AAL08447.1|FEATURES|megares|chloramphenicol|catI|antibiotic inactivation|1
MEKKITGYTTVDISQWHRKEHFEAFQSVAQCTYNQTVQLDITAFLKTVKKNKHKFYPAFI
HILARLMNAHPEFRMAMKDGELVIWDSVHPCYTVFHEQTETFSSLWSEYHDDFRQFLHIY
SNDVACYGENLAYFPKNFNENMNFVSANPWVSFTSFDLNVANMDNFFAPVFTMGKYYTQG
DKVLMPLAIQVHHAVCDGFHVGRMLNELQQYCDEWQGGA
>WP_001289561.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MYSSGNTHDKNFRKSAKTVGDVIGQYHPHGDSSVYEAMVRLSQDWKLRHVLIEMHGNNGS
IDNDPPAAMRYTEAKLSLLAEELLRDINKETVSFIPNYDDTTLEPMVLPSRFPNLLVNGS
TGISAGYATDIPPHNLAEVIQATLKYIDNPDITVNQLMKYIKGPDFPTGGIIQGIDGIKK
AYESGKGRIIVRSKVEEETLRNGRKQLIITEIPYEVNKSSLVKRIDELRADKKVDGIVEV
RDETDRTGLRIAIELKKDVNSESIKNYLYKNSDLQISYNFNMVAISDGRPKLMGIRQIID
SYLNHQIEVVANRTKFELDNAEKRMHIVEGLIKALSILDKVIELIRSSKNKCDAKENLIE
VYEFTEEQAEAIVMLQLYRLTNTDIVALEGEHKELEALIKQLRHILDNHDALLNVIKEEL
NEIKKKFKSERLSLIEAEIEEIKIDKEVMVPSEEVILSMTRHGYIKRTSIRSFNASGVED
IGLKDGDSLLKHQEVNTQDTVLVFTNKGRYLFIPVHKLADIRWKELGQHVSQIVPIEEDE
VVINVFNEKDFNTDAFYVFATQNGMIKKSTVPLFKTTRFNKPLIATKVKENDDLISVMRF
EKDQLITVITNKGMSLTYNTSELSDTGLRAAGVKSINLKAEDFVVMTEGVSENDTILMAT
QRGSLKRISFKILQVAKRAQRGITLLKELKKNPHRIVAAHVVTGEHSQYTLYSKSNEEHG
LINDIHKSEQYTNGSFIVDTDDFGEVIDMYIS
>CAH14961.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MSENYTAEAIEVLSGLEPVQRRPGMYTDTTRPNHLAQEVIDNSVDEVLAGFASRIIVTLH
EDGSIEVEDDGRGMPVDLHPQLGLSGVEVIMTRLHAGGKFSDKNYSFSGGLHGVGVSVVN
ALSERLDVTIKRNGIIYQMTFANGDKLCELNETGVTKKRETGTVIRFWPNGKYFDTTKIS
VKHLTHVLRAKAVLCSGLSMTFINKITNEEMNWCYEQGLTDYLRQTLPEDYLPEEPFAGA
FKSDEATVDWALAWSDSANGNLNESYVNLIPTIQGGTHVNGLRSGLFEAMSEFCELRNLL
PRGVKLTADDLWESCQYVLSIKMKEPQFAGQTKERLSSRQTSGLVSNVIKDAFAIWLNQH
RNQGEAIAALAIERAQKRLKQAKQVARKRVSQGPALPGKLADCLQTDLGQAELFLVEGDS
AGGSAKQARNKDYQAILPLRGKILNSWEVDSSQVLASQEIHDISVAIGVDPGSSDLEGLR
YGKICILADADSDGAHIATLICALFLRHFKPLVKAGHVFVAMPPLYRIDAGKLIHYALDD
EEKNRIVQHLSQTTKSKVNVQRFKGLGEMNPIQLRETTMDPNTRRLVQLTLDDEEQTEAI
MDMMLNKKRASDRKLWLETKGNLAEI
>AAK21274.1|FEATURES|megares|multidrug|omp36|reduced permeability to antibiotic|0
MKVKVLSLLVPALLVAGAANAAEIYNKDGNKLDLYGKIDGLHYFSSDDSVDGDQTYMRIG
VKGETQINDQLTGYGQWEYNVQANNTESSSDQAWTRLAFAGLKFGDAGSFDYGRNYGVVY
DVTSWTDVLPEFDGDTYGSDNFLQSRANGVATYRNSDFFGLVDGLNFALQYQGKNGSVSG
EDQTNNGRGFQKQNGEGFGTSVTYEIWDGISAGFAYSSSKRTDEQNNSTYFSKSYQRTYG
VLGEGDHAETYTGGLKYDANNIYLATQYTQTYNATRTGDIGFANKAQNFEVVAQYQFDFG
LRPSVAYLQSKGKDMGRYGDQDILKYVDLGATYYFNKNMSTYVDYKINLLDDNKFTKDAS
ISTDNVVALGLVYQF
>WP_001289589.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MYSSGNTHDKNFRKSAKTVGDVIGQYHPHGDYSVYEAMVRLSQDWKLRHVLIEMHGNNGS
IDNDPPAAMRYTEAKLSLLAEELLRDINKETVSFIPNYDDTTLEPMVLPSRFPNLLVNGS
TGISAGYATDIPPHNLAEVIQATLKYIDNPDITVNQLMKYIKGPDFPTGGIIQGIDGIKK
AYESGKGRIIVRSKVEEETLRNGRKQLIITEIPYEVNKSSLVKRIDELRADKKVDGIVEV
RDETDRTGLRIAIELKKDVNSESIKNYLYKNSDLQISYNFNMVAISDGRPKLMGIRQIID
SYLNHQIEVVANRTKFELDNAEKRMHIVEGLIKALSILDKVIELIRSSKNKRDAKENLIE
VYEFTEEQAEAIVMLQLYRLTNTDIVALEGEHKELEALIKQLRHILDNHDALLNVIKEEL
NEIKKKFKSERLSLIEAEIEEIKIDKEVMVPSEEVILSMTRHGYIKRTSIRSFNASGVED
IGLKDGDSLLKHQEVNTQDTVLVFTNKGRYLFIPVHKLADIRWKELGQHVSQIVPIEEDE
VVINVFNEKDFNTDAFYVFATQNGMIKKSTVPLFKTTRFNKPLIATKVKENDDLISVMRF
EKDQLITVITNKGMSLTYNTSELSDTGLRAAGVKSINLKAEDFVVMTEGVSENDTILMAT
QRGSLKRISFKILQVAKRAQRGITLLKELKKNPHRIVAAHVVTGEHSQYTLYSKSNEEHG
LINDIHKSEQYTNGSFIVDTDDFGEVIDMYIS
>ADA79632.1|FEATURES|megares|glycopeptide|brp|antibiotic inactivation|1
MLQSIPALPVGDIKKSIGFYCDKLGFTLVHHEDGFAVLMCNEVRIHLWEASDEGWRSRSN
DSPVCTGAESFIAGTASCRIEVEGIDELYQHIKPLGILHPNTSLKDQWWDERDFAVIDPD
NNLISFFQQIKS
>CAJ68315.1|FEATURES|megares|sulfonamide|folp|antibiotic target replacement|0
MSLIVFDYGKRTYIMGILNVTPDSFSDGGDFNNLDIAIQHAKDMVDQGADIIDLGGESTR
PGHSYVDSDEELRRVIPVIKKLKQELDIPISIDTYKADVAEEALKLGVTMVNDVWGLRKD
KNMASVIGKYDAEVCIMHNQDGTNYDKDIMESIKDFFKVSIEMAMSCGVKKEKIVLDPGV
GFGKDFEQNIEVLRRLNELKDLGYPILLGTSRKSVIGKVLPVEPKKRLEGTIATTVLGIR
DGVDIVRVHDVYENLMAARMTDAIYRK
>WP_012578770.1|FEATURES|megares|elfamycin|tufab|antibiotic target alteration|0
MAKAKFERNKPHVNVGTIGHVDHGKTTLTAAIATICAKTYGGEAKDYSQIDSAPEEKARG
ITINTSHVEYDSPTRHYAHVDCPGHADYVKNMITGAAQMDGAILVCAATDGPMPQTREHI
LLSRQVGVPYIIVFLNKCDLVDDEELLELVEMEVRELLSTYDFPGDDTPVIRGSALAALN
GEAGPYGEESVLALVAALDSYIPEARACNRQSILDANRRRILNFWSWYSSNRPC
>AAS09879.1|FEATURES|megares|beta_lactam|shv5|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKNGASKRGARG
IVALLGPNNKAERIVVIYLRDTPANMAERNQQIAGIGAALIEHWQR
>WP_001557340.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MNKQNNYSDDSIQVLEGLEAVRKRPGMYIGSTDKRGLHHLVYEIVDNSVDEVLNGYGNEI
DVTINKDGSISIEDNGRGMPTGIHKSGKPTVEVIFTVLHAGGKFGQGGYKTSGGLHGVGA
SVVNALSEWLEVEIHRDGSIYHQSFKNGGSPSSGLVKKGKTKKTGTKVTFKPDDTIFKAS
TSFNFDVLSERLQESAFLLKNLKITLNDLRSGKERQEHYHYEEGIKEFVSYVNEGKEVLH
DVATFSGEANGIEVDVAFQYNDQYSESILSFVNNVRTKDGGTHEVGFKTAMTRVFNDYAR
RINELKTKDKNLDGNDIREGLTAVVSVRIPEELLQFEGQTKSKLGTSEARSAVDSVVADK
LPFYLEEKGQLSKSLVKKAIKAQQAREAARKAREDARSGKKNKRKDTLLSGKLTPAQSKN
TEKNELYLVEGDSAGGSAKLGRDRKFQAILPLRGKVINTEKARLEDIFKNEEINTIIHTI
GAGVGTDFKIEDSNYNRVIIMTDADTDGAHIQVLLLTFFFKYMKPLVQAGRVFIALPPLY
KLEKGKGKTKRVEYAWTDEELNKLQKELGKGFTLQRYKGLGEMNPEQLWETTMNPETRTL
IRVQVEDEVRSSKRVTTLMGDKVQPRREWIEKHVEFGMQEDQSILDNSEVQVLENDQFDE
EEI
>BAA35952.1|FEATURES|megares|peptide|phoP|antibiotic efflux|0
MRVLVVEDNALLRHHLKVQIQDAGHQVDDAEDAKEADYYLNEHIPDIAIVDLGLPDEDGL
SLIRRWRSNDVSLPILVLTARESWQDKVEVLSAGADDYVTKPFHIEEVMARMQALMRRNS
GLASQVISLPPFQVDLSRRELSINDEVIKLTAFEYTIMETLIRNNGKVVSKDSLMLQLYP
DAELRESHTIDVLMGRLRKKIQAQYPQEVITTVRGQGYLFELR
>BAE78115.1|FEATURES|megares|polymyxin|pmrA|antibiotic target alteration|0
MKILIVEDDTLLLQGLILAAQTEGYACDSVTTARMAEQSLEAGHYSLVVLDLGLPDEDGL
HFLARIRQKKYTLPVLILTARDTLTDKIAGLDVGADDYLVKPFALEELHARIRALLRRHN
NQGESELIVGNLTLNMGRRQVWMGGEELILTPKEYALLSRLMLKAGSPVHREILYNDIYN
WDNEPSTNTLEVHIHNLRDKVGKARIRTVRGFGYMLVANEEN
>WP_078132003.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|0
MLSKANRAKTAICGIINVTPDSFSDGGQFFALEQALQQARKLIAEGASMLDIGGESTRPG
SSYYVEIEEEIQRVVPVIKAIRKESDVLISIDTWKSQVAEAALAAGANLVNDITGLMGDE
KMAHVIAKDGAKVVIMFNPVMARPQHPSSLIFPHFGFNQAFTEEELADFETLPIEELMET
FFERALARANQAGIAQENILLDPGIGFGLTKKENLLLLRDLDKLHQKGYPIFLGVSRKRF
VINILEENGFEVNPETELGFHNRDTASAHVTSIAARQGVEVVRVHDVASHRMAVEIASAI
RLADEAENLDLKQYK
>WP_015891553.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MLSNQIINQSFAEIMGKRFGDYANLVILSRAIPDARDGLKPVQRRILYAMYQEGNTNDKP
YRKSAKTVGYVMGTYHPHGDSAIYETMVRMAQWWKMRQVLIQGHGNFGSLDADPPAAMRY
TESRLSALANELLRDIEKDTVTFIPNYDNSAQQPAVLPSRFPNLLVNGAAGIAVGFATDI
PTHNLGEVIDAAVAQMKNPNISLDELMQHVKGPDFPTGGIVQGLSGIRKAFETGRGQFII
RGKTHVEEPKGGKIKKIVVSEIPYEVVKSKLVGQIDELVMERKIEGALAVRDETGRKEAE
QKKVRIVVDIRKEADEQAILNYLYKNTDLQIYYNYNMNVIHEGTIRQMGLKALLGAYIDH
QKEVVTNRCQYDLDRKQSREHIVEGLIRAKSILRQIVDTIMDSEDRADAKKNIMEKYGFT
DNQADAILSIQLASLTRLDIVKLEKELATLAKEIEELKSILASEKKLIQVITGELNEIKK
KYAEERLTEIQGEIEEIKIDIAMQINAEDCIVTLTNEGYIKRTSPRSFKSVGGTLETCGV
KEGDRVRYFMETNTSHTALFFTQDGKYFATLVNAFPDDKWKDIGSALVNIIPLEKNQRIV
GFTIVENFKQPLYVYHVSKNGLMKKTALSEYETNRSSALVAAKLKGGDDEFMNVFVADEA
GAILGATKDGMGIRFQRSEVSATGRASSGVKAIALAPGDDVITMLPIEEVDSRAFSLLTA
EGVVKRTAIGAIPLQARAGKGVQLIRKRKNNPHELVAMFLEETVYAWTSQNEWTLVETEQ
VIVNEQGGIGRQLIEGGVKAVAFETILPTDEPKDEATAKGSGDGSGTAGQQKTSNVQANL
FDGDHRK
>AAC43480.1|FEATURES|megares|macrolide-lincosamide-streptogramin|ErmB|antibiotic target alteration|1
MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGSIPYHLSTQIIKKVVFESHAS
DIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTT
DVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTVTYEQVLSIFNSYLL
FNGRK
>YP_003614006.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MSDLAREITPVNIEEELKSSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAMNVLGNDWN
KAYKKSARVVGDVIGKYHPHGDSAVYDTIVRMAQPFSLRYMLVDGQGNFGSIDGDSAAAM
RYTEIRLAKIAHELMADLEKETVDFVDNYDGTEKIPDVMPTKIPNLLVNGSSGIAVGMAT
NIPPHNITEVINGCLAYIDDEDISIEGLMEHIPGPDFPTAAIINGRRGIEEAYRTGRGKI
YIRARAEVEADAKTGRETIIVHEIPYQVNKARLIEKIAELVKEKRVEGISALRDESDKDG
MRIVIEIKRDAVGEVVLNNLYSQTQLQVSFGINMVALHHGQPKIMNLKEILSAFVRHRRE
VVTRRTIFELRKARDRAHILEALAVALANIDPIIELIRRAPTPAEAKTALISRPWDLGNV
AAMLERAGDDAARPEWLEPEFGVRDGQYYLTEQQAQAILDLRLQKLTGLEHEKLLDEYKE
LLEQIAELLHILGSAERLMEVIREELELIRDQFGDERRTEITANSADINIEDLINQEDVV
VTLSHQGYVKYQPLTDYEAQRRGGKGKSAARIKEEDFIDRLLVANTHDTILCFSSRGRLY
WMKVYQLPEASRGARGRPIVNLLPLEANERITAILPVREYEEGVNVFMATASGTVKKTAL
TEFSRPRSAGIIAVNLNEGDELIGVDLTSGKDEVMLFSAAGKVVRFKEDAVRAMGRTATG
VRGIKLAGEDSVVSLIIPRGEGAILTVTQNGYGKRTAEGEYPTKSRGTQGVISIKVTERN
GSVVGAVQVDDADQIMMITDAGTLVRTRVSEISVVGRNTQGVILIRTAEDENVVGLQRVA
EPVDDEELDSIDGSVAEGDDDIAPEVDTDDDAADDADE
>CBA31120.1|FEATURES|megares|fosfomycin|FosA4|antibiotic inactivation|1
MLSGLNHLTLAVRDVARSLAFYQSLPGLRLHARWDGGAYLSCGSLWLCLSLDENAGSPAA
DYTHYAFTVSEADFPQVVETLTAAGVTPWKTNRSEGDSWYFLDPDGHQLELHVGSLATRL
AACRAAPYKGMRFYD
>AEK32501.1|FEATURES|megares|aminoglycoside|AadA2|antibiotic inactivation|1
MRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADHLEEFIRFVKGEIIKSVGK
>AEG42370.1|FEATURES|megares|aminoglycoside|ANT(2'')-Ia|antibiotic inactivation|1
MNKSIIIILLITVLAATMLRSRAVALKQRLGRMDTTQVTLIHKILAAADERNLPLWIGGG
WAIDARLGRVTRKHDDIDLTFPGERRGELEAIVEMLGGRVMEELDYGFLAEIGDELLDCE
PAWWADEAYEIAEAPQGSCPEAAEGVIAGRPVRCNSWEAIIWDYFYYADEVPPVDWPTKH
IESYRLACTSLGAEKVEVLRAAFRSRYAA
>WP_001833269.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MSNIQNMSLEDIMGERFGRYSKYIIQDRALPDIRDGLKPVQRRILYSMNKDSNTFDKSYR
KSAKSVGNIMGNFHPHGDSSIYDAMVRMSQNWKNREILVEMHGNNGSMDGDPPAAMRYTE
ARLSEIAGYLLQDIEKKTVPFAWNFDDTEKEPTVLPAAFPNLLVNGSTGISAGYATDIPP
HNLAEVIDAAVYMIDHPTAKIDKLMEFLPGPDFPTGAIIQGRDEIKKAYETGKGRVVVRS
KTEIEKLKGGKEQIVITEIPYEINKANLVKKIDDVRVNNKVAGIAEVRDESDRDGLRIAI
ELKKDANTELVLNYLFKYTDLQINYNFNMVAIDNFTPRQVGIVPILSSYIAHRREVILAR
SRFDKEKAEKRLHIVEGLIRVISILDEVIALIRASENKADAKENLKVSYDFTEEQAEAIV
TLQLYRLTNTDVVVLQEEEAELREKIAMLAAIIGDERTMYNLMKKELREVKKKFATPRLS
SLEDTAKAIEIDTASLIAEEDTYVSVTKAGYIKRTSPRSFAASTLEEIGKRDDDRLIFVQ
SAKTTQHLLMFTSLGNVIYRPIHELADIRWKDIGEHLSQTITNFETNEEILYVEVLDQFD
DATTYFAVTRLGQIKRVERKEFTPWRTYRSKSVKYAKLKDDTDQIVAVAPIKLDDVVLVS
QNGYALRFNIEEVPVVGAKAAGVKAMNLKEDDVLQSGFICNTSSFYLLTQRGSLKRVSIE
EILATSRAKRGLQVLRELKNKPHRVFLAGAVAEQGFVGDFFSTEVDVNDQTLLVQSNKGT
IYESRLQDLNLSERTSNGSFISDTISDEEVFDAYLQEVVTEDK
>CAH14593.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MAVAEAKPQYSHAEKKRFRKSFGKQTDIMPIPNLLEIQLKSYRDFLQTDTKLSEQLNTGL
HAAFSSVFPIESFSGNARLEYVGYKLGEPAFDVRECKLRGLTYSAPLRVKIRLVVLDKDA
SDDPKPIKDIREQDVFMGEIPLMTDVGTFVVNGTERVVVSQLHRSPGVIFEHDKGKTHSS
GKLLYSARIIPYRGSWLDFEFDPKDCVYVRIDRRRKLPVTILLRALGYEAEDILNEFFET
TCCHLKNGEYHIDLIPQRLRGEIASFDIHVPETGELIVEQGRRITARHIKQMEKSQMQDL
VVPRDYLIGKTLAKNIIDTSTGEFLAQANDEITEELLDAMASHGILQIDMIYTNDLDHGS
YISDTLKIDPTGSQLEALVEIYRMMRPGEPPTKEAAEALFKNLFFVEERYDLSAVGRMKF
NRRVGIKSDEGPGTLTKEDILSVIKTLIDIRNGIGMVDDIDHLGNRRVRSVGEMTENQFR
VGLVRVERAVKERLSLVESENLMPQDLINAKPVSAAIKEFFGSSQLSQFMDQVNPLSGVT
HKRRVSALGPGGLTRERAGFEVRDVHTTHYGRVCPIETPEGPNIGLINSLSVYARTNEYG
FIETPCRKVVNGRVTDEVEYLSAIEEVDQYIAQSNVELDAQGNILADLVPCRHQNEFSLT
TPDKINYMDVSPKQIVSVAASLIPFLEHDDANRALMGSNMQRQAVPTLRSEKPLVGTGME
RIVASDSGVSVVAKRGGVIDLVDASRIVVRVNDDETTAGETGVDIYNLTKYFRSNQDTCI
NQRPIVSTGDRIQRGDVLADGPCTDMGELALGQNLLVAFMPWNGYNFEDSILISERIVHD
DRFTTIHIEELTCIARDTKLGTEEITADIPNVGESALSNLDESGVVYIGAEVKAGDILVG
KVTPKGETQLTPEEKLLRAIFGEKASDVKDSSLRVPSGMNGTVIDVQVFTRDGLEKDARA
KSIEEEHLARVRKDLIDERRIREEDIYHRVSHLLLDKVATGGPGSLKPGSKITQDYLDKV
EREKWFDIRIEDDAISQQLEQLSKQLELLTKEMEKRFNDSRKKIIQGDDLAPGVLKIVKV
YLAVKRRIQPGDKMAGRHGNKGVISIVVPVEDMPHMEDGTAVDIVLNPLGVPSRMNIGQV
LETHLGLAAKGLGRKIAQMLDEKQTPEAIKAYLEKIYNHDGVQRVNLKCLNDDELMTLAD
NLRAGVPMATPVFDGATEQEIKSMLQLADLPADGKTVLIDGRTGNKFDNPVTVGYMYMLK
LNHLVDDKMHARSTGSYSLVTQQPLGGKAQFGGQRFGEMEVWALEAYGAAYTLQEMLTVK
SDDVGGRTKIYKNIVDGDHRMDPGMPESFNVLLKEIRALGIDIELEHD
>NP_358692.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MQDKNLVNVNLTKEMKASFIDYAMSVIVARALPDVRDGLKPVHRRILYGMNELGVTPDKP
HKKSARITGDVMGKYHPHGDSSIYEAMVRMAQWWSYRYMLVDGHGNFGSMDGDSAAAQRY
TEARMSKIALEMLRDINKNTVDFVDNYDANEREPLVLPARFPNLLVNGATGIAVGMATNI
PPHNLGETIDAVKLVMDNPEVTTKDLMEVLPGPDFPTGALVMGKSGIHKAYETGKGSIVL
RSRTEIETTKTGRERIVVTEFPYMVNKTKVHEHIVRLVQEKRIEGITAVRDESNREGVRF
VIEVKRDASANVILNNLFKMTQMQTNFGFNMLAIQNGIPKILSLRQILDAYIEHQKEVVV
RRTRFDKEKAEARAHILEGLLIALDHIDEVIRIIRASETDAEAQAELMSKFKLSERQSQA
ILDMRLRRLTGLERDKIQSEYDDLLALIADLADILAKPERVSQIIKDELDEVKRKFSDKR
RTELMVGQVLSLEDEDLIEESDVLITLSNRGYIKRLDQDEFTAQKRGGRGVQGTGVKDDD
FVRELVSTSTHDHLLFFTNKGRVYRLKGYEIPEYGRTAKGLPVVNLLKLDEDESIQTVIN
VESDRSDDAYLFFTTRHGIVKRTSVKEFANIRQNGLKALNLKDEDELINVLLAEGDMDII
IGTKFGYAVRFNQSAVRGMSRIATGVKGVNLREGDTVVGASLITDQDEVLIITEKGYGKR
TVATEYPTKGRGGKGMQTAKITEKNGLLAGLMTVQGDEDLMIITDTGVMIRTNLANISQT
GRATMGVKVMRLDQDAQIVTFTTVAVAEKEEVGTENETEGEA
>AFJ11387.1|FEATURES|megares|chloramphenicol|cat|antibiotic inactivation|1
MTNFFESPFKGIPLDQQVTHPNIVVGRHSYYSGYYHGHGFDDCARYVLPDADADRLIIGA
FCSIGSGAAFIMAGNQGHRHEWVSTFPFFYANESWQQAQAADGYLPAGDTVIGNDVWIGS
EAIIMPGVRVGDGAIIGTRALVTRDVEPYAIVGGNPARVLRKRFDEDRIALLLEMRWWDW
PDAAIEATMPLMTSGDIEGLHAAWQRQTRR
>AAK21275.1|FEATURES|megares|multidrug|omp36|reduced permeability to antibiotic|0
MKVKVLSLLVPALQVAGAAYAAEIYNKDGNKLDLYGKIDGLHYFSSDDSVDGDQTYMRIG
VKGETQINDQLTGYGQWEYNVQANNTESSSDQAWTRLAFAGLKFGDAGSFDYGRNYGVVY
DVTSWTDVLPEFGGDTYGSDNFLQSRANGVATYRNSDFFGLVDGLNFALQYQGKNGSVSG
EDQTNNGRGYQKQNGEGFGTSVTYDIWDGISAGFAYSSSKRTDEQNSVNTRYTDSNGVSR
RVLGEGDHAETYTGGLKYDANNIYLATQYTQTYNATRTGIIGFANKAQNFEVVAQYQFDF
GLRPSVAYLQSKGKDMGRYGDQDILKYVDLGATYYFNKNVSTYVDYKINLLDDNCFTKDA
SISTDNVVALGLVYQF
>ABQ54809.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MVYLAKEVLPVNIEDELKQSYLDYAMSVIVGRALPDVRDGLKPVHRRVLFAMSELGNDWN
KPYKKSARVVGDVIGKYHPHGDTAVYDTIVRMAQPFSMRYLLIDGQGNFGSVDGDAPAAM
RYTEVRMSKVAHALLADLDKETVDFSPNYDETEFAPVVLPSRIPNLLVNGSSGIAVGMAT
NIPPHNLTEVINACIALVDEPDTSLEDLMEIIPGPDFPTAAIINGRAGIIEGYRTGKGRV
VIRARTEIETDENSGRQSIIIQELPYQVNKARLIERIAELVRDKKIEGISGLRDESDKQG
MRVVIELKRNEVADVVLNNLFAHTQMQNVFGINMVALVDGQPRTLNLKQILEYFIKHRRE
VVTRRTIFELKKARNRAHLLEGLGIALANIDEMIALIKQSPTPQDAKNALLSKIWQPGLV
KAMLEKAGSNASRPDDLTEEYGLHENGYKLSEAQAQAILELRLHRLTALEQDKIINEFEE
LLNLIKELLDILASPERLMQVIRDELIEIKSQFGDERRTEITASQEDLTIEDLITEEDVV
VTLSHQGYVKYQPITAYQAQRRGGKGKSATHVKDEDFVERLVIASTHDTLLCFSNHGKLY
WLKAYQLPQASRTSRGRPIINILPLAEGEEINAMLPVREYKDGSYVFMATKKGTVKKVPL
NAFSRPRSNGIIAVDLEEDDSLVGVDITDGARDIMLFTDAGKVIRFDESKVRPMGRTARG
VRGIRVEKDQAVKSLVVVDPSGGTILTATENGYGKRTHIDEYRVSGRGGQGVISIQVTER
NGKVVRSLQVTDNDEAMLITDKGTLVRFKVNELSVIGRNTQGVRLINVSSGETVVGMQKI
VDLGEELEESEDSSLNADDNSDE
>ACD35502.1|FEATURES|megares|tetracycline|tetR|antibiotic efflux|0
MTNPAPLGRRERKKAATRKAISDVATAMFLERGFDEVSIREVADAADVSPTTVFAHFPQK
EALVFDEDDEQRDRLVAAVRERPSGSTINRAIHDFYASELRANVDEHGDEITRTFMRFLN
ETPALRDYAAKMWLRHEDALSDAIADELGLDTPTPEIRVYSRFILQMQLLVNENDDPFGT
LEAGFVILENGWAPVEAGLSGSAS
>AEE68735.1|FEATURES|megares|elfamycin|tufab|antibiotic target alteration|0
MAKGKFERTKPHVNVGTIGHVDHGKTTLTAAITTVLSNKFGGEARGYDQIDAAPEEKARG
ITINTSHVEYETETRHYAHVDCPGHADYVKNMITGAAQMDGAILVVSAADGPMPQTREHI
LLSRQVGVPYIIVFLNKADMVDDAELLELVEMEVRELLSKYDFPGDDTPIVKGSAKLALE
GDKGELGEQAILSLAQALDTYIPTPERAVDGAFLMPVEDVFSISGRGTVVTGRIERGVVK
VGEEIEIVGIKPTVKTTCTGVEMFRKLLDQGQAGDNVGILLRGTKREDVERGQVLAKPGS
INPHTDFTAEVYILSKEEGGRHTPFFNGYRPQFYFRTTDVTGTIDLPADKEMVLPGDNVS
MTVKLLAPIAMEEGLRFAIREGGRTVGAGVVAKIIK
>AEX49909.1|FEATURES|megares|polymyxin|pmrA|antibiotic target alteration|0
MRILLAEDDLLLGDGIRAGLRLEGDTVEWVTDGVAAENALVTDEFDLLVLDIGLPRRSGL
DILRNLRHQGRLTPVLLLTARDKVADRVAGLDSGADDYLTKPFDLDELQARVRALTRRTT
GRALPQLVHGELRLDPATHQVTLSGQAVELAPREYALLRLLLENSGKVLSRNQLEQSLYG
WSGDVESNAIEVHVHHLRRKLGNQLIRTVRGIGYGIDQPAP
>AAT30688.1|FEATURES|megares|macrolide-lincosamide-streptogramin|mph|antibiotic inactivation|1
MTTLKVKQLANKKGLNILEDSIEINESGVDFQVAHVTEQNGDKWILRIPRRPESMRHALR
EKEALEIMKKHAAFQVPNWSIFSEELIAYKQLSGFPAATIDIEQQKYVWNFNEKNVPTEY
YISLGKVLANVHSLSQQKFNNIGVEILTANELRTSMKQRMNRVKEQYHINQNLWDRWQAW
LAEDSFWPSHVGVKHGDIHPGHILIDKKNNVTGLIDWTEVGIGDVSIDFTSHYLLFGKDG
LTKLIHSYDNAGGKTWSRMDEHIIELLTTSSITVAEYAQVSGLKDMHEAAIHMLATEC
>CAC85829.1|FEATURES|megares|sulfonamide|sul2|antibiotic target replacement|1
MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVS
SDTEIARIAPVLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDAAFYPQLAK
SSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFF
LGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAAA
GGADFSRTHEPRPLRDGLAVLAALKETARIR
>ATB17820.1|FEATURES|megares|beta_lactam|DHA-1|antibiotic inactivation|1
MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYF
NYGFADVQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQW
KGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGAL
TANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESY
GVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKD
MIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>WP_012683793.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MAEETARFPKVDISHEMRESFISYAMSVIVSRALPDVRDGLKPVHRRILYAMHDMGLTPD
KPFRKSANVVGEVMANYHPHGDSSIYEAMVRMAQDFNMRYMLVEGQGNFGSVDGDPAAAM
RYTESRFSKLALELLRDIDKETVDFIPNYDGRKEEPVVLPSRFPNLLLNGASGIAVGMAT
NIPPHNLTEVVDGVIAMIDNPDITIQDLMKIIKGPDFPTAGEILGYSGIRRAYETGRGSI
IMRAKTQIEEDGKGKPRIIVTEIPYQVNKARLVEKIAELVREKKIEGITDLRDESDRKGM
RIVMELRRDVIPKVVLNNLFKHTQMQSTFGVNMLALVDSRPRVLNLRDMLYYYLEHQRVI
IRRRTEYDLKQAEARAHILEGLRIALDHIDEIISLIRSSQTTEEARTGLMENYSLSYEQA
QAILDMRLQRLTGLEREKIENEYQELMVKIAELRAILADEAKIYAIIRDELGEIKEKFGD
ERRTEITFDENHIEDADLIPEEDVVITLTHDGYIKRLPVSTYRSQKRGGRGVQGLGTKDD
DFVEHLYITNSHDYIMFFTSKGKVYRLKGFEIPDLSRTAKGTPIINLIQIEKGERVSAVI
PVKEFDQEHYLFFATKKGIIKKTTLESYENIRKGGLIAVNLREDDELIGVRLTDGQQQII
MGTHKGMSVRFNEGDVRTMGRNATGVKGITLDDDDDVIDMDVIKPNAEVLIVTANGYGKR
TPVDEYRIQSRGGKGIKTHNVTDRSGPVVGLKVVEPEEDLMIITTSGIIIRTEMKGISVM
GRYTQGVKLIRLSENEQVGSVAKCPPTEEEDMTDEDAEEGIEDLQDGETVEATEPIEPTE
PTEE
>AAD25062.1|FEATURES|megares|macrolide-lincosamide-streptogramin|myrA|antibiotic target alteration|0
MSALAAPGLSAIRDSLRCPICAGRLELTPGALRCRQRHTFNIARHGYVSLLSGTNAISGD
DAPMIQARERFLATGAYEPIRRAVSTMVSHTIPRDGIVLDVGCGTGYYLAGALDKVTGAR
GLGLDSSVRALRVAARVHERAAAASWDVFRPYPLADQSVDAVLNMFAPRNPGEFHRVLRP
NGSLIVVRPTVDHLAELRRDVPDSVTIDVSKEQRLHDALAPFFEQERDQHVGYIAEIEPQ
TARDLLGMTPSARHITPAEVSDDDLPERVTISVLVSSYRLRET
>WP_000952923.1|FEATURES|megares|beta_lactam|mecA|antibiotic target replacement|1
MLSIISSLLTICVIFLVRMLYIKYTQNIMSHKIWLLVLVSTLIPLIPFYKISNFTFSKDM
MNRNVSDTTSSVSHMLDGQQSSVTKDLAINVNQFETSNITYMILLIWVFGSLLCLFYMIK
AFRQIDVIKSSSLESSYLNERLKVCQSKMQFYKKHITISYSSNIDNPMVFGLVKSQIVLP
TVVVETMNDKEIEYIILHELSHVKSHDLIFNQLYVVFKMIFWFNPALYISKTMMDNDCEK
VCDRNVLKILNRHEHIRYGESILKCSILKSQHINNVAAQYLLGFNSNIKERVKYIALYDS
MPKPNRNKRIVAYIVCSISLLIQAPLLSAHVQQDKYETNVSYKKLNQLAPYFKGFDGSFV
LYNEREQAYSIYNEPESKQRYSPNSTYKIYLALMAFDQNLLSLNHTEQQWDKHQYPFKEW
NQDQNLNSSMKYSVNWYYENLNKHLRQDEVKSYLDLIEYGNEEISGNENYWNESSLKISA
IEQVNLLKNMKQHNMHFDNKAIEKVENSMTLKQKDTYKYVGKTGTGIVNHKEANGWFVGY
VETKDNTYYFATHLKGEDNANGEKAQQISERILKEMELI
>CAF05909.1|FEATURES|megares|aminoglycoside|ant3-dprime|antibiotic inactivation|1
QFLRPPSDIDLLVTVTVRLDETTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPW
RYPAKRELQFGEWQRNDILAGIFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPE
QDLFEALNETLTLWNSPPDWAGDERNVVLTLSRIWYSAVTGRIAPKDVAADWAMERLPAQ
YQPVILEARQAYLGQEEDRLASRADQLEEFVHYVKGEITKVVGK
>AAK91785.1|FEATURES|megares|macrolide-lincosamide-streptogramin|vatE|antibiotic inactivation|1
MTIPDANAIYPNSAIIEVVFIKNVIKSPNIEIGDYTYYDDPVNPTDFEKHVTHHYEFLGD
KLIIGKFCSIASGIEFIMNGANHVMKGISTYPFNILGGDWQQYTPELTDLPLKGDTVVGN
DVWFGQNVTVLPGVKIGDGAIIGANSVVTKDVAPYTIVGGNPIQLIGPRFEPEVIQALEN
LAWWNKDIEWITANVPKLMQTTPTLELINSLMEK
>CAA47093.1|FEATURES|megares|macrolide-lincosamide-streptogramin|ErmB|antibiotic target alteration|1
MYHFRSDYMNKNIKYSQNFLTNEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISK
QVTSIELDSHLFNLSSEKLKLNIRVTLIHQDILQFQFPNKQRYKIVGNIPYHLSTQIIKK
VVFESHASDIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVL
IKLTRHTTDVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTVTYEQVL
SIFNSYLLFNGRK
>ADZ05811.1|FEATURES|megares|sulfonamide|sul1|antibiotic target replacement|1
MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPAD
EIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVCYLNDIQGFPDPALYPDIAEADC
RLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFL
SPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGN
GADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA
>CBO78207.1|FEATURES|megares|sulfonamide|sul2|antibiotic target replacement|1
MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVS
SDTEIERIAPVLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDAAFYPQLAK
SSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFF
LGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAAA
GGADFIRTHEPRPLRDGLAVLAALKETARIR
>CAA94712.1|FEATURES|megares|quinolone|gyrB|antibiotic target alteration|0
MYVGSTGERGLHHLIWEVVDNSVDEAMAGYATQVDVRLFDDGSVEVADNGRGIPVAVHAT
GVPTVDVVMTQLHAGGKFGGKDSGYNVSGGLHGVGVSVVNALSTRVEVDIKRDGYEWSQF
YDKAVPGILKQGEATEATGTTIRFWADPDIFETTKYDFGTVARRIQEVAFLNKGLTINLV
DERVKQDEVVDDVVSDTAEAPVAMTVEEKSTESSAPHKVRHRTFHYPGGLVDFVKHINRT
KTPIQQSIIDFDGKGAGHEVEVAMQWNGGYSESVHTFANTINTHEGGTHEEGFRSALTSV
VNKYAKDKKLLKDKDPNLTGDDIREGLAAVISVKVSEPQFEGQTKTKLGNTEVKSFVQRV
CNEQLIHWFEANPVDAKAVVNKAISSAQARIAARKARELVRRKSATDLGGLPGKLADCRS
TDPRSSELYVVEGDSAGGSAKSGRDSMFQAILPLRGKIINVEKARIDRVLKNTEVQAIIT
ALGTGIHDEFDISRLRYHKIVLMADADVDGQHISTLLLTLLFRFMRPLIEHGYVFLAQPP
LYKLKWQRMDPEFAYSDSERDGLLETGLKLGKKINKEDGIQRYKGLGEMDAKELWETTMD
PSVRVLRQVTLDDAAAADELFSILMGEDVDARRSFITRNAKDVRFLDV
>BAP39824.1|FEATURES|megares|beta_lactam|blaPER-8|antibiotic inactivation|1
MNVIIKAVVTASTLLMVSFSSFETSAQSPLLKEQIESIVIEKKATVGVAVWGPDDLEPLL
INPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWAPIMKAYQGDQF
SVPVQQLLQYSVSHSDNVACDLLFELVGGPAALHDYIQSMGIKETAVVANEAQMHADDQV
QYQNWTSMKGAAEILKKFEQKTQLSETSQALLWKWMVETTTGPERLKGLLPAGTVVAHKT
GTSGVRAGKTAATNDLGIILLPDGRPLLVAVFVKDSAESSRTNEAIIAQVAQAAYQFELK
KLSALSPN
>AAY52017.1|FEATURES|megares|glycopeptide|vanXA|antibiotic target alteration|1
MEKGFVFLDEILHGVRWDAKYATWDNFTGKPVDGYEVNRIVGTHALALALLKAQKQAAAL
GYGLLLWDGYRPKRAVDCFLRWSEQPEDNLTKERYYPNIERTEMVSKGYVASKSSHSRGS
AIDLTLYRLDTGELVPMGSGFDFMDERSHHAAKGIASMEAQNRRRLRSIMENSGFEPYSF
EWWHYVLRNETIPQ
>AFQ65930.1|FEATURES|megares|beta_lactam|ampH|antibiotic inactivation|0
MALVVIDGNQRVFRSFGETRPGNNQHPQLDSVIRIASLSKLMTSEMLVKLLDQGVVKLND
PLSKYAPPGARVPDWQGKPITLVNLATHTSALPREQPGGAAHRPVFVWPTRQQRWNWLST
ATLKAAPGSQAAYSNLAFDLLADALATAAGKPYPQLFEEQITRPLGMKDTTFTPSPDQCQ
RLMIPEKGASPCNNTLAAIGSGGVYSTPGDMMRWMQQFLSSDFYTRSQQADRMQTLIYQR
NQLTRVIGMDVPGRADALGLGWVYMKPKNGHPGIIQKTGGGGGFITYMAMNPQANVGAFV
VVTRSPLTRFNNMSDGINDLVSELSGAQPNMQTASQ
>AAA27431.1|FEATURES|megares|macrolide-lincosamide-streptogramin|ErmF|antibiotic target alteration|1
MTKKKLPVRFTGQHFTIDKVLIKDAIRQANISNQDTVLDIGAGKGFLTVHLLKIANNVVA
IENDTALVEHLRKLFSDARNVQVVGCDFRNFAVPKFPFKVVSNIPYGITSDIFKILMFES
LGNFLGGSIVLQLEPTQKLFSRKLYNPYTVFYHTFFDLKLVYEVGPESFLPPPTVKSALL
NIKRKHLFFDFKFKAKYLAFISCLLEKPDLSVKTALKSIFRKSQVRSISEKFGLNLNAQI
VCLSPSQWLNCFLEMLEVVPEKFHPS
>ABR76005.1|FEATURES|megares|multidrug|ramR|antibiotic efflux|0
VARPKSEDKKQALLEAATAAFAQSGIAASTSAIARSAGVAEGTLFRYFATKDELLNELYL
AIKLRLVRTMIAGLDPDEKRPKENARNIWNSYIDWGVRNPMEHKAIRRMALSERITDETR
RQVKESFPELNEMCQLSVKEIFLSEAYRAFGDALFLSLAETTIEFASHDPQRAREIIALG
FEAMWHALHEADA
>CAC44895.1|FEATURES|megares|tetracycline|tetG|antibiotic efflux|1
LLIVGLDAMGLGLIMPVLPALLRELVPAEQVAGHYGALLSLYALMQVIFAPVLGQFSDAY
GRRPVLLASLAGAAVDYTIMASAPVLWVLYIGRIVSGVTGATGAVAASTIADSTGEGSRA
RWFGYMGACYGAGMIAGPALCGMLGGISAHAPFIAAALLNGFAFLLAYIFLKETHHSHGG
TRKPVRIKPFVLFRLDDTLRGLGALFAVFFIIQLIGQVPAALWVIYGEDRFQWDTTTVGL
SLAAFGATHAIFQAFVTGPLSSRLGERRTLLFGMAADATGFILLAFATQGWMVFPILLLL
AAGGVGMPALQAMLSNNVSGNKQGALQGTLTSLTNLSSIAGPLGFTALYSATAGAWNGWV
WIVGAILYLICLPILRRPFA
>AFK58692.1|FEATURES|megares|peptide|cls|antibiotic target alteration|0
MLLYVRRNIFVVSSIITALYLLNALIALVAILIKPRDVAAIWAWLLVLFALPGVGFVLYL
FFGRGLTDKKKFYLRQSDLKELENFQSFRGDTIEHYDPDMGDKDKQQFVDFFSSLNRMPL
TRMNSVTLLTDGQEKLDSLLQDLKKAKHSIHIEYYAFVTDNIGQQVLHVLEEKAAEGVEV
RILYDAFGSHGTKAKDFNRLIKNGGHVHTFVTSQRALLRFRLNYHDHRKIVVIDGKISYT
GGFNIANQYVNTTKKFGYWRDTHIRIFGAASSLLQLRFLTDWNVSVPEEKKVGYHLNYFF
KKADRDESKLADTSIQLVSSGPNNEREQIKLSFIKLITSAKKRVWIQTPYLVPDESVIAA
LKIATASGVDVKIMIPNKPDHPFIYRATQYYARQLIKENVQILVYENGFLHAKTLIMDDE
ICMVGSANQDIRSYRLNFETSAVIYDPEFLEELATQFKEDETHCSSMTTETVKEMSNWLL
FKQQISRLFSPIL
>CAJ87111.1|FEATURES|megares|trimethoprim|dfrA17|antibiotic target replacement|1
LKISLIAAQSENGVIGNGPDIPWSAKGEQLLFKALTYNQWLLVGRKTFESMGILPNRKYA
VLSKNGISHLPENVLVFSSIENALYELAKVTDHLYISGGGQIYNSLIESADTIHLSIIHK
EVEGEVRFPKIPPNYKLVFEQYYSSNINYTYQIWQKGX
>YP_001706375.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|0
MQLISLPKQILQCGQLQLDLSQPHVMGILNVTPDSFSDGGKHNQLDQAVDHALSMIEQGA
TIIDIGGESTRPGASEVAVEEEVRRVVPVVEALSHHNVILSIDTSQPEVIRAAKAAGAHI
WNDVRALTGPNALKTAVELDIPVVIMHMRGEPTTMNQLDQYTDVTLDVMQELQQRIDEAL
AAGVKKHNIIVDPGFGFAKNAQQNLKLLKEFWKLNELGYPILSGLSRKRFIGEALQGAPA
DQRAVGSVTGHLLSIQQGASIVRAHDVKEMHEAILVWKAMQQA
>YP_499066.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MAELPQSRINERNITSEMRESFLDYAMSVIVARALPDVRDGLKPVHRRILYGLNEQGMTP
DKSYKKSARIVGDVMGKYHPHGDSSIYEAMVRMAQDFSYRYPLVDGQGNFGSMDGDGAAA
MRYTEARMTKITLELLRDINKDTIDFIDNYDGNEREPSVLPARFPNLLANGASGIAVGMA
TNIPPHNLTELINGVLSLSKNPDISIAELMEDIEGPDFPTAGLILGKSGIRRAYETGRGS
IQMRSRAVIEERGGGRQRIVVTEIPFQVNKARMIEKIAELVRDKKIDGITDLRDETSLRT
GVRVVIDVRKDANASVILNNLYKQTPLQTSFGVNMIALVNGRPKLINLKEALVHYLEHQK
TVVRRRTQYNLRKAKDRAHILEGLRIALDHIDEIISTIRESDTDKVAMESLQQRFKLSEK
QAQAILDMRLRRLTGLERDKIEAEYNELLNYISELEAILADEEVLLQLVRDELTEIRDRF
GDDRRTEIQLGGFEDLEDEDLIPEEQIVITLSHNNYIKRLPVSTYRAQNRGGRGVQGMNT
LEEDFVSQLVTLSTHDHVLFFTNKGRVYKLKGYEVPELSRQSKGIPVVNAIELENDEVIS
TMIAVKDLESEDNFLVFATKRGVVKRSALSNFSRINRNGKIAISFREDDELIAVRLTSGQ
EDILIGTSHASLIRFPESTLRPLGRTATGVKGITLREGDEVVGLDVAHANSVDEVLVVTE
NGYGKRTPVNDYRLSNRGGKGIKTATITERNGNVVCITTVTGEEDLMIVTNAGVIIRLDV
ADISQNGRAAQGVRLIRLGDDQFVSTVAKVKEDAEDETNEDEQSTSTVSEDGTEQQREAV
VNDETPGNAIHTEVIDSEENDEDGRIEVRQDFMDRVEEDIQQSSDEE
>AAA63165.1|FEATURES|megares|macrolide-lincosamide-streptogramin|ErmF|antibiotic target alteration|1
MTKKKLPLRFTGQHFTIDKVLIKDAIRQANISNQDTVLDIGAGKGFLTVHLLKIANNVVA
IENDTALVEHLRKLFSDARNVQVVGCDFRNFAVPKFPFKVVSNIPYGITSDIFKILMFEN
LENFLGGSIVLQFEPTQKLFSRKLYNPYTVFYHTFFDLKLVYEVGPESFLPPPTVKSALL
NIKRKHLFFDFKIKAKYLAFISCLLEKPDLSVKTALKSIFRKSQVRTISEKFGLNLNAQI
VCLSPSQWLNCFLEMLEVVPEKFHPS
>ABQ56518.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MSENYTAEAIEVLSGLEPVQRRPGMYTDTTRPNHLAQEVIDNSVDEVLAGFASRIIVTLH
EDGSIEVEDDGRGMPVDLHPQLGLSGVEVIMTRLHAGGKFSDKNYSFSGGLHGVGVSVVN
ALSERLDVTIKRNGIIYQMTFANGDKLCELNETGVTKKRETGTVIRFWPNGKYFDTTKIS
VKHLTHVLRAKAVLCSGLSMTFINKITNEEMNWCYEQGLTDYLQQTLPEDYLPEEPFAGA
FKSDEATVDWALAWSDSANGNLNESYVNLIPTIQGGTHVNGLRSGLFEAMSEFCELRNLL
PRGVKLTADDLWESCQYVLSIKMKEPQFAGQTKERLSSRQTSGLVSNVIKDAFAIWLNQH
RNQGEAIAALAIERAQKRLKQAKQVARKRVSQGPALPGKLADCLQTDLSQAELFLVEGDS
AGGSAKQARNKDYQAILPLRGKILNSWEVDSSQVLASQEIHDISVAIGVDPGSSDLEGLR
YGKICILADADSDGAHIATLICALFLRHFKPLVKAGHVFVAMPPLYRIDAGKLIHYALDD
EEKNRIIQHLSQTTKSKVNVQRFKGLGEMNPIQLRETTMDPNTRRLVQLTLDDEEQTEAI
MDMMLNKKRAADRKLWLETKGNLAEI
>CAH25815.1|FEATURES|megares|sulfonamide|sul2|antibiotic target replacement|1
MNKSLIIFGIVNITSDSFSDGGRYLAPDAAITQARKLMAEGADVIDLGPASSNPDAAPVS
SDTEIARIAPVLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDAAFYPQLAK
SSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFF
LGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAAA
GGADFIRTHEPRPLRDGLAVLAALKETARIR
>AEA35203.1|FEATURES|megares|tetracycline|tetA(P)|antibiotic efflux|1
WIAEEEKNKDLDEIYIKGAQAGQIGAFIGIVLSTVIANFSVRLPIIVSGVLFIILALFLW
LYMPENNFKPSAPGDLNTFKKMVYTFKSGLKIVKSKSIIMILLAVTLFYGLSSEGYDRLS
NAHFLQDTTLPKLGNLSSVTWFGIFGILGMILSFIVMHFMAKNLKNEDNRKNGKLLLCIN
ILYISSMLIFALTKNFSLMLIAYLATNTFRIINEPIFSAWLNGHI
>AAS18387.1|FEATURES|megares|sulfonamide|sul2|antibiotic target replacement|1
MNKSLIIFGIVNITSDSFSGGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVS
SDTEIERIAPVLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDAAFYPQLAK
SSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFS
LGAAPETSLSVLARFDELRLRLDLPVLLSVSRKSFLRAPTGRGPGDVGAATLAAGLAAAA
GGADFIRTHEPRPLRDGLAVLAALKETARIR
>WP_000819096.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MAELPQSRINERNITSEMRESFLDYAMSVIVARALPDVRDGLKPVHRRILYGLNEQGMTP
DKSYKKSARIVGDVMGKYHPHGDSSIYEAMVRMAQDFSYRYPLVDGQGNFGSMDGDGAAA
MRYTEARMTKITLELLRDINKDTIDFIDNYDGNEREPSVLPARFPNLLANGASGIAVGMA
TNIPPHNLTELINGVLSLSKNPDISIAELMEDIEGPDFPTAGLILGKSGIRRAYETGRGS
IQMRSRAVIEERGGGRQRIVVTEIPFQVNKARMIEKIAELVRDKKIDGITDLRDETSLRT
GVRVVIDVRKDANASVILNNLYKQTPLQTSFGVNMIALVNGRPKLINLKEALVHYLEHQK
TVVRRRTQYNLRKAKDRAHILEGLRIALDHIDEIISTIRESDTDKVAMESLQQRFKLSEK
QAQAILDMRLRRLTGLERDKIEAEYNELLNYISELETILADEEVLLQLVRDELTEIRDRF
GDDRRTEIQLGGFEDLEDEDLIPEEQIVITLSHNNYIKRLPVSTYRAQNRGGRGVQGMNT
LEEDFVSQLVTLSTHDHVLFFTNKGRVYKLKGYEVPELSRQSKGIPVVNAIELENDEVIS
TMIAVKDLESEDNFLVFATKRGVVKRSALSNFSRINRNGKIAISFREDDELIAVRLTSGQ
EDILIGTSHASLIRFPESTLRPLGRTATGVKGITLREGDEVVGLDVAHANSVDEVLVVTE
NGYGKRTPVNDYRLSNRGGKGIKTATITERNGNVVCITTVTGEEDLMIVTNAGVIIRLDV
ADISQNGRAAQGVRLIRLGDDQFVSTVAKVKEDAEDETNEDEQSTSTVSEDGTEQQREAV
VNDETPGNAIHTEVIDSEENDEDGRIEVRQDFMDRVEEDIQQSSDEDEE
>WP_000167947.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|0
MTKTKIMGILNVTPDSLSDGGKFNNVESAINRVKAMIDEGADIIDVGGVSTRPGHEMVSL
EEEMNRVLPVVEAIVGFDVKISVDTFRSEVAEACLKLGVDMINDQWAGLYDHRMFQIVAK
YDAEIILMHNGNGNRDEPVVEEMLTSLLAQAHQAKIAGIPSNKIWLDPGIGFAKTRNEEA
EVMARLDELVATEYPVLLATSRKRFTKKMMGYDTTPVERDEVTAATTAYGIMKGVRAVRV
HNVELNAKLAKGIDFLKENENARHNLS
>CAJ14963.1|FEATURES|megares|nitroimidazole|nimE|antibiotic inactivation|1
MFREMRRKRQLLPQEESVAILEKMTNGTLALHGDNGYPYAVPLSYFYADGKIYFHCAKIG
HKVDAIMQNNKVSFCVVEQDNIKPAEFTTYFRSVIVFGKAYILTDETEKRMAMTLLVNKY
SFGEPGLSDEIAKSINHLLMVKIDI
>AAA24297.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MYVIMDRALPFIGDGLKPVQRRIVYAMSELGLNASAKFKKSARTVGDVLGKYHPHGDSAC
YEAMVLMAQPFSYRYPLVDGQGNWGAPDDPKSFAAMRYTESRLSKYSELLLSELGQGTAD
WVPNFDGTLQEPKMLPARLPNILLNGTTGIAVGMATDIPPHNLREVAQAAIALIDQPKTT
LDQLLDIVQGPDYPTEAEIITSRAEIRKIYENGRGSVRMRAVWKKEDGAVVISALPHQVS
GARVLEQIAAQMRNKKLPMVDDLRDESDHENPTRLVIVPRSNRVDMDQVMNHLFATTDLE
KSYRINLNMIGLDGRPAVKNLLEILSEWLVFRRDTVRRRLNYRLEKVLKRLHILEGLLVA
FLNIDEVIEIIRNEDEPKPALMSRFGLTETQAEAILELKLRHLAKLEEMKIRGEQSELEK
ERDQLQGILASERKMNNLLKKELQADAQAYGDDRRSPLQEREEAKAMSEHDMLPSEPVTI
VLSQMGWVRSAKGHDIDAPGLNYKAGDSFKAAVKGKSNQPVVFVDSTGRSYAIDPITLPS
ARGQGEPLTGKLTLPPGATVDHMLMESDDQKLLMASDAGYGFVCTFNDLVARNRAGKALI
TLPENAHVMPPVVIEDASDMLLAITQAGRMLMFPVSDLPQLSKGKGNKIINIPSAEAARG
EDGLAQLYVLPPQSTLTIHVGKRKIKLRPEELQKVTGERGRRGTLMRGLQRIDRVEIDSP
RRASSGDSEE
>AEL00447.1|FEATURES|megares|quinolone|QnrB17|antibiotic target protection|1
MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>EEW38810.1|FEATURES|megares|fosfomycin|FosA5|antibiotic inactivation|1
MLSGLNHLTLAVSQLAPSVAFYQQLLGMTLHARWDSGAYLSCGDLWLCLSLDPQRRVTPP
EESDYTHYAFSISEADFASFAARLEAAGVAIWKLNRSEGASHYFLDPDGHKLELHVGSLA
QRLAACREQPYKGMVFFDQ
>WP_000819066.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MAELPQSRINERNITSEMRESFLDYAMSVIVARALPDVRDGLKPVHRRILYGLNEQGMTP
DKSYKKSARIVGDVMGKYHPHGDLSIYEAMVRMAQDFSYRYPLVDGQGNFGSMDGDGAAA
MRYTEARMTKITLELLRDINKDTIDFIDNYDGNEREPSVLPARFPNLLANGASGIAVGMA
TNIPPHNLTELINGVLSLSKNPDISIAELMEDIEGPDFPTAGLILGKSGIRRAYETGRGS
IQMRSRAVIEERGGGRQRIVVTEIPFQVNKARMIEKIAELVRDKKIDGITDLRDETSLRT
GVRVVIDVRKDANASVILNNLYKQTPLQTSFGVNMIALVNGRPKLINLKEALVHYLEHQK
TVVRRRTQYNLRKAKDRAHILEGLRIALDHIDEIISTIRESDTDKVAMESLQQRFKLSEK
QAQAILDMRLRRLTGLERDKIEAEYNELLNYISELEAILADEEVLLQLVRDELTEIRDRF
GDDRRTEIQLGGFENLEDEDLIPEEQIVITLSHNNYIKRLPVSTYRAQNRGGRGVQGMNT
LEEDFVSQLVTLSTHDHVLFFTNKGRVYKLKGYEVPELSRQSKGIPVVNAIELENDEVIS
TMIAVKDLESEDNFLVFATKRGVVKRSALSNFSRINRNGKIAISFREDDELIAVRLTSGQ
EDILIGTSHASLIRFPESTLRPLGRTATGVKGITLREGDEVVGLDVAHANSVDEVLVVTE
NGYGKRTPVNDYRLSNRGGKGIKTATITERNGNVVCITTVTGEEDLMIVTNAGVIIRLDV
ADISQNGRAAQGVRLIRLGDDQFVSTVAKVKEDAEDETNEDEQSTSTVSEDGTEQQREAV
VNDETPGNAIHTEVIDSEENDEDGRIEVRQDFMDRVEEDIQQSSDEE
>AAO82906.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MKSLAGHVVKYGKHRERRSFARISEVLELPNLIEIQTDSYQWFLDEGLREMFEDILPIDD
FQGNLSLEFVDYELKEPKYTVEEARAHDANYSAPLHVTLRLTNRETGEIKSQEVFFGDFP
LMTEMGTFIINGAERVIVSQLVRSPGVYFHGKVDKNGKEGFGSTVIPNRGAWLEMETDAK
DISYVRIDRTRKIPLTVLVRALGFGSDDTIFEIFGDSESLRNTIEKDLHKNASDSRTEEG
LKDIYERLRPGEPKTADSSRSLLTARFFDPKRYDLANVGRYKVNKKLDLKTRLLNLTLAE
TLVDPETGEIIVEKGTVLTHQIMETLGEYIDNGLNSVTYYPSEDAVVTEPMTIQVIQVLS
PKDPERIVNVIGNGYPDDSVKTVRPADIVASMSYFFNLMEDIGNVDDIDHLGNRRIRSVG
ELLQNQFRIGLARMERVVRERMSIQDTETLTPQQLINIRPVVASIKEFFGSSQLSQFMDQ
TNPLGELTHKRRLSALGPGGLTRDRAGYEVRDVHYSHYGRMCPIETPEGPNIGLINSLSS
YAKVNKFGFIETPYRRVDRATGRVTDQVDYLTADIEDHYIVAQANSLLNEDGTFANDVVM
ARLQSENLEVAVDKVDYMDVSPKQVVAVATACIPFLENDDSNRALMGANMQRQAVPLIQP
RSPWVGTGMEYKSAHDSGAALLCKHDGVVEFVDAKEIRVRRDNGALDKYMVTKFRRSNSG
TSYNQRPIVHLGEKVEKGDTLADGPSMEEGEMALGQNVLVAFMTWEGYNYEDAIIMSRRL
VKDDVYTSVHIEEYESEARDTKLGPEEITREIPNVGEDALKDLDEMGIIRIGAEVQDGDL
LVGKVTPKGVTELSAEERLLHAIFGEKAREVRDTSLRVPHGGGGIVHDVKIFTREAGDEL
SPGVNMLVRVYIVQKRKIHEGDKMAGRHGNKGVVSRIMPEEDMPFLPDGTPVDIMLNPLG
VPSRMNIGQVLELHLGMAARQLGIHVATPVFDGATDEDVWETVREAGMASDAKTVLYDGR
TGEPFDNRISVGVMYMIKLAHMVDDKLHARSIGPYSLVTQQPLGGKAQFGGQRFGEMEVW
ALEAYGAAYTLQEILTYKSDDVVGRVKTYEAIVKGEPIPKPGVPESFRVLVKELQSLGLD
MRVLDIEEAEIELRDMDDDDDDLITVDALTKFAEQQSAKQLEKEAESVVKEEAQDVVQEI
ETAEDRD
>ABB62283.1|FEATURES|megares|multidrug|asmA|antibiotic efflux|0
MRRFLTTLMILLVVLVAGLSALVLLVNPNDFRDYMVKQVAARSGYQLQLDGPLRWHVWPQ
LSILSGRMSLTAQGASQPLVRADNMRLDVALLPLLSHQLSVKQVMLKGAVIQLTPQTEAV
RSEDAPVAPRDNTLPDLSDDRGWSFDISSLKVADSVLVFQHEDDEQVTIRNIRLQMEQDP
QHRGSFEFSGWVNRDQRDLTISLNGTVDASDYPHDLTAAIEQINWQLQGADLPKQGIQGQ
GSFQAQWQELHKRLSFNQISLTANDSTLSGQAQVTLTEKPEWQLRLQFPQLNLDNLIPLN
ETANGENGAAQQGQSQSTLPRPVISSRIDEPAYQGLQGFTADILLQASNVRWRGMNFTDV
ATQMTNKSGLLEITQLQGKLNGGQVSLPGTLDATSINPRINFQPRLENVEIGTILKAFNY
PISLTGKMSLAGDFSGADIDADAFRHNWQGQAHVEMTDTRMEGMNFQQMIQQAVERNGGD
VKAAENFDNVTRLERFTTDLTLKAGVVTLNDMQGQSPVLALTGEGMLNLAAQTCDTQFDL
RVVGGWNGESKLIDFLKETPVPLRVYGNWQQLNYSLQVDQLLRKHLQDEAKRRLNDWAER
NKDSRNGKDVKKLLEKM
>ABG77966.1|FEATURES|megares|multidrug|acrB|antibiotic efflux|0
MPNFFIDRPIFAWVIAIIIMLAGGLSILKLPVAQYPTIAPPAVTISATYPGADAKTVQDT
VTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQ
EVQQQGVSVEKSSSSFLMVVGVINTNGTMTQEDISDYVGANMKDAISRTSGVGDVQLFGS
QYAMRIWMDPNKLNNFQLTPVDVINAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRL
TSADEFSKILLKVNQDGSQVRLRDVAKVELGGENYDIIAKFNGKPASGLGIKLATGANAL
DTATAIRAELKKMEPYFPSGLKIVYPYDTTPFVKISIHEVVKTLAEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAILAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
AEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMAL
SVLVALILTPALCATMLKPIQKGGHGEHKGFFGWFNRMFDKSTHHYTDSVGNILRSTGRY
LLLYIIIVAGMAILFVRLPSSFLPDEDQGVFLTMAQLPAGASQERTQKVLDEVTDYYLTK
EKDNVESVFAVNGFGFAGRGQNTGIAFVSLKDWSERPGKENKVEAITGRAMGTFSQIKDA
MVFAFNLPAIVELGTATGFDFQLIDQGGLGHEKLTQARNQLFGEVAKHPDLLVGVRPNGL
EDTPQYKIDIDQEKAQALGVSISDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAQYRM
LPNDINSWFVRGSNGQMVPFSAFSTSRWEYGSPRLERYNGLPSMEILGQAAPGRSTGEAM
NLMEELASKLPSGVGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSV
MLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGLI
EATLEAVRMRLRPILMTSLAFILGVLPLVISSGAGSGAQNAVGTGVMGGMITATVLAIFF
VPVFFVVVRRRFSRKNEDVEHAHSVEPH
>WP_000037277.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MSKKEININNYNDDAIQVLEGLDAVRKRPGMYIGSTDGAGLHHLVWEIVDNAVDEALSGF
GDRIDVTINKDGSLTVQDHGRGMPTGMHAMGIPTVEVIFTILHAGGKFGQGGYKTSGGLH
GVGSSVVNALSSWLEVEITRDGAVYKQRFENGGKPVTTLKKIGTAPKSKTGTKVTFMPDA
TIFSTTDFKYNTISERLNESAFLLKNVTLSLTDKRTDEAIEFHYENGVQDFVSYLNEDKE
ILTPVLYFEGEDNGFQVEVALQYNDGFSDNILSFVNNVRTKDGGTHETGLKSAITKVMND
YARKTGLLKEKDKNLEGSDYREGLAAVLSILVPEEHLQFEGQTKDKLGSPLARPVVDGIV
ADKLTFFLMENGELASNLIRKAIKARDAREAARKARDESRNGKKNKKDKGLLSGKLTPAQ
SKNPAKNELYLVEGDSAGGSAKQGRDRKFQAILPLRGKVVNTAKAKMADILKNEEINTMI
YTIGAGVGADFSIEDANYDKIIIMTDADTDGAHIQTLLLTFFYRYMRPLVEAGHVYIALP
PLYKMSKGKGKKEEVAYAWTDGELEELRKQFGKGATLQRYKGLGEMNADQLWETTMNPET
RTLIRVTIEDLARAERRVNVLMGDKVEPRRKWIEDNVKFTLEEATVF
>CAA25643.1|FEATURES|megares|aminoglycoside|AAC(3)-IVa|antibiotic inactivation|1
MPSWSGLDDEPFDPATSPVTPDLGVVSDTFWRLPNVKRSAHPFAFAAAGPQAEQIISDPL
PLPPHSPASPVARVHELDGQVLLLGVGHDANTTLHLAELMAKVPYGVPRHCTILQDGKLV
RVDYLENDHCCERFALADRWLKEKSLQKEGPVGHAFARLIRSRDIVATALGQLGRDPLIF
LHPPEGGMRRMRCRSPVDWLSS
>AEU17993.1|FEATURES|megares|multidrug|phoQ|antibiotic target alteration|0
MLGAAALAVLFMLALLPALQRAFGIALENTIEQRLAADVATLVSAARVEKGRLVMPEHLP
VEEFNLPEAKVLGYIYDQNGDLLWRSTSAADESINYTPRYDGRGNEFHTTRDAKGEEFFV
FDVEIDLLRGKQAAYSIVTMQSVSEFESLLKGFREQLYLWLGGALLVLLGLLWLGLTWGF
RAMRGLSSELDQIESGERESLSEEHPRELLRLTHSLNRLLRSEHKQRERYRHSLGDLAHS
LKTPLAVLQGVGDQLAEEPGNREQVRVLQGQIERMSQQIGYQLQRASLRKSGLVRHREQL
APLVETLCDALDKVYRDKRVSLQRDFSPSFSVPVERGALLELLGNLLENAYRLCLGRVRV
GARLGPGYSELWVEDDGPGVPAEQRARIIRRGERADTQHPGQGIGLAVALDIIESYDGEL
SLDDSELGGACFRIRFATV
>ACO86898.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|0
MIIELNKNSFPEEFNKIEVHEGSVNIFMNKNSITPLKIFNVLAPAANIIKQEILALGGDC
AVNKYCINCKVETSDIILLGTKRQYKKLLQKLKCMTFFRIEEIVGELENYINNHKKIKTV
LRDGREINYENLKVMGIINCTPDSFYEGSRKNSIEEALKTAEKMLKEGAEILDIGGESTR
PGSDPVDEEEEIKRVVPVIREIKNKFKDVIISIDTYRANTAKAAIEAGADIVNDISAMKY
DENMVKVVKEYNIPVILMHVKGKPKDMQIDPVYENLMKEIHLYFNERIEYCKSHGITEDK
IILDPGIGFGKTVEHNLKIMNRLEELKSFNLPVLLAASRKATIGKVLGNLSTEERLEGTI
ALSCLAVNSGLQMVRVHDVKENVRAIRMLEAVRKI
>NP_275030.1|FEATURES|megares|multidrug|porB|reduced permeability to antibiotic|0
MKKSLIALTLAALPVAAMADVTLYGTIKAGVETSRSVFHQNGQVTEVTTATGIVDLGSKI
GFKGQEDLGNGLKAIWQVEQKASIAGTDSGWGNRQSFIGLKGGFGKLRVGRLNSVLKDTG
DINPWDSKSDYLGVNKIAEPEARLISVRYDSPEFAGLSGSVQYALNDNAGRHNSESYHAG
FNYKNGGFFVQYGGAYKRHHQVQEGLNIEKYQIHRLVSGYDNDALYASVAVQQQDAKLTD
ASNSHNSQTEVAATLAYRFGNVTPRVSYAHGFKGLVDDADIGNEYDQVVVGAEYDFSKRT
SALVSAGWLQEGKGENKFVATAGGVGLRHKF
>CAA58028.1|FEATURES|megares|macrolide-lincosamide-streptogramin|ErmB|antibiotic target alteration|1
MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGNIPYHLSTQIIKKVVFESRAS
DIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTT
DVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTITYEQVLSIFNSYLL
FNGRK
>WP_000918672.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MFRDISPIEDFTGNLSLEFVDYRLGEPKYDLEESKNRDATYAAPLRVKVRLIIKETGEVK
EQEVFMGDFPLMTDTGTFVINGAERVIVSQLVRSPSVYFNEKIDKNGRENYDATIIPNRG
AWLEYETDAKDVVYVRIDRTRKLPLTVLLRALGFSSDQEIVDLLGDNEYLRNTLEKDGTE
NTEQALLEIYERLRPGEPPTVENAKSLLYSRFFDPKRYDLASVGRYKTNKKLHLKHRLFN
QKLAEPIVNTETGEIVVEEGTVLDRRKIDEIMDVLESNANSEVFELHGSVIDEPVEIQSI
KVYVPNDDEGRTTTVIGNAFPDSEVKCITPADIIASMSYFFNLLSGIGYTDDIDHLGNRR
LRSVGELLQNQFRIGLSRMERVVRERMSIQDTESITPQQLINIRPVIASIKEFFGSSQLS
QFMDQANPLAELTYKRRLSALGPGGLTRERAQMEVRDVHYSHYGRMCPIETPEGPNIGLI
NSLSSYARVNEFGFIETPYRKVDLDTHAITDQIDYLTADEEDSYVVAQANSKLDENGRFM
DDEVVCRFRGNNTVMAKEKMDYMDVSPKQVVSAATACIPFLENDDSNRALMGANMQRQAV
PLMNPEAPFVGTGMEHVAARDSGAAITAKHRGRVEHVESNEILVRRLVEENGVEHEGELD
RYPLAKFKRSNSGTCYNQRPIVAVGDVVEYNEILADGPSMELGEMALGRNVVVGFMTWDG
YNYEDAVIMSERLVKDDVYTSIHIEEYESEARDTKLGPEEITRDIPNVSESALKNLDDRG
IVYIGAEVKDGDILVGKVTPKGVTELTAEERLLHAIFGEKAREVRDTSLRVPHGAGGIVL
DVKVFNREEGDDTLSPGVNQLVRVYIVQKRKIHVGDKMCGRHGNKGVISKIVPEEDMPYL
PDGRPIDIMLNPLGVPSRMNIGQVLELHLGMAAKNLGIHVASPVFDGANDDDVWSTIEEA
GMARDGKTVLYDGRTGEPFDNRISVGVMYMLKLAHMVDDKLHARSTGPYSLVTQQPLGGK
AQFGGQRFGEMEVWALEAYGAAYTLQEILTYKSDDTVGRVKTYEAIVKGENISRPSVPES
FRVLMKELQSLGLDVKVMDEQDNEIEMTDVDDDDVVERKVDLQQNDAPETQKEVTD
>AAA22595.1|FEATURES|megares|macrolide-lincosamide-streptogramin|ErmD|antibiotic target alteration|1
MKKKNHKYRGKKLNRGEYPNFSGQHLMHNKKLIEEIVDRANISIDDTVLELGAGKGALTT
MLSQKAGKVLAVENDSKFVAILTRKTAQHPNTKIIHQDIMKIHLPKEKFVVVSNIPYAIT
TPIMKMLLNNPASGFQKGIIVMEKGAAKRFTSKFIKNSYVLAWRMWFDIGIVREISKEHF
SPPPKVDSAMVRITRKKDAPLSHKHYIAFLGLAEYALKEPQAPFCVALRGIFTPRQMKHL
RKSLKINNEKTVGTLTENQWAVIFNTMTQYVMHHKWPRANKRKPGEI
>AJG01378.1|FEATURES|megares|beta_lactam|OXA-208|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASRSDDKAEKIKNLFNEAHTTGVLVIHQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWNGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AAG33663.1|FEATURES|megares|aminoglycoside|AAC(6')-Ib10|antibiotic inactivation|1
MTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPI
GYAQSYVALGSGDGWWEEETDPGVRGIDQLLANASQLGKGLGTKLVRALVELLFNDPEVT
KIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSDA
>AAB24796.2|FEATURES|megares|tetracycline|tetG|antibiotic efflux|1
MGLGLIMPVLPTLLRELVPAEQVAGHYGALLSLYALMQVVFAPMLGQLSDSYGRRPVLLA
SLAGAAVDYTIMASAPVLWVLYIGRLVSGVTGATGAVAASTIADSTGEGSRARWFGYMGA
CYGAGMIAGPALGGMLGGISAHAPFIAAALLNGFAFLLACIFLKETHHSHGGTGKPVRIK
PFVLLRLDDALRGLGALFAVFFIIQLIGQVPAALWVIYGEDRFQWNTATVGLSLAAFGAT
HAIFQAFVTGPLSSRLGERRTLLFGMAADGTGFVLLAFATQGWMVFPILLLLAAGGVGMP
ALQAMLSNNVSSNKQGALQGTLTSLTNLSSIAGPLGFTALYSATAGAWNGWVWIVGAILY
LICLPILRRPFATSLVI
>CAB64978.1|FEATURES|megares|macrolide-lincosamide-streptogramin|msrC|antibiotic target protection|0
ANGVGKTTLLEHIRKQGEGILLSPKVSFQVYQQKGYQMTSEESIIRFVMRQTEFSESLVR
SLLNHLGVAQETLTKPLCTLSGGEATRLTIALLFTKPSNVLLLDEPTNFIDMATIEALEK
LMQIYPGTILFTSHD
>AAK21277.1|FEATURES|megares|multidrug|omp36|reduced permeability to antibiotic|0
MKVKVLSLLVPALLVAGAANAAEIYNKDGNKLDLYGKIDGLHYFSSDDSVYGDQTYMRIG
VKGETQINDQLTGYGQWEYNVQANNTESSSDQAWTRLAFAGLKFGDAGSFDYGRNYGVVY
DVTSWTDVLPEFDGDTYGSDNFLQSRANGVATYRNSDFFGLVDGLNFALQYQGKNGSVSG
EDQTNNGRGFQKQNGEGFGTSVTYEIWDGISAGFAYSSSKRTDEQNNSTYFSKSYRRTYG
VLGEGDHAETYTGGLKYDANNIYLATQYTQTYNATRTGDIGFANKAQNFEVVAQYQFDFG
LRPSVAYLQSKGKDMGRYGDQDILKYVDLGATYYFNKNMSTYVDYKINLLDDNKFTKDAS
ISTDNVVALGLVYQF
>BAH76607.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MAQLTKNFGKIVKTLTIPHLLNLQIDSYELFLQKDIPPTSREDAGLEGVFRSVFPIEDFN
RTASLEYVSYEIGEPKYDVPECIAKGLTFEAPLRIKVRLVVYDVDEETENRTIRDIKEQI
IYFGTVPLMTEKGTFIINGTERVIVNQLQRSPGIIFEHDSGKSHTSRKVLYSCRIIPMRG
SWLDFDYDHKDILYVRIDRRRKMPATILFKAMGMSRADILRYFYEVEHFTFEPHHVFRQV
LPDFYRKEKAYSEIRDSEGKVIVAVDKPITKRAWRLMLEAGIEKVEVDPATLLGLFLAED
LADPATGEVMAEAGDELNADLIEKLKDAGIVELSLLHTRGVDTSSSIRDTLALDKTIDTI
TAQVEIYRRLRPSSPPTPEIAANFFENLFRNPDYYDLSPVGRYKINARLKVDQPLDFRTL
ANDDILKAVKHLTFLKDSHGPADDIDHLGNRRVRPVGELVENQYRIGLVRMERAIKERMS
LQEVATLMPHDLINPKPVAAVLKEFFGTSQLSQFMDQTNPLSEVTHKRRLSALGPGGLTR
ERAGFEVRDVHTSHYGRICPIETPEGPNIGLIVSLTTHSKVNDFGFIETPYKVVKDGQLT
GETIYLDATREIDEVIAGANAPLDENKAFINSMVGARIRGDQVVIPREQVTLMDISPSQI
VSVSAALIPFLEHDDANRALMGSNMQRQAVPLLRCEQPLVGTGMEGAVAKDSGSCILAEG
EGFVHYADAERIIVCYDDPAVGTDTGSAKTYELLKHHKSNQNTCFGQVPRVLVGQRVVKG
DVLADGPGIRDGELALGKNLLVAFMPWCGYNYEDSILISENAVKDDTFTSVHIEEFEVVA
RDTKLGPEEITRDIPNVGEEMLKDLDDCGIIRIGARVAPDDILVGKITPKGETQLTPEEK
LLRAIFGDKARDVKNTSLKVPPGIEGTVIDVRVFNRRSGEKDDRTRQIEDFELARLDTKE
GQHAAAIAANVRRRLWPVVSGKTVFQTIKGVKKGEVLLEANHPMTQEVLEALPVKKLSGL
FTSKETNEAVAEVLDEYDRHIQFIKGLYDQKREKTTEGDDLPPGVIKMVKVYVAVKRKLN
VGDKMAGRHGNKGVVSCILPIEDMPFFSHGRPVDIVLNPLGVPSRMNIGQILETHLGWAG
MELGRQLAEMVDSGKAMEGVRDRAKAVFDTEETTALIDGMSDDDLRDALRALKNGIVAKT
PVFDGATEDELWSWLKLAGLPEDGKVTLYDGRTGEAFHRPVTVGCMYILKLHHLVDEKIH
ARSTGPYSLVTQQPLGGKAQFGGQRLGEMEVWALEAYGASYLLQEFLTVKSDDVGGRVKM
YEKIVKGDNFLEAGLPESFNVLVKELMSLGLDVDLIQDEKKIAKAPPRR
>AAO47227.1|FEATURES|megares|aminocoumarin|gyrB|antibiotic target alteration|0
MYIGSTGERGLHHLVQELVDNSVDEALAGVADRIDVTVLADGGVRVVDNGRGIPVGMHPV
EKRPAVEVVLTVLHAGGKFGGGGYTVSGGLHGVGLSVVNALSARLSAEIWTDGHRWTQDY
RDGAPTAPLVRREATSRTGTSLTFWADGSIFETTDYSFETLARRFQEMAFLNRGLTLTLT
DERASARATAATDEVHPDPAAKTVSYRYDGGITDFVAYLNSRKGEPVHPSVVTIAADDTE
RLLSAEIALQWNGQYTDSVYSYANAIHTHEGGTHEEGFRTALTTVVNRYARDKKLLREKD
ANLAGEDIREGLTAIISVKLREPQFEGQTKTKLGNTEVRTFVQKVVHEHLTDWFDRNPNE
AADIVRKAVQAATARVAARKARDLTRRKGLLETASLPGKLSDCQSNDPAMSEIFIVEGDS
AGGSAKSGRNPQYQAILPIRGKILNVEKARIDRILQNQEIQALISAFGTGMHEDFDIAKL
RYHKVILMADADVDGQHINTLLLTVLFRFMRPLIEEGHVYLSRPPLYKIKWSRDHVEYAY
SDRERDTLLELGRRDGRRVRDDSIQRFKGLGEMNAEELRVTTMDPDHRVLGRVALDDAAV
ADDLFSVLMGEDVEARRHFIQRNAKDVRFLDI
>ADU81552.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MQDHLVNETKNIVEVGIDSSIEESYLAYSMSVIIGRALPDARDGLKPVHRRILYAMHELG
LTSKVAYKKSARIVGDVIGKYHPHGDNAVYDALVRMAQDFSMRLELVDGQGNFGSIDGDN
AAAMRYTEARMTKASEEILRDIDKDTIDFVPNYDDTLKEPDILPSRLPNLLVNGANGIAV
GMATSIPPHRIDEIIDALAHVLENPNAELDEILEFVKGPDFPTGGIIYGKAGIVEAYKTG
RGRVKVRAKVHVEKTKNKEIIVLDEMPFQTNKAKLVEQISDLAREKQIEGISEVRDESDR
EGIRVVIELKRDAMSEIVLNHLYKLTTMETTFSIILLAIYNKEPKIFTLLELLRLFLNHR
KTIIIRRTIFELEKAKARAHILEGYLIALDNIDEIVRLIKTSPSPEAAKNALMERFSLSE
IQSKAILEMRLQRLTGLERDKIKEEYQNLLELIDDLNGILKSEDRLNEVVKTELLEVKEQ
FSSPRRTEIQESYESIDTEDLIANEPMVVSMSYKGYVKRVDLKAYERQNRGGKGKLSGST
YEDDFIENFFVANTHDILLFITNKGQLYHLKVYKIPEASRIAMGKAIVNLISLAPNEKIM
ATLSTKDFSDERSLAFFTKNGVVKRTNLSEFGGNRSYSGIRAIVLDEGDELVGAKVVDKN
AKHLLIASYLGMFIKFPLEDVREIGRTTRGVMGIRLNENDFVVGAVVISDDSNKLLSVSE
NGLGKQTLAEAYREQSRGGKGVIGMKLTQKTGNLVSVISVDDENLDLMILTASAKMIRVS
IKDIRETGRNASGVKLINTADKVVYVNSCPKEEEPENLETSRAQNLFE
>AAA26079.1|FEATURES|megares|chloramphenicol|cmlA1|antibiotic efflux|0
MSFTAYSDPCWPWSRGRPIARSARRHVAWVAGYLCVSRFGHDRCICRRGSFWPETRVQRV
AGLQWSQLLLPVKCLNFWLYTLCYAAGMGSFFVFFSIAPGLMMGRPRCVSAWLQPAVRHS
AIAMVFTARFMGSVIPKWGSPSVLRMGMGCLIAGAVLLAITEIWALHRVRLYCSNVASGI
GVATAVSVPMALFEDSTMLLERSRQSTSAWACTARKHRNVDHFAVAAQRLGPCRVTVWTL
ATVVLGLSCVSRVKGSRGQGEHDAGRATNVGKYIKSQSLRECGKLSPNKCCSRPKTYAFR
LG
>AAG21808.1|FEATURES|megares|multidrug|floR|antibiotic efflux|1
MTTTRPAWAYTLPAALLLMAPFDILASLAMDIYLPVVPAMPGILNTTPAMIQLTLSLYMV
MLGVGQVIFGPLSDRIGRRPILLAGATAFVIASLGAAWSSTAPAFVAFRLLQAVGASAML
VATFATVRDVYANRPEGVVIYGLFSSILAFVPALGPIAGALIGEFLGWQAIFITLAILAM
LALLNAGFRWHETRPLDQVKTRRSVLPIFASPAFWVYTVGFSAVMGTFFVFFSTAPRVLI
GQAEYSEIGFSFAFATVALVMIVTTRFAKSFVARWGIAGCVARGMALLVCGAVLLGIGEL
YGSPSFLTFILPMWVVAVGIVFTVSVTANGALAEFDDIAGSAVAFYFCVQSLIVSIVGTL
AVALLNGDTAWPVICYATAMAVLVSLGLVLLRLRGAATEKSPVV
>ABW76137.1|FEATURES|megares|beta_lactam|OXA-136|antibiotic inactivation|1
MSKKNFILIFIFVILISCKNTEKISNETTLIDNIFTNSNAEGTLVIYNLNDDKYIIHNKE
RAEQRFYPASTFKIYNSLIGLNEKAVKDVDEVFYKYNGEKVFLESWAKDSNLRYAIKNSQ
VPAYKELARRIGLKKMKENIEKLDFGNKSIGDSVDTFWLEGPLEISAMEQVKLLTKLAQN
ELPYPIEIQKAISDITILEQTYNYTLHGKTGLADSKNMTTEPIGWFVGWLEENDNIYVFA
LNIDNINSDDLAKRINIVKESLKALNLLK
>CAD55840.1|FEATURES|megares|sulfonamide|sul2|antibiotic target replacement|1
MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVS
SDTEIARIAPVLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDAAFYPQLAK
SSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFF
LGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAAA
GGADFIRTHEPRPLRDGLAVLAALKETARRCL
>AVM21122.1|FEATURES|megares|macrolide-lincosamide-streptogramin|rlmH|antibiotic target alteration|0
MKITILAVGKLKEKYWKQAIAEYEKRLGPYTKIDIIEVPDEKAPENMSDKEIEQVKEKEG
QRILAKIKPQSTVITLEIQGKMLSSEGLAQELNQRMTQGQSDFVFVIGGSNGLHKDVLQR
SNYALSFSKMTFPHQMMRVVLIEQVYRAFKIMRGEAYHK
>CCC87252.1|FEATURES|megares|tetracycline|tet38|antibiotic efflux|1
MNVEYSKIKKAVPILLFLFVFSLVIDNSFKLISVAIADDLNISVTTVSWQATLAGLVIGI
GAVVYASLSDAISIRTLFIYGVILIIIGSIIGYIFQHQFALLLVGRIIQTAGLAAAETLY
VIYVAKYLSKEDQKTYLGLSTSSYSLSLVIGTLSGGFISTYLHWTNMFLIALIVVFTLPF
LFKLLPKENNTNKAHLDFVGLILVATIATTVMLFITNFNWLYMIGALIAIIVFALYIKNA
QRPLVNKSFFQNKRYASFLFIVFVMYAIQLGYIFTFPFIMEQTYHLQLDTTSLLLVPGYI
VAVIVGALSGKIGEYLNSKQAIITAIILIALSLILPAFAVGNHISIFVISMIFFAGSFAL
MYAPLLNEAIKTIDLNMTGVAIGFYNLIINVAVSVGIAIAAALIDFKALNFPGNDALSSH
FGIILIILGLMSIVGLVLFVILNRWTQSEK
>ACF06160.1|FEATURES|megares|sulfonamide|sul1|antibiotic target replacement|1
MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPAD
EIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADC
RLVVMHSAQRDGIATRTGHLRLEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFL
SPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGN
GADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA
>AEY63633.1|FEATURES|megares|sulfonamide|sul1|antibiotic target replacement|1
MTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPADE
IRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCR
LVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLS
PAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNG
ADYVRTHAPGDLRSAITISETLAKFRSRDARDRGLDHA
>AEE65537.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MPYSYTEKKRIRKSFAKREDVQNVPFLLATQLQSYLTFLQADTATSDRVNEGLQAAFSSI
FPIVSHNGMARLEFVSYALGEPVFDVKECQQRGLTYASPLRAKVRLVLLDREVSKPTIKE
VKEQEVYMGEIPLMTGTGSFVINGTERVIVSQLHRSPGVFFEHDRGKTHSSGKLLFSARV
IPYRGSWLDFEFDPKDVLFFRVDRRRKMPVTILLKAIGMTPESILAHFFDFDNFELKSEG
GMMEFVAERWKGEMARFDIADRDGKVIVEKDKRINAKHLRDLAAGGIQRVSVPEDFLYGR
VLAKNIVDPDTGEVVAHANDEITESVLNAMRAANVRDIQTLYTNDLDRGPYISQTLRADE
TADQMAARVAIYRMMRPGEPPTEEAVEALFQRLFYSEETYDLSRVGRMKVNSRLGRGDDS
TGPMTLTNEDILETIKVLVELRNGRGQIDDIDHLGNRRVRCVGELAENQFRAGLVRVERA
VKERLGQAETENLMPHDLINSKPISAAIKEFFGSSQLSQFMDQTNPLSEITHKRRVSALG
PGGLTRERAGFEVRDVHPTHYGRVCPIETPEGPNIGLINSMALYARLNEYGFLETPYRKI
IDGKVSDQIDYLSAIEESHYVIAQANAALDDEGRFVDDLVACREAGETMLTAPGNVHYMD
VAPSQIVSVAASLIPFLEHDDANRALMGANMQRQAVPCLRPEKPLVGTGVERTVAVDSGT
TVQALRGGVVDHVDADRVVIRVNDEENVAGEVGVDIYNLIKYTRSNQNTNINQRPIVARG
DKVAKGDVLADGASTDLGELALGQNMLIAFMPWNGYNFEDSILISERVVADDRYTSIHIE
ELTVVARDTKLGPEEITRDISNLAETQLNRLDDSGIVYIGAEVSADDVLVGKVTPKGETQ
LTPEEKLLRAIFGEKASDVKDTSLRVPSGMTGTVIDVQVFTREGIVRDKRAQSIIDDELR
RYRQDLNDQLRIVENDQFDRIEKMLVGKTVNGGPRKLAKGATLTKAYLADLDRWQWFDIR
LADEQHAVVLEQAKESLEQKRHQFDLAFEEKRKKLTQGDELPPGVLKMIKVYLAVKRRLQ
PGDKMAGRHGNKGVVSRITPVEDMPHMADGTPADIVLNPLGVPSRMNVGQVLEVHLGWAA
KGVGYRIADMLRDERTAQAKSVRGYLEKVYNTTGSSAHIDSLTDEEVLELANNLKKGVPF
ATPVFDGATEEEIGKMLELAYPDDVAARMRLTASRSQAWLYDGRTGEQFERPVTIGYMHY
LKLHHLVDDKMHARSTGPYSLVTQQPLGGKAQFGGQRFGEMEVWALEAYGASYTLQEMLT
VKSDDITGRTKVYENIVKGDHVIDAGMPESFNVLVKEIRSLALDMDLERN
>AFU25737.1|FEATURES|megares|trimethoprim|dfrA7|antibiotic target replacement|1
MGVLPNRKYAVVSRKGISSSNENVLVFPSIEIALQELSKITDHLYVSGGGQIYNSLIEKA
DIIHLSTVHVEVEGDINFPKIPENFNLVFEQFFLSNINYTYQIWKKG
>ADD83116.1|FEATURES|megares|tetracycline|tetX|antibiotic inactivation|1
MTMRINTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTL
DLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVKPENRFDNPEINRNDL
RAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKVRKFVTD
TEVEETGTFNIQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNNGALHFGISFK
TPDEWKNQTQVDFQNRNSVVDFLLKKFSDWDERYKELIHATLSFVGLATRIFPLEKPWKS
KRPLPITMIGDAAHLMPPFAGQGVNSGLVDALILSDNLADGKFNSIEEAVKNYEQQMFIY
GKEAQEESTQNEIEMFKPDFTFQQLLNV
>EDS78884.1|FEATURES|megares|tetracycline|tet44|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYTSGAILELGSVDKGTTRTDTMFLERQRGITIQAAV
TSFNWNDYKINIVDTPGHTDFITEVYRSLSVLDGAILVISAKDGVQAQTRILFHALQKMN
IPTIIFINKIDQDGINLNNIYQNIKEKLSNDIIVMQNVTLTPEISIKNIIDLDDWDPVIS
RNDKLLKKYIAGEKLTIQELTYEEYRCVKKGSLFPIYHGSARNNIGTQQLIEAISNLFCS
EMNENGSELCGRVFKIEYTDHKQRLVYLRLYSGTLHLRDTIILPEKKKVKLTEIYIPSNG
EMIQTKIVCSGDIFIIPNNTLRLNDIIGNEKILPCNVWNDNTAPILRTRIEPIKIEEREK
LLDALTEIADTDPLLRYYVDTITHEIIISFLGTVQLEVICSLLIEKYHINIRIEDPTVIY
LEKPLQKADYTIHIEVPPNPFWASIGLSITPLPIGSGIQYESKVSLGYLNQSFQNAVREG
INYGLEQGLYGWKVTDCKICFEYGVYYSPVSTPSDFRFLAPIVLEQTLKKAGTQLLEPYL
SFILFTPQEYFSRAYNDAQKHCAIIETSQSKNDEVIFTGHIPARCINEYRNTLTLYTNGQ
AVFLTELKDYQIATCEPVIQSRRPNNRIDKVRHMFNKKEN
>NP_253438.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|0
MSNPQYPTRLPCGSRVLDLARPHVMGILNVTPDSFSDGGRYDRLDDALRHAERMVLEGAT
LIDVGGESTRPGARSVSPTEELERVAPVVERIARELDVVISVDTSTPAVMRETARLGAGL
INDVRSLQRDGALDAAVDSGLAVCLMHMRGEPQTMQDAPAYQDVVAEVGAFLQERVDACV
AAGIDRERLLLDPGFGFAKTLEHNLVLFRHLQALHGLGLPLLVGVSRKSMIGKVLGREVD
ERLYGSLALAALALAKGARIIRVHDVAATVDVMRMISAVEMAD
>ABQ56814|FEATURES|megares|multidrug|pmrA|antibiotic efflux|0
MKKLMEYGGKIKEYLLRLKPKRWLTLTNVIIFIGFLTAIIYVFSYLIPFTDNAFVVNNVR
PVAALTSGYITELYVKNGDAVRKGQKLFTVFKKPYEYTVEQLSADLAGAQAKLAVLKATY
ERDLKLSENEQKIYKKLAQDDQKYLKGYAIKSVSLITLQNSQQETKAAKDKWQASLKQLE
IDQHQITVQENEIKSIQARLKNAKVNLDLTDVYAQGNGVIQNLFFTIGTPVNINQPLFSL
VDQDNIYIQANFNETDLRDVRKGSKVLIFPRMYLGRKIFHGVIDSDYWSANRQLVDDRTQ
LQNVINENQWILLPQRLPVIIKVTDPDPKYPLRVGASAYVYVEVY
>ABQ56916.1|FEATURES|megares|tetracycline|tufab|antibiotic target alteration|0
MAKEKFERKKPHVNVGTIGHVDHGKTTLTAAITTIMAKKYGGTAKAYDQIDAAPEERERG
ITISTAHVEYESASRHYAHVDCPGHADYVKNMITGAAQMDGAILVVSAADGPMPQTREHI
LLSRQVGVPYIVVFMNKADMVDDPELLELVEMEVRDLLSSYDFPGDDIPIVVGSALKALE
GEDSDIGVKAIEKLVETMDSYIPEPVRNIDKPFLLPIEDVFSISGRGTVVTGRVESGIVK
VGEEVEIVGIRDTQKTTCTGVEMFRKLLDEGRAGDNVGVLLRGTKRDEVERGQVLAKPGT
IKPHTKFEAEVYVLSKEEGGRHTPFFNGYRPQFYFRTTDVTGTCDLPSGVEMVMPGDNVQ
LVVSLHAPIAMDEGLRFAIREGGRTVGAGVVAKIIE
>AAV74572.1|FEATURES|megares|glycopeptide|vanSB|antibiotic target alteration|1
MERKGIFIKVFSYTIIVLLLLVGVTATLFAQQFVSYFRVMELQQTVKSYQPLVELIQNSD
RLDIQEVAGLFHYNNQSFEFYIEDKEGSVLYATPNANTSNSFRPDFLYVVHRDDNISIVA
QSKAGVGLLYQGLTIRGIVMIAIMVVFSLLCAYIFARQMTTPIKALADSANKMANLKDVP
PPLERKDELGALAHDMHSMYVRLKETIARLEDEIAREHELEETQRYFFAAASHELKTPIA
ATSVLLEGMLENIGDYKDHSKYLRECIKMMDRQGKIISEILELVSLNDGRIVPIAEPLDI
GRTVAELLPDFQTLAEANNQRFVTDIPAGQIVLSDPRLLQKALSNVILNAVQNTPQGGEV
RIWSEPGAEKCRLFVLNMGVHIDDTALPRLFTPFYRIDQARSRKSGRSGLGLAIVQKTLD
AMSLQYALENTSDGVLFWLDLPLTSTLX
>AAF24088.1|FEATURES|megares|macrolide-lincosamide-streptogramin|vatA|antibiotic inactivation|1
MNGANHRMDGSTYPFHLFRMGWEKYMPSLKDLPLKGDIEIGNDVWIGRDVTIMPGVKIGD
GAIIAAEAVVTKNVAPYSIVGGNPLKFIRKRFSDGVIEEWLALQWWNLDMKIINENLPFI
INGDIEMLKRKRKLLDDT
>CAR63502.1|FEATURES|megares|trimethoprim|dfrA1|antibiotic target replacement|1
MKLSLMVAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYA
VGTRSSFTSDNENVLIFPSIKDALTNLKKITDHVIVSGGGEIYKSLIDQVDTLHISTIDI
EPEGDVYFPEIPSNFRPVFTQDFASNINYSYQIWQKG
>AEI54991.1|FEATURES|megares|chloramphenicol|cmlA5|antibiotic efflux|1
MDMYLPAVPFMPNALGTTASTIQLTLTTYLVMIGAGQLLFGPLSDRLGRRPVLLGGGLAY
VVASMGLALTSSAEVFLGLRILQACGASACLVSTFATVRDIYAGREESNVIYGILGSMLA
MVPAVGPLLGALVDMWLGWRAIFAFLGLGMIAASAAAWRFWPETRVQRVAGLQWSQLLLP
VKCLNFWLYTLCYAAGMGSFFVFFSIAPGLMMGRQGVSQLGFSLLFATVAIAMVFTARFM
GRVIPKWGSPSVLRMGMGCLIAGAVLLAITEIWASQSVLGFIAPMWLVGIGVATAVSVSP
NGALRGFDHVAGTVTAVYFCLGGVLLGSIGTLIISLLPRNTAWPVVVYCLTLATVVLGLS
CVSRVKGSRGQGEHDVVALQSAESTSNPNR
>WP_000633128.1|FEATURES|megares|multidrug|adeH|antibiotic efflux|0
MGSLLLAGCSLAPEYQPAKVIVPVKFKESDPKLEDNNWKIAQPADQQTRGEWWRIYNDAQ
LNELEQQAIAGNQNLKAVAANIQASRALRSAAQAERLPSIDAGFGPTRQKPSPASLGLDD
NAHTSAQTLWRAQANVSYELDLFGRVASSVNAATADLQQQEALYQSALLALQADVAQGYF
LIRQLDTEQAIYNRTIKLLGETRDLMQLRFKNGLVSELDVSRAQTELATAQTTALNIARN
RASAEHALAVLLGKPPADFNLAVQPLTANSIRLPAGLPSTLLERRPDIAAAERAMAADNA
RIGIARAAFFPKLSLTGALGYESSSLSELGKWSSRTFLLGPVAGTILSLPLFDGGQRKAG
VAQARAAYEESVANYRQTVLNAFREVENGLSDQRILDQQIQAQNQALSSSRHANQLSHLR
YREGAISYLDVIDSDRTILQQEQLAAQLKGSQIIASINLIRALGGGWSS
>CAR63501.1|FEATURES|megares|rifampin|arr-2|antibiotic inactivation|1
MLWSSNDVTQQGSRPKTKLCSQIPTIKGLKMVKDWIPISHDNYKQVQGPFYHGTKANLAI
GDLLTTGFIFHFEDGRILKHIYFSALMEPAVWGAELAMSLSGLEGRGYIYIVEPTGPFED
DPNLTNKKFPGNPTQSYRTCEPLRIVGVVEDWEGHPVELIRGMLDSLEDLKRRGLHVIED
>ABF71542.1|FEATURES|megares|sulfonamide|sul2|antibiotic target replacement|1
MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVS
SDTEIERIAPVLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDAAFYPQLAK
SSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFF
LGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFNRALTNRGPGDVGAATLAAELAAAA
GGADFIRTHEPRPLRDGLAVLAALKETARIR
>CAQ87573.1|FEATURES|megares|beta_lactam|cflA|antibiotic inactivation|1
ILISMLFPVAVMAQKSVKISDDISITQLSDKVYTYVSLAEIEGWGMVPSNGMIVINNHQA
ALLDTPINDAQTEMLVNWVTDSLHAKVTTFIPNHWHGDCIGGLGYLQRKGVQSYANQMTI
DLAKEKGLPVPEHGFTDSLTVSLDGMPLQCYYLGGGHATDNIVVWLPTENILFGGCMLKD
NQATSIGNISDADVTAWPKTLDKVKAKFPSARYVVPGHGDYGGTELIEHTKQIVNQYIES
TSKP
>CBK33710.1|FEATURES|megares|trimethoprim|dfrK|antibiotic target replacement|1
MKVSLIAAMDKNRVLGKENDIPWRIPKDWEYVKNTTKGYPIILGRKNLESIGRALPGRRN
IILTRDKGFSFNGCEIVHSIEDVFEICNNEEEIFIFGGEQIYNLFLPYVEKMYITKIHYE
FEGDTFFPEVNYEEWSEVSVTQGITDEKNPYTYYFHIYERKAY
>AGS60939.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MTQSSYNAKDIEVLNGLEPVRRRPGMYTDTTRPNHLAQEVIDNSVDEALAGHATKVEVIL
YADQSIEVIDNGRGMPVDIHPELKVSAIELILAHLHAGGKFSNKNYQYSGGLHGVGISVV
NALSKRIEVTVRREGKIYQIAFENGDKVEELHQIGTCAKRDTGTSVHFWPDSTYFDIPRF
SSKSLSHVLKAKAVLCPGVNVSFTDKVNNTQETWCYADGLTDYLSEAVAEFVRLPEEPFT
GKFEGDNEAVEWSMLWLPEGGDLLTESYVNLIPTVQGGTHVNGLRQGVLDAMREFCEFHN
LLPRGIKLTADDTWERCAYVLSVKMQDPQFAGQTKERLSSRQTSAFVASAVKNAFSLWLN
QNVQVGELLAEMAISSAQRRMRAAKKVVRKKLTSGPALPGKLADCTSQDLRYTELFLVEG
DSAGGSAKQARDREYQAIMPLRGKILNTWEVSSDEVLASQEVHDISVAIGMDPDSDDLSQ
LRYGKICILADADSDGLHIATLLCALFVRHFPALVKQGHVYMAMPPLYRIDLGKEVSYAL
DEAEKNAILQRLSRKKGKPNVQRFKGLGEMNPLQLRETTLDPNTRRLVQLVIDDENYQET
LGMMDMLLAKKRSEDRRNWLQEKGDEVDIEV
>AAZ73126.1|FEATURES|megares|sulfonamide|sul1|antibiotic target replacement|1
MFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPADEIR
RIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAETDCRLV
VMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLSPA
PETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNGAD
YVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA
>WP_041202518.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MNKQNNYSDDSIQVLEGLEAVRKRPGMYIGSTDKRGLHHLVYEIVDNSVDEVLNGYGNEI
DVTINKDGSISIEDNGRGMPTGIHKSGKPTVEVIFTVLHAGGKFGQGGYKTSGGLHGVGA
SVVNALSEWLEVEIHRDGNIYHQSFKNGGSPSSGLVKKGKTKKTGTKVTFKPDDTIFKAS
TSFNFDVLSERLQESAFLLKNLKITLNDLRSGKERQEHYHYEEGIKEFVSYVNEGKEVLH
DVATFSGEANGIEVDVAFQYNDQYSESILSFVNNVRTKDGGTHEVGFKTAMTRVFNDYAR
RINELKTKDKNLDGNDIREGLTAVVSVRIPEELLQFEGQTKSKLGTSEARSAVDSVVADK
LPFYLEEKGQLSKSLVKKAIKAQQAREAARKAREDARSGKKNKRKDTLLSGKLTPAQSKN
TDKNELYLVEGDSAGGSAKLGRDRKFQAILPLRGKVINTEKARLEDIFKNEEINTIIHTI
GAGVGTDFKIEDSNYNRVIIMTDADTDGAHIQVLLLTFFFKYMKPLVQAGRVFIALPPLY
KLEKGKGKTKRVEYAWTDEELNKLQKELGKGFTLQRYKGLGEMNPEQLWETTMNPETRTL
IRVQVEDEVRSSKRVTTLMGDKVQPRREWIEKHFEFGMQEDQSILDNSEVQVLENDQFDE
EEI
>AAO82932.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|0
MIDLKKNYQIMGIVNTTPDSFSDGGSYTTVDVAYQHALHLLEAGADILDIGGQSTRPGYE
EVSPQVEADRVLPLIKKIRETSLAPISVDTYYPEVAEAAIQAGATMINDIKGLDTPGMAE
VLAQYPEVQVVIMHSRKRQSLSLKEELHQFYTEKIEQCQKYGLSLEKICFDPGIGFHKTV
AENLQLLKDPNAFRYQDYPLLYGVSRKRTIGALTNEPEPANRDFGSAAASLYAAQQGVEI
LRVHNVQGLKQTFDVWRALSEKE
>EJR71705.1|FEATURES|megares|macrolide-lincosamide-streptogramin|mphB|antibiotic inactivation|1
MNKQKAIEIARKYGLEVKEGSIIFNESGLDFLVAYAEDYKGEEWVLRFPRRDDVMPRTIV
EKKALDLVNKYATFQVPVWSLYKNDLIAYKKLTGVPAGTIDPEIQNYLWEMDYENVPERF
HQTLAKALASLHTIPKEEALKVGLFVQTAEEARKSMIERMEKVKAKFDVGKSLWNRWQAW
IKNEELWPQKTGLIHGDVHAGHTMIDKDANVTGLIDWTEAKVTDVSNDFVFQYRAFGEAS
LEKLIQHYRQAGGIYWPAMKEHVIELNAAYPVAIAEFAIISGLEEYEQMAKETLQVNDR
>WP_012683946.1|FEATURES|megares|sulfonamide|folp|antibiotic target replacement|0
MPAKLRARRELNCGQYVLPLGERTLVMGILNVTPDSFSDGGRYVNVEAALAQARAMVEAG
ADLIDIGGESTRPGSEAVDEATELDRVLPVIRMLSQELSVPLSIDTYKAAVAERAILEGA
HIINDVWGAKRDPRMAEVAARLDVPIILMHNREDTDYHDFFPNYIKDLRESVQIALQAGV
KQERIILDPGIGFVRTVEQNLETMRRLDDLVGLGYPVLLATSRKRMIGHVLDLPVDERVE
GTAATVALGAAKGCHMVRVHDVKEMKRVTKMMDAMLKGGI
>AAY52005.1|FEATURES|megares|glycopeptide|VanSA|antibiotic target alteration|1
MAAVVFVLFLRLFIKGTLGEWIVRFLENSYHLERQDAMKIYQYTIRNNIEIFIYVAIAIS
ILILCRVMLSKFAKYFDEINTGIDILIQNEDKQIELSAEMEFMEQKLNTLKRTLEKREQD
AKLAEQRKNDVVMYLAHDIKTPLTSVIGYLSLLDEAPDMPVEQKAKYVHITLDKAYRLEQ
LIDEFFEITRYNLQTITLTKKHIDLYYMLVQMTDEFYPQLAANGKQAVIHASEDLTVSGD
PDKLARVFNNILKNAAAYSEDNSVIDITAGLSGDVVSIVFKNAGSIPKDKLAAIFEKFYR
LDDARSSDTGGAGLGLAIAKEIIVQHGGQIYAESNDNYTTFTVELPALPDLVDKRSS
>ABR79724.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MGRLVSELRNPMVYSYTEKKRIRKDFGKRPQVLDVPYLLSIQLDSFQKFIEQDPEGQYGL
EAAFRSVFPIQSYSGNSELQYVSYRLGEPVFDVKECQIRGVTYSAPLRVKLRLVIYEREA
PEGTVKDIKEQEVYMGEIPLMTDNGTFVINGTERVIVSQLHRSPGVFFDSDKGKTHSSGK
VLYNARIIPYRGSWLDFEFDPKDNLFVRIDRRRKLPATIILRALNYTTEQILDLFFEKVV
FEIRDNKLQMELIPERLRGETASFDIEANGKVYVEKGRRITARHIRQLEKDDIKHIEVPV
EYIAGKVAAKDYIDEATGELICPANMELSLDLLAKLSQSGHKRIETLFTNDLDHGPYISE
TVRVDPTNDRLSALVEIYRMMRPGEPPTREAAESLFENLFFSEDRYDLSAVGRMKFNRSL
LRDEIEGSGILSKDDIIEVMKKLIDIRNGKGEVDDIDHLGNRRIRSVGEMAENQFRVGLV
RVERAVKERLSLGDLDTLMPQDMINAKPISAAVKEFFGSSQLSQFMDQNNPLSEITHKRR
ISALGPGGLTRERAGFEVRDVHPTHYGRVCPIETPEGPNIGLINSLSVYAQTNEYGFLET
PYRKVTDGVVTDEIHYLSAIEEGNYVIAQANSNLDENGHFVEDLVTCRSKGESSLFSRDQ
VDYMDVSTQQVVSVGASLIPFLEHDDANRALMGANMQRQAVPTLRADKPLVGTGMERAVA
VDSGVTAVAKRGGTVQYVDASRIVIKVNEDEMYPGEAGIDIYNLTKYTRSNQNTCINQMP
CVSLGEPIERGDVLADGPSTDLGELALGQNMRVAFMPWNGYNFEDSILVSERVVQEDRFT
TIHIQELACVSRDTKLGPEEITADIPNVGEAALSKLDESGIVYIGAEVTGGDILVGKVTP
KGETQLTPEEKLLRAIFGEKASDVKDSSLRVPNGVSGTVIDVQVFTRDGVEKDKRALEIE
EMQLKQAKKDLSEELQILEAGLFSRIYAVLVSGGVEAEKLDKLPRDRWLELGLTDEEKQN
QLEQLAEQYDELKHEFEKKLEAKRRKITQGDDLAPGVLKIVKVYLAVKRRIQPGDKMAGR
HGNKGVISKINPIEDMPHDANGTPVDIVLNPLGVPSRMNIGQILETHLGMAAKGIGDKIN
AMLKQQQEVAKLREFIQRAYDLGADVRQKVDLNTFSDEEVLRLAENLRKGMPIATPVFDG
AKEAEIKELLQLGDLPTSGQITLFDGRTGEQFERPVTVGYMYMLKLNHLVDDKMHARSTG
SYSLVTQQPLGGKAQFGGQRFGEMEVWALEAYGAAYTLQEMLTVKSDDVNGRTKMYKNIV
DGNHQMEPGMPESFNVLLKEIRSLGINIELEDE
>WP_001819727.1|FEATURES|megares|peptide|rpoB|antibiotic target alteration|0
MKIGLASPEKIRSWSFGEVKKPETINYRTLKPEKDGLFCERIFGPTKDWECSCGKYKRVR
YKGMVCDRCGVEVTKSKVRRERMGHIELAAPVSHIWYFKGIPSRMGLLLDMSPRALEEVI
YFASYVVVDPGPTGLEKKTLLSEAEFRDYYDKYPGQFVAKMGAEGIKDLLEEIDLDEELK
LLRDELESATGQRLTRAIKRLEVVESFRNSGNKPSWMILDVLPIIPPEIRPMVQLDGGRF
ATSDLNDLYRRVINRNNRLKRLLDLGAPGIIVQNEKRMLQEAVDALIDNGRRGRPVTGPG
NRPLKSLSHMLKGKQGRFRQNLLGKRVDYSGRSVIAVGPSLKMYQCGLPKEMALELFKPF
VMKELVQREIATNIKNAKSKIERMDDEVWDVLEEVIREHPVLLNRAPTLHRLGIQAFEPT
LVEGRAIRLHPLVTTAYNADFDGDQMAVHVPLSKEAQAEARMLMLAAQNILNPKDGKPVV
TPSQDMVLGNYYLTLERKDAVNTGAIFNNTNEVLKAYANGFVHLHTRIGVHASSFNNPTF
TEEQNKKILATSVGKIIFNEIIPDSFAYINEPTQENLERKTPNRYFIDPTTLGEGGLKEY
FENEELIEPFNKKFLGNIIAEVFNRFSITDTSMMLDRMKDLGFKFSSKAGITVGVADIVV
LPDKQQILDEHEKLVDRITKQFNRGLITEEERYNAVVEIWTDAKDQIQGELMQSLDKTNP
IFMMSDSGARGNASNFTQLAGMRGLMAAPSGKIIELPITSSFREGLTVLEYFISTHGARK
GLADTALKTADSGYLTRRLVDVAQDVIVREEDCGTDRGLLVSDIKEGTEMIEPFIERIEG
RYSKETIRHPETDEVIIRPDELITPEIAKKITDAGIEQMYIRSAFTCNARHGVCEKCYGK
NLATGEKVEVGEAVGTIAAQSIGEPGTQLTMRTFHTGGVAGSDITQGLPRIQEIFEARNP
KGQAVITEIEGVVEDIKLAKDRQQEIVVKGANETRSYLASGTSRIIVEIGQPVQRGEVLT
EGSIEPKNYLSVAGLNATESYLLKEVQKVYRMQGVEIDDKHVEVMVRQMLRKVRIIEAGD
TKLLPGSLVDIHNFTDANREAFKHRKRPATAKPVLLGITKASLETESFLSAASFQETTRV
LTDAAIKGKRDDLLGLKENVIIGKLIPAGTGMRRYSDVKYEKTAKPVAEVESQTEVTE
>NP_463022.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MVYSYTEKKRIRKDFGKRPQVLDVPYLLSIQLDSFQKFIEQDPEGQYGLEAAFRSVFPIQ
SYSGNSELQYVSYRLGEPVFDVQECQIRGVTYSAPLRVKLRLVIYEREAPEGTVKDIKEQ
EVYMGEIPLMTDNGTFVINGTERVIVSQLHRSPGVFFDSDKGKTHSSGKVLYNARIIPYR
GSWLDFEFDPKDNLFVRIDRRRKLPATIILRALNYTTEQILDLFFEKVVFEIRDNKLQME
LIPERLRGETASFDIEANGKVYVEKGRRITARHIRQLEKDDIKHIEVPVEYIAGKVVSKD
YVDESTGELICAANMELSLDLLAKLSQSGHKRIETLFTNDLDHGPYISETVRVDPTNDRL
SALVEIYRMMRPGEPPTREAAESLFENLFFSEDRYDLSAVGRMKFNRSLLRDEIEGSGIL
SKDDIIDVMKKLIDIRNGKGEVDDIDHLGNRRIRSVGEMAENQFRVGLVRVERAVKERLS
LGDLDTLMPQDMINAKPISAAVKEFFGSSQLSQFMDQNNPLSEITHKRRISALGPGGLTR
ERAGFEVRDVHPTHYGRVCPIETPEGPNIGLINSLSVYAQTNEYGFLETPYRRVVDGVVT
DEIHYLSAIEEGNYVIAQANSNLDDEGHFVEDLVTCRSKGESSLFSRDQVDYMDVSTQQV
VSVGASLIPFLEHDDANRALMGANMQRQAVPTLRADKPLVGTGMERAVAVDSGVTAVAKR
GGTVQYVDASRIVIKVNEDEMYPGEAGIDIYNLTKYTRSNQNTCINQMPCVSLGEPVERG
DVLADGPSTDLGELALGQNMRVAFMPWNGYNFEDSILVSERVVQEDRFTTIHIQELACVS
RDTKLGPEEITADIPNVGEAALSKLDESGIVYIGAEVTGGDILVGKVTPKGETQLTPEEK
LLRAIFGEKASDVKDSSLRVPNGVSGTVIDVQVFTRDGVEKDKRALEIEEMQLKQAKKDL
SEELQILEAGLFSRIRAVLVSSGVEAEKLDKLPRDRWLELGLTDEEKQNQLEQLAEQYDE
LKHEFEKKLEAKRRKITQGDDLAPGVLKIVKVYLAVKRRIQPGDKMAGRHGNKGVISKIN
PIEDMPYDENGTPVDIVLNPLGVPSRMNIGQILETHLGMAAKGIGDKINAMLKQQQEVAK
LREFIQRAYDLGADVRQKVDLSTFSDDEVLRLAENLRKGMPIATPVFDGAKEAEIKELLK
LGDLPTSGQITLFDGRTGEQFERPVTVGYMYMLKLNHLVDDKMHARSTGSYSLVTQQPLG
GKAQFGGQRFGEMEVWALEAYGAAYTLQEMLTVKSDDVNGRTKMYKNIVDGNHQMEPGMP
ESFNVLLKEIRSLGINIELEDE
>WP_001040568.1|FEATURES|megares|elfamycin|tufab|antibiotic target alteration|0
MAKEKFDRSKEHANIGTIGHVDHGKTTLTAAIATVLAKNGDSVAQSYDMIDNAPEEKERG
ITINTSHIEYQTDKRHYAHVDCPGHADYVKNMITGAAQMDGGILVVSAADGPMPQTREHI
LLSRNVGVPALVVFLNKVDMVDDEELLELVEMEVRDLLSEYDFPGDDVPVIAGSALKALE
GDAQYEEKILELMEAVDTYIPTPERDSDKPFMMPVEDVFSITGRGTVATGRVERGQIKVG
EEVEIIGLHDTSKTTVTGVEMFRKLLDYAEAGDNIGALLRGVAREDVQRGQVLAAPGSIT
PHTEFKAEVYVLSKDEGGRHTPFFSNYRPQFYFRTTDVTGVVHLPEGTEMVMPGDNVEMT
VELIAPIAIEDGTRFSIREGGRTVGSGVVTEIIK
>AAQ76282.1|FEATURES|megares|beta_lactam|OXA-50|antibiotic inactivation|1
MRPLLLSALLLLSGHTQASEWNDSQAVDKLFGAAGVKGTFVLYDVQRQRYVGHDRERAET
RFVPASTYKVANSLIGLSTGAVRSADEVLPYGGKPQRFKAWEHDMSLREAIKASNVPVYQ
ELARRIGLERMRANVSRLGYGNAEIGQVVDNFWLVGPLKISAMEQTHFLLRLAQGELPFP
APVQSTVRAMTLLESGPGWELHGKTGWCFDCTPELGWWVGWVKRNERLYGFALNIDMPGG
EADIGKRVELGKASLKALGILP
>YP_001708330.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MAYSYTEKKRIRKNFGKLPQVMDAPYLLSIQVDSYRTFLQDGKSPKNREDIGLQAAFRSV
FPIESYSGNAALEFVEYSLGKPEFDVRECILRGSTYAAPMRVKIRLIIKDRETKSIKDVR
EQEVYMGEIPLMTENGTFVINGTERVIVSQLHRSPGVFFDHDKGKTHSSGKVLYSARIIP
YRGSWLDFEFDAKDLVYVRIDRRRKLLATVVLRALGYNNEQILNLFYEKLPVYLDMGSYQ
IDLVPERLRGEMAQFDITDNEGKVIVEQGKRINARHVRQMEAAGLTKLSVPDEYLYERIT
AEDITLRDGEVIAANTLLSHEVMVKLAEGGVKQFNILFTNDIDRGSFVADTLRADLTRDR
EEALVEIYKVMRPGEPPTKEAAENLFNNLFFSSERYDLSPVGRMKFNRRLGRPYEVGTDQ
KSREVEGILSHEDIIDVLRTLVEIRNGKGEVDDIDHLGNRRVRSVGEMTENQFRVGLVRV
ERAVKERLSQAETDNLSPQDLINAKPVAAAIKEFFGSSQLSQFMDQNNPLSEITHKRRVS
ALGPGGLTRERAGFEVRDVHQTHYGRVCPIETPEGPNIGLINSLSVYAKANDFGFLETPY
RKVVDGRVTDDVEYLSAIEEVGTVIAQADSAVDKDGNLTEEFVSVRHQGEFVRMPPEKVT
HMDVSAQQVVSVAASLIPFLEHDDANRALMGSNMQRQAVPTLRADKPLVGTGMEANVARD
SGVCVIANRGGVIEYVDASRIVIRVNEDEMVAGEAGVDIYNLIKYTRSNQNTCINQNVIV
NLGDKVARGDILADGPSTDMGELALGQNMRVAFMTWNGYNYEDSILLSERVLQEDRLTSI
HIQELSCVARDTKLGAEEITADIPNVGEAALSKLDESGIVYIGAEVTAGDILVGKVTPKG
ETQLTPEEKLLRAIFGEKAADVKDSSLRVPSGTKGTVIDVQVFTRDGLEKDDRALAIEKA
QLDSYRKDLKEEYKIFEEAARERVIRLLKGQESNGGGSTKRGDKLSEDLLSGLELVDLLE
IQPADEAIAERLTQIQVFLKEKSAEIDEKFAEKKRKLATGDELTTGVLKVVKVYLAVKRR
IQPGDKMAGRHGNKGVVSNILPVEDMPHDANGVPVDIVLNPLGVPSRMNVGQILETHLGM
AAKGLGDKIEKMLKEQRTVLELREFLDKIYNKVGGEQEDLDSLTDEEILALAGNLRAGVP
LATPVFDGAEESQIKDLLELADISRTGQTVLFDGRTGEQFDRPVTVGYMYMLKLNHLVDD
KMHARSTGSYSLVTQQPLGGKAQFGGQRFGEMEVWALEAYGAAYTLQEMLTVKSDDVEGR
TRIYKNIVDGNHYMDPGMPESFNVLTKEIRSLGINIELKNGD
>AJG01376.1|FEATURES|megares|beta_lactam|OXA-69|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDDKAEKIKNLFNEAHTTGVLVIHQGQ
TQQSYGNDLARASTEYVPASTFKMLNALISLEHHKATTTEVFKWDGEKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>WP_000195976.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MYTDTSRPNHLAQEVIDNAVDEALAGHADKICVTVYKDGSLSVEDNGRGMPVDIHPEYGQ
SGIEIILTKLHAGGKFSTDNYQFSGGLHGVGISVVNALSTRVEVEVQRQGNLYQMAFEQG
EPVAPLAVLEGKAPKRATGTTVRFWPEAKYFDSPKFALKALKHNLKAKAVLAAGLKITYI
DQINDEKIEWQFENGLVDYLMDELQDREILPNPAFVSSGQADRAACEFAICWNVEGGEQV
QESYVNLIPTAQGGTHVNGLRSGVTEALREFCELRNLLPRNLKLSAEDVWDGVNYILSLK
FQEPQFSGQTKERLSSREAANIVLNIAKDAFALWLNQHAEIAMQLAEMAISKAGRRLKAA
KKVERKKIVSGPALPGKLADCVGQTREESELFIVEGDSAGGSAKQARDKNFQAIMPIRGK
ILNTWEVSSDEVLASSQEVHDIAIAIGVDPGSDDLSELRYGKICILADADSDGLHIATLL
CALFVKHFPALVEEGHLYVAMPPLFRIDIGKDVHYALDDEELETILKNVKGNKNPQITRF
KGLGEMNAIQLRETTMDPNTRRLVQLDLDDAHLTAGLLDKLLAKKRAADRKQWLEQKGNL
ADITV
>AAB60006.1|FEATURES|megares|chloramphenicol|cmlA5|antibiotic efflux|1
MDMYLPAVPFMPNALGTTASTIQLTLTTYLVMIGAGQLLFGPLSDRLGRRPVLLGGGLAY
VVASMGLALTSSAEVFLGLRILQACGASACLVSTFATVRDIYAGREESNVIYGILGSMLA
MVPAVGPLLGALVDMWLGWRAIFAFLGLGMIAASAAAWRFWPETRVQRVAGLQWSQLLLP
VKCLNFWLYTLCYAAGMGSFFVFFSIAPGLMMGRQGVSQLGFSLLFATVAIAMVFTARFM
GRVIPKWGSPSVLRMGMGCLIAGAVLLAITEIWALQSVLGFIAPMWLVGIGVATAVSVAP
NGALRGFDHVAGTVTAVYFCLGGVLLGSIGTLIISLLPRNTAWPVVVYCLTLATVVLGLS
CVSRVKGSRGQGEHDVVALQSAESTSNPNR
>ACH50230.1|FEATURES|megares|multidrug|ramR|antibiotic efflux|0
MARPKSEDKKQALLEAATQAIAQSGIAASTAVIARNAGVAEGTLFRYFATKDELINTLYL
HLKQDLCQSMIMELDRSITDAKMMTRFIWNSYISWGLNHPARHRAIRQLAVSEKLTKETE
QRADDMFPELRDLCHRSVLMVFMSDEYRAFGDGLFLALAETTMDFAARDPARAGEYIALG
FEAMWRALTREEQ
>ABB63227.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MSDMAERLALHEFTENAYLNYSMYVIMDRALPFIGDGLKPVQRRIVYAMSELGLNASAKF
KKSARTVGDVLGKYHPHGDSACYEAMVLMAQPFSYRYPLVDGQGNWGAPDDPKSFAAMRY
TESRLSKYSELLLSELGQGTADWVPNFDGTLQEPKMLPARLPNILLNGTTGIAVGMATDI
PPHNLREVAQAAIALIDQPKTTLDQLLDIVQGPDYPTEAEIITSRAEIRKIYENGRGSVR
MRAVWKKEDGAVVISALPHQVSGARVLEQIAAQMRNKKLPMVDDLRDESDHENPTRLVIV
PRSNRVDMDQVMNHLFATTDLEKSYRINLNMIGLDGRPAVKNLLEILSEWLVFRRDTVRR
RLNYRLEKVLKRLHILEGLLVAFLNIDELIEIIRNEDEPKPALMSRFGLTETQAEAILEL
KLRHLAKLEEMKIRCEQSELEKERDQLQGILASERKMNNLLKKELQADAQAYGDDRRSPL
QEREEAKAMSEHDMLPSEPVTIVLSQMGWVRSAKGHDIDAPGLNYKAGDSFKAAVKGKSN
QPVVFVDSTGRSYAIDPITLPSARGQGEPLTGKLTLPPGATVDHILMESDDQKLLMASDA
GYGFVCTFNDLVARNRAGKALITLPENAHVMPPVVIEDASDMLLAITQAGRMLMFPVSDL
PQLSKGKGNKIINIPSAEAARGEDGLAQLYVLPSQSTLTIHVGKRKIKLRPEELQKVTGE
RGRRGTLMRGLQRIDRVEIDSPRRASSGDSEE
>WP_000202263.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MTSLAHHATENRSVAEFTEQAYLNYAMYVIMDRALPHISDGLKPVQRRIVYAMSELGLKS
SGKPKKSARTVGDVLGKYHPHGDSACYEAMVLMAQPFSYRYPLIEGQGNWGSPDDPKSFA
AMRYTEAKLSAYSELLLSELGQGTSEWQDNFDGSLKEPITLPARVPNILLNGTTGIAVGM
ATDIPPHNLREVVKGTIALIRNPQTSDGKLAEYIPAPDLPTKAEIITPPEELLKIQTTGR
GSYRMRAVYTIEKNEIVITELPYQVSGSKVITQIADQMQAKKLPLVVDVRDESDHENPTR
LVIVLRSNRIDAEAVMSHLFATTDLESSYRVNLNMIGEDGRPQVKSIRRILLEWIEIRKK
TVTRRLQYHLNRIEKRLHILAGLLIAYLDIDTVIRIIREEDQPKPVLMEHFNIDEIQAEA
ILELKLRHLAKLEEMEIRHEQDELSAKAAIIREQLENPESLKNLIIGELKEDAKKFGDER
RSPIVARAEAVQIKEQDLMPAETVTVVLSEAGWVRAAKGADVDAENLNYRAGDQYLSHAV
GKTNQRVYFLDETGRSYALPISNLPSARGLGDPLSSKLSPASGVSFIQVYLDDDESELIA
ASSAGYGFKTQTKQLDTNAKAGKTFLTVPDKAKALPLISAQNMTHLAVLSSAGRLLILDL
VELPNLNKGKGNKLIQLEGKEQILSMTTLNLDEIIQVVAGQQHLKLKGDDLQKYMGKRAS
KGQLLPRGYQKANKLLIQR
>ACQ59434.1|FEATURES|megares|elfamycin|tufab|antibiotic target alteration|0
MSKEKFERTKPHVNVGTIGHVDHGKTTLTAAICTVLAKVYGGKARDFASIDNAPEERERG
ITINTSHVEYDTPNRHYAHVDCPGHADYVKNMITGAAQMDGGILVVAATDGPMPQTREHI
LLGRQVGIPYIIVFMNKCDMVDDEELLELVEMEVRELLSEYDFPGDDLPVIQGSALGALN
GEAQWEAKIVELAEALDTYIPEPERAVDMAFLMPIEDVFSIQGRGTVVTGRIERGILKVG
DEVAIVGIKETVKTTCTGVEMFRKLLDEGRAGENVGALLRGTKREEVERGQVLAKPGSIT
PHTKFESEVYVLSKDEGGRHTPFFKGYRPQFYFRTTDVTGSIELPEGVEMVMPGDNVKMV
VDLIAPIAMDEGLRFAIREGGRTVGAGVVAKIIA
>AEE66656.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MSDSNQPGLFDGGATDPHEAITLGRYAEQAYLDYAVSVVRGRALPDVGDGQKPVQRRILY
AMQAMGLAAGAKPVKSARVVGDVLGKYHPHGDQAAYDAMVRMAQDFSLRYPLIDGHGNFG
SRDGDNAAAMRYTEARLTPFSKLLLDELEEGTVDFVPNYDGSQQEPAMLPARLPVMLLNG
ASGIAVGMATEIPSHNLREVAQACVALIRNPKLPQEELLALVPGPDFAGGGQIITPAADI
AQIYATGRGSLKARARWQFEEMARGQWQLVVTELPPGTSGQKVLEEIEEITNPKVRAGKK
SLSAEQQQAKAVMLSLLDAVRDESGKDAAVRLVFEPKTSRVDRDEFVNTLLAQTSMESNV
PVNVVCIGTDGRPRQKSLRDVLEEWVAFRTDTVVRRTRHRLDKVLDRIHVLEGRMVVYLN
VDEVIQTIREAEEPRAALMARFGLTERQAEDILEMRLRQLARLEGIKIEQELAGKREEQL
RLQDLLDNPGSLKRLLIKEIEGDAKQYGDDRRTLIETAERAVLETKVVDEPVTVIVSQKG
WLRARQGHGHDAGQFSFKQGDDLYGAFECRTTDTLIAVGDNGRVYSVAVSGLPSARGDGQ
PVTTMIDLEAGTRIVHTIAAAPDSRWLLATRRGFGFAARLSDMSSRQRAGKQFITLEKGD
ELLRPVPLFEGATQLALLSAKGKFLVFDLDEVKSLSGGGRGTILMGLDTADKLDQTVPIG
AAGLRAAGIYRNKQTEDILAGAALAPYVGKRARKGRQLNVRPRQPVLSPVF
>WP_050815728.1|FEATURES|megares|macrolide-lincosamide-streptogramin|mphE|antibiotic inactivation|0
MTETSPSSPSSATADAGTPPPADLEQLLALAADHGLDLLGDSLRTEEIGLDFRVAFARSR
DWQDWVLRIPRRAEVLARAAVEGRLLAHLAPHLDIAIPDWRISTERLIAYPLLPGTPGLT
VSADGTVEWHVDMASTEYARALGTFLAQLHTVDPEEAAATGIPSRTPSEVRGVWREDLTR
VAEAFPIAPALRERWEAWLAEDSYWPDRSVLTHGEVYPGHTLVEGERLSAVLDWTTASVG
DPARDLMFHRSSAPPEAFAATLAAYVAGGGTLHPRLGEHAEEMFSASPLAYGLYALETGE
EEHRAAAAAALDPPDAD
>AJG01377.1|FEATURES|megares|beta_lactam|OXA-91|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVSTNPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AEK32499.1|FEATURES|megares|streptothricin|estX|antibiotic inactivation|0
MLWSSNDVTQQGSRPKTKLYVELEGNLSMKEKVVVDKAISLYTESFGDPAHEPIILIMGA
MSSAVWWPDEFCSQLAKMGRYVIRYDHRDTGKSTSYEPGQAPYSVEELADDVVRVIDGYG
LEAAHLVGMSLGGFLSQLVALKYPKRVKSLTLIASERLADADPDMPAFDPAIIEYHQRAE
SLDWSDRDAVVAYQVGAWRINSGTAHAFDAEKIQNIAELNFDRTPNILTTFNHTTLGGGE
RWLGRLNEIAVPTLIIHGTEDPVLPYVHGLALKDAIRGSKMLTLEGTGHELHHEDWPRII
QAIKGQTS
>WP_011461303.1|FEATURES|megares|glycopeptide|vanRI|antibiotic target alteration|1
MAANILIVDDEQAIADLVEVYLKNENYNLFKFYNGKDALDCIEKEKLDLAILDVMLPDVD
GFSICRQIREKHNFPVIMLTAKEEEIDKITGLTLGADDYITKPFRPLELIARVKAQLRRF
TKYNSAEPNQEEHVIAFSGLVLDMDTHECTLNEKKLSLTPTEFSILWVLCSNRGRVVSSE
ELFSEVWGDKYFTNSNNTVMVHIRHLREKMQDSAEHPKYIKTVWGVGYKIEK
>AAK84314.1|FEATURES|megares|macrolide-lincosamide-streptogramin|ErmB|antibiotic target alteration|1
MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGNIPYHLSTQIIKKVVFESRAS
DIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTT
DVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTITYEQVLSIFNS
>ACL31576.1|FEATURES|megares|aminoglycoside|rmtB|antibiotic target alteration|1
YGTIHDALTSILASKKYRALCPDTVRRILTEEWGRHKSPKQTVEAARTRLHGICGAYVTP
ESLKAAAAALSAGDVKKALSLHASTKERLAELDTLYDFIFSAETPRRVLDIACGLNPLAL
YERGIASVWGCDIHQGLGDVITPFAREKDWDFTFALQDVLCAPPAEAGDLALIFKLLPLL
EREQAGSAMALLQSLNTPRMAVSFPTRSLGGRGKGMEANYAAWFEGGLPAEFEIEDKKTI
GTELIYLIKKNG
>AAD25064.1|FEATURES|megares|tetracycline|tetR|antibiotic target alteration|0
MTHHRKRLDRTSVLLGARQVLDETGLDGFTTRALAAHLQVQQPGLYWHFRTKAELLAALA
SDVLDREHHASFPESDEKWDAFLLRNARSFRHALHAVRDGARLHAEHHRRPSGDDTDEGA
EASGQQVGLLVSQGFDEQTAISMLIAVSRYTVGVVLEEQTAEVGNASVPERDREFDFGLT
ALIDGFSHSRTASLTSSES
>BAJ34818.1|FEATURES|megares|macrolide-lincosamide-streptogramin|Erm(42)|antibiotic target alteration|1
MDMNKNTKIKNKNFNIKDSQNFLHNTKLVEDLLFKSNITKEDFVVEIGPGKGIITKALSK
ICKAVTAIEFDSVLADKLTHEFKSSNVSIIEADFLKYNLPDHNYKVFSNIPFNITASILN
KLLDSENPPLDTFLIMQYEPFLKYAGAPSYKESYKSLLYKPFFKTNILHSFSKFDFKPAP
NANIILGQFSYKDFTDINLEDRHAWKDFLAFVFLEKGVTFKEKTKRIFSYKQQKIILKES
RINDDSNISNWSYEFWLKMFKLYNSNMVSKDKKVLVNNSYKRMLEHESSLEKIHRNRKQN
NRK
>ACH43053.1|FEATURES|megares|aminoglycoside|AAC(6')-IIa|antibiotic inactivation|1
MPSTAPEVTQRLMVKRDLVMLHEWLNRPHIVEWWGGEEARPTLQEVQSHYLPRVLAEEAV
TPYIAMLGSEPIGYAQSYVALGSGDGWWEDETDPGVRGIDQSLANPEQLGKGLGTRLVCT
LVKTLFNDPSVTKIQTDPAPNNVRAIRCYEKAGFRQQKVITTPDGPAVYMVQTRASFEAA
RGAA
>AEL00449.1|FEATURES|megares|quinolone|QnrB29|antibiotic target protection|1
MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMVDFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>WP_017780889|FEATURES|megares|tetracycline|tetE|antibiotic efflux|1
MLWGIGIIMPVLPALLREFVGKANVAENYGVLLALYAMMQVIFAPLLGRWSDRIGRRPVL
LLSLLGATLDYALMATASVVWVLYLGRLIAGITGATGAVAASTIADVTPEESRTHWFGMM
GACFGGGMIAGPVIGGFAGQLSVQAPFMFAAAINGLAFLVSLFILHETHNANQVSDELKN
ETINETTSSIREMISPLSGLLVVFFIIQLIGQIPATLWVLFGEERFAWDGVMVGVSLAVF
GLTHALFQGLAAGFIAKHLGERKAIAVGILADGCGLFLLAVITQSWMVWPVLLLLACGGI
TLPALQGIISVRVGQVAQGQLQGVLTSLTT
>ACQ61253.1|FEATURES|megares|beta_lactam|gyrA|antibiotic target alteration|0
MSDLAKEITPVNIEDELRSSYLDYAMSVIVGRALPDVRDGLKPVHRRVLFAMNVLGNDWN
KAYKKSARVVGDVIGKYHPHGDSAVYDTIVRMAQPFSLRYMLVDGQGNFGSIDGDSAAAM
RYTEVRMSKIAHELLADLDKETVDYVPNYDGTEQIPAVLPTKIPNLLINGASGIAVGMAT
NIPPHNLGEVIDGCLAYIDNEAITIDELMDYIPGPDFPTAALISGRKGIIDAYKTGRGKV
YMRSKAEIETDKNGKETIIVSEIPYQVNKARLIEKIAELVKEKKVEGISALRDESDKDGM
RIVIECKRDAVGEVVLNNLYANTQLQTTFGINMVALDNGQPKLFNLKEMLKCFVDHRREV
VTRRTIFELRKARERAHILEGLALALANIDEIIELIRRAATPAEAKEGLIARGWDLGNVA
AMLERAGTDAARPEWLEPQYGIRDGKYFLTEQQAQAILDLRLHKLTGLEHEKILDEYKQL
LEEIAALMHILASTERLMEVIREELEAIRAGFSDARRTEITAATHDIDMEELIAREDVVV
TLSHEGYVKYQLLSDYEAQRRGGKGKSATKMKEEDYIERLLVANTHDNILLFSTRGKTYR
MKVYQLPLASRTARGKPIVNLLPLEENERITAILPVTEFSEDKFIFMATGDGTVKKTSLD
QFANVRANGLIALNLRDEDSLIGVDITDGESEIMLFSKFGKVVRFKESEETAVVDENGQP
VLDENGQPEIKFKGVRPMGRTAAGVRGMKLADGDQVVSLIVPKTEGDVLTVTENGYGKRT
SLSEYPTKGRGTQGVVSIKVSERNGSVVGAVQVAEGDEFMMITNAGTLVRTRVAEVSQVG
RNTQGVTLIRTSEGESVVGLQRIDEIEESELPEGEEALVENDAPVAQDDDGEQE
>AGS60314.1|FEATURES|megares|multidrug|gyrA|antibiotic target alteration|0
MSDIAREITPVNIEEELKSSYLDYAMSVIVGRALPDVRDGLKPVHRRVLFAMNVLGNDWN
KPYKKSARVVGDVIGKYHPHGDSAVYETIVRLAQPFSMRYMLVDGQGNFGSVDGDSAAAM
RYTEVRMAKIAHELLADLEKETVDFVPNYDGTENIPAVMPTRIPNLLVNGSSGIAVGMAT
NIPPHNLGEVIDGCLAYVDNEDITIEELMEYITGPDFPTAAIINGRRGILDAYRTGRGKI
YIRAQADIETDEKTGRETIIVTEIPYQVNKARLIEKIAELVKDKRIEGISGLRDESDKDG
MRIVVEIKRDAVGEVVLNHLFSQTQMQVSFGINMVALHQGQPKLLNLKEIIAAFIRHRRE
VVTRRTIFELRKARDRAHILEALAVALANIDPVIELIRQAPTPAEAKAALIAQPWDLGSV
STMLERAGDSNVARPEWLEPQFGVHDGKYYLTEQQAQAILDLRLQKLTGLEHEKLLDEYR
ELLLQIAELLHILRSPERLMDVIREELTAIKTQYNDPRRTEITENTADINIEDLINEENV
VVTLSHQGYVKYQPLTDYEAQRRGGKGKSAARIKEEDFIDRLLVANTHDTILCFSSRGRL
YWMKVYQLPEASRGARGRPIINLLPLEQDERITAILPVREYEEGKFVFMATASGTVKKTP
LQDFSRPRSAGIIAVNLNDGDELIGVDLTDGSNEAMLFSADGKVVRFAEECVRPMGRTAT
GVRGMKLVDDDKVVSLIIPRGEGDILTVTENGYGKRTVQSEYPTKNRATQGVISIKVSER
NGKVVGAIQVEETDQIMMITNAGTLVRTRVSEVSIVGRNTQGVTLIRTTEDELVVGLQRV
EDEDDALDDDEVDEMISDNISDVPESEPTDDADSEEE
>WP_003690105.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MNYSFTEKKRIRKSFAKRENVLEVPFLLATQIDSYAKFLQLENAFDKRTDDGLQAAFNSI
FPIVSHNGYARLEFVYYTLGEPLFDIPECQLRGITYAAPLRARIRLVILDKEASKPTVKE
VRENEVYMGEIPLMTPSGSFVINGTERVIVSQLHRSPGVFFEHDKGKTHSSGKLLFSARI
IPYRGSWLDFEFDPKDLLYFRIDRRRKMPVTILLKALGYNNEQILDIFYDKETFYLSSNG
VQTDLVAGRLKGETAKVDILDKEGNVLVAKGKRITAKNIRDITNAGLTRLDVEQESLLGK
ALAADLIDSETGEVLASANDEITEELLAKFDINGVKEITTLYINELDQGAYISNTLRTDE
TAGRQAARVAIYRMMRPGEPPTEEAVEQLFNRLFFSEDSYDLSRVGRMKFNTRTYEQKLS
EAQQNSWYGRLLNETFAGAADKGGYVLSVEDIVASIATLVELRNGHGEVDDIDHLGNRRV
RSVGELTENQFRSGLARVERAVKERLNQAESENLMPHDLINAKPVSAAIKEFFGSSQLSQ
FMDQTNPLSEVTHKRRVSALGPGGLTRERAGFEVRDVHPTHYGRVCPIETPEGPNIGLIN
SLSVYARTNDYGFLETPYRRVIDGKVTEEIDYLSAIEEGRYVIAQANADLDSDGNLIGDL
VTCREKGETIMATPDRVQYMDVATGQVVSVAASLIPFLEHDDANRALMGANMQRQAVPCL
RPEKPMVGTGIERSVAVDSATAIVARRGGVVEYVDANRVVIRVHDDEATAGEVGVDIYNL
VKFTRSNQSTNINQRPAVKAGDVLQRGDLVADGASTDLGELALGQNMTIAFMPWNGYNYE
DSILISEKVAADDRYTSIHIEELNVVARDTKLGAEDITRDIPNLSERMQNRLDESGIVYI
GAEVEAGDVLVGKVTPKGETQLTPEEKLLRAIFGEKASDVKDTSLRMPTGMSGTVIDVQV
FTREGIQRDKRAQSIIDSELKRYRLDLNDQLRIFDNDAFDRIERMIVGQKANGGPMKLAK
GSEITTEYLAGLPSRHDWFDIRLTDEDLAKQLELIKLSLQQKREEADELYEIKKKKLTQG
DELQPGVQKMVKVFIAIKRRLQAGDKMAGRHGNKGVVSRILPVEDMPYMADGRPVDIVLN
PLGVPSRMNIGQILEVHLGWAAKGIGERIDRMLKERRKAGELREFLNKLYNGSGKKEDLD
SLTDEEIIELASNLRKGASFASPVFDGAKESEIREMLNLAYPSEDPEVEKLGFNDSKTQI
TLYDGRSGEAFDRKVTVGVMHYLKLHHLVDEKMHARSTGPYSLVTQQPLGGKAQFGGQRF
GEMEVWALEAYGAAYTLQEMLTVKSDDVNGRTKMYENIVKGEHKIDAGMPESFNVLVKEI
RSLGLDIDLERY
>WP_000167933.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|0
MTKTKIMGILNVTPDSFSDGGKFNNVESAVTRVKAMMDEGADIIDVGGVSTRPGHEMISL
EEELNRVLPVVEAIVGFDVKISVDTFRSEVAEACLKLGVDIINDQWAGLYDHRMFQVVAK
YDSEIVLMHNGNGNRDEPVVEEMLTSLLAQAHQAKIAGIPSNKIWLDPGIGFAKTRNEEA
EVMARLDELVATEYPVLLATSRKRFTKEMMGYDTTPVERDEVTAATTAYGIMKGVRAVRV
HNVELNAKLAKGIDFLKENENARHNLS
>AAN40996.1|FEATURES|megares|sulfonamide|sul2|antibiotic target replacement|1
MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVS
SDTEIARIAPVLDALKADGIPVSLDSYQPATQAYALSRGGPYLNNIRGFPDAAFYPQLAK
SSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFF
LGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAAA
GGADFIRTHEPRPLRDGLAVLAALKETARIR
>ABY65242.1|FEATURES|megares|macrolide-lincosamide-streptogramin|ErmA|antibiotic target alteration|1
DNVIEIGSGKGHFTKELVKMSRWVDSIEIDEDLCQVTQKVVKPFQNIKVIHTDILKFNFP
KNKDYKIFGNIPFNISTDIVKKIAFESNSKYSYLIVENGFAKRLQNTKRALGLLLMVELD
IRVLKKVPRAYFHPKPNVDSVLIVLERHQPLILKKDYKEYQSFVYKWVNREYRVLFTKNQ
FRQALKHANVTNINKLSK
>ABQ56921.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MAVAEAKPQYSHAEKKRFRKSFGKQTDIMPIPNLLEIQLKSYRDFLQTDTKLSEQLNTGL
HAAFSSVFPIESFSGNARLEYVGYKLGEPAFDVRECKLRGLTYSAPLRVKIRLVVLDKDA
SDDPKPIKDIREQDVFMGEIPLMTDVGTFVVNGTERVVVSQLHRSPGVIFEHDKGKTHSS
GKLLYSARIIPYRGSWLDFEFDPKDCVYVRIDRRRKLPVTILLRALGYEAEDILSEFFET
TRCHLKNGEYHIDLIPQRLRGEIASFDIHVPETGELIVEQGRRITARHIKQMEKSQMQDL
VVPRDYLIGKTLAKNIIDTSTGEFLAQANDEITEELLDAMANHGILQIDMIYTNDLDHGS
YISDTLKIDPTGSQLEALVEIYRMMRPGEPPTKEAAEALFKNLFFVEERYDLSAVGRMKF
NRRVGIKSDEGPGTLTKEDILSVIKTLIDIRNGIGMVDDIDHLGNRRVRSVGEMTENQFR
VGLVRVERAVKERLSLVESENLMPQDLINAKPVSAAIKEFFGSSQLSQFMDQVNPLSGVT
HKRRVSALGPGGLTRERAGFEVRDVHTTHYGRVCPIETPEGPNIGLINSLSVYARTNEYG
FIETPCRKVVNGRVTDEVEYLSAIEEVDQYIAQSNVELDAQGNILADLVPCRHQNEFSLT
TPDKINYMDVSPKQIVSVAASLIPFLEHDDANRALMGSNMQRQAVPTLRSEKPLVGTGME
RIVASDSGVSVVAKRGGVIDLVDASRIVVRVNDDETTAGETGVDIYNLTKYFRSNQDTCI
NQRPIVSTGDRIQRGDVLADGPCTDMGELALGQNLLVAFMPWNGYNFEDSILISERIVHD
DRFTTIHIEELTCIARDTKLGTEEITADIPNVGESALSNLDESGVVYIGAEVKAGDILVG
KVTPKGETQLTPEEKLLRAIFGEKASDVKDSSLRVPSGMNGTVIDVQVFTRDGLEKDARA
KSIEEEHLARVRKDLIDERRIREEDIYHRVSHLLLDKVATGGPGSLKPGSKITQDYLDKV
EREKWFDIRIEDDAVSQQLEQLSKQLELLTKEMEKRFNDSRKKIIQGDDLAPGVLKIVKV
YLAVKRRIQPGDKMAGRHGNKGVISIVVPVEDMPHMEDGTAVDIVLNPLGVPSRMNIGQV
LETHLGLAAKGLGRKIAQMLDERQTPEAIKAYLEKIYNHDGVQRVNLKCLNDDELMTLAD
NLRAGVPMATPVFDGATEQEIKSMLQLADLPADGKTVLIDGRTGNKFDNPVTVGYMYMLK
LNHLVDDKMHARSTGSYSLVTQQPLGGKAQFGGQRFGEMEVWALEAYGAAYTLQEMLTVK
SDDVGGRTKIYKNIVDGDHRMDPGMPESFNVLLKEIRALGIDIELEHD
>ABR79111.1|FEATURES|megares|tetracycline|tufab|antibiotic target alteration|0
MSKEKFERTKPHVNVGTIGHVDHGKTTLTAAITTVLAKTYGGSARAFDQIDNAPEEKARG
ITINTSHVEYDTPTRHYAHVDCPGHADYVKNMITGAAQMDGAILVVAATDGPMPQTREHI
LLGRQVGVPYIIVFLNKCDMVDDEELLELVEMEVRELLSQYDFPGDDTPIVRGSALKALE
GDAEWEAKIIELAGHLDTYIPEPERAIDKPFLLPIEDVFSISGRGTVVTGRVERGIIKVG
EEVEIVGIKETAKTTCTGVEMFRKLLDEGRAGENVGVLLRGIKREEIERGQVLAKPGTIN
PHTKFESEVYILSKDEGGRHTPFFKGYRPQFYFRTTDVTGTIELPEGVEMVMPGDNIKMV
VTLIHPIAMDDGLRFAIREGGRTVGAGVVAKVLG
>CCQ22202.1|FEATURES|megares|tetracycline|tufab|antibiotic target alteration|0
MAKEKFDRSKPHVNIGTIGHVDHGKTTLTAAITTVLAKKGYADAQAYDQIDGAPEERERG
ITISTAHVEYQTDSRHYAHVDCPGHADYVKNMITGAAQMDGAILVVSAADGPMPQTREHI
LLSRQVGVPYIVVFMNKCDMVDDEELLELVEMEIRDLLTEYEFPGDDIPVIKGSALKALQ
GEADWEAKIDELMEAVDSYIPTPERDTDKPFMMPVEDVFSITGRGTVATGRVERGQVKVG
DEVEVIGIEEESKKVVVTGVEMFRKLLDYAEAGDNIGALLRGVAREDIQRGQVLAKPGSI
TPHTNFKAETYVLTKEEGGRHTPFFNNYRPQFYFRTTDVTGIVTLPEGTEMVMPGDNIEL
AVELIAPIAIEDGTKFSIREGGRTVGAGVVSNISK
>ACX34100.1|FEATURES|megares|macrolide-lincosamide-streptogramin|vgaALC|antibiotic target protection|1
MKIMLEGLHIKHYVQDRLLLNINRLNIYQNDRIGLIGKNGSGKTTLLHILYKKIVPEEGI
VKQFSHCELIPQLKLIESTKSGGEVTRNYIRQALDKNPELLLADEPTTNLDNNYIEKLEQ
DLKNWHGAFIIVSHDRAFLDNLCTTIWEIDEGRITEYKGNYSNYVEQKELERHREELEYE
KYEKEKKRLEKAINIKEQKAQRATKKPKNLSLSEGKITGAKPYFAGKQKKLRKTVKSLET
RLEKLESVEKRNELPPLKMDLVNLESVKNRTIIRGEDVSGTIEGRVLWKAKSFSIRGGDK
MAIIGSNGTGKTTFIKKIVHGNPGISLSPSVKIGYFSQKIDTLELDKSILENVQSSSQQN
ETLIRTILARMHFFRDDVYKPISVLSGGERVKVALTKVFLSEVNTLVLDEPTNFLDMEAI
EAFESLLKEYNGSIIFVSHDRKFIEKVATRIMTIDNKEIKIFDGTYEQFKQAEKPTRNIK
EDKKLLLETKITEVLSRLSIEPSEELEQEFQNLINEKRNLDK
>ABX79419.1|FEATURES|megares|glycopeptide|vanC|antibiotic target alteration|1
MKKIAIIFGGNSPEYTVSLASATSAIEALQSSPYDYDLSLIGITPDAMDWYLYTGELENI
RQDTWLLDTKHKQKIQPLFEGNGFWLSEEQQTLVPDVLFPIMHGKYGEDGSIQGLFELMK
LPYVGCGVAGSALCMNKWLLHQAAAAIGVQSAPTILLTNQANQQEQIEAFIQTHGFPVFF
KPNEAGSSKGITKVTCVEEIASALKEAFTYCSAVLLQKNIVGVEIGCGILGNDSLTVGAC
DTISLVDGFFDFEEKYQLISAKITVPAPLPETIETKVKEQAQLLYRSLGLKGLARIDFFV
TDQGELYLNEINTMPGFTSHSRYPAMMAAVGLSYQELLQKLLVLAKEEVK
>ACH50233.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MSDMAERLALHEFTENAYLNYSMYVIMDRALPFIGDGLKPVQRRIVYAMSELGLNASAKF
KKSARTVGDVLGKYHPHGDSACYEAMVLMAQPFSYRYPLVDGQGNWGAPDDPKSFAAMRY
TESRLSKYAELLLSELGQGTADWVPNFDGTMQEPKMLPARLPNILLNGTTGIAVGMATDI
PPHNLREVAKAAITLIEQPKTTLDQLLDIVQGPDYPTEAEIITPRAEIRKIYENGRGSVR
MRAVWTKEDGAVVISALPHQVSGAKVLEQIAAQMRNKKLPMVDDLRDESDHENPTRLVIV
PRSNRVDMEQVMNHLFATTDLEKSYRINLNMIGLDGRPAVKNLLEILTEWLAFRRDTVRR
RLNYRLEKVLKRLHILEGLLVAFLNIDEVIEIIRNEDEPKPALMSRFGISETQAEAILEL
KLRHLAKLEEMKIRGEQDELEKERDQLQGILASERKMNTLLKKELQADADAYGDDRRSPL
REREEAKAMSEHDMLPSEPVTIVLSQMGWVRSAKGHDIDAPGLNYKAGDSFKAAVKGKSN
QPVVFIDTTGRSYAIDPITLPSARGQGEPLTGKLTLPPGATVEHMLMEGDDQKLLMASDA
GYGFVCTFNDLVARNRAGKALITLPENAHVMPPLVIEDEHDMLLAITQAGRMLMFPVDSL
PQLSKGKGNKIINIPSAEAAKGDDGLAHLYVLPPQSTLTIHVGKRKIKLRPEELQKVVGE
RGRRGTLMRGLQRIDRIEIDSPHRVSHGDSEE
>NP_253288.1|FEATURES|megares|multidrug|mexD|antibiotic efflux|0
MSEFFIKRPNFAWVVALFISLAGLLVISKLPVAQYPNVAPPQITITATYPGASAKVLVDS
VTSVLEESLNGAKGLLYFESTNNSNGTAEIVVTFEPGTDPDLAQVDVQNRLKKAEARMPQ
AVLTQGLQVEQTSAGFLLIYALSYKEGAQRSDTTALGDYAARNINNELRRLPGVGKLQFF
SSEAAMRVWIDPQKLVGFGLSIDDVSNAIRGQNVQVPAGAFGSAPGSSAQELTATLAVKG
TLDDPQEFGQVVLRANEDGSLVRLADVARLELGKESYNISSRLNGTPTVGGAIQLSPGAN
AIQTATLVKQRLAELSAFFPEDMQYSVPYDTSRFVDVAIEKVIHTLIEAMVLVFLVMFLF
LQNVRYTLIPSIVVPVCLLGTLMVMYLLGFSVNMMTMFGMVLAIGILVDDAIVVVENVER
IMAEEGISPAEATVKAMKQVSGAIVGITLVLSAVFLPLAFMAGSVGVIYQQFSVSLAVSI
LFSGFLALTFTPALCATLLKPIPEGHHEKRGFFGAFNRGFARVTERYSLLNSKLVARAGR
FMLVYAGLVAMLGYFYLRLPEAFVPAEDLGYMVVDVQLPPGASRVRTDATGEELERFLKS
REAVASVFLISGFSFSGQGDNAALAFPTFKDWSERGAEQSAAAEIAALNEHFALPDDGTV
MAVSPPPINGLGNSGGFALRLMDRSGVGREALLQARDTLLGEIQTNPKFLYAMMEGLAEA
PQLRLLIDREKARALGVSFETISGTLSAAFGSEVINDFTNAGRQQRVVIQAEQGNRMTPE
SVLELYVPNAAGNLVPLSAFVSVKWEEGPVQLVRYNGYPSIRIVGDAAPGFSTGEAMAEM
ERLASQLPAGIGYEWTGLSYQEKVSAGQATSLFALAILVVFLLLVALYESWSIPLSVMLI
VPIGAIGAVLAVMVSGMSNDVYFKVGLITIIGLSAKNAILIVEFAKELWEQGHSLRDAAI
EAARLRFRPIIMTSMAFILGVIPLALASGAGAASQRAIGTGVIGGMLSATFLGVLFVPIC
FVWLLSLLRSKPAPIEQAASAGE
>AAN41428.1|FEATURES|megares|aminoglycoside|AAC(6')-29b|antibiotic inactivation|1
MKEQDAADWLALRNLLWLADDHASEIEQYFSGGLEEPVEVLIARDATGAAVGHVELSIRH
DLEELQGIKTGYIEGLYVAPSHRSTDLVKRFLRESEKWALEQGCSAFASDRSDRVITHRK
FAGSAV
>AAR37057.1|FEATURES|megares|glycopeptide|vanSD|antibiotic target alteration|1
MACSILIIAAVYLFVLKDNFANVVVAILDSFIYHDRDEAVAVYLRTFKAYEIWLFLIAVM
GVFFMIFRRYLDSISKYFKEINRGIDTLVHEDTNDIALPPELASTERKINSIRHTLTKRK
TDAELAEQRKNDLVMYLAHDLKTPLSSVIGYLNLLRDENQISEELREKYLSISLDKAERL
EELINEFFEITRFNLSNITLVYSKINLTMMLEQLGHEFKPMLAGKNLKCEFDVQPDMMLS
CDANKLQRVFDNVLRNAVSYCYENTTIQVNARQAEDYVLIQVINEGDTIPGERLERIFEQ
FYRLDVSQSSSTGGAGLGLAIAREIVELHHGQITARSENGITSFEVTLPTVGKS
>WP_000918675.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MFRDISPIEDFTGNLSLEFVDYRLGEPKYDLEESKNRDATYAAPLRVKVRLIIKETGEVK
EQEVFMGDFPLMTDTGTFVINGAERVIVSQLVRSPSVYFNEKIDKNGRENYDATIIPNRG
AWLEYETDAKDVVYVRIDRTRKLPLTVLLRALGFSSDQEIVDLLGDNEYLRNTLEKDGTE
NTEQALLEIYERLRPGEPPTVENAKSLLYSRFFDPKRYDLASVGRYKTNKKLHLKHRLFN
QKLAEPIVNTETGEIVVEEGTVLDRRKIDEIMDVLESNANSEVFELHGSVIDEPVEIQSI
KVYVPNDDEGRTTTVIGNAFPDSEVKCITPADIIASMSYFFNLLSGIGYTDDIDHLGNRR
LRSVGELLQNQFRIGLSRMERVVRERMSIQDTESITPQQLINIRPVIASIKEFFGSSQLS
QFMYQSNPLSDLTHKRRLSALGPGGLTRERAQMEVRDVHYSHYGRMCPIETPEGPNIGLI
NSLSSYARVNEFGFIETPYRKVDLDTHAITDQIDYLTADEEDSYVVAQANSKLDENGRFM
DDEVVCRFRGNNTVMAKEKMDYMDVSPKQVVSAATACIPFLENDDSNRALMGANMQRQAV
PLMNPEAPFVGTGMEHVAARDSGAAITAKHRGRVEHVESNEILVRRLVEENGVEHEGELD
RYPLAKFKRSNSGTCYNQRPIVAVGDVVEYNEILADGPSMELGEMALGRNVVVGFMTWDG
YNYEDAVIMSERLVKDDVYTSIHIEEYESEARDTKLGPEEITRDIPNVSESALKNLDDRG
IVYIGAEVKDGDILVGKVTPKGVTELTAEERLLHAIFGEKAREVRDTSLRVPHGAGGIVL
DVKVFNREEGDDTLSPGVNQLVRVYIVQKRKIHVGDKMCGRHGNKGVISKIVPEEDMPYL
PDGRPIDIMLNPLGVPSRMNIGQVLELHLGMAAKNLGIHVASPVFDGANDDDVWSTIEEA
GMARDGKTVLYDGRTGEPFDNRISVGVMYMLKLAHMVDDKLHARSTGPYSLVTQQPLGGK
AQFGGQRFGEMEVWALEAYGAAYTLQEILTYKSDDTVGRVKTYEAIVKGENISRPSVPES
FRVLMKELQSLGLDVKVMDEQDNEIEMTDVDDDDVVERKVDLQQNDAPETQKEVTD
>AHH83942.1|FEATURES|megares|glycopeptide|vanWB|antibiotic target alteration|1
MDRKRLTQRFPFLLPMRRAQRKMCFYAGMRFDGCRYAQTIGEKSLSHLLFETDCALYNHN
TGFDMIYQENKVFNLKLAAKTLNGLLIRPGETFSFWWLVRHAAYKDGLTVTNGKLTTMSG
GGMCQMSNLLFWMFLHTPLTIIQRRGHEVKEFPEPNSDEIKGVDATISEGWIDLKVRNDT
DCTYQIWVTLDDEKIIGQVSADKEPQALYKITNGSIQYVRESGGIYEYAQVKRMQVALGT
GEIIDCKLLYTNKCKICYPLPESVDIQEENQ
>WP_000195974.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MTQYTAQSLEVLSGLDPVRRRPGMYTDTSRPNHLAQEVIDNAVDEALAGHADKICVTVYK
DGSLSVEDNGRGMPVDIHPEYGQSGIEIILTKLHAGGKFSTDNYQFSGGLHGVGISVVNA
LSTRVEVEVQRQGNLYQMAFEQGEPVAPLAVLEGKAPKRATGTTVRFWPEAKYFDSPKFA
LKALKHNLKAKAVLAAGLKITYIDQINDEKIEWQFENGLVDYLMDELQDREILPNPAFVS
SGQADRAACEFAICWNVEGGEQVQESYVNLIPTAQGGTHVNGLRSGVTEALREFCELRNL
LPRNLKLSAEDVWDGVNYILSLKFQEPQFSGQTKERLSSREAANIVLNIAKDAFALWLNQ
HAEIAMQLAEMAISKAGRRLKAAKKVERKKIVSGPALPGKLADCVGQTREESELFIVEGD
SAGGSAKQARDKNFQAIMPIRGKILNTWEVSSDEVLASQEVHDIAIAIGVDPGSDDLSEL
RYGKICILADADSDGLHIATLLCALFVKHFPALVEEGHLYVAMPPLFRIDIGKDVHYALD
DEELETILKNVKGNKNPQITRFKGLGEMNAIQLRETTMDPNTRRLVQLDLDDAHLTAGLL
DKLLAKKRAADRKQWLEQKGNLADITV
>YP_001085750.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MDAPYLLSIQVDSYRTFLQDGKSPKNREDIGLQAAFRSVFPIESYSGNAALEFVEYSLGK
PEFDVRECILRGSTYAAPMRVKIRLIIKDRETKSIKDVREQEVYMGEIPLMTENGTFVIN
GTERVIVSQLHRSPGVFFDHDKGKTHSSGKVLYSARIIPYRGSWLDFEFDAKDLVYVRID
RRRKLLATVVLRALGYNNEQILNLFYEKVPVYLDMGSYQIDLVPERLRGEMAQFDITDNE
GKVIVEQGKRINARHVRQMEAAGLTKLSVPDEYLYERITAEDITLRDGEVIAANTLLSHE
VMVKLAEGGVKQFNILFTNDIDRGSFVADTLRADLTRDREEALVEIYKVMRPGEPPTKEA
AENLFNNLFFSSERYDLSPVGRMKFNRRLGRPYEVGTDQKSREVEGILSHEDIIDVLRTL
VEIRNGKGEVDDIDHLGNRRVRSVGEMTENQFRVGLVRVERAVKERLSQAETDNLSPQDL
INAKPVAAAIKEFFGSSQLSQFMDQNNPLSEITHKRRVSALGPGGLTRERAGFEVRDVHQ
THYGRVCPIETPEGPNIGLINSLSVYAKANDFGFLETPYRKVIDGRVTDDVEYLSAIEEV
GTVIAQADSAVDKDGNLTEEFVSVRHQGEFVRMPPEKVTHMDVSAQQVVSVAASLIPFLE
HDDANRALMGSNMQRQAVPTLRADKPLVGTGMEANVARDSGVCVIANRGGVIEYVDASRI
VIRVNEDEMVAGEAGVDIYNLIKYTRSNQNTCINQNVIVNLGDKVARGDILADGPSTDMG
ELALGQNMRVAFMTWNGYNYEDSILLSERVLQEDRLTSIHIQELSCVARDTKLGAEEITA
DIPNVGEAALSKLDESGIVYIGAEVTAGDILVGKVTPKGETQLTPEEKLLRAIFGEKAAD
VKDSSLRVPSGTKGTVIDVQVFTRDGLEKDDRALAIEKAQLDSYRKDLKEEYKIFEEAAR
ERVIRLLKGQESNGGGSTKRGDKLSEDLLSGLELVDLLEIQPADEAIAERLTQIQVFLKE
KSAEIDEKFAEKKRKLATGDELTTGVLKVVKVYLAVKRRIQPGDKMAGRHGNKGVVSNIL
PVEDMPHDANGVPVDIVLNPLGVPSRMNVGQILETHLGMAAKGLGDKIEKMLKEQRTVLE
LREFLDKIYNKVGGEQEDLDSLTDEEILALAGNLRAGVPLATPVFDGAEESQIKDLLELA
DISRTGQTVLFDGRTGEQFDRPVTVGYMYMLKLNHLVDDKMHARSTGSYSLVTQQPLGGK
AQFGGQRFGEMEVWALEAYGAAYTLQEMLTVKSDDVEGRTRIYKNIVDGNHYMDPGMPES
FNVLTKEIRSLGINID
>AAD22147.1|FEATURES|megares|chloramphenicol|cmlB|antibiotic efflux|1
MDMYLPAVPFMPHALGTTAGTIQLTLTTYLVMIGAGQLLFGPLSDRLGRRPVLLAGGAAY
VAASIGLVVTSSAGVFLGFRILQACGASACLVATFATVRDIYAGRKESNVIYGLLGSMLA
MVPAIGPLLGAVIDTWFGWRAIFAFLGLGMIAALTAAWRLWPETRVQRPAALQWSQLLLP
IKHLNFWLYTVCYAAGMGSFFVFFSIAPGLMMGRQGMSQFGFSLLFATVAIAMMLAARFM
GRVIAKWGSLSALRMGMGCLIAGAVLLVITELWIPQSVLGFIAPMWLVGVGVATAVSVAP
NGALRGFDHIAGAVTAVYFCLGGLLLGSVGTLIISLLPRDTAWPVIAYCLVLATIVLGLS
CVSRARDLRGHGEYDAVART
>AFA38016.1|FEATURES|megares|sulfonamide|sul1|antibiotic target replacement|1
MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPAD
EIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPAPALYPDIADADC
RLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFL
SPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGN
GADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA
>AKZ58683.1|FEATURES|megares|multidrug|drrA|antibiotic efflux|0
MRRRLDLAASLVGRPDVLFLDEPTTGLDPATRIALWETVEKLVAGGTTVLLTTQYLDEAD
RLADWITVLSKGRVVASDTTDRLKADLGHRSVRVVLPPAADLTAAAAALTAGGFRPRSDA
GEHALTTPVDTSAGIAGVIRALDTVGTQAVELTVKEPSLDDVYLALTHPSPAADAA
>ABD84038.1|FEATURES|megares|beta_lactam|blaA|antibiotic inactivation|1
MINTGNGTKILYRGARRFPFCSTFKFMLAAAVLGQSQSQPNLLNKHINYHESDLLSYAPI
TRKNLAHGMTVSELCAATIQYSDNTAANLLLKELGGLAAVNQFARSIGDQMFRLDRWEPD
LNTALPNDPRDTTTPAAMAASINKLVLGDALHPAQRSQLTAWLKGNTTGDATIRAGAPTD
WIVGDKTGSGDYGTTNDIAVLWPTKGAPIVLVVYFTQREKDANPVPDVLALCQPKYFGRK
F
>CAB45462.1|FEATURES|megares|glycopeptide|vanA|antibiotic target alteration|1
MARLKVGIVFGGSSEEHAVSVKSAQEVARNLDTEKYQPFFVGITKDGAWRLCDGPGQDWE
NGDCRPVVLSPDRSVHGLLVLEQGQYRSVRLDVVLPVLHGTLGEDGATQGLLELSGIPYV
GCDVQSSALCMDKSLAYVVARSAGIATPDFWTVTGDETIDPGRLTYPVFVKPARSGSSFG
VSKVCRPEDLATAVESARRYDTKVLIEAAVVGSEVGCAILGNDPDLIVGEVDRIALSHGF
FRIHQEEQPENGSENSTPVVPADIPTEKRSLVQETAKAVYRALGCRGLSRVDMFLKEDGE
VVLNEVNTLPGMTSYSRYPRMMAAAGLPLSEVIDRTLSLALTGKLR
>AAO81398.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MAKKINNEYNDASIQVLEGLEAVRKRPGMYIGSTDSRGLHHLVYEIVDNAVDEALSGYGN
EINVTIQKDNSICVADSGRGMPTGMHASGIPTVEVIFTVLHAGGKFGQGGYKTSGGLHGV
GASVVNALSKWLEVHIVRDGVEYMERFEDGGKPVGTLKKIGKTKKRNGTSVTFLPDDTIF
STTNFSYEILAERLRESAFLLKGVKITLTDERGEEPKEEVFHYEEGIKEFVAYLNEEKDT
LTPVVYFSGAKEGIEVELAYQYNDGYSENVLSFVNNVRTKDGGTHEVGMKTSMTKAYNEY
ARKVGLLKEKDKNLEGSDFREGLAAVLSIRVPENLLQFEGQTKGKLGTPLARTVVDNVVG
EQMGFYLQENSEMSQSLIRKAIKAREAREAARKAREESRNGKKRKKGESLLSGKLTPAQS
RNPKKNELYLVEGDSAGGSAKQGRDRKFQAILPLRGKVINTEKAKMQDILKNEEINTMIY
TIGAGVGPEFSIEDCNYDKIIIMTDADTDGAHIQVLLLTFFYRYMKPLIEAGKVYIALPP
LYKVSKGTGKKSVIEYAWTDGELAEVIDKVGKGYMLQRYKGLGEMNAEQLWETTMDPETR
TLIRVRIDDAAQAERRVTTLMGDKVEPRRKWIEQHVQFTLEEDGSILDRSEEDTSAPTGE
SLLDAEKTKEAEQTDDTEISLFDIE
>WP_000259031.1|FEATURES|megares|sulfonamide|folp|antibiotic target replacement|1
MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPAD
EIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADC
RLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFL
SPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGN
GADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA
>YP_001706419.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MSVSEIRPIAIEDELKHSYLDYAMSVIVSRALPDVRDGLKPVHRRVLYAMHELGNDYNKA
YKKSARVVGDVIGKYHPHGDSAVYETIVRMAQDFSLRYLLVDGQGNFGSIDGDSAAAMRY
TEVRMTKLAHELLADLEKDTVDWEGNYDGSERIPEVLPTRVPNLLINGAAGIAVGMATNM
APHNMTEVVNACLAYADNPNISIEGLMEYITGPDFPTSGIIYGKSGIVDAYRTGKGRLHI
RGKYHFEEDEKTGRTTIVFTEIPYQVNKARVIERIAELVKEKKLEGISELRDESDKEGMR
IAIDLKRGENAEVVVNNLFLNTQLENSFSINMVCLDNGQPKLMNLKDIIAAFIRHRQEVV
TRRTMFELRKARERGHILEGLTVALANIDEIIETIKTSANPAEARERLLAGEWAGGGVVA
LLEKAGAISVRPDEIEGEDPNRPFGLSDSIYRLSPTQVGAILELRLHRLTGLEQDKLHAE
YTEILGQIAELTAILNDFNLLMGVIREELAQVLQQYGDARRTEIVESRVDFCREDLIPEE
QVVLTVSQTGYAKTQPLSDYQAQRRGGRGKSATSMKDDDFIQHLIVASNHATVLCFTNVG
KVYRLKVFEVPQASRGAKGRPIVNLLPLDATETVTAILPLTEFLENHYVFMATASGTVKR
VELEQFANIRSNGLRAIELNEEDTLIGVAITDGNQQIMLFSNEGKAIRFAETDVRAMGRT
AKGVRGMRVSFASSTLSEEDADVENDDSDDNDDSADSSLVSRIVSLVVVPETGEVLCASA
NGYGKRTPVNDFPTKKRGGKGVIAIKTSERNGELVGAVSIDETKELLLISDGGTLVRTRA
AEVAMTGRNAQGVRLIRLSEEETLVGVVSIETVEDEEELLEGEVDTTETDSEEAVSNNED
TSEE
>AFI47934.1|FEATURES|megares|aminoglycoside|ant3-dprime|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEDRLAS
RADQLEEFVHYVKGEITKVVGK
>NP_312865.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MSDLAREITPVNIEEELKSSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAMNVLGNDWN
KAYKKSARVVGDVIGKYHPHGDSAVYDTIVRMAQPFSLRYMLVDGQGNFGSIDGDSAAAM
RYTEIRLAKIAHELMADLEKETVDFVDNYDGTEKIPDVMPTKIPNLLVNGSSGIAVGMAT
NIPPHNLTEVINGCLAYIDDEDISIEGLMEHIPGPDFPTAAIINGRRGIEEAYRTGRGKV
YIRARAEVEVDAKTGRETIIVHEIPYQVNKARLIEKIAELVKEKRVEGISALRDESDKDG
MRIVIEVKRDAVGEVVLNNLYSQTQLQVSFGINMVALHHGQPKIMNLKDIIAAFVRHRRE
VVTRRTIFELRKARDRAHILEALAVALANIDPIIELIRHAPTPAEAKTALVANPWQLGNV
AAMLERAGDDAARPEWLEPEFGVRDGLYYLTEQQAQAILDLRLQKLTGLEHEKLLDEYKE
LLDQIAELLRILGSADRLMEVIREELELVREQFGDKRRTEITANSADINLEDLITQEDVV
VTLSHQGYVKYQPLSEYEAQRRGGKGKSAARIKEEDFIDRLLVANTHDHILCFSSRGRVY
SMKVYQLPEATRGARGRPIVNLLPLEQDERITAILPVTEFEEGVKVFMATANGTVKKTVL
TEFNRLRTAGKVAIKLVEGDELIGVDLTSGEDEVMLFSAEGKVVRFKESSVRAMGCNTTG
VRGIRLGEGDKVVSLIVPRGDGAILTATQNGYGKRTAVAEYPTKSRATKGVISIKVTERN
GLVVGAVQVDDCDQIMMITDAGTLVRTRVSEISIVGRNTQGVILIRTAEDENVVGLQRVA
EPVDEEDLDTIDGSAAEGDDEIAPEVDVDDEPEEE
>CAI47809.1|FEATURES|megares|aminoglycoside|AAC(6')-Ib'|antibiotic inactivation|1
MTEHDLPMLHDWLNRPHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPI
GYAQSYVALGSGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRALVELLFNDPEVT
KIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSVA
>NP_359500.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MSKKEININNYNDDAIQVLEGLDAVRKRPGMYIGSTDGAGLHHLVWEIVDNAVDEALSGF
GDRIDVTINKDGSLTVQDHGRGMPTGMHAMGIPTVEVIFTILHAGGKFGQGGYKTSGGLH
GVGSSVVNALSSWLEVEITRDGAVYKQRFENGGKPVTTLKKIGTALKSKTGTKVTFMPDA
TIFSTTDFKYNTISERLNESAFLLKNVTLSLTDKRTDEAIEFHYENGVQDFVSYLNEDKE
ILTPVLYFEGEDNGFQVEVALQYNDGFSDNILSFVNNVRTKDGGTHETGLKSAITKVMND
YARKTGLLKEKDKNLEGSDYREGLAAVLSILVPEEHLQFEGQTKDKLGSPLARPVVDGIV
ADKLTFFLMENGELASNLIRKAIKARDAREAARKARDESRNGKKNKKDKGLLSGKLTPAQ
SKNPAKNELYLVEGDSAGGSAKQGRDRKFQAILPLRGKVINTAKAKMADILKNEEINTMI
YTIGAGVGADFSIEDANYDKIIIMTDADTDGAHIQTLLLTFFYRYMRPLVEAGHVYIALP
PLYKMSKGKGKKEEVAYAWTDGELEELRKQFGKGATLQRYKGLGEMNADQLWETTMNPET
RTLIRVTIEDLARAERRVNVLMGDKVEPRRKWIEDNVKFTLEEATVF
>AAK91786.1|FEATURES|megares|macrolide-lincosamide-streptogramin|vatE|antibiotic inactivation|1
MTIPDANAVYPNLILIELDFIKNVIKSPNIEIGDYTYYDDPVNPTDFEKHVTHHYEFLGD
KLIIGKFCSIASGIEFIMNGANHVMKGISTYPFNILGGDWQQYTPELTDLPLKGDTVVGN
DVWFGQNVTVLPGVKIGDGAIIGANSVVTKDVAPYTIVGGNPIQLIGPRFEPEVIQALEN
LAWWNKDIEWITANVPKLMQTTPTLELINSLMEK
>CAH15775.1|FEATURES|megares|aminoglycoside|APH(9)-Ia|antibiotic inactivation|1
MLRNNIPDQHLIALLKVYYGIDIHTVQLIVGGADMNAFGYKADSESNSYFVKLKYGHHDE
INLSIIRLLHDSGIKEIIFPIYTRDTKLFQQIDHFKIIVYPFINAPNGFTQNLTEKQWHQ
LGKVLRQIHETSVPTAIQQRLRKETYSPKWREMVRSFYNKIGFDDSDDQITTDFKTFFNQ
NIDSIHRLVDSSEELSKKIQPDLDKYVLCHSDVHAGNVLVVNEESIYIIDWDEPMLAPKE
CDLMFIGGGIGNVWNKHHEINYFYEGYGKTNVDKIILSYYRHERIVEDIAVYGQDLLSRD
QNDESRLESFKHFKSMFTPNDVVEIAFSSD
>WP_011764800.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MTQFAKETLPISLEEEMRHSYLDYAMSVIVGRALPDARDGLKPVHRRVLYAMHELSNDWN
RAYKKSARIVGDVIGKYHPHGDSAVYDTIVRMAQDFSLRYMLVDGQGNFGSVDGDNAAAM
RYTEIRMARIGHELLADIDKETVDFGPNYDGSEKEPLILPARIPNLLINGSSGIAVGMAT
NIPPHNLGEVVDACLKLLEDPETDLEALIEIVKAPDFPTAGLIYGLHGVHEGYRTGRGRV
VMRARTHIEPIGKNSDREAIIVDELPYQVNKRTLLERIAELVNEKKVEGISEIRDESDKS
GMRVVIELKRNEMPEVVLNNLYKHTQLQDTFGMNMVALVDGKPRLLNLKQMLVCFLEHRR
EVVTRRTIFELKKARDRGHILEGLAVALSNVDEIIALIKAAPTPADAKRGLMERTWRSPL
VEEMLSRALADSYRPEGLDPEFGFSAQGYKLSDAQAQAILELRLQRLTGLEQDKIVGEYR
EVMDLITDLLDILARPERITAIIVEELTAIRNQFGDPRRSEIVLSTAEINIEDLITPEDM
VVTLSHTGYFKRQPLADYRAQRRGGRGKQATSMKDEDFIDHLFVANTHDTVLCFSSRGRA
YWLKVYEVPEGTRNSRGKPIVNLFPLIEGEKITAVLPVQTFDEEHFVFMATSEGTVKKTA
LTAFANPRKAGIIAVNLDDGDHLIGVAITDGECDVMLFSDAGKAVRFAESDVRPMGREAR
GVRGMTLEDGQRVIAMLVAKGETQSVLTATENGYGKRTPVAEYTRHGRGTKGMIAIQTSD
RNGKLVGAVLVDPTDEVMLISTGAVLIRTKVQDIRELGRATQGVTLINLDEGTYLAGIEK
VAESGAEADELVEGGEEGAADGEDAGAPGAAGEGEQE
>CDO20205.1|FEATURES|megares|tetracycline|tetR|antibiotic efflux|0
MFERGLENVTREDIANLAGVSLRTFTNYFNGKYDALAYRQVERMRRSIETLRNRPVGEPL
WTSVIEAVLEPLDEDFEDMYGAENVLPTRQQLAEVRKLLMVPEIRDATFRAMFDEWVAVI
AERTGTDPAHDMYPRLVVAVVRAVGDVAMDQYANADPPVSFTELLRQGFAAVTAGLPEPE
RKK
>WP_000167922.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|0
MTKTKIMGILNVTPDSFSDGGKFNNVESAINRVKAMIDEGADIIDVGGVSMRPGHEMVSL
EEEMNRVLPVVEAIVGFDVKISVDTFRSEVAEACLKLGVDMINDQWAGLYDHRMFQIVAK
YDAEIILMHNGNGNRDEPVVEEMLTSLLAQAHQAKIAGIPSNKIWLDPGIGFAKTRNEEA
EVMARLDELVATEYPVLLATSRKRFTKKMMGYDTTPVERDEVTAATTAYGIMKGVRAVRV
HNVELNAKLAKGIDFLKENENARHNLS
>AAZ06275.1|FEATURES|megares|tetracycline|tet33|antibiotic efflux|1
LIALYAVMQFIFAPVLGTLSDRFGRRRVLLVSLAGATVDYLVLATTSALSVFYIARAVAG
ITGATNAVTATVIADITPPHQRAKRFGLLSACYGGGMIAGPAMGGLFGAISPHLPFLLAA
LLSASNLALTFILLRETRPDSPARSASLAQHRGRPGLSAVPGITFLLIAFGLVQFIGQAP
GATWVLFTEHRLDWSPVEVGISLSVFGIVQVLVQALLTGRIVEWIGEAKTVIIGCITDAL
GLVGLA
>AAR12142.1|FEATURES|megares|aminoglycoside|AAC(6')-Ib'|antibiotic inactivation|1
MTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPI
GYAQSYVALGSGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRALVELLFNDPEVT
KIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSVA
>AAK45502.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|0
MRSTPPASAGRSTPPALAGHSTPPALAGHSTLCGRPVAGDRALIMAIVNRTPDSFYDKGA
TFSDAAARDAVHRAVADGADVIDVGGVKAGPGERVDVDTEITRLVPFIEWLRGAYPDQLI
SVDTWRAQVAKAACAAGADLINDTWGGVDPAMPEVAAEFGAGLVCAHTGGALPRTRPFRV
SYGTTTRGVVDAVISQVTAAAERAVAAGVAREKVLIDPAHDFGKNTFHGLLLLRHVADLV
MTGWPVLMALSNKDVVGETLGVDLTERLEGTLAATALAAAAGARMFRVHEVAATRRVLEM
VASIQGVRPPTRTVRGLA
>AUX81729.1|FEATURES|megares|tetracycline|tetR|antibiotic efflux|0
MAKLDKEQVIDNALILLNEVGIEGLTTRKLAQKIGVEQPTLYWHVKNKRALLDALAETIL
QKHHHHVLPLPNETWQDFLRNNAKSFRQALLMYRDGGKIHAGTRPSESQFETSEQQLQFL
CDAGFSLSQAVYALSSIAHFTLGSVLETQEHQESQKEREKVETDTVAYPPLLTQAVAIMD
SDNGDAAFLFVLDVMISGLETVLKSAK
>AAG42227.1|FEATURES|megares|macrolide-lincosamide-streptogramin|ErmB|antibiotic target alteration|1
MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNLSSEKLKLNIRVTLIHQDILQFQFPNKQRYKIVGSIPYHLSTQIIKKVVFESHAS
DIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTT
DVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTVTYEQVLSIFNSYLL
FNGRK
>WP_000918664.1|FEATURES|megares|multidrug|rpoB|antibiotic target alteration|0
MAGQVVQYGRHRKRRNYARISEVLELPNLIEIQTKSYEWFLREGLIEMFRDISPIEDFTG
NLSLEFVDYRLGEPKYDLEESKNRDATYAAPLRVKVRLIIKETGEVKEQEVFMGDFPLMT
DTGTFVINGAERVIVSQLVRSPSVYFNEKIDKNGRENYDATIIPNRGAWLEYETDAKDVV
YVRIDRTRKLPLTVLLRALGFSSDQEIVDLLGDNEYLRNTLEKDGTENTEQALLEIYERL
RPGEPPTVENAKSLLYSRFFDPKRYDLASVGRYKTNKKLHLKHRLFNQKLAEPIVNTETG
EIVVEEGTVLDRRKIDEIMDVLESNANSEVFELHGSVIDEPVEIQSIKVYVPNDDEGRTT
TVIGNAFPDSEVKCITPADIIASMSYFFNLLSGIGYTDDIDHLGNRRLRSVGELLQNQFR
IGLSRMERVVRERMSIQDTESITPQQLINIRPVIASIKEFFGSSQLSQFMDQANPLAELT
HKRRLSALGPGGLTRERAQMEVRDVHYSHYGRMCPIETPEGPNIGLINSLSSYARVNEFG
FIETPYRKVDLDTHAITDQIDYLTADEEDSYVVAQANSKLDENGRFMDDEVVCRFRGNNT
VMAKEKMDYMDVSPKQVVSAATACIPFLENDDSNRALMGANMQRQAVPLMNPEAPFVGTG
MEHVAARDSGAAITAKHRGRVEHVESNEILVRRLVEENGVEHEGELDRYPLAKFKRSNSG
TCYNQRPIVAVGDVVEFNEILADGPSMELGEMALGRNVVVGFMTWDGYNYEDAVIMSERL
VKDDVYTSIHIEEYESEARDTKLGPEEITRDIPNVSESALKNLDDRGIVYIGAEVKDGDI
LVGKVTPKGVTELTAEERLLHAIFGEKAREVRDTSLRVPHGAGGIVLDVKVFNREEGDDT
LSPGVNQLVRVYIVQKRKIHVGDKMCGRHGNKGVISKIVPEEDMPYLPDGRPIDIMLNPL
GVPSRMNIGQVLELHLGMAAKNLGIHVASPVFDGANDDDVWSTIEEAGMARDGKTVLYDG
RTGEPFDNRISVGVMYMLKLAHMVDDKLHARSTGPYSLVTQQPLGGKAQFGGQRFGEMEV
WALEAYGAAYTLQEILTYKSDDTVGRVKTYEAIVKGENISRPSVPESFRVLMKELQSLGL
DVKVMDEQDNEIEMTDVDDDDVVERKVDLQQNDAPETQKEVTD
>WP_000918668.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MAGQVVQYGRHRKRRNYARISEVLELPNLIEIQTKSYEWFLREGLIEMFRDISPIEDFTG
NLSLEFVDYRLGEPKYDLEESKNRDATYAAPLRVKVRLIIKETGEVKEQEVFMGDFPLMT
DTGTFVINGAERVIVSQLVRSPSVYFNEKIDKNGRENYDATIIPNRGAWLEYETDAKDVV
YVRIDRTRKLPLTVLLRALGFSSDQEIVDLLGDNEYLRNTLEKDGTENTEQALLEIYERL
RPGEPPTVENAKSLLYSRFFDPKRYDLASVGRYKTNKKLHLKHRLFNQKLAEPIVNTETG
EIVVEEGTVLDRRKIDEIMDVLESNANSEVFELHGSVIDEPVEIQSIKVYVPNDDEGRTT
TVIGNAFPDSEVKCITPADIIASMSYFFNLLSGIGYTDDIDHLGNRRLRSVGELLQNQFR
IGLSRMERVVRERMSIQDTESITPQQLINIRPVIASIKEFFGSSQLSQFMDQANPLAELT
HKRRLSALGPGGLTRERAQMEVRDVHYSHYGRMCPIETPEGPNIGLINSLSSYARVNEFG
FIETPYRKVDLDTHAITDQIDYLTADEEDSYVVAQANSKLDENGRFMDDEVVCRFRGNNT
VMAKEKMDYMDVSPKQVVSAATACIPFLENDDSNRALMGANMQRQAVPLMNPEAPFVGTG
MEHVAARDSGAAITAKHRGRVEHVESNEILVRRLVEENGVEHEGELDRYPLAKFKRSNSG
TCYNQRPIVAVGDVVEYNEILADGPSMELGEMALGRNVVVGFMTWDGYNYEDAVIMSERL
VKDDVYTSIHIEEYESEVRDTKLGPEEITRDIPNVSESALKNLDDRGIVYIGAEVKDGDI
LVGKVTPKGVTELTAEERLLHAIFGEKAREVRDTLLRVPHGAGGIVLDVKVFNREEGDDT
LSPGVNQLVRVYIVQKRKIHVGDKMCGRHGNKGVISKIVPEEDMPYLPDGRPIDIMLNPL
GVPSRMNIGQVLELHLGMAAKNLGIHVASPVFDGANDDDVWSTIEEAGMARDGKTVLYDG
RTGEPFDNRISVGVMYMLKLAHMVDDKLHARSTGPYSLVTQQPLGGKAQFGGQRFGEMEV
WALEAYGAAYTLQEILTYKSDDTVGRVKTYEAIVKGENISRPSVPESFRVLMKELQSLGL
DVKVMDEQDNEIEMTDVDDDDVVERKVDLQQNDAPETQKEVTD
>AEP40321.1|FEATURES|megares|beta_lactam|NDM-1|antibiotic inactivation|1
ALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQHTSYLDMPGFGAVASNGLI
VRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTHAHQDKMGGMDALHAAGIAT
YANALSNQLAPQEGMVAAQHSLTFAANGWVEPATAPNFGPLKVFYPGPGHTSDNITVGID
GTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAFPKASMIVMSHSAPDSRAAI
T
>AAC74213.1|FEATURES|megares|multidrug|phoQ|antibiotic target alteration|0
MKKLLRLFFPLSLRVRFLLATAAVVLVLSLAYGMVALIGYSVSFDKTTFRLLRGESNLFY
TLAKWENNKLHVELPENIDKQSPTMTLIYDENGQLLWAQRDVPWLMKMIQPDWLKSNGFH
EIEADVNDTSLLLSGDHSIQQQLQEVREDDDDAEMTHSVAVNVYPATSRMPKLTIVVVDT
IPVELKSSYMVWSWFIYVLSANLLLVIPLLWVAAWWSLRPIEALAKEVRELEEHNRELLN
PATTRELTSLVRNLNRLLKSERERYDKYRTTLTDLTHSLKTPLAVLQSTLRSLRSEKMSV
SDAEPVMLEQISRISQQIGYYLHRASMRGGTLLSRELHPVAPLLDNLTSALNKVYQRKGV
NISLDISPEISFVGEQNDFVEVMGNVLDNACKYCLEFVEISARQTDEHLYIVVEDDGPGI
PLSKREVIFDRGQRVDTLRPGQGVGLAVAREITEQYEGKIVAGESMLGGARMEVIFGRQH
SAPKDE
>AAW82618.1|FEATURES|megares|beta_lactam|GOB-1|antibiotic inactivation|1
MRNFAILFFLLITFSWKAQVVKEPENTNEEWSRSYEPFRIAGNLYYVGTYDLASYLIVTD
KGNILINTGLAGSLPMIKENIKKLGFNYKDIKILLLTQAHYDHTGALKDLQTETGAKFYA
DSADADVLKTGGKSDYEMGKYGATFKAIKPDILLKDQDKIKLGNTTLTLLHHPGHTKGSC
SFIFETKDENRNYKVLIANMPSVIVDRKFSEIKDYPNIQADYAYTFKAMKKLDFDLWVAS
HASQFDLHTKHKEGDPYNPQVFMDKANYFAFLNSLETDYLEKIKNDSQKK
>CAB11783.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MSEQNTPQVREINISQEMRTSFLDYAMSVIVSRALPDVRDGLKPVHRRILYAMNDLGMTS
DKPYKKSARIVGEVIGKYHPHGDSAVYESMVRMAQDFNYRYMLVDGHGNFGSVDGDSAAA
MRYTEARMSKISMEILRDITKDTIDYQDNYDGSEREPVVMPSRFPNLLVNGAAGIAVGMA
TNIPPHQLGEIIDGVLAVSENPDITIPELMEVIPGPDFPTAGQILGRSGIRKAYESGRGS
ITIRAKAEIEQTSSGKERIIVTELPYQVNKAKLIEKIADLVRDKKIEGITDLRDESDRTG
MRIVIEIRRDANANVILNNLYKQTALQTSFGINLLALVDGQPKVLTLKQCLEHYLDHQKV
VIRRRTAYELRKAEARAHILEGLRVALDHLDAVISLIRNSQTAEIARTGLIEQFSLTEKQ
AQAILDMRLQRLTGLEREKIEEEYQSLVKLIAELKDILANEYKVLEIIREELTEIKERFN
DERRTEIVTSGLETIEDEDLIERENIVVTLTHNGYVKRLPASTYRSQKRGGKGVQGMGTN
EDDFVEHLISTSTHDTILFFSNKGKVYRAKGYEIPEYGRTAKGIPIINLLEVEKGEWINA
IIPVTEFNAELYLFFTTKHGVSKRTSLSQFANIRNNGLIALSLREDDELMGVRLTDGTKQ
IIIGTKNGLLIRFPETDVREMGRTAAGVKGITLTDDDVVVGMEILEEESHVLIVTEKGYG
KRTPAEEYRTQSRGGKGLKTAKITENNGQLVAVKATKGEEDLMIITASGVLIRMDINDIS
ITGRVTQGVRLIRMAEEEHVATVALVEKNEEDENEEEQEEV
>WP_000819088.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MAELPQSRINERNITSEMRESFLDYAMSVIVARALPDVRDGLKPVHRRILYGLNEQGMTP
DKSYKKSARIVGDVMGKYHPHGDSSIYEAMVRMAQDFSYRYPLVDGQGNFGSMDGDGAAA
MRYTEARMTKITLELLRDINKDTIDFIDNYDGNEREPSVLPARFPNLLANGASGIAVGMA
TNIPPHNLTELINGVLSLSKNPDISIAELMEDIEGPDFPTAGLILGKSGIRRAYETGRGS
IQMRSRAVIEERGGGRQRIVVTEIPFQVNKARMIEKIAELVRDKKIDGITDLRDETSLRT
GVRVVIDVRKDANASVILNNLYKQTPLQTSFGVNMIALVNGRPKLINLKEALVHYLEHQK
TVVRRRTQYNLRKAKDRAHILEGLRIALDHIDEIISTIRESDTDKVAMESLQQRFKLSEK
QAQAILDMRLRRLTGLERDKIEAEYNELLNYISELEAILADEEVLLQLVRDELTEIRDRF
GDDRRTEIQLGGFENLEDEDLIPEEQIVITLSHNNYIKRLPVSTYRAQNRGGRGVQGMNT
LEEDFVSQLVTLSTHDHVLFFTNKGRVYKLKGYEVPELSRQSKGIPVVNAIELENDEVIS
TMIAVKDLESEDNFLVFATKRGVVKRSALSNFSRINRNGKIAISFREDDELIAVRLTSGQ
EDILIGTSHASLIRFPESTLRPLGRTATGVKGITLREGDEVVGLDVAHANSVDEVLVVTE
NGYGKRTPVNDYRLSNRGGKGIKTATITERNGNVVCITTVTGEEDLMIVTNAGVIIRLDV
ADISQNGRAAQGVRLIRLGDDQFVSTVAKVKEDAEDETNEDEQSTSTVSEDGTEQQREAV
VNDETPGNAIHTEVIDSEENDEDGRIEVRQDFMDRVEEDIQQSSDEE
>AAN65247.1|FEATURES|megares|aminocoumarin|gyrB|antibiotic target alteration|0
MSKSSCTPVPNAEMSAWISWLCRILSIRAFSTLRILPRIGRIAWYCGLRPDLAEPPAESP
STTKISDIAGSFD
>ABR78840.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MTQSSYNADAIEVLTGLEPVRRRPGMYTDTTRPNHLGQEVIDNSVDEALAGHAKRVEVIL
HADQSLEVIDDGRGMPVDIHPEEGVPAVELILCRLHAGGKFSNKNYQFSGGLHGVGISVV
NALSKRVEVNVRRDGQVYSIAFENGEKVEDLHVTGTCGKRNTGTSVHFWPDESFFDSPRF
SVSRLTHLLKAKAVLCPGVEIVFRDQVNNSEQSWCYADGLNDYLSEAVNGLPLLPEKPFV
GAFSGETEAVDWALLWLPEGGELLTESYVNLIPTMQGGTHVNGLRQGLLDAMREFCEYRN
ILPRGVKLSAEDIWDRCAYVLSVKMQDPQFAGQTKERLSSRQCAAFVSGVVKDAFSLWLN
QNVQAAELLAEMAISSAQRRLRAAKKVVRKKLTSGPALPGKLADCTAQDLNRTELFLVEG
DSAGGSAKQARDREYQAIMPLKGKILNTWEVSSDEVLASQEVHDISVAIGIDPDSDDLSQ
LRYGKICILADADSDGLHIATLLCALFVRHFRTLVKEGHVYVALPPLYRIDLGKEVYYAL
TEEEKTGVLEQLKRKKGKPNVQRFKGLGEMNPMQLRETTLDPNTRRLVQLVISDEDEQQT
TAIMDMLLAKKRSEDRRNWLQEKGDMADLEV
>BAM98940.1|FEATURES|megares|aminoglycoside|AAC(6')-Ib10|antibiotic inactivation|1
MTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPI
GYAQSYVALGSGDGWWEEETDPGVRGIDQLLANASQLGKGLGTKLVRALVELLFNDPEVT
KIQTDPSPSNLRAIRCYEKAGFEKQGTVTTPDGPAVYMVQTRQAFERTRSDA
>YP_003610761.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MVYSYTEKKRIRKDFGKRPQVLDIPYLLSIQLDSFQKFIEQDPEGQYGLEAAFRSVFPIQ
SYSGNSELQYVSYRLGEPVFDVQECQIRGVTYSAPLRVKLRLVIYEREAPEGTVKDIKEQ
EVYMGEIPLMTDNGTFVINGTERVIVSQLHRSPGVFFDSDKGKTHSSGKVLYNARIIPYR
GSWLDFEFDPKDNLFVRIDRRRKLPATIILRALNYTTEQILDLFFEKVIFEIRDNKLQME
LVPERLRGETASFDIEADGKVYVEKGRRITARHIRQLEKDDIKHIEVPVEYIAGKVAAKD
YVDESTGELICPANMELSLDLLAKLSQAGHKRIETLFTNDLDHGPYISETVRVDPTNDRL
SALVEIYRMMRPGEPPTREAAESLFENLFFSEDRYDLSAVGRMKFNRSLLRDEIEGSGIL
SKDDIIEVMKKLIDIRNGKGEVDDIDHLGNRRIRSVGEMAENQFRVGLVRVERAVKERLS
LGDLDTLMPQDMINAKPISAAVKEFFGSSQLSQFMDQNNPLSEITHKRRISALGPGGLTR
ERAGFEVRDVHPTHYGRVCPIETPEGPNIGLINSLSVYAQTNEYGFLETPYRKVTDGVVT
DEIHYLSAIEEGNYVIAQANSNLDDEGHFVEDLVTCRSKGESSLFSRDQVDYMDVSTQQV
VSVGASLIPFLEHDDANRALMGANMQRQAVPTLRADKPLVGTGMERAVAVDSGVTAVAKR
GGTVQYVDASRIVIKVNEDEMYPGEAGIDIYNLTKYTRSNQNTCINQMPCVSLGEPVERG
DVLADGPSTDLGELALGQNMRVAFMPWNGYNFEDSILVSERVVQEDRFTTIHIQELACVS
RDTKLGPEEITADIPNVGEAALSKLDESGIVYIGAEVTGGDILVGKVTPKGETQLTPEEK
LLRAIFGEKASDVKDSSLRVPNGVSGTVIDVQVFTRDGVEKDKRALEIEEMQLKQAKKDL
SEELQILEAGLFSRIYAVLVAGGVEAEKLDKLPRDRWLELGLTDEEKQNQLEQLAEQYDE
LKHEFEKKLEAKRRKITQGDDLAPGVLKIVKVYLAVKRQIQPGDKMAGRHGNKGVISKIN
PIEDMPHDANGTPVDIVLNPLGVPSRMNIGQILETHLGMAAKGIGDKINAMLKQQQEVAK
LREFIQRAYDLGTDVRQKVDLNTFSDEEVLRLAENLRKGMPIATPVFDGAKEAEIKELLQ
LGGLPTSGQITLFDGRTGEQFERPVTVGYMYMLKLNHLVDDKMHARSTGSYSLVTQQPLG
GKAQFGGQRFGEMEVWALEAYGAAYTLQEMLTVKSDDVNGRTKMYKNIVDGNHQMEPGMP
ESFNVLLKEIRSLGINIELEDE
>WP_012117653.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MHADGNTFDKNFRKAAKTVGNVIGNYHPHGDSSVYEAMVRMSQDWKVRNVLIEMHGNNGS
IDGDPPAAMRYTEARLSSIASELLRDIDKNTVEFVPNFDDTSKEPVVLPAMFPNLLVNGS
TGISAGYATDIPPHHLGEVIDAVIKRIESPDCTVDDLMQVIKGPDFPTGGIIQGVDGIRK
AYETGKGKIIIRGKAEVESVRGGREQIVITEIPFEVNKANLVKKMDEYRIDKKVEGISEV
RDETDRTGLRVVVELKKEADAKGILNFLYKNTDLQTTYNFNMVAIHNRRPMLMSLTAILD
AYISHQKEVVTNRSVFELQKAKERHHIVEGLMKALSVLDEVIAVIRASSDKKDAKQNVMS
KFTFTEPQAEAIVSLQLYRLTNTDITALKEEAEELSKKIQELEAILSHDKKLLKVITSSL
KKLKKTYADSRRSVIEEKIEEIKINLEVMVASEDVYVTVTKDGYVKRTSQRSFAASNGQD
FGMKDTDRLIHQFEMNTTDVLLLFTNKGSYVYCPVHQLPDIRWKDMGQHVTNIITIDRDE
TIVKAIPVKEFDPSSYLLFMTKNGMVKRTEMTHYKAQRYSKALVALNLKGDDELIDVHVT
DGGSQLFIATRLGYGLWFGEDEVNVVGARAAGVKGINVKDGDTVVSGQILHETDSLVLVT
QRGAIKRMNLSEFEKTSRAKRGVIMLRELKKNPHRAVGVFACALADMIAAETEKGERIEI
AVKSLRANDRYSNGSFFTDEDETGPVTDVWRIPASDV
>CAA57832.1|FEATURES|megares|chloramphenicol|catB8|antibiotic inactivation|1
MKNYFDSPFKGELLSEQVKNPNIKVGRYSYYSGYYHGHSFDECARYLHPDRDDVDKLIIG
SFCSIGSGASFIMAGNQGHRHDWASSFPFFYMQEEPAFSSALDAFQRAGDTAIGNDVWIG
SEAMIMPGIKIGDGAVIGSRSLVTKDVVPYAIIGGSPAKQIKKRFSDEEISLLMEMEWWN
WPLDKIKTAMPLLCSSNIFGLHKYWREFVV
>WP_001071160.1|FEATURES|megares|peptide|mprF|antibiotic target alteration|0
MNQEVKNKIFSILKITFATALFIFVVITLYRELSGINFKDTLVEFSKINRMSLVLLFIGG
GASLVILSMYDVILSRALKMDISLGKVLRVSYIINALNAIVGFGGFIGAGVRAMVYKNYT
HDKKKLVHFISLILISMLTGLSLLSLLIVFHVFDASLILNKITWVRWVLYAVSLFLPLFI
IYSMVRPPDKNNRYVGLYCTLVSCVEWLAAAVVLYFCGVIVDVHVSFMSFIAIFIIAALS
GLVSFIPGGFGAFDLVVLLGFKTLGVPEEKVLLMLLLYRFAYYFVPVIIALILSSFEFGT
SAKKYIEGSKYFIPAKDVTSFLMSYQKDIIAKIPSLSLAILVFFTSMIFFVNNLTIVYDA
LYDGNHLTYYLLLAIHTSACLLLLLNVVGIYKQSRRAIIYAMISIILIIVATLFTYASYI
LITWLVIIFALLIVAFRRARRLKRPIRMRNLVAMLLFSIFILYINHIFIAGTFYALDVYT
IEMHTSVLKYYFWITILIIAIIVGAIAWLFDYQFSKVRISSNIEECEEIIDQYGGNYLSH
LIYSGDKQFFTNEDKNAFLMYRYKASSLVVLGDPIGDENAFDELLEAFYNYAEYLGYDVI
FYQVTDQHMPLYHNFGNQFFKLGEEAIIDLTQFSTSGKKRRGFRATLNKFDELNISFEII
EPPFSTEFINELQHVSDLWLDNRQEMHFSVGQFNETYLSKAPIGVMRNENNEVIAFCSLM
PTYFNDAISVDLIRWLPELDLPLMDGLYLHMLLWSKEQGYTKFNMGMATLSNVGQLHYSY
LRERLAGRVFEHFNGLYRFQGLRRYKSKYNPNWEPRFLVYRKDNSLWESLSKVMRVIRHK
>AAB05245.1|FEATURES|megares|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
TSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQWDTVIE
GNDDLLEKYMSGKSLEALELEQEESIRFQNCSLFPLYHGSAKSNIGIDNLIEVITNKFYS
STHRGPSELCGNVFKIEYTKKRQRLAYIRLYSGVLHLRDSVRISEKEKIKITEMYTSING
ELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRKRIENPHPLLQTTVEPSKPEQREM
LLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKEPTVIY
MERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGR
SVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>ABS43700.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|0
MKFFKINPNTDFNLLCSLINPHKMGQKIMSEKTKTHYIFIKDISTPAANILKQDALRVGA
ELITHKEVITAKITHSNALLMASKEQIQKLIAKEKLQDFGLKNLALFLQKDFLKPKKAEL
MAVINVNEDSFNAKSRVSEKDFEKRLNDFLALKPEYIDIGAVSSRPGSEYCGKEEEFKRL
KKILDLIHEKNYHEKAIFSLDSFDEYCLEYALNKGFKLINDITSLRNLNLAKLASKYEAK
YCLMHMQNNPNNMQDNPFYEDLLDEMTLFFKEKLELLESFGVKESILDVGIGFGKSAEHN
MILIKHLEHFLQFNKPLLIGASRKSVINAYFQSEIKDRLAGTLYLHLKAFENGASIIRVH
DLYEHKQLFALVQAMDNIGV
>CCQ19309.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MAETPNQRITEINLNKEMRTSFLDYAMSVIVARALPDVRDGLKPVHRRILYAMNDLGMTS
DKAYKKSARIVGEVIGKYHPHGDTAVYFTMVRMAQDFSYRNMLVDGHGNFGSVDGDMAAA
MRYTEARMSKISMELLRDINKDTIDYADNYDGSEREPVILPARFPNLLVNGSSGIAVGMA
TNIPTHHLGEVIDGVLALSHDPEITIRDLMEYIPGPDFPTAGMIMGRSGIRRAYESGRGS
ITVRGRVDIEEKKNGKETIVITEIPYQVNKARLVERIAELAREKKIDGITSLNDESDRSG
MRIVIEVRRDISASVIVNNLFKMTALQTTFGINMLALVDNHPKVLNLKEILYYYLEHQKV
VIRRRTEFELRKAEARAHILEGLRIALDNIDAIIKLIRGSKTSDVAKEGLMTQFNLSDKQ
AQAILDMRLQRLTGLEREKIEEEYQNLVALINDLKAILADDERILEIIREELEEIKVKYA
DKRRTEILAGDLVSLEDEDLIPEEEVAITLTKRGYIKRLPLSTYRSQRRGGRGIQGMSTH
EDDFVEHLVATSTHDTLLFFTNTGKVYRSKGYEVPEYGRTAKGIPIINLLGIESQEQVNA
VINLSEFTDDSYLFFTTKHGVVKRTTLSQFAKIRQSGLRAVELRENDELISVQMTDGSKN
MIIATKHGQSIYFPEENIRVMGRTAAGVRGIRLREDDEVIGMEVLEDDEKVLVVTEKGYG
KQTPASQYPLRNRGGMGVKTVTITEKNGNLVAMKTVTGEEDLMLMTVSGVLIRFEIDTVS
QTGRSAMGVKLIRLDEDEKVATVAKVPKEEDEVELEEEIDETLITQVPDESFEDAPGSDI
EE
>CAU08345.1|FEATURES|megares|rifampin|arr-3|antibiotic inactivation|1
MSSDWTPISHENCQQVRGPFYHGTKAHLSIGDLITTGHLSHFEDGRALKHVYFSALMEPA
IWGAELAMSLSRLDGRGYIYIVEPTGPFEDDPNLTNKRFPGNPTKSYRTCDPLRIVGSVE
DWQGHPADVLQQMLESLEDLKRRGLAIIED
>AAN79199.1|FEATURES|megares|elfamycin|tufab|antibiotic target alteration|0
MITGAAQMDGAILVVAATDGPMPQTREHILLGRQVGVPYIIVFLNKCDMVDDEELLELVE
MEVRELLSQYDFPGDDTPIVRGSALKALEGDAEWEAKILELAGFLDSYIPEPERAIDKPF
LLPIEDVFSISGRGTVVTGRVERGIIKVGEEVEIVGIKETQKSTCTGVEMFRKLLDEGRA
GENVGVLLRGIKREEIERGQVLAKPGTIKPHTKFESEVYILSKDEGGRHTPFFKGYRPQF
YFRTTDVTGTIELPEGVEMVMPGDNIKMVVTLIHPIAMDDGLRFAIREGGRTVGAGVVAK
VLG
>WP_000819067.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MAELPQSRINERNITSEMRESFLDYAMSVIVARALPDVRDGLKPVHRRILYGLNEQGMTP
DKSYKKSARIVGDVMGKYHPHGDLSIYEAMVRMAQDFSYRYPLVDGQGNFGSMDGDGAAA
MRYTEARMTKITLELLRDINKDTIDFIDNYDGNEREPSVLPARFPNLLANGASGIAVGMA
TNIPPHNLTELINGVLSLSKNPDISIAELMEDIEGPDFPTAGLILGKSGIRRAYETGRGS
IQMRSRAVIEERGGGRQRIVVTEIPFQVNKARMIEKIAELVRDKKIDGITDLRDETSLRT
GVRVVIDVRKDANASVILNNLYKQTPLQTSFGVNMIALVNGRPKLINLKEALVHYLEHQK
TVVRRRTQYNLRKAKDRAHILEGLRIALDHIDEIISTIRESDTDKVAMESLQQRFKLSEK
QAQAILDMRLRRLTGLERDKIEAEYNELLNYISELETILADEEVLLQLVRDELTEIRDRF
GDDRRTEIQLGGFEDLEDEDLIPEEQIVITLSHNNYIKRLPVSTYRAQNRGGRGVQGMNT
LEEDFVSQLVTLSTHDHVLFFTNKGRVYKLKGYEVPELSRQSKGIPVVNAIELENDEVIS
TMIAVKDLESEDNFLVFATKRGVVKRSALSNFSRINRNGKIAISFREDDELIAVRLTSGQ
EDILIGTSHASLIRFPESTLRPLGRTATGVKGITLREGDEVVGLDVAHANSVDEVLVVTE
NGYGKRTPVNDYRLSNRGGKGIKTATITERNGNVVCITTVTGEEDLMIVTNAGVIIRLDV
ADISQNGRAAQGVRLIRLGDDQFVSTVAKVKEDAEDETNEDEQSTSTVSEDGTEQQREAV
VNDETPGNAIHTEVIDSEENDEDGRIEVRQDFMDRVEEDIQQSSDEDEE
>CAD12205.1|FEATURES|megares|tetracycline|tet33|antibiotic efflux|1
MGLVMPILPALLHEAGVTADAVPLNVGVLIALYAVMQFIFAPVLGTLSDRFGRRRVLLVS
LAGATVDYLVLATTSALSVFYIARAVAGITGATNAVTATVIADITPPHQRAKRFGLLSAC
YGGGMIAGPAMGGLFGAISPHLPFLLAALLSASNLALTFILLRETRPDSPARSASLAQHR
GRPGLSAVPGITFLLIAFGLVQFIGQAPGATWVLFTEHRLDWSPVEVGISLSVFGIVQVL
VQALLTGRIVEWIGEAKTVIIGCITDALGLVGLAIVTDAFSMAPILAALGIGGIGLPALQ
TLLSQRVDEQHQGRLQGVLASINSVTSIFGPVAFTTIFALTYINADGFLWLCAAALYVPC
VILIMRGTAASPKFGSWASGDSM
>ADK11275.1|FEATURES|megares|beta_lactam|IMP-45|antibiotic inactivation|1
MSKLFVFFMFLFCSITAAGESLPDLKIEKLDEGVYVHTSFEEVNGWGVIPKHGLVVLVNT
DAYLIDTPFTAKDTENLVNWFVERGYRIKGSISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKYSFSGVSYWLVKKKIEVFYPGSGHAPDNVVVWLPENRVLFGGCFVKP
YGLGNLGDANLEAWPKSAKLLMSKYSKAKLVVPGHSDIGDSSLLKLTWEQTVKGFNESKK
STTAH
>BAD02332.1|FEATURES|megares|trimethoprim|dfrA17|antibiotic target replacement|1
MGVLPNRKYAVVSKNGISSSNENVLVFPSIENALKELSKVTDHVYVSGGGQIYNSLIEKA
DIIHLSTVHVEVEGDIKFPIMPENFNLVFEQFFMSNINYTYQIWKKG
>AAK89233.1|FEATURES|megares|tetracycline|tetR|antibiotic efflux|0
MAIGRDRIVDEALRLLNEVGIDKLSTRKLAERLGVQQPALYWHFRNKAELLDAINSEMLL
RYHCDRLPKPGQDWITFTLANARSIRKTLLTVRDGARLTAGTRPSVAEFADVESVLQLYV
ETGFSAEEAFGIAICITRYVVGYVLEEQGERERDRMDQHSPNTDIMAELAQFPLLAKALE
SFPTVGTVNTEAVFESGLSYLLAGMKEKLREKQSR
>BAH76064.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|0
MRPTMRQIRSTAPISGPGDSMEQDMASIWRLGGGRTLDCSGDRVIGIVNATPDSFYDGGR
HGDVAAAVSHGLRLAGEGADMLDIGGESTRPGAAPVTDAEEIDRVVPVIAELARRLPDMP
IAVDTYRAGCATAALAAGACAVNDVSGLAFDPALLEVVAQRQPGYVLMHTKGRPDVMQRD
PRYDDVIGEILAYFEQGLTRLTRAGLPEDHVVLDPGIGFGKLSEHNLEILRNLERFTVFG
RPVYLGLSNKSFFGALLGLPVGERTVATAVASALCAGRGARLHRVHDVAAVKQALGLAAA
LAG
>ABL75154.1|FEATURES|megares|beta_lactam|OKP-B-6|antibiotic inactivation|1
CLISLIAALPLAVFASPQPLEQIKISESQLAGRVGYVEMDLASGRTLAAWRASERFPLMS
TFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMS
DNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPASMATTL
RKLLTTPSLSARSQQLLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRGIVALLG
PDGKAERIVVIYLRDTAATMAERNQQIAGIGAAL
>CAB46686.1|FEATURES|megares|aminoglycoside|AAC(6')-Ib9|antibiotic inactivation|1
MLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYV
ALGSGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPS
PSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSDA
>WP_001289562.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MYSSGNTHDKNFRKSAKTVGDVIGQYHPHGDSSVYEAMVRLSQDWKLRHVLIEMHGNNGS
IDNDPPAAMRYTEAKLSLLAEELLRDINKETVSFIPNYDDTTLEPMVLPSRFPNLLVNGS
TGISAGYATDIPPHNLAEVIQATLKYIDNPDITVNQLMKYIKGPDFPTGGIIQGIDGIKK
AYESGKGRIIVRSKVEEETLRNGRKQLIITEIPYEVNKSSLVKRIDELRADKKVDGIVEV
RDETDRTGLRIAIELKKDVNSESIKNYLYKNSDLQISYNFNMVAISDGRPKLMGIRQIID
SYLNHQIEVVANRTKFELDNAEKRMHIVEGLIKALSILDKVIELIRSSKNKRDAKENLIE
VFEFTEEQAEAIVMLQLYRLTNTDIVALEGEHKELEALIKQLRHILDNHDALLNVIKEEL
NEIKKKFKSERLSLIEAEIEEIKIDKEVMVPSEEVILSMTRHGYIKRTSIRSFNASGVED
IGLKDGDSLLKHQEVNTQDTVLVFTNKGRYLFIPVHKLADIRWKELGQHVSQIVPIEEDE
VVINVFNEKDFNTDAFYVFATQNGMIKKSTVPLFKTTRFNKPLIATKVKENDDLISVMRF
EKDQLITVITNKGMSLTYNTSELSDTGLRAAGVKSINLKAEDFVVMTEGVSENDTILMAT
QRGSLKRISFKILQVAKRAQRGITLLKELKKNPHRIVAAHVVTGEHSQYTLYSKSNEEHG
LINDIHKSEQYTNGSFIVDTDDFGEVIDMYIS
>BAP39825.1|FEATURES|megares|fosfomycin|fosA|antibiotic efflux|0
MQLLGSVASPFVRRLRLVLAGQPYQFVALNIFESEGRSVLVQHNPARKVPVLVDGEQVIF
DSGVIYRYLASKLKFKPLSWDQENGLTTINACTDSLVELLLCKRSGFDVTEDKLFFNLQH
ERIQATLEALEQQIRAGHFGDWDYPGISLFTLIDWILFRDLVDLKPFPVLLQFRNAHLNR
PMVAETDPRLS
>WP_000255583.1|FEATURES|megares|aminocoumarin|gyrB|antibiotic target alteration|0
MVTALSDVNNTDNYGAGQIQVLEGLEAVRKRPGMYIGSTSERGLHHLVWEIVDNSIDEAL
AGYANQIEVVIEKDNWIKVTDNGRGIPVDIQEKMGRPAVEVILTVLHAGGKFGGGGYKVS
GGLHGVGSSVVNALSQDLEVYVHRNETIYHQAYKKGVPQFDLKEVGTTDKTGTVIRFKAD
GEIFTETTVYNYETLQQRIRELAFLNKGIQITLRDERDEENVREDSYHYEGGIKSYVELL
NENKEPIHDEPIYIHQSKDDIEVEIAIQYNSGYATNLLTYANNIHTYEGGTHEDGFKRAL
TRVLNSYGLSSKIMKEDKDRLSGEDTREGMTAIISIKHGDPQFEGQTKTKLGNSEVRQVV
DKLFSEHFERFLYENPQVARTVVEKGIMAARARVAAKKAREVTRRKSALDVASLPGKLAD
CSSKSPEECEIFLVEGDSAGGSTKSGRDSRTQAILPLRGKILNVEKARLDRILNNNEIRQ
MITAFGTGIGGDFDLAKARYHKIVIMTDADVDGAHIRTLLLTFFYRFMRPLIEAGYVYIA
QPPLYKLTQGKQKYYVYNDRELDKLKSELNPTPKWSIARYKGLGEMNADQLWETTMNPEH
RALLQVKLEDAIEADQTFEMLMGDVVENRRQFIEDNAVYANLDF
>BAP18874.1|FEATURES|megares|beta_lactam|CTX|antibiotic inactivation|0
LKDQITYLPDNADRSVAKQKFKITNWPTYNKALINRGSITFWLDDEAIQAWYESATPSSR
GRPQRYSDLAITTVLVIKRVFRLTLRAAQGFIDSIFSLMNVPLRCPDYSCVSRRAKSVNI
SFKTPTRGEIAHLVIDSTGLKVFGEGEWKVKKHGQERRRIWRKLHLAVDSKTHEIICADL
SLNNVTDSEAFPGLIRQTHRKIRSAAADGAYDTRLCHDELRRKKISALIPPRKGAGYWPG
EYADRNRAVANQRMTGSNARWKWTTDYNRRSIAETAMYRVKQLFGGSLTLRDYDGQVAEA
MALVRALNKMTKAGX
>AAN41426.1|FEATURES|megares|aminoglycoside|ant3-dprime|antibiotic inactivation|1
MGEFFPAQVFEQLSHARAVIERHLAATLDTIHLFGSAIDGGLKPDSDIDLLVTVSAAPND
SLRQALMLDLLKVSSPPGDGGTWRPLELTVVARSEVVPWRYPARRELQFGEWLRHDILSG
TFEPAVLDHDLAILLTKARQHSLALLGPSAATSFEPVPKEHFSKALFDTIAQWNAESDWK
GDERNVVLALARIWYSASTGLIAPKDVAAAWVSERLPAEHRPLICKARAAYLGSEDDDLA
MRVEETAAFVRYAKATIERILR
>ADZ05750.1|FEATURES|megares|sulfonamide|sul1|antibiotic target replacement|1
MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGADVVDVGPAASHPDARPVSPAD
EIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADC
RLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFL
SPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGN
GADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA
>ABX45061.1|FEATURES|megares|beta_lactam|OXA-51|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEVHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEIAYKSLEQLGIL
>AAC74603.2|FEATURES|megares|multidrug|marR|antibiotic efflux|0
MKSTSDLFNEIIPLGRLIHMVNQKKDRLLNEYLSPLDITAAQFKVLCSIRCAACITPVEL
KKVLSVDLGALTRMLDRLVCKGWVERLPNPNDKRGVLVKLTTGGAAICEQCHQLVGQDLH
QELTKNLTADEVATLEYLLKKVLP
>AKF41838.1|FEATURES|megares|beta_lactam|OXA-23|antibiotic inactivation|1
MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGK
IVAFALNMEMRSEMPASIRNELLMNSLKQ
>WP_001289560.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MSEIIQDLSLEDVLGDRFGRYSKYIIQERALPDVRDGLKPVQRRILYAMYSSGNTHDKNF
RKSAKTVGDVIGQYHPHGDSSVYEAMVRLSQDWKLRHVLIEMHGNNGSIDNDPPAAMRYT
EAKLSLLAEELLRDINKETVSFIPNYDDTTLEPMVLPSRFPNLLVNGSTGISAGYATDIP
PHNLAEVIQATLKYIDNPDITVNQLMKYIKGPDFPTGGIIQGIDGIKKAYESGKGRIIVR
SKVEEETLRNGRKQLIITEIPYEVNKSSLVKRIDELRADKKVDGIVEVRDETDRTGLRIA
IELKKDVNSESIKNYLYKNSDLQISYNFNMVAISDGRPKLMGIRQIIDSYLNHQIEVVAN
RTKFELDNAEKHMHIVEGLIKALSILDKVIELIRSSKNKRDAKENLIEVYEFTEEQAEAI
VMLQLYRLTNTDIVALEGEHKELEALIKQLRHILDNHDALLNVIKEELNEIKKKFKSERL
SLIEAEIEEIKIDKEVMVPSEEVILSMTRHGYIKRTSIRSFNASGVEDIGLKDGDSLLKH
QEVNTQDTVLVFTNKGRYLFIPVHKLADIRWKELGQHVSQIVPIEEDEVVINVFNEKDFN
TDAFYVFATQNGMIKKSTVPLFKTTRFNKPLIATKVKENDNLISVMRFEKDQLITIITNK
GMSLTYNTSELSDTGLRAAGVKSINLKAEDFVVMTEGVSENDTILMATQRGSLKRISFKI
LQVAKRAQRGITLLKELKKNPHRIVAAHVVTGEHSQYTLYSKSNEEHGLINDIHKSEQYT
NGSFIVDTDDFGEVIDMYIS
>ABC68329.1|FEATURES|megares|aminoglycoside|APH(3'')-Ic|antibiotic inactivation|1
IAAVGCVLSWIAAATTIEVAPVLEGEPATTAISYSSPLLVLALALAGLAGVLAVLGIARL
RRSVTEWLPVTRGESGAGVFRNSDGSSYAKVVDAAAVADLAAERDRVSWAHRHGVPGPAV
IDWRVTEDGGACLITSTVRGVAADRLSESALRAAWPAIVEAVRTLHALPADGCPYRRDLD
DMLARARAVVGAGAVNPEFLSDEDREVPAEALLDRVEREADLRRREEAADWVVCHGDLCL
PNILVDPDRHTVEGFIDLGRLGLADRHADLA
>CBZ41938.1|FEATURES|megares|beta_lactam|blaZ|antibiotic inactivation|1
MYALNTQNGKELSFNENKRFAYASTLKTISSAMLLEQTPYNKLDKKIHINKDDIVPYSPV
LEKYIGKEITLKKLIEATMLFSDNTANNKIIDELGGYGQVKTKLIDLGDTTTHPSRKEPD
LNFYSPKDKRDTSTPLAYGKTLKKLIADGDLSKANKDFLLNLMFKNKSGDTLIKDGAPSN
FKVMDKSGQALTYGSRNDVAFVYPDGQDKPIILVIFTNKDRKDGKPNDKIVSEVAEIVLK
NINE
>WP_011765121.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|0
MPNFVCGRFELDLTQPRIMAIINVTDDSFSGDGLRGNLDGALNKAERALAEGADILDLGA
ESTRPGSDPVPEQQEIDRLVPLIEALQGCGVPLSVDTLKPSVMRAALAAGADLINDVNGF
RAEGAVEAVAAGTAGLCVMHMQGEPRTMQQAPQYANVVDEVGAFLVRRTEVLLRAGVRRE
RVLLDPGFGFGKSTEHNLALVRGLGALRDLGYPLLVGLSRKSLLGAITGKPVEARGPASV
AAALMAVQYGAAIVRVHDVAPTRDALAVWQAMS
>CBA33631.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MTQSYNADAIEVLTGLEPVRRRPGMYTDTSRPNHLGQEVIDNSVDEALAGHARRVDVILH
ADQSLEVIDDGRGMPVDIHPEEGVPAVELILCRLHAGGKFSNKNYQFSGGLHGVGISVVN
ALSKRVEVNVKRDGQIYNIAFENGEKVKELSVVGTCPKRQTGTSVHFWPDEKFFDSPRFS
VSRLTHLLKAKAVLCPGVEINFKDQVNNTEQRWCYLDGLNDYLCEAVNGLITLPEKPFIG
NFSGETEAVDWALLWLPEGGELLTESYVNLIPTMQGGTHVNGLRQGLLDAMREFCEYRNI
LPRGVKLSAEDIWERCAYVLSVKMQDPQFAGQTKERLSSRQCAAFVSGVVKDAFSLWLNQ
NVQAAEQLAELAIASAQRRLRAAKKVVRKKLTSGPALPGKLADCTAQDLNRTELFLVEGD
SAGGSAKQARDREYQAIMPLKGKILNTWEVSSDEVLASQEVHDISVAIGIDPDSDDLSQL
RYGKVCILADADSDGLHIATLLCALFVKHFRSLVKGGHVYVAMPPLYRIDLGKEVYYALD
EEEKAGVLEQLKRKKGKPNVQRFKGLGEMNPMQLRETTLDPNTRRLVQLTISDDDDARTL
AVMDMLLAKKRSEDRRNWLQEKGDMADIEV
>WP_000202262.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MTSLAHHATENRSVAEFTEQAYLNYAMYVIMDRALPHISDGLKPVQRRIVYAMSELGLKS
SGKPKKSARTVGDVLGKYHPHGDSACYEAMVLMAQPFSYRYPLIEGQGNWGSPDDPKSFA
AMRYTEAKLSAYSELLLSELGQGTSEWQDNFDGSLKEPITLPARVPNILLNGTTGIAVGM
ATDIPPHNLREVVKGTIALIRNPQTSDEKLAEYIPAPDLPTKAEIITPPEELLKIQTTGR
GSYRMRAVYTIEKNEIVITELPYQVSGSKVITQIADQMQAKKLPLVVDVRDESDHENPTR
LVIVLRSNRIDAEAVMSHLFATTDLESSYRVNLNMIGEDGRPQVKSIRRILLEWIEIRKK
TVTRRLQYHLNRIEKRLHILAGLLIAYLDIDTVIRIIREEDQPKPVLMEHFNIDEIQAEA
ILELKLRHLAKLEEMEIRHEQDELSAKAAIIREQLENPESLKNLIISELKEDAKKFGDER
RSPIVARAEAVQIKEQDLMPAETVTVVLSEAGWVRAAKGADVDAENLNYRAGDQYLSHAV
GKTNQRVYFLDETGRSYALPISNLPSARGLGDPLSSKLSPASGVSFIQVYLDDDESELIA
ASSAGYGFKTQTKQLDTNAKAGKTFLTVPDKAKALPLISAQNMTHLAVLSSAGRLLILDL
AELPNLNKGKGNKLIQLEGKEQILSMTTLNLDEIIQVVAGQQHLKLKGDDLQKYMGKRAS
KGQLLPRGYQKANKLLIQR
>CAB11853.1|FEATURES|megares|sulfonamide|folp|antibiotic target replacement|0
MAQHTIDQTQVIHTKPSALSYKEKTLVMGILNVTPDSFSDGGKYDSLDKALLHAKEMIDD
GAHIIDIGGESTRPGAECVSEDEEMSRVIPVIERITKELGVPISVDTYKASVADEAVKAG
ASIINDIWGAKHDPKMASVAAEHNVPIVLMHNRPERNYNDLLPDMLSDLMESVKIAVEAG
VDEKNIILDPGIGFAKTYHDNLAVMNKLEIFSGLGYPVLLATSRKRFIGRVLDLPPEERA
EGTGATVCLGIQKGCDIVRVHDVKQIARMAKMMDAMLNKGGVHHG
>AAY52012.1|FEATURES|megares|glycopeptide|vanHF|antibiotic target alteration|1
MKNIGITIYGCEQDEADVFKELSPRFGVIPAITSSAVSETNVMLAPGNQCISVGHKSEIS
ESILLALKESGVKYISTRSIGYNHIDMKAAESMGIAVGNVAYSPDSVADYTLMLMLMAVR
NAKSIVRSVEKHDFKLDSVRGKVLRDMTVGVLGTGHIGKRVIERLRGFGCHVLAYGHNKE
AAANYVSLNELLQKSDILTIHVPLSADTYHMIGREQIKAMKQGAFLINTARGGLIDTDVL
VKALENGKLGGAALDVLEGEEGLFYFDCTQKPIDNQFLLKLQRMPNVIITPHTAYYTEQA
LRDTVENTIKNCLEFERRETLV
>WP_001289569.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MSEIIQDLSLEDVLGDRFGRYSKYIIQERALPDVRDGLKPVQRRILYAMYSSGNTHDKNF
RKSAKTVGDVIGQYHPHGDSSVYEAMVRLSQDWKLRHVLIEMHGNNGSIDNDPPAAMRYT
EAKLSLLAEELLRDINKETVSFIPNYDDTTLEPMVLPSRFPNLLVNGSTGISAGYATDIP
PHNLAEVIQATLKYIDNPDITVNQLMKYIKGPDFPTGGIIQGIDGIKKAYESGKGRIIVR
SKVEEETLRNGRKQLIITEIPYEVNKSSLVKRIDELRADKKVDGIVEVRDETDRTGLRIA
IELKKDVNSESIKNYLYKNSDLQISYNFNMVAISDGRPKLMGIRQIIDSYLNHQIEVVAN
RTKFELDNAEKRMHIVEGLIKALSILDKVIELIRSSKNKRDAKENLIEVYEFTEEQAEAI
VMLQLYRLTNTDIVALEGEHKELEALIKQLRHILDNHDALLNVIKEELNEIKKKFKSERL
SLIEAEIEEIKIDKEVMVPSEEVILSMTRHGYIKRTSIRSFNASGVEDIGLKDGDSLLKH
QEVNTQDTVLVFTNKGRYLFIPVHKLADIRWKELGQHVSQIVPIEEDEVVINVFNEKDFN
TDAFYVFATQNGMIKKSTVPLFKTTRFNKPLIATKVKENDDLISVMRFEKDQLITVITNK
GMSLTYNTSELSDTGLRAAGVKSINLKAEDFVVMTEGVSENDTILMATQRGSLKRISFKI
LQVAKRAQRGITLLKELKKNPHRIVAAHVVTGEHSQYTLYSKSNEEHGLINDIHKSEQYT
NGSFIVDTDDFGEVIDMYIS
>WP_000196697.1|FEATURES|megares|beta_lactam|BLAZ|antibiotic inactivation|1
LKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALNTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMTY
SDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKKNKNFLLDLMFNNKNGDTLIKDGVPKDYKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>CAB11883.2|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MTGQLVQYGRHRQRRSYARISEVLELPNLIEIQTSSYQWFLDEGLREMFQDISPIEDFTG
NLSLEFIDYSLGEPKYPVEESKERDVTYSAPLRVKVRLINKETGEVKDQDVFMGDFPIMT
DTGTFIINGAERVIVSQLVRSPSVYFSGKVDKNGKKGFTATVIPNRGAWLEYETDAKDVV
YVRIDRTRKLPVTVLLRALGFGSDQEILDLIGENEYLRNTLDKDNTENSDKALLEIYERL
RPGEPPTVENAKSLLDSRFFDPKRYDLANVGRYKINKKLHIKNRLFNQRLAETLVDPETG
EILAEKGQILDRRTLDKVLPYLENGIGFRKLYPNGGVVEDEVTLQSIKIFAPTDQEGEQV
INVIGNAYIEEEIKNITPADIISSISYFFNLLHGVGDTDDIDHLGNRRLRSVGELLQNQF
RIGLSRMERVVRERMSIQDTNTITPQQLINIRPVIASIKEFFGSSQLSQFMDQTNPLAEL
THKRRLSALGPGGLTRERAGMEVRDVHYSHYGRMCPIETPEGPNIGLINSLSSYAKVNRF
GFIETPYRRVDPETGKVTGRIDYLTADEEDNYVVAQANARLDDEGAFIDDSIVARFRGEN
TVVSRNRVDYMDVSPKQVVSAATACIPFLENDDSNRALMGANMQRQAVPLMQPEAPFVGT
GMEYVSGKDSGAAVICKHPGIVERVEAKNVWVRRYEEVDGQKVKGNLDKYSLLKFVRSNQ
GTCYNQRPIVSVGDEVVKGEILADGPSMELGELALGRNVMVGFMTWDGYNYEDAIIMSER
LVKDDVYTSIHIEEYESEARDTKLGPEEITRDIPNVGEDALRNLDDRGIIRIGAEVKDGD
LLVGKVTPKGVTELTAEERLLHAIFGEKAREVRDTSLRVPHGGGGIIHDVKVFNREDGDE
LPPGVNQLVRVYIVQKRKISEGDKMAGRHGNKGVISKILPEEDMPYLPDGTPIDIMLNPL
GVPSRMNIGQVLELHMGMAARYLGIHIASPVFDGAREEDVWETLEEAGMSRDAKTVLYDG
RTGEPFDNRVSVGIMYMIKLAHMVDDKLHARSTGPYSLVTQQPLGGKAQFGGQRFGEMEV
WALEAYGAAYTLQEILTVKSDDVVGRVKTYEAIVKGDNVPEPGVPESFKVLIKELQSLGM
DVKILSGDEEEIEMRDLEDEEDAKQADGLALSGDEEPEETASADVERDVVTKE
>AAY43211.1|FEATURES|megares|aminoglycoside|ANT(2'')-Ia|antibiotic inactivation|1
MDTTQVTLIHKILAAADERNLPLWIGGGWAIDARLGRVTRKHDDIDLTFPGERRGELEAI
VEMLGGRVMEELDYGFLAEIGDELLDCEPAWWADEAYEIAEAPQGSCPEAAEGVIARRPV
RCNSWEAIIWDYFYYADEVPPVDWPTKHIESYRLACTSLGAEKVEVLRAAFRSRYAA
>ABC25482.1|FEATURES|megares|beta_lactam|SHV-66|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPDNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ABX79412.1|FEATURES|megares|glycopeptide|VanSC|antibiotic target alteration|1
MLLLILIPLTVRFVAGLRVWYGYEPIYQILRLFADYWLVCLAIGALLIWASTTIYYMSKA
ISYLNETIQATNQLIAEPTKRIILSSNLNDVQEEMNQLREKNLQDQRAAKEAEQRKNDLI
VYLAHDLRTPLTSVIGYLTLLEEEPQLSTELRARYTKIALQKAQRLELLISEFFEITRFN
LTTIALQTETTDLSLMLEQLTFEFLPLLEEKNLHWQLQLQKKVFATVDTEKMERVFDNLI
RNAINYSYTDSPLHLAISASDDILIRLTNHGKTIPAEKIGLIFEPFYRMDASRATATGGT
GLGLPIAREIVEALGGKIWAESRDETIVFSIRLPKAAMEKNEQRSKPHPSEPTA
>ABB63696.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MVYSYTEKKRIRKDFGKRPQVLDVPYLLSIQLDSFQKFIEQDPEGQYGLEAAFRSVFPIQ
SYSGNSELQYVSYRLGEPVFDVQECQIRGVTYSAPLRVKLRLVIYEREAPEGTVKDIKEQ
EVYMGEIPLMTDNGTFVINGTERVIVSQLHRSPGVFFDSDKGKTHSSGKVLYNARIIPYR
GSWLDFEFDPKDNLFVRIDRRRKLPATIILRALNYTTEQILDLFFEKVIFEIRDNKLQME
LVPERLRGETASFDIEANGKVYVEKGRRITARHIRQLEKDDVKLIEVPVEYIAGKVVAKD
YIDESTGELICAANMELSLELLAKLSQSGHKRIETLFTNDLDHGPYISETLRVDPTNDRL
SALVEIYRMMRPGEPPTREAAESLFENLFFSEDRYDLSAVGRMKFNRSLLREEIEGSGIL
SKDDIIDVMKKLIDIRNGKGEVDDIDHLGNRRIRSVGEMAENQFRVGLVRVERAVKERLS
LGDLDTLMPQDMINAKPISAAVKEFFGSSQLSQFMDQNNPLSEITHKRRISALGPGGLTR
ERAGFEVRDVHPTHYGRVCPIETPEGPNIGLINSLSVYAQTNEYGFLETPYRKVTDGVVT
DEIHYLSAIEEGNYVIAQANSNLDEEGHFVEDLVTCRSKGESSLFSRDQVDYMDVSTQQV
VSVGASLIPFLEHDDANRALMGANMQRQAVPTLRADKPLVGTGMERAVAVDSGVTAVAKR
GGVVQYVDASRIVIKVNEDEMYPGEAGIDIYNLTKYTRSNQNTCINQMPCVSLGEPVERG
DVLADGPSTDLGELALGQNMRVAFMPWNGYNFEDSILVSERVVQEDRFTTIHIQELACVS
RDTKLGPEEITADIPNVGEAALSKLDESGIVYIGAEVTGGDILVGKVTPKGETQLTPEEK
LLRAIFGEKASDVKDSSLRVPNGVSGTVIDVQVFTRDGVEKDKRALEIEEMQLKQAKKDL
SEELQILEAGLFSRIRAVLVAGGVEAEKLDKLPRDRWLELGLTDEEKQNQLEQLAEQYDE
LKHEFEKKLEAKRRKITQGDDLAPGVLKIVKVYLAVKRRIQPGDKMAGRHGNKGVISKIN
PIEDMPYDENGTPVDIVLNPLGVPSRMNIGQILETHLGMAAKGIGDKINAMLKQQQEVAK
LREFIQRAYDLGADVRQKVDLSTFSDEEVMRLAENLRKGMPIATPVFDGAKEAEIKELLK
LGDLPTSGQIRLYDGRTGEQFERPVTVGYMYMLKLNHLVDDKMHARSTGSYSLVTQQPLG
GKAQFGGQRFGEMEVWALEAYGAAYTLQEMLTVKSDDVNGRTKMYKNIVDGNHQMEPGMP
ESFNVLLKEIRSLGINIELEDE
>AEE66480.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|0
MANNFQCGRFEFDLERPLVMGIVNVTPDSFSDGGEHADTDSAIAHARQLIDEGAHILDLG
GESTRPGAQPVSAADELARILPLIEGLRDCGVPLSIDTFKPEVMRAVLDAGADMINDIYG
FRQPGAIDAVARSRCGLCVMHMKGEPRTMQEAPEYADLMGEIGVFLGARAQRLRAAWVDP
RRIVLDPGFGFGKTMDQNYQLLRRLASLRVSSYPLLVGVSRKSMIGAATGKPVGDRLAGS
VAAALACVARGAAIVRVHDVAATVDALKVWQAAEQGAVPT
>ABB63349.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|0
MLRGFFLSIHTRDNIMKLFAQGTSLDLSHPHVMGILNVTPDSFSDGGTHNSLIDAVKHAN
LMINAGATIIDVGGESTRPGAAEVSVEEELQRVIPVVEAIAQRFEVWISVDTSKPEVIRE
SAKVGAHIINDIRSLSEPGALEAAAETGLPVCLMHMQGNPKTMQEAPKYDDVFAEVNRYF
IEQIARCEQAGIAKEKLLLDPGFGFGKNLSHNYSLLARLAEFHHFNLPLLVGMSRKSMIG
QLLNVGPSERLSGSLACAVIAAMQGAHIIGVHDVKETVEAMRVVEATLSAKENKRYE
>NP_274695.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|0
MARHVWQAGRFEIGLDKPKIMGIVNLTPDSFSDGGVYSQNAQTALAHAEQLLKEGADILD
IGGESTRSGADYVSPEEEWARVEPVLAEVAGWGVPISLDTRRTVIMEKALALGGIDIIND
VAALNDEGAVELLARQADTGICLMHMQGLPKTMQINPKYQDVVGEVARYLKARSAECIAA
GIAPQRIILDPGFGSGFGKPLQHNIALMRHLPELMAETGFPLLIGVSRKSTIGELTGEAN
AAERVHGSVAAALASVARGAQIVRVHDVKATADALKVWEALGINL
>ABR76392.1|FEATURES|megares|multidrug|ompF|reduced permeability to antibiotic|0
MMKRNILAVVIPALLVAGAANAAEIYNKNGNKLDFYGKMVGEHVWTTNGDTSSDDTTYAR
IGLKGETQINDQLIGYGQWEYNMDASNVEGSQTTKTRLAFAGLKAGEYGSFDYGRNYGAI
YDVEAATDMLVEWGGDGWNYTDNYMTGRTNGVATYRNSDFFGLVDGLSFALQYQGKNDHD
RAIRKQNGDGFSTAATYAFDNGIALSAGYSSSNRSVDQKADGNGDKAEAWATSAKYDANN
IYAAVMYSQTYNMTPEEDNHFAGKTQNFEAVVQYQFDFGLRPSIGYVQTKGQGPAVACWL
LRRRCGSG
>ADI46760.1|FEATURES|megares|trimethoprim|dfrA14|antibiotic target replacement|1
MAAKAKNGVIGCGPDIPWSAKGEQLLFKALTYNQWLLVGRKTFESMGALPNRKYAVVTRS
GWTSNDDNVVVFQSIEEAMDRLAEFTGHVIVSGGGEIYRETLPMASTLHLSTIDIEPEGD
VFFPSIPNTFEVVFEQHFTSNINYCYQIWKKG
>ABX79410.1|FEATURES|megares|glycopeptide|vanTC|antibiotic target alteration|1
MKKNQGIDQFRVILAMMVVAIHCLPLHRLWPDGDILITLTLFRIAVPFFFMISGYYVFSD
LATQNSYPARQRVWHFIKKQLQVYLIATLLFLPLAWYSGMLGLNMPLGTFIQTLLVNGIL
YHLWYFPAIITGSLLVMGLLTRLSFKQVFFIAVGLYVVGLGGDSWSGLAAQTPLASLYSL
IFQLLAGTRNGIFFAPLFLLLGVLARRFAQKPASPHRYSYLMISLICLLLESYLLHHFTT
PKHDSMYVFLPFVLLFLFPIIQQWQAPMIWKQAGRLSLWLYLLHPYTIAVTHFLSQKLPL
LQNNLINYIVVLGLTIGLIYGLFALQKLFSFPKKTPPHLQRATKEFSAPALLHNLQEIKR
VIPSTTKVMAVVKADAYGCDAKTVAGTLERAGVDFFAVATIEEAIELRRAGIKSRLLILG
YTSAQRAKELNRYSLIQTVVSEAHGQALARTGLPIECHLAVDTGMHRLGVAPDLETVRKL
FALPSLKITGIFSHLGSSDQLDTASILRTQAQITCFDDLLAGLSARNIAYGLTHLQSSYG
ILNYPEKHYDYVRPGILLTGSLSVPNEPTKQKINVQPILTLKALLVDKKTVAAGEAIGYG
LGTVFDRPATIGIVSIGYCDGVPRALSNQGFQLSYQGVLLPQIGLVCMDMLLIDLTDYPE
LAVESSLEVISDWTTAADQAQTITNELISRLGSRITSSAK
>AAM27272.1|FEATURES|megares|chloramphenicol|catB8|antibiotic inactivation|1
MKNYFNSPFKGELLSEQVKNPNIRVGRYSYYSGYYHGHSFDECARYLFPDRDDVDKLIIG
SFCSIGSGASFIMAGNQGHRHDWASSFPFFYMQEEPAFSSALDAFQRAGDTVIGNDVWIG
SEAMIMPGIKIGDGAVIGSRSLVTKDVEPYALIGGNPAKQIKKRFSDEEISLLMEMEWWN
WPLDKIKTTMPLLCSSNIFGLHKYWREFAV
>AAK48071.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|0
MGVLNVTDDSFSDGGCYLDLDDAVKHGLAMAAAGAGIVDVGGESSRPGATRVDPAVETSR
VIPVVKELAAQGITVSIDTMRADVARAALQNGAQMVNDVSGGRADPAMGPLLAEADVPWV
LMHWRAVSADTPHVPVRYGNVVAEVRADLLASVADAVAAGVDPARLVLDPGLGFAKTAQH
NWAILHALPELVATGIPVLVGASRKRFLGALLAGPDGVMRPTDGRDTATAVISALAALHG
AWGVRVHDVRASVDAIKVVEAWMGAERIERDG
>WP_012683975.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MAGKVIQSGRHRQRRTYSRINEVLGLPNLIEIQQKSYQWFLDEGLREMFQDISPIQDFTG
NLVLEFIDYSLGEPKYDVDESKERDVTYAAPLRVKVRLLNKETGEVKEQEVFMGDFPLMT
ETGTFIINGAERVIVSQLVRSPSVYYNTKVDKNGKQTFTATVIPNRGAWLELETDAKDVI
YVRIDRTRKIPVTVLLRALGFGSDIEILNLLGEDEYIKNTLEKDNTDSTEKALIEIYERL
RPGEPPTVENAKSLLISRFFDPKRYDLASVGRYKMNKKLHLKNRLYNQRLAETLIDTTTG
EIFAEAGQMIDRRVLERIVPALEGSIGFIDVRTHGGVLEDEAIHLQSINIFSPIEDGKII
KVIGNGNVDKSFKHITPADIVSAINYFMNLLHSVGSTDDIDHLGNRRLRSVGELLQNQFR
IGLSRMERVVRERMSIQDQNQITPQALINIRPVIASLKEFFGSSQLSQFMDQTNPLAELT
HKRRLSALGPGGLTRERAGFEVRDVHHSHYGRMCPIETPEGPNIGLINSLSSFARINDYG
FIETPRRKVDPETGFVLTDISYLTADEEDVFNVAQANQPLDEDGRFVNDMVICRRKGEIL
SVPRDKVDFMDVSPKQVVSVATALIPFLENDDANRALMGSNMQRQAVPLLIPQAPFVGTG
MEHKAAQDSGVAIVAKHPGQVERVTAREIWIRRYQEIDGRKVAGDLDKYKMHKFIRSNQG
TCINQRPIVSTGDWIEKGDIVGDGPSTEKGELALGRNVIVAFMTWEGYNYEDAILLSEKL
VKDDVYTSIHIEEYESEARDTKLGPEEITRDIPNVGEDALKNLDERGIIRVGAEIQDGDI
LVGKVTPKGVTELTAEERLLHAIFGEKAREVRDTSLRVPHGGSGIIVDVKVFTRENGDEL
PPGVNQLVRVYIAQKRKISVGDKMAGRHGNKGVIARIMAEEDMPFLPDGSPVEIVLNPLG
VPSRMNIGQVLETHLGMAAKLLGIHVATPVFDGARQAEVFETLAEAGLDRDGKTILFDGR
TGEPFDRRVTVGCVYMLKLAHLVDDKIHARSTGPYSLVTQQPLGGKAQFGGQRFGEMEVW
ALEAYGAAYTLQEILTVKSDDVVGRVKTYEAIVKGENVPEPGVPESFKVLIKELQSLGMD
VKILSGDEQEIEMREMEDEDEGNGEKLNLVLEGGSLNEE
>WP_001242578.1|FEATURES|megares|glycopeptide|BRP|antibiotic inactivation|1
MRMLQSIPALPVGDIKKSIGFYCDKLGFTLVHHEDGFAVLMCNEVRIHLWEASDEGWRSR
SNDSPVCTGAESFIAGTASCRIEVEGIDELYQHIKPLGILHPNTSLKDQWWDERDFAVID
PDNNLISFFQQIKS
>AGS60938.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MSELTHDGVERQPLHLFTENAYLNYSMYVIMDRALPFIGDGLKPVQRRIVYAMSELGLNS
SAKFKKSARTVGDVLGKYHPHGDSACYEAMVLMAQPFSYRYPLIDGQGNWGAPDDPKSFA
AMRYTESRLSKYSQILLSELGHGTVDWIPNFDGTLQEPKMLPARLPNILLNGTTGIAVGM
ATDIPPHNAREIGQALTMLLDNPDAGLSDVMQYVQGPDYPTEAEVITAPEDIKKIYKTGR
GSIRMRAVWQKEEGCAVITALPHQVSGAKVLEQIAALMRAKKLPLVDDLRDESDHENPTR
LVIVPRSNRVDLEQVMYYLFVNTDLEKSYRVNLNMIGLDNRPAVKGLLTILNEWLVYRRQ
TVTNRLNHRLEKVLRRLEILKGLLIAYLNIDEVIEIIRYEDEPKAELMRRFALSDIQAEA
ILELRLRHLAKLEEIKLQAESDELEKERDSIEKLLNSPRRLNTLLKKEIEADAKEFGDER
RSPIRPQEEAKVVNEQDMLPSEPVTIVLSEMGWVRSAKGHEIDPSTMSYRAGDSYHSAVR
GMSNQPVLFLDSTGRSYSLSPNDMPSGRSQGEPLTGKLTFPPDASVKYMLAGAAKQEYLL
ATKEGYGSVLSYEEMETKNKTGKGLLTVSDETELLAPFLVDAEKKNNQHWLVIITDKTRI
LAISAEHLNEMNKKGRGTRLVTLGKEQSDVIEQIVLIAKNEALTFTVDGQQQTLKAEEIS
YFSGDVGDEPIPLKHLHPEAVTVIMSEKGLIRCQKGHNIDAKSVGFKTGDDYFDAVEGMS
NQAVHLIDTTGQSYTVDVDALPSGRSKGDDLTGRLKVQKGAQLRHVVMGESSDKILMASD
AGYGFICSIDDLTSKNRAGKSLLTLPENALPLPPQRLNDELSDLIMIITQGGRMLIFEAS
ELPTMVKGKGNQMVSIPASQAASGEDKVAWLRVLPENASVTLHFGKRKLTMSMNELQTFK
AKRGRRGTSLPRGAQSIDHIDIETH
>AGS59331.1|FEATURES|megares|multidrug|ompF|reduced permeability to antibiotic|0
MFAGAANAAEMYNKDGNKVDIYGKVDVRHYFADADTKGDHESGDASRARIGFKGETQINK
DLTGFGRFEYEVKTNTTEGENKAKTRLAYAGLKFADFGSLDYGRNYGVIYDTNAWTDVLP
LWGGDSMAQTDVYMTSRTTGVLTYRNTDMFGYVDGLSFALQYQGKNNENTNNKRKDNAEA
NGDGFGFSTAYNLGWGVTLGGGYSSSARTNWQEHKSDATGKRAEAWNVGGKFEANNVYLA
AMYGETRNMNYYGDGAIANKTQNIELTAQYDFADLGIKPSLGYVQSKGKDLNNGVGGLKD
NNHDLVKYISVGSFYKFNKNMTAVVDYKINLLDEDDFTKANGVATDNVVGLGLTYQF
>CAA55770.1|FEATURES|megares|macrolide-lincosamide-streptogramin|lmrB|antibiotic target alteration|1
MRRILVAPAWVSAVLVVQWEVARRRAGIGGCSLVTAESWPWFDFSVLKRVPRFAFRPAPS
VDGGILVIERRPEPLVRERREYQDFVRQVFTGRGHGLREILQRIGRVQDSDLSAWFRAHG
VSPQALPKDLTAEQWASLWGMARGGRSVPRTRRPRGLPPRTSRGPRRNSG
>AAO15534.1|FEATURES|megares|chloramphenicol|cmlA5|antibiotic efflux|1
MDMYLPAVPFMPNALGTTASTIQLTLTTYLVMIGAGQLLFGPLSDRLGRRPVLLGGGLAY
VVASMGLALTSSAEVFLGLRILQACGASACLVSTFATVRDIYAGREESNVIYGILGSMLA
MVPAVGPLLGALVDMWLGWRAIFAFLGLGMIAASAAAWRFWPETRVQRVAGLQWSQLLLP
VKCLNFWLYTLCYAAGMGSFFVFFSIAPGLMMGRQGVSQLGFSLLFATVAIAMVFTARFM
GRVIPKWGSPSVLRMGMGCLIAGAVLLAITEIWASQSVLGFISPMWLVGIGVATAVSVAP
NGALRGFDHVAGTVTAVYFCLGGVLLGSIGTLIISLLPRNTAWPVVVYCLTLATVVLGLS
CVSRAEGSRGQGEHDVVALQSAESTSNPNR
>EED25201|FEATURES|megares|fosfomycin|FosC2|antibiotic inactivation|1
VILGLNHITIAVSDLERSLKFYRETLGFTAHAKWDNGAYLSVGELWFCLSHDEPCPKTDY
THVAFDIEPKEFEAFAKRVVSLGVEVWKQNKSEGQSLYILDPDGHKLEIHSGSLKSRLES
LRTKLYSGLVWL
>WP_000907145.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MAGHDVQYGKHRTRRSFSRIKEVLDLPNLIEIQTDSFKAFLDHGLKEVFEDVLPISNFTD
TMELEFVGYEIKEPKYTLEEARIHDASYSAPIFVTFRLINKETGEIKTQEVFFGDFPIMT
EMGTFIINGGERIIVSQLVRSPGVYFNDKVDKNGKVGYGSTVIPNRGAWLELESDSKDIT
YTRIDRTRKIPFTTLVRALGFSGDDEIFDIFGDSELVRNTVEKDIHKNPMDSRTDEALKE
IYERLRPGEPKTAESSRSLLVARFFDPRRYDLAAVGRYKINKKLNVKTRLLNQTIAEPLV
DPETGEILVEAGTIMTRSVIESIESHLDGDLNKIVYIPNDAAVVTEPVVLQKFKVVAPTD
PDRVVTIIGNANPDDKVRTVTPADILAEMSYFLNLAEGLGRVDDIDHLGNRRIRAVGELL
ANQVRLGLSRMERNVRERMSVQDNEVLTPQQIINIRPVTAAVKEFFGSSQLSQFMDQHNP
LSELSHKRRLSALGPGGLTRDRAGYEVRDVHYTHYGRMCPIETPEGPNIGLINNLSSYGH
LNKYGFVQTPYRKVDRETGVVTNEIVWLTADEEDEYTVAQANSRLNEDGTFAEKIVMGRH
QGVNQEYPANIVDYMDVSPKQVVAVATACIPFLENDDSNRALMGANMQRQAVPLINPQAP
YVGTGMEYQAAHDSGAAVIAQYDGKVTYADADKVEVRREDGSLDVYHIQKFRRSNSGTAY
NQRTLVKVGDVVEKGDFIADGPSMENGEMALGQNPIVAYMTWEGYNFEDAVIMSERLVKD
DVYTSVHLEEYESETRDTKLGPEEITREIPNVGEDALKDLDEMGIIRIGAEVKEGDILVG
KVTPKGEKDLSAEERLLHAIFGDKSREVRDTSLRVPHGADGVVRDVKIFTRVNGDELQSG
VNMLVRVYIAQKRKIKVGDKMAGRHGNKGVVSRIVPVEDMPYLPDGTPVDIMLNPLGVPS
RMNIGQVMELHLGMAARTLGIHIATPVFDGASSEDLWSTVKEAGMDSDAKTILYDGRTGE
PFDNRVSVGVMYMIKLHHMVDDKLHARSVGPYSTVTQQPLGGKAQFGGQRFGEMEVWALE
AYGASNVLQEILTYKSDDINGRLKAYEAITKGKPIPKPGVPESFRVLVKELQSLGLDMRV
LDEDDQEVELRDLDEGMDEDVIHVDDLEKAREKAAQEAKAAFEAEEAEKATKAEATEEAA
EQE
>WP_000819068.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MAELPQSRINERNITSEMRESFLDYAMSVIVARALPDVRDGLKPVHRRILYGLNEQGMTP
DKSYKKSARIVGDVMGKYHPHGDLSIYEAMVRMAQDFSYRYPLVDGQGNFGSMDGDGAAA
MRYTEARMTKITLELLRDINKDTIDFIDNYDGNEREPSVLPARFPNLLANGASGIAVGMA
TNIPPHNLTELINGVLSLSKNPDISIAELMEDIEGPDFPTAGLILGKSGIRRAYETGRGS
IQMRSRAVIEERGGGRQRIVVTEIPFQVNKARMIEKIAELVRDKKIDGITDLRDETSLRT
GVRVVIDVRKDANASVILNNLYKQTPLQTSFGVNMIALVNGRPKLINLKEALVHYLEHQK
TVVRRRTQYNLRKAKDRAHILEGLRIALDHIDEIISTIRESDTDKVAMKSLQQRFKLSEK
QAQAILDMRLRRLTGLERDKIEAEYNELLNYISELETILADEEVLLQLVRDELTEIRDRF
GDDRRTEIQLGGFEDLEDEDLIPEEQIVITLSHNNYIKRLPVSTYRAQNRGGRGVQGMNT
LEEDFVSQLVTLSTHDHVLFFTNKGRVYKLKGYEVPELSRQSKGIPVVNAIELENDEVIS
TMIAVKDLESEDNFLVFATKRGVVKRSALSNFSRINRNGKIAISFREDDELIAVRLTSGQ
EDILIGTSHASLIRFPESTLRPLGRTATGVKGITLREGDEVVGLDVAHANSVDEVLVVTE
NGYGKRTPVNDYRLSNRGGKGIKTATITERNGNVVCITTVTGEEDLMIVTNAGVIIRLDV
ADISQNGRAAQGVRLIRLGDDQFVSTVAKVKEDAEDETNEDEQSTSTVSEDGTEQQREAV
VNDETPGNAIHTEVIDSEENDEDGRIEVRQDFMDRVEEDIQQSSDEDEE
>AHH83941.1|FEATURES|megares|glycopeptide|vanSB|antibiotic target alteration|1
MERKGIFIKVFSYTIIVLLLLVGVTATLFAQQFVSYFRVMELQQTVKSYQPLVELIQNSD
RLDIQEVAGLFHYNNQSFEFYIEDKEGSVLYATPNANTSNSFRPDFLYVVHRDDNISIVA
QSKAGVGLLYQGLTIRGIVMIAIMVVFSLLCAYIFARQMTTPIKALADSANKMANLKDVP
PPLERKDELGALAHDMHSMYVRLKETIARLEDEIARLEDEIAREHELEETQRYFFAAASH
ELKTPIAATSVLLEGMLENIGDYKDHSKYLRECIKMMDRQGKIISEILELVSLNDGRIVP
IAEPLDIGRTVAELLPDFQTLAEANNQRFVTDIPAGQIVLSDPRLLQKALSNVILNAVQN
TPQGGEVRIWSEPGAEKCRLFVLNMGVHIDDTALPRLFTPFYRIDQARSRKSGRSGLGLA
IVQKTLDAMSLQYALENTSDGVLFWLDLPLTSTL
>AAA25634.1|FEATURES|megares|macrolide-lincosamide-streptogramin|ErmB|antibiotic target alteration|1
MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNLSSEKLKSNTRVTLIHQDILQFQFPNKQRYKIVGNIPYHLSTQIIKKVVFESHAS
DIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPRVNSVLIKLTRHTT
DVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTVTYEQVLSIFNSYLL
FNGRK
>WP_000167936.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|0
MTKTKIMGILNVTPDSFSDGGKFNNVESAVTRVKAMMDEGADIIDVGGVSTRPGHEMITV
EEELNRVLPVVEAIVGFDVKISVDTFRSEVAEACLKLGVDIINDQWAGLYDHRMFQVVAK
YDAEIVLMHNGNGNRDEPVVEEMLTSLLAQAHQAKIAGIPSNKIWLDPGIGFAKTRNEEA
EVMARLDELVATEYPVLLATSRKRFTKEMMGYDTTPVERDEVTAATTAYGIMKGVRAVRV
HNVELNAKLAKGIDFLKENENARHNFS
>AAG12998.1|FEATURES|megares|macrolide-lincosamide-streptogramin|msrD|antibiotic target protection|1
MELILKAKDISVEFKGHDVLDINELEVYDYDRIGLVGANGAGKSTLFKVLLGELIPPGCK
MNHLGELAYIPQLDEVTLQEEKDFALVGKLGVEQLNIQTMSGGEETRLKIAQALSAQVHG
ILADEPTSHLDREGIDFLIGQLKYFTGALLVISHDRYFLDEIVDKIWELKDGKITEYWGN
YSDYLRQKEEERKRQAAEYEQFIAERARLERAAEEKRKQARKIEQKAKGSSKKKSTEGGG
RLAHQKSIGSKEKKMHNAAKSLENRIAALGKVEAPEGIRRIRFRQSKALELHNPYPIVGA
EINKVFGDKALFENASFQIPLGAKVALTGGNGTGKTTLIQMILNHEEGISISPKAKIGYF
AQNGYKYNSNQNVMEFMQKDCDYNISEIRSVLASMGFKQNDIGKSLSVLSGGEIIKLLLA
KMLMGRYNILIMDEPSNFLDIPSLEALEILMKEYTGTIVFITHDKRLLENVADVVYEIRD
KKIKLKH
>AEM66522.1|FEATURES|megares|chloramphenicol|catB3|antibiotic inactivation|1
MKNFFESPFKGKIIKDHITNPNIISGKYSYYSGYYHGHSFDDCARYLFPDRNDVDKLIIG
SYCSIGSGASFIMAGNQGHKYDWISSFPFFYMSEFDVFSKSQDGFQKAGDTVVGNDVWIG
SEAMIMPGVQIGDGAVIGSRALVTKDVEPYSIVGGNPAKLIKKRFSDDDIQKLQEMKWWE
WDEETLFEAMPILCSNKIDLLYKFFRKMK
>AAO38185.1|FEATURES|megares|tetracycline|tetA|antibiotic efflux|1
MPVLPGLLRDLVHSNDVTAHYGILLALYALVQFACAPVLGALSDRFGRRPILLVSLAGAT
VDYAIMATAPFLWVLYIGRIVAGITGATGAVAGAYIADITDGDERARHFGFMSACFGFGM
VAGPVLGGLMGGFSPHAPFFAAAALNGLNFLTGCFLLPESHKGERRPLRREALNPLASFR
WARGMTVVAALMAVFFIMQLVGQVPAALWVIFGEDRFHWDATTIGISLAAFGILHSLAQA
MITGPVAARLGERRALMLGMIADGTGYILLAFATRGWMAFPIMVLLASGGIGMPALQAML
SRQVDEERQGQLQGSLAALTSLTSIVGPLLFTAIYAASITTWNGWAWIAGAALYLLCLPA
LRRGLWSGAGQRADR
>AAA25527.1|FEATURES|megares|macrolide-lincosamide-streptogramin|ErmB|antibiotic target alteration|1
MKKNIKYSQNFLTNEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNLSSEKLKLNIRVTLIHQDILQFQFPNKQRYKIVGSIPYHLSTQIIKKVVFESHAS
DIYLIVEEGFYKRTLDIHRSLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTT
DVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTVTYEQVLSIFNSYLL
FNGRK
>WP_011244871.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MAEEDVPRLRERQIDEEMKESFIDYAMSVIVSRALPDVRDGMKPVHRRILYAMFELGMTP
DKPYKKSARIVGEVLGKYHPHGDTSVYDAMVRMAQDFSYRYMLVNGHGNFGSIDGDSAAA
MRYTESKMSKISMELVRDLNKDTVDFIDNYDGTEREPKVMPSRFPNLLVNGTSGIAVGMA
TNIPPHQLGEVIDGVLALAKNPDISIPELMEYIPGPDFPTGGEILGRSGIRKAYSTGRGS
ITVRAKTEIVENKGKQSIIVTELPYQVNKARLIEKIAELVRDKKIDGITELRDSSDRNGM
NIVIDVRRDANPNVILNNLFKQTALQTSFGINMLALVNGRPEVLNLKQTLEQYLAHQVEV
IRRRTQFDLNKAEARAHILEGLRIALDHIDEIIALIRGSDTAEIARNGLIERFELSYDQA
QAILDMRLQRLTGLERDKLEQEYKDVLARIAELRAILASDEKVIDVIQEEILAIKEKFND
ERRTVISASEEHLEDEDLIPRQNIVITITHNGYIKRLPISTYRAQKRGGKGVQGMGTNDD
DFVQHLFTTNTHHTVLVFTNKGKAYRLKGYEIPELGRTAKGIPAINLLPFDPGETISTVI
PIECFDDDSYLFFVTEHGIAKRTKLSAFANIRKGGLFAINLREGDSLHGVRLTDGNREVM
IGTKQGMAIRFPETDVRLMGRTAGGVKGITLSENDGVVGMEVVDENQSVLVVTEKGYGKR
TPLDEYRVQSRGGKGIKTCNITDKNGPLVSLKMVADEDDIMIVTANGIIIRTNVDGISTT
GRNTQGVTLIRVNEGEEVATVARVNINDDEVDDLEDDDEQEQPTSEENAE
>ACN39575.1|FEATURES|megares|sulfonamide|sul2|antibiotic target replacement|1
MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVS
SDTEIARIAPVLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDAAFYPQLAK
SSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFF
LGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAAA
GGADFIRTHEPRPLRDGLAVLAALKETARIRYQKTEGTSIESN
>ABQ56968.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|0
MNSEQFLGWLERKSQPASSLVFEKPLIMGVLNVTSDSFYDGGKYLSVDRAYEQAIQLIAC
GADLIDIGGESTKPGAPPVPLDVELSRVLPIIKQLRAFTDVCISIDTNKPEVMEAAINAG
AHVINDVYALRRDGALNVAAQLDVPVCLMHMKGEPRTMQENPSYPEGIMKELQHFFEERI
DKCQKAGLNRNKLILDPGFGFGKRVQDNLQLIYHLNELHSFGLPILLGVSRKSTIGAVLN
TEVEQRLIGSITLGIYAALKGTAIIRTHDVDETNQALTMINAIYQAAKEIS
>ACD03449.1|FEATURES|megares|tetracycline|tet39|antibiotic efflux|1
PSLLWLYIGRIFAGITGANMAVATAYVSDITPAHERAKRFGLLGAVFGIGFIAGPVIGGV
LGEWNLHAPFFAAAFMNGINLIMTAVLLKESKHSNKMTEKVQEQSILKKLSYLITQPNMA
PLLGIFLIITLVSQVPATLWVIYGQDRYGWSIFIAGVSLASYGICHSIAQAFAIAPMVKR
FGEKNTLLCGIACDAIGLLLLSIAVEEWVPFALLPLFALGGVAVPALQAMMSRGIS
>AAQ76280.1|FEATURES|megares|beta_lactam|OXA-50|antibiotic inactivation|1
MRPLLFSALLLLSGHAQASEWNDSQAVDKLFGAAGVKGTFVLYDVQRQRYVGHDRERAET
RFVPASTYKVANSLIGLSTGAVKSADEVLPYGGKPQRFKAWEHDMSLRDAIKASNVPVYQ
ELARRIGLERMRANVSRLGYGNAEIGQVVDNFWLVGPLKISAMEQTRFLLRLAQGELPFP
APVQSTVRAMTLLESGPGWELHGKTGWCFDCTPELGWWVGWVKRNERLYGFALNIDMPGG
EADIGKRVELGKASLKALGILP
>AEE66364.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MDSFAKETLPVSLEEEMRRSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAMHELNNDWN
RAYKKSARIVGDVIGKYHPHGDQSVYDTIVRMAQDFSMRYMLVDGQGNFGSIDGDNAAAM
RYTEIRLAKIAHELLADIDQETVDFGPNYDGSEQEPLLLPSRLPNLLVNGSSGIAVGMAT
NIPPHNLQEVVDGCLYCLRNPECSIDELIELIPAPDFPTGGVIYGITGVREGYRTGRGRV
IMRAKTHFEDMEKGNRQAIVVDAIPYQVNKKTLQERIAELVNDKKIEGISDIRDESDKDG
MRLVIELKRGEVPEVVLNNLYKNTQLQDTFGMNLVALVDGQPRLLNLKQLIEYFLQHRRE
VVTRRTVFQLRKARERGHVLEGLAVALANIDDFIAIIKAAPTPPVARQELMARSWDSSLV
REMLARVDGDAAGGVAAFRPDDLAPEYGLQGDGNYRLSETQAQEILNMRLQRLTGLEQDK
IIGEYKDVMATIADLLDILARPDRITTIISEELQAIKAEFSTSAKDTRRAEIEVNATELD
TEDLITPMDMVVTLSHGGYIKSQPLSEYRSQKRGGRGKQATAMKENDWVDQLFIANTHDY
LLCFSNRGRVYWLKVWEVPQGTRNSRGKPIVNMFPLADGEKVTVVLPVKEFSEDHYVFMA
TSRGTVKKTPLSDFSNPRKAGIIAVDLDDGDYLIGADLTDGKHDVMLFSDAGKAVRFDEN
DVRPMGRNARGVRGMMLEEGQTVIALLVAGDETQSVLTATENGYGKRTPITEYTRHGRGT
KGMIAIQTSSRNGRVVGAVLVMPSDEIMLITTGGVLVRTRVAEIREMGRATQGVTLISVD
DGSSLSGVRRVVESDADADDEDGGEEGGEEGGDQGGDDTGAQGKDSEPTEPTE
>AKF41839.1|FEATURES|megares|beta_lactam|OXA-23|antibiotic inactivation|1
MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVINQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGK
IVAFALNMEMRSEMPASIRNELLMKSLKQLNII
>CAC81945.1|FEATURES|megares|sulfonamide|sul2|antibiotic target replacement|1
MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVS
SDTEIARIAPVLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDAAFYPQLAK
SSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFF
LGAAPETSLSVLARFDELRVRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAAA
GGADFIRTHEPRPLRDGLAVLAALKETARIR
>WP_000116442.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MSVSEIRPIAIEDELKHSYLDYAMSVIVSRALPDVRDGLKPVHRRVLYAMHELGNDYNKA
YKKSARVVGDVIGKYHPHGDLAVYETIVRMAQDFSLRYLLVDGQGNFGSIDGDSAAAMRY
TEVRMTKLAHELLADLEKDTVDWEDNYDGSERIPEVLPTRVPNLLINGAAGIAVGMATNM
APHNMTEVVNACLAYADNPNISIEGLMEYITGPDFPTGGIIYGKSGIVDAYRTGKGRLHI
RGKYHFEEDEKTGRTTIVFTEIPYQVNKARVIERIAELVKEKKLEGISELRDESDKEGMR
IAIDLKRGENAEVVVNNLFLNTQLENSFSINMVCLDNGQPKLMNLKDIIAAFIRHRQEVV
TRRTMFELRKARERGHILEGLTVALANIDEIIETIKTSANPAEARERLLAGEWAGGGVVA
LLEKAGAISVRPDEIEGEDPNRPFGLSDSIYRLSPTQVGAILELRLHRLTGLEQDKLHAE
YTEILGQIAELTAILNDFNLLMGVIREELAQVLQQYGDARRTEIVESRVDFCREDLIPEE
QVVLTVSQTGYAKTQPLSDYQAQRRGGRGKSATSMKDDDFIQHLIVASNHATVLCFTNVG
KVYRLKVFEVPQASRGAKGRPIVNLLPLDATETVTAILPLTEFPENHYVFMATASGTVKR
VELEQFANIRSNGLRAIELNEEDTLIGVAITDGNQQIMLFSNEGKAIRFAETDVRAMGRT
AKGVRGMRVSFASSTLSEEDADVENDDSDDNDDSADSSLVSRIVSLVVVPETGEVLCASA
NGYGKRTPVNDFPTKKRGGKGVIAIKTSERNGELVGAVSIDETKELLLISDGGTLVRTRA
AEVAMTGRNAQGVRLIRLSEEETLVGVVSIEAVEDEEELLEGEVDTTETDSEEAVSNNED
TSEE
>CAD11595.1|FEATURES|megares|trimethoprim|dfrA1|antibiotic target replacement|1
MVAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYAVVTRS
SFTSDNENVVIFPSIKDALTNLKKITDHVIVSGGGEIYKSLIDQVDTLHISTIDIEPEGD
VYFSEIPSNFRPVFTQDFASNINYSYQIWQKG
>WP_001174940.1|FEATURES|megares|multidrug|MdtK|antibiotic efflux|0
MQKYISEARLLLALAIPVILAQIAQTAMGFVDTVMAGGYSATDMAAVAIGTSIWLPAILF
GHGLLLALTPVIAQLNGSGRRERIAHQVRQGFWLAGFVSVLIMLVLWNAGYIIRSMENID
PALADKAVGYLRALLWGAPGYLFFQVARNQCEGLAKTKPGMVMGFIGLLVNIPVNYIFIY
GHFGMPELGGVGCGVATAAVYWVMFLAMVSYIKRARSMRDIRNEKGTAKPDPAVMKRLIQ
LGLPIALALFFEVTLFAVVALLVSPLGIVDVAGHQIALNFSSLMFVLPMSLAAAVTIRVG
YRLGQGSTLDAQTAARTGLMVGVCMATLTAIFTVSLREQIALLYNDNPEVVTLAAHLMLL
AAVYQISDSIQVIGSGILRGYKDTRSIFYITFTAYWVLGLPSGYILALTDLVVEPMGPAG
FWIGFIIGLTSAAIMMMLRMRFLQRLPSAIILQRASR
>AKL59536.1|FEATURES|megares|beta_lactam|OXA-24|antibiotic inactivation|1
MKKFILPIFSISILVSLSACSSIKTKSEDNFHISSQQHEKAIKSYFDEAQTQGVIIIKEG
KNLSTYGNALARANKEYVPASTFKMLNALIGLENHKATTNEIFKWDGKKRTYPMWEKDMT
LGEAMALSAVPVYQELARRTGLELMQKEVKRVNFGNTNIGTQVDNFWLVGPLKITPVQEV
NFADDLAHNRLPFKLETQEEVKKMLLIKEVNGSKIYAKSGWGMGVTPQVGWLTGWVEQAN
GKKISFSLNLEMKEGMSGSIRNEITYKSLENLGII
>CCM44120.1|FEATURES|megares|beta_lactam|blaZ|antibiotic inactivation|1
MLALILSACNTKHSTNNDIEKLEKKYGANIGMYALNTQNSEALSFNENKRFAYASTLKAI
SSAMLLEQTPYNKLDKKIHINKDDIVPYSPVLEKYIGKEITIKKLIEATMLFSDNTANNK
IIDELGGYEHVKNRLTDLGDTTTHPSRKEPDLNFYSPKDKRDTTTPMAYGKSLNKLIVDG
NLSKANKDLLLDLMLKNKSGDTLIKDGAPSNFKVMDKSGQALTYGSRNDVALVYPDGQDK
PIILVIFTNKDKKDGKPNDKIVSEVAEIVLKNMSK
>ABR78833.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MSDMAERLALHEFTENAYLNYSMYVIMDRALPFIGDGLKPVQRRIVYAMSELGLNASAKF
KKSARTVGDVLGKYHPHGDSACYEAMVLMAQPFSYRYPLVDGQGNWGAPDDPKSFAAMRY
TESRLSKYAELLLSELGQGTVDWVPNFDGTLQEPKMLPARLPNILLNGTTGIAVGMATDI
PPHNLREVAKAAITLIEQPKTTLDELLDIVQGPDFPTEAEIITSRAEIRKIYQNGRGSVR
MRAVWSKEDGAVVISALPHQVSGAKVLEQIAAQMRNKKLPMVDDLRDESDHENPTRLVIV
PRSNRVDMEQVMNHLFATTDLEKSYRINLNMIGLDGRPAVKNLLEILSEWLVFRRDTVRR
RLNHRLEKVLKRLHILEGLLVAFLNIDEVIEIIRTEDEPKPALMSRFGISETQAEAILEL
KLRHLAKLEEMKIRGEQSELEKERDQLQAILASERKMNNLLKKELQADADAFGDDRRSPL
HEREEAKAMSEHDMLPSEPVTIVLSQMGWVRSAKGHDIDAQGLSYKAGDSWKASAKGKSN
QPVVFIDTTGRSYAIDPITLPSARGQGEPLTGKLTLPPGATVEHMLMESDDQKLLMASDA
GYGFVCTFNDLVARNRAGKALITLPDNAHVMPPLVIEDESDMLLAITAAGRMLMFPVSDL
PQLSKGKGNKIISIPAAEAAAGQDGLAHLFVLPPQSTLTIHVGKRKIKLRPEELQKVTGE
RGRRGSLMRGLQKIDRVEIDSPRRAAAGDSEE
>ABO21417.1|FEATURES|megares|beta_lactam|GOB-1|antibiotic inactivation|1
MRNFATLFFMFICLGLNAQVVKEPENMPKEWNQTYEPFRIAGNLYYVGTYDLASYLIVTD
KGNILINTGTAESLPIIKANIQKLGFNYKDIKILLLTQAHYDHTGALQDLKTETGAKFYA
DKADADVLRTGGKSDYEMGKYGVTFKPVTPDKTLKDQDKITLGNTILTLLHHPGHTKGSC
SFIFETKDEKRKYRVLIANMPSVIVDKKFSEVTAYPNIQSDYAYTFKAMKNLDFDLWVAS
HASQFDLHEKRKEGDPYNPQLFMDKQSYFQNLNDLEKSYLDKIKKDSQDK
>ACO84640.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MEERIDNTKDYDVTKLTSLEKLEPVRVRPGMYIGSTGIKGLHHCIWEILDNAIDEISNGY
GDTAEVILNKDKSVTVVDNGRGIPTGIHPIKKKSGVEMVFTELHTGGKFNNSIYKTSGGL
HGVGASVVNALSEWTEVEVYQNDKIYKQRFEYALDKKLNKKMPGTPVTKLKIVGDTDKTG
TRVTFKPDKEVFSTIDFKFDVIDERLQELAFQNKGIILKLIDNRKEEPEIKEYHSERGLL
DFIDYLNESKAPIHNPAVLFEGEKEINNLKMEGEICFQFTDSSTENIASYVNNIPTTEAG
THETGFKTGMTRAFKEGAKKLSLIKEKDKEFDGDDLREGITAIVRIKISNPVFEGQTKTK
LGNNEAYTMMNDLAYSKFLEWIEDNKEVSTLIINNALAAAARREKIKKINEAEKKKIGKG
LAPLAGKIAVCTLRDSNVTEFIVVEGDSAGGSAKQARDRRFQSIMPSKGKIMNTEKQKIE
NVLGSEELKIFNTAIGTGVLDNYKEEDLKYDKIIILSDADVDGYHIRTLWMTYIYRYMKS
LVANGHLYIAMPPLYKVYKKDKKGEKSVYCYNDEELQKAKKQIGRGYLIQRYKGLGEMNP
EQLWETTLNPETRTLQRITIEDAAKAEKMVSLLMGDVVEPRKNYLYKYAEF
>ABM67077.1|FEATURES|megares|aminoglycoside|AAC(6')-Ib|antibiotic inactivation|1
MTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPI
GYAQSYVALGSGDGWWEEETDPGVRGIDQLLANASQLGKGLGTKLVRALVELLFNDPEVT
KIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSVA
>WP_011245006.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MTGQLIQYGRHRQRRSYARINEVLELPNLIEIQTASYQWFLDEGLREMFQDISPIQDFTG
NLVLEFIDYSLGEPKYPVDESKERDVTFAAPLRVKVRLINKETGEVKEQEVFMGDFPLMT
ETGTFIINGAERVIVSQLVRSPSVYYSQKLDKNGKKGFTATVIPNRGAWLELETDAKDIV
YVRIDRTRKIPVTVLLRALGFGSDQEIVDLLGENEYLRNTLEKDNTDSTDKALLEIYERL
RPGEPPTVENAKSLLESRFFDPKRYDLANVGRYKINKKLHIKNRLFNQRLAEKLVDPETG
EVLAEEGTLLDRRTLDKLIPHLEKNVGFRTARTSGGVLEESDVEIQSVKIYVADDYEGER
VISVISNGMVERDVKHIAPADIIASISYFFNLLHGVGDTDDIDHLGNRRLRSVGELLQNQ
FRIGLSRMERVVRERMSIQDPNVITPQALINIRPVIASIKEFFGSSQLSQFMDQTNPLAE
LTHKRRLSALGPGGLTRERAGMEVRDVHYSHYGRMCPIETPEGPNIGLINTLSSYAKVNE
FGFMETPYRRVDPETGKVTSRIDYLTADEEDNYVVAQANAKLNDDGSFVDDNIIARFRGE
NTVVPCDRVDYMDVSPKQVVSAATSCIPFLENDDSNRALMGANMQRQAVPLLVPEAPLVG
TGMEHVSAKDSGAAVVSKYAGIVERVTAKEIWVRRIEEVDGKETKGDLDKYKLQKFVRSN
QGTSYNQRPIVREGDRIEKREILADGPSMEMGEMALGRNVLVAFMTWDGYNYEDAIILSE
RLVKDDVYTSIHIEEYESDARDTKLGPEEITRDIPNVGEDALRNLDERGIIRIGAEVKDG
DILVGKVTPKGVTELTAEERLLHAIFGEKAREVRDTSLRAPHGGDGIVLDVKIFNREDGD
ELPPGVNQLVRVYIVQKRKINQGDKMAGRHGNKGVISRILPEEDMPFLPDGTPVDIMLNP
LGVPSRMNIGQVLELHLGMAARKLGIHVASPVFDGASEEDVWGTLEEAGMARDGKTILYD
GRTGEPFDNRVSVGIMYMIKLAHMVDDKLHARSTGPYSLVTQQPLGGKAQFGGQRFGEME
VWALEAYGAAYTLQEILTVKSDDVVGRVKTYEAIVKGENVPEPGVPESFKVLIKELQSLG
MDVKMLSSNEEEIEMRELDDEEDQTSEKLNLNLETNESQL
>AEE66654.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MATPRYTEASIRVLKGLEPVRQRPGMYTRTENPLHIVQEVIDNAADEALAGYGKQIQVTL
HGDGSISVEDDGRGIPVGLHPEENAPVVELVFTRLHAGGKFDKQGGGAYAFSGGLHGVGV
SVTNALATRLEVVVWRDGAVHRLVFAGGDVIEALAPYPEGGRKKSGTRVRVWPDAKYFDS
PAIPMAELTHLLRSKAVLLPGVKVSLVNEKTGDTRTWQYQEGLRGYLAEALAGAELMIPF
FEGQQYAGADHDSFAEGEGAQWVVAWAEDGNVVRESYVNLIPTPAGGTHESGLREGLFGA
VKGFAELHSLLPKGVKLLPEDVFTRASFVLSAKVLDPQFQGQIKERLNSRDAVRLVGCFA
KSALDLWLHSNVEYGKKLAELAIRQAQARQRSAQKVEKRKSSGVAVLPGKLTDCESSDAS
RTEVFLVEGDSAGGSAKMGRDKEFQAILPLRGKVLNSWEVDRDRLFANNEIHDISVAIGV
DPHGPGDEPDLSGLRYGRICILSDADVDGSHIQVLLLTLFYRHFPKLIEAGNVFVARPPL
FRVDVPAQGKRPARKIYCLDAGELEAAQDKLRKEGVRESAWSVSRFKGLGEMNPEQLWET
TMNPDTRRLLPVGYGDLTPGDTTRMFDMLMGKGESSQRRAWIEEKGNLAELDI
>ABR78980.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|0
MKLVAQGSTLDLSHPHVMGILNVTPDSFSDGGAHNSLIEAVKHANLMINAGATIIDIGGE
STRPGAAEVSVEEELARVIPVVEAIAQRFEVWISVDTSKAEVIRQSARAGAHIINDIRSL
TEPGALQAAAETGLPVCLMHMQGQPKTMQEAPKYEDVFADVERFFNEHIVRCEQAGIAKE
KLLLDPGFGFGKNLSHNYQLLARLGEFHHFGLPLLVGMSRKSMVGQLLNVGPSERLNGSL
ACAVIAAMQGAQIIRVHDVKETVEALRVVEATLAAKGKKRYE
>WP_001289546.1|FEATURES|resfam|quinolone|parC|antibiotic target alteration|0
MSEIIQDLSLEDVLGDRFGRYSKYIIQERALPDVRDGLKPVQRRILYAMYSSGNTHDKNF
RKSAKTVGDVIGQYHPHGDFSVYEAMVRLSQDWKLRHVLIEMHGNNGSIDNDPPAAMRYT
EAKLSLLAEELLRDINKETVSFIPNYDDTTLEPMVLPSRFPNLLVNGSTGISAGYATDIP
PHNLAEVIQATLKYIDNPDITVNQLMKYIKGPDFPTGGIIQGIDGIKKAYESGKGRIIVR
SKVEEETLRNGRKQLIITEIPYEVNKSSLVKRIDELRADKKVDGIVEVRDETDRTGLRIA
IELKKDVNSESIKNYLYKNSDLQISYNFNMVAISDGRPKLMGIRQIIDSYLNHQIEVVAN
RTKFELDNAEKRMHIVEGLIKALSILDKVIELIRSSKNKRDAKENLIEVFEFTEEQAEAI
VMLQLYRLTNTDIVALEGEHKELEALIKQLRHILDNHDALLNVIKEELNEIKKKFKSERL
SLIEAEIEEIKIDKEVMVPSEEVILSMTRHGYIKRTSIRSFNASGVEDIGLKDGDSLLKH
QEVNTQDTVLVFTNKGRYLFIPVHKLADIRWKELGQHVSQIVPIEEDEVVINVFNEKDFN
TDAFYVFATQNGMIKKSTVPLFKTTRFNKPLIATKVKENDDLISVMRFEKDQLITVITNK
GMSLTYNTSELSDTGLRAAGVKSINLKAEDFVVMTEGVSENDTILMATQRGSLKRISFKI
LQVAKRAQRGITLLKELKKNPHRIVAAHVVTGEHSQYTLYSKSNEEHGLINDIHKSEQYT
NGSFIVDTDDFGEVIDMYIS
>ABB62915.1|FEATURES|megares|multidrug|emrR|antibiotic efflux|0
MDSSFTPIEQMLKFRASRHEDFPYQEILLTRLCMHMQSKLLENRNKMLKAQGINETLFMA
LITLESQENHSIQPSELSCALGSSRTNATRIADELEKRGWIERRESDNDRRCLHLQLTEK
GHEFLREVLPPQHNCLHQLWSALSTTEKDQLEQITRKLLSRLDQMEQAGVVLEAMS
>CAJ65910.1|FEATURES|megares|sulfonamide|sul2|antibiotic target replacement|1
MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVS
SDTEIARIAPVLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDAAFYPQLAK
SSAKLVVMHSVQDGQARSARGHPLATFMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGF
FLGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAA
AGGADFIRTHEPRPLRDGLAVLAALKETARIR
>AGS61245.1|FEATURES|megares|quinolone|rpoB|antibiotic target alteration|0
MVYSYTEKKRIRKDFGKRPQVLDVPYLLSIQLDSFQKFIEQDPDGQNGLEAAFRSVFPIQ
SYSGNAELQYVSYRLGEPVFDVKECQIRGVTYSAPLRVKLRLVIYEREAPEGTVKDIKEQ
EVYMGEIPLMTDNGTFVINGTERVIVSQLHRSPGVFFDSDKGKTHSSGKVLYNARIIPYR
GSWLDFEFDPKDNLFVRIDRRRKLPATIILRAMNYSTEDILNLFFEKTTFEISNNKLMMT
LVPERLRGETASFDIEANGKVYVEKGRRITARHIRQLEKEQIERIEVPVEYIAGKVVARD
YIDEATGELICAANMEISLDVLARLSQAGHKTIETLFTNDLDHGAYISETIRVDPTNDRL
SALVEIYRMMRPGEPPTREAAENLFENLFFSEDRYDLSAVGRMKFNRSLGREEVEGSGIL
SQEDIIEVMKKLIDIRNGKGEVDDIDHLGNRRIRSVGEMAENQFRVGLVRVERAVKERLS
LGDLDALMPQDMINAKPISAAVKEFFGSSQLSKFMDQNNPLSEITHKRRISALGPGGLTR
ERAGFEVRDVHPTHYGRVCPIETPEGPNIGLINSLSVYAQTNEYGFLETPYRVVENNAVT
DEIHYLSAIEEGNFIIAQANSVLDDDGHFVEELVTCRHKGESSLFSRDQVQYMDVSTQQV
VSVGASLIPFLEHDDANRALMGANMQRQAVPTLRGDKPLVGTGMERAVAVDSGVTAVAKR
GGTVQYVDASRIVIKVNEDETYAGEAGIDIYSLTKYTRSNQNTCINQTPCVSLGEPVERG
DVLADGPSTDLGELALGQNMRVAFMPWNGYNYEDSILVSERVVQEDRFTTIHIQELACVS
RDTKLGPEEITADIPNVGEAALSKLDESGIVYIGAEVKGGDILVGKVTPKGETQLTPEEK
LLRAIFGEKASDVKDSSLRVPNGVSGTVIDVQVFTRDGVEKDKRALEIEESQLREVKKDL
TEELRIFEAGLFARIRGVLIAGGIEADKLDKLPRERWLELGLADEEKQNQLEQLAEQYDE
LKAEFAKKLEAKRRKITQGDDLAPGVLKIVKVYLAVKRQIQPGDKMAGRHGNKGVISKIN
PIEDMPYDENGNPVDLVLNPLGVPSRMNIGQILETHLGMAAKGIGDKINAMLKQQQEVAK
LREFIQKAYDLGMAPRQKVDLDTFSDEEVLRLAENLKKGMPTATPVFDGAEEMEIKEMLK
LADLPTSGQITLFDGRTGEQFERPVTVGYMYMLKLNHLVDDKMHARSTGSYSLVTQQPLG
GKAQFGGQRFGEMEVWALEAYGAAYTLQEMLTVKSDDVNGRTKMYKNIVDGNHQMEPGMP
ESFNVLLKEIRSLGINIELEDE
>AAU95769.1|FEATURES|megares|multidrug|mepB|antibiotic efflux|0
MCKSKILLKNIFSEESEVKDLTEEKYNQDYEALTFSFKEETYQSRLAKKTPTKSGYFVTC
WTKDEDNYNRPYKIEEFADYLIVAVIDDELNGYFLFPRELLVEKGILASSKYQGKMAFRV
YPKWCNQLNKTAGQTQKWQCKYFFEY
>AAA26780.1|FEATURES|megares|macrolide-lincosamide-streptogramin|mgt|antibiotic inactivation|1
MKRKELHETSRLAYGRRMTTRPAHIAMFSIALHGHVNPSLEVIRELVARGHRVTYAIPRL
LADKVAEAGAEPKLWNSTLPGPDADPEAWGSTLLDNVEPFLADAIQSLPQLAQAYEGDEP
DLVLHDIASYTARVLGRRWEVPVISLSPCMVAWEGYEQEVGEPMWEEPRKTERGQAYYAR
FHAWLEENGITDHPDPFIGRPDRSLVLIPKALQPHADRVDETTYTFVGACQGDRTAEGDW
ARPEGAEKVVLVSLGSAFTKQPAFYRECVRAFGELPGWHTVLQVGRHVDPAELGDVPDNV
EVRTWVPQLAILQQADLFVTHAGAGGSQEGLATATPMIAVPQAADQFGNADMLQGLGVAR
TLPTEEATAKALRTAALALVDDPEVAARLKEIQARMAQEAGTRGPADLIEAELAAARG
>AAK44229.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MTDTTLPPDDSLDRIEPVDIQQEMQRSYIDYAMSVIVGRALPEVRDGLKPVHRRVLYAMF
DSGFRPDRSHAKSARSVAETMGNYHPHGDASIYDTLVRMAQPWSLRYPLVDGQGNFGSPG
NDPPAAMRYTEARLTPLAMEMLREIDEETVDFIPNYDGRVQEPTVLPSRFPNLLANGSGG
IAVGMATNIPPHNLRELADAVFWALENHDADEEETLAAVMGRVKGPDFPTAGLIVGSQGT
ADAYKTGRGSIRMRGVVEVEEDSRGRTSLVITELPYQVNHDNFITSIAEQVRDGKLAGIS
NIEDQSSDRVGLRIVIEIKRDAVAKVVINNLYKHTQLQTSFGANMLAIVDGVPRTLRLDQ
LIRYYVDHQLDVIVRRTTYRLRKANERAHILRGLVKALDALDEVIALIRASETVDIARAG
LIELLDIDEIQAQAILDMQLRRLAALERQRIIDDLAKIEAEIADLEDILAKPERQRGIVR
DELAEIVDRHGDDRRTRIIAADGDVSDEDLIAREDVVVTITETGYAKRTKTDLYRSQKRG
GKGVQGAGLKQDDIVAHFFVCSTHDLILFFTTQGRVYRAKAYDLPEASRTARGQHVANLL
AFQPEERIAQVIQIRGYTDAPYLVLATRNGLVKKSKLTDFDSNRSGGIVAVNLRDNDELV
GAVLCSADDDLLLVSANGQSIRFSATDEALRPMGRATSGVQGMRFNIDDRLLSLNVVREG
TYLLVATSGGYAKRTAIEEYPVQGRGGKGVLTVMYDRRRGRLVGALIVDDDSELYAVTSG
GGVIRTAARQVRKAGRQTKGVRLMNLGEGDTLLAIARNAEESGDDNAVDANGADQTGN
>AVH49725.1|FEATURES|megares|tetracycline|tetR|antibiotic efflux|0
MSKKDIAPQRLTREIVLRTALDMLNEEGIDSITTRKLAQRLGIKSPTLYWHFKNKSLLME
AMAETIINEHHLVSLPIDGMTWQDWLLANSVSFRRALLAYRDGARLHARTSPSQGHFNTI
EAQVALLSHAGFSPVEAVALLMTLGRFIVGWVLEEQQEEIRSDPPFEADPTIYPLMLQGV
NTLQNMNADDIFENGIRMVIIGAERQLDIKMQT
>YP_002344422.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MENIFSKDSDIELVDIENSIKSSYLDYSMSVIIGRALPDARDGLKPVHRRILYAMQNDEA
KSRTDFVKSARIVGAVIGRYHPHGDTAVYDALVRMAQDFSMRYPSITGQGNFGSIDGDSA
AAMRYTEAKMSKLSHELLKDIDKDTVDFVPNYDGSESEPDVLPSRVPNLLLNGSSGIAVG
MATNIPPHSLNELIDGLLYLLDNKDASLEEIMQFIKGPDFPTGGIIYGKKGIIEAYRTGR
GRVKVRAKTHIEKKTNKDVIVIDELPYQTNKARLIEQIAELVKERQIEGISEVRDESNKE
GIRVVIELKREAMSEIVLNNLFKSTTMESTFGVIMLAIHNKEPKIFSLLELLNLFLTHRK
TVIIRRTIFELQKARARAHILEGLKIALDNIDEVIALIKNSSDNNTARDSLVAKFGLSEL
QANAILDMKLGRLTGLEREKIENELAELMKEIARLEEILKSETLLENLIRDELKEIRSKF
DVPRITQIEDDYDDIDIEDLIPNENMVVTITHRGYIKRVPSKQYEKQKRGGKGKLAVTTY
DDDFIESFFTANTHDTLMFVTDRGQLYWLKVYKIPEGSRTAKGKAVVNLINLQAEEKIMA
IIPTTDFDESKSLCFFTKNGIVKRTNLSEYQNIRSVGVRAINLDENDELVTAIIVQRDED
EIFATGGEENLENQEIENLDDENLENEESVSTQGKMLFAVTKKGMCIKFPLAKVREIGRV
SRGVTAIKFKEKNDELVGAVVIENDEQEILSISAKGIGKRTNAGEYRLQSRGGKGVICMK
LTEKTKDLISVVIVDETMDLMALTSSGKMIRVDMQSIRKAGRNTSGVIVVNVENDEVVSI
AKCPKEENDEDELSDENFGLDLQ
>WP_001300761.1|FEATURES|megares|polymyxin|PmrB|antibiotic target alteration|0
MHFLRRPISLRQRLILTIGAILLVFELISVFWLWHESTEQIQLFEQALRDNRNNDRHIMR
EIREAVASLIVPGVFMVSLTLFICYQAVRRITRPLAELQKELEARTADNLTPIAIHSATL
EIEAVVSALNDLVSRLTSTLDNERLFTADVAHELRTPLAGVRLHLELLAKTHHIDVAPLV
ARLDQMMESVSQLLQLARAGQSFSSGNYQHVKLLEDVILPSYDELSTMLDQRQQTLLLPE
SAADITVQGDATLLRMLLRNLVENAHRYSPQGSNIMIKLQEDDGAVMAVEDEGPGIDESK
CGELSKAFVRMDSRYGGIGLGLSIVSRITQLHHGQFFLQNRQETSGTRAWVRLKKDQYVA
NQI
>EJR79613.1|FEATURES|megares|macrolide-lincosamide-streptogramin|mph|antibiotic inactivation|1
MNTLKVKQLANKEGLNILEDSIEINESGVDFQVAHVKEQNGDKWILRIPRRRESMRHALR
EKEALEIMKKHAEFQVPDWSIFSEELIAYKQLSGVPAATIDIEQQGYIWTFNEKDVPTEY
YISLGKVLANLHSLPQQKFNSIGVEILTANELRTSMKQRMNRVKEQYHINQNLWDRWQAW
LAEDSFWPSHVGVKHGDIHPGHILIDNKNKVTGLIDWTEVGIGDVSIDFTSHYLLFGKDG
LTKLIHSYDNAGGKTWSRMDEHIIELLTTSSITVAEYAQVSGLKDMHEIAVHMLSTES
>ACJ63263.1|FEATURES|megares|beta_lactam|OXA|antibiotic inactivation|0
MKEKVVVDKAISLYTESFGDPAHEPIILIMGAMSSAVWWPDEFCSQLAKMGRYVIRYDHR
DTGKSTSYEPGQAPYSVEELADDVVRVIDGYGLEAAHLVGMSLGGFLSQLVALKYPKRVK
SLTLIASERLADADPDMPAFDPAIIEYHQRAESLDWSDRDAVVAYQVGAWRINSGTAHAF
DAEKIQNIAELNFDRTPNILTTFNHTTLGGGERWLGRLNEIAVPTLIIHGTEDPVLPYVH
GLALKDAIRGSKMLTLEGTGHELHHEDWPRIIQAIKGQTS
>CAC16665.1|FEATURES|megares|beta_lactam|BLAZ|antibiotic inactivation|1
MKKLIFLIAIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKIHINKDDIVAYSPILEKYVGKDITLKELIEASMAY
SDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKENKKFLLDLMLNNKSGDTLIKDGVSKDCKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>WP_001176042.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|0
MQLISLPKQILQCGQLQLDLSQPHVMGILNVTPDSFSDGGKHNQLDQAVDHALSMIEQGA
TIIDIGGESTRPGASEVVVEEEVRRVVPVVEALSYHNVILSIDTSQPEVIRAAKAAGAHI
WNDVRALTRPNALKTAVELDIPVVIMHMRGEPTTMNQLDQYTDVTLDVMQELQQRIDEAL
AAGVKKHNIIVDPGFGFAKNAQQNLKLLKEFWKLNELGYPILSGLSRKRFIGEALQGVPA
DQRAVGSVTGHLLSIQQGASIVRAHDVKEMHEAILVWKAMQQA
>AAM21660.1|FEATURES|megares|sulfonamide|sul2|antibiotic target replacement|1
MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVS
SDTEIARIAPVLDALKADGIPVSLDSYHPATQAYALSRGVAYLNDIRGFPDAAFYPQLAK
SSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFF
LGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAAA
GGADFIRTHEPRPLRDGLAVLAALKETARIR
>EHL91134.1|FEATURES|megares|fosfomycin|FosA5|antibiotic inactivation|1
MLSGLNHLTLAVSQLAPSVAFYQQLLGMTLHARWDSGAYLSCGDLWLCLSLDPQRRVTPP
EESDYTHYAFSISEADFASFAARLEAAGVAIWKLNRSEGASHYFLDPDGHKLELHVGSLA
QRLAACREQPYKGMVFFAE
>WP_001047619.1|FEATURES|megares|multidrug|mexT|antibiotic efflux|0
MNLERVDLNLLIYLDVLLREKNVTRAAEQLGVTQPAMSNILRRLRNLFNDPLLIRSSEGM
TPTERALELQPRIRDALSDLSMILEPRTEFRPYTSNRVFRIMTSDYAEATLVPRLVKALR
SEAPNVVLDFLTPSDVSYRDMEQGKVDLAINRFNEIPQSFHQVLVWRDSFSCILNDKHPA
VTHLNLKSYLDAQHIWVSKTGMGVGFGVNPDKQGGLGWIDQALERIGQRRKISVFTRHYQ
MPALLAQNVDLIATLPTRMARLQAQNPKLVIKDPPFYIPEFELKMAWCPLLHHHPAHRWL
RQLILFVARQMIEEENREFLTNNSQFSHY
>NP_358351.1|FEATURES|megares|aminoglycoside|parC|antibiotic target alteration|0
MYLMSNIQNMSLEDIMGERFGRYSKYIIQDRALPDIRDGLKPVQRRILYSMNKDSNTFDK
SYRKSAKSVGNIMGNFHPHGDSSIYDAMVRMSQNWKNREILVEMHGNNGSMDGDPPAAMR
YTEARLSEIAGYLLQDIEKKTVPFAWNFDDTEKEPTVLPAAFPNLLVNGSTGISAGYATD
IPPHNLAEVIDAAVYMIDHPTAKIDKLMEFLPGPDFPTGAIIQGRDEIKKAYETGKGRVV
VRSKTEIEKLKGGKEQIVITEIPYEINKANLVKKIDDVRVNNKVAGIAEVRDESDRDGLR
IAIELKKDANTELVLNYLFKYTDLQINYNFNMVAIDNFTPRQVGIVPILSSYIAHRREVI
LARSRFDKEKAEKRLRIVEGLIRVISILDEVIALIRASENKADAKENLKVSYDFTEEQAE
AIVTLQLYRLTNTDVVVLQEEEAELREKIAMLAAIIGDERTMYNLMKKELREVKKNFATP
RLSSLEDTAKAIEIDTASLIAEEDTYVSVTKAGYIKRTSPRSFAASTLEEIGKRDDDRLI
FVQSAKTTQHLLMFTSLGNVIYRPIHELADIRWKDIGEHLSQTITNFETNEAILYVEVLD
QFDDATTYFAATRLGQIKRVERKEFTPWRTYRSKSVKYAKLKDDTDQIVAVAPIKLDDVV
LVSQNGYALRFNIEEVPVVGAKAAGVKAMNLKEDDVLQSGFICNTSSFYLLTQRGSLKRV
SIEEILATSRAKRGLQVLRELKNKPHRVFLAGAVAEQGFVGDFFSTEVDVNDQTLLVQSN
KGTIYESRLQDLNLSERTSNGSFISDTISDEEVFDAYLQEVVTEDK
>AGJ50602.1|FEATURES|megares|beta_lactam|pbp2|antibiotic target replacement|0
LSNNDYRKLTNNKKEPLLNKFQITTSPGSTQKILTSIIALKENKLDKNTNFDIYGKGWQK
DASWGNYNITRFKVVNGNIDLKQAIX
>ADI55020.1|FEATURES|megares|beta_lactam|PER-1|antibiotic inactivation|1
MNVIIKAVVTASTLLMVSFSSFETSAQSPLLKEQIESIVIGKKATVGVAVWGPDDLEPLL
INPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWAPIMKAYQGDEF
SVPVQQLLQYSVSHSDNVACDLLFELVGGPAALHDYIQSMGIKETAVVANEAQMHADDQV
QYQNWTSMKGAAEILKKFEQKTQLSETSQALLWKWMVETTTGPERLKGLLPAGTVVAHKT
GTSGIKAGKTAATNDLGIILLPDGRPLLVAVFVKDSAESSRTNEAIIAQVAQTAYQFELK
KLSALSLN
>AAF85648.1|FEATURES|megares|beta_lactam|mecA|antibiotic target replacement|0
IDGKGWQKDKSWGGYNVTRYEVVNGNIDLKQAIESSDNIFFARVALELGSKKFEKGMKKL
GVGEDIPSDYPFYNAQISNKNLDNEILLADSGYGQGEILINPVQILSIYSALENNGNINA
PHLLKDTKNKVWKKNIISKENINLLTDGMPQVVNKTHKEDIYRSYANLIGKSGTAELKMK
QGETGRQIGWFISYDKDNPNMMMAINVKDVQDKGMASYNAKISGKVYDELYENGNKKYDI
DE
>CCQ20405.1|FEATURES|megares|multidrug|MepA|antibiotic efflux|0
MKHSDNYYLTKASIPKAIAHLSIPMMLGMSVGVIYNIVNAFFIGLLHDTSMLTAVTLGLP
MFTILMAIGNMFGVGGGTYISRLLGKEEGTKAKQVSAFVLYGSLVAF
>ABB62496.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MSDLAREITPVNIEEELKSSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAMNVLGNDWN
KAYKKSARVVGDVIGKYHPHGDSAVYDTIVRMAQPFSLRYMLVDGQGNFGSIDGDSAAAM
RYTEIRLAKIAHELMADLEKETVDFVDNYDGTEKIPDVMPTKIPNLLVNGSSGIAVGMAT
NIPPHNLTEVINGCLVYIDDEDISIEGLMEHIPGPDFPTAAIINGRRGIEEAYRTGRGKV
YIRARAEMEVDAKTGRETIIVHEIPYQVNKARLIEKIAELVKEKRVEGISALRDESDKDG
MRIVIEVKRDAVGEVVLNNLYSQTQLQVSFGINMVALHHGQPKIMNLKDIIAAFVRHRRE
VVTRRTIFELRKARDRAHILEALAVALANIDPIIELIRHAPTPAEAKTALVANPWQLGNV
AAMLERAGDDAARPEWLEPEFGVRDGLYYLTEQQAQAILDLRLQKLTGLEHEKLLDEYKE
LLDQIAELLRILGSADRLMEVIREELELVREQFGDKRRTEITANSADINLEDLITQEDVV
VTLSHQGYVKYQPLSEYEAQRRGGKGKSAARIKEEDFIDRLLVANTHDHILCFSSRGRVY
SMKVYQLPEATRGARGRPIVNLLPLEQDERITAILPVTEFEEGVKVFMATANGTVKKTVL
TEFNRLRTAGKVAIKLVEGDELIGVDLTSGEDEVMLFSAEGKVVRFKESSVRAMGCNTTG
VRGIRLGEGDKVVSLIVPRGDGAILTATQNGYGKRTAVAEYPTKSRATKGVISIKVTERN
GLVVGAVQVDDCDQIMMITDAGTLVRTRVSEISIVGRNTQGVILIRTAEDENVVGLQRVA
EPVDEEDLDTIDGSAAEGDDEIAPEVDVDDEPEEE
>WP_011767147.1|FEATURES|megares|quinolone|rpoB|antibiotic target alteration|0
MAYSYTEKKRIRKSFAKRAAVLDAPFLLATQIESFASFLQAETPPESRYNQGLQAAFTSI
FPISSHSGNARLEFVQYMLGEPAFDVKECQQRGLTFASPLRARVRLVIMDREAPKETIKE
VKEQEVYMGEIPLMTTTGSFVINGTERVIVSQLHRSPGVFFEHDRGKTHSSGKLLFSARI
IPYRGSWLDFEFDPKDYLYFRVDRRRKMPVTILLRAIGMTPEEILETFHDFDAFHLSAEG
AQFELVPDRLRGEVARFDIVDPTGKVIVARDKRITAKHIRELDQAGIKMIGVPDDFVLGR
IIARNVVDPETGELLARANEEITEDLLGKLRDAGVRDLVTLYVNDLDRGAYISSTLRIDE
TADQWAARVAIYRMMRPGEPPTEEAVEALFQGLFYAPERYDLSTVGRMKFNRRAYPEKID
DKAPGWLKRFYDKVGPHGEEGEGVLANEDILAVIGVLVELRNGRGEIDDIDHLGNRRVRS
VGELAENQFRAGLVRVERAVKERLSQAESDNLMPHDLINAKPISAAIKEFFGSSQLSQFM
DQTNPLSEITHKRRVSALGPGGLTRERAGFEVRDVHPTHYGRVCPIETPEGPNIGLINSL
AVYARTNRHGFLETPYRKVTDGKVTDQIDFLSAIEEGQYVIAQANAEIGGDGALEGDLVS
CRHKGEFMLATADQVQYMDVAPGQIVSVAASLIPFLEHDDANRALMGANMQRQAVPCLRP
EKPLVGTGIERTVAVDSGTAVQAMRGGVVDYVDAQRVVVRVNDNEALAGEVGVDIYNMIK
YTRSNQNTNINQRPVVRVGDLIAKGDVIADGASTDLGELALGQNMLVAFMPWNGYNFEDS
ILISERVVADDRFTSIHVEELTVVARDTKLGPEEITRDIASLGEAQLSRLDESGIVYIGA
EVEAGDVLVGKVTPKGETQLTPEEKLLRAIFGEKASDVKDTSLRVPSGMTGTVIDVQVFT
REGIERDKRAQSIIDDQLRSFKTDLADQMRIVERDAFARIQRMIVGQKANGGPKKLAKGA
AITAEYLETLEFYHWFDIRMADEELAIQLEAVREGLEKTRKDFEQAFEIKKKKLTQGDEL
PPDVQKMVKVYLAVKRRLQPGDKMAGRHGNKGVVSKIVPVEDMPYMEDGTPVDIVLNPLG
VPSRMNIGQILETHLGWAAKGLGQKIDRLLRANAAAGEVRGLLEEIYNGSGKPEDFSEFT
DGDVIELATNLKKGVPFATPVFDGAKEEEIAKMLELAGLPVGGQVTLFDGRTGEAFERKV
TVGYKHVLKLHHLVDDKMHARSTGPYSLVTQQPLGGKAQFGGQRFGEMEVWALEAYGAAY
TLQEMLTVKSDDVTGRTKVYENIVKGEHKIDSGMPESFNVLVKEIRSLAIDIDLDRE
>AAK91783.1|FEATURES|megares|macrolide-lincosamide-streptogramin|vatE|antibiotic inactivation|1
MTIPDANAIYPNLAIKEVVFIKNVIKSPNIEIGDYTYYDDPVNPTDFEKHVTHHYEFLGD
KLIIGKFCSIASGIEFIMNGANHVMKGISTYPFNILGGDWQQYTPELTDLPLKGDTVVGN
DVWFGQNVTVLPGVKIGDGAIIGANSVVTKDVAPYTIVGGNPIQLIGPSFEPEVIQALEN
LAWWNKDIEWITANVPKLMQTTPTLELINSLMEK
>CAD57667.1|FEATURES|megares|multidrug|floR|antibiotic efflux|1
MTTTRPAWAYTLPAALLLMAPFDILASLAMDIYLPVVPAMPGILNTTPAMIQLTLSLYMV
MLGVGQVIFGPLSDRIGRRPILLAGATAFVIASLGAAWSSTAPAFVAFRLLQAVGASAML
VATFATVRDVYANRPEGVVIYGLFSSILAFVPALGPIAGALIGEFLGWQAIFITLAILAM
LALLNAGFRWHETRPLDQVKTRRSVLPIFASPAFWVYTVGFSAGMGTFFVFFSTAPRVLI
GQAEYSEIGFSFAFATVALVMIVTTRFAKSFVARWGIAGCVARGMALLVCGAVLLGIGEL
YGSPSFLTFILPMWVVAVGIVFTVSVTANGALAEFDDIAGSAVAFYFCVQSLIVSIVGTL
AVALLNGDTAWPVICYATAMAVLVSLGLVLLRLRGAATEKSPVV
>BAB43879.1|FEATURES|megares|beta_lactam|BLAZ|antibiotic inactivation|1
LKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMTY
SDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKKNKNFLLDLMFNNKNGDTLIKDGVPKDYKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>AJG06173.1|FEATURES|megares|beta_lactam|blc|antibiotic inactivation|0
MRILPVIAAVTAAFLVVACSSPTPPPSVTVVSNFDAQRFLGTWYEIARMDHQFERGLEKV
TASYSARDDGGIQVINR
>ADQ43422.1|FEATURES|megares|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGPAIRTPHARLWPVLTAAGEPAMLKISSETEEQNSHRLLRWWNGDG
AARLLAHEGPAILIERARGDSLRQRSIEGDDDACTAILCQVLQRLHRPRSAPPAELVCLR
RWFADLLQPRAVLPPLLEQCRSLAEGLLRDEQEIRPLHGDLHHDNVLDFGPRGWLAIDPK
RLLGDRAFDYATMFSNPDLCGPGIHVATRPERFAIRLEQVCALAELERTRLLRWIAASTA
LSAVWFRDDGDPADIDETVARMALEALAEA
>ADY20942.1|FEATURES|megares|macrolide-lincosamide-streptogramin|mph|antibiotic inactivation|1
MTTLKVKQLANKKGLNILEDSIEINESGVDFQVAHVTEQNGDKWILRIPRRPESMRHALR
EKEALEIMKKHAAFQVPNWSIFSEELIAYKQLNGFPAATIDIEQQRYVWNFNEKNVPIEY
YISLGKVLANVHSLPQQKFNNIGVEILIANELRTSMQQRMNRVKEQYHINQNLWDRWQAW
LAEDSFWPSHVGVKHGDIHPGHILIDKKNNVTGLIDWTEVGIGDVSIDFTSHYLLFGKDG
LTKLIHSYDNAGGKTWSRMDEHIIELLTTSSITVAEYAQVSGLKDMHEAAIHMLATEC
>CAC42502.1|FEATURES|megares|tetracycline|tetA|antibiotic efflux|1
MPVLPGLLRDLVHSNDVTAHYGILLALYALMQFACAPVLGALSDRFGRRPVLLVSLAGAA
VDYAIMATAPFLWVLYIGRIVAGITGATGAVAGAYIADITDGDERARHFGFMSACFGFGM
VAGPVLGGLMGGFSPHGPFFAAAALNGLNFLTGCFLLPESHKGERRPLRREALNPLASFR
WARGMTVVAALMAVFFIMQLVGQVPAALWVIFGEDRFHWDATTIGISLAAFGILHSLAQA
MITGPVAARLGERRALMLGMIADGTGYILLAFATRGWMAFPIMVLLASGGIGMPALQAIL
SRQVDEERQGQLQGSLAALTSLTSIVGPLLFTAIYAASITTWNGWAWIAGAALYLLCLPA
LRRGLWSGAGQRADR
>ABB02504.1|FEATURES|megares|tetracycline|tet39|antibiotic efflux|1
IGRIFAGITGANMAVATAYVSDITPAHERAKRFGLLGAVFGIGFIAGPVIGGVLGEWNLH
APFFAAAFMNGINLIMTAVLLKESKHSNKMTEKVQEQSILKKLSYLITQPNMAPLLGIFL
IITLVSQVPATLWVIYGQDRYGWSIFIAGVSLASYGICHSIAQAFAIAPMVKRFGEKNTL
LCGIACDAIGLLLLSIAVEEWVPFALLPLFALGGVAVPALQAMMS
>CAH15608.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MVYLAKEVLPVNIEDELKQSYLDYAMSVIVGRALPDVRDGLKPVHRRVLFAMSELGNDWN
KPYKKSARVVGDVIGKYHPHGDTAVYDTIVRMAQPFSMRYMLIDGQGNFGSVDGDAPAAM
RYTEVRMSKVAHALLADLDKETVDFSPNYDETEFAPVVLPSRIPNLLVNGSSGIAVGMAT
NIPPHNLTEVINACIALVDEPDTSLEDLMEIIPGPDFPTAAIINGRAGIIEGYRTGKGRV
VIRARTEIETDESSGRQSIIIQELPYQVNKARLIERIAELVRDKKIEGISGLRDESDKQG
MRVVIELKRNEVADVVLNNLFAHTQMQNVFGINMVALVDGQPRTLNLKQILEYFIKHRRE
VVTRRTIFELKKARNRAHLLEGLGIALANIDEMIALIKQSSTPQDAKSALLSKIWQPGLV
KAMLEKAGSNASRPDDLTEEYGLHENGYKLSEAQAQAILELRLHRLTALEQDKIINEFEE
LLNLIKELLDILASPERLMQVIRDELIEIKSQFGDERRTEITASQEDLTIEDLITEEDVV
VTLSHQGYVKYQPITAYQAQRRGGKGKSATHVKDEDFVERLVIASTHDTLLCFSNHGKLY
WLKAYQLPQASRASRGRPIINILPLAEGEEINAMLPVREYKDGSYVFMATKKGTVKKVPL
NAFSRPRSNGIIAVDLEEDDSLVGVDITDGARDIMLFTDAGKVIRFDESKVRPMGRTARG
VRGIRVEKDQAVKSLVVVDPSGGTILTATENGYGKRTHIDEYRVSGRGGQGVISIQVTER
NGKVVRSLQVTDNDEAMLITDKGTLVRFKVNELSVIGRNTQGVRLINVSSGEAVVGMQKI
VDLGEELEEAEDSSLNAEDSSDE
>ACH52168.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MVYSYTEKKRIRKDFGKRPQVLDVPYLLSIQLDSFQKFIEQDPEGQYGLEAAFRSVFPIQ
SYSGNSELQYVSYRLGEPVFDVQECQIRGVTYSAPLRVKLRLVIYEREAPEGTVKDIKEQ
EVYMGEIPLMTDNGTFVINGTERVIVSQLHRSPGVFFDSDKGKTHSSGKVLYNARIIPYR
GSWLDFEFDPKDNLFVRIDRRRKLPATIILRALNYTTEQILDLFFEKVVFEIRDNKLQME
LIPERLRGETASFDIEANGKVYVEKGRRITARHIRQLEKDDIKHIEVPVEYIAGKVVSKD
YVDESTGELICAANMELSLDLLAKLSQSGHKRIETLFTNDLDHGPYISETVRVDPTNDRL
SALVEIYRMMRPGEPPTREAAESLFENLFFSEDRYDLSAVGRMKFNRSLLRDEIEGSGIL
SKDDIIDVMKKLIDIRNGKGEVDDIDHLGNRRIRSVGEMAENQFRVGLVRVERAVKERLS
LGDLDTLMPQDMINAKPISAAVKEFFGSSQLSQFMDQNNPLSEITHKRRISALGPGGLTR
ERAGFEVRDVHPTHYGRVCPIETPEGPNIGLINSLSVYAQTNEYGFLETPYRRVVDGVVT
DEIHYLSAIEEGNYVIAQANSNLDDEGHFVEDLVTCRSKGESSLFSRDQVDYMDVSTQQV
VSVGASLIPFLEHDDANRALMGANMQRQAVPTLRADKPLVGTGMERAVAVDSGVTAVAKR
GGTVQYVDASRIVIKVNEDEMYPGEAGIDIYNLTKYTRSNQNTCINQMPCVSLGEPVERG
DVLADGPSTDLGELALGQNMRVAFMPWNGYNFEDSILVSERVVQEDRFTTIHIQELACVS
RDTKLGPEEITADIPNVGEAALSKLDESGIVYIGAEVTGGDILVGKVTPKGETQLTPEEK
LLRAIFGEKASDVKDSSLRVPNGVSGTVIDVQVFTRDGVEKDKRALEIEEMQLKQAKKDL
SEELQILEAGLFSRIRAVLVSGGVEAEKLDKLPRDRWLELGLTDEEKQNQLEQLAEQYDE
LKHEFEKKLEAKRRKITQGDDLAPGVLKIVKVYLAVKRRIQPGDKMAGRHGNKGVISKIN
PIEDMPYDENGTPVDIVLNPLGVPSRMNIGQILETHLGMAAKGIGDKINAMLKQQQEVAK
LREFIQRAYDLGADVRQKVDLSTFSDDEVLRLAENLRKGMPIATPVFDGAKEAEIKELLK
LGDLPTSGQITLFDGRTGEQFERPVTVGYMYMLKLNHLVDDKMHARSTGSYSLVTQQPLG
GKAQFGGQRFGEMEVWALEAYGAAYTLQEMLTVKSDDVNGRTKMYKNIVDGNHQMEPGMP
ESFNVLLKEIRSLGINIELEDE
>AAN75468.1|FEATURES|megares|aminocoumarin|gyrB|antibiotic target alteration|0
MYIGSTGERGLHHLVQELVDNSVDEALAGVADRIDVTILADGGVRVVDNGRGIPVGTHPV
EKRPAVEVVLTVLHAGGKFGGGGYAVSGGLHGVGLSVVNALSTRLSAEIWTDGYRWTQDY
RDGAPTAPLARHEATSRTGTSLTFWADGDIFETTEYSFETLARRFQEMAFLNRGLTLTLT
DERPSARATAAADEADSDPAAKTVSYRYDGGITDFVAYLNSRKGEPAHPSVITIAAEDTE
RLLSAEVALQWNGQYTDSVYSYANGIHTHEGGTHEEGFRTALTTVVNRYAREKKLLREKD
ANLSGEDVREGLTAIISVKLGEPQFEGQTKTKLGNTEARTFVQKIVHEHLTDWFDRNPNE
AADIVRKAIQAATARVAARKARDLTRRKGLLETAALPGKLSDCQSNDPAMSEIFVVEGDS
AGGSAKSGRNPQYQAILPIRGKILNVEKARIDKILHNQEIQALISAFGTGVHEDFDIAKL
RYHKIILMADADVDGQHINTLLLTFLFRFMRPLVEEGHVYLSRPPLYKIKWGRDHVEYAY
SDRERDVLLERGRQDGRRIKDDSIQRFKGLGEMNAEELRVTTMDPDHRVLGQVTLDDAAV
ADDLFSVLMGEDVEARRHFIQRNAKDVRFLDI
>ABQ57180.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MKKIPNMNEVTEKKPLTEFTEKAYLDYSMYVILDRALPSIADGLKPVQRRIVYAMSELGL
KATAKYKKSARTVGDVLGKFHPHGDSACYEAMVLMAQPFSYRYPFVDGQGNWGSPDDPKS
FAAMRYTEARLSLYADVLLGELLQGTVDWVDNFDGTLQEPALLPARLPNILLNGATGIAV
GMASDILPHNLTEVANACIHLLDNPQADIKTICEYIKGPDFPTEAEIISPSETIRAMYES
GNGSIKMRAIYAQEKQNIVITALPYQVSGARVMEQIALQMQQKKLPMVEDLRDESDHEHP
TRLVIIPRSNRVDIESLMSHLFATTDLERSYRVNFNMIGLDGKPRVKGLLAILTEWLEFR
LTTVKRRLQFRLEKVLERIHILEGLLIAYLNIDEVIAIIREHEQPKQGLISRFNLTERQA
EAILEMKLRHLAKLEEIKLRGELDELSDERDTLQKTLASHSLLKELVKEEITKDRDEFGD
PRRSPIITREDSQALKEEDILPNEPITVVLSKNGWVRAAKGHDVDGKELSYKAGDEFKAQ
TLARTNQQVLFFDGEGKVYSLPGHALPSARGQGEPLTGKLNPAEGVLFEAIVGGEPEQKV
LLATDSGYGFIAKIEDLYVKNRNGKACIKLSENSHILPPRLIPNREQLFVACATNVGRLL
IFSLEELPELSRGKGNKLISIPVAKAVSREEYIVDMQVLTTNDSLTVHAGKRHFTLKGED
LTHYKGERGRRGNRLPRGLQNVSQLHVTQSE
>EHT14135.1|FEATURES|megares|fosfomycin|FosA5|antibiotic inactivation|1
MLSGLNHLTLAVSSLAPSVAFYHQLLGMTLHARWDGGAYLSCGDLWLCLSLDPQRRVTPP
EESDYTHYAFSVAEADFAGFSARLETAGVAVWKVNRSEGASYYFLDPDGHKLELHVGSLA
LRLAACREQPYKGMVFYDE
>AAP97130.1|FEATURES|megares|beta_lactam|cphA|antibiotic inactivation|1
MMKGWIKYGLAGALVLVASFWGGSVHAAAISLTQVSGPVYVVEDNYYVKENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSNKPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVRAFYLGPAHTPDGIF
VYFPDQQVLYGNCILKETLGNLSFADVKAYPQTLERLRAMKLPIKIVVGGHDSPLHGPEL
IDHYEELIKASPHS
>AEY90465.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MADENTPVTPEEGGELVMRVEPVGLETEMQRSYLDYAMSVIVSRALPDVRDGLKPVHRRV
LYAMYDGGYRPERGFYKCARVVGDVMGNYHPHGDSSIYDALVRLAQPWSMRMPLVDSNGN
FGSPGNDPAAAMRYTECKMAPLSMEMVRDIDEETVDFTDNYDGRSQEPTVLPARFPNLLI
NGSAGIAVGMATNIPPHNLREVAAGAQWYLENPEVSHEELLDALMERIKGPDFPTGALVV
GRKGIEEAYRTGRGSITMRAVVEVEEIQGRQCLVVTELPYQVNPDNLAQKIADLVKDGKI
GGIADVRDETSSRTGQRLVIVLKRDAVAKVVLNNLYKHTDLQTNFGANMLALVDGVPRTL
SLDAFIRHWVTHQIEVIVRRTRFRLRKAEERAHILRGLLKALDAIDEVIALIRRSETVEI
ARSGLMGLLEIDEIQANAILEMQLRRLAALERQKIVQEHDELQAKINEYNEILASPVRQR
GIVSEELAAIVEKYGDDRQTKLIPYEGDMSIEDLIAEEDIVVTVTRGGYVKRTKTDDYRA
QKRGGKGVRGTKLKEDDIVDHFFVSTTHHWLLFFTNKGRVYRAKAYELPEAGRDARGQHV
ANLLAFQPDEAIAEILAIRDYEAAPYLVLATKSGLVKKTPLKDYDSPRSGGVIAINLRER
EDGSDDELIGAELVSADDDLLLISKKAQSIRFTASDESLRPMGRATSGVKGMSFREGDEL
LSMNVVRPGTFVFTATDGGYAKRTAVDEYRVQGRGGLGIKAAKIVEDRGSLVGALIVEEN
DEILAITLSGGVIRTRVSEVRETGRDTMGVQLINLGKRDAVVGIARNAEAGREAEEVDGD
VAVDETAEGAAITGTDEGEAPSAE
>ABB63219.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MTQTYNADAIEVLTGLEPVRRRPGMYTDTTRPNHLGQEVIDNSVDEALAGHAKRVDVILH
ADQSLEVIDDGRGMPVDIHPEEGVPAVELILCRLHAGGKFSNKNYQFSGGLHGVGISVVN
ALSKRVEVNVRRDGQIYNIAFENGEKVQDLQVVGTCGKRNTGTSVHFWPDETFFDSPRFS
VSRLTHVLKAKAVLCPGVEITFKDEINNTEQRWCYQDGLNDYLAEAVNGLPTLPEKPFIG
NFAGDTEAVDWALLWLPEGGELLTESYVNLIPTMQGGTHVNGLRQGLLDAMREFCEYRNI
LPRGVKLSAEDIWDRCAYVLSVKMQDPQFAGQTKERLSSRQCAAFVSGVVKDAFILWLNQ
NVQAAELLAEMAISSAQRRMRAAKKVVRKKLTSGPALPGKLADCTAQDLNRTELFLVEGD
SAGGSAKQARDREYQAIMPLKGKILNTWEVSSDEVLASQEVHDISVAIGIDPDSDDLSQL
RYGKICILADADSDGLHIATLLCALFVKHFRALVKHGHVYVALPPLYRIDLGKEVYYALT
EEEKEGVLEQLKRKKGKPNVQRFKGLGEMNPMQLRETTLDPNTRRLVQLTIDDEDDQRTD
AMMDMLLAKKRSEDRRNWLQEKGDMAEIEV
>ABG12898.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MSDLAREITPVNIEEELKSSYLDYAMSVIVGRALPDVRDGLKPVHRRVLFAMNVLGNDWN
KPYKKSARVVGDVIGKYHPHGDSAVYDTIVRMAQPFSLRYMLVDGQGNFGSVDGDSAAAM
RYTEIRMSKIAHELLADLEKDTVDFVPNYDGTEQIPAVMPTRIPNLLVNGSSGIAVGMAT
NIPPHNLSEVIDGCLAYIEDENISIEGLMEYIPGPDFPTAAIINGRRGIEEAYRTGRGKV
YIRARAEVEADAKTGRETIIVHEIPYQVNKARLIEKIAELVKEKRVEGISALRDESDKDG
MRIVIEIKRDAVGEVVLNNLYSLTQLQVTFGINMVALSQGQPKLLNLKDILVAFVRHRRE
VVTRRTIFELRKARDRAHILEALAIALANIDPIIELIRRASTPAEAKAGLIASPWELGNV
ASMLERAGDDAARPEWLEAEFGIRDGKYYLTEQQAQAILDLRLQKLTGLEHEKLLDEYKE
LLTLIGELIFILENPDRLMEVIREELVAIKEQYNDLRRTEITANTSDINIEDLINQEDVV
VTLSHQGYVKYQPLSDYEAQRRGGKGKSAARIKEEDFIDRLLVANTHDTILCFSSRGRLY
WMKVYQLPEASRGARGRPIVNLLPLEPNERITAILPVREYEEGCHVFMATASGTVKKTAL
TEFSRPRSAGIIAVNLNEGDELIGVDLTDGSNEVMLFSALGKVVRFPEGQVRSMGRTATG
VRGINLNGDDRVISLIIPRGDGEILTVTENGYGKRTAVAEYPTKSRATQGVISIKVSERN
GKVVGAVQVAPTDQIMMITDAGTLVRTRVSEVSVVGRNTQGVTLIRTAEDEHVVGLQRVA
EPEEDDDILDGESSEGEEGSEENAALNAPSDDVADEDTDAEDDTDVEDDNA
>WP_000988063.1|FEATURES|megares|aminoglycoside|AAC(3)-VIa|antibiotic inactivation|1
MMTDPRKNGDLHEPATAPATPWSKSELVRQLRDLGVRSGDMVMPHVSLRAVGPLADGPQT
LVDALIEAVGPTGNILAFVSWRDSPYEQTLGHDAPPAAIAQSWPAFDPDHAPAYPGFGAI
NEFIRTYPGCRRSAHPDASMAAIGPDAAWLVAPHEMGAAYGPRSPIARFLAHAGKILSIG
AGPDAVTALHYAEAVARIEGKRRVTYSMPLLREGKRVWVTTSDWDSNGILDEYAAPDGPD
AVERIARDYLARTRVAQGPVGGAQSRLIDAADIVSFGIEWLEARHAAPAAAALKPKQRRD
>AEP40502.1|FEATURES|megares|glycopeptide|vanTN|antibiotic target alteration|1
MKNVNTGINQFRLIAAFMVVAIHCFPFQSFSKTLDILITLTLFRTAVPFFLMVTGFYLIG
PIATKRGYPAYLKIKKFLKKQVKLYVLATLIYLPLAFYSGVITFKTSVIQFFQLIFFEGV
LYHLWYFPALILGVLIVYCLLQRFTLRQVLLVTFLFYLLCLGGDSWWGLARQIPVLEKSY
QGIFTLMIHTRNGLFFAPFFLTLGASFHQSEWNMRTSKAKYFLLIASLGMLVESYLLHSF
SSPKHDSAYLFLPVVMFFLFPLILNWQPTRVIADASTISLGIYVLHPYVIAVVHTLAKKI
TILNNSLIYYLCVSLLTSLIILYVHSKKKKTTKNQATFVPRTKKVLSKQAVIHNLAQINQ
VIPKTTKIMAVIKANAYGTDDTEFARILEQQGVDFFAVATIDEGIRLRENGIKSKILILG
YTPSIRIKELAHYTLIQTIVSKEHAYSLNQQKIPISCHLKIDTGMHRLGVEPVVQEVSSL
YRLPYLNIQGIYSHLGSADDRSDKGMKRTRKQISIFDYLLHELELQKIDVGVTHLQSSYG
ILNYPELVYDYVRPGILLYGYLSEHNGDSKINLNLQPILDVQALLVSKKWVAAGEYLGYS
LDTKLVSPKLIGIVSIGYADGVPRELSHNEFYLAYQGQNLPQIGRICMDMLLVDLTDSPE
IKVESQISIFPELEQTANQTNTLTNEIISRLGNRFYTEWS
>ADM92620.1|FEATURES|megares|sulfonamide|sul2|antibiotic target replacement|1
MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVS
SDTEIARIAPVLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDAAFYPQLAK
SSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFF
LGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTVRGPGDVGAATLAAELAAAA
GGADFIRTHEPRPLRDGLAVLAALKETARIRYQKTEGTSIESN
>CAW30930.1|FEATURES|megares|rifampin|arr-3|antibiotic inactivation|1
MSSDWTPISHENCQQVRGPFYHGTKAHLSIGDLITTGHLSHFEDGRALKHVYFSALMEPA
IWGAELAMSLSRLDGRGYIYIVEPTGPFEDDPNLTNKRFPGNPTKSYRTCDPLRIVGSVE
DWQGHPADVLQQMLESLEDLERRGLAIIED
>ABR79716.1|FEATURES|megares|elfamycin|tufab|antibiotic target alteration|0
MSKEKFERTKPHVNVGTIGHVDHGKTTLTAAITTVLAKTYGGSARAFDQIDNAPEEKARG
ITINTSHVEYDTPTRHYAHVDCPGHADYVKNMITGAAQMDGAILVVAATDGPMPQTREHI
LLGRQVGVPYIIVFLNKCDMVDDEELLELVEMEVRELLSQYDFPGDDTPIVRGSALKALE
GDAEWEAKIIELAGHLDTYIPEPERAIDKPFLLPIEDVFSISGRGTVVTGRVERGIIKVG
EEVEIVGIKETAKTTCTGVEMFRKLLDEGRAGENVGVLLRGIKREEIERGQVLAKPGTIN
PHTKFESEVYILSKDEGGRHTPFFKGYRPQFYFRTTDVTGTIELPEGVEMVMPGDNIKMV
VTLIHPIAMDDGLRFAIREGGRTVGAGVVAKVLG
>AGS61873.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|0
MKLIARGRELNLSSPQVMGILNVTPDSFSDGGTHNSLNDAINHAAKLIAEGASIIDIGGE
STRPGASDVSVDEELHRVIPVVEAIQQRFDVWISVDTSKAQVITESAQAGASIINDIRSL
TEPGALQAAAKTGLPVCIMHMQGLPKTMQHSPQYKNVMIEVDAFLAENIQRCIDAGIEKN
QIILDPGFGFGKNLAHNYQLLAHLSDFHHFGLPILAGMSRKSMVGQLLNVPPQERVAGSV
ACAVIAAMQGAQIIRVHDVKETVDAMKVVQATLSAKENNE
>AFK58771.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MENRQEVQELTLEEVMGDRFGRYSKYIIQERALPDIRDGLKPVQRRILFAMNKDGNTYDK
GFRKSAKSVGNIMGNYHPHGDSSIYEAMVRMSQDWKLREVLIEMHGNNGSMDGDPPAAMR
YTEARLSKLSGEMLADIEKETVDLVWNFDDTEKEPTVLPARYPNLLVNGSTGISAGYATE
IPTHNLAEVIDGTIYMIDHPQASLEKLMEYIPGPDFPTGGILQGKDEIKKAYETGRGKVI
LRSKTKIEAMKGNKQQIVITEIPYEVNKATLVKKMDEIRLNKKIDGIAEVRDESDRTGLQ
IVVELKKDANAQGILNYLFKNTELQINYNFNMVAIDHMTPHQVGLKDILRSYIEHRKQVI
TKRSQFDLAKAQKRQHIVEGLMKALSILDEVIATIRESKDKKDAKKNLVDVFQFTEEQAE
AIVTLQLYRLTNTDITELQKESESLIAQITELNKILSNDKELFSVMKKELREVKKNYSSA
RLTTIEDEIEEIKIDTQVLVAQEDVIVSVTREGYVKRTSLRSYSASKPEEIGMREGDYLL
YSGELSTLDHVLLITNKANVIYRPVHELPDLKWKDAGEHISQTISNLSVDESILAVFPYQ
KIQAEKTFVFISKNGLIKQTRMTEFEPWRTYKSRPLSCMKLKAEEDELIAVYLKEDQPGL
DVFLVTHQGMGLRYPLTDVPVVGAKAAGVKSMNLKDGDRIINGLLVLAEGDTPIVIVTQR
GAVKRMLAQEISQTSRAKRGVTVMRELKKNPHRIIYMSEGRSKEITLMNQKGQQLTIDPT
DFPIGDRTSNGSFAMDEKKGGEVIEVIDAPEIFIES
>AAO47225.2|FEATURES|megares|aminocoumarin|gyrB|antibiotic target alteration|0
MYIGSTGERGLHHLVQELVDNSVDEALAGVADRIDVTVLADGGVRVVDNGRGIPVGMHPV
EKRPAVEVVLTVLHAGGKFGGGGYAVSGGLHGVGLSVVNALSTRLSAEIWTDGHRWTQDY
RDGAPTAPLARHEATSRTGTSLTFWADGDIFETTEYSFETLARRHQEMAFLNGGLTLTLT
DERSSARATAAVDEADSDPTAKTVSYRYDGGITDFVVHLNARKGEPAHPSVITIAAEDTE
RLLSAEIALQWNGQYTDSVYSYANAIHTHEGGTHEEGFRTALTTVVNRYAREKRLLRDKD
ANLSGEDIREGLTAIISVKLGEPQFEGQTKTKLGNTEVRTFVQKIVHEHLADWFDRNPNE
AVDIVRKAVQAATARVAARKARDLTRRKGLLETAALPGKLSDCQSNDPATSEIFIVEGDS
AGGSAKAGRNPQYQAILPIRGKILNVEKARIDKVLQNQEIQALISAFGTGVHEDFDIAKL
RYHKIILMADADVDGQHISTLLLTFLFRFMRPLVEEGHVHLSRPPLYKIKWSREHVEYAY
SDRERNTLLERGRRDGRRIRDDSIQRFKGLGEMNAEELRVTTMDPDHRVLGQVTLDDAAF
ADDLFSVLMGEDVEARRHFIQRNAQDVRFLDI
>WP_000167924.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|0
MTKTKIMGILNVTPDSFSDGGKFNNVESAINRVKAMIDEGADIIDVGGVSTRPGHEMVSL
EEEMNRVLPVVEAIVGFDVKISVDTFRSEVAEACLKLGVDMINDQWAGLYDHRMFQIVAK
YDAEIILMHNGNGNRDEPVVEEMLTSLLAQAHQAKIAGIPSNKIWLDPGIGFAKTRNEEA
EVMARLDELVATEYPVLLATSRKRFTKEMMGYDTTPVERDEVTAATTAYGIMKGVRAVRV
HNVELNAKLAKGIDFLKENENARHNLS
>CAJ68894.1|FEATURES|megares|macrolide-lincosamide-streptogramin|ErmB|antibiotic target alteration|1
MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGSIPYHLSTQIIKKVVFESRAS
DIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIKQLLKLPAECFHPKPKVNSALIKLTRHTT
DVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKYAKVNDLSTVTYEQVLSIFNSYLL
FNGRK
>WP_000819100.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MAELPQSRINERNITSEMRESFLDYAMSVIVARALPDVRDGLKPVHRRILYGLNEQGMTP
DKSYKKSARIVGDVMGKYHPHGDSSIYEAMVRMAQDFSYRYPLVDGQGNFGSMDGDGAAA
MRYTEARMTKITLELLRDINKDTIDFIDNYDGNEREPSVLPARFPNLLANGASGIAVGMA
TNIPPHNLTELINGVLSLSKNPDISIAELMEDIEGPDFPTAGLILGKSGIRRAYETGRGS
IQMRSRAVIEERGGRRQRIVVTEIPFQVNKARMIEKIAELVRDKKIDGITDLRDETSLRT
GVRVVIDVRKDANASVILNNLYKQTPLQTSFGVNMIALVNGRPKLINLKEALVHYLEHQK
TVVRRRTQYNLRKAKDRAHILEGLRIALDHIDEIISTIRESDTDKVAMESLQQRFKLSEK
QAQAILDMRLRRLTGLERDKIEAEYNELLNYISELEAILADEEVLLQLVRDELTEIRDRF
GDERRTEIQLGGFEDLEDEDLIPEEQIVITLSHNNYIKRLPVSTYRAQNRGGRGVQGMNT
LEEDFVSQLVTLSTHDHVLFFTNKGRVYKLKGYEVPELSRQSKGIPVVNAIELENDEVIS
TMIAVKDLESEDNFLVFATKRGVVKRSALSNFSRINRNGKIAISFREDDELIAVRLTSGQ
EDILIGTSHASLIRFPESTLRPLGRTATGVKGITLREGDEVVGLDVAHANSVDEVLVVTE
NGYGKRTPVNDYRLSNRGGKGIKTATITERNGNVVCITTVTGEEDLMIVTNAGVIIRLDV
ADISQNGRAAQGVRLIRLGDDQFVSTVAKVKEDADEVNEDEQSTVSEDGTEQQREAVVND
ETPGNAIHTEVIDSEENDEDGRIEVRQDFMDRVEEDIQQSSDEDEE
>CCJ23762.1|FEATURES|megares|aminoglycoside|APH(9)-Ib|antibiotic inactivation|0
MAEQDGQKLFLKRNSNPFIAALSAEGIVPKLVWTKRIETGEVVTAQHWKNGRELSSNEMK
QTRVAHLLKKIHNSRPLLSMLKRMEMEPITPEIMLNKINASLSREVLTHHIVRKSLTYLE
EHIPSLDSRFFTVVHGDVNHNNWLLSDRDELFLVDWEGAMIADPAIDIGMLLYNYVPQQQ
WSEWLETYGVQESLNLNKRMKWYTVIQSIGLVQWYEEQKRYKDMNTWLKFLNEVMNSNMF
I
>ALC76810.1|FEATURES|megares|beta_lactam|VEB-1a|antibiotic inactivation|1
MQSVMKFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKTWSPIKEEFPNGTTLTIEQILN
YTVSESDNIGCDILLKLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQNWATPT
AMNKLLINTYNNKNQLLSKKSYDFFWKIMRETTTGSNRLKGQLPKNTIVAHKTGTSGINN
GIAAATNDVGVITLPNGQLIFISVFVAES
>AFN51949.1|FEATURES|megares|ethambutol|embA|antibiotic target alteration|0
MGIPGGAGTLPPEKKPQVGGIFTDLKVGAQPGLSARVDIDTRFITTPGALKKAVMLLGVL
AVLVAMVGLAALDRLSRGRTLRDWLTRYRPRVRVGFASRLADAAVIATLLLWHVIGATSS
DDGYLLTVARVAPKAGYVANYYRYFGTTEAPFDWYTSVLAQLAAVSTAGVWMRLPATLAG
IACWLIVSRFVLRRLGPGPGGLASNRVAVFTAGAVFLSAWLPFNNGLRPEPLIALGVLVT
WVLVERSIALGRLAPAAVAIIVATLTATLAPQGLIALAPLLTGARAIAQRIRRRRATDGL
LAPLAVLAAALSLITVVVFRDQTLATVAESARIKYKVGPTIAWYQDFLRYYFLTVESNVE
GSMSRRFAVLVLLFCLFGVLFVLLRRGRVAGLASGPAWRLIGTTAVGLLLLTFTPTKWAV
QFGAFAGLAGVLGAVTAFTFARIGLHSRRNLTLYVTALLFVLAWATSGINGWFYVGNYGV
PWYDIQPVIASHPVTSMFLTLSILTGLLAAWYHFRMDYAGHTEVKDNRRNRILASTPLLV
VAVIMVAGEVGSMAKAAVFRYPLYTTAKANLTALSTGLSSCAMADDVLAEPDPNAGMLQP
VPGQAFGPDGPLGGISPVGFKPEGVGEDLKSDPVVSKPGLVNSDASPNKPNAAITDSAGT
AGGKGPVGINGSHAALPFGLDPARTPVMGSYGENNLAATATSAWYQLPPRSPDRPLVVVS
AAGAIWSYKEDGDFIYGQSLKLQWGVTGPDGRIQPLGQVFPIDIGPQPAWRNLRFPLAWA
PPEADVARIVAYDPNLSPEQWFAFTPPRVPVLESLQRLIGSATPVLMDIATAANFPCQRP
FSEHLGIAELPQYRILPDHKQTAASSNLWQSSSTGGPFLFTQALLRTSTIATYLRGDWYR
DWGSVEQYHRLVPADQAPDAVVEEGVITVPGWGRPGPIRALP
>AAQ81635.1|FEATURES|megares|macrolide-lincosamide-streptogramin|Erm(38)|antibiotic target alteration|1
MQWEVARRRAAVGGATMMTAQWWPWFEFGLARKVSAASFTPRPAVDAGLLTITRRSRPLV
DVADRARYQALVHRVFTGRGHGMAQILQRLPTPVPRTWLRANGIAPNSLPRQLSAAQWAA
LFEQTRLTGAQRVDRPRDVQHGRAHRRRGGEVDRPATHHKQTGPVVGQRQPQRGRDADAD
PDDQRTAPPVTRHHQGERRDEDQADHQDRPLTGEHLAGEFLWRHASFDSSASTTLVSRKA
RVNGPTPPGLGDT
>AAF71282.1|FEATURES|megares|glycopeptide|vanWG|antibiotic target alteration|0
MKFDGNRYAKKTSEKLLPNTVFETSSLMLNENSGFDMKYQINKVHNLKLAAKTINKVIIE
PKETFSFWQLVRWADRHEKYKDGLNLVNGKIVGSYGGGLCQLSNMLFWLFLHTPLVIVER
HGHAVESFPSTTEEMPRRNEATINEGWLDLKPRKKTNILSRLRLVLMTTLVWCNFVAKLV
NIDIRFLFVCFLFQAREKVYQIASVCRTEKDKMTGSQTEKELYVNQCKIAYKLPDGVKIE
ERGV
>AAZ98828.1|FEATURES|megares|beta_lactam|SHV|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLTSGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAR21615.1|FEATURES|megares|aminoglycoside|AAC(3)-Id|antibiotic inactivation|1
MFGEAFNDQDSYARNKPSSSYLQKLLSTSSFIALAAVDEQKVIGAIAAYELQKFEQQRSE
IYIYDLAVAATRRREGIATALIKKLKAIGAARGAYVIYVQADKGVEDQPAIELYKKLGTI
EDVFHFDIAVEQSKNHA
>CBA29682.1|FEATURES|megares|multidrug|ompF|reduced permeability to antibiotic|0
MKRNILAVVIPALLVAGAANAAEIYNKNGNKLDLYGKVTAEHDFVTSGDNTSNGDATYAQ
LGFKGETQINDQLTGYGQWEYRAYATSAESEQGANNSNRTRLAFAGLKIADAGSIDYGRN
YGIVYDVESYTDMAPSYSGMTWANYSDNFMTGRTTGVLTYRNTGFFGLADGLNFGIQYQG
KNDRDNVATSNGDGVGYSLGYDFGEGFSLIGAYSNSNRTLQQKLDDKGDRAEAWAVGAKY
DANNLYLATVYAETRNMTREADNTFANKTQNFEAIAQYQFDFGLRPSLSYVQSKGKNLTA
RGTFDGGDADLQKYVEVGAYYYFNKNFNVYVDYQINLIDNDAYARNVGIVNGRDDQVALA
ATYQF
>ACO84027.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MAKKIVIPKDNNIISFPLEEAMPENYLPYAVEVSKERALPDVRDGLKPVQRRIVYGSYML
KAFPDKPYYKSARIVGDILGKYHPHGDSSVYDAMVILAQDFTTRMPLIDGHGNWGSQDGD
SAAAMRYTEARLTPIAMEMIRDIDKDVVNMVDNYSNSEKEPEVLPAKYPNILVNGAFGIA
VGLATNIPPHNLVEVIDGTLAYIDKNEITTKELLNYIKGPDLPTGGVIIGKKSMLSAYET
GEGRVTLRAKTTIEKLENGRLSIVITEFPFRKNKAKLLQFISEMTADKKHSKALENITDI
RDESDRNGIRAVIEFKKIATEDIVEKTLKYLYKKTDLQSNISFNMVALADGKPKTLGLKS
MLKYYVEHQKEVITRRTKRELEIAEKRFHIVEGFIKAIGIMDEIIKTIRESKSKKNAREN
LIEKFSFTDIQAEAILELMLYKLTGLEVVAFEKEYKELEKLINKLTKILKSEKELLKVIK
KELIEVKETYNDKRRTAIIEDDEKAKIDVEEIIVEEDVVLTLSNEGFTKRIALKSYNRSS
ANVEDIEYREGDFNRFLIQCNTKDTLCLVTKEGNMYQIKVINIPEFKWKEKGVKLDEIIK
TIDLSETIIEAFSIEDFTAQKDMLFITDSGYIKKTTLDKFNTNYTKIMALKLKKGESLVK
SDLVDRTREEKFFNIKTQKGLSFNIEEPSLEPVDRNIIGYKLFDILPNDSIKKVDFCDNY
EYKSFYVNISKEGLITISDLKDNKSHISLFTDSSKTLVLFDDEGKAYYIPAFMLQSIKEE
GVNISAFTGDKISLLNAISTFRFEEDISIYFSSEKGLIKRTLLGELKIEGNSTQVYKFKH
KDDKLVSILIKEHEEQKNILIITEKAMVIRFKSEAVNPMGKMASGVTGISLKDLDKVILA
LIIDENDTRKIKIKTKAKDKGTIEINKIKVQNRAGIGNSLMPLLLNDFVEVVEFKK
>WP_001289553.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MSEIIQDLSLEDVLGDRFGRYSKYIIQERALPDVRDGLKPVQRRILYAMYSSGNTHDKNF
RKSAKTVGDVIGQYHPHGDFSVYEAMVRLSQDWKLRHVLIEMHGNNGSIDNDPPAAMRYT
EAKLSLLAEELLRDINKETVSFISNYDDTTLEPMVLPSRFPNLLVNGSTGISAGYATDIP
PHNLAEVIQATLKYIDNPDITVNQLMKYIKGPDFPTGGIIQGIDGIKKAYESGKGRIIVR
SKVEEETLRNGRKQLIITEIPYEVNKSSLVKRIDELRADKKVDGIVEVRDETDRTGLRIA
IELKKDVNSESIKNYLYKNSDLQISYNFNMVAISDGRPKLMGIRQIIDSYLNHQIEVVAN
RTKFELDNAEKRMHIVEGLIKALSILDKVIELIRSSKNKRDAKENLIEVYEFTEEQAEAI
VMLQLYRLTNTDIVALEGEHKELEALIKQLRHILDNHDALLNVIKEELNEIKKKFKSERL
SLIEAEIEEIKIDKEVMVPSEEVILSMTRHGYIKRTSIRSYNASGVEDIGLKDGDSLLKH
QEVNTQDTVLVFTNKGRYLFIPVHKLADIRWKELGQHVSQIVPIEEDEVVINVFNEKDFN
TDAFYVFATQNGMIKKSTVPLFKTTRFNKPLIATKVKENDDLISVMRFEKDQLITIITNK
GMSLTYNTSELSDTGLRAAGVKSINLKAEDFVVMTEGVSENDTILMATQRGSLKRISFKI
LQVAKRAQRGITLLKELKKNPHRIVAAHVVTGEHSQYTLYSKSNEEHGLINDIHKSEQYT
NGSFIVDTDDFGEVIDMYIS
>ABX79409.1|FEATURES|megares|glycopeptide|VanXYC|antibiotic target alteration|1
MNPYLQLVSKEFPLEKKQEPPHLVLAAFSEEEVYLQPEAAKQWERLVKALKLENEICLLD
GYRTEKQQRYLWEYSLKENGLAYTKQFVALPGCSDHQLGLAIDVGLKGSQNDLICPRFRD
SAAADLFTQEMMNYGFILRYPADKQEITGIGYEPWHFRYVGLPHSQIMANQQWTLEEYHQ
YLEQTTRQFA
>AAC44614.1|FEATURES|megares|beta_lactam|pbp2b|antibiotic target alteration|0
MQVYNKSFYTKKLEDNSKYTVRIASERGQIFDAKGIALTTNQSKDVITFTRSNLVSSDTM
KSVAERLATLVTLTETKVTDRQKREFYLADSANYKRVVNDLPNDKKTDKFGNKLAEATIY
NNAINAVPDEAVDYSEDELKIVYIYSHMNAVSNFSTVILKTADLTPDQIAIVAAKQKELN
GIRVAKDWERHTSDSSLSPLIGRVSSSEAGLPQEDAKDYLKKGYALNDRVGTSYLEKEYE
EELQGKHTVREITVDKEGKVDSDKIIQKGSKGNNLKLTIDLDFQKGVEDILGQQLSSEIS
GNKATYSEGMYAVVMNADTGAVLAMAGQKHEQGAQDFKADALGTITDVFTPGSVVKGATL
TAGWRSGAIYGDQVLTDQPINIASSPPITSWFTDKGSRAITATQALEYSSNTYMVQIAIK
RLGQQYVPGMSLSTDNMEKAMTTLRDTYAEFGMGVSTGLDLPGESEGYIPKNYNVANVLT
EAFGQYDSYTTIQLAQYVASIANGGKRVAPHIVGGIYDAGKNGSLGTLSSTVDTRVLNKL
SLDSKQLGIIQQGFHDVVNSGSSLATGKAMASSIIPISGKTGTAETYATDGSGNSVTTVN
LNAVAYATAKDGTKLAVGIMYPHALDWKSKAHQNAVKAIMELYQNTH
>AGS61712.1|FEATURES|megares|elfamycin|tufab|antibiotic target alteration|0
MSKEKFERSKPHVNVGTIGHVDHGKTTLTAAITTVLAKTYGGAARAFDQIDNAPEEKARG
ITISTSHVEYDTPTRHYAHVDCPGHADYVKNMITGAAQMDGAILVVAATDGPMPQTREHI
LLGRQVGVPYIIVFLNKCDMVDDEELLELVEMEVRELLSQYDFPGDDTPVIRGSALKALE
GEAEWEAKIVELAEALDSYIPEPERAIDKPFLLPIEDVFSISGRGTVVTGRVERGIIKVG
DEVEIVGIKETTKTTCTGVEMFRKLLDEGRAGENVGVLLRGTKREEIERGQVLAKPGSIN
PHNKFESEVYILSKDEGGRHTPFFKGYRPQFYFRTTDVTGTIELPEGVEMVMPGDNVNMI
VELIHPIAMDEGLRFAIREGGRTVGAGVVAKVLG
>WP_003156440.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MTGQLVQYGRHRQRRSYARISEVLELPNLIEIQTSSYQWFLDEGLREMFQDISPIEDFTG
NLSLEFIDYSLGDPKYPVEESKERDVTYSAPLRVKVRLINKETGEVKDQDVFMGDFPIMT
DTGTFIINGAERVIVSQLVRSPSVYFSGKVDKNGKKGFTATVIPNRGAWLEYETDAKDVV
YVRIDRTRKLPVTVLLRALGFGSDQEILDLIGENEYLRNTLDKDNTENSDKALLEIYERL
RPGEPPTVENAKSLLDSRFFDPKRYDLANVGRYKINKKLHIKNRLFNQRLAETLVDPETG
EILAEKGQILDRRTLDKVLPYLENGIGFRKLYPNGGVVEDEVMLQSIKIYAPTDAEGEQT
INVIGNAYIEEAIKNITPADIISSISYFFNLLHGVGDTDDIDHLGNRRLRSVGELLQNQF
RIGLSRMERVVRERMSIQDTNTITPQQLINIRPVIASIKEFFGSSQLSQFMDQTNPLAEL
THKRRLSALGPGGLTRERAGMEVRDVHYSHYGRMCPIETPEGPNIGLINSLSSFAKVNRF
GFIETPYRRVDPETGKVTPRIDYLTADEEDNYVVAQANAKLSDDGSFLDDSIVARFRGEN
TVVARNRVDYMDVSPKQVVSAATACIPFLENDDSNRALMGANMQRQAVPLMQPEAPIVGT
GMEYVSGKDSGAAVICKHPGIVERVEAKNVWVRRYEEIDGQKVKGNLDKYSLLKFVRSNQ
GTCYNQRPIVSVGDEVVKGEILADGPSMELGELALGRNVMVGFMTWDGYNYEDAIIMSER
LVKDDVYTSIHIEEYESEARDTKLGPEEITRDIPNVGEDALRNLDDRGIIRIGAEVNDGD
LLVGKVTPKGVTELTAEERLLHAIFGEKAREVRDTSLRVPHGGGGIIHDVKVFNREDGDE
LPPGVNQLVRVYIVQKRKISEGDKMAGRHGNKGVISKILPEEDMPYLPDGTPIDIMLNPL
GVPSRMNIGQVLELHMGMAARYLGIHIASPVFDGAREEDVWETLEEAGMSRDAKTVLYDG
RTGEPFDNRVSVGIMYMIKLAHMVDDKLHARSTGPYSLVTQQPLGGKAQFGGQRFGEMEV
WALEAYGAAYTLQEILTVKSDDVVGRVKTYEAIVKGDNVPEPGVPESFKVLIKELQSLGM
DVKILSGDEEEIEMRDLEDEEDAKQADGLALSGDEAPEETASPDVERDAVTKE
>CBA27171.1|FEATURES|megares|quinolone|rpoB|antibiotic target replacement|0
MDRVGRLVSELRNPMVYSYTEKKRIRKDFGKRPQVLDVPYLLSIQLDSFQKFIEQDPEGQ
YGLEAAFRSVFPIQSYSGNSELQYVSYRLGEPVFDVKECQIRGVTYSAPLRVKLRLVIYE
REAPEGTVKDIKEQEVYMGEIPLMTDNGTFVINGTERVIVSQLHRSPGVFFDSDKGKTHS
SGKVLYNARIIPYRGSWLDFEFDPKDNLFVRIDRRRKLPATIILRALDYTTEQILDLFFE
KVVFEIRDNKLQMELIPERLRGETASFDIEANGKIYVEKGRRITARHIRQLEKDEIKLIE
VPVEYIAGKVAAKDYVDASTGELICPANMELSLDLLAKLSQSGHKRIETLFTNDLDHGPY
MSETVRVDPTTDRLSALVEIYRMMRPGEPPTREAAESLFENLFFSEDRYDLSAVGRMKFN
RSLLRDEIEGSGILSKADIIDVMKKLIDIRNGKGEVDDIDHLGNRRIRSVGEMAENQFRV
GLVRVERAVKERLSLGDLDTLMPQDMINAKPISAAVKEFFGSSQLSQFMDQNNPLSEITH
KRRISALGPGGLTRERAGFEVRDVHPTHYGRVCPIETPEGPNIGLINSLSVYAQTNEYGF
LETPYRKVTDGVVTDEIHYLSAIEEGNYVIAQANTNLTEEGRFADDLVTCRSKGESSLFS
ADQVDYMDVSTQQVVSVGASLIPFLEHDDANRALMGANMQRQAVPTLRADKPLVGTGMER
AVAVDSGVTAVAKRGGTVQYVDASRIVIKVNEDEMYPGEAGIDIYNLTKYTRSNQNTCIN
QMPCVSLNEPVERGDVLADGPSTDLGELALGQNMRVAFMPWNGYNFEDSILVSERVVQED
RFTTIHIQELACVSRDTKLGPEEITADIPNVGEAALSKLDESGIVYIGAEVTGGDILVGK
VTPKGETQLTPEEKLLRAIFGEKASDVKDSSLRVPNGVSGTVIDVQVFTRDGVEKDKRAL
EIEEMQLKQAKKDLSEELQILEAGLFSRIRAVLIAGGVEAEKLDKLPRDRWLELGLTDEE
KQNQLEQLAEQYDELKHEFEKKLEAKRRKITQGDDLAPGVLKIVKVYLAVKRQIQPGDKM
AGRHGNKGVISKINPIEDMPYDENGTPVDIVLNPLGVPSRMNIGQILETHLGMAAKGIGD
KINAMLKRQEEVAKLREFIQKAYDLGQDVRQKVDLNTFSDEEVLRLAENLRKGMPLATPV
FDGAKEAEIKELLQLGDLPTSGQITLFDGRTGEQFERPVTVGYMYMLKLNHLVDDKMHAR
STGSYSLVTQQPLGGKAQFGGQRFGEMEVWALEAYGAAYTLQEMLTVKSDDVNGRTKMYK
NIVDGNHQMEPGMPESFNVLLKEIRSLGINIELEDE
>AAK91784.1|FEATURES|megares|macrolide-lincosamide-streptogramin|vatE|antibiotic inactivation|1
MTIPDANAIYPNSAMIEVVFIKNVIKSPNIEIGDYTYYDDPVNPTDFEKHVTHHYEFLGD
KLIIGKFCSIASGIEFIMNGANHVMKGISTYPFNILGGDWQQYTPELTDLPLKGDTVVGN
DVWFGQNVTVLPGVKIGDGAIIGANSVVTKDVAPYTIVGGNPIQLIGPRFEPEVIQALEN
LAWWNKDIEWITANVPKLMQTTPTLELINSLMEK
>CAD32686.1|FEATURES|megares|macrolide-lincosamide-streptogramin|ErmT|antibiotic target alteration|1
MNKNIKDSQNFITSKHHINEILRNVHLNTNDNIIEIGSGKGHFTFELAKRCNYVTAIEID
PKLCRITKNKLIEYENFQVINKDILQFKFPKNKSYKIFGSIPYNISTDIIRKIVFESTAT
ESYLIVEYGFAKRLLNTNRSLALFLMTEVDISILSKIPREYFHPKPKVNSVLIKLTRHTT
DVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTITYEQVLSIFNSYLL
FNGRK
>WP_001152989.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MQDKNLVNVNLTKEMKASFIDYAMSVIVARALPDVRDGLKPVHRRILYGMNELGVTPDKP
HKKSARITGDVMGKYHPHGDSSIYEAMVRMAQWWSYRYMLVDGHGNFGSMDGDSAAAQRY
TEARMSKIALEMLRDINKNTVDFVDNYDANEREPLVLPARFPNLLVNGATGIAVGMATNI
PPHNLGETIDAVKLVMDNPEVTTKDLMEVLPGPDFPTGALVMGKSGIHKAYETGKGSIVL
RSRTEIETTKTGRERIVVTEFPYMVNKTKVHEHIVRLVQEKRIEGITAVRDESNREGVRF
VIEVKRDASANVILNNLFKMTQMQTNFGFNMLAIQNGIPKILSLRQILDAYIEHQKEVVV
RRTRFDKEKAEARAHILEGLLIALDHIDEVIRIIRASETDAEAQAELMSKFKLSERQSQA
ILDMRLRRLTGLERDKIQSEYDDLLALIADLADILAKPERVSQIIKDELDEVKRKFSDKR
RTELMIGQVLSLEDEDLIEESDVLITLSNRGYIKRLDQDEFTAQKRGGRGVQGTGVKDDD
FVRELVSTSTHDHLLFFTNKGRVYRLKGYEIPEYGRTAKGLPVVNLLKLDEDESIQTVIN
VESDRSDDAYLFFTTRHGIVKRTSVKEFANIRQNGLKALNLKDEDELINVLLAEGDMDII
IGTKFGYAVRFNQSAVRGMSRIATGVKGVNLREGDTVVGASLITDQDEVLIITEKGYGKR
TVATEYPTKGRGGKGMQTAKITEKNGLLAGLMTVQGDEDLMIITDTGVMIRTNLANISQT
GRATMGVKVMRLDQDAQIVTFTTVAVAEKEEVGTENETEGEAMARRARVDAELVRRGLAR
SRQQAAELIGAGKVRIDGLPAVKPATAVSDTTALTVVTDSERAWVSRGAHKLVGALEAFA
IAVAGRRCLDAGASTGGFTEVLLDRGAAHVVAADVGYGQLAWSLRNDPRVVVLERTNARG
LTPEAIGGRVDLVVADLSFISLATVLPALVGCASRDADIVPLVKPQFEVGKGQVGPGGVV
HDPQLRARSVLAVARRAQELGWHSVGVKASPLPGPSGNVEYFLWLRTQTDRALSAKGLED
AVHRAISEGP
>WP_012503694.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MTDATIRHDHKFALETLPVSLEDEMRKSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAM
HELKNNWNAAYKKSARIVGDVIGKYHPHGDFAVYGTIVRMAQNFAMRYVLIDGQGNFGSV
DGLAAAAMRYTEIRMAKISHEMLADIEEETVNFGPNYDGSEHEPLVLPTRFPTLLVNGSS
GIAVGMATNIPPHNLTDTINACLRLLDEPKTEIDELIDIIQAPDFPTGATIYGLGGVREG
YKTGRGRVVMRGKTHIEPIGKNGEREAIVIDEIPYQVNKAKLVEKIGDLVREKTLEGISE
LRDESDKSGMRVVIELKRNENAEVVLNQLYKLTPLQDSFGINMVVLVDGQPRLLNLKQIL
SEFLRHRREVVTRRTLFRLKKARHEGHIAEGKAVALSNIDEIIKLIKESPNAAEAKEKLL
ARPWRSSLVEEMLTRSGLDLEMMRPEGLAANIGLKKQGYYLSEIQADAILRMSLRNLTGL
DQKEIIESYKNLMGKIIDFVDILSKPERITQIIRDELEEIKTNYGDERRSEINPFGGDIA
DEDLIPQREMVVTLTHGGYIKTQPTTDYQAQRRGGRGKQAAATKDEDFIETLFVANTHDY
LMCFTNLGKCHWIKVYKLPEGGRNSRGRPINNVIQLEEGEKVSAILAVREFPEDQYVFFA
TAQGMVKKVQLSAFKNVRAQGIKAIALKEGDYLVGAAQTGGADDIMLFSNLGKAIRFNEY
WEKSGNDEAEDADIETEISDDLEDETADNENTLPSGKNGVRPSGRGSGGLRGMRLPADGK
IVSLITFAPETEESGLQVLTATANGYGKRTPIADYSRKNKGGQGSIAINTGERNGDLVAA
TLVGETDDLMLITSGGVLIRTKVEQIRETGRAAAGVKLINLDEGETLVSLERVAEDESEL
SGASVISNVTEPEAEN
>ABR78057.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MSDLAREITPVNIEEELKNSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAMNVLGNDWN
KAYKKSARVVGDVIGKYHPHGDYAVYDTIVRMAQPFSLRYMLVDGQGNFGSIDGDSAAAM
RYTEIRLAKIAHELMADLEKETVDFVDNYDGTERIPDVMPTKIPNLLVNGASGIAVGMAT
NIPPHNLTEVINGCLAYVDDEDISIEGLMAHIPGPDFPTAAIINGRRGIEEAYRTGRGKV
YIRARAEVEVDAKSGRETIIVHEIPYQVNKARLIEKIAELVKEKRVEGISALRDESDKDG
MRIVIEVKRDAVGEVVLNNLYSQTQLQVSFGINMVALHHGQPKIMNLKDIIAAFVRHRRE
VVTRRTIFELRKARDRAHILEALAVALANIDPIIELIRRAPTPAEAKTALVAQAWDLGNV
AAMLERAGDDAARPEWLEPEFGVRDGKYYLTEQQAQAILDLRLQKLTGLEHEKLLDEYKE
LLEQIAELLHILGSADRLMEVIREELELIRDQFGDERRTEITANSADINIEDLINQEDVV
VTLSHQGYVKYQPLTDYEAQRRGGKGKSAARIKEEDFIDRLLVANTHDTILCFSSRGRLY
WMKVYQLPEASRGARGRPIVNLLPLEADERITAILPVREYEEGVNVFMATASGTVKKTAL
TEFSRPRSAGIIAVNLNEGDELIGVDLTSGQDEVMLFSAAGKVVRFKEDAVRAMGRTATG
VRGIKLAENDSVVSLIIPRGEGAILTVTQNGYGKRTAAAEYPTKSRATQGVISIKVTERN
GSVVGAVQVDDCDQIMMITDAGTLVRTRVSEVSIVGRNTQGVILIRTAEDENVVGLQRVA
EPVDDEELDAIDGSAAEGDDDIAPEADTDDDIAEDEE
>ACK43805.1|FEATURES|megares|chloramphenicol|catB8|antibiotic inactivation|1
MKNYFNSPFKGELLSEQVKNPNIRVGRYSYYSGYYHGHSFDECARYLLPDRDDVDKLIIG
SFCSIGSGASFIMAGNQGHRHDWASSFPFFYMQEEPAFSRALDAFQRAGDTVIGNDVWIG
SEAMIMPGIKIGDGAVIGSRSLVTKDVEPYAIIGGNPAKHIKKRFSDEEISLLMEMEWWN
WPLDKIKTAMPLLCSSNIFGLHKYWREFAV
>AFK80332.1|FEATURES|megares|tetracycline|tetR|antibiotic efflux|0
MGYSPVFGKRIKEAVTITKRLTRQQSRQVTREQILRSAAALFAGQGVSGTSVEQIVESAG
YTRGAFYGNFEGKHELVLALLEQRTQHELEEIQAMSREAATFEEMLDHLRSWHRRRDENL
ASWLALRTELWLYGLRDPELLPLLADRERRSRDAIAQSLEQGFAARGVTTPAPVELLALI
VHALDDGLSIQRVLFPSDSGTDSVVDVVELLMKSWTALARSTAPAPAAEPAAEPPTEKLE
KNP
>ACJ05192.1|FEATURES|megares|beta_lactam|OXA-20|antibiotic inactivation|0
LIIRFLALLFSAVVLVSLGHAQEKTHESSNWGKYFSDFNAKGTIVVVDERTNGNSTSVYN
ESRAQQRYSPASTFKIPHTLFALDAGAVRDEFHVFRWDGAKRSX
>WP_000167944.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|0
MTKTKIMGILNVTPDSFSDGGKFNNVETAINRVKAMIDEGADIIDVGGVSTRPGHEMVTL
EEELNRVLPVVEAIVGFDVKISVDTFRSEVAEACLKLGVDMINDQWAGLYDHRMFQIVAK
YDAEIILMHNGNGNRDEPVVEEMLTSLLAQAHQAKIAGIPSNKIWLDPGIGFAKTRNEEA
EVMARLDELVATEYPVLLATSRKRFTKEMMGYDTTPVERDEVTAATTAYGIMKGVRAVRV
HNVELNAKLAKGIDFLKENENARHNLS
>NZ_AEXB01000013|FEATURES|megares|fosfomycin|FosA2|antibiotic inactivation|1
MLQSLNHLTLAVSDLQKSVTFWHELLGLALYARWNTGAYLTCGDLWVCLSYDEARQYVPP
QESDYTHYAFTVAEEDFEPFSQRLEQAGVTVWKQNKSEGASFYFLDPDGHKLELHVGSLA
ARLAACREKPYAGMVFTSDEA
>AEX26000.1|FEATURES|megares|aminoglycoside|aadB|antibiotic inactivation|1
MDTTQVALILQFLAAADERNLPLWIGGGWAIDARLGRVTRKHDDIDLTFPGERRGELEAI
VEMLGGRVTEELDYGFLAEIGDELLDCEPAWWADEAYEIAEAPQGSCPEAAEGVIAGRPV
RCNSWEAIIWDYFYYADEVPPVDWPTKHIESYRLACTSLGAEKVEVLRAAFRSRYAA
>WP_042852888.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MNKQNNYSDDSIQVLEGLEAVRKRPGMYIGSTDKRGLHHLVYEIVDNSVDEVLNGYGNEI
DVTINKDGSISIEDNGRGMPTGIHKSGKPTVEVIFTVLHAGGKFGQSGYKTSGGLHGVGA
SVVNALSEWLEVEIHRDGNIYHQSFKNGGSPSSGLVKKGKTKKTGTKVTFKPDDTIFKAS
TSFNFDVLSERLQESAFLLKNLKITLNDLRSGKERQEHYHYEEGIKEFVGYVNEGKEVLH
DVATFSGEANGIEVDVAFQYNDQYSESILSFVNNVRTKDGGTHEVGFKTAMTRVFNDYAR
RINELKTKDKNLDGNDIREGLTAVVSIRIPEELLQFEGQTKSKLGTSEARSAVDSVVADK
LPFYLEEKGQLSKSLVKKAIKAQQAREAARKAREDARSGKKNKRKDTLLSGKLTPAQSKN
TDKNELYLVEGDSAGGSAKLGRDRKFQAILPLRGKVINTEKARLEDIFKNEEINTIIHTI
GAGVGTDFKIEDSNYNRVIIMTDADTDGAHIQVLLLTFFFKYMKPLVQAGRVFIALPPLY
KLEKGKGKTKRVEYAWTDEELNKLQKELGKGFTLQRYKGLGEMNPEQLWETTMNPETRTL
IRVQVEDELRSSKRVTTLMGDKVQPRREWIEKHVEFGMQEDQSILDNSEVQVLENDQFDE
EEI
>ACO54189.1|FEATURES|megares|sulfonamide|sul1|antibiotic target replacement|1
MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPAD
EIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADC
RLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGLGFFL
SPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGN
GADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA
>CAA54273.1|FEATURES|megares|nitroimidazole|nimD|antibiotic inactivation|1
MFREMPRKRQLLPTEESVAILERMTNGTLALHGDDGYPYAVPVSYVYADGKIYFHSAMQG
PKVDAILRNDKVSFCVVEQDEVKPAEFTTYFRSVIVFGKARILTDENEKRNALNLLADKY
SHGEAGMEAEMAKGFNHLLMIEITVEQMTGKEAIELTRGRNGCS
>AJG01375.1|FEATURES|megares|beta_lactam|OXA-381|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDKKAEKIKNLFNEAHTTGVLVIQQDQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLELLGIL
>ACZ52980.1|FEATURES|megares|trimethoprim|dfrA17|antibiotic target replacement|1
MGVLPNRKYAVVSKNGISGSNENVLVFPSIENALQELSKITDHVYISGGGQIYESLIEKA
DIIHLSTIHVEVEGDIKFPILPEGFNLVFEQFFVSNINYTYQIWKKG
>CAQ45829.1|FEATURES|megares|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGPALRTPHARLWPVLTAAGEPAMLKISSETEEQNSHRLLRWWNGDG
AARLLAHEGPAILIERARGDSLRQRSIEGDDDACTAILCQVLQRLHRPRSAPPAELVCLR
TWFADLLQPRAVLPPLLEQCRSLAEGLLHDEQEIRPLHGDLHHDNVLDFGPRGWLAIDPK
RLLGDRAFDYTTMFSNPDLCGPGIHVATRPERFAIRLEQVCALSELERTRLLRWIAASTA
LSAVWFRDDGDPADIDETVARMALEALAEK
>CAA26631.1|FEATURES|megares|chloramphenicol|cat|antibiotic inactivation|1
MTFNIIKLENWDRKEYFEHYFNQQTTYSITKEIDITLFKDMIKKKGYEIYPSLIYAIMEV
VNKNKVFRTGINSENKLGYWDKLNPLYTVFNKQTEKFTNIWTESDNNFTSFYNNYKNDLF
EYKDKEEMFPKKPIPENTIPISMIPWIDFSSFNLNIGNNSSFLLPIITIGKFYSENNKIY
IPVALQLHHAVCDGYHASLFINEFQDIINKVDDWI
>WP_011766471.1|FEATURES|megares|multidrug|ompR|antibiotic efflux|0
MTNQPDHILIVDDDRDIRSLLADYLEKQGLRCTTAADGREMKAALERHRVDLIVLDLMLP
GEDGLTLCRNLRAGGSHANTPILMLTARGEDMDRIIGLEMGADDYLPKPFVPRELYARVR
AILRRARALPPNLDTQPQAQARELRFAQWRLDTVNRHLIDAQGTVVPLSGAEYRMLGVFL
AHPQRVLSRDQLMELTQGREADVFDRSIDLMVSRLRQRLGDNAREPAIIKTVRNEGYVLS
AEVVAGDGSLSQ
>CCE94501.1|FEATURES|megares|aminoglycoside|AAC(6')-Ib'|antibiotic inactivation|1
VTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESV
TPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRA
LVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERT
RSVA
>ABY60427.1|FEATURES|megares|sulfonamide|sul1|antibiotic target replacement|1
MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPAD
EIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADC
RLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFL
SPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGN
GADYVRTHAPGDLRSAITFSETLAKFRSRDARDTRPADSTRAAATMPHCNKVR
>WP_011246831.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MAKSERYLDLPLEEVIGDRFSRYSKYIIQERALPDARDGLKPVQRRILYAMYNEGNTADK
PYRKAAKTVGNVIGNYHPHGDSSVYEAMVRMSQEWKVREQLIDMHGNNGSVDGDPPAAMR
YTEARLSAISAELMRDLDKGTVDYIPNFDDSIEEPVVLPAMFPNLLVNGSTGISAGYATD
IPPHHLPEIIDGITLLMQKPHTSLDELLEIIKGPDFPTGGIVQGSNGIRQAYETGKGKIV
VRGRTAIEETRGGRKQIVITEIPYEVVKASLVKKMDEIRFDKKVDGIAEVRDDTDRTGMR
IVVELKKEADPEAILHYLFKNTDLQVTYHFNMVAIHNKTPKLMGLLDLMQAYIDHQKQVF
TRRSQFELKKAVDRAHIVEGLMKAVSILDEVIAVIRASKDKKDAKANLQSQFGFTEPQAE
AIVTLQLYRLTNTDITTLQKEAEELEKQIAELKAILASEKKLISVIKKELNQIKKTFASP
RRTEIRAEIEEIKINMDMLIASEDVRVTITKAGYVKRTSLRSYSASSQDGPGMKEGDRLL
LSQEANTTDVVLLFTKRGSYLYVPVHSLPDIRWKDDGQHVANLVAIDADDEIIAAQIIRE
FAETKYLLFMTRAGMAKRSTLNLYQAQRYSKPLMALKLKEGDEVVRVLLTDGQQELFVAT
AFGYGLWFSEEDVSLVGQRAAGVKGINLKEGDYCIGAEAFGLEDSVEFLVATHRGAVKKM
AITEFEKSSRAKRGVLMLRELKNNPHRLVGLKRVRSQDETFAIETAKGDMIAISPRDYRR
ADRYSNGSYAFDQHESGDALTLVRVIQ
>ACO83795.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MVHPVQVGKRTRMSFSRLKEVGQMPNLIEVQLDSYDWFLKEGLQEVFDDINPIQDYTGNL
NLEFVGYKLDLDSIKYSVEECKERDSTYAAPLKVKVRLLNKETGEIKEQEVFMGDFPLMT
EQGTFIINGAERVIVSQLVRSPGVYYDMTVDKTGSKLFSATVIPNRGAWLEYETDSNNII
YVRIDKTRKLPITILARALGYGTDAEIIEFFGEDERLKATIEKDNTKTREEALLEIYKRL
RPGEPPTVDSAESLIESLFFDAKRYDLSRVGRYKFNKKLAIHLRITNQIADQDIVNPQTG
EILVQKGEKIDKDKAIEIQNCGINEVYIKIDDKSFKVIGNHFVDIHSLVPFDISDLNIKE
YVFYPVLKEILDNYADEESIKEEIRKNIYRLIPKHIIREDIYATINYELGLSYDIGYKDD
IDHLGNRRLRSVGELLQNQFRIGLSRMERVVKERMTIQDQEVITPQALINIRPVAASIKE
FFGSSQLSQFMDQTNPLSELTHKRRLSALGPGGLSRERAGFEVRDVHHSHYGRMCPIETP
EGPNIGLINSLATFAKVNEYGFIETPYRRIDPKNKRATNDIVYMTADEEDLYVIARSDEP
IDENGYFIDDKVTVRAKEEVLVVPVSEVEYMDISPRQLVSVATAMIPFLENDDASRALMG
SNMQRQAVPLLKPQAPIVGTGIEYKAATDSGVLPKAKNAGTVVYVSADEIRVRRDSDGGI
DKYKLLKFKRSNQGTCINQRPIVSKGEVVAKETLLADGPSTDLGEIALGKNILMGFITWE
GYNYEDAMLISEQLVKEDVFTSIHIEEYEAEARDTKLGPEEITRDIPNVGEEALKDIDER
GIIRIGAEVRSGDILVGKVTPKGETELTAEERLLRAIFGEKAREVRDTSLRVPHGEAGII
VDVKIFTRENGDELPPGVNKLVRCYIAQKRKISVGDKMAGRHGNKGVISRVLPEEDMPFL
PDGRPLQICLNPLGVPSRMNIGQVLEVHLGLAASKLGWHIATPVFDGAIESDIVDCLRKA
GYSEDGKTVLYDGRTGEPFDNRVTVGYMYILKLAHLVDDKIHARSTGPYSLVTQQPLGGK
AQFGGQRFGEMEVWALEAYGAAHTLQEILTVKSDDVVGRVKTYEAIVKGENIPEPGVPES
FKVLIKELQALCLDVKVLNDDNQEIKLKESVDEDADELEVNIEGTENQPEEKEEKEKEDS
DEYDDLREEDVEPDLEELSLDDLDLDDFGDEH
>AAQ76279.1|FEATURES|megares|beta_lactam|OXA-50|antibiotic inactivation|1
MRPLLFSALLLLSGHAQASEWNDSRAVDKLFGAAGVKGTFVLYDVQRQRYVGHDRERAET
RFVPASTYKVANSLIGLSTGAVRSADEVLPYGGKPQRFKAWEHDMSLRDAIKASNVPVYQ
ELARRIGLERMRANVSRLGYGNAEIGQVVDNFWLVGPLKISAMEQTRFLLRLAQGELPFP
APVQSTVRAMTLLESGPGWELHGKTGWCFDCTPELGWWVGWVKRNERLYGFALNIDMPGG
EADIGKRVELGKASLKALGILP
>ACH58979.1|FEATURES|megares|tetracycline|tetR|antibiotic efflux|0
MPKVLSDEDVGEFRQRLLKTAEAAFATHGVDGVSMRQLAQQLGCSATTPYRYFKNKDEIL
AAVTAAALNRFSATLEKAFAAKGSSAEKAVAVRKAYIRFAFKNPKAYRLMFDAPHPSLLD
YADLSEASSRADRIMAAPLALLAQEGIVKGDSRLLGRVFWSAIHGAVSLQLAGKLAAKPT
FEAVLEQTLQLIMAGAMATRHSA
>WP_011246832.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MAKQHVEYNEDAIQVLEGLEAVRKRPGMYIGSTDVRGLHHLVYEIVDNAVDEALGGYGNT
IKVTIHKDQSVSIEDEGRGMPVGMHRSGKPTPEVIFTVLHAGGKFGQGGYATSGGLHGVG
ASVVNALSEWLEVEIKRDGYRYTQRFEQGGKPVTTLEKKGKTRASGTTVRFKPDEGIFST
IQFNSEILAERLREAAFLLKGVQIELTDKRPEKELHEVFKFDTGLEAFVDYLNEGKEALH
PVVSFSGSANDIQMDFSFQFHDAYTENVLSFVNNVRTRDGGTHELGAKTAMTRIMNEHAR
KIGVLKEKDKNLDGSDIREGFTAVVSVRVPEAKLQFEGQTKSKLGTPEARSAVDAIVSEN
LSYFLEENPAVATMLLKKAMKAAQAREAARKAREDARNGKKNKRKDVLLSGKLTPAQSRN
PARNELYLVEGDSAGGSAKQGRDRKFQAVLPLRGKVINTEKAKLDDIMKNEEIRTIIHTI
GAGVGADFDSADCNYDKVVIMTDADTDGAHIQVLLLTFFYRYMKPLIDEGKIYIALPPLY
KVSKGSGKKEQVEYAWDENELQAALKKVGRGSTVQRYKGLGEMNATQLWETTMDPATRTL
IRVRLEDAARAEKHVATLMGDKVEPRRKWIESHVAFGLEEDTNILENENLQVGEEA
>AAP93923.1|FEATURES|megares|tetracycline|tetR|antibiotic efflux|0
MSEKNTAARLTRETVLRGALALLDDIGIDALSTRRLAQHLGVQSPTLYWHFKNKAELLKA
MAETIMLDHREEVPADMPWQAWVTANAINFRRALLAYRDGARLHAGTRPQEPQFAIIEAK
VALLCRAGFTPEHAVNLLFAVGRFVVGWVLEEQQMQPDDALNEADRRRYPLLCGGWEKLQ
DKGADALFEAGLRLLVDGAEAALTNANNHGAQS
>ABR77935.1|FEATURES|megares|multidrug|asmA|antibiotic inactivation|0
MILLAVIVAGLTSLVLLVNPNDFRAYMVHEVAERSGYQLDLDGPLRWHVWPQLSILSGRM
TLTARGAEEPVIRADNMRLDVALLPLLSHQLQVKQVMLKGAVIQLTPKTEAVRDSSAPVV
PHDNTLPLAPEDRGWSYDVRQLQVADSVLFFQHENGEQVTVRDIRLQMEQDENHRATVDF
SGRVNRDQRDLALNFSATVQGGDYPHSLKADFTQLSWQLRGAELPPDGINGQGSLQASWQ
EDDKTLRFDNLNLMANRSTVTGSGSVVLGDRPDWSLDLHATTLDLDSLLAQRSPATDSSA
SQQGQSQTRPLRPVIADSDEREDYQSLRGFNGRMALSADQLQWRGLNFTQVQSEISNQQG
LLTVSKMQGNLDGGQLSLPGTLDARGDTPLATFQPALQNVEIGSLIKAFNYSLNLTGKLS
LSGEFSGTRIDADDFRRHWQGQAQLQMADTRTEGLNFQQLVQQAVERSTNVRAQENYDNA
TRLDSVSSRLTLDNGLVTLNRLQGQSDVMAMTGEGQLDLQKENCDMRFNVRVLGGWKGEG
KLIDRLKQTAIPLRIYGEWQSLSYSLQVDQILRKQLQDEAKQRLNDWVERNKGSKDGNDA
KKLLDKL
>AFK58770.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MYIGSTDSRGLHHLVYEIVDNAVDEALSGYGSEIDVTIHEDNSITVADSGRGMPVGMHAS
GIPTVEVIFTVLHAGGKFGQGGYKTSGGLHGVGASVVNALSKWLIVTIVRDGVEYQQKFK
NGGKPDGTLKKIGKTKKANGTTVHFLPDDTIFSTTKFSYEILAERLRESAFLLKGVKISL
SDLRGEEPVKEIFHYEEGIKEFVDYLNEEKDTLTPVVYFSGEKEGIEVEVAYQYNDGYSE
NVLSFVNNVRTKDGGTHEAGMKAAMTKSYNEYARKVGLLKERDKNLEGSDFREGLAAVLS
IRVPENLLQFEGQTKEKLGTPVARTVVDNVISEQMGFYLQENSEMSQMLVRKAIKAREAR
EAARKAREESRNGKKRKKGESLLSGKLTPAQSRNPKKNELYLVEGDSAGGSAKQGRDRKF
QAILPLRGKVINTEKAKMQDILKNEEINTMIYTIGAGVGPEFSIEDCNYDKVIIMTDADT
DGAHIQVLLLTFFYRYMKPLIEAGKVYIALPPLYKVSKGQGKKQVIEYAWTDDELAAMIK
KVGKGYMLQRYKGLGEMNAEQLWETTMDPTSRTLIRVRIDDAAQAERRVTTLMGDKVEPR
RKWIENHVQFTLEEDGSILDKKEDTEISPSVSNDLLDEERADKNENNQLFEVE
>WP_000116444.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MSVSEIRPIAIEDELKHSYLDYAMSVIVSRALPDVRDGLKPVHRRVLYAMHELGNDYNKA
YKKSARVVGDVIGKYHPHGDLAVYETIVRMAQDFSLRYLLVDGQGNFGSIDGDSAAAMRY
TEVRMTKLAHELLADLEKDTVDWEDNYDGSERIPEVLPTRVPNLLINGAAGIAVGMATNM
APHNMTEVVNACLAYADNPNISIEGLMEYITGPDFPTGGIIYGKSGIVDAYRTGKGRLHI
RGKYHFEEDEKTGRTTIVFTEIPYQVNKARVIERIAELVKEKKLEGISELRDESDKEGMR
IAIDLKRGENAEVVVNNLFLNTQLENSFSINMVCLDNGQPKLMNLKDIIAAFIRHRQEVV
TRRTMFELRKARERGHILEGLTVALANIDEIIETIKTSANPAEARERLLAGEWAGGGVVA
LLEKAGAISVRPDEIEGEDPNRPFGLSDSFYRLSPTQVGAILELRLHRLTGLEQDKLHAE
YTEILGQIAELTAILNDFNLLMGVIREELAQVLQQYGDARRTEIVESRVDFCREDLIPEE
QVVLTVSQTGYAKTQPLSDYQAQRRGGRGKSATSMKDDDFIQHLIVASNHATVLCFTNVG
KVYRLKVFEVPQASRGAKGRPIVNLLPLDATETVTAILPLTEFPENHYVFMATASGTVKR
VELEQFANIRSNGLRAIELNEEDTLIGVAITDGNQQIMLFSNEGKAIRFAETDVRAMGRT
AKGVRGMRVSFASSTLSEEDADVENDDSDDNDDSTDSSLVSRIVSLVVVPETGEVLCASA
NGYGKRTPVNDFPTKKRGGKGVIAIKTSERNGELVGAVSIDETKELLLISDGGTLVRTRA
AEVAMTGRNAQGVRLIRLSEEETLVGVVSIEAVEDEEELLEGEVDTTETDSEEAVSNNED
TSEE
>AAK60187.1|FEATURES|megares|aminoglycoside|ant3-dprime|antibiotic inactivation|1
MTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRR
ALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
AMIDIGLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDER
NVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRAD
HLEEFIRFVKGEIIKSVGK
>NP_252960.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MAYSYTEKKRIRKDFSKLPDVMDVPYLLAIQLDSYREFLQAGATKEQFRDVGLHAAFKSV
FPIISYSGNAALEYVGYRLGEPAFDVKECVLRGVTFAVPLRVKVRLIIFDRESSNKAIKD
IKEQEVYMGEIPLMTENGTFIINGTERVIVSQLHRSPGVFFDHDRGKTHSSGKLLYSARI
IPYRGSWLDFEFDPKDCVFVRIDRRRKLPASVLLRALGYSTEEILNAFYATNVFHIKGET
LNLELVPQRLRGEVASIDIKDGSGKVIVEQGRRITARHINQLEKAGVSQLEVPFDYLIGR
TIAKAIVHPATGEIIAECNTELTLDLLAKVAKAQVVRIETLYTNDIDCGPFISDTLKIDN
TSNQLEALVEIYRMMRPGEPPTKEAAETLFGNLFFSAERYDLSAVGRMKFNRRIGRTEIE
GPGVLSKEDIIDVLKTLVDIRNGKGIVDDIDHLGNRRVRCVGEMAENQFRVGLVRVERAV
KERLSMAESEGLMPQDLINAKPVAAAIKEFFGSSQLSQFMDQNNPLSEITHKRRVSALGP
GGLTRERAGFEVRDVHPTHYGRVCPIETPEGPNIGLINSLATYARTNKYGFLESPYRVVK
DSLVTDEIVFLSAIEEADHVIAQASATLNEKGQLVDELVAVRHLNEFTVKAPEDVTLMDV
SPKQVVSVAASLIPFLEHDDANRALMGSNMQRQAVPTLRADKPLVGTGMERNVARDSGVC
VVARRGGVIDSVDASRVVVRVADDEVETGEAGVDIYNLTKYTRSNQNTCINQRPLVSKGD
VVARGDILADGPSTDMGELALGQNMRVAFMPWNGFNFEDSICLSERVVQEDRFTTIHIQE
LTCVARDTKLGPEEITADIPNVGEAALNKLDEAGIVYVGAEVQAGDILVGKVTPKGETQL
TPEEKLLRAIFGEKASDVKDTSLRVPTGTKGTVIDVQVFTRDGVERDSRALSIEKMQLDQ
IRKDLNEEFRIVEGATFERLRAALVGAKAEGGPALKKGTEITDDYLDGLERGQWFKLRMA
DDALNEQLEKAQAYISDRRQLLDDKFEDKKRKLQQGDDLAPGVLKIVKVYLAIKRRIQPG
DKMAGRHGNKGVVSVIMPVEDMPHDANGTPVDIVLNPLGVPSRMNVGQILETHLGLAAKG
LGEKINRMLEEQRKVAELRKFLHEIYNEIGGREENLDELGDNEILALAKNLRGGVPMATP
VFDGAKEREIKAMLKLADLPESGQMRLFDGRTGNQFERPTTVGYMYMLKLNHLVDDKMHA
RSTGSYSLVTQQPLGGKAQFGGQRFGEMEVWALEAYGAAYTLQEMLTVKSDDVNGRTKMY
KNIVDGDHRMEAGMPESFNVLIKEIRSLGIDIELETE
>AEM66521.1|FEATURES|megares|multidrug|floR|antibiotic efflux|1
MTDKQKQRPAWAYTLPAALLLMAPFDILASLAMDIYLPVVPAMPGILNTTPAMIQLTLSL
YMVMLGVGQVIFGPLSDRIGRRPILLAGATAFVIASLGAAWSSTAPAFVAFRLLQAVGAS
AMLVATFATVRDVYANRPEGVVIYGLFSSMLAFVPALGPIAGVLIGEFLGWQAIFITLAI
LAMLALLNAGFRWHETRPLDQVKTRRSVLPIFASPAFWVYTVGFSAGMGTYFVFFSTAPR
VLIGQAEYSEIGFSFAFATVALVMIVTTRFAKSFVARWGIAGCVARGMALLVCGAVLLGI
GELYGSPSFLTFILPMWVVAVGIVFTVSVTANGALAEFDDIAGSAVAFYFCVQSLIVSIV
GTLAVALLNGDTAWPVICYATAMAVLVSLGLVLLRLRGAATEKSPVV
>AJG01379.1|FEATURES|megares|beta_lactam|OXA-208|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDDKAEKIKNLFNEAHTTGVLVIHQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWNGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSDEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>BAB86848.1|FEATURES|megares|chloramphenicol|catII|antibiotic inactivation|1
MNFTRIDLNTWNRREHFALYRQQIKCGFSLTTKLDITALRTALAETDYKFYPVMIYLISR
VVNQFPEFRMAMKDNALIYWDQTDPVFTVFHKETETFSALFCRYCPDISEFMAGYNAVMA
EYQHNTALFPQGALPENHLNISSLPWVSFDGFNLNITGNDDYFAPVFTMAKFQQEDNRVL
LPVSVQVHHAVCDGFHAARFINTLQMMCDNILK
>ABS43870.1|FEATURES|megares|quinolone|rpoB|antibiotic target alteration|0
MENIFSKDSDIELVDIENSIKSSYLDYSMSVIIGRALPDARDGLKPVHRRILYAMQNDEA
KSRTDFVKSARIVGAVIGRYHPHGDTAVYDALVRMAQDFSMRYPSITGQGNFGSIDGDSA
AAMRYTEAKMSKLSHELLKDIDKDTVDFVPNYDGSESEPDVLPSRVPNLLLNGSSGIAVG
MATNIPPHSLNELIDGLLYLLDNKDVSLEEIMQFIKGPDFPTGGIIYGKKGIIEAYRTGR
GRVKVRAKTHIEKKTNKDVIVIDELPYQTNKARLIEQIAELVKEKQIEGISEVRDESNKE
GIRVVIELKREAMSEIVLNNLFKSTTMESTFGVIMLAIHNKEPKIFSLLELLNLFLTHRK
TVIIRRTIFELQKARVRAHILEGLKIALDNIDEVIALIKNSSDNNTARDSLVAKFGLSEL
QANAILDMKLGRLTGLEREKIENELAELMKEIARLEEILKSETLLENLIRDELKEIRSKF
DVPRITQIEDDYDDIDIEDLIPNENMVVTITHRGYIKRVPSKQYEKQKRGGKGKLAVTTY
DDDFIESFFTANTHDTLMFVTDRGQLYWLKVYKIPEGSRTAKGKAVVNLINLQAEEKIMA
IIPTTDFDESKSLCFFTKNGIVKRTNLSEYQNIRSIGVRAINLNENDELVTAIIVQRDED
EIFASGGEENLENQEIENLDDENLENEESASTQGKMLFAVTKKGMCIKFPLVKVREIGRV
SRGVTAIKFKEKNDELVGAVVIENDEQEILSVSAKGIGKRTNAGEYRLQSRGGKGVICMK
LTEKTKDLISVVIVDETMDLMALTSSGKMIRVDMQSIRKAGRNTSGVIVVNVENDEVVSI
AKCPKEENDEDELSDENFGLDL
>AFH54425.1|FEATURES|megares|macrolide-lincosamide-streptogramin|ErmB|antibiotic target alteration|1
MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGNIPYHLSTQIIKKVVFESHAS
DIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTT
DVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTVTYEQVLSIFNSYLL
FNGRK
>CBA33605.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MSDLTHDGAERLALHEFTENAYLNYSMYVIMDRALPFIGDGLKPVQRRIVYAMSELGLNA
SAKFKKSARTVGDVLGKYHPHGDSACYEAMVLMAQPFSYRYPLVDGQGNWGAPDDPKSFA
AMRYTESRLSKYAEVLLGELGQGTVDYVPNFDGTLNEPKMLPARLPNILLNGTTGIAVGM
ATDIPPHNLREVAKAAVSLIDSPKTTLDELLDIVQGPDYPTEAEIITSRAEIRKIYQSGR
GSVRMRAVWKKEDGAVVISALPHQVSGARVLEQIASQMRAKKLPMVDDLRDESDHENPTR
LVIVPRSNRVDMDQVMNHLFATTDLEKSYRINLNMIGLDGRPAVKNLLEILTEWLVFRRD
TVRRRLNYRLDKVMRRLHILEGLLVAFLNIDEVIEIIRGEDEPKPVLMSRFGISETQAEA
ILELKLRHLAKLEEMKIRGEQSDLEKERDQLQGILASERKMNTLLKKEIQADADAYGDDR
RSPLHEREEAKAMSEHDMLPSEPVTIVLSQMGWVRSAKGHDIDAKALSYKAGDNWLSSAK
GKTNQPVVFIDSTGRSYALDPVSLPSARGQGEPLTGKLTLPPGAVVEHMLMTGEDQKLLM
ASDAGYGFVCTFNDLVARNRAGKALITLPENAHVLKPLEIEHDDDMLLAITAAGRMLMFP
VADLPQLSKGKGNKIISIPSADAAKGDDKLAYLTILPPQSTVTLHVGKRKIKLRPEELQK
VHGERGRRGTLMRGLQRIDSVEVDAPSRPKADDGEA
>CAD57197.1|FEATURES|megares|sulfonamide|sul1|antibiotic target replacement|1
MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHSNARPVSPAD
EIRRIGPLLDALSDQMHRVSINSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADC
RLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFL
SPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGN
GADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA
>CAI29521.1|FEATURES|megares|trimethoprim|dfrA15|antibiotic target replacement|1
MAAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYAVVTRS
SFTSSDENVLVFPSIDEALNHLKTITDHVIVSGGGEIYKSLIDKADTLHISTIDIEPEGD
VYFPEIPGSFRPVFSKDFVSNINYSYQIWQKG
>CBB44503.1|FEATURES|megares|macrolide-lincosamide-streptogramin|vgaA|antibiotic target protection|1
MKIMLEGLHIKHYVQDRLLLNINHLKIYQNDRIGLVGKNGNGKTTLLHILYKKIVPEEGI
VKQFSHCELIPQLKLIESTKSGGEVTRNYIRQALDKNPELLLADEPTTNLDNNYIEKLEQ
DLKNWHGAFIIVSHDRAFLDNLCTTIWEIEEGRITEYKGNYSKYVEQKELERHREDLEYE
KYEKEKKRLEKAINIKEQKAQRATKKPKNLSSSEGRIKGTKPYFAGKQKKLRKTVKSLET
RLEKLESVEKRNELPPLKMDLVNLESVKNRTIIRGEDVSGTIEGRVLWKAKSFSIRGGDK
MAIIGSNGTGKTTFIKKIVHGNPGISLSPSVKIGYFSQKIDTLELDKSILENVQSSSQQN
ETLIRTILARMHFFRDDVYKPINVLSGGERVKVALTKVFLSEVNTLVLDEPTNFLDMEAI
EAFESLLKEYNGSIIFVSHDRKFIEKVATRIMTIDNKEIKIFDGTYEQFKQAEKPTRNIK
EDKKLLLETKITEVLSRLSIEPSEELEQEFQNLINEKRNLDK
>CAJ29622.1|FEATURES|megares|sulfonamide|sul1|antibiotic target replacement|1
MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPAD
EIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADC
RLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRVILDPGMGFFL
RPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGN
GADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA
>CBA32359.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MSDLAREITPVNIEEELKNSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAMNVLGNDWN
KAYKKSARVVGDVIGKYHPHGDSAVYDTIVRMAQPFSLRYTLVDGQGNFGSIDGDSAAAM
RYTEIRLAKIAHELMADLDKETVDFVDNYDGTEKIPDVMPTKIPNLLVNGSSGIAVGMAT
NIPPHNLTEVINGCLAYIDDEDISIEGLMEHIPGPDFPTSAIINGRRGIEEAYRTGRGKI
YIRARAEVEVDPKNGRETIIVHEIPYQVNKARLIEKIAELVKDKRVEGISALRDESDKDG
MRIVIEIKRDAVGEVVLNNLYSQTQLQVSFGINMVALHHGQPKIMALKEILAAFVRHRRE
VVTRRTIFELRKARERAHILEGLAIALANIDPIIELIRRAPNPSEAKAGLIAQAWELGTV
SAMLERAGDDAARPEWLEPEFGIRDGKYWLTEQQAQAILDLRLQKLTGLEHEKLLDEYKE
LLEQIAELLHILGSADRLMEVIREELELIRDQFGDERRTEITANSADINIEDLINQEDVV
VTLSHQGYVKYQPLTDYEAQRRGGKGKSAARIKEEDFIDRLLVANTHDTILCFSSRGRLY
WMKVYQLPEASRGARGRPIVNLLPLEANERITAILPVREYEEGVNVFMATASGTVKKTAL
TEFSRPRTAGIIAVNLNEGDELIGVDLTAGKDEVMLFSAQGKVVRFKEDAVRPMGRTATG
VRGIRLGEGDSVVSLIVPRGEGAILTATQNGYGKRTAVEEYPTKSRATKGVISIKVTDRN
GPVVGAVQVDDADQIMMITDAGTLVRTRVSEISVVGRNTQGVILIRTAEDENVVGLQRVA
EPVDDEELDSIDGSVAEGDDEIAPETDVDDDAADDADE
>ABX45064.1|FEATURES|megares|beta_lactam|OXA-70|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDKKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWNGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQHEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVRPQG
NIVAFSLNLEMKKGIASSVRKEITYKSLEQLGIL
>YP_002343912.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MCDMLDNKLGNRLRVDFSNISKQIEIPNLLQLQKKSFDYFLNLDNGESGIEKVFKSIFPI
HDPQNRLSLEYVSSEIGKPKYTIRECMERGLTYSVNLKMKIRLTLHEKDEKTGEKVGVKD
IKEQEIYIREIPLMTDRVSFIINGVERVVVNQLHRSPGVIFKEEESSTVANKLVYTAQII
PDRGSWLYFEYDAKDVLYVRINKRRKVPVTMLFRALGYKKQDIIKLFYPIQTIHVKKDKF
LTEFNPNDFMDRIEYDIKDEKGKIVHQAGKRLTKKKAEQLIKDGLKWIEYPVEILLNRYL
ANPIIDKESGEVLFDSLTLLDESKLAKIKEQKSFDIANDLANGVDAAIINSFAQDGETLK
LLKQSENIDDENDLAAIRIYKVMRPGEPVVKDAAKAFVNDLFFNPERYDLTKVGRMKMNH
KLGLEVPEYVTVLTNEDIIKTAKYLIKVKNGKGHIDDRDHLGNRRIRSIGELLANELHLG
LAKMQKAIRDKFTSLNADLDKVMPYDLINPKMITTTIIEFFTGGQLSQFMDQTNPLSEVT
HKRRLSALGEGGLVKERAGFEVRDVHATHYGRICPVETPEGQNIGLINTLSTYAKVNELG
FVEAPYRKVVNGKVTNEVVYLTATQEEGLFIAPASTKVDAKGNIVEEFVEARQDGETILA
RREEVQLIDLCSGMVVGVAASLIPFLEHDDANRALMGSNMQRQAVPLLTASAPIVGTGME
QIIARDAWEAVKAKRGGVVEKVDNKSIFILGEDDKGPFIDHYTMEKNLRTNQNTNYIQHP
IVKKGDIVKAGQIIADGPSMDQGELAIGKNALIAFMPWNGYNYEDAIVVSERIIREDTFT
SVHIYEKEIEARELKDGIEEITKDIPNVKEEDVAHLDESGIAKIGTHIKPGMILVGKVSP
KGEVKPTPEERLLRAIFGEKAGHVVNKSLYATASLEGVVVDVKIFTKKGYEKDDRAIKSY
DKEKMALEKEHHDRLLMMDREEMLRVCALLSKASLNSDQKIGDKNYKKGQTADISELEKI
NRFTLTTLIKAYSKEIQKEYDDLKNHFQNEKKKLKAEHDEKLEILEKDDILPSGVIKLVK
VYIATKRKLKVGDKMAGRHGNKGIVSTIVPEVDMPYLPNGKSVDIALNPLGVPSRMNIGQ
ILESHLGLVGLRLGDQIQEIFDRKQKDFLKELRAKILEICSIPRLANEKEFIKSLSDEEL
LNYARDWSKGVKFSTPVFEGVNIEEFSKLFKMAKIDMDGKTELYDGRTGEKIAERVHVGC
MYMLKLHHLVDEKVHARSTGPYSLVTQQPVGGKALFGGQRFGEMEVWALEAYGAAHTLRE
MLTIKSDDVEGRFSAYKALTKGENVPATGIPETFFVLTNELKSLALDVEIFDKDEDNE
>AAG34545.1|FEATURES|NCBI|bleomycin|bleomycin|antibiotic inactivation|1
DQATPNLPSRDFDSTAAFYERLGFGIVFRDAGWMILQRGDLKLEFFAHPGLDPLASWFSC
CLRLDDLAEFYRQCKSVGIQETSSGYPRIHAPELQEWGGTMAALVDPDGTLLRLIQN
>WP_021018480.1|FEATURES|NCBI|bleomycin|bleomycin|antibiotic inactivation|1
DQATPNLPSRDFDSTAAFYEKLGFRSVFRDSGWMILQRGDLILEFFAHPELDPLASWFSC
CLRLDDLAGFYERCKSVGIQETSRGYPRIHAPELQEWGGTMAALVDSDGTLLRLIQN
>SEP37262.1|FEATURES|NCBI|bleomycin|bleomycin|antibiotic inactivation|1
DHATPNLPSRDFDATIAFYERLGFRAGFRDTGWMILEREGLVLEFFAYPELDPLTSWFSC
CLRLDHLAEFYAQCKAAGIPESANGNPRLHAPKAQECGGIMAALIDLDGTLLRLIAN
>WP_000349358.1|FEATURES|NCBI|bleomycin|bleomycin|antibiotic inactivation|1
DHATPNLPSRDFDATVAFYERLGFRLRFRDTGWMILERGGLVLEFLRHPELDPLTSWFSC
CLRLDDLAGFYAHCEAAGITEATKGYPRLHAPQAQEWGGTMAALIDLDGTLLRLIAN
>WP_018641422.1|FEATURES|NCBI|bleomycin|bleomycin|antibiotic inactivation|1
DLAIPNLPSRSFDRTQEFYRRLGFTLAYRDDEWMILNRGRVVLEFFAHPGLDPLASWFSC
CLRLDELSEFYELCKSAGLEEKGSGYPRLHPPEEQDGGGRMGALIDLDGTLLRLIQN
>NG_047757.1|FEATURES|NCBI|trimethoprim|dfrI|antibiotic target replacement|1
MNQNRDDHNRAADREKTAEKRGENQCIISLILAMADNGTIGDKNALPWHLPNDLQFLKKS
TMGKPIVMGRKTYQSIGRPLPGRTNVVISRSLEKEALPGCLIYSDLSVAIAALKKEPEVE
EIMIMGGAQIYRAALPMMDRLYLTHVHANIEGDTQMPPFDFSHATLIFEEKHFKDEKNRY
DYTFEIWDFKK
>SCJ62418.1|FEATURES|NCBI|aminoglycoside|APH(2'')-IIa|antibiotic inactivation|1
MVNLDAEIYEHLNKQIKINELRYLSSGDDSDTFLCNEQYVVKVPKRDSVRISQKRELELY
RFLENCKLSYQIPAVVYQSDRFNIMKYIKGERITYEQYHKLSEKEKDALAYDEATFLKEL
HSIEIDCSVSLFSDALVNKKDKFLQDKKLLISILEKEQLLTDEMLEHIETIYENILNNAV
LFKYTPCLVHNDFSANNMIFRNNRLFGVIDFGDFNVGDPDNDFLCLLDCSTDDFGKEFGR
KVLKYYQHKAPEVAERKAELNDVYWSIDQIIYGYERKDREMLIKGVSELLQTQAEMFIF
>WP_002592615.1|FEATURES|NCBI|aminoglycoside|APH(2'')-IIa|antibiotic inactivation|1
MIDLDVEIYQHLNEQIKINKLCYLSSGDDSDTFLCNEQYVVKVPKRDSVRFAQKREFELY
RFLENCNLSYQTPAVVYQSDRFNIMKYIKGERITYEQYHKLSEKEKDALAYDEATFLKEL
HSIEIDCSVSLFSDALVNKKDKFLQDKKLLISILEKEQLLTDEMLEHIETIYENILSNAV
LFKYTPCLVHNDFSANNMIFRNNRLFGVIDFGDFNVGDPDNDFLCLLDCSTDDFGKEFGR
KVLKYYQHKAPEVAERKAELNDVYWSIDQIIYGYERKDREMLIKGVSELLQTQAEMFIF
>AGV79345.1|FEATURES|NCBI|aminoglycoside|APH(2'')-IIa|antibiotic inactivation|1
MIDLDVEIYQHLNEQIKINKLCYLSSGDDSDTFLCNEQYVVKVPKRDSVRFAQKREFELY
RFLENCNLSYQTPAVVYQSDRFNIMKYIKGERITYEQYHKLSEKEKDALAYDEATFLKEL
HSIEIDCSVSLFSDALVNKKDKFLQDKKLLISILEKEQLLTDEMLEHIETIYENISSNAV
IFNYIPCLVHNDFSANNLIFRNNRLFGVIDFGDFNVGDPDNDFLCLLDCSTDDFGKEFGR
KVLKYYQHKAPEVAERKAELNDVYWSIDQIIYGYERKDREMLIKGVSELLQTQAEMFIF
>WP_033639326.1|FEATURES|NCBI|aminoglycoside|ERS381432_03028|antibiotic inactivation|1
MIVNCDHDNLDAWLALRSALWPTCPLEEHRAEMREILASPHHTAFMARGLDGAFVGFAEV
ALRHDYVNGCESSPVAFLEGIYTAERARRQGWAARLIAQVQEWAKQQGCSELASDTDIAN
LDSQRLHAALGFAETERVVFYRKTLG
>WP_021505085.1|FEATURES|NCBI|aminoglycoside|SMDB11_3538|antibiotic inactivation|1
MIVNCDHDNLDAWLALRAALWPTCPLEEHRAEMREILASPHHTAFMARGLDGAFVGFAEV
ALRHDYVNGCESSPVAFLEGIYTVERARRQGWAARLIAQVQEWAKQQGCSELASDTDIAN
LDSQRLHAALGFAETERVVFYRKTLG
>WP_046687856.1|FEATURES|NCBI|aminoglycoside|SMDB11_3538|antibiotic inactivation|1
MIVNCDHDNLDAWLALRSALWPTCLREEHRAEMREILASPHHTAFMARGLDGAFVGFAEI
ALRYDYVNGCESSPVAFLEGIYTVERARRQGWAARLIAQVQEWAKQQGCSELASDTDIAN
LDSQRLHAALGFAETERVVFYRKMLG
>WP_047026538.1|FEATURES|NCBI|aminoglycoside|SMDB11_3538|antibiotic inactivation|1
MIVNCDHDNLDAWLALRSALWPTCPREEHRAEMREILASPHHTAFMARGLDGAFVGFAEV
ALRYDYVNGCESSPVAFLEGIYTVERARRQGWAARLIAQVQEWAKQQGCSELASDTDIAN
LDSQRLHAALGFAETERVVFYRKTLG
>WP_048325528.1|FEATURES|NCBI|aminoglycoside|JL05_07470|antibiotic inactivation|1
MIVICDHDNLDAWLALRSALWPTCPLEEHRAEMREILASPHHTAFMARGLDGAFVGFAEV
ALRYDYVNGCESSPVAFLEGIYTVECARRQGWATRLIAQVQEWAKQQGCSELASDTDIAN
LDSQRLHAALGFAETERVVFYRKTLG
>WP_049204401.1|FEATURES|NCBI|aminoglycoside|SMDB11_3538|antibiotic inactivation|1
MIVNCDHDNLDAWLALRSALWPTCPLEEHRAEMREILASPHHTAFMARGLDGAFVGFAEV
ALRYDYVNGCESSPVAFLEGIYTVERARRQGWATRLIAQVQEWAKQQGCSELASDTDIAN
LDSQRLHAALGFAETERVVFYRKTLG
>WP_049241494.1|FEATURES|NCBI|aminoglycoside|SMDB11_3538|antibiotic inactivation|1
MIVNCDHDNLDAWLALRSALWPTCPLEEHRAEMREILASPHHTAFMARGLDGVFVGFAEV
ALRHDYVNGCESSPVAFLEGIYTVEHARRQGWAARLIAQVQEWAKQQGCSELASDTDIAN
LDSQRLHAALGFAETERVVFYRKTLG
>WP_004937175.1|FEATURES|NCBI|aminoglycoside|SMDB11_3538|antibiotic inactivation|1
MIVNCDHDNLDAWLALRSALWPTCPLEEHRAEMHEILASPHHTAFMARGLDGVFVGFAEV
ALRHDYVNGCESSPVAFLEGIYTVERARRQGWAARLIAQVQEWAKQQGCSELASDTDIAN
LDSQRLHAALGFAETERVVFYRKTLG
>WP_049189080.1|FEATURES|NCBI|aminoglycoside|SMDB11_3538|antibiotic inactivation|1
MIVNCDHDNLDAWLALRSALWPTCPLEEHRAEMREILASPHHTAFMARGLDGVFVGFAEV
ALRHDYVNGCESSPVAFLEGIYTVERARRQGWATRLIAQVQEWAKQQGCSELASDTDIAN
LDSQRLHAALGFAETERVVFYRKTLG
>WP_044030410.1|FEATURES|NCBI|aminoglycoside|ERS381446_03540|antibiotic inactivation|1
MIVNCDHDNLDAWLALRAALWPSSSPEEHRAEMREILASPHHTAFMARGPDGVFVAFAEV
ALRYDYVNGCESSPVAFLEGIYTVERARRQGWAARLIAQVQEWAKQQGCSELASDTDIAN
LDSQRLHAALGFAETERVVFYRKTLG
>WP_039569351.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Ic|antibiotic inactivation|1
MIVICDHGNLDAWLALRTALWPSGSPEEHRAEMREILASPHHTAFMARGLDGTFVAFAEV
ALRYDYVNGCESSPVAFLEGIYTTERARRQGWAARLIAQVQEWAKQQGCSELASDTDIAN
LDSQRLHAALGFAETERVVFYRKTLG
>WP_019453091.1|FEATURES|NCBI|aminoglycoside|AAY84_08625|antibiotic inactivation|1
MIVICDHDNLDAWLALRAALWPSSSPEDHRAEMREILASPHHTAFMARGLDGAFIGFAEV
ALRYDYVNGCESSPVAFLEGIYTVERARRQGWATRLIAQVQEWAKQQGCSELASDTDIAN
LDSQRLHAALGFAETERVVFYRKTLG
>WP_048234935.1|FEATURES|NCBI|aminoglycoside|ERS381490_00812|antibiotic inactivation|1
MIVICDHDNLDAWLALRTALWPSSSPEDHRAEMREILASPHHSAFMARGLDGAFVGFAEV
ALRYDYVNGCESSPVAFLEGIYTVEGARRQGWAARLIAQVQEWAKQQGCSELASDTDIAN
LDSQRLHAALGFAETELVVFYRKTLV
>WP_049198488.1|FEATURES|NCBI|aminoglycoside|ERS381446_03540|antibiotic inactivation|1
MIVICDHDNLDAWLALRTALWPSSSPEEHRAEMREILASPHHTAFMARGLDGAFVGFAEV
ALRYDYVNGCESSPVAFLEGIYTVERARRQGWAARLIAQVQEWAKQQGCSELASDTDIAN
LDSQRLHAALGFAETERVVFYRKTLG
>WP_033636082.1|FEATURES|NCBI|aminoglycoside|ERS381446_03540|antibiotic inactivation|1
MIVICDHDNLDAWLALRSALWPSSSPEAHRAEMREILASPHHTAFMARGLDGAFVGFAEV
ALRYDYVNGCESSPVAFLEGIYTVERARRQGWAARLIAQVQEWAKQQGCSELASDTDIAN
LDSQRLHAALGFAETERVVFYRKTLG
>NP_863640.1|FEATURES|NCBI|qa_compound|qacD|antibiotic efflux|1
MPYIYLIIAISTEVIGSAFLKSSEGFSKFIPSLGTIISFGICFYFLSKTMQHLPLNITYA
TWAGLGLVLTTVVSIIIFKEQINLITIVSIVLIIVGVVSLNIFGTSH
>BAF76917.1|FEATURES|NCBI|fosfomycin|bleO|antibiotic inactivation|1
MRMLQSIPALPVGDIKKSIGFYCDKLGFTLVHHEDGFAVLMCNEVRIHLWEASDEGWRSR
SNDSPVCTGAESFIAGTASCRIEVEGIDELYQHIKPLGILHPNTSLKDQWWDERDFAVID
PDNNLISFFQQIKS
>CAA02068.1|FEATURES|NCBI|multidrug|ble|antibiotic inactivation|1
MVKFTGAIPVLTAVDVPADVAFWVGTLGFEEDFADEGFAGIHRGDVQLFISRTEHQLVAD
NTSAWVEVLGLDELHAKWSRVLSTDYADTSGPAMTEVTSSPSGREFAVRDPAGNCVHFAA
EH
>NZ_KQ236707.1|FEATURES|NCBI|trimethoprim|dfr|antibiotic target replacement|1
MNKEIQFSMIVARGVNGEIGQDGDLPWHVEGVRLKEDLKRFKAITMGKTLVMGRKTFESI
PNGLPGRNVIVLTREPYDKADITERGDGTFVAWGNSCHLFEVAEHLGVTEIIVAGGAEIY
NLHKDVITKVFETKVLRAYPAADTHVDVFWESPGYDTEGRQWRVTSRGHIIENGSFTIAT
TYER
>YP_001096451.1|FEATURES|NCBI|multidrug|tetC|antibiotic efflux|0
MFLRLSRPHHHDTINILTVCYFKSIMENKNHQQENFKSTYQSLVNSARILFVEKGYQAVS
IDEISGKALVTKGAFYHHFKNKKQLLSACYKQQLIMIDAYITTKTDLTNGWSALESIFEH
YLDYIIDNNKNLIPIQEVMPIIGWNELEKISLEYITGKVNAIVSKLIQENQLKAYDDDVL
KNLLNGWFMHIAIHAKNLKELADKKGQFIAIYRGFLLSLKDK
>ACI31325.1|FEATURES|NCBI|aminoglycoside|aac|antibiotic inactivation|1
MSILPVKEQDAADWLALRNLLWLADDHASEIEQYFSGGLEGLVEVLIARDATGAAVGHVE
LSIRHDLEELQGIKTGYIEGLYVAPSHRSTDLVRRFLRESEKWALEQGCSAFASDRSDRV
ITHRKFAGSAV
>WP_061723211.1|FEATURES|NCBI|aminoglycoside|APH(9)-Ia|antibiotic inactivation|1
MLKQPIQAQQLIELLKIHYGIDIHTAQFIQGGADMNAFAYQADSETKSYFIKLKFGYHDE
INLSIIRLLHDNGVKEIIFPINTLEAKLFQQLKHFKIIAYPFIHAPNGFTQNLTGKQWKK
LGKVLRQIHETSVPTSIQQQLRKEMYSPKWREIVRSFYSQIEIDNSDDKLCAAFKSFFNQ
HSAAIHQLVDTSEKLSKKIQPDLDKYVLCHSDIHAGNVLVGNDESIYIIDWDEPMLAPKE
RDLMFVGGGIGNVWNKPHEIQYFYEGYGEVNVDKTILSYYRHERIVEDIAVYGQDLLSRI
QNNHSRLESFKYFKEMFDPNNVVEIALATE
>WP_045095476.1|FEATURES|NCBI|aminoglycoside|APH(9)-Ia|antibiotic inactivation|1
MLKKLIQEQQIIELLNKHYGIDIHAAQLIPGGADMNALAYKADSKSNSYFVKLKYGYHNE
INLSIIRLLHDSGINEIIFPIPTLEAKLFQQWDHFKIIVYPFIHAPNGFTQNLTEKQWEQ
LGKVLRQIHETSVPSLIQQQLRKEIYSTKWREIVRSFYSKIELDASDDKITAGFKSFFNQ
NIDSIRQLVDSAEELSKKIQPDLDKYVLCHSDIHAGNVLVVNEESIYIIDWDEPMLAPKE
RDLMFIGGGVCGVWNKPHEIHYFYEGYDQTNVDKTILSYYRHERIVEDIAEYGQDLLSRN
QNDESRLESFKHFKSMFEPNNVVETAFATG
>WP_058477694.1|FEATURES|NCBI|aminoglycoside|APH(9)-Ia|antibiotic inactivation|1
MSKKTIQEKQLIELLNVHYGLDIHTTQLVLGGADMNAFGYKADSESNSYFVKIKYGFHDE
INLSIIRLLHDSGIKEIIFPIHTLETKLFQQLDHFKLIVYPFIHAANGFTQNLTEKQWKE
LGKVLRQIHETSVPASIQQQLRKETYSGKWREIVRSFYSKIKSDSSDDKITADFKSFFNQ
NIASIHQLVDSAEELSKKIQLDLDKYVLCHSDIHAGNVLVVDEESIYIIDWDEPMLAPKE
RDLMFIGGGVGNVWNKPHEIHYFYEGYGKTNVDKTILSYYRHERIVEDIAVYGQDLLTSA
QSDQSRLESLKHFKSMFEPNDVIEIAFATP
>WP_058515178.1|FEATURES|NCBI|aminoglycoside|APH(9)-Ia|antibiotic inactivation|1
MLKKTIQDQQLIALLNNHYGFDIHRIQLILGGADMNAFGYKADSESSSYFVKLKYGHHDE
INLSIIRLLHDAGIKEIIFPIHTLETQLFQQLDYFKIIVYPFIHAPNGFTQNLTEKQWKQ
LGKVLRQIHETSVPTPIQQQLRKEMYSTKWREMVRSFYSKTEFDNSDDKITADFKSFFNQ
NIDSIQQLVNASEKLSKKIKPGLDNYVLCHSDIHAGNILVVNEEFIYIIDWDEPILAPKE
RDLMFIGAGVGNVWNKPSEIHYFYEGYGETKVDKTILSYYRYERIVEDMAVYGQDLLSRE
QNDQSRLESFKHFKEMFDPSNVVEIAFATG
>WP_028378894.1|FEATURES|NCBI|aminoglycoside|APH(9)-Ia|antibiotic inactivation|1
MLRNNIPDQQLIELLKVYYGIDIHAVQLIVGGADMNAFGYKADSESNSYFVKLKYGHHDE
INLSIIRLLHDSGIKEIIFPIYTRDAKLFQQIDHFKIIVYPFIDAPNGFTQNLTEKQWQQ
LGKVLRQIHETSVPAAIQQRLRKETYSPKWREIVRSFYSKIGFDDSDDQITADFKSFFNQ
NIDSIHRLVDSSEELYKKIQPDLDKYVLCHSDVHAGNVLVVNEESIYIIDWDEPMLAPKE
RDLMFIGGGIGNVWNKHHEINYFYEGYGKINVDKIILSYYRHERIVEDIAVYGQDLLSSD
QNDESRLESFKHFKSMFDPNNVVEIALSSD
>WP_061692069.1|FEATURES|NCBI|aminoglycoside|APH(9)-Ia|antibiotic inactivation|1
MLRNNITDQHLIALLKVYYGIDIHTVQLIVGGADMNAFGYKADSESNSYFVKLKYGHHDE
INLSIIRLLHDSGIKEIIFPIYTRDTKLFQQIDHFKIIVYPFINAPNGFTQNLTEKQWHQ
LGKVLRQIHETSVPTAIQQRLRKETYSPKWREMVRSFYNKIGFDDSDDQITTDFKTFFNQ
KIDSIHRLVDSSEELSKKIQLDLDKYVLCHSDVHAGNVLVVNEESIFIIDWDEPMLAPKE
RDLMFIGGGIGNVWNKPHEIDYFYEGYGKTNVDKIILSYYRHERIVEDIAVYGQDLLSRD
QNNESRLESFKHFKSMFDPNDVVEIAFSSD
>WP_027221672.1|FEATURES|NCBI|aminoglycoside|APH(9)-Ia|antibiotic inactivation|1
MLRNNIPDQQLIELLKVYYGIDIHAVQLIVGGADMNASGYKADSESNSYFVKLKYGHHDE
INLSIISLLHNSGVKEIVFPVHTLEAKLFQQVDHFKMIVYPFIDAPDGFTKNLTEKQWKQ
LGKVLRQIHETTVPTSIQQRLRKETYSPKWREMVRSFYSQIGLDESDDQITTDFKSFFNQ
KIDSIHRLVDSSDDLSKKIQPDLDKYVLCHSDVHAGNVLVVNEESIYIIDWDEPMLAPKE
RDLMFIGGGIGNVWNKPHEIDYFYEGYGKTNVDKIILSYYRHERIVEDIAIYGQDLLSRV
QNDESRLESFKHFKSMFDPNDVIEIAFSSD
>WP_061466569.1|FEATURES|NCBI|aminoglycoside|APH(9)-Ia|antibiotic inactivation|1
MLRNNIPDQHLIALLKVYYGIDIHTVQLIVGGADMNAFGYKADSESNSYFVKLKYGHHDE
INLSIIRLLHDSGVKEIVFPIYTLEANLFQQVDHVKIIVYPFIDAPNGFTKNLTEKQWKQ
LGKILRQIHGTSVPTSILQRLRKETYSPKWREIVRSFYSQLGFDECDDQITTDFKSFFNQ
NIDLIHQLVNSSEELSKKIQPDFEKYVLCHSDIHAGNVLVVDEESIYIIDWDEPMLAPKE
RDLMFIGGGIGNVWNKPHENDYFYEGYGKTSVDKTILSYYRHERIVEDIAVYGHDLLSRD
QNAQSRLESFKHFKSMFDPNDVIEIAFASE
>WP_027224994.1|FEATURES|NCBI|aminoglycoside|APH(9)-Ia|antibiotic inactivation|1
MLRNNIPDQQLIELLKVYYGIDIHTLQLLVGGADMNAFGYKADSESNSYFVKLKYGHHDE
INLSIIRLLHDSGVKEIVFPINTLEANLFQQVDHVKIIVYPFIDAPNGFTKNLTEKQWKQ
LGKILRQIHETSVPTPIQQRLRKETYSPKWREMVRSFYSQIGFDKSDDQITTDFKSFFNK
NIDLIHQLVNSSEELSKKIQPDFEKYVLCHSDIHAGNVLVIDEESIYIIDWDEPMFAPKE
RDLMFIGGGIGNVWNKPHQIDYFYEGYGKTSVDKTILSYYRHERIVEDIAVYGHDLLSRD
QNAQSRLESFKHFKSMFDPNDVIEIAFASD
>WP_027267093.1|FEATURES|NCBI|aminoglycoside|APH(9)-Ia|antibiotic inactivation|1
MLRNNIPDQHLIELLKVYYGIDIHTVQLIVGGADMNAFGYKADSESNSYFVKLKYGHHDE
INLSIIRLLHDSGVKEIVFPINTLEANLFQQVDHVKIIVYPFIDAPNGFTKNLTEKQWKQ
LGKILRQLHGTSVPTSIQQRLRKETYSSKWREMVRSFYSQIRFDESDDQITTDFKSFFNQ
NIDSIHQLVNSSEELSKKIQPDFEKYVLCHSDIHAGNVLVVDEESIYIIDWDEPMFAPKE
RDLMFIGGGIGNVWNKHHEIDYFYEGYGTTNVDKIILSYYRHERIVEDIAVYGQDLLSRD
QNDESRLESLKHFKSMFDPNNVVEIALSSD
>AEU11363.1|FEATURES|NCBI|quinolone|qnrS|antibiotic target protection|1
MEIYSHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFD
VADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFIS
GCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLC
HAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD
>ACO89576.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|erm|antibiotic target alteration|0
MSGQRSRRQWGWYPLTDDWAARIVAESGVRSGEFVVDLGAGHGALTAHLVAAGARVLAVE
LHPGRARHLRSRFAEEDVRVAEADLLAFRWPRRPFRVVASPPYQVTSALIRSLLTPESRL
LAADLVLQRGAVHKHAKRALVRHWTLRAGITLPRSAFHHPPQVDSSVLVIRRR
>NZ_CP023410.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|lnu|antibiotic inactivation|1
MIGINDACEILSWAYNNNIEIWLDGGWGVDALLGKETRQHNDIDLFVEEKNYNKFIEIIK
NKGFNEIVVEYTSEVHTIWSDNKLRIIDLHMFKDNCDGTICYEGEVFQKNIFDGVGKIGN
IMVSCINAKNQVLFHLGYEFGESDIHDVKLLCKEFNIPIPKEYENF
>ACX29951.1|FEATURES|NCBI|aminoglycoside|aadB|antibiotic inactivation|1
MDTTQVTLIHQILAAADERNLPLWIGGGWAIDARLGRVTRKHDDIDLTFPGERRGELEAM
VEMLGGRVTEELDYGFLAEIGDELLDCEPAWWADEAYEIAEAPQGSCPEAAEGVIAGRPV
RCNSWGAIIWDYFYYADEVPPVDWPTKHIESYRLACTSLGAEKVEVLRAAFRSRYAA
>NG_047480.1|FEATURES|NCBI|rifampin|arr|antibiotic inactivation|1
MSATATMFAQSFFHGTKAALAPGDLIAVGYRSNFTDAKSLSWVYFTGTLDAAIWGAELAG
GSGTERIYVVEPTGAIEEDPNLTDKKFPGNPTLSYRSRDPLRVIAEVTKWQAHTAQRLRE
MKEGLARLNAEGAEIID
>ACA23029.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
MKNWIFLAVAIFGEVIATSALKSSHGFTRLVPSVVVVAGYGLAFYFLSLALKSIPVGIAY
AVWAGLGIVLVAAIAWIFHGQKLDFWAFIGMGLIVSGVAVLNLLSKVSAH
>AAK40353.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
MKNWIFLAVAIFGEVIATSALKSSHGFTRLVPSVVVVAGYGLAFYFLSLALKSIPVGIAY
AVWAGLGIVLVAAIAWIFHGQKLDFWAFIGIGLIVSGVAVLNPLSKVSAH
>AAS76334.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
MKNWLFLAIAIFGEVVATSALKSSHGFTKLVPSVVVVAGYGLAFYFLSLALKSIPVGIAY
AVWAGLGIVLVAAIAWIFHGQKLDLWAFVGMGLIVSGVAVLNLLSKVSAH
>ABO47752.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
MKNWLFLAIAIFGEVVATSALKSSHGFTRLVPSVVVVAGYGLAFYFLSLALKSIPVGIAY
AVWAGLGIVLVAAVAWIFHGQKLDFWAFIGMGLIVSGVAVLNLLSKVSAH
>NG_048515.1|FEATURES|NCBI|glycopeptide|vanY|antibiotic target alteration|1
MRRSEGDDEPRTLPPRARDRVYTAVTRVLAVLLLPVAFVRQPGRARELACGWALRMRFPA
EDLTGLTDGARAAFTAARAEALWRHGQLVGLTSGYRDPRVQQRMFEEEVRRSGSVAAARM
FVAPPAESNHVKGMALDVRPHEGARWLEAHGARYDLYRIYDNEWWHFEHRPECGGTPPRR
LPHPGAAWASRNGGRV
>WP_000622778.1.|FEATURES|NCBI|quinolone|qacB|antibiotic efflux|1
MISFFTKTTDMMTSKKRWTALVVLAVSLFVVTMDMTILIMALPELVRELEPSGTQQLWIV
DIYSLVLAGFIIPLSAFADKWGRKKALLTGFALFGLVSLAIFFAESAEFVIAIRFLLGIA
GALIMPTTLSMIRVIFENPKERATALAVWSIVSSIGAVFGPIIGGALLEQFSWHSAFLIN
VPFVIIAVVAGLFLLPESKLSKEKSHSWDIPSTILSIAGMIGLVWSIKEFSKEGLADIIP
WVVIVLAITMIVIFVKRNLSSSDPMLDVRLFKKRSFSAGTIAAFMTMFAMTSVLLLASQW
LQVVEELSPFKAGLYLLPMEIGAMVFAPIAPGLAARFGPKIVLPSGIGIAAIGMFIMYFF
GHPLSYSTMALALILVGAGTASLAVASALIMLETPTSKAGNAAAVEESMYDLGNVFGVAV
LGSLSSMLYRVFLDISSFSSKGIVGDLAHVAEESVVGAVEVAKATGIKQLANEAVTSFND
AFVATALVGGIIMIIISIVVYLLIPKSLDITKQK
>WP_031943933.1|FEATURES|NCBI|kasugamycin|AAC(2')-IIb|antibiotic inactivation|1
HWLKTDYRTLFRLCPDGRIERENDPDCSPGPRFWLAGCSEGNVFGVRADVPDDIALKLEE
LASVEPPFTPPAIPKHLERYLSLLGSDGPVTHDLGLIYELPHAQQYPSKARLIGSGSEEG
ESLMQTWAEDRVPEALFELGFREVADFWTPWCAAVVDGEVASIAFAARLADAGAELGLVT
AKAFRGQGFAAAATAGWSRLSALRSRTLFYSTDRDNISSQRVAARLGLRLRGASLRIS
>NP_862227.1|FEATURES|NCBI|multidrug|tet|antibiotic efflux|1
MAPDYARTDAVAPASVKETFAYLSALPNALDRRWWAGLLLIQALIVAVYTTQSNLFGRSV
DPLTGGEVPLLGTGTRAFVWTVGLALACMLVEMFLRALGNYVVGLKVARASIDLRRRCLD
AILRAPVPRVMELGTGNVITRMTKDIDDVVQTITAIGSRVLTTVFVFPITFIGLLLIDVR
FALILLLICICTYPFARAVVRAIPDASNAVSVAEARRNAVLLDTVRGLPTLRAFDLERWA
LARMRRTSWGAVEAEMDRVHWFIRLTGIGQVAFAAWVLLTLGVGAWLASAGVVTRAAQRA
GRPLCHARGGTTTALVGTSGAGKSTLAALIAGLVEPTAGSIRVGAVETSQVSDTWTAKNV
TLLTQDVHLFAGTLREDLSMAAQDATDADLLRALASVGLDPEGTQFARLFPKGLDTAVGA
GAEDIPPEVEQQLALARVALSGPKVLILDEATAEAGSDATNALEDAAARITADTTALVVA
HRLDQAAAADRILVMDAGRIIEDGTHTELVAADGRYAQLFAAWSGGGH
>AGC82133.1|FEATURES|NCBI|aminoglycoside|rmtF|antibiotic target alteration|1
MDERAQAALDALLSAKNLRDVCPETVRRVFMELLPRYRKPXDAEKXARTHLHQITGAFMT
ADAQKKARALLARWNEGDESALAAALSLHASTRERLPGADEWMRRVSPFLGADARVLDLA
CGLNPILLGSMGVTNALGMDIHLGCVRLVNETARARGWHTRARACDLLSEIPAEEADAAL
LMKLLPVLEAQKTGRAAELLASLRAPRLVVTFPTRTLGGRGVGMEKHYADWFERILPDTL
SVRDRFTVSDELVYLVERT
>WP_052285801.1.|FEATURES|NCBI|aminoglycoside|aac|antibiotic inactivation|1
MQYSIRSVRVSDTSDWLRLRNLLWEGDDHETEIAQFFAGALAEPNEVLVAHDDAGAVVGH
VELSIREDVAGLEGIRAGYIEGLYIEEAHRSSSVATQLLRHSEQWAQSQGCRAFASDRED
RLIIHKRFSVSPLSNPSFQRTAFGGR
>WP_005475717.1.|FEATURES|NCBI|fosfomycin|fosA|antibiotic inactivation|1
MILGLNHITIAVSDLERSLKFYRETLGFTAHAKWDNGAYLSVGELWFCLSHDEPCPKTDY
THVAFDIEPKEFEAFAKRVVSLGVEVWKQNKSEGQSLYILDPDGHKLEIHSGSLKSRLES
LRTKLYSGLVWL
>WP_010494170.1|FEATURES|NCBI|fosfomycin|fosA|antibiotic inactivation|1
MKATGFNHVTIRVSDLSRSLLFYESLLGMKLVHRGRLDVYLEWGSAWICLIERSCESSEK
PSYGVDHIAFSITEEDFHDAAVKLQGSGVPIVRGPLERGGGYSINFLDPDGTELELFTGS
LAERMKGWS
>WP_053258911.1|FEATURES|NCBI|aminoglycoside|SeKA_A1070|antibiotic inactivation|0
MDIRHMNKTHLEHWRGLRKQLWPGHPDDAHLADGEEILQTDHLASFIAMADGVAIGFADA
SIRHDYVNGCDSSPVVFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTSPEN
TISQKVHQALGFEETERVIFYRKRC
>WP_006898231.1|FEATURES|NCBI|aminoglycoside|LTSEINV_2403|antibiotic inactivation|0
MDIRQMNKTHLEHWRGLRKQLWPGHPDDAHLADGEEILQADHLASFIAMADGVAIGFADA
SIRHDYVNGCDSSPVAFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTSPEN
TISQKVHQALGFEETERDIFYRKRC
>WP_023376089.1|FEATURES|NCBI|aminoglycoside|LTSEINV_2403|antibiotic inactivation|0
MDIRQMNKTHLEHWRGLRKQLWPGHPDDAHLADGEEILQADHLASFIAMADGVAIGFADA
SIRHDYVNGCDSSPVAFLEGIFVLPSLRQRGVAKQLIAAVQRWGTNKGCREMASDTSPEN
TISQKVHQALGFEETERVIFYRKRC
>WP_045900228.1|FEATURES|NCBI|aminoglycoside|SG9_1532|antibiotic inactivation|0
MDIRQMNKTHLEHWRGLRKQLWPGHPDDAHLADGEEILQADYLASFIAMADGVAIGFADA
SIRHDYVNGCDSSPVAFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTTPEN
TISQKVHLALGFEETERVIFYRKRC
>WP_023260570.1|FEATURES|NCBI|aminoglycoside|A670_03335|antibiotic inactivation|0
MDIRQMNKTHLELWRGLRKQLWPGHPDDAHLADGEEILQTDHLASFIAMADGVAIGFADA
SIRHDYVNGCDSSPVAFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTTPEN
TISQKVHLALGFEETERVIFYRKRC
>WP_001748408.1|FEATURES|NCBI|aminoglycoside|SEET0819_14790|antibiotic inactivation|0
MDIRQMNKTHLEHWRGLRKQLWPGHPDDAHLADGEEILQTEHLASFIAMADGVAIGFADA
SIRHDYVNGCDSSPVAFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTSPEN
TISQKFHQALGFEETERVIFYRKRC
>WP_023239286.1|FEATURES|NCBI|aminoglycoside|CFSAN002050_14495|antibiotic inactivation|0
MDIRQMNKTHLEHWRGLRKQLWPGHPDDAHLADGEEILQTEHLASFIAMADGVAIGFADA
SIRHDYVNGCDSSPVAFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTTPEN
TISQKVHQALGFEETERVIFYRKRC
>WP_053529047.1|FEATURES|NCBI|aminoglycoside|L287_02619|antibiotic inactivation|0
MDIRQMNKTNLEHWRGLRKQLLPGHPDDAHLADGEEILQADHLASFIAMADGVAIGFADA
SIRHDYVNGCDSSPVAFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTTPEN
TISQKIHQALGFEETERVIFYRKRC
>WP_047622667.1|FEATURES|NCBI|aminoglycoside|aac|antibiotic inactivation|0
MDIRQMNKTHLEHWRGLRKQLWPGHPDDAHLADGEEILQADHLASFIAMADGVAIGFADA
SIRHDYVNGCDSSPVVFLEGIFVLPSFRQRGLAKQLIAAVQRWGTNKGCREMASDTTPEN
TISQKVHLALGFEETKRVIFYRKRC
>WP_048590989.1|FEATURES|NCBI|aminoglycoside|CFSAN001590_08465|antibiotic inactivation|0
MDIRQMNKTNLEHWRGLRKQLWPGHPDDAHLADGEEILQADHLASFIAMADGVPIGFADA
SIRHDYVNGCDSSPVVFLEGIFVLPSFRQRGLAKQLIAAVQRWGTNKGCREMASDTSPEN
TISQKVHLALGFEETERVIFYRKRC
>WP_048348829.1|FEATURES|NCBI|aminoglycoside|SEET0819_14790|antibiotic inactivation|0
MDIRQMNKTNLEHWRGLRKQLWPGHPDDAHLADGEEILQTDHLASFIAMADGVAIGFADA
SIRHDYVNGCDNSPVVFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTSPEN
TISQKVHQALGFEETERVIFYRKRC
>WP_023220234.1|FEATURES|NCBI|aminoglycoside|SeKA_A1070|antibiotic inactivation|0
MDIRHMNKTHLEHWRGLRKQLWPGHTDDAHLADGEEILQTDHLASFIAMADGVAIGFADA
SIRHDYVNGCDSSPVVFLEGIFVLSSFRQRGVAKQLIAAVQRWGTNKGCREMASDTSPEN
TISQKVHQALGFEETERVIFYRKRC
>WP_023215744.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Iy|antibiotic inactivation|0
MDIRQMNRTHLEHWRGLRKQLWPGHPDDAHLADGEEILQADHLASFIAMADGVAIGFADA
SIRHDYVNGCDSSPVVFLEGIFVLPSFRQRGVAKQLIAAVQRWGANKGCREMASDTSPEN
TISQKVHQALGFEETERVIFYRKRC
>WP_023212386.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Iy|antibiotic inactivation|0
MDIRQMNRTHLEHWRGLRKQLWPGHPDDAHLADGEEILQADHLASFVAMADGVAIGFADA
SIRHDYVNGCDSSPVVFLEGIFVLPSFRQRGVAKQLIAAVQRWGKNKGCREMASDTSPEN
TISQKVHQALGFEETERVIFYRKRC
>WP_023224993.1|FEATURES|NCBI|aminoglycoside|LTSESEN_2493|antibiotic inactivation|0
MDIRQMNRTHLDHWRGLRKQLWPGHPDDAHLADGEEILQADHLASFIAMADGVAIGFADA
SIRHDYVNGCNSSPVAFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTSPEN
TISQKVHQALGFEETERVIFYRKRC
>WP_000354866.1|FEATURES|NCBI|aminoglycoside|aac6|antibiotic inactivation|0
MDIRQMNRTHLDHWRGLRKQLWPGHPDDAHLADGEEILQADHLASFVAMADGVAIGFADA
SIRHDYVNGCDSSPVVFLEGIFVLPSFRQRGLAKQLIAAVQRWGTNKGCREMASDTTPEN
TISQKVHQALGFEETERVIFYRKRC
>WP_023176579.1|FEATURES|NCBI|aminoglycoside|LFZ48_07285|antibiotic inactivation|0
MDIRQMNETNLEHWRGLRKQLWPGHPDDGHLADGEEILQADHLASFVAIEDGVAIGFADA
SIRHDYVNGCDSSPVAFLEGIFVLPSFRQRGVAKQLIAAVQQWGMNKGCREIASDTSPEN
TISQKVHQALGFEETERVIFYRKRC
>WP_000354863.1|FEATURES|NCBI|aminoglycoside|LFZ48_07285|antibiotic inactivation|0
MDIRQMNKTNLEHWRGLRKQLWPGHPDDGHLADGEEILQADHLVSFVAIEDGVAIGFADA
SIRHDYVNGCDSSPVAFLEGIFVLPSFRQRGVAKQLIAAVQQWGMNKGCREIASDTSPEN
TISQKVHQALGFEETERVIFYRKRC
>AAY52008.1|FEATURES|NCBI|glycopeptide|vanZ|antibiotic target alteration|1
MGCSGFFSSYMYALFKIIVLKFGPTVVEFLWVRLMRNSTNPECIAARLHAGNLIPLKEIS
RASDSMSGHSLLNLFGNVGIFVPLGIFLGVLAKSGKLTLAGSSLVLECTQVLFSIGKFDV
DDLILNSTGGSIGFVVYALCARL
>WP_011342944.1.|FEATURES|NCBI|quinolone|qacF|antibiotic efflux|1
MSPYIPLSIAIVAEVIATTAMKSSDNFTRLVPSVIVVVGYVVAFYFLSITFKFIPTGIAY
AIWAGAGIVLITLMGWIVHKQTLDLAAMLGMGLIVSGVLVINIFSKSGAH
>WP_004308783.1.|FEATURES|NCBI|macrolide-lincosamide-streptogramin|linAn|antibiotic inactivation|1
MTKKEHTTITELFQVLDLLESLDMQFWLDGGWGVDVLYGQQTRLHRDIDIDFDANYTDQL
LDLLQERGYQIETNWLPTRVELYSKELGYIDIHPFVLNADGTSKQADLDGGWYEFQPDYF
GTAVFEGRSIPCISAKGQQVFHSGYDLREKDIHDLSIIKQCITTMSLTIR
>WP_063853729.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mef|antibiotic efflux|1
MNHWKSTLAVIGIGQLISILTSTIVGFSIIFWISNEFKSPTALSLAILAGFLPQFVLGLF
AGVYVDRWNRKKTMFYSDLFIAFCTLCLFIVITKGYKDLSFFYLLTACRSIGSTFHAPAL
QASIPLLVPKHHLVRVSGLYHSIQSFSEVIAPVVGASLVVWLPIQYILLIDVIGAVAACL
TLLCVQIPSLQKTKVLPDFKKELTEWLHTLRRTMGILPLFVCFTLVTFVLMPVFTLFPFM
TLLHFNGNILQMGVVEMGWGSGALLGGLVLACKALKSKQTLVMHTAYVILGLYLISASYL
PSSAFIGFVCLTFTGGIAYSIYHALFIAIIQQNLASDMLGRTFSLIFSLSTFPSMLGIVA
SGYWVEAWGITSVFMISGWVIFLIGVGANFISSIKQLDNYA
>WP_030945209.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|carA|antibiotic target protection|1
MSTAQLALHDITKRYQDHAVLDRVGFTIRPGEKVGVIGDNGSGKSTLVKLIAGREQPDNG
TLTVVAPGGVGYLAQTLELPPESTVQDAVDLALADLRELEAGMRRTEAQLAERPYEVGQA
GQQDAGLAALLENYAALVDQYQARGGYEADSRVEIALHGLGLPGLERDRRLGTLSGGERS
RLALAATLAAEPELLLLDEPTNDLDDGAVGWLEEHLRGHRGTVVAVTHDRLFLDRLTTTI
LEVDSGRVARYGNGYAGYLAAKAAERERRLLEYERWRAELDRSRDLIASNVARLDNIPRK
LPLAVFGAGGFRTRGRGHGAMVRIRNAKERVARLTENPVAPPPEPLAFTAEITTEAAAQP
QETVAELTDVGVGDRLTVDSLRLVPGERLLITGPNGAGKTTLLRILAGELAPDSGTVRVS
GRVGHLRQDQVPWPEGLTVLQAFGDGRVGDLDEHTEALLSLGLFSPDDLRRRVEDLSYGQ
RRRIELARLVTEPVDLLLLDEPTNHLSPALVEELEEALTDYQGAVAVVTHDRRMRSRFSG
SHLTLRDGRVAEFSGG
>EZX24288.1|FEATURES|NCBI|multidrug|salA|antibiotic target protection|1
MLFLFEEKALEVEHKVLIPELTFSIEDHEHLAIVGVNGVGKSTLLKVIHQDQTVDSAMME
QDLTPYNDWTVMDYIIESYPEIAKVRSQLNHTDMINKYIELDGYLIEGEIVTEAKKLGIK
EEQLEQKISTLSGGEQTKVSFLKVKMSKASLLLIDEPTNHMDLEMKEWLTKAFKQEQRAI
LFVSHDRTFLNETPDAILELSPDGAKKYIGKYDKYKQQKDIEHETLKLQYEKQQKEQAAI
EETIKKYKAWYQKAEQSASVRNPYQQKQLSKLAKRFKSKEQQLNRKLDQEHIANPNKKEK
AFSIQHHDFKSHYLVQFNHVSFAYDNRKIFEDVSFYIKRNQNVIIEGRNGTGKSTLIKLI
LGELEPTKGNITVHPELEIGYFSQDFENLNMHNTVLDEILEIPEMNEADARTILASFYFD
KDRINDVVETLSMGEKCRLQFVKLYFSNPHIMILDEPTNYFDIGMQEKIIQLIQSFQGSV
LIVSHDDYFKSQIKDQIWTIKNHQMTHENVQVKDPINTESMKHQLKELEQYTEERNRETE
F
>WP_000182645.1|FEATURES|NCBI|beta_lactam|mecI|antibiotic target replacement|1
MTNKQVEISMAEWDVMNIIWDKKSVSANEIVVEIQKYKEVSDKTIRTLITRLYKKEIIKR
YKSENIYFYSSNIKEDDIKMKTAKTFLNKLYGGDMKSLVLNFAKNEELNNKEIEELRDIL
NDISKK
>WP_002436859.1|FEATURES|NCBI|beta_lactam|mecI|antibiotic target replacement|1
MANKQVEISMAEWDVMNIIWDKKSVSANEIVVEIQKYKEVSDKTIRTLITRLYKKEIIKR
YKSENIYFYSSNIKEDDIKMKTAKTFLNKLYGGDMKSLVLNFAKKEELNNKEIEELRDIL
NDISKK
>WP_031875417.1|FEATURES|NCBI|beta_lactam|mecI|antibiotic target replacement|1
MANKQVEISMAEWDVMNIIWDKKSVSANEIVVEIQKYKEVSDKTIRTLITRLYKKEIIKR
YKSENIYFYSSNIKEDDIKMKTAKTFLNKMYGGDMKSLVLNFAKNEELNNKEIEELRDIL
NDISKK
>WP_031786790.1|FEATURES|NCBI|beta_lactam|mecI|antibiotic target replacement|1
MANKQVEISMAEWDVMNIIWDKKSVSANEIVVEIQKYKEVSDKTIRTLITRLYKKEIIKR
YKSENIYFYSSNIKEDDIKMKTAKIFLNKLYGGDMKSLVLNFAKNEELNNKEIEELRDIL
NDISKK
>WP_001284656.1|FEATURES|NCBI|beta_lactam|mecI|antibiotic target replacement|1
MANKQVEISMAEWDVMNIIWGKKSVSANEIVVEIQKYKEVSDKTIRTLITRLYKKEIIKR
YKSENIYFYSSNIKEDDIKMKTAKTFLNKLYGGDMKSLVLNFAKNEELNNKEIEELRDIL
NDISKK
>CNC13957.1|FEATURES|NCBI|glycopeptide|VanI|antibiotic target alteration|1
MDRLKIAIIFGGCSEEHPVSVKSAGEVAKNLDLDKYEPFYIGITKNGVWQLCRYPEANWE
NGICPSVILSPDRSLQGLLVLEQGQYKTIPLDLVFPVLHGKFGEDGAVQGLLELSGIPYV
GCDIPSSALCMDKSLAYIVAGNAGIATPKFRTVTAKEAIDAERLAYPVYVKPARSGSSFG
VTKVCRQEELLSAVAIASQYDSKVLIEEAVIGTEVGCAIFGNDLDLMAGEVDQIRLSHGF
FRIHQENEPEKGSENSTLIVPADISPQARSRVQETAKAIYRALGCKGLARVDMFLKEDGE
VILNEVNTLPGMTSYSRFPRMMAAAGLPFAEVIDRLVSLALQ
>NP_627790.1|FEATURES|NCBI|glycopeptide|ddlA|antibiotic target alteration|1
MARLKVGIVFGGSSEEHAVSVKSAQEVARNLDTEKYQPFFVGITKDGAWRLCDGPGQDWE
NGDCRPVVLSPDRSVHGLLVLEQGQYRSVRLDVVLPVLHGTLGEDGATQGLLELSGIPYV
GCDVQSSALCMDKSLAYVVARSAGIATPDFWTVTGDETIDPGRLTYPVFVKPARSGSSFG
VSKVCRPEDLATAVESARRYDTKVLIEAAVVGSEVGCAILGNDPDLIVGEVDRIALSHGF
FRIHQEEQPENGSENSTPVVPADIPTEKRSLVQETAKAVYRALGCRGLSRVDMFLKEDGE
VVLNEVNTLPGMTSYSRYPRMMAAAGLPLSEVIDRTLSLALT
>WP_063856526.1|FEATURES|NCBI|glycopeptide|vanA|antibiotic target alteration|1
MYRVKIAILFGGCSEEHDVSVKSAKEIANNINTEKYEPIYIGITRSGVWKMCEKPCMDWD
NENCRSAVLSPDKRMHGLLVMRDKGYQIQRIDAAFSVLHGKSGEDGAIQGLFELSGIPYV
GCDIQSSAVCMDKSLAYIIAKNDGIATPEFWVINKDDRPAAAAFTYPVFVKPARSGSSYG
VKKVNGADELDAAIESARQYDSKILIEQAVLGCEVGCAVLGNSSELIVGEVDQIRLQHGI
FRIHQEAEPEKGSENAVITIPADLSAEERGRIRDTAKKIYKALGCRGLARVDMFLQDNGR
IVLNEVNTLPGFTSYSRYPRMMVAAGITLPELIDRLIVLALK
>NG_048396.1|FEATURES|NCBI|glycopeptide|VanM|antibiotic target alteration|1
MNRLKIAILFGGCSEEHNVSVKSAAEIANNIDIGKYEPIYIGITQSGVWKTCEKPCIDWD
NEHCRSAVLSPDKKMHGLLIMQDKGYQIQRIDVVFSVLHGKSGEDGAIQGLFELSGIPYV
GCDIQSSAVCMDKSLAYIIAKNAGIATPEFQVIYKDDKPAADSFTYPVFVKPARSGSSYG
VNKVNSADELDSAIDLARQYDSKILIEQGVLGYEVGCAVLGNSFDLIVGEVDQIRLQHGI
FRIHQEAEPEKGSENATITVPAELSAEERERIKEAAKNIYKALGCRGLSRVDMFLQDNGR
IVLNEVNTMPGFTSYSRYPRMMVSAGITIPELIDHLIVLAVK
>WP_023042300.1.|FEATURES|NCBI|glycopeptide|VanD|antibiotic target alteration|1
MYKLKIAVLFGGCSEEHDVSVKSAMEVAANINKEKYQPFYIGITKSGAWKLCDKPCRDWE
NYAGYPAVISPDRRTHGLLIQKDGGYESQPVDVVLPMIHGKFGEDGTIQGLLELSGIPYV
GCDIQSSVTCMDKSLAYMVVKNAGIEVPGFRVLQKGDSLKAETLSYPVFVKPARSGSSFG
VNKVCRAEELQAAVTEAGKYDCKILVEEAVSGSEVGCAILGNENALMAGEVDQIELRHGF
FKIHQEAQPEKGSENAVIRVPAVLPDEVRERIQKTAMKIYRILGCRGLARIDLFLREDGC
IVLNEVNTMPGFTSYSRYPRMMTAAGFTLTEILDRLIELSLR
>WP_063856689.1|FEATURES|NCBI|glycopeptide|vanD|antibiotic target alteration|1
MFKIKVAVLFGGCSEEHNVSIKSAMEIAANIDTKKYQPYYIGITKSGVWKMCEKPCLGWE
QYAGDPVVFSPDRSTHGLLIQKDTGYEIQPVDVVFPMIHGKFGEDGSIQGLLELSGIPYV
GCDIQSSVICMDKALAYTVVKNAGIAVPGFRILQEGDRLETEDLVYPVFVKPARSGSSFG
VNKVCKAEELQAAIREARKYDSKILIEEAVTGSEVGCAILGNENDLMAGEVDQIELRHGF
FKIHQEAQPEKGSENAVIRVPAALPDEVRERIRKTAMKIYRILGCRGLARIDLFLREDGC
IVLNEVNTMPGFTSYSRYPRMMTAAGFTLSEILDRLIEFSLR
>WP_063856693.1|FEATURES|NCBI|glycopeptide|vanD|antibiotic target alteration|1
MYRINVAVLFGGCSEEHTVSIKSAMELAANIDTEKYQPFYIGITKSGVWKLCEKPCLDWE
QYAKYPVVFSPGRNTHGFLIQKEDRYEIQPVDVVFPIIHGKFGEDGSIQGLLELSGIPYV
GCDIQSSVICMDKSLAYTTVKNAGIEVPDFQIIQDGDSPKTECFSFPLFVKPARSGSSFG
VNKVDKAEDLCAAINEARQYDRKVLIEQAVSGSEVGCAVLGTGTDLIVGEVDQISLKHGF
FKIHQEAQPEKGSENATIEVPADLPAKVRERIQKTAKKIYQVLGCRGLARIDLFLREDGH
IVLNEVNTMPGFTSYSRYPCMMTAAGFTLSELIDRLIELALR
>ABX79430.1|FEATURES|NCBI|glycopeptide|vanC|antibiotic target alteration|1
KKIAIIFGGNSPEYTVSLASATSAIEALQSSPYDYDLSLIGIAPDAMDWYLYTGELENIR
QDTWLLDTKHKQKIQPLFEGNGFWLSEEQQTLVPDVLFPIMHGKYGEDGSIQGLFELMKL
PYVGCGVAGSALCMNKWLLHQAAAAIGVQSAPTILLTNQANQQEQIEAFIQTHGFPVFFK
PNEAGSSKGITKVTCVEEIASALKEAFTYCSAVLLQKNIAGVEIGCGILGNDSLTVGACD
AISLVDGFFDFEEKYQLISAKITVPAPLPETIETKVKEQAQLLYRSLGLKGLARIDFFVT
DQGELYLNEINTMPGFTSHSRYPAMMAAVGLSYQELLQKLLVLAKEE
>ABX79422.1|FEATURES|NCBI|glycopeptide|vanC|antibiotic target alteration|1
KKIAIIFGGNSSEYTVSLASATSAIEALQSSPYDYDLSLIGIAPDAMDWYLYTGELENIR
QDTWLLDTKHTQKIQPLFEENGFWLSEAQQTLVPDVLFPIMHGKYGEDGSIQGLFELMKL
PYVGCGVAASALCMNKWLLHQAAAAIGVQSAPTILLTNQDNQQQQIEAFIQTHGFPVFFK
PNEAGSSKGITKVTCVEEIAPALKEAFAYCSAVLLQKNIAGVEIGCGILGNDSLTVGACD
AISLVEGFFDFEEKYQLISAKITVPAPLPETIETKVKEQAQLLYHSLGLKGLARIDFFVT
DQGELYLNEINTMPGFTSHSRYPAMMAAIGLSYQELLQKLLVLAKEE
>AHN05315.1|FEATURES|NCBI|multidrug|hp1184|antibiotic efflux|0
MAKNMEILETDSVKKIYFRYLIPSLVGMLLMSLNIVIDGIFVGHKLGGVALAGINIAVPV
FTIFTAISIWIGIGAATQFSFAIGEKNVAKAQTIFTNAILAVVSITVIIGIIAFIFKVPL
AYFLGANDDTIGYVLEYMNILLVFGFALTLENILSIFVRNDGDPNLSMIALIVTAISNVI
LNYLFLFVFEWGVTGSALATMIAIIIGVLILITHFFKKSSRLKFVKVDWNKAFFKKTLAI
GLPSFLAEVGVSVFTLGYNISIAAIAGTAGVAAFSVLNYTHSVILMLFLGMGSAIQPLIS
YYRGAKARQKEIETLKIAIMVAFSTGVGFLLVGLFGSNLLVSMFGNFSPEIKDLASNGIK
LFYTAYLFMGFNFVMMTYFQTSDKVKMATWITISREIIFMVIFLLVLPPIIGIPGVWLAI
PISEMIVAASIIFYMKKKHILFK
>BAJ10054.1|FEATURES|NCBI|fosfomycin|FosA3|antibiotic inactivation|1
MLQGLNHLTLAVSDLASSLAFYQQLPGMRLHASWDSGAYLSCGALWLCLSLDEQRRKTPP
QESDYTHYAFSVAEEEFAGVVALLAQAGAEVWKDNRSEGASYYFLDPDGHKLELHVGNLA
QRLAACRERPYKGMVFFD
>WP_046930149.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Isa|antibiotic inactivation|1
ELHGDKVVLRPVTDGDTEILERVVREPEVAAWWSPPDDYEGMLAVVFEGEVIGAVQFDEE
TDPEFRHAGIDIFLTARRHGKGLGADTVRTLARWLVQERGHHRLTIDPAAANTAAIRCYS
KVGFKPVGIMRAYGRDHRTGAWQDGLLMDLLADELS
>WP_039639671.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Isa|antibiotic inactivation|1
ELRGDDVVLRPVGDGEGEVLDRIVREPEVAAWWSPPEDYEGMLAIVFEGEVIGAVQFEEE
TDPEFRRAGIDIFLTARHHGKGLGADAVRTLARWLVRECGHHRLTIDPAAANTAAIRSYG
KVGFRPVGIMRAYGRDHQTGLWQDALLMDLLAEELT
>WP_033268654.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Isa|antibiotic inactivation|1
ELRGDRVVLRPVAEGDPEVLDRIVREPEVAAWWSPPDDYAGMLAVVLGGDVIGAVQFDEE
TDPEFRRAGIDIFLTARRHGQGLGTDTVRTLARWLVRERGHHRLTIDPAAANTAAIRSYR
KVGFKPVGIMRKYWRGHRTGTWQDGLLMDLLADELT
>WP_043911783.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Isa|antibiotic inactivation|1
ELRGAEVVLRPVAAGDEEVLDRIVREPEVAAWWSPPDDFQRMLAVVLQGEVIGAIQYQEE
TDPEFRHAGLDVFLTARHHGKGLGTDAVRTLARWLVHDRGHHRLTIDPAAANTAAIRSYR
KVGFKPVGIMRSYWRDHRTGTWQDGLLMDLLAEELT
>WP_031084431.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Isa|antibiotic inactivation|1
RLHGNQVVLRAVTGSDIGTLDRIVREPEVAAWWSPPEDYRGMLAVVFEGEVVGAVQFHEE
TDPEFRHAGIDIFLTARQHGKGLGTDTVRTLARWLVEERGHHRLTIDPAAANTAAIRCYA
GVGFKPVGIMRAYARDHRTGTWQDGLLMDLLAAELT
>WP_053638058.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Isa|antibiotic inactivation|1
RLHGNQVVLRAVTESDIGTLDRIVREPEVAAWWSPPEDYGGMLAVVFEGEVVGAVQFHEE
TDPEFRHAGIDIFLTARQHGKGLGTDTVRTLARWLVEERGHHRLTIDPAAANTAAIRCYA
GVGFKPVGIMRAYARDHRTGTWQDGLLMDLLAAELT
>WP_030403494.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Isa|antibiotic inactivation|1
RLHGNQVVLRAVTGSDIGTLDRIVREPEVAAWWSPPEDYGGMLAVVFEGEVVGAVQFHEE
TDPEFRHAGIDIFLTARQHGKGLGTDTVRTLARWLVEERGHHRLTIDPAAANTAAIRCYA
GVGFKPVGIMRAYARDHRTGTWQDGLLMDLLAAELT
>WP_046928126.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Isa|antibiotic inactivation|1
ELRGTDVLLRPVQDTDIATLDRIVREPAVAAWWSPPDDYADMLAITHSGKVIGAIQFSEE
TDPDFRHAGIDIFLTTSHHGKGLGTDAVRTLAHWLIHERGHHRLTIDPAAANTAAIASYR
KVGFKPVGIMRAYGRDYRTGGWADGLLMDLLADELT
>WP_016575755.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Isa|antibiotic inactivation|1
ELRGDDVVLRPVADGEGEVLDRIVREPEVAAWWSPPEDFAGMLAIVFEGEVVGAIQFYEE
TDPEFHHAGIDVFLTARHQGKGLGTDAVRTLARWLVAERGHHRLTIDPAAANTAAIRSYR
KVGFRPVGIMRAYGRDHRTGRWQDALLMDLLADELT
>WP_026328431.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Ib-SK|antibiotic inactivation|1
ELHGEKVVLRPVEDSETETLDRIVREPEVAAWWSPPNDYRNTFAVFLDDEIIGAVQFTEE
SDPEYRHAGIDVFLTARRTGAGLGTDTVRTLARWLLDDRGHHRLTIDPAAENAPAIASYR
KVGFQPVGVLRRYWRDHQTGEWRDGLLMDLLADELA
>WP_029391459.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Ib-SK|antibiotic inactivation|1
ELHGEKVVLRPVEDSETETLDRIVREPEVAAWWSPPNGYENTFAVFLDDEIIGAVQFTEE
SDPEYRHAGIDVFLTARRTGAGLGTDTVRTLARWLLDDRGHHRLTIDPAAENAPAIASYR
KVGFQPVGVLRRYWRDHQTGEWRDGLLMDLLADELT
>WP_046502149.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Isa|antibiotic inactivation|1
ELRGNEVVLRTTAEGDSEVLDRILREPEVAAWWPPLDDYEGMLAVVFGGEVIGAVTFDEE
TDPEFRRAGIDIFLTASHHGKGLGADTVRTLARWLLQERGHHRLTIDPAAANTAAIRSYS
RAGFKPVGIMRAYWRDRRTGTWQDGLLMDLLADELT
>WP_047139664.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Isa|antibiotic inactivation|1
ELRGERVLLRSTAPADTPVLDAIVREPEVARWWPPPEAYAAMLAVVVDGEVIGAIQFSEE
SDPEFRHAGIDLFLSARWHGQGLGPDAVRTLARWLIAERGHHRLVIDPAAANTRAIRSYR
KVGFAPVGIMRAYWRDHRTGAWEDGLLMDLLAAELT
>WP_047467383.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Isa|antibiotic inactivation|1
ELRGERVLLRSTVPADTPVLDAIVREPEVARWWPPPEAYAAMLAVVVDGEVIGAIQFSEE
SDPEFRHAGIDLFLSARWHGQGLGPDAVRTLARWLIAERGHHRLVIDPAAANTHAIRSYR
KVGFAPVGIMRAYWRNHRTGAWEDGLLMDLLAAELT
>WP_023417224.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Isa|antibiotic inactivation|1
ELRGERVLLRSTTPADTALLDRIVREPEVALWWPPPQGYARMLAVVVDGEVIGAIQFSEE
TDPEFRHAGIDLFLSARWQGQGLGPDAVRTLARWLIAERGHHRLVIDPAAANAHAIRSYR
KVGFAPVGIMRAYWRNHRTGEWEDGLLMDLLAGELT
>WP_018893623.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Isa|antibiotic inactivation|1
ELRGERVLLRSTTPADTAALDRIVREPEVALWWPPPEGYARMLAVVVDGEVIGAIQFSEE
TDPEFRHAGIDLFLSARWHGQGLGPDAVRTLARWLIAERGHHRLVIDPAAANTYAVRSYR
KVGFAPVGIMRAYWRDHRTGEWEDGLLMDLLAAELT
>WP_003950682.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Isa|antibiotic inactivation|1
ELRGERVLLRSTTPADTAALDRIVREPEVALWWPPPEGYERMLAVVVDGEVIGAIQFSEE
TDPEFRHAGIDLFLSARWHGQGLGPDAVRTLARWLIAERGHHRLVIDPAAANTYAVRSYR
KVGFAPVGIMRAYWRNHRTGEWEDGLLMDLLAAELT
>WP_053927904.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Isa|antibiotic inactivation|1
ELRGTDILLRPVQDTDTATLDRIVREPAVAAWWSPPDDYADMLAITHSGKVIGAIQFSEE
TDPEFRHAGIDIFLTTSHHGQGLGTDAVRTLAHWLIHERGHHRLTIDPAAANTAAIASYR
KVGFKPVGIMRAYGRDYRTGGWADGLLMDLLADELT
>WP_023529211.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Ib-SK|antibiotic inactivation|1
ELHGDRVALRTVVDADTDTLHRIVREPEVAAWWSTPEDFDGMLVIVLDSEVVGAVQYEEE
DDPDYRHASIDLFLSARHHGRGIGAETVRTLARWLIEVRGHHRLTIDPAAANTTAIRSYT
RVGFKPVGVLRAYERDPLTGTWRDGLLMDLLAGELT
>WP_010642533.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Isa|antibiotic inactivation|1
ELRGERVLLRSTTPADTAALDRIVREPEVALWWPPPQGYARMLAVVVDGEVIGAIQFSEE
TDPEFRHAGIDLFLSARWHGQGLGPDAVRTLARWLIAERGHHRLVIDPAAANTYAVRSYR
KVGFAPVGIMRAYWRNHRTGEWEDGLLMDLLAAELT
>WP_037790839.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Ib-SK|antibiotic inactivation|1
ELRGDRIVLRPVMADDTPTLHRIVREPEVAAWWGTPEGFDDMLAVVLDGEVIGSVQYEEE
DDPDYRHAGIDLFLSARHHGRGLGAETVRTLARWLIDARGHHRLTIDPAAANTTAVRSYT
RVGFRPVGVLRAYERDPLTGDWRDGLLMDLLADELA
>WP_018088143.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Isa|antibiotic inactivation|1
ELHGAAVVLRPTTDTDIPTLDRIIREPEVAAWWSVPDDYRDMLAILCHDEVIGAIQFSEE
TDPEFRHASIDIFLTARRHGQGLGTDAVRTLAHWLTHARGHHRLTIDPAAANTPAIRSYR
KVGFQPVGIMRAYGRDHRTGGWADGLLMDLLADELT
>WP_030695745.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Isa|antibiotic inactivation|1
EQRGERVLLRSTVPADTPVLDAIVRESEVARWWPPPEAYAAMLAVVVEGEVIGAIQFSEE
SDPEFRHAGIDLFLSARWHGQGLGPDAVRTLARWLIAERGHHRLVIDPAAANTHAIRSYR
KVGFAPVGIMRAYWRNHRTGAWEDGLLMDLLAAELT
>KDH28639.1|FEATURES|NCBI|beta_lactam|blaLEN-9|antibiotic inactivation|1
MRYVRLCVISLLATLPLVVYAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLVDGMTIGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPASMAERNQHIAGIGAALIEHWQR
>ADC58623.1|FEATURES|NCBI|beta_lactam|blaLEN-13|antibiotic inactivation|1
MRYVRLCVISLLATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLVDGMTIGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVLYLRDTPASMAERNQHIAGIGAALIEHWQR
>WP_017000318.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mphC|antibiotic inactivation|1
MTQHNEIIKCAEKYQLHIQPQTISVNESGLDFQVAFGEDEQGVEWVLRLPRRPDVYKRTK
SEKQTVDFLQNNVSFEVPKWKVHEKDLIAYPKLTGKPAATIDPQIQNYVWEIEHKPVPEN
FVNTLAETLVDLHNIPEENITAHHINIKTIQEIRNDFQRRMNKVKETYGVADELWNRWQQ
WLENDELWPQHATMIHGDLHPGHIMVDNEANVTGLIDWTEATHSDPSMDFMGHHRVFGDE
GLEQLITSYDKAGGETWPRMKEHILELNAVFPMFIAEFAMESGEAAYEKMALKELGMEE
>WP_021459390.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mphC|antibiotic inactivation|1
MTQHNEIIKCAEKYQLHIQPQTIALNESGLDFQVAFGEDEHGVEWVLRLPRRPDVYKRTK
SEKQTVDFLQKNVSFEVPKWKIHEQDLIAYPKLTGQPAATIDPELQDYVWEIEHKPVPEN
FINTLAETLVDLHNIPEENISAQHIKIKNIQEVKDDFQRRMNKVKETYGVADDLWNRWQR
WLENDELWPRHATMIHGDLHPGHIMVDNQANVTGLIDWTEAIHSDPSMDFMGHHRVFGDE
GLEQLITAYGKAGGETWPRMKEHIIELNAVFPMFIAEFAMESGEAAYEKMALKELGMEA
>WP_017724236.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mphC|antibiotic inactivation|1
MTQHNEIIKCAEKHQLHIQPRTISLNESGLDFQVAFGKDEHGIEWVLRLPRRSDVYKRTK
PEKQVVDFLQSNVSFEIPKWKVHAKDLIAYPKLTGNPAATIDPEIQDYVWEIEHKPVPEN
FVNTLAEALVDLHNIPEENITAQHIKIKTIQEVKNDFQRRMNKVKETYGVVYELWNRWKQ
WLENDELWPRHATMIHGDLHPGHIMVDNQANVTGLIDWTEATHSDPSMDFMGHHRIFGEE
GLEQLITAYGKAGGEIWPRMKEHIIELNAVFPMFIAEFAMKSGESAFEKMALKELGMEE
>WP_000155092.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mphD|antibiotic inactivation|1
MTIQDIQSLAEAHGLLLTDKMNFNEMGIDFKVVFALDTKGQQWLLRIPRRDGMREQIKKE
KRILELVKKHLSVEVPDWRISSTELVAYPILKDNPVLNLDAETYEIIWNMDKDSPKYITS
LAKTLFEIHSIPEKEVRENDLKIMKPSDLRPEIANNLQLVKSEIGISEQLETRYRKWLDN
DVLWADFTQFIHGDLYAGHVLASKDGAVSGVIDWSTAHIDDPAIDFAGHVTLFGEESLKT
LIIEYEKLGGKVWNKLYEQTLERAAASPLMYGLFALETQNESLIVGAKAQLGV
>WP_006261873.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mphD|antibiotic inactivation|1
MTIKDIQILAEAHGLLLTEKMKFNEMGIDFKVGFAIDRSGQQWLLRIPRRNDMGEQIEKE
KRILELVKKHLSIEVPDWQISSPELVAYPMLKYNPVLTFNAETYEVSWHMDKDSPKYITS
LAKTLVEIHSIPEIEVLGNDLKIMKSSNLRPEIASHLQLVKSEIGISEQLETRYRKWLDN
DALWADFTQFIHGDLYAGHVLASKEGIVSGIIDWSTAHIGDPAIDFSGHATVFGEESLKG
LIMEYEKQGGKVWDKLYEQTLERAAAAPLAYGFFALETQDESHIAGAKVQLGV
>CDS98980.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mphD|antibiotic inactivation|1
MTIKDIQILAEEHGLLLTENIRFNEMGIDFRVGFAIDNKGQRWLLRIPRRNDMSEQIDKE
KRILHLVKKHLSVKVPDWKITSPKLIAYPLIKEKPALTVDAETYGMVWNMDKDSPNYIQS
LAKSLVELHDITEEEVIKNHLKIMKPSDLRPEIDNQLKTVKSEIGISSELELRYKKWLDN
DKLWPDFTQFIHGDLYAGHILTSQDGIVAGIIDWSTAHLGDPANDFSGHVTIFGEASLRK
LITAYENQGGRTWGQLYEQAIERASASALAYGYFALETNDENHIMGAKVQLGV
>WP_026966955.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mphG|antibiotic inactivation|1
MEIKDIQDLAREHGLLLSEEMEFNEMGIDFRVGFAKDLDGRPWLLRIPRREGLGEQIDEE
KRILKLAGQHLSVQVPDWKIATPNLVAYPLLDGKPALTFDADTYEVTWNMDQNSPHYIPS
LAKALVELHGIPQEEVRANGLKVLSPQAVRTEIADRLQLVKSELGISEALEQRYLKWLDQ
DALWPDFTRFIHGDLYAGHVLTSPTGAVSGIIDWSTAQVADIALDFSGHATVFGEESLKA
LVTEYQKQGGEVWDKLFEQSLERAAAAPLAYGFFAVETQDEKHILGAKAQLGV
>AHW59590.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mphG|antibiotic inactivation|1
MKNTDIQKLAERHGLMLSDKMKFNEMGIDFKVGFATDKDENQWLLRIPRRPDLGKQIAKE
KLILQLVCKHLTAQVPDWKIANEELVAYPLLDGKPALTYDAETYEVSWNMDKDSPNYIQS
LAKILVQLHAIPKEEVVLNGLEVTTPESLRSEISERLRLVKSELGISNDLENRYKKWLDN
DTLWPNFTKFIHGDLYAGHILTYADGNVCGIIDWSTARISDISQDFSGHLTVFGEESLKS
LISEYEKQGGKIWNMIFEQAVERAAAAPLAYGYFAVETQDEVHINGAKVQLGV
>WP_014386803.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mphG|antibiotic inactivation|1
MKNRDIQKLAERNGLILSDEMSFNEMGIDFKVGFATDRDGTKWLLRIPRRTTLGEQIANE
KRILQLVSKYLSVQVPDWRIANEKLVAYPLLDGKPALTYDAETYEVTWNMSKENDLYIPS
LAKALIELHSIPTEEVLRNNLKILTPEQVRNEISERLILVKSELGINAELELRYQKWLDN
DALWPNFTKFIHGDLYAGHTLTHHNGEVCGIIDWSTAQVSDIAQDFSGHVTVFGEESLKN
LIAAYEKQGGEVWDKLFEQAVERAAAAPLAYGYFALETQDEIHLSSAKLQLGV
>WP_021070327.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mphD|antibiotic inactivation|1
MTIKDIQILALEHGLKISDDISINEMGIDFRVAFVKEVDGQNWVLRIPRRKDMIEQIQNE
SRILDLAKRNLSVHVPDWKIVSERLIAYPLLEDAPALTFDAVTHEISWNIDPNSVAYVRS
LAKSLAELHRVASDDVRKSNLKIMEPNELRTETANRIQLVKSELGISETLESRYRRWLDN
DLLWPDFTCFIHGDLYAGHVLTTKEGKVSGIIDWSTAHMGDPAMDFSGHLSVFGEDSLKL
LITEYVKQGGTIWDKIYEQSIERAAAAPLAYGAFAIECNDDRHISAAKTALGI
>WP_000369216.1|FEATURES|NCBI|beta_lactam|mecI|antibiotic target replacement|1
MDNKTYEISSAEWEVMNIIWMKKYASTNNIIEEIQMQKDWSPKTIRTLITRLYKKGFIDR
KKDNKIFQYYSLVEESDIKYKTSKNFINKVYKGGFNSLVLNFVEKEDLSQDEIEELRNIL
NKK
>BAE06301.1|FEATURES|NCBI|beta_lactam|mecI|antibiotic target replacement|1
MDNKTYEISSAEWEVMNIIWMKKYASANNIIEEIQMQKDWSPKTIRTLITRSYKKGFIDR
KKDNKIFQYYSLVEESDIKYKTSKNFINKVYKGGFNSLVLNFVEKEDLSQDEIEELRNIL
NKK
>WP_002485790.1|FEATURES|NCBI|beta_lactam|mecI|antibiotic target replacement|1
MDNKTYEISSAEWEVMNIIWMKKYASANNIIEEIQMQKDWSPKTIRTLITRLYKKGFIDR
KKDNKNFQYYSLVEESDIKYKTSKNFINKVYKGGFNSLVLNFVEKEDLSQDEIEELRNIL
NKK
>1SD6_A|FEATURES|NCBI|beta_lactam|mecI|antibiotic target replacement|1
MDNKTYEISSAEWEVMNIIWMKKYASANNIIEEIQMQKDWSPKTIRTLITRLYKKGFIDR
KKDNKIFQYYSLVEESDIKYKTSKNFINKVYKGGFNSLVLNFVEKEELSQDEIEELRNIL
NKK
>WP_031921728.1|FEATURES|NCBI|beta_lactam|mecI|antibiotic target replacement|1
MDNKTYEISSAEREVMNIIWMKKYASANNIIEEIQMQKDWSPKTIRTLITRLYKKGFIDR
KKDNKIFQYYSLVEESDIKYKTSKNFINKVYKGGFNSLVLNFVEKEDLSQDEIEELRNIL
NKK
>WP_025904161.1|FEATURES|NCBI|beta_lactam|mecI|antibiotic target replacement|1
MDNKTYDISSAEWEVMNIIWMKKYASANNIIEEIQMQKDWSPKTIRTLITRLYKKGFIDR
KKDNKIFQYYSLVEESDIKYKTSKNFINKVYKGGFNSLVLNFVEKEDLSQDEIEELRNIL
NKK
>CAA73545.1|FEATURES|NCBI|beta_lactam|mecI|antibiotic target replacement|1
MDNKTYEISSAEWEVMNIIWMKKYASANYMIEEIQMQKDWSPKTIRTLITRLYKKGFIDR
KKDNKIFQYYSLVEESDIKYKTSKNFINKVYKGGFNSLVLNFVEKEDLSQDEIEELRNIL
NKK
>CDH98055.1|FEATURES|NCBI|beta_lactam|mecI|antibiotic target replacement|1
MTHEGYDISASEWEIMNTIWNKKLISANDVIEIVQQRKEWSPKTIRTLINRLYKKKFIDR
ISRNKIFEYFPRVEEKDMKYKTSKVFLDKVYEGGLNSLVLNFVENEELSEDDIEELKNIL
NTKKD
>CCM44123.1|FEATURES|NCBI|beta_lactam|mecI|antibiotic target replacement|1
MKNEGYDISASEWEIMNTIWNKKLISANEVIEIVQQHKEWSPKTIRTLINRLYKKKFIDR
TNRNKIFEYFPIVEEKNMKYKTSKVFLDKVYEGGLNSLVLNFVENEELSEEEIEELKNIL
NKKKD
>AIS76191.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLLGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGSVLTIVAFYMELPVWMVMIVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSMWELNAIIAIDVLGAVI
ASITVAIVRIPKLGDHVQSLDPNFIREMKEGMAVLRQNKGLFALLLVGTLYMFVYMPINA
LFPLISMDYFNGTPMHISITEISFASGMLIGGLLLGLFGNYQKRILLITASIFMMGISLT
ISGLLPQSGFFIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSALFADRIGVNHWFLLSGILIICIAIVCPMITEIRKLDLK
>WP_009288847.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVALYMELPIWMVMVVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWELNAIIAIDVLGAVI
ASITVAIVRIPKLGDQVQSLKPNFIREMKEGMAVLRQNKGLFALLLVGTLYMFVYMPINA
LYPLITMEYFNGTPMHISITEIAYASGMLIGGLLLGLFGNYQKRILLITASIFMMGISLT
ISGLLPQSGFFIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSGFFADRIGVNHWFLLSGILIICIAIVCPMITEIRKLDLK
>WP_027625762.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVALYMELPIWMVMVVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWELNAIIAIDVLGAVI
ASITVAIVRIPKLGDQVQSLKPNFIREMKEGMAVLRQNKGLFALLLVGTLYMFVYMPINA
LYPLITMEYFNGTPMHISITEIAYASGMLIGGLLLGLFGNYQKRILLITASIFMMGISLT
ISGLLPQSGFFIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSGFFADRIGVNHWFLLSGILIICIAIVCPMITEIRKLDAK
>WP_009317659.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVALYMELPIWMVMVVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWGLNAIIAIDVLGAVI
ASITVAIVRIPKLGDQVQSLKPNFIREMKEGMAVLRQNKGLFALLLVGTLYMFVYMPINA
LYPLITMEYFNGTPMHISITEIAYASGMLIGGLLLGLFGNYQKRILLITASIFMMGISLT
ISGLLPQSGFFIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSGFFADRIGVNHWFLLSGILIICIAIVCPMITEIRKLDAK
>WP_005816151.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVALYMELPIWMVMVVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWELNAIIAIDVLGAVI
ASITVAIVRIPKLGDQVQSLKPNFIREMKEGMAVLRQNKGLFALLLVGTLYMFVYMPINA
LYPLITMEYFNGTPMHISITEIAYASGMLIGGLLLGLFGNYQKRILLITASIFMMGISLT
ISGLLPQSGFFIFVVCCAIMGLSGPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSGFFADRIDVNHWFLLSGILIICIAIVCPMITEIRKLDAK
>WP_012102963.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVALYMELPIWMVMVVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWELNAIIAIDVLGAMI
ASITVAIVRIPKLGDQVQSLKPNFIREMKEGMAVLRQNKGLFALLLVGTLYMFVYMPINA
LYPLITMEYFNGTPMHISITEIAYASGMLIGGLLLGLFGNYQKRILLITASIFMMGISLT
ISGLLPQSGFFIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSGFIADRIGVNHWFLLSGILIICIAIVCPMITEIRKLDLK
>WP_018664415.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVVFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVALYMELPIWMVMVVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWELNAIIAIDVLGAMI
ASITVAIVRIPKLGDQVQSLKPNFIREMKEGMAVLRQNKGLFALLLVGTLYMFVYMPINA
LYPLITMEYFNGTPMHISITEIAYASGMLIGGLLLGLFGNYQKRILLITASIFMMGISLT
ISGLLPQSGFFIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSGFIADRIGVNHWFLLSGILIICIAIVCPMITEIRKLDLK
>WP_008976876.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAIVLSMASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVALYMELPIWMVMVVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWELNAIIAIDVLGAVI
ASITVAIVRIPKLGDQVQSLKPNFIREMKEGMAVLRQNKGLFALLLVGTLYMFVYMPINA
LYPLITMEYFNGTPMYISITEIAYASGMLIGGLLLGLFGNYQKRILLITASIFMMGISLT
ISGLLPQSGFFIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSGFFADRIGVNHWFLLSGILIICIAIVCPMITEIRKFDLK
>WP_009246943.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVALYMELPIWMVMVVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWELNAIIAIDVWGAVI
ASITVAIVRIPKLGDQVQSLKPNFIREMKEGMAVLRQNKGLFALLLVGTLYMFVYMPINA
LYPLITMEYFNGTPMYISITEIAYASGMLIGGLLLGLFGNYQKRILLITASIFMMGISLT
ISGLLPQSGFFIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSGFFADRIGVNHWFLLSGILIICIAIVCPMITEIRKFDLK
>WP_002941309.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFYMELPVWMVMIVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVI
ASITVALVRIPKLGDQVQSLEPNFIGEMKEGMAVLRQNKGLFALLLVGTLYMFVYMPINA
LYPLITMEYFNGTPMHISITEIAYASGMLIGGLLLGLFGNYQKRILLIMASIFMMGISLT
ISGLLPQSGFFIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSGFFADRIGVNHWFLLSGILIICIAIVCPMITEIRKLDAK
>WP_008665090.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFYMELPVWMVMIVLFIRSIGTAFHT
PALNSVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVI
ASITVAIVRIPKLGDRVQSLEPNFIREMKEGMAVLRQNKGLFALLLVGTLYMFVYMPINA
LYPLITMECFNGTPMHISITEIAYASGMLIGGLLLGLFGNYQKRILLITASIFMMGISLT
ISGLLPQSGFFIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSGFFADRIGVNHWFLLSGVLIIGIAIACPMITEVRKLDLK
>ACG58977.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLLGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGSVLTIVAFYMELPVWMVMIVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWELNAIIAIDVLGAVI
ASITVAIVRIPKLGNQVQSLEPNFIREMKEGVVVLRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMEHFNGTPVHISITEISFAFGMLAGGLLLGRLGGFEKHVLLMTSSFFIMGTSLA
VSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSALFADRIGVNHWFLLSGILIICIAIVCPMINEIRKLDLK
>WP_024410015.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKRKFYAIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAIL
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFYMELPVWIVMIVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVI
ASITVAIVRIPKLGNQVQSLEPNFIREMKEGVVVLRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMEYFNGTPVHISITEISFAFGMLAGGLLLGRLGSFEKPVLLITSSFFIMGASLA
VSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALYQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSGFFADKIGVNHWFLLSGILIIGIAIVCPMITEVRRLDLK
>ETI84131.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKRKFYAIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAIL
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFCMELPVWMIMIVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVI
ASITVAIVRIPKLGNQVQSLEPNFIREMKEGVVVLRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMEHFNGTPVHISITEISFAFGMLAGGLLLGRLGGFEKHVLLITSSFFIMGTSLA
VSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSGFFADKIGVNHWFLLSGILIIGIAIVCQMITEVRKLDLK
>WP_000417520.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKRKFYAIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAIL
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFCMELPVWMIMIVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVI
ASITVAIVRIPKLGNQVQSLEPNFIREMKEGVVVLRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMEYFNGTPVHISITEISFAFGMLAGGLLLGRLGGFEKHVLLITSSFFIMGTSLA
VSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLIGSIMSLAMP
IGLILSGFFADKIGVNHWFLLSGILIIGIAIVCQMITEVRKLDLK
>CDL74288.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKRKFYAIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAIL
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFCMELPVWMIMIVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVI
ASITVAIVRIPKLGNQVQSLEPNFIREMKEGVVVLRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMEHFNGTPVHISITQISFAFGMLAGGLLLGRLGGFEKHVLLITSSFFIMGTSLA
VSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLIGSIMSLAMP
IGLILSGFFADKIGVNHWFLLSGILIIGIAIVCQMITEVRKLDLK
>WP_023918145.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKRKFYAIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAIL
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFCMELPVWMIMIVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVTALLYSVWDLNAIIAIDVLGAVI
ASITVAIVRIPKLGNQVQSLEPNFIREMKEGVVVLRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMEHFNGTPVHISITEISFAFGMLAGGLLLGRLGGFEKHVLLITSSFFIMGTSLA
VSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLIGSIMSLAMP
IGLILSGFFADKIGVNHWFLLSGILIIGIAIVCQMITEVRKLDLK
>WP_000417521.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKRKFYAIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAIL
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFCMELPVWMIMIVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVI
ASTTVAIVRIPKLGNQVQSLEPNFIREMKEGVVVLRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMEHFNGTPVHISITEISFAFGMLAGGLLLGRLGGFEKHVLLITSSFFIMGTSLA
VSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLIGSIMSLAMP
IGLILSGFFADKIGVNHWFLLSGILIIGIAIVCQMITEVRKLDLK
>WP_000417518.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKRKFYAIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAIL
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFCMELPVWMIMIVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVI
ASITVAIVRIPKLGNQVQSLEPNFIREMKEGVVVLRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMEHFNGTPVHISITEISFAFGMLAGGFLLGRLGGFEKHVLLITSSFFIMGTSLA
VSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLIGSIMSLAMP
IGLILSGFFADKIGVNHWFLLSGILIIGIAIVCQMITEVRKLDLK
>WP_032461793.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKRKFYAIWAGQAVSLITSAILQIAIIFYLTEKTGSAMVLSMASLVGFLPYAIL
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFCMELPVWMIMIVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVI
ASITVAIVRIPKLGNQVQSLEPNFIREMKEGVVVLRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMEHFNGTPVHISITEISFAFGMLAGGLLLGRLGGFEKHVLLITSSFFIMGTSLA
VSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLIGSIMSLAMP
IGLILSGFFADKIGVNHWFLLSGILIIGIAIVCQMITEVRKLDLK
>KGF31920.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKRKFYAIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAIL
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFCMELPVWMIMIVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVI
ASITVAIVRIPKLGNQVQSLEPNFIREMKEGVVVLRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMEHFNGTPVHISITEISFAFGMLSGGLLLGRLGGFEKHVLLITSSFFLMGTSLA
VSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLIGSIMSLAMP
IGLILSGFFADKIGVNHWFLLSGILIIGIAIVCQMITEVRKLDLK
>ACG58974.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFYMELPVWMVMIVLFIRSIGTAFHT
PALNSVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVI
ASITVAIVRIPKLGDRVQSLEPNFIREMKEGIVVLRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMDYFNGTPVHISITEISFASGMLAGGLLLGRLGSFEKRVLLITSSFFIMGASLA
VSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSGFFADRIGVNYWFLLSGVLIIGIAIACPMITEVRKLDLK
>ACG58972.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTERTGSAMVLSMASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVALYMELPVWMVMVVLFIRSVGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVI
ASITVAIVRIPKLGDRVQSLEPNFIREMKEGIVVLRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMDYFNGTPVHISITEISFASGMLAGGLLLGRLGSFEKRVLLITSSFFIMGASLA
VSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSGFFADRIGVNHWFLLSGILIIGIAIACPMITEVRKLDLK
>AAQ62547.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSLASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAASSVLTIVALYMELPVWMVMIVLFIRSIGTAFHN
PALNSVTPLLVPEEQLTKCAGYSQSLQSISYIVSPALAALLYSVWDLNAIIAIDVLGAVI
ASITVAIVRIPKLGNPVQSLEPNFIREMREGIVVLRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMEHFNGTPVHISITEISFAFGMLAGGLLLGRLGSFEKRVLLITSSFFIMGASLA
VSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSGFFAERIGVNDWFLLSGVLIIGIAIACPMITEVRKLDLK
>WP_024399345.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKRKFYAIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAIL
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFYMELPVWMVMIVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVI
ASITVAIVRIPKLGNQVQSLEPNFIREMKEGIVALRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMEYFNGTPVHISITEIAFASGMLVGGLLLGRLGNFEKRVLLITGSFFIMGASLA
VSGLLPPSGFVIFVACCAVMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSFAMP
IGLILSGFYADRIGVNHWFLLSGILIIGIAIVCPMITEIRKLDAK
>AAQ62548.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKFKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSIASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVALYTELSVWMVMVVLFIRSIGTAFHS
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIISPAAAALLYSVWKLNAIIAIDVLGAVI
ASITVAIVSIPKLGDQVQSLKPNFLREMKEGIVALRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMEYFNGTPVHISITEIAFASGMLVGGLLLGRLGNFEKRVLLITGSFFIMGASLA
VSGLLPSSGFVIFVACCAVMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSFAMP
IGLILSGFYADRIGVNHWFLLSGILIIGIAIVCPMITEVRKLDLK
>AAQ62544.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKFKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVALYTELSVWMVMVVLFIRSIGTAFHS
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIISPAAAALLYSVWKLNAIIAIDILGAMI
ASITVAIVSIPKLGDQVQSLKPNFLREMKEGIVALRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMEYFNGTPVHISITEIAFASGMLVGGLLLGRLGNFEKRVLLITGSFFIMGASLA
VSGLLPPSGFVIFVACCAVMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSFAMP
IGLILSGFFADRIGVNHWFLLSGILIIGIAIVCPMITEVRKLDLK
>AAQ62545.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKFKFYTIWAGQAVSLITSAILAMAIIFYLTEKTGSAMVLSMASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVALYTELSVWMVMVVLFIRSIGTAFHS
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIISPAAAALLYSVWKLNAIIAIDILGAMI
ASITVAIVSIPKLGDQVQSLKPNFLREMKEGIVALRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMEYFNGTPVHISITEIAFASGMLVGGLLLGRLGNFEKRVLLITGSFFIMGASLA
VSGLLPPSGFVIFVACCAVMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSFAMP
IGLILSGFFADRIGVNHWFLLSGILIIGIAIVCPMITEVRKLDLK
>WP_031577801.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYINWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVALYTELSVWMVMVVLFIRSIGTAFHS
PALNAVTPLLVPEEQLTKCAGYSQSVQSISYIISPAAAALLYSVWKLNAIIAIDVLGAVI
ASITVAIVSIPKLGDQVQSLELNFLREMKEGIVALRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMECFNGTPVHISITEIAFASGMLVGGLLLGRLGNFEKRVLLITGSFFIMGASLA
VSGLLPPSGFVIFVACCAVMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSFAMP
IGLILSGFFADRIGVNHWFLLSGILIIGIAIVCPMITEVRKLDLK
>CDG57849.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKRKFYAIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLLGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAVAGAVLAIVALFTELSVWMVMVVLFIRSIGTAFHS
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIISPAAAALLYSVWKLNAIIAIDVLGAVI
ASITVAIVSIPKLGDQVQSLKPNFLREMKEGIVALRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMEYFNGTPVHISITEIAFASGMLVGGLLLGRLRNFEKRVLLITGSFFIMGASLA
VSGLLPPSGFVIFVACCAVMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSFAMP
IGLILSGFYADRIGVNHWFLLSGILIIGIAIVCPMITEVRKLDLK
>ABE02098.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVALYMELPVWIVMIVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVI
ASITVAIVRIPKLGDQVQSLEPNFIREMKEGIVVMRQNKGLFALLLLGTLYTFVYMPINA
LYPLISMEYFNGTPMHISITEIAFASGMLAGGLILGRLGSYEKRVPLITGSFFMMGASLA
IAGLLPPSGFIIFVVCCAIMGLSVPFYSGVQTALFQQKIKPEYLGRVFSFTGSIMSLAMP
LGLILSGFFADRIGINHWFLISGILIIGIAIVCPMMTEVRKLDLK
>BAA03776.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mphA|antibiotic inactivation|1
MTVVTTADTSQLYALAARHGLKLHGPLTVNELGLDYRIVIATVDDGRRWVLRIPRRAEVS
AKVEPEARVLAMLKNRLPFAVPDWRVANAELVAYPMLEDSTAMVIQPGSSTPDWVVPQDS
EVFAESFATALAALHAVPISAAVDAGMLIRTPTQARQKVADDVDRVRREFVVNDKRLHRW
QRWLDDDSSWPDFSVVVHGDLYVGHVLIDNTERVSGMIDWSEARVDDPAIDMAAHLMVFG
EEGLAKLLLTYEAAGGRVWPRLAHHIAERLAFGAVTYALFALDSGNEEYLAAA
>CAJ98570.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mphA|antibiotic inactivation|1
MLHDTDRILKLAREAGLELAPGSLRLNEMGLDFQVAFGRDGDAVEWVLRMPRRTDVACAA
VKEAKILDYFRSRLPVAVPDWKVFSDDLIAYPSLPGNPGLTFDASTYETTWHFDQNSPVY
VETLGAALAQLHGLDTDDAISAGLSNLSIDAVRENWTRDLETVEKSFEVPAARLALWRAW
LADLSFWPTHAASVHGDLYVGHVMVKSDGTVCGIIDWSEAHIGDPGIDLAGHLKVFGEAS
LRDLLGHYEAAGGQTWPRIVEHCKMLQSAEGIRYAMFALKTGSAEHLEGAQGLLSAPGI
>WP_000163435.1|FEATURES|NCBI|mupirocin|ileS|antibiotic target alteration|1
MTKKYLNTQNEISAFWNTQKIFKKSIDNRKGQESFVFYDGPPTANGLPHAGHVLGRVIKD
LVARLKTMQGFYVERKAGWDTHGLPVELEVEKKIGIKGKQDIEKYGIENFINECKKSVFN
YEKEWRDFSKDLGYWVDMDSPYITLENNYIESVWNILSTFHKKGLLYKGHKVTPYCTHDQ
TALSSHEVAQGYKNVKDLSAVVKFQLTNSKDTYFLSWTTTPWTLPANVALAINKDLNYSK
IRVENEYYILATDLINSIITEKYEIIDTFSGSNLINLKYIPPFESDGLVNAYYVVDGEFV
TNSEGTGIVHIAPAHGEDDYQLVLERDLDFLNVITREGVYNDRFPELVGNKAKNSDIEII
KLLSKKQLLYKKQKYEHNYPHCWRCGNPLIYYAMEGWFIKTTNFKNEIINNNNNIEWFPS
HIKEGRMGNFLENMVDWNIGRNRYWGTPLNVWICNDCNHEYAPSSIKDLQNNSINKIDED
IELHRPYVDNITLSCPKCNGKMSRVEEVIDVWFDSGSMPFAQHHYPFDNQKIFNQHFPAD
FIAEGVDQTRGWFYSLLVISTILKGKSSYKRALSLGHILDSNGKKMSKSKGNVINPTELI
NKYGADSLRWALISDSAPWNNKRFSENIVAQTKSKFIDTLDNIYKFYNMYNKIDHYNPNN
EITKSRNTLDNWALSRLNTLIKESNIYVNNYDFTSAARLINEYTNTISNWYIRRSRGRFW
EQGISNDKKDAYNTLYEILTTLSRLVAPFVPFISEKIHYNLTGKSVHLQDYPQYKESFIN
QALEDEMHTVIKIVELSRQARKNADLKIKQPLSKMVIKPNSQLNLSFLPNYYSIIKDELN
IKNIELTDNINDYITYELKLNFSSVGPKLGNKTKNIQTLIDSLSEYDKKSLIESNNFKSL
SSDAELTKDDFIIKTLPKDSYQLSEDNDCVILLDKNLSPELIREGHARELIRLIQQLRKK
KNLPINQRIDIYIGVTGELLESIKTNKNMFKENLLIKNIHLNVIDEYENTIHFNNKEIKI
SLLY
>WP_012818050.1|FEATURES|NCBI|mupirocin|ileS|antibiotic target alteration|1
MTKKYLNTQNEISAFWNTQKIFKKSIDNRKGQESFVFYDGPPTANGLPHAGHVLGRVIKD
LVARLKTMQGFYVERKAGWDTHGLPVELEVEKKIGIKGKQDIEKYGIENFINECKKSVFN
YEKEWRDFSKDLGYWVDMDSPYITLENNYIESVWNILSTFHKKGLLYKGHKVTPYCTHDQ
TALSSHEVAQGYKNVKDLSAVVKFQLTNSKDTYFLSWTTTPWTLPANVALAINKDLNYSK
IRVENEYYILATDLINSIITEKYEIIDTFSGSNLINLKYIPPFESDGLVNAYYVVDGEFV
TNSEGTGIVHIAPAHGEDDYQLVLERDLDFLNVITREGVYNDRFPELVGNKAKNSDIEII
KLLSKKQLLYKKQKYEHNYPHCWRCGNPLIYYAMEGWFIKTTNFKNEIINNNNNIEWFPS
HIKEGRMGNFLENMVDWNIGRNRYWGTPLNVWICNDCNHEYAPSSIKDLQNNSINKIDED
IELHRPYVDNITLSCPKCNGKMSRVEEVIDVWFDSGSMPFAQHHYPFDNQKIFNQHFPAD
FIAEGVDQTRGWFYSLLVISTILKGKSSYKRALSLGHILDSNGKKMSKSKGNVINPTELI
NKYGADSLRWALISDSAPWNNKRFSENIVAQTKSKFIDTLDNIYKFYNMYNKIDHYNPNN
EITKSRNTLDNWALSRLNTLIKESNIYVNNYDFTSAARLINEYTNTISNWYIRRSRGRFW
EQGISNDKKDAYNTLYEILTTLSRLVAPFVPFISEKIHYNLTGKSVHLQDYPQYKESFIN
QALEDEMHTVIKIVELSRQARKNADLKIKQPLSKMVIKPNSQLNLSFLPNYYSIIKDELN
IKNIELTDNINDYITYELKLNFSSVGPKLGNKTKNIQTLIDSLSEYDKKSLIESNNFKSL
SSDAELTKDDFIIKTLPKDSYQLSEDNDCVILLDKNLSPELIREGHARELIRLIQQLRKK
KNLPINQRIDIYIGVTGELLESIETNKNMFKENLLIKNIHLNVIDEYENTIHFNNKEIKI
SLLY
>WP_031784491.1|FEATURES|NCBI|mupirocin|ileS|antibiotic target alteration|1
MTKKYLNTQNEISAFWNTQKIFKKSIDNRKGQENFVFYDGPPTANGLPHAGHVLGRVIKD
LVARLKTMQGFYVERKAGWDTHGLPVELEVEKKIGIKGKQDIEKYGIENFINECKKSVFN
YEKEWRDFSKDLGYWVDMDSPYITLENNYIESVWNILSTFHKKGLLYKGHKVTPYCTHDQ
TALSSHEVAQGYKNVKDLSAVVKFQLTNSKDTYFLSWTTTPWTLPANVALAINKDLNYSK
IRVENEYYILATDLINSIITEKYEIIDTFSGSNLINLKYIPPFESDGLVNAYYVVDGEFV
TNSEGTGIVHIAPAHGEDDYQLVLERDLDFLNVITREGVYNDRFPELVGNKAKNSDIEII
KLLSKKQLLYKKQKYEHNYPHCWRCGNPLIYYAMEGWFIKTTNFKNEIINNNNNIEWFPS
HIKEGRMGNFLENMVDWNIGRNRYWGTPLNVWICNDCNHEYAPSSIKDLQNNSINKIDED
IELHRPYVDNITLSCPKCNGKMSRVEEVIDVWFDSGSMPFAQHHYPFDNQKIFNQHFPAD
FIAEGVDQTRGWFYSLLVISTILKGKSSYKRALSLGHILDSNGKKMSKSKGNVINPTELI
NKYGADSLRWALISDSAPWNNKRFSENIVAQTKSKFIDTLDNIYKFYNMYNKIDHYNPNN
EITKSRNTLDNWALSRLNTLIKESNIYVNNYDFTSAARLINEYTNTISNWYIRRSRGRFW
EQGISNDKKDAYNTLYEILTTLSRLVAPFVPFISEKIHYNLTGKSVHLQDYPQYKESFIN
QALEDEMHTVIKIVELSRQARKNADLKIKQPLSKMVIKPNSQLNLSFLPNYYSIIKDELN
IKNIELTDNINDYITYELKLNFSSVGPKLGNKTKNIQTLIDSLSEYDKKSLIESNNFKSL
SSDAELTKDDFIIKTLPKDSYQLSEDNDCVILLDKNLSPELIREGHARELIRLIQQLRKK
KNLPINQRIDIYIGVTGELLESIKTNKNMFKENLLIKNIHLNVIDEYENTIHFNNKEIKI
SLLY
>WP_002449603.1|FEATURES|NCBI|mupirocin|ileS|antibiotic target alteration|1
MTKKYLNTQNEISVFWNTQKIFKKSIDNRKGQESFVFYDGPPTANGLPHAGHVLGRVIKD
LVARLKTMQGFYVERKAGWDTHGLPVELEVEKKIGIKGKQDIEKYGIENFINECKKSVFN
YEKEWRDFSKDLGYWVDMDSPYITLENNYIESVWNILSTFHKKGLLYKGHKVTPYCTHDQ
TALSSHEVAQGYKNVKDLSAVVKFQLTNSKDTYFLSWTTTPWTLPANVALAINKDLNYSK
IRVENEYYILATDLINSIITEKYEIIDTFSGSNLINLKYIPPFESDGLVNAYYVVDGEFV
TNSEGTGIVHIAPAHGEDDYQLVLERDLDFLNVITREGVYNDRFPELVGNKAKNSDIEII
KLLSKKQLLYKKQKYEHNYPHCWRCGNPLIYYAMEGWFIKTTNFKNEIINNNNNIEWFPS
HIKEGRMGNFLENMVDWNIGRNRYWGTPLNVWICNDCNHEYAPSSIKDLQNNSINKIDED
IELHRPYVDNITLSCPKCNGKMSRVEEVIDVWFDSGSMPFAQHHYPFDNQKIFNQHFPAD
FIAEGVDQTRGWFYSLLVISTILKGKSSYKRALSLGHILDSNGKKMSKSKGNVINPTELI
NKYGADSLRWALISDSAPWNNKRFSENIVAQTKSKFIDTLDNIYKFYNMYNKIDHYNPNN
EITKSRNTLDNWALSRLNTLIKESNIYVNNYDFTSAARLINEYTNTISNWYIRRSRGRFW
EQGISNDKKDAYNTLYEILTTLSRLVAPFVPFISEKIHYNLTGKSVHLQDYPQYKESFIN
QALEDEMHTVIKIVELSRQARKNADLKIKQPLSKMVIKPNSQLNLSFLPNYYSIIKDELN
IKNIELTDNINDYITYELKLNFSSVGPKLGNKTKNIQTLIDSLSEYDKKSLIESNNFKSL
SSDAELTKDDFIIKTLPKDSYQLSEDNDCVILLDKNLSPELIREGHARELIRLIQQLRKK
KNLPINQRIDIYIGVTGELLESIKTNKNMFKENLLIKNIHLNVIDEYENTIHFNNKEIKI
SLLY
>WP_012816701.1|FEATURES|NCBI|mupirocin|ileS|antibiotic target alteration|1
MTKKYLNTQNEISVFWNTQKIFKKSIDNRKGQESFVFYDGPPTANGLPHAGHVLGRVIKD
LVARLKTMQGFYVERKAGWDTHGLPVELEVEKKIGIKGKQDIEKYGIENFINECKKSVFN
YEKEWRDFSKDLGYWVDMDSPYITLENNYIESVWNILSTFHKKGLLYKGHKVTPYCTHDQ
TALSSHEVAQGYKNVKDLSAVVKFQLTNSKDTYFLSWTTTPWTLPANVALAINKDLNYSK
IRVENEYYILATDLIKSIITEKYEIIDTFSGSNLINLKYIPPFESDGLVNAYYVVDGEFV
TNSEGTGIVHIAPAHGEDDYQLVLERDLDFLNVITREGVYNDRFPELVGNKAKNSDIEII
KLLSKKQLLYKKQKYEHNYPHCWRCGNPLIYYAMEGWFIKTTNFKNEIINNNNNIEWFPS
HIKEGRMGNFLENMVDWNIGRNRYWGTPLNVWICNDCNHEYAPSSIKDLQNNSINKIDED
IELHRPYVDNITLSCPKCNGKMSRVEEVIDVWFDSGSMPFAQHHYPFDNQKIFNQHFPAD
FIAEGVDQTRGWFYSLLVISTILKGKSSYKRALSLGHILDSNGKKMSKSKGNVINPTELI
NKYGADSLRWALISDSAPWNNKRFSENIVAQTKSKFIDTLDNIYKFYNMYNKIDHYNPNN
EITKSRNTLDNWALSRLNTLIKESNIYVNNYDFTSAARLINEYTNTISNWYIRRSRGRFW
EQGISNDKKDAYNTLYEILTTLSRLVAPFVPFISEKIHYNLTGKSVHLQDYPQYKESFIN
QALEDEMHTVIKIVELSRQARKNADLKIKQPLSKMVIKPNSQLNLSFLPNYYSIIKDELN
IKNIELTDNINDYITYELKLNFSSVGPKLGNKTKNIQTLIDSLSEYDKKSLIESNNFKSL
SSDAELTKDDFIIKTLPKDSYQLSEDNDCVILLDKNLSPELIREGHARELIRLIQQLRKK
KNLPINQRIDIYIGVTGELLESIKTNKNMFKENLLIKNIHLNVIDEYENTIHFNNKEIKI
SLLY
>WP_031906628.1|FEATURES|NCBI|mupirocin|ileS|antibiotic target alteration|1
MTKKYLNTQNEILAFWNTQKIFKKSIDNRKGQESFVFYDGPPTANGLPHAGHVLGRVIKD
LVARLKTMQGFYVERKAGWDTHGLPVELEVEKKIGIKGKQDIEKYGIENFINECKKSVFN
YEKEWRDFSKDLGYWVDMDSPYITLENNYIESVWNILSTFHKKGLLYKGHKVTPYCTHDQ
TALSSHEVAQGYKNVKDLSAVVKFQLTNSKDTYFLSWTTTPWTLPANVALAINKDLNYSK
IRVENEYYILATDLINSIITEKYEIIDTFSGSNLINLKYIPPFESDGLVNAYYVVDGEFV
TNSEGTGIVHIAPAHGEDDYQLVLERDLDFLNVITREGVYNDRFPELVGNKAKNSDIEII
KLLSKKQLLYKKQKYEHNYPHCWRCGNPLIYYAMEGWFIKTTNFKNEIINNNNNIEWFPS
HIKEGRMGNFLENMVDWNIGRNRYWGTPLNVWICNDCNHEYAPSSIKDLQNNSINKIDED
IELHRPYVDNITLSCPKCNGKMSRVEEVIDVWFDSGSMPFAQHHYPFDNQKIFNQHFPAD
FIAEGVDQTRGWFYSLLVISTILKGKSSYKRALSLGHILDSNGKKMSKSKGNVINPTELI
NKYGADSLRWALISDSAPWNNKRFSENIVAQTKSKFIDTLDNIYKFYNMYNKIDHYNPNN
EITKSRNTLDNWALSRLNTLIKESNIYVNNYDFTSAARLINEYTNTISNWYIRRSRGRFW
EQGISNDKKDAYNTLYEILTTLSRLVAPFVPFISEKIHYNLTGKSVHLQDYPQYKESFIN
QALEDEMHTVIKIVELSRQARKNADLKIKQPLSKMVIKPNSQLNLSFLPNYYSIIKDELN
IKNIELTDNINDYITYELKLNFSSVGPKLGNKTKNIQTLIDSLSEYDKKSLIESNNFKSL
SSDAELTKDDFIIKTLPKDSYQLSEDNDCVILLDKNLSPELIREGHARELIRLIQQLRKK
KNLPINQRIDIYIGVTGELLESIKTNKNMFKENLLIKNIHLNVIDEYENTIHFNNKEIKI
SLLY
>WP_031899433.1|FEATURES|NCBI|mupirocin|ileS|antibiotic target alteration|1
MTKKYLNTQNEILAFWNTQKIFKKSIDNRKGQESFVFYDGPPTANGLPHTGHVLGRVIKD
LVARLKTMQGFYVERKAGWDTHGLPVELEVEKKIGIKGKQDIEKYGIENFINECKKSVFN
YEKEWRDFSKDLGYWVDMDSPYITLENNYIESVWNILSTFHKKGLLYKGHKVTPYCTHDQ
TALSSHEVAQGYKNVKDLSAVVKFQLTNSKDTYFLSWTTTPWTLPANVALAINKDLNYSK
IRVENEYYILATDLINSIITEKYEIIDTFSGSNLINLKYIPPFESDGLVNAYYVVDGEFV
TNSEGTGIVHIAPAHGEDDYQLVLERDLDFLNVITREGVYNDRFPELVGNKAKNSDIEII
KLLSKKQLLYKKQKYEHNYPHCWRCGNPLIYYAMEGWFIKTTNFKNEIINNNNNIEWFPS
HIKEGRMGNFLENMVDWNIGRNRYWGTPLNVWICNDCNHEYAPSSIKDLQNNSINKIDED
IELHRPYVDNITLSCPKCNGKMSRVEEVIDVWFDSGSMPFAQHHYPFDNQKIFNQHFPAD
FIAEGVDQTRGWFYSLLVISTILKGKSSYKRALSLGHILDSNGKKMSKSKGNVINPTELI
NKYGADSLRWALISDSAPWNNKRFSENIVAQTKSKFIDTLDNIYKFYNMYNKIDHYNPNN
EITKSRNTLDNWALSRLNTLIKESNIYVNNYDFTSAARLINEYTNTISNWYIRRSRGRFW
EQGISNDKKDAYNTLYEILTTLSRLVAPFVPFISEKIHYNLTGKSVHLQDYPQYKESFIN
QALEDEMHTVIKIVELSRQARKNADLKIKQPLSKMVIKPNSQLNLSFLPNYYSIIKDELN
IKNIELTDNINDYITYELKLNFSSVGPKLGNKTKNIQTLIDSLSEYDKKSLIESNNFKSL
SSDAELTKDDFIIKTLPKDSYQLSEDNDCVILLDKNLSPELIREGHARELIRLIQQLRKK
KNLPINQRIDIYIGVTGELLESIKTNKNMFKENLLIKNIHLNVIDEYENTIHFNNKEIKI
SLLY
>WP_002487653.1|FEATURES|NCBI|mupirocin|ileS|antibiotic target alteration|1
MTKKYLNTQNEILAFWNTQKIFKKSIDNRKGQESFVFYDGPPTANGLPHAGHVLGRVIKD
LVARLKTMQGFYVERKAGWDTHGLPVELEVEKKIGIKGKQDIEKYGIENFINECKKSVFN
YEKEWRDFSKDLGYWVDMDSPYITLENNYIESVWNILSTFHKKGLLYKGHKVTPYCTHDQ
TALSSHEVAQGYKNVKDLSAVVKFQLTNSKDTYFLSWTTTPWTLPANVALAINKDLNYSK
IRVENEYYILATDLINSIITEKYEIIDTFSGSNLINLKYIPPFESDGLVNAYYVVDGEFV
TNSEGTGIVHIAPAHGEDDYQLVLERDLDFLNVITREGVYNDRFPELVGNKAKNSDIEII
KLLSKKQLLYKKQKYEHNYPHCWRCGNPLIYYAMEGWFIKTTNFKNEIINNNNNIEWFPS
HIKEGRMGNFLENMVDWNIGRNRYWGTPLNVWICNDCNHEYAPSSIKDLQNNSINKIDED
IELHRPYVDNITLSCPKCNGKMSRVEEVIDVWFDSGSMPFAQHHYPFDNQKIFNQHFPAD
FIAEGVDQTRGWFYSLLVISTILKGKSSYKRALSLGHILDSNGKKMSKSKGNVINPTELI
NKYGADSLRWALISDSAPWNNKRFSENIVAQTKSKFIDTLDNIYKFYNMYNKIDHYNPNN
EITKSRNTLDNWALSRLNTLIKESNIYVNNYDFTSAARLINEYTNTISNWYIRRSRGRFW
EQGISNDKKDAYNTLYEILTTLSRLVAPFVPFISEKIHYNLTGKSVHLQDYPQYKESFIN
QALEDEMHTVIKIVELSRQARKNADLKIKQPLSKMVIKPNSQLNLSFLPNYYSIIKDELN
IKNIELTDNINDYITYELKLNFSSVGPKLGNKTKNIQTLIDSLSEYDKKSLIESNNFKSL
SSDAELIKDDFIIKTLPKDSYQLSEDNDCVILLDKNLSPELIREGHARELIRLIQQLRKK
KNLPINQRIDIYIGVTGELLESIKTNKNMFKENLLIKNIHLNVIDEYENTIHFNNKEIKI
SLLY
>WP_032488596.1|FEATURES|NCBI|nitroimidazole|nimA|antibiotic inactivation|1
MFREMRRKRQLLPPEESLAILERMTGGTLALHGDNGYPYAVPVSYVYADGKIYFHGAVQG
HKMDAIRQHPEVSFCVVEQDRIVPAEFTTYFRSVIVFGKARILTDEVEKRAALLRLAEKY
SSGESGMQDEIDKGFDHLVMVEITVEHMTGKEA
>CAB82516.1|FEATURES|NCBI|nitroimidazole|nimE|antibiotic inactivation|1
MFREMRRKRQLLPQEESVAILEKMTNGTLALHGDNGYPYAVPLSYVYADGKIYFHCAKIG
HKVDAIMQNNKVSFCVVEQDNIKPAEFTTYFRSVIVFGKAYILTDETEKRMALTLLMNKY
SFGEPGLSDEIAKSFNHLLMVKIDIEHMTGKEA
>WP_063854492.1|FEATURES|NCBI|nitroimidazole|nimD|antibiotic inactivation|1
MFREMPRKRQLLPTEESVAILERMTNGTLALHGDDGYPYAVPVSYVYADGKIYFHSAMQG
PKVDAILRNDKVSFCVVEQDEVKPAEFTTYFRSVIVFGKARILTDENEKRNALNLLADKY
SHGEAGMEAEMAKGFNHLLMIEITVEQMTGKEA
>WP_063854490.1|FEATURES|NCBI|nitroimidazole|nimB|antibiotic inactivation|1
MFREMRRKRQLLPTEESVAILERMTNGTLALHGDDGYPYAVPISYVYADGKIYFHSAMKG
HKVDAILQNDKVSFCVVEQDDIRPSEFTTYFRSVIVFGKAHILTDELEKRVALGLLADKY
SYGEAGMEAEIAKGFNHLLIVKIAIEHITGKEA
>WP_063854491.1|FEATURES|NCBI|nitroimidazole|nimC|antibiotic inactivation|1
MFRAMRPKRHELPTDESVGILKRMTNGTLALHGDGDYPYAVPVSYVYSDGRIYFHTATQG
HKVDALMRNDKVSFCVVEQDDVKSAEFTTYFRSVIPFGRARILTDETENGAALQLLADKY
SSGMPGLEAVIAKGFRHLLMVEIDIEHLTGKES
>EFF39147.1|FEATURES|NCBI|multidrug|PmpM|antibiotic efflux|0
MLLDLDRFSFSVFLKEIRLLTALALPMLLAQVAQVGIGFVDTVMAGGAGKEDLAAVALGS
SAFATVYITFMGIMAALNPMIAQLYGAGKTGEAGETGRQGIWFGLILGIFGMILMWAAIT
PFRNWLTLSDYVEGTMAQYMLFTSLAMPAAMVHRALHAYASSLNRPRLIMLVSFAAFVLN
VPLNYIFVYGKFGMPALGGAGCGVATMAVFWFSALALWIYIAKEKFFRPFGLTAKFGKPD
WAVFKQIWKIGAPIGLSYFLEASAFSFIVFLIAPFGEDYVAAQQVGISLSGILYMIPQSV
GSAGTVRIGFSLGRREFSRARYISGVSLVSGWVLAVITVLSLVLFRSPLASMYNDDPAVL
SIASTVLLFAGLFQPADFTQCIASYALRGYKVTKVPMFIHAAAFWGCGLLPGYLLAYRFD
MGIYGFWTALIASLTIAAVALVWCLEKYSMELVKSHKAV
>WP_025091335.1|FEATURES|NCBI|beta_lactam|ampC|antibiotic inactivation|1
MRKSTTLLIGFLAGSAVIPASGALAAGTINDDELRRIVDETVRPLMAGQKIPGMGVAISI
DGKSHFFGYGVASKESGQKVDKDTIFEIGSISKTFTATLGGYGLATGAFSPSDPATRWAP
ELAGSSFDKITMLDLGTYTPGGLPLQFPDAVTDDSSMLAYFRKWKPDYPAGAQRRYSNPS
IGLFGYLAARSMGQPFDVLMEQKLLPAFGLKNTFVHVPESRMKDYAYGYAKADKPTRVAS
GTRDAEAYGIKTTAPDLLRFVELNIDSASLAPDFQKAVAATHTGYYRVGANNQGLGWEIY
TYPVTLKTLLAGNSSDMTLKSHKIEKFDPPHAPSADMFINKTGSTKGFGAYAAFVPAKKT
GIVLLANRNYPNDERIKAAYRILQAIDKSE
>WP_023318187.1|FEATURES|NCBI|beta_lactam|OKP-B-7|antibiotic inactivation|1
MRYVRLYLISLIAALPLAVFASPQPLEQIKISESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKIVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTAATMAERNQQIAGIGAALIEHWQR
>WP_023289605.1|FEATURES|NCBI|beta_lactam|OKP-A-4|antibiotic inactivation|1
MRYVRLCLFSLIAALPLAVFASPPPLEQVTRSESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMAATLRKLLTSHALSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPNGKAERIVVIYLRDTPATMAERNQQIARIGAALIEHWQR
>WP_003651390.1|FEATURES|NCBI|beta_lactam|OXA-324|antibiotic inactivation|1
MYKKALIVTTSILFLSACSSNSVKQHQIHSMSANKNSEEIKSLFDQAQTTGVLVIKRGKT
EEIYGNDLKRASTAYIPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPDWEKDMTLG
NAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNANIGSKVDNFWLVGPLKITPQQETQF
AYQLAHKTLPFSKDVQEQVQSMVFIEEKNGSKIYAKSGWGWDVEPQVGWLTGWVVQPQGE
IVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGIL
>WP_005041180.1|FEATURES|NCBI|beta_lactam|OXA-332|antibiotic inactivation|1
MYKKALIAATSILFLSACSSNTVKQHQIHSISANKNSEEIKSLFDQAQTMGVLVIKRGQT
EEIYGNDLKRASTAYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPDWEKDMTLG
DAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNANIGSKVDDFWLVGPLKITPQQETLF
AYQLAHKTLPFSQDVQEQVQSMVFIEEKNGSKIYAKSGWGWDVEPQVGWLTGWVVQSQGE
IVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGIL
>WP_026056097.1|FEATURES|NCBI|beta_lactam|OXA-348|antibiotic inactivation|1
MYKKALIVATSILFLSACSSNMVKQHQIHSISANKNSEEIKSLFDQAQTTGVLVIKRGRT
EEIYGNDLKRASTDYVPASTFKMLNALIGLEHHKATTTEVFKWNGQKRLFPDWEKDMTLS
DAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNANIGSKVDDFWLVGPLKITPQQETQF
AYQLAHKTLPFSKNVQEQVQSMVFIEEKNGSKIYAKSGWGWDVEPQVGWLTGWVVQPQGE
IVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGIL
>WP_017389475.1|FEATURES|NCBI|beta_lactam|OXA-332|antibiotic inactivation|1
MYKKALIVATSILFLSACSSNSVKQHQIHSISANKSSEEIKSLFDQAQTTGVLVIKRGQT
QEIYGNDIKRASTAYVPASTFKMLNALIGLEYHKATTTEVFKWDGQKRLFPDWDKDMTLG
DAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNANIGSKVDNFWLVGPLKITPQQETQF
AYQLAHKTLPFSKNVQEQVQSMVFIEEKNGSKIYAKSGWGWDVEPQVGWLTGWVVQPQGE
IVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGIL
>WP_010890145.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
KGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYA
VWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIVSGVVVLN
>WP_064161975.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
KGWLFLAISIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYA
VWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIVSGVVVLN
>ACN22662.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
KGWLFLAIAIVGEVIATFALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYA
VWSGLGVVIITAIAWLLRGQKLDAWGFVGMGLIVSGVVVLN
>AMQ12639.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
KGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYA
VWSGLGVVIITAIAWLLHGQKLDAWGFVGMGFIIAAFLLAR
>WP_046181458.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
KGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYA
VWSGLGVVIITAIAWLLHGQKLDALGFVGMGLIIAAFLLAR
>WP_064907052.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
KGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYA
VWLGLGVVIITAIAWLLHGQKLDAWGFVGMGLIIAAFLLAR
>AHK10254.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
KGWLFLVIAISGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYA
VWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIIAAFLLAR
>CAG34239.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
KGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYA
VWSGLGAVIITAIAWLLHGQKLDAWGFVGMGLIIAAFLLAR
>CAF18335.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
KGCLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYA
VWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIIAAFLLAR
>WP_031995338.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
KGWLFLVIAIVGEVIATSALKSSEGFTKLATSAVVIIGYGIAFYFLSLVLKSIPVGVAYA
VWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIIAAFLLAR
>AAS18386.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
KGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYA
VWSGLGVVIIAAIAWLLHGQKLDAWGFVGMGLIIAAFLLAR
>WP_053276349.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
KGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAYYFLSLVLKSIPVGVAYA
VWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIIAAFLLAR
>WP_052925775.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
KGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYA
VWSGLGVVIITAIAWLLHGQKLDSWGFVGMGLIIAAFLLAR
>ABQ96628.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
KGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLRSIPVGVAYA
VWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIIAAFLLAR
>T45122|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
KGWLFLVIAIVGEVIATSALKSSEGFAKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYA
VWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIIAAFLLAR
>WP_031989990.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
KGWLFLVIAIVSEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYA
VWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIIAAFLLAR
>WP_032164557.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
KAWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYA
VWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIIAAFLLAR
>AMP48605.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
KGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYA
VWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLLIAAFLLAR
>WP_058662444.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
KGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGDGIAFYFLSLVLKSIPVGVAYA
VWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIIAAFLLAR
>WP_046612238.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
DGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYA
VWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIIAAFLLAR
>AAO15536.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
KGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVPKSIPVGVAYA
VWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIIAAFLLAR
>WP_050956219.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
KGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYA
VWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIIAAFLLAQ
>WP_063101704.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
KGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYA
VWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIIAALLLAR
>CAE81271.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
MKNWLFLATAIIFEVIATSALKSSEGFTRLVPSFIVVAGYAAAFYFLSLTLKSIPVGIAY
AVWSGLGIVLVTAIAWVLHGQKLDMWGFVGVGFIISGVAVLNLLSKASVH
>YP_009075630.1|FEATURES|NCBI|qa_compound|Qac|antibiotic efflux|1
MPYLYLLLSIVSEVIGSAFLKSSDGFSKLYPTITTIISFLICFYFLSKTMQHLPLNITYA
SWAGLGLVLTTIVSVLIFKEQINLISIISIILIIFGVVLLNTFGSSH
>AGX26873.1|FEATURES|NCBI|multidrug|ykkD|antibiotic efflux|1
MGWIYLILAGVFEVGWPVGLKMAQTPETRWSGIGVAVAFMTVSGFLLWLAQRQIPIGTAY
AVWTGIGAAGTFFVGVLYYGDPTSFFRYMGVALIIAGVITLKLAH
>YP_002791403.1.|FEATURES|NCBI|sulfonamide|sul|antibiotic target replacement|1
VTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPADE
IRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCR
LVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGLGFFLS
PAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNG
ADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA
>WP_063855074.1|FEATURES|NCBI|sulfonamide|sul|antibiotic target replacement|1
VTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPTASHPDARPVSPADE
IRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCR
LVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLS
PAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNG
ADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA
>WP_000259018.1|FEATURES|NCBI|sulfonamide|sul|antibiotic target replacement|1
VTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGADVVDVGPAASHPDARPVSPADE
IRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCR
LVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLS
PAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNG
ADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA
>WP_032490794.1|FEATURES|NCBI|sulfonamide|sul|antibiotic target replacement|1
VTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHSNARPVSPADE
IRRIGPLLDALSDQMHRVSINSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCR
LVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLS
PAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNG
ADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA
>WP_007929940.1.|FEATURES|NCBI|sulfonamide|sul|antibiotic target replacement|1
VTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPADE
IRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCR
LVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLS
PAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNG
ADYVRTHAPGDLRSAITFSETLAKFRSRNARDRGLDHA
>NG_048085.1|FEATURES|NCBI|sulfonamide|sul|antibiotic target replacement|1
VTVFGILNPTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPADE
IRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCR
LVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLS
PAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATAGLPVKDLGPASLAAELHAIGNG
ADYVRTHAPGELRSAIAFSETLAKFRSRDARDRGLDHA
>YP_007547181.1|FEATURES|NCBI|sulfonamide|sul2|antibiotic target replacement|1
RNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVS
SDTEIARIAPVLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDAAFYPQLAK
SSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFF
LGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAAA
GGADFIRTHEPRPLRDGLAVLAALKETARIR
>EZK20693.1|FEATURES|NCBI|sulfonamide|sul2|antibiotic target replacement|1
MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVS
SDTEIERIAPVLDALKADGIPVSLDSYHPATQAYALSRGVAYLNDIRGFPDAAFYPQLAK
SSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFF
LGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAAA
GGADFIRTHEPRPLRDGLAVLAALKETARIR
>WP_004202660.1|FEATURES|NCBI|beta_lactam|bla|antibiotic inactivation|1
MNHSPLRRSLLVAAISTPLIGACAPLRGQAKNVAAAERQLRELESTFDGRLGFVALDTAT
GARIAHRGDERFPFCSTSKMMLCAAVLARSAGEPALLQRRIAYAKGDLIRYSPITEQHVG
AGMSVAELCAATLQYSDNTAANLLIALLGGPQTVTAYARSIGDATFRLDRREPELNTALP
GDERDTTTPAAMAASVHRLLVGDALGAAQRAQLNAWMLGNKTGDARIRAGVPADWRVADK
TGTGDYGTANDIGVAYPPNRAPIVFIVYTTMRNPNAQARDDVIASATRIAARAFA
>WP_024530279.1|FEATURES|NCBI|beta_lactam|BL2be_ctxm|antibiotic inactivation|1
MVKNTLRQTTLMVATVMPLLFGSAPLWAQSANAKANIQQQLSELEKNSGGRLGVALIDTA
DNSQILYRADERFPMCSTSKVMAVSALLKQSETDKNLLAKRMEIKQSDLVNYNPIAEKHL
DTGMTLAEFSAATIQYSDNTAMNKILEHLGGPAKVTEFARTIGDKTFRLDRTEPTLNTAI
PGDKRDTTSPLAMAKSLQNLTLGKALGEPQRAQLVEWMKGNTTGGASIRAGLPTTWVVGD
KTGSGDYGTTNDIAVIWPANHAPLVLVTYFTQPQQNAEARKDVLAAAAKIVTEGL
>WP_025123646.1|FEATURES|NCBI|beta_lactam|BL2be_ctxm|antibiotic inactivation|1
MVKNTLRQTTLMVAAVMPLLFGSASVWAQPANAKNTIQQQLADLEKSSGGRLGVALIDTA
DNSQILYRADERFAMCSTSKVMAVSALLKQSETDKNLLDRRMAIKQSDLVNYNPIAEKHL
DTGMTLGEFSAATIQYSDNTAMNKILEHLGGPAKVTTFARSIGDKTFRLDRTEPTLNTAI
PGDERDTTSPLAMAKSLQNLTLGKALGEPQRAQLVEWMKGNTTGGASIRAGLPAKWIVGD
KTGSGDYGTTNDIAVIWPSNNAPLVLVTYFTQPQQNAEARKDVLAAAAKIVTEGF
>ACN76562.1|FEATURES|NCBI|beta_lactam|CF70_016075|antibiotic inactivation|1
MNVILNRRTFLLTSAVVSASYSLGTLAGANRDDASFQDRLAKLEQQLNGRLGVCAIDTAN
GAQLGYRANERFAMNSTFKVMLASAFLARSQDEPGLLEERLTYTRADLVTYSPVTEKHVS
TGMTVAELCAAGIQYSDNTAANVLMKKLGGPEAVTAFARSIGDTHFRLDRWETELNSAIP
GDPRDTSTPQAMAMSLQRLALGDMLAADKQHQLQAWLKGNTTGGKRIRAGVPAGWQVGDK
TGTGDYGSANDVAILWPPRRTPVVLALYSALENQQAEARNDVLADAARIVAEWVTG
>ACN76563.1|FEATURES|NCBI|beta_lactam|CF70_016075|antibiotic inactivation|1
MNVILNRRTFLLASAVVSASYSLGTLAGANRDDASFQDRLAKLEQKLNGRLGVCAIDTAN
GAQLGYRANERFAMNSTFKVMLASAFLARSQDEPGLLEERLMYTRADLVTYSPVTEKHVS
TGMTVAELCAAGIQYSDNTAANVLMKKLGGPEAVTAFARSIGDTHFRLDRWETELNSAIP
GDPRDTSTPQAMAMSLQRLALGDMLAADKQHQLQAWLKGNTTGGKRIRAGVPAGWQVGDK
TGTGDYGSANDVAILWPPRRAPVVLALYSALENQQAEARNDVLADAARIVAEWVTG
>ACN76566.1|FEATURES|NCBI|beta_lactam|CF70_016075|antibiotic inactivation|1
MNVILNRRTFLLASAVVSASYSLGTLAGANRDDASFQDRLAKLEQKLNGRLGVCAIDTAD
GAQLGYRANERFAMNSTFKVMLASAFLARSQDEPGLLEERLTYTRADLVTYSPVTEKHVS
TGMTVAELCAAGIQYSDNTAANVLMKKLGGPEAVTAFARSIGDTHFRLDRWETELNSAIP
GDPRDTSTPQAMAMSLQRLALSDMLAADKQHQLQAWLKGNTTGGKRIRAGVPAGWQVGDK
TGTGDYGSANDVAILWPPRRAPVVLALYSALESQQAEARNDVLADAARIVAEWVTG
>ACN76564.1|FEATURES|NCBI|beta_lactam|CF70_016075|antibiotic inactivation|1
MNVILNRRTFLLASAVVSASYSLGTLAGANRDDASFQDRLAKLEQKLNGRLGVCAIDTAN
GAQLGYRANERFAMNSTFKVMLASAFLARSQDEPGLLEERLTYTRADLVTYSPVTEKHVS
TGMTVAELCAAGIQYSDNTAANVLMKKLGGPEAVTAFARSIGDTHFRLDRWETELNSAIP
GDPRDTSTPQAMAMSLQRLALGDMLAADKQHQLQAWLKGNTTGGKRIRAGVPAGWQVGDK
TGTGDYGSANDVAILWPPRRAPVVLALYSALESQQAEARNDVLADAARIVAEWVTG
>ACN76565.1|FEATURES|NCBI|beta_lactam|CF70_016075|antibiotic inactivation|1
MNVILNRRTFLLASAVVSASYSLGTLAGANRDDASFQDRLAKLEQKLNGRLGVCAIDTAD
GAQLGYRANERFAMNSTFKVMLASAFLAQSQDEPGLLEERLTYTRADLVTYSPVTEKHVA
TGMTVAELCAAGIQYSDNTAANVLMKKLGGPEAVTAFARSIGDTHFRLDRWETELNSAIP
GDPRDTSTPQAMAMSLQRLALGDMLAADKQHQLQAWLKGNTTGGKRIRAGVPAGWQVGDK
TGTGDYGSANDVAILWPPRRAPVVLALYSALENQQAEARNDVLADAARIVAEWVTG
>NG_047751.1|FEATURES|NCBI|trimethoprim|dfrB|antibiotic target replacement|1
MDQGSNEVGNPVAGQFSFPSNAAFSMGDRVRKKSGAAWQGQIVGWYCTKLTPEGYAVESE
AHPGSVQIYPVAALERIN
>CAY33090|FEATURES|NCBI|trimethoprim|dfrK|antibiotic target replacement|1
KVSLIAAMDKNRVIGKENDIPWRIPEDWEYVKNTTKGYPIILGRKNLESIGRALPGRRNI
ILTRDKGFSFNGCEIVHSIEDVFELCNSEEEIFIFGGEQIYNLFLPYVEKMYITKIHYEF
EGDTFFPEVNYEEWNEVSVTQGITNEKNPYTYYFHIYERKA
>WP_015741374.1|FEATURES|NCBI|fosfomycin|FosA4|antibiotic inactivation|1
LSGLNHLTLAVRDVARSLAFYQSLPGLRLHARWDGGAYLSCGSLWLCLSLDENAGSPAAD
YTHYAFTVSEADFPQVVETLTAAGVTPWKTNRSEGDSWYFLDPDGHQLELHVGSLATRLA
ACRAAPYKGMRFYD
>WP_007698054.1|FEATURES|NCBI|fosfomycin|FosA4|antibiotic inactivation|1
LSGLNHLTLAVRDVARSLAFYRTLPGLRLHARWDGGAYLSCGDLWLCLSLDDNAGQPARD
YTHYAFTVSEADFPQVVDTLTAAGVKIWKTNRSEGDSWYFLDPDGHQLELHVGSLATRLA
ACRTRPYRGMTFFD
>WP_007793725.1|FEATURES|NCBI|fosfomycin|FosA5|antibiotic inactivation|1
LSGLNHLTLAVRDVARSLAFYQTLLGLRLHARWDGGAYLSCGDLWLCLSLDDNAGQPARD
YTHYAFTVSEADFPLMVDTLTAAGVKTWKSNRSEGDSWYFLDPDGHQLELHVGSLATRLA
ACRARPYRGMTFFD
>WP_032970145.1|FEATURES|NCBI|fosfomycin|FosA5|antibiotic inactivation|1
LSGLNHLTLAVRDVAQSLAFYHSLLGLRLHARWDGGAYLSCGDLWLCLSQDDNAGQPARD
YTHYAFTVSEADFPLMVDILTAAGVKTWKTNRSEGDSWYFLDPDGHQLELHVGSLATRLA
ACRARPYRGMTFFD
>WP_032989463.1|FEATURES|NCBI|fosfomycin|FosA5|antibiotic inactivation|1
LSGLNHLTLAVRDVAQSLAFYHSLLGLRLHARWDGGAYLSCGDLWLCLSQDDNAGQPARD
YTHYAFTVSEADFPLMVGKLIASGVKTWKSNRSEGDSWYFLDPDGHQLELHVGSLATRLA
ACRARPYRGMTFFD
>WP_069682229.1|FEATURES|NCBI|fosfomycin|FosA5|antibiotic inactivation|1
LSGLNHLTLAVRDVAQSLAFYHSLLGLRLHARWDGGAYLSCGDLWLCLSQDDSAGQPAAD
YTHYAFTVSETDFPLMVDKLTAAGVKTWKTNRSEGDSWYFLDPDGHQLELHVGSLATRLA
ACRAEPYKGMRFYD
>WP_038883625.1|FEATURES|NCBI|fosfomycin|FosA5|antibiotic inactivation|1
LSGLNHLTLAVRDVARSVAFYHTLLGLRRHAVWDGGAYLSCGDLWLCLSLDDGAGAPPAD
YTHYAFTVSEADFPRMVETLTRAGVQTWKTNRSEGDSWYFLDPDGHQLELHVGSLATRLA
ACRARPYQGMTFFE
>WP_038862786.1|FEATURES|NCBI|fosfomycin|FosA3|antibiotic inactivation|1
LNGLNHLTLAVRDVARSVAFYHTLLGLRLHAVWDGGAYLSCGELWLCLSLDDAAGTPPAD
YTHYAFSVSEADFPRLVEKLTLAGVQTWKTNRSEGDSWYFLDPDGHPLELHVGSLATRLA
ACRARPYRGMRFFD
>AEU08355.1|FEATURES|NCBI|fusidic_acid|fusB|antibiotic inactivation|1
MKTMIYPHQYNYIRSVILRLKNVYKTVNDKETVKVIQSETYNDISEIFGHIDDDIEESLK
VLMNIRLSNKEIEAILNKFLEYVVPFELPSPQKLQKVFKKVKKIKIPQFEEYDLKVSSFV
GWNELASNRKYIIYYDEKKQLKGLYGEISNQVVKGFCTICNKESNVSLFMKKSKTNSDGQ
YVKKGDYICRDSIHCNKQLTDINQFYNFIDKLD
>CCP89052.1|FEATURES|NCBI|fusidic_acid|fusD|antibiotic inactivation|1
MNKIAVYKFVKVKQLVYQLIKLYRTNDMNSHKTQKDFLLNEINDIFKEKEIDISDFITSI
DDVKLTKKKAEHLLNELKVYIQDFEIPSSSQLEKIFPKVKKLKRPDINLIDTKEISYLGW
NDNSSNRKYIVYKNLDDKFEGIYGEISPNKVKGFCKICNQESDTSLFLNKTKHNKSSGTY
TKKGDYICYDSFKCNQNLDDINNLYEFIVKTK
>ACL98099.1|FEATURES|NCBI|streptothricin|sat-1|antibiotic inactivation|1
MKISVIPEQVAETLDAENHFIVREVFDVHLSDQGFELSTRSVRPFRKDYISDDDSDEDSA
CYGAFIDQELVGKIELNSTWNDLASIEHIVVSHTHRGKGVAHSLIEFAKKWALSRQLLGI
RLETQTNNVPACNLYAKCGFSLGGIDLFTYKTRPQVSNETAMYWYWFSGAQDDA
>BAD10981.1|FEATURES|NCBI|streptothricin|sat-1|antibiotic inactivation|1
MKISVIPEQVAETLDAENHFIVREVFDVHLSDKGFELSTRSVSPYQNDYISDDDSDEDSA
CYGAFIDQELVGKIELNSTWNDLASIEHIVVSHTHRGKGVAHSLIEFAKKWALSRQLLGI
RLETQTNNVPACNLYAKCGFTLGGIDLFTYKTRPQVSNETAMYWYWFSGAQDDA
>AAC12648.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|oleI|antibiotic inactivation|1
MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQGLVARGQRVSYGITDEFGAQVKAGRA
TAVVYGFILPEEFNPEELLAEDQGSRWACSLAEAFRVLPQLRTATPTTGRDLIVYDIASW
PAPVLGRKWDIPFVQLSPTSVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAE
DGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVGCRAPSQIKGDTVGDNYTFVGPTYG
DRSHQGTWEGPGHGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADL
GEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERI
VELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGIL
AEAG
>WP_035278955.1|FEATURES|NCBI|aminoglycoside|kamB|antibiotic target alteration|1
MRRVTGKQVVDLDAAGFAAHRARYPRAVLDVGTGDGKHPQHLARERPDTLVVGLDAAKDN
MRKAATRAAAKPARGGLPNLLYVWSAAEHLPEGLTGFTELHVLMPWGSLLRGVLGSDPTM
LRGLAAACEPGAEFLVTLNLHAWQPPVPEVGEHPEPTPESAVEDLGPALAAAGWRLDTAA
YLDAAEIAALATSWTRRLNSSRDRLEVLALTGVVNP
>WP_035302981.1|FEATURES|NCBI|aminoglycoside|kamB|antibiotic target alteration|1
MRRVTGKQVVQVDRAEFAALRGRYTAALLDVGTGDGKHALHLARAHPDLLVIGLDAATDN
MRRAATKAAASPKKGGLPNLLYLWAAAEQPPAELSDITEVHVLMPWGSLLRGVLGSDPAM
LTALAALCAPDTPFLITLNLHAWRPPVPEVGTHPEPTPDSAAEDLGPALKAAHWHLHAAE
YLDDAGIAALATSWTRRLNSSRDRLDVLALRGLINP
>WP_018685137.1|FEATURES|NCBI|aminoglycoside|kamB|antibiotic target alteration|1
MRRVTGKQVVDLGPSEFAELRARHVGAVLDVGTGDGKHALHLARTHPDHLVIGLDAAKDN
LRKSAAKSAASPRKGGLPNLLYIWAAAEQLPAELREITELHVLMPWGSLLRGILGDDPAM
LSGLANLCAPDARFLITLNLHAWRPPVPEVGDNPEPTPDSATESLGPLLAAAGWHLDEAA
YLDADAIAALATSWTRRLNSSRDQLEVLALTGVVNP
>WP_007782418.1|FEATURES|NCBI|glycopeptide|SCO3595|antibiotic target alteration|1
MDKLKIAIIFGGCSEEHPISVKSAQEVAKNLDLEKYEPFYIGITKNGVWKLCPRPEANWE
KGSCRSVMLSPDRSVHGLLVLEQGQYKTIPLDMVFPVLHGKLGEDGAMQGLLELSGIPYA
GCDVQSSALCMDKSLAYIVAGKAGIATPNFRTVTAKGTIDADGLTYPVFVKPARSGSSFG
VSKVCRKEELLSAVAIARQYDSKVLIEEAVAGSEVGCAILGNDPDLMAGEVDQISLSYGF
FRIHQENEPEKGSENSTFIVPADISAEARLQVQETAKAVYRALGCRGLARVDMFLKEDGK
VILNEVNTLPGMTSYSRYPRMVAAAGLSFAEVIDRIVALTL
>WP_018211347.1|FEATURES|NCBI|glycopeptide|SCO3595|antibiotic target alteration|1
MNKLKIAIIFGGCSEEHPVSVKSAQEVADNLDLEKYEPFYIGITKSGVWKLCHRPEANWE
KGSCLPAILSPDRSVQGLLVLEHGHYKTIPLDMVFPVLHGKFGEDGAMQGLLELSGIPYA
GCDVPSSALCMDKALAYIVAGSAGIATPNFRTVTAEEDIDADGLAYPVFVKPARSGSSFG
VTKVCRKEDLLSAVASAREYDTKVLIEEAVAGSEVGCAIFGNDPDLVAGEVDQICLSHGF
FKIHQEDEPEKGSENSKLIVPSDIPAEARLQVQETAKAIYRALGCRGLARVDMFLKEDGE
VILNEVNTLPGMTSYSRFPKMVAAAGLPFAEVLDRIISLAL
>WP_015943583.1|FEATURES|NCBI|glycopeptide|SCO3595|antibiotic target alteration|1
MSKLKIAIIFGGCSEEHPVSVKSAGEVAKNLDLEKYEPFYIGITKDGVWQLCHYPEANWE
KGSCRPAILSPDRSVQGLLVLEQGQYQRIPLDLVFPVLHGKFGEDGAIQGLLELSGIPYV
GCDIPSSALCMDKSLAYIVAGKAGIATPKFRTVTAKETIDAERLAYPVYVKPARSGSSFG
VTKVCRQEELLSAVEIARQYDSKVLIEEAVVGSEVGCAIFGNDLDLMAGEVDQICLSHGF
FRIHQENEPEKGSENSTLIVPADISPEARSRVQETAKAIYRALGCRGLARVDMFLKEDGT
VILNEVNTLPGMTSYSRFPRMMAAAGLPFAEVIDRLVSLAF
>WP_041219811.1|FEATURES|NCBI|glycopeptide|SCO3595|antibiotic target alteration|1
MNRLKIAIIFGGCSEEHSVSVKSAQEVAKNLDLEKYEPYYIGITQNGVWKLCHFPEANWE
NSCCLPAMLAPDSGVHGLIVLEQGKYKMIPLDMVFPVLHGKFGEDGAIQGLLELSCIPYV
GCDIQSSALSMDKSLAYIVAGNARIATPNFWTFTENEDMDPDRFIYPVFVKPARSGSSFG
VTKVCREEELLSAVEIARQYDSKVLIEEAVVGSEVGCAIFGDDPDLTAGEVDQISLSHGF
FRIHQESEPENGSENSTIIVPADISTEMRLHIQETAKAIYRALGCRGLARVDMFLKEDGE
VILNEVNTLPGMTSYSRFPRMMAAAGLTFAEVIDRIVALTL
>WP_003975347.1|FEATURES|NCBI|glycopeptide|vanJ|antibiotic target alteration|1
MVLRSAARPELWKRAPVLTVSALLLGLVMMLHAEIPNRFGSIGSLVETFLPWFGLFVPVL
AAGALWRRSAAAVTALVLPVTVWLSLFGGLLGDKSGAGGEFTMASHNVGAENPDPAGTAR
DLAASGVDVLALEEITAQDREVYEKGLAREYPYHTVQGTVGLWSKLPLSGTRPVDIATDY
GPLADTKPADVTMAGNRALRTTVATEKGPLVVYVTHLGSVRLNPRAGFWTDSRDRNAWAL
GEALAADRSERIALLGDLNGTVDDRALAGITSQLHSVQEAAGNGFGFTWPAKFPVARIDQ
ILVRGVEPTGSWTLPATGSDHLPVAAGVSW
>WP_030867848.1|FEATURES|NCBI|glycopeptide|vanJ|antibiotic target alteration|1
MVLRSAARPELWKRAPVLTVSALFLGLVMMLHAQIPNRFGSVGSLVETFLPWFGLFVPVL
AAGALWRRSPAAVTALVLPVTVWLSLFGGLLGDKSGAGGDLTMASHNVGAENPDPAGTAR
DLAASGVDVLALEEITAQDREVYEKGLAREYPYHTVQGTVGLWSKLPLSGTRPVDIATDY
GPLADTKPADVTMAGNRALRTTVATEKGPLVVYVAHLGSVRLNPRAGFWTDSRDRNAWAL
GEALAADRSERIALLGDLNGTVDDRALAGITSQLHSVQEAAGNGFGFTWPAKFPVARIDQ
ILVRGVEPTGSWTLPATGSDHLPVAAGVSW
>WP_003126779.1|FEATURES|NCBI|glycopeptide|vanXYC|antibiotic target alteration|1
TLQLINKNHPLKKNQEPPHLVLAPFSDHDVYLQPEVAKQWERLVRATGLEKDIRLVDGYR
TEKEQRRLWEYSLKENGLAYTKQFVALPGCSEHQIGLAIDVGLKKQEDDDLICPHFRDSA
AADLFMQQMMNYGFILRYPEDKQEITGISYEPWHFRYVGLPHSQVITAQKWTLEEYHDYL
>CPR17499.1|FEATURES|NCBI|multidrug|emrB|antibiotic efflux|0
RKPLKGASLAWMTVALSLATFMQVLDSTIANVAIPTIAGNLGASNSQGTWVITSFGVANA
ISIPITGWLAKRFGEVRLFLLSTALFAFTSWMCGISSSLEMLIFARVLQGIVAGPLIPLS
QSLLLNNYPPARRSIALALWSMTVVVAPICGPILGGWISDNYHWGWIFFINVPLGVAVVV
ITLQTLRGRETKTEIKPIDTVGLALLIVGIGSLQMMLDRGKELDWFNSNEIIILTVIAVI
TLTFLIVWELTDDHPVVDLSLFKSRNFTIGCLCLSLAYMFYFGAIVLLPQLLQEVYGYTA
TWAGLASAPVGLMPVVLSPIIGRFAPRLDMRQLVTFSFIMYAVCFYWRAYTFEPGMDFGA
SAWPQFVQGFAVACFFMPLTTITLSGLPPERMAAASSLSNFTRTLAGSIGTSITTTLWAQ
RESLHHAHLTESITPYNPQAQEAYQQLQQTLGMSQSQASSYIASEITAQGLIISANEIFW
AAAAVFLMLLVLVWFARPPFTS
>WP_037420882.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|1
LNPAQPLSSAPPYTLFEQWAQPVAPFQMFPHVYYVGTRNLSSVLLSTPEGLILIDAALDA
SAPTIKAHIEALGFDIKDLRYILNSHARLDQAGGIARLKAWSGAKVVASAANAEQLALGG
KQDFALGDALSFPPVKADIIVGEGDSITLGGLTLTALMTPGHLPGATSWLTTLRQGEQNY
RLVYADSLATPDYYLIDNKNYPDLVQDIRGSFARLAEQQADIFIANKGTRFDLENKMVRL
RAGDLDAFVDRQGLQHYVKESQKVFEAQLA
>WP_048759255.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|0
LDPAQPLSSAPPYSLFEQWAQPVAPFQIFPQLYYVGTRNLSSVLFSTPEGLILIDAGLDA
SAPVIKSHIEALGFNIKDLRFILNSHARLDQAGGIARLKAWSGAKVVASAANAQQLARGG
KQDFALGDALGFPPVKVDIIVGQGDSVTLGGLKFTALMTPGHLPGATSWTTTLRQSGKTY
RLVYADSLATPDYYLVDNKNYPSLVQDIRSSFRLLAQQHADIFIANKGTRFDLENKMARL
QAGDRDAFVDRLGLQQYVQQSQRSFETQLK
>WP_033632530.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|0
LDPAQPLSSAPPYSLFEEWAQPIAPFQIFEQVYYVGTSNLSSVLLSTPQGLILIDAGLES
SAPGIKANIERLGFSIKDLKYILNSHARLDQAGGIAQLKRWSGARLVASAANARQLALGG
RQDFALGDTLTFPAVQTDIVVADGDSITLGGLTLTAMMTPGHLPGATSWLTTLRHNGKPY
RFIYADSLATPGYYLIGNKNYPQLIEDIRGSFARLARVQADIFIANKGTRFALADKWRRL
QAGDTQAFIDPAGLQRYVQESQQGFEEQLK
>WP_004857142.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|0
LDPAQPLTEAPPMSLFESWNKPIAPFQIFKNVYYVGTENLSSILIDTGKGLVLIDAGIDQ
SAEQIKGNIERLGFDIKNVKYLLNSHARLDQAGGFAKLKQWSGAQLVASPENAKMLENGA
ATDFALGAQLPFPPVKADVILKDGESIHLGRQTFTAHATPGHLPGSTSWTTKIRKNFKTY
NLIYADSLFTGGYYLINNKNYPTIVSDIEGTFSKLNAIHADIFLANKADRFDMLAKLKRL
QAGDQQAFIDPQGLQNYVKKGQDDFEKQLQ
>WP_034610906.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|0
LNAQQALTDAPPMSLFESWNTPIEPFKIFNHVYYVGTENLSSVLFDTGDGLVLIDSGIDQ
SAVQIKANIEKLGFKITDVKYLLNSHARLDQAGGFAKLKQWSGAQLVASAANAEMLENGG
VTDFALGKQLPFPSVAVDIIIKDGQQLKLGRQIFTAHATPGHLPGATSWTTDIRYHFKNY
KVIYADSLFTGGYYLLNNNNYPNLVSDIRHTFKTLDAIHADIFLANKADRFHMKQKLAKL
NAGDKKAFIDQTGLQNYVAKGRIEFEQQLQ
>WP_005030815.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|0
LNSQQALTEAPPMSLFELWNAPIEPFKIFHHVYYVGTENLSSVLFDTGAGLVLIDSGIDQ
SAVQIKSNIEKLGFKITDVKYLLNSHARLDQAGGFAKLKQWSGAKLIASAENAEMLANGA
STDFALGNQLPFPPVKADLIFKDGEQLKLGEQVFTAHATPGHLPGATSWTTEVQYHFKHY
QIIYADSLFTGGYHLLNNKNYPHIVTDMQKTFQTLNAIHADIFLANKADRFNMKQKLIRL
KAGDQNAFIDPDGLQNYVAKGKAEFEQQLQ
>CDO67671|FEATURES|NCBI|beta_lactam|mecB|antibiotic target replacement|1
MKNKALAILIICICLLIAYNFVKKDEVDKIFDAIELRDSEYLNEHATFLSKSLYDKDQRY
KRMDKIDASLGIKEVKVSNVRLVQKKKNKRQYSANLNFRTKYGNFSREGNYSFEKDEITK
NWFLDWSPEVIIPGLTDRNQISIETLESFRGKILDRNGIDIAKDGIHYEVGIDIKNLNKK
NKKNISKLLSISESTLNKKLKQTWVKEGVFVPLKSYIELDDELKLGIQKYHLTVNQTKGR
VYPLREATVHLLGYVGEINAEELKNKKFKDYDEHSIVGKSGIELQYDKQLQNKDGYKVVM
TSDDALNNDEDVLLEKKPKNGQDIILTIDSKVQRSIYSHLKEDNGSGVAMNPKTGELLAL
VSYPAYDPYEFMFGISDENYKKIVNDKKEPLLNKFQTTSSPGSTQKLITSIIGLKNGTID
ASTNYNIVTKGWQRNASWGGYEVTRFEEVNGDIDLEKAIAHSDNIFFARATLDMGSEKFI
KGMKALDIGRNIPSDYYFQKGQIANPESLKNNLKNEILLADSGYGQGEILISPVQILSIY
SALINEGKMMKPKLFETTKEDIWKNHIISKDDVDILTRSMRKVVTGTHRLDAERNYAQFA
GKTGTAELKTSREEGLGAQIGWFVGYDQNNPNMMLGISVKNVENRGMSSYNARKFAEIMD
ELYENGNKKYEIDR
>BAJ14745.2|FEATURES|NCBI|beta_lactam|mecC|antibiotic target replacement|1
MKKIIIALLILIVAAAGVGTYFYASKDKKINETVDAIEDKNFKQVYKDSTYRSKNDNGEV
EMTDRPIKIYESLGVKDINIQDRKIKKVSKNKKQVDAQYKIKTNYGTIDRNVRFNFVKED
GKWKLDWNQSVIIPDMQKDQSIHIEPVKSERGKILDRNNVELANTGTAHEIGIVPTSVSK
EDYKAIAQKLSISEDHINQQMNQDWVQDDTFVPLKTVKTMDKDLSDFVKKHHLTTNETES
RNYPLEKATSHLLGYVGPINSEELKKKEFKGYEDDAVVGKKGLEKLYDKKLQHKDGYRVT
IMDDNSNKVAHTLVEKKKKDGKDIQLTIDANVQKSIYNNMKNDYGSGTAIHPQTGELLAL
VSTPSYDVYPFMNGMSDEAYKKLTEDKKEPLLNKFQITTSPGSTQKILTAMIGLNNKTLD
DQTNYKINGKGWQKDKSWGDYNVTRYEVVNGNIDLKQAIESSDNIFFARVALELGSKQFE
KGMKKLGVGEDIPSDYPFYNAQISNKDLDNEILLADSGYGQGEILINPVQILSIYSALEN
NGNINAPHVLKDTKNKVWKKNIISAENINLLTDGMQQVVNKTHREDIYRPYANLVGKSGT
AELKMKQGETGRQIGWFISYDKDNPNMMMAINVKDVQDKGMASYNAKISGKVYDDLYENG
DKKFDIDK
>CAJ15588.2|FEATURES|NCBI|beta_lactam|mecC|antibiotic target replacement|1
MKKIKIVPLILIVAAAGVGTYFYASKDKKINETVDAIEDKNFKQVYKDSTYRSKNDNGEV
EMTDRPIKIYESLGVKDINIQDRKIKKVSKNKKQVDAQYKLKTNYGTIDRNVRFNFVKED
GKWKLDWNQSVIIPDMQKDQSIHIEPVKSERGKILDRNNVELANTGTAHEIGIVPTSVSK
EDYKAIAQKLSISEGHINQQMNQDWVQDDTFVPLKTVKTMDKDLSDFVKKHHLTTNETES
RNYPLEKATSHLLGYVGPINSEELKKKEFKGYEDDAVVGKKGLEKLYDKKLQHKDGYRVT
IMDDNSNKVAHTLVEKKKKDGKDIQLTIDANVQKSIYNNMKNDYGSGTAIHPQTGELLAL
VSTPSYDVYPFMNGMSDEAYKKLTEDKKEPLLNKFQITTSPGSTQKILTAMIGLNNKTLD
DQTNYKINGKGWQKDKSWGDYNVTRYEVVNGNIDLKQAIESSDNIFFARVALELGSKQFE
KGMKKLGVGEDIPSDYPFYNAQISNKDLDNEILLADSGYGQGEILINPVQILSIYSALEN
NGNISAPHVLKDTKNKVWKKNIISEENINLLTDGMQQVVNKTHREDIYRPYANLVGKSGT
AELKMKQGETGRQIGWFISYDKDNPNMMMAINVKDVQDKGMASYNAKISGKVYDDLYENG
NKKYDIDE
>CEJ95855.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|ErmB|antibiotic target alteration|1
MNQNIKFTQNFITNEKLLSNIMKQINIDENDIIYEVGTGKGHLTSKLAEKCKHVYSIELD
KKLYELSSNKLQDNSRVTLINQDILQFNYPYRKKYKIVGNIPFNISTQIVKDAVFRSQAS
EMYFIVEEGFYKRMIDTRRTLSLQLQTQVYIQQLLPIPAGSFHPKPKVNCILIKLTRHIS
DIKDKHKKKYEFFISKWVNKEYSKLFTKNQYHQALKHARIKDLNKISYEQVLSVFESYIL
FNPRK
>AIG22448.1|FEATURES|NCBI|beta_lactam|blaOXA-372|antibiotic inactivation|1
MMHIFLVFLILCSNFALAEDKAISAIFSTEGVDGTIILKSLRGDKTITHNDARASRRFAS
ASTFKIFNTLIAVQENVVSLSGTAFRWDGKTHDIPDWNRDQTLESAFKVSCVWCYQEIAK
QVGEETYRRYLTLARYGVLTNVADTTTFWLDGSFTVSAVEQIALLEKIYLRELPFRDEAY
DALKQVMLAEQTDSYKLYAKTGWAARMNPQIGWYVGYVETSDDVWFFAINLTLRSELDLG
LRQKITKAALRAERIIP
>ENV74419|FEATURES|NCBI|beta_lactam|blaOXA-280|antibiotic inactivation|1
MKTLQLGLIVLITTFGSACTIIRSPSIETAKNHEQQSAQQQIQQAFDQLQTTGVIVIKDK
HGLHSYGNDLSRAQTPYVPASTFKMLNALIGLEHGKATSTEVFKWDGQKNSFPAWEKDMT
LGQAMQASAVPVYQELARRIGLDLMQKEVQRIGYGNQQIGTVVDNFWLVGPLQITPVQEV
LFVEKLANTQLAFKPDVQHTVQDMLLIEQKPNYKLYAKSGWGMDLEPQVGWWTGWVETAT
GEKVYFALNMHMKTGISASVREQLVKQSLTALGII
>ABP68837|FEATURES|NCBI|quinolone|qnrB6|antibiotic target protection|1
MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>WP_033648215.1|FEATURES|NCBI|beta_lactam|SRT-2|antibiotic inactivation|1
MTKMNRLAAALIAALILPTAQAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
VASKQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQGKLSFNDPASRYLPELRGSAFDGV
SLLNLATHTSGLPLFVPDDVTNDAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKS
LDQPFIQAMEQGMLPALGMSHTYVQVPAAQMANYAQGYSKDDKPVRVNPGPLDAESYGIK
SNARDLIRYLDANLQQVKVAQPWRDALAATHVGYYKAGAFTQDLMWENYPYPVKLSRLIE
GNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFP
NDDRVEAAYHIVQALEKR
>WP_048233629.1|FEATURES|NCBI|beta_lactam|ampC|antibiotic inactivation|1
MTKMNRLAAALIAALILPTAHAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
VASKQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQGKLSFKDPASHYLPELRGSAFDGV
SLLNLATHTSGLPLFVPDDVTNNAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKS
LGQPFIQAMEQGMLPALGMSHTYVQVPAAQMANYAQGYSKDDKPVRVNPGPLDAKSYGIK
SNARDLIRYLDANLQQVKVAQPWRDALAATHVGYYKAGAFTQDLMWENYPYPVQLSRLIE
GNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFP
NDDRVEAAYHIIQALEKR
>WP_049201909.1|FEATURES|NCBI|beta_lactam|ampC|antibiotic inactivation|1
MTKMNRLAAALIAALILPTAHAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
VASKQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQGKLSFKDPASHYLPELRGSAFDGV
SLLNLATHTSGLPLFVPDDVTNNAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKS
LDQPFIQAMEQGMLPALGMSHTYVQVPAAQMANYAQGYSKDDKPVRVNPGPLDAESYGIK
SNARDLIRYLDANLQQVKVAQPWRDALAATHVGYYKAGAFTQDLMWENYPYPVKLSRLIE
GNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFP
NDDRVEAVYHIIQALEKR
>WP_016927879.1|FEATURES|NCBI|beta_lactam|classC|antibiotic inactivation|1
MTKMNRLASALIAALILPTAHAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
VASKQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQGKLSFNDPASRYLPELRGSAFDGV
SLLNLATHTSGLPLFVPDDVTDNAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKS
LDQPFTQAMEQGMLPALGMSHTYVQVPAAQMANYAQGYNKDDKPVRVNPGPLDAESYGIK
SNARDLIRYLDANLQQVKVAQPWREALTATHVGYYKAGAFTQDLMWENYPYPVKLSRLIE
GNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFP
NDDRVEAAYRIVQALDKR
>WP_047575941.1|FEATURES|NCBI|beta_lactam|ampC|antibiotic inactivation|1
MTKMNRLAAALIAALILPTAHAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
VASKQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQGKLSFSDPASHYLPELRGSAFDGV
SLLNLATHTSGLPLFVPDDVTDNAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKS
LDRPFIQAMEQGMLPALGMSHTYIQVPAAQMANYAQGYNKDDKPVRVNPGPLDAESYGIK
SNARDLIRYLDANLQQAKVAQPWREALAATHVGYYKAGVFTQDLMWENYPYPVKLSRLIE
GNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFP
NDDRVEAAYHIIQALDKR
>WP_025159717.1|FEATURES|NCBI|beta_lactam|ampC|antibiotic inactivation|1
MTKMNRLAAALIAALILPTAHAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
VASKQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQGKLSFSDPASRYLPELRGSAFDGV
SLLNLATHTSGLPLFVPDDVTDNTQLMAYYRAWQPKHPVGSYRVYSNLGIGMLGMIAAKS
LDQPFIQAMEQGMLPALGMSHTYIQVPAAQMANYAQGYNKDDKPVRVNPGPLDAESYGIK
SNARDLIRYLDANLQQVKVAQPWREALAGTHVGYYKAGAFTQDLMWENYPYPVKLPRLIE
GNNAGMIMNGTPATVLTPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFP
NDDRVEAAYRIIQALDKR
>WP_004621313.1|FEATURES|NCBI|beta_lactam|CAU-1|antibiotic inactivation|1
MPANWTKPTRPYRVVGNIYYVGTEGISSWLIVSSEGHVLLDAGPNAEVGKQIERNITALG
FQLTDVKVLINTHAHYDHAGGFAQLKADIPTAKLWISRGDAPAIEQGHHIGDNENGPTPM
PPVKVDKTFGDGAKLKLGETALIAHLTPGHTIGCTSWTTAVIERGRPLNVTFPCSLSVAG
NVLVGNKTHRNIVADYRQSFVKLRAIPTDVMLPAHEEQGDLLAKRRKQLRGDPNAFVDPT
ELGRFVDASEAAFNQELARQQAA
>WP_041538501.1|FEATURES|NCBI|beta_lactam|CAU-1|antibiotic inactivation|1
MPANWTKPTKPYRVVGNIYYVGTEGISSWLITSSEGHVILDGGPNAETGKQIERNIASLG
FQLADVKFLINTHAHYDHAGGLAQLKADIPAAKLWISRGDEPAIEQGHHIGDNENGPTPM
PAVKVDRAFGDGQKLKLGETSLVAHLTPGHTIGCTTWTTAVIEKGRPLNVTFPCSLSVAG
NMLVGNKGHKTIVADYRASFATMRAIPTDVVLPSHEEQGDLLAKRQKQLRGDPNAFVDPT
EMGRFVDGYEAAFNKGLARQQGV
>WP_051139090.1|FEATURES|NCBI|aminoglycoside|AAC(6')-34|antibiotic inactivation|1
MLVQQGRLAIRVLQKSDAPVMLRWLQDERVLEFYEGRDKHFDLQTIIEVFIDDQGETTPC
LVLLDDKPLGYVQFYPLDREDKQALELPVEDVIYGLDQFIGEPDFWGLGLGTQLVLLVRD
YLITKKAAHRLVLDPQSRNSRAIACYEKCGFEKLRMLPAHEMHEGQLQDCWLMQYYPARS
NLIASSRPKI
>WP_000960976.1|FEATURES|NCBI|aminoglycoside|AAC(6')-34|antibiotic inactivation|1
MLVQQGRLAIRALQKSDAPVMLRWLQDERVLEFYEGRDKHFDLQTVIEVFIEDQGETTPC
LVLLDDKPLGYVQFYPLDSEDKQALELPVEDVIYGLDQFIGEPDFWGLGLGTELVSLVRD
YLITDKAAQRLVLDPQSRNSRAIACYEKCGFEKLRLLPAHEMHEGQLQDCWLMQYYPARS
SLMASSRPKI
>CAM88403.1|FEATURES|NCBI|aminoglycoside|AAC(6')-34|antibiotic inactivation|1
MLVEQGRLAIRALQKSDAPVMLHWLQDERVLEFYEGRDKRFDLQTVIEVFIEDQGETTPC
LVLLDDKPLGYVQFYPLDSEDKQALELPVEDVIYGLDQFIGEPDFWGLGLGTELVSLVRD
YLITDKAAQRLVLDPQSRNLRAIACYEKCGFEKLCLLPAHEMHEGQLQDCWLMQYYPARS
SLIASSRPKI
>WP_033954903|FEATURES|NCBI|beta_lactam|blaOXA-/1-262|antibiotic inactivation|1
MRPLLFSALLLLSGRAQASEWNDSQAVDKLFGAAGVKGTFVLYDVQRQRYVGHDRERAET
RFVPASTYKVANSLIGLSTGAVRSADEVLPYGGKPQRFKAWEHDMSLRDAIKASNVPVYQ
ELARRIGLERMRANVSHLGYGNAEIGQVVDNFWLVGPLKISAMEQTRFLLRLAQGELPFP
APVQSTVRAMTLLESGPGWELHGKTGWCFDCTPELGWWVGWVKRNERLYGFALNIDMPGG
EADIGKRVELGKASLKALGILP
>CAL34450|FEATURES|NCBI|beta_lactam|blaOXA-193|antibiotic inactivation|1
MKKITLFLLFLNLVFGQDKILNNWFKEYNTSGTFVFYDGKTWASNDFSRAMETFSPASTF
KIFNALIALDSGVIKTKKEIFYHYRGEKVFLSSWAQDMNLSSAIKYSNVLAFKEVARRIG
IKTMQEYLNKLHYGNAKISKIDTFWLDNSLKISAKEQAILLFRLSQNSLPFSQEAMNSVK
EMIYLKNMENLELFGKTGFNDEQKIAWIVGFVYLKDENKYKAFALNLDIDKFEDLYKREK
ILEKYLDELVKK
>AKI29916|FEATURES|NCBI|beta_lactam|blaOXA-451|antibiotic inactivation|1
MKKITLFLLFLNLVFGQDKILNNWFKEYNTSGTFVFYDGKTWASNDFSRAMETFSPASTF
KIFNALIVLDSGVIKTKKEIFYHYRGEKVFLSSWAQDMNLSSAIKYSNVLAFKEVARRIG
IKTMQEYLNKLHYGNAKISKIDTFWLDNSLKISAKEQAILLFRLSQNSLPFSQEAMNSVK
EMIYLKNMENLELFGKTGFNDEQKIAWIVGFVYLKDENKYKAFALNLDIDKFEDLYKREK
ILEKYLDELVKK
>AKI29914|FEATURES|NCBI|beta_lactam|blaOXA-450|antibiotic inactivation|1
MKKITLFLLFLNLVFGQDKILNNWFKEYNTSGTFVFYDGKTWASNDFSRTMETFSPASTF
KIFNALIALDSGVIKTKKEIFYHYRGEKVFLSSWAQDMNLSSAIKYSNVLAFKEVARRIG
IKTMQEYLNKLHYGNAKISKIDTFWLDNSLKISAKEQAILLFRLSQNSLPFSQEAMNSVK
EMIYLKNMENLELFGKTGFNDEQKIAWIVGFVYLKDENKYKAFALNLDIDKFEDLYKREK
ILEKYLDELVKK
>AKI29920|FEATURES|NCBI|beta_lactam|blaOXA-460|antibiotic inactivation|1
MKKITLFLLFLNLVFGQDKILNNWFKEYNTSGTFVFYDGKTWASNDFSRAMETFSPASTF
KIFNALIALDSGVIKTKKEIFYHYRGEKVFLSSWAQDMNLSSAIKYSNVLAFKEVTRRIG
IKTMQEYLNKLHYGNAKISKIDTFWLDNSLKISAKEQAILLFRLSQNSLPFSQEAMNSVK
EMIYLKNMENLELFGKTGFNDEQKIAWIVGFVYLKDENKYKAFALNLDIDKFEDLYKREK
ILEKYLDELVKK
>ENU64030|FEATURES|NCBI|beta_lactam|blaOXA-282|antibiotic inactivation|1
MKILILLPLLSCLGLTACSLPVSSLLSQSTSTQSTQAIAQLFDQAQSAGVLVIQRGQQIQ
VYGNDLSRADTEYVPASTFKMLNALIGLQHGKATTNEIFKWDGKKRSFAAWEKDMTLGEA
MQASAVPVYQELARRIGLELMQQEVQRIQFGNQQIGQQVDNFWLVGPLKVTPKQEVQFVS
ALAREQLAFDPQVQQQVKAMLFLQERKAYRLYVKSGWGMDVEPQVGWLTGWVETPQAEIV
AFSLNMQMQNGIDPAIRLEILQQALAELGLYPKAEG
>ENX16434|FEATURES|NCBI|beta_lactam|blaOXA-284|antibiotic inactivation|1
MKTLIFLPLLNCLSLTACTLPVSSSPSHITSTQSTQAIAQLFDQAQSSGVLVIQRGQQIQ
VYGNDLSRADTEYVPASTFKMLNALIGLQHGKATTNEIFKWDGKKRSFSAWEKDMTLGEA
MQASAVPVYQELARRIGLELMQQEVQRIQFGNQQIGQQVDNFWLVGPLKITPKQEVEFVS
ALAREQLAFDPQVQQQVKAMLFLQERKAYRLYVKSGWGMDVEPQVGWLTGWVETPQAEIV
AFSLNMQMQNGIDPAIRLEILQQALAELGLYPKAEG
>ENV13583|FEATURES|NCBI|beta_lactam|blaOXA-276|antibiotic inactivation|1
MKILILWPLLSYLSLTACSFPVSNSPSQITSTQSIQAIAKLFDQAQSSGVLVIQRGPHLQ
VYGNDLSRAHTEYVPASTFKIFNALIGLQHGKATTNEIFKWDGKKRSFAAWEKDMTLGQA
MQASAVPVYQELARRIGLELMQQEVQRIQFGNQQIGHQVDNFWLVGPLKVTPKQEVEFAS
ALAQEQLAFDPRVQQQVKTMLLLQERQAYRLYAKSGWGMDVEPQVGWLTGWIETPQDEIV
AFSLNMQMQSNMDPAIRLKILQQALAELGLYPKAEG
>WP_044403015.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MRTLTTLGLALLLAQPAVAAQAVLPQLQPYTAPAAWLTPVAPLRIADNTWHIGTASITAL
LVKTPEGAVLLDGGMPQVADHLLANMRELGVAPGDLKLILHSHAHIDHVGPLAAIKKATG
AQLVSNAESAVLLQRGDSQDIHFGDDMVFAPVQVDRLVQDGETVELGGMTFTAHFTPGHT
PGSLSWTWTDRRDGKPLRIAYSDSLSAPGYSLWMNPRFPKIAEAFRSGFAAVRALPCDLL
ITPHAEASGWDYTNAEHPNPSPMSCKAYADKAEAAFDAQLKKQRGG
>ADC79555.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MRTLTTLGLALLLAQPAVAAQAVLPQLQPYTAPAAWLTPVAPLRIADNTWHIGTASITAL
LVKTPEGAVLLDGGMPQVADHLLANMRELGVAPGDLKLILHSHAHIDHVGPLAAIKKATG
AQLVSNAESAMLLQRGDSQDIHFGDDMVFAPVQVDRLVQDGETVELGGMTFTAHFTPGHT
PGSLSWTWTDRRDGKPLRIAYSDSLSAPGYSLWMNPRFPKIAEAFRSGFAAVRALPCDLL
ITPHAEASGWDYTNAEHPNPSPMSCKAYADKAEAAFDAQLKKQRGG
>ADC79567.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MRTLTTLGLALLLAQPAVAAQAVLPQLQPYTAPAAWLTPVAPLRIADNTWHIGTASITAL
LVKTPEGAVLLDGGMPQVADHLLANMRELGVAPGDLKLILHSHAHIDHVGPLAAIKKATG
AQLVSNAESAVLLQRGDSQDIHFGDDMVFAPVQVDQLVQDGETVELGGMTFTAHFTPGHT
PGSLSWTWTDRRDGKPLRIAYSDSLSAPGYSLWMNPRFPKIAEAFRSGFAAVRALPCDLL
ITPHAEASGWDYTNAEHPNPSPMSCKAYADKAEAAFDAQLKKQRGG
>ADC79563.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MRTLTTLGLALVMAQTALAAQAVLPQLQPYTAPAAWLTPVAPLRIADNTWHIGTASITAL
LVKTPEGAVLLDGGMPQVADHLLANMRELGVAPGDLKLILHSHAHIDHVGPLAAIKKATG
AQLVSNAESAVLLQRGDSQDIHFGDDMVFAPVQVDRLVQDGETVELGGMTFTAHFTPGHT
PGSLSWTWTDRRDGKPLRIAYSDSLSAPGYSLWMNPRFPKIAEAFRSGFAAVRALPCDLL
ITPHAEASGWDYTNAEHPNPSPMSCKAYADKAEAAFDAQLKKQRGG
>WP_016650254.1|FEATURES|NCBI|beta_lactam|MUS-2|antibiotic inactivation|1
MHRILSVITMLICTTLVHAQSDKLKIKQLNDNMYIYTTYQEFQGVTYSSNSMYVLTDEGA
ILIDTPWDKDQYEPLVDYIRTNHNKEIKWVITTHFHEDRSGGLGYFNSTGAQTYTYALTN
EILKERNEPQAQHSFNKEKQFTFGNEKLAVYFLGEGHSLDNTVVWFPKEEVLYGGCLIKS
AEATTIGNIADGNVIAWPKTIEAVKQKFKNAKVIIPGHDEWDMIGHIENTERILSAYNQQ
HSTKND
>WP_036471842.1|FEATURES|NCBI|beta_lactam|MUS-1|antibiotic inactivation|1
MRKILSAITMLICTTLVHAQSDKLKIKQLNDNMYIYTTYQEFQGVTYSCNSMYVLTDEGV
ILIDTPWDKDQYEPLVDYIRTNHNKEIKWVITTHFHEDRSGGLGYFNSIGAQTYTYALTN
KILKERNEPQAQHSFNKEKQFTFGNEKLAVYFLGEGHSLDNTVVWFPKEEVLYGGCLIKS
AEATTIGNIADGNVIAWPKTIEAVKQKFKNAKVIIPGHDEWDMTGHIENTERILSAYNQQ
HSTKND
>WP_025125210.1|FEATURES|NCBI|beta_lactam|MUS-1|antibiotic inactivation|1
MRKILSAITMLICTTLVHAQSDKLKIKQLNDNMYIYTTYQEFQGVTYSCNSMYVLTDEGV
ILIDTPWDKDQYEPLVDYIRTNHNKEIKWVITTHFHEDRSGGLGYFNSTGVQTYTYALTN
KILKERNEPQAQHSFNKEKQFTFGNEKLTVYFLGEGHSLDNTVVWFPKEEVLFGGCLIKS
AEATTIGNIADGNVIAWPKTIEAIKQKFKNAKVIIPGHDEWDMTGHIENTERILSAYNQQ
HSTKND
>WP_041894747.1|FEATURES|NCBI|beta_lactam|MUS-1|antibiotic inactivation|1
MRKILSSIAMLICTTLVHAQSDKLKIKQLNDNMYIYTTYQEFQGVTYSCNSMYVLTDEGV
ILIDTPWDKDQYEPLVEYIRTNHNKEIKWVITTHFHEDRSGGLGYFNSTGAQTYTYALTN
KILKERNEPQAQHSFNKEKQFTFGNEKLAVYFLGEGHSLDNTVVWFLKEEVLFGGCLIKS
AEATTLGNISDSDVIAWPKTIEAVKQKFKNAKVIIPGHDEWDMTGHIENTERILSEYNQQ
HSTKND
>WP_019976234.1|FEATURES|NCBI|beta_lactam|EBR-1|antibiotic inactivation|1
MKKIVSLLTLISVFAFGQIKPIQIDSIRNNLFVYQTFNTFQGVEYNVNAMYLVTKKGIVL
FDVPWQKSQYQTLNDLLEKKYNLPVIAVFVTHSHEDRAGDLSFYNDLNIPTYASALTNTI
LRKEGKATSKFEIELGKTYTFGKEKFVVEYFGQGHTEDNVVVWFPKYKVLNGGCLIKGAD
AINLGYTGEANITEWPETMKKLVSKYPTIKQVIPGHDNWKASGHIENTFKLLENN
>WP_034707448.1|FEATURES|NCBI|beta_lactam|TLA-2|antibiotic inactivation|1
MKKIGLFFLLISSLAVAQKSALEQKINSITEGKKATVGISVLGFENNFKYSKNGDQKLPM
LSVFKFHIAAAALDLVDKGKLSLDQKVFVSKTDLKEKTWSPFREKYPAGNIEVTLNEVID
YTVALSDNNLCDLLLKLIGGTKKVQQFMDSKGVKDFQIRYNEQEMHEKNWKSLYENYTTP
NSAAQVLKKFYDGKLLSKKSTDYLMKIMTGTKTGTNKIIEQLPKNTPTAHKTGSSGKNDN
GLTIAENDIGIITLPNGKHYAIAVFVSNSTEADAVNCKMVSDISKAVWDDFNK
>WP_019542800.1|FEATURES|NCBI|beta_lactam||antibiotic inactivation|1
MKKFCFLFLIICGLMVFCLQDCQARQKLNLADLENKYNAVIGVYAVDMENGKKICYKPDT
RFSYCSTLKVFTAAELLRQKNTSDLNEIRKFSAEDILSYAPITKDHVADGMTLAEICSAS
LRWSDNTAANLILQEIGGVENFKVALKNIGDKTTKPARNEPELNLFNPKDNRDTSTPRQM
VKNLQVYIFGDILSDDKKKLLIDWMSDNSITDTLIKAETPQGWKVIDKSGSGDYGARNDI
AVIYPPNRKPIVMAIMSRRTEKNAKSDDAMIAEAAKRIFDNLVF
>WP_007810578.1|FEATURES|NCBI|beta_lactam|JOHN-1|antibiotic inactivation|1
MRKLVVSIILFLTILSNGFGQSKNSELPISHLTGDFYIYKTFHDYKGTQISANAMYLVTD
KGVVMFDAPWDKAQFQPLLDSIKAKHNKEVIMCFATHSHDDRAGGIAFYKQKGIKTFTAK
LTDEILKKNKEPRARYVIPNDTVFSVGQHAFRVYYPGKGHAPDNIVVWFEKEKILYGGCF
IKSTEAEDLGYLGDADVKEWEQSIKRVESKFKNPKYIIPGHEDWENTESLNHTLKMVQEY
NAE
>WP_047502869.1|FEATURES|NCBI|fusidic_acid|fusD|antibiotic inactivation|1
MEKQLYPYQFNYIKERVAHLVNAYNSVNDPNTIASIKDITRDEILNTFNSRDTTIRSNVE
KLMNVQLTKEQAQKILTTIQMYVKPFEHPSKKQVTNLFKKVKKLKTPLISDEVLQTSTYI
GWNDIASNRKFIIYYDNFGKLNGVYGDISNQTVKGFYSICNKESRVALFMRKTRTGNDGQ
YTKKGDYICFDSTLCNHQISDLSHFHHFLNKIQ
>WP_048787200.1|FEATURES|NCBI|fusidic_acid|fusD|antibiotic inactivation|1
MEKQLYPYQFNYIKERVAHLVNAYNSVNDPNTIASIKDITRDEILNTFNSRDTTIRSNVE
KLMNVQLTKEQAQKILTTIQMYVKPFEHPSKKQVTNLFKKVKKLKTPLISDEVLQTSTYI
GWNDIASNRKFIIYYDNFGKLNGVYGDISNQTVKGFCSICNKESRVALFMRKTRTGNDGQ
YTKKGDYICFDSTLCNHQISDLSHFHHFLNKIQ
>CRV25694.1|FEATURES|NCBI|fusidic_acid|fusD|antibiotic inactivation|1
MEKQLYPYQFNYIKERVAHLVNAYNSVNDPNTIASIKDVTRDEILNTFNSRDTTIRSNVE
KLMNVQLTKEQAQKILTTIQMYVKPFEHPSKKQVTNLFKKVKKLKTPLISDEVLQTSTYI
GWNDIASNRKFIIYYDNFGKLNGVYGDISNQTVKGFCSICNKESRVALFMRKTRTGNDGQ
YTKKGDYICFDSTLCNHQISDLSHFHHFLNKIQ
>WP_041079788.1|FEATURES|NCBI|fusidic_acid|fusD|antibiotic inactivation|1
MEKQLYPYQFNYIKERVAHLVNAYNSVNDPNTIASIKDVTRDEILSTFNSRDTTIRSNVE
KLMNVQLTKEQAQKILTTIQMYVKPFEHPSNKQVTNLFKKVKKLKTPLISDEVLQTSTYI
GWNDIASNRKFIIYYDNFGKLNGVYGDISNQTVKGFCSICNKESRVALFMRKTRTGNDGQ
YTKKGDYICFDSTLCNHQISDLSHFHHFLNKIQ
>WP_002484106.1|FEATURES|NCBI|fusidic_acid|fusD|antibiotic inactivation|1
MEKQLYPYQFNYIKERVAHLVNAYNSVNDPNTIASIKDVTRDEILSTFNSRDNTIRSNVE
KLMNVQLTKEQAQKILTTIQMYVKPFEHPSNKQVTNLFKKVKKLKTPLISDEVLQTSTYI
GWNDIASNRKFIIYYDNFGKLNGVYGDISNQTVKGFCSICNKESRVALFMRKTRTGNDGQ
YTKKGDYICFDSTLCNHQISDLSHFHHFLNKIQ
>AAZ14834.1|FEATURES|NCBI|fosfomycin|FosC2|antibiotic inactivation|1
MLRGLNHITIAVSDLGRSLAFYTDIVGMLAHVRWDNGAYLSLGGVWFCLSCDKVMPSKDY
SHIALDISEDDFASFLEKLRRADVTEWKQNSSEGYSVYFLDPDGNKLEAHSGSLQSRLSS
LKDKPYPGLVWL
>WP_044291145.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|Erm(37)|antibiotic target alteration|1
MSALGRSRRAWGWHRLHDEWAARVVSAAAVRPGELVFDIGAGEGALTAHLVRAGARVVAV
ELHPRRVGVLRERFPGITVVHADAASIRLPGRPFRVVANPPYGISSRLLRTLLAPNSGLV
AADLVLQRALVCKFASRNARRFTLTVGLMLPRRAFLPPPHVDSAVLVVRRRKCGDWQVR
>WP_031745439.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|Erm(37)|antibiotic target alteration|1
MSALGRSRRAWGWHRLHDEWAARVVSAAAVRPGELVFDIGAGEGALTAHLVRAGARVLAV
ELHPRRVGVLRERFPGITVVHADAASIRLPGRPFRVVANPPYGISSRLLRTLLAPNSGLV
AADLVLQRALVCKFASRNARRFTLTVGLMLPRRAFLPPPHVDSAVLVVRRRKCGDWQGR
>WP_044096634.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|Erm(37)|antibiotic target alteration|1
MSALGRSRRAWGWHRLHDEWAARVVSAAAVRPGELVFDIGAGEGALTAYLVRAGARVVAV
ELHPRRVGVLRERFPGITVVHADAASIRLPGRPFRVVANPPYGISSRLLRTLLAPNSGLV
AADLVLQRALVCKFASRNARRFTLTVGLMLPRRAFLPPPHVDSAVLVVRRRKCGDWQGR
>WP_031743169.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|Erm(37)|antibiotic target alteration|1
MSALGRSRRAWGWHRLHDEWAARVVSAAAVRPGELVFDIGAGEGALTAHLVRAGARVVAV
ELHPRRAGVLRERFPGITVVHADAASIRLPGRPFRVVANPPYGISSRLLRTLLAPNSGLV
AADLVLQRALVCKFASRNARRFTLTVGLMLPRRAFLPPPHVDSAVLVVRRRKCGDWQGR
>WP_031730929.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|Erm(37)|antibiotic target alteration|1
MSALGRSRRAWGWHRLHDEWAARVVSAAAVRPGELVFDIGAGEGALTAHLVRAGARVVAV
ELHPRRVGVLRERFPGITVVHADAASIRLPGRPFRVVANPPYGISSRLLRTLLAPNSGLV
AADLVLQRALVCEFASRNARRFTLTVGLMLPRRAFLPPPHVDSAVLVVRRRKCGDWQGR
>WP_031701027.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|Erm(37)|antibiotic target alteration|1
MSALGRSRRAWGWHRLHDEWAARVVSAAAVRPGELVFDIGAGEGALTAHLVRAGARVVAV
ELHPRRVGVLRERFLGITVVHADAASIRLPGRPFRVVANPPYGISSRLLRTLLAPNSGLV
AADLVLQRALVCKFASRNARRFTLTVGLMLPRRAFLPPPHVDSAVLVVRRRKCGDWQGR
>WP_011094382.1|FEATURES|NCBI|beta_lactam|BJP-1|antibiotic inactivation|1
ATAHTLPSQGTETKGAETNSPAITSLTGCGPSSAINQFFNQFGSSGKMPAELGRWLNDAK
AQAVEPYQVFDNVYYVGICWVSAWLIKTSEGPVLIDTLYGEFTDQLMDNIKKIGVEPSDI
KMVLLTHGHFDHVGGVSKLKSLTNARFVMSEEGWKEAQADAKKTLGKPSAWAMPDPATTD
ILVKDGDALTVGDTTFHAYITPGHTWGTTSYVLDVKERNNTYHAITIGGLGLNAIDGPQQ
VEAYIRSIDRIKVMVEDSKHPITVHLTAHPFSNGQIEMQNQLKVHQPDQPHPMVDAKGLL
KQLATLRAGAIERLAVEQAR
>WP_048260993.1|FEATURES|NCBI|beta_lactam|BJP-1|antibiotic inactivation|1
ATAHTFPSQGTETKGTKTNSPATTSLTGCGPSSTINQLFNQFGNSGKMPAELGSWLNDAK
AQTVEPYQAFDNVYYVGICWVSAWLIKTSEGPVLIDTLYGEFTDQLIDNIKKIGVEPADI
KMVLLTHGHFDHVGGVSKLKSFTNARFVMSEKGWKEAQADANKTQGKPNAWTMPDPATTD
ILVKDGSALSVGDTTFYAYITPGHTWGTTSYVFDVKEGNNTYHAMTIGGLGLNAIDGPQQ
VEAYIRSIDRIKEMVEDAKHPITVHLTAHPFSNGQIEIQNQLKVRQPNQPHPMVDAEGLL
KQLATLRARAVERLAVEQAR
>WP_031576412.1|FEATURES|NCBI|tetracycline|tetA(46)|antibiotic efflux|1
MIRAILEYIRERKWRYVKIAMVLILYDYTLLIPTQVIQRLVDHLSQQTLTQSNFVWDMVL
LVGSAILNYLTAFYWQLRLFQSSVHFKATLQGQAFRKLVAMRRPFFEKFRSGDLLTRFTT
DVDGMADMAGYGMMVLLFGGGLFAFIIPTMFFISWQLTLISFIPMIFLVVSTYFLSRKQE
EYVEQNREAVAQLNDEVLESIEGIRVMRAYSRRDQQVKQFQKKTASLSKTGDKIASIQYS
FGPLALLFIGFSTVLLLLFGGQSLASGQLSLGKLLALQLYLVFLIEPMWMMADLILVYQT
GQMSYKKLKEVIDETDDLEPDGPHYLEQIDLVQFKDYSFSYPGVERKSLSGIDWTIQKGQ
TVGIVGRTGAGKTTLVRQFLRQYPVGEGEFLVNQQPIVDYNRHSIEEKIGYVSQEHILFS
KSIRENIALGKKGASQDDLVEAVAQAAFADDLERMSQAMDTLIGEKGVSVSGGQKQRISL
ARAFLRDAELLLLDDSLSAVDAKTEQAIIDTIQKERKDKTTIIVSHRLSAVHQADWIIVL
DQGQIVEEGRASDLLAQEGWYYEQYQRQQKQEGE
>WP_006595860.1|FEATURES|NCBI|tetracycline|tetA(46)|antibiotic efflux|1
MIRAIWEYIRERKWRYISIAVVLILYDYTLLIPTQVIQRLVDHLSQQTLTQSNFVWDMVL
LVGSAILNYLTAFYWQLRLFQSSVHFKATLQGQAFRKLVAMRRPFFEKFRSGDLLTRFTT
DVDGMADMAGYGMMVLLFGGGLFAFIIPTMFFISWRLTLISFIPMIFLIVSTYFLSRKQE
DYVEQNREAVAQLNDEVLESIEGIRVMRAYSKRDQQVKQFQKKTASLSKTGDKIASIQYS
FGPLALMFIGFSTVLLLVFGGQSLAIGQLSLGKLLALQLYLVFLIEPMWMMADLILVYQT
GQMSYKKLKEVIDETDDLEPDGPNYLEQIDSVQFKDYSFSYPGAERKSLSGIDWTIQKGQ
TVGIVGRTGAGKTSLIRQFLRQYPVGEGEFLVNQQPIVDYNRHSIEAKIGYVSQEHILFS
KSIRDNIALGKNGASEEDLVEAVAQAAFADDLERMSQGMDTMIGEKGVSVSGGQKQRISL
ARAFLRDADLLLLDDSLSAVDAKTEQAIIDTIQTERKGKTTLIVSHRLSAVHQADWIIVL
DQGQIVEEGRASDLLAQEGWYYEQYQRQQKQEGE
>WP_048689629.1|FEATURES|NCBI|tetracycline|tetA(46)|antibiotic efflux|1
MIRAIWEYIRERKWRYVKIAMVLILYDYTLLIPTQVIQRLVDHLSQQTLTQSNFVWDMVL
LVGSAILNYLTAFYWQLRLFQSSIHFKSTLQEQAFRKLVAMRRPFFEKFRSGDLLTRFTT
DVDGMADMAGYGMMIILYGGGLFTFIILAMFFLSWQLTLICFIPMIFLVVSTYFLSKKQE
DYIEQNREAVAQLNDEVLESIEGIRVMRAYSRREQQVKQFQTKTASLAKTGDKIASIQYS
FGPLALLFIGVSTVLLLVFGGQSLASGQLSLGKLLALQLYLVFLVEPMWMLSDFILVYQT
GQMSFKKLKEVIDETDDLEPDGPHYLTQIDSVEFKDYSFRYPGAERKSLSGIYWTVQKGQ
TVGIVGRTGSGKTTLIRQFLRQYPVGEGGFLINQQPVVAYNRRSIEDKIGYVSQEHILFS
KSIRDNIALGKNGASDEDIVEAVAQAAFADDLERMSQGMDTMIGEKGVSVSGGQKQRISL
ARAFLRDADLLLLDDSLSAVDAKTEQAIIDTIQKERKDKTTIIVSHRLSAVHQADWIIVL
DQGQIVEEGRACDLLAQEGWYYEQYQRQQKQEGE
>WP_023027111.1|FEATURES|NCBI|tetracycline|tetA(46)|antibiotic efflux|1
MIRAIWEYIRERKWRYISIAVVLILYDYTLLIPTQVIQRLVDHLSQQTLTKSNFVWDMVL
LVGSAILNYLTAFYWQLRLFQSSIHFKSTLQEQAFRKLVAMRRPFFEKFRSGDLLTRFTT
DVDGMADMAGYGMMIILYGGGLFTFIILAMFFLSWQLTLICFIPMIFLVVSTYFLSKKQE
DYIEQNREAVAQLNDEVLESIEGIRVMRAYSRRDQQVKQFQTKTASLAKTGDKIASIQYS
FGPLALLFIGVSTVLLLVFGGQSLASGQLSLGKLLALQLYLVFLVEPMWMLSDFILVYQT
GQMSFKKLKEVIDETDDLEPDGPHFLEQIDSVEFKDYSFRYPGAERESLSGIDWTVQKGQ
IVGIVGRTGSGKTSLVRQFLRQYPVGEGEFLVNQQPIVAYNRRSIEDKIGYVSQEHILFS
KSIRDNIALGKNGASEEDLVEAVAQAAFADDLERMSQGMDTMIGEKGVSVSGGQKQRISL
ARAFLRDADLLLLDDSLSAVDAKTEQAIIDSIQTERKGKTTIIVSHRLSAVHQADWIIVL
DQGQIVEEGRASDLLAQEGWYYEQYQRQQKQEGE
>WP_041826406.1|FEATURES|NCBI|tetracycline|tetB(46)|antibiotic efflux|1
MKVLKRLLSRITLYPTVFLAGFICLLLATIFSELSPFLLQKMIDGPLTALTHGGGQGDLL
QMGGFYLLVLSLGQLISYMGNRILLHGSNQVTASLRDQAFQVMQGMPISYFDDKPAGKIA
TRIVNDTETLRTQFYNSCMILVIYLVRFLFILGILFYLSPMMGLLLCLVFPIFYGIQYLY
KVMTDQPMKDFFDARSEVNTQVNELLHGASMIQLYHQEPGVVEEFEATTQKMLGANDRIL
LADSIASWTLTELLKFLVIAGILTIAGISFLQGNIGVTAGFLFININYVINLFDLMANLS
RQFPNIRRSLETGSRVLAFLDQPLEADGALELKIEKAEVVFDDVQFAYEEGKPVLRDIAF
QASPGQTIALVGHTGSGKSSIMNLLYRFYDPQEGAILIDGQDIRQVSRESLRSHMGIVLQ
DPYLFTGTIASNVAMSQEHIDRDAVKDALKKVGAWPFVERLEKGIDHPVVEKGSAFSSGE
RQLISFARTLYMNPQILILDEATSHIDTETEEIIQKAMAVLQKGRTTFIIAHRLSTIQDA
DQILVLSEGRIVERGRHEELVAQGGIYAQMNAIQQTVV
>WP_006597334.1|FEATURES|NCBI|tetracycline|tetB(46)|antibiotic efflux|1
MKVLKRLLSQITLYPTVFLSGFICLLLATIFSELSPFLLQKMIDGPLTALTHGGGQGDLL
QMGSFYLLVLSLGQLISYLGNRILLHGSNQVTASLRDQAFQVMQGLPISYFDDKPAGKIA
TRIVNDTETLRTQFYNSCMILVIYLVRFLFILGILFYLSPMMGLLLCLVFPIFYGIQYLY
KVMTDQPMKDFFDARSEVNTQVNELLHGASMIQLYHQEPGVVEEFEATTQKMLGANDRIL
LADSIASWTLTELLKFLVIAGILTIAGISFLQGNIGVTAGFLFININYVINLFDLMANLS
RQFPNIRRSLETGSRVLAFLDQPLEADGVSELKIEKAQVVFDDVQFAYEEGKPVLQDIAF
QASPGETIALVGHTGSGKSSIMNLLYRFYDPQEGAILIDGQDIRQVSRESLRSHMGIVLQ
DPYLFTGTIASNVAMSQDHIDRDAVKDALKKVGAWPFVERLEKGIDHPVVEKGSAFSSGE
RQLISFARTLYMNPQILILDEATSHIDTETEEIIQQAMAVLQKGRTTFIIAHRLSTIQDA
DQILVLSEGRIVERGRHEELVTQGGIYALMNAIQQTVV
>WP_040276885.1|FEATURES|NCBI|thiostrepton|tsnr|antibiotic target alteration|1
MADLETITSKSDPAVQRIMDVTKHSRASVKTTLIEDTEPLLECIGAGVEFIEVYGSDNAE
ISGELLDLCREKDIPVRLVDFSIVNQIFKGERKAKTFGIARVPRPAKFGDIAALDGDVVV
LDGVKIVGNVGAIVRTAYGLGASGMVLVDSDLTTIADRRLLRSSRGYVFSLPIVLAEREE
AAAFVRDSGMPLTVLDSHGDISVKELGGKQERLALLFGSEKGGHSDPFDEASATTVSIPM
LSAAAESLNVSVAVGIALHERAERNLS
>AGT57825.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|lnuE|antibiotic inactivation|1
MGKNNVTEKHLFYILDLLKDLQITYWLDGGWGVDVLTGKQQREHRDIDIDFDSQHTDKLV
KKLKEIGYITVVDWMPSRMELKHEEYGYLDIHPLDLKKDGTATQADPKGGFYLFEKDWFT
TTNYKNRKIPCISKEAQLLFHSGYELTEKDQFDIKNLNSI
>ACG60763.1|FEATURES|NCBI|bleomycin|Turpa_2231|antibiotic inactivation|1
MAVLLSGVPVLAALDVSTTQKFWIEVLGFTEEFLTEDFGGVSRDGVELFICSVEDQVVPD
NTQAWLRVRDIDALHAEWSARVSSDYADASHPAMTAIREVPWGREFGLRDPAGNLVHFSE
LSEAAETTRTVR
>CQD12588.1|FEATURES|NCBI|aminoglycoside|GLE_1155|antibiotic inactivation|1
MTTTNEIRVAEVADAGVVAKLLRDFNTEFDTPVPEGLEERFAQIIAHDDAFVLLAGDIGF
AYVTLRPSPYYDGPVAMLDELYVAPAHRNRGVGTALLQRVFEEIRKHSAGELQINVDEVD
TDARRFYERHGLTNIEQGSRMLLYIREL
>AAB00461.1|FEATURES|NCBI|aminoglycoside|AAC(6')-34|antibiotic inactivation|1
MTEHPRAHTAHLRTARLELTPLDPAADARHLHHAYGDEEVMRWWTRPACADPAETERYLT
SCAAAPGARLWTIRAPDGTVPGMAGLLGGTDVPGLTWLLRRDSWGHGYATEAAAAVVGHA
LEDGGLDRVEAWIEAGNRRSLAVAARVGLTERARLAQHYPHRPGPHEMVVLGKARAEEPL
TTLAVITELPVRDVAATLRLVEAALGARTAFAIGDPPEFAEAALTPWSAGPRFRLAAVPG
PGPVEPVRLHLDAAGTADSLHRRAVDAGARVDGPPVRRPWGRSEFVITLPEGHELTVSAP
V
>ABL74962.1|FEATURES|NCBI|glycopeptide|vanXYC|antibiotic target alteration|1
MELRTPRLRLIPLDPDRDASGLHAAFGDPEVMRWWNHVVCADVAETRERLRESVDRDGAH
LWVIRRGEACEPAGMVGLLGEVDVPGLTWLLCKDAWGRGLATEAAGAVVEHALGPLDLPR
VEAWVEATNERSLAVARRVGLTERGRLAQRYPHRERPHEMVVLGRARDHEPTPMLNAEVA
LPVRDVAATLTLLREALGGRTLFSVGDPPEVAGVSFGPWSVGPRLQLVSTRRWRIARVTL
YLDVGVELEALHDRAVDAGADVVQRPTEQPWGMRECVVQLPEGHHIVLTAPA
>CAA37050.1|FEATURES|NCBI|bacitracin|uppP2|antibiotic inactivation|1
MAKLTSAVPVLTARDVAGAVEFWTDRLGFSRDFVEDDFAGVVRDDVTLFISAVQDQVVPD
NTLAWVWVRGLDELYAEWSEVVSTNFRDASGPAMTEIGEQPWGREFALRDPAGNCVHFVA
EEQD
>AAW53146|FEATURES|NCBI|fosfomycin|fosB|antibiotic inactivation|1
ITNVNHICFSVSDLNTSIQFYKDILHGDLLVSGRTTAYLTIGHTWIALNQEKNIPRNEIS
HSYTHVAFSIDEEDFQQWIQWLKENQVNILKGRPRDIKDKKSIYFTDLDGHKIELHTGTL
KDRMEYYKCEKTHMQFY
>AHB87392|FEATURES|NCBI|fosfomycin|FosB|antibiotic inactivation|1
IQSINHICYSVSDLKNSIRFYKNILCGELLVSGKTTAYFNIGGLWVALNEEKDIPRNEVQ
YSYTHVAFTIDESEFNDWYQWFKENDVNILEGRTRDVRDKQSIYFTDPDGHKLELHTGTL
ENRLNYYKETKPHMVFY
>AAP50248.1|FEATURES|NCBI|fosfomycin|FosK|antibiotic inactivation|1
MITGINHITFSVRDLRASIEFYRDLLGMKLHVFWDTGAYLTAGNTWLCLSLGQPEPAKDY
THVAFSVREGELLELRAKLKQAGVEEWKQNTSEGDSIYLLDPNGHRLELHCGTLATRLAE
LESSPYKGLVWS
>AAA98399|FEATURES|NCBI|fosfomycin|fosA|antibiotic inactivation|1
MLQSLNHLTLAVSDLQKSVTFWHELLGLTLHARWNTGAYLTCGDLWVCLSYDEARQYVPP
QESDYTHYAFTVAEEDFEPLSQRLEQAGVTIWKQNKSEGASFYFLDPDGHKLELHVGSLA
ARLAACREKPYAGMVF
>EMI48985.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Iak|antibiotic inactivation|1
MTGSAATTRPATAADAVAWAQLRLGLWPDADDPLETLVAALAEDAGAVFLACAAGGQAIG
FAEVRLRHDYVNGTDSSPVGFLEGWYVQPQWQGRGVGRALLAAVRAWTRDAGCRELASDS
RVEDVQAHAAHRACGFEETERVVYFRMPLEPSA
>AGV79343.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Ie-APH(2'')-Ia|antibiotic inactivation|1
MDIRKTIEEKCNIVIESIKLIGEGYDSKAYIVNNEYVFKIKFSANKKKGYEKEKAVYDFL
NKKLHTSVNIPNIEYSYISDEISILGYKEIKGTFLTPEIYFSMSLEQQDLLKQDIAMFLR
QMHDLDFDEISSYTIDNKQNVLEEYQLLRETIYESLTDIEKQYIEEFMQRLYSTTIFDGK
KCLCHNDFSCNHLLLDDNNRLVGVIDFGDSGIIDEYCDFIYLLEDSEEEIGVSFGEDILK
LYGNIDISKAKEYQDVVEQYYPIETIVYGVKNNRDDFIEKGRKEIYLRTRKDEKTRK
>ENV20093|FEATURES|NCBI|beta_lactam|OXA-230|antibiotic inactivation|1
MKFKMKGLFCVILSSLAFSGCVYDSKLQRPVISERETEIPLLFNQAQTQAVFVTYDGIHL
KSYGNDLSRAKTEYIPASTFKMLNALIGLQNGKATNTEVFQWNGEKRAFSAWEKDMTLAE
AMQASAVPVYQELARRIGLKLMREEVKRVGFGNAEIGQQVDNFWLVGPLKISPEQEVQFA
YQLAMKQLPFDRNVQQQVKDMLYIESRGDSKLYAKSGWGMDVEPQVGWYTGWVEQPNGKV
TAFALNMNMQAGDDPAERKQLTLSILDKLGLFFYLR
>ALQ43092.1|FEATURES|NCBI|beta_lactam|OXA-85|antibiotic inactivation|1
MKKFILVMLLFMFSIISFGNENQFMKEIFERKGLNGTFVVYDLKNDKIDYYNLDRANERF
YPASSFKIFNTLIGLENGIVKNVDEMFYYYDGSKVFLDSWAKDSNLRYAIKVSQVPAYKK
LARELGKERMQEGLNKLNYGNKEIGSEIDKFWLEGPLKISAMEQVKLLNLLSQSKLPFKL
ENQEQVKDITILEKKDDFILHGKTGWATDNIVVPIGWFVGWIETSDNIYSFAINLDISDS
KFLPKREEVVREYFKNINVIK
>BAQ33930.1|FEATURES|NCBI|fusidic_acid|fusD|antibiotic inactivation|1
MEKQIYPYQFNYIKERIAHLLNAYKSVNDLNTIASIKETTKIDIYQQFHQIDDTLTEAIE
KLMNIRITKVQVDKILETLQTYVIPFEHPSKKQVEKTFRKIKKLKSPLISDEILLESTYI
GWNDIASNRKFIIYYNEQGTLTGFYGDIANQTVKGYCAICNKESNVALFMRKTRTSGDGQ
YTKKGDYICFDSIKCNQQLSDITQFYQFVDKIHS
>BAQ33942.1|FEATURES|NCBI|fusidic_acid|fusD|antibiotic inactivation|1
MEKQLYPYQFNYIKERIAHLLNTYKSVNDLNTITSIKETTKEDIYQQFHQTDDTLIEAID
KLMNIRISKTQVDKILATLQTYVRPFEHPSKKQIEKTFRKIKKLKSPLISDEILLESTYI
GWNDIASNRKFIIYYDEQELLTGFYGDIANQTVKGYCAICNKESNVALFMRKTRTSGDGQ
YTKKGDYICFDSIKCNQQLSDITQFYQFVDKIQS
>WP_011116969.1|FEATURES|NCBI|multidrug|msbA|antibiotic efflux|1
MKTYSWFVPPAPPADDPARLHPARWSSGNRVVRDMVGAYPGVLVLHILSYLIGSGISAFV
PVVVGMIVDGLVGEEKFNAWWLFAVLVGIFIIQFIGEATGDGLATASVRRVTHNAQQHLS
SGVLRRGAGAMSPGTVLNTIDADANTVGRYRELLSFPLMAIGYAVCAMVAMWSVSPWISL
AIPASALIIALFAAWTAGPVTRVSLKRRAAEADVAGLATDASQGIRTVKGLGAGATVATR
FHAETAKANGLMLTHLRVEVWLGFARFCVAWLCNLGIVGLSAWMTLRGEITPGQLTSVAL
LVQPALTMAGLAFGDLASGWGRAVASGQRIEQLHHAGDDAAGPEPTDTPVPGAGLWILEP
AERSYATAAAWAQRADVLFPPHTVNVFEGTIADNVNPRGDVPEDVVKQALAAAHCQDILR
RLGGINEAGELPDAPLGEAGLNLSGGQRQRVALARALAADPEVLILDDPTTGLDSVTQAD
VVAAVAALRADKTTVVITGNAAWQHAGTELEVA
>WP_041628446.1|FEATURES|NCBI|multidrug|msbA|antibiotic efflux|1
MKTYSWFVPPVPPADDPARLHPARWSSGNRVVRDMVGAYPGVLVLHILSYLIGSGIAAFV
PVVVGMIVDGLVGEEKFNAWWLFAVLVGIFIIQFIGEATGDGLATASVRRVTHNAQQHLS
SGVLRRGAGAMSPGTVLNTIDADANTVGRYRELLSFPLMAIGYAVCAMVAMWSVSPWISL
AIPASALIIALFAAWTAGPVTRVSLKRRAAEADVAGLATDASQGIRTVKGLGAGATVATR
FHAETAKAKRLMLTHLRVEVWLGFARFCVAWLCNLGIVGLSAWMTLRGEITPGQLTSVAL
LVQPALTMAGLAFGDLASGWGRAVASGQRIEQLHHAGDDTAGPELTDTPVPGAGLWILEP
EERSYATAAAWAQRADVLFPPHTVNVFEGTIADNVNPRGDVPEDVVKQALAAAHCQDILR
RLGGINEAGELPNAPLGETGLNLSGGQRQRVALARALAADPDVLILDDPTTGLDSVTQAD
VVEAVAALRADKTTVVITGNAAWQHAGTALEVA
>WP_005323423.1|FEATURES|NCBI|multidrug|tetAB|antibiotic efflux|1
MKTYSWFVPPAPPADDPARLHPARWSSGNRVVRDMVGAYPGVLVLHILSYLIGTGISAFV
PVVVGMIVDGLVGEEKFNAWWLFAVLVGIFIIQFIGEATGDGLATASVRRVTHNAQQHLS
SGVLRRGAGAMSPGTVLNTIDADANTVGRYRELLSFPLMAIGYAAGAMVAMWSVSPWISL
AIPASALIIALFAAWTAGPVTRVSLKRRAAEADVAGLATDASQGIRTVKGLGAGATVAER
FHSETAKAKRLMLTHLRVEVWLGFARFCVAWLCNLAIVGLSAWMTLRGEITPGQLTSVAL
LVPPALDMAGFAFGDLASGWGRAVASGQRIEQLHHAGDDAAGPEPTDTPVPGAGLWILEP
AERSYATAAAWAQRADVLFPPHTVNVFEGTIADNVNPRGDVPEDVVKQALAAAHCQDILR
RLGGIDAGGELPDAPLGEAGLNLSGGQRQRVALARALAADSDVLILDDPTTGLDSVTQAD
VVAAVAALRADKTTVVITGNAAWQHAGTELEVA
>WP_034998978.1|FEATURES|NCBI|multidrug|msbA|antibiotic efflux|1
MKTYSWFVPPAPPADDPARLHPARWSSGNRVVRDMVGAYPGVLVLHILSFLIGSGIAAFA
PVVVGMIVDGLVGEEKFNAWWLFGVLVGIFIIQFAGEATGDGLAAASVRRVTHNAQQHLS
SGVLRRGAGAMSPGTVLNTIDADANTIGRYRELLSFPLMAIGYAAGAIVAMWTVSPWVSL
AIPVSALVIALFAAWTAGPVTRVSLKRRAAEADVASLATDTSQGLRTVKGLGAGGTVAHR
FHTETAKAKRLMLTHLRVEVWLGFARLCVAWLCNLGIVGLAAWMTLRGEITPGQLTSVAL
LVPPALNMAGFAFGDLASGWGRAVASGQRIQQLHHAGDDTAGPEPTDTPVPGAGLWILEP
AERSYATAVAWAQRADVLFPPHTVNVFEGTIADNVNPRGDVPEDAVKQALAAAHCQDILR
RLGGIGENGELPDAPLGEAGLNLSGGQRQRVALARALAADPEVLILDDPTTGLDSVTQAD
VVEAVAVLRADKTTVVITGNSAWQHAGTALEVA
>AAA88548.1|FEATURES|NCBI|aminoglycoside|aac(6')-Ie|antibiotic inactivation|1
MNIVENEICIRTLIDDDFPLMLKWLTDERVLEFYGGRDKKYTLESLKKHYTEPWEDEVFR
VIIEYNNVPIGYGQIYKMYDELYTDYHYPKTDEIVYGMDQFIGEPNYWSKGIGTRYIKLI
FEFLKKERNANAVILDPHKNNPRAIRAYQKSGFRIIEDLPEHELHEGKKEDCYLMEYRYD
DNATNVKAMKYLIEHYFDNFK
>CAD60196.1|FEATURES|NCBI|aminoglycoside|aac(6')-Ie|antibiotic inactivation|1
MNIVENEICIRTLIDDDFPLMLKWLTDERVLEFYGGRDKKYTLESLKKHYTEPWEDEVFR
VIIEYNNVPIGYGQIYKMYDELYTDYHYPKTDEIVYGMDQFIGEPNYWSKGIGTRYIKLI
FEFLKKERNANAVILDPHKNNPRAIRAYQKSGFRIIEDLPEHELHEGKKEDCYLMEYRYD
DIATNVKAMKYLIEHYFDNFK
>AAA88548.1|FEATURES|NCBI|aminoglycoside|aph(2'')-Ia|antibiotic inactivation|1
VDSIEIIGSGYDSVAYLVNNEYIFKTKFSTNKKKGYAKEKAIYNFLNTNLETNVKIPNIE
YSYISDELSILGYKEIKGTFLTPEIYSTMSEEEQNLLKRDIASFLRQMHGLDYTDISECT
IDNKQNVLEEYILLRETIYNDLTDIEKDYIESFMERLNATTVFEGKKCLCHNDFSCNHLL
LDGNNRLTGIIDFGDSGIIDEYCDFIYLLEDSEEEIGTNFGEDILRMYGNIDIEKAKEYQ
DIVEEYYPIETIVYGIKNIKQEFIENGRKEIYKRTYK
>AAA26057.1|FEATURES|NCBI|chloramphenicol|cmlA1|antibiotic efflux|1
MSSKNFSWRYSLAATVLLLSPFDLLASLGMDMYLPAVPFMPNALGTTASTIQLTLTTYLV
MIGAGQLLFGPLSDRLGRRPVLLGGGLAYVVASMGLALTSSAEVFLGLRILQACGASACL
VSTFATVRDIYAGREESNVIYGILGSMLAMVPAVGPLLGALVDMWLGWRAIFAFLGLGMI
AASAAAWRFWPETRVQRVAGLQWSQLLLPVKCLNFWLYTLCYAAGMGSFFVFFSIAPGLM
MGRQGVSQLGFSLLFATVAIAMVFTARFMGRVIPKWGSPSVLRMGMGCLIAGAVLLAITE
IWALQSVLGFIAPMWLVGIGVATAVSVAPNGALRGFDHVAGTVTAVYFCLGGVLLGSIGT
LIISLLPRNTAWPVVVYCLTLATVVLGLSCVSRVKGSRGQGEHDVVALQSAGSTSNPNR
>ADC34600|FEATURES|NCBI|chloramphenicol|cmlA8|antibiotic efflux|1
MRSKNFSWRYSLAATVLLLSPFDLLASLGMDMYLPAVPFMPNALGTTTSTIQLTLTTYLV
MIGAGQLLFGPLSDRLGRRPVLLGGGLAYVVASMGLALTSSAEVFLGLRILQACGASACL
VSTFATVRDIYAGREESNVIYGILGSMLAMVPAIGPLLGALVDTWLGWRAIFAFLGLGMI
AASAAAWRFWPETRVQRVAGLQWSQLLLPIKCLNFWLYTLCYTAGMGSFFVFFSIAPGLM
MGRQGVSQLDFSLLFATVAIAMVFTARFMGRVIPKWGSPSVLRMGMGCLIAGAVLLAITE
IWVSQSVLGFIAPMWLVGVGVATAVSVAPNGALRGFDHVAGTVTAVYFCLGGVLLGSIGT
LIIWLLPRNTAWPVVVYCLTLATVVLGLSCVSRAKGFRGQREHDVVALQNAESTSNPNR
>KGT10052.1|FEATURES|NCBI|beta_lactam|TLA-3|antibiotic inactivation|1
MKRISIIFLFLSLFVFSQNSKPELLEKINTITKDKKATVAVSVLGIENDFQFSNANGNLK
MPMLSVFKFHIALAVLNQVDKGNLTLDQKILIKKSDLLENTWSPLREKYPDGNVELPLSE
IITYTVAQSDNNGCDILLRLIGGTKTVQKLMDVNGVKNFQIKYNEEEMHKNDVKTLYANY
TTTASMVKTLKAFYKGMFLSKRSTIFLMDIMTKTNTGMSKLPGLLPKVRMARKTGSSGKM
KNGLTIAENDSGIVTLANGKHYAIAVFVKDSMESEEVNCGIIAQVSKIVWDALNKKNKP
>ZP_18898211.1|FEATURES|NCBI|beta_lactam|BEL-1|antibiotic inactivation|1
PTLMPPAPRYLVPQSALTSVRNPKEIEEETGGRMGIALVDREGALILGFNRDDRFAMCST
FKAPLAAAVLIGAQGGKFGLEGEIPFTKDDILDYAPVVKKNKKRGRMSMAELAEAAVEVS
DNSAANLLLPMLGGPEGLTSFIRAHGDKITRLDRIEPELNENVAGDPRDTTSPAAMAGLM
GRLLFRDMQAADADRLRGWLNASTTGDKRIKAGLPEGWTSGSKTGSCGTAYNDVALVKSP
AGEEYILAIYLDRPTVDDKKAEAAIAEAAHSALEFVSKAQKSGLD
>ZP_09907955.1|FEATURES|NCBI|beta_lactam|BEL-1|antibiotic inactivation|1
PTLLPPAPRYLVPQSALTSVRNPKEIEEETGGRMGIALVDREGALILGFNRDDRFAMCST
FKAPLAAAVLIGAQGGKFGLEGEIPFTKDDILDYAPVVKKNKKRGRMSMAELAAAAVEVS
DNSAANLLLPMLGGPEGLTSFIRAHGDKITRLDRIEPDLNENIAGDPRDTTSPAAMAGLM
GRLLFRDMAAADADRLRGWLNASTTGDKRIKAGLPEGWTSGSKTGSCGTAYNDVALVKSP
AGEEYILAIYLDRPTVDDKKAEAAIAEAAHSALEFVSKAQKSGLN
>ZP_10541948.1|FEATURES|NCBI|beta_lactam|BEL-1|antibiotic inactivation|1
PTQLPPAPRYLVPQSALTSVRNPKEIEEETGGRMGIALVDRDGALILGFNRDDRFAMCST
FKAPLAAAVLIGAEGGKFGLDGEIPFTKDDILDYAPVVKKNRKRGRMSMAELAQAAVEVS
DNSAANLLLPMLGGPEGLTAFMRAHGDKITRLDRNEPALNENIEGDGRDTTSPAAMAGLM
SRLLFRDMQAADADRLRGWLNASTTGDKRIKAGLPEGWTSGSKTGSCGTAYNDVALVKAP
SGEEYILAIYLDRPTVDQKAAEAAIAEAAHSALEFVSKAKKSGLD
>WP_009821475.1|FEATURES|NCBI|beta_lactam|BEL-1|antibiotic inactivation|1
DNLMPAAPRYLVPQSALEQVRNPKEIEEETGGRLGVALVDRQGALLLGFNRDERFAMCST
FKAPLAAAVLTGADGGKFGLEGTIPFGKEDVLDYAPVVKKNLKRGRMSMEELARAAVEVS
DNSAANLLLPMLGGPEGLTAFMRVHGDDVTRLDRTEPALNENAEGDPRDTTTPAAMAGLM
ARLFFRDLKAESADRLRAWFNASSTGDKRIKAGLPEGWTSGSKTGSCGTAYNDVALVKSP
TGEEYILAIYLDRPTIDAKKAEAAIAEAARAALNFVGQARKSGLE
>YP_004552835.1|FEATURES|NCBI|beta_lactam|BEL-1|antibiotic inactivation|1
QSLLPPPPRYMVSESAMKSVRNPKEIESESGGRLGVALVDSKGALILGFNRDERFAMCST
FKAPLAAAVLSGAEGNKFGLEGQIGFTKADLLDHAPVVKKNARRGRMSMEELAAAAVEVS
DNSAANLLLPMIGGPEGFTRYVRAHGDNVTRLDRTEPALNENAEGDERDTTSPAAMAGLM
RRLIFTDLKPESAARLRGWLNASTTGGNRIKAGLPKDWTSGSKTGTCGTAYNDVALVKAP
SGEEYILAIYLDRPTVDAKAAEAAIAETARAALDFVGKAQKTGLE
>YP_003545618.1|FEATURES|NCBI|beta_lactam|BEL-1|antibiotic inactivation|1
QSLLPPPPRYMVSESAMKSVRNPKEIETESGGRLGVALVDGKGALILGFNRDERFAMCST
FKAPLAAAVLAGAEGGKFGLEGQISFAKADLLDYAPVVRKNVKRGRMSMEELAAAAVEVS
DNSAANLLLPMVGGPEGLTRFIRAHGDMVTRLDRNEPSLNENAEGDERDTTSPAAMAGLM
GRLIFRDLAPESAGKLRGWLNASTTGANRIKAGLPKGWISGSKTGSCGTAYNDVALVKAP
SGEEYILAIYLDRPTVDAKAAEAAIAETARAALDFVDKAQKTGLE
>ZP_10221377.1|FEATURES|NCBI|beta_lactam|BEL-1|antibiotic inactivation|1
PSLLPPPPRYMVSESAMRSVRNPKEIETESGGRLGVALVDGKGALILGFNRDERFAMCST
FKAPLAAAVLAGAEGGKFGLEGQISFAKADLLDYAPVVRKNVKRGRMSMEELAAAAVEVS
DNSAANLLLPMVGGPEGLTRFIRAHDDMVTRLDRNEPSLNENAEGDERDTTSPAAMAGLM
GRLIFRDLAPESAGKLRGWLNASTTGANRIKAGLPKGWTSGSKTGSCGTAYNDVALVKAP
SGEEYILAIYLDRPTVDAKAAEAAIAETARAALDFVDKAQKTGLE
>WP_003015518.1|FEATURES|NCBI|beta_lactam|blaA|antibiotic inactivation|1
MRLLVTTLSLIPSIILAAPQLDDSFKNLENKYDGKIGIYTLNTDDKTNIKYNESYHFPIC
SVFKFLLVGAILDYDMHNQGFLDKKIPINQDDIGKLGYAPITAKNVGKTLTISQLNYAAI
LSDSPASNILVRELGGLQNLNKFIKKLGDNDTIITADEPEINYTQPHSNINKITPKAITK
DIYKLAFGNILDKKHKDIFIKYLQDNNTGANRIAFGMPKDWIIGDKTGTCGQYAATNDVA
IIWPKNQQPIALGILYTNPNDKNAPSNEEIIQQAAKLIANDLTNTYK
>WP_003036826.1|FEATURES|NCBI|beta_lactam|blaA|antibiotic inactivation|1
MRLLVTTLSLIPSIILAAPQLDDSFKNLENKYDGKIGIYTLNTDDKTNIKYNESYHFPIC
SVFKFLLVGAILDYDMHNQGFLDKKIPINQNDIGKLGYAPITAKNVGKTLTISQLNYAAI
LSDNPAANILVRELGGLQNLNKFIKKLGDNDTIITADEPEVNYTQPHSNINKTTPKAITK
DIYKLAFGNILDKKHKDIFIKYLQDNNTGANRIAFGMPKDWIIGDKTGTCGQYAATNDVA
IIWPKNQQPIALGILYTNPNDKNAPSNEEIIQQAAKLIANNLTKTYK
>WP_003034156.1|FEATURES|NCBI|beta_lactam|blaA|antibiotic inactivation|1
MRILVTTLSLIPTIILAGPLLNDSFKSLENKYDGKIGIYTLNTDDKTNIKYNESYHFPIC
SVFKFLLVGAILDYDMHNQGFLDKKIPITQDDIGKLGYAPITAKNVGKTLTISQLNYAAI
LSDNPAANILVRELGGLQSLDKFIKKLGDNDTIITADEPEVNYTQPHSNINKTTPKAITK
DIYKLAFGNILDKKHKDIFIKYLQDNNTGTNRIAFSMPKDWIIGDKTGTCGQYAATNDVA
IIWPKNQQPIALGILYTNPNDKNAPSNEEIIQQAAKLIANNLTNTYK
>WP_044247329.1|FEATURES|NCBI|beta_lactam|blaA|antibiotic inactivation|1
MRLLVTTLSLIPSIILATPQLHDSFKSLENKYDGKIGIFTVNTDNKTNIKYNENYHFPIC
SVFKFLLVGAVLDYDMHNQGFLDKKIPITQDDIGTLGYAPITAKNIDKSLTISQLNYAAI
LSDNPAANILVREIGGLQNLNKFIKKLGDKDTIIIADEPKVNHTKPDSNINKTTPKAITK
DIYKLAFGNVLDKKHKDIFIKYLQDNNTGANRIAFSMPKDWIIGDKTGTCGQYAATNDVA
IIWPKNQQPIGLGILYTNPNYKNAPSNEEIIQQAAKLIANDLANVYK
>WP_002415370.1|FEATURES|NCBI|multidrug|salA|antibiotic target protection|1
MSKATFAIASTNAKEDMKMQYKIINGAVYYDGNMVLENIDIEINDNEKIAIVGRNGCGKT
TLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDM
ENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADYKKPI
SEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRM
FLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFR
YKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTP
LAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMDGVAALSGDFKFGYNVEISYFDQQLAQI
SGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKR
PNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFV
QSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQ
YDEELERLNKIISEPNNSSDYIVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM
>WP_050571857.1|FEATURES|NCBI|multidrug|salA|antibiotic target protection|1
MSEATFAIASTYAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKT
TLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDM
ENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADDKKPI
SEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRM
FLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFR
YKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTP
LAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMGGVAALSGDFKFGYNVEISYFDQQLAQI
SGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKR
TNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFV
QSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQ
YDEELERLNKIISEPNNSSDYIVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM
>WP_009040233.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|EreB|antibiotic inactivation|1
MKNIKPLTFPFNSENNTSIKQSLFRFREYFDSSTIVGLGENAHFIKEFFTFRHQVIEFLV
TECDFDTLAFEFGFSEGLEVDKWIKSQIPFDDLDKLLSHFYYPNEFKDTLLWLRRYNQDN
NNQITFLGVDIPKNGGSYFPNFRIVSDYLQRLSIVSSDVLQKILNLAEKFDFYSTSQLAL
NLSLFDEAEHNELKALLLKVYIRLITLQPKLESLEFQSIVHQVKGLIYMNYNADAMESFI
TERGIEGDMGAKDQYMAESIDWFLKNSLGKKIILVAHNAHIQKTPVDFDGFISCYPMGQR
LSMTFGEKYKAFAITNLRGETAALYPDNDYQFGFRVDKFPLDFPESDSVEFIMQEFGGKE
CCLLMNRSTELKNCNKIRFDSMCLKTEIEEAFDGIFLIEKSTVSEVVD
>WP_015345560.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|EreB|antibiotic inactivation|1
MKNIKPLTFPFNSENNTSIKQSLFRFREYFDSSTIVGLGENSHFIKEFFTFRHQVIEFLV
TECDFDTLAFEFGFSEGLEVDKWIKSQIPFDDLDKLLSHFYYPNEFKDTLLWLRRYNQDN
NNQITFLGVDIPKNGGSYFPNFRIVSDYLQRLSIVSSDVLQKILNLAEKFDFYSTSQLAL
NLSLFDEAEHNELKALLLKVYIRLVTLQPKLESLEFQSILHQVKGLIYMNYNADAMESFI
TEKGIEGDMGAKDQYMAESIDWFLKNSLGKKIILVAHNAHIQKTPVDFDGFISCYPMGQR
LSMTFGEKYKAFAITNLRGETAALYPDNDYQFGFRVDKFPLDSPESDSVEFFMQELSGKE
CCLIINKSKELKNCSKIRFDSIYLKTEIVDSFDGIFLIEKSTVSEIVD
>WP_023572056.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|EreB|antibiotic inactivation|1
MKNIKPLTFPFNSENNTSIKQSLFQFREYFDSSTIVGLGENSHFIKEFFKFRHQVIEFLV
TECDFDTLAFEFGFSEGLEVDKWIKSQIPFDDLDKLLSHFYYPNEFKDTLLWLRRYNQDN
NNQITFLGVDIPKNGGSYFPNFHIVSDYLQRLSIVSSDVLQKILNLAEKFDFYSTSQLAL
NLSLFDEAEHNELKALLLKVYIRLVTLQPKLESLEFQSILHLVKGLIYMNYNADAMESFI
TEKGIEGDMGAKDQYMAESIDWFLKNSLGKKIILVAHNAHIQKTPVDFDGFISCYPMGQR
LSMTFGEKYKAFAITNLRGETAALYPDNDYQFGFRVDKFPLDSPESDSVEFFMQELSGKE
CCLIINKSKELKNCSKIRFDSIHLKTEIVDSFDGIFLIEKSTVSEIVD
>WP_014519945.1|FEATURES|NCBI|beta_lactam|III_02866|antibiotic inactivation|1
MKKIVNSKLKLNKFKMCIFISILIFSLTGCGNVENKTSENTKPEIQYNSAFSKIESDYGV
KLGVYAFNTETNKEVTYNADKRFAYCSTFKSLISGAILQKYSSDQLKQVIKYSPKDVLSY
APVTKNHVDKGMTIEELCDAAVRFSDNTAANLLINLIGGPNGFKSALNQLGDTVTEPARI
EPELNVATPGDNRDTSTPRQLSIDLKEYTTGNILSDDKKKILIDWMSGNATGDKLIRAGA
PKDWMVSDKSGTGSYGTRNDIAIVIPPNKKPIFVAILSSKNAKDAKYDDKTISEASKIVF
DYFINTRK
>WP_012704143.1|FEATURES|NCBI|beta_lactam|III_02866|antibiotic inactivation|1
MKKIVNSKLKVNKFKMCIFISILIFSLTGCGNVENKTSENTKPEIQYNSAFSKIESDYGV
KLGVYAFDTETNKEVTYNADKRFAYCSTFKSLISGAILQKYSSDQLKQVIKYSPKDVLSY
APVTKNHVDKGMTIEELCDAAVRFSDNTAANLLINLIGGPNGFKSALNQLGDTVTEPARI
EPELNVATPGDNRDTSTPRQLSIDLKEYTTGNILSDDKKKILINWMSGNATGDKLIRAGA
PKDWMVSDKSGTGSYGTRNDIAIVIPPNKKPIFIAILSSKNDKDAKYDDKTISEASKIVF
DYFINTRK
>WP_045904844.1|FEATURES|NCBI|beta_lactam|III_02866|antibiotic inactivation|1
MKKIVNSKLKVNKFKMCIFISILIFSLTGCGNVENKTSENTKPEIQYNSAFSKIESDYGV
KLGVYAFDTETNKEVTYNADKRFAYCSTFKSLISGAILQKYSSDQLKQVIKYSPKDVLSY
APVTKNHVDKGMTIEELCDAAVRFSDNTAANLLINLIGGPNGFKSALNQLGDTVTEPARI
EPELNVATPGDNRDTSTPRQLSIDLKEYTTGNILSDDKKKILINWMSGNATGDKLIRAGA
PKDWMVSDKSGTGSYGTRNDIAIVIPSNKKPIFIAILSSKNDKDAKYDDKTISEASKIVF
DYFINTRK
>ENW94121.1|FEATURES|NCBI|beta_lactam|F895_00180|antibiotic inactivation|1
MSKKLKMLTLSISMMLGLPLMACQSFSQQKQQIMTQEREQQQITSLFQNAQTSGVLVIYD
GKKIQKFGNDVHRADQRYIPASTFKMLNALIGIQHHKTTPKEVFKWDGQKRAFSSWEKDL
TLAEAMQASAVPVYQELARRIGLELMTREVKRVGYGNKNIGTQVDNFWLVGPLKITPVEE
VRFAYALAKQKLPFDQSTQQQVKGMLLVDEVHGTKIYAKSGWGMDVSPQVGWWTGWIEQA
NGKITAFSLNMEMSRPEHTEARKAIVYQALQQLDLLAN
>WP_032877719.1|FEATURES|NCBI|beta_lactam|F895_00180|antibiotic inactivation|1
MSAKLKILTLSISLVLGLPLMACQSFSQQKQQIMTQKSEQQQIASLFQNAQTSGVLVIYD
GKKIQKYGNDTSRAEHRYIPASTFKMLNALIGIQHHKTTPNEIFKWDGRKRAFSSWEKDL
TLAEAMQASAVPVYQELARRIGLELMTQEIKRVGYGNNNVGTQVDNFWLVGPLKITPVEE
VRFAYALAKQKLPFDQSTQQQVKGMLLLDEVQGAKIYAKSGWGMDVSPQVGWWTGWIEQA
NGKITAFSLNMEMSQPEHAETRKAIVYQALQQLDLLVN
>ENX38336.1|FEATURES|NCBI|beta_lactam|F895_00180|antibiotic inactivation|1
MSKRLKTLALSASFTFALPLVACQSFGDQTQHIMAQKSEQQNIATLFQQAQTSGVLVIYD
GKKIQKYGNDTSRAEQRYIPASTFKMLNALIGIQHHKTTPNEVFKWDGQKRAFSSWEKDL
TLAEAMQASAVPVYQELARRIGLELMTREVKRVGYGNKNIGTQVDNFWLVGPLKITPVEE
VRFAYALAKQKLPFDQSTQQQVKGMLLIDEVQGTKIYAKSGWGMDVNPQVGWWTGWIEQA
NGKVTAFSLNMEMNRPEHADARKAIVYQALQQLDLLAN
>WP_032865068.1|FEATURES|NCBI|beta_lactam|F895_00180|antibiotic inactivation|1
MSKKLKCLALFTAVFFAIPMTACQSFSQQKQQFSTQKNEQQQISSLFQSAQTSGVLMIYD
GKKIQSYGNDLDRAEQRYIPASTFKMLNALIGIQHHKTTPDEVFKWDGKKRAFSSWEKDL
TLAEAMQASAVPVYQELARRIGLELMTREVKRVGYGNKNIGTQVDNFWLVGPLKITPIEE
VRFAYALAKQKLPFDQPTQQQVKAMLLVDQIQGTKIYAKSGWGMDVSPQVGWWTGWIEQP
NGKITAFSLNMQMSQPEHADARKVIVYQALQELGLLAH
>ENX18112.1|FEATURES|NCBI|beta_lactam|F895_00180|antibiotic inactivation|1
MSKKLKCLALLTPCILILQLTACQSVSQQKQQLSTQTNEQQQISSLFQSAQTKGVLVIYD
GKKIQSYGNDLNRAEQRYIPASTFKILNALIGIQYHKTTPNEVFKWDGKKRTFSSWEKDL
SLAEAMQASAVPVYQELARRIGLELMTREVKRVGYGNKNIGTQVDNFWLVGPLQITPVEE
VRFVYALAKQKLPFDQSTQQQVKGMLLADERQGTKIYAKSGWGMDVSPQVGWWTGWIEQP
NGKTIAFSLNMQMSQPEHANARKVIVYQALQELGLLAN
>WP_032879257.1|FEATURES|NCBI|beta_lactam|F889_02977|antibiotic inactivation|1
MSKKLKCLALLTPLILILPLTACQSPSQKKQQVVSLQNEQQRVANLFQQAQTTGVLVIYD
GKQIQTYGNATRRADQRFIPASTFKILNALIGIQHHKTTPNEVFKWDGQKRAFSSWEKDL
SLAEAMQASAVPVYQELARRIGLELMTREVKRVGYGNKHIGTQVDNFWLVGPLKITPVEE
VRFVYALAKQKLPFDQSTQQQVKDMLLVDEHQGTKIYAKSGWGMDVTPQVGWWTGWIEQP
NGKIIAFSLNMQMSQPAHADARKVIVYQALQELGLLAN
>ABV63006.2|FEATURES|NCBI|beta_lactam|OXA-247|antibiotic inactivation|1
MKKKYIKRLFSCIMLMAFCISQPSSTEARSIAWSVDEFFKNREGTFVIQEVKEKSPWVYN
KKRAKERFAPQSTFKVANALIGLQTGAVRDEYDIKYWDGVKREIDNWNRDHTLGSGMRDS
VVWYYQAMARDIGEERMNHWVKAIHYGNKDISGGIDQFWLSSTLRISPIEQVRFLKQLYE
ETLPFDLKNMRTVKRMMVQEEEKHATLYGKTGSGSDIGWYVGFIKHEHKTYILATNIKGT
GIEAKDITYRILKKYHLMEASV
>WP_060596701.1|FEATURES|NCBI|beta_lactam|OXA-247|antibiotic inactivation|1
MKKKYIKWLITGMMLMALCISQPSSTEGASPAWSVDEFMKDREGTFVIQEVKEKSPWVYN
KKRAKERFAPQSTFKVANSLIGLQTGAVRDEYHIKYWDGVKREIDNWNRDHTLGSGMRDS
VVWYYQAMARDIGEERMNHWVKAIHYGNKDISGGIDQFWLSSTLRISPIEQVRFLKQLYE
ETLPFDLKNMRTVKRMMVQEEEKHATLYGKTGSGSDIGWYVGFIKHEHKTYIFATNIKGT
GIEAKDITYRILKKYHLIEASV
>WP_044139565.1|FEATURES|NCBI|beta_lactam|OXA-247|antibiotic inactivation|1
MKKKYIKWLFSGIVLMALCISQSSSTEARSPAWSVDEFFKNREGTFVIQEVKEKSPWVYN
KKRAKERFAPQSTFKVANALIGLQTGAVRDEYDIKYWDGVKREIDSWNRDHTLGSGMRDS
VVWYYQAMARDIGEKRMNHWVKAIHYGNKDISGGIDQFWLSSTLRISPIEQVRFLKQLYE
ETLPFDLKTMRTVKRMMVQEEEKHATLYGKTGSGSGIDWYVGFIKHENKTYIFATNIEGT
GIEAKDITYRILKKYHLIEASA
>WP_034662014.1|FEATURES|NCBI|beta_lactam|OXA-247|antibiotic inactivation|1
MKKKYIKWLFTGMMLMALCISQPSSTEGASPAWSVDEFLKDREGTFVIQEVKEKSPWVYN
KKRAKERFAPQSTFKVANALIGLQTGAVRDEYDIKYWDGVKREIDRWNRDHTLGSGMRDS
VVWYYQAMARDIGEERMSQWVKAIHYGNEDISGGIDQFWLSSTLRISPVEQVRFLKQLYE
ETLPFDLNAMRTVKRMMIQEEEKHGTLYGKTGSGSGIGWYVGFIKHENKTYIFATNIEGT
GIEAKEITYLILKKYHLIEASV
>WP_064497915.1|FEATURES|NCBI|beta_lactam|OXA-247|antibiotic inactivation|1
MKKKHMKWLVSSIMLMTLCIGQPSSSEGTSPAWSVDEFLKDREGTFVIQEVKEKSPWVYN
KKRANQRFAPQSTFKVANALIGLQTGAVRDEYDIKYWDGVKREIDNWNKDHTLGSGMRDS
VVWYYQAMARDIGEERMSHWVKAIHYGNEDISGGIDQFWLSSSLRISPIEQVHFLKQLYE
ESLPFDLSVMRTVKRMMIQEEEKHATLYGKTGSGSGIGWYVGFIKHENKTYIFATNIEGT
GLEAKEITYRILKKYHLIEASV
>WP_034280751.1|FEATURES|NCBI|beta_lactam|OXA-247|antibiotic inactivation|1
MKKKHMKWLFCTIMLMAFCIGQPSSSEGTSPAWSVDEFMKDREGTFVIQEVKEKSPWVYN
KKRANERFAPQSTFKVANALIGLQTGAVRDEYDIKYWDGVKREIDNWNKDHTLGSGMRDS
VVWYYQAMARDIGEERMNHWVKAIHYGNEDISGGIDQFWLSSSLKLSPVEQVHFLKQLYE
ESLPFDLSVMRTVKRMMIQEEEKHATLYGKTGSGSGIGWYAGFIKHENKTYIFATNIEGT
GLKAKEITYRILKKYHLMEASV
>WP_048003296.1|FEATURES|NCBI|beta_lactam|OXA-247|antibiotic inactivation|1
MQKKKMKWLIAGVMLAALCMSKPASSEGTSPKWSVDEFMKEREGTFVIQEVKEKSPWVYN
KKRANKRFAPQSTFKIANALIGLQTGAVKDEYDIKYWDGVKREIDNWNKDHTLGSGMRDS
VVWYYQAMARDIGEERMGHWIKAIHYGNQDISGGIDQFWLSSTLRISPVEQVHFLKQLYE
ESLPFDLSVMRTVKRMMIQEEEKHATLYGKTGSGSGIGWYAGFIKHENKTYIFATNIEGT
GLEAKEITYRILKKYHLVEASV
>WP_034324889.1|FEATURES|NCBI|beta_lactam|OXA-247|antibiotic inactivation|1
MKKKHMKWLFSGVMLMALCMSQPLSSEGTAPTWSVDDIMKDREGTFVIQEVNEKSPRVYN
KKRANKRFAPQSTFKVANALIGLQTGAVRDEYDIKYWDGVKREIDSWNRDHTLGSGMRDS
VVWYYQAMARDIGEERMSQWVKAIHYGNQDISGGIDQFWLSSTLRISPLEQVRFLKQLYE
ERLPFDRSVMKTVKRMMIQEEEENATLYGKTGSGSGIGWYVGFIKYKSKTYIFATNIEGT
GIEAKAITYRIFKKYHLIEASL
>WP_000175803|FEATURES|NCBI|aminoglycoside|aadA7|antibiotic inactivation|0
MTLSIPPSIQCQTEAACRLITRVTGDTLRAIHLYGSAVAGGLKPNSDIDLLVTICQPLTE
AQRATLMQELLALSSPPGASAEKRALEVTVVLYSQLVPWCFPPSREMQFGEWLREDICQG
IYEPAQQDWDMVLLITQILETSIPLKGERAERLFTPAPAAQLLKALRYPLDLWQSTADVQ
GDEYHIVLTLARIWYTLSTGRFTSKDAAADWLLPQLPEDYAATLRAAQREYLGLEQQDWH
ILLPAVVRFVDFAKAHIPTQFT
>WP_052970651.1|FEATURES|NCBI|aminoglycoside|aadA7|antibiotic inactivation|0
MTLPIPPSIQCQTEAACRLITRVTGDTLRAIHLYGSAVAGGLKPNSDIDLLVTICQPLTE
TQRATLMQELLALSSPPGASAEKRALEVTVVLYSQLVPWCFPPAREMQFGEWLREDICQG
IYEPAQQDWDILLLITQILETSIPLKGERAERLFTPAPVAQLLKALRYPLDLWQSTADVQ
GDEYHIVLTLARIWYTLSTGRFTSKDAAADWLLPQLPEDYAATLRAAQREYLGLEQQDWH
ILLPAVVRFVDFAKAHIPTQFT
>WP_001728085.1|FEATURES|NCBI|aminoglycoside|aadA7|antibiotic inactivation|0
MTLSIPPSIQCQTEAACRLITRVTGDTLRAIHLYGSAVAGGLKPNSDIDLLVTICQPLTE
TQRATLMQELLALSSPPGASAEKRALEVTVVLYSQLVPWCFPPSREMQFGEWLREDIYQG
IYEPAQQDWDIVLLITQILETSIPLKGERAERLFTPAPAAQLLKALRYPLDLWQSAADVQ
GDKYHIVLTLARIWYTLSTGRFTSKDAAADWLLPQLPEEYAATLRAAQREYLGLEQQDWH
ILLPAVVRFVDFAKAHIPTQFT
>WP_045900075.1|FEATURES|NCBI|aminoglycoside|aadA7|antibiotic inactivation|0
MTLSIPPSIQCQTEAACRLITRVTGDTLRAIHLYGSAVAGGLKPNSDIDLLVTICQPLTE
AQRATLMQELLALSSPPGASAEKRALEVTVVLYSQLVPWCFPPAREMQFGEWLREDICQG
IYEPAQQDWDIVLLITQILETSIPLKGERAERLFTPAPAAQLLKALRYSLDLWQSTADVQ
GDEYHIVLTLARIWYTLSTGRFTSKDAAADWLLPQLPEEYAATLLAAQREYLGLEQQDWH
ILLPAVVRFVDFAKAYIPTQFT
>WP_023214503.1|FEATURES|NCBI|aminoglycoside|aadA7|antibiotic inactivation|0
MTLSIPPSIQCQTEAACRLITRVTGDTLRAIHLYGSAVAGGLKPNSDIDLLVTICQPLTE
TQRAMLMQELLALSSPPGASAEKRALEVTVVLYSQLVPWCFPPSREMQFGEWLREDICQG
IYEPAQQDWDMVLLITQILETSIPLKGERAERLFTPAPAAQLLKALRYPLDLWQSTADVQ
GDEYHIVLTLARIWYTLSTGKFTSKDAAADWLLPQLPEEYAATLRAAQREYLGLEQKDWH
ILLPAVVRFVDFAKTHIPTQFT
>WP_023255163.1|FEATURES|NCBI|aminoglycoside|aadA7|antibiotic inactivation|0
MTLSIPPSIQCQTEAACRLITRVTGDTLRAIHLYGSAVAGGLKPNSDIDLLVTICQPLTE
AQRATLMQELLVLSSPPGASAEKRALEVTVVLYSQLVPWCFPPSREMQFGEWLREDIYQG
IYEPAQQDWDIVLLITQILETSIPLKGERAERLFTPAPVAQLLKALRYPLDLWQSTADVQ
GDEYHIVLTLARIWYTLSTGRFTSKDAAADWLLPQLPEEYAATLRAAQREYLGLEQQDWH
ILLTAVVRFVDFAKAHIPTQFT
>WP_023204046.1|FEATURES|NCBI|aminoglycoside|aadA7|antibiotic inactivation|0
MTLSIPPSIQCQTDAACRLITRVTGDTLRAIHLYGSAVAGGLKPNSDIDLLVTICQPLTE
TQRATLMQELLVLSSPPGASAEKRALEVTVVLYSQLVPWCFPPSREMQFGEWLREDICQG
IYEPAQQDWDIVLLITQILETSIPLKGERAERLFTPAPVAQLLKALRYPLDLWQSTADVQ
GDEYHIVLTLARIWYTLSTGRFTSKDAAADWLLPQLPEDYAAPLRAAQREYLGLEQQDWH
ILLPAVVRFVDFAKTHIPTQFT
>WP_058145124.1|FEATURES|NCBI|aminoglycoside|aadA7|antibiotic inactivation|0
MTLSIPPSIQCQTEAACRLITRVTGDTLRAIHLYGSAVAGGLKPNSDIDLLVTICQPLTE
AQRATLMQELLALSSPPGASAEKRALEVTVVLYSQLVPWCFPPAREMQFGEWLREDICQG
IYEPAQQDWDIVLLITQILETSIPLKGERAERLFTPAPAVQLLKALRYPLDLWQSTADVQ
GDEYHIVLTLARIWYTLSTGRFTSKDAAADWLLPQLPEDYAAPLRAAQREYLGLEQQDWH
ILLPAVVRFVEFAKTHIPTQFT
>WP_039517854.1|FEATURES|NCBI|aminoglycoside|aadA7|antibiotic inactivation|0
MTLSIPPSIQCQTDAACRLIIRVTGDTLRAIHLYGSAVAGGLKSNSDIDLLVTICQPLTE
AQRVTLMQELLALSSPPGASAEKRALEVTVVLYSQLVPWCFPPSREMQFGEWLREDICQG
IYEPAQQDWDIVLLITQILETSIPLKGERAERLFTPAPAAQLLKALRYPLDLWQSTADVQ
GDEYHIVLTLARIWYTLSTGRFTSKDAAADWLLPQLPEEYAATLRAAQREYLGLEQQDWH
VLLPAVVRFVDFAKAHIPTQFT
>WP_052934797.1|FEATURES|NCBI|aminoglycoside|aadA7|antibiotic inactivation|0
MTLSIPPSIQCQTDAACRLITRVTGDTLRAIHLYGSAVAGGLKPNSDIDLLVTICQPLTE
TQRATLMQELLALSSPPGASAEKRALEVTVVLYSQLAPWCFPPSREMQFGEWLREDICQG
IYEPAQQDWDIVLLITQILETSIPLKGERAERLFTPVPAAQLLKALRYPLGLWQSTADVQ
GDEYHIVLTLARIWYTLSTGRFTSKDAAADWLLPQLPEDYAATLRTAQREYLGLEQQDWH
ILLPAVVRFVDFAKAHIPTQFT
>WP_046093434.1|FEATURES|NCBI|aminoglycoside|aadA9|antibiotic inactivation|0
MTLSIPPSIQRQTDAACRLITHVTGDTLRAIHLYGSAVAGGLKPNSDIDLLVTIGQPLTE
AQRATLMQELLALSSPSGASAETRALEVTVVLYSQLVPWCFPPSREMQFGEWLREDICQG
IYEPAQQDWDIVLLITQILETSIPLKGERAERLFTPVPTAQLLKALRYPLDLWQSAADVQ
GDEYHIVLTLARIWYTLSTGRFTSKDAAADWLLPQLPEDYAATLRAAQREYLGLEKKDWH
ILLPTVVRFVDFAKAHIPTQFT
>WP_000171874|FEATURES|NCBI|aminoglycoside|AADA2|antibiotic inactivation|0
MTLFKPPSIQRQTDAACRLITRVTGDTLRAIHLYGSAVAGGLKPNSDIDLLVTIGQPLTE
VQRATLMQELLALSSPSGASAETRALEVTVVLYSQLAPWCFPPSREMQFGEWLREDICQG
IYEPAQQDWDIVLLITQILETSIPLKGERAEQLFTPVPTAQLLKALRYPLDLWQSAADVQ
GDEYHIVLTLARIWYTLSTGRFTSKDAAADWLLPQLPEDYAATLRAAQREYLGLEKKDWH
ILLPTVVRFVDFAKAHIPTQFT
>WP_023184937.1|FEATURES|NCBI|aminoglycoside|aadA7|antibiotic inactivation|0
MTLSIPPSIQRQTDAACRLITRVTGDTLRAIHLYGSAVTGGLKPNSDIDLLVTICQPLTE
AQRATLMQELLALSSPSGASAEKRALEVTVVLYSQLVPWCFPPSREMQFGEWLREDICQG
IYEPAQQDWDIVLLITQILETSIPLKGERAERLFTPVPAAQLLKALRYPLDFWQSAADVQ
GDEYHIVLTLARIWYTLSTGRFTSKDAAADWLLPQLPEDYAATLRAAQREYLGLEKKDWR
ILLPAVIRFVDFAKAHIPTQFT
>WP_000175809|FEATURES|NCBI|aminoglycoside|aadA9|antibiotic inactivation|0
MTLSIPPSIQRQTDAACRLITRVTGDTLRAIHLYGSAVAGGLKPNSDIDLLVTIDQPLTE
AQRATLMQELLALSSPSGASAETRALEVTVVLYSQLVPWCFPPSREMQFGEWLREDICQG
IYEPAQQDWDIVLLITQILETSIPLKGERAERLFTPVPAAQLLKALRDPLDLWQSAADVQ
GDEYHIVLTLARIWYTLSTGRFTSKDAAADWLLPQLPVDYAATLHAAQREYLGLEKKDWH
ILLPAVVRFVDFAKAHIPTQFT
>WP_023247969.1|FEATURES|NCBI|aminoglycoside|aadA7|antibiotic inactivation|0
MILSIPPSIQCQTDAACRLITRVTGDTLRAIHLYGSAVAGGLKPNSDIDLLVTICQPLTE
VQRATLMRELLALSSPSGLSAEKRALEVTVVLYSQLVPWRFPPSREMQFGEWLREDICQG
IYEPAQQDWDIVLLITQILEASIPLKGEHAERLFTPAPAAQLVKALRYPLDLWQSAADVQ
GDEYHIVLTLARIWYTLSTGRFTSKNAAADWLLPQLPEDYAATLRAAQREYLGLEKKDWR
ILLPAVVRFVDFAKAHIPTQFT
>ADZ53064.1|FEATURES|NCBI|aminoglycoside|aadA7|antibiotic inactivation|0
MTLSIPPSIQCQTEAACRLITPVTGDTLGAIHLYGSAVAGGLKPNSDIDLLVTICQPLTE
AQRATLMQELLALSSPPAASADKRALEVTVVLYTQLVPWCFPPSREMQFGEWLREDICQG
IYEPAQQDWDMVLLITQILVTSIPLMGERAERLFTPAAAAQLLKALRYPLDLWQSTADVQ
GDEYHIVLTLARIWYTLSTARFTSKDAAADWLLPQLPEDYAATLRAGQREYLGLEQQDWH
ILLPAVVRFVEFAKAHIPTQFT
>WP_038985126.1|FEATURES|NCBI|beta_lactam|MUS-1|antibiotic inactivation|1
MRKILSTVALLICATVAHAQSDKLKIEKLNDHMYVYTTYQEFKGVQYSSNALYILTNDGA
LLIDTPWDKDQYEPLVNHIKKEHHKDVKWVITTHFHEDRSGGLDYFNKLGAQTYTYSLTN
DILKDRNEPQALHTFGQEKQFTFGKEKLAVYFLGEGHSKDNTVVWFPKEKILYGGCLIKS
AEATTIGNIEDGNVADWPKTIEVVKRKFSEAKQVIPGHDAWDMSGHIENTERILSAYAQQ
NSIKNK
>WP_060874262.1|FEATURES|NCBI|beta_lactam|TUS-1|antibiotic inactivation|1
MYKFLSSILLLASTTFVFAQSKPLKVEKLQDNIYVYITYQMYNGVEYSSNALYIVTDEGA
ILIDTPWDKEQNDPLVEHIRKQHNKEVKWVITTHFHEDRSGGLDYFRKAGAETYTYALTN
EILKNRNEPQAEFTFGKEKHFTFGKEEIVVYFLGEGHSKDNTVVWFPKEKVLYGGCLIKS
AEATDIGYIGDGNTDAWPATIKAVKSKFKQAKTVIPGHDNWNQSGHIENTERILSAYNAQ
KVKNNK
>WP_002988050.1|FEATURES|NCBI|beta_lactam|TUS-1|antibiotic inactivation|1
MYHYFSSLFVLIFSTLVYPQSDKLKIEPLNDHMYVYTTYQVFQGVEYSSNALYVVTDEGV
ILIDTPWDKDQYAPLVEHIRREHNKEIKWVITTHFHEDRSGGLDYFNKAGAETYTYALTN
EILKQRNEPQATFTFGSTKQFNLGKEKIEVYFLGEGHSKDNTVVWFPEEAILYGGCLIKS
AEATTIGNIVDGNVEAWPTTIKAVKRKFKKAKVIIPGHDAWNQSGHLENTARILSAYQAQ
KLKNNK
>WP_025403994.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDTIVEWIDDNLHQPLRIDDIARHAGYSKWHLQQLFLQYKGESLGRYIRERKLL
LAARDLRDTDQRVYDICLKYGFDSQQTFTRVFTRTFNQPPGAYRKENH
>WP_024130566.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDTIVEWIDDNLNQPLRIDDIARHAGYSKWHLQRLFMQYKGESLGRYIRERKLR
LAARDLRDTDQRVYDICLKYGFDSQQTFTRIFTRTFNQPPGAYRKENH
>WP_041144482.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIETIVGWIDDNLHQPLRIDDIARHSGYSKWHLQRLFLQYKGESLGRYIRERKLR
LAARDLRDTDQRVYDICLKYGFDSQQTFTRIFTRTFNQPPGAYRKENH
>WP_043017862.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDTIVEWIDENLNQPLRIDDIARHAGYSKWHLQRLFMQYKGESPGRYIRERKLL
LAARDLRDTDQKVYDICLKYGFDSQQTFTRIFTRTFSQPPGAYRKENH
>WP_045901073.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDTIVEWIDDNLNQPLRIDDIARHAGYSKWHLQRLFMQYKGESLGRYVRERKLK
LAARDLRDTDQKVYDICLKYGFDSQQTFTRVFTRTFNLPPGAYRKEKH
>WP_042391810.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
NISAQVIDTIVDWIDDNLHQPLRIDDIARHAGYSKWHLQRLFMQYKGESLGRYIRERKLR
LAAQELRDTDQKVFDICVKYGFDSQQTFTRIFTRTFNQPPGAYRKENH
>WP_061493847.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDTIVEWIDDNLHQPLRIDDIAAHAGYSKWHLQRLFLQYKGESLGRYIRERKLS
LAARDLRDTDQRVYDICLKYGFDSQQTFTRIFTRTFNLPPGAYRRENH
>WP_020454607.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDTIVEWIDDNLHQPLRIDDIAAHAGYSKWHLQRLFLHYKGESLGRYIRTRKLS
LAARDLRNTDQKVYDICLKYGFDSQQTFTRIFTRTFNQPPGAYRRENH
>WP_039058858.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDTIVEWIDDNLHQPLRIDDIAAHAGYSKWHLQRLFLQYKGESLGRYIRERKLS
RAAQDLVTTDQKVYDICLKYGFDSQQTFTRIFTRTFNQPPGAYRRENH
>WP_007370976.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDTIVEWIDDNLHQPLRIDDIAAHAGYSKWHLQRLFMQYKGESLGRYIRERKLA
LAAQDLRNTDQKVYDICLKYGFDSQQTFTRTFTRTFNQPPGAYRRENH
>WP_041852221.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDTIVEWIDDNLHQPLRIDDIARHAGYSKWHLQRLFLHYKGESLGRYIRERKLS
LAARDLLNTNDKVYDICLKYGFDSQQTFTRIFTRTFNQPPGAWRKENH
>WP_044185010.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDTIVEWIDDNLHQPLRIDEIARHAGYSKWHLQRLFLQYKGQSLGRYIRERKLS
LAAQDLLNTDQKVYDICLKYGFDSQQTFTRIFTRTFHQPPGAYRKENH
>WP_015965440.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDTIVEWIDDNLHQPLRIDDIARHAGYSKWHLQRLFLQYKGESLGRYIRQRKLS
LAAQELRTTNQRVYDICLKYGFDSQQTFTRVFTRTFNQSPGAYRRENY
>WP_049839937.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDTIVEWIDDNLHQPLRIEEIARHSGYSKWHLQRLFLQYKGESLGRYIRERKLL
LAARDLRDTDQRVYDICLKYGYESQQTFTRVFTRTFNQPPGAYRRENH
>WP_029882604.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDTIVEWIDDNLHQPLRIEDIARHAGYSKWHLQRLFMQYKGESLGRYIRERKLL
LAARDLRESDARVYDICLRYGFDSQQTFTRIFTRTFNQPPGAYRKENH
>WP_043001487.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDTIVEWIDDNLNQPLRIDDIARHAGYSKWHLQRLFLQYKGESLGRYIRERKLL
LAARDLRESDEKVYDICLRYGFDSQQTFTRIFTRTFNQPPGAYRKENH
>WP_028018442.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDTIVEWIDDNLHQPLRIDEIARHAGYSKWHLQRLFMQYKGESLGRYIRERKLL
LAARDLRESDERVYEICLRYGYDSQQTFTRIFTRTFNQPPGAYRKENH
>WP_045136121.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDTIVEWIDDNLHQPLRIEEIARKAGYSKWHLQRLFMQYKGESLGRNIRERKLL
MAARDLRESDERVYDICLRYGFDSQQTFTRIFTRTFNQPPGAYRKENH
>WP_039031578.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDTIVDWIDDNLHQPLRIEDIARHAGYSKWHLQRLFMQYKGESLGRYIRERKLR
LAARDLRESDEKVYDICLRYGFDSQQTFTRVFTRTFNQPPGAYRKDNH
>WP_061708302.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDTIVEWIDDNLHQPLRIEDIARHAGYSRWHLQRLFMQYKGESLGRYIRKRKLQ
LAARDLRESDEKVYEICLRYGFDSQQTFTRIFTRTFNQPPGAYRRENH
>WP_064561429.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDTIVQWIDDNLHQPLRIDDIALHAGYSKWHLQRLFMQYKGESLGKYIRDRKLL
LAARDLRDTDNKVYDISLKYGFDSQQTFTRIFTRTFNQPPGRYRRENH
>WP_034460676.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDTIVQWIDDNLHQPLRIDDIADHAGYSKWHLQRLFMQYKGESLGRYIRERKLL
LAARDLRDTDNKVYDISLKYGFDSQQTFTRIFTRTFHQPPGRYRRDNH
>WP_048286929.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDTIVEWIDDNLHRPLRIDDIARHAGYSKWHLQRLFLQYKGESLGRYIRTRKLY
LAARDLRDTDERVYDISLKYGFDSQQTFTRVFTRAFKQPPGAWRKEHQ
>WP_049849962.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIETIVEWIDDNLHQPLRIDDIARHAGYSKWHLQRLFLQYTGKSLGRYIRDRKLL
LAARDLRDTDQRVYDICLKYGFDSQQTFTRIFTRTFKQPPGAWRKQNH
>WP_038254648.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISTQVIETIVEWIDDNLHQPLRIDDIARHAGYSKWHLQRLFLQHKGESLGRYIRERKLQ
SAARDLRDTDQKVYDICLKYGFDSQQTFTRIFTRAYKQPPGAWRKAHH
>WP_013367196.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDAIVDWIDDNLHQPLRIEDIARHAGYSKWHLQRLFVQHKGENLGRYIRKRKLL
LAAQDLRDTNQKVYDISLKYGFDSQQTFTRVFTRTFKQPPGAWRKEHQ
>WP_052283763.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
ELATQVIDTLVEWIDNNLHQPLRIDEIARRAGYSKWHLQRIFLQHKGESLGRYIRTRKLN
LAADELCTTDQKVYDICLKYGFDSQQTFTRIFTRTFNQSPGAYRKENH
>WP_064548100.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
ELATQVIDTLVEWIDENLHQPLRIDEIARRAGYSKWHLQRLFLQHKGESLGRYIRQRKLN
LAADELCTTDQKVYDICLKYGFDSQQTFTRIFTRTFNQSPGAYRKVHH
>WP_062777133.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
ELATQVVDTLVEWIDNNLHQPLRIDEIARRAGYSKWHLQRIFLQHKGESLGRYIRKRKLD
LAADELCTTDQKVYDICLKYGFESQQTFTRIFTRTFNQPPGAYRKENH
>WP_035891756.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
ELATQVVDTLVEWIDDNLHQPLRIDEIARRAGYSKWHLQRIFLQHKGESLGRYIRHRKLH
LAADELCTTNQKVYDICLKYGFDSQQTFTRIFTRTFHQSPGAYRKENH
>WP_017372583.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
SIPEQVIETLIDWIDHNLDQPLRIDDIARHAGYSKWHLQRLFLQHKGESIGRYIRTRKLH
MAARDLRNSNEKVFEICLRYGFDSQQTFTRIFTKTFHQPPGAWRKDTS
>WP_024555500.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
ELPAQVIETLTGWIDDNLHKPLRIDDVARHAGYSKWHLQRLFHHHKGESLGRYIREKKLN
LAARDLRATDERVLDISLKYGFESQQTFTRLFTRHFRLSPGSYRRQAN
>WP_024551435.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
ELPAQVIETLTGWIDDNLHKPLRIDDVARHAGYSKWHLQRLFHHHKGESLGRYIREKKLS
LAARDLRATNEKVLDISLKYGFESQQTFTRLFTRHYSLSPGSYRRQAN
>WP_007665712.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
ELPAQVIETLTDWIDDNLHKPLRIDDIARHAGYSKWHLQRLFHHHKGESIGRYIREKKLR
LAAQDLRATNDRVLDISMKYGFDSQQTFTRLFTRKFQMSPGTWRKQGD
>WP_024549283.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
ELPAQVIETISDWIDENLHKPLRIDDIARHAGYSKWHLQRLFQHHKGESLGRYIREKKLK
LAAQDLRATNDRVLDISMKYGFDSQQTFTRLFTRRFSMSPGSYRRQRD
>WP_031520556.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
ELPAQVIETIADWIDDNLHKPLRIDDVARHAGYSKWHLQRLFHHHKGESLGRYIREKKLK
LAAQDLCATNDRVLDISMKYGFDSQQTFTRLFTRRFSMSPGNYRRQGG
>WP_002436152.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
ELPAQVIETITGWIDDNLHKPLRIDEIARHAGYSKWHLQRLFQHHTGESLGRYIREKKLR
LAAQDLRQTDARVLDISLKYGFESQQSFTRLFTRKFNMSPGHYRRQGD
>WP_032742463.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TIPAKVIDYVVKWIDKNLDQPLRIDHIALYSGYSKWHLQRLFLKHKGESLGRYIRKRKLF
MAAQDLRNTDVKICDISIKYGYESQQTFTRIFTRTFHYPPGLYRHINK
>WP_004871504.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
FISESVIAVIIDWIDDNLHKPLRIEQIAHYSGYSKWYLQRLFLQYKGESLGRYIRHKKLD
SAARDLRETDENIYSIGLRYGYDSQQTFTRLFTRHFHLPPGEYRKKNK
>WP_064377368.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
FISEAVIAVIIDWIDNNLHKPLRIEQIARYSGYSKWYLQRLFLQYRGESLGRYIRNKKLD
SAARDLRETDENIYSIGLRYGYDSQQTFTRLFTRHFHLPPGEYRKKNK
>AAL55263.1|FEATURES|NCBI|beta_lactam|blaCGB-1|antibiotic inactivation|1
KKSIPFFIISMLLSPLANAQDTQVRDFVIEPQIQPNFYIYKTFGVFGGKEYSTNAVYLVT
KKGVVLFDVPWQKTQYQSLMDTIQKRHHLPVIAVFATHSHEDRAGDLSFYNKKGIKTYAT
AKTNEILKKEGKATSTEIIKTGKPYRIGGEEFVVDFLGEGHTADNVVVWFPKYKILDGGC
LVKSKAAADLGYTGEANVAQWPKTMEKLKSKYAQATLIIPGHDEWKGGGHVEHTLDLLNK
K
>ALT07696.1|FEATURES|NCBI|beta_lactam|blaIMP-55|antibiotic inactivation|1
MSKLSVFFIFLICSIATAAESLPDLKIEKLEEGVYVHTSFKEVNGWGVVPKHGLVVLVNA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSRSIPTYASELT
NELLKKDGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKIFFGGCFIKP
YGLGKLGDANIEAWPKSAKLLKSKYGKAKLVVPSHSEVGDASLLKLTLEQAVKGLNESKK
PSKPS
>BAM37538.1|FEATURES|NCBI|beta_lactam|blaIMP-34|antibiotic inactivation|1
MSKLSVFFIFLFCSIATAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIGWLNSRSIPTYASELT
NELLKKDGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILFGGCFIKP
YGLGNLGDANIEAWPKSAKLLKSKYGKAKLVVPSHSEVGDASLLKLTLEQAVKGLNESKK
PSKPS
>WP_063978070.1|FEATURES|NCBI|beta_lactam|HMB-1|antibiotic inactivation|1
HLWISLGLLLLTNIVLAEEPLPELEVKKIDEGVYLHTSYENYPSWGLVASHGLVFVDGKD
AYIIDTPATVKDTEVLVQWINDQGFKPKASISTHFHDDSTIGIAYLNSKSIPTYASEQTN
ELLNKEVAAQATHSFKKNPYWLLKNKIEAFYPGAGHTPDNLVVWLPKQKILFGGCFVKPE
GLGNLSHAVVSEWPASAEKLINRYSDAKIVVPGHGTMGDASLLEKTKQRALEAVAKKK
>WP_032492430.1|FEATURES|NCBI|beta_lactam|KHM-1|antibiotic inactivation|1
ALVISFGLLLFTNMVCADDSLPELDIQKIEDGVYLYTAYEKIEGWGLVGSNGLVVLDNKN
AYLIDTPISATDTEKLVKWIDAQGFTAKASISTHFHTDSTGGIAFLNSKSIPTYASKLTN
QLLKNKGEEQATHSFGKNPYWLLKNKIEAFYPGAGHTPDNLVVWLPKQKILFGGCFVKPE
GLGNLSHAVIAEWPASAEKLIARYSNATMVVPGHGKVGDASLLEKTRQRAVEALAAKK
>WP_062058075.1|FEATURES|NCBI|beta_lactam|BL3_cit|antibiotic inactivation|1
APILSFCLLLLANIVSADEPLPELEIKKIEDGVYLYTAYENVKGWGLVGSNGLVVVDNKD
AYLIDTPISATDTEKLVQWIDAQGFTAKASISTHFHSDSTRGIAFLNSKSIPTYVSKLTN
KLLKNKGEAQATHSFSENPFWLLNKKIEVFYPGAGHTSDNVVVWLAEQKILFGGCFVKPE
GLGYLGDAVIADWPASAEKLIARYGTAKIVVPGHGKIGDASLLEKTKQRALEAVTAKK
>WP_007639185.1|FEATURES|NCBI|beta_lactam|O59_000556|antibiotic inactivation|1
KAFLAAILFLLSNITFAEDPLPELEIKKIEEGVYLYTAYEKIEGWGLVGSNGLVVLDNKD
AYLIDTPISAKDTEVLLQWIDAQGLTAKASISTHFHSDSSGGIAFLNSKSIPTYASKLTN
KLLKNKGEAQATHSFIKNPFWLVNKKIEVFYPGAGHTSDNVVVWMPEQKILFGGCFVKPE
GLGNLSHAVIEEWPASAEKLITRYGTAKLVVPGHGKVGDASFLEKTKQRAFEATAAKK
>WP_023603253.1|FEATURES|NCBI|quinolone|QnrVC1|antibiotic target protection|1
MAKYNEIFDNVDFSKQDLRESYFEGCKFYRCDFNRTNLRDSRFVDCVFIEQGAIEGCHFD
YCDLRDASFKRCRLTMSNFKGANCFGVEFRECDLKGANFVQASFVNQISHQMYFCSAYIT
GCNLSYANFERLCIEKCDLFENKWNGANLQGASFKGSDLSRGAFSEDSWGQFRMQDANLC
HCELDGLDPRRIDLTGVKICAWQQEQLLEPLGLVVLPD
>WP_025518018.1|FEATURES|NCBI|quinolone|QnrC|antibiotic target protection|1
MNYSHKTYDQIDFSGQDLSSHHFSHCKFFGCNFNRVNLRDAKFMGCTFIESNDFEGCNFI
YADLRDASFMNCMLSMANFQGANCFGLELRECDLKGANFSEANFVSHVSNKMYFCSAYIT
GCNLSYANFDKQCLEKCDLFENKWVGASLQGASFKESDLSRGSFSDDFWEQCRIQGGDLT
HSELNGLEPRKVDLTGVKICSWQQEQLLAQLGVIVIPDKLL
>WP_017025661.1|FEATURES|NCBI|quinolone|QnrC|antibiotic target protection|1
MNYSYKTYDQIDFSGQDLSSHQFTHCKFFGCNFNRVNLRDAKFADCTFIEPNDFEGCNFI
YADLRDTSFMNCMLSMSNFQGANCFGLELRECDLKGANFQGANFVNHVSNKMYFCSAYIT
GCNLSYANFDKQCLEKCDLFENRWVGASLHGASFKESDLSRGSFSDDFWEQCRIQGCDLT
HSELNGLEPRKVDLTGVKICSWQQEQLLEQLGVIVIPDKVF
>AMP47005.1|FEATURES|NCBI|tetracycline|tetQ|antibiotic target protection|1
MNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRAST
TSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFSTLQKLQ
IPTIIFINKIDRAGVNLERLYMDIKTNLSQDVLFMQTVVDGSVYPVCSQTYIKEEYKEFV
CNHDDDILERYLADSEISPADYWNTIIALVAKAKVYPVLHGSAMFNIGINELLDAISSFI
LPPASVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDVVRINDSEKFIKIKNLKTIY
QGREINVDEVGANDIAIVEDIEDFRIGDYLGAKPCLIQGLSHQHPALKSSVRPNKPEERS
KVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTI
YKERPIKKVNKIIQIEVPPNPYWATIGLTLEPLPLGAGLQIESDISYGYLNHSFQNAVFE
GIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPM
LCFELQIPQVASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKG
LGIFMVKPCGYQITKDGYSDNIRMNEKDKLLFMFQKSM
>WP_005816789.1|FEATURES|NCBI|tetracycline|tetQ|antibiotic target protection|1
MNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRAST
TSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQ
IPTIIFINKIDRAGVNLERLYLDIKTNLSQDVLFMQTVVDESVYPVCSQTYIKEEYKEFV
CNHDDDILERYLADSEISPADYWNTIIGLVAKAKVYPVLHGSAMFNIGINELLDAISSFI
LPPASVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDVVRINDSEKFIKIKNLKTIY
QGREINVDEVGANDIAIVEDIEDFRIGDYLGAEPCLIQGLSHQHPALKSSVRPDKPEERS
KVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTI
YKERPVKKVNKIIQIEVPPNPYWATIGLTLEPLPLGTGLQIESDISYGYLNHSFQNAVFE
GIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPM
LCFELQIPQEASSKAITDLQKMMSEIEDISCNNEWCRIKGKVPLNTSKDYASEVSSYTKG
LGVFMVKPCGYQITKGGYSDNIRMNENDKLLFMFQKSM
>WP_006255810.1|FEATURES|NCBI|tetracycline|tetQ|antibiotic target protection|1
MNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRAST
TSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQ
IPTIIFINKIDRAGVNLERLYLDIKTNLSQDVLFMQTVVDGSVYLVCSQTYIKEEYKEFV
CNHDDDILERYLADSEISPADYWNTIIALVAKAKVYPVLHGSAMFNIGINELLDAISSFI
LPPASVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDVVRINDSEKFIKIKNLKTIY
QGREINVDEVGANDIAIVEDMEDFRIGDYLGAKPCLIQGLSRQHPALKSSVRPDRPEERS
KVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTI
YKERPVKKVNKIIQIEVPPNPYWATIGLTIEPLPLGTGLQIESDISYGYLNHSFQNAVFE
GIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPM
LYFELQIPQVASSKAITDLQKMMSEIEDIICNNEWCHIKGKVPLNTSKDYASEVSSYTKG
LGVFMVKPCGYQITKGDYSDNIRMNEKDKLLFMFQKSM
>WP_004293868.1|FEATURES|NCBI|tetracycline|tetQ|antibiotic target protection|1
MNIINLGILAHIDAGKTSVTENLLFASGATEKCGCVDNGDTITDSMDIEKRRGITVRAST
TSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQ
IPTIIFINKIDRAGVNLERLYLDIKANLSQDVLFMQNVVDGSVYPVCSQTYIKEEYKEFV
CNHDDNILERYLADSEISPADYWNTIIALVAKAKVYPVLHGSAMFNIGINELLDAITSFI
LPPASVSNRLSSYLYKIEHDPKGHKRSFLKIIDGSLRLRDVVRINDSEKFIKIKNLKTIN
QGREINVDEVGANDIAIVEDMDDFRIGNYLGAEPCLIQGLSHQHPALKSSVRPDRPEERS
KVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTI
YKERPVKKVNKIIQIEVPPNPYWATIGLTLEPLPLGTGLQIESDISYGYLNHSFQNAVFE
GIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPM
LYFELQIPQAASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKG
LGIFMVKPCGYQITKGGYSDNIRMNEKDKLLFMFQKSM
>WP_042987717.1|FEATURES|NCBI|tetracycline|tetQ|antibiotic target protection|1
MNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRAST
TSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQ
IPTIIFINKIDRAGVNLERLYLDIKTNLSQDVLFMQTVVDGSVYPICSQTYIKEEYKEFV
CNHDDNILERYLADSEISPADYWNTVIALVAKAKVYPVLHGSAMFNIGINELLDAISSFI
LPPASVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDVVRINDSEKFIKIKNLKTIY
QGREINVDEVGANDIAIVEDIADFRIGDYLGAKPCLIQGLSHQHPALKSSVRPDKPEERS
KVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTI
YKERPIKKVNKIIQIEVPPNPYWATIGLTLEPLPLGTGLQIESDISYGYLNHSFQNAVFE
GIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPM
LYFELQIPQVASSKAITDLQKMMSEIEDISCNNDWCHIKGKVPLNTSKDYVSEVSSYTKG
LGVFMVKPCGYQITKGDYSDNIRMNEKDKLLFMFQKSM
>AMP47132.1|FEATURES|NCBI|tetracycline|tetQ|antibiotic target protection|1
MNIINLGILAHIDAGKTSVTENLLFVSGATEKCGCVDNGDTITDSMDIEKRRGITVRAST
TSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQ
IPTIIFINKIDRAGVNLERLYLDIKTNLSQDALIMQTVVDGLVYPICSQTYIQEEYKEFV
CNHDDNILERYLADSEISPADYWNTIIALVAKAKVYPVLHGSAMFNIGINELLDAISSFI
LPPASVSNRLSSYLYKIEHDPKGHKRSFLKIIDGSLRLRDVVRINDSEKFIKIKNLKTIY
QGREINVDEVGANDIAIVEDIEDFRIGDYLGAKPCLIQGLSHQHPALKSSVRPNKPEERS
KVISALNTLWIEDPSLSFSINAYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTI
YKERPVKKVYKIIQIEVPPNPYWATIGLTLEPLPLGTGLQIESDISYGYLNHSFQNAVFE
GIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPM
LCFELQIPQMASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKG
LGVFMVKPCGYQITKGDYSDNIRMNEKDKLLFMFQKSM
>WP_005796948.1|FEATURES|NCBI|tetracycline|tetQ|antibiotic target protection|1
MNIINLGILAHIDAGKTSVTENLLFASGATEKCGCVDNGDTITDSMDIEKRRGITVRAST
TSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQ
IPTIIFINKIDRAGVNLERLYLDIKTNLSQDVLFMQTVVDGLVYPICSQTYIKEEYKEFV
CNHDDNILERYLADSEISPADYWNTIIALVEKAKVYPVLHGSAMFNIGINELLDAISSFI
LPPASVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDVVRINDSEKFIKIKNLKTIY
QGREINVDEVGANDIAIVEDMEDFRIGDYLGAKPCLIQGLSHQHPALKSSVRPDKPEERS
KVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTI
YKERPVKKVNKIIQIEVPPNPYWATIGLALEPLPLGTGLQIESDISYGYLNHSFQNAVFE
GIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPM
LCFELQIPQMASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKG
LGIFMVKPCGYQITKGGYSDNIRMNEKDKLLFMFQKSM
>WP_063856408|FEATURES|NCBI|tetracycline|tetQ|antibiotic target protection|1
MNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRAST
TSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQ
IPTIIFINKIDRDGVNLERLYLDIKTNLSQDVLFMQTVVDGLVYPICSQTYIKEEYKEFV
CNHDDNILERYLADSEISPADYWNTIIDLVAKAKVYPVLHGSAMFNIGINELLDAISSFI
LPPESVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDIVRINDSEKFIKIKNLKTIY
QGRKINVDEVGANDIAIVEDMEDFRIGDYLGTKPCLIQGLSHQHPALKSSVRPDRSEERS
KVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTI
YKERPVKKVNKIIQIEVPPNPYWATIGLTLEPLPLGTGLQIESDISYGYLNHSFQNAVFE
GIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPM
LYFELQIPQAASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPYNTSKDYASEVSSYTKG
LGVFMVKPCGYQITKGDYSDNIRMNEKDKILFMFQKSN
>WP_008148693.1|FEATURES|NCBI|tetracycline|tetQ|antibiotic target protection|1
MNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRAST
TSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQ
IPTIIFINKIDRDGVNLERLYLDIKTNLSQDVLFMQTVVDGLVYPICSQTYIKEEYKEFV
CNHDDNILERYLADSEISPADYWNTIIDLVAKAKVYPVLHGSAMFNIGINELLDAITSFI
LPPASVSNRLSSYLYKIEHDPKGHKRSFLKIIDGSLRLRDVVRINDSEKFIKIKNLKTIN
QGREINVDEVGANDIAIVEDMDDFRIGNYLGAEPCLIQGLSHQHPALKSSVRPDRPEERS
KVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTI
YKERPIKKVNKIIQIEVPPNPYWATIGLTLEPLPLGAGLQIESDISYGYLNHSFQNAVFE
GIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPM
LCFELQIPQVASSKAITDLQKLMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKG
LGIFMVKPCGYQITKDGYSDNIRMNEKDKLLFMFQKSI
>WP_063856409|FEATURES|NCBI|tetracycline|tetQ|antibiotic target protection|1
MNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRAST
TSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQ
IPTIIFINKIDRAGVNLERLYLDIKTNLSQDVLCMQTVVDGSVYPVCSQTYIKEEYKEFV
CDHDDNILERYLADSEIPPTDYWNTIIALVAKAKVYPVLHGSAMFNIGINELMDAITSFI
LPPASVSDRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDVVRINDSEKSIKIKNLKTIY
QGREINVDEVGANDIAIVEDMEDFRIGDYLGAEPCLIQGLSHQHPALKSSVRPDKPEERS
KVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTI
YKERPIKKVNKIIQIEVPPNPYWATIGLTLEPLPLGAGLQIESDISYGYLNHSFQNAVFE
GIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPM
LYFELQIPQEASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKG
LGIFMVKPCGYQITKDGYSDNIRMNEKDKLLFMFQKSM
>WP_016278665.1|FEATURES|NCBI|tetracycline|tetQ|antibiotic target protection|1
MNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRAST
TSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLHKLQ
IPTIIFINKIDRAGVNLERLYLDIKANLSQDVLFMQTVTDGSVYPVCSQTYIKEEYKEFV
CNHDDDILERYLSDSEISPADYWNTIIALVAKAKVYPVLHGSAMFNIGINELMDAITSFI
LPPESVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDVVRINDSEKSIKIKNLKTIY
QGREINFDEVGANDIAIVEDMEDFRIGDYLGVKPCLIQGLSHQHPALKSSVRPDKPEERS
KVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTI
YKERPVKKVNKIIQIEVPPNPYWATIGLTLEPLPLGTGLQIESDISYGYLNHSFQNAVFE
GIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPM
LCFELQIPQEASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKG
LGVFMVKPCGYQITKGGYSDNIRMNEKDKLLFMFQKSM
>AKG19864.1|FEATURES|NCBI|aminoglycoside|adenylyltransferase|antibiotic inactivation|1
ESIADQLSDTLSILENHLGETIQAVHLFGSAVDGGLKPFSDIDLLITVSTPLGESTRVAL
MSDLLLVSAFPGTDAKRRALEVTILAQKDVVPWRYPARRQMQFGEWLRHDINAGIFEPAM
TDHDLAILLTKVRLHSLALYGPAAQEFFDEIPAIDVQRSLLETLALWTTEADWEGDERNI
VLALVRIWYTAMTGDIASKDAAADWALQRLPSEHKHIVIAARDGYLGLGTVDLAAYPQER
AELLNYIRSSVTTKLQ
>CAB41476.2|FEATURES|NCBI|aminoglycoside|aadA4|antibiotic inactivation|1
AQISEQLSHARGVIERHLAATLDTIHLFGSALDGGLKPDSDIDLLVTVSAAPNDSLRQAL
MLDLLKVSSPPGDGGPWRPLEVTVVARSEVVPWRYPAIRELQFGEWLRHDILSGTFEPSV
LDHDLAILLTKARQHSLALLGPSAVTFFEPVPNEHFSKALFDTIAQWNSESDWKGDERNV
VLALARIWYSASTGLIAPKDVAAAWVSERLPAEHRPIICKARAAYLGSEDDDLAMRVEET
AAFVRYAKATIERILR
>CAM98048.2|FEATURES|NCBI|aminoglycoside|aadA24|antibiotic inactivation|1
AEISTQLLEVLSVIERHLEPTLLAVHLYGSAVNGGLKPYSDIDLLVTVTVRLNETTRRAL
LNDLLEVSTFPGESEALRAIEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPAT
IDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLKLWNSQPDWAGDERNV
VLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVLLEARQAYLGQEEDRLALHADQL
EEFVHYVKGESTKVVG
>AAV49760.1|FEATURES|NCBI|aminoglycoside|aadA12|antibiotic inactivation|1
IEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVTVRLDETTRRAL
INDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPAT
IDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERNV
VLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRADHL
EEFIRFVKGEIIKSVG
>CAA31362.1|FEATURES|NCBI|aminoglycoside|aadA1|antibiotic inactivation|1
AEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRRAL
INDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPAT
IDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERNV
VLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRADQL
EEFVHYVKGEITKVVG
>AAB60002.1|FEATURES|NCBI|aminoglycoside|aadA2|antibiotic inactivation|1
IEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRRAL
LNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPAM
IDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDERNV
VLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRADHL
EEFIRFVKGEIIKSVG
>ABL95942.1|FEATURES|NCBI|aminoglycoside|aadA21|antibiotic inactivation|1
IEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRRAL
LNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPAT
IDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERNV
VLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRADQL
EEFVHYVKGEITKVVG
>AAN60064.1|FEATURES|NCBI|aminoglycoside|aadA11|antibiotic inactivation|1
AEISVQLSLALNAIERHLESTLLAVHLYGSALDGGLKPYSDIDLLVTVAAQLDETVRQAL
VVDLLEISASPGQSEALRALEVTIVVHGDVVPWRYPARRELQFGEWQRKDILAGIFEPAT
TDVDLAILLTKVRQHSLALAGSAAEDFFNPVPEGDLFKALSDTLKLWNSQPDWEGDERNV
VLTLSRIWYSAATGKIAPKDIVANWAIERLPDQHKPVLLEARQAYLGQGEDCLASRADQL
AAFVHFVKHEATKLLG
>ACD45687.1|FEATURES|NCBI|aminoglycoside|aadA16|antibiotic inactivation|1
AEISVQLSQALNVIEHHLGSTLLAVHLYGSALDGGLKPCSDIDLLVTVTAQLDETVRQAL
FVDFLEVSASPGQSEALRALEVTIVVYGDVVPWRYPARRELQFGEWQRKDILAGIFEPAT
TDVDLAILLTKARQHSLALAGSAAEDFFNSVPESDLFKALADTLKLWNSQPDWAGDERNV
VLTLSRIWYSAATGKIAPKDVAANWVMERLPVQHQPVLLEAQQAYLGQGMDCLASRADQL
TAFIYFVKHEAASLLG
>WP_005413282.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGPAIRTPHARLWPVLTAADEPAMLKISSETEEQNSHRLLRWWNGDG
AARLLAHEGPAILIERARGDSLRQRSIKGDDDACTAILCQVLQRLHRPRSAPPAKLVCLR
TWFADLLQPRAVLPPLLEQCRSLAEGLLRDEQEIRPLHGDLHHDNVLDFGPRGWLAIDPK
RLLGDRAFDYTTMFSNPDLCGPGIHVATRPERFAIRLEQVCALAELERTRLLRWIAASTA
LSAVWFRDDGDPADIDETVARMALEALAER
>WP_053505284.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGPAIRTPHARLWPVLTADGEPAMLKIAGETEEQNSHRLLRWWDGDG
AARLLAQEGPAILIERASGQSLRQRSIDGADDACTTILCQVLQRLHRPRSAPPADLVCLR
RWFADLLQPRAALPPLLEQCRSLAEGVLQEEQEIRPLHGDLHHDNVLDFGARGWLAIDPK
RLLGDRAFDYTTLFSNPDLCGPGIHVATRPERFAARLEQVSALAGLERTRLLRWIAASAA
LSAVWFRDDGDPADIDEAVARMALEALAER
>WP_049412369.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGPAIETPHARLWPVLTATGAPAMLKIADETEEQNSHRLLRWWDGDG
AARLLAHEGPAILIERASGQSLRQRSIDGADDACTTILCQVLQRLHRPRSAPPADLVCLR
RWFADLLQPRAALPPLLEQCRSLAEGVLQEEQEIRPLHGDLHHDNVLDFGARGWLAIDPK
RLLGDRAFDYTTMFSNPDLCGPGIHVATRPERFAARAEQVTALAGLERTRLLRWVAASAG
LSAVWFRDDGDPADVDESVARMALQALAEA
>WP_021201775.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGPAICTPHARLWPVLTAAGAPAMLKISSEAEEQNSHRLLRWWDGDG
AARLLAHEGPAILIERASGDSLRQRSIAGDDDACTTVLCQVLQRLHRPRSAPPAELVCLR
RWFADLLQPRAALPPLLEQCRSLAEGVLRDEQEIRPLHGDLHHDNVLDFGARGWLAIDPK
RLLGDRAFDYTTLFSNPDLCGPGIHVATRPERFAARVEQVTALAGLERTRLLRWVAASAG
LSAVWFRDDGDPAVVDESVARMALQALAEA
>WP_058980063.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGPAICTPHARLWPVLTAAGAPAMLKISSEREEQNSYRLLRWWDGDG
AARLLAHEGPAILIERAEGDSLRQRSIAGDDDACTTVLCQVLQRLHRPRSARPAELVCLR
RWFADLLQPRAALPPLLEQCRSLAEGVLRDEQEIQPLHGDLHHDNVLDFGARGWLAIDPK
RLLGDRAFDYTALFSNPDLCGPGIHIATRPERFAARLEQVTALAGLERTRLLRWIAASAG
LSAVWFRDDSDPAEVDEAVARMALEALAEA
>WP_014037144.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGPAIETPHARLWPVLTAAGTPAMLKISSETEEQNSHRLLRWWDGDG
AARLLAHAGPAILIERAGGDSLRQRSIEGDDEACTTILCQVLQRLHRPRSAPPAELVCLR
RWFVDLLEPRAALPPLLEQCRSLAEGLLQDEREIRPLHGDLHHDNVLDFGARGWLAIDPK
RLLGDRAFDYTTMFSNPDLCGPGIHVATRPERFAARLEQVSALAGLERTRLLRWIAASMA
LSAVWFRDDGDPADVDEAVARMALEALAEG
>WP_065184884.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGPAIETAHARLWPVLTAAGTPAMLKISSETEEQNSHRLLRWWDGDG
AARLLAHAGPAILIERAGGDSLRQRSIEGDDEACTTILCQVLQRLHRPRSAPPAELVCLR
TWFADLLQPRAALPPLLEQCRSLAEGLLQEEREVRPLHGDLHHDNVLDFGARGWLAIDPK
RLLGDRAFDYTTMFSNPDLCGPGIHVATRPERFAARLEQVSALAGLERTRLLRWIAASAG
LSAVWFRDDGDPADVDEAVARMALEALAES
>WP_049460784.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGPAIETAHARLWPVLTAAGTPAMLKISSEAEEQNSHRLLRWWDGDG
AARLLAHAGPAILIERAGGDSLRQRSIEGDDEACTTILCQVLQRLHRPRSAPPAELVWLR
TWFADLLQPRAALQPLLEQCRSLAEGLLQEEREVRPLHGDLHHDNVLDFGARGWLAIDPK
RLLGDRAFDYTTMFSNPDLCGPGIHVATRPERFAARLEQVSALAGLERTRLLRWIAASMA
LSAVWFRDDGDPAEVDEAVARMALEALAES
>WP_005416478.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGPAIETPHARLWPVLTAAGEPAMLKISSEAEEQNSHRLLCWWDGDG
AARLLAHAGPAILIERAGGDSLRQRSIEGDDEACTTILCQVLQRLHRPRSAPPAELVCLR
TWFADLLQPRAALPPLLEQCRSLAEGLLQEEREVRPLHGDLHHDNVLDFGARGWLAIDPK
RLLGDRAYDYTTMFSNPDLCGPGIHVATRPERFAARLEQVSALAGLERTRLLRWIAASMA
LSAVWFRDDGDPADVDEAVARMALEALAES
>WP_053496675.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGPAIETPHARLWPVLTAAGTPAMLKISSETEEQNSHRLLRWWDGDG
AARLLAHAGPAILIERAGGDSLRQRSIEGDDEACTTILCQVLQRLHRPRSAPPAELACLR
TWFADLLQPRAALPPLLEQCRSLAEVLLMEEREVRPLHGDLHHDNVLDFGRRGWLAIDPK
RLLGDRAFDYTTMFSNPDLCGPGIHVATRPERFAARLEQVSALAGLERTRLLRWIAASMA
LSAVWFRDDGDPADVDEAVARMALEALAEA
>CRX67081.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGPAIETPHARLWPVLTAAGEPAMLKISSEAEEQNSHRLLRWWDGDG
AARLLAHAGPAILIERAGGDSLRQRSIEGDDEACTTILCQVLQRLHRPRSAPPAELVCLR
TWFADLLQPRAALPPLLEQCRSLAEGLLRDEQEIRPLHGDLHHDNVLDFGARGWLAIDPK
RLLGDRAFDYTTLFSNPDLCGPGIHVATRPERFAARLEQVTALAGLERTRLLRWIAASAG
LSAVWFRDDGDPAEVDEAVARMALEALAAG
>WP_061478689.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGPAMETPHARLWPVLTAAGEPAMLKISSEAEEQNSHRLLRWWDGDG
AARLLAHAGPAILIERAGGDSLRQRSIEGDDEACTTILCQVLQRLHRPRSAPPAELVCLR
TWFADLLQPRAALPPLLEQCRSLAEALLMEEREVRPLHGDLHHDNVLDFGRRGWLAIDPK
RLLGDRAFDYTTLFSNPDLCGPGIHVATRPERFAARLEQVTALASLERTRLLRWIAASAG
LSAVWFRDDGDPADVDEAVARMALEALAAG
>WP_049445378.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGPAIETPHAQLWPVLTAAGEPAMLKVSSETEEQNSHRLLRWWDGDG
AARLLAHEGPAILIERAGGDSLRQRSIDGDDDACTTLLCQVLQRLHRPRSAPPDDLVCLR
RWFVDLLQPRAALPPLLEQCRSLAEGLLRDEREIRPLHGDLHHDNVLDFGARGWLAIDPK
RLLGDRAFDYTTMFSNPDLCGAGIHVATRPERFAARLEQVSALAGLERTRLLRWIAASTA
LSAVWFRDDGDPADVDEAVARMALEALAEG
>WP_049421949.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGAAIETPHAQLWPVLTAAGEPAMLKISSETEEQNSHRLLRWWDGDG
AARLLAHEGPAILIERAGGDSLRQRSIKGDDDTCTTVLCQVLQRLHRPRSAPPAELVCLR
TWFADLLQPRAALPTLLEQCRSLAEGLLQQEQEIRPLHGDLHHDNVLDFGARGWLAIDPK
RLLGDRAFDYTTMFSNPDLCGPGIHVATRPERFATRLEQVGALAGLERTRLLRWIAASAG
LSAVWFRDDGDPAEVDEAVARMALEALAEG
>WP_032127359.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGAAIETPHARLWPVLTATGKPAMLKISSETEEQNSHRLLRWWDGDG
AARLLAHEGPAILIERAGGDSLRQRSIKGDDDTCTTVLCQVLQRLHRPRSAPPAELVCLR
TWFADLLQPRAALQPLLEQCRSLAEGLLQQEQEIRPLHGDLHHDNVLDFGARGWLAIDPK
RLLGDRAFDYTTMFSNPDLCGPGIHVATRPERFATRLEQVGALAGLERTRLLRWIAANAG
LSAVWFRDDGDPAEVDEAVARMALEALAEG
>WP_054171716.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGAAIETPHAQLWPVLTTAGEPAMLKISSETEEQNSHRLLRWWEGDG
AARLLAHEGPAILIERAGGDSLRQRSIEGDDDACTTILCQVLQRLHRPRSAPPAELVCLR
RWFADLLQPRAALPPLLEQCRSLAEGLLQEEREIRPLHGDLHHDNVLDFGARGWLAIDPK
RLLGDRAFDYTTLFSNPDLCGPGIHVATQPERFAARLEQVSALAGLERTRLLRWIAASAG
LSAVWFRDDGDPAEVDETVARMALEALAEA
>WP_057502846.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGAAIETPHAQLWPVLTIAGEPAMLKISSETEEQNSHRLLRWWEGDG
AARLLAHEGPAILIERAGGDSLRQRSIKGDDDACTTILCQVLQRLHRPRSAPPAELVCLR
RWFADLLQPRAALPPLLEQCRSLAEGLLQEEREIRPLHGDLHHDNVLDFGTRGWLAIDPK
RLLGDRAFDYTTLFSNPDLCGPGIHVATQPERFAARLEQVSALAGLERTRLLRWIAASAG
LSAVWFRDDGAPAEVDEAVARMALEALAEG
>WP_049446763.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGAAIETPHAQLWPVLTAAGEPAMLKISSETEEQNSHRLLRWWEGDG
AARLLAHEGPAILIERAGGDSLRQRSIGGDDDACTTILCQVLQRLHRPRSAPPAELVCLR
RWFADLLQPRAVLPPLLEQCRSLAEALLQEEREIRPLHGDLHHDNVLDFGARGWLAIDPK
RLLGDRAFDYTTMFSNPDLCGPGIHVATRPERFAARLEQVSVLAGVERTRLLRWIAASAG
LSAVWFRDDGDPAEVDEAVARMALEALAEA
>WP_049399366.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGAAIETPHARLWPVLTAAGAPAMLKISSETEEQNSHRLLRWWDGDG
AARLLAHEGPAILIERAGGDSLRQRSIEGDDDTCTTVLCQVLQRLHRPRSAPPAELVCLR
TWFADLLQPRAPLPSLLEQCGLLAAALLQEEHEIRPLHGDLHHDNVLDFGARGWLAIDPK
RLLGDRAFDYTTMFSNPDLCGPGIHVATRPERFAARLEQVSALAGLERTRLLRWIAASMA
LSAAWFRDDGDPADVDEAVARMALEALAEG
>WP_032961884.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGAAIETPHAQLWPVLTADGEPAMLKVSSETEEQNGHRLLRWWDGDG
AARLLAHEGPAILIERAGGDSLRQRSIEGDDDACTTILCQVLRQLHRPRSAPPAELVCLR
TWFADLLQPRAALPPLLEQCRSLAERVLREEHEIRPLHGDLHHDNVLDFGTRGWLAIDPK
RLLGDRAFDYTTMFSNPDLCGPGIHVATRPERFAARLEQVSALAGLERARLLRWIAASTA
LSAVWFRDDGDPADVDETVARMALEALAEA
>KLO00119.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGAAIETPHAQLWPVLTADGEPAMLKVSSETEEQNGHRLLRWWDGDG
AARLLAHEGPAILIERADGDSLRQRSIEGDDDACTTILCQVLRQLHRPRSAPPAELVCLR
TWFADLLQPRAALPPLLEQCRSLAERVLREEHEIRPLHGDLHHDNVLDFGARGWLAIDPK
RLLGDRAFDYTTMFSNPDLCGPGIHVATRPERFAARLQQVSALAGLERTRLLRWIAASTA
LSAVWFRDDGDPADIDEAVARMALEALAEA
>WP_014647081.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGAAIETPHAQLWPVLTADGEPAMLKVSSETEEQNGHRLLRWWDGDG
AARLLAHEGPAILIERAGGDSLRQRSIEGDDDACTTILCQVLRQLHRPRSAPPAELVCLR
TWFADLLQPRAALPPLLEQCRSLAERVLQEEREIRPLHGDLHHDNVLDFGTRGWLAIDPK
RLLGDRAFDYTTMFSNPDLCGPGIHVATRPERFAARLQQVSALAGLERTRLLRWIAASAG
LSAVWFRGDGDPAEVDEAVARMALEALAEA
>WP_049457662.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGASIRTPHAQLWPVLTAAGEPAMLKVASETEEQNSHRLLRWWDGDG
AARLLAHEGPAILIERARGDALRQRSIDGDDDACTTILCQVLQRLHRPRSAPPAELACLR
TWFADLLQPRAVLPPLLEQCRSLAEGVLQDEQEIRPLHGDLHHDNVLDFGPRGWLAIDPK
RLLGDRAFDYTTLFSNPDLCGPGIHVATRPERFAARLEQVSTLAGLERGRLLRWIAASMG
LSAVWFRDDGDPADVDEAVARMALEALAEG
>WP_008265677.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGKAIETPRAQLWPVLTAAGEPAMLKVSSETEEQNSHRLLRWWDGDG
AARLLAHEGPAILIERARGDSLRQRSIDGDDDACTTILCQVLQRLHQPRSTPPAELVCLR
TWFADLLQPRAALPPLMEQCRSLAEELLQDEQEIRPLHGDLHHDNVMDFGPRGWLAIDPK
RLLGDRAFDYTTLFSNPDLCGPGIHVATRPERFAARLEQVSTLAGLERGRLLRWIAASMG
LSAVWFRDDGDPADVDEAVARMALEALAEG
>CCP11623.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGASIKTPHAQLWPVLTAAGAPAMLKVSSETEEQNSHRLLRWWDGDG
AAHLLAHEGPAILIERARGDSLRQRSIDGDDDACTTILCQVLRRLHRPRSTPPAELVCLS
TWFADLLQPRAALSPLLEQCRSLAEELLQDEQEIRPLHGDLHHDNVLDFGPRGWLAIDPK
RLLGDRAFDYTTLFSNPDLCGPGIHVATRPERFAARLEQVSTLAGLERRRLLRWIAASMG
LSAVWFRDDGDPADVDEAVARMALEALAAG
>WP_053449693.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGASIKTPHAQLWPVLTAAGEPAMLKVSSETEEQNSHRLLRWWDGDG
AARLLAHEGPAILIERACGDSLRQRSIDGNDDACTTILCQVLQQLHRPRSAPPAELVCLR
TWFADLLQPRAALPPLLEQCRSMAEELLQDEQEIRPLHGDLHHDNALDFGPRGWLAIDPK
RLLGDRAFDYTTLFSNPDLCGPGIHVATRPERFAVRLEQVSTLAGLERARLLRWIAASMG
LSAVWFRDDGDPADVDEAVARMALEELAEG
>WP_053511873.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGASIKTPHALLWPVLTAAGEPAMLKVSSETEEQNSHRLLRWWDGDG
AARLLAHDGPAILIERARGDSLRQRSIDGNDDACTTILCQVLQQLHRPRSAPPAELVCLR
TWFADLLQPRAALPPLLEQCRSMAEELLQDEQEIRPLHGDLHHDNVLDFGPRGWLAIDPK
RLLGDRAFDYTTLFSNPDLCGPGIHVATRPERFAARLEQVSTLAGLERARLLRWIAASVG
LSAVWFRDDGDLADVDGAVARMALEALAAG
>WP_012510997.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGAAIETPHAQLWPVLTIAGQPAMLKISSETEEQNSHRLLRWWDGDG
AARLLAHEGPAILIERAGGDSLRQRSIEGDDDTCTTILCQVLQRLHRPRSAPPAELVCLR
TWFADLLQPRAALPSLLEQCGSLAAALLQEEQEIRPLHGDLHHDNVLDFGARGWLAIDPK
RLIGDRAFDYTTLFSNPDLCGPDIHVATQPERFAARVEQVTALAGIERHRLLRWIAASAG
LSAVWFRDDGDTADIDDAVARMALEALAEG
>WP_049432229.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSLWRLRRDGEAIETPRAHLWPVLTAAGEPAMLKVSDEPEEQNAHRLLRWWAGDG
AAQLLAHEGPAILIERAGGDSLRQRSIQGDDDACTTILCEVLQRLHRPRSATPAELVCLR
TWFADLLQPRAALPPLLEQCRSLAEGLLQDEREIRPLHGDLHHDNVLDFGARGWLAIDPK
RLLGDRAFDYTTLFSNPDLCGPGIHVATRSERFAARLQQVSALAGLERTRLLRWIAASTG
LSAVWFRDDGDPADIDETVAQMALEALAEA
>WP_057496342.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSHWRLRRDGAAIETPHARLWPVLTAAGEPAMLKVSDEAEEQNAHRLLRWWDGDG
AARLLAHEGPAILIERAAGDSLRQRSINGEDDTCTTLLCQVLQRLHRPRSTAPSDLVRLR
TWFADLLQPRAALPPLLEQCRSLALTLLQDEQEIRPLHGDLHHDNVLDFGARGWLAIDPK
RLLGDRAFDYTTMFSNPDLCGPGIHVATRPERFAARLQQVSALAGIEPRRLLRWIAASAG
LSAVWFRDDGDPADIDEAVARMALEALAEG
>WP_053517941.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGPAIRTPHARLWPVLTADDLPAMLKISSETEEQNSHRLLRWWDGDG
AARLLAHEGPAILIERAGGQSLRERSIGGDDSTCTTILCQVLQRLHRPRSAPPAELVCLP
TWFADLLQPRGSLPPLLEQCRSLAVALLEAEQEVRPLHGDLHHDNVLDFGTRGWLAIDPK
RLIGDRAFDYTTLFSNPDLCGPGIHVATRPERFAARVTEVSALADLDRTRLLRWIAASAG
LSAVWFRNDGDPADIDETVAAMALEALAEG
>WP_025879128.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGPSIRTPHARLWPVLTASGEAAMLKVSTETEEQNGHRLLRWWNGDG
AARLLAHEGPAILIERAHGDSLRQRSIKGEDDACTMILCQVLQQLHRPRSAPPEDLVCLR
RWFADLLQPRAPLPPLLEQCRSLAMALLEDEQEIRPLHGDLHHDNVLDFGARGWLAIDPK
RLLGDRAFDYTTMFSNPDLCGPGIHVATRPERFHARVEQVCRLADLERTRLLRWIAASAG
LSAVWFRDDGDPADIDEAVAVMALQALAEA
>WP_049467360.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGPSIRTPHARLWPALTASGEAVMLKVSTETEEQNGHRLLRWWNGDG
AARLLAHEGPAILIERAHGDSLRLRSIKGDDDACTVILCQVLQQLHRPRSAPPEDLVCLR
RWFADLLQPRAPLPPLLEQCRSLAMALLEDEQEIRPLHGDLHHDNVLDFGARGWLAIDPK
RLLGDRAFDYTTMFSNPDLCGPGIHVATRPERFHARVEQVCRLADLERARLLRWIAASAG
LSAVWFRDDGDPADIDEAVAVMALQALAEA
>WP_065198619.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGDAVQTPHARLWPVLTAAGEAAMLKVSSEPEEQHSHRLLRWWDGDG
AARLLAHEGPAILIERAHGDSLRRHAIAGADDACTTILCQVLQRLHRPRRDPPSDLVRLH
TWFADLLLPRAPLPPLLEQCRSLAGTLLQEEHEIRPLHGDLHHDNVLDFGARGWLAIDPK
RLLGDRVFDYTTLFSNPDLCGPGIHVATRPERFAARVEQVTSLAGIERTRLLRWVAASAG
LSAVWFRDDGDPADVDESVARMALQALAEA
>AAB24284.1|FEATURES|NCBI|aminoglycoside|aac(6')-Ib4|antibiotic inactivation|1
VTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAML
NGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRALVELLFN
DPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSDA
>ACH43055.1|FEATURES|NCBI|aminoglycoside|aac(6')-IIa|antibiotic inactivation|1
VTQRLMVKRDLVMLHEWLNRPHIVEWWGGEEARPTLQEVQSHYLPRVLAEEAVTPYIAML
GSEPIGYAQSYVALGSGDGWWEDETDPGVRGIDQSLANPEQLGKGLGTRLVCTLVKTLFN
DPSVTKIQTDPAPNNVRAIRCYEKAGFRQQKVITTPDGPAVYMVQTRASFEAARGAA
>WP_011245129.1|FEATURES|NCBI|beta_lactam|blaI|antibiotic inactivation|0
NQTPSISEAEWEVMKVLWKKGPQTANQVISAIQEQTDWKPKTIRTLLDRLTKKKVVGVDK
EQKIYVFFPLYSEEECKHAEAQSFVKRVYGGTVKPLLVQFLEEESLTKEELDELYAILEQ
K
>WP_035346186.1|FEATURES|NCBI|beta_lactam|blaI|antibiotic inactivation|0
NRLPSISEAEWEIMKVLWKNGSQTAHQVIQAIQKQTDWKPKTIRTLLDRLMKKQVVGVNK
EQKVYIFFPLYSEDECKRAETQSFIKRIYGGTFKPMLVQFIEEESLTKEELDELRSILER
K
>WP_047971837.1|FEATURES|NCBI|beta_lactam|blaI|antibiotic inactivation|0
KEMPSITEAEWEVMKVLWKESPLPANKVCTAIQAHEDWNPKTIRTLLDRLTKKKVVAVNK
EQRVYTFTPLYSEHECQRAETQSFIDRIYGGTTKSLLVQFIEDETLSKEELKELREILDK
K
>WP_059103198.1|FEATURES|NCBI|beta_lactam|blaI|antibiotic inactivation|0
RKVPSISQSEWEVMKMLWGNAPQTANEVIASIREQTDWSPKTIRTLLDRLTKKEVIDVNK
EKKVYTFFPLYSEDECQRAETQSLIKKIHGGTMKSMLIQFIEEDSFSEEEIQELRSILDK
K
>WP_019380241.1|FEATURES|NCBI|beta_lactam|blaI|antibiotic inactivation|0
DRIPSISESEWEVMTVLWHGAPKTANEVILSLQESTDWKPKTIRTLLDRLVHKNVVGVNK
NQRIYTFFPLYSQDECQRAEAQSFIKRIYGGTVKSMLVQFIQEDSLSDEEINELQTILAK
K
>WP_062197191.1|FEATURES|NCBI|beta_lactam|blaI|antibiotic inactivation|0
KEIPNISESEWEVMKVLWKRAPQTANDVISSLQEQTDWKPKTIRTLLDRLVHKKVIGVNK
NQRVYTFFPLYSQDECQRAEAQSFIKRIYGGALKSMLVQFVQEDSLSETEIRELRSILNE
R
>WP_010283772.1|FEATURES|NCBI|beta_lactam|blaI|antibiotic inactivation|0
KEIPNISESEWEVMNVLWENAPLTANDVISSLQEKTDWKPKTVRTLLDRLVQKNVIGVNK
NQRVYTFFPLYSQDECQRAEAQSFIKRIYGGALKSMLVQFVQEDSLSEEDISELRSILDE
K
>WP_025784473.1|FEATURES|NCBI|beta_lactam|blaI|antibiotic inactivation|0
KNIPSISESEWEIMNVLWDKAPQTANDIILSLQESTDWKPKTIRTLLDRLVQKDVVGVNK
DLRIYTFYPLYTQEKCQRAETESFIKRIYGGTLKSMLVQFIQEDTLSEDDINELRFILNK
K
>WP_060669155.1|FEATURES|NCBI|beta_lactam|blaI|antibiotic inactivation|0
KEIPNISESEWEIMHVLWEKSPRTASEVISSMQEKTDWKPKTIRTLLDRLTKKKAVGVNK
DQRVYTFYPLYSQEECQRAEARSFVDRIYGGTLKSMLVQFIQEESLSEDDIKELRSILDK
K
>WP_014369847.1|FEATURES|NCBI|beta_lactam|blaI|antibiotic inactivation|0
GQVPSISEAEWEVMNVLWERAPQTANEVIACLQERTDWKPKTTRTLLDRLVKKEVVGVDQ
NQKVYTFYPLYSQSECQLAEAQSFLKRIYGGTLKSMLVQFIEEQPMSEEEMKELHTILQE
K
>WP_040739251.1|FEATURES|NCBI|beta_lactam|blaI|antibiotic inactivation|0
EQVPKISEAEWEVMNVLWERSPLTASEVIQALQEKTDWKPKTIRTLLDRLVKKEVVGVNQ
NQKVYTFTPLYSQSECQRAEAKSFLNRIYGGTMKSMLVHFFEEESLTEEEIKELRNMLNE
K
>WP_040387795.1|FEATURES|NCBI|beta_lactam|blaI|antibiotic inactivation|0
KKVPNISEAEWEVMNVLWDRAPQTANEVIHSLQERTEWKPKTVRTLLDRLVQKKVVGVNR
NQKVYTFFPLYSQKECQHAEAQSFLKRIYGGTLKSMLIQFIQEDSLTEEDIKELRSILNE
K
>WP_042531371.1|FEATURES|NCBI|beta_lactam|blaI|antibiotic inactivation|0
EKVPSISEAEWEVMNVLWEKSPQTANDVITSLQGQKDWKAKTVRTLLDRLVQKGVAGVNK
EQRVYTFYPLYSQDECQRAEAESFIKRIYGGTVKSMLVQFIEEDSLSEEEIEELKSILDE
K
>WP_010529130.1|FEATURES|NCBI|beta_lactam|blaI|antibiotic inactivation|0
NKIPTISESEWEVLKVLWEKAPQTANDIISSLQAQTNWKPKTVRTLLDRLTKKEVVGVHK
NQRVYTFYPFYSQDECQRAKTDSFVKRFYDGTLKSMLVQFIQDEDLSEEDIKELRSILDK
K
>WP_026287266.1|FEATURES|NCBI|beta_lactam|blaI|antibiotic inactivation|0
NKIPTISESEWEVLKVLWQKAPQTANEIISSLPAETNWKPKTVRTLLDRLSKKEVIGVNK
DQRVYTFYPLYSQNECQRAKTESFVKRFYDGTLKSMLVQFMQDEDLSEDDIKELRAILDN
K
>WP_026568830.1|FEATURES|NCBI|beta_lactam|blaI|antibiotic inactivation|0
NEIPSISESEWEVLKVLWHKAPQTANDIISSLPAQTTWKPKTVRTLLDRLTKKQVIGVNK
DQRVYTFYPLYSQNECQRAKTASFVKRFYDGTFKSMIVQFMEDEELSDEDIKELQSILES
K
>WP_047911872.1|FEATURES|NCBI|beta_lactam|blaI|antibiotic inactivation|0
KQVPKISESEWEVMTVLWERAPRTAGEVIDALQQRTDWKPKTIRTLLDRLVKKQAVSINQ
DTKVYTFAPLFSQYECQQAETQSFVKRIYGGTMKSMLVHFFEDNAVSDEEIKELRSLLNE
K
>WP_035396666.1|FEATURES|NCBI|beta_lactam|blaI|antibiotic inactivation|0
KNMPSISDAEWEVMKVLWKNPPKSASQVVTELKALVDWKPKTIRTHLDRLTKKEIIKVNR
DERLYTFTPLFSEDECKRAETNSFIKRVHDGTTKSMMLQFIEDETLTKEDLQELRSLLDE
K
>WP_064206686.1|FEATURES|NCBI|qa_compound|Qac|antibiotic efflux|1
MPYLYLVISIITEIIGTSFLKTAEGFTKLWPTLGTLISFGICFYFLSVTMKYLPLNVSYA
TWAGLGLVLTTIVSVVIFKESVNLISIFSIILIIIGVVLLNVFGSSH
>WP_064127842.1|FEATURES|NCBI|qa_compound|Qac|antibiotic efflux|1
MPYLYLAIAIITEIIGTSFLKSAEGFTKLWPTLGTLISFGICFYFLSVTMKYLPLNISYA
TWAGLGLVLTTIVSVVIFKESVNLISIFSIILIIIGVVLLNVFGSSH
>ADE08372.2|FEATURES|NCBI|tetracycline|tet(45)|antibiotic efflux|1
ILLWLCVLSFFSVLNEMVLNVSLPDIASDFNKEPASINWVNSSFILTFSIGTAVYGKLSD
QLGIKKLLLFGIIVNCFGSVIGFVGHFFFPVLILARFIQGVGAAAFPALVMVVIARYIPK
ENRGKAFGIIGSIVTMGEGVGPSVGGVIAEYAHWSYILLLPVVTIITVPFLAKLLKQEEV
IKGSFDTKGIIFMSVGIVFFIMFTTCYRVSFLVVSIICFLIFVKNIRKVSNPFINPSLGK
NVSFMIGIICGGLIFGTVAGFISMVPYMMKDVYQLSTAAIGSGIIFPGAMSVIVFGYIGG
LLVDKKGSLFVLTTGVAFLSISFLVAALFIETTPWLITIILIFVFGGLSFTKTVISTIVS
SSLEQKEAGAGMSLLNFTSFLSEGTGIAIVGGLLSIHLLNRKLLPINAEPSTHLYSNLLL
LFAGITIISWLVTIKMHKRSRGNI
>AAB28795.1|FEATURES|NCBI|tetracycline|tet(K)|antibiotic efflux|1
VLFWLCILSFFSVLNEMVLNVSLPDIANHFNTTPGITNWVNTAYMLTFSIGTAVYGKLSD
YINIKKLLIIGISLSCLGSLIAFIGHNHFFILIFGRLVQGVGSAAFPSLIMVVVARNITR
KKQGKAFGFIGSIVALGEGLGPSIGGIIAHYIHWSYLLILPMITIVTIPFLIKVMVPGKS
TKNTLDIVGIVLMSISIICFMLFTTNYNWTFLILFTIFFVIFIKHISRVSNPFINPKLGK
NIPFMLGLFSGGLIFSIVAGFISMVPYMMKTIYHVNVATIGNSVIFPGTMSVIVFGYFGG
FLVDRKGSLFVFILGSLSISISFLTIAFFVEFSMWLTTFMFIFVMGGLSFTKTVISKIVS
SSLSEEEVASGMSLLNFTSFLSEGTGIAIVGGLLSLQLINRKLVLEFINYSSGVYSNILV
AMAILIILCCLLTIIVFKRSEKQF
>WP_063855882.1|FEATURES|NCBI|tetracycline|tet42|antibiotic efflux|1
MLIVLTMLTVIGMTVVLPVLPFVVLQYVSHESDLAIWVGVLEAINGLCAFLVAPFLGRLS
DRFGRRPVIIVAAFGAAFSMALFGFGGALWVLVLARVIQGLTAGDLPALFAYLADITPPE
QRAKRFGLLGALSGIGTMIGPAIGGLLAAISIQLPVFLTAAVALTIAILSIFLLPESLKP
GNRITAIKLRDVQPFAVFKEAFGRKELRGLMIGFGLLALPFGFFVNNFSVLALDSIQWGP
TQIGLLTAAVGIIDILIQGVLLGILLPRIGERGVIVSGIVAQMIGLAALAVVASVFAQPW
VFIVGALMLAAGQGASQAAMDGAMSNAVGDDEQGWLGGATQSLNAAMGTAAPLIAGALYA
LVSHAAPYWLGVALMIVAVTVVSRAHIANTAKRPAGETTGDAPAALVETAG
>WP_017201638.1|FEATURES|NCBI|tetracycline|tet42|antibiotic efflux|1
MLIVLTMLTVIGMTVVLPVLPFVVLQYVSHESDLAIWVGVLEAVNGLCAFLAAPFLGRLS
DRFGRRPVIIVAAFGAALSMALFGVGGALWILVLARVIQGLTAGDLPALFAYLADITPPE
KRAQRFGLLGALSGIGTMIGPALGGLLAAVSIQLPVFLTAAVALTIAILSIFLLPESLKP
GNRISTITLRDVQPFAVFKEAFGRRELRGLMIGFGLLALPFGFFVNNFSVLALDSIQWGP
TQIGLLTAAVGIIDILIQGVLLGILLPRIGERGVIVSGIVAQLIGLAALAVVASFFAQPW
VFIVGALMLAAGQGASQAAMDGAMSNAVGDDEQGWLGGATQSLNAAMGTAAPLIAGALYA
LVSHAAPYWLGVALMVVAVIVVSRAHIANTAKRPAGETTGDAPAALVETAG
>WP_028502503.1|FEATURES|NCBI|tetracycline|tet42|antibiotic efflux|1
MLIVLTMLTVIGMTVVLPVLPFVVLQYVSHESDLAIWVGVLEAINGLCAFLVAPFLGRLS
DRFGRRPVIIVAAFGAAFSMALFGFGGAIWVLVLARVIQGLTAGDLPALFAYLADITPPE
QRAKRFGLLGALSGIGTMIGPAIGGLLAAVSIQLPVFLTAAVALTIAILSIFLLPESLKP
GNRIATIKLRDVQPFAVFKDAFGRKELRGLMIGFGLLALPFGFFVNNFSVLALDSIQWGP
TQIGLLTAAVGIIDIVIQGVLLGILLPRIGERGVIVSGIIAQMIGLAALAIVASVFAQPW
VFIVGALMLAAGQGASQAAMDGAMSNAVGDDEQGWLGGATQSLNAAMGTAAPLIAGALYA
LVSHAAPYWLGVALMIVAAIVVSRAHIADTAKRPTGDTTGETPAELAETVG
>WP_055874188.1|FEATURES|NCBI|tetracycline|tet42|antibiotic efflux|1
MLIVLTMLTVIGMTVVLPVLPFVVLQYVSHESDLAIWVGVLEAVNGLCAFLAAPFLGRLS
DRFGRRPVIIVAAFGAAFSMALFGFGGAIWVLVLARVIQGLTAGDLPALFAYLADITPPE
QRAKRFGLLGALSGIGTMIGPAIGGLLAAVSIQLPVFLTAAVALTIAILSIFLLPESLKP
GNRIATIKLRDVQPFAVFKEAFGRKELRGLMIGFGLIALPFGFFVNNFSVLALDSIQWGP
TQIGLLTAAVGVVDILIQGVLLGILLPRIGERGVIVSGIVAQMFGLAALAIVASIFAQPW
VFIVGALMLAAGQGASQAAMDGAMSNAVGDDEQGWLGGATQSLNAAMGTAAPLIAGALYA
LVSHAAPYWLGVALMIVAVIVVSRAHIANSAKRPEGPVVHGISTEVAETVV
>EQM73317.1|FEATURES|NCBI|tetracycline|tet42|antibiotic efflux|1
MLIVLTMLTVIGMTVVLPVLPFVVLQYVSHESDLAIWVGVLEAVNGLCAFLVAPFLGRLS
DRFGRRPVIIVAAFGAAFSMALFGIGGAIWVLVLARMIQGLTAGDLPALFAYLADITPPE
QRAKRFGLLGALTGIGTMVGPGIGGLLAAVSIQLPVFLTSAVALTIAILSIFLLPESLKP
GNRISAIRLRDVQPFAVFKEAFGRKELRGLMIGFGLLALPFGFFVNNFSVLALDSIQWGP
TQIGLLTAAVGIIDILIQGVLLGILLPRIGERGVIISGIVAQMVGLAALAIVASIFAQPW
VFIVGALMLAAGQGASQAAMDGAMSNAVGDDEQGWLGGATQSLNAAMGTAAPLIAGALYA
LVSHAAPYWLGVALMIVAVIVVSRAHIANTAKRPVTDGVGAPPVEAVETVG
>WP_024448191.1|FEATURES|NCBI|tetracycline|tetV|antibiotic efflux|1
VLAPFRFREYRLLIAAVSVSIFAEGMWAVVMALQVIELSNDPAALSLVATCLGVGLVAFV
LVGGLAADRLNQRAIIIAVEAVNTAVVAGIAVLGMVGALQIWHMAVAAAALGIAAAFFFP
AYSAILPRILPAEQLLAANGVEGMVRPVFQRAVGPAVAGLLIGATFPSLGAVAVAALFGV
GLILLVATRSSIVKNVDPQADQENPHLLRDLRDGVSFVRRTPWLLWTLLFASIFVLVVLG
PIEVLLPFIAQDRFTHGAQSYGFILAFFGVGSALGALTVSSRRMPRRYLTTMMAMWGVGS
IPLVIVGITSSFPLMALATFVIGVTDGAGMVIWGTLLQRRVPPEMLGRVSSLDFFVSLAF
MPVSFAIVGPLSKIVPMETIFLAAGIVPVLVAVVAIRAAKMHRDELTHPL
>WP_064280346.1|FEATURES|NCBI|tetracycline|tetV|antibiotic efflux|1
VLAPFRIREYRLLITAVSLSIFAEGMWAVVMALQVIELSNDPAALSLVAACLGAGLVAFV
LVGGLAADRLNQRAIIIAVEAVNTAVVAVIAVLGIVGALRIWHMAVGAAALGIAAAFFFP
AYSAILPRILPAEQLLAANGIEGMVRPVFQRAVGPAVAGLLIGATYPSLGAVTVAMLFGV
GLILLVATRPAMVKDVDPQPDQPRPHLLRDLRDGFSFVRRTPWLLWTLLFASIFVLVILG
PIEVLLPFIAQDRFTHGAQSYGFILAFFGVGSALGALTVSSRRMPRRYLTTMMAMWGAGS
IPLIVVGMTSSFPLMALATFVIGVTDGAAMVIWGTLLQRRVPPEMLGRVSSLDFFVSLAF
MPVSFAIVGPLSKVVAMETIFLAAGIVPVLLAAVAIWAAKMHRDELAHPL
>AEM62948.1|FEATURES|NCBI|tetracycline|tetL|antibiotic efflux|1
MNTPHSHSNLRHNQILLWLCVLSFFSVLNEMVLNVSLPDIASDFNKEPASINWVNSSFIL
TFSIGTAVYGKLSDQLGIKKLLLFGIIVNCFGSVIGFVGHFFFPVLILARFIQGVGAAAF
PALVMVVIARYIPKENRGKAFGIIGSIVTMGEGVGPSVGGVIAEYAHWSYILLLPVVTII
TVPFLAKLLKQEEVIKGSFDTKGIIFMSVGIVFFIMFTTCYRVSFLVVSIICFLIFVKNI
RKVSNPFINPSLGKNVSFMIGIICGGLIFGTVAGFISMVPYMMKDVYQLSTAAIGSGIIF
PGAMSVIVFGYIGGLLVDKKGSLFVLTTGVAFLSISFLVAALFIETTPWLITIILIFVFG
GLSFTKTVISTIVSSSLEQKEAGAGMSLLNFTSFLSEGTGIAIVGGLLSIHLLNRKLLPI
NAEPSTHLYSNLLLLFAGITIISWLVTIKMHKRSRGNI
>AAA98167.1|FEATURES|NCBI|tetracycline|tet(L)|antibiotic efflux|1
MNTSYSQSNLRHNQILIWLCILSFFSVLNEMVLNVSLPDIANDFNKPPASTNWVNTAFML
TFSIGTAVYGKLSDQLGIKRLLLFGIIINCFGSVIGFVGHSFFSLLIMARFIQGAGAAAF
PALVMVVVARYIPKENRGKAFGLIGSIVAMGEGVGPAIGGMIAHYIHWSYLLLIPMITII
TVPFLMKLLKKEVRIKGHFDIKGIILMSVGIVFFMLFTTSYSISFLIVSVLSFLIFVKHI
RKVTDPFVDPGLGKNIPFMIGVLCGGIIFGTVAGFVSMVPYMMKDVHQLSTAEIGSVIIF
PGTMSVIIFGYIGGILVDRRGPLYVLNIGVTFLSVSFLTASFLLETTSWFMTIIIVFVLG
GLSFTKTVISTIVSSSLKQQEAGAGMSLLNFTSFLSEGTGIAIVGGLLSIPLLDQRLLPM
EVDQSTYLYSNLLLLFSGIIVISWLVTLNVYKHSQRD
>CAA30827.1|FEATURES|NCBI|tetracycline|tet(L)|antibiotic efflux|1
MNTSYSQSTLRHNQVLIWLCVLSFFSVLNEMVLNVSLPDIANEFNKLPASANWVNTAFML
TFSIGTALYGKLSDQLGIKNLLLFGIMVNGLGSIIGFVGHSFFPILILARFIQGIGAAAF
PALVMVVVARYIPKENRGKAFGLIGSLVAMGEGVGPAIGGMVAHYIHWSYLLLIPTATII
TVPFLIKLLKKEERIRGHIDMAGIILMSAGIVFFMLFTTSYRFSFLIISILAFFIFVQHI
RKAQDPFVDPELGKNVFFVIGTLCGGLIFGTVAGFVSMVPYMMKDVHHLSTAAIGSGIIF
PGTMSVIIFGYIGGLLVDRKGSLYVLTIGSALLSSGFLIAAFFIDAAPWIMTIIVIFVFG
GLSFTKTVISTVVSSSLKEKEAGAGMSLLNFTSFLSEGTGIAIVGGLLSIGFLDHRLLPI
DVDHSTYLYSNMLILFAGIIVICWLVILNVYKRSRRH
>AAL75558.1|FEATURES|NCBI|tetracycline|tetD|antibiotic efflux|1
MNKPAVIALVITLLDAMGIGLIMPVLPSLLREYLPEADVANHYGILLALYAVMQVCFAPL
LGRWSDKLGRRPVLLLSLAGAAFDYTLLALSNVLWMLYLGRIISGITGATGAVAASVVAD
STAVSERTAWFGRLGAAFGAGLIAGPAIGGLAGDISPHLPFVIAAILNACTFLMVFFIFK
PAVQTEEKPAEQKQESAGISFITLLKPLALLLFVFFTAQLIGQIPATVWVLFTESRFAWD
SAAVGFSLAGLGAMHALFQAVVAGALAKRLSEKTIIFAGFIADATAFLLMSAITSGWMVY
PVLILLAGGGIALPALQGIISAGASAANQGKLQGVLVSLTNLTGVAGPLLFAFIFSQTQH
SADGTVWLIGTALYGLLLAICLLIRKPAPVAATC
>WP_054424918.1|FEATURES|NCBI|tetracycline|tetD|antibiotic efflux|1
MNKPAVIALVITLLDAMGIGLIMPVLPSLLREYLPEADVANHYGILLALYAVMQVCFAPL
LGRWSDKLGRRPVLLLSLAGAALDYTLLALSGVLWMLYLGRIISGITGATGAVAASVVAD
STAVSERTAWFGRLGAAFGAGLIAGPAVGGLAGDISPHLPFVIAAILNACTFLMVFFLFK
PAVQAEEKPAEQKAESAGISFVTLLKPLALLLFVFFTAQLIGQIPATVWVLFTESRFAWD
SAAVGFSLAGLGAMHVLFQAVVAGILAKRLSEKTIIFAGFIADATAFLLMSAITSGWMVY
PVLILLAGGGIALPALQGIISAGASAANQGKLQGVLVSLTNLTGVTGPLLFAFIFSQTQQ
SADGTVWLIGTALYGLLLAICLLIRKPAPVAAAC
>WP_025154280.1|FEATURES|NCBI|tetracycline|tetD|antibiotic efflux|1
MNKPAVIALVITLLDAMGIGLIMPVLPSLLREYLPEADVANHYGILLALYAVMQVCFAPL
LGRWSDKLGRRPVLLLSLAGAAFDYTLLALSGVLWMLYLGRIISGITGATGAVAASVVAD
STAVSERTAWFGRLGAAFGAGLIAGPAVGGLAGDISPHLPFVIAAMLNACTFLMVFFLFK
PAVQADEKPAEQKAESAGIRFITLLKPLALLLFVFFTAQLIGQIPATVWVLFTESRFAWD
SAAVGFSLAGLGAMHALFQAVVAGALATRLSEKTIIFAGFIADATAFLLMSAITSGWMAY
PVLILLAGGGIALPALQGIISAGASAANQGKLQGVLVSLTNLTGVAGPLLFAFIFSQTQQ
SADGTVWLIGTALYGLLLAICLLIRKPAQVAVTC
>BAA78835.1|FEATURES|NCBI|tetracycline|tet(B)|antibiotic efflux|1
MNSSTKIALVITLLDAMGIGLIMPVLPTLLREFIASEDIANHFGVLLALYALMQVIFAPW
LGKMSDRFGRRPVLLLSLIGASLDYLLLAFSSALWMLYLGRLLSGITGATGAVAASVIAD
TTSASQRVKWFGWLGASFGLGLIAGPIIGGFAGEISPHSPFFIAALLNIVTFLVVMFWFR
ETKNTRDNTDTEVGVETQSNSVYITLFKTMPILLIIYFSAQLIGQIPATVWVLFTENRFG
WNSMMVGFSLAGLGLLHSVFQAFVAGRIATKWGEKTAVLLGFIADSSAFAFLAFISEGWL
VFPVLILLAGGGIALPALQGVMSIQTKSHQQGALQGLLVSLTNATGVIGPLLFAVIYNHS
LPIWDGWIWIIGLAFYCIIILLSMTFMLTPQAQGSKQETS
>WP_000804063.1|FEATURES|NCBI|tetracycline|tet(A)|antibiotic efflux|1
KPNRPLIVILSTVALDAVGIGLIMPVLPGLLRDLVHSNDVTAHYGILLALYALMQFACAP
VLGALSDRFGRRPVLLVSLAGAAVDYAIMATAPFLWVLYIGRIVAGITGATGAVAGAYIA
DITDGDERARHFGFMSACFGFGMVAGPVLGGLMGGFSPHAPFFAAAALNGLNFLTGCFLL
PESHKGERRPLRREALNPLASFRWARGMTVVAALMAVFFIMQLVGQVPAALWVIFGEDRF
HWDATTIGISLAAFGILHSLAQAMITGPVAARLGERRALMLGMIADGTGYILLAFATRGW
MAFPIMVLLASGGIGMPALQAMLSRQVDEERQGQLQGSLAALTSLTSIVGPLLFTAIYAA
SITTWNGWAWIAGAALYLLCLPALRRGLWRNSSN
>CAA53389.1|FEATURES|NCBI|tetracycline|tet(A)|antibiotic efflux|1
KPNIPLIVILSTVALDAVGIGLIMPVLPGLLRDLVHSNDVTAHYGILLALYALVQFACAP
VLGALSDRFGRRPILLVSLAGATVDYAIMATAPFLWVLYIGRIVAGITGATGAVAGAYIA
DITDGDERARHFGFMSACFGFGMVAGPVLGGLMGGFSPHAPFFAAAALNGLNFLTGCFLL
PESHKGERRPLRREALNPLASFRWARGMTVVAALMAVFFIMQLVGQVPAALWVIFGEDRF
HWDATTIGISLAAFGILHSLAQAMITGPVAARLGERRALMLGMIADGTGYILLAFATRGW
MAFPIMVLLASGGIGMPALQAMLSRQVDEERQGQLQGSLAALTSLTSIVGPLLFTAIYAA
SITTWNGWAWIAGAALYLLCLPALRRGLWSGAGQ
>WP_060557577.1|FEATURES|NCBI|tetracycline|tetJ|antibiotic efflux|1
MNKSIIIILLVTVLDAIGIGLIMPVLPTLLNEFVSENRLANHYGILLALYATMQVIFAPI
LGKLSDKYGRKPILLFSLLGAALDYLLMACSTSLWMLYIGRIIAGITGATGAVCASAMTD
VTHPHERTRYFGFLGGAFGVGLIIGPMLGGLLGEISAHTPFIFAAISHSLLFIFSLLCFQ
ETQTTKISTEISALNQDTAPHSATVFIKKSLYFWLIAYFIIQLIGQIPATIWVLFTQVRF
AWHTTEVGLSLAFLGVLHIFFQAVLAGKLAQKWGERNTVIISMSIDAFGCLLLAWISHVW
VMLPALICLAAGGMGQPALQGYLSKSVDHHVQGQLQGTLVSLTNITGIVGPLLFSFIYSY
SVEYWDGLLWFIGAMLYCGLLVASYFKQKSPILKKFPL
>WP_046334921.1|FEATURES|NCBI|tetracycline|tetJ|antibiotic efflux|1
MNKSIIIILLVTVLDAIGIGLIMPVLPTLLNEFVSENRLANHYGILLALYATMQVIFAPI
LGKLSDKYGRKPILLFSLLGAALDYLLMACSTSLWMLYIGRIIAGITGATGAVCASAMTD
VTHPHERTRYFGFLGGAFGVGLIIGPMLGGLLGEISAHTPFIFAAISHSLLFIFSLLCFQ
ETQTTKISTEISVLNQNTAPHSATDFIKKSLFFWLIAYFIIQLIGQIPATIWVLFTQVRF
AWHTTEVGLSLAFLGVLHIFFQAVLAGKLAQKWGERNTVIISMSIDAFGCLLLAWISHVW
VMLPALICLAAGGMGQPALQGYLSKSVDHHVQGQLQGTLVSLTNITGIVGPLLFSFIYSY
SVEYWDGLLWFIGAMLYSGLLVASYFKQKSPILKKFPS
>WP_060555694.1|FEATURES|NCBI|tetracycline|tetJ|antibiotic efflux|1
MNKSIIIILLVTVLDAIGIGLIMPVLPTLLNEFVSENRLANHYGILLALYATMQVIFAPI
LGKLSDKYGRKPILLFSLLGAALDYLLMACSTSLWMLYIGRIIAGITGATGAVCASAMTD
VTHPHERTRYFGFLGGAFGVGLIIGPMLGGLLGEISAHTPFIFAAISHSLLFIFSLLCFQ
ETQTTKISTEISALNQETAPHSATGFIKKSLFFWLIAYFIIQLIGQIPATIWVLFTQVRF
AWHTTEVGLSLAFLGILHIFFQAVLAGKLAQKWGERNTVIISMSIDAFGCLLLAWISHVW
VMLPALICLAAGGMGQPALQGYLSKSVDHHVQGQLQGTLVSLTNITGIVGPLLFSFIYSY
SVEYWDGLLWFIGAMLYSGLLVASYFKQKSPILKKFPS
>WP_063108606.1|FEATURES|NCBI|tetracycline|tetJ|antibiotic efflux|1
MNKSIIIILLVTVLDAIGIGLIMPVLPTLLNEFVSENRLANHYGILLALYATMQVIFAPI
LGKLSDKYGRKPILLFSLLGAALDYLLMACSTSLWMLYIGRIIAGITGATGAVCASAMTD
VTHPHERTRYFGFLSGAFGVGLIIGPMLGGLLGEISAHTPFIFAAISHSLLFIFSLLCFQ
ETQTTKISTEISALNQDTAPHSTTGFIKKSLCFWLIAYFIIQLIGQIPATIWVLFTQVRF
AWHTTEVGLSLAFLGVLHIFFQAVLAGKLAQKWGERNTVIISMSIDAFGCLLLAWISHVW
VMLPALICLAAGGMGQPALQGYLSKSVDHHVQGQLQGTLVSLTNITGIVGPLLFSFIYSY
SVEYWDGLLWFIGAMLYSGLLVASYFKQKSPILKKFPS
>WP_049196983.1|FEATURES|NCBI|tetracycline|tetJ|antibiotic efflux|1
MNKSIIIILLVTVLDAIGIGLIMPVLPTLLNEFVSENRLANHYGILLALYATMQVIFAPI
LGKLSDKYGRKPILLFSLLGAALDYLLMACSTSLWMLYIGRIIAGITGATGAVCASAMTD
VTHPHERTRYFGFLGGAFGVGLIIGPMLGGLLGEISAHTPFIFAAISHSLLFIFSLLCFQ
ETQTTKISTEISVLNQDTAPHSATGFIKKSLCFWLIAYFIIQLIGQIPATIWVLFTQVRF
AWHTTEVGLSLAFLGVLHIFFQAVLAGKLAQKWGERNTVIISMSIDAFGCLLLAWISHVW
VMLPALICLAAGGMGQPALQGYLSKSVDHHVQGQLQGTLVSLTNITGIVGPLLFSFIYSY
SVEYWDGLLWFIGAMLYSGLLVASYFKQKSPILKKFTS
>WP_062814523.1|FEATURES|NCBI|tetracycline|tetJ|antibiotic efflux|1
MNKSIIIILLVTVLDAIGIGLIMPVLPTLLNEFVSENRLANHYGILLALYATMQVIFAPI
LGKLSDKYGRKPILLFSLLGAALDYLLMACSTSLWMLYIGRIIAGITGATGAVCASAMTD
VTHPHERTRYFGFLGGAFGVGLIIGPMLGGLLGEISAHTPFIFAAISHSLLFIFSLLCFQ
ETQTTKISTEISALNQDTTPHSATGFIKKSLCFWLIAYFIIQLIGQIPATIWVLFTQVRF
AWHTTEVGLSLAFLGVLHIFFQAVLAGKLAQKWGERNTVIISMSIDAFGCLLLAWISHVW
VMLPALICLAAGGMGQPALQGYLSKSVDHHVQGQLQGTLVSLTNITGIVGPLLFSFIYSY
SVEYWDGLLWFIGAMLYSGLLVACYFKQKSPILKKFPS
>WP_032490787.1|FEATURES|NCBI|tetracycline|tetH|antibiotic efflux|1
MNKSIIIILLITVLDAIGIGLIMPVLPTLLNEFVSENSLATHYGVLLALYATMQVIFAPI
LGRLSDKYGRKPILLFSLLGAALDYLLMAFSTTLWMLYIGRIIAGITGATGAVCASAMSD
VTPAKNRTRYFGFLGGVFGVGLIIGPMLGGLLGDISAHMPFIFAAISHSILLILSLLFFR
ETQKREALVANRTPENQTASNTVTVFFKKSLYFWLATYFIIQLIGQIPATIWVLFTQYRF
DWNTTSIGMSLAVLGVLHIFFQAIVAGKLAQKWGEKTTIMISMSIDMMGCLLLAWIGHVW
VILPALICLAAGGMGQPALQGYLSKSVDDNAQGKLQGTLVSLTNITGIIGPLLFAFIYSY
SVAYWDGLLWLMGAILYAMLLITAYFHQRKTT
>AKG19644.1|FEATURES|NCBI|tetracycline|tetH|antibiotic efflux|1
MNKSIIIILLITVLDAIGIGLIMPVLPTLLNEFVSENSLATHYGVLLALYATMQVIFAPI
LGRLSDKYGRKPILLFSLLGAALDYLLMAFSTTLWMLYIGRIIAGITGATGAVCASAMSD
VTPAKNRTRYFGFLGGAFGVGLIIGPMLGGLLGDISAHMPFIFAAISHSILLILSLLFFR
ETQKREALVANRTPENQTASNTVTVFFKKSLYFWLATYFIIQLIGQIPATIWVLFTQYRF
DWNTTSIGMSLAVLGVLHIFFQAIVAGKLAQKWGEKTTIMISMSIDMMGCLLLAWIGHVW
VILPALICLAAGGMGQPALQGYLSKSVDDNAQGKLQGTLVSLTNITGIIGPLLFAFIYSY
SVAYWDGLLWLMGAILYAMLLITAYFHQRKHT
>WP_015328224.1|FEATURES|NCBI|tetracycline|tetH|antibiotic efflux|1
MNKSIIIILLITVLDAIGIGLIMPVLPTLLNEFVSENSLATHYGVLLALYATMQVIFAPI
LGRLSDKYGRKPILLFSLLGAALDYLLMAFSTTLWMLYIGRIIAGITGATGAVCASAMSD
VTPAKNRTRYFGFLGGAFGVGLIIGPMLGGLLGDISAHMPFIFAAISHSILLILSLLFFR
ETQKREALVANRTPENQTASNTVTVFFKKSLYFWLATYFIIQLIGQIPATIWVLFTQYRF
DWNTTSIGMSLAVLGVLHIFFQAIVAGKLAQKWGEKTTIMISMSIDMMGCLLLAWIGHVW
VILPALICLAAGGMGQPALQGYLSKSVDDNAQGKLQGTLVSLTNITGIIGPLLFAFIYSY
SVAYWDGLLWLMGAILYAMLLITAYFHQRKNK
>WP_015431547.1|FEATURES|NCBI|tetracycline|tetH|antibiotic efflux|1
MNKSIIIILLITVLDAIGIGLIMPVLPTLLNEFVSENSLATHYGVLLTLYATMQVIFAPI
LGRLSDKYGRKPILLFSLLGAALDYLLMAFSTTLWMLYIGRIIAGITGATGAACASAMSD
VTPAKNRTRYFGFLSGAFGVGLIIGPMLGGLLGDISAHMPFIFAAISHSILLILSLLFFR
ETQKREALVANRTPENQTASNTVTVFFKKSLYFWLATYFIIQLIGQIPATIWVLFTQYRF
DWNTTSIGMSLAVLGVLHIFFQAIVAGKLAQKWGEKTTIMISMSIDMMGCLLLAWIGHVW
VILPALICLAAGGMGQPALQGYLSKSVDDNAQGKLQGTLVSLTNITGIIGPLLFAFIYSY
SVAYWDGLLWLMGAILYAMLLITAYFHQRKTT
>ABR77055.1|FEATURES|NCBI|multidrug|marA|antibiotic efflux|0
MSRRNNDAITIHSILSWIEDNLESPLSLEKVSERSGYSKWHLQRMFKKETGHSLGQYIRS
RKLTEIAQKLKQSNEPILYLAERYGFESQQTLTRTFKNYFDVPPHKYRITNVPGESRYLH
PLNN
>AAC74604.2|FEATURES|NCBI|multidrug|marA|antibiotic efflux|0
MSRRNTDAITIHSILDWIEDNLESPLSLEKVSERSGYSKWHLQRMFKKETGHSLGQYIRS
RKMTEIAQKLKESNEPILYLAERYGFESQQTLTRTFKNYFDVPPHKYRMTNMQGESRFLH
PLNH
>EFZ06149.1|FEATURES|NCBI|multidrug|marA|antibiotic efflux|0
MSRRNTDAITIHSILDWIEDNLESPLSLEKVSERSGYSKWHLQRMFKKETGHSLGQYIRS
RKMTEIAQKLKESNEPILYLAERYGFESQQTLTRTFKNYFDVPPHKYRITNMHGESRYML
PLNH
>WP_063844229.1|FEATURES|NCBI|chloramphenicol|cmlv|antibiotic inactivation|1
MPLAVYILGLSAFALGTSEFMLSGLVPPIAEDMNVSIPRAGLLISAFAIGMVVGAPLLAV
ATLRLPRKTTLIALITVFGLRQMAGALAPNYAVLFASRVISALPCAGFWAVGAAVAIAMV
PVGSRARALAVMIGGLSIANVLRVPAGAFLGEHLGWASAFWAVGLASAIALVGVVTRIPR
IPLPETRPRPLKNEVAIYRDRQVLLSIAVTALAAGGVFCAFSYLAPLLTDVSGLDEAWVS
GVLGLFGIGAVVGTTIGGRVADAHLFGVLLTGISASTVFLVALALFASNPAATIVLTFLL
GVSAFYTAPALNARMFNVAGAAPTLAGATTTAAFNLGNTGGPWLGGTVIDANLGFASTAW
AGAAMTVLGLGTAALALRLTKRPAPGHVVARSRGAGGTTPSEPARGKATSSC
>WP_024160909.1|FEATURES|NCBI|chloramphenicol|cmlA5|antibiotic efflux|1
MRSKDFSWRYSLAATLLLLSPFDLLASLGMDMYLPVVPFMAGALGAGAGTIQLTLTVYLV
LLGAGQLLFGPLSDLLGRRPVLLGGGITYILASFGLAAASSPEVFLSFRILQACGASACL
VSTFATVRDIYSGSEESNVIYGLLGSMLAMVPAIGPLLGALVDAWLGWRAIFGLLGIAMI
GAVTAAWRFWPETRRQRTADLQWSQLLLPVKCLNFWLYTLCYSAGMGSFFVFFSTAPWLM
MGRQALSQLSFSLLFATVAIAMMATARIMGRLIPRWGSLNTLRVGMGCLVVGALLLAVGE
TLIPNSVLGFIAPMWLVGVGIATAASVAPNGALRGFDHIAGTATAVYFCLGGLLLGGIGT
FIIALLPSDTTWPIIAYCLILAIAVLCLSCFNPNRHHPSDDEHDSLA
>EEI47439.1|FEATURES|NCBI|tetracycline|tet(J)|antibiotic efflux|1
MNKSIIIILLVTVLDAIGIGLIMPVLPTLLNEFVSENRLANHYGILLALYATMQVIFAPI
LGKLSDKYGRKPILLFSLLGAALDYLLMACSTSLWMLYIGRIIAGITGATGAVCASAMTD
VTHPHERTRYFGFLGGAFGVGLIIGPMLGGLLGEISAHTPFIFAAISHSLLFIFSLLCFQ
ETQTTKISTEISALNQDTAPHSATGFIKKSLCFWLIAYFIIQLIGQIPATIWVLFTQVRF
AWHTTEVGLSLAFLGVLHIFFQAVLAGKLAQKWGERNTVIISMSIDAFGCLLLAWISHVW
VMLPALICLAAGGMGQPALQGYLSKSVDHHVQGQLQGTLVSLTNITGIVGPLLFSFIYSY
SVEYWDGLLWFIGAMLYSGLLVASYFKQKSPI
>ABX79441.1|FEATURES|NCBI|glycopeptide|vanC1|antibiotic target alteration|1
MKKIAVLFGGNSPEYSVSLTSAESVIQAINPLKYEVMTIGIAPTMDWYWYQGNLANVRND
TWLEDHKNCHQLTFSSQGFILGEKRIVPDVLFPVLHGKYGEDGCIQGLLELMNLPYVGCH
VAASALCMNKWLLHQLADTMGIASAPTLLLSRYENDPATIDRFIQDHGFPIFIKPNEAGS
SKGITKVTDKTALQSALTTAFAYGSTVLIQKAIAGIEIGCGILGNEQLTIGACDAISLVD
GFFDFEEKYQLISATITVPAPLPLALESQIKEQAQLLYRNLGLTGLARIDFFVTNQGAIY
LNEINTMPGFTGHSRYPAMMAEVGLSYEILVEQLIALAEEDKR
>WP_011727797.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|ermB|antibiotic target alteration|1
MSTPHHGRHELGQNFLSDRRVIADIVEIVSRTNGPIIEIGAGDGALTIPLQRLARPLTAV
EVDARRARRLAQRTARSAPGPASRPTEVVAADFLRYPLPRSPHVVVGNLPFHLTTAILRR
LLHGPGWTTAVLLMQWEVARRRAAVGGATMMTAQWWPWFEFGLARKVSAASFTPRPAVDA
GLLTITRRSRPLVDVADRARYQALVHRVFTGRGHGMAQIRQRLPTPVPRTWLRANGIAPN
SLPRQLSAAQWAALFEQTRLTGAQRVDRPRDVQHGRAHRRRGGEVDRPATHHKQTGPVVG
QRQPQRGRDADADPDDQRTAPPVTRHHQGERRDEDQADHQDRPLTGEHLAGEFLWRHASF
DSSASTTLVSRKARVNGPTPPGLGDT
>WP_015382135.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|ermB|antibiotic target alteration|1
MNKNIKYSQNFFTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGSIPYHLSTQIIKKVVFESHAS
DIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHST
DVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTVTYEQVLSIFNSYLL
FNGRK
>WP_050236693.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|ermB|antibiotic target alteration|1
MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNLSSEKLKLNIRVTLIHQDILQFQFPNKQRYKIVGNIPYHLSTQIIKKVVFESHAS
DIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKINSVLIKLTRHTT
DVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTVTYEQVLSIFNSYLL
FNGRK
>WP_021406957.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|ermB|antibiotic target alteration|1
MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGSIPYHLSTQIIKKVVFESHAS
DIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLKNLPRHTT
DVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTVTYEQVLSIFNSYLL
FNGRK
>BAU88433.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|ermB|antibiotic target alteration|1
MNKNIKYSQNFLTSEKVLNQIIKQLNLKEKDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNNSSEKLKLNIRVTLIHQDILQFQFPNKQRYKIVGNIPYHLSTQIIKKVVFESHAS
DIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQTLKLPAECFHPKPKVNSVLIKLTRHTT
DVPDKYWKLYTYFVSKWVNREYRQLFTKNQCHQAMKHAKVNNLSTVTYEQVLSIFNSYLL
FNGRK
>WP_029188719.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|ermB|antibiotic target alteration|1
MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGNIPYHLSTQIIKKVVFESRAS
EIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTT
DVPDKYWKLYKYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTVTYEQVLSIFNSYLL
FNGRK
>WP_007596156.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|ermB|antibiotic target alteration|1
MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGNIPYHLSTQIIKKVVFESRAS
DIYLIFEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFDPKPKVNSVLIKLTRHTT
DVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTITYEQVLSIFNSYLL
FNGRK
>WP_041152457.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|ermB|antibiotic target alteration|1
MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGNIPYNLSTQIIKKVVFESRAS
DIYLTVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTT
DVPDKYWKLYKYFVSKWVNREYRQLFTKNQFRQAMKHAKVNNLSTITYEQVLSIFNSYLL
FNGRK
>WP_032495453.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|ermB|antibiotic target alteration|1
MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGNIPYHLSTQIIKKVVFESHAS
DIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFYPKPKVNSVLIKLTRHTT
DVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKYAKVNDLSTVTYEQVLSIFNSYLL
FNGRK
>WP_050883549.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|ermB|antibiotic target alteration|1
MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGSIPYHLSTQIIKKVVFESRAS
DIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIKQLLKLPAECFHPKPKVNSALKKLPRHTT
DVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKYAKVNDLSTVTYEQVLSIFNSYLL
FNGRK
>WP_002360844.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|ErmA|antibiotic target alteration|1
MNQKNPKDTQNFITSKKHVKEILNHTNINKQDNVIEIGSGKGHFTKELVKMSRWVDSIEI
DEDLCQVTQKVVKPFQNIKVIHTDILKFNFPKNKDYKIFGNIPFNISTDIVKKIAFESNS
KYSYLIVENGFAKRLQNTKRALGLLLMVELDIRVLKKVPRAYFHPKPNVDSVLIVLERHQ
PLILKKDYKEYQSFVYKWVNREYRVLFTKNQFRQALKHANVTNINKLSKEQFLSIFNSYK
LFQ
>WP_041902801.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|ErmA|antibiotic target alteration|1
MNRKNPKDTQNFITSKKHVKEILDRTNICKRDHVIEIGSGKGHFTKELVKMSRSVTAIEI
DEDLCRSTQNAVYPFENIKVIHTDILKYAFPKRTNYKIFGSIPYNISTDIVKKITFESQA
KYSYLIVEKGFAKRLQNLQRALGLLLMVEMNVNILKKVPRAYFHPKPSVDSVLILLERHE
PLILKKDYKKYQAFVYRWVNKEYHTLFTKNQFRQALKHANVTTLNKLSKEQFISIFNSYK
LFH
>WP_018930853.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|ErmA|antibiotic target alteration|1
MNEKNPKDTQNFITSKKHVKEILNHTNINKQDNVIEIGAGKGHFTKELVEMSQSVTAIEI
EEDLCRATQKAVELFQNIKVIHTDILKFAFPKNAGYKIYGNIPFNISTDIVKKIAFESRS
KYSYLLVEEGFAKRLQNTQRALGLLLMVEIDIKILKKVPREYFHPKPSVDSVLIVLERHK
PLILKKDYKKYQSFVYKWVNREYHLLFTKNQFRQALKHANVTNFNKISKEQFISIFNSYK
LFT
>WP_052255513.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|ErmA|antibiotic target alteration|1
MNQKNPKDTQNFITSKKNVKEILNHTNFNKQDKVIELGSGKGHFTKELVKMSQSLTAIEI
DKNLWRTTQKAVESFENVKVIHTDILKFAFPQNTNYKIFGNIPFNISTEIVKKITFESQA
KYSYLIVEKGFSKRLKNLQRALGLLLMVEMDIKILTKVPRMYFHPKPSVDSVLIILERHE
PLILKKDYKKYQSFVYRWTNKEYYALFTKNQFRQALKHANVTDPNKVSKEQFISIFNSYK
LFQ
>WP_040356223.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|ErmA|antibiotic target alteration|1
MKQKNPKHTQNFITSRKHVKEILKYTNISKQDKVIEIGSGKGHFTKELVEMSQWVTAVEI
DENLCKTTEKAVKPFNNIEVIHEDILKFNFPKSNDYKIFGNIPYNISTDIVKKIAFDSQS
KYSYLIVERGFAKRLRNTQRALGLLLMLELDIEILKKVPPTYFHPKLSVDSVLIVLERHK
PLILKKDYKKYRSFVYKWVNREYHVLFTKNQLRQALKHGNVSDLDKISNEQFLSIFNSYK
LFQ
>WP_064968553.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|ErmF|antibiotic target alteration|1
MTKKKLPVRFTGQHFTIDKVLIKDAIRQANISNQDTVLDIGAGKGFLTVHLLKIANNVVA
IENDTALVEHLRKLFSDARNVQVVGCDFRNFAVPKFPFKVVSNIPYGITSDIFKILMFES
LENFLGGSIILQLEPTQKLFSRKLYNPYTVFYHTFFDLKLVYEVGPESFLPPPTVKSALL
NIKRKHLFFDFKFKAKYLAFISCLLEKPDLSVKTALKSIFRKSQVRLISEKFEINLNSQI
VCLSPSQWKNCFLEMLEVVPEKFHPS
>WP_024531368.1|FEATURES|NCBI|beta_lactam|Sfh-1|antibiotic inactivation|1
MILNIKYLFTAVTFLLIACESMASEKNLTLTHFKGPLYIVEDKEYVQENSMVYIGTDGIT
IIGATWTPETAETLYKEIRKVSPLPINEVINTNYHTDRAGGNAYWKTLGAKIVATQMTYD
LQKSQWGSIVNFTRQGNNKYPNLEKSLPDTVFPGDFNLQNGSIRAMYLGEAHTKDGIFVY
FPAERVLYGNCILKENLGNMSFANRTEYPKTLEKLKGLIEQGELKVDSIIAGHDTPIHDV
GLIDHYLTLLEKAPK
>OAE14554.1|FEATURES|NCBI|beta_lactam|TU73_12825|antibiotic inactivation|1
KLINILSVISLACITSQVFANKSDLTLTHFKGPLYIVEDKEYVQENSMVYVGEQHITVIG
ATWTPATAEKLEQEIRKISPLPIKEVINTNYHTDRAGGNAYWKKLGASIVSTQMTYDLEK
SQWRSIVDFTRQGMEHYPILEQSLPDQVYPGNFDLQNGHVRALYLGASHTEDGIFVYFPE
ERVLYGNCILKEKLGNMTFANRSEYPKTLKKLQGLIRSGELPVEAIIAGHNSPIQNVELI
DHYLTLLEHGEQ
>WP_004937161.1|FEATURES|NCBI|multidrug|adeS|antibiotic efflux|0
KNSIGISAQLLIMMSVLNLGITIFSFGLGYLVYGWATEKGLLDLKNACPDNFSFTSVDYL
WTFLVVLTGFLLSTFLAFRYAKRYTQPINALANVVKQIQQGNLSLRIEQQQAHIPHELMS
LIQNFNAMANQLEISVKNSTLWNAAIAHELRTPITILQGRLQGIVDGVFEADQQLHQSLL
SQVEGLSYLVEDLRTLTLVENQQFRLDIQETNLQNSIFKCFQMFQDRFEHKGLHVVFNLT
HETARCDVTRMEQVLIALFSNASRYADAGKLSITTKTTQDHWILMLEDQGPGIDEQHLEH
LFKPFYRLEESRSRSEGGTGLGLAVIYAIIEAHQGQITYTTSTDLGGSCFTILLKK
>WP_010326702.1|FEATURES|NCBI|multidrug|adeS|antibiotic efflux|0
KNSVGINFQFIIMMSLLNLGVTLLSFMIGYFVYSWAIEIGFLDFQSVNSNEFFITSVDFI
WLFLVLLTGFFLSTLLAFKYGKRYTQPISDLADVIQQIQQGNLALRIKQPHHDIPHEIKS
LIENFNAMANQLEVSVKNSTVWNAAIAHELRTPVTILQGRLQGIVDGVFIADQALHQSLL
NQVEGLSYLVEDLRTLTLIENKQLRLELEKTNLKDSIEKCLQMFHERFQFKGLTTVLNLT
DELVCVDVRRMEQVFIALFSNFLRYSNAGQINITTVTTTEHWVLTFEDEGPGINESHLEH
LFKPFYRLEDSRSRLDGGTGLGLAVIDAIIEAHQGHIYYSKSKSLGGSCFTIQLKA
>WP_004721352.1|FEATURES|NCBI|multidrug|adeS|antibiotic efflux|0
KNNIGISRQLIITMAKVSLLTTCFSLIFGYLTYFVAIEFKLVSLEQLNSEDWSFNFVDLT
WILLVTLCGSLTSVYLGLKLAQRFIAPLNSLAIAAREISLGNLSVRAQLDNPSSVAEITK
MINDFNRMAEKLEISVNNASIWNAAIAHELRTPVTILQGRLQGVLDDIFTPDKALLKNLL
NQVEQLSFLIEDLRTLSLADNQQLRLNLESVCLSDVITQSVNLLQDRFDQAKLVIETNLS
DQACFFDRQRLEQILIALFENEIRYAQAGILRISTQKKSEGLVLTIEDQGPGIADQHIPF
IFDAFYRLEESRGKKNGGSGLGLSVVNAIMIAHEGRIEYSKSQALGGSCFSILFKP
>WP_016656849.1|FEATURES|NCBI|multidrug|adeR|antibiotic efflux|0
TPSSFQFDHPGKTILVVEDDYDIGDIVENYLKKSDFHVIRAMNGLQALEIQASTTVDLII
LDVKMPQMTGWDVLSTLRQNKSTPVIMLTALDQEVDKIVALRMGADDFVVKPFNPNELVA
RVQALLRRSSLTTQRQSQQTIIYKNIVINCETHHVSIKHQQHIQALNLTLTEYKILHLMA
QYPNKVFTRHELMTQCLPDSDALERTVDSHVSKLRKKLEDQKLMNLLINVRGVGYRLDQV
>WP_023912127.1|FEATURES|NCBI|aminoglycoside|ANT(4')-IIb|antibiotic inactivation|1
MHHTIARWVDRLREEYADAVAILLKGSYARGEAATWSDIDFDVLVGTQDVEDYRTWIEPV
GDRLVHISAAIEWVTGWERDTVDPSSWSYGLPTQETTRLMWAIDDDTRRRLDRPYKPHPA
AEPEVEDTVEALGKIRNAIARGDDLGVYQSAQTVARLLPTLLIPINPPAVVSHARQAIEV
ILAFPRVPEGFADDWLTCLGLVEQRTAQSTATAAERMVRGVLEMLPPDPDVVGEDIARLM
NAGLLEKYVQQ
>WP_049094497.1|FEATURES|NCBI|fosfomycin|FosA2|antibiotic inactivation|1
MLQSLNHLTLAVSNLQTSLTFWRGLLGLQLHAEWDTGAYLTCGDLWICLSYDVSRHYVAP
QESDYTHYAFSIAAEDFEPFSYKLKQAGVTVWKDNKSEGQSFYFLDPDGHKLELHVGDLA
SRLAKCREKPYSGMRFGPGK
>WP_049152503.1|FEATURES|NCBI|fosfomycin|FosA2|antibiotic inactivation|1
MLQSLNHLTLAVSNLQTSLTFWRDLLGLQLHAEWDTGAYLTCGDLWICLSYDVSRNYVAP
QESDYTHYAFSIAPEDFEPFSYKLKQSGVTVWKDNKSEGQSFYFLDPDGHKLELHVGDLA
SRLTKCREKPCSGMRFGSGK
>WP_064580700.1|FEATURES|NCBI|fosfomycin|FosA2|antibiotic inactivation|1
MLQSLNHLTLAVSNLQTSLTFWRDLLGLQLHAEWDTGAYLTCGDLWICLSYDVSRNYVAP
QESDYTHYAFSIAPEDFERFSYKLKQAGVTVWKDNKSEGQSFYFLDPDGHKLELHVGDLV
SRLAQCREKPYSGMRFGLGK
>WP_064582324.1|FEATURES|NCBI|fosfomycin|FosA2|antibiotic inactivation|1
MLQSLNHLTLAVSNLQTSLTFWRDLLGLQLHAEWDTGAYLTCGDLWICLSYDVSRNYVAP
QESDYTHYAFSIAPEDFEPFSYKLKQAGVPVWKDNKSEGQSFYFLDPDGHKLELHAGDLA
SRLAQCREKPYSGMRFGSGK
>WP_064760099.1|FEATURES|NCBI|fosfomycin|FosA2|antibiotic inactivation|1
MLQSLNHLTLAVSNLQTSLTFWRDLLGLQLHAEWDTGAYLTCGDLWICLSYDVSRNYVAP
QESDYTHYAFSIAPEDFEPFSYKLKQAGVPVWKDNKSEGQSFYFLDPDGHKLELHVGDLA
SRLAQCREKPYSGMRFGPGE
>WP_047737563.1|FEATURES|NCBI|fosfomycin|FosA2|antibiotic inactivation|1
MLQSLNHLTLAVSNLQTSLTFWRDLLGLQLHAEWDTGAYFTCGDLWICLSYDVSRNYVAP
QESDYTHYAFSIAPEDFEPFSYKLKQAGVTVWKDNKSEGQSLYFLDPDGHKLELHVGDLA
SRLAQCREKPYSGMRFGPGK
>WP_064757576.1|FEATURES|NCBI|fosfomycin|FosA2|antibiotic inactivation|1
MLLSLNHLTLAVSNLQTSLTFWRDLLGLQLHAEWDTGAYLTCGDLWICLSYDVSRNYVAP
QESDYTHYAFSIAPEDFEPFSYKLKQAGVTVWKDNKSEGKSFYFLDPDGYKLELHVGDLA
SRLAQCREKPYSGMRFGSGK
>WP_023231494.1|FEATURES|NCBI|fosfomycin|FosA2|antibiotic inactivation|1
MLQSLNHLTLAVSNLQTSLTFWRDLLGLQLHVEWDTGAYLTCGDLWVCLSYDVSRNYVAP
QESDYTHYAFSIAPEDFEPFSYKLKQAGVTVWKDNKSEGQSFYFLDPDGHKLELHVGDLA
SRLTQCRERPYSGMRFGPGK
>WP_000941935.1|FEATURES|NCBI|fosfomycin|FosA2|antibiotic inactivation|1
MLQSLNHLTLAVSNLQTSLTFWRDLLGLQLHAEWDTGAYLTCGDLWVCLSYDVSRNYVAP
QESDYTHYAFSIAPEDFEPFSCKLKQAGVTVWKDNKSEGQSFYFLDPDGHKLELHVGDLA
SRLTQCREKPYSGMRFGPGK
>WP_047360629.1|FEATURES|NCBI|fosfomycin|FosA2|antibiotic inactivation|1
MLQSLNHLTLAVSNLQTSLTFWRDLLGLQLHAEWDTGAYLTCGDLWICLSYDVSRNYVAP
QESDYTHYAFSIAPEDFEPFSYKLKQSGVTVWKDNKSEGLSFYFLDPDGHKLELHVGDLA
SRLTQCRERPYPGMRFGPGK
>WP_063252610.1|FEATURES|NCBI|fosfomycin|FosA2|antibiotic inactivation|1
MLQSLNHLTLAVSNLQTSLTFWRDLLGLQLHAEWDTGAYLTCGDLWICLSYDVSRNYVAP
QESDYTHYAFSIAPEDFEPFSYKLKQSGVTVWKDNKSEGQSFYFLDPDGHKLELHVGDLA
SRLAQCRERPYSGMRFGPGK
>WP_033450617.1|FEATURES|NCBI|aminoglycoside|ASF14_19185|antibiotic inactivation|1
YREVNCVAMPVPAGLSEEVKGYSWARNNVGESGGVVYRLYGKAGAPDLFLKHGRDTVAND
LVDEMVRLRWMANHIAVPTVTHFVSTTDEAWLLMTALAGETAYQALEARPEERTTIVDAL
ADFLRTLHAIPISECPFTSDHSYRLGLARKRIDAGLVEEDDFDEEREGWTAEQVWQEMHR
HLPFMADQVVTHGDFSLDNLLMVDGVVIGCIDAGRVGIADRYQDLAILWNCLGEFDEALQ
DRFFARYGVPKPDPSKLLFHLMLDELF
>EKF18778.1|FEATURES|NCBI|aminoglycoside|HMPREF9710_02755|antibiotic inactivation|1
DPKEVYEVAPMPAGLSEELTGYAWARNTIGQAGGTVYRLHGKPGAPDLFLKHGRNTVAND
LVDEMVRLRWLADHVPVPIVTHFVSTSDEAWLLMTALPGETAYQAIEAHPANRVAIVDAL
AEFLRTLHTIPISSCPFTSNHAHRLGLARKRIDAGLVDEDDFDDDRDGWTAEQVWQEMQK
NLPLAPDPVVTHGDFSLDNLLILDGRVTGCVDAGRVGIADRYQDLAILWNGLGEFGEPLQ
ERFLTRYGISEMDRGKLLFHLLLDELF
>WP_063977000|FEATURES|NCBI|aminoglycoside|HMPREF9710_02755|antibiotic inactivation|1
EREQASPVMPVPSSMTASVDGYAWARDTIGESGGTVYRLHGKAGEPDLYLKHGRDAVADD
IVSEMVRLRWLAPHKVAPAVCCFVSTDSDAWLLMDALPGKTAYQLLEDCPDERMAVVDAI
TDFLRRLHDIPVVECPFNSDHHLRLALAQKRMDAGLVDTDDFDDERSGWTAQQVWRDMTA
LLPLTPDPVVTHGDYSLDNLLLRNGHVVGCIDVGRVGIADRYQDLAILWNCLGEFGPEFQ
VRMLTRYGIHDADEHKLRFHLMLDEFF
>WP_056433730.1|FEATURES|NCBI|aminoglycoside|ASF14_19185|antibiotic inactivation|1
DREEACAAISVPESMSAPLVGYEWARDNVGESGGAVYRLHGKLDAPDLFLKHGRSSVAAD
VIDEMVRLRWLARHIPVPAVEGFVAMQDEAWLLMTALPGQTAYQLLEAQPDAHVGIVDAL
AAFLRRLHAIPVNECPFNSDHAYRLARARERIHAGLVEEDDFDDEREGWTAEQVWEAMQR
LLPMPSDPVVTHGDFSLDNILMVDGEVVGCIDAGRVGVADRYQDLAILWNCLGEFDALLQ
NRLLEQYGIADVDERKLQFHLMLDEMF
>EKU81965.1|FEATURES|NCBI|aminoglycoside|HMPREF9710_02755|antibiotic inactivation|1
NREEACRVVTVPESMSAALAGYAWARDRVGESGGAVYRLHGKPGAPDLYLKHGRHAVADA
IGDEMTRLRWLAGRMPVPAVVHFDRSADEAWLLMTAVPGRTAYQLLQADPAQHDIVVDAL
ARFLQRLHAIPTSACPFNSDHDYRLGLARSRIEAGLVDEDDFDEERAGWTARQVWDAMQA
LLPLAPDPVVTHGDYSLDNLLIVDGQVAGCIDAGRVGIADRYQDLAIAWNCLGEFGGSLQ
ERFLRQYGIAAPDRRKLQFHLMLDELF
>WP_023460056.1|FEATURES|NCBI|aminoglycoside|AEAC466_20400|antibiotic inactivation|1
EREKACAAPQIPIVMSAQVNGYGWARDTIGESGAAVYRLDGKGRAPDFFLKHGKDAVADD
VTDEMVRLGWLSGFMPVSTVVQFVRTPNEAWLLMAAIQGKTAYQILAADPDARAAVVDAL
AAFLRRLHAIPVNQCPFNSDHAFRLARARARIDAGLVETDDFDEEREGWTAEQVWEALQA
LLPFTPDPVVTHGDFSLDNLLIVDGEVIGCIDLGRVGIADRYQDLAILWNCLGEFDPSLQ
DRLFQQYGIPDPDPGKLQFHLILDELF
>WP_026792830.1|FEATURES|NCBI|aminoglycoside|APH(3')-Ib|antibiotic inactivation|1
DREDAEAAPPVPLSMSAEVEGYAWVRDTIGESGGAVYRLRDKAGAPDLFLKHGWDAVADA
ITEEMVRLRWLAAYVPVPAVVQFVRTANEAWLLMTAIPGKTAYQILSSSVAARPAVVDAL
SAFLRRLHAIPTSACPFSSDHAHRLAIARWRIDAGLVDADDFDEERQGWTVEQVWNGLQE
LLPLEAEPVVTHGDFSLDNLLIHNGAVVGCIDVGRAGIADRYQDLAILWNCLHEFGPSLQ
GRLFQQYGATDPDRRKLQFHLMLDELF
>WP_039187979.1|FEATURES|NCBI|aminoglycoside|LA66_00505|antibiotic inactivation|1
DREESCAIPFVPSNMSVEVHGYKWARDTIGQAGGAVYRLYGRVGAPDLFLKHGRDEVADD
VTDEMVRLRWLAGYTSVPSVQNFVRTKDEAWLLMTAIPGKTVYQVLEENADARFIVVDAI
AAFLRRVHAIPVCECPFNSDYTYRLSRARARIDSGLVDADDFDTEREGLTPEQVWEEMQH
LLPFPADPVVTHGDFSPDNLLMNEGEILGCIDVGRVGIADRYQDLAILWNRLEEFGSPLQ
ERFFQRYGVADVDRRKLQFHLMLDEFF
>WP_062773153|FEATURES|NCBI|aminoglycoside|APH(3')-Ia|antibiotic inactivation|1
QRETSCAGLRFNSNLDTELHGYKWARDKVGQSGAAIYRLYDKTDAPELYLKHGTDTEADD
ITDEMIRLNWLQAFIPVPNIMYFTRTPNDAQLLTTAISGKTAFQMLEESPDAQIEIVDAL
ATFLRRLHAIAVSSCPFNSNHIFRLALAQKRMNDGLVDADDFDDERKGLSAEQVWKEMHT
LLPLSSDPVVTHGDFSLDNLIFDKGELAGCIDVGRVGIADRYQDLAILWNCLGEFSPSLQ
KRFLQKYGMTYPDMNKLQFHLMLDEFF
>WP_048216288.1|FEATURES|NCBI|aminoglycoside|SK35_04809|antibiotic inactivation|1
HRESTCARLQLNSSLDHELDGYKWARDHVGQSGAAIYRLYDKVDAPELYLKQGNGSVAND
ITDEMVRLIWLKDYIPLPNVKHFSRTPDVALLVTTAIPGKTAFQMLEEHPDMSNDIVDAL
ATFLRRLHAIPVNSCPFNSNHQFRLTLAQNRMKNNLVDAEDFDDERNGCSVEQVWEKMHT
LLPFSSVPVVTHGDFSLDNIIFCNDEIVGCLDVGRVGIADQYQDLAILWNCLGEFSHSLQ
NRLFQQYGIPQPDEKKLQFHLMLDEFF
>WP_055823613.1|FEATURES|NCBI|aminoglycoside|HMPREF9710_02755|antibiotic inactivation|1
ERDILCVPAAVPAGLADAVAGYRWARDQVGESGGAVYRLSGKADAPDLFLKQGQGSVADD
IVDEMVRLRWLAGKVPVPRLVGFVATADDAWLLTTALAGETAWQLLDRAPEQREPVVDAL
AALLQQLHALPVAACPFDSGFERRLRLARQRIDAGLVDADDFDEQRAGWSAEQVWDALQR
HRPLTPDPVVTHGDFSLDNILLREGRVTGCIDLGRVGVADRYQDLAILSANLAEFDDALP
QRLFARYGIDTIDTAKVEAHLLLDELF
>WP_056402240.1|FEATURES|NCBI|aminoglycoside|APH(3')-Ia|antibiotic inactivation|1
ERETACAPVEVPSAFAADVAGYRWSRDGVGESGATIYRLHGKAGVPERFLKHGHGTVADD
IVDELVRLRWLAGRIAVPALVRCEATADTAWLLTTALPGRTAWQILDTEPERADELVDAL
VDFLRSFHAIPVSDCPFDSGHGVRLAAARARIDAGLVDEADFDDARQGWSAGQVWDAMGR
LLPLSPDAVVTHGDFSLDNVLIDGGRVVGCIDLGRVGVADRYQDLAILGHGLDEFDAALT
RRMFDRYGIAKPEQRKIDFHLLLDELF
>ALA52629.1|FEATURES|NCBI|beta_lactam|bcl1|antibiotic inactivation|1
MLKTKITSSILVGACLLIGCSNGNEQPVSNEPEPEESVETGEAVFKALEEEYAARLGVFA
LDTGTGQTVSYRSDERFTYASAHKPLAVAVLLQQKSIEELEQLITYSADDLVNYNPITEN
HVETGMTLRELSDASIRYSDNTAANFIFDEIGGPEGFKEGLRAIGDTVTEPERIEPELNH
VEPGEIQDTSTPEALAKSLQEFALGEALPADKQELLIDWLIGNTTGDALIRAGVPEGWEV
GDKTGAGSYGTRNDIAILWPPEKEPIILAVLSSKDEKDAEYDDELIAKATEEVINLLAQT
E
>ACX94064.1|FEATURES|NCBI|aminoglycoside|APH(3')-IIa|antibiotic inactivation|1
AVALDEVSELKNLLSPLLDECTFEEVEYGQSDARVIRVLFPDRNTAYLKYASGSSAQEIL
QEHQRTRWLRTRALVPEVISYVSTSTVTILLTKALIGHNAADAADADPVIVVAEMARALR
DLHSISPDDCPFDERLHLRLKLASGRLEAGLVDEEDFDHARQGMLARDVYEQLFIQMPGA
EQLVVTHGDACPENFIFQGNAFVGFIDCGRVGLADKYQDLALASRNIDAVFGPELTNQFF
IEYGEPNPNIAKIEYYRILDEFF
>ABY48974.1|FEATURES|NCBI|aminoglycoside|APH(3')-IIa|antibiotic inactivation|1
TVALDEVSELKNLLSPLLDECTFEEVEYGQSDARVIRVLFPDRNTAYLKYASGSSAQEIL
QEHQRTRWLRTRALVPEVISYVSTSTVTILLTKALIGHNAADAAHADPAIVVAEMARALR
DLHSISPDDCPFDERLHLRLKLASGRLEAGLVDEEDFDHARQGMLARDVYEQLFLQMPGA
EQLVVTHGDACPENFIFQGNAFVGFIDCGRVGLADKYQDLALASRNIDAVFGPELTNQFF
IEYGEPNPNIAKIEYYRILDEFF
>AIF29520.1|FEATURES|NCBI|aminoglycoside|APH(3')-IIIa|antibiotic inactivation|1
MAKMRISPELKKLIEKYRCVKDTEGMSSAKVYKLVGENENLYLKMTDSRYKGTTYDVERE
KDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIR
LFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYNFLKTEKP
EEELVFSHGDLGDSNILVKDGKVSGFIDLGRSGRADKWYDIAFCVRSIREDIGEEQYVEL
FFDLLGIKPDWEKIKYYILLDELF
>AHF51365.1|FEATURES|NCBI|aminoglycoside|APH(3')-IIIa|antibiotic inactivation|1
MAKMRISPELKKLIGKYRCVKDTEGVSPAKVYKLVGENENLYLKMTDSRYKGTTYDVGRE
KDMMLWLEGKLPVPKALHFERHDGWSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIR
LFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKP
EEELVLSHGDLGDSNIFVKDGKVSGFIDLGRSGRADKWYDIAFCVRSIREDIGEEQYVEL
FFDLLGIKPDWEKIKYYILLDELF
>WP_042227921.1|FEATURES|NCBI|aminoglycoside|butA|antibiotic inactivation|1
MNESTRNWPEELLELLGQTELTVNKIGYSGDHVYHVKEYKGAPAFLKIAPSIWWRTLQPE
IEALAWLDGKLPVPKILYTAEHGGMDYLLMEALPGKDGSHETIQAKPEFFVKLYAEGLRN
IHGLDIRECPLSNGLEKKLRDAKRIVDESLVDPTDIKEEYDCTPEELYQQLIAKKPATED
PVFAHGDYCAPNLIIAGEKLTGFIDLGRAGVADRYQDISLAIRSLRHDYGDDRYKALFLE
LYGLDGLDEDKVKYYIWLDEFF
>WP_030646682.1|FEATURES|NCBI|aminoglycoside|AC230_04535|antibiotic inactivation|1
MDDALRALRGRYPGCEWVAVQDGASGAGVYRLRGGGRELFAKVAALGAGVGLLGEAERLV
WLAEVGIPVPRVVESGGDERVAWLVTEAVPGRPASARWPRGQRLDVAVALAGLARSLHAL
DWERCPFDRSLVVTVPQAARAVAEGSVDLEDLDEEREGWSGERLLAELERTRPADEDLAV
CHGDLCPDNVLLDPRTCEVTGLIDVGRVGRADRHSDLALVLRELAHEEDPWFGPECSAAF
LREYGRGWDGAVSEEKLAFYRLLDEFF
>WP_031191644.1|FEATURES|NCBI|aminoglycoside|AC230_04535|antibiotic inactivation|1
MDDALRALRGRYPGCEWVAVEDGASGAGVYRLRGGGRELFAKVAALGAGVGLLGEAERLV
WLAEVGIPVPRVVESGGDERVAWLVTEAVPGRPASARWPRGQRLDVAVALAGLARSLHEL
DWERCPFDRSLAVTVPQAARAVAEGSIDLEDLDEEREGWSGERLLAELERTRPADEDLAV
CHGDLCPDNVLLDPRTCEVTGLIDVGRVGRADRHSDLALMLRELDHEEDPWFGPECAAAF
LREYGRGWDGAVSEEKLAFYRLLDEFF
>WP_053699462.1|FEATURES|NCBI|aminoglycoside|AC230_04535|antibiotic inactivation|1
MDDALRALRGRYSGCEWAAVGDGASGADVYRLRGGGRELFVKVAAAGPGVGLLGEAERLG
WLAGEGISVPRVVESGGDGRVAWLVTEAVPGRPASARWPRRQRLDVAVALAGLARSLHAL
DWERCPFDRSLAVTVPQAARAVAEGSVDLEDLDEEREGWSGERLLAELERTRPADEDLAV
CHGDLCPDNVLLDPRTCEVTGLIDVGRVGRADRHSDLALVLRELAHEEDPWFGPECVAAF
LREYGRGWEGEVSEEKLAFYRLLDEFF
>WP_030600485.1|FEATURES|NCBI|aminoglycoside|AC230_04535|antibiotic inactivation|1
MDDALRALRGRYPGCEWGAVGDGASGADVYRLRGGGRELFVKVADAKPGVGLLGEAERLA
WLAEAGISVPRVVESGGDGRVAWLVTEAVPGRPASARWPRGQRLDVAVALAGLARSLHAL
DWERCPFDRGLAVTVPQAARAVAEGSVDLEDLDEQREGWSGERLLAELERTRPADEDLVV
CHGDLCPDNVLLDPRTCEVTGLIDVGRVGRADRHSDLALVLRELAHEEDPWFGPECAAAF
LREYGRGWDGEVSEEKLAFYRLLDEFF
>WP_060732357.1|FEATURES|NCBI|aminoglycoside|AC230_04535|antibiotic inactivation|1
MDDALRALRGRYPGCEWGAVGDGASGADVYRLRGGGRELFVKVAAAEPGVGLFGEAERLA
WLAEAGISVPRVVESGGDGKVAWLVTEAVPGRPASARWPRGQRLDVAVALAGLARSLHAL
DWERCPFDRGLAVTVPQAARAVAEGSVDLEDLDEEREGWSGERLLAELERTRPADEDLVV
CHGDLCPDNVLLDPRTCEVTGLIDVGRVGRADRHSDLALVLRELAHEEDPWFGPECVAAF
LREYGRGWDGEVSEEKLAFYRLLDEFF
>AAO32357.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Ib|antibiotic inactivation|1
MKTFNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESV
TPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRA
LVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERT
RSDA
>WP_063840320.1|FEATURES|NCBI|aminoglycoside|aac(6')-ib-cr|antibiotic inactivation|1
MTNCNDSVTLRLMTEHDLAMLYGWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESV
TPYIAMLNGEPIGYAQSYVALGSGDGRWEEETDPGVRGIDQLLANASQLGKGLGTKLVRA
LVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPYGPAVYMVQTRQAFERT
RSDA
>WP_063840321.1|FEATURES|NCBI|aminoglycoside|aac(6')-ib-cr|antibiotic inactivation|1
MTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESV
TPYIAMLNGEPIGYAQSYVALGSGDGRWEEETDPGVRGIDQLLANASQLGKGLGTKLVRA
LVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPYGPAVYMVQTRQAFERT
RSDA
>WP_063840281.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Ib|antibiotic inactivation|1
MTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESV
TPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQLLANASQLGKGLGTKLVRA
LVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERT
RRFA
>WP_063840283.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Ib|antibiotic inactivation|1
MTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESV
TPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQLLANASQLGKGLGTKLVRA
LVELLFNDPEVTKIQTDPAPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERT
RSVA
>WP_063840319.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Ib|antibiotic inactivation|1
MTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESV
TPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQLLANAAQLGKGLGTKLVRA
LVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERT
RSVA
>WP_063840282.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Ib|antibiotic inactivation|1
MTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESV
TPCIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQLLANASQLGKGLGTKLVRA
LVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERT
RSVA
>WP_049443010.1|FEATURES|NCBI|aminoglycoside|STRNTR1_0556|antibiotic inactivation|1
VPTIRQATPADVAAWAQLRLGLWPDADDPLEELAESLADAEGAVFLACLAGGEAVGFAEV
RLRHDYVNGTESSPVGFLEGWYVQPQWQGHAVGRALLAAVQAWTRTAGCSELASDSRVED
VQAHAAHRACGFEETERVVYFRMVLDAE
>WP_053518652.1|FEATURES|NCBI|aminoglycoside|STRNTR1_0556|antibiotic inactivation|1
AATIRQATPADAAAWSQLRVGLWPDADDPLEELAQSLADPEGAVFLACAADGEAVGFAEV
RLRHDHVNGTGSSPVGFLEGWYVTPQWQGRAVGRALLAEVQAWTRDAGCSELASDSRLED
VEAHAAHRACGFEETERVVYFRMPLDAA
>WP_049677835.1|FEATURES|NCBI|aminoglycoside|ERS008437_00710|antibiotic inactivation|1
IKKLSSANINLWIALREQLWPHHPENANRSDGKNIILSDELASFIAVDEDGLGIGFADAS
IRNDYVNGCIHSPVAFLEGIFIVPSSRRGGVAKQLVDAVQAWGLEKGCQELASDTALDNV
LSQQVHEALGFKETERVVYYRK
>WP_049646085.1|FEATURES|NCBI|aminoglycoside|ERS008437_00710|antibiotic inactivation|1
IKKLSSANINLWIALREQLWPHHPENANRSDGKNIILSDELASFIAVDEDGLGIGFADAS
IRNDYVNGCIHSPVAFLEGIFIVPPSRRGGVAKQLVDAVQAWGLEKGCQELASDTALDNV
LSQQVHEALGFKETERVVYYRK
>WP_063838853.1|FEATURES|NCBI|aminoglycoside|AAC(6')-30/AAC(6')-Ib'|antibiotic inactivation|1
LIRPVEQSDAESWERLRNLLWEGDDHKSEITQFFNGEVEEPNEVLLAVTEENDAIAHIEL
SLRYDIDGLTGIKTGYIEGLFVEERHRAAGVVLKLLRAAEFWARDQGCLAFASDRDDRVI
IYARYTGAP
>WP_051208285.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Iae|antibiotic inactivation|1
NWSEFDVCKHPSLHADAAALLMNTFQAKGITSWPNIESARQTLDECIAVPNLCLGMLIDG
KLAGWVGLRPMYDKTWELHPLVVAPAQQGQGVGKALLQTLEQRAKAQGLIGIVLGTDDEL
FETSLSQTDLNGSNVLAELKRLSNRARHPFEFYQKCGYSVIGAVPNANGKNKPDIMMWKD
L
>AEX88635.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Iaf|antibiotic inactivation|1
IYNIINIADSEKNKEDAAQILYSAFRGKGKDAWPTLDSAREEIAECIASPNICLGITLDD
RLVGWGGLRPMYETTWELHPLVIDPDYQGNGLGKLLLSKIESTATTNRIIGIMLGTDDET
LSTSLSMTDIDESNIFQEIKNIINIKNHPFEFYKKCGYIIVGIVPNANGYRKPDIWMWKN
L
>KTK23273.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Ia|antibiotic inactivation|1
NYQIVNIAECSNYQLEAANILTEAFNDLGNNSWPDMTSATKEVKECIESPNLCFGLLINN
SLVGWIGLRPMYKETWELHPLVIRPDYQNKGIGKILLKELENRAREQGIIGIALGTDDEY
YRTSLSLITITEDNIFDSIKNIKNINKHPYEFYQKNGYYIVGIIPNANGKNKPDIWMWKS
L
>ACT99625.1|FEATURES|NCBI|aminoglycoside|AAC(6')-33|antibiotic inactivation|1
AYEFCEIGESNEYIILAARILTKSFLDIGNNSWPDMKSATKEVEECIEKPNICLGIHENE
KLLGWIGLRPMYKLTWELHPLVISTQYQNKGIGRLLINELEKKAKQIGIIGIVLGTDDEY
FKTSLSAVDLYGENILDEIRTIKNIKNHPYEFYQKCGYSIVGVIPDANGKRKPDIWMWKK
I
>AIT97187.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Iae|antibiotic inactivation|1
EYKIVDIALDSKLVKVAAEILFYTFSEINNESWPTINSATEEVKECIEDKNICIGVLVED
KLVGWIGLRPMYENTWELHPMVVLSKWQGKGLGKILIFELEKRAKEQGINGIVLGTDDET
FRTSLSMKELDKNDLFEEIKNIKNINHHPYEFYQKCGYKIIGVIPDANGKNKPDIWMWKK
I
>ACO54181.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IIb|antibiotic inactivation|1
MNTRETIAADLSRLGVQSGALVMVHASLKAIGPVDGGAASIVSALLDAVGPTGSLMGYAS
WDRSPYEETLNGARMDAELRHRWPPFDPAISGTYRGFGLLNRFLLQTPGARRSAHPDASM
VAVGPLAGTLTRPHELGQAFGPGSPLERFVERAGKVLLLGAPLDSVTVLHYAEAIARIPN
KRRVSYEMPIRSEDGGVRWKRAEDFDSNGILDCFAIEGEPDAVETITNAYVELRRHREGL
VGQAHCYLFEARDIVSFGVDYLQRHFGS
>WP_056320428.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IIb|antibiotic inactivation|1
MNTKETIAADLERLGVQSGDLVMVHASLKAMGPVDGGAASVVSALLDAVGPNGTLMGYAS
WDRSPYEETLNGAEMDAELRHRWPPFDPVTSGTYRGFGLLNQFLLQAPEARRSAHPDASM
VVVGPLAGKLTQPHELGQAFGPGSPLERFLEYSGKVLLLGAPLDSVTVLHYTEAIAYIPN
KRRVTYEMPIRNKDGGVRWERAEDFDSNGILDYFAIDGKPDAVETIASAYVELRRHREGI
VGQAFSYLFEARDIVSFGVDYLERHFGS
>WP_062562100.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IIc|antibiotic inactivation|1
MHGKATITADLRRLGLQPGDLVMVHASLKALGPVEGGAAGVAQALMDAVGPGGTVMGYAS
WDRSPYEETLNGARMDEDLRRDWPAFDPRTAGIYRGFGLLNQFLAELPGARRSAHPDASM
VAVGPLAGILVEPHRLGQALGEGSPLERFVRLGGKILLLGAPLDAVTVLHYAEAIADIPG
KRRVSYEMPMLGPDGRTIWEAATDFDSNGILDCFAVEGRPDAVETIARAYVATGRHREGV
VGAAHCHLFDAQDIVAFGVEWLERQFGS
>WP_036761389.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IIc|antibiotic inactivation|1
MRGKATITADLRRLGLQPGDLVMVHASLKALGPVEGGAAGVAQALMDAVGRGGTVMGYAS
WDRSPYEETLNGARMDEDLRRAWPAFDPRTAGTYRGFGLLNQLLAELPAARRSAHPDASM
VAVGPLAQTLVEPHRLGQALGEGSPLERFVRLGGKTLLLGAPLDAVTVLHYAEAIADIPG
KRRVSYKMPVLGPDGRTVWEAATDFDSNGILDCFAVEGQPDAVETIARAYVQTGRHREGV
VGAAHCHLFDARDIVAFGVDWLERQFGS
>WP_024844582.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IIb|antibiotic inactivation|1
MRGKATIAADLRRLGLRPGDLVMVHASLKALGPVEGGGAGVAQALMDAVGPDGTVMGYAS
WDRSPYEETLNGARMDEALRRDWPAFDPRTAGTYRGFGLLNRFLAALPDARRSAHPDASM
VAVGRLAGTLVEPHRLGQALGEGSPLERFVRLGGKTLLLGAPLDAVTVLHYAEAVADIPG
KRRVSYEMPVRGPDGRTVWEAATDFDSNGILDCFAVEGRPDAVETIARAYVETGRHCEGV
VGAARCHLFDAQDIVAFGVGWLERQFGS
>WP_052095933.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IIb|antibiotic inactivation|1
MRSKATITADLRRLGLRPGDLVMVHASLKALGPVEGGAAGVVQALMDAVGPGGTVMGYAS
WDRSPYEETLNGVRMDEALRRDWPAFDPRTAGTYRGFGLLNRFLAELPGARRSAHPDASM
VAVGPLAGTLVEPHRLGQALGEGSPLERFVRLGGKTLLLGAPLDAVTVLHYAEAVADIPG
KRRVSYEMPMQGPDGRTVWEAATDFDSNGILDCFAVEGRPDAVETIARAYVETGRHREGM
VGAARCHLFDAQDIVAFGVGWLERHFGS
>WP_028714409.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IIc|antibiotic inactivation|1
MRGKATITADLRRLGLRPGDLVMVHVSLKALGPVEGGAIGVAQALMDAVGPDGTVMGYAS
WDRSPYEETLNGARMDEALRRDWPAFDPRTAGTYRGFGLLNQFLAELPGARRSAHPDASM
VAIGPLAGALVEPHRLGQALGEGSPLERFVRLGGKTLLLGAPLDAVTVLHYAEAVADIPG
KRRVSYEMPMLGPDGRTVWEAATDFDSNGILDCFAVEGRPDAVETIARAYVEMGRHREGV
VAAARCHLFDAQDIVAFGVEWLEKMFGS
>WP_011749422.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IIc|antibiotic inactivation|1
MRGKASITADLRRLGLKPGDLVMVHASLKALGPVEGGAAGVVQALLDALRPGGTVMGYAS
WDRSPYEETLNGARMDEALRRDWPAFDPRTAGTYRGFGLLNQFLADLPEARRSAHPDASM
VAVGPLAGTLDEPHRLGQALREGSPLERFVRLGGKTLLLGAPLDAVTVLHYAEAVADIPG
KRRVSYEMPMPGPDGRTIWEAATDFDSNGILDCFAVEGQPDAVETIARAYVATGRYREGM
VGAARCHLFDAQDIVAFGVDWLERQFGS
>WP_051329242.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IIc|antibiotic inactivation|1
MHTEESIARNLRDLGILAGDLVMVHASLKALGPVEGGAATVLACLLQAVGPAGTLMGYAS
WDRSPYEETLDGARLDEASRRSWPGFDPATSGTYRGFGLLNQFLAEHPGARRSAHPDASM
VAVGPLAQALTEPHELGQALGEGSPLERFVRLGGKILLLGAPLDAVTALHYAEAIANIPD
KRRVTYEMPIRGKDGQVAWERCEDFDSNGILDCYAAEGRPDAVETIARAYVRLGRHQEGF
VASARCRLLDARDVVAFGVAYLERHHGA
>WP_052171736.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IIb|antibiotic inactivation|1
MKSRASVIADLHRLGVRPGDLLMVHASLKALGPVEGGATGLLTALLEAVGPTGTLMGYAS
WDRSPYEETLNGASLDEEKRRAWPAFDSDTAGTYRGFGLLNQFLADFPGARRSAHPDASM
VALGAYARELTEQHPLGQALGRGSPLERLVHLGGRVLLLGAPLDAVTVLHYAEAIADIPG
KRRVTYEMPLRGPDGGAVWVRVEDFDTNGILDCFAIEGQPDAVETIAKAYVDLGRHREGR
VGDAHCHLFEAPEIVAFGVHFLEQHFGG
>AAN34370.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IIc|antibiotic inactivation|1
MHTRKAITEAIRKLGVQTGDLLMVHASLKAIGPVEGGAETVVAALRSAVGPTGTVMGYAS
WDRSPYEETLNGARLDDKARRTWPPFDPATAGTYRGFGLLNQFLVQAPGARRSAHPDASM
VAVGPLAETLTEPHELGHALGKGSPVERFVRLGGKALLLGAPLNSVTALHYAEAVADIPN
KRWVTYEMPMLGRNGEVAWKTASEYDSNGILDCFAIEGKPDAVETIANAYVKLGRHREGV
VGFAQCYLFDAQDIVTFGVTYLEKHFGA
>WP_006473458.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IIc|antibiotic inactivation|1
MHTRKAITEALQKLGVQSGDLLMVHASLKAIGPVKGGAETVVAALRAAVGPTGTVMGYAS
WDRSPYEETLNGARLDDKARRTWPPFDPATAGTYRGFGLLNQFLVQAPGARRSAHPDASM
VAVGPLAETLTEPHELGHALGEGSPVERFVRLGGKVLLLGAPLNSVTALHYAEAVADIPD
KRRVTYEMPMLGSDGEVTWEAASDYDSNGILDCFAIEGTPDAVETIANAYVKFGRHQEGV
VGFAQCYLFDAQDIVTFGVTYLEKHFGG
>WP_058327775.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IIc|antibiotic inactivation|1
MHTRRSITDALQKLGVQFADLLMVHASLKAIGPVEGGAETVVAALSSAVGPTGTVMGYAS
WDRSPYEETLNGARLDDEARRTWPPFDPATAGTYRGFGLLNQFLVQAPGARRSAHPDASM
VAVGPLAEMLTEPHELSHALGEGSPIERFVRLGGKVLLLGAPLNSVTVLHYAEAIADIPG
KRRVTYEMPMVGSDGKVVWKTAADFDSNGILDCFAIEGKPDAVETIANAYVKLGRHRGDI
VGCAQCHLFDAQDIVSFGVTYLEQHFGT
>WP_003525983.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IIc|antibiotic inactivation|1
MHTRGSIIESLQKLGVQPGDLLMVHASLKAIGPVEGGAETVVAALRSAVGPSGTVMGYAS
WDKSPYEETLNGARLGDEARRSWPPFDPATAGTHRGFGLLNQFLVQAPGARRSAHPDASM
VAVGRLAETLTQPHDLGHALGEGSPVERFVRLGGKVLLLGAPLNSVTALHYAEAVADIPN
KRRVTYEMPIAGNDGEVVWETAADFDSNGILDCFAMEGEPDAVETIATAYVQLGRHRDGI
VGSAPCYLFDAQDIVSFGVSYLEQHFRP
>WP_022652262.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IIc|antibiotic inactivation|1
MHTEAAITKALEELGVEKGNLLMLHASLKAIGPVEGGAETIVRALRSAVGPSGTLMGYAS
WDRSPYEETLNGVQLDDEVRASWPPFNPATADIYCGFGLLNRFLVQAPGARRSPHPDASM
VAIGPLAANLIEPHELGHAFGQGSPTERFVRWAGKVLLLGAPLDSVTVLHYAEAVADIPN
KRRVTYEMPIAGSDGEVVWKAASDFDSNGILDCFAIEGKPDAVETIACAYVELGRHRAGI
VGSAPCYLFDAQDLVSFGVTYLEQNFGS
>WP_034799972.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IIc|antibiotic inactivation|1
MKTRTEITTDLRQLGVRTGDLVMVHASLKAVGAVKGGPTAIVGALLDAIGSSGTLMGYAS
WDRSPYEETLNGVRMADEARRTWPPFDPATARTYPGFGLLNQFLVEAPGARRSAHPDASM
VAVGPLSETLIEPHRLGQALGNGSPIQRFVELRGKVLLLGAPLNSVTALHYAEAIADIPG
KRRVTYEMPLLGPNGETVWETAEDFDTNGILDRFAVAGQADAVETIANAYVATSRHRSGT
VGDAFCHLFDARDIVSFGVAYLESRFGK
>WP_058323800.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IIb|antibiotic inactivation|1
MKTRIEIAADLQRLGIQPGDLVMVHASLKAIGGVELGAATVVGALLDAIGPTGTVMGYAS
WDRSPYEETLNGAKMDEELRRNWPPFDSATSATYRGFGMLNRFLVQNRGARRSAHPDASM
VAIGPLAETLTEPHCLGQALGKGSPLERFVRLGGKVLLLGAPLASVTALHYAEAIANIPG
KRRVTYEMPLLGPDGQTIWELTEDFDSNGILDCFAVDGQPDAVETIARAYIALERHQIGR
VGDACSYLFDAQDIVSFGVTYLESRFRE
>WP_062803490.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IIc|antibiotic inactivation|1
MRSQTTITCELRSLGVNAGDLVMVHASLKAIGPIEGGAVGLVAALRDAVGTEGTLLGYAS
WDRSPYDETLHGAKMDDQQRRNWPPFDPATAGTYRGFGLLNHYLATSPGALRSGHPDASM
VALGPRARFLIEPHRLGEAFGNGSPIERFVNEGGKVLLLGAGLDALTVLHYAEAIAEIPG
KRRVTYEMPLQGADGQTVWEAVEDFDSNGILDCFAIEGQPDGVETIARAYVPLGRHTQGQ
VGCAHCYLFDARDIVAFGVSYLEQRYFA
>WP_012356520.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IIc|antibiotic inactivation|1
MRNQTTITCELRSLGVHAGDLVMVHASLKAIGPVEGGAVAIVAALRDAVGPEGTLMSYAS
WDRSPYEQTLNGARMDEDDRRNWPPFDPATAGTYRGFGLLNQYLAASPGATRSAHPDASM
VALGPRARYLTEPHRLGEAFGKGSPLERFVDGGGKVLLLGAGLDSVTILHYAEAIADIPG
KRRITYEMPLRGADGHTVWEVVEEFDSNGILDCFAVEGQPDGVETMATAYVALGRHTEGQ
VGCAHCYLFDAQDIVAFGVSYLEQHHSP
>WP_009492021.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IIb|antibiotic inactivation|1
MASRTSITTELRRLGMSGGDVLMVHASLKKIGPVVGGAHAIVGALCHAVAPAGTLMGYAS
WDRSPYGETLNGAQLDEEMRHNWPPFKPDTARVYPGFSLLNQFLVDTPGALRSAHPDAST
VAVGPHAAELIEPHRLGQAFGPGSPLERFVKREGKVLMFGAPLDSVTVLHYAEAIADIPT
KRRVTYEMPLLGPNGQTVWERAEDFDSSGILDCFANDGEMDAVETIARAYVALRRHQEGR
VANAHCYLLDAQDIVSFGASYLEQRFAG
>WP_057205564.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IIc|antibiotic inactivation|1
MNDKATITGNLRALGVQSGDLLMVHASLKAIGAVEGGPPAIVASILKAVGPNGTLMGYAS
WDRSPYDETLNGAQLSEERRRNWPPFHPETAGTYRGFGVLNQYLVDTPDALRSAHPDASM
VAVGSLAREMIEPHVLGRAFGQGSPLERFVKRGGKVLLLGAPLDAVTVLHYAEAIAEIPG
KRRVTYEMPLLDPQGQTIWAHTEDFDSNGILSCFAIDGEPDAVETIANAYVLLGRHREGP
VARAHSYLFDAKDIVEFGVEYLERNFGA
>WP_020696664.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IVa|antibiotic inactivation|1
ESEIVNQLRTLGVEAGGVLLVHTSFRALRPIEGGPLGLIAALRTALGPDGTLVMPSWTGD
DATPFDPATTPAAADLGVTADLFWRQPGVVRSDHAFACAASGPKAEAIVKTALPLPPHAP
DSPVGRVRDHDGQVLLLGVGHDADTSLHVAELLTPVPYGVPRHITGRGDDGRPMRVDYRE
NDHCCQRFALADDWLRARGLQAEGPVGHGTARLARAQDIVRLAVDALRAVPLLFLHGAEE
GCEECDEARASVP
>ODT18015.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IVa|antibiotic inactivation|1
VSDVVGQLRALGVEAGGVLLVHTSFRALRPIEGGPPGLIAALRTALGPDGTLVMPSWTGD
DATPFDPATTAAAPDLGVTADLFWRQPGTLRSDHAFACAAVGPKAEAIVKTALPLPPHTP
DSPVGRVRDHDGQVLLLGVGHDADTSLHVAELLAKVPYGVPRHITGRGDDGRPMRIDYRE
NDHCCRRFALADDWLRAWGLQAEGPIGHGTARLARAQDIVRLAADALRDDPLLFLHGAEE
GCEECDEARASLP
>AAT34976.1|FEATURES|NCBI|aminoglycoside|str|antibiotic inactivation|1
RTEKEILNLVSEFAYQRSNVKIIALEGSRTNENIKKDKFQDYDFAFFVSDIECFTHEESW
LSLFGELLFIQKPEDMELFPPDLDYGYSYIMYFKDGIKMDITLINLKDLNRYFSDSDGLV
KILVDKDNLVTQEIVPDDSYYWLKKPTEREFYDCCNEFWSVSTYVAKGVFRREILFALDH
FNNILRPELLRMISWYIGFNRGFDFSLGKNYKFINKYLTDKEFNMFLATFEMNGYRKTYQ
SFKLCCELFKYYSNKVSCLGNYKYPNYEKNIENFIRNNYE
>WP_035417850.1|FEATURES|NCBI|aminoglycoside|str|antibiotic inactivation|1
RTERQMMACVDEFIKSEDLIRVAVVEGSRTNKQIERDWFQDYDLSFFVTDMEVYKGDESW
LDHFGKRRMMQKPEAMELYPAEIGNGFSYLIYFDDGIKMDLTLYPLEDLHDYFNQSDGLV
ELLCDKDQRIHKAIEPTDQAYWLMKPSSRMFDDCCNEFWCLASYVAKGLYRQEIFFALDH
LNQLLRPELLRMISWRIGAEKGFSFSIGKHGKFLDKQLQEDELQKLLETYNCGGIKETWQ
AFERCCTLFRSYSRQVAASFNYQYPDYDQQMTAFIYESYA
>WP_066163049.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RTEAEMFQIFSNFATEDERIRISMLEGSRTNNTIPKDSYQDYDVSFFVTNMSSYLKNDDW
LRAFGELIFVQKPEDMELFPAEFENYFTYIMYFADGIKVDLSLIPLTELTSYLQKSDGLI
EVLLDKDGHIEQAIVPSDEKYWLTKPSARSFDDCCNEFWSVATYVAKGLARNEFLFAVDH
LHHNIRQELLRMLSWDIGIQNGFSFSVGKNYKFIHQHLPAQQYERLLSTYATASIAQTWT
AFELCCEMFRETSRKVAQALGYPYPNYDENITKWIENTYK
>WP_053993359.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RKENELITLFETIIIDDDRIRLAVLEGSRTNTNIPKDNFQDYDISFFVTDIESYKKSDHW
LNVFGGIVFMQKPEAMELYPAELGNWFSYIMYFSDGIKIDLTLIPLNEVDQYIADSDGLV
EVLIDKDKRIKEKIIPNDTKYWIKRPSEREFDDCCNEFWNVSAYVAKGLLRKELLYALDH
FNQILRPELLRMMSWDIGIREGCHFSVGKNYKFIGKYLPEKELERLVQTFSLAGYKVTWN
SFNLCCEMFRFYSKKVASLLNYTYPDYDEKMTNIIQNIYI
>AHJ80331.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RKEKEMINLFEYIVMNDDGIRLSVLEGSRTNKNITKDYFQDYDISFFVTDIDSYKKDDCW
LEVFGDLTFMQKPEDMELFPSELGNWFSYIMYFNDGVKIDLTMIPLNEIDDYLSDSDGLV
EVLIDKDNRINEKIVPSDKKYWIKRPSEREFDDCCNEFWNVSAYVAKGLFRKELLFALDH
FNQILRPELLRMISWEVGLRKGFNFSVGKNYKFIDQYLPEKEFDKLTKTFSLSGYRESWE
SFELCCQMFRTYSKKVASSLGYKYPEYDQKMTRFIRNVYE
>WP_001243406.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RNENEMMSLFENIAMNDDRIRLSVLEGSRTNKNIPKDDFQDYDISFFVSDIESYKKDDYW
LEIFGDLIFMQKPEDMELFPAELGNWFSYIMYFNDGIKIDLTLIPLNEIDQYLSDADGLV
EILIDKDKHINEKIVPNDKKYWIKKPSEREFDDCCNEFWCVSAYIAKGFYRKELFYALDH
FNQILRPELLRMMSWEVGIREGFNFSVGKNHKFIGNYLPEEELEKLIKTFSQSGYKESWG
SFKLCCDMFRAYSKKVASLLDFNYPDYDEKMTDFIQHNYT
>AFJ49145.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
REENEMINLFKNIVMNDDTIRLSVLEGSRTNKNIPKDDFQDYDISFFVTNMESYKKDDLW
LDIFGDLVFMQKPEDMELFPSELGNWFSYIMYFNDGIKVDLTLIPLNELDDYLSNSDGLV
EILIDKDNRINKRIVPSDEKYWIEKPSGQEFDDCCNEFWSVSSYVAKGLLRKEFFFALDH
FNQILRPELLRMMSWEVGIREGFNFSVGKNYKFIDNYLPKAELEKLIDTYSQSGYIESWE
SFELCCELFRAYSKKVASSLGYRYPEYDEKMTNFIQNNYT
>WP_028596644.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RSKQEMMELGMNFAQSCEQIRIFTLEGSLTNVNIPNDEFQDYDFSYFVTDMEHFKRNDDW
LNYFGKRIMMQKPEAMELFPPELGNWFSYIMIFEDGTKMDLTLIPLHEYADYFANSDGLV
EVLLDKDNLILEPIIPTDQMYHIDKPSCQSFDDCCNEFWMSSTYVAKGLARNELLFAADM
MNQVFRPNLLTMLRWKVGIETEFSLSIGKSDKFLEKYVSSETWITLLATYEMGSRENIWE
ALYTSYALFRKSAQFVADQLGYSYPDYDENVSPYIDSIRR
>WP_065107267.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RSKKEIMELGMNFAINCEKIRIFTLEGSLTNSNIPEDEFQDYDFSYFVTDMDFFKKSDDW
LDYFGQRIILQKPEAMELFPPELGNWFSYLMIFEDGSKIDLTLIPLNEFEDYFKESDGLV
EVLLDKDQLIKKTIIPSDAKYHIQRPSMQSFDDCCNEFWMTSTYVAKGLARKEILFANDI
MNSAFRPNLLTMLRWKIGIETNFSLSIGKSDKFLKKYVSNETWDTLLSTYNMSTYQAVWD
ALNFSFELFRESSLYVSKTLGYPYPEYDKKVTNYIERIQR
>WP_035400726.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RSKKEMMDLGMNFALNCEKIRLFTLEGSLTNTNIPKDEFQDYDFSYFVTDMDYFKKSDDW
LSSFGERIIMQKPEAMELYPPELGNWYSYLMIFEDGTKIDLTLIPLNEYEDYFKNSDGLV
EVLLDKDNLIQNSVIPTDSMYHIQKPSEQSFDDCCNEFWMTSTYVVKGLARREILFAIDI
MNNAFRPSLHTMLRWKVGMETGFSLSIGKSDKFLKEYISEDMWNKVLSTYDMGSYKKMWE
ALNTSIELFRETSHFIAETFGFKYPNYDEKVSMYIESIRK
>WP_010788791.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RSESEMMRLILDLGNRDKRIRLVTLEGSRTNKNVPRDRFQDYDISYFVTDIDSFKSNDEW
LKHFGEMIMMQKPEDMELFPPELGDWFSYLMLFKDDSKIDLTLIPIDQMEQYFSDSDGLV
EVLLDKDLRVKNTITATDERYHIKKPTAREFDDCCNEFWMVSTYVVKGLMRKEILFAWDH
LYEILRPNLLRMISWNIGIQHNFSLSVGKNYKYIQRYMDEKDWGHLLNTCVGDTYENMWK
SLFGCYELFRKYSRTVAAQFNYDYPHYDEQLSAYSMKFYN
>WP_061861938.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RSEDEMMKLILDIAMKDERIRLVTLEGSRTNKNVPRDRFQDYDISYFVTDMDSFTSDESW
LDQFGERMMMQKPEDMELFPPELGDWFSYLMLFKDHHKIDLTLIPLSQTEDYFTQGDGLA
EIVLDKDDRINHKIIASDEQYHIKKPTPREFDDCCNEFWMVTTYVIKGLMRKEILFALDH
MNDILRPNVLRMIAWNIGIENQFSLSVGKNYKYIQHYMNAKDWEILLNTYVGNTYESVWK
ALFDCQGLFRAYSKSVAVLLRYEYPEYDQQITEYTLKHYQ
>WP_057764669.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RSVQEMMEIILSIAKKDERIRIVTLEGSRTNKNIPKDKFQDYDISYFVTDIDSFKSTDEW
LNAFGKRIIMQKPEDMELFPPELGNWFSYLMLFDDGNKIDLTLIPLDEAESYFLNTDGLV
EVLLDKDSSIKDTLEPTDKKFHIKKPSAKEFDDCCNEFWMVSTYVVKGLARKEILFAIDH
LNEIARPNLLRMMSWYIGIETNFSLSLGKNYKYLQKHLDKNDWDQLLYTFAENSYENMWQ
SLFNCYDLFRKYSKLVANKLCYDYPVYDEQITNYTQKVYH
>WP_057982850.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RSEAKMMEMLMGFAKNDKRIRLIMLEGSRTNPSITRDAFQDFDLSFFVTELESFKRSDDW
LDIFGKRLIMQKPEDMELFPPELGNWFSYLMLFEDGNKVDLTLIPLQEVEEYFFKSDGLV
EVLLDKDSLVKKELQANDRQYWLKRPTAREFDDCCNEFWMVATYVVKGLARKEILFAIDH
LHEIARPNLLRMMSWQIGLEHGYTFSVGKNYKFIQQYLPKEDWEAFLSTYSQASESKMWQ
SLFTCYRLFRQYAKLVASELGFLYPDYDVAITAYTERVYH
>WP_010270625.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RSEQEMMDLLLGFARGDERIRLVTLEGSRTNPNIPPDSFQDYDISYFVTDMASFKKDDAW
LEPFGRRLMMQKPEAMELFEPELGNWFSYLMLFEDGSKVDLTLIPIEETEFYFTRNDGLV
KVLLDKDRLIPHEVVATDSQYWIRKPTAGEFDDCCNEFWMVSTYVVKGLARQEILFAIDH
LNEIARPNLLRMMAWQIGFTHGYTFSLGKNYKFLQRYLPQNDWNTLLSTYAVNSCEAVWE
SLFTCYQLFRSCSRTLAQNLGYPYPHYDEAITRYTDFIYK
>WP_026326919.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RSEQEMMELLIDCAKKDERIRVVTLEGSRTNPNIPKDRFQDFDISYFVTDMDSFKENDRW
LDIFGRRAMLQKPEDMELFPPELGNWFSYIILFEDGNKLDLTLIPLNEIDEYFASSDGLV
EVLLDKDRRVQHEVVANDRNYWIIEPTARQFDDCCNEFWMASTYVVKGLARKEILFAIDL
LHEVVRPNLLRMMAWHIGWERGYTFSLGKNYKFIDRYLPPESWEALLSTYSGNSYDHMWK
SLFTCHALFRQYSKAVAANLGYRYPDYDDAISRYTDTVYR
>WP_026682661.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RSEQEMMNLLISFAKNDNRIRLVTLEGSRTNKSIPKDSFQDYDISYFVTDMDSFKEDDEW
LDVFGKRLIMQKPEDMELFPPELGGWFSYLMLFKDRNRIDLKLIPIDEVEDYFFNNDGLV
KVLLDKDSLVENDIIPSDRKYWIKKPTVREFDDCCNEFWWVSTYVVKGLARKEILFAIDH
LNEIARPNLLRMMSWQVGLEKGYSFSVGKNYKFIDSYLPQEDWETLLTTYSEGSYSNMWQ
SLFTCYDLFRKYSKSLAEDLGYKYPDYDESISKYTQNIYK
>WP_065292925.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RTEREMMDLFIEFAKQDDRIRLVTLEGSRTNKNIIPDTYQDYDISYFVTNLDSFKADDQW
LDVFGARLMMQKPEDMELFPPELGNWFSYLILFEDGNKLDLTLIPMNEVEAYFADSDGLV
EVLLDKDTLVPDGVVPDDRQYWIKKPSAREFDDCCNEFWMVSTYVVKGLARKEILFAIDH
LHEVARPNLLRMMAWHIGTEHGYTFSVGKNYKFIDRYLIEEDWDLLLSTYAESSYPSMWQ
SLFTCYELFRKYSKAVAEHHGYPYPDYDRAITTYVREIYD
>WP_021255911.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RKEREMMDMFIEFAKQDDRIRLATLEGSRTNKNITPDTYQDYDISYFVTNLDSFKANDQW
LDAFGARLMMLKPENMELFPPGLGNWFSYLILFEDGNKLDLTLIPLNEVEAYFTDNDGLV
EVLLDKDTLIPNKVVPNDSQYWIKKPSARKYDDCCNEFWMVSTYVVKGLGRKEILFAIDH
LHEVARPNLLRMMAWHIGAERGYTFSVGKNYKFIDRYLPPEDWETLLATYAESTYPSMWQ
SLFACCELFRKYSKAVAEHHGYMYPDYDQVITTYMRGIYD
>WP_021257631.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RKEREMMDMFIEFAKQDDRIRLATLEGSRTNINITPDAYQDYDISYFVTNLDSFKANDQW
LDAFGERLMMQKPENMELFPPELGNWFSYLILFKDGNKLDLTLIPLNEVEAYFTDSDGLV
EVLLDKDSLIPNEVVPNDVQYWIKKPTARELDDCCNEFWMVSTYVLKGLERKEILFAIDH
LHEVARPNLLRMMAWHIGAERGYTFSVGKNYKFIDRYLPPEDWETLLVTYAESSYPSMWQ
SLFTCCELFRKYSKAVAEHHGYPYPDYDRAISTYMKGIYD
>WP_024714945.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RSEQEMMDIFLDFALNDERIRLVTLEGSRTNKNIPPDPFQDYDISYFVTDMESFKGNDRW
LEFFGTRIMMQKPEDMELFPPELGNWFSYIILFEDGNKLDLTLIPIHEAEAYFAESDGLV
EVLLDKDTFIKHKVIPNDRQYWIKKPTAREFDDCCNEFWMVSTYVVKGLARKEILFAIDH
VNEIVRPNVLRMVAWHIASQQGYTCSMGKNYKFMNRYLSNKEWEELMATYSVNGYQEMWK
SLFNCYALFRKYSKAVSESLGYQYPDYDEGITKYTKRIYE
>WP_044428795.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RSEQVMMDIFLDFALNDERIRLVTLEGSRTNRNILPDNFQDYDISYFVTDMESFKENDRW
LEFFGTRIMMQKPEDMELFPPELGNWFSYIILLEDGNKLDLTLIPISEVEDYFAKNDGLV
EVLLDKDNFIKNKVIPNDRQYWIKKPSAREFDDCCNEFWMVSTYVVKGLARKEILFAIDH
LNEIVRPNLLRMMAWHIASQQGYTFSLGKNYKFIKRYLSNKEWEELMSTYSMNGYQEMWK
SLFTCYELFRKYSKVVSESLRYKYPDYDKGITKYTESIYN
>AAA22190.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RSEQEMMDIFLDFALNDERIRLVTLEGSRTNRNIPPDNFQDYDISYFVTDVESFKENDQW
LEIFGKRIMMQKPEDMELFPPELGNWFSYIILFEDGNKLDLTLIPIREAEDYFANNDGLV
KVLLDKDSFINYKVTPNDRQYWIKRPTAREFDDCCNEFWMVSTYVVKGLARNEILFAIDH
LNEIVRPNLLRMMAWHIASQKGYSFSMGKNYKFMKRYLSNKEWEELMSTYSVNGYQEMWK
SLFTCYALFRKYSKAVSEGLAYKYPDYDEGITKYTEGIYC
>WP_035204920.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RSEQEMMALFLDFAKNDERIRLVTLEGSRTNKAITPDKFQDYDISYFVTDIDSFKENDQW
LDPFGKAIMMQKPEDMKLFPPELGNWFSYIILFEDGNKLDLTLIPLNEVKDYFSQSDGLV
EVLLDKDRLVKNEIVADDRHYWLKKPTEREFDDCCNEFWMVSTYVVKGLARKEILFAIDH
LNGIARPNLLRMMAWYVGSERGYTFSVGKNYKFIDRYLPKEDWEALLSTYCEKGYAETWQ
SLFTCYELFRKYSKGLSASLGYNYPDYDEAITAYSASIYD
>WP_036624446.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RSEQEMMNLFLDFAAKEDRIRLVTMEGSRTNVNIPPDSFQDFDISYFVTDMDFFKESDEW
LGVFGKRIMMQKPEDMELFPPELGNWFSYIILFEDGNKLDLTLIPVNESELYFAESDGLV
KVLLDKDRLVKNEATATDRGYWLKKPTAREFDDCCNEFWMVSTYVVKGLARQEILFAIDH
LNEIARPNLLRMMAWHIGSVHGYTFSVGKNYKFIDRYLPREDWETLLSTYNGTGYPEMWR
SLFTCYELFRKYSKAVAESLGITYPDYDEAITKYTGAIYD
>WP_026043025.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RTVQEMMSMLIDFARKDDRIRLVTLEGSRTNKNIPADPFQDYDISYFVTEMDSFKENDQW
LDVFGNRIMMQKPEDMELFPSELGNWFSYLMLFEDGNKVDLTLIPIDETEQYFADSDGLV
EVLLDKDELIKHEVVASDRQYWTRKPTSREFDDCCNEFWMVSTYVVKGLARKEILFAIDH
LNEIARPNLLRMMAWQIGCEKGFTFSVGKNYKFIDHYLPTEDWEALRSTYHENGYTQMWE
SLFTCYELFRKYAKAVAESLGYPYPDYDEAITKYAKNIYH
>WP_063207627.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RSEQEMLDMLVKFAMNDERIRLVTLEGSRTNFNILPDSFQDYDISYFVTDMDSFRESDQW
LHVFGNRLMMQKPEDMELFPSELGNWFSYIILFDDGNKLDLTLIPMNEVEDYFTNSDGLV
EVLLDKDALIQEEVIANDRQYWIKKPTAREFDDCCNEFWMVSTYIVKGLARKEILFAIDH
LNEIARPNLLRMMAWKIGSEQGYTFSVGKNYKFINQYLPNEDWESLLSTYSENGYREMWQ
SLLTCYALFRTYAKAVASSLKYEYPDYDEAITRYTENIYN
>WP_028608516.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RSEQDMMNIIVDFAVHDDRIRLVTLEGSRTNKNIPPDRFQDYDISYFVADMDSFKENDQW
LTLFGSRVMMQKPEDMELFPSDLGNWFSYLMLFDDGNKLDLTLIPLNEADDYFTNSDGLV
EVLLDKDNRVKNDVIADDRHYWIKKPTAREFDDCCNEFWMVSTYVVKGLARKEILFAIDH
LNEIARPNLLRMMAWQIGSEHGYTFSVGKNYKFINRYLPNEDWETLLSTYSENGYPEMRR
SLLTCYELFRKYSRAVAERLGYTYPKYDEAVTTYTENIFN
>WP_042234623.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RSEQEMMNILVDFARNDDRIRLATLEGSRTNKNIPPDTYQDYDISYFVTDMDSFKENDQW
LETFGKRVMLQKPEDMELFPSELGNWFSYLILFGDGNKVDLTLIPINEAEDYFTNSDGLV
EVLLDKDTLIKNEVIADDRQYWIKKPTAREFDDCCNEFWMVSTYVVKGLARKEILFAIDH
LNEIARPNLLRMMAWQIGSEQGYTFSVGKNYKFINRYLPNEDWESLLSTYSENGYPEMWQ
SLLTCYELFRKCSKAVAESLDYTYPDYDETITAYTERIYT
>WP_043066377.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RSEQEMMNMLVDFAMKDNRIRLVTLEGSRTNKNIPPDTFQDYDISYFVTNIDSFKENDQW
LNIFGNRMMMQKPEDMELFPSELGNWFSYIILFEDGNKLDLTLIPINEVEDYFTKSDGLV
KVLLDKDTLIKNEVIADDRQYWIKKPTAREFDDCCNEFWMVSTYVVKGLARKEILFAIDH
LNEIARPNLLRMMAWQIGSEQGYTFSVGKNYKFINRYLPNEDWEAILSTYSQNGYQEMWQ
SLFACYELFRKYSKAVAGSLGYKYPDYDEAITTYTVNIYN
>WP_059040609.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RSEQEMMNILIDFAKNDNRIRLVTLEGSRTNKNISPDAFQDYDISYFVTDIDSFKENDQW
LRVFGNRVMMQKPEDMELFPPEIGNWFSYLMLFEDGTKVDLTLIPINEVEDYFSNSDGLV
EVLLDKDTLIKNEVIATDRQYWIKKPTAREFDDCCNEFWMVSTYVVKGLARKEILFAIDH
LNEIARPNLLRMMAWKIGSEQGYTFSVGKNYKFINRYLPNEDWEKLLLTYSEDGYQKMWK
SLLICYELFRKYSKAVSESLGYKYPDYDEAITKYTDHVYT
>WP_032944434.1|FEATURES|NCBI|quinolone|qnrB30|antibiotic target protection|1
ALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKD
AIFKSSDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSY
ANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGD
LDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>WP_053221259.1|FEATURES|NCBI|beta_lactam|ACR52_25270|antibiotic inactivation|1
DLTLTNFKGPLYIVEDKEYVQENSMVYIGEQHITVIGATWTPATAEKLEQEIRKVSPLPI
KEVINTNYHTDRAGGNAYWRELGASIVSTQLTYDLEKSQWRSIVDFTRQGMEHYPVLEQS
LPDQVYPGDFALQNGHVRALYLGASHTEDGIFVYFPEERVLYGNCILKEKLGNMTFANRS
EYPKTLKKLQGLISSGELPVETIIAGHNSPIQSVELIDHYLNLLE
>WP_038635452.1|FEATURES|NCBI|beta_lactam|EY04_27815|antibiotic inactivation|1
AITLTHFKGPLYIVEDKAYVQENSMVYIGADDITIIGATWTPETAEALEKEIRKVSALPI
KEVINTNYHTDRAGGNAHWKKLGASIVSTQMTYDLEKSQWKSIVDFTRQGFDKYPRLKES
LPDKVYSGDFELQSGRVRALYLGPAHTEDGIFVYFPSERVLYGNCILKEKLGNLSFANRT
EYPKTLKKLKELIDQGELQVESIIAGHDTPIHGVELIDHYLALLE
>ANH58931.1|FEATURES|NCBI|beta_lactam|blaCTX-M-185|antibiotic inactivation|1
MMRKSVSRAILMTTACVSLLLASVPLYAQANDIQQKLAALEKSSGGRLGVALINTADNTQ
TLYRADERFAMCSTSKVMAAAAVLKQSETQKDLLSQRVEIKSSDLINYNPIAEKHVNGTM
TLGELSAAALQYSDNTAMNKLIAHLGGPGKVTAFARVIGDDTFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLRNLTLGNALGDTQRAQLVTWLKGNTTGAASIQAGLPTSWVVGDKTGS
GDYGTTNDIAVIWPEGRAPLVLVTYFTQPKPKAESRRDVLAAAARIVTDGY
>WP_010815298.1|FEATURES|NCBI|glycopeptide|vanSB|antibiotic target alteration|1
MERKGIFIKVFSYTIIVLLLLVGVTATLFAQQFVSYFRAMEAQQTVKSYQPLVELIQNSD
RLDIQEVAGLFHYNNQSFEFYIEDKEGSVLYATPNADTSNSVRPDFLYVVHRDDNISIVA
QSKAGMGLLYQGLTIRGIVMIAIMVVFSLLCAYIFARQMTTPIKALADSANKMANLKDVP
PPLERKDELGALAHDMHSMYVRLKETIARLEDEIAREHELEETQRYFFAAASHELKTPIA
ATSVLLEGMLENIGDYKDHSKHLRECIKMMDRQGKIISEILELVSLNDGRIVPIAEPLDI
GRTVAELLPDFQTLAEANNQRFVTDIPAGQIVLSDPRLLQKALSNIILNAVQNTPQGGEV
RIWSELGAEKCRLFILNMGVHIDDTALPRLFTPFYRIDQARSRKSGRSGLGLAIVQKTLD
AMSLKYALENTSDGVLFWLDLPLTSTL
>WP_010815684.1|FEATURES|NCBI|glycopeptide|vanSB|antibiotic target alteration|1
MERKGIFIKVFSYTIIVLLLLVGVTATLFAQQFVSYFRVMELQQTVKSYQPLVELIQNSD
RLDIQEVAGLFHYNNQSFEFYIEDKEGSVLYATPNANTSNSFRPDFLYVVHRDDNISIVA
QSKAGVGLLYQGLTIRGIVMIAIMVVFSLLCAYIFARQMTTPIKALADSANKMANLKDVP
PPLERKDELGALAHDMHSMYVRLKETIARLEDEIAREHELEETQRYFFAAASHELKTPIA
ATSVLLEGMLENIGDYKDHSKYLRECIKMMDRQGKIISEILELVSLNDGRIVPIAEPLDI
GRTVAELLPNFQTLAEANNQRFVTDIPAGQIVLSDPRLLQKALSNVILNAVQNTPQGGEV
RIWSEPGAEKCRLFVLNMGVHIDDTALPRLFTPFYCIDQARSRKSGRSGLGLAIVQKTLD
AMSLQYALENTSDGVLFWLDLPLTSTL
>ANW86196.1|FEATURES|NCBI|glycopeptide|vanSB|antibiotic target alteration|1
MERKGIFIKVFSYTIIVLLLLVGVTATLFAQQFVSYFRVMELQQTVKSYQPLVELIQNSD
RLDIQEVAGLFHYNNQSFEFYIEDKEGSVLYATPNANTSNSFRPDFLYVVHRDDNISIVA
QSKAGVGLLYQGLTIRGIVMIAIMVVFSLLCAYIFARQMTTPIKALADSANKMANLKDVP
PPLERKDELGALAHDMHSMYVRLKETIARLEDEIAREHELEETQRYFFAAASHELKTPIA
ATSVLLEGMLENIGDYKDHSKYLRECIKMMDRQGKIISEILELVSLNDGRIVPIAEPLDI
GRTVAELLPDFQTLAEANNRRFVTDIPAGQIVLSDPKLLQKALSNVILNAVQNTPQGGEV
RIWSEPGAEKYRLSVLNMGVHIDDTALSKLFIPFYRIDQARSRKSGRSGLGLAIVQKTLD
AMSLQYALENTSDGVLFWLDLPPTSTL
>WP_000781800.1|FEATURES|NCBI|beta_lactam|ICG_02197|antibiotic inactivation|1
MHSLLKVGVCVSLLGATQFVSTISSVQAERTVEQKVIKNETGTISLSQLNKNVWVHTELG
YFNGVAVPSNGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHADRI
GGIKTLKERGIKAHSTALTAELAKKNGYEEPIGDLQTITNLKFGNMKVETFYPGKGHTED
NIVVWLPQYNILAGGCLVKSAEAKDLGNVADAYVNEWSTSIENVLKRYGNININSVVPGH
GEVGDRGLLLHTLDLLK
>AAK53749.2|FEATURES|NCBI|beta_lactam|BLA1|antibiotic inactivation|1
VLKNKKMLKIGMCVGILGLSITSLVTFTGGALQVEAKEKTGQVKHKNQATHKEFSQLEKK
FDARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTKKLDEVITYTKEDL
VDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRQMGDRVTMS
DRFETELNEAIPGDIRDTSTAKAIATNLKAFTAGNALPNHKRNILTKWMKGNATGDKLIR
AGVPTNWVVADKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKGATYDNQLIAEAAE
VIVNAFR
>WP_033669393.1|FEATURES|NCBI|beta_lactam|bcere0021_23020|antibiotic inactivation|1
ILKNKRMLKIGICVGILGLSLTSLEAFTGGPMQVEAKEKKGQIKHKNQATHKEFSQLEKK
FDARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTMKLDEVITYTKEDL
VDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHQIGGPKGYEKALRQMGDRVTMS
DRFETELNEAIPRDIRDTSTAKAIATNLKAFTAGNALPNHKRNILTEWMKGNATGDKLIR
AGVPTDWVVADKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKGATYDNQLIAEAAE
VIVNAFR
>WP_041184920.1|FEATURES|NCBI|beta_lactam|bla|antibiotic inactivation|1
ILKNKKMLKIGMCVGILGLSFTSLEAFTGGPLQVEAKEKKGQIKHKKQATHKEFSQLEKK
FDAQLGVYAIDTGSNQTIAYRPNERFAFASTYKALAAGVLLQQNSTKKLDEVITYTKEDL
VDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFNKIGGPKGYEKALRKMGDRITMS
DRLETELNEAIPGDIRDTSTAKAVAMNLKAFTAGNALPNHKRNILTEWMKGNATGDKLIR
AGVPTDWVVADKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEAAE
VVVNAFK
>WP_042988862.1|FEATURES|NCBI|beta_lactam|bthur0007_56400|antibiotic inactivation|1
VLKNKKMLKIGMCVGILGLSITSIEAFTGGPLQVEAKEKTGQVKHKNQATHKEFSQLEKK
FDARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTKKLDEVITYTKEDL
VDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRKMGDRVTMS
DRFETELNEAIPGDIRDTSTAKAIARNLKDFTVGNALPHQKRNILTEWMKGNATGDKLIR
AGVPTDWVVADKSGAGSYGTRNDIAIVWPPNRSPIIIAILSSKDEKEATYDNQLIAEAAE
VVVNAFK
>WP_033671989.1|FEATURES|NCBI|beta_lactam|II9_03025|antibiotic inactivation|1
ILKNKMLLKIGICVGILGLSLTSLEAFTGGPLQVEAKEKTGKVKHKNQATHKEFSQLEKK
FDARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTKKLDEVITYTKEDL
VDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRKMGDRVTMS
DRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATGDKLIR
AGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRSPIIIAILSSKDEKEATYDNQLIKEAAE
VVIDAIK
>WP_029438368.1|FEATURES|NCBI|beta_lactam|AT270_13635|antibiotic inactivation|1
ILKNKRLLKIGICVGILGLSLTSLEAFTGGSLQVEAKEKNGQIKHKNQATHKEFSQLEKK
FDARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTKKLDEVITYTKEDL
VDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRKMGDRVTMS
DRFETELNEAIPGDIRDTSTAKAVATNLKDLTVGNALPHQKRNILTDWMKGNATGDKLIR
AGVPTDWVVADKSGAGSYGTRNDVAIVWPPNRSPIIIAILSSKDEKEAAYDNQLIAEAAE
VVVNAFK
>WP_041184610.1|FEATURES|NCBI|beta_lactam|B4079_5004|antibiotic inactivation|1
ILKNKRMLKIGVCVGILGLSITSLHAFKGEILQVEAKEKTGKVKHKNQATHKEFSQLEKK
FDAQLGVYAIDTGTNETIAYRPNERFAFASTYKALAAGVLLQQNSIDTLNEVIKFTKEDL
VDYSPITEKHIDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRQMGDRVTMS
DRFETELNEAIPGDIRDTSTAKAIATNLKDFTVGNALPDDKRKVLTDWMKGNATGDKLIR
AGVPTDWEVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKGATYDNQLIAEAAE
VVVNAFK
>WP_033691456.1|FEATURES|NCBI|beta_lactam|penPC|antibiotic inactivation|1
ILKNKRMLKIGICVGILGISLTSLEVFKGGTLQVEAKEKTGQVKHKNQATHKEFSKLEQK
FDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDTLNEVITFTKEDL
VDYSPVTEKHVDTGMKLGEIAEAAVRYSDNTAGNILFHKIGGPKGFEKALRKMGDRVTMS
DRFETELNEAIPGDIRDTSTAKAIARNLKDFTIGNALPHQKRNILTDWMKGNATGDKLIR
AGVPTDWVVADKSGAGSYGTRNDIAIVWPPNRSPIIIAILSSKDEKEATYDNQLIKEAAE
VVIDAIK
>Q45726.1|FEATURES|NCBI|beta_lactam|BcI|antibiotic inactivation|1
ILKNKRMLKIGICVGILGLSITSLEAFTGGALQVEAKQKTGQVKHKNQATHKEFSQLEKK
FDARVGVYAIDTGTNQTISYRSNERFAFASTYKALAAGVLLQQNSIDTLNEVITFTKEDL
VDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRKMGDRVTMS
DRFETELNEAIPGDIRDTSTAKRIATNLKAFTVGNALPAEKRKILTEWMKGNATGDKLIR
AGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEASYDNQLIAEATE
VIVKALK
>WP_033665770.1|FEATURES|NCBI|beta_lactam|BcI|antibiotic inactivation|1
ILKNKRMLKIGMCVGILGLSVTSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFSQLEKK
FDARLGVYAIDTGTNQTISYRHNERFAFASTYKALAAGVLLQQNSIDTLNEVIKFTKEDL
VDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFHKIGGPKGYEKALRQIGDRVTMS
DRFETELNEAIPGDIRDTSTAKAIASNLKAFTVGNALPAEKRKILTEWMKGNATGDKLIR
AGVPTDWIVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEATE
VLVKALR
>WP_064056613|FEATURES|NCBI|beta_lactam|IEI_02596|antibiotic inactivation|1
ILKNKRMLKIGICVGILGLSVTSLEAFTGGSLQVEAKEKTGQVKHKNQATHKEFSQLEKK
FDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDTLNEVIKFTKEDL
VEYSPVTEKHVDTGMTLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGDRITMA
DRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAHKRNILTEWMKGNATGDKLIR
AGVPTDWIVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEATE
VIVKSLK
>WP_016117948.1|FEATURES|NCBI|beta_lactam|AT268_05175|antibiotic inactivation|1
ILKNKRMLKIGICVGILGLSITSLEAFTGESLQVEAKEKTGQVKHKNQATHKEFSQLEKK
FDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDSLNEVITYTKEDL
VDYSPVTEKYVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRHMGDRITMS
DRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILKEWMKGNATGDKLIR
AGVPTDWVVGDKSGAGSYGTRNDIAVVWPPNREPIIIVILSSKDEKEATYDNQLIADATK
VIVKALR
>WP_033712221.1|FEATURES|NCBI|beta_lactam|IEQ_02112|antibiotic inactivation|1
ILKNKRLLKIGICVGILGLSLTSLETFTGGALQVEAKEKTGQVKHKKHASYKEFSQLEKK
FDARLGVYAIDTGTNRTIAYRPNERFAFASTYKAVAAGVLLQQNSTDKLNEVITYTKDDL
VEYSPVTEKHVDTGMTLGEIAEAAVRSSDNTAGNILFHKIGGPKGYEKALRQMGDRVTMA
DRFETELNEAIPGDIRDTSTAKAIAINLKAFTVGNALPDHKRNILTEWMKGNATGDKLIR
AGVPTDWGVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEATE
IIVNALR
>WP_064475214|FEATURES|NCBI|beta_lactam|TU65_24875|antibiotic inactivation|1
ILKNKRMLKIGICIGILGISLTSLETFTGGALQVEAKEKTGQVKHKKHATYKEFSQLEKK
FDARLGVYAIDTGTHQTIAYRPNERFAFASIYKALAAGVLLQQNSTNKLNEVITYTKDDL
VEYSPVTEKHVDTGMTLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGDRITMA
DRFETELNEAIPGDIRDTSTAKAIATNLKALTVGNALPVHKRNILTEWMKGNATGDKLIR
AGVPTDWIVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEAAE
VIVKALR
>EJS76559.1|FEATURES|NCBI|beta_lactam|ICY_02429|antibiotic inactivation|1
VLKNKKMLKLGMCVGILGLSITSLATFTGGALQVEAKKKPGQVKHKNHATYQEFSQLEKK
FDARLGVYAIDTGTNRTIAYRPNERFAFASTYKALAAGVLLQQNSIDKLNEVITYTKDDL
VEYSPVTEKHVDTGMTLGEIAEAAVRSSDNTAGNILFHKIGGPKGYEKALRQMGDRVTMS
DRLETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPDHKRKVLTEWMKGNATGDKLIR
AGVPTDWIVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEAAE
VVIDAIR
>WP_068987176|FEATURES|NCBI|beta_lactam|AT258_18160|antibiotic inactivation|1
ILKNKRMLKIGICVGILGLSISSLQAFTGGASQVEAKEKTEPVKHNNHATYKDFSQLEKK
FDARLGVYAIDTGTNQTISYRSNERFAFASTYKALAAGVLLQKNSTEKLNEVVTYTKEDL
VDYSPVTEKHVDTGMKLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRQIGDRVTMS
DRLETELNEAIPGDNRDTSTAKAIATNLKDFTVGNALPDKKRNILTDWMRGNATGDKLIR
AGVPKDWIVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEATE
VIVNAIR
>AMP53257.1|FEATURES|NCBI|beta_lactam|CfxA6|antibiotic inactivation|1
MKKNRKKQIVVLCIALVCIFILVFSLSHKSATKGSANPPLTDVLTDSISQIVSACPGEIG
VAVIINNTDTVSVNNKSIYPMMSVFKVHQALALCNDFDKKGLSLDTLVKINREKLDPKTW
SPMMKDYSAPVISLTVRDLLRYTLSQSDNNASNIMFKNMLNTAQTDSFIAKLIPRSSFQI
AYTEEEMSADHDKAYSNYTSPLGAAMLMNRLFTESLISNEKQDFIKNALKECKTGIDRIV
APLLDKEGVVIAHKTGSGDVNENGILAAQNDVAYICLPNKVCYTLAVFVKDFKGNESQAS
QFVAHISAVVYSLLINTAL
>AAM48120.1|FEATURES|NCBI|beta_lactam|cfxa2|antibiotic inactivation|1
MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIG
VAVIVNNRDTVKVNNKSVYPMMSVFKVHQVLALCNDFDNKGISLDTLVNINRDKLDPKTW
SPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQI
AYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIA
APLLDKEGVVIAHKTGSGDVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQAS
QYVAHISAVVYSLLMQTSV
>WP_008770854.1|FEATURES|NCBI|beta_lactam|BL2e_cfxa|antibiotic inactivation|1
MKKSRRKRLVILCIALVCIIVLVFLLFSKSTSNNSTNPPLTDVLTDSISRIVSACPGEIG
VAIIINNTDTVKVNDKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVKIDRNRLDSKTW
SPMMKDYSELVISLTVRDLLRYTIAQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQI
AYTEEEMSADHDRAYFNYTSPLGAAMLMNRLFTESIVSGEKQSFIKNTLKECVTGTDRIV
APLLDKERVSIAHKTGSGDVNENGILAAHNDVAYICLPNNVCYTLAIFVKDFKGNESQAS
QYVAHISEVVYSLLIQNSA
>WP_030877515.1|FEATURES|NCBI|beta_lactam|BL2d_moxa|antibiotic inactivation|1
MRIRPTRRLLLGAVAPLALVPLVACGQASGSESAGSSPASAVRTSAHGSADAHEKEFRAL
EKKFDATLGVYAIDTADGQEITHRADERFAYGSTFKALQAGAILRKFSETGAKSGGGAEA
DGMDKVVHYGQDAILPNSPVTEKHVADGMSLRELCDAVVRYSDNTAANLLFDQLGGPKGL
NAVLKQLGDHTTSMDRYEQELGSAVPGDPRDTSTPRAFAEDLRAFAVEDGEKAALAPNDR
EQLNDWMSGNATGDALIRAGVPKDWKVADKSGQVKYGTRNDIAVVRPPGRAPIVVSVMSH
GDTQDAEPHDELVAEAASVVADGLK
>WP_030892446.1|FEATURES|NCBI|beta_lactam|BL2d_moxa|antibiotic inactivation|1
MRIRPTRRLLLGAVAPLALVPLVACGQASGSESAGSSPASAVRTSAHGSADAHEKEFRAL
EKKFDATLGVYAIDTADGQEITHRADERFAYGSTFKALQAGAILRKFSETGAKSGAGAEA
DGMDKVVHYGQDAILPNSPVTEKHVADGMSLRELCDAVVRYSDNTAANLLFDQLGGPKGL
NAVLKQLGDHTTSMDRYEQELGSAVPGDPRDTSTPRAFAEDLRAFAVEDGKKAALAPNDR
EQLNDWMSGNATGDALIRAGVPKDWKVADKSGQVKYGTRNDIAVVRPPGRAPIVVSVMSH
GDTEDAEPHDELVAEAASVVADGLK
>WP_032597912.1|FEATURES|NCBI|beta_lactam|cepA|antibiotic inactivation|1
MQKRLIHLSIIFFLLCPALVVAQNSPLETQLKKAIEGKKAEIGIAVIIDGQDTITVNNDI
HYPMMSVFKFHQALALADYMHHQKQPLETRLLIKKSDLKPDTYSPLREIYPQGGIEMSIA
DLLKYTLQQSDNNACDILFNYQGGPDAVNKYLHSLGIRECAVIHTENDMHENLEFCYQNW
TTPLAAAKLLEIFRNENLFDKEYKNFIYQTMVECQTGQDRLIAPLLDKKVTMGHKTGTGD
RNAKGQQIGCNDIGFILLPDGHAYSIAVFVKDSEADNRENSEIIAEISRIVYEYVTQQID
>WP_032567550.1|FEATURES|NCBI|beta_lactam|cepA|antibiotic inactivation|1
MQKRLIHLSIIFFLLCPALVVAQNSPLETQLKKAIEGKKAEIGIAVIIDGQDTITVNNDI
HYPMMSVFKFHQALALADYMHHQKQPLKTRLLIKKSDLKPDTYSPLRETYPQGGIEMSIA
DLLKYTLQQSDNNACDILFNYQGGPDAVNKYLHSLGIRECAVIHTENDMHKNLEFCYQNW
TTPLAAAKLLEIFRNENLFDKEYKNFIYQTMVECQTGQDRLIAPLLDKKVTMGHKTGTGD
RNAKGQQIGCNDIGFILLPDGHAYSIAVFVKDSEADNRENSEIIAEISRIVYEYVTQQID
>WP_032582677.1|FEATURES|NCBI|beta_lactam|cepA|antibiotic inactivation|1
MQKRLIHLSIIFFLLCPALVVAQNSPLETQLKKAIEGKKAEIGIAVIIDGQDTITVNNDI
HYPMMSVFKFHQALALADYMHHQKQPLKTRLLIKKSDLKPDTYSPLRETYPQGGIEMSIA
DLLKYTLQQSDNNACDILFNYQGGPDAVNKYLHSLGIRECAVIHTENDMHENLEFCYQNW
TTPLAAAKLLEIFRNKNLFDKEYKNFIYQTMVECQTGQDRLIAPLLDKKVTMGHKTGTGD
RNAKGQQIGCNDIGFILLPGGHAYSIAVFVKDSEADNRENSEIIAEISRIVYEYVTQQID
>WP_005801014.1|FEATURES|NCBI|beta_lactam|cepA|antibiotic inactivation|1
MQKRLIHLSIIFFLLCPALVVAQNSPLETQLKKAIEGKKAEIGIAVIIDGQDTITINNDI
HYPMMSVFKFHQALALADCMHHQKQPLKTRLLIKKSDLKPDTYSPLRETYPQGGIEMSIA
DLLKYTLQQSDNNACDILFNYQGGPDAVNKYLHSLGIRECAVIHTENDMHENLEFCYQNW
TTPLAAAKLLEIFRNENLFDKEYKNFIYQTMVECQTGQDRLIAPLLDKKVTIGHKTGTGD
RNAKGQQIGCNDIGFILLPDGHAYSIAVFVKDSEADNRENSEIIAEISRIVYEYVTQQID
>WP_032593664.1|FEATURES|NCBI|beta_lactam|cepA|antibiotic inactivation|1
MQKRLIHLSIIFFLLCPALVVAQNSPLKTQLKKAIEGKKAEIGIAVIIDGQDTITVNNDI
HYPMMSVFKFHQALALADYMHHQKQPLETRLLIKKSDLKPDTYSPLRETYPQGGIEMSIA
DLLKYTLQQSDNNACDILFNYQGGPDAVNKYLHSLGIRECAVIHTENDMHENLEFCYQNW
TTPLAAAKLLEIFRNKNLFDKEYKNFIYQTMVECQTGQDRLIAPLLDKKVTMGHKTGTGD
RNAKGQQIACNDIGFILLPSGHAYSIAVFVKDSEADNRENSEIIAEISRIVYEYVTQQID
>WP_046982544.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MRPHMLALSLAAAVLPIACASAAEAPLPQLRAYTVDASWLQPMAPLQIADHTWQIGTENL
TALLVQTAEGAVLLDGGMPQMAGHLLDNMKARGVAPQYLRLILLSHAHADHAGPVAELKR
RSGAHVVANAESAVLLARGGSDDLHFGDGITYPPANADRIVMDGEVVEVGGIEFTAHFMP
GHTPGSTAWTWTDTREGKPVRIAYADSLSAPGYQLKGNPRYPRLVEDYKRSFATVRALPC
DVLLTPHPGASNWDYAAGARAGAKALTCKAYADAAEQKFDAQLAKETAGAR
>WP_063857824.1|FEATURES|NCBI|beta_lactam|blaB-15|antibiotic inactivation|1
KKMKWALVLALGLTGLNAFGQETPEVKIEKLKDNLYVYTTYNTFNGTKYAANAVYLVTSK
GVVVIDSPWGEEKFKNFTDEIYKRHGKKVIMNIATHSHDDRAGGLEYFKSLGVKTYSTKM
TDSILAKDNKPRAQYTFDNNKSFKVGKDEFQVYYPGKGHTADNVVVWFPKDKVLVGGCII
KSGDSKDLGFLGEAYVNDWTQSVHNIQKKFPNVQYVVAGHDDWKDQTAIQHTLDLISEYQ
QKQKASN
>WP_045184442.1|FEATURES|NCBI|beta_lactam|blaB1|antibiotic inactivation|1
KGLKGLLVLALGFTGLQVFGQQNPDIKIEKLKDNLYVYTTYNTFKGTKYAANAVYVVTDK
GVVVIDSPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKLGAKTYSTKM
TDSILAKENKPRAQYTFDNNKSFKVGKTEFQVYYPGKGHTADNVVVWFPKDKVLVGGCIV
KSGDSKDLGYIGEAYVNDWTQSIHNIQQKFPDVQYVVAGHDDWKDQTSIQHTLDLISDYQ
QKQKASN
>WP_068801164.1|FEATURES|NCBI|beta_lactam|KS04_10900|antibiotic inactivation|1
KRLKGLLVLALGFTGLQVFGQQNPDIKIEKLKDNLYVYTTYNTFKGTKYAANAVYMVTDK
GVMVIDSPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKLGAKTYSTKM
TDSILAKENKPRAKYTFDNNKSFKVGKTEFQVYYPGKGHTADNVVVWFPKDKVLVGGCIV
KSGDSKDLGYIGEAYVNDWTQSIHNIQQKFPDVQYVVAGHDDWKDQTSIQHTLDLISDYQ
QKQKASN
>WP_065083535.1|FEATURES|NCBI|beta_lactam|blaB-15|antibiotic inactivation|1
KRLKGLLVLALGFTGLQVFGQENPDVKIEKLKDNLYVYTTYNTFKGTKYAANAVYMVTDK
GVVVIDSPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKLGAKTYSTKM
TDSILAKENKPRAKYTFDNNKSFKVGKTEFQVYYPGKGHTADNVVVWFPKDKVLVGGCIV
KSGDSKDLGFIGEAYVNDWTQSIHNIQQKFPDVQYVVAGHDDWKDQTSIQHTLDLISEYQ
QKQKASN
>WP_059154943.1|FEATURES|NCBI|beta_lactam|blaB1|antibiotic inactivation|1
KGLKGLLVLALGFTGLQVFGQQNPDIKIEKLKDNLYVYTTYNTFKGTKYAANAVYMVTDK
GVVVIDSPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKLGAKTYSTKM
TDSILAKENKPRAKYTFDNNKSFKVGNTEFQVYYPGKGHTADNVVVWFPKDKVLVGGCIV
KSGDSKDLGFIGEAYVNDWTQSIHNIQQKFPDVQYVVAGHDDWKDQTSIQHTLDLISEYQ
QKQKASN
>WP_063842622.1|FEATURES|NCBI|beta_lactam|BlaB|antibiotic inactivation|1
KKIKISLILALGLTSLQAFGQENPDVKIEKLKDNLYVYTTYNTFNGTKYAANAVYLVTDK
GVVVIDCPWGEDKFKSFTDEIYKKHGKKVIINIATHSHDDRAGGLEYFGKIGAKTYSTKM
TDSILAKENKPRAQYTFDNNKSFKVGKSEFQVYYPGKGHTADNVVVWFPKEKVLVGGCII
KSADSKDLGYIGEAYVNDWTQSVHNIQQKFSGAQYVVAGHDDWKDQTSIQHTLDLISEYQ
QKQKASN
>WP_034818525.1|FEATURES|NCBI|beta_lactam|BlaB|antibiotic inactivation|1
KKIKISLILALGLTSLQAFGQENPDVKIEKLRDNLYVYTTYNTFNGTKYAANAVYLVTDK
GVVVIDCPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKIGAKTYSTKM
TDSILAKENKPRAQYTFDNNKSFKVGKSEFQVYYPGKGHTADNVVVWFPKEKVLVGGCII
KSADSKDLGYIGEAYVNDWTQSVHNIQQKFSGAQYVVAGHDDWKDQRSIQRTLDLINEYQ
QKQKASN
>WP_034848068.1|FEATURES|NCBI|beta_lactam|BlaB|antibiotic inactivation|1
KNIMRALILVFGFMSFFMFGQENPDVKIEKLRDNLYVYTTYNTFNGTKYAANAVYLVTDK
GVVVIDCPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKIGAKTYSTKM
TDSILAKENKPRAQYTFDNNKSFKVGKSEFQVYYPGKGHTADNVVVWFPKEKVLVGGCII
KSADSKDLGYIGEAYVNDWTQSVHNIQQKFSGAQYVVAGHDDWKDQRSIQRTLDLINEYQ
QKQKASN
>WP_058877933.1|FEATURES|NCBI|beta_lactam|D505_09853|antibiotic inactivation|1
KNIMRALILVFGFMSFFMFGQENPDVKIDKLKDNLYVYTTYNTFNGTKYAANAVYLVTDK
GVVVIDCPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKIGAKTYSTKM
TDSILAKENKPRAQYTFDNNKSFKVGKSEFQVYYPGKGHTADNVVVWFPKEKVLAGGCII
KSADSKDLGYIGEAYVNDWTQSVHNIQQKFSGAQYVVAGHDDWKDQRSIQRTLDLINEYQ
QKQKASN
>WP_061544131.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MAKLLIMSIVSFCFIFLLLLFFRYILKRYFNYMLNYKVWYLTLLAGLIPFIPIKFSLFKF
NNVNNQAPTVESKSHDLNHNINTTKPIQEFATDIHKFNWDSIDNICTVIWIVLVIILSFK
FLKALLYLKYLKKQSLYLNENEKNKIDTILFNHQYKKNIVIRKAETIQSPITFWYGKYII
LIPSSYFKSVIDKRLKYIILHEYAHAKNRDTLHLIIFNIFSIIMSYNPLVHIVKRKIIHD
NEVEADRFVLNNINKNEFKTYAESIMDSVLNVPFFNKNILSHSFNGKKSLLKRRLINIKE
ANLKKQSKLILIFICIFTFLLMVIQSQFLMGQSITDYNYKKPLHNDYQILDKSKIFGSNS
GSFVMYSMKKDKYYIYNEKESRKRYSPNSTYKIYLAMFGLDRHIINDENSRMSWNHKHYP
FDAWNKEQDLNTAMQNSVNWYFERISDQIPKNYTATQLKQLNYGNKNLGSYKSYWMEDSL
KISNLEQVIVFKNMMEQNNHFSKKAKNQLSSSLLIKKNEKYELYGKTGTGIVNGKYSNGW
FVGYVITNHDKYYFATHLSDGKPSGKNAELISEKILKEMGVLNGQ
>WP_062912850.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MAKLLIMSVVSFCFIFLLLVFFRYILKRYFNYSLNYKVWYLTVLAGLIPFIPIKFSFIKF
NNVNNQAPTVESKSHDLNHNIITTKPVQEFATDIHKFNWDSIDNICTVIWIVLVIILSFK
FLKALLYLKYLKKQSLYLNENEKNKIDTILFNHQYXKNIVIRKAEAIQSPITFWYGKYII
LIPSSYFKSVIDKRLKYIILHEYAHAKNRDTLHLIIFNIFSIIMSYNPLVHIVKRKIIHD
NEVEADRFVLNNINKNEFKTYAESIMDSVLKTSFFNKNILSHSFNGKKSLLKNRLINIKE
ADLKKQSKLILIFICIFTFFIMIIQSQFLMGQSLTDYNYKKPLQSDYQILDESKNFGSNS
GSFVMYSMKKDKYYIYNEKESRKRYSPDSTYKIYLALFGLDRHIISDKNSRMSWNHKHYL
FESWNKEQDLNTAMQNSVNWYFERISNQIPKNYTAAQLKQLNYGNENLGSYKSYWMEDSL
KISNLEQVIVFKNMMEQNNHFSKKAKNQLSSSLLIKKNEKYELYGKTGTGIVNGKYNNGW
FVGYVITNHDKYYFATHLSDGNPSGKNAELISEKILKGMGVLNGQ
>WP_001608097.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MAKLLIMSVVSFCFIFLLLVFFRYILKRYFNYSLNYKVWYLTMLAGLIPFIPIKFSFIKF
NNVNNQAPTVESKSHDLNHNINTTKPIQEFTTDIHKFNWDSIDNICTVIWIVLVIILSFK
FLKALLYLKYLKKQSLYLNENEKNKIDTILFNHQYKKNIVIRKAEAIQSPITFWYGKYII
LIPSSYFKSVIDKRLKYIILHEYAHAKNRDTLHLIIFNIFSIIMSYNPLVHIVKRKIIHD
NEVEADRFVLNNINKNEFKTYAESIMDSVLKTPFSNKNILSHSFNGKKSLLKSRLINIKE
ADLKKQSKLILIFICIFTFFIMIIQSQFLMGQSITDYNYKKPLQNDHQILDESKNFGSNS
GSFVMYSMKKDKYYIYNEKESRKRYSPDSTYKIYLAMFGLDHHIISDKNSRMSWNHKHYP
FESWNKEQDLNTAMQNSVNWYFERISNQIPKNYTAAQLKQLNYGNENLGSYKSYWMEDSL
KISNLEQVIVFKNMMEQNNHFSKKAKNQLSSSLLIKKNEKYELYGKTGTGIVNGKYNNGW
FVGYVITNHDKYYFATHLSDGNPSGKNAELISEKILKGMGVLNDQ
>WP_064134774.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MAKLLITSVVSFCFIFLLLVFFKYILKRYFNYSLNYKVWYLTVLAGLIPFIPIKFSFIKF
NNVNNQAPTVESKSHDLNHNINTTKPIQEFTTDIHKFNWDSIDNICTVVWIVLVIILSFK
FLKSLLYLKYLKKQSLYLNENEKNKVDTILFNHQYKKNIVIRKAETIQSPITFWYGKYII
LIPSSYFKSVIDKRLKYIILHEYAHAKNRDTLHLIIFNIFSIVMSYNPLIHIVKRKIIHD
NEVEADRFVLNNINKNEFKTYAESIMDSVLNIPFFNKNILSHSFNGKKSLLKRRLINIKE
ANLKKQSKLIPIFICIFTFLLIVIQSQFLMGQSITDYNYKKPLQNDHQILDESKNFGSNS
GSFVMYSMKKDKYYIYNEKESRKRYSPDSTYKIYLAMFGLDRHIISDKNSRMSWNHKHYP
FESWNKEQDLNTAMQNSVNWYFERISNQIPKNYTAAQLKQLNYGNENLGSYKNYWMEDSL
KISNLEQVIVFKNMMEQNNHFSKKAKNQLSSSLLIKKNEKYELYGKTGTGIVNGKYNNGW
FVGYVITNHDKYYFATHLSDGKPSGKNAELISEKILKEMGVLNGQ
>WP_020366668.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MAKLLIMSVVSFCFIFLLLVFFRYILKCYFNYSLNYKVWYLTVLAGLIPFIPIKFSFIKF
NNVNNQSPTVESRSHDLNHNINTTKPVQEFTTDIHKFNWDSIDNICTVIWIVLVIILSFK
FLKSLLYLKYLKRQSLYLNENEKNKIDTILFNHQYKKNIVIRKAETIQSPITFWYGKYII
LIPSSYFKSVIDKRLKYIILHEYAHAKNRDTLHLIIFNIFSIVMSYNPLIHIVKRKIIHD
NEVEADRFVLNNINKNEFKTYAESIMDSVLNIPFFNKNILSHSFNGKKSLLKRRLINIKE
ANLKKQSKLIPIFICIFTFLLMVIQSQFLMGQSITDYNYKKPLQNDHQILDESKNFGSNS
GSFVMYSMKKDKYYIYNEKESRKRYSPDSTYKIYLAMFGLDHHIISDKNSRMSWNHKHYP
FESWNKEQDLNTAMQNSVNWYFERISNQIPKNYTAAQLKQLNYGNENLGSYKSYWMEDSL
KISNLEQVIVFKNMMEQNNHFSKKAKNQLSSSLLIKKNEKYELYGKTGTGIVNGKYNNGW
FVGYVITNHDKYYFATHLSDGKPSGKNAELISEKILKEMGVLNGQ
>WP_054192916.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MAKLLIMSIVSFCFIFLLLLFFRYILKRYFNYMLNYKVWYLTLLAGLIPFIPIKFSFFKF
NNVNNQAPKVESKSHDLNHNINTTKPIQEFTTDIHKFNWDSIDNICTVIWIVLVIILSFK
FLKALLYLKYLKKQSLYLNENEKNKIDTILFNHQYKKNIVIRKAETIQSPITFWYGKYII
LIPSSYFKSVIDKRLKYIILHEYAHAKNRDTLHLIIFNIFSIIMSYNPLVHIVKRKIIHD
NEVEADRFVLNNINKNEFKTYAESIMDSVLNVPFFNKNILSHSFNGKKSLLKRRLINIKE
ANLKKQSKLIPIFICIFTFLLIVIQSQFLMGQSITDYNYKKPLQNDHQILDESKNFGSNS
GSFVMYSMKKDKYYIYNEKESRKRYSPDSTYKIYLAMFGLDRHIISDKNSRMSWNHKHYP
FESWNKEQDLNTAMQNSVNWYFERISNQIPKNYIAAQLKQLNYGNENLGSYKSYWMEDSL
KISNLEQVIVFKNMMEQKNHFSKKAKNQLSSSLLIKKNEKYELYGKTGTGIVNGKYNNGW
FVGYVITNHDKYYFATHLSDGNPSGKNAELISEKILKEMGVLNGQ
>WP_049325223.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MAKLLIMSIVSFCFIFLLLLFFRYILKRYFNYMLNYKVWYLTLLAGLIPFIPIKFSFFKF
NNLNNQEPTVESNSHNLNPNINTTKPVHEFTTDIHKFNWDSIDNICTVIWIVLVIILSFK
FLNSLLYLKYLKKQSLYLNEKEKDKINKILFNHQYKRNIVIRKAESIHSPITFWYGKYII
LIPSLYFKSINDKKLKYIILHEYAHAKNRDTLHLIIFNIFSIVMSYNPLIHIVKRKIIHD
NEVEADRFVLNNINKNEFKTYAESIMDSVLNIPFFNKNILSHSFNGKKSLLKRRLINIKE
ANLKKQSKLIPIFICIFTFLLMVIQSQFLMGQSITDYNYKKPLQNDHQILDESKNFGSNS
GSFVMYSMKKDKYYIYNEKESRKRYSPDSTYKIYLAMFGLDHHIISDKNSRMSWNHKHYP
FESWNKEQDLNTAMQNSVNWYFERISNQIPKNYTAAQLKQLNYGNENLGSYKSYWMEDSL
KISNLEQVIVFKNMMEQNNHFSKKAKNQLSSSLLIKKNEKYELYGKTGTGIVNGKYNNGW
FVGYVITNHDKYYFATHLSDGKPSGKNAELISEKILKEMGVLNGQ
>WP_049385819.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MAKLLIMSIVSFCFIFLLLLFFRYILKRYFNYMLNYKVWYLTLLAGLIPFIPIKFSFFKF
NNLNNQEPTVESNSHNLNPNINTTKPVHEFTTDIHKFNWDSIDNICTVIWIVLVIILSFK
FLNSLLYLKYLKKQSLYLNEKEKDKINKILFNHQYKRNIVIRKAESIHSPITFWYGKYII
LIPSLYFKSINDKKLKYIILHEYAHAKNRDTLHLIIFHIFSIAMSYNPLIQIVKRKMIHD
NEVEADRFVLNNINKNEFKSYAEAIMDSVLKTSFFNKNILSHSFNGKKSLLKRRLINIKE
GNLKKQSKLILIFICIFTFFIMIIQSQFLMGQSLTDYNYKKPLQSDYQILDESKNFGSNS
GSFVMYSMKKDKYYIYNEKESRKRYSPDSTYKIYLAMFGLDRHIISDKNSRMSWNHKHYP
FESWNKEQDLNTAMQNSVNWYFERISNQIPKNYIAAQLKQLNYGNENLGSYKSYWMEDSL
KISNLEQVIVFKNMMEQKNHFSKKAKNQLSSSLLIKKNEKYELYGKTGTGIVNGKYNNGW
FVGYVITNHDKYYFATHLSDGNPSGKNAELISEKILKEMGVLNGQ
>WP_061649395.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MAKLLIMSIVSFCFIFLLLLFFRYILKRYFNYMLNYKVWYLTLLAGLIPFIPIKFSFFKF
NNLNNQEPTVESNSHNLNPNINTTKPVHEFTTDIHKFNWDSIDNICTVIWIVLVIILSFK
FLNSLLYLKYLKKQSLYLNEKEKDKINKILFNHQYKRNIVIRKAESIHSPITFWYGKYII
LIPSLYFKSINDKKLKYIILHEYAHAKNRDTLHLIIFHIFSIAMSYNPLIQIVKRKMIHD
NEVEADRFVLNNINKYEFKSYAEAIMDSVLKTSFFNKNILSHSFNGKKSLLKRRLINIKE
ANLKKQSKLILIFICIFTFFIMIIQSQFLMGQSLTDYNYKKPLQSDYQILDKSKNFGSNS
GSFVMYSMKKDKYYIYNEKESRKRYSPDSTYKIYLALFGLDRHIISDKNSRMSWNHNHYP
FDSWNKDQDLNTAIQNSVNWYFERISNQLSKNYTSDQLKQLNYGNKNLGSYKAYWLEDSL
KISNLEQVIVLKNMMEQNNHFSKNEKKQLSSSLLIRKNENYELYGKTGTGIVNGKYNNGW
FVGYVITNHDKYYFSTHLSDEKASGENAKLINEKILKEMGVLNGQ
>WP_049305913.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MAKLLIMSIVSFCFIFLLLVFFRYILKRYFNYMLNYKVWYLTLLAGLIPFIPIKFSLFKF
NNLNNQAPTVESNSHNLNPNINTTKPVHEFTTDIHKFNWDSIDNICTVIWIVLVIILSFK
FLNSLLYLKYLKKQSLYLNEKEKNKINKILFNHQYKRNIVIRKAESIHSPTTFWYGKYII
LIPSLYFKSINDKKLKYIILHEYAHAKNRDTLHLIIFNIFSIIMSYNPLVHIVKRKIIHD
NEVEADRFVLNNINKNEFKSYAEAIMDSVLKTPFFNKNILSHSFNGKKSLLKRRLINIKE
ANLKKQSKLILIFICIFTFFIMIIQSQFLMGQSLTDYNYKKPLQSDYQILDESKNFGSNS
GSFVMYSMKKDKYYIYNEKESRKRYSPDSTYKIYLALFGLDRHIISDKNSRMSWNHNHYP
FDSWNKDQDLNTAIQNSVNWYFERISNQISKNYTSDQLKQLNYGNKNLGSYKAYWLEDSL
KISNLEQVIVLKNMMEQNNHFSKNEKKQLSSSLLIRKNENYELYGKTGTGIVNGKYNNGW
FVGYVITNHDKYYFATHLSDGNPSGKNAELISEKILKGMGVLNGQ
>WP_025663215.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MAKLLIMSVVSFCFIFLLLVFFRYILKRYFNYSLNYKVWYLTVLAGLIPFIPIKFSFIKF
NNVNNQSPTVESRSHDLNHNINTTKPVQEFTTDIHKFNWDSIDNICTVIWIVLVIILSFK
FLKSLLYLKYLKRQSLYLNENEKNKIDTILFNHQYKKNIVIRKAETIQSPITFWYGKYII
LIPSSYFKSVIDKRLKYIILHEYAHAKNRDTLHLIIFNIFSIVMSYNPLIQIVKRKMIHD
NEVEADRFVLNNINKYEFKSYAEAIMDSVLKTSFFNKNILSHSFNGKKSLLKRRLINIKE
ANLKKQSKLILIFICIFTFFIMIIQSQFLMGQSLTDYNYKKPLQSDYQILDESKNFGSNS
GSFVMYSMKKDKYYIYNEKESRKRYSPDSTYKIYLALFGLDRHIISDKNSRMSWNHNHYP
FDSWNKDQDLNTAIQNSVNWYFERISNQLSKNYTSDQLKQLNYGNKNLGSYKAYWLEDSL
KISNLEQVIVLKNMMEQNNHFSKNEKKQLSSSLLIRKNENYELYGKTGTGIVNGKYNNGW
FVGYVITNHDKYYFSTHLSDEKASGENAKLINEKILKEMGVLNGQ
>WP_049287941.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MAKLLIMSVVSFCFIFLLLVFFRYILKRYFNYSLNYKVWYLTVLAGLIPFIPIKFSFIKF
NNVNNQAPTVESKSHDLNHNIITTKPVQEFATDIHKFNWDSIDNICTVIWIVLVIILSFK
FLKALLYLKYLKKQSLYLNENEKNKIDTILFNHQYKKNIVIRKAEAIHSPTTFWYGKYII
LIPSLYFKSINDKKLKYIILHEYAHAKNRDTLHLIIFNIFSIAMSYNPLIQIVKRKMIHD
NEVEADRFVLNNINKNEFKSYAEAIMDSVLKTPFFNKNILSHSFNGKKSLLKRRLINIKE
ANLKKQSKLILIFICIFTFFIMIIQSQFLMGQSLTDYNYKKPLQSDYQILDESKNFGSNS
GSFVMYSMKKDKYYIYNEKESRKRYSPDSTYKIYLALFGLDRHIISDKNSRMSWNHNHYP
FDSWNKDQDLNTAIQNSVNWYFERISNQISKNYTSDQLKQLNYGNKNLGSYKAYWLEDSL
KISNLEQVIVLKNMMEQNNHFSKNEKKQLSSSLLIRKNENYELYGKTGTGIVNGKYNNGW
FVGYVITNHDKYYFATHLSDEKASGENAKLINEKILKEMGVLNGQ
>WP_031922911.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MLSSFLMLSIISSLLTICVIFLVRMLYIKYTQNIMSHKIWLLVLVSTLIPLIPFYKISNF
TFSKDMMNRNVSDTTSSVSHMLDGQQSSVTKDLAINVNQFETSNITYMILLIWVFGSLLC
LFYMIKAFRQIDVIKSSSLESSYLNERLKVCQSKMQFYKKHITISYSSNIDNPMVFGLVK
SQIVLPTVVVETMNDKEIEYIILHELSHVKSHDLIFNQLYVVFKMIFWFNPALYISKTMM
DNDCEKVCDRNVLKILNRHEHIRYGESILKCSILKSQHINNVAAQYLLGFNSNIKERVKY
IALYDSMPKPNRNKRIVAYIVCSISLLIQAPLLSAHVQQDKYETNVSYKKLNQLAPYFKG
FDGSFVLYNEREQAYSIYNEKESRKRYSPDSTYKIYLALMAFDQNLLSLNHTEQQWDKHQ
YPFKEWNQDQNLNSSMKYSVNWYYENLNKHLRQDEVKSYLDLIEYGNEEISGNENYWNES
SLKISAIEQVNLLKNMKQHNMHFDNKAIEKVENSMTLKQKDTYKYVGKTGTGIVNHKEAN
GWFVGYVETKDNTYYFATHLKGEDNANGEKAQQISERILKEMELI
>WP_031925325.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MLSSFLMLSIISSLLTICVIFLVRMLYIKYTQNIMSHKIWLLVLVSTLIPLIPFYKISNF
TFSKDMMNRNVSDTTSSVSHMLDGQQSSVTKDLAINVNQFETSNITYMILLIWVFGSLLC
LFYMIKAFRQIDVIKSSSLESSYLNERLKVCQSKMQFYKKHITISYSSNIDNPMVFGLVK
SQIVLPTVVVETMNDKEIEYIILHELSHVKSHDLIFNQLYVVFKMIFWFNPALYISKTMM
DNDCEKVCDRNVLKILNRHEHIRYGESILKCSILKSQHINNVAAQYLLGFNSNIKERVKY
IALYDSMSKPNRNKRIVAYIVCSISLLIQAPLLSAHVQQDKYETNVSYKKLNQLAPYFKG
FDGSFVLYNEREQAYSIYNEPESKQRYSPNSTYKIYLALMAFDQNLLSLNHTEQQWDKHQ
YPFKEWNQDQNLNSSMKYSVNWYYENLNKHLRQDEVKSYLDLIEYGNEEISGNENYWNES
SLKISAIEQVNLLKNMKQHNMHFDNKAIEKVENSMTLKQKDTYKYVGKTGTGIVNHKEAN
GWFVGYVETKDNTYYFATHLKGEDNANGEKAQQISERILKEMELI
>WP_064125810.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MLSSFLMLSIISSLLTICVIFLVRMLYIKYTQNIMSHKIWLLVLVSTLIPLIPFYKISNF
TFSKDMMNRNVSDTTSSVSHMLDGQQSSVTKDLAINVNQFETSNITYMILLIWVFGSLLC
LFYMIKAFRQIDVIKSSSLESSYLNERLKVCQSKMQFYKKHITISYSSNIDNPMVFGLVK
SQIVLPTVVVETMNDKEIEYIILHELSHVKSHDLIFNQLYVVFKMIFWFNPALYISKTMM
DNDCEKVCDRNVLKILNRHEHIRYGESILKCSILKSQHINNVAAQYLLGFNSNIKERVKY
IALYDAMPKPNRNKRIVAYIVCSISLLIQAPLLSAHVQQDKYETNVSYKKLNQLAPYFKG
FDGSFVLYNEREQAYSIYNEPESKQRYSPNSTYKIYLALMAFDQNLLSLNHTEQQWDKHQ
YPFKEWNQDQNLNSSMKYSVNWYYENLNKHLRQDEVKSYLDLIEYGNEEISGNENYWNES
SLKISAIEQVNLLKNMKQHNMHFDNKAIEKVENSMTLKQKDTYKYVGKTGTGIVNHKEAN
GWFVGYVETKDNTYYFATHLKGEDNANGEKAQQISERILKEMELI
>WP_061824589.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MLSSFLMLSIISSLLTICVIFLVRMLYIKYTQNIMSHKIWLLVLVSTLIPLIPFYKISNF
TFSKDMMNRNVSDTTSSVSHMLDGQQSSVTKDLAINVNQFETSNITYMILLIWVFGSLLC
LFYMIKAFRQIDVIKSSSLESSYLNERLKVCQSKMQFYKKHITISYSSNIDNPMVFGLVK
SQIVLPTVVVETMNDKEIEYIILHELSHVKSHDLIFNQLYVVFKMIFWFNPALYISKTMM
DNDCEKVCDRNVLKILNRHEHIRYGESILKCSILKSQHINNVAAQYLLGFNSNIKERVKY
IALYDSMPKPNRNKRIVAYIVCSISLLIQAPLLSAHVQQGKYETNVSYKKLNQLAPYFKG
FDGSFVLYNEREQAYSIYNEPESKQRYSPNSTYKIYLALMAFDQNLLSLNHTEQQWDKHQ
YPFKEWNQDQNLNSSMKYSVNWYYENLNKHLRQDEVKSYLDLIEYGNEEISGNENYWNES
SLKISAIEQVNLLKNMKQHNMHFDNKAIEKVENSMTLKQKDTYKYVGKTGTGIVNHKEAN
GWFVGYVETKDNTYYFATHLKGEDNANGEKAQQISERILKEMELI
>WP_000952924.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MLSSFLMLSIISSLLTICVIFLVRMLYIKYTQNIMSHKIWLLVLVSTLIPLIPFYKISNF
TFSKDMMNRNVSDTTSSVSHMLDGQQSSVTKDLAINVNQFETSNITYMILLIWVFGSLLC
LFYMIKAFRQIDVIKSSSLESSYLNERLKVCQSKMQFYKKHITISYSSNIDNPMVFGLVK
SQIVLPTVVVETMNDKEIEYIILHELSHVKSHDLIFNQLYVVFKMIFWFNPALYISKTMM
DNDCEKVCDRNVLKILNRHEHIRYGESILKCSILKSQHINNVAAQYLLGFNSNIKERVKY
IALYDSMPKPNRNKRIVAYIVCSISLLIQAPLLSAHVQQDKYETNVSYKKLNQLAPYFKG
FDGSFVLYNEREQAYSIYNEPESKQRYSPNSTYKIYLALMAFDQNLLSLNHTEQQWDKHQ
YPFKEWNQDQNLNSSMKYSVNWYYENLNKHLRQYEVKSYLDLIEYGNEEISGNENYWNES
SLKISAIEQVNLLKNMKQHNMHFDNKAIEKVENSMTLKQKDTYKYVGKTGTGIVNHKEAN
GWFVGYVETKDNTYYFATHLKGEDNANGEKAQQISERILKEMELI
>WP_031771022.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MLSSFLMLSIISSLLTICVIFLVRMLYIKYTQNIMSHKIWLLVLVSTLIPLIPFYKISNF
TFSKDMMNRNVSDTTSSVSHMLDGQQSSVTKDLAINVNQFETSNITYMILLIWVFGSLLC
LFYMIKAFRQIDVIKSSSLESSYLNERLKVCRSKMQFYKKHITISYSSNIDNPMVFGLVK
SQIVLPTVVVETMNDKEIEYIILHELSHVKSHDLIFNQLYVVFKMIFWFNPALYISKTMM
DNDCEKVCDRNVLKILNRHEHIRYGESILKCSILKSQHINNVAAQYLLGFNSNIKERVKY
IALYDSMPKPNRNKRIVAYIVCSISLLIQAPLLSAHVQQDKYETNVSYKKLNQLAPYFKG
FDGSFVLYNEREQAYSIYNEPESKQRYSPNSTYKIYLALMAFDQNLLSLNHTEQQWDKHQ
YPFKEWNQDQNLNSSMKYSVNWYYENLNKHLRQDEVKSYLDLIEYGNEEISGNENYWNES
SLKISAIEQVNLLKNMKQHNMHFDNKAIEKVENSMTLKQKDTYKYVGKTGTGIVNHKEAN
GWFVGYVETKDNTYYFATHLKGEDNANGEKAQQISERILKEMELI
>WP_031796024.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MLSSFLMLSIISSLLTICVIFLVRMLYIKYTQNIMSHKIWLLVLVSTLIPLIPFYKISNF
TFSKDMMNRNVSDTTSSVSHMLDGQQSSVTKDLAINVNQFETSNITYMILLIWVFGSLLC
LFYMIKAFRQIDVIKSSSLESSYLNERLKVCQSKMQFYKKHITISYSSNIDNLMVFGLVK
SQIVLPTVVVETMNDKEIEYIILHELSHVKSHDLIFNQLYVVFKMIFWFNPALYISKTMM
DNDCEKVCDRNVLKILNRHEHIRYGESILKCSILKSQHINNVAAQYLLGFNSNIKERVKY
IALYDSMPKPNRNKRIVAYIVCSISLLIQAPLLSAHVQQDKYETNVSYKKLNQLAPYFKG
FDGSFVLYNEREQAYSIYNEPESKQRYSPNSTYKIYLALMAFDQNLLSLNHTEQQWDKHQ
YPFKEWNQDQNLNSSMKYSVNWYYENLNKHLRQDEVKSYLDLIEYGNEEISGNENYWNES
SLKISAIEQVNLLKNMKQHNMHFDNKAIEKVENSMTLKQKDTYKYVGKTGTGIVNHKEAN
GWFVGYVETKDNTYYFATHLKGEDNANGEKAQQISERILKEMELI
>WP_031890271.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MLSSFLMLSIISSLLTICVIFLVRMLYIKYTQNIMSHKIWLLVLVSTLIPLIPFYKISNF
TFSKDMMNRNVSDTTSSVSHMLDGQQSSVTKDLAINVNQFETSNITYMILLIWVFGSLLC
LFYMIKAFRQIDVIKSSSLESSYLNERLKVCQSKMQFYKKHITISYSSNIDNPMVFGLVK
SQIVLPTVVVETMNDKEIEYIILHELSHVKSHDLIFNQLYVVFKMIFWFNPALYISKTMM
DNDCEKVCDRNVLKILNRHEHIRYGESILKCSILKSQHINNVAAQYFLGFNSNIKERVKY
IALYDSMPKPNRNKRIVAYIVCSISLLIQAPLLSAHVQQDKYETNVSYKKLNQLAPYFKG
FDGSFVLYNEREQAYSIYNEPESKQRYSPNSTYKIYLALMAFDQNLLSLNHTEQQWDKHQ
YPFKEWNQDQNLNSSMKYSVNWYYENLNKHLRQDEVKSYLDLIEYGNEEISGNENYWNES
SLKISAIEQVNLLKNMKQHNMHFDNKAIEKVENSMTLKQKDTYKYVGKTGTGIVNHKEAN
GWFVGYVETKDNTYYFATHLKGEDNANGEKAQQISERILKEMELI
>WP_064131164.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MLSSFLMLSIISSLLTICVIFLVRMLYIKYTQNIMSHKIWLLVLVSTLIPLIPFYKISNF
TFSKDMMNRNVSDTTSSVSHMLDGQQSSVTKDLAINVNQFETSNITYMILLIWVFGSLLC
LFYMIKAFRQIDVIKSSSLESSYLNERLKVCQSKMQFYKKHITISYSSNIDNPMVFGLVK
SQIVLPTVVVETMNDKEIEYIILHELSHVKSHDLIFNQLYVVFKMIFWFNPALYISKTMM
DNDCEKVCDRNVLKILNRHEHIRYGESILKCSILKSQHINNVAAQYLLGFNSNIKERVKY
IALYDSMPKPNRNKRIVAYIVCSISLLIQAPLLSAHVQQDKYETNVSYKKLNQLAPYFKG
FDGSFVLYNEREQAYSIYNEPESKQRYSPNSTYKIYLALMAFDQNLLSLNHTEQQWDKHQ
YPFKEWNQDQNLNSSMKYSVNWYYENLNKHLRQDEVKSYLDLIEYGNEEISGNENYWNES
SLKISAIEQVNLLKNMKQHNMHFDNKAIEKVENSMTLKQKDTYKYVGKTGTGIVNHKEAN
GWFVGYVETKDNTYYFATHLKGEDNANGEKAQQISEHILKEMELI
>WP_053000968.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MLSSFLMLSIISSLLTICVIFLVRMLYIKYTQNIMSHKIWLLVLVSTLIPLIPFYKISNF
TFSKDMMNRNVSDTTSSVSHMLDGQQSSVTKDLAINVNQFETSNITYMILLIWVFGSLLC
LFYMIKAFRQIDVIKSSSLESSYLNERLKVCQSKMQFYKKHITISYSSNIDNPMVFGLVK
SQIVLPTVVVETMNDKEIEYIILHELSHVKSHDLIFNQLYVVFKMIFWFNPALYISKTMM
DNDCEKVCDRNVLKILNRHEHIRYGESILKCSILKSQHINNVAAQYLLGFNSNIKERVKY
IALYDSMPKPNRNKRIVAYIVCSISLLIQAPLLSAHVQQDKYETNVSYKKLNQLAPYFKG
FDGSFVLYNEREQAYSIYNEPESKQRYSPNSTYKIYLALMAFDQNLLSLNHTEQQWDKHQ
YPFKEWNQDQNLNSSMKYSVNWYYENLNKHLRQDEVKSYLDLIEYGNEEISGNENYWNES
SLKISAIEQVNLLKNMKQHNMHFDNKAIEKVENSMTLKQKDTYKYVGKTGTGIVNHKEAN
GWFVGYVETKDNTYYFATHLKGEGNANGEKAQQISERILKEMELI
>ABI95380.2|FEATURES|NCBI|tetracycline|tetX|antibiotic inactivation|1
MNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEA
MKKAGLLQTYYDLALPMGVNIADKKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLEN
DTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKVRKFVTDTEVEETGTFN
IQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNNGALHFGISFKTPDEWKNQTQ
VDFQNRNSVVDFLLKEFSDWDERYKELIHTTLSFVGLATRIFPLEKPWKSKRPLPITMIG
DAAHLMPPFAGQGVNSGLVDALILSDNLADGKFNSIEEAVKNYEQQMFMYGKEAQEESTQ
NEIEMFKPDFTFQQLLNV
>OBP63446.1|FEATURES|NCBI|tetracycline|tetX|antibiotic inactivation|1
MNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEA
MKRAGLLQTYYDLALPMGVNIVDEKGNILTTKNVRPENRFDNPEINRNDLRAILLNSLEN
DTVIWDRKLVALEPDKEKWVLSFEDKPNETADLVIIANGGMSKVRKYVTDTEVEETGTFN
IQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNNGALHFGISFKTPDEWKNQTQ
VDFQNRNSVVDFLLKKFSDWDERYKELIHTTLSFVGLATRIFPLEKPWKSKRPLPITMIG
DAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAIENYEQQMFAYGREAQEESTQ
NEIEMFKPDFTFQQLLNV
>OBP41431.1|FEATURES|NCBI|tetracycline|tetX|antibiotic inactivation|1
MNLLSDKNVAIIGAGPVGLTMARLLQQNGVDVTVYERDKDRDARIFGGTLDLHRDSGQEA
MKKAGLLQTYYDLALPMGVNIADEKGNILTTKNVKPENRFDNPEINRNDLRTILLNSLQN
NTVIWDRKLVALEPDKEKWVLSFEDKPNETADLVIIANGGMSKVRKYVTDTEVEETGTFN
IQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNNGALHFGISFKTPDEWKNQTQ
VDFQNRNSVVDFLLKKFSDWDERYKELIHTTLSFVGLATRIFPLEKPWKSKRPLPITMIG
DAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAIENYEQQMFIYGKEAQEESTQ
NEIEMFKPDFTFQQLLNV
>OBP58430.1|FEATURES|NCBI|tetracycline|tetX|antibiotic inactivation|1
MNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEA
MKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVKPENRFDNPEINRNDLRTILLNSLQN
DTVIWDRKLVTLEPDKEKWTLTFEDKPSETADLVIIANGGMSKVRKFVTDTEVEETGTFN
IQADIHQPEVNCPGFFQLCNGNRLMAAHQGNLLFANPNNNGALHFGISFKTSDEWKSKTL
VDFQDRNSVVDFLLKKFSDWDERYKELIRVTSSFVGLATRIFPLDKSWKSKRPLPITMIG
DAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAIENYEQQMFIYGKEAQEESTQ
NEIEMFKPDFTFQQLLNV
>AMP57029.1|FEATURES|NCBI|tetracycline|tetX|antibiotic inactivation|1
MNLLNNKKVTIIGGGPVGLTMARLLQQNDIDVTVYERDKDRQARIFGGTLDLHKTSGQEA
MKKAGLLKAYYDLALPMGVNIADEKGNILTTKNVKPENRFDNPEINRNDLRTILLNSLQN
DTVIWDRKLVTLEPDKEKWTLTFEDKPSETADLVIIANGGMSKVRKFVTDTEVEETGTFN
IQADIHQPEVNCPGFFQLCNGNRLMAAHQGNLLFANPNNNGALHFGISFKTSDEWKSKTL
VDFQDRNSVVDFLLKKFSDWDERYKELIRVTSSFVGLATRIFPLGKSWKSKRPLPITMIG
DAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAIENYEQQMFAYGREAQAESII
NETEMFSSDFSFQKLMNL
>CRL66316.1|FEATURES|NCBI|tetracycline|tetX|antibiotic inactivation|1
MTLLKNKKITIIGAGPVGLTMARLLQQNRVDVTVYERDKDRDARIFGGTLDLHRDSGQEA
MKRAGLLQTYYDLALPMGVNIADEKGNILTTKNVKPENRFDNPEINRNDLRTILLNSLQN
DTVIWDRKLVTLEPDKEKWTLTFEDKPSETADLVIIANGGMSKVRKFVTDTEVEETGTFN
IQADIHQPEVNCPGFFQLCNGNRLMAAHQGNLLFANPNNNGALHFGISFKTSDEWKSKTL
VDFQDRNSVVDFLLKKFSDWDERYKELIRVTSSFVGLATRIFPLGKSWKSKRPLPITMIG
DAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAIENYEQQMFAYGREAQAESII
NETEMFSSDFSFQKLMNL
>AMP54231.1|FEATURES|NCBI|tetracycline|tetX|antibiotic inactivation|1
MTLLKHKKITIIGAGPVGLTMARLLQQNRVDVTVYERDKDRDARIFGGTLDLHRDSGQEA
MKRAGLLQTYYDLALPMGVNIVDEKGNILTTKNVRPENRFDNPEINRNDLRTILLNSLQN
DTVIWDRKLVTLEPDKEKWILTFEDKSSETADLVIIANGGMSKVRKFVTDTEVEETGTFN
IQADIHQPEVNCPGFFQLCNGNRLMAAHQGNLLFANPNNNGALHFGISFKTPDEWKSKTR
VDFQDRNSVVDFLLKKFSDWDERYKELIRLTSSFVGLATRIFPLDKSWKSKRPLPITMIG
DAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAIENYEQQMFAYGREAQAESII
NETEMFSSDFSFQKLMNL
>AKL03765.1|FEATURES|NCBI|aminoglycoside|APH(3')-IIIa|antibiotic inactivation|1
MDKLPNFIFENYSDLKIERDTEGWSPAEVYSVTTKKKRWFLKRSHTRYNKTTYNVRREKE
IIEWAYPKFRVPQIIHYEEAKEYNSLLMNHIGGSSLEMLGPSITLEKYIDYYVQSLKLMQ
SINIENCPYNNCIKNRIIELEYLLENDLADINSNNWEEDTREHFRNGKDLFNYIVNNKPN
EDLVFSHGDMTNSNIFIENEEVGFIDLGRCGLADKWVDIAFCVRDIREISNENKWIKMLF
DKLEIVPNWDKMRYYILLDELF
>WP_062750112.1|FEATURES|NCBI|glycopeptide|vanRF|antibiotic target alteration|1
MKTISILIADDEEEIADLLAIHLEKEGYYVVKAGDGQEAIHIVETQPIDLLILDIMMPKM
DGYEVTRRIRETHNMPIIFLSAKTSDFDKVHGLVIGADDYITKPFTPIELVARVNAQLRR
FMKLNQPYTVVDPKTRLEYRGLVISLEQRTVTLYGENIELTPKEFDILYLLASHPKKVFS
VENIFKQVWGEAYFEGANTVMVHIRTLRKKLEEDKRKDKWIKTVWGVGYAFNG
>WP_060209917.1|FEATURES|NCBI|glycopeptide|vanRF|antibiotic target alteration|1
MKDISILIADDEKEIADLIALHLEKEGYHVIKVSDGEEAVHVAQTESIDLLILDIMMPKM
DGYEVASRIREQYNMPIIFLSARTSDFDKVQGLVIGADDYMTKPYSPIELVARVNAQLRR
FMKLNQSDTNKGNNPRVEYGGLVISPDQRTVTLYDESIQLTPKEFDILYLLASHPKKVFS
VENIFHQVWGEDYYEGNNTVMVHIRTLRKKMKEDKNKNKLIKTVWGVGYSFDG
>AGG19392.1|FEATURES|NCBI|glycopeptide|vanWB|antibiotic target alteration|1
MDRKRLTQRFPFLLPMRRAQRKMCFYAGMRFDGCRYAQTIGEKSLSHLLFETDCALYNHN
TGFDMIYQENKVFNLKLAAKTLNGLLIRPGETFSFWWLVRHADKDTPYKDGLTVTNGKLT
TMSGGGMCQMSNLLFWMFLHTPLTIIQRRGHEVKEFPEPNSDEIKEVDATISEGWIDLKV
RNDTDCTYQIWVTLDDEKIIGQVSADKEPQALYKITNGSIQYVRESGGIYEYAQVKRMQV
ALGTGEIIDCKLLYTNKCKICYPLPESVDIQEENQ
>SAM46405.1|FEATURES|NCBI|glycopeptide|vanWB|antibiotic target alteration|1
MDRKRLTQRFPFLLPMRRAQRKMCFYAGMRFDGCRYAQTIGEKSLSHLLFETDCALYNHN
TGFDMIYQENKVFNLKLAAKTLNGLLIRPGETFSFWWLVRHADKDTPYKDGLTVTNGKLT
TMSGGGMCQMSNLLFWMFLHTPLTIIQRRGHEVKEFPEPNSDEIKGVDATISEGWIDLKV
RNDTDCTYQIWVTLDDEKIIGQVFADKEPQALYKITNGSIQYVRESGGIYEYAQDKRMQV
ALGTGEIIDCKLLYTNKCKICYPLPESVDIQEENQ
>WP_061100012.1|FEATURES|NCBI|glycopeptide|vanWB|antibiotic target alteration|1
MDRKRLTQRFPFLLPMRRAQRKMCFYAGMRFDGCRYAQTIGEKSLSHLLFETDCALYNHN
IGFDMIYQENKVFNLKLAAKTLNGLLIRPGETFPFWWLVRHADKDTPYKDGLTVTNGKLT
TMSGGGMCQMSNLLFWMFLHTPLTIIQRRGHEVKEFPEPNSDEIKGVDATISEGWIDLKV
RNDTDCTYQIWVTLDDEKIIGQVSADKEPQALYKITNGSIQYVRESGGIYEYAQVKRMQV
ALGTGEIIDCKLLYTNKCKICYPLPESVDIQEENQ
>ANW86194.1|FEATURES|NCBI|glycopeptide|vanWB|antibiotic target alteration|1
MNRKRLTQRFPFLLPMRQAQRKICFYAGMRFDGCRYAQTIGEKSLSHLLFETDCALYNHN
TGFDMIYQENKVFNLKLAAKTLNGLLIRPGETFSFWWLVRHADKDTPYKDGLTVTNGKLT
TMSGGGMCQMSNLLFWMFLHTPLTIIQRRGHEVKEFPEPNSDEIKGVDATISEGWIDLKV
RNDTDCTYQIWVTLDDEKIIGQVFADKQPQALYKIANGSIQYVRESGGIYEYAQVKRMQV
ALGTGEIIDCKLLYTNKCKICYPLPESVDIQEENQ
>CBL15929.1|FEATURES|NCBI|glycopeptide|vanWG|antibiotic target alteration|1
KRKRLTQVFPFLLPIRKWQRKKLFYLEMLIDGNKYAKNKSEALLPNTVFETSSLMLNENS
GFDMKYQINKVHNLKLAARTINKVIIEPNETFSFWQLVRWADHHEKYKDGLNLVDGKIVG
SYGGGLCQLSNMLFWLFLHTPLTVVERHGHAVESFPSTTEDLPCGTDATINEGWLDLKIR
NDTDNTFQIEISFDDKYMYGRILSQSPVNIEYSVFNSSVSYFKREEKIYQIASVCRTEKD
KMTGRQTEKELYVNQCEIAYKLPDDIKIEERGV
>AEC49686.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|Erm(39)|antibiotic target alteration|0
MKEKVVFDNAISLYTESFGDPTDEPIILIMGAMSSAVWWPDEFCSELATMGRYVIRYDHR
DTGKSTSYEPGQAPYSVEELADDVVRVIDGYGLEAAHLVGMSLGGFLSQLVAIKYPKRVK
SLTLIASERLADADPNMPSFDPAIIEYHQRAESLDWSDRDAVVAYQVGAWRINSGTAHVF
DAEKIQKIAELNFDRTPNILTTFNHTTLGGGEKWLGRLNEIAVPALIIHGTEDPVLPYVH
GLALKDAIRGSKILKLEGSGHELHHEDWPKIIQAIREQTS
>BAD10980.1|FEATURES|NCBI|bacitracin|BacA|antibiotic inactivation|0
MKEKVVVDNAISLYTESFGDPAHEPIILIMGAMSSAVWWPDEFCSQLAKMGRYVIRYDHR
DTGKSTSYEPGQAPYSVEELADDVVRVIDGYGLEAAHLVGMSLGGFLSQLVALKYPKRVK
SLTLIASERLADADPDMPAFDPAIIEYHQRAESLDWSDRDAVVAYQVGAWRINSGTAHAF
DAEKIQNIAELNFDRTPNILTTFNHTTLGGGERWLGRLNEIAVPTLIIHGTEDPVLPYVH
GLALKDAIRGSKMLTLEGTGHELHHEDWPRIIQAIKGQTS
>BAD10974.1|FEATURES|NCBI|bacitracin|BacA|antibiotic inactivation|0
MKEKVVVDKAISLYTESFGDPAHEPIILIMGAMSSAVWWPDEFCSQLAKMGRYVIRYDHR
DTGKSTSYEPGQAPYSVEELADDVVRVIDGYGLEAAHLVGMSLGGFLSQLVALKYPKRVK
SLTLIASEWLADADPDMPAFDPAIIEYHQRAESLDWSDKDAVVAYQVGSWRINSSTAHAF
DAEKIQNIAELNFDRTPNILTTFNHTTLGGGERWLGRLNEIAVPTLIIHGTEDPVLPYVH
GLALKEAIRGSKMLTLEGTGHELHHEDWPRIIQAIKGQTS
>AFQ43752.1|FEATURES|NCBI|glycopeptide|vanZA|antibiotic target alteration|1
VKILSRGLLAVYLVILIWLVLFKLQYNILSVFNYNHRSLNLNPFAAPLKLNGRINFGEMI
NNFIIFIPFGILLNVNYKRFRFLPKFTLILVFSLTAELIQFIFAIGATDIIDVITNTVGG
ILGLILYRLSNKYISSKKLDWVIIAFGTLLLMFLLYYRIFILRLIY
>WP_034602208.1|FEATURES|NCBI|glycopeptide|vanZA|antibiotic target alteration|1
VKILSRGLLAVYLVILIWLVLFKLQYDILSVFNYNHRSLNLNPFAAPLKLNGSINFGEMI
NNFIIFIPFGMLINVNYKRVGFLPKFTMILGFSLTAELIQFIFAIGATDIIDVITNTVGG
ILGLKLYSFSNKYISSIVLDRVIIAFGTLLLVFLLYYRIFILRLIY
>EHJ00311.1|FEATURES|NCBI|glycopeptide|vanZA|antibiotic target alteration|1
GKVLSRGLLALYLGILIWLVLFKLQYNILSVFNYHHRSLNLDPFTFPLKLNGSINFGELI
DNIIIFIPFGVLLNVNFKKVRFLSKLTLILVFSITCELIQFIFAIGAADITDVITNTVGG
FLGLVLYSLSNKYVNNKKLDRVIIFVGILLLILLLYYRIHVLILKY
>ODA40045.1|FEATURES|NCBI|glycopeptide|vanZA|antibiotic target alteration|1
GKILSRGLLALYLVILIWLVLFKLQYNILSVFNYHHRSLNLNPFAAPLNINGRINFGEMI
DNVIIFIPFGLLLNVNFKKIGFLPKFALILVFSLTCELIQFIFAIGATDITDVITNTVGG
FLGLELYSLSNKYINNKRLDRVIIFVGPLLLVLLLYYRIHILRLKY
>AAM18213.1|FEATURES|NCBI|aminoglycoside|aadA1t|antibiotic inactivation|1
IAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSVIDLLVTVTVRLDETTRRA
LINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPA
TIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERN
VVLTLSRIWHSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRADQ
LEEFVHYVKGEITKVVGK
>AAN41409.1|FEATURES|NCBI|aminoglycoside|aadA1aq|antibiotic inactivation|1
IAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRRA
LINDLLETSASPGVSEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPA
TIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERN
VVLTLSRTWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRADQ
LEEFVHYVKGEITKVVGK
>AAN41437.1|FEATURES|NCBI|aminoglycoside|aadA1an|antibiotic inactivation|1
IAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLGETTRRA
LINDLLETSASPGEGEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPA
TIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERN
VVLTLSRIWYSAVTGKIAPKDVAADWAMERLPARYQPVILEARQAYLGQEEDRLASRADQ
LEEFVHYVKGEITKVVGK
>AAY43149.1|FEATURES|NCBI|aminoglycoside|aadA1k|antibiotic inactivation|1
IAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRRA
LINDLLETSASPGESEILRAVVVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPA
TIDIDLAILLTKAREHSVALVGPAVEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERN
VVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRVDQ
LEEFVHYVKGEITKVVGK
>AEQ26262.1|FEATURES|NCBI|aminoglycoside|aadA1bp|antibiotic inactivation|1
IAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRRA
LINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPA
TIGIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERN
VVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLATRADQ
LEEFVHYVKGEITKVVGK
>CAP69683.1|FEATURES|NCBI|aminoglycoside|aadA1ae|antibiotic inactivation|1
IAEVSTQLSEVVGVIERHLEPTLLAVHLCGSAVDGGLKPHSDIDLLVTVTVRLDETTRRA
LINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPA
TIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGAERN
VVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRADQ
LEEFVHYVKGEITKVVGK
>CAQ51305.3|FEATURES|NCBI|aminoglycoside|aadA1bt|antibiotic inactivation|1
IAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRRA
LINDLLETSASPGESEILRAVEVTIVVHDDIIPRRYPAKRELQFGEWQRNDILAGIFEPA
TIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERN
VVLTSSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRADQ
LEEFVHYVKGEITKVVGK
>CCF70752.1|FEATURES|NCBI|aminoglycoside|aadA1br|antibiotic inactivation|1
IAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRRA
LFNDLLETSASAEESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPA
TIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERN
VVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRADQ
LEEFVHYVKGEITKVVGK
>ABG88877.1|FEATURES|NCBI|aminoglycoside|aadA3c|antibiotic inactivation|1
TIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRRA
LLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPA
MIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDERN
VVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQEEDRLASRADQ
LEEFVHYVKGEITKVVGK
>AIA09138.1|FEATURES|NCBI|aminoglycoside|aadA8|antibiotic inactivation|1
TIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRRA
LLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPA
MIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDERN
VVLTLSRICYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRADQ
LEEFVHYVKGEITKVVGK
>ACJ63285.1|FEATURES|NCBI|aminoglycoside|aadA3|antibiotic inactivation|1
MRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADQLEEFVHYVKGEITKVVGK
>EEF67505.1|FEATURES|NCBI|glycopeptide|vanWG|antibiotic target alteration|1
SRRRVTEFLPFLLPLRRKQKIWCFYQKMKHDGNRYARRQAEERLPYIQYECTQGLINPDS
GYDIQYQYNKAHNLKVVSRRMQQLIIEPGEVFSFWQLARGADHDDPYRPGLGLHDGKIVP
VHGGGLCFMSELLYWMVLHTPLTVIEKHPHLVISLPANPNAEMPAGIDATIQEGWSDLKF
RNDTDQPFQLILDFDEDSVHAQFRCAQPPCYRYEVTGSALVYSRKKGKIYRTQDISRTLY
AAADGELVREEACYTSRSRIDYPLPPETEITE
>WP_020226403.1|FEATURES|NCBI|glycopeptide|vanWG|antibiotic target alteration|1
SRRRVTEFLPFLLPLRRKQKIWCFYQKMKHDGHRYARHQAENRLPYLQYECTQGLINPDS
GYDIQYQYNKAHNLKVVSRRMQQLIIEPGEVFSFWQLAQGADHDDPYLPGLGLHDGKIVP
VHGGGLCFMSELLYWMVLHTPLTVIEKHPHLVISLPANPNAEMPAGIDATIQEGWSDLKF
RNDTDMPFQLILDFDEASVHAQFRCGQPPQYRYEVLGSELIYSRKKGKIFRTQQISRTLY
DAESGEVVRQEACYTSRSRIDYPLSPDTEIIE
>BAN78519.1|FEATURES|NCBI|aminoglycoside|aacA48|antibiotic inactivation|1
NVVPCKTPDHPGWLELRLQLWPDGSTEEFLPEMAAACAEPDRFGQFLFLSPGGLAEGLVE
VALRTDYVNGTESSPVAFLEGVFVVPASRGLGIARALVAAAEGWARDRGCTEFASDAEVS
NVGSHAMHAALGFVETERVVFFRKVVA
>WP_052484405.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
MKSWLFLTVAILGEVVATSALKSSEGFTKLVPSFIVIVGYGIAFYFLSLVLKSIPIGVAY
AVWSGLGVVLVTAVAWGLYGQKIDAWGFVGISLIVCGVLVLNLLSKASVH
>WP_058576636.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
MKSWLFLTVAILGEVVATSALKSSEGFTKLVPSFIVIVGYGIAFYFLSLVLKSIPIGVAY
AIWSGLGVVLVTAVAWGLYGQKIDAWGFVGISLIVCGVLVLNLLSKASVH
>AGY30885.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
MKSWLFLTIAILGEVVATSALKSSEGFTKLVPSFIVIVGYGIAFYFLSLVFKSIPVGVAY
AVWSGLGVVLVTAVAWGLYVQKIDAWGFVGISLIVCGVLVLNLLSKASVH
>WP_034732386.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
MKSWLFLTISILGEVVATSALKSSEGFTKLVPSFIVIVGYGIAFYFLSLVLKSIPVGVAY
AVWSGLGVVLVTAVAWGLYGQKIDAWGFVGISLIVCGVLVLNLLSKASVH
>WP_039227222.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
KNWIFLSAAIICEVIATSSLKSSEGFTKLAPSLLVVAGYGAAFYLLSLTLKSIPVGIAYA
IWSGLGIVLVTLVAWLMHGQKLDLWGAVGMAFIVTGVVVLNLLSKASAH
>WP_025265915.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
KNWLFLSAAIICEVIATSSLKPSEGFTKIAPSLLVIIGYGAAFYLLSLTLKSIPVGIAYA
IWSGLGIVLVTLIAWFIHGQKLDLWGYVGMGLIVGGVVVLNLLSKTSAH
>WP_068511193.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
KNWLFLSAAIICEVIATSSLKSSEGFTKIAPSLLVIIGYGAAFYLLSLTLKSIPVGIAYA
VWSGLGIVLVTLVAWFMHGQKLDLWGYVGMGLIVGGVVVLNLLSKTSAH
>WP_058818681.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
KSWIFLAVAIVGEVIATSALKSSEGFTRLIPSAIVVVGYAVTFYCLSLALKTIPVGIAYA
VWAGLGIVLVAGIAWAMHGQTLDAWAVVGIALIVCGVAVLNLLSNVSAH
>WP_027069939.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
KSWLFLAIAIVAEVVATSALKSSEGFTRLGPSALVVGGYGVAFYFLSLVLKTIPVGVAYA
VWSGLGIVLIAAVAWLVHGQKLDAWAFVGMGLIVSGVAVLNLLSRTSVH
>WP_009836365.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
MKGWLFLAIAIVGEVVATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAY
AVWSGLGVVIITAIAWLLYGQKLDAWGFVGMGLIVSGVVVLNLLSKASAH
>ACN22639.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
MKGWLLLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVMKSIPVGVAY
AVWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIVSGVVVLNLLSKASAH
>ACN22665.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
MKGWLFLAIAIVGEVIATFALKSSEGFTKLAPSAAVIIGYGIAFYFLSLVLKSIPVGVAY
AVWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIVSGVVVLNLLSKASAH
>ACN22676.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
KNWLFLATAIIFEVIATSALKSSEGFTRLVPSFIVVAGYAAASCFLSLTLKSIPVGIAYA
VWSGLGIVLVTAIAWVLHGQKLDMWGFVGVGFIISGVAVLNLLSKASVH
>ACN22630.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
KNWLFLATAIISEVIATSALKSSEGFTRLVPSFIVVAGYAAAFYFLSLTLKSIPVGIAYA
VWSGLGIVLVTAIAWVLHGRKLDMWGFVGVGFIINGVAVLNLLSKASVH
>WP_048269931.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
KIWLFLATSIISEVIATSALKSSEGFTRLVPSFIVVAGYAAAFYFLSLTLKSIPVGIAYA
VWSGLGIVLVTAIAWVLHGQKLDMWGFVGVGFIISGVAVLNLLSKASVH
>ACS73678.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
KNWLFLATAIISEVIATSALESSEGFTRLVPSFIVVAGYAAAFYFLSLTLKSIPVAIAYA
VWSGLGIVLVTAIAWVLHGQKLDMWGFVGVGFIISGVAVLNLLSKASVH
>WP_022951155.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
NHWLLLLVAIVGEVVATSALKSSEGFTKLFPSMIVVVGYGLAFYFLSVALKTIPVGIAYA
VWAGLGIVLVAFIAYIMHGQKLDFWAFVGISLIVSGVAVLNLLSKTSTH
>WP_047135584.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
KSWLLLAVAIVGEVVATSALKSSEGFTRPIPSAIVVVGYGLAFYALSLALKSIPVGIAYA
VWAGLGIVLVTAIAWIFHGQKLDPWGFVGMGLIVSGVAVLNLLSKTSAH
>ACN22626.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
KNWIFLAVAIFGEVIATSALKSSHGFTRLVPSVVVVAGYGLAFYFLSLALKSIPVGIAYA
VWAGLGIVLVAAIAWIFHGQKLDFWAFIGMGPIVSGVAVLNLLSKVGAH
>ACS73595.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
KNWIFLAVSILGEVIATSALKSSHGFTRLVPSVVVVAGYGLAFYFLSLALKSIPVGIAYA
VWAGLGIVLVAAIAWIFHGQKLDFWAFIGMGLIVSGVAVLNLLSKVSAH
>WP_049237932.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
KNWIFLAVAIFGEVIATSALKSSHGFTRLVPSVVVVAGYGLAFYFLSLALKSMPVGIAYA
VWAGLGIVLVAAIAWIFHGQKLDFWAFIGIGLIVSGVAVLNLLSKVSAH
>WP_049194240.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
KNWIFLAVSIFGEVIATSALKSSHGFTKLVPSVVVVAGYGLAFYFLSLALKSIPVGIAYA
VWAGLGIVLVAAIAWIFHGQKLDLWAFVGMGLIVSGVAVLNLLSKVSAH
>WP_043106116.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
KNWLFLAIAIFGEVVATSALKSSHGFTRLVPSVVVVAGYGLAFYFLSLALKSIPVGIAYA
VWAGLGIVLVAAVAWIFHGQKLDFWAFIGMGLIVSGVAVLNLLSKVSAH
>WP_015059047.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|1
KNWLFLAIAIFGEVVATSALKSSHGFTKLVPSVVVVAGYGLAFYFLSLAIKSIPVGIAYA
VWAGLGIVLVAAIAWIFHGQKLDLWAFVGMGLIVSGVAVLNLLSKVSAH
>WP_049392010.1|FEATURES|NCBI|beta_lactam|blaZ|antibiotic inactivation|1
MKKLIFLIAIALVLSACNSNSPHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKIHINKDDIVAYSPILEKYVGKDITLKELIEASMTY
SDNTANNKIIKEIGGNKKVKQRLKGLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKENKKFLLDLMLNNKSGDTLIKDGVSKDCKVADKSGQAITYASRNDVAF
VYPKNQSEPIILVIFTNKDNKSDKPNDKLISETAKNVINKF
>WP_031916968.1|FEATURES|NCBI|beta_lactam|PC1|antibiotic inactivation|1
MKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMKY
SDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKKNKNFLLDLMLNNKNGDTLIKDGVPKDYKVADKSGQAITYASRNDVAF
IYPKNQSEPIILVIFTNKDNKSDKPNDKLISETAKNVINKF
>WP_000733620.1|FEATURES|NCBI|beta_lactam|SH09_09290|antibiotic inactivation|1
MKKLILLIAIALVLSACNSTSSHAKELNNLEKKYNANIGVYALDTKSGKEVKFNADKRFA
YASTSKAINSAILLEQVPYNKLNKKIHINKDDIVAYSPILEKYVGKDITLKELIEASMKY
SDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKENKKFLLDLMLNNKNGDTLIKDGVPKDYKVADKSGQAITYASRNDVAF
IYPKNQSEPIILVIFTNKDNKSDKPNDKLISETAKNVINKF
>WP_049401912.1|FEATURES|NCBI|beta_lactam|PC1|antibiotic inactivation|1
MKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMKY
SDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKTNKNFLLDLMLNNKNGDTLIKDGIPKDYKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>WP_000733402.1|FEATURES|NCBI|beta_lactam|blaZ|antibiotic inactivation|1
MKKLIILVVLALILSACNSKNSTNNDIEKIEKKYGANVGMYALNTQNGKELSFNENKRFA
YASTLKTISSAMLLEQTPYNKLDKKIHINKDDIVPYSPVLEKYIGKEITLKKLIEATMLF
SDNTANNKIIDELGGYGQVKTKLIDLGDTTTHPSRKEPDLNFYSPKDKRDTSTPLAYGKT
LKKLIADGDLSKANKDFLLNLMFKNKSGDTLIKDGAPSNFKVMDKSGQALTYGSRNDVAF
VYPDGQDKPIILVIFTNKDRKDGKPNDKIVSEVAEIVLKNINE
>WP_069996661.1|FEATURES|NCBI|beta_lactam|blaZ|antibiotic inactivation|1
MKKLIILVMLALILSACNTKHSTNNDIEKLEKKYGANIGMYALNTQNGEELSFNENKRFA
YASTLKAISSAMLLEQTPYNKLDKKIHINKDDIVPYSPVLEKYIGKEITIKKLIEATMLF
SDNTANNKIIDELGGYEHVKNRLTDLGDTTTHPSRKEPDLNFYSPKDKRDTTTPIAYGKT
LNKLIVDGKLSKANKDFLLDLMFKNKSGDTLIRDGASSNFKVMDKSGQALTYGSRNDVAL
VYPDGQNKPIILVIFTNKDKKDGKPNDKIVSEVAKIVLKSINE
>WP_065381445.1|FEATURES|NCBI|beta_lactam|V070_01895|antibiotic inactivation|1
MKKLIIMIASILLLSACSTADATTQDLKKVEDKYDANIGVYALNTATDEEITFNEDKRFA
YASTFKAVSSAMLLEKTPHNELNKKVHVSKEDIVPYSPVLEKFINKDITIKKLIEATMLY
SDNTANNMIIEELGGYKEVNKRLKSLDDKTTKPSRMEPELNIYDPKSNRDTSTPQAFGKT
LNKLINDGRLSKENKAFLIDLMINNKSGDTLIKKGAPKNFKVADKSGQAITYASRNDVAF
VYPKGESKPIVLVIFTNKEGKTDKPNDKVVSETAKVVLEKF
>WP_064210958.1|FEATURES|NCBI|beta_lactam|blaZ|antibiotic inactivation|1
MKKLIILSVLLLVLSACNNKDSNNSAIDKIEKKYDANVGMYALNTQNGEELSFNEDKRFS
YASTLKAVSSAMLLEKVPSNKLDKKIHISKDDIVTYSPVLEKYVDKEITLKKLIEANMLY
SDNTANNKVIDELGGYKEVKKRLVDLGDTMTYPSRKEPDLNLYTPKDKRDTTTPSAFGKT
LNKLIIDGNLSKSNKDFLMNLMLKNKSGDTLIKDGAPSDFKVMDKSGQAVTYGSRNDVAF
IYPKGQDKPIILVIFTNKNNKDAKPNDKIVSEVAEEVLKNI
>WP_048792890.1|FEATURES|NCBI|beta_lactam|blaZ|antibiotic inactivation|1
MKKLLFLIALALLLSACSTKKSTNDEIKKIEKKHNANIGMYALNTKNGKALSFNKDKRFA
YASTFKTISSAMLLEKTPHNKLDKKIHITKDDIVPYSPVLEKYIGKDITLHKLIEANMLY
SDNTANNKIIDELGGYKQVKNRLENLGDTTTHPSRKEPNLNLYAPKDKRDTSTPLAYGKT
LNKLITDGKLSKTNKDFLLDLMLKNKSGDTLIKDGAPSNFKVKDKSGQALTYGSRNDVAF
VYPKGQDKPIILVIFTNKDKKDAKPNDKTVSEVAKVVLKNI
>WP_032036997.1|FEATURES|NCBI|multidrug|AdeC|antibiotic efflux|0
MSKSTIVSRGLILSTLSIALVACVNMQAPQPAITSHIPQNFSQNHSGKTIAEKSYKEFIS
DPKLVQVIEISLNNNRDLRTATLNIERVQQEYQITKNSQLPTIGVTGNAVRQVSPSINPN
NPVSTFQVGLGMTAYELDFWGRVQNLKDAALNNYLATQSAKEAVQISLISNITQVWLNYA
FAQANLNLAEQTLKAQVNAYNLNKKRFDVGIDSEVPLKQAQISVETARNDVATYKIQIQQ
AKNLLDLLAGHPVPQNLLPDHAIQNITFEKNFAAGLPSDLLNYRPDLKAAEYELRAAGAN
IGAAKARMFPTISLTGSTGYASSELKDLFKTGNFAWSIRPSIDLPIFDWGTRKTNIKIAE
TDQKIALAKYEKAIQSAFREVNDALATHAHIGERLDAQRRLVSATAATYKLSMARYRAGV
DSYFTVLDAQRSAYAAQQGLLALEQMQLNNQIELYKVLGGGTSKV
>WP_032046739.1|FEATURES|NCBI|multidrug|AdeC|antibiotic efflux|0
MSKSIIVSRGLILSTLSIALVACVNMQAPQPAITSHIPQNFSQNHSGKTIAEKSYKEFIS
DPKLVQVIEISLNNNRDLRTAKLNIERVQQEYQITKNSQLPTIGVTGNAVRQVSPSINPN
NPVSTFQVGLGMTAYELDFWGRVQNLKDAALNNYLATQSAKEAVQISLISNITQVWLNYA
FAQANLNLAEQTLKAQVDAYNLNKKRFDVGIDSEVPLKQAQISVETARNDVATYKTQIQQ
AKNLLDLLAGHPVPQNLLPDHAIQNITFEKNFAASLPSDLLNHRPDLKAAEYELRAAGAN
IGAAKARMFPTISLTGSTGYASTELKDLFKSGNFAWSIGPSIDLPIFDWGTRKTNIKIAE
TDQKIALAKYEKAIQSAFREVNDALATHAHIGERLDAQRRLVSATAATYKLSMVRYRAGV
DSYFTVLDAQRSAYAAQQGLLALEQMQLNNQIELYKVLGGGTSKV
>WP_005128660.1|FEATURES|NCBI|multidrug|AdeC|antibiotic efflux|0
MSKSAIVSRGLILSTLSIALVACVNMQAPQPAITSHIPQNFSQNHSGKTIAEKSYKEFIS
DPKLVQVIEISLNNNRDLRTATLNIERVQQEYQITKNSQLPTIGVTGNAVRQVSPSINPN
NPVSTFQVGLGMTAYELDFWGRVQNLKDAALNNYLATQSAKEAVQISLISNITQVWLNYA
FAQANLNLAEQTLKAQVDAYNLNKKRFDVGIDSEVPLKQAQISVETARNDVATYKTQIQQ
AKNLLDLLAGHPVPQNLLPDHAIQNITFEKNFAAGLPSDLLNHRPDIKAAEYELRAAGAN
IGAAKARMFPTISLTGSTGYVSSELKDLFKSGNFAWSIGPSIDLLIFDWGTRKTNIKIAE
TDQKIALAKYEKAIQSAFREVNDVLATHAHMGERLDAQRRLVSATAATYKLSMARYRAGV
DSYFTVLDAQRSAYAAQQGLLALEQMELNNQIELYKVLGGGISKV
>WP_031379797.1|FEATURES|NCBI|multidrug|AdeC|antibiotic efflux|0
MSKVAIVSRGLILSTLSIALIACVNMQAPQPAITSHIPQNFSQNHSGKTIAERSYKEFIS
DPKLLQVIEISLNNNRDLRTATLNIERVQQEYQITKNNQLPTIGVTGNAVRQVSPSINPN
NPVSTFQVGLGMTAYELDFWGRVQNLKDAALNNYLATQSAKEAVQIGLISNITQVWLNYA
FAQANLNLAEQTLKAQVDAYNLNKKRFDVGIDSEVPLKQAQISVETARNDVATYKTQIQQ
AKNLLDLLAGHPVPQNLLPDHAIQNITFEKNFAAGLPSDLLNHRPDLKAAEYELRAAGAN
IGAAKARMFPTISLTGSTGYASSELKDLFKTGNFAWSIGPNIDLPIFDWGTRKTNIKIAE
TDQKIALAKYEKAIQSAFREVNDALATHAHIGERLDAQRRLVSATAATYKLSMARYRAGV
DSYFTVLDAQRSAYAAQQGLLALEQMELNNQIELYKVLGGGTSKI
>WP_024433862.1|FEATURES|NCBI|multidrug|AdeC|antibiotic efflux|0
MSKSTIVSRGLILSTLSIALVACVNMQAPQPAITSHIPQNFAQNSSGTTIAEKSYKEFIS
DPKLVQVIEISLNNNRDLRTATLNIERVQQQYQITKNSQLPTIGVTGNAVRQVSPSINPN
NPASTFQVGLGMTAYELDFWGRVQNLKDAALNNYLATQSAKEAVQISLISNISQVWLNYA
FAQANLNLAEQTLKAQVDAYNLNKKRFDVGIDSEVPLKQAQISVETARNDVATYKTQIQQ
AKNLLDLLAGHPVPQNLLPDHVIQNITFEKNFAAGLPSDLLNHRPDLKAAEYELRAAGAN
IGAAKARMFPTISLTGSTGYASSELKDLFKTGNFAWSIGPNIDLPIFDWGTRKTNIKIAE
TDQKIALAKYEKAIQSAFREVNDALATHAHIGERLDAQRRLVSATSSTYKLSMARYKAGV
DSYFTVLDAQRSAYAAQQGLLALEQMELNNQIELYKVLGGGTSKV
>WP_000048141.1|FEATURES|NCBI|multidrug|AdeC|antibiotic efflux|0
MSKVAIVSRGLVVSALSVALVACVNMQAPQPAITSHIPQNFAQISSGTTIAEKSYKEFIS
DPKLLQVIEIGLNNNRDLRTATLNIERVQQQYQITKNSQLPTIGVTGNAVRQVSPSINPN
NPVSTFQVGLGMTAYELDFWGRVQNLKDAALNNYLATQSAKEAVQISLISNITQVWLNYA
FAQANLNLAEQTLKAQVDAYNLNKKRFDVGIDSEVPLKQAQISVETARNDVATYKTQIQQ
AKNLLDLLAGHPVPQNLLPDHAIQNITFEKNFAAGLPSDLLNHRPDLKAAEYELRAAGAN
IGAAKARMFPTISLTGSTGYASSELKDLFKTGNFAWSIGPNIDLPIFDWGTRKTNIKIAE
TDQKIALAKYEKAIQSAFREVNDVLATHAHIGERLDAQRRLVSATAATYKLSMARYRAGV
DSYFTVLDAQRSAYAAQQGLLALEQMELNNQIELYKVLGGGISKV
>WP_000045117.1|FEATURES|NCBI|multidrug|AdeC|antibiotic efflux|0
MSKSAIVSRGLILSTLSIALVACVNMQAPQPAITSHIPQNFSQNHSGKTIAEKSYKEFIS
DPKLVQVIEISLNNNRDLRTATLNIERVQQEYQITKNNQLPTIGVMGSAVRQVNPSINPN
NPASTFQVGLGMTAYELDFWGRVQNLKDAALNNYLATQSAKEAVQISLISNITQVWLNYA
FAQANLNLAEQTLKAQVDAYNLNKKRFDVGIDSEVPLKQAQISVETARNDVATYKTQIQQ
AKNLLDLLAGHPVPQNLLPDHVIQNITFEKNFAAGLPSDLLNHRPDLKAAEYELRAAGAN
IGAAKARMFPTISLTGSTGYASSELKDLFKSGNFAWSIGPSIDLPIFDWGTRKTNIKIAE
TDQKIALAKYEKAIQSAFREVNDALATHAHIGERLDAQRRLVSATAATYKLSMARYRAGV
DSYFTVLDAQRSAYAAQQGLLALEQMELNNQIELYKVLGGGTSKV
>WP_047480810.1|FEATURES|NCBI|multidrug|AdeC|antibiotic efflux|0
MSKSAIVSRGLILSTLSIALVACVNMQAPQPAITSHIPQNFSQNHSGKTIAEKSYKEFIS
DPKLLQVIEIGLNNNRDLRTATLNIERVQQEYQITKNNQLPTIGVMGSAVRQVNPSINPN
NPASTFQVGLGMTAYELDFWGRVQNLKDVALNNYLATQSASEAVQISLISNITQVWLNYA
FAQANLNLAEQTLKAQVDAYNLNKKRFDVGIDSEVPLKQAQISVETARNDVATYKTQIQQ
AKNLLDLLAGYSVPQNLLPDHSIQNITIEKNFAAGLPSDLLNHRPDLKVAEYELRAAGAN
IGAAKARMFPTISLTGSTGYASTELKDLFKSGNFAWSIGPSIDLPIFDWGTRKTNIKIAE
TDQKIALAKYEKAIQSAFREVNDALATHAHIGERLDAQRRLVSATAATYKLSMARYRAGV
DSYFTVLDAQRSAYAAQQGLLALEQMELNNQIELYKVLGGGTSKV
>WP_032063003.1|FEATURES|NCBI|multidrug|AdeC|antibiotic efflux|0
MSKSAIVSRGLILSTLSVTLVACVNMQAPQPAITSHIPQNFSQNHSGKTIAEKSYKEFIS
DPKLLQVIEISLNNNRDLRTATLNIERVQQEYQVTKNNQLPTIGVMGSAVRQVNPSINPN
NPASTFQVGLGMTAYELDFWGRVQNLKDAALNNYLATQSASEAVQISLISNITQVWLNYA
FAQANLNLAEQTLKAQLDSYHLNKKRFDVGIDSEVPLKQAQISVETARNDVATYKTQIQQ
AKNLLDLLAGYSVPQNLLPDHSIQNITIEKNFAAGLPSDLLNHRPDLKVAEYELRAAGAN
IGAAKARMFPTISLTGSTGYASTELKDLFKTGNFAWSIGPSIDLPIFDWGTRKTNIKIAE
TDQKIALAKYEKAIQSAFREVNDALATHAHIGERLDAQRRLVSATSATYKLSMARYRAGV
DSYFTVLDAQRSAYAAQQGSLALEQMKLNNQIELYKALGGGISKG
>WP_002049977.1|FEATURES|NCBI|multidrug|AdeC|antibiotic efflux|0
MSKSAIVSRGLILSTLSIALIACVNMQAPQPAITSHIPQNFSQNHSGKTIAERSYKEFIS
DPKLAQVIEITLNNNRDLRTATLNIERVQQEYQITKNSQLPTIGVMGSAARQVDPSINPN
NPVSTFQVGLGMTAYELDFWGRVQNLKDAALNNYLATQSVKEAVQISLISNVTQAWLNYA
FAQANLNLAEQTLKTQLDSYHLNKKRFEVGIDSEVPLKQAQISVETARNDVATYKTQIQQ
AKNLLDLLAGHPVPQNLLPDHTIQNITFEKTFAAGLPSDLLNHRPDLKAAEYELRAAGAN
IGAAKARMFPTISLTGSTGYASSELKDLFKTGNFAWSIGPTIDLPIFDWGTRKANIKIAE
TDQKIALAKYEKAIQSAFREVNDALATHAHIGERLDAQRRLVSATEATYKLSMARYRAGV
DSYFTVLDAQRSAYAAQQGLLALEQMKFNNQIEIYKALGGGISKS
>WP_004708755.1|FEATURES|NCBI|multidrug|AdeC|antibiotic efflux|0
MSKSATVSRGLVISTLSIALVACVNMQAPQPAITSHIPHNFSQNTSGKTIAEQSYKEFIS
DPKLAQVIEITLNNNRDLRTATLNIERVQQEYQITKNSQLPTIGVIGSAVRQVDPSINPN
NPVSTFQVGLGMTAYELDFWGRVQNLKDAALNNYLATQSAKEAVQISLISNVTQAWLNYA
FAQANLNLAEQTLKTQLDSYHLNKKRFEVGIDSEVPLKQAQISVETARNDVATYKIQIQQ
AKNLLDLLAGHPVPQNLLPDHTIQNITFEKTFAAGLPSDLLNHRPDLKAAEYELRAAGAN
IGAAKARMFPTISLTGSTGYASSELKDLFKTGNFAWSIGPSVDLPIFDWGTRKANIKIAE
TDQKIALAKYEKAIQSAFREVNDALATHAHIGERLDAQRRLVSATDATYKLSMARYRAGV
DSYFTVLDAQRSAYAAQQGLLALEQMKFNNQIEIYKALGGGISKR
>WP_032010424.1|FEATURES|NCBI|multidrug|AdeC|antibiotic efflux|0
MSKSATVSRGLVISTLSIALVACVNMQAPQPAITSHIPHNFSQNASGKTIAEQSYKEFIS
NPKLAQVIEITLNNNRDLRTATLNIERVQQEYQITKNSQLPTIGVMGSAARQVDPSINPN
NPASTFQVGLGMTAYELDFWGRVQNLKDAALNNYLATQSAKEAVQISLISNVTQAWLNYA
FAQANLNLAEQTLKTQLDSYHLNKKRFEVGIDSEVPLKQAQISVETARNDVATYKTQIQQ
AKNLLDLLAGHPVPQHLLPDHPIQNITFEKTFAAGLPSDLLNHRPDLKAAEYELRAAGAN
IGAAKARMFPTISLTGSTGYASSELKDLFKTGNFAWSIGPTIDLPIFDWGTRKANIKIAE
TDQKIALAKYEKAIQSAFREVNDALATHAHIGERLDAQRRLVSATDATYKLSMARYRTGV
DSYFSVLDAQRSAYAAQQGLLALEQMKFNNQIEIYKALGGGISKS
>WP_016805753.1|FEATURES|NCBI|multidrug|AdeC|antibiotic efflux|0
MSKSATVSRGLVISTLSIALVACVNMQAPQPVITSHIPLNFSQNASGKTIAEQSYKEFIS
NPKLAQVIEITLNNNRDLRTATLNIERVQQEYQITKNSQLPTIGVMGSAARQVDPSINPN
NPVSTFQVGLGMTAYELDFWGRVQNLKDAALNNYLATQSAKEAVQISLISNVTQAWLNYA
FAQANLNLAEQTLKIQLDSYRLNKKRFEVGIDSEVPLKQAQISVEIARNDVATYKTQIQQ
AKNLLDLLAGYPVPQNLLPDHSIQNITFEKTFAAGLPSDLLNHRPDLKAAEYELRAAGAN
IGAAKARMFPTISLTGSTGYASSELKDLFKTGNFAWSIGPSVDLPIFDWGTRKANIKIAE
TDQKIALAKYEKAIQSAFREVNDALATHAHIGERLDAQRRLVSATDATYKLSMARYRAGV
DSYFTVLDAQRSAYAAQQDLLALEQMKFNNQIEIYKALGGGISKS
>WP_032041245.1|FEATURES|NCBI|multidrug|AdeC|antibiotic efflux|0
MSKSATVSRGLVISTLSIALVACVNMQAPQPAITSHIPHNFSQNASGKTIAEQSYKEFIS
DPKLAQVIEITLNNNRDLRTATLNIERVQQEYQITKNSQLPTIGVMGRAARQVDLSINPN
NPVSTFQVGLGMTAYELDFWGRVQNLKDAALNNYLATQSAKEAVQISLISNVTQAWLNYA
FAQANLNLAEQTLKIQLDSYRLNKKRFEVGIDSEVPLKQAQISVEIARNDVATYKTQIQQ
AKNLLDLLAGHPVPQNLLPDHSIQNITFEKTFAAGLPSDLLNHRPDLKAAEYELRAAGAN
IGAAKARMFPTISLTGSTGYASSELKDLFKTGNFAWSIGPTIDLPIFDWGTRKANIKIAE
TDQKIALAKYEKAIQSAFREVNDALATHAHIGERLDAQRRLVSATDATYKLSMARYRAGV
DSYFSVLDAQRSAYAAQQGLLALEQMKLNNQIEIYKALGGGISKS
>WP_042077412.1|FEATURES|NCBI|multidrug|AdeC|antibiotic efflux|0
MSKSATVSRGLVISTLSIALVACVNMQAPQPAITSHIPHNFSQNASGKTIAEQSYKEFIS
DPKLAQVIEITLNNNRDLRTATLNIERVQQEYQITKNSQLPTIGVMGSAARQVDPSINPN
NPVSTFQVGLGMTAYELDFWGRVQNLKDAALNNYLATQSAKEAVQISLISNVTQAWLNYA
FAQANLNLAEQTLKTQLDSYHLNKKRFEVGIDSEGPLKQAQISVETARNDVATYKTQIQQ
AKNLLDLLAGYPVPQNLLPDHSIQNITFEKTFAAGLPSDLLNHRPDLKAAEYELRAAGAN
IGAAKARMFPTISLTGSTGYASSELKDLFKTGNFAWSIGPTIDLPIFDWETRKANIKIAE
TDQKIALVKYEKAIQSAFREVNDALATHAHIGERLDAQRRLVSATDATYKLSMTRYRAGV
DSYFTVLDAQRSAYAAQQGLLTLEQMKLNNQIEIYKALGGGISKS
>WP_017392737.1|FEATURES|NCBI|multidrug|AdeC|antibiotic efflux|0
MSKSATVSRGLVISTLSIALVACVNMQAPQPAITSHIPHNFSQNASGKTIAEQSYKEFIS
DSKLAQVIEITLNNNRDLRTATLNIERVQQEYQITKNSQLPTIGVMGSAARQVDPSINPN
NPASTFQVGSGMTAYELDFWGRVQNLKDAALNNYLATQSAKEAVQISLISNVTQAWLNYA
FAQANLNLAEQTLKTQLDSYHLNKKRFEVGIDSEVPLKQAQISVETARNDVATYKTQIQQ
AKNLLDLLAGHPVPQNLLPDHSIQNITFEKTFAAGLPSDLLNYRPDLKAAEYELRAAGAN
IGAAKARMFPTISLTGSTGYASSELKDLFKTGNFAWSIGPTIDLPIFDWGTRKANIKIAE
TDQKIALAKYEKAIQSAFHEVNDALAMHAHIGERLGAQRRLVSATDATYKLSMARYRAGV
DSYFTVLDAQRSAYAAQQGLLALEQMKLNNQIEIYKALGGGISKS
>WP_005305392.1|FEATURES|NCBI|multidrug|AdeC|antibiotic efflux|0
MSKVAIVSRGLVVSALSVALVACVNMQAPQPTAISHIPQNFAQNSSGTTIAEKSYKEFIS
DPKLLQVIEIGLNNNRDLRTATLNIERVQQHYQITKNSQLPTIGVTGNAVRQVSPSINPN
NPVSTFQVGLGMTAYELDFWGRVQNLKDAALNNYLATQSAKEAVQIGLISNITQVWLNYA
FAQANLNLAEQTLKAQVDAYNLNKKRFDVGIDSEVPLKQAQISVETARNDVATYKTQILQ
AKNLLDLLAGSPIPENLLPSDSIKNITLEKNFAAGLPSDLLNHRPDIKAAEYGLRAAGAN
IGAAKARMFPTISLTGSTGYASTELKDLFKSGNFAWSIGPSIDLPIFDWGTRKAGIKIAE
IDQKVALSEYEKSIQTAFKEVNDALATHAHIEERLDAQRRLVSATSATYKLSMARYKAGV
DSYFTVLDAQRSAYAAQQGLLTLEQVKLNNQIEIYKVLGGGLSKE
>WP_049836683.1|FEATURES|NCBI|multidrug|AdeC|antibiotic efflux|0
MSKAAIVSRGLVVSALSVAMVACVNMQAPQPTAISHIPQNFAQNSSGTTIAEKSYKEFIS
DTKLLQVIEIGLNNNRDLRTATLNIERVQQQYQITKNSQLPTIGVTGNAVRQVSPSINPN
NPVSTFQVGLGMTAYELDFWGRVQNLKDAALNNYLATQSAKEAVQIGLISNITQVWLNYA
FAQANLNLAEQTLKAQVDAYNLNKKRFEVGIDSEVPLKQAQISVETARNDVATYKTQILQ
AKNLLDLLAGSPVPQNLLPSDSIKNITLEKNFAAGLPSDLLNHRPDLKAAEYSLRAAGAN
IGAAKARMFPTISLTGSTGYASAELKDLFKSGNFAWSIGPSVDLPIFDWGTRKAGIKIAE
IDQKVALSEYEKSIQTAFKEVNDALATHAHIEERLDAQRRLVSATSATYKLSMARYKAGV
DSYFTVLDAQRSAYAAQQGLLALEQVKLNNQIEIYKVLGGGLSKE
>CAW30932.1|FEATURES|NCBI|rifampin|arr-3|antibiotic inactivation|1
VRGPFYHGTKAHLSIGDLITTGHLSHFEDGRALKHVYFSALMEPAIWGAELAMSLSRLDG
RGYIYIVEPTGPFEDDPNLTNKRFPGNPTKSYRTCDPLRIVGSVEDWQGHPADVLQQMLE
SLEDLERRGLAIIED
>EDS78926.1|FEATURES|NCBI|tetracycline|tet(44)|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYTSGAILELGSVDKGTTRTDTMFLERQRGITIQAAV
TSFNWNDYKINIVDTPGHTDFITEVYRSLSVLDGAILVISAKDGVQAQTRILFHALQKMN
IPTIIFINKIDQDGINLNNIYQNIKEKLSNDIIVMQNVTLTPEISIKNIIDLDDWDPVIS
RNDKLLKKYIAGEKLTIQELTYEEYRCVKKGSLFPIYHGSARNNIGTQQLIEAISNLFCS
EMNENGSELCGRVFKIEYTDHKQRLVYLRLYSGTLHLRDTIILPEKKKVKLTEIYIPSNG
EMIQTKIVCSGDIFIIPNNTLRLNDIIGNEKILPCNVWNDNTAPILRTRIEPIKIEEREK
LLDALTEIADTDPLLRYYVDTITHEIIISFLGTVQLEVICSLLIEKYHINIRIEDPTVIY
LEKPLQKADYTIHIEVPPNPFWASIGLSITPLPIGSGIQYESKVSLGYLNQSFQNAVREG
INYGLEQGLYGWKVTDCKICFEYGVYYSPVSTPSDFRFLAPIVLEQTLKKAGTQLLEPYL
SFILFTPQEYFSRAYNDAQKHCAIIETSQSKNDEVIFTGHIPARCINEYRNTLTLYTNGQ
AVFLTELKDYQIATCEPVIQSRRPNNRIDKVRHMFNKKE
>ODU72116.1|FEATURES|NCBI|chloramphenicol|chloramphenicol_hydrolase|antibiotic inactivation|1
MALNAQVEALLAMFAQMPPVDFAAISARALREINDQRPVQMGPPPAVAIAEDLSLDLAGR
TIPARLYVPEGSGENPPLVLYYHGGGWVIGTLDTHDGTCRALARASGAAVLSIGYRLAPE
HPFPAPFDDCYDALVWARDHASDLGVDGTRIAVAGDSAGGNLAAAVAIRARDEGGPALRH
QLLIYPVTDADFSLPSYAANGGGQYFLSTAAMRWFWNQYVGTEADGHIHGATVLRTENLA
GLPSATVITAQYDPLRDEGVAYAERLAAAGVPVEAEEAPGMIHGFFSMFAFVPDAVAYID
RAGARLKAALA
>AGU13987.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Ia|antibiotic inactivation|1
MNIQILNLAECTEFQESAARVLLDGFREVGKIAWATYEEAMVEVQECTEIPNIAICAVDN
NKVVGWVGIRPMYDYVWELHPMIVTKKYQKKGIGTKLLKEIEQIAKEKGLLGLALGTDDE
TDSTSLSKCDFSRDNILIEIANIKSSMSHPYAFYEKNGYFIVGVIPNANGKRKPDIWMWK
ELES
>WP_038893172.1|FEATURES|NCBI|beta_lactam|y56|antibiotic inactivation|1
MKHSSLRRSLLLAGITLPLVSFALPAWANALPASVDKQLAELERNANGRLGVAMINTGNG
TKILYRAAQRFPFCSTFKFMLAAAVLDQSQSQPNLLNKHINYHESDLLSYAPITRKNLAH
GMTVSELCAATIQYSDNTAANLLIKELGGLAAVNQFARSIGDQMFRLDRWEPDLNTARPN
DPRDTTTPAAMAARMNKLVLGDALRPAQRSQLAVWLKGNTTGDATIRAGAPTDWIVGDKT
GSGDYGTTNDIAVLWPTKGAPIVLVVYFTQREKDAKPRRDVLASVTKIILSQIS
>WP_050334115.1|FEATURES|NCBI|beta_lactam|y56|antibiotic inactivation|1
MKHSSLRRALLLAGITLPLVNFSLPTWAAAISGSLDKQLAALEHSANGRLGIAMINTGNC
TKILYRGARRFPFCSTFKFMLAAAVLGQSQSQPNLLNKHINYHESDLLSYAPITRKNLAH
GMTVSELCAATIQYSDNTAANLLLKELGGLAAVNQFARSIGDQMFRLDRWEPDLNTALPN
DPRDTTTPAAMAASINKLVLGDALHPAQRSQLTAWLKGNTTGDATIRAGAPTDWIVGDKT
GSGDYGTTNDIAVLWPTKGAPIVLVVYFTQREKDAKPRRDVLASATKIILSQIS
>WP_050548367.1|FEATURES|NCBI|chloramphenicol|cat|antibiotic inactivation|1
MPKLTSAIPVLTALDVAAAVQFWTRQLGFSELFNSAGEFAGVGRDSVTLYISYAEDQSIP
DNTQAWIRVADLDALHAEWQEVLGADAAGSSDATLTDIGEMPWGNEFVVIDPAGNCVHFA
AE
>WP_034051940.1|FEATURES|NCBI|beta_lactam|BL1_sm|antibiotic inactivation|1
RCNKNVLSVVLLGALSLSAGNAFGQVSQADVDAVIRPLMSKYKIPGMAVALSVDGQHTFY
NYGVASKATGQAVTPTTLFEIGSLSKTFTATLASYAQGQGKLQWSDQASHYLPSLKGSAF
DRVTLLNLATHTSGMPLFVPDEVTNQEQLMAWYQAWQPTAPIGSQRVYSNLGIGMLGLIT
AQSLQKPFSEAMEQDLLAPLGMKHSWVKVPENQMAEYAQGYNKLDEPVRVTPGPPDAEAY
GLKSSSADLLRWLDLNMAITPPSPAWQQAITETHKGYYQTGEFTQALIWEYYPWPTTKET
LLAGNSSERIMKGLGAKPLTPPQAGPEQAWYNKTGSTNGFSTYAVFIPGQKTALILLANK
WYPNDARIEAAYELVQRLKK
>AMP47510.1|FEATURES|NCBI|beta_lactam|BL1_sm|antibiotic inactivation|1
RCNKNVLSVVLLGALTLSAGSAFGQLSRADVDAVIRPLMSQYQIPGMAVALSVDGQHTFY
NYGVASKATGQAVTPTTLFEIGSLSKTFTATLASYAQGQGKLQFNELASHYLPSLKGSAF
DRVTLLNLATHTSGMPLFVPDEVTNQEQLMAWYQTWQPTSPIGSQRVYSNLGIGMLGLIT
AQSLQKPFSEAMEQDLLTPLGMKHSWVKVPENQMAEYAQGYNKLDEPVRVTPGPLDAEAY
GLKSSSADLLRWLDLNMAISPLSPAWQHAIAESHKGYYQTGEFTQALMWEYYPWPTTKEK
LLAGNSSERIMKGLGAKPLTPPQAGPEQAWYNKTGSTNGFSTYAVFIPGQKTALILLANK
WYPNDARIEVAYELIERLKK
>API65130.1|FEATURES|NCBI|beta_lactam|LEN-22|antibiotic inactivation|1
RRFACALAFTLSLPLASEAGPLMDTVGQLETEVGGRIGVVLRHTGSDWAVEHREDERFPM
ASTFKALLCGAVLSRVDRGEESLDDLVTYKATELVSYSPVTKNHVASGMSVGQLCEATVT
MSDNSAANLLLKRVDGPEGLTRFLRGLGDRVTRLDRNEPAMNEARRGDPRDTTSPSAVLK
TLDRLLFEGVLLPSSRAQLQQWMVDDKVADVLIRKHLPKGWRIADKSGAGHNGSRGIISV
IWPETGQPYLAAAYMTGSDASIKQRNAVIAEIGKAMIEEIKQR
>WP_057463840.1|FEATURES|NCBI|beta_lactam|CARB-10|antibiotic inactivation|1
RRFACALAFTLSLPLVSEAGPLMDTVSQLETEVGGRIGVVLRHTGSDWAVEHRADERFPM
ASTFKALLCGAVLSRVDRGEESLGDLVTYKATELVPYSPVTENHVASGMSVGQLCEATVT
MSDNSAANLLLKRVDGPEGLTRFLRGLGDRVTRLDRNEPAMNEARRGDPRDTTSPSAVLK
TLDRLLFEDVLLPSSRAQLQQWMVDDKVADELIRKHLPKDWRIADKSGAGYNGSRGIIAV
LWPETGKPYLAAAYMSGSDASFKQRNAVIAEIGKAMIEEIKQR
>KZK95120.1|FEATURES|NCBI|beta_lactam|LEN-22|antibiotic inactivation|1
RRFACALAFTLSLPLASEAGPLMDTVSQLETEVGGRIGVVLRHTGSDWAVEHRADERFPM
ASTFKALLCGAVLSRVDRGEESLGDLVTYKATELVSYSPVTENHVASGMSVGQLCEATVT
MSDNSAANLLLKRVDGPEGLTRFLRGLGDRVTRLDRNEPAMNEARHGDPRDTTSPSAVLK
TLDRLLFEDVLLPSSRAQLQQWMVDDKVADELIRKHLPKGWRIADKSGGGQNGSRGIISV
IWPDAGAPYLASVYMMGSDASFRQRNAVIAEIGKAMIEEIKQR
>WP_063311740.1|FEATURES|NCBI|beta_lactam|OKP-A-6|antibiotic inactivation|1
RVFSCTLAIVWGLPAAAVSGELMDTVTRLESEVGGRIGVVLQHTGSEWGIEHREDERFPM
ASTFKALLCGAVLSRVDRGEESLDDLVTYKATELVSYSPVTKNHVASGMSVGQLCEATVT
MSDNTAANLLLKRVDGPEGLTRFLRGLGDRVTRLDRNEPALNEAKHGDSRDTTTPSAVLK
TLDRLLFEDVLLPSSRAQLQQWMVDDKVADELIRKHLPKGWRIADKSGGGQNGSRGIISV
IWPETGKPYLASVYMMGSDASFKQRNAVIADIGKAMIEEIKQR
>WP_037035924.1|FEATURES|NCBI|beta_lactam|CARB-10|antibiotic inactivation|1
KRVSFALVVACGVPAVGAAGELLDTVNRLENEVGGRIGVVLQHTGSDWAIESRADERFPM
ASTFKALLCGAVLARVDRGEERLGEVVAYSKAELVSYSPVTKKHVAEGMRVGELCEATVT
MSDNTAANLLLKRVDGPKGLTRFLRGLGDRVTRLDRREPEMNEAKPGDARDTTSPRAVVQ
TLDRLLFEEVLQPSSRAQLQQWMVDDKVADALIRKHLPSDWRIADKSGAGHNGSRGIIAA
IWPETGEPYLAAVYMTGSDANFKKRNAVIAEIGKAIIEEIQQR
>WP_026290570.1|FEATURES|NCBI|aminoglycoside|Aac3VIII|antibiotic inactivation|1
MNEMELLERAGGPVTRSRIVNDLTTLGVHRGDTVMVHTRMSAIGFVPGGTRTVVEALAET
VGDTGTLMAYCGWNDAPPYSLADWPENWREAARSAWPAFDPLLSEADHGVGRVPEALRRW
PGAVRSRHPDASCVAAGPAAHRLLDDHPWDDPHGPDSPLARLTAIGGRVLLLGAPLDTLT
LLHHAEALAEAPGKRYVTYEQPITVAGKRVWRRFRDVDTETEAFDYGQVLPSGVWPFTAI
AQEVLDAGLGRTGMVGAARSHLFEAADVVRFGVDWIESHLGAAAPA
>WP_019710657.1|FEATURES|NCBI|aminoglycoside|Aac3VIII|antibiotic inactivation|1
MDEKELIERAGGPVTRGRLVRDLRALGVCGGDTVMVHTRMSAVGYVVGGTQTLIGALLDT
VGDAGTLMAYCGWNDAPPYDLADWPLGWREAARAEWPAYDPLFSEADHSVGRVPEALRHW
PGAVRSRHPDASFVAVGPAAHRLMDDHPWEDPHGPDSPLARLARDGGRVLLLGAPLDALT
LLHHAEALAEAPGKRYVEYEQPVIVDGRREWRRFRDIDTENEAFPYGRVVPEGVWPFTVI
AEDMLVAGIGRTGRVGAAPSHLFEAPDVVQFGVEWIEGRLGEAADD
>WP_063840271.1|FEATURES|NCBI|aminoglycoside|Aac3VIII|antibiotic inactivation|1
MDERELIERADGPVTRCRLVRDLKELGVGPGDTVMVHTRMSAVGYVVGGTQTLIGALLNA
VGDTGTLMAYCGWNDAPPYDLADWPPEWRDAARAAWPAYDTRFSEADHGVGRVPEALRHW
PGAVRSRHPDASFVAVGPAAHRLMDDHPWDDPHGPDSPLGRLTRDGGRVLLLGAPLDALT
LLHHAEALAEAPGKRYVEYEQPITVDGRRVWRRFRDVDTQTEAFPYGRVVPEGVWPFTVM
AEEMLAAGIGRTGRVGAAPSHLFEAPDVVRFGVEWIESRLGEAADG
>EKP66760.1|FEATURES|NCBI|beta_lactam|CAU-1|antibiotic inactivation|1
KKKILFTGSILLTSLSASATPLKLPDDWTQNTQPFQITENIYYVGTHGLGTYLLTSDHQA
LLIDTGLPENTKQIEQNIKKLGFKLSDVKIMVTSHAHWDHVGALARIKQDTGAKLIAMQQ
DVRALEIGKPIGENTFQSIPFTPVKVDKVIHDGEVVKLGKLKLKATLTPGHTPGCTTWST
EVKSNGKNLNVVFPCSLSVAGNVLQNNHQYPNIVEDYRQSFKRLKNMKADIVLTSHPEVA
DVMGNKARKDAGQVNAFIQPEKLSAIVKDAEIAFEKSLVSSKS
>ENV02791.1|FEATURES|NCBI|beta_lactam|CAU-1|antibiotic inactivation|1
KKKMLFIGSILLTSLSTSAAPLKLPDNWTQNTQPFQITENIYYVGTHGLAAYLLASGHQA
LLIDTGLPENTEQIEQNIKQLGFKLSDVKIMVTSHAHWDHVGALARIKQDTGAKLIAMQQ
DVQALEIEKPIGENTFQTIPFTPVKVDKVIHDGEVVKLGKFRLKATLTPGHTPGCTTWST
EVKSNGENLNVVFPCSLCVAGNVLQNNHQYPNIVEDYRKSFERLKNMKADIVLTSHPEVA
DVLGNKARKDAGQPNAFIQPEKLFSIVKDAEMAFEKSLVSSHP
>ESK45647.1|FEATURES|NCBI|beta_lactam|CAU-1|antibiotic inactivation|1
KKKMLFIGSILLTSLSTSAAPLKLPDDWTQNTQPFQITENIYYVGTHGLAAYLLASGHQA
LLIDTGLPENTEKIEQNIKQLGFKLSDVKIMVTSHAHWDHVGALARIKQDTGAKLIAMQQ
DVKALEIGKPIGENTFQTIPFTPVKVDKVIHDGEVVKLGKLKLKATLTPGHTPGCTTWST
EIKSNGKNLTVVFPCSLSVAGNVLQNNHQYPNIVADYRKSFERLKNMKADIVLISHPEVA
DVLGNKARKDAGQTNAFIQPEKLSSIVKDAEMAFEKSLVSSHP
>WP_031944967.1|FEATURES|NCBI|beta_lactam|CAU-1|antibiotic inactivation|1
KKKMLFIGSILLTSLSTSAAPLKLPDDWTQNTQPFQITENIYYVGTHGLAAYLLASGHQA
LLIDTGLPENTEQIEQNIKQLGFKLSDVKIMVTSHAHWDHVGALARIKQDTGAKLIAMQQ
DVKALEIGKPIGENTFQTIPFTPVKVDKVIHDGEVVKLGKFKLKATLTPGHTPGCTTWST
EVKSNGKNLNVVFPCSLSVAGNVLQNNHQYPNIVADYRKSFERLKNMKADIVLTSHPEVA
DILGNKARKDAGQTNAFIQPEKLSSIVKDAEMAFEKSLVSSHP
>WP_049065661.1|FEATURES|NCBI|beta_lactam|CAU-1|antibiotic inactivation|1
KKKMLFIGSILLTSLSSSAAPLKLPDDWTQNTQPFQITENIYYVGTHGLAAYLLASGHQA
LLIDTGLPENTEQIEQNIKQLGFKLSDVKIMVTSHAHWDHVGALARIKQDTGAKLIAMQQ
DVKALEIGKPIGENTFQTISFTPVKVDKVIHDGEVVKLGKFKLKATLTPGHTPGCTTWST
EVKSNGKNLNVVFPCSLSLAGNVLQNNHQYPNIVADYRKSFDRLKNMKADIVLTSHPEVA
DVLGNKARKDDGQINAFIQPEKLSNIVKDAEMAFEKSLVSSHP
>ANV82483.1|FEATURES|NCBI|beta_lactam|RD02_10175|antibiotic inactivation|1
MKHFRLCLIPVLAAFSLPVFAHPATLDTIKDAESRLHGRVGYAELDLVSGKMMDSYRSDE
RFPMMSTFKVILCGAVLARVDAGQEQLDRRIRYRQNDLVEYSPVTEKHLAEGMNVGELCH
AAITMSDNTAANLLISTLGGPSGLTAFLRKTGDSVSRLDRWETALNEALPGDERDTTTPE
SMARTLHNLLTGDALSAESRRQLMRWMEMDNVAGPLLRSVLPAGWFIADKTGAGERGSRG
IVAALGPDGKPSRIVVIYLTGTKATMDERNKQIADIGAALINHW
>WP_043592266.1|FEATURES|NCBI|beta_lactam|VK98_00160|antibiotic inactivation|1
MFKHLILFASLAAPLTQAVAADPLAVAADKLAKLERDFGGSIGVYAIDTGSGATVANRPN
ERFPMCSSFKGFLAAGVLAQSQDKPGLLDKRIRYSKAALPNWSPITTKHQASGMTVAELN
AASVQYSDNGAANLLLKEINGPAALTAFMRSIGDASFRLDRREPELNSAIPGDPRDTSTP
KAVAESAQKLALGKALPEPQRQQLADWLKGNTTGNARIRAAVPAGWEVGDKTGTCGVYGT
ANDFAVIWPPKRAPIVLAVYTKHAKKEAKHSDEVIAAAARAALEAFNVKK
>ENV80847.1|FEATURES|NCBI|aminoglycoside|ANT(3'')-IIc|antibiotic inactivation|1
MSETLQLEQLTASLQQLLGEALFGIYLYGSAVDGGLGPESDLDLLVVITQALTLQQRKQL
AETLLQISHPIGAVQRALEVTIVHKDHILSGSYPLSYELQFGEWLRDELNQGVILSEHAD
PDLSILLKKAQMHHLTLLGPSFSQWSVEIPVQQLWQAMADTYPSIVAHWDEDADERNQIL
ALCRIYFSLVTNEIAPKDQAAQWVIAQLQPQHQPVLQRMSQEYKGQIAKQNWQDEYQALQ
PIVDFLSSRIDEQFKKKS
>ESK39014.1|FEATURES|NCBI|aminoglycoside|ANT(3'')-IIc|antibiotic inactivation|1
MSETLQLEQLTGSLQQLLGESLFAIYLYGSAVDGGLGPESDLDVLVVVSQALTLQQRQQL
AETLLKISYPIGAAQRALEVTIVLKAQILSGSYPLSYELQFGEWLREELNQGALLRTHTD
PDLSILLKKAQVHHRSLLGPSLTQWSTAIPEQHLWQAMADTYPSIVEHWDEDADERNQIL
ALCRIYFSLVTSEIVPKDQAAHWVIAQLPSQHQPILQRMIQEYKGEIGKQSWQQQHQALG
AVVDFLSSKIDEQFKKKS
>ENX32354.1|FEATURES|NCBI|aminoglycoside|ANT(3'')-IIc|antibiotic inactivation|1
MLETLQLDQLQTALQQLLGESLFAIYLYGSAIDGGLGPESDLDILVVVNQVLTLQQRQQL
AETLLLISHPIGRAQRALEVTIVLKQQILSGSYPLSYELQFGEWLRDALSQGAILSTHTD
PDLSILLKKAQMHHRTLLGPSLTQWSAEIPNQQLWLAMADSYPSIVAHWDEDADERNQIL
ALCRIYFSLVMDDIVPKDQAAQWVIPQLQQQHQIALQRMSQEYKGEIGKQHWPSEHPTLQ
AIVDFLNMKITALLEHKI
>CAJ77832.1|FEATURES|NCBI|aminoglycoside|ANT(3'')-IIa|antibiotic inactivation|1
MSDFIQLEYLQEKLQQLLAESLFAIYLYGSAVDGGLGPESDLDVLVVVTQPLTSALREQL
AQELLKISQPVGELQRPLEVTILLKDEIQSGNYPLSYEMQFGEWLREELKEGGTLSSQKD
PDISILLRKARFHHAVLFGPALDQWAPEISDQELWQAMSDTYPEIVAHWDEDADERNQIL
ALCRIYFSLVMKDIASKGNAARWVMPQLPPEQKFVLQRLIQEYRGEIGKQNWQEEHYALQ
PIVNFLSSKIEEQFEQKR
>WP_002785795.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
MQNQDKFLKQFKKLALLDKNIRLVTLEGSRVNKKAKKDKYQDYDISFFVPLDKMKDFLGL
NEKQNFNECKNLPKCILELEKSSYFKKILMLQMPECMEFYPPDLPQNWISFLVLFESGVR
LDLTIIPLEDLKNYYEFEPLSQALLDKNGLFTHTIPKAPFSITHLSQRSFDDVCNEFYFL
YSCLKKALLRKQFILSNHLLNSLRKALFDLLSFKIGLNFGFEIWLGKEYTNILEFLEEKE
VKIILKSFNTATLEHIKKARKKLEILFHKNAKFVAKKSDFKLFPYRKNVKRYCKILGKL
>WP_072229212.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
MQNQDKFLKQFKKLALCDENIRLVTLEGSRVNKKAKKDKYQDYDVSFFVPLDKMKDFLGL
NEKQNFNECKNLPKCILELEKSSYFKKILMLQMPECMEFYPPDLPQNWISFLVLFESGMR
LDLTIIPLEDLKNYYEFEPLSQALLDKNGLFTHTIPKAPFSITHLSQRSFDDVCNEFYFL
YSCLKKALLRKQFILSNHLLNSLRKALFDLLSFKIGLNFGFEIWLGKEYTNILEFLEEKE
VKIILKSFNTATLEHIKKARKKLEILFHKNAKFVAKKSDFKLFPYRKNVKKYCKILRKL
>WP_075446173.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
MQNQDKFLKQFKKLALLDKNIRLVTLEGSRVNKKAKKDKYQDYDVSFFVPLDKMKDFLGL
NEKQNFNECKNLPKCILELEKSSYFKKILMLQMPECMEFYPPNLPQNWISFLVLFESGVR
LDLTIIPLEDLKNYYEFEPLSQALLDKNGLFTHTIPKAPFSITHLSQRSFDDVCNEFYFL
YSCLKKALLRKQFILSNHLLNSLRKALFDLLSFKIGLNFGFEIWLGKEYTNILEFLEEKE
VKIILKSFNTTSIKQIKKTRKKLEILFHKNAKFVAKKNDFKLFPYRKNVKKYCKILRKL
>WP_072216485.1|FEATURES|NCBI|aminoglycoside|ANT(6)-Ib|antibiotic inactivation|1
MQNQDKFLKQFKKLALCDENIRLVTLEGSRVNKRAIQDRYQDYDVSFFVPLDKMKDFLGL
NEKQNFNECKNLPKCILELEKSSYFKKILMLQMPECMEFYPPDLPQNWISFLVLFESGVR
LDLTIIPLEDLKNYYEFEPLSQALLDKNGLFTHTIPKAPFSITHLSQRSFDDVCNEFYFL
YSCLKKALLRKQFILSNHLLNSLRKALFDLLSFKIGLNFGFEIWLGKEYANILEFLEEKE
VKIILKSFNTATLEHIKKARKKLEILFHKNAKFVAKKSDFKLFPYRKNVKRYCKILGKL
>WP_072228818.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
MQNQDKFLKQFKKLALCDENIRLVTLEGSRVNKRAIQDRYQDYDVSFFVPLDKMKDFLGL
NEKQNFNECKNLPKCILELEKSSYFKKILMLQMPECMEFYPPDLPQNWISFLVLFESGVR
LDLTIIPLEDLKNYYEFEPLSQALLDKNGLFTHTIPKAPFSITHLSQRSFDDVCNEFYFL
YSCLKKALLRKQFILSNHLLNSLRKALFDLLSFKIGLNFGFEIWLGKEYANILEFLEEKE
VKIILKSFNTTSIKQIKKTRKKLEILFHKNAKFVAKKNDFKLFPYRKNVKRYCKILGKL
>ARF19224.1|FEATURES|NCBI|quinolone|QnrB17|antibiotic target protection|1
MALIFEGEKIGRNRFTGEKIENAIFRNCDFSGTDLTSSEFIGCQFYDRESQQGGNFNRAQ
LKDAIFKSCDLSMADFRHSNALGIEIRECRAQGADFRGASFMNMITTRTWFCCAYITKSN
LSYANFSKVVLEKCELWENRWNGAQILGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSE
LGDLDVRGIDLQGVKLDSYQVSQLMERLGIAVLG
>AMJ70645.1|FEATURES|NCBI|quinolone|QnrB|antibiotic target protection|1
MTLIFESEKIGRTRFTGEKIENAIFRNCDFSGTDLTSTEFIGCQFYDRESQQGGNFNRAQ
LKDAIFKSCDLSMADFRHSNALGIEIRECRAQGADFRGASFMNMITTRTWFCCAYITKSN
LSYANFSKVVLEKCELWENRWNGAQILGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSE
LGDLDVRGIDLQGVKLDSYQISQLMERLGIVVLG
>KZQ37978.1|FEATURES|NCBI|quinolone|QnrB3|antibiotic target protection|1
MALIFEGEKIGRTRFTGEKIENAIFRNCDFSGTDLTSTEFIGCQFYDRESQQGGKFTRAQ
LKDAIFKSCDLSMADFTHSNALGIEIRECRAQGADFRGASFMNMITTRTWFCSAYITKSN
LSYANFSKVVLEKCELWENRWNGAQILGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSE
LGELDVRGIDLQGVKLDSYQIAQLMERLGIVVLG
>CZU17723.1|FEATURES|NCBI|quinolone|QnrB3|antibiotic target protection|1
MALIFEGERIGRTRFTGEKIENAIFRNCDFSGTDLTNTEFIGCQFYDRESQQGGKFSRAQ
LKDAIFKSCDLSMADFRHSNALGIEIRECRAQGADFRGASFMNMITTRTWFCSAYITKSN
LSYANFSKVVLEKCELWENRWNGAQILGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSE
LGELDVRGIDLQGVKLDSYQIAQLMERLGIVVLG
>AMX05089.1|FEATURES|NCBI|quinolone|QnrB|antibiotic target protection|1
MALIFEGEKIGRTRFTGEKIENAIFRNCDFSGTDLTSTEFIGCQFYDRESQQGGKFTRAQ
LKDAIFKSCDLSMADFRHSNALGIEIRECRAQGADFRGTSFMNMITTRTWFCSAYITKSN
LSYANFSKVVLEKCELWENRWNGAQILGATFSGSDLSGGEFPSFDWRAANFTHCDLTNSE
LGELDVRGIDLQGVKLDSYQIAQLMERLGIVVLG
>WP_080669011.1|FEATURES|NCBI|quinolone|QnrB|antibiotic target protection|1
MALIFEGEKIGRTRFTGEKIENAIFRNCDFSGTDLTSTEFIGCQFYDRESQQGGKFTRAQ
LKDAIFKNCDLSMADFRHSNALGIEIRECRAQGADFRGASFMNMITTRTWFCSAYITKNN
LSYANFSKVVLEKCELWENRWNGAQILGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSE
LGELDVRGIDLQGVKLDSYQIAQLMERLGIVVLG
>EWG75371.1|FEATURES|NCBI|quinolone|QnrB3|antibiotic target protection|1
MALIFEGEKIGRTRFTGEKIENAIFRNCDFSGTDLTSTEFIGCQFYDRESQQGAKFTRAQ
LKDAIFKSCDLSMADFRHSNALGIEIRECRAQGADFRGASFMNMITTRTWFCSAYITKSN
LSYANFSKVVLEKCELWENRWNGAQILGATFSGSDMSGGEFSSFDWRAANFTHCDLTNSE
LGELDVRGTDLQGVKLDSYQVSQIMERLGIAIIG
>APY23733.1|FEATURES|NCBI|beta_lactam|V070_01895|antibiotic inactivation|1
MKKFFTIFVLLCVCFAYTTATASAQGLTKLEHKNDATVGVYGINTATGQTYSHNADTRFA
YASTFKAITSGLLLQQNSPEALNKTVTIKESDIVAYSPVTEQYVGKTMTLRQLISAAMLQ
SDNTASNIIMEQLGGLDQLSSRLQALGDTTTNPQRYEPELNNYDPQSTADTSTPRATAHN
LQKLLTTDAVAPQQRKFLQNLMFNNKTGESLIKKGVPNSYKVGDKSGQGTTYGTRNDVAV
IYPKHQTKPIILVVFTKHQQQDAQPQDELVAQAARHAIHQLD
>WP_021459345.1|FEATURES|NCBI|beta_lactam|PC1|antibiotic inactivation|1
MKKFFTIFVLLCVCFAYTTATASAQGLTKLEHKNDATVGVYGINTATGQTYSHNADTRFA
YASTFKAITSGLLLQQNSPEALNKTVTIKESDIVAYSPVTEQYVGKTMTLRQLISAAMLQ
SDNTASNIIMEQLGGLDQISSRLQALGDTTTNPQRYEPELNNYDPQSTADTSTPRATAHS
LQQLLTTDAVAPQQRKFLQNLMFNNETGDSLIKKGVPDSYKVGDKSGQGTTYGTRNDVAL
IYPKHQTKPIVLVVFTKHQQQDAQPQDELVAQAARHAIHQLD
>APY23862.1|FEATURES|NCBI|beta_lactam|PC1|antibiotic inactivation|1
MKKFFTIFVLLCVCFAYTTASASAQDLTKLEHKNDATVGVYGINTATGKTYSHNADTRFA
YASTFKAITSGLLLQQSSPEALNKTVTIKESDIVAYSPVTEQYVGKTMTLRQLISAAMLQ
SDNTASNVIMEQLGGLDQISSRLQALGDTTTNPQRYEPELNNYDPQSTADTSTPRATAHS
LQQLLTTDAVAPQQRKFLQNLMFNNETGDSLIKKGVPDSYKVGDKSGQGTTYGTRNDVAL
IYPKHQTKPIVLVVFTKHKQQDAKPQDALVAQAARQAIQQLD
>WP_034682171.1|FEATURES|NCBI|aminoglycoside|ANT(6)-Ib|antibiotic inactivation|1
KAREEKLKQIINWAKENPDIRTVLLTSSLVNPYAPVDDFSDLDVELVFEGMKPYESDKKW
IECFGTPISMVEEDETFFDGKHAMKMVLYEDHVKVDFKLYEKSEFIKEVDGETLPEDWDV
GYKVLIDKDDLTKELKPPTHQSIMIKKPTEQRFQQLINDFWWDTTYVAKCLKRDDIFYAK
FMMEDVIRTDYLVPMLEWYIASEKEWNNITTNKHGRLFKKYLSPELWKQVEATFSGSSIE
DNWNALFACADLVHEVGTFLAKKIGSPYPLEMENKVRKYLNEIKE
>WP_034742152.1|FEATURES|NCBI|aminoglycoside|ANT(6)-Ib|antibiotic inactivation|1
KAREDKLERIISWAESNSDIRAVLLTSSLVNPHAPVDDFSDLDIELVFENMQEYQANNQW
IDLFGTPISMIEEDDSYFDGKHAMKMVLYADHVKVDFKLYQKSEFIKEVHEEALPDDWDV
GYKVLIDKDDLTKDLQPPTYRSVMIHQPSEKRFRQLINDFWWDTTYVAKCLKRDDLFYAK
FMSEDVIRTDYLVPLIEWYIASTYNWKNITTNKHGRLFKKYLPEELWKQIEATFSGSNIN
DNWSALYSAADLVHELGTVLSYRLSFEYPHKLENDIRKYLDEIRS
>WP_034703427.1|FEATURES|NCBI|aminoglycoside|ANT(6)-Ib|antibiotic inactivation|1
KAREEKLKQIISWAEGNPDLRAVLLTSSLVNPYAPVDDFSDLDIELVFENMNEYENDKKW
IDLFGKPISMIEENETYFDGKHAMKMVLYTDHVKVDFKLYHKLEFLKEIAEETLPEDWDV
GYKVLVDKDDLTKNMKPPTYQSIMIRKPTEQGFQQLMNDFWWDTTYVAKCLKRGDLFYAK
FMSENVIRTDYLVPLIEWYIAANSDWKDITANKHGRLFKKYLSAELWIKAEATFAGSSIE
DNWNALYAAADLVHELGTALAKKLNFRYPQKLEDDIRNYLDEVKS
>WP_080778132.1|FEATURES|NCBI|aminoglycoside|ANT(6)-Ib|antibiotic inactivation|1
KAREEKLKQVISWAENNTDIRCVLLTSSLVNPYAPVDDFSDLDIELVFEDRERYEQDKSW
IFLFGETVSMVEEDTTCFDGKHAMKMVLYTDHVKIDFKLYQKSEFVKEVQGEDLPEDWDV
GYKVLVDKDNLTRDLKAPTYQSIMITKPTEKEFGQLMNDFWWDTTYVAKCLKRGDLFYAK
FMSENVIRTDYLVPLIEWYIASFHDWNNITTNKHGRLFKKYLSEELWNKVEATFSGSSIE
DNWQALYVSADLVHELGTFLADRLGFEYSHQHESDVRKYLDEVKN
>WP_076509785.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
KAREEKLKHIISWADNNPDIRTVLLTSSLVNPYAPVDDFSDLDIELVFENLKDYETDKKW
MHLFGDPVSMVEEDDPYFDGKHAMKMVLYSDHVKVDFKLYQKSEFVKEVQKERLPDDWDV
GYKVLIDKDHLTKDLKPPTYQSVMIRKPEEQKFQQLINDFWWDTTYVAKCLKREDLFYAK
FMSENVIRTDYLVPLIEWSVASFHDWKNMPTNKHGRLFKKYLSAELWAKVEATFSGSNIE
DNWRALYASADLVHDLGTALAENLNVEYPQKHEEDIRKYLDEVQS
>WP_034693616.1|FEATURES|NCBI|aminoglycoside|ANT(6)-Ib|antibiotic inactivation|1
KVREEKLEQIIHWAENNPDIRAVLLTSSLVNPYAPVDDFSDLDVELVFENRASYESGNKW
IRLFGEPISMIEEDDSVFDGKHAMKMVLYKDHVKVDFKLYQVAEFIEEIKEENLPEDWDV
GYKVLIDKDKLTENLKPPTYQSIMIQKPSEKEFQQLMNDFWWDTTYVAKCLKRGDIFYAK
FMSENILRTDYFVPLIEWHIAGNHGWNNITTNKHGRLFKKYLSADLWNKVEKTFSGSDIE
ENWNALFAYADVVHELGTSLAEKLHFIYPEKLEEDIRNYLKEVQT
>SMC86227.1|FEATURES|NCBI|aminoglycoside|ANT(6)-Ib|antibiotic inactivation|1
KIREEKLEQIIQWAENNPDIRAVLLTSSLVNPYAPVDDLSDLDVELVFESRKDYESGNSW
LQLFGDPISMIEEDDTVFEGRHAMKMVLYRDHVKVDFKLYQVSEFMEEVQKGALPEDWDV
GYKVLIDKDGLTKDLKPPTYQSIMIHKPDEKEFQQLMNDFWWDTTYVAKCLKRGDIFYAK
FMSENILRAEYLVSLVEWHIGNDHNWDNMTTNKHGRLFKKYLPEDLWSRMEATFSGSSID
ENWTALFAFADLVHELGTALAQKLNFTYPSKLESDIRTYLLEVKS
>WP_062701324.1|FEATURES|NCBI|aminoglycoside|ANT(6)-Ib|antibiotic inactivation|1
KTREEKLKQIISWAENNPDIRAVLLTSSLVNPYAPVDNFSDLDVELVFENREPYESHHEW
LSLFGTPISMIEEDDRVFEGKHAMKMVLYRDHVKVDFKLYQKVDFLAEVQQESLPEDWDV
GYKILVDKDDLTKGLKPPTYQSVMIHKPEEEEFSKLINDFWWDTTYVAKCLQRGDIFYAK
FMSENVIRTDYLVPLIEWHIAGSQGWSNITTNKHGRLFPKYLPEDLWKRVEATFSGSNIE
ENWASLLAFADLVHELGTALAGKLSFTYPDQLEKDIRNYLAEVKS
>WP_027373595.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
KIREDKLEQIIQWATDNRDVRVVLLTSSLVNPYAPVDDFSDLDVELVFESRKPYEDDHQW
ISLFGQPISMVEEGDEVFEGKHAMKMVLYKDHVKVDFKLYQLSDFIAEIKAEKLPDDWDL
GYKVLVDKDELTTEMKPPSYRSIMIHQPEEKEFRQLLNDFWWDTTYVAKCLKRGDIFYAK
FMSENILRTDYLVPLIEWYIASSHDWNNITTNKHGRLFKKYLSQELWNKVELTFSGSNIE
ENWAALFAFADLVHELGTALAYQLNFTYPVTLENDIRNYLAEVRE
>WP_050022107.1|FEATURES|NCBI|aminoglycoside|ANT(6)-Ib|antibiotic inactivation|1
ITREEKLQQIIQWCENNPDIRAALLTSSLVNPHAPVDDFSDLDIELVFQNRSVYEADHTW
LDLFGEPISMIEEDDTVFDGKHAMKMVLYKDHVKVDFKLYQVADFLKDIDLEVLPDDWDL
GYRVLIDKDNLTENIKAPTYQSIMIQKPDEQKFRQLINDFWWDTTYVAKCLKRGDIFYAK
FMSENILRTDYLVPLIEWYIANLHSWHNITTNKHGRLFKKYLPANIWKDIESTFSGSDIE
ENWIALFAFADLVHNLATDLALKLGFVYPEQLENDIRNYLSEVRA
>AAL02176.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|EmtA|antibiotic target alteration|1
TLYFASVLSGLEYVLSNEINNKVSDSEIIQINRGKVFFTTAESFTCLSSLRSADHLFQVI
DQFQIGPHKKHLSQVSERISQLDLEFIDHKDLFWVNASRKGKQTYSRFELAKKAMEGINK
RYPDWNIGTSQNHQIEFRLDIEHHNVIFSLRLTDATFRFRNQTRRFSRASLLPSVAHAMV
WLSDPESKDVFVDFCCGSGTILSERATYPANQIIGGDISEAVTKIAKSNLDDSKVQVNVW
DARKLPFSTGCVDKIVTNLPFGRQISPDEDLELFNHHIMIEVCRVLKPNGRAVILSESVN
QLFWEAKRLGLFCLESYPLSLKGVNPTLFVFEKQDG
>WP_077718888.1|FEATURES|NCBI|bacitracin|uppP|antibiotic target alteration|1
TLYFASVLPGLEDVLSDEINHKLIDSEVIQINRGKVFFTAAESFTCFNSLRSADNLFQVL
DQFQIGPHKKHLSQVRERISQLDLGFMGRKDAFWVNASRKGKQTYSRFEVAKEAIEGIHK
RYPDWKIGTSRNHQIEFRIDVEHHHVIFSLRLTKATFRFRNQRRRFSPASLRPPVAHAMV
WLSEPASTDVFVDPCCGSGTILSERGAYPADEIVGGDISDEITKIAKSNLDGLEVVVHVW
DARKLPFSDGCVDKVVTNLPFGRQISPDGDLQLFNHQMMHEIWRVLKPNGRAVILSDSAN
QLFWEAERLDLYCLKSYLLSLKGLNPTLFVFEKQGR
>WP_032063602.1|FEATURES|NCBI|fosfomycin|FosA4|antibiotic inactivation|1
MKLSGLNHLTISIENVDRSFSFYKDVLGFTPRAKWNKGAYLSLGELWLCLSLDVVSITSD
YTHYCFSISEEHIDEFRQKIKLLNIREWKNNQSEGESIYFLDPDGHKLEVHVGNLLSRLE
SCKKNPYEGMVFFDE
>WP_005066968.1|FEATURES|NCBI|fosfomycin|FosA5|antibiotic inactivation|1
MKLSGLNHLTISVANVDRSFSFYKDVLGFTPRAKWNKGAYLSLGELWLCLSLDEVSITSD
YTHYCFSISEDHIDAFRQKIKLLNIREWKNNQSEGESIYFLDPDGHKLEVHLGNLSSRLE
SCKKNPYEGMVFFDE
>WP_014207881.1|FEATURES|NCBI|fosfomycin|FosA5|antibiotic inactivation|1
MKLSGLNHLTISVENVDRSFSFYKDVLGFTPRAKWNKGAYLSLGELWLCLSLDEVRITSD
YTHYCFSISEDDIDEFRQKIKLLNIREWKNNQSEGESIYFLDPNGHKLEVHVGNLSTRLD
SCKKNPYEGMVFFDE
>WP_016142826.1|FEATURES|NCBI|fosfomycin|FosA5|antibiotic inactivation|1
MKLSGLNHLTISVENVDRSFSFYKDVLGFTPRAKWNKGAYLSLGELWLCLSLDEVSISSD
YTHYCFSISEDDIDEFRQKIKLMNIHEWKNNQSEGESIYFLDPDGHKLEVHVGTLSSRLQ
SCKKNPYEGMVFFDE
>WP_000777202.1|FEATURES|NCBI|fosfomycin|FosA5|antibiotic inactivation|1
MKLSGLNHLTISVANVDRSFNFYKDILGFTPKAKWKKGAYLSLGKLWLCLSLDEVSVSSD
YTHYCLSISEDDIDEFRQKIKLLNIREWKNNQSEGESIYFLDPDGHKLEVHVGNLSTRLE
SCRKNPYEGMVFFDE
>WP_086261308.1|FEATURES|NCBI|fosfomycin|FosA5|antibiotic inactivation|1
MKLSGLNHLTISVANVDRSFNFYKDILGFTPKAKWKKGAYLSLGELWLCLSLDEVSISSD
YTHYCFSISEDNIDEFRQKIKMMNIPEWKTNQSEGESIYFLDPDGHKLEVHVGNLSTRLE
SCRKNPYEGMVFFDE
>WP_057991970.1|FEATURES|NCBI|beta_lactam|ADC-2|antibiotic inactivation|1
MFFNQKYFFQASFITMVIGFGMNLNASEVSQNEQNIEKVVTQSFKPLMDEYGVAGMAIGV
IYNGKSYEKYYGVRSKDTNESVNSQTLFELGSLSKTFTAISGTYANNQGKISFNDHPSKY
VPALKNSEIDKVNLLELLTYTSGNLPLQFPDNIKTDKQILEYFKNWKVKNPPGTYREYSN
PSIGLFGYLTAKSMNVPFSSLLEKTVFPQLNLKHTYVNVPEAQKTNYAFGYDENNKPIRV
NPGPLSDEAYGVKSTLPDMLKFVNSNLNVDTNSPAMKKAILDTHKGYFKVSDSGMTQALG
WEMFSYPTTSEILQASNSKQILLGSNPVVKELSQPKSKVFHKTGSTNGFGAYVLFIPEEG
FGLVMLMNKKIPNVDRIKAAYNVFETLKDN
>WP_079863305.1|FEATURES|NCBI|beta_lactam|ADC-2|antibiotic inactivation|1
MFFNQKYFFQASFITMVIGFGMNLNASEVSQNEKNIEKVVTQSFKPLIDEYGVAGMAIGV
IYNGKSYEKYYGVRSKDTNESVNSQTLFELGSLSKTFTAISGTYANNQGKISFNDHPSKY
VPALKNSEIDKVNLLELLTYTSGNLPLQFPDNIKTDKQILEYFKNWKVKNPPGTYREYSN
PSIGLFGYLTAKSMNVPFSSLLEKTVFPQLNLKHTYVNVPEAQKTNYAFGYDENNKPIRV
NPGPLSDEAYGVKSTLPDMLKFVNSNLNVDTNSPAMKKAILDTHKGYFKVSDSGMTQALG
WEMFSYPTTSEILQASNSKQILLGSNPVVKELSQPKSKVFHKTGSTNGFGAYVLFIPEEG
FGLVMLMNKKIPNVDRIKASYNVFETLKDN
>WP_086374409.1|FEATURES|NCBI|beta_lactam|ADC-2|antibiotic inactivation|1
MIFNQKYFFQASFITMVMGFGMNLHASEVSQDEKNIEKVVTQSFKPLMDEYGVAGMAIGV
IYKGKSYEKYYGVRFKDTNESVNGQTLFELGSLSKTFTAISGTYAKNQGKISFNDQPSKY
IPALKNSEINKVNLLELLTYTSGNLPLQFPDDVKTDKQILEYFKNWKANNPPGAYREYSN
PSIGLFGYLTAKSMNVSFSSLLEEIIFPQLNLKHTYVNVPEEQKMNYAFGYDENNKPIRV
NPGPLSDEAYGVKSTLPDMLKFVKSNLNVDTNSPAMKKAILDTHKGYFKVADSGMTQALG
WEMFSYPTTSEILQASNSKQILLGLNPVVKELSQPKSKVFHKTGSTNGFGAYILFIPEED
FGLVMLMNKKIPNVDRIKAAYNVFEILKNN
>WP_087879616.1|FEATURES|NCBI|polymyxin|eptA|antibiotic target alteration|1
MPSLIKIKIVPLMFFLALYFAFVLNWRGVLHFYEILYKLEDFKFGFAISLPILLVAALNF
VFVPFSIRYLIKPFFALLIALSAIVSYTMMKYRVLFDQNMIQNIFETNQNEALAYLSLPI
IVWVTIAGFIPAILLFFVEIEYEEKWFKGILTRALSMFASLIVIAVIAALYYQDYVSVGR
NNSNLQREIVPANFVNSTVKYVYNRYLAEPIPFTTLGDDAKRDTNQSKPTLMFLVVGETA
RGKNFSMNGYEKDTNPFTSKSGGVISFNDVRSCGTATAVSVPCMFSNMGRKEFDDNRARN
SEGLLDVLQKTGISIFWKENDGGCKGVCDRVPNIEIEPKDHPKFCDKNTCYDEVVLQDLD
SEIAQMKGDKLVGFHLIGSHGPTYYKRYPDAHRQFTPDCPRSDIENCTDEELTNTYDNTI
RYTDFVIGEMIAKLKTYEDKYNTALLYVSDHGESLGALGLYLHGTPYQFAPDDQTRVPMQ
VWMSPGFTKEKGVDMACLQQKAADTRYSHDNIFSSVLGIWDVKTSVYEKGLDIFSQCRNV
Q
>WP_065801616.1|FEATURES|NCBI|polymyxin|eptA|antibiotic target alteration|1
MPSLIKIKIVPLMFFLALYFAFMLNWRGVLHFYEILYKLEDFKFGFAISLPILLVAALNF
VFVPFSIRYLIKPFFALLIALSAIVSYTMMKYRVLFDQNMIQNIFETNQNEALAYLSLPI
IVWVTIAGFIPAILLFFVEIEYEEKWFKGILTRALSMFASLIVIAVIAALYYQDYVSVGR
NNSNLQREIVPANFVNSTVKYVYNRYLAEPIPFTTLGDDAKRDTNQSKPTLMFLVVGETA
RGKNFSMNGYEKDTNPFTSKSGGVISFNDVRSCGTATAVSVPCMFSNMGRKEFDENRARN
SEGLLDVLQKTGISIFWKENDGGCKGVCDRVPNIEIEPKDHPKFCDKNTCYDEVVLQDLD
SEIAQMKGDKLVGFHLIGSHGPTYYKRYPDAHRQFTPDCPRSDIENCTDEELTNTYDNTI
RYTDFVIGEMIAKLKTYEDKYNTALLYVSDHGESLGALGLYLHGTPYQFAPDDQTRVPMQ
VWMSPGFTKEKGVDMACLQQKAADTRYSHDNIFSSVLGIWDVKTSVYEKGLDIFSQCRNV
Q
>WP_065804663.1|FEATURES|NCBI|polymyxin|eptA|antibiotic target alteration|1
MPSLIKIKIVPLMFFLALYFAFMLNWRGVLHFYEILYKLEDFKFGFAISLPILLVAALNF
VFVPFSIRYLIKPFFALLIALSAIVSYTMMKYRVLFDQNMIQNIFETNQNEALAYLSLPI
IVWVTIAGFIPAILLFFVEIEYEEKWFKGILTRALSMFASLIVIAVIAALYYQDYVSVGR
NNSNLQREIVPANFVNSTVKYVYNRYLAEPIPFTTLGDDAKRDTNQSKPTLMFLVVGETA
RGKNFSMNGYEKDTNPFTSKSGGVISFNDVRSCGTATAVSVPCMFSNMGRKEFDDNRARN
SEGLLDVLQKTGISIFWKENDGGCKGVCDRVPNIEIEPKDHPKFCDKNTCYDEVVLQDLD
SEIAQMKGDKLVVFHLIGSHGPTYYKRYPDAHRQFTPDCPRSDIENCTDEELTNTYDNTI
RYTDFVIGEMIAKLKTYEDKYNTALLYVSDHGESLGALGLYLHGTPYQFAPDDQTRVPMQ
VWMSPGFTKEKGVDMACLQQKAADTRYSHDNIFSSVLGIWDVKTSVYEKGLDIFSQCRNV
Q
>WP_042021679.1|FEATURES|NCBI|polymyxin|eptA|antibiotic target alteration|1
VKIRVVPFILLLALVFAFLLNWPVLLHFYEIFTNMEHFKIGFAISIPVLLVAALNFVFMP
FSVRYLIKPFFAFLFVAGSIVSYTMLKYRVLFDRDMIQNIFETNQSEAYSYISLPIVAWV
LLAGVVPAVLLFFVKIEYPKKWYTGLFQRGLSMLGSLAIVGIIAAFYYQDYVSVGRNNQT
LNREIVPANFVYSTTKYLYKRYLAEPVPFTTLGDDAKRVVTNEEKPTLMFLVVGETARGK
NFSMNGYEKETNAFTSKSGGVISFNDVRSCGTATAVSVPCMFSNMVRKEYDDNRARNSEG
LLDVLHKTGVSVFWKENDGGCKGVCDRVLNIEIKPKDHPQFCDNNTCYDEVVLQNLDDEV
AQMKGDKLVGFHLIGSHGPTYYKRYPDAHRQFLPDCPRSDIENCTDEELVNTYDNTIRYT
DFVIAELIAKLKTYEEKYNTALIYVSDHGESLGALGLYLHGTPYKFAPDDQTRVPMQVWM
SPGFSREKGLDMGCLQQKATDTRYSHDNLFSSVLGIWDVKTAVYDQGLDIFSQCRT
>WP_011638903.1|FEATURES|NCBI|polymyxin|eptA|antibiotic target alteration|1
MISRFKTLSVNQFTFITALFYVAIFNLPLFGIVRKGIEKQPEVDPLFIASMPLFLTFALS
FLFSIFTVKYLLKPFFIVLTLLSSSVFFAAYQYNVVFDYGMIENTFQTHPAEALMYVNLA
SITNLLLTGLLPSYLIYKADIHYQPFFKELLHKLAFMLLMFVGIGIVAFFYYQDYAAFGR
NNSELRRYIVPTYFVSSASKYLNEHYLQTPMEYQQLGLDAKNASRNPNTKPNLLVFVVGE
TARSMSYQYYGYNKPTNAHTQNQGLIAFNDTSSCGTATAVSLPCMFSRMGRADYDPRRAN
AQDTVIDVLSHSGIKVQWFDNDSGCKGVCDQVENLTIDLKSDPKLCSGQYCFDQVLLNKL
DKILAVAPSQDTVIFLHIIGSHGPTYYLRYPPEHRKFIPDCPRSDIQNCSQEELINTYDN
TILYTDFILSEVVNKLKGKQDMFDTAMLYLSDHGESLGEKGMYLHGAPYSIAPKEQTSVP
MLAWVSNDFSQDNQLNMTCVAQRAEQGGFSHDNLFDSLLGLMNVKTTVYQSQLDIFAPCR
Y
>WP_085886528.1|FEATURES|NCBI|beta_lactam|NPS|antibiotic inactivation|1
MRFPASVLSRVATGLTLGLFMATASLAETPVEALSNTVARIEEQLDARVGLSLVETGSGW
SWSHREDERFLMNSTVKVPVCGAILARWDAGTLSLSEALPVRKADLVPYAPVTETRVGGT
MTLDQLCLAAIDMSDNVAANLLIGHLGGPEAVTQFFRSVGDITSRLDRIEPELNDFTPGD
ERDTTSPAAMSETLRALLLSDALSPQARGQLAEWMRHGGVTGALLRAEADDDWLILDKSG
SGSHTRNLVAVIQPDGEAPWIATMFVSDTDAEFEARNEALKDLSRAVVAVVRE
>WP_026141143.1|FEATURES|NCBI|beta_lactam|blaAQU-2|antibiotic inactivation|1
MKQTSPLSLLALSALLLSPLTQAAPADPLVGVVDEVIRPLVKEHRIPGMAVAVFKEGQPH
YFNYGVAELATGKKVSEQTLFEIGSVSKTLTATLGAYAVVKGGIGLDDKVSRHAPWLKGS
AFDGITMAELATYSAGGLPLQFPDEVESLEQMQAYYRQWTPAYQPGSHRQYSNPSIGLFG
YLAASSLQQPFAQFMEQTLLPGLGLHHTYINVPKQAMANYAYGYSKEDKPIRVTPGVLAD
EAYGIKTSSADLLAFVKANINGVDDKGLQQAIALTHQGHYSVGGMTQGLGWESYPYPVSE
QTLLTGNSAQVIMKANPTTAAPKEMGSQRLFNKTGSTNGFGAYVAFVPAKGVGIVMLANR
NYPIQERVKAANAILSKLAP
>WP_026141765.1|FEATURES|NCBI|beta_lactam|AQU-1|antibiotic inactivation|1
MKQTSPLSLLALSALLLSPLTQAAPADPLVGVVDDVIRPLVKEHRIPGMAVAVLKGGQAH
YFNYGVAELATGKKVSEQTLFEIGSVSKTLTATLGAYAVVKGSIGLDDKVSRHAPWLKGS
AFDGITMAELATYSAGGLPLQFPDEVESLEQMQAYYRQWTPAYQPGSHRQYSNPSIGLFG
YLAASSLQQPFAQLMEQTLLPGLGLHHTYINVPKQAMANYAYGYSKEDKPIRVNPGMLAD
EAYGIKTSSADLLAFVKANISGVDDKGLQQAIALTHQGRYSVGGMTQGLGWESYPYPVSE
QTLLAGNSAQVIMKANPTTAEPKEMGSQRLFNKTGSTNGFGAYVAFVPAKGVGIVMLANR
NYPIQERVKAAHAILSKLAP
>WP_094698575.1|FEATURES|NCBI|beta_lactam|blaAQU-2|antibiotic inactivation|1
MKQTSPLSLLALSALLLSSLTQAAPADPLAGVVDDVIRPLVKEHRIPGMAVAVFKEGQPH
YFNYGVAELATGKKVSEQTLFEIGSVSKTLTATLGAYAVVKGGIGLDDKVSRHAPWLKGS
AFDGITMAELATYSAGGLPLQFPDGVESVAQMQAYYRQWTPAYQPGSHRQYSNPSIGLFG
YLAASSLQQPFAQLMEQTLLPGLGLHHTYVDVPKQAMANYAYGYSKEDKPIRVTPGVLAD
EAYGIKTSSADLLAFVKANINGVDDKGLQQAIALTHQGHYSVGGMTQGLGWESYPYPISE
QALLAGNSAQVIMKANPTTAAPKEMGSQRLFNKTGSTNGFGAYVAFVPAKGVGIVMLANR
NYPIQERVKAAHAILSKLAP
>WP_071218948.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|VatI|antibiotic inactivation|1
TGPNPNERYPIPGDNNLQFIKNTITKPNIIAGDYSYYYALNGESFEDQVLYHYEFIGTKL
MIGKFCSIASEVRFMMDGGNHRMDGSTFPFNIFGNGWEKFTPSLDQLPIKGDTIIGNDVW
IGRRATIMSGVRIGDGAIIAAEAVVVKDVEPYTIVGGNPAKDIRKRYSTEVIQELLDIKW
WDCDIEVINQYIGAIVSGDMDLLRKMRQ
>WP_036693005.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|VatI|antibiotic inactivation|1
IGPNPNEKYPVPGNTNVQFIRNTITKPNIIVGDYSYYDAVNGESFEDQVLYHYEVIGTKL
IIGKFCSIAPEVRFMMDGGNHRMDGSTFPFNIFGNGWEKHTPSLEQLPIKGDTIVGNDVW
IGRRATIMPGVRIGDGAIIAAEAVVVKDVEPYTIVGGNPAREIRKRFSPEVIQELLDIKW
WDSDIELISQYIGSIVSGDMDTLRKMKQ
>WP_044639852.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|VatI|antibiotic inactivation|1
IGPDPNDKYPIPGNSNLQFIKNMITKPNIIVGDYSYYDALNGESFEDQVLYHYEIIGTKL
IIGKFCSIAPEVRFLMDGGNHRMDGSTFPFNIFGNGWEVHTPSLKDLPIKGDSIVGNDVW
IGRRATIMPGVRIGDGAIIGAEAVVVKDVEPYTIVGGNPAREIQKRFSPEIIQELLDIQW
WDAEIELINLYIGAIVSGDINTLRKMKQ
>SHE15091.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|VatI|antibiotic inactivation|1
IGPNPNEKYPIPGNRNLQFIKNTITKPNIIVGDYSYYDALDGELFEDQVLYHYEVIGTKL
IIGKFCSIAPEVRFLMDGGNHRMDGSTFPFNIFGHGWEKHTPSLNQLSIKGDTVVGNDVW
IGRRATIMPGVRIGDGSIVSAEAVVVKDVEPYTVVGGNPAREIKQRFSQEVIQEFLEIKW
WDFDIELINQYIGAIVSGDIETLKKIKQ
>WP_019639548.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|VatI|antibiotic inactivation|1
RGPNPNEKYPIPGNTNLQFIKNTVTIPNIIAGDYSYYDALNGEAFEEQVLYHYEVLGTKL
IIGKFCSIAPETRFMMDGGNHRMDGSTFPFNLFGNGWEEFTPTLEELPIKGDTIIGNDVW
IGRRATIMPGVRIGDGAIVGAEAVVTKDVEPYTIVGGNPAKEIRKRFSPEVIQELLEIKW
WDRDIELIQQNIGAIVSGNLNILREMKR
>WP_028406647.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|VatI|antibiotic inactivation|1
LGPDPNEKVPIPGNPNVQFIKNTITKPNIVVGDYTYYDAANGELFEDQVLYHYEVIGTKL
IIGKFCSIAPEVRFIMDGGNHRMDGSTYPFNIFGNGWEAHTPSLDNLPIKGDTIVGNDVW
IGRRATIMPGVRIGDGAVIAAEAVVVSDVEPYTIVGGNPAKVIRKRFSTQDIQEWLDIRW
WDADIERIHSYIGAIVSGDLESLRKMKD
>WP_090666825.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|VatI|antibiotic inactivation|1
LGPNPREKYPIPGNKNVQFINNTITKSNIIVGDYSYYDALHGESFEDQVLYHYEVLGTKL
VIGKFCSIAPETRFIMGGGNHRMDGSTYPFNIFGNGWEAYTPTLEQLPLKGDTVVGNDVW
IGRRATIMPGVRIGDGAIIGAESVVVKDVKPYTIVGGNPAKEIRKRYSPEIIEELLEIRW
WDNDIEIINQNIEAIVSGDIESLRKMRS
>WP_006677628.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|VatI|antibiotic inactivation|1
TGPNPQDKYPIPGNNNVQFIRNVITMPNIVAGEYSYYDAMNGESFEEQVLYHYEAIGTKL
IIGKFCSIAPEARFIMGGGNHRMDGSTYPFNIFGHGWEIHAPSLEQLPLKGDTVVGNDVW
IGRRATIMPGVTIGDGAIIGAEAVVVRDVEPYTIVGGNPAREIRRRFSPEVIAELLEIRW
WDCGIELINRYIGAIVSGDMAQLREMKR
>WP_094943952.1|FEATURES|NCBI|qa_compound|Qac|antibiotic efflux|1
MNPYVLLISAILFEVFGSSMMKASNGFKKLVPTVGLVIGMGSAFYFLSKALEHIPLGTAY
AIWSGAGTALTAIVGILVWKEKFNLKILLGLLIIIAGVVVLKLSH
>WP_003725293.1|FEATURES|NCBI|multidrug|EmrE|antibiotic efflux|1
MNPYVLLIGAILFEVFGSSMMKASNGFKKLVPTVGLVIGMGSAFYLLSKALEHIPLGTAY
AIWSGGGTALTAIVGILVWKEKFNLKILLGLLIIIAGVVVLKLSH
>WP_031642485.1|FEATURES|NCBI|qa_compound|Qac|antibiotic efflux|1
MKGYVALGIAIIGEIFGTSMLKLSEGFTNIYPTIGVAIGFFIAFYTLSLSLKTLPLSLAY
AIWSGVGTALTALIGVLVWNEPFNILTFIGLVMIIGGVIILNQRSADTKTSTSD
>WP_061107820.1|FEATURES|NCBI|qa_compound|Qac|antibiotic efflux|1
MKGYVALGIATISEIFGTSMLKLSEGFTNIYPTIGVAIGFFIAFYTLSLSLKTLPLSLAY
AIWSGVGTALTALIGVLVWNEPFNILTFIGLVMIVGGVIILNQRSADTKTSTSH
>AFN94077.1|FEATURES|NCBI|qa_compound|emrE|antibiotic efflux|1
MKGYVALGIAIIGEIFGTSMLKLSEGFTNIYPTIGVAIGYFIAFYTLSLSLKTLPLSLAY
AIWSGVGTALTALIGVLVWNEPFNILTFIGLVMIVGGVIILNQRSADTKTSTSH
>WP_083090492.1|FEATURES|NCBI|qa_compound|Qac|antibiotic efflux|1
MKEYVALGIAIIGEIFGTSMLKLSEGFTNIYPTIGVAIGFFIAFYTLSLSLKTLPLSLAY
AIWSGVGTALTALIGVLVWNEPFNILTFIGLVMIVGGVIILNQRSADTKTSTSH
>AFN94071.1|FEATURES|NCBI|qa_compound|emrE|antibiotic efflux|1
MKGYVALGIAIIGEIFGTSMLKLSEGFTNIYPTIGVAIGFFIAFYTLSLSLKTLPLSLAY
AIWSGVGTALTALIGVLAWNEPFNILTFIGLVMIVGGVIILNQRSADTKTSTSH
>WP_010710386.1|FEATURES|NCBI|trimethoprim|dfrC|antibiotic target replacement|1
MLAAIWAQDEQGVIGKEGKLPWHLPNDLKFFKEKTIHNTLVLGRATFEGMGCRPLPNRTT
IVLTSNPDYRAEGVLVMHSVEEILAYADNYEGVTVIGGGSVVFKELIPACDVLYRTMIHE
TFEGDTFFPEIDWFVWEKVATVPGVVDEKNLYAHDYETYHRNDK
>WP_048947910.1|FEATURES|NCBI|trimethoprim|dfrC|antibiotic target replacement|1
MLAAIWTQDEQGVIGKEGKLPWHLPNDLKFFKEKTIHNTLVLGRATFEGMGCRPLPNRTT
IVLTSNPDYQAEGVLVMHSVEEILAYADKYEGVTVIGGGSVVYKELIPACDVLYRTMIHE
TFEGDTFFPEIDWSVWEKVATVPGVVDEKNLYAHDYETYHRNDK
>CAA25642.1|FEATURES|resfam|aminoglycoside|AAC(3)-IVa|antibiotic inactivation|1
MQYEWRKAELIGQLLNLGVTPGGVLLVHSSFRSVRPLEDGPLGLIEALRAALGPGGTLVM
PSWSGLDDEPFDPATSPVTPDLGVVSDTFWRLPNVKRSAHPFAFAAAGPQAEQIISDPLP
LPPHSPASPVARVHELDGQVLLLGVGHDANTTLHLAELMAKVPYGVPRHCTILQDGKLVR
VDYLENDHCCERFALADRWLKEKSLQKEGPVGHAFARLIRSRDIVATALGQLGRDPLIFL
HPPEGGMRRMRCRSPVDWLSS
>AAM52493.1|FEATURES|resfam|aminoglycoside|AAC(6')-Ib9|antibiotic inactivation|1
MKNTIHSIVTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLP
SVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQSLANASQLGKG
LGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQ
TRQAFERTRSDA
>WP_011767294.1|FEATURES|resfam|multidrug|msbA|antibiotic efflux|0
MSRADAPAPSSLRIYFRLLGYVRPYVGQFVLSIVGFLIFASSQPMLAGVIKYFVDGLNDP
GATPFTGVPLLASLPLMSAVPVLIILIVVWQGIGSYLGNYFLAKVSLGLVHDLRMALFDS
LLRLPNRYFDNHNSGHLVSRITFNVTMVTGAATDAIKVVIREGLTVVFLFGYLLWMNWKL
TLVMVAILPVIGLMVTSASRKFRKQSKKIQVAMGDVTHIASETIQGYRVVRSFGGEAYES
RRFQAASEDNTAKQLRMVKTGATYTPMLQLVTYVAMAALLFLVLLLRGDASPGDLVAYIT
AAGLLPKPIRQLSEVSSTVQKGVAGAESIFEQLDEPAELDRGTVERERIAGRLEVRGLSF
RYPGTERVVLDDISFVVEPGQMVALVGRSGSGKSTLASLVPRFYHHEQGQILLDGVEVED
YTLRNLRRHIALVTQQVTLFNDTVANNIAYGDLAEAPRAQVEAAAEAAYAREFIDRLPQG
FDTLVGENGVMLSGGQRQRLAIARALLKDAPILILDEATSALDTESERHIQAALDSAMRG
RTTLVIAHRLSTIEKADVIMVMEQGRIVERGSHAELLAAGGAYARLHAMQFRDEAEAAES
>NP_253684.1|FEATURES|resfam|multidrug|MsbA|antibiotic efflux|0
MSDSPQNPGPSSLKIYFRLLGYVKPYIGMFLLSIVGFLIFASTQPMLAGILKYFVDGLSN
PDAALFPNVQWPWLRDLHLVYAVPLLIILIAAWQGLGSFLGNFFLAKVSLGLVHDLRVAL
FNKLLVLPNRYFDTHSSGHLISRITFNVTMVTGAATDAIKVVIREGLTVVFLFLYLLWMN
WKLTLVMLAILPVIAVMVTTASRKFRKQSKKIQVAMGDVTHVASETIQGYRVVRSFGGEA
YEEKRFLDASQSNTDKQLRMTKTGAVYTPMLQLVIYVAMAILMFLVLWLRGDASAGDLVA
YITAAGLLPKPIRQLSEVSSTVQRGVAGAESIFEQLDEAAEEDQGTVEKERVSGRLEVRN
LSFRYPGTDKQVLDDISFIAEPGQMIALVGRSGSGKSTLANLVPRFYQHNDGKILLDGVE
VEDYRLRNLRRHIALVTQQVTLFNDSVANNIAYGDLAGAPREEIERAAKAANAKEFIDNL
PQGFDTEVGENGVLLSGGQRQRLAIARALLKDAPLLILDEATSALDTESERHIQAALDEV
MKGRTTLVIAHRLSTIEKADLILVMDQGQIVERGSHAELLAQNGHYARLHAMGLDEQAPA
PVG
>WP_011766047.1|FEATURES|resfam|multidrug|msbA|antibiotic efflux|0
MKDAVTLYRRLLGSLAPYRGVVALSLLAMVAAAALEPVLPALLKPLVDDSLIARRTAAQW
QVPLLILLAFVAKGVAEYVASVSSQWIANKAITDLRRRVFRHQLHLPLAVHQAEAGGRML
SRILYDIPQVGAALSTAWIVVIRDACIIVGLVGYLVYTAWELTVLIVAIAPLVAWLIRIA
SRKLRGTNRAMQETTGAVTGAVEESLAGIREIKLFGSHDWEDARFATLAERLRKQTMRSV
RIAAANAPLVQILAAAAVSAVIWVASLLSAENRLTPGEFVAFVTAMAMLFEPIRRLTNIN
AVIQRGLAGAQSLFELLDTPAEADATGGTDQRPPARGELRLEHVGFRYPGQDTPALDDFS
LTVRPGETVALVGASGSGKSTLVNLVARFHQPQHGRILLDGDALDALPLAWLRSQIAWVG
QQVVLFDDTVAANIAYGRPDVSRTAIEAAARAAHAWDFIAALPQGLDTRIGHDGDQLSGG
QRQRIAIARAFLRDAPILLLDEATSALDNASERAVKDALDRLRRQRTTLVIAHRLSTVRD
ADRIMVMAHGRIVESGTHDELVAAGGAYARLLAGGGQAEPALALAEPA
>YP_001707102.1|FEATURES|resfam|multidrug|msbA|antibiotic efflux|0
MNQDFKVYLRLISYLKPYWGVALLVLIGFGMNSATEVSVAKLIKFIIDAIQNASRADLDW
FPLLIILLVFFRGLGLFMGGYYTAVISRSLVFSIRQEVYAKLLRLPAQYYLDNSSGHITA
KIMYNVEQLTAASSESLKTIVRDGMITLGLLGYLFYTNWRLTICIMVFLPVIGILVRKAS
KRMRKLSMQVQDTMGDVNHVVQESINGNAVVKSFAGEESEQERFYKSSEENLKRGLKMVI
VQNLNSPVVQVVMACAMALIVWLALRPQILGNTTAGEFVAYITAAGLLSKPVKNLTDVNE
KLQRGLAAAHSVFELLDLPEEQNSGELKPQLQGAIRFDHVVLNYADGTQAIKDFSLDIRP
GETVALVGRSGAGKTSLVNMLVLFQEVSSGQIYLDDLPIRDIELSSLRTQIAMVNQQVVL
FNRTVRENIAYGQLHNASDEDVIAAAKAAYAHDFIMNLPNGYDTVLGAQGLNLSGGQRQR
IAIARAILKNAPILILDEATSALDNESEHFIQQAFDEAMQDRTTIVIAHRLSTIENADRI
VVMDRGQIVEQGTHQELLAKHGAYYQLHQRNFEDH
>WP_001070729.1|FEATURES|resfam|multidrug|msbA|antibiotic efflux|0
MNQDFKVYLRLISYLKPYWGVALLVLIGFGMNSATEVSVAKLIKFIIDAIQNASRADLDW
FPLLIILLVFFRGLGLFMGGYYTAVISRSLVFSIRQEVYAKLLRLPAQYYLDNSSGHITA
KIMYNVEQLTAASSESLKTIVRDGMITLGLLGYLFYTNWRLTICIMVFLPVIGILVRKAS
KRMRKLSMQVQDTMGDVNHVVQESINGNAVVKSFAGEESEQERFYKSSEENLKRGLKMVI
VQNLNSPVVQVVMACAMALIVWLALRPQILGNTTAGEFVAYITAAGLLSKPVKNLTDVNE
KLQRGLAAAHSVFELLDLPEEQNSGELKPQLQGAIRFDHVVLNYADGTQAIKDFSLDIRP
GETVALVGRSGAGKTSLVNMLVRFQEVSSGQIYLDDLPIRDIELSSLRTQIAMVNQQVVL
FNRTVRENIAYGQLHNASDEDVIAAAKAAYAHDFIMNLPNGYDTVLGAQGLNLSGGQRQR
IAIARAILKNAPILILDEATSALDNESEHFIQQAFDEAMQDRTTIVIAHRLSTIENADRI
VVMDRGQIVEQGTHQELLAKHGAYYQLHQRNFEDH
>YP_185623.1|FEATURES|NCBI|multidrug|msbA|antibiotic efflux|0
MKKLTTILFQYKIFPVLMFLVSTGLGIIVITQNILIADFLAKIIRHQFQGLWIVLFILLG
VLLLRATVQFLNQWLGDTLAFKVKHMLRQRVIYKNNGHPIGEQMTILTENIDGLAPFYKS
YLPQVFKSMMVPLIIIIAMFFIHFNTALIMLITAPFIPLFYIIFGLKTRDESKDQMTYLN
QFSQRFLNIAKGLVTLKLFNRTEQTEKHIYDDSTQFRTLTMRILRSAFLSGLMLEFISML
GIGLVALEATLSLVVFHNIDFKTAAIAIILAPEFYNAIKDLGQAFHTGKQSEGASDVVFE
FLEQPNYNNEFLLKYEENQKPFIQLTDISFRYDDSDRLVLNDLNLEIFKGDQIALVGPSG
AGKSTLTHLIAGVYQPTIGTISTNQRDLNIGILSQQPYIFSASIKENITMFKDIENNTIE
EVLDEVGLLDKVQSFTKGINTIIGEGGEMLSGGQMRRIELCRLLVMKPDLVIFDEPATGL
DIQTEHMIQNVLFQHFKDTTMIVIAHRDNTIRHLQRRLYIENGRLIADDRNISVNITENG
DDL
>YP_185624.1|FEATURES|NCBI|multidrug|sav1866|antibiotic efflux|0
MKTRLKFQVDKDLLLAIVVGVCGSLVALAMFFLSGYMVTQSALGAPLYALMILVVTVKLF
GFLRAITRYVERLISHKATFTMLRDIRVQFFGKLVNVIPNVYRKLSSSDLISRMISRVEA
LQNIYLRVYYPPVVIGLTALVTVIVLAFISIGHALLIMVSMLFTLLIVPWLSSKKARTLK
KHAANEQARFLNHFYDYKAGMDELRRFNQINHYRDNLMAKLNHFDKLQLKEQRFLTIYDF
ILNIIAMLSIFGSLVLGLIQINAGQLNIIYMTSIVLMVLTLFEQAVPMTNVAYYKADTDQ
ALHDINEVISVPSTNGKKRLNDKYDATNIYEVKDASFKYWNQQTYVLSDINFNVNRGEKI
AIVGPSGSGKSTLLQIMAGLYQLDSGSVRFENMDMFEIDDKDKFESLNVLLQSQQLFDGT
IRQNLFTDEKDEAVQAIFKQLDLEHLALERQIDLDGHTLSGGEIQRLAITRMLLKDTAST
WILDEPTTALDKQNSLKVMDLIEAHAETLIVATHDLTLLSRFETIIVMINGKIVEKGNYQ
QLLANQGALWNMIQYNA
>AAP23225.1|FEATURES|resfam|aminoglycoside|aadA|antibiotic inactivation|1
MRVAVTIEISNRLSEVLSVIERHLESTLLAVHLYGSAEDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADHLEELIRFVKGEIIKSVGK
>WP_001209508.1|FEATURES|resfam|aminoglycoside|aadA|antibiotic inactivation|1
MRASLVAKTKLNIMREVVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSD
IDLLVTVTVRLDETTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKREL
QFGEWQRNDILAGIFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALN
ETLTLWNSPPDWAGDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEA
RQAYLGQEEDRLASRADQLEEFVHYVKGEITKVVGK
>WP_001255866.1|FEATURES|resfam|aminoglycoside|aad(6)|antibiotic inactivation|1
MTLEGSRANINIPKDEFQDYDITYFVSDIEPFISNDDWLNQFGNIIMMQKPEDMELFPPE
EKGFSYLMLFDDYNKIDLTLLPLEELDNYLKGDKLIKVLIDKDCRIKRDIVPTDIDYHVR
KPSAREYDDCCNEFWNVTPYVIKGLCRKEILFAIDHFNQIVRHELLRMISWKVGIETGFK
LSVGKNYKFIERYISEDLWEKLLSTYRMDSYENIWEALFLCHQLFRAVSGEVAERLHYAY
PEYDRNITKYTRDMYKKYTGKTGCLDSTYAADIEERREQ
>ACX47985.1|FEATURES|NCBI|aminoglycoside|ANT(4')-IIb|antibiotic inactivation|1
MQHTIARWVDRLREEYADAVAILLKGSYARGDAATWSDIDFDVLVSTQDVEDYRTWIEPV
GDRLVHISAAVEWVTGWERDTVDPSSWSYGLPTQETTRLMWAINDETRRRLDRPYKTHPA
AEPEVEDTVEALGKIRNAIARGDDLGVYQSAQTVAKLVPTLLIPINPPVTVSHARQAIEA
ILAFPRVPVGFAADWLTCLGLVEERSARSTAAAAERMVRGVLEMLPTDPDLLGEDIARLM
NAGLLEKYVQQ
>CBW28895.1|FEATURES|resfam|aminoglycoside|rpsL|antibiotic target alteration|0
MATINQLVRKPRVKKVVKSNVPALEACPQKRGVCTRVYTTTPKKPNSALRKVCRIRLTNG
FEVTSYIGGEGHNLQEHSVVLIRGGRVKDLPGVRYHTVRGALDCAGVKDRKQGRSKYGVK
RPKA
>WP_023434793.1|FEATURES|resfam|aminoglycoside|RmtF-2|antibiotic target alteration|1
MDERAQAALDALLSAKNLRDVCPETVRRVFMELLPRYRKPKDAEKAARTHLHQITGAFMT
ADAQEKARALLARWNEGDESALAAALSLHASTRERLPGADEWMRRVSPFLGADARVLDLA
CGLNPILLGSMGVTNALGMDIHLGCVRLVNETARARGWHTRARACDLLSEIPAEEADAAL
LMKLLPVLEAQKTGRAAELLASLRAPRLVVTFPTRTLGGRGVGMEKHYADWFERILPDTL
SVRDRFTVSDELVYLVERT
>resfam_RmtF-3|FEATURES|resfam|aminoglycoside|RmtF-3|antibiotic target alteration|1
VPKAALARPLPTRQTRQKGRLNFLYPELLPRYRKPKDAEKAARTHLHQITGAFMTADAQK
KARALLARWNEGDESALAAALSLHASTRERLPGADEWMRRVSPFLGADARVLDLACGLNP
ILLGSMGVTNALGMDIHLGCVRLVNETARARGWHTRARACDLLSEIPAEEADAALLMKLL
PVLEAQKTGRAAELLASLRAPRLVVTFPTRTLGGRGVGMEKHYADWFERILPDTLSVRDR
FTVSDELVYLVERT
>resfam_RmtF-4|FEATURES|resfam|aminoglycoside|RmtF-4|antibiotic target alteration|1
MDERAQAALDALLSAKNLRDVCPETVRRVFMELLPRYRKPKDAEKAARTHLHQITGALEL
LPRYRKPKDAEKAARTHLHQITGAFMTADAQKKARALLARWNEGDESALAAALSLHASTR
ERLPGADEWMRRVSPFLGADARVLDLACGLNPILLGSMGVTNALGMDIHLGCVRLVNETA
RARGWHTRARACDLLSEIPAEEADAALLMKLLPVLEAQKTGRAAELLASLRAPRLVVTFP
TRTLGGRGVGMEKHYADWFERILPDTLSVRDRFTVSDELVYLVERT
>YP_001838371.1|FEATURES|NCBI|beta_lactam|BAGA_16895|antibiotic inactivation|1
MVMWFVKTKAIQISFLGIYFLLGVFVSGCQRQIVSESPNQVTFPGSITKLSENSSPQHLE
WIKIKETVWIHKSFGNFLGKTYESNGLVVLSSRGVVVIDTPWTESQTEELFEGIKTKFQK
EILFLIVTHAHDDRMAGVTQFQNRNIPVYSTSLTSKLAKEKGLGKTNPILDLQTRVSAGN
VSVEIFFPGHGHSPDNIVVWLPNTHILFGGCLVKAIDATDLGNVKDANLLEWENAVKRVL
SRYPDAEVVVPGHGNWGKLDLLRHTIRLLVSTNH
>YP_003388071.1|FEATURES|NCBI|beta_lactam|BAGA_16895|antibiotic inactivation|1
MRTLLTLLFFSGLIVSLQAQSAKKPGLLVTPLNKQVFVHTTYGLYKNEAVPSNGLIIKTK
GGIVLVDTGWDTDTNTDNTRELLRWVSTNLHQPVRLCIVTHAHEDRVGGISELRKAGVRV
VSTPLTAQKSVKLGFESPEAVLPNDTTFSIGNEPIRCYFPGQGHTPDNIVVWLPNQKILY
GGCLVKSVAAFGMGNLADANLNEWGNSIQNLMTQFKSARIVVPGHDEWTDTRSLAHTLQL
LKKHAEAKK
>YP_005567024.1|FEATURES|NCBI|beta_lactam|ICS_02171|antibiotic inactivation|1
MKNTLLKLGVCVSLLGTTQFVSTISSVQAERTVEQKVIKNETGTISISQLNKNVWIHTEL
GYFNGEAVPSNGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFKKSVTDVIITHAHADR
IGGIKTLKERGIKAHSTTLTAELAKKNGYEEPLGDLQTVTKLKFGNMKVETFYPEKGHTE
DNIVVWLPQYQILAGGCLVKSASSKDLGNVADAYVNEWSTSIENVLKRYGNINLVVPGHG
EVGDRGLLLHTLDLLK
>2UYX_A|FEATURES|NCBI|beta_lactam|BcII|antibiotic inactivation|1
ASQKVEKTVIKNETGTISISQLNKNVWVHTELGSFNGEAVPSNGLVLNTSKGLVLVDSSW
DDKLTKELIEMVEKKFQKRVTDVIITHAHASRIGGIKTLKERGIKAHSTALTAELAKKNG
YEEPLGDLQTVTNLKFGNMKVETFYPGKGHTEDNIVVWLPQYNILVGGCLVKSTSAKDLG
NVADAYVNEWSTSIENVLKRYRNINAVVPGHGEVGDKGLLLHTLDLLK
>WP_002056912.1|FEATURES|NCBI|beta_lactam|BAGA_16895|antibiotic inactivation|1
MWEQIYHVDCLLSVIALLEKEAAKKGAIIVKKKMILKVGLCASILGFSQFASSILPVQAA
EKVEQIKNKDQEKDVSISQLHPKVWMHTSIGVVNGTRIPANGLILETSKGLVLIDTPWND
TLTDQLLQILKKQFPTKEVTEAIVTHAHDDRIGGIKTLIKKGVKVHSTALTADLAEKQGF
DKPLGDLKKRDNMRFGDINVETFYPGKGHTQDNITVWLPKYKILFGGCLIKSLDTQEIVQ
TPGSYVSNWSKAIKKVEKKYNDINMIVPGHGDPGDNRLFTHTLNLLKNNEN
>YP_003793151.1|FEATURES|NCBI|beta_lactam|BcII|antibiotic inactivation|1
MKNTLLKLGVCVSLLGITPFVSTISSVQAERTVEHKVIKNETGTISISQLNKNVWVHTEL
GYFNGEAVPSNGLILTTSKGLVLVDSSWDDKLTKELIEMVEKKFKKSVTDVIITHAHADR
IGGIKTLKERGIKAHSTTLTAELAKKNGYEEPLGDLQAITKLKFGNMKVETFYPGKGHTE
DNIVVWLPQYNMLVGGCLVKSASAKDLGNVTDAYVNEWSTSIENVLKRYENINFVVPGHG
EVGDKGLLLHTLDLLK
>WP_006095170.1|FEATURES|NCBI|beta_lactam|BAGA_16895|antibiotic inactivation|1
MKMKKKLILKVGLCASILGISQFASSIFPVQAAEKVEQIKNKDQEKDVSISQLYPKVWMH
TSIGVVNGTRIPANGLILETSKGLVLIDTPWNDDLTDQLLQILKKQFPTKEVTGAIVTHA
HDDRIGGIKTLTKKGVKVHSTALTADLAEKQGFDKPLGDLKKRDNMRFGDINVETFYPGK
GHTQDNITVWLPKYKILFGGCLIKSLDTQEIVQTPGSYVSNWSKAIKKVEKKYSDINIIV
PGHGDPGDSRLFTHTLNLLKNNEN
>2BFK_A|FEATURES|NCBI|beta_lactam|BcII|antibiotic inactivation|1
SQKVEKTVIKNETGTISISQLNKNVWVHTELGSFNGEAVPSNGLVLNTSKGLVLVDSSWD
DKLTKELIEMVEKKFQKRVTDVIITHAHADCIGGIKTLKERGIKAHSTALTAELAKKNGY
EEPLGDLQTVTNLKFGNMKVETFYPGKGHTEDNIVVWLPQYNILVGGCLVKSTSAKDLGN
VADAYVNEWSTSIENVLKRYRNINAVVPGHGEVGDKGLLLHTLDLLK
>WP_003198347.1|FEATURES|NCBI|beta_lactam|BAGA_16895|antibiotic inactivation|1
MKMKKKLILKVGLCASILGISQFASSIFPVQAAEKVEQIKNKDQEKDVSISQLYPKVWMH
TSIGVVNGTRIPANGLILETSKGLVLIDTPWNDDLTDQLLQILKKQFPTKEVTEAIVTHA
HDDRIGGIKTLTKKGVKVHSTALTADLAEKQGFDKPLGDLKKRDNMRFGDINVETFYPGK
GHTQDNITVWLPKYKILFGGCLIKSLDTQEIVQTPGSYVSNWSKAIKKVEKKYSDINIIV
PGHGDPGDSRLFTHTLNLLKNNEN
>1DXK_A|FEATURES|NCBI|beta_lactam|BcII|antibiotic inactivation|1
SQKVEKTVIKNETGTISISQLNKNVWVHTELGSFNGEAVPSNGLVLNTSKGLVLVDSSWD
DKLTKELIEMVEKKFQKRVTDVIITHAHADRIGGIKTLKERGIKAHSTALTAELAKKNGY
EEPLGDLQTVTNLKFGNMKVETFYPGKGHTEDNIVVWLPQYNILVGGSLVKSTSAKDLGN
VADAYVNEWSTSIENVLKRYRNINAVVPGHGEVGDKGLLLHTLDLLK
>2BC2_A|FEATURES|NCBI|beta_lactam|BcII|antibiotic inactivation|1
SQKVEKTVIKNETGTISISQLNKNVWVHTELGSFNGEAVPSNGLVLNTSKGLVLVDSSWD
DKLTKELIEMVEKKFQKRVTDVIITHAHADRIGGIKTLKERGIKAHSTALTAELAKKNGY
EEPLGDLQTVTNLKFGNMKVETFYPGKGHTEDNIVVWLPQYNILVGGXLVKSTSAKDLGN
VADAYVNEWSTSIENVLKRYRNINAVVPGHGEVGDKGLLLHTLDLLK
>3FCZ_A|FEATURES|NCBI|beta_lactam|BcII|antibiotic inactivation|1
KTVIKNETGTISISQLNKNVWVHTELGSFNGEAVPSSGLVLNTSKGLVLVDSSWDDKLTK
ELIEMVEKKFQKRVTDAIITHAHADRIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLG
DLQTVTNLKFGNMKVETFYPGKGHTEDNIVVWLPQYNILVGGCLVKSTSAKDLGNVADAY
VNEWSTSIENVSKRYRNINAVVPSHGEVGDKGLLLHTLDLLK
>3KNR_A|FEATURES|NCBI|beta_lactam|BcII|antibiotic inactivation|1
SQKVEKTVIKNETGTISISQLNKNVWVHTELGSFNGEAVPSNGLVLNTSKGLVLVDSSWD
DKLTKELIEMVEKKFQKRVTDVIITHAHADRIGGIKTLKERGIKAHSTALTAELAKKNGY
EEPLGDLQTVTNLKFGNMKVETFYPGKGHTEDNIVVWLPQYNILVGGDLVKSTSAKDLGN
VADAYVNEWSTSIENVLKRYRNINAVVPGHGEVGDKGLLLHTLDLLK
>2NZE_A|FEATURES|NCBI|beta_lactam|BcII|antibiotic inactivation|1
KTVIKNETGTISISQLNKNVWVHTELGSFNGEAVPSNGLVLNTSKGLVLVDSSWDDKLTK
ELIEMVEKKFQKRVTDVIITHAHADHIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLG
DLQTVTNLKFGNMKVETFYPGKGHTEDNIVVWLPQYNILVGGSLVKSTSAKDLGNVADAY
VNEWSTSIENVLKRYRNINAVVPGHGEVGDKGLLLHTLDLLK
>2NXA_A|FEATURES|NCBI|beta_lactam|BcII|antibiotic inactivation|1
TVIKNETGTISISQLNKNVWVHTELGSFNGEAVPSNGLVLNTSKGLVLVDSSWDDKLTKE
LIEMVEKKFQKRVTDVIITHAHADHIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGD
LQTVTNLKFGNMKVETFYPGKGHTEDNIVVWLPQYNILVGGDLVKSTSAKDLGNVADAYV
NEWSTSIENVLKRYRNINAVVPGHGEVGDKGLLLHTLDLLK
>2BFZ_A|FEATURES|NCBI|beta_lactam|BcII|antibiotic inactivation|1
SQKVEKTVIKNETGTISISQLNKNVWVHTELGSFNGEAVPSNGLVLNTSKGLVLVDSSWD
DKLTKELIEMVEKKFQKRVTDVIITHAHADCIGGIKTLKERGIKAHSTALTAELAKKNGY
EEPLGDLQTVTNLKFGNMKVETFYPGKGHTEDNIVVWLPQYNILVGGXLVKSTSAKDLGN
VADAYVNEWSTSIENVLKRYRNINAVVPGHGEVGDKGLLLHTLDLLK
>YP_005545038.1|FEATURES|NCBI|beta_lactam|BAGA_16895|antibiotic inactivation|1
MGLFTAGMKPAHAAEGSELKGVTLTQLAPHVWMHTSTGMADGRPVPANGLLLDTSKGIVL
IDTPWNDSLTEQLMTQINQQFPGKRMTDAIVTHAHDDRIGGLNTLYKYGVKVHSTKLTAD
FARKQGYARPLGDLKNVAKLQFGDMEMETFYPGKGHTEDNITVWLPQDKLLFGGCLIKSL
ETKEIVPTPGFYPDQWPRAVQKVMKRYQDISIVVPGHGSPGDGRLLPHTISLLKEK
>YP_003919855.1|FEATURES|NCBI|beta_lactam|BAGA_16895|antibiotic inactivation|1
MRRFTLFIAGLFLLGLFTAGMKPAHAAEGSELKGVTLTQLAPHVWMHTSTGMADGRPVPA
NGLLLDTSKGIVLIDTPWNDSLTEQLMTQINQQFPGKRMTDAIVTHAHDDRIGGLNTLYK
YGVKVHSTKLTADFARKQGYARPLGDLKNVAKLQFGDMEMETFYPGKGHTEDNITVWLPQ
DKLLFGGCLIKSLETKEIVPTPGFYPDQWPRAVQKVMKRYQDISIVVPGHGSPGDGRLLP
HTISLLKENK
>3I0V_A|FEATURES|NCBI|beta_lactam|BcII|antibiotic inactivation|1
TVIKNTISISQLNKNVWVHTELVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFQ
KRVTDVIITHAHADRIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQTVTNLKFG
NMKVETFYPGKGHTEDNIVVWLPQYNILVGGXCLVKSTSAKDLGNVADAYVNEWSTSIEN
VLKRYRNINAVVPGHGEVGDKGLLLHTLDLLK
>3I14_A|FEATURES|NCBI|beta_lactam|BcII|antibiotic inactivation|1
KTVIKNETGTISISQLNKNVWVHTELVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVE
KKFQKRVTDVIITHAHADRIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQTVTN
LKFGNMKVETFYPGKGHTEDNIVVWLPQYNILVGGXCLVKSTSAKDLGNVADAYVNEWST
SIENVLKRYRNINAVVPGHGEVGDKGLLLHTLDLLK
>YP_001420781.1|FEATURES|NCBI|beta_lactam|BAGA_16895|antibiotic inactivation|1
MRKLSLLIAGLFLFGLFTAGMKPAHAAEGSAAKDVTLTQLAPHVWMHTSTGTADGNPVPA
NGLLLETSKGIVLIDTPWNDSLTEQLMTQIKKRFPGKRMTDAIVTHAHDDRIGGLNTLYK
YGVKVHSTKLTADFARQQGYDRPLGDLKNVTKLQFGDMKIETFYPGKGHTEDNITVWLPE
DKLLFGGCLIKALETKEIVPTPGFYPDQWPRAVRKVMKRYRDISIVVPGHGSPGDDRLLP
HTINLLKET
>WP_004156189.1|FEATURES|NCBI|beta_lactam|BAGA_16895|antibiotic inactivation|1
MTKLTTTCFVLALSLLSYACYAQKIKVKKLEKNVYVHISYKKMGNTNVPSNGLIVKTNKG
VWIIDTAWDDDQTKQIIGWVKKNLKKPIQQVIITHAHDDRAGGIQAFLDEKIPVTSTQLT
AKRTVKSGLPSPQPVLKKSQVIDCGNNNLEIFSPGWGHAPDNIVVYLTKQKVLFGGCFIK
STDTRKLGNTKDAHLKLWKKGLLKVQSKFKEVETVVPGHQDWGDGRLITHTMDLLDVSLH
R
>WP_009879416.1|FEATURES|NCBI|beta_lactam|BcII|antibiotic inactivation|1
MEKMKNTLLKLGVCVSLLGITPFVSTISSVQAERKVEHKVIKNETGTISISQLNKNVWVH
TELGYFNGEAVPSNGLILNTSKGLVLVDSSWDDKLTKELIEMAEKKFKKSVTDVIITHAH
ADRIGGIKTLKERGIKAHSTTLTAELAKKNGYEEPLGDLQAITKLKFGNMKVETFYPGKG
HTEDNIVVWLPQYNMLVGGCLVKSASAKD
>WP_003302143.1|FEATURES|NCBI|beta_lactam|IK7_02258|antibiotic inactivation|1
MVEKKFQKRVTDFIITHAHADRIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQT
ITSLKFGNTKVETFHPGKGRTEDNIVVWLPQYKILAGGCLVKSAEAKDLGNVADAYVNEW
STSIENVLKRYGNINSVVPGHGEVGDKGLLLHTLDLLK
>YP_003973246.1|FEATURES|NCBI|beta_lactam|BAGA_16895|antibiotic inactivation|1
MKISKGWIGKVVFSLLLTLSVFMTSFNDQMIAQSKKSPPTQITNPDKTIVLTKLDDKVWA
HTSYNDWNGTTYDHDQKTEELLKMIKKHFKKKVVLALITHAHDDSISGIRALLNQGIDVR
STLLTAKLAKEYGYPSPSPTLDVKPVMKVGNTVIEAFYPGEGHSSDNITVWLPQYNLLFG
GCFIKSLDAKDLGNLSDANVEQWDESVKKVIEKYRDVKTVVPGHGNWGDESLLFHTIDLI
KQHTHNKS
>YP_084742.1|FEATURES|NCBI|beta_lactam|BcII|antibiotic inactivation|1
MAEKKFKKSVTDVIITHAHADRIGGIKTLKERGIKAHSTTLTAELAKKNGYEEPLGDLQA
ITKLKFGNMKVETFYPGKGHTEDNIVVWLPQYNMLVGGCLVKYASAKDLGNVTDAYVNEW
STSIENVLKRYENINFVVPGHGEVGDKGLLLHTLDLLKEKSEEKQFLLAFF
>WP_003190608.1|FEATURES|NCBI|beta_lactam|M2E15_0562|antibiotic inactivation|1
MKEGVEKMKKNILLKVGVCVSLLGTIQFVSTISSVKAEQKLEQKVIKNETGTISISQLNK
NVWVHTELGYFNGVAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVI
ITHAHADRIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQTRERAYRR
>NP_772870.1|FEATURES|NCBI|beta_lactam|BJP-1|antibiotic inactivation|1
MRRLTAALCALTLLSTGAQAQTIKDFLAVAMKKWTAPFEPFQLIDNIYYVGTDGIAVYVI
KTSQGLILMDTAMPQSTGMIKDNIAKLGFKVADIKLILNTHAHLDHTGGFAEIKKETGAQ
LVAGERDKPLLEGGYYPGDEKNEDLAFPAVKVDRAVKEGDRVTLGDTTLTAHATPGHSPG
CTSWEMTVKDGKEDREVLFFCSGTVALNRLVGQPTYAGIVDDYRATFAKAKAMKIDVLLG
PHPEVYGMQAKRAEMKDGAPNPFIKPGELVTYATSLSEDFDKQLAKQTAALEKK
>ABO21418.1|FEATURES|NCBI|beta_lactam|BD94_2866|antibiotic inactivation|1
MLKKIKISLILALGLTSLQAFGQENPDVKIEKLRDNLYVYTTYNTFNGTKYAANAVYLVT
DKGVVVIDCPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKIGAKTYST
KMTDSILAKENKPRAQYTFDNNKSFKVGKSEFQVYYPGKGHTADNVVVWFPKEKVLVGGC
IIKSADSKDLGYIGEAYVNDWTQSVHNIQQKFSGAQYVVAGHDDWKDQRSIQRTLDLINE
YQQKQKASN
>ABO21420.1|FEATURES|NCBI|beta_lactam|BD94_2866|antibiotic inactivation|1
MLKKIKISLILALGLTSLQAFGQENPDVKIEKLKDNLYVYTTYNTFNGTKYAANAVYLVT
DKGVVVIDCPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKIGAKTYST
KMTDSILAKENKPRAQYTFDNNKSFKVGKSEFQVYYPGKGHTADNVLVWFPKEKVLVGGC
IIKSADSKDLGYIGEAYVNDWTQSVHNIQQKFSGAQYVVAGHDDWKDQRSIQRTLDLINE
YQQKQKASN
>WP_005799525.1|FEATURES|NCBI|beta_lactam|cepA|antibiotic inactivation|1
DLVKDLDTSRQTKNLNKLLIRILLHLQVEFSQRTQSYMQKRLIHLSIIFFLLCPALVVAQ
NSPLETQLKKAIEGKKAEIGIAVIIDGQDTITVNNDIHYPMMSVFKFHQALALADYMHHQ
KQPLETRLLIKKSDLKPDTYSPLRETYPQGGIEMSIADLLKYTLQQSDNNACDILFNYQG
GPDAVNKYLHSLGIRECAVIHTENDMHKNLEFCYQNWTTPLAAAKLLEIFRNENLFDKEY
KNFIYQTMVECQTGQDRLIAPLLDKKVTMGHKTGTGDRNAKGQQIGCNDIGFILLPDGHA
YSIAVFVKDSEADNRENSEIIAEISRIVYEYVTQQID
>WP_000069819.1|FEATURES|resfam|beta_lactam|CTX-M-45|antibiotic target alteration|0
MSNNSPKALVSERRKYKVLNTQQAKGIAENHLKSIGFNAIAISYGLPEIDDRYHVWRVPV
LREKGRIGEVVIDAYTSNVDISKSTDRQVLETATPIHTNKKLTKKEITLSELENMVIEGN
SIESLKYLPEDSVNLIFTSPPYYNAKPEYSEYSTYEEYLELMRQVIKGCHRVLSEGRFFV
LNISPVLIRRASRSESSKRIAVPFDFHKLFIEEGFEFIDDIHWVKPEGAGWAFGRGRRFA
ADRNPLQYKPVPVTEYILVYRKKTDRLIDWNIRKHPDQKAVEESKVEDGYETTNLWRINP
SRSKDHPATFPVELAEKVIKYYSFKNDVVLDPFGGSGTTGIAALNLNRRFVMMELESKYI
QVMKKRFSSFDLFTPISFIKNKDL
>WP_000626897.1|FEATURES|resfam|multidrug|cfr|antibiotic target alteration|0
MITAEKKKKNKFLPNFDKQSIYSLRFDEMQNWLVEQGQQKFRAKQIFEWLYQKRVDSIDE
MTNLSKDLRQLLKDNFTVTTLTTVVKQESKDGTIKFLFELQDGYTIETVLMRHDYGNSVC
VTTQVGCRIGCTFCASTLGGLKRNLEAGEIVSQVLTVQKALDATEERVSQIVIMGIGEPF
ENYDEMMDFLRIVNDDNSLNIGARHITVSTSGIIPRIYDFADEDIQINFAVSLHAAKDEV
RSRLMPINRAYNVEKLIEAIQYYQEKTNRRVTFEYGLFGGVNDQLEHARELAHLIKGLNC
HVNLIPVNHVPERNYVKTAKNDIFKFEKELKRLGINATIRREQGSDIDAACGQLRAKERQ
VETR
>WP_000093084.1|FEATURES|resfam|multidrug|cfr|antibiotic target alteration|0
MSSAVVVSSENLDGQQQSSSTPASPAAEKVNLLGMSRAELEKFFEDIGEKKFRAGQVMKW
IHQYFVTDFAEMTNISGKLRAKLEQICEIKAPEVVHRHYSKDGTRKWVFRVGEGSGSLVE
TVLIPAEDKTGSRKTLCISSQVGCALDCSFCSTGKQGFQRDLTPDEIIGQLWMANYSYME
EVPVAERERSVTNVVMMGMGEPLLNYDAVLSSMHIMLDDFAYGMSKRRVTLSTSGVVPKI
DQLAKDIDVALAISLHAPNDELRNELVPINKKYPLAQLIAACQRYIAKDGNESARKHVTI
EYVMLEGVNDQPEHAQQLLKLLKNLPSKINLIPFNPFPHAPYGRSSRNRIISFQKTLSDA
GFVCTIRQTRGDDIDAACGQLVGQVADRTRRAEQWQKKVAQRQEILRTQG
>WP_000380747.1|FEATURES|resfam|chloramphenicol|catB9|antibiotic inactivation|0
MDTPLINTPVRHWCEFEFISKTVKNPNIHIKGNYSYYSAYWDQGFERCVVRYLHDKPSTP
DKPIDQLYIGNFVCFGAECVIMMGGNQLHRPDWISTFPFDTRSFLAAGDTIIADGCWIGS
RAMIMQGVKIGEGAVVATGAVVTKDVPPYTIVGGVPAKIIKYRFPQEQIEKLLALKIYDL
DEKQVLKMREYLQTDDIDALTAHLKKLQSE
>WP_000132359.1|FEATURES|resfam|chloramphenicol|catB2|antibiotic inactivation|0
MTDSLLKYREQHKHRLNYMPWLYWTLKPKHRVWAEEWQKEYQAYLMDMETVEIGENCFIS
PLAHIFAEPGRKIKIGNNCFIAADCSLHGPLEIGNEVAINHHCILDGGRAGIKLHDQVRI
AAYCHLYAFDHGMQLDRPLYQQPVRSQGIEIEKDVWLGAHVGIKDGIKIGKHAVVGMNSM
VTKDVEPYHIVGGNPAKFIRLRE
>YP_209357.1|FEATURES|NCBI|chloramphenicol|cmlA1|antibiotic efflux|1
MSSKNFSWRYSLAATVLLLSPFDLLASLGMDMYLPAVPFMPNALGTTASTIQLTLTTYLV
MIGAGQLLFGPLSDRLGRRPVLLGGGLAYVVASMGLALTSSAEVFLGLRILQACGASACL
VSTFATVRDIYAGREESNVIYGILGSMLAMVPAVGPLLGALVDMWLGWRAIFAFLGLGMI
AASAAAWRFWPETRVQRVAGLQWSQLLLPVKCLNFWLYTLCYAAGMGSFFVFFSIAPGLM
MGRQGVSQLGFSLLFATVAIAMVFTARFMGRVIPKWGSPSVLRMGMGCLIAGAVLLAITE
IWALQSVLGFIAPMWLVGIGVATAVSVAPNGALRGFDHVAGTVTAVYFCLGGVLLGSIGT
LIISLLPRNTAWPVVVYCLTLATVVLGLSCVSRVKGSRGQGEHDVVALQSAESTSNPNR
>AAB36569.1|FEATURES|resfam|chloramphenicol|chloramphenicol_phosphotransferase|antibiotic inactivation|1
MTTRMIILNGGSSAGKSGIVRCLQSVLPEPWLAFGVDSLIEAMPLKMQSAEGGIEFDADG
GVSIGPEFRALEGAWAEGVVAMARAGARIIIDDVFLGGAAAQERWRSFVGDLDVLWVGVR
CDGAVAEGRETARGDRVAGMAAKQAYVVHEGVEYDVEVDTTHKESIECAWAIAAHVVP
>NP_822052.1|FEATURES|NCBI|multidrug|lsaB|antibiotic inactivation|1
MADVIVLNGGSSSGKSGIVRCLQAVLPDPWLALGTDTLVDAMPASMQASDAGIEFAPDGE
VIVGPEFRTLEAAWIEGVAAMARAGARVIVDEVFLGGADSQQRWQKALRDLRVLWVGVRC
DGAVAAGREIARGDRVIGMAASQADVVHRGVVYDLEVDTTHAESMECARAIATHVR
>NP_386095.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|macB|antibiotic inactivation|0
MKSGCNPGRIVILNGAPRSGKSSIAEAIQETFDGPWMNLGVDAYMERVMPRRCLPGIGLR
PGGELPEIEALVPLFYAALYESVAAHSRLGLNVVADVGHHDAYGEPRHILPDCARRLLGL
PVLFVGVRCPVETIMERRNRGQPGREGGYLTGSEAEPVPRQVLAWQREVHRPGIYDLAVD
TSMMTPDECAALIRKRLEAEPMAPTAFQRLARMASISQPD
>NP_821962.1|FEATURES|NCBI|beta_lactam|ampC|antibiotic inactivation|0
MAIEAVPGTADLVHARIPDTTAAGMVILLNGTSSSGKTSMARALLDILDGTWFHMPVDAF
HAMRCKRDISDEELQPEIDRTAKGFHRAVAGMAAGGNNLVVDYPLSRRWRLLDLLDLLVP
EDTVLVGVRCPLPELERRESERGDRQPGLAAMQYGAVHSHELHDLDIDSSLHTPAECALR
IRDFLPDRPRPTAFETLRRTLRRPHRPTAHTPAEAGPD
>NP_104819.1|FEATURES|resfam|chloramphenicol|chloramphenicol_phosphotransferase|antibiotic inactivation|0
MRSGSGSTIVPPPMSSARNCRASAGPVWWCATGSSIRSRIVFLLRVVESCSEAASKVKAR
IVLLNGVGSAGKSSIARALQTITAAPFLHVQMDSFLEMLPDALQDHADGFSYETVRQDGK
PAVVIRAGPVGERTLRGMRHAIAAMAGQGNDLIVDDVLCNGELSDCVDLLSAFDFHLVGV
MAPLEVLEAREARRADRLPGLARWQYERVHAGISYDLEVDTSQSTPLECARRIQQRFQL
>YP_130954.1|FEATURES|NCBI|chloramphenicol|catB10|antibiotic inactivation|0
MANIIFLHGTSSSGKSTLSQVIQKQSETPFWHFASDQFVEAGMLPKRVNDGGDFDWSKNR
PLFFDAFHGCIKAVADAGNNIILDHIIESKEWFHYLQELLSNHDVFFVGIHCPIEVLRER
EINRGDGSIGNRYLGESEYHLKHVHTYSAYDYEIDTSSQPTEHSAEMVLSAWEQRGQSAF
FSVLEK
>WP_015630486.1|FEATURES|resfam|chloramphenicol|Chloramphenicol_3-O-phosphotransferase|antibiotic inactivation|0
MINPTRARRMRYRLAAMAGMPEGKLILLNGGSSAGKTSLALAFQDLAAECWMHIGIDLFW
FALPPEQLDLARVRPEYYTWDSAVEADGLEWFTVHPGPILDLAMHSRYRAIRAYLDNGMN
VIADDVIWTREWLVDALRVFEGCRVWMVGVHVSDEEGARRELERGDRHPGWNRGSARAAH
ADAEYDFELDTTATPVHELARELHESYQACPYPMAFNRKLRKRFLS
>ABO21413.1|FEATURES|NCBI|beta_lactam|IND-2|antibiotic inactivation|1
MKKSIQLLMMSMFLSPLINAQVKDFVIEPPVKPNLYLYKSFGVFGGKEYSANAVYLTTKK
GVVLFDVPWQKEQYQTLMDTIQKRHHLPVIAVFATHSHDDRAGDLSFYNQKGIKTYATAK
TNELLKKDGKATSTEIIKTGKPYKIGGEEFMVDFLGEGHTVDNVVVWFPKYKVLDGGCLV
KSRTAADLGYTGEANVKQWPETMRKLKMKYAQATLVIPGHDEWKGGGHVQHTLDLLDKNK
KPE
>ACZ65151.1|FEATURES|NCBI|beta_lactam|IND-14|antibiotic inactivation|1
MKKRIQFFMVSMMLSPLFSAQVKDFVIEPPIKKNLHIYKTFGVFGGKEYSANSVYLVTQK
GVVLFDVPWEKVQYQSLMDTIQKRHNLPVIAVFATHSHDDRAGDLSFFNNKGIKTYATAK
TNEFLKKDGKATSTEIIKTGKPYRIGGEEFVVDFLGEGHTADNVVVWFPKYNVLDGGCLV
KSKAATDLGYIKEANVEQWPKTINKLKSKYSKASLVIPGHDEWKGGGHVEHTLELLNKK
>ABO21415.1|FEATURES|NCBI|beta_lactam|IND-5|antibiotic inactivation|1
MKKRIQFFMVSMMLAPMFNAQVKDFVIEPPIKNNLHIYKTFGVFGGKEYSANSVYLVTKK
GVVLFDVPWEKAQYQSLMDTIKKRHNLPVIAVFATHSHDDRAGDLSFFNNKGIKTYATSK
TNEFLKKDGKATSTEIIKTGKPYRIGGEEFTVDFLGEGHTADNVVVWFPKYNVLDGGCLV
KSNSATDLGNIKEANVEQWPITIDKLKAKYSKATLIIPGHEDWKGGGHVEHTLELLNKK
>WP_002995710.1|FEATURES|NCBI|beta_lactam|CGB-1|antibiotic inactivation|1
MRFNKSIFLLLFLLTMAHSGFSQEPGLKIEKLTKDFYIYTTYVAYSGVKTSANALYMLSK
DGVILFDTPWDPDQYQPLLDSIRNRHHQEVIAVYATHSHEDRAGGFGFFNKNGIPTYATA
ATNAILKADHKPEATHLIEPDKTIHIGGKQFVIKYFGEGHTADNVVVWFPKEKILDGGCL
IKSSEAKNLGYVGEANVKEWPKTIRKIQQTFKKINWVIPGHDGWKQQGHLENTLKLLTQ
>YP_004346432.1|FEATURES|NCBI|beta_lactam|PEDO-3|antibiotic inactivation|1
MRAFLFSLACFFSIGSNAQLDFKKISDSSYVFSTYHTFDSVRYSAHGFLKITDLGVVMID
TPWDSLQFQPLLDSIKVKFHQSVILVVSTHWHEDRTAGLDYYNQKGISTYSTYATKNLCV
ENHLPQAKYTFEGDTTFRIGNTIFETYYPGAGHSSDNIVVYFPKEKILVGGCFVKSIEAK
DLGNLSDANIGMWPIAAKNLIKKYPKVKTVIPGHQKISSGKKALKYTLKLTKAKYKGRKL
DKKKAKH
>YP_003075067.1|FEATURES|NCBI|beta_lactam|DIM-1|antibiotic inactivation|1
MRVFLVIFILFIAGDLCAGEEMPGFSVEEIEKNVFLHGSYSQVNGFGLVSSNGLVVIENK
KAFIVDTPWSEKDTINLVQWIEGRNLVLIGSISTHSHEDRTAGIKWLNAHSIPTYASALT
NELLKKDDKEVATKSFEGAELMLADGLIEAYYPGGGHTIDNIVVWLPKSQILFGGCLVRS
VDSTGLGYVGEADIKNWSSSVENVLSKYPEIKAVVPGHGKIGGLSLLTHTKKLAISALPK
LSN
>YP_749578.1|FEATURES|NCBI|beta_lactam|SFB-1|antibiotic inactivation|1
MFSRILILLIGFICCMPLAISAESSGQLTITPLSSNALVKANQAQATQIQLFEYQSYFKT
DDFGLVDANGLVVVEGKDAYLIDTPWSEKDTIALVEWIKQQNFILKASISTHSHADRTAG
ISYLNSIGVSTHVSAMTQKILTTQHKALASQPFDGDSFTLANGLLEARYLGAGHTIDNIV
VWLPKAQLLFGGCLVKSAHSKSMGYIAEASLTDWPVTISKVKATFVDAEVVVPGHGAIGN
AGLLNHTQELVNIYLSKHQLD
>YP_001475146.1|FEATURES|NCBI|beta_lactam|BL3_shw|antibiotic inactivation|1
MSIYLDFVAAAFSFAIPYLRAGAVVLLLGASFSSVAEIHHPEAAWSSDAIKIKQVSPALY
LVKSYKEIKLYQDKPAMTFDSNSFIYVDKHNAYLIDTPWSESDMPDLMSWLKIQKLLLKG
TIVTHYHQDRAGGLGYLDKHGFATYASDMTNQLLVKDKQPMSNHSFSGDKFELLKGQIET
YYPGSGHSMDNLVVWLPKENILIGGCLLKSNETNNLGWTGDADLANWYHSASKVKADFPQ
AKFIFPGHGDGAEGQSILEHTMALTKGVASLK
>WP_006229611.1|FEATURES|NCBI|beta_lactam|GIM-1|antibiotic inactivation|1
MNKLILSLLFVFSLTSLPSFAENNNSKLDITLVTDNVYLVKSYRILKPLDPLEQSITMDA
NSIIYVDGKDAYYIDTPWNATDMPELMAWLDDHELILKKTVFTHFHEDQTGGLNYLLDHK
FETYASQKTNQLLIKEGKSAANNEFTVGSFEFLKDKIEVYYPGAGHTSDNLVVWLPKENV
LIGGCLLRASEIKNIGWIGDADTEQWTQSVQKVQGKFPNVKFVIPGHGAVGGNHSIITHT
IKVVNEFNTKK
>WP_003013519.1|FEATURES|NCBI|beta_lactam|CGB-1|antibiotic inactivation|0
TYATAATNAILKADHKPEATHLIELDKTIHIGGKQFVIKYFGEGHTADNVVIWFPKEKIL
DGGCLIKSSEAKNLGYVGEANVKEWPKTISKIQQT
>YP_001761954.1|FEATURES|NCBI|beta_lactam|BL3_shw|antibiotic inactivation|1
MSKQIDLFITKFKVIRLFTHLLPCLFLLGVSSITAAAPSSSQVNWSSELIKITQVYPTLY
LVKSYKTIKLYQDKPAQTFDSNSFIYVDNSDAYLIDTPWSESDMPDLMRWLEVKKLQLKG
TIVTHYHQDRAGGLGYLDRLGSATYASKMTNKLLVNDKQPTSNHSFSGDKFALLKGKIEA
FYPGSGHSMDNLVIWLPEEKVIVGGCLLKDNKVNNLGWTGDADLANWYHSISKVKAEFPK
VEFIFPGHGEGAKGQSILDHSLSVTKEVARFE
>WP_008681849.1|FEATURES|NCBI|beta_lactam|CcrA|antibiotic inactivation|1
MLALIVCCWSPAKTAAQEIGESARVAEDLDVVRLSGRVYMHVSRYEMPPFGLVPANGLIL
VDKGEAFLFDTPWTESQTEVLLDWIENVLHARVTACVPNHWHKDAMGGLPAVRRRGIPTY
AYDGTIAIARQKGLRPPEHGFASERTLKLHGLEVRNVYLGGGHSTDGIFVWIPAENLLFP
GCMAKDAKTVNLGNTEDADVRAWPGTMEKALAAFPDACIVVPGHGQPGGPELLRHTRDLA
LRAGGSR
>WP_002614052.1|FEATURES|NCBI|beta_lactam|VIM-29|antibiotic inactivation|1
MDPAGHLSGGSWHASAGGNRRWICQSVRADVRHAMLILYLPASIGAQPPCRSLTHGAHHI
RSPHERGALPPGAGMLSPSMHPPLRPHPLWCSLRPATLALLLGVFGCRTSVPAPRPAAEP
FTSITEDLRIQPLAPGVWRLVALSGEEWGHIPANGLVIAEGGGVLLVDPGWTEAQGERLL
QWVEDTLKVPVHAGVATHFHADRTGGLRALQARGIPTHALALTAALTSQQDRPAPTHLFP
GPAQQLGPVELFFPGPGHAPDNITVWHAASGILFGGCMVKDLKASSLGNLSDADLASWPR
SVESLQARYPAARTVIPGHGEPGDTSLLAHTLELLRAGSR
>YP_002155877.1|FEATURES|NCBI|beta_lactam|DIM-1|antibiotic inactivation|1
MFKFITGIVAAFVSFNTLSAPVIKPLQFEEVTTNIFLVKSFREFKNLKSPDNPIVIDANS
LIYIDGKDAYLIDTPWNAENMPQLMTWIENRDLTLKKTVFTHFHEDQTGGLEYLQEHGFD
TYATKLTNTRLVNDNKKAATHELDAQESVLLDNKIEVFYPGPGHSKDNSVVWFPKEKVLL
GGCLMRANEVNTIGWTGDADLAQWAQSAKNVLIKYPETKLVIPGHGDIGKGTSVISHTVN
IAESL
>YP_004041894.1|FEATURES|NCBI|beta_lactam|ATN06_17210|antibiotic inactivation|1
MKPKIHLTLFVFLLSLTNLFAQTNYQLTKNKADQLDRNFAITQLTNNAFLIQSSFAANGQ
LDCNHLLIIDTKDLVLVNTPVNDSLTSVLLACIEKKFKRKVTKVIVSHFHEDSSGGLRQI
CKLGINSFGLSKTASLLKSQNKHIDFLFTSFFALDLQTLHLELFYPGAGHSIDNIVIWLP
EDKILFGGCLLKSLEAKDKGNIKDADLKAWPVSVELIKKKYQDAIIVIPGHGEIGNTSVF
EHTLKLLANN
>1A7T_A|FEATURES|NCBI|beta_lactam|CcrA|antibiotic inactivation|1
AQKSVKISDDISITQLSDKVYTYVSLAEIEGWGMVPSNGMIVINNHQAALLDTPINDAQT
EMLVNWVTDSLHAKVTTFIPNHWHGDCIGGLGYLQRKGVQSYANQMTIDLAKEKGLPVPE
HGFTDSLTVSLDGMPLQCYYLGGGHATDNIVVWLPTENILFGGCMLKDNQTTSIGNISDA
DVTAWPKTLDKVKAKFPSARYVVPGHGNYGGTELIEHTKQIVNQYIESTSKP
>YP_002262687.1|FEATURES|NCBI|beta_lactam|GIM-1|antibiotic inactivation|1
MKFMFKLTLALLSSVIGFNAAAEPVVKPLQFEEITNNVFLVKSYREFKNLQSPKKPILVD
ANSLVYVDGKDAYLIDTPWNASNMPQLMTWIENRGLTLKKTVFSHFHEDQTGGLEYLQEH
HFETYASALTNKFLKGDNKKATNHQFSGDNFVLLENKIEVFYPGGGHTKDNAVVWLPKEK
VLLGGCLMRANEVNTIGWTGDADMKAWAGSAQKVLTKYPQANFVVPGHGNVGEGTSIISH
TVDITGKI
>ACU65239.1|FEATURES|NCBI|beta_lactam|IMP-6|antibiotic inactivation|1
MSKLSVFFIFLFCSIATAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSRSIPTYASELT
NELLKKDGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILIGGCFIKP
YGLGNLGDANIEAWPKSAKLLKSKYGKAKLVVPGHSEVGDASLLKLTLEQAVKGLNESKK
PSKPSN
>ACU65238.1|FEATURES|NCBI|beta_lactam|IMP-6|antibiotic inactivation|1
MSKLSVFFIFLFCSIATAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSRSIPTYASELT
NELLKKDGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILYGGCFIKP
YGLGNLGDANIEAWPKSAKLLKSKYGKAKLVVPGHSEVGDASLLKLTLEQAVKGLNESKK
PSKPSN
>4ZNB_A|FEATURES|NCBI|beta_lactam|CcrA|antibiotic inactivation|1
AQKSVKISDDISITQLSDKVYTYVSLAEIEGWGMVPSNGMIVINNHQAALLDTPINDAQT
ETLVNWVADSLHAKVTTFIPNHWHGDCIGGLGYLQKKGVQSYANQMTIDLAKEKGLPVPE
HGFTDSLTVSLDGMPLQCYYLGGGHATDNIVVWLPTENILFGGSMLKDNQATSIGNISDA
DVTAWPKTLDKVKAKFPSARYVVPGHGDYGGTELIEHTKQIVNQYIESTSKP
>ACU65237.1|FEATURES|NCBI|beta_lactam|IMP-6|antibiotic inactivation|1
MSKLSVFFIFLFCSIATAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDGTGGIEWLNSRSIPTYASELT
NELLKKDGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILFGGCFIKP
YGLGNLGDANIEAWPKSAKLLKSKYGKAKLVVPGHSEVGDASLLKLTLEQAVKGLNESKK
PSKPSN
>YP_927055.1|FEATURES|NCBI|beta_lactam|SLB-1|antibiotic inactivation|1
MRIAISWCTALMIGTIANTQALEITPLSDGLFLHQSEKEVEGFGKVSANGLIIVDGKEAF
VVDTPWTDADAEALLEWTKAKDLTVKAVLATHWHEDRAGSFGVFERAGIATLSSEATQAL
LRQHQKTLATHTFSGDEIQYFGNKVEVFYPGAGHAMDNLVVYLPHEKLLFGGCLVREAST
RFMGFYGDGSLPDWPESMSRLIAKFPEVITVVPGHGALGDKRLLEHTRGLAEAALKAQ
>YP_004318456.1|FEATURES|NCBI|beta_lactam|CcrA|antibiotic inactivation|1
MKHCFFYGLAFLLLSCKLSAQTDKSYVSDDFTIKKVKDNVYEHTSYLLTDDFGKVPCNGM
IVYDGGEAIVFDTPTNDSIADILIDWVKDSLDCTIVAVIPTHFHDDCLGGLAAFHKNRIP
SYASNKTIAFAKAKNLIMPQHGFHKKLELKVGERKIIAEFNGEGHTKDNIIGYFPNRRVM
FGGCLIKEMNASKGYLGDSNVESWSETVMKIKQKYPEAELIIPGHGKSGGQELLDYTINL
FKQ
>ACU65241.1|FEATURES|NCBI|beta_lactam|IMP-1|antibiotic inactivation|1
MSKLSVFFIFLFCSIATAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSRSIPTYASELT
NELLKKDGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILYGGCFIKP
YGLGNLGDANIEAWPKSAKLLKSKYGKAKLVVPAHSEVGDASLLKLTLEQAVKGLNESKK
PSKPSN
>ACU65242.1|FEATURES|NCBI|beta_lactam|IMP-1|antibiotic inactivation|1
MSKLSVFFIFLFCSIATAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSRSIPTYASELT
NELLKKDGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILFGGCFIKP
YGLGNLGDANIEAWPKSAKLLKSKYGKAKLVVPAHSEVGDASLLKLTLEQAVKGLNESKK
PSKPSN
>ACU65240.1|FEATURES|NCBI|beta_lactam|IMP-1|antibiotic inactivation|1
MSKLSVFFIFLFCSIATAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSRSIPTYASELT
NELLKKDGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILYGGCFIKP
YGLGNLGDANIEAWPKSAKLLKSKYGKAKLVVPSHSEVGDASLLKLTLEQAVKGLNESKK
PSKPSN
>ACU65236.1|FEATURES|NCBI|beta_lactam|IMP-1|antibiotic inactivation|1
MSKLSVFFIFLFCSIATAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSRSIPTYASELT
NELLKKDGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILFGGCFIKP
YGLGNLGDANIEAWPKSAKLLKSKYGKAKLVVPVHSEVGDASLLKLTLEQAVKGLNESKK
PSKPSN
>1WUP_A|FEATURES|NCBI|beta_lactam|IMP-1|antibiotic inactivation|1
AESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNAEAYLIDTPFTAKDTEKLV
TWFVERGYKIKGSISSHFHSESTGGIEWLNSRSIPTYASELTNELLKKDGKVQATNSFSG
VNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILFGGCFIKPYGLGNLGDANIEAWPKSA
KLLKSKYGKAKLVVPSHSEVGDASLLKLTLEQAVKGLNESKKPSKPSN
>ACY78406.1|FEATURES|NCBI|beta_lactam|VIM-2|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVGSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>ACE77794.1|FEATURES|NCBI|beta_lactam|VIM-17|antibiotic inactivation|1
MFKLLSKLLVYLTASSMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>ABO21416.1|FEATURES|NCBI|beta_lactam|VIM-2|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLIVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>WP_008199227.1|FEATURES|NCBI|beta_lactam|CcrA|antibiotic inactivation|1
MKTQAFLLILLFVYQQQSVFGQKKEFAYNSESLQVEQISQNTFLHISYLNTDDFGKVACN
GMIVINEGEALVFDTPANEEASLELINWLEKEQQVTVKGVVATHFHWDCLGGLDEFHRKG
IHSYASAKTIALAKSVGYPVPEIDFKKKLILEAGSIKIVNQFFGEGHTKDNFISYVPADQ
VIFGGCMIKAIGAGKGNLEDANLSEWSATVEKVKSAFPDTQIVIPGHGKIGGTELLDYTA
EMFEKK
>YP_006410297.1|FEATURES|NCBI|beta_lactam|CcrA|antibiotic inactivation|1
MKPTLRKRLSYLLLALLDFASACDREPVDRNSAGNSIFAAEIQPVIMPKNMSALRPFLFA
LLLAATAAACTFRRIDIGNDITVQRLAEGIYLYTAVDEIEGYGPVPSNGVLIVREGEAVL
LDTPVGDAQTKTLTDWAAETLRACVTTFVPNHWHSDCMGGLGYLKTLGVKSYAHRLTHSI
AQREGKPVPDIGFGDSLRLDLHGTEIRCYYFGGGHSEDNIAVWIPSAKLLFAGCMVKEMA
AQNAGNLSDAVPAAWPATLDSLLVRFPDARIVVPGHGAPGGPELIRHTKALLSEAASTDN
RRKE
>YP_003085783.1|FEATURES|NCBI|beta_lactam|CcrA|antibiotic inactivation|1
MQNHILTCLLALVCAYAHAQTPDKSFKTDDLIVQKLTDHTYQHLTYLQTQTFGKVPCNGL
IVFDGGEAVIFDTPADDATSEKVIRWVEDSLKCKVKAVIATHFHEDCVGGLKAFHEHGIP
SYATNKTIAFDKEHKFPVPQKGFDNKLELNVGTKPVVAAFYGEGHTRDNIIGYFPSEKVM
FGGCLIKEVDATKGNLADANVDVWPATVANIRKQYSDVKVVIPGHGKIGGSELLDYTIKL
FSQK
>WP_003002951.1|FEATURES|NCBI|beta_lactam|PEDO-3|antibiotic inactivation|0
MRFNKSIFLILFLLTMAHSGFSQEPGLKIEKLTKDFYIYTTYVAYSGVKTSANALYMLSK
DGVILFDTPWDPDQYQPLLDSIRNRHHQEVIAVYATHSHEDRAGGFGFFN
>YP_564153.1|FEATURES|NCBI|beta_lactam|IMP-41|antibiotic inactivation|1
MRFILCLLLMVSSLTYAAQGPSKLKIVQLSDIVYQHTSLSDGDAYGVMAANGLIVIVGKQ
AYLIDTPWTEADTNTLIQWVTVKGLTIGGVIVTHFHQDSSGGLAVLNKLKINTYATTLTN
QLLKANNREPASNEITSETFDLVPGVIQAYYPGAGHTQDNLVVWLAKSNLLFGGCLVQSF
NNRKLLNIEDASIKDWPKSLQNVMVKYPNIDMVIPGHGQIGDVSLLELTQQLARKAL
>1WUO_A|FEATURES|NCBI|beta_lactam|IMP-1|antibiotic inactivation|1
AESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNAEAYLIDTPFTAKDTEKLV
TWFVERGYKIKGSISSHFHSASTGGIEWLNSRSIPTYASELTNELLKKDGKVQATNSFSG
VNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILFGGXFIKPYGLGNLGDANIEAWPKSA
KLLKSKYGKAKLVVPSHSEVGDASLLKLTLEQAVKGLNESKKPSKPSN
>YP_002446910.1|FEATURES|NCBI|beta_lactam|BG10_6932|antibiotic inactivation|1
MVEKKFQKRVTDFIITHAHADRIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQT
ITSLKFGNTKVETFHPGKGRTEDNIVVWLPQYKILAGGCLVKSAEAKDLGNVADAYVNEW
STSIENVLKRYGNIDSVVPGHGEVGDRGLLLHTLDLLK
>YP_003861292.1|FEATURES|NCBI|beta_lactam|CcrA|antibiotic inactivation|1
MKIKYTLFLVSLILIIGCKAQNSTNSSFESENLRIKQLTENTYVHISYLETDTWGKVPCK
GMIVTDNGEAIVFDTPTNDVASVELLNWLKNDLKYQVNAVVATHFHVDCIGGLKEFHKNN
IPSYATNMTIDLMKNGVVPENGFDKYLELKVGNKKVVSQYFGGGHTSDNIVGYFSSEKVL
FGGCLVKSIGAGKGNLEDADVQAWSKTVENVKKQFKKVEVVIPGHGEAGNAGLLDYTIEL
FKQE
>YP_628702.1|FEATURES|NCBI|beta_lactam|CcrA|antibiotic inactivation|1
MTLFPLRWFCAGALLITLSTACTRSTPAATVERNIPVKAQSQGPDEYVLADDVSVRKLAP
GVWLHITVVTLEPFGRVSTNGLIIEDGETSLLVDTGWDARQGALLLDWARDTLRRPVRAA
VVTHFHEDRLGGVPALAPHGIPVHGLEETARIATSLGLPGPTETFAKTSTVDSLELFFPG
AGHAKDNIVVWHRDSGVLFGGCFVKDGASTNLGNVADADVAAWPASLSRTRQRFPEARVV
VPGHGQPGGPELLGHTEALLR
>ACT52235.1|FEATURES|NCBI|beta_lactam|IMP-7|antibiotic inactivation|1
TSFEEVNGWGVVPKHGLVVLVNTDAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFH
SDSTGGIEWLNSQSIPTYASELTNELLKKDGKVQAKNSFSGASYWLVKKKIEIFYPGPGH
TPDNVVVWLPEHRVLFGGCFVKPYGLGNLGDANLEAWPKSAKLLVSKYGKAKLVPSHSEV
G
>2FHX_A|FEATURES|NCBI|beta_lactam|SPM-1|antibiotic inactivation|1
SDHVDLPYNLTATKIDSDVFVVTDRDFYSSNVLVAKMLDGTVVIVSSPFENLGTQTLMDW
VAKTMKPKKVVAINTHFHLDGTGGNEIYKKMGAETWSSDLTKQLRLEENKKDRIKAAEFY
KNEDLKRRILSSHPVPADNVFDLKQGKVFSFSNELVEVSFPGPAHSPDNVVVYFPKKKLL
FGGXMIKPKELGYLGDANVKAWPDSARRLKKFDAKIVIPGHGEWGGPEMVNKTIKVAEKA
VGEMRL
>ABB99430.1|FEATURES|NCBI|beta_lactam|IMP-4|antibiotic inactivation|1
DECVYVHTSFEEVNGWGVVPKHGLVVLVDAEAYLIDTPFTAKDTEKLVTWFVERGYKIKG
SISSHFHSDSTGGIEWLNSQSIPTYASELTNELLKKDGKVQAKNSFGGVNYWLVKNKIEV
FYPGPGHTPDNLVVWLPERKILFGGCFIKPYGLGNLGDANLEAWPKSAKLLISKYGKANW
V
>CAQ87575.1|FEATURES|NCBI|beta_lactam|CcrA|antibiotic inactivation|1
MKTVFILISMLFPVAVMAQKSVKISDDISITQLSDKVYTYVSLAEIEGWGMVPSNGMIVI
NNHQAALLDTPINDAQTEMLVNWVTDSLHAKVTTFIPNHWHGDCIGGLGYLQRKGVQSYA
NQMTIDLAKEKGLPVPEHGFTDSLTVSLDGMPLQCYYLGGGHATDNIVVWLPTENILFGG
CMLKDNQTTSIGNISDADVTAWP
>YP_003270512.1|FEATURES|NCBI|beta_lactam|NDM-6|antibiotic inactivation|1
MLFRVELLSSAIAALALSAGCGAHQPAASQAPQAAATPSSTDSTDSTATDEASETGRDEL
EFTQLGEGVWMHTSWKDVPPWGPVMSNGLIVADGEGSFLIDTAWNDEQTAAILDWAEREL
GRPVRGAVFTHAHEDKMGGVGTVRARGIRTYALALSNQLAAEGGVMPAEASLRLEAGGEP
QTLGPVQVFYPGGGHTRDNIVVAVDGGVLFGGCLIRPGGTNSLGNTADADLDHWDEAVSA
VAKRFPDRSVVIPSHGPPGGRELLDQTIQLVQSDEKKP
>EAQ37928.1|FEATURES|NCBI|beta_lactam|SFB-1|antibiotic inactivation|1
MKRLLQMLGICLAVLLLHSCFDKSKYAPEPYLRPLEIIKLSDQDYMHVSYLKDGKDGYIP
CNGYIRKEGDEVFVFETPLDDSTSVQLIDFIQNDLNATIKAVMVSHAHIDGAGGVKAFNE
AGIPTYGSSKAAALLARDTITLSNTFQLKDSLMLGKTLIKMDYLGPAHTDDNAIAYLEGP
EILLGGCMIKSLEAGKGNLADANLKEWAKTVATAKYLYPDVKQVIPGHGMRGDSTLLTYT
IKMFQVEKPIIKELTNTNEQETVQL
>AAY46154.1|FEATURES|NCBI|beta_lactam|IMP-4|antibiotic inactivation|1
DLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVDAEAYLIDTPFTAKDTEKLVTWFVE
RGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELTNELLKKDGKVQAKNSFGGVNYWL
VKNKIEVFYPGPGHTPDNLVVWLPERKILFGGCFIKPYGLGNLGDANLEGWPKSAK
>ABX00642.1|FEATURES|NCBI|beta_lactam|IMP-9|antibiotic inactivation|1
SAAGESLPDLKIEKLDEGVYVHTSFEEVNGWGVIPKHGLVVLVNTDAYLIDTPFTAKDTE
NLVNWFVERGYRIKGSISSHFHSDSTGGIEWLNSQSIPTYASELTNELLKKDGKVQAKYS
FSGVSYWLVKKKIEVFYPGPGHAPDNVVVWLPENRVLFGGCFVKPYGLGNLGDANLEAWP
>YP_458405.1|FEATURES|NCBI|beta_lactam|NDM-6|antibiotic inactivation|1
MIARVLALAAALALPACVPGEIRSSVAEQEADRDIIRFGEVSFSQLAEGVWMHTTYLDLM
GFGPIPSNGLLVVNGDNTILVDTAWTDEQTEQIVAWASMVLAKPVRAAVVTHAHQDKMGG
MAALHGANIATWAHPLSNELAPEEGLVPARNAITFDANGWATGEAAQSLAPLRLYYPGGA
HTRDNITVGLPELGIAFGGCMIKAGDASNLGNLADADTAAYAQSVRNFAAAFPDARTIAM
SHSPPEGRKAIERTLDLAEEL
>YP_003061440.1|FEATURES|NCBI|beta_lactam|NDM-6|antibiotic inactivation|1
MRYTLIGISLLLGFVFLSGCMHQVPVLSQQSEQSTHIEGVAEKPVEFVKLGTGVWMHTGY
KVVPPWGNIRTNGLIIERGDYSVLVDTAWNDAQTAEIVAWAKDTLQKPIRASIHTHAHSD
KMGGMDALHMLGVETFATDLTNRLAIERGLMPAKNVLNISEIGSQIEWEGLTILYPGGGH
SEDNIVVNEGVNNILFGGCMIRPGMTTSLGNIDDANLGYWSKAVENAANAFPDSQIVIPS
HGKPAGREILKNTAYIARPKLD
>ADL70857.1|FEATURES|NCBI|beta_lactam|NDM-10|antibiotic inactivation|0
MGGMDALHAAGIATYANALSNQLAPQEGMVAAQHSLTFAANGWVEPATAPNFGPLKVFYP
GPGHTSDNITVGIDCSDIAFGGCLIKDSKAKSLGNLGDADTEHY
>ACT52233.1|FEATURES|NCBI|beta_lactam|VIM-11|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVYSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGSEIPTHSLEGLSS
>CBX26624.1|FEATURES|NCBI|beta_lactam|VIM-17|antibiotic inactivation|0
RSLPVHGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRVGGVD
VLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAH
>CBX26623.1|FEATURES|NCBI|beta_lactam|VIM-23|antibiotic inactivation|0
SLPVHGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRVGGVDV
LRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGLR
>CBX26622.1|FEATURES|NCBI|beta_lactam|VIM-23|antibiotic inactivation|0
RDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRVGGVDVLRAAGVATY
ASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPVAAH
>ACI25600.1|FEATURES|NCBI|beta_lactam|SPM-1|antibiotic inactivation|0
TDRDFYSSNVLVAKMLDGTVVIVSSPFENLGTQTLMDWVAKTMKPKKVVAINTHFHLDGT
GGNEIYKKMGAETWSRDL
>1X8H_A|FEATURES|NCBI|beta_lactam|cphA7|antibiotic inactivation|1
AGMSLTQVSGPVYVVEDNYYVQENSMVYFGAKGVTVVGATWTPDTARELHKLIKRVSRKP
VLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQTRDLMKSDWAEIVAFTRKGLPEYPDLPL
VLPNVVHDGDFTLQEGKVRAFYAGPAHTPDGIFVYFPDEQVLYGGCILKEKLGNLSFADV
KAYPQTLERLKAMKLPIKTVIGGHDSPLHGPELIDHYEALIKAAPQSS
>YP_004391384.1|FEATURES|NCBI|beta_lactam|cphA6|antibiotic inactivation|1
MMKSWMKCTLAGAVVLMASFWGGSVRAAGISLKQVSGPVYVVEDNYYVKENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVRAFYAGPAHTPDGIF
VYFPDEQVLYGNCILKEKLGNLSFANVKAYPQTIERLKAMKLPIKTVIGGHDSPLHGPEL
IDHYEELIKAAPQS
>WP_004874166.1|FEATURES|NCBI|beta_lactam|cphA8|antibiotic inactivation|1
MLKTILQFFVLFTVTQGAYASKIALVKLSDNLYVVEDDYYYRENSMVYIGKDYITVIGAT
WTPDTAKELDAQIKKISKKPIAEVINTNYHTDRAGGNLYWKSIGAELISTKMTYNLMEKH
WQDILETTRKGYDGFPDIPLVLPTKTFDNNFELQNGEIKAIYTGESHTPDGIFVYFPKEK
TLYGNCIIKEKLGNLASANIKEYPKTLQKLKNLNLDIKTVVGGHDSPIHGSELIDSYKKL
IEAANK
>ABE01852.1|FEATURES|NCBI|beta_lactam|cphA7|antibiotic inactivation|1
LTQVSGPVYVVEDNYYVQENSMVYFGAKGVTVVGATWTPDTARELHKLIKRVSSKPVLEV
INTNYHTDRAGGNAYWKSIGAKVVATRQTRDLMQSDWAEIVAFTRKGLPEYPDLPLVLPN
VVHGGDFTLQEGKVRAFYAGPAHTPDGIFVYFPDEQVLYGNCILKEKLGNLSFADVKAYP
QTIERLKAMKLPIKTVVGGHDS
>ABE01851.1|FEATURES|NCBI|beta_lactam|imiS|antibiotic inactivation|1
LTQVSGPVYVVEDNYYVQENSMVYFGAKGVTVVGATWTPDTARELHKLIKGVSRKPVLEV
INTNYHTDRAGGNAYWKSIGAKVISTRQTRDLMKSDWAEIVAFTRKGLPEYPDLPLVLPN
VVHEGDFTLQEGKLLAFYAGPAHTPDGIFVYCPDQQVLYGNCILKEKLGNLSFADVKAYP
QTLERLKAMKLPIKTVVGGHDSPLHGPELI
>NP_902820.1|FEATURES|NCBI|beta_lactam|cphA6|antibiotic inactivation|1
MDIKMRTVFGFAGALLGLAAAACAAQGGLALKHLKGGVYVVEDGYYAKENSVVYVGAEHV
TVVGATWTPDTARELARQIRAVTDKPIAEVVNPNYHPDRAGGNAYWKSIGARIVSTRQTA
DEMRRGWDEVVAFTRRGFPDYPALPVSLPDREHPGDFELQDGRIKAFHLGAAHTRDGIFV
HFPQERVLYGNCILKQELGNLSYADLNEYPKTLERLKLSELDFDTVIAGHLDALHGPELI
DHYQRLLKRQASDAAAERS
>ACF39942.1|FEATURES|NCBI|beta_lactam|cphA|antibiotic inactivation|0
YFGAKGVTVVGATWTPDTARELHKLIKRVSRKPVLEVINTNYHTDRAGGNAYWKSIGAKV
VSTRQTRELMKSDWAE
>3Q6V_A|FEATURES|NCBI|beta_lactam|Sfh-1|antibiotic inactivation|1
MSEKNLTLTHFKGPLYIVEDKEYVQENSMVYIGTDGITIIGATWTPETAETLYKEIRKVS
PLPINEVINTNYHTDRAGGNAYWKTLGAKIVATQMTYDLQKSQWGSIVNFTRQGNNKYPN
LEKSLPDTVFPGDFNLQNGSIRAMYLGEAHTKDGIFVYFPAERVLYGNCILKENLGNMSF
ANRTEYPKTLEKLKGLIEQGELKVDSIIAGHDTPIHDVGLIDHYLTLLEKAPK
>1JT1_A|FEATURES|NCBI|beta_lactam|FEZ-1|antibiotic inactivation|1
AYPMPNPFPPFRIAGNLYYVGTDDLASYLIVTPRGNILINSDLEANVPMIKASIKKLGFK
FSDTKILLISHAHFDHAAGSELIKQQTKAKYMVMDEDVSVILSGGKSDFHYANDSSTYFT
QSTVDKVLHDGERVELGGTVLTAHLTPGHTRGCTTWTMKLKDHGKQYQAVIIGSIGVNPG
YKLVDNITYPKIAEDYKHSIKVLESMRCDIFLGSHAGMFDLKNKYVLLSKGQNNPFVDPT
GCKNYIEQKANDFYTELKKQETG
>CAC15063.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MRFTLLAFALAVALPAAHASAAEAPLPQLRAYTVDASWLQPMAPLQVADHTWQIGTEDLT
ALLVQTAEGAVLLDGGMPQMAGHLLDNMKLRGVAPQDLRLILLSHAHADHAGPVAELKRR
TGAHVAANAETAVLLARGGSNDLHFGDGITYPPASADRIIMDGEVVTVGGIAFTAHFMPG
HTPGSTAWTWTDTRDGKPVRIAYADSLSAPGYQLKGNPRYPRLIEDYKRSFATVRALPCD
LLLTPHPGASNWNYAAGSKASAEALTCNAYADAAEKKFDAQLARETAGAR
>BAF47409.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MRSTLLAFALAVALPAAHASAAEAPLPQLRAYTVDASWLQPMAPLQVADHTWQIGTEDLT
ALLVQTAEGAVLLDGGMPQMAGHLLDNMKLRGVAPQDLRLILLSHAHADHAGPVAELKRR
TGAHVAANAETAVLLARGGSNDLHFGDGITYPPASADRIIMDGEVVTVGGIAFTAHFMPG
HTPGSTAWTWTDTRDGKPVRIAYADSLSAPGYQLKGNPRYPRLIEDYKRSFATVRALPCD
LLLTPHPGASNWNYAAGSKASAEALTCNAYADAAEKKFDAQLAKETAGAR
>WP_005413585.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MRDAMKEAHASFWASFKRTWIMRFTLLAFALAVALPAAHASAAEAPLPQLRAYTVDASWL
QPMAPLQVADHTWQIGTEDLTALLVQTAEGAVLLDGGMPQMAGHLLDNMKLRGVAPQDLR
LILLSHAHADHAGPVAELKRRTGAHVAANAETAVLLARGGSNDLHFGDGITYPPASADRI
IMDGEVVTVGGIAFTAHFMPGHTPGSTAWTWTDTRDGKPVRIAYADSLSAPGYQLKGNPR
YPRLIEDYKRSFATVRALPCDLLLTPHPGASNWNYAAGSKASAEALTCNAYADAAEKKFD
AQLARETAGTR
>ABO60986.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MRSTLLAFALAVALPAVHASAAEAPLPQLRAYTVDASWLQPMAPLQVADHTWQIGTEDLT
ALLVQTAEGAVLLDGGMPQMAGHLLDNMKLRGVAPQDLRLILLSHAHADHAGLVAELKRR
TGAHVAANAETAVLLARGGSNDLHFGDGITYPPASADRIIMDGEVVTVGGIAFTAHFMPG
HTPGSTAWTWTDTRDGKPVRIAYADSLSAPGYQLKGNPRYPRLIEDYKRSFATVRALPCD
LLLTPHPGASNWNYAAGSKASAEALTCNAYADAAEKKFDAQLAKETAGAR
>ABC02083.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MRSTLLAFALAAALPFAQAHAAEAPLPQLRAYTVDASWLQPMAPLQIADHTWQIGTQELT
ALLVQTAEGAVLLDGGMPQMAGHLLDNMKARGVAPQDLRLILLSHAHADHAGPVAELKRR
TGAKVVANAESPVLLARGGSDDLHFGDGITYPPASADRIIMDGEVFSIGGIDFTAHFMPG
HTPGSTAWTWTDTRDGKPVRIAYADSLSAPGYQLKDNPRYPRLIEDYKRTFATVRGLPCD
LLLTPHPGASNWSYAAGSKASANALTCKAYADAAEKKFEAQLAKETAGAR
>ABO60992.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MRLCLTPLALAATLVFDVAAADAPPPQLRAYTVDASWLQPMAPLQIADHTWQIGTEDLTA
LLVRTTEGAVLLDGGMPQMAGHLLDNMKARGVAPQDLRLILLSHAHADHAGPVAELKRRT
GAQVVANAETAVLLPRGGSNDLHFGDDITYPPASADRIIMDGERVTVGGMAFTAHFMPGH
TPGSTAWTWTDTRDGKPVRIAYADSLSAPGYQLQYNARYPRLVEDYRRSFTTVRGLPCDL
LLTPHPGASRWNYAAGAEAGANVLTCKAYADAAEKAFDAQLAKETTGAR
>ABO60987.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MRLCLTTLALTATLAFDVTAADAPLLQLQAYTVDASWLQPMAPLQIADRTWQIGTEDLTA
LLVQTADGAVLLDGGMPQMAGHLLDNMKARGVAAQDLRLILLSHAHADHAGPVAELKRRT
GASVAANAESAVLLARGGSNDLHFGDSITFPPASADRIIMDGEEVTVGGIAFTAHFMPGH
TPGSTAWTWTDTRDGQPVRIAYADSLSAPGYQLQGNARYPRLVEDYRRSFATVRGLPCDL
LLTPHPGASNWNYAAGAEAGANALTCKAYADAAEKKFDAQLAKETATAR
>2QJS_A|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
AEVPLPQLRAYTVDASWLQPMAPLQIADHTWQIGTEDLTALLVQTPDGAVLLDGGMPQMA
SHLLDNMKARGVTPRDLRLILLSHAHANHAGPVAELKRRTGAKVAANAESAVLLARGGSD
DLHFGDGITYPPANADRIVMDGEVITVGGIVFTAHFMAGHTPGSTAWTWTDTRNGKPVRI
AYADSLSAPGYQLQGNPRYPHLIEDYRRSFATVRALPCDVLLTPHPGASNWDYAAGARAG
AKALTCKAYADAAEQKFDGQLAKETAGAR
>ABO60999.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MRLCLTTLALTATLAFDVTAADAPLPQLQAYTVDASWLQPMAPLQIADRTWQIGTEDLTA
LLVQTADGAVLLDGGMPQMAGHLLDNMKARGVAAQDLRLILLSHAHADHAGPVAELKRRT
GASVAANAESAVLLARGGSNDLHFGDSITFPPASADRIIMDGEEVTVGGIAFTAHFMPGH
TPGSTAWTWTDTRDGQPARIAYADSLSAPGYQLQGNARYPRLVEDYRRSFATVRGLPCDL
LLTPHPGASNWNYAAGAEAGANALTCKAYADAAEKKFDAQLAKETATAR
>2QIN_A|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
AEVPLPQLRAYTVDASWLQPMAPLQIADHTWQIGTEDLTALLVQTPDGAVLLDGGMPQMA
SHLLDNMKARGVTPRDLRLILLSHAHACHAGPVAELKRRTGAKVAANAESAVLLARGGSD
DLHFGDGITYPPANADRIVMDGEVITVGGIVFTAHFMAGHTPGSTAWTWTDTRNGKPVRI
AYADSLSAPGYQLQGNPRYPHLIEDYRRSFATVRALPCDVLLTPHPGASNWDYAAGARAG
AKALTCKAYADAAEQKFDGQLAKETAGAR
>ABO61003.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MRLCLTPLALAATLVFDVAAADAPLPQLRAYTVDASWLQPMAPLQIADHTWQIGTEDLTA
LLVRTTEGAVLLDGGMPQMAGHLLDNMKARGVAPQDLRLILLSHAHADHAGPVAELKRRS
GAQVVANAETAVLLPRGGSNVLHFGDDITYPPASADRIIMDGERVTVGGMAFTAHFMPGH
TPGSTAWTWTDTRDGKPVRIAYADSLSAPGYQLQYNARYPRLVEDYRRSFTTVRGLPCDL
LLTPHPGASRWNYAAGAEAGANVLTCKAYADAAEKAFDAQLAKGTTGAR
>BAF47405.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
AAEPPLPQLRAYTVDASWLQPMAPLQIADHTWQIGTEDLTALLVQTPQGAVLLDGGMPQM
ADHLLRNMKARGVAPQDLRLILLSHAHADHAGPVAALKRSTGAQIVANAESAVLLARGGS
HDLHFGDGITYPPANADRIIMDGEVVTVGGIDFTAHFMPGHTPGSTAWTWTDTRDGTPVR
IAYADSLSAPGCQLRDNPRYPRLIEDYKRSFATVRALPCDELLTPHPGASNWNYSAGAKA
GAKALTCKAYADEAEKKFDAQLAKETAGAR
>BAF47406.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MRLQTLAISLAALLPAAAYAAEPQLPQLRAYTVDASWLQPMAPLQIADHTWQIGTEDLTA
LLVQTPQGAVLLDGGMPQMADHLLRNMKARGVAPQDLRLILLSHAHADHAGPVAALKRST
GAQIVANAESAVLLARGGSHDLHFGDGITYPPANADCIIMDGEVVTVGGIDFTAHFMPGH
TPGSTAWTWTDTRDGTPVRIAYADSLSAPGYQLQDNPRYPHLIDDYRRSFATVRALPCDI
LLTPHPGASNWNYSAGAKAGAKALSCKAYADEAEKKFDAQLAKETAGAR
>BAF47408.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
HTWQIGTEDLTALLVQTADGAVLLDGGMPQMAGHLLDNMKARGVAAQDLRLILLSHAHAD
HAGPVAELKRRTGASVAANAESAVLLARGGSNDLHFGDSITFPPASADRIIMDGEGVTVG
GIAFTAHFMPGHTPGSTAWTWTDTRDGQPVRIAYADSLSAPGYQLQGNARYPRLVEDYRR
SFATVRGLPCDLLLTPHPGASNWNYAAGAEAGANALTCKAYADAAEKKFDAQLAKETAGA
R
>BAE44415.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
EDLTALLVQTADGAVLLDGGMPQMAGHLLDNMKLRDVAPQDLRLILLSHAHADHAGPVAE
LKRRTGAHVAANAETAVLLARGGSNDLHFGDSITFPPVSPDRIIMDGEVVNVGGIAFTAH
FMPGHTPGSTAWTWTDTRDGKPVRIAYADSLSAPGYQLQGNARYPRLVQDYRRSFAMVRG
LPCDLLLTPHPGASNWNYAAGSNASEKVLSCK
>BAE44414.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
EDLTALLVQTADGAVLLDGGMPQMASHLISNMKVRDVAPQDLRLILLSHAHADHAGPVAE
LKRRTGAMVVANAESAVLLARGGSNDLHFGDSITFPPASTDRIIMDGEVVTVGGIAFTAH
FMPGHTPGSTAWTWTDTRDGKPVRIAYADSLSAPGYQLQGNARYPHLVEDYRRSFATVRG
LPCDLLLTPHPGASNWNYAAGSKASDKALNCK
>BAE44413.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
EDLTALLVQTADGAVLLDGGMPQMASHLISNMKVRDVAPQDLRLILLSHAHADHAGPVAE
LKRRTGAMVVANAESAVLLARGGSNDLHFGDSITFPPASTDRIIMDGEVVTVGGIAFTAH
FMPGHTPGSTAWTWTDTRDGKPVRIAYADSLSAPGYQLQGNARYPYLVEDYRRSFATVRG
LPCDLLLTPHPGASNWNYAAGSKASDKALNCK
>BAE44419.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
ENLTALLVQTAEGAVLLDGGMPQMAGHLLDNMKARGVAPQDLRLILLSHAHADHAGPVAE
LKRRSGAHVVANAESAVLLARGGSDDLHFGDGITYPPASADRIVMDGEVVEVGGIEFTAH
FMPGHTPGSTAWTWTDTREGKPLRIAYADSLSAPGYQLQGNARYPRLVEDYKRSFATVRA
LPCDVLLTPHPGASNWDYAAGARAGAKALTCK
>CAB94704.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
EAPLPQLRAYTVDASWLQPMAPLQVADHTWQIGTEDLTALLVQTAEGAVLLDGAMPQMAG
HLLDNMKLRGVAPQDLRLILLSHAHADHAGPVAELKRRTGAHVAANAETAVLLARGGSND
LHFGDGITYPPASADRIIMDGEVVTVGGIAFTAHFMPGHTPGSTAWTWTDTRDGKPVRIA
YADSLSA
>ADC79554.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MTTLGLALLLAQPAVAAQAVLPQLQPYTAPAAWLTPVAPLRIADNTWHIGTASITALLVK
TPEGAVLLDGGMPQVADHLLANMRELGVAPGDLKLILHSHAHIDHVGPLAAIKKATGAQL
VSNAESAVLLQRGDSQDIHFGDDMVFAPVQVDRLVQDGETVELGGMTFTAHFTPGHTPGS
LSWTWTDRRDGKPLRIAYSDSLSAPGYSLWMNPRFPKIAEAFRSGFAAVRALPCDLLITP
HAEASGWDYTNAEHPNPSPMSCKAYADKAEAAFDAQLK
>ADC79565.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MRTLTTLGLALLLAQPAQAVLPQLQPYTAPAAWLTPVAPLRIADNTWHIGTASITALLVK
TPEGAVLLDGGMPQVADHLLANMRELGVAPGDLKLILHSHAHIDHVGPLAAIKKATGAQL
VSNAESAVLLQRGDSQDIHFGDDMVFAPVQVDRLVQDGETVELGGMTFTAHFTPGHTPGS
LSWTWTDHRDGKPLRIAYSDSLSAPGYSLWMKPRFPKIAEAFRSGFAAVRALPCDLLITP
HAEASGWDYTNAEHPNPSPMSCKAYADKAEAAFDAELKKQRGG
>CAB94702.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
EVPLPQLRAYTVDASWLQPMAPLQIADHTWQIGTEDLTALLVQTPDGAVLLDGGMPQMAS
HLLDNMKARGVTPRDLRLILLSHAHADHAGPVAELKRRTGAKVAANAESAVLLARGGSDD
LHFGDGITYPPANADRIVMDGEVITVGGIVFTVHFMAGHTPGSTAWTWTDTRNGKPVRIA
YADSLSA
>CAB94701.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
EVPLPQLRAYTVDASWLQPMAPLQIADHTWQIGTEDLTALLVQTPDGAVLLDGGMPQMAS
HLLDNMKARGVTPRDLRLILLSHAHADHAGPVAELKRRTGAKVAANAESAVLLARGGSDD
LHFGDGITYPPANADRIVMDGEVITVGGIVFTVHFMAGHTPGSTVWTWTDTRNGKPVRIA
YADSLSA
>CAB94703.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
EVPLPQLRAYTVDASWLQPMAPLQIADHTWQIGTEDLTALLVQTPDGAVLLDGGMPQMAS
HLLDNMKARGVTPRDLRLILLSHAHADHAGPVAELKRRTGAKVAANAESAVLLARGGSDD
LHFGDGITYPPANADRIVMDGEVITVGGILFTVHFMAGHTPGSNAWTWTDTRNGKPVRIA
YAGSLSA
>ADC79557.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MRTLTTLGLALLLAQPAMAAQAVLPQLQPYTAPAAWLTPVAPLRIADNTWHIGTASITAL
LVKTPEGAVLLDGGMPQVADHLLANMRELGVAPGDLKLILHSHAHIDHVGPLAAIKKATG
AQLVSNAESAVLLQRGDSQDIHFGDDMVFAPVQVDRLVQDGETVELGGMTFTAHFTPGHT
PGSLSWTWTDRRDGKPLRIAYSDSLSAPGYSLWMNPRFPKIAEAFRSGFAAVRALPCDLL
ITPHAEASGWDYTNAEHPNPSPMSCKAYADKAEA
>ADC79559.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MRTLTTLGLALLLAQPAVAAQAVLPQLQPYTAPAAWLTPVAPLRIADNTWHIGTASITAL
LVKTPEGAVLLDGGMPQVADHLLANMRELGVAPGDLKLILHSHAHIDHVGPLAAIKKATG
AQLVSNAESAVLLQRGDSQDIHFGDDMVFAPVQVDRLVQDGETVELGGMTFTAHFTPGHT
PGSLSWTWTDRRDGKPLRIAYSDSLSAPGYSLWMNPRFPKIAEAFRSGFAAVRALPCDLL
ITPHAEASGWDYTNAEHPNPSPMSCKAYADKADAT
>WP_007150152.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MLLVSAAQAEPVTPLPQLEAYTVPEAWLQPMAPLQIADNVWQIGTDELTSLLLKTRDGAI
LIDGGMPQSAEHLLANMEAVGVAPQTLKWILVSHGHGDHAGSLAAIKQATGARLVANAET
AMLMADGGANDIHFGDDILYPPVRVDRQIQDGEQVSLGNLTLTAHFIPGHTPGSMAWTWQ
SMRDGEKVDIAYVDSLTAPGYQLVDNPRYPHIVEAFTGTFKTVKQLPCDLLLTPHPGASG
WNYTDVTQSTRMDCADYAKKAEKTLREQRKAQQAD
>CAB94700.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
EVPLPQLRAYTVDASWLQPMAPVQIADHTWQIGTEDLTALLVQTPDGAVLLDGGMPQMAS
HLLDNMKARGVTPRDLRLILLSHAHADHAGPVAELKRRTGAKVAANAESAVLLARGGSDD
LHFGDGITYPPPNADRIIMDGEVITVGGIVFTAHFMAGHTQGSTAWTWTDTRIGKPVRIA
YAGSLSA
>ADC79558.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MRTLTTLGLALLLAQPAVAAQAVLPQLQPYTAPAAWLTPVAPLHIADNTWHIGTASITAL
LVKTPEGAVLLDGGMPQVADHLLANMRELGVAPGDLKLILHSHAHIDHVGPLAAIKKATG
AQLVSNAESAVLLQRGDSQDIHFGDDMVFAPVQVDRLVQDGETVELGGMTFTAHFTPGHT
PGSLSWTWTDRRDGKPLRIAYSDSLSAPGYSLWMNPRFPKIAEAFRSGFAAVRALPCDLL
ITPHAEASGWDYTNAEHPNPSPMSCKAYADK
>ADC79561.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MRTLTTFGLALLLAQPAMAAQAVLPQLQPYTAPAAWLTPVAPLRIADNTWHIGTASITAL
LVKTPEGAVLLDGGMPQVADHLLANMRELGVAPGDLKLILHSHAHIDHVGPLAAIKKATG
AQLVSNAESAVLLQRGDSQDIHFGDDMVFAPVQVDRLVQDGETVELGGMTFTAHFTPGHT
PGSLSWTWTDRRDGKPLRIAYSDSLSAPGYSLWMNPRFSKIAEAFRSGFAAVRALPCDLL
ITPHAEASGWDYTNAEHPNPSPMSCKAYADKAEA
>NP_001170718.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|0
MDGEVITVGGIAFTAHFMPGHTPGSTAWTWTDTREGKPVRIAYADSLSAPGYQLQGNPRY
PHLIEDYRHSLATVRALPCDVLLTPHPGASNWDYAAGSKASAKALTCKAYADAAEQKFDA
QLAKETAGAR
>YP_001817999.1|FEATURES|NCBI|beta_lactam|FEZ-1|antibiotic inactivation|1
MCRNFLGPLFHLCVWFATFVGPAVSAQPTELWRSWNQPVAPFRIVENVYYVGASDIAAYL
ITTPDGHILLETGFAETVPLVRASLRQLGIEPRDIRILLTSHAHIDHAGGLKAMKALTGA
RLIASAPEAAALARGGRGDFHYGDQLAFEPVTVDEIVADGGTVTLGGVTLTAHLTPGHTP
GSTTWTCRVRTGGRELDVVFAASVSAPGYQLVNNAAYPDIWRDLQASIAALRALPCDVFL
APHGQVFGLTNKARRLAEHPETHPFIDPDGYRAFCDDAEARLRKQHAEQAAALEARNKR
>WP_006832294.1|FEATURES|NCBI|beta_lactam|AIM-1|antibiotic inactivation|1
MSARTLLLASLSLAATACANATAQPASDPVVAPPASEAAPTPRERVAAFLETCEEWDEWD
KPAPPFHILGNTWYVGTCGISAILVTSPQGHVLIDSGTERGAEIVLANIEAAGFAPRDVR
YLLPSHEHFDHVGGFAKIREATGADVVASSIAAEVLRSGVVNEGDPQAAVLDPMAPVEVA
RVVNDGEVVMLGDLEFTAHATPGHTPGALSWSWTACSNPGEPPICRRIAYVDSLSPVSAD
GYRFSDHPAYVGAFRTSIDRVRALPCDELFTPHPSASGMIGNMRTGKIASCTDYAAALTR
KLDERLAKEAAQ
>ABX23698.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|0
MFKAWAKPIEPFQITEGVWYVGTENLSSILLTTPAGHILIDAGLDESAPQIKANIETAGF
RLTDVRYLLNSHARLDQAGGMARLKAWSGAQLVASQPNAEQMARGGRQDFALGDALPFPP
VTTDKIIHDRESISLGGITVTALFTPGHLPGATSWRVTLRNGKTLIYADSLATPDYLLIN
NKNYPDLVTDIQHSFKTLDAQYVDIFIANKGDRFGLLEKRQQLRNGDTQAFFDPNGLQQY
VERSRQRFITQLTAQQP
>YP_002131811.1|FEATURES|NCBI|beta_lactam|FEZ-1|antibiotic inactivation|1
MIRRTYGISGAAVLWAAAFACPAAAQGQAPEPGNAPVKPFQVADGVWWVGASDVAAYLIQ
SNKGLILIDGGYESTAPQILDNIRRLGFDPAGQVKIILNSHAHVDHAGGLSALKAATGAK
LYASAEDGRLMARGGKGDFFLGDKYAYPPVKPDRTLRDGQKVKLGERTLTARLTPGHTRG
CTTWTFPVTVAGVERQAMILCSNTVLPGYRLTGQESYPGIAADFEKSYAVWRQAPCEVFL
ASHAMFFRAHEKAKSGRPDAFMDPEGCRAFFEKGYAGFKAILSRQQQAADR
>WP_001082958.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|0
MNRYALFFVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPIKPFQITEGVWYVGTE
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRLTDIRYLLNSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGREDFALGDALPFPPVTTDKIIHNQESISLGGITVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLVTDIQSSFKTLAAQHVD
IFIANKGDRFGLLEKRQQLRNGDTQAFFDSNGLQQYVERSRQRFITQLTGQQPQ
>YP_006888122.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|0
MNRYALFFVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPIKPFQITEGVWYVGTE
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRLTDVRYLLNSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGREDFALGDALPFPPVTTDKIIHNQESISLGGITVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLVTDIQSSFKTLAAQRVD
IFIANKGDRFGLLEKRQQLRNGDTHAFFDSNGLQQYVERSRQRFITQLTAQQP
>YP_002042986.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|0
MNRYALFFVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPIKPFQITEGVWYVGTE
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRLTDVRYLLNSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGRQDFALGDALPFPPVTTDKIIHNQESISLGGITVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLVTDIQGSFKTLAAQHVD
IFIANKGDRFGLLEKRQQLRNGDTQAFFDSNGLQQYVERSRQRFITQLTAQQP
>YP_002148668.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|0
MNRYALFIVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPIKPFQITEGVWYVGTE
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRLTDVRYLLNSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGREDFALGDALPFPPVTTDKIIHNQESISLGGITVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLVTDIQGSFKTLAAQHVD
IFIANKGDRFGLLEKRQQLRNGDTQAFFDSNGLQQYVERSRQRFITQLTAQQP
>YP_002116679.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|0
MNRYALFFVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPMKPFQITEGVWYVGTE
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRLTDIRYLLNSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGREDFALGDALPFPPVTTDKIIHNQESISLGGITVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLVTDIQSSFKTLAAQHVD
IFIANKGDRFGLLEKRQQLRNGDTQAFFDSNGLQQYVERSRQRFITQLTAQQP
>YP_152702.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|0
MNRYVLFFVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPMKPFQITEGVWYVGTE
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRLTDVRYLLSSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGRQDFALGDALPFPPVTTDKIIHNQESISLGGVTVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLVTDIQSSFKTLAAQHVD
IFIANKGDRFGLLEKRQQLRNGDTQAFFDSNGLQQYVERSRQRFITQLTAQQPQ
>WP_001082971.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|0
MNRYALFFVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPMKPFQITEGVWYVGTE
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRLTDVRYLLNSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGREDFALGDALPFPPVTTDKIIHNQESISLGGITVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLVTDIQSSFKTLAAQHVD
IFIANKGDRFGLLEKRQQLRNGDTQAFFDSNGLQQYVERSRQRFITQLTAQQP
>WP_001082978.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|0
MNRYALFLVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPIKPFQITEGVWYVGTK
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRLTDVRYLLNSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGREDFALGDALPFPPVTTDKIIHNQESISLGGITVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLVTDIQSSFKTLAAQHVD
IFIANKGDRFGLLEKRQQLRNGDTQAFFDSNGLQQYVERSRQRFIIQLTAQQPQ
>WP_001082968.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|0
MNRYALFFVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPIKPFQITEGVWYVGTK
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRLTDVRYLLNSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGRQDFALGDALPFPPVTTDKIIHNQESISLGGITVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLVTDIQSSFKTLAAQHVD
IFIANKGDRFGLLEKRQQLRNGDTQAFFDSNGLQQYVERSRQRFITQLTAQQPQ
>YP_002217697.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|0
MNRYALFFVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPIKPFQITEGVWYVGTK
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRLTDVRYLLNSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGREDFALGDALPFPPVTTDKIIHNQESISLGGITVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLVTDIQSSFKTLAAQHVD
IFIANKGDRFGLLEKRQQLRNGDTQAFFDSNGLQQYVERSRQRFITQLTAQQP
>WP_001522169.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|0
MNRYALFLVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPIKPFQITEGVWYVGTK
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRLTDVRYLLNSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGREDFALGDALPFPPVTTDKIIHNQESISLGGISVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLVTDIQSSFKTLAAQHVD
IFIANKGDRFGLLEKRQQLRNGDTHAFFDSNGLQQYVERSRQRFITQLTAQQP
>YP_001238554.1|FEATURES|NCBI|beta_lactam|BJP-1|antibiotic inactivation|1
MLVATLSLAAGSAAAQSLPDLMKQMIAAWNKPTEPFKVIDNIYYVGTNGLASYLITTPQG
HILIDTVMPESTAQIEASIAKLGFKVADIKYILNTHAHIDHTGGLAQIKQETGAQMVAGA
KDVPLLEGGFYPGREQESHLNFPPVKVDRAVHEGDTVTLGGVTLTAHETPGHSPGCTSWT
TDVKDGEATRSVIFFCSATVALNQLVGRPTYPGIVDDYKKTYAWAKTVHPDILLAPHPEM
FDLAAKRAKIAEGGPNPFVRPGEFNAYLDRLETQFNEGLSKQTAALQTGK
>WP_001082980.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|0
MNRYALFLVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPIKPFQITEGVWYVGTK
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRLTDVRYLLNSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGREDFALGDALPFPPVTTDKIIHNQESISLGGITVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLVTDIQSSFKTLAAQHVD
IFIANKGDRFGLLEKRQQLRNGDTQAFFDSNGLQQYVERSRQRFITQLTAQQPQ
>WP_010239973.1|FEATURES|NCBI|beta_lactam|AIM-1|antibiotic inactivation|1
MSARLAALAALALVAGGCAPAPESPATADPVAHDVVSSPDMAASFPQSAFLEKCEDWDEW
DTPAPPFELLGDTWYVGTCGISALLVIGDGEHILIDSGVEDAAPLILANIRALGIDPRDV
GYLLMSHEHFDHVGAHAALVEATGAEVIASPIAAQVLSSGEASADDPQAAIHPAMTPVKV
DRIVSDGEVLTLGGKEFTAHFTPGHTPGAMSWTWNACSLPWQPPVCRRVAYVDSLSPVSA
DDYRFSDHPAVVADFRRSIAKVAKLPCDLLTTPHPSASGMLDRMADGGLLDGAACADYAK
AIEKRLNERLAKEGE
>YP_001590783.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|0
MNRYALFFVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPIKPFQITEGVWYVGTK
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRLTDVRYLLNSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGRQDFALGDVLPFPPVTTDKIIHNQESISLGGITVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLVTDIQSSFKTLAAQHVD
IFIANKGDRFGLLEKRQQLRNGDTQAFFDSNGLQQYVERSRQRFITQLTAQQP
>YP_001479485.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|1
MKKNLGYLTAMTVALCFGAQAQLNPAQPLSSAPPYSLFEQWAQPVAPFQMFPHVYYVGTR
NLSSVLLSTPEGLILIDAALDASAPAIRAHIEALGFNIKDLRYILNSHARLDQAGGIARL
QVWSGAKVVASAANAQQLALGGKQDFALGDALSFPPVKVDIIVGEGDSITLGDLKLTALM
TPGHLPGATSWLTTLHQGGQSYRLVYADSLATPDYYLIDNKNYPSLVQDIRGSFARLAQQ
QADIFIVNKGTRFDLDNKMQRLQAGDLDAFVDRQGLQQYVQQSQQTFEAQLKQQQSKM
>NP_462637.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|0
MNRYALFLVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPIKPFQITEGVWYVGTK
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRLTDVRYLLNSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGRQDFALGDALPFPPVTTDKIIHHQESIILGGITVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLVTDIQSSFKTLAAQHVD
IFIANKGDRFGLLEKRQQLRNGDTQAFFDSNGLQQYVERSRQRFITQLTAQQP
>WP_001528135.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|0
MNRYALFFVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPMKPFQITEGVWYVGTE
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRLTDIRYLLNSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGREDFALGDALPFPPVTTDKIIHNQESISLGEITVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLVTDIQSSFKTLAAQHVD
IFIANKGDRFGLLEKRQQLRNGDTQAFFDSNGLQQYVERSRQRFITQLTGQQP
>YP_002245625.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|0
MNRYALFFVCIFSTSALPAMAALDPSQPLSPTPPLSLFKAWAKPIKPFQITEGVWYVGTK
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRLTDVRYLLNSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGRQDFALGDALPFPPVTTDKIIHHQESIILGGITVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLVTDIQGSFKTLAAQHVD
IFIANKGDRFGLLEKRQQLRNGDTQAFFDSNGLQQYVERSRQRFITQLTAQQP
>WP_001082967.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|0
MNRYALFFVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPIKPFQITEGVWYVGTK
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRLTDVRYLLNSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGRQDFALGDALPFPPVTTDKIIHNQESISLGGITVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLATDIQSSFKTLAAQHVD
IFIANKGDRFGLLEKRQQLRNGDTQAFFDSNGLQQYVERSRQRFITQLTAQQPQ
>YP_002228462.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|0
MNRYALFFVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPIKPFQITEGVWYVGTK
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRLTDVRYLLNSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGRQDFALGDALPFPPVTTDKIIHHQESIILGGITVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLVTDIQGSFKTLAAQHVD
IFIANKGDRFGLLEKRQQLRNGDTQAFFDSNGLQQYVERSRQRFITQLTAQQP
>YP_218647.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|0
MNRYALFFVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPIKPFQITEGVWYVGTK
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRLTDVRYLLNSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGREDFALGDALPFPPVTTDKIIHHQESIILGGITVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLVTDIQGSFKTLAAQHVD
IFIANKGDRFGLLEKRQQLRNGDTQAFFDSNGLQQYVERSRQRFITQLTAQQP
>WP_001082965.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|0
MNRYALFFVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPIKPFQITEGVWYVGTK
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRLTDVRYLLNSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGREDFALGDALPSPPVTTDKIIHNQESISLGGITVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLVTDIQSSFKTLAAQHVD
IFIANKGDRFGLLEKRQQLRNGDTQAFFDSNGLQQYVERSRQRFITQLTAQQP
>NP_807403.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|0
MNRYVLFFVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPMKPFQITEGVWYVGTE
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRFTDVRYLLSSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGRQDFALGDALPFPLVTTDKIIHNQESISLGGVTVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLVTDIQSSFKTLAAQHVD
IFIANKGDRFGLLEKRQQLRNGDTQAFFDSNGLQQYVERSRQRFITQLTAQQPQ
>NP_458189.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|0
MNRYVLFFVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPMKPFQITEGVWYVGTE
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRLTDVRYLLSSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGRQDFALGDALPFPLVTTDKIIHNQESISLGGVTVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLVTDIQSSFKTLAAQHVD
IFIANKGDRFGLLEKRQQLRNGDTQAFFDSNGLQQYVERSRQRFITQLTAQQPQ
>YP_001438455.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|0
MSFQLSRIKKALIILRLLIQEMIMKPRIALFSCLMSLLSVPAHAALDPAQPLAEAPPYSL
FEAWAKPVQPFAIWPGVWYVGTENLSSVLLTTPQGHILIDAGLDASAPQIRRNIEALGFR
MADIRYIANSHARLDQAGGIARLKAWSGARVIASHANAEQMARGGKEDFALGDALPFPPV
SVDMEAQDGQQWHLGGVTLAAIFTPGHLPGATSWKVTLADGKTLIYADSLATPGYPLINN
RNYPTLVEDIRRSFARLEAQQVDIFLANKGERFGLMDKMARKARGENNAFIDKAGLAQYV
AQSRAAFEKQLAAQRAQP
>YP_002762743.1|FEATURES|NCBI|beta_lactam|Rm3|antibiotic inactivation|1
MSFCIPLSRSQRAAMALAWCVASSALLLGGPVGVSAQSATRAVVTPVPPTPNCPDCAEWN
APHAPFRIFGNSYYVGTHGLSAILVTSPDGHVLVDGALPESAPQIVAGIEAMGFRVGDIK
IIVNSHAHFDHAGALAEIQRLSGATVAASPSSARWLMAGQSSNDDPQYGMNPGFAKVPRV
RVLRDGEVVKVGTLSLTAHFTGGHTPGGTSWSWRSCEGTQCLDLVYADSQTPVSADDFFY
TRSTTYRTGVADFRRGQALLSRLSCDILITPHPAASSLWERLASSDRSASPAGARPALVD
REACRRYASRAAEALEKRIAKEKIAPR
>WP_005019677.1|FEATURES|NCBI|beta_lactam|CAU-1|antibiotic inactivation|1
MKIRNTFLFIFGLATVSTGNILAEPLKLPAEWTQSIEPFRIAGSIYYVGTRGLGSYLLVS
GSKAILIDTGLTENAALIEQNILKLGLNLSDVKIILVSHAHWDHVGALAQIQKNTGAKVF
AMDKEVTALTTGKPKGDNILQSFSYTPVKVDHILRDKEVIKMGKIHLKATLTPGHTPGCT
TWSTSLKEHGKTLNVVFPCSLSVAGNVLSNNQTYPGIVQDYQLSFHRLSKMPADIVLTSH
PEAADLMNRKAKSEAGQLDAFTDRKLLEKIIKDAEFSFNQSLDNQKK
>YP_001204253.1|FEATURES|NCBI|beta_lactam|BJP-1|antibiotic inactivation|1
MLAATLAWTAGPAAAQSLPDFMKQVIATWNTPTEPFKVIDNIYYVGTNGLASYLITTPQG
HILIDTVMPESTALIETSIGKLGFKVADIKYVINTHAHIDHTGGLAQIKQETGAQMVAGA
KDVPLLEGGFYPGREEERYLNFPPVKVDRAVREGDTVTLGGVTLTAHETPGHSPGCTSWT
TEVKDGDATRSVIFFCSATVALNQLVGRPTYPGIVDDYKKTYAWAKTVHPDVLLAPHPEM
YGMADKRAKIADGAPNPFVKPGEFNAYLDKLEAQFNEGLAKQTAALQSGK
>WP_006580921.1|FEATURES|NCBI|beta_lactam|CAU-1|antibiotic inactivation|1
MKKKILFTGSILLTSLSASATPLKLPDDWTQNTQPFQITENIYYVGTHGLGTYLLTSDHQ
ALLIDTGLPENTEQIEQNIKKLGFKLSDVKIMVTSHAHWDHVGALARIKQDTGAKLIAMQ
QDVKALEIGKPIGENTFQSIPFTPVKVDKVIHDGEVVKLGKLKLKATLTPGHTPGCTTWS
TEVKSNGKNLNVVFPCSLSVAGNVLQNNHQYPNIVEDYRQSFKRLKNMKADIVLTSHPEV
ADVMGNKARKDAGQVNAFIQPEKLSAIVKDAEMAFEKSLVSSKP
>WP_007413547.1|FEATURES|NCBI|beta_lactam|FEZ-1|antibiotic inactivation|1
MGIQNRIIRGVGMLMLAAGLPLTSLAQTNAPVDPGNAAVKKMWESWNAPFKPFRIINNVY
YVGATGVSSFLITTPEGHILIDTGFESTVPRIRASVAQLGFRPEDIKIILSSHAHLDHTG
GHALMKQLTGAKVMISKADADLLASGGTKDYTPYAPKMMAYSPVKADRILVDEEKVSLGK
TTLTCHLTPGHTKGCTTWTMDTTEAGKVYHVLFFGSTSVLSDVKLVNNPKYPNIAEDYLH
SYQKLKTLQCDVFLAPHGSFFGLSEKAEKLAQGGKTNPFIDSESYRNFIQKAENTFLEQL
AQERAKASRALGN
>YP_003732270.1|FEATURES|NCBI|beta_lactam|CAU-1|antibiotic inactivation|1
MTSLSTSAAPLKLPDDWTQNTQPFQITENIYYVGTHGLAAYLLASGHQALLIDTGLPENT
EKIEQNIKQLGFKLSDVKIMVTSHAHWDHVGALARIKQDTGAKLIAMQQDVKALEIGKPI
GENTFQTIPFTPVKVDKVIHDGEVVKLGKLKLKATLTPGHTPGCTTWSTEIKSNGKNLTV
VFPCSLSVAGNVLQNNHQYPNIVADYRKSFERLKNMKADIVLISHPEVADVLGNKARKDA
GQTNAFIQPEKLSSIVKDAEMAFEKSLVSSHP
>YP_828073.1|FEATURES|NCBI|beta_lactam|FEZ-1|antibiotic inactivation|1
MPTFSVRCALIAAFAAGSAAQSSSSWTEPFPPHRIAGNLYYVGSRGLASYLIATPEGHIL
INSSLKTSVPLIETSITKLGFQLSDVKILLVSHAHWDHNAGSADLKGRTGAKYMVMEPDV
PVTEDGGKSDFFYGDSPESLYPPAKVDRVLHDGDQVKIGGSVLTAHLTPGHTKGCTTWTM
KVSEGGKTYDAVIVGSPNVNAGFQLVNNAKYPRIADDYVRTFEVLRALHCDIFLGAHGDY
YGLERKFSRYAANGPGVFIDPDGYRAYVAEREEAFRRELERQKKK
>YP_004184760.1|FEATURES|NCBI|beta_lactam|FEZ-1|antibiotic inactivation|1
MLARTLLLLLAFASPLFAQMDSTWTTNHPPFRIAGDLYYVGSDDLAAYLITTPQGNILIN
TNLASSVPQIRQNIEKLGFRVADTKIMLNSQAHFDHVAGTAEMKRLTHAKVEVMEGDVVP
MESGGRKDFFFFNDPSAYFPPVKVDKVLHDGEQVSLGGTVLTAHLTAGHTMGCTTWTMQI
TEDGKTYNVVIVGGASMNGGNNLIHDPRYPTEAEDFLRAFRTLRGLPCDFFLGAHGKYFD
LKLKYPKLQAGAANPFLDPDGYKAFLDDREQAFRKELAKQTAAHK
>YP_002129188.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|1
MRNLFLALALATATAAPSVSIAQDAAQRAEWNRPAAPFRIAGPVYYVGTEGLGAYLVADP
GGHALIDGGLPESAPLIAANIEALGFKLEDVRYLLVNHAHFDHAGGLAELKRRTGAALVA
SAGDAPDLGAGRTLGRPELDGFPAVAVDQVVADGDTLRLGQASLTAHVTPGHTRGCTSWS
LAGPSGTVLFACSLTVAGQKLHGDPAYPDAAADFRRTFARLRTLHADYFLNFHPEFFDMA
GKRARRAAGEPDPFRDPAELARQVDRAEAMFERELARQAAR
>WP_006271975.1|FEATURES|NCBI|beta_lactam|CAU-1|antibiotic inactivation|1
MKPLFFSFAALGLILASPTLADGDPSWSAPHEPYHIVDNVWYVGTAGIGVYLITTDEGHF
LIDGATKDGAAIVEDNIKTLGFDIKDVKYIVETHAHYDHVGGLARLKADSGAELVASVAD
RTALEAGQHEGDNIYGASTFPAVKVDRIVGEGGTITLADSTLMARLTPGHTKGATTWTLT
ALDNGQPRRVVFASSVSVAGNVLVDNATYPHIVRDYRIAFDRLETISADIFLSSHPTFAS
LEDKYQKQKTIKYPEDKAQPFVDSTEFPKYVAQARADFETELARQENAKK
>YP_616949.1|FEATURES|NCBI|beta_lactam|THIN-B|antibiotic inactivation|1
MIEVMSLFLWLAGAGGTPVPAIDPLTQPIETSRSAEWLAPAEPEKIFGNTYLVGFAGLSV
ALIDTGDGLVLVDGALPQAAPAILANVRKLGFDPQDIKYILSTEPHFDHAGGLAALARDT
GAAVVASVRGAEGLRSGRHAADDPQLGYGGSWPAVANVRTMKDGEVLRLGTTAITAIATP
GHTMGSMSWTWQACEGRVCKAVVFASSLNPVSADGYRFTSRAGKPFIKGFEASYRKMDAV
PCDILISAHPDNAGNGRYSEKAGACRAYADRSRRALARRLASERVETPK
>YP_001204321.1|FEATURES|NCBI|beta_lactam|FEZ-1|antibiotic inactivation|1
MMMRKIKMPMRLPATLMSTLLLALAWPVEAQVLPPNVPSKEQLANDNHLFLSLARKIFKW
EEPAEPVRIVGPIYFVGTRGLGAFLIVTSEGHILMNTGMPSSGPMIVESIRKLGFKPDDV
KLMINGHAHIDHAGAFAFMKRLTGAQLAIMKDDVAAIESGDRGDFKYADDLAYEGVTVDR
VLRDGDQIRMGDVLLTAYHTPGHTRGATTWIANLVVDGKAYLVAFPDGAGVNPGYRLAKD
PSYPGIEGDYRKTHHALEMIKPDIWLAQHNEYYDFEGKRKRAETQGVSAWIDPEGYRRFI
AGKKRAFEDEVDEELGAPKAAATSSADAPSNNR
>WP_006871733.1|FEATURES|NCBI|beta_lactam|FEZ-1|antibiotic inactivation|1
MSLVEFFRIKMKKVSLFLSLAITLFCNLCFAYPVGNPFPPFRVAGNLYYVGTDDLASYLI
VTPKGNILINSDLEVNVPMIKKSIEALGFKFSDTKILLISHAHLDHAAGSQLIKQETKAK
YMVMAEDVPVIESGGKSDFHYANDTSMYFPATTVDRTLHDGDTVKLGGTVLTAHLTAGHT
KGCITWTMQVMEHGKPYQVVMVGSLGVNPGYKLINNTTYPNIAKDYEHAIKVLKSLHCDI
FLGAHAMYFDLGKKYALLNRSVINPFVDPEGYKKHVAQKEHEFYTELKKQESALSLKSA
>NP_420942.1|FEATURES|NCBI|beta_lactam|CAU-1|antibiotic inactivation|1
MKRLILAAAASLLALASAAHADDMPANWTKPTKPYRVVGNIYYVGTEGISSWLITSSEGH
VVLDGGPNAETGKLVERNITALGFQLADVKILINTHAHYDHAGGLAQLKADTGAKLWISR
DDAPAMTAGHHIGDNIYGPTPMPAVKPDRSFGDQTKLKLGEIAMVAHLTPGHTIGCTSWT
TAVVEKGRPLTVTFPCSLSVAGNVLVGNKTHRTIVADYRASFAKLRAIPTDVMLPAHEEQ
GNLLAKRQKQLRGDPNAFVDPTELARFVDASEAAFNKELARQQAAGPKR
>CAC48262.1|FEATURES|NCBI|beta_lactam|CAU-1|antibiotic inactivation|1
MKRLILAAAASLLALASAAHADDMPANWTKPTKPYRVVGNIYYVGTEGISSWLITSSEGH
VVLHGGPNAETGKLVERNITALGFQLADLKILINTHAHYDHAGGLAQLKADTGAKLWISR
DDAPAMAAGHHIGDNIYGPTPMPAAKPDRSFGDQTKLKLGEIAMVAHLTPGHTIGCTSWT
TAVVEKGRPLTVTFPCSLSVAGNVLVGNKTHRTIVADYRASFAKLRAIPTDVMLPAHEEQ
GNLLAKRQKQLRGDPNAFVDPGELARFVDASEAAFNKELARQQAAGPKP
>WP_006275253.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|1
MVKSISLCAAVLLAGCTATAPQGLSPLADDRQVLNAEAAPLADMAAEAHWNDPFAPFKVV
GNIYYVGTTGVSAWLITTPRGHFLLDGALPQTPPQIIANIQALGFDIRDVKYLLNSHAHF
DHAGGLAALQRAAGATMVASAADRAVLESGRVGYGPTADISVPPVRVDRLVGQGDTLSLG
GVTLTAHLTPGHTPGCTSWSMDVRGDDGELHHVFFHCSTTTGGQSLVPESYPGMIASYRA
TFAYIRNVKADIFLANHANFFNLADKRARQIAGDSDAFVSSTALADFNAQSERDFDAELA
RQQAAASQ
>1L9Y_A|FEATURES|NCBI|beta_lactam|FEZ-1|antibiotic inactivation|1
AYPMPNPFPPFRIAGNLYYVGTDDLASYLIVTPRGNILINSDLEANVPMIKASIKKLGFK
FSDTKILLISHAHFDHAAGSELIKQQTKAKYMVMDEDVSVILSGGKSDFHYANDSSTYFT
QSTVDKVLHDGERVELGGTVLTAHLTPGHTRGCTTWTMKLKDHGKQYQAVIIGSIGVNPG
AKLVDNITYPKIAEDYKHSIKVLESMRCDIFLGSHAGMFDLKNKYVLLSKGQNNPFVDPT
GCKNYIEQKANDFYTELKKQETG
>YP_001685033.1|FEATURES|NCBI|beta_lactam|CAU-1|antibiotic inactivation|1
MKRAASILLALLALAQAGAARAADPANWSKPIRPYRVVGNIYYVGSEGLSAWLISSSEGH
VLLDSGPAPAGAKLIEANITALGFKLSDVKILINTHAHFDHAGGLAQLKADTGAKVWASR
PDEPALEKGQHFGDNANGLTPFAAVKVDKAFGDGQKLKLGETTLIAHLTPGHTIGCTSWT
TQVIDRGRPLNVTFPCSASVADNVLVGNSAYKTIVADYRATFATLKALPTDVMLPAHEEQ
GHLLDKRKKMLAGDVNAFIDPTELARYAATSEQAFDKELARQQGARKP
>YP_003559460.1|FEATURES|NCBI|beta_lactam|THIN-B|antibiotic inactivation|1
MIATMTIAASLAISPAAAATGPEPEAMAAADRAGGARPSDDPLTRPMAVERAKEWLAPLP
PERIFGNSYLVGFAGLSVALIDTGAGLVLIDGALPQAAPMILSNVRKLGFDPRDIKFILS
TEPHYDHAGGIAALARDTGATVVASRRGAEGLRAGAHAKDDPQFDYGGAWPAVSRLRVVK
DGEVLRIGRASIAAHATPGHTMGSMTWNWNACEGKRCKAIVFASSLNPVSADRYRFTAPS
SAPIVKGFEASYRRMGALNCDILISAHPDNAGAGRYGSGSGACRSYAERSRRLLAKRLAE
ERRETSK
>WP_009024763.1|FEATURES|NCBI|beta_lactam|BJP-1|antibiotic inactivation|1
MDVTNKYFSGVLLPIAVGVAMTVSQPGAAQQSTALSSASDTLTKIQSLSTEADTTSFNWQ
ETFPSWFEHMEPFRLAGSGDTEIYYVGTKGLGMFFIPTTEGHIVIDGGMPGQGQLIAENI
KKLGFDAKDVRILLNTHAHIDHSGGLAELKSLTGAQLIASEGDRWALESGLIPGSEDVSY
VQSPPVTVDRVIVDGEKVIIGNLTMTARITPGHTQGCTSWTTTLQPTASAPPQEVLFFCS
ASVAANSLVNPPQYPGIVEDYHKTFALTADWEPEVFLANHGEFFDLVARHDRLSNGEASA
FHDRESFQRFRTKMKDMFEQALIAQSEEAKISAHSKEH
>YP_826370.1|FEATURES|NCBI|beta_lactam|LRA-19|antibiotic inactivation|1
MKISILMAAMVLTCMAADPPEWRQPFAAHRVVGNIYYVGTYDLASFLIVTPAGNVLINGG
MGDSVPLMRKSVADLGFQWKDIRWMLTTQAHADHVAAFAEIQRTTGAKVMATEADAKLLE
DGGKSDFHFTGAEYHYAPVKVVERLHDGQTLKFGGTEITVYLHPGHTKGSASYAIPVTEG
GRTYRVLIANIGTINPGVKLLGEKNYPGIAADYAMTFEKQKALSCDIFLSSHAGQYGLHS
KYKPGAPYDPARFVDPAGYQKAVAGAEAAYRKQLAEEKAAH
>ABK64103.1|FEATURES|NCBI|beta_lactam|THIN-B|antibiotic inactivation|1
MTLLAKLMLATVATMAAGTVQAKTPAPVQDKPVDCDNCKEWNAPVKPFNIYGNSWYVGTA
GLSAVLVTSPQGHILLDGALPQSAPLIVANIKALGFRIEDVKYILNSHAHWDHAGGIAAL
QRASGATVMASAAAAPVLQSGTNGKDDPQYQANPVVHVAKVSKVSLVGEGDTVKVGPLTL
TAHMTPGHTPGGTTWTWTSCEGARCLNVVYADSLNPYASGDFTYTGKGKTPDISASFEAS
IAKVAALPCDIIIPVHPGTTDVLGKAAKRSGTDNPLIDANACRAYAAEAGGLLAKRLAKE
RGVALPAEAKSAAHAH
>YP_497017.1|FEATURES|NCBI|beta_lactam|AIM-1|antibiotic inactivation|1
MSIVLASLAAGAATLAAPATPADPQAARDLVRRCEGKESFSDPAPPARIFGNVWYVGTCN
VTVLLVTGPAGHILVDAATEEAVPSILDNIRAAGFEPKDVRWIVSSHEHFDHVGGLAALA
RATGARVAATRAAAKVIRSGKVSPADPQAQEIHGSRPARVDRLIDTGDVVRAGPLALTAF
ATPGHTEGSTSWHWKSCDGADCRTVTYVDSVTALPLGTYRFADHPERVAMFRNTFAQVEA
LECGILLTPHPSASAMFERMSAERRLDEPGACKALAAGARDRLEKALAQ
>YP_003124215.1|FEATURES|NCBI|beta_lactam|LRA-12|antibiotic inactivation|1
MTLPKKLLPIALIAALIGGMTPRSQAQKLIKDLYVDKEWSADYQPFRIAGNLYYIGTYDL
GMFLITTPKGHILINTGVAGSDTLIKAHMKTLGFKFKDIRILLTTHAHYDHVGAMAAVKQ
QTHAKMMVNEKDAALLADGGNSDYVMGGKGSMFLPVKADRLLHDGDSIQLGGMKIVMRQH
PGHTPGANSFLFDVKDAVRTYKVLIANIPSILNDTKLSGMPLYPEVGKDYAYTLKAMKAL
KFDLWLAPHAGQYELHKKHQPGDAYNPAAFSDRAGYDDVLDEWQQIYDKRVKEE
>ABK64020.1|FEATURES|NCBI|beta_lactam|THIN-B|antibiotic inactivation|1
MTLLAKLMLATVATMAAGTVQAKTPVPVQDKPVNCDNCKEWNAPVKPFNVYGNTWYVGTA
GLSAVLVTSPQGHILLDGALPQSAPLIIASIKALGFRIEDVKYILNSHAHWDHAGGIAAL
QRASGATVMASAAAAPVLQSGTNGKDDPQYQADPVVHVAKVSKVSLVGEGDTVKVGPLTL
TAHMTPGHTPGGTTWTWTSCEGQRCLDVVYADSLNPYASGDFRYTGKGAGKGGSPDVSAS
FEASIAKVAALPCDIIIPVHPGTTDVLGKAAKRSGTDNPLIDANACRAYAAEAGGMLAKR
LAKERGVAVPAEAKGAAHAH
>YP_003592397.1|FEATURES|NCBI|beta_lactam|CAU-1|antibiotic inactivation|1
MTLLAPPPSRRVSAPIHLPRCSGEDATVSSSPAKRGVWRDAKHRVGGGALAALATLLLAL
APAAHADMPANWTKPTKPYRVVGNIYYVGTEGISSWLITSSEGHVILDGGPNAETGKQIE
RNIASLGFQLADVKFLINTHAHYDHAGGLAQLKADIPAAKLWISRGDEPAIEQGHHIGDN
ENGPTPMPAVKVDRAFGDGQKLKLGETSLVAHLTPGHTIGCTTWTTAVIEKGRPLNVTFP
CSLSVAGNMLVGNKGHKTIVADYRASFATMRAIPTDVVLPSHEEQGDLLAKRQKQLRGDP
NAFVDPTEMGRFVDGYEAAFNKGLARQQGVGGAQ
>YP_592954.1|FEATURES|NCBI|beta_lactam|FEZ-1|antibiotic inactivation|1
MSARLRTLIAALFFVVVCLSGMAKENPDYTAALPPFRIADNLYYVGSRDLAAYLVTTPAG
NILINANLESSPPLIRASVEKLGFSWKNTKILLNGQAHSDHMGGAAQVIRETRAQDMVMD
GDADVVSSGGRKDFAFGTDGLTTYPPARVDRVLHDGDTVLLGGVTLTAHRTAGHTRGCTT
WTLRAHIASDPAGRLRDVVIVGGWRALSQYQIVGTPGHPASYPGINEDFEKTFATLRALP
CDIFLGAHGVYFDLLPKLKRMPTEGEAAFVDPKGYAEAVNAAQADFEKTVAAQRAKK
>YP_005055871.1|FEATURES|NCBI|beta_lactam|FEZ-1|antibiotic inactivation|1
MSPCRKLLCLVVILFSFGGLHAQMNPDWTTPVSPFRIADNLYYVGSRDLASYLVTTPAGN
ILINANLPSSPPQIRASVEQLGFRWKDTKILLNGQAHFDHMGGSAQILRETHAKNMVMEG
DADVVRSGGRTDFAAGTPGILQYAPARVDRVLHDGDTLSLGGVILTAHKTGGHTRGCTTW
AFRVHIPSDPPGKLRDVVIIGGFTVLSQYRLTAIAPQPGYYPGIAQDYAHTFATLRALPC
DLFLADHGSHFGLLEKLARLPKEGATVWLDPEGYKRAVAEHQKDFEDELEKQRRGGL
>WP_007164418.1|FEATURES|NCBI|beta_lactam|AIM-1|antibiotic inactivation|1
MALANSTQALAEGPVTEAERKQAEIARFSQECEKWDDWDKPAHPYRIHANTYYVGTCGIA
AILITSDDGHILIDSGTEAGAQVVLDNIESLGFALEDVEILLHSHEHFDHVGGHALVAER
TGARVGASPLAKPVLETGQVADNDPQHAIHPAMAPVAVGFTLESGRSVSLGKLRIYPFTT
AGHTPGARSYFWRSCEDRDCKAIVFADSMSPVSSDDYRFSEHPDYVSEYRAGIERVAGMS
WRCDILLTPHPSHSKMIERAAAGRLDNGMSCEAFAAGKTEDLNARLEREAGANQ
>YP_003084992.1|FEATURES|NCBI|beta_lactam|PEDO-1|antibiotic inactivation|1
MPSIKKSLFTTLIAGAILAPFATEAQNKPRKLPYVQQEWTKEYRPFRIAGNLYYVGTYDL
ACYLIATPKGHILINTGLESSVPVIRKHVQALGFKFEDIKILLATHAHYDHVEGMAAIKQ
ATGARLLIQEKDGKAMTDGGASDYALGGHGSTFEPVTPDQLLKNGEIIKLGTMQVKLLHH
PGHTPGASSFSFTVRDEKRAYKVFIANMPSILDETKLSGMPGYPEVGKDYAKTLAVMKNE
RFDIWLSSHASQFALHQKHKPGSPYRPEAFFDQAGYDSALAGLKKRYDEKSKEK
>WP_008504272.1|FEATURES|NCBI|beta_lactam|LRA-12|antibiotic inactivation|1
MKRILTLLIFLCVNCCTLAQNVSEPSSKMHPEWSKPYPPFQIAGNLYYVGTYDLACYLIV
TPKGNILINTGLASSGQLIKTSIESLGFKLTDTRILLTTQAHFDHMGAMAELKRLTGAKM
MVDEGDAAVVADGGLSDYDLQGKVCVFKPVKVDRILHNGDSIMLGGMKLTTLHHPGHTKG
SCSYLFDVQDNDRKYSVLIANMPTIVTDKKFADVLAYPNIANDYAYTLNAMKHITFDIWL
ASHASQFNLTDKHQPGTAYNPGAFMDKKYYYDKIDDLRKEYDSKVNSK
>YP_001085388.1|FEATURES|resfam|beta_lactam|ampC|antibiotic inactivation|1
MAVGVIQNNKKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDD
TPGKYWKVLKNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEY
RQYSNPSIGLFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQEN
QPIRVNPGPLDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGFYQVNTMYQ
ALGWEEFSYPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIP
KENIGLVMLTNKRIPNEERIKAAYAVLNAIKK
>ACC57876.1|FEATURES|resfam|beta_lactam|ADC-2|antibiotic inactivation|1
MSTFIPAFYFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNNKKYEMYY
GLQSVQDKKAVNRSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKELKNTPIDQ
VNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWQPKNPIGEYRQYSNPSIGLFRKVVA
LSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYG
VKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGFYQVNTMYQALGWEEFSYPATLQTL
LDSSSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVMLTNKRIPN
EERIKAAYAVLDAIKK
>WP_001159761.1|FEATURES|resfam|beta_lactam|ADC-2|antibiotic inactivation|1
MQFKKISCLLLSPLFIFSTSIYADNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGFYQVNTMYQALGW
EEFSYPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENI
GLVMLTNKRIPNEERIKAAYAVLNAIKK
>NP_313158.1|FEATURES|resfam|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>ABB64281.1|FEATURES|resfam|beta_lactam|WRSd3_03658|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHISPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLHQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARSVKAITPPTPAVRASWVHKTGSTGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>AAM11671.1|FEATURES|NCBI|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLITASCSALSAPQQLNEIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADVDKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEINLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANASIGLFGALAVK
PSDLSFEQAMQTRVFQPLKLNHTWINVPPAEEKHYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLTPRDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDTII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>AAM93471.1|FEATURES|NCBI|beta_lactam|AN672_11615|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDVTDKAELLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LVVKHSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASLVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>AAO16528.1|FEATURES|NCBI|beta_lactam|ampC|antibiotic inactivation|1
MMKKSLTGVLLLGASFSIFAAPQTAEQLRELVNQTITPLMKEQTIPGMAVAVIYRGKPYY
FTWGQADVAGQRPVTRQTLFELGSVSKTFTGVLGGDAVARGEIKLSDPAQKYWPQLTGQQ
WQGISLLHLATYTAGGLPLQVPDEVTDEAALLRYYQNWQPQWAPGSKRLYANASIGLFGA
LAVKPSGMSFEQAMSQRVLQPLKLSHTWINVPPAQSKDYAWGYRDGKAVHVSPGQLDAEA
YGVKSSIEDMAHWVLANMNSEAVQDKNLRQGIQLAQSRYWRAGEMYQGLGWEMLNWPVPA
EVVINGSDNKVALAATPVTAVNPPAPSVKASWVHKTGSTGGFGSYVAFIPQQDLGIVMLA
NKSYPNPERVKAAYHILEALQ
>AAP40275.1|FEATURES|NCBI|beta_lactam|ampC|antibiotic inactivation|1
MKLRSQAVMVAVLASAYSLGAVAAPDVETTVSQAIKPLIDQQNIPGMAVAVLVKGKPYYF
TWGMADKEQHLPVTQDTLFELGSVSKTFTGVLGGVAVAKGEIALNDRASQYWPALNLPQW
RNITLLQLATYTAGGLPLQVPDAVTDEDRLKNFYQQWQPQWAPGETRQYANSSIGLFGML
AVKPTGLSFEQAMQQRVLTPLKLTHTFITVPEASENAYAWGYRDGKPVRVSPGMLDAESY
GVKSSIKDMLRWMQANMNPEQVGDKTLQQGLALAQTRYYRTDALYQGLGWEMLDWPEQST
LAIRGADSPMALGPQQVRDAQSHPRVKASWVHKTGATGGFGAYVAFIPQKQIGIVMLANK
NYPNTLRVKVAMQIVKALE
>ABA70720.1|FEATURES|NCBI|beta_lactam|ampC|antibiotic inactivation|1
MMHKTLSCALLLVASGSTFATPQTEKKLSGIVDNVVIPLMKEQAIPGMAVAVIYQGQPYY
FTWGMADVAGKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPVSKYWPALSGKQ
WEGISLLNLATYTAGGLPLQVPDNITDETSLQNYYETWQPQWAPGTKRFYSNASIGMFGK
LAVKPSGMSFEQAMNKRVFQPLNLTHTWIHVPEREEKHYAWGYRDGKAVHVSPGMLDAEA
YGVKSSIKDMASWVRANMTPSEVKDASLQKGILLAQSRYLQVGDMYQGLGWEMLNWPMKA
TIAVGGSDNKVALAPLSAVEINPPAPALNSSWVHKTGSTGGFGSYVAFIPEKNLGIVMLA
NKSYPNPARVEAAYRILEALSVE
>ABO48510.1|FEATURES|NCBI|beta_lactam|ETAF_2879|antibiotic inactivation|1
MMNTRLSCTLALSALLLSSGAQASTPPSAEMRVAEAVKQTIPALMQQQQIPGMAVAVIYQ
GTPYYFSYGVADKATRRAVTPQTLFELGSVSKTFTGVLGGYALQRGDIRLQDTVASQWPA
LNGPQWRAITLQQLATYTAGGLPLQVPDAVTDTAQLLDFYQRWQPRWAPGTMRSYSNASI
GLFGMLAVRPSGMDFSQAMTRWVLQPLGLKHTYFRVPPAAEGEYAWGYREGKALRVSPGM
LEQEAYGIKSSAQDMATWLQANLDPAAVTQATLRQALLRAQTRYYQSGEMYQGLGWEMLS
WPLQAQTLIDGSDNRVALQPQPVHLIEPPTPPQPASWVHKTGSTNGFGAYIAFIPGSRLG
IVMLANKNYPNPARVQAAYTILQQLQ
>BAD16740.1|FEATURES|NCBI|beta_lactam|BCh11DRAFT_01667|antibiotic inactivation|1
MKGWLLGVSLTLLGGGSVALAQDDASDRQTREVLDPIVASLMEAQQIPGMAIALVRPEGT
TISHYGAADRETGTPVDDDTLFEIGSLSKTLTATLASLAEVEGKLDFDAPVSRYLPELEG
SAFDDISGLNLGTHTGGGLPLFVPDEVTDRASLMAWYREWQPTEPIGESRTYSNLGIGLL
GLETAASLDGEFVPTMRAKVLAPLGMQDTWYDVPEARMADYAMGEDKDGQPTRVSPGVLD
DEAYGIKTTAADLAKLVRANLHLADVDAELQQAIDATRQGHYRVGDMTQALIWEQYSLPV
APETLRAGNGYDMILEPNAAEALEPPQSPRDDVWVNKTGSTNGFGGYIVMLPGKHTGLVM
LANKNYPNDARVEAAYRILSGLGAIDVP
>Q48743.1|FEATURES|NCBI|beta_lactam|ampC|antibiotic inactivation|1
MKRLLAFCLLFFAALGQAKVPPPARSAADAEIQRAVAAFMQQYQVPGVAVGITVDGAERY
YNYGVSSRKTQAKVGANTLFEVGSVSKTFTATLASYAQVNQQLSLADHPGKYLPEMKGHD
FDKVTLLNLGTHTAGGFPMQVPTQVKTDQQLTAYFQSWHPQYPAGTKRTYANPGIGMLGV
IAAKSMRMPFQKAMTGVLLPKLGLTNTYLTVPPAKMAFYAQGYDDKGQPVRMSPGALWEP
TYGIKTTARDLLRFVEINLDQVKVEPKLKRAIDGTHVGYYRLGEMTQGLVWEQLPYPASE
TSLQANSSQKVIFESNAVAALTPPRPPQANVLINKTGSTRGFGAYVAFNPARKIGIVLLM
NRSVPMDGRIKLAHTILDTAGGMAK
>O05465.1|FEATURES|NCBI|beta_lactam|A3K91_1255|antibiotic inactivation|1
MKLFTSTLTAKKSSTHKPLISLALSVLISTLLISETAQAADANDRLEQEVDKQAKQLMAQ
YQIPGMAFGIIVDGKSHFYNYGLADKQRNQPVSEDTIFELGSVSKTFAATLASYSELNGT
LSLDDTADKYIPYLKNSAIGNTKLISLVTYSAGGYHYRCLKTLENNKELLQYYKSWHPDF
PVNSKRLYSNASIGLFGYISALSMHSDYTKLIENTVLPSLKMTNTFVDVPANKMEDYAFG
YNAAGEPIRVNPGMLDAEAYGIKSTSADMTRFMAANMGLVTVDSQMQQALDNNRKGYYRT
KSFTQGLAWEMYPLPTTLQQLVEGNSTETILQPQPIQLNEPPTPVLNDVWVNKTGATNGF
GAYIAYMPAKKTGMFILANKNYPNTERVKAAYTILDSVMNN
>O69773.1|FEATURES|NCBI|beta_lactam|PROSTU_00250|antibiotic inactivation|1
MDNSMKNIFRQGRLFIALSLAMTSISAFALTQQEVDDIIKPLMKQEQIPGMSVAISVNGK
QAIYHYGVQSKQTQIPVSDRTLYEIGSLSKTFTATLATYAQIQGKLDFSQSVSHYLPELK
GSAFDNVSVMNLATHTSGLSLFVPSDIKTNDQLMAYYQKWLPDNEVGQYRSYSNLGVGLL
GIVTAKQLNMPFSQAMEKLMLPSLGLKHTYIHVPKSQEKYYAQGYNKQNQPVRLNLEILG
PEAYGLKSNAKDLIRYLEINMQSIKVAKTWQEAIENTHTGVYLTDSFVQDMMWESYPWPV
SLSQLLQGNRDDMALKPQKVELIKPAMAPEVRAYYNKTGSSNGFATYAIFIPEEKIAIVM
LSNKWIPIPQRITATYQLLEKIER
>CAC85358.1|FEATURES|NCBI|beta_lactam|ampC|antibiotic inactivation|1
MKKSLCCALLLGVSCTTFAAPMSEKQLADVVERTITPLMKAQAVPGMAVAVIYQGKPHYF
TFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAVARGEISLSDKATKYWPELTGKQW
QCISLLDLATYTAGGLPLQVPDDVTDNASLLHFYQTWQPQYHPGSTRLYANASIGLFGAL
AVKPSGMSFEQAMTERVFKPLKLAHTWINVPPQETQHYAWGYRDGKAVHVSPGMLDAQAY
GVKTNVEDMASWVIANMTPDSVQDASLKQGITLAQSRYWRIGSMYQGLGWEMLNWPVDAK
TVVNGSDNKVALAALPVKEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKDLGIVMLAN
KSYPNPARVEAAYRILSALQP
>CAC85359.1|FEATURES|NCBI|beta_lactam|ampC|antibiotic inactivation|1
MKKSLSCALLLSVACSAFAAPMSEKQLANVVERNVTPLMKAQAIPGMAVAVIYQGQPHYF
TFGKADVAANKPVTPQTLFELGSVSKTFTGVLGGDAIARKEISLADPVTKYWPELTGKQW
QGIRLLDLATYTAGGLPLQVPDAVTDNASLLRFYQSWQPKWAPGTTRLYANTSIGLFGSL
AVKPSGMRFEEAMTERVFKPLKLNHTWINIPHAEEPHYAWGYREGKAVHVSPGLLDAEAY
GVKSNVKDMASWVMANMAPETIQQPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDAK
TVVDGSDNKVALAPLPAAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLAN
KSYPNPLRVETA
>CAD32304.2|FEATURES|NCBI|beta_lactam|CMY-34|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNRPITQNTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTRYWPELTGKQ
WQNISLLHLATYTAGGLPLQIPNEVTNKTALLRFYQNWQPQWAPGAKRLYANSSIGLFGV
LAVKPSGMSYEEAMIRRVLQPLKLTHTWITVPQSEQRDYAWGYRDGKPVHVSPGQLDAEA
YGVKSSIMDMARWVQANMDASHVQEKTLQQGIGLAQSRYWRIGEMYQGLGWEMLNWPVKA
DTIINGSDSKIALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFIPEKNLGIVMLA
NKSYPNPARVDAAWRILEKLQ
>WP_002459970.1|FEATURES|NCBI|beta_lactam|BL1_ec|antibiotic inactivation|1
MFKTTLCALLLAISYSTLAASHSEQQINEIVHRTMTPLIEQQKIPGMAVAVIYQGKPYYF
TWGYADVEKNRPVTQKTLFELGSVSKTFTGVLGGDAIAREEITLSDPVTKYWPELTAKQW
NRITLLHLATYTAGGLPLQVPDDVKSATDLLRFYQNWQPEWAPGTQRLYANSSIGLFGAL
VVKPSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAY
GVKSTIEDMARWLQSNMNPQEIKDKTLQQGIQLAQSRYWQSGDMYQGLGWEMLDWPVNPD
IIINGSDNKIALAARPVKAITPPAPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLAN
KNYPNPVRVAAAWQILNALQ
>NP_900980.1|FEATURES|NCBI|beta_lactam|ampC|antibiotic inactivation|1
MMQSLKFRTLAGMLGCLTFLPLAAQAANDAGKSDLDAAVEATIPPLMKAKDIPGMAVAVL
ADGKAHYFNYGVASRETGQPVTQDTLFELGSISKTFTGILGGYALAQGKLSLADKASRYQ
PELKGSVFDRVSLLQLATYSAGGLPLQFPDAVAGQASMLAYYRGWKPDYAPGERRLYSNP
SIGLFGHLAARSLGQPFDQAMERGLLPKLGLSHTFIHVPEAEQSRYAWGYAKAGKPIRVG
AGVLDAEAYGIKSSAADLLKYLAINMSPPADPALQRALDASHAAYYRVGDMRQGLGWEGY
RYPISLERLLAGNSNEIAFQPQKVEWLNPPRLAEGDVLLNKTGSTSGFGAYVLFVPARKV
GIVMLANRNYPNAERVRAAYRILSAVDPSLVRRRGD
>YP_001006653.1|FEATURES|NCBI|beta_lactam|ampC|antibiotic inactivation|1
MMKKSIINTLIFTAIATFPLYTLAQTKLTQQQVATIVNNTLTPLLEKQDIPGMAVAVFYD
GKPQFFNYGMADIKAGRPVTENTLFELGSVSKTFTGVAGEYAMQTGIMNLNDPVTEYAPE
LTGSQWKDVKMLHLATYTAGGLPLQLPDSVTDQKALWQYYQQWQPQWAPGVMRNYSNASI
GLFGALAVKRSQLTFENYMKEYVFQPLKLDHTFITIPESMQSNYAWGYKDGQPVRVTLGM
LGEEAYGVKSTSQDMVRFMQANMDPESLPAANDKLKEAIIASQSRYFQAGDMFQGLGWEM
YNWPINPQRVIADSGNDIALKPRKVEALVPAQPAVRASWVHKTGATNGFGAYIVFIPEEK
VGIVMLANKNYPNPVRVQAAYDILQALR
>YP_313059.1|FEATURES|NCBI|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLTPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAIKPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAACQILNALQ
>YP_349452.1|FEATURES|NCBI|beta_lactam|ampC|antibiotic inactivation|1
MSSTNLRKLKSYSAFGLFFSAATCLAAPQTDDQLQALVKATVTPVMQQQDIAGLAVAVTV
NGKAHYFNYGVADKSTGQAVSENTLFEIGSVSKTFTAILAAYAQASGKLQLSDKASQHWP
ELKGSAFDHISLLQLGTYSAGGLPLQFPDAADSADKMLGYYQQWKPTYPAGSHRLYSNPS
IGLFGYLAAKSLGQPFNQVMTETLLPKLGLKHTFLSVPASEQKLYAQGYDKNNKPIRVSP
GALDSEAYGVKTSAADLLQYVQANLDTAKLETPLQKAIALTHTGYYTVGDMTQGLGWERY
AYPISLDRLLDGNSTPMAMEAHKVKWLNPPQPEPANVLLNKTGSTGGYGAYVAFVPSKKV
GIVILANRNYPNGERVKIAHRILGELTR
>YP_410551.1|FEATURES|NCBI|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQMPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLTPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAIKPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAACQILNALQ
>YP_691594.1|FEATURES|NCBI|beta_lactam|ampC|antibiotic inactivation|1
MAGRFVWKPDLMFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLPPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDSIINGSDNKIALAARPVKAIKPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAACQILNALQ
>YP_888266.1|FEATURES|NCBI|beta_lactam|MSMEI_3884|antibiotic inactivation|1
MFTAGRICAALIVLVALISAAPTASADPSAAVARAFAPLLDQYDVPGMAVAVTVDGRQHF
YEFGVVSKQTQAPVTRDTLFEIGSVSKTFTATLAGYAATRGVLNLDDHPGRYLPALAGTP
IDRAELRNLGTYTAGGLPLQFPESVTDDEQMIAYFQQFQPVTAPGKIRQYSNPSVGLLGH
ISARALGGQFTDLMQSQILTGLGLRRSFVDVTDEAMDFYAWGYDKKNHPVRVNPGVFDAE
AYGVKSTTADMIRFIEHNIDPGALEPTLREAVKSTQVGYYKVGPMVQDLGWEQYPYPVAL
DQLLAGNSGEMAMSPQAATAIAPPSVGSALFNKTGSTDGFGAYAAFVPERRIGIVMLANK
NFPIPARVTAAHTVLDALDA
>WP_004874984.1|FEATURES|NCBI|beta_lactam|ampC_2|antibiotic inactivation|1
MMKKSLITTLVLTAIAASPLSTSAQTKLTEQQVAAIVNDTLKPLIEKQDIPGMAVAVFYD
GKPQFFNYGVADIKAGTPVTENTLFELGSVSKTFTGVAGEYAMQTGIMNLNDPVTDYAPE
LTGSQWKAVKMLHLATYTAGGLPLQLPDSVTDQKSLWQYYQQWQPEWAPGEMRNYSNASI
GLFGALAVKRSQLTFEEYMKKSVFQPLKLNHTFITVPESMLPNYAWGYKEGQPMRVTLGM
LGEEAYGVKSTTKDMVRFMQANMNPESLPVENDKLKQALIAAQSRYFQAGEIFQGLGWEM
YNWPIDPQRVIADSGNDVALKPRKAKELLPPPPAVRASWVHKTGATNGFGAYIVFIPEQN
IGIVMLANKNYPNPVRVQAAYNILQALR
>YP_001084546.1|FEATURES|resfam|beta_lactam|OXA-100|antibiotic inactivation|1
MLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTLGDAMKASAIPVYQDLARRIGLEL
MSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQFAYKLANKTLPFSQKVQDEVQSM
LFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQGNIVAFSLNLEMKKGIPSSVRKEI
TYKSLEQLGIL
>AAZ76618.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|Erm(38)|antibiotic target alteration|1
MSKPHHGRHELGQNFLSDRRVIADIVEIVSHTTGPIIEIGAGDGALTVPLQGLVRPLTAI
EVDARRAHRLAQRTAKSTEIVVADFLRHPLPHSPHVVVGNLPFHLTTAILRRLLHGPGWT
TAVLVVQWEVARRRAAVGGATMMTAQWWPWFEFALAQKIPASSFRPRPAVDAGLLTITRR
NRPLVDSADRARYQALVHRVFTGRGRGMAQILRRLPTPVPRNWLRANGVAPNALPRQLSA
AQWAALHEATLAGTERVDRPRDVQHGRAHRRGGGEVDRPAPHHKQTRPLIGQRQPQRGGD
PDADPDDQCAAAPVTGHHQGERRDEDQADHQDRPLTGEHLADELSWRHASFDSSASTTLV
SRKARVNGPTPPGLGDT
>CAP17168.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|ErmB|antibiotic target alteration|1
MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNLSSEKLKLNIRVTLIHQDILQFQFPNKQRYKIVGSIPYHLSTQIIKKVVFESHAS
DIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTT
DVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTITYEQVLSIFNSYLL
FNGRK
>CAM96571.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|ErmN|antibiotic target alteration|1
MTLKSPLPPQSVSAPADSRSTARREWGQNFFRTAAAACRFSAQLDGSDTIPPDSPNDLMT
VEIGAGSGRVTKVLASPGTPLLAVEIDPRWARRLAAESLPDVTVVNEDFLTLQLPGQPVR
LIGNLPFVTGTRMLRRCLDMGPARMRQGVFLLQREYVGKRTGAWGGNLFNAQWEPWYSFD
RGLAFSRQDFTPVPRADTQTLMVAPHRRPSVPWREKAAYQRFVQRVFDTGQMTVGDAARK
VLRRGHAQFVRGAGVRPADRVKDLTVPEWTALFRAYGRTADR
>YP_007078965.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|ErmB|antibiotic target alteration|1
MDPRDAGASGAGMNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLA
KISKQVTSIELDSHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGSIPYHLSTQ
IIKKVVFESHASDIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKV
NSVLIKLTRHTTDVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTVTY
EQVLSIFNSYLLFNGRK
>NP_311274.1|FEATURES|resfam|multidrug|emrK|antibiotic efflux|0
MEQINSNKKHSNRRKYFSLLVIVLFIAFSGAYAYWSMELEDMISTDDAYVTGNADPISAQ
VSGSVTVVNHKDTNYVRQGDILVSLDKTDATIALNKAKNNLANIVRQTNKLYLQDKQYSA
EVASARIQYQQSLEDYNRRVPLAKQGVISKETLEHTKDTLISSKAALNAAIQAYKANKAL
VMNTPLNRQPQVVEAADATKEAWLALKRTDIKSPVTGYIAQRSVQVGETVSPGQSLMAVV
PARQMWVNANFKETQLTDVRIGQSVNIISDLYGENVVFHGRVTGINMGTGNAFSLLPAQN
ATGNWIKIVQRVPVEVSLDPKELMEHPLRIGLSMTATIDTKNEDIAEMPELASTVTSMPA
YTSKALVIDTSPIEKEISNIISHNGQL
>YP_001086116.1|FEATURES|resfam|tetracycline|tet41|antibiotic efflux|0
MTHSTHISIYMGILASLYAAMQFIFSPLLGALSDRWGRRPVLLISLAGSAVNYLFLTFSH
SLILLLVGRIIAGITSANMAVASAYIVDVLHENNRAKYFGLINAMFGAGFIIGPVLGGFL
SEYGLRLPFFAAAILTGLNLLSAYFVLPETRRVTSEGKQLSTLNPFKIFAGISSIRGVLP
FVMTFFIFSAIGEVYGVCWALWGHDTFQWSGFWVGLSLGAFGLCQMLVQIFIPSHASRLL
GNRNAVLIGIACSCLALAVMAFAQSGWMIFAIMPIFALGSMGTPSLQALASQKVSADQQG
QFQGVITSTVSLASMIAPLFFSTLYFQFQKKWPGAIWLSVILIYLITLPIILYSTQPVEQ
QR
>WP_001082092.1|FEATURES|resfam|tetracycline|tet41|antibiotic efflux|0
MPDFSIGRFMNRSLFIIFATIALDAIGIGLIFPILPLLLQDMTHSTHISIYMGILASLYA
AMQFIFSPLLGALSDRWGRRPVLLISLAGSAVNYLFLTFSHSLILLLVGRIIAGITSANM
AVASAYIVDVLHENNRAKYFGLINAMFGAGFIIGPVLGGFLSEYGLRLPFFAAAILTGLN
LLSAYFVLPESRKVTLENKQLSTLNPFKIFAGISSIRGVLPLITTFFIFSAIGEVYGVCW
ALWGHDTFQWSGFWVGLSLGAFGLCQMLVQALIPSHASRLLGNRNAVLAGIACSCFALAV
MAFAQSGWMIFAIMPIFALGSMGTPSLQALASQKVSADQQGQFQGVIASTVSMASMIAPM
FFSTLYFQFQEKWPGAIWLSVILIYLLTLPIILYSTRPVVQQR
>WP_001082093.1|FEATURES|resfam|tetracycline|tet41|antibiotic efflux|0
MNRSLFIIFATIALDAIGIGLIFPILPLLLQDMTHSTHISIYMGILASLYAAMQFIFSPL
LGALSDRWGRRPVLLISLAGSAVNYLFLTFSHSLILLLVGRIIAGITSANMAVASAYIVD
VLHENNRAKYFGLINAMFGAGFIIGPVLGGFLSEYGLRLPFFAAAILTGLNLLSAYFVLP
ESRKVTLENKQLSTLNPFKIFAGISSIRGVLPLITTFFIFSAIGEVYGVCWALWGHDTFQ
WSGFWVGLSLGAFGLCQMLVQALIPSHASRLLGNRNAVLAGIACSCFALAVMAFAQSGWM
IFAIMPIFALGSMGTPSLQALASQKVSADQQGQFQGVIASTVSMASMIAPMFFSTLYFQF
QEKWPGANWLSVILIYLLTLPIILYSTRPVVQQR
>CAC20134.1|FEATURES|resfam|tetracycline|tetC|antibiotic efflux|1
NNALIVILGTVTLDAVGIGLVMPVLPGLLRDIVHSDSIASHYGVLLALYALMQFLCAPVL
GALSDRFGRRPVLLASLLGATIDYAIMATTPVLWILYAGRIVAGITGATGAVAGAYIADI
TDGEDRARHFGLMSACFGVGMVAGPVAGGLLGAISLHAPFLAAAVLNGLNLLLGCFLMQE
SHKGERRPMPLRAFNPVSSFRWARGMTIVAALMTVFFIMQLVGQVPAALWVIFGEDRFRW
SATMIGLSLAVFGILHALAQAFVTGPATKRFGEKQAIIAGMAADALGYVLLAFATRGWMA
FPIMILLASGGIGMPALQAMLSRQVDDDHQGQLQGSLAALTSLTSITGPLIVTAIYAASA
STWNGLAWIVGAALYLVCL
>NP_253981.1|FEATURES|resfam|multidrug|NorA|antibiotic efflux|0
MSSPSLVELKAILRLAGPLIAAQLAYVAMVFTDTVMMGKLGPDALAAGGLGAVSYAFVST
FCVGVVAAVGNLVAIRHGCDDAAGAAAAARSGLWVGAALALAAGLLLWNLRPLLLVFGQA
PQTVDGAMQFLHSLTFALPGYMAFMVLRGFTSAIDRAGPVMAISVLGALANLALNYSFIE
GLFGLPRLGLAGIGLVTALVMNCMPLLLALYIRLQPAYAEYSLLRGLGRPQRAMVEEILR
LGLPIGGTYAVESGMFTVATLCMGIIGDHALAAHQIAIQAVYVAFMVPVGLSYATTYRIG
QHFGAGRLLEARRAGRVGIGFGALCMLLFAGLFWWMPEAIIGLFLDRDAPANREVAAMAV
SLLAIAAWFELFDGTQNVAMGAIRGLKDARTTFLVGLACYWLVGVPLACLLAFAAGWGAA
GVWWGLAGGLACAAIGLTLAFEWKTARLLPKATASEASALNCRAAGRGAPSARLCPGNAP
VPPTAAAD
>YP_788912.1|FEATURES|NCBI|multidrug|mexi|antibiotic efflux|0
MTFTDLFVRRPVLALVVSTLILLLGLFSLGKLPIRQYPLLESSTITVTTEYPGASADLMQ
GFVTQPIAQAVSSVEGIDYLSSTSVQGRSVVTIRMLLNRDSTQAMTETMAKVNSVRYKLP
ERAYDSVIERSSGETTAVAYVGFSSKTLPIPALTDYLSRVVEPMFSSIDGVAKVQTFGGQ
RLAMRLWLDADRLAGRGLTASDVAEAIRRNNYQAAPGMVKGQYVLSNVRVNTDLTNVDDF
REMVIRNDGNGLVRLRDVGTVELGAAATETSALMDGDPAVHLGLFPTPTGNPLVIVDGIR
KLLPEIQKTLPPDVRVDLAYETSRFIQASIDEVVRTLVEALLIVVLVIYLCLGSLRSVLI
PVATIPLSMLGAAALMLAFGFSVNLLTLLAMVLAIGLVVDDAIVVVENVHRHIEEGKSPV
AAALIGAREVAGPVIAMTITLAAVYTPIGLMGGLTGALFREFALTLAGAVIVSGVVALTL
SPVMSSLLLQAHQNEGRMGRAAEWFFGGLTRRYGQVLEFSLGHRWLTGGLALLVCISLPL
LYSMPKRELAPTEDQAAVLTAIKAPQHANLDYVELFARKLDQVYTSIPETVSTWIINGTD
GPAASFGGINLAAWEKRERDASAIQSELQGKVGDVEGSSIFAFQLAALPGSTGGLPVQMV
LRSPQDYPVLYRTMEEIKQKARQSGLFVVVDSDLDYNNPVVQVRIDRAKANSLGIRMQDI
GESLAVLVGENYVNRFGMEGRSYDVIPQSLRDQRFTPQALARQFVRTQDGNLVPLSTVVR
VELQVEPNKLIQFDQQNAATLQAIPAPGVSMGQAVAFLDDVARGLPAGFSHDWQSDSRQY
TQEGNTLVFAFLAALVVIYLVLAAQYESLADPLIILITVPLSICGALLPLALGYATMNIY
TQIGLVTLIGLISKHGILMVEFANELQLHERLDRRAAILRAAQIRLRPVLMTTAAMVFGL
VPLLFASGAGAASRFGLGVVIVSGMLVGTLFTLFVLPTVYTLLARNHAEVDKSPRSRQLA
EADLLVNKA
>YP_001346277.1|FEATURES|NCBI|multidrug|mexi|antibiotic efflux|0
MTFTDLFVRRPVLALVVSTLILLLGLFSLGKLPIRQYPLLESSTITVTTEYPGASADLMQ
GFVTQPIAQAVSSVEGIDYLSSTSVQGRSVVTIRMLLNRDSTQAMTETMAKVNSVRYKLP
ERAYDSVIERSSGETTAVAYVGFSSKTLPIPALTDYLSRVVEPMFSSIDGVAKVQTFGGQ
RLAMRLWLDADRLAGRGLTASDVAEAIRRNNYQAAPGMVKGQYVLSNVRVNTDLTNVDDF
REMVIRNDGNGLVRLRDVGTVELGAAATETSALMDGEPAVHLGLFPTPTGNPLVIVDGIR
KLLPEIQKTLPPDVRVDLAYETSRFIQASIDEVVRTLVEALVIVVLVIYLCLGSLRSVLI
PVATIPLSMLGAAALMLAFGFSVNLLTLLAMVLAIGLVVDDAIVVVENVHRHIEEGKSPV
AAALIGAREVAGPVIAMTITLAAVYTPIGLMGGLTGALFREFALTLAGAVIVSGVVALTL
SPVMSSLLLQAHQNEGRMGRAAEWFFGGLTRRYGQVLEFSLGHRWLTGGLALLVCISLPL
LYSMPKRELAPTEDQAAVLTAIKAPQHANLDYVELFARKLDQVYTSIPETVGTWIINGTD
GPAASFGGINLAAWDKRERDASAIQSELQGKVGDVEGSSIFAFQLAALPGSTGGLPVQLV
LRSPQDYPVLYRTMEEIKQKARQSGLFVVVDSDLDYNNPVVQIRIDRAKANSLGIRMQDI
GESLAVLVGENYINRFGMEGRSYDVIPQSLRDQRFTPQALARQFVRTQDGNLVPLSTVVR
VELKVEPNKLIQFDQQNAATLQAIPAPGVSMGQAVAFLDEVARGLPAGFSHDWQSDSRQY
TQEGNTLAFAFLAALVVIYLVLAAQYESLADPLIILITVPLSICGALLPLALGYATMNIY
TQIGLVTLIGLISKHGILMVEFANELQVHERLDRRAAILRAAQIRLRPVLMTTAAMVFGL
VPLLFASGAGAASRFGLGVVIVCGMLVGTLFTLFVLPTVYTLLARNHAEVDQSPRNRQLA
EADLLVNKT
>YP_792720.1|FEATURES|NCBI|multidrug|mexW|antibiotic efflux|0
MAFTDPFIRRPVLASVVSLLIVLLGMQAFSKLVIREYPQMENALITVTTLYAGANAETIQ
GYITQPLQQSLASAEGIDYMTSVSRQNYSTISIYARIGANTDRLVTELLAKSNEVKSQLP
PDAEDPVLQKEAADASALMYISFYSEQMNNPQITDYLSRVIQPKLATLPGIAEAEILGNQ
VFAMRLWLDPVKMAAFGVTAGEINQAVQQYNFLAAAGEVKGQLVVTSVNASTDLKSPQAF
AAIPVKTDGDRRVLMGDVARVELGAASYDAISSFNGIPSVYIGIKGTPSANPLDVIKEVR
AKMPELEEQLPPNLKVSIAYDATRFIQASIDEVVKTLGEAVLIVIVVVFLFLGAFRSVLI
PVVTIPLSMIGVLFFMQAMGYSINLLTLLAMVLAIGLVVDDAIVVVENIHRHIEEGKPPF
EAALEGAREIAVPVVSMTITLAAVYAPIGFLTGLTGALFKEFAFTLAGAVIISGIVALTL
SPMMCSRLLRHEENPSGLAHRLDLIFEGLKRRYQRALHGTLDTRPVVLVFAVLVLALIPV
LLMFTKKELAPEEDQGIVFLMTNSPQTANLDYLNRYTAEFEGIFRSFPEYYSAFQINGYN
GVQAGIGGMLLKPWDEREKSQMELLHAVQAKLNEIPGVQIFAFNLPSLPGTGEGLPFQFV
LNTANDYESLLQVAQRVKQRASESGKFAFLDLDLAFDKPELVVDIDREKAAQMGVSMQDL
GVALASLLGEGEINRFTIDGRSYKVIAQVERPYRDNPGWLGSYYVKSRNGQLVALSTLIE
THERARPRQLNQFQQLNSAIISGFPIVSMGEAIETVQQIAREEAPRGFAVDYAGASRQYV
QEGSALLVTFGLALAIIFLVLAAQFESFRDPLVIMVTVPLSICGALIPLFLGVSSLNIYT
QVGLVTLIGLISKHGILIVEFANQLRHEQGLGRREAIEQAAAIRLRPVLMTTAAMVLGVI
PLILATGAGAVSRFDIGIVIATGMSVGTLFTLFVLPCIYTLVARPDAPPGVTQAANAH
>YP_005977049.1|FEATURES|NCBI|multidrug|mexW|antibiotic efflux|0
MAFTDPFIRRPVLASVVSLLIVLLGMQAFSKLVIREYPQMENALITVTTLYAGANAETIQ
GYITQPLQQSLASAEGIDYMTSVSRQNYSTISIYARIGANTDRLVTELLAKSNEVKSQLP
PDAEDPVLQKEAADASALMYISFYSEQMNNPQITDYLSRVIQPKLATLPGIAEAEILGNQ
VFAMRLWLDPVKMAAFGVTAGEINQAVQQYNFLAAAGEVKGQLVVTSVNASTDLKSPQAF
AAIPVKTDGDRRVLMGDVARVELGAASYDAISSFNGIPSVYIGIKGTPSANPLDVIKEVR
AKMPELEEQLPPNLKVSIAYDATRFIQASIDEVVKTLGEAVLIVIVVVFLFLGAFRSVLI
PVVTIPLSMIGVLFFMQAMGYSINLLTLLAMVLAIGLVVDDAIVVVENIHRHIEEGKPPF
EAALEGAREIAVPVVSMTITLAAVYAPIGFLTGLTGALFKEFAFTLAGAVIISGIVALTL
SPMMCSRLLRHEENPSGLAHRLDLIFEGLKRRYQRALHGTLDTRPVVLVFAVLVLALIPV
LLMFTKKELAPEEDQGIVFLMTNSPQTANLDYLNRYTAEFEGIFRSFPEYYSAFQINGYN
GVQAGIGGMLLKPWDEREKSQMELLHAVQAKLNEIPGVQIFAFNLPSLPGTGEGLPFQFV
LNTANDYESLLQVAQRVKQRASESGKFAFLDLDLAFDKPELVVDIDREKAAQMGVSMQDL
GVALASLLGEGEINRFTIDGRSYKVIAQVERPYRDNPGWLGSYYVKSHNGQLVALSTLIE
THERARPRQLNQFQQLNSAIISGFPIVSMGEAIETVQQIAREEAPRGFAVDYAGASRQYV
QEGSALLVTFGLALAIIFLVLAAQFESFRDPLVIMVTVPLSICGALIPLFLGVSSLNIYT
QVGLVTLIGLISKHGILIVEFANQLRHEQGLGRREAIEQAAAIRLRPVLMTTAAMVLGVI
PLILATGAGAVSRFDIGIVIATGMSVGTLFTLFVLPCIYTLVARPDAPPGVTQAANAH
>YP_001350280.1|FEATURES|NCBI|multidrug|mexW|antibiotic efflux|0
MAFTDPFIRRPVLACVVSLLIVLLGMQAFSKLVIREYPQMENALITVTTLYAGANAETIQ
GYITQPLQQSLASAEGIDYMTSVSRQNYSTISIYARIGANTDRLVTELLAKSNEVKSQLP
PDAEDPVLQKEAADASALMYISFYSEQMNNPQITDYLSRVIQPKLATLPGIAEAEILGNQ
VFAMRLWLDPVKMAAFGVTAGEINQAVRQYNFLAAAGEVKGQLVVTSVNASTDLKSPQAF
AAIPVKTDGDRRVLMGDVARVELGAASYDAISSFNGIPSVYIGIKGTPSANPLDVIKEVR
AKMPELEEQLPPNLKVSIAYDATRFIQASIDEVVKTLGEAVLIVIVVVFLFLGAFRSVLI
PVVTIPLSMIGVLFFMQAMGYSINLLTLLAMVLAIGLVVDDAIVVVENIHRHIEEGKTPF
DAALEGAREIAIPVVSMTITLAAVYAPIGFLTGLTGALFKEFAFTLAGAVIISGIVALTL
SPMMCSRLLRHEENPSGLAHRLDLLFEGLKRRYQRALHGTLETRPVVLVFAVLVLALIPL
LLMFTKKELAPEEDQGIVFLMTSSPQTANLDYLNRYTAEFEGIFRSFPEYYSAFQINGYN
GVQAGIGGMLLKPWDEREKSQMELLHAVQARLNEIPGVQIFAFNLPSLPGTGEGLPFQFV
LNTANDYESLLQVAQRVKQRATESGKFAFLDLDLAFDKPELVVDIDREKAAQMGVSMQDL
GVALASLLGEGEINRFTIDGRSYKVIAQVERPYRDNPGWLGSYYVKSSDGQLVALSTLIE
TRERARPRQLNQFQQLNSAIISGFPIVSMGEAIETVQQIAREEAPRGFAVDYAGASRQYV
QEGNALLVTFGLALAIIFLVLAAQFESFRDPLVIMVTVPLSICGALVPLFLGVSSLNIYT
QVGLVTLIGLISKHGILIVEFANQLRHEQGLGRREAIEQAAAIRLRPVLMTTAAMVLGVI
PLILASGAGAVSRFDIGIVIATGMSVGTLFTLFVLPCIYTLVARPDAPPGVTQAAGAH
>YP_001186705.1|FEATURES|NCBI|multidrug|mexW|antibiotic efflux|0
MAFTDPFIRRPVLATVVSLLIVLLGFQAFSKLSIRQYPQMENALITVTTAYPGANAETIQ
GYITQPLQQSLASAEGIDYMTSSSQQNLSTISIYAHIGADTDRLFTELLAKANEVKNQLP
QDAEDPVLSKEAADASALMYVSFYSDELSNPQITDYLSRVIQPKLATLPGMAEAQILGNQ
VFAMRLWLDPVKMAAYGITAGDLNSAVRKYNFLSAAGEVKGQYVVTSINASTDLKSAEAF
GAIPVKTLGDTRVLVRDIARVEMGAENYDSISSFDGIPSVYIAIKGTPSANPLDVIKEVR
GILPELEAQLPPNLKVAIAYDATLFIQASIDEVVKTLVEAVLIVIVVVFLFLGAFRSVLI
PVITIPLSMIGVLFFMQLMGYSINLLTLLAMVLAIGLVVDDAIVVVENIHRHIEEGKTPF
DAAIEGAREIAVPVVSMTITLAAVYAPIGFLEGLTGALFKEFALTLAGAVIISGIVALTL
SPMMCAKLLRHDENPSGLAHRLDMIFDRLKQRYQKMLHGTLNTRPVVVVFGVIVMALIPV
LLSFTESELAPEEDQGVVFLFANAPQPTNLDYVNAYTDQFVEIFKSFPEYYSSFQINGFD
GVQSGIGGFLLTPWNDRERTQMEILPEVQARLNHIPGLQIFGFNLPSLPGTGEGLPFQFV
VNTPNDYESLLQVAERVKARALESGKFAFLNIDLAFDKPEIVVDIDRAKAAQMGVSMEDL
GATLASLLGEGEINRFTIDGRSYKVIAQVERAYRDNPGWLDNYHVRSESGAMVPLGTLIS
LSDRARPTKLKQFQQLNSAIIEGVPIVSQGEAIDTITAIAREEAPRGYSFDYAGASRQYI
QEGSALFVTFALALAIIFLVLAAQFESFRDPLVILVTVPLSICGALVPIFLGFSTMNIYT
QVGLVTLIGLISKHGILIVEFANQLRHEKGLPLREAIEEAAAIRLRPVLMTTAAMVFGMV
PLILASGAGAVSRFDIGLVIATGMSVGTLFTLFVLPCVYSLLAKPDAEPQAQAVPVH
>YP_001266290.1|FEATURES|NCBI|multidrug|mexW|antibiotic efflux|0
MAFTDPFIRRPVLASVVSLLILLLGFQAWNKLQIRQYPQMENALITVTTAYPGANAETIQ
GYITQPLQQSLASAEGIDYMTSVSRQNFSIISIYARVGADSDRLFTELLAKANEVRNKLP
QDSEDPVLSKEAADASALMYVSFYSKEMSNPQITDYLSRVIQPKLATLPGMAEAEILGNQ
VFAMRLWLDPVKLAGFGLSATDVTNAVRRYNFLSAAGEVKGEYVVTSVNASTELKSAEAF
AALPLKTSGDSRVLLGDVARVEMGAENYDTVSSFDGTPSVYIGIKATPAANPLDVIKEVR
RIMPELESQLPSALKVSIAYDATRFIQASIDEVIKTLGEAVLIVIVVVFLFLGALRSVLI
PVVTIPLSMIGVLFFMQMMGYSLNLLTLLAMVLAIGLVVDDAIVVVENIHRHMEEGKSPF
DAALEGAREIAMPVVSMTITLAAVYAPIGFLTGLTGALFKEFALTLAGAVVISGIVALTL
SPMMCALLLRREQNPSGLAHRLDQLFERLKGRYQRVLHATLDSRPVVLVFAVIILCLIPV
LLKFTQNELAPNEDQGVIFMMSSSPQPANLDYLNAYTDQFTPLFKAFPEYYSSFQINGFN
GVQTGIGGFLLKPWNERERTQMELLPLVQAKLEEISGLQIFGFNLPSLPGTGEGLPFQFV
INTAGDYPALLDVAQRIKTRAQASGKFAFLDIDLAFDKPEVVVDIDRAKAAQMGVSMDTL
GGTLATLLGEAEINRFTLEGRSYKVIAQVERPYRDNPGWLNNYYVKNEQGQLLPLSTLIT
LTDRARPRQLNQFQQLNAAIIQGVPMVSLGEALKTVQDIAREEAPEGFAFDYAGVARQYV
QEGSALWVTFGLALAIIFLVLAAQFESFRDPLVILVTVPLSICGALLPLFLGVSSMNIYT
QVGLVTLIGLISKHGILIVEFANQLRDERGLSVREAIEEAAAIRLRPVLMTTAAMVFGMV
PLILATGAGAVSRFDIGMVIATGMSIGTLFTLFVLPCVYTLLAHKASAKAPAIA
>NP_743067.1|FEATURES|NCBI|multidrug|mexW|antibiotic efflux|0
MAFTDTFIQRPVLASVVSLLILLLGFQAWNKLQIRQYPQMENALITVTTAYPGANAETIQ
GYITQPLQQSLASAEGIDYMTSVSRQNFSIISIYARIGADSDRLFTELLAKANEVRNKLP
QDSEDPVLSKEAADASALMYVSFYSKEMSNPQITDYLSRVIQPKLATLPGMAEAEILGNQ
VFAMRLWLDPVKLAGFGLSATDVTNAVRRYNFLSAAGEVKGEYVVTSVNASTELKSAEAF
AALPLKTSGDSRVLLGDVARVEMGAENYDTVSSFDGTPSVYIGIKATPAANPLDVIKEVR
RIMPELESQLPSALNVSIAYDATRFIQASIDEVIKTLGEAVLIVIVVVFLFLGALRSVLI
PVVTIPLSMIGVLFFMQMMGYSLNLLTLLAMVLAIGLVVDDAIVVVENIHRHMEEGKSPF
DAALEGAREIAMPVVSMTITLAAVYAPIGFLTGLTGALFKEFALTLAGAVIISGIVALTL
SPMMCALLLRREQNPSGLAHRLDQLFERLKGRYQRLLHATLDSRPVVLVFAVIILCLIPV
LLKFTQNELAPNEDQGVIFMMSSSPQPANLDYLNAYTDQFTPLFKAFPEYYSSFQINGFN
GVQTGIGGFLLKPWNERERTQMELLPLVQAKLEEISGLQIFGFNLPSLPGTGEGLPFQFV
INTAGDYPALLDVAQRIKTRAQESGKFAFLDIDLAFDKPEVVVDIDRAKAAQMGVSMDTL
GGTLATLLGEAEINRFTLEGRSYKVIAQVERPYRDNPGWLNNYYVKNDQGQLLPLSTLIT
LTDRARPRQLNQFQQLNAAIIQGVPMVSLGEALKTVQDIAREEAPEGFAFDYAGAARQYV
QEGSALWVTFGLALAIIFLVLAAQFESFRDPLVILVTVPLSICGALLPLFLGVSSMNIYT
QVGLVTLIGLISKHGILIVEFANQLRDERGLSVREAIEEAAAIRLRPVLMTTAAMVFGMV
PLILASGAGAVSRFDIGMVIATGMSIGTLFTLFVLPCIYTLLAHKASAKAPAIA
>YP_001670703.1|FEATURES|NCBI|multidrug|mexW|antibiotic efflux|0
MAFTDPFIRRPVLASVVSLLILLLGFQAWNKLQIRQYPQMENALITVTTAYPGANAETIQ
GYITQPLQQSLASAEGIDYMTSVSRQNFSIISIYARIGADSDRLFTELLAKANEVRNKLP
QDSEDPVLSKEAADASALMYVSFYSKEMSNPQITDYLSRVIQPKLATLPGMAEAEILGNQ
VFAMRLWLDPVKLAGFGLSATDVTNAVRRYNFLSAAGEVKGEYVVTSINASTELKSAEAF
AALPVKTSGDSRVLLGDVARVEMGAENYDTVSSFDGTPSVYIGIKATPAANPLEVIKEVR
RIMPELQSQLPSALKVSIAYDATLFIQASIDEVIKTLGEAVLIVIVVVFLFLGALRSVLI
PVVTIPLSMIGVLFFMQMMGYSLNLLTLLAMVLAIGLVVDDAIVVVENIHRHMEEGKSPF
DAALEGAREIAMPVVSMTITLAAVYAPIGFLTGLTGALFKEFALTLAGAVIISGIVALTL
SPMMCALLLRQEQNPSGLAHRLDQLFERLKVRYQKLLHATLDSRPVVLVFAVIILCLIPV
LLKFTQNELAPNEDQGVIFMMSSSPQPANLDYLNAYTDQFTPLFKAFPEYYSSFQINGFN
GVQTGIGGFLLKPWNERERTQMELLPLVQAKLEEIGGLQIFGFNLPSLPGTGEGLPFQFV
INTAGDYPALLEVAQRIKARAQESGKFAFLDVDLAFDKPEVVVDIDRAKAAQMGVSMDTL
GGTLATLLGEAEINRFTLEGRSYKVIAQVERPYRDNPGWLNNYYVKNDQNQLLPLSTLIT
LTDRARPRQLNQFQQLNSAIIQGVPMVSLGEALKTVQDIAREEAPEGFAFDYAGVARQYV
QEGSALWVTFGLALAIIFLVLAAQFESFRDPLVILVTVPLSICGALLPLFLGISSMNIYT
QVGLVTLIGLISKHGILIVEFANQLREERGLSVREAIEEAAAIRLRPVLMTTAAMVFGMV
PLILATGAGAVSRFDIGTVIATGMSIGTLFTLFVLPCIYTLLAHKAKAKEAAIA
>YP_350221.1|FEATURES|NCBI|multidrug|mexW|antibiotic efflux|0
MAFTDPFIRRPVLATVVSLLIVLLGFQAWSKLPLRQYPQMENALITVTTAYPGANAETIQ
GYITQPMQQSLASAEGIDYMTSVSRQNFSVISIYARIGSNSDRLFTELLAKANEVKNKLP
QDAEDPVLSKEAADASALMYISFFSKELNNPQITDYLSRVIQPKLATLPGMAEAEILGNQ
VFAMRLWIDPVKLAGFGLSASDVTNAVRQYNFLSAAGEVKGEYVVTSINANTELKSAEAF
GKIPLKVSGDSRVLLSDVARVEMGAENYNSISSFGGTPSVYIGIKATPGANPLDVIKEVR
KIMPELEAQLPPNLKSEIAYDATLFIQASIDEVVKTLFEAVLIVIVVVFLFLGALRSVVI
PVVTIPLSMIGVMFFMQMMGYSINLLTLLAMVLAIGLVVDDAIVVVENIHRHIEEGKTPL
EAALEGAREIAMPVVSMTITLAAVYAPIGFLTGLTGALFKEFALTLAGAVVISGVVALTL
SPMMCAMLLRHDENPTGLAHRLDRIFDSLKRRYQRMLHGTLNTRPVVLVFAVIVLCLIPV
LLKFTKSELAPDEDQGIIFMMANAPQPTNLDYLNTYTDEFIKIFKEFPEYYSSFQINGYN
GVQSGIGGFLLKPWNERSRTQMEILPEVQGKLEGIPGLQIFGFNLPSLPGTGEGLPFEFV
INTANDYELLLQVADRIKKRAMESGKFAFVDLDLAFDKPEVVVDIDRAKAAQMGVSMQDL
GGTLATLLGEAEINRFTIEGRSYKVIAQVERAYRDNPDWLNNYYVKNTQGELLPLSTLIT
VTDRARPRQLNQFQQLNAAKLSGFPLVSMGEAIDSVLQIAREEAPAGFAFDYGGASRQFV
QEGSALWVTFALALAIIFLVLAAQFESFRDPLVILVTVPLSICGALIPLFLGWSSMNIYT
QVGLVTLIGLISKHGILIVEFANQLRKDKGLTPREAVEEAAAIRLRPVLMTTAAMVFGMV
PLIVATGAGAVSRFDIGTVIATGMSIGTLFTLFVLPCVYTVLAKPDPRE
>YP_606823.1|FEATURES|NCBI|multidrug|mexW|antibiotic efflux|0
MAFTDPFIRRPVLACVVSLLILLLGAQAWSKLQIRQYPQMENALITVTTAYPGANAETIQ
GYITQPLQQSLASADGIDYMTSVSRQNFSVISVYARIGSDTDRLFTQLLAKANEVRNKLP
QDSEDPVLSKEAADASALMYISFYSNEMSNPQITDYLSRVIQPKLATLPGMAEAQILGNQ
LFAMRIWIDPVKLAGFGLSAVDVTNAVRHYNFLAAAGEVKGEYVVTSVNATTELKSAEAF
AALPVKIAGDSRVLLGDVARIEMGAENYDTVSSFDGTPSVYIGIKATPAANPLQVIKEVR
RIMPQLEEQLPSGLKVSIAYDATLFIQASINEVIKTLGEAVLIVIVVVFLFLGALRSVLI
PVVTIPLSMIGVLFFMQMMGYSLNLLTLLAMVLAIGLVVDDAIVVVENIHRHIEEGKTPR
DAALEGAREIALPVVSMTITLAAVYAPIGFLTGLTGALFKEFALTLAGAVIISGVVALTL
SPMMCALLLRHEQNPSGLAHRLDVLFEQLKVRYQRLLHGTLNSRPVVLVFAVIILGLIPV
LLKFTQSELAPNEDQGVIFMMSNSPQTANLDYLNAYTDEFTPLFKTFPEYYSSFQINGFN
GVQSGIGGFLLKPWSERQRTQMELLPLVQAKLEEVGGLQIFGFNLPSLPGTGEGLPFQFV
INTAGDYTALLEVAQRVKERAQASGKFAFLDIDLAFDKPEVMIDIDRAKAAQMGVSMDTL
GGTLATLLGEAEINRFTLEGRSYKVIAQVERAYRATPGWLNNYYVKNEQGQLLPLSTLIT
LSDRARPRQLNQFQQLNSAIIQGVPLVSMGEALDTVRTIAHEEAPEGFAVDYAGTARQFV
QEGSALWVTFGLALAMIFLVLAAQFESFRDPLVILVTVPLSICGALVPLFLGVSSMNIYT
QVGLVTLIGLITKHGILIVEFANQLREEKGLGVREAIEEAAAIRLRPVLMTTAAMVFGMV
PLILATGAGAVSRFDIGTVIATGMSVGTLFTLFVLPCIYTVLAHRGGREVA
>YP_001747848.1|FEATURES|NCBI|multidrug|mexW|antibiotic efflux|0
MAFTDPFIRRPVLASVVSLLILLLGFQAWNKLQIRQYPQMENALITVTTAYPGANAETIQ
GYITQPLQQSLASAEGIDYMTSVSRQNFSIISIYARIGADSDRLFTELLAKANEVRNQLP
QDAEDPVLSKEAADASALMYISFYSKEMSNPQITDYLSRVIQPKLATLPGMAEAEILGNQ
VFAMRIWIDPVKLAAFGLAATDVTSAVRRYNFLAAAGEVKGEYVVTSINANTELKSAEAF
AALPLKTSGDSRVLLGDVARVEMGAENYDTVSSFDGTPSVYIGIKATPAANPLEVIKEVR
RIMPELESQLPSALKGSIAYDATLFIQASIDEVVKTLGEAVLIVIVVVFLFLGALRSVLI
PVVTIPLSMIGVLFFMQMMGYSLNLLTLLAMVLAIGLVVDDAIVVVENIHRHMEEGKSPL
DAALEGAREIAMPVVSMTITLAAVYAPIGFLTGLTGALFKEFALTLAGAVIISGVVALTL
SPMMCALLLRREHNASGLAHRLDVLFERIKGRYQRLLHSTLNSRPVVLVFAVIILCLIPV
LLKFTQNELAPNEDQGVIFMISSSPQPANLDYLNAYTDQFTPLFKAFPEYYSSFQINGFS
GVQSGIGGFLLKPWNERDRTQMELLPLVQAKLDNISGLQIFGFNLPSLPGTGEGLPFQFV
INTAGGYPALLEVAQRVKERAQASGKFAFLDIDLAFDKPEVVVDIDRAKAAQMGVSMDVL
GGTLATLLGEGEINRFTLEGRSYKVIAQVERPYRDNAGWLNSYYVKNDQGQLLPLSTLIT
LSDRARPRQLNQFQQLNSAIIQGVPLVSIGEALQTVRDIAAEQAPEGFSFDYAGAARQYI
QEGSALWVTFGLALAIIFLVLAAQFESFRDPLVILVTVPLSICGALLPLFLGVSSMNIYT
QVGLVTLIGLISKHGILIVEFANQLREEKGLSARDAIEEAAAIRLRPVLMTTAAMVFGMV
PLILATGAGAVSRFDIGTVIATGMSIGTLFTLFVLPCIYTLLAHKTAPTEPVVA
>YP_002874485.1|FEATURES|NCBI|multidrug|mexW|antibiotic efflux|0
MKFTDVFIRRPVLAMVVSLLIVLLGFQAYSKLPLRQYPSMENALITVTTAYPGANAETIQ
GYITQPLQQSLASAEGIDYMTSVSRQNFSVISIYARIGANSDRLFTELLAKANEVKNKLP
QDAEDPVLSKEAADASALMYISFSSGQLSNPQITDYLSRVIQPKLATLPGMAEAEILGNQ
VFAMRIWLDPVKLAGFGLSASDITDAVRRYNFLSAAGEVKGEFVVTSINANTDLKSADAF
GAITVKTAGDSRVLLRDVARVEMGAENYNAISSFGGTPSVYIGIKATPSANPLDVIKEVR
KIMPELESQLPPTLKAEIAYDATLFIQASINEVVKTLFEAVLIVIVVVFLFLGALRSVVI
PVITIPLSMIGVLFFMQLMGYSINLLTLLAMVLAIGLVVDDAIVVVENIHRHIEDGKTPL
DAALEGAREIALPVVSMTVTLAAVYAPIGFLEGLTGALFKEFALTLAGAVIISGIVALTL
SPMMCALLLRHDENPSGLAHRLDRIFDSLKRRYQSMLHGTLNTRPVVIVFALIVLCLIPV
FLKFTQSQLAPDEDQGIIFMMASAPQPTNLDYLNTYTDEFIKIFKEFPEYYSSFQINGFN
GVQSGIGGFLLKPWNERDRTQMQILPEVQKRLEQIPGLQVFGFNLPSLPGTGEGLPFGFV
INTANDYESLLDVANRVKKRAMASGKFAFVDIDLAFDKPEVVVDIDRAKAAQMGVSMQDL
GGTLATLLAEAEINRFTLDGRSYKVIAQVERAYRDNPDWLNNYYVKNAQGELLPLSTLIT
LTDRARPRQLNQFQQLNSALISGFPIVSMGEAIDTVRQIALEETPPGYAFDYSGASRQFI
QEGTALWVTFGLALAIIFLVLAAQFESFRDPLVILVTVPLSICGALIPLFLGWSSMNIYT
QVGLVTLIGLISKHGILIVEFANQLRKDKGLTPRQAVEEAAAIRLRPVLMTTAAMVFGMV
PLIFATGAGAVSRFDIGMVIATGMSIGTLFTLFVLPCVYTLLAKPDKA
>NP_311359.1|FEATURES|resfam|aminoglycoside|acrD|antibiotic efflux|0
MANFFIDRPIFAWVLAILLCLTGTLAIFSLPVEQYPDLAPPNVRVTANYPGASAQTLENT
VTQVIEQNMTGLDNLMYMSSQSSGTGQASVTLSFKAGTDPDEAVQQVQNQLQSAMRKLPQ
AVQNQGLTVRKTGDTNILTIAFVSTDGSMDKQDIADYVASNIQDPLSRVNGVGDIDAYGS
QYSMRIWLDPAKLNSFQMTAKDVTDAIESQNAQIAVGQLGGTPSVDKQALNATINAQSLL
QTPEQFRDITLRVNQDGSEVRLGDVATAEMGAEKYDYLSRFNGKPASGLGVKLASGANEM
ATAELVLNRLDELAQYFPHGLEYKVAYETTSFVKASIEDVVKTLLEAIALVFLVMYLFLQ
NFRATLIPTIAVPVVLMGTFSVLYAFGYSVNTLTMFAMVLAIGLLVDDAIVVVENVERIM
SEEGLTPREATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGTTGAIYRQFSITIVAAMVL
SVLVAMILTPALCATLLKPLKKGEHHGQKGFFAWFNQMFNRNAERYEKGVAKILHRSLRW
IVIYVLLLGGMVFLFLRLPTSFLPLEDRGMFTTSVQLPSGSTQQQTLKVVEQIEKYYFTH
EKDNIMSVFATVGSGPGGNGQNVARMFIRLKDWSERDSKTGTSFAIIERATKAFNQIKEA
RVIASSPPAISGLGSSAGFDMELQDHAGAGHDALMAARNQLLALAAENPELTRVRHNGLD
DSPQLQIDIDQRKAQALGVAIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQAAAPYRML
PDDINLWYVRNKDGGMVPFSAFATSRWETGSPRLERYNGYSAVEIVGEAAPGVSTGTAMD
IMESLVKQLPNGFGLEWTAMSYQERLSGAQAPALYAISLLVVFLCLAALYESWSVPFSVM
LVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANEMNQKGHDLFEA
TLHACRQRLRPILMTSLAFIFGVLPMATSTGAGSGGQHAVGTGVMGGMISATILAIYFVP
LFFVLVRRRFPLKPRPE
>WP_011763962.1|FEATURES|resfam|multidrug|MuxB|antibiotic efflux|0
MFNWIVRYSLANRLFVLALALLMMAYGAYTAWKTPVDVFPDLNKPVVTVLTEAGGMAPEE
VEQLVTFPLETALGGMPGVTRVRSVSGVGLSIVYAEFDWGTDIYRNRQLVSERLSLVREQ
LPTGITPMMGPVSSIMGEVMLIGLPLAADGKVSAMQAREYADFVLRPRLLSIAGVSQVIP
IGGEVRQLRVEPDTARMAQVGVSLTQVEEALRGFASNAGGGFIDLNRREYLIRHLGRGNN
VEDLAGLAVAWKDGRPVLLEQVATVRFAPSLKRGDAGYNGGPAVIVSVQKQPDADTVKLT
GQIEVALAELDHGRPAGLAAPKVLFRQANFIEASIGNVSEALRDGAIMVAIVLFAFLLSA
RTTLISLVAIPLSLAVTALVFQLLGQSINVMTLGGLAIAIGELVDDAVVDVENILRRLKQ
NRALPNPAPVLEVVAAASVEVRSGIVYATIIVCLVFVPLFALPGIEGRLFSPLGIAYIVS
ILASMLVSMTVTPALSSFLLPRMKRLDHGDSPLVAKLKVWDAKLLTWSFPRAKLLIGIAA
LAVAAAAASVPFFPRAFLPAFNEGSLVLGMVLNPGTSLEEANRLGALAETLIREVPEVTQ
VGRRTGRAELDEHAEGVHAAEIDVDLHPSERGREAVMADIRDKLSVLPAQVAIGQPISHR
LDHLLSGVRAQVAVKIFGDDIDTLRGLAEQMRQGLASVPGLVDLTVEKQVLIPQITVRLD
HRKAAQAGLTPGEAVRLLQALTDGAHSAEIVDGPRRYDLVLRLADARRSPQDLARTLIDT
PAGRLPVSAIATVQETDGPNQVGRENGRRRIVVYANTDGSDMGRVIADVRAVIARTPMPA
GNFVTLEGQFQAQEQATRLIAGLSLVSLAMIFLVLYSRYKSAVLAGVIMANIPLALIGSV
VAMWLAGVTLSVASMVGFITLAGIATRNGILKVSHYINLCRFEGETFGDAMIVRGSLERL
TPVLMTALVAAFALTPLLLAADAPGKEILHPVAVVIFGGLVSSTLLDTLLTPVIFRLVGE
KPTRRLLEGGEEGAVQGLPQEAY
>WP_041643050.1|FEATURES|resfam|multidrug|amrB|antibiotic efflux|0
MSVLARLVEFSLTQRLLVLVLTALLVGAGAMALRSLPIDAFPDVSTTQVKIIVKAPGMTP
EEVEARITVPIEQELLGIPAQRMLRAVSKYGITDITVDFDDGTDIYWARQQVSERLDAAM
SGLPAQASGGLAPITTPLGEMFMFTIEGPLSLEEKRTLLDRVIRPQLRTIRGVADVNSLG
GHVRSYEVVPNPQLLAARGLGLNLLREAIERNNRNDGAGRLGDGEETLIVRAEGAVNEPA
DLAAVVVATRDGVPVRLGDVAEVRIGSLTRYGAVTRDGAGETVQGLVLGLRGANAQAVIA
GVKARLAELAPSLPPGVSIVPFYDRSALVDRAVGTVSKALFEAIALVVVLLLAFLGNLRA
ALVVALTLPLAALGTFILMRYTGVSANLMSLGGLAIAIGMLVDAAVVVVENVETQLAADG
VQARLPLLHVVYRAVREVALPVASGIAIIIIVFVPLLTLQGLEGKLFVPVALSIVYALAS
SLVLALTVIPVLASLLLKRGEAHTPWLVRRLDAAYAPALDWALANARTVIAVALLSLALA
AAGYAFVGKTFMPTMDEGDLIMQLEKLPSIGLEQTIAVDSRVQRTILEQVPEVKSVVARS
GSDELGLDPMGLNQTDSFLVLKPVAEWRQPDKAWLTDELRRVVAEFPGIDVTFTQPIDMR
VSEMLTGVRGDIAIKVFGTDLAALGRAAGEIEALLAAMDGAEDVFTAKNEGVQYLRVEID
HLAAGRLGLSVDDVQSALRSLVEGEQAGAVIEAGRRVPILIRADEGVRASASRFADLRLA
LPGGGAVPLSAVARLERVAGPVKVDRENGSRYVTVQSNVRGRDLVGFVEEAQARVAATVK
LPAGYRLEWSGQFENQQRAAARLAVVVPVALLLIFLLLFSTFGSVRQAALVLANVPFALV
GGVFALLLAGEYLSVPASVGFIALLGIAVLNGVVMVTYFNQLIEQGMPLARVVVEGARRR
LRPVLMTASIAAFGLVPLLFATGPGSEIQRPLAIVVIGGLISSTLLTLLLLPILFRRFGM
DRAPALSAPEALLP
>WP_011766065.1|FEATURES|resfam|multidrug|MuxB|antibiotic efflux|0
MNPSRLYILRPVATSLLMLAILLAGLIGYRLLPVAALPEVEYPTIQVSTLYPGASPEVVA
SSITAPLERQLGQIAGLKQMSSTSSGGASVITLQFALGLSMDVSQQEVLAAINAASALLP
GDLPMPPVFSKVNPADAPIVTLAISSDTLSLPQVADLVDTRLAQKISRIAGVGLVSIGGG
QRPAVRIQVNPQALAAQGLNLEDIRTAIGEANVNIAKGSFDGPLRASTLDANDQLRSADE
YRRLIIAWKNGAPIRLGDIAELVDGAENTRLAAWADTRPAVILNIQRQPGANVIDTVDRI
KALLPTLQASLPATVDLRLLSDRTTTIRASVRDVGHELLLAIALVVMVIFIFLRNLPATF
IPSVAVPLSLVGTFAVMYLAGFSINNLTLMALTIATGFVVDDAIVMIENIVRHLEEGESP
LEAALKGAQQIGFTIISLTFSLIAVLIPLLFMGDVVGRLFREFAITLAVAILISAVVSLT
LTPMMCARLLHHAPEENHGAFFRLTGAFIDRCIARYAVALRWVLARQGLTLAVAGATLGL
TVLLYLIVPKGFFPSQDTGLIQGITDAPQNVSFAAMAQRQQAAVSAILADPAVDSVSSVV
GVDGVNATLNSGRLLIALKPLGERDAGAAAVIQRLQARLKAVPDIAVYMQAVQDLTIESR
AARTQYQFSLEGANAEQLGEWVHLLRDRLAREPALADVATDWLDQGRQAYVDIDRDSAGR
LGITPADIDAALYNAFGQRQISTIFTQTNLYRVVLEVKPEFQRGLAALDSLYLVSANGAQ
VPLSAVARISERPTLLAINHIGQFPAATFSFNLAPGAALSNAVEDIRAAFAELDPPASLS
LHFQGAAQAFQASLTSTVWLIVAAIVTMYIVLGVLYESYIHPVTILSTLPSAGVGALLAL
LLAGSDLGIIGIVGIILLIGIVKKNAIMMIDFALEAERDHGKSPDEAIFEACLLRFRPIL
MTTLAALLGALPLMLSTGVGAELRQPLGITMVGGLIVSQVLTLFTTPVIYLAFDRLGRRA
RHRLGGLGAQAGEG
>WP_011763980.1|FEATURES|resfam|multidrug|acrB|antibiotic efflux|0
MARFFIDRPIFAWVVAIVIMLAGALSILSLPVSQYPAIAPPQIAINATYPGATAKAVEDS
VTQVIEQKMTGLDNLLYMNSTSDSYGRVTVTLTFNAGTNPDIAQVQVQNKLQTALPLLPQ
AVQQQGVQVAKSTRNFLMVLGFVSRDGSQSANDLSDFLASTVQDPLSRVTGVGEVQVFGS
QYAMRVWLDPAKLNNYKLMPSDVRSALEAQNTQVSAGQLGGTPALPGQGFTASITAQSRL
QTAEQFENILLKSSAQGGEVRLRDVARVEVGAQDYGFTARYNGKPAAGIGIKLAAGSNAL
DTAKAVRKAIDGMSRYFPAGVEVVTPYDTTPFVRLSIEEVVKTLVEAIVLVFLVMFLFLQ
NLRATLIPTIAVPVVLLGTFGLMAAFGFSINTLTMFGVVLAIGLLVDDAIVVVENVERIM
TEEGLSPREATRKSMGQITGALIGIGLVLSAVFVPMAFFGGSTGVIYRQFSITIVSAMAL
SVLVAIVFTPALCATMLKPVEKGHDHSEGGWFSGFFRWFNRMFARNTTRYESAVGGILRR
SGRFLLIYALIVGVLAFLFLRMPTSFLPEEDQGVMFTQVMLPAGATQERTIEVLKKVENH
FLEGEKDYAKSIFTVAGFSFAGSGQNMAIGFVHLRDWDERKGPAGNVKAVAGRAMAAFSQ
IREAMVFAFVPPAVLELGTSNGFDVQLQDRSGLGHDALIAARNQFLGMAAQDKRLVAVRP
NGQEDMQEYVLDIDHAKAGALGVSVSDINATLSTAWGGVYVNDFLDRGRIKKVYLQSQAE
GRMRPEDLTKWYVRNKAGEMVPLSAFASGHWAFGSPRLERYNGQSSVEVLGQGAPGVSSG
DAMAAVEEIIAKLPPGIGYEWTGTSYEERRSGSQAPALYALSLIVVFLCLAALYESWSVP
FAVMLVVPLGVLGAIVAATGRGLSNDVYFQVGLLATIGLSAKNAILIVEFAKEQMEKEGK
ALIDATLEAVRMRLRPILMTSLAFGLGVLPLAVATGAGSGSQNAIGTGVLGGTIFATVLG
IFFIPLFYVAIKRIFKDKPAADAAPLAVQEAR
>WP_000592303.1|FEATURES|resfam|multidrug|mdtb|antibiotic efflux|0
MIKKLLQFSLGNKFAIFLMVVLVVLGGVYASAKLKLELLPNVQNPVISVTTTMPGATPQS
TQDEISSKIDNQVRSLAYVKNVKTQSIQNASIVTVEYENNTDMDKAEEQLKKEIDKIKFK
DEVGQPELRRNSMDAFPVLAYSFSNKENDLKKVTKVLNEQLIPKLQTVDGVQNAQLNGQT
NREITLKFKQNELEKYGLTADDVENYLKTATRTTPLGLFQFGDKDKSIVVDGQYQSVDAF
KNINIPLTLAGGQGQSQSQSDNKQNSAMSDVNQASPQQNSKASAPNNISGMPTAKLGDLA
DITVGDVRTSISKTNGKDAVNLQITKAQDANTVQVAKDVQRKIDTFVDENKDFNVTKTMD
TAKPVEKSLYTMVEKASLGTIVAIIVILLFLRNIRTTAISIISIPLSLLMALIALKLSDV
SLNILTLGALTVAIGRVIDDSIVVVENIYRRLTDSEEQLKGENLIISATTEVFKPIMSST
LVTIIVFLPLVFVSGSVGEMFRPFALAIAFSLLASLLVSITLVPALAATLFKKGVKRRNK
QHQEGLGVVSTTYKKVLHWSLNHKWIVIILSTLILVATIVFGGPRLGTSFISAGDDKFLA
ITYTPKPGETEQAVLNHAKDVEKYLKQKKHVKTIQYSVGGSSPVDPTGSTNSMAIMVEYD
NDTPNFDVEADKVIKHADGFKHPGEWKNQDLGTGAGNKSVEVTVKGPSMDAIKSTVKDIE
QKMKQVKGLANVKSDLSQTYDQYEIKVDQNKAAENGISASQLAMHLNENLPEKTVTTVKE
NGKTVDVKVKQNKQTDWSEDKLNNITLKKPTGGTIKLGDIATLVKTTTPSKLTQEQGDYA
TTVSAKVTNKDVGGTTRQVMSKINNLDKPNNVKVNIGGASDDINNAMTQLAFAMLAAIII
VYLILVITFKGGLAPFTILFSLPFTVIGVIIALLITGETISVPSLIGMLMLIGIVVTNAI
VLIDRVINNEQQGMEMKEALIEAGGTRIRPILMTAIATIGALVPLLFGQDSSILISKGLA
ATVIGGLISSTLLTLVVVPVIYEILFTLKKRFTKR
>WP_000592290.1|FEATURES|resfam|multidrug|mdtb|antibiotic efflux|0
MIKKLLQFSLGNKFAIFLMVVLVVLGGVYASAKLKLELLPNVQNPVISVTTSMPGATPQS
TQDEISSKIDNQVRSLAYVKNVKTQSIQNASIVTVEYENNTDMDKAEEQLKKEIDKIKFK
DEVGQPELRRNSMDAFPVLAYSFSNKENDLKKVTKVLNEQLIPKLQTVDGVQNAQLNGQT
NREITLKFKQNELEKYGLTADDVENYLKTATRTTPLGLFQFGDKDKSIVVDGQYQSVDAF
KNINIPLTLAGGQGQSQSQSDNKQNSAMSDVNQASPQQNSKTSASNNISGMPTAKLGDLA
DITVGDVRTSISKTNGKDAVNLQITKAQDANTVQVAKDVQRKIDTFVDENKDFNVTKTMD
TAKPVEKSLYTMVEKASLGTIVAIIVILLFLRNIRTTAISIISIPLSLLMALIALKLSDV
SLNILTLGALTVAIGRVIDDSIVVVENIYRRLTDSEEQLKGENLIISATTEVFKPIMSST
LVTIIVFLPLVFVSGSVGEMFRPFALAIAFSLLASLLVSITLVPALAATLFKKGVKRRNK
QHQEGLGVVSTTYKKVLHWSLNHKWIVIILSTLILVTTIVFGGPRLGTSFISAGDDKFLA
ITYTPKPGETEQAVLNHAKDVEKYLKQKKHVKTIQYSVGGSSPVDPTGSTNSMAIMVEYD
NDTPNFDVEADKVIKHADGFKHPGEWKNQDLGTGAGNKSVEVTVKGPSMDAIKSTVKDIE
QKMKQVKGLANVKSDLSQTYDQYEIKIDQNKAAENGISASQLAMHLNENLPEKTVTTVKE
NGKTVDVKVKQNKQTDWSEDKLNNITLKKPTGGTIKLGDIATLVKTTTPSKLTQEQGDYA
TTVSAKVTNKDVGGTTRQVMSKINNLDKPNNVKVNIGGASDDINNAMTQLAFAMLAAIII
VYLILVITFKGGLAPFTILFSLPFTVIGVIIALLITGETISVPSLIGMLMLIGIVVTNAI
VLIDRVINNEQQGMEMKEALIEAGGTRIRPILMTAIATIGALVPLLFGQDSSILISKGLA
ATVIGGLISSTLLTLVVVPVIYEILFTLKKRFTKR
>WP_011764518.1|FEATURES|resfam|multidrug|mexN|antibiotic efflux|0
MNVSAWSIRNPIPAGMLFVLLSFAGLLSFAGMKVQNFPDIDLPTVTVTASLPGATPSQLE
NDVARKIENAIATLQGLKHIYTKVQDGSVVITVEFRLEKPVQEAVDDVRSAVARVKADLP
GDLRDPIVNKVDLAGQPVLAFTIRSARMDDEALSWFVDDTVSRRLLAVRGVGAVTRVGGV
TRELRVTLDPLRLQALGATAAAISHQLRQVQTESAGGRADLGGGEQPVRTLATVASAAEL
ADLELALSDGRSIRLSQVASITDTFAEPRSAALLNGQPVVGFEVARSRGESEVEVGAAVQ
GALDELRAAHPDIEITEAFNFVAPVQEEYDGSLQLLYEGALLAVLVVWLFLRDWRATFVS
AVALPLSVIPAFIGMYLLGFSVNVITLLALSLVVGILVDDAIVEVENIVRHLRMGKTPYE
AAMEAADEIGLAVIATTFTLIAVFLPTAFMSGVAGKFFKQFGWTAALAVFASLVVARVLT
PMMAAYILKPVVGTHREPRWLAWYERWAERCLRHRALTMLAAAAFFIGSLMLVPLLPTGF
IPPDDNSQTQVYLELPPGATLATTRAVAEEARLALTRVDHVVSVYTTIGAGSAGGDPFAP
KGEGEVRKATLTVQLSPRGERPRKQDIENRIRAALEPLPGVRSKVGLGGSGEKYVLVLTG
EDPRALQATALAVERDLRTIPGLGSVASTASLIRPEIAVRPDFARAADLGVTSSAIGETL
RVATLGDYDMSLAKLNLSQRQVPILVRLDESARQDLALLERLAVPGAEGPVMLRQVATLE
VAGGPAVIDRYDRSRNINFEIELSGLPLGDVTAAVAELPSVKNLPPGIRVVPVGDAEVMG
ELFASFGLAMLTGVLCIYIVLVLLFKDLLHPVTILMALPLSLGGAFVGLLIAQKSFSMPS
LIGLIMLMGIATKNSILLVEYAIVARRDHGMSRSEALLDACRKRARPIVMTTIAMGAGMM
PIAIGAGAADTSFRSPMAIAVIGGLITSTVLSLLVVPVVFTYVDSFKNRFLALFGRG
>WP_000592298.1|FEATURES|resfam|multidrug|MuxC|antibiotic efflux|0
MIKKLLQFSLGNKFAIFLMVVLVVLGGVYASAKLKLELLPNVQNPVISVTTTMPGATPQS
TQDEISSKIDNQVRSLAYVKNVKTQSIQNASIVTVEYENNTDMDKAEEQLKKEIDKIKFK
DEVGQPELRRNSMDAFPVLAYSFSNKENDLKKVTKVLNEQLIPKLQTVDGVQNAQLNGQT
NREITLKFKQNELEKYGLTADDVENYLKTATRTTPLGLFQFGDKDKSIVVDGQYQSVDAF
KNINIPLTFAGGQGQSQSQSDNKQNSAMSDVNQASPQQNSKASAPNNISGMPTAKLGDLA
DITVGDVRTSISKTNGKDAVNLQITKAQDANTVQVAKDVQRKIDTFVDENKDFNVTKTMD
TAKPVEKSLYTMVEKASLGTIVAIIVILLFLRNIRTTAISIISIPLSLLMALIALKLSDV
SLNILTLGALTVAIGRVIDDSIVVVENIYRRLTDSEEQLKGENLIISATTEVFKPIMSST
LVTIIVFLPLVFVSGSVGEMFRPFALAIAFSLLASLLVSITLVPALAATLFKKGVKRRNK
QHQEGLGVVSTTYKKVLHWSLNHKWIVIILSTLILVVTIVFGGPRLGTSFISAGDDKFLA
ITYTPKPGETEQAVLNHAKDVEKYLKQKKHVKTIQYSVGGSSPVDPTGSTNSMAIMVEYD
NDTPNFDVEADKVIKHADGFKHPGEWKNQDLGTGAGNKSVEVTVKGPSMDAIKSTVKDIE
QKMKQVKGLANVKSDLSQTYDQYEIKVDQNKAAENGISASQLAMHLNENLPEKTVTTVKE
NGKTVDVKVKQNKQTDWSEDKLNNITLKKPTGGTIKLGNIATLVKTTTPSKLTQEQGDYA
TTVSAKVTNKDVGGTTRQVMSKINNLDKPNNVKVNIGGASDDINNAMTQLAFAMLAAIII
VYLILVITFKGGLAPFTILFSLPFTVIGVIIALLITGETISVPSLIGMLMLIGIVVTNAI
VLIDRVINNEQQGMEMKEALIEAGGTRIRPILMTAIATIGALVPLLFGQDSSILISKGLA
ATVIGGLISSTLLTLVVVPVIYEILFTLKKRFTKR
>WP_011766859.1|FEATURES|resfam|multidrug|mexW|antibiotic efflux|0
MVLSEICIKRPVFATVLSLMVLLVGLMSYSRLTVREYPNIDEPVVTVETLYTGASAEIVE
SQVTKPLEDSLAGIEGVDVLSSISRQERSQITVRFRIERDADSAAADVRDRVSRVRRRLP
DDVEEPVIAKVEADASPIIWVAFASDRHSALEMSDVASRIIKPRLQTLPGAADARVFGER
RYAMRIWLDRDRLAAFGLTPQDVEDAIRRQNIELPAGRIESREREFAVVARTDLAEPAQF
EAVVVRQAGTPGGYPVRIRDIGRVEVAPADERTSVRFMGKPAISLGLIKQSTANPLDLKR
GLMELLPRLEEELPAGMTMSIANDSTVFIERSIASVFSTIWEAVVLVALVCLFFLRNWRA
MLVPLVTIPVSLVGAFALMLVFGFSINTLTLLALVLAIGLVVDDAIVVLENIYRHIEDGM
APLAAAFRGAKEIGFAVVAMTITLAAVYAPVAFMTGRTGKLFTEFALTLAGAVIVSGFVA
LTLSPMMCSRLLRHEPRHGRVYNAIEGFLEWLTAGYRRALEAMLGLRWVVMLAFVAVAAF
AGLLLTQMKSELSPIEDRGRVMAIFNGPEGATIDYMTRYAGQIEDIFSRTGDVDRYFVVA
GNPTVSQGISFIGFNDWSQRKRSAQEIAAELQPQLRAIPGLNAFPVLPAAFGQSPRTRPV
SFVIVTSASYDELAAYTERMLDEMHRHPGFVSPDTDLKLTKPELAVEVDRDRAADLGVSV
EVIGRTLETMLGGRQVTRYKKDAEQYDVLVQVAAGERAGPRDIRDIFVRARGGDMVPLAS
LVRVQETVSPRELNHFGQRRAVTISANLAPGFALGEALDFLDAAAARILPPGYTTDYDGM
SREFKTSSASLALAFVLALAFIYLVLAAQFESFRDPLIIMLTVPLSMAGALAALRLTGGT
LNVYSQIGLVTLVGLITKHGILIVEFANQLREQGRALREALVEAAVLRLRPILMTTGAMV
LGAIPLALATGAGAESRQQIGWVIVGGLSLGTFFTLFVVPTVYTLLARREREHDSDTVES
ASAGMAG
>WP_011766066.1|FEATURES|resfam|multidrug|mdtc|antibiotic efflux|0
MSLAARFIRRPVATVLLTLGVALVGLAAFFQLPAALLPQVDYPVISVRASLPGASPDTMA
ASVAMPLERALGSIAGVNEITSRSSLGSTEVVLQFDLSRDIDGAARDIQAAINASRSQLP
SGMAGNPTLRKSNPNDSPILILAMTSDVLSRTQIYDAAVTILAQKLAQVEGVGQVSVGGS
SLPAVRVELNPLALARSGVSAETVRGAIASGNVNRPKGFVEDGGRHWQIGANDQALSAAD
YTPMIVRWQQGAALRLSDVAEVRDGAQELRNAGVASGRPAVLLMVNRQPNANIIATVDHI
LKLLPELQAAIPPQIRLEVSQDRSTTVRASLRDVGVCLVLSVLLVVLVVIGFLRDRRAAL
IPAVTVPVALVGTLALMYLAGFSINNLSLMALTVAAGFVVDDIVVVLENTTRHIEHGLSP
LQAALRGVGEVSGTLVSMALSLAAVFIPIIFMEGVVGRLFGEFALTLVAAIGVSLLLSIA
TAPMLCSRLLRPTTALPAPGRFGRLRERTLAALLAAYRRSLGWALDHRATMLLALAGVVG
LNVYLYTVVPKGFLPQQDTGRLIAFIEGDQSSSFQAMYEHLTVIDSILRQDPAVLRTSGS
VGGNGPGGGTVTSARMFVTLKPLGERREPAQAVIERLRPRLARVAGARVFVMSAQEIRIG
GRGGSSDYLYTLQSDDLDALRAWEPKIRTALAALPQLADVNTDTRDKGLQTRLVVDREAA
ARLGLSQRAIDLALNNYFGERLVSTIHHPLNQYRVVMGAAPHFWRSPTVLADIVLVAEDG
SRVPLSAVAHWEPGNAPLTVNHQSQFAASTVSFALAPGVPLGEATRAITAAMAQLGVPSS
IFGSFEGAARAFQSAGNSQLLLILAAIVAVYLVLGILYESLLHPLTILSTLPSAGIGAVL
ALLAFGTEFTVIALIGVILLAGIVMKNAIMMIDFALHAQRSRGLAPREAILDACVLRFRP
IMMTTAAAILGALPLALGSGDGAELRQPLGIAIVGGLLVGQWLTLYTTPVVYLALDRLRL
RLARQAHKRIAAPAAAPAPAVDPA
>WP_011764581.1|FEATURES|resfam|multidrug|mexK|antibiotic efflux|0
MSRRRGFNISAWGLAHPALVLYCLIALSLIGILAYSRLGQSEDPPFTFKIMVVRTEWPGA
SAREVEQQVTDKIEKKLQEIAQLDFVRSFSKPGESMVLVLAKDSTPAREVEGIWYQVRKK
VGDIRDYLPAGVKGPYFNDEFGDTYGNIFALVGDGISHAELKRHAEAVRGELLRVPDVGK
VSFFGEQAQRVYIELSNTKLATFGLGLADIAAALSAQNAKAGSGFFETADERIWLRPSGQ
FDDLQAIADTLIRAQGRVFRLGDVAEIRRGYVDPPSERMRFNGADAFGIGVAMRAGGDIV
ALGRHLDEAAARIEAQLPVGIRFERVADQPRAVRNSVGEFVQVLTEAVIIVMTVSLLSLG
FRTGVVVLIIIPVVLAITFLFMHLFGIGLHKISLGALIIALGLLVDDAIIAVEMMATKME
QGWERAKAASFAYTSTAMPMLSGTLVTAAGFLPIATAASSTGEYTRSIFQVTVTALLVSW
VAAVLFVPYLGYHLLPDFRARNGRPSRLAGWIGRVSPGLAARLQARASHGHAQHDEYAIY
HTPFYTRLRTLVGWCVAHRWLVIALTLASFVLSLVVFVRFVPQQFFPDSTRPELLVDLRL
AEGASHEATERAVHRLEGWLQQQEGVENFVAWLGAGSPRFYLPLDQQLAQTNFAQLVVLT
KGIAEREAVRSRLIRLFEDEAWPLRATINRLENGPPVGFPVQYRVSGQDIDTLRTIAHRV
AEAMRTDRNLSNVHLDWEEPAKSIRLKVDQDKARLLGVSSRDLASLLATSLQGTTVSEFR
EGTETIQMVLRGAGAERAHLGLLSDLAVPVSGGRSVPLAQLATLEYGFEEGVIWRRNRIP
TVTVRASLYGGTQPAVVVQQLGPQIEAIRAALPLGYRVEVGGAVEESSKGGGSVAAGVPL
FIGVVLTVLMLQLQSFSRTLLVVLTAPLGMIGVTVFLLAFNKPFGFVAMLGTIALSGMIM
RNSVILVDQIRQDVDAGRTPWDAVVEATVRRFRPIVLTAAAAILAMIPLSRSAFFGPMAV
AIMGGLTVATVLTMLFLPALYAAWYRIRRTPAPLPPAPPSGANMEAVQGARM
>WP_000671305.1|FEATURES|resfam|multidrug|mexK|antibiotic efflux|0
MKFNLSEWALNNKGIVLYFMLLLGIIGAISYSKLSQSEDPPFTFKVMVVQTYWPGATAKE
VSTLVTDRIEKELMTTGQYDKIMAYSRPGESMVTFVAKDSLTSAQIPDVWYNVRKKVNDI
RHELPSGVQGPFFNDEFGDTFGNIYVLTGKDFDYALLKEYADRLQLQLQRVKDVGKVELI
GLQDQKIWIEISNTKAVQLGIPVSAIQEALQKQNSMASAGFFETGTDRIQIRVSGQLQSV
EDIKKMPLLVGDKTIQLGDVADVYRGFSQPAQPRMRFMGDNGIGIAVSMRKGGDIIALGK
NLETEFAQLQKTLPLGMKLQKVSDQPVAVQRSIHEFVKVLAEAVIIVLLVSFFSLGFRTG
LVVAFSIPLVLAMTFAGMNLFDVGLHKISLGALILALGLLVDDAIIAVEMMAIKMEQGYS
RIKAAGFAWKTTAFPMLTGTLITAAGFLPIATAQSSTGEYTRSIFQVVTIALLVSWVAAV
LFVPYLGEKLLPDFTKTGHQAPWYVRLWARVTKKPQPQTVAISQDHHYDPYQSSFYLRFR
KMVEFCVTYRKTVIATTVGIFVLSVLMFKMVPQQFFPPSNRAEILVDLKLEEGASLTATE
QAVKKVEQFLSKQKGIDNYVAYVGTGSPRFYLPLDQQLPQASFAQFVVLASSLDDRDEIR
RSLETQIKQLLPQVRTRVSLLENGPPVGYPLQYRVSGEDLNLVRKEAQQVARVISENPNT
TNVHLDWGEPSKIISIQIDQDRARQMGVSSLDLANFLNASITGSAIEQYREKRELIEIRL
RGDKAERVEVASLASLAVPTANGTTVPLAQIAKIEYKFEDGLIWHRNRLPTITVRADIRT
NLQPATVVGELAESMDKLRAELPSGYLIEVGGTVEESARGQSSVNAGMPLFLAVVMTLLM
IQLKSLSRATIVFLTAPLGLIGVVLFLLLFNKPFGFVAMLGTIALSGMIMRNSLILIDQI
EQDRQAGHPTWEAIIDATVRRFRPIILTALAAVLAMIPLSRSIFFGPMAVAIMGGLIVAT
LLTLFFLPALYAAWFKVKKTA
>WP_011766296.1|FEATURES|resfam|multidrug|ceoB|antibiotic efflux|0
MNISKFFIDRPIFAGVLSVLILLGGLLAMFQLPISEYPEVVPPSVVVRAQYPGANPKVIA
ETVASPLEESINGVEDMLYMQSQANSDGNLALTVHFRLGMDPDKAQQLVQNRVSQALPRL
PEDVQRLGVTTVKSSPTLTLVVHLISPDDRYDATYLRNYAVLNVKDRLARIQGVGEVSIW
GAGNYAMRVWLDPNKVAQRGLTASDVVRAIREQNVQVAAGVIGASPTLPDVPLQFSVNAQ
GRLKTEVEFRDIVLKTAADGGVTRLGDVARVELDAAEYGLRSLLDNKPAIGMGIMQAPGA
NALAVSAAVRDAMAELKQDFPSSVDYRIEYDPTQFVRASIKAVIVTLLEAVALVVLVVIL
FLQTWRASIIPLLAVPVSIVGTFGLMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVE
RNIAAGLSPRDATYRAMQEVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAIST
VISAFNSLTLSPALAALLLKPHHDHNPDWLTRAMNRVFGGFFARFNHAFGRASENYGRGV
TGVIGRKSKVMAVYAVLLALTAGVSYVVPGGFVPAQDKQYLISFAQLPNGASLDRTESVI
RRMSQIALEQPGVQSAIAFPGLSINGFTNSSSAGIVFVTLKPFDERRAPELSAGAITAAL
HGKYAAIKDSFIAVFPPPPVMGLGTLGGFKLQIEDRGALGYAELDAAAKAFIAAAQKAPE
LGPSFTSYQINVPQLDVDLDRVKAKQLGVSVTDVFDTMQIYLGSLYVNDFNRFGRVYQVR
AQADAPFRARPEDIGQLKTRNAAGEMVPLSSMVRVHNSFGPEMVVRYNGYTAADINGGPA
PGYSSDQAEAAAERIAAETLPPGIKFEWTDLTYQKILAGNAGVWIFPLSVLLVFLVLAAQ
YESLTLPLAVIMIVPMSILAALTGVWLTAGDNNLFTQIGLMVLVGLSAKNAILIVEFARE
LELQGSTPKEAAIEASRLRLRPILMTSIAFIMGVVPLVLSSGAGSEMRHAMGVAVFFGML
GVTLFGLFLTPVFYVLLRSLGRGSKLHTASPHAAPIPAPHLVS
>WP_011767098.1|FEATURES|resfam|multidrug|adeJ|antibiotic efflux|0
MAAEQGLAGRLAAAFQRNAITPLIALVLMLAGVFATLVTPREEEPQIDVTMANVIVPFPG
ASARDVEALVARPAEQVLSRMAGVEHVYSVSRPGMAVITVQFEVGVPNQTALVRLYDTVH
SNRDWLSPQLGVGEPVVKPKGIDDVPILALTLWSADDTRAAYEMQQVSRALELELKRLPG
TRDVQTLGGPDRVVKVDMDVARMNAHGISAQDLRGALQLANASQPAGSMVADNREVLVQT
GAFIESAEDVRQLVVGVSGGRPVYLRDVAEVGDGPDQPSRYVWFGSGAAAAAKGIDGAGR
FPAVTLALSKKPGANAADVAAAALARVEALRGSLIPDGVQLTVTRNYGETANDKAQKLIG
KLVFATAAVVALVFFALGWREALIVGIAVSLTLAATLFASWAWGFTLNRVSLFALIFSIG
ILVDDAIVVVENIHRWHTLEPDTPLWRLIPRAVDEVGGPTILATFTVIAALLPMAFVTGL
MGPYMSPIPINASMGMFISLVVAFVVTPWLAQRLLKSAEAGHHPGDDALTRRLDGMFRRV
MTPMLDATHGARARARLWLAVLVLIAVSLALPAMQWVVLKMLPFDNKSEFQVVLDMPVGT
PVEETARVLGEIGEHLGTVAEVTDWQAYAGTAAPINFNGLVRQYYLRSSPELGDIQVNLT
DKAQRTRKSHEIAVSVREAVAAIARRNGGNAKVVEVPPGPPVLSPIVAEIYGPDYAGQAE
VAARVRAVFERTADIVGVDDTVDEAAPKLLLRVDQAKAARLGVAQADIVDVLRLGLAGEN
VTPLHGGDNKYEVPVRVQLPARHQSDIGNLLAMKVRARGAESGGRLVAVGELVTVQETRR
EQVIYRKDLLPVVYVTGDMGGRLDSPLYGMFGIRVEVKDMALGGAPGLAGTLDEWFIRPP
ADAWSGYSLKWDGEWQVTYETFRDMGAAYAVGLVLIYLLVVAQFRSYLVPLIIMAPIPLT
LIGVMPGHALLGAQFTATSMIGMIALAGIIVRNSILLVDFINQQLAEGSDFGEAVIRAAA
VRAKPIGLTALAAMIGAVFILDDPIFNGLAISLIFGVFISTVLTLVVIPMLYFAAMRRRA
GALNSQPQGETA
>resfam_SHV-4|FEATURES|resfam|beta_lactam|SHV-4|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQLQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-6|FEATURES|resfam|beta_lactam|SHV-6|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARATTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-10|FEATURES|resfam|beta_lactam|SHV-10|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASRTLTAWRADER
FPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAA
AITMGDNSAANLLLRTVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPAS
MAATLRNVLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARGI
VALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-16|FEATURES|resfam|beta_lactam|SHV-16|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETDRWETELNEALPGDARD
TTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGE
RGARGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-19|FEATURES|resfam|beta_lactam|SHV-19|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEAFPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-20|FEATURES|resfam|beta_lactam|SHV-20|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEAFPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-21|FEATURES|resfam|beta_lactam|SHV-21|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGEFCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEAFPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-22|FEATURES|resfam|beta_lactam|SHV-22|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDKVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-23|FEATURES|resfam|beta_lactam|SHV-23|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGEFCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAGTLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-75|FEATURES|resfam|beta_lactam|SHV-75|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNHKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>WP_065365892.1|FEATURES|resfam|beta_lactam|SHV-86|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASRRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-90|FEATURES|resfam|beta_lactam|SHV-90|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMTATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-91|FEATURES|resfam|beta_lactam|SHV-91|antibiotic inactivation|1
MRYIRLCIISLLATLSLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-103|FEATURES|resfam|beta_lactam|SHV-103|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALRGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-106|FEATURES|resfam|beta_lactam|SHV-106|antibiotic inactivation|1
MRYFRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-112|FEATURES|resfam|beta_lactam|SHV-112|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPDNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-113|FEATURES|resfam|beta_lactam|SHV-113|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAAKLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-114|FEATURES|resfam|beta_lactam|SHV-114|antibiotic inactivation|1
MRYIRLCIISLLAVLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITVSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-115|FEATURES|resfam|beta_lactam|SHV-115|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWHADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAKRNQQIAGIGAALIEHWQR
>resfam_SHV-116|FEATURES|resfam|beta_lactam|SHV-116|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWHADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-117|FEATURES|resfam|beta_lactam|SHV-117|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYLQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-121|FEATURES|resfam|beta_lactam|SHV-121|antibiotic inactivation|1
MRYARLCIISLLATLPLVVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITVSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-123|FEATURES|resfam|beta_lactam|SHV-123|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGGNIKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-124|FEATURES|resfam|beta_lactam|SHV-124|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLDQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-125|FEATURES|resfam|beta_lactam|SHV-125|antibiotic inactivation|1
MRYIRLNIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-126|FEATURES|resfam|beta_lactam|SHV-126|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGKRGARG
IVALLGPNNKAERTVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-127|FEATURES|resfam|beta_lactam|SHV-127|antibiotic inactivation|1
MRFIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNNAERMVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-130|FEATURES|resfam|beta_lactam|SHV-130|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMTATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ACN39713.1|FEATURES|resfam|beta_lactam|SHVL-2|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWKTELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>WP_004143591.1|FEATURES|resfam|beta_lactam|SHVL-9|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGLNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHVL-10|FEATURES|resfam|beta_lactam|SHVL-10|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKNGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ACL01091.1|FEATURES|resfam|beta_lactam|SHVL-11|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIELWQR
>AAP20890.1|FEATURES|resfam|beta_lactam|SHVL-13|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLHKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHVL-15|FEATURES|resfam|beta_lactam|SHVL-15|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKNGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAU84950.1|FEATURES|resfam|beta_lactam|SHVL-17|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERVVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ACN72587.1|FEATURES|resfam|beta_lactam|SHVL-19|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLEREIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHVL-58|FEATURES|resfam|beta_lactam|SHVL-58|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIAEKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHW
>ABY66124.1|FEATURES|resfam|beta_lactam|SHVL-59|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASXRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEH
>resfam_SHVL-62|FEATURES|resfam|beta_lactam|SHVL-62|antibiotic inactivation|1
WVIFPIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADERF
PMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAA
ITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASM
AATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARGIV
ALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAA
>resfam_SHVL-68|FEATURES|resfam|beta_lactam|SHVL-68|antibiotic inactivation|1
QPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAVLARVDAG
DEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAG
LTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQL
LQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLSPNNKAERIVVIYLRDTP
ASMAERNQQIAGIGAALI
>AAV91755.1|FEATURES|resfam|beta_lactam|SHVL-70|antibiotic inactivation|1
LEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAVLARVDAGDQ
QLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLT
AFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQ
WMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARGIVALLGPNNKAERIVVIYLRDTPAS
MAERNQQI
>AAV91760.1|FEATURES|resfam|beta_lactam|SHVL-71|antibiotic inactivation|1
LEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAMLARVDAGDE
QLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLT
AFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQ
WMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARGIVALLGPNNKAERIVVIYLRDTPAS
MAERNQQI
>AAV91756.1|FEATURES|resfam|beta_lactam|SHVL-73|antibiotic inactivation|1
LEQIKLSESQLSGSVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAVLARVDAGDQ
QLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLT
AFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQ
WMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARGIVALLGPNNKAERIVVIYLRDTPAS
MAERNQQI
>AAV91759.1|FEATURES|resfam|beta_lactam|SHVL-74|antibiotic inactivation|1
LEQIKLSESQLSGSVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAVLARVDAGDE
QLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLT
AFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQ
WMVADRVAGPLIRSVLPAGWFIADKPGASKRGARGIVALLGPNNKADRILVIYLRDTPAS
MAERNQQI
>AAV91761.1|FEATURES|resfam|beta_lactam|SHVL-75|antibiotic inactivation|1
LEQIKLSESQLSGRGGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAMLARVDAGDQ
QLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLT
AFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQ
WMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARGIVALLVPNNKAERIVVIYLRDTPAS
RAERNQQI
>2V1Z_A|FEATURES|resfam|beta_lactam|TEM1|antibiotic inactivation|1
PETLVKVKDAEDQLCRTSHRPCRVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAV
LSRIDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLT
TIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLTGELLT
LASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGRRGSRGIIAALGPDGKPSRIVV
IYTTGSRKKTDERNRQIAEIGASLIKHWGLEQKLISEEDLNSAVDHHHHHH
>ABD90508.1|FEATURES|resfam|beta_lactam|TEML-40|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASWQQLIDWVEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIK
>WP_011078081.1|FEATURES|resfam|beta_lactam|TEML-42|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGXKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTXM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVXYPTGSQATMDERNRQIAEIGASLD
>ABY81266.1|FEATURES|resfam|beta_lactam|TEML-43|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDDRNR
>ABQ14361.1|FEATURES|resfam|beta_lactam|TEML-46|antibiotic inactivation|1
AIIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABN09740.1|FEATURES|resfam|beta_lactam|TEML-47|antibiotic inactivation|1
MSIQHFRVALIPAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTF
KVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDN
TAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRK
LLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPD
GKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ABQ14362.1|FEATURES|resfam|beta_lactam|TEML-48|antibiotic inactivation|1
RLIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14389.1|FEATURES|resfam|beta_lactam|TEML-49|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYAPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14418.1|FEATURES|resfam|beta_lactam|TEML-51|antibiotic inactivation|1
ALIPFFVAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14373.1|FEATURES|resfam|beta_lactam|TEML-52|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14393.1|FEATURES|resfam|beta_lactam|TEML-53|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWIEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14404.1|FEATURES|resfam|beta_lactam|TEML-54|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQRLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14401.1|FEATURES|resfam|beta_lactam|TEML-55|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLATIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14422.1|FEATURES|resfam|beta_lactam|TEML-56|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGVTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14417.1|FEATURES|resfam|beta_lactam|TEML-57|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWVEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14416.1|FEATURES|resfam|beta_lactam|TEML-58|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATAL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14441.1|FEATURES|resfam|beta_lactam|TEML-59|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
AFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14385.1|FEATURES|resfam|beta_lactam|TEML-60|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYPQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14413.1|FEATURES|resfam|beta_lactam|TEML-61|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSHIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14391.1|FEATURES|resfam|beta_lactam|TEML-62|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIYYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14403.1|FEATURES|resfam|beta_lactam|TEML-63|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDSKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14400.1|FEATURES|resfam|beta_lactam|TEML-64|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEMHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14384.1|FEATURES|resfam|beta_lactam|TEML-65|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHSMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14376.1|FEATURES|resfam|beta_lactam|TEML-66|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYLPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14432.1|FEATURES|resfam|beta_lactam|TEML-67|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPHLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14409.1|FEATURES|resfam|beta_lactam|TEML-68|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLPLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14381.1|FEATURES|resfam|beta_lactam|TEML-69|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKGAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14390.1|FEATURES|resfam|beta_lactam|TEML-70|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNGERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14426.1|FEATURES|resfam|beta_lactam|TEML-71|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAERGA
>ABQ14412.1|FEATURES|resfam|beta_lactam|TEML-72|antibiotic inactivation|1
ALIPFLAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14425.1|FEATURES|resfam|beta_lactam|TEML-73|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTALLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14397.1|FEATURES|resfam|beta_lactam|TEML-74|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVRDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGPRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14415.1|FEATURES|resfam|beta_lactam|TEML-75|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILKSFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYPQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14386.1|FEATURES|resfam|beta_lactam|TEML-76|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEEHFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGKRGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14394.1|FEATURES|resfam|beta_lactam|TEML-77|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHCSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14428.1|FEATURES|resfam|beta_lactam|TEML-78|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPASWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIG
>ABQ14440.1|FEATURES|resfam|beta_lactam|TEML-79|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLAKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVAIYTTGSQATMDERNRQIAEIGA
>ABQ14405.1|FEATURES|resfam|beta_lactam|TEML-80|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNAAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDEHDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14427.1|FEATURES|resfam|beta_lactam|TEML-81|antibiotic inactivation|1
ALIPFFAAFYLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14371.1|FEATURES|resfam|beta_lactam|TEML-82|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKANDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRFVVIYTTGSQATMDERNRQIAEIGA
>ABQ14402.1|FEATURES|resfam|beta_lactam|TEML-83|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMG
TLKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTM
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14396.1|FEATURES|resfam|beta_lactam|TEML-84|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFRVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHPTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIG
>ABQ14433.1|FEATURES|resfam|beta_lactam|TEML-85|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESLRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSSVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14366.1|FEATURES|resfam|beta_lactam|TEML-86|antibiotic inactivation|1
ARIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELPTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14408.1|FEATURES|resfam|beta_lactam|TEML-87|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDMVEYSPVTEKHLTDGMTVRGLCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAEPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14421.1|FEATURES|resfam|beta_lactam|TEML-88|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMVS
TFKVLLRGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14436.1|FEATURES|resfam|beta_lactam|TEML-89|antibiotic inactivation|1
GLIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLFRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTAIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDGRDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14423.1|FEATURES|resfam|beta_lactam|TEML-90|antibiotic inactivation|1
ALIPFFAAFCLPVLAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYPPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHATRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14444.1|FEATURES|resfam|beta_lactam|TEML-91|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIRYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIITALG
PDSKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14392.1|FEATURES|resfam|beta_lactam|TEML-92|antibiotic inactivation|1
ALIPSFAAFCLPVFAHPETLVKVKDAGDQLGARVGYIELDLNSGKILESFRPKERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14431.1|FEATURES|resfam|beta_lactam|TEML-93|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RRLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSEAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAERGA
>ABQ14388.1|FEATURES|resfam|beta_lactam|TEML-94|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERGTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLCSALPAGWLIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14420.1|FEATURES|resfam|beta_lactam|TEML-95|antibiotic inactivation|1
ALIPFFAASCLPVLAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYPPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14377.1|FEATURES|resfam|beta_lactam|TEML-96|antibiotic inactivation|1
ALIPFSAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPIDERDTTMPVAMATTL
RKPLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14439.1|FEATURES|resfam|beta_lactam|TEML-98|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRTHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAADLLLATIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDRMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14367.1|FEATURES|resfam|beta_lactam|TEML-99|antibiotic inactivation|1
ALIPFFAAFCLPVFALPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRVDAGQEQLGRRIHYSQNGLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
LDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>AAA80669.1|FEATURES|resfam|beta_lactam|TEML-101|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTSGNYG
>ABQ14429.1|FEATURES|resfam|beta_lactam|TEML-102|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLRGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVIIYTTGSQATMDERNRQIA
>ABQ14407.1|FEATURES|resfam|beta_lactam|TEML-104|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILGSFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHCSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLTSRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAE
>resfam_TEM-7|FEATURES|resfam|beta_lactam|TEM-7|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>WP_102607453.1|FEATURES|resfam|beta_lactam|TEM-9|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYMTGSQATMDERNRQIAEIGASLIKHW
>WP_075985685.1|FEATURES|resfam|beta_lactam|TEM-36|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMVSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERDRQIAEIGASLIKHW
>resfam_TEM-31|FEATURES|resfam|beta_lactam|TEM-31|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
CGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEM-74|FEATURES|resfam|beta_lactam|TEM-74|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
SGIIAALGPDGKPSRIVVIYMTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEM-27|FEATURES|resfam|beta_lactam|TEM-27|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGKRGS
RGIIAALGPDGKPSRIVVIYMTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEM-108|FEATURES|resfam|beta_lactam|TEM-108|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAELSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTSELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERSRQIAEIGASLIKHW
>resfam_TEM-102|FEATURES|resfam|beta_lactam|TEM-102|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYMTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEM-123|FEATURES|resfam|beta_lactam|TEM-123|antibiotic inactivation|1
MSIKHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDEANRQIAEIGASLIKHW
>resfam_TEM-44|FEATURES|resfam|beta_lactam|TEM-44|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
SGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEM-18|FEATURES|resfam|beta_lactam|TEM-18|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEM-124|FEATURES|resfam|beta_lactam|TEM-124|antibiotic inactivation|1
MSIKHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDEANRQIAEIGASLIKHW
>WP_047028173.1|FEATURES|resfam|beta_lactam|TEM-26|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEM-41|FEATURES|resfam|beta_lactam|TEM-41|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
TGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEM-39|FEATURES|resfam|beta_lactam|TEM-39|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMLSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRREPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERDRQIAEIGASLIKHW
>resfam_TEM-59|FEATURES|resfam|beta_lactam|TEM-59|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMGDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEM-5|FEATURES|resfam|beta_lactam|TEM-5|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGTGKRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEM-37|FEATURES|resfam|beta_lactam|TEM-37|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMISTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERDRQIAEIGASLIKHW
>resfam_TEM-51|FEATURES|resfam|beta_lactam|TEM-51|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
HGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEM-13|FEATURES|resfam|beta_lactam|TEM-13|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYMTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEM-61|FEATURES|resfam|beta_lactam|TEM-61|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGKRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEM-60|FEATURES|resfam|beta_lactam|TEM-60|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDPNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEM-46|FEATURES|resfam|beta_lactam|TEM-46|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGKRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEM-73|FEATURES|resfam|beta_lactam|TEM-73|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
CGIIAALGPDGKPSRIVVIYMTGSQATMDERNRQIAEIGASLIKHW
>WP_094353585.1|FEATURES|resfam|beta_lactam|TEM-103|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDELNRQIAEIGASLIKHW
>WP_063864910.1|FEATURES|resfam|beta_lactam|TEM-35|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMLSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERDRQIAEIGASLIKHW
>resfam_TEM-56|FEATURES|resfam|beta_lactam|TEM-56|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLRNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEM-66|FEATURES|resfam|beta_lactam|TEM-66|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLDRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEM-58|FEATURES|resfam|beta_lactam|TEM-58|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
SGIIAALGPDGKPSRIVIIYTTGSQATMDERNRQIAEIGASLIKHW
>WP_052944427.1|FEATURES|resfam|beta_lactam|TEM-32|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMISTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEM-38|FEATURES|resfam|beta_lactam|TEM-38|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMVSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDELNRQIAEIGASLIKHW
>resfam_TEM-42|FEATURES|resfam|beta_lactam|TEM-42|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGVRVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASKRGS
RGIIAALGPDGKPSRIVVIYMTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEM-25|FEATURES|resfam|beta_lactam|TEM-25|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYMTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEM-65|FEATURES|resfam|beta_lactam|TEM-65|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
CGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEM-50|FEATURES|resfam|beta_lactam|TEM-50|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMLSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERDRQIAEIGASLIKHW
>ABI20743.1|FEATURES|resfam|beta_lactam|TEML-112|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIDEIGASLIKHW
>AAA72841.1|FEATURES|resfam|beta_lactam|TEML-113|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWLEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ABI20745.1|FEATURES|resfam|beta_lactam|TEML-114|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EEHFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAA77064.1|FEATURES|resfam|beta_lactam|TEML-115|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFFHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAR02602.1|FEATURES|resfam|beta_lactam|TEML-117|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDVGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ABI20744.1|FEATURES|resfam|beta_lactam|TEML-118|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMAVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ABA60617.1|FEATURES|resfam|beta_lactam|TEML-119|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNGGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>1ZG6_A|FEATURES|resfam|beta_lactam|TEM-116_with_artificial_S70G_mutation_[_S70G_V84I_A184V]|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMGTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAZ95767.1|FEATURES|resfam|beta_lactam|TEML-121|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGHSLIKHW
>AAB83984.1|FEATURES|resfam|beta_lactam|TEML-122|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PPAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAV27316.1|FEATURES|resfam|beta_lactam|TEML-123|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPFRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAZ95768.1|FEATURES|resfam|beta_lactam|TEML-124|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGLSLIKHW
>ABJ97318.1|FEATURES|resfam|beta_lactam|TEML-125|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAISMSDNTAANLLLTTIGGPKELTAFFHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAC73065.1|FEATURES|resfam|beta_lactam|TEML-126|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQAAMDERNRQIAEIGASLIKHW
>AAD28531.1|FEATURES|resfam|beta_lactam|TEML-127|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMPTTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAD28611.1|FEATURES|resfam|beta_lactam|TEML-128|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDPGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAB68655.1|FEATURES|resfam|beta_lactam|TEML-129|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERHTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ABF81660.1|FEATURES|resfam|beta_lactam|TEML-130|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRDDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAV54522.1|FEATURES|resfam|beta_lactam|TEML-131|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGALVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>WP_012477537.1|FEATURES|resfam|beta_lactam|TEML-132|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVLSHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAA99042.1|FEATURES|resfam|beta_lactam|TEML-134|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
LYAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>CAC83818.1|FEATURES|resfam|beta_lactam|TEML-135|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWLLADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAZ95766.1|FEATURES|resfam|beta_lactam|TEML-136|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMEERNRQIAEIGLSLIKHW
>AAQ05031.1|FEATURES|resfam|beta_lactam|TEML-137|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADRVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAD49603.1|FEATURES|resfam|beta_lactam|TEML-138|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERSPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAB47269.1|FEATURES|resfam|beta_lactam|TEML-139|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVDASPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEML-141|FEATURES|resfam|beta_lactam|TEML-141|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILEGFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGTGKRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ABQ43167.1|FEATURES|resfam|beta_lactam|TEML-142|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEASPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ABI20750.1|FEATURES|resfam|beta_lactam|TEML-143|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAKPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADTSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAW48997.1|FEATURES|resfam|beta_lactam|TEML-144|antibiotic inactivation|1
MSFQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGGILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLRNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAD31807.1|FEATURES|resfam|beta_lactam|TEML-146|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRILYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMPTTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>WP_003713939.1|FEATURES|resfam|beta_lactam|TEML-147|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESLRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLATIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGSLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEML-149|FEATURES|resfam|beta_lactam|TEML-149|antibiotic inactivation|1
MSIQHFRVAALSFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLDRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAF09467.1|FEATURES|resfam|beta_lactam|TEML-153|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHFDLLVFVKDCEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLFRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ADW95860.1|FEATURES|resfam|beta_lactam|TEML-156|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCDTLLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDESDTTM
PVAMPTTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKRSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAD28563.1|FEATURES|resfam|beta_lactam|TEML-157|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCHTLLSRIDAGQEQLGRRARYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMPTTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAK28131.1|FEATURES|resfam|beta_lactam|TEML-159|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCHTLLSRIDAGQEQLGRRARYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDESDTTM
PVAMPTTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAA56743.1|FEATURES|resfam|beta_lactam|TEML-160|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PTAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>1CK3_A|FEATURES|resfam|beta_lactam|TEM-116_with_artificial_N276D_mutation_(N-23)_[_V84I_A184V_N276D]|antibiotic inactivation|1
HPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRID
AGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGP
KELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLASRQ
QLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTG
SQATMDERDRQIAEIGASLIKHW
>resfam_TEM-1_D214X|FEATURES|resfam|beta_lactam|TEM-1_with_an_undefined_D214X_mutation_(N-23)_[_D214X]|antibiotic inactivation|1
HPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVD
AGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGP
KELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQ
QLIDWMEAXKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTG
SQATMDERNRQIAEIGASLIKHW
>ANG35171.1|FEATURES|resfam|beta_lactam|TEM-1_with_artificial_S235A_mutation_(N-23)_[_S235A]|antibiotic inactivation|1
HPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVD
AGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGP
KELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQ
QLIDWMEADKVAGPLLRSALPAGWFIADKAGAGERGSRGIIAALGPDGKPSRIVVIYTTG
SQATMDERNRQIAEIGASLIKHW
>1FQG_A|FEATURES|resfam|beta_lactam|TEM-1_with_artificial_E166N_mutation_(N-23)_[_E166N]|antibiotic inactivation|1
HPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVD
AGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGP
KELTAFLHNMGDHVTRLDRWNPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQ
QLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTG
SQATMDERNRQIAEIGASLIKHW
>1JVJ_A|FEATURES|resfam|beta_lactam|TEM-1_with_artificial_N132A_mutation_(N-23)_[_N132A]|antibiotic inactivation|1
HPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVD
AGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDATAANLLLTTIGGP
KELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQ
QLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTG
SQATMDERNRQIAEIGASLIKHW
>1JWV_A|FEATURES|resfam|beta_lactam|TEM-1_with_artificial_G238A_mutation_(N-23)_[_G238A]|antibiotic inactivation|1
HPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVD
AGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGP
KELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQ
QLIDWMEADKVAGPLLRSALPAGWFIADKSGAAERGSRGIIAALGPDGKPSRIVVIYTTG
SQATMDERNRQIAEIGASLIKHW
>1PZP_A|FEATURES|resfam|beta_lactam|TEM-1_with_artificial_N100R_mutation_(N-23)_[_N100R]|antibiotic inactivation|1
HPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVD
AGQEQLGRRIHYSQRDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGP
KELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQ
QLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTG
SQATMDERNRQIAEIGASLIKHW
>1XXM_A|FEATURES|resfam|beta_lactam|TEM-1_with_artificial_V84I,_E104A,_Y105A_mutations_(N-23)_[_V84I_E104A_Y105A]|antibiotic inactivation|1
HPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRID
AGQEQLGRRIHYSQNDLVAASPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGP
KELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQ
QLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTG
SQATMDERNRQIAEIGASLIKHW
>2B5R_A|FEATURES|resfam|beta_lactam|TEM-1_with_artificial_V84I,_E104Y,_Y105N_mutations_(N-23)_[_V84I_E104Y_Y105N]|antibiotic inactivation|1
HPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRID
AGQEQLGRRIHYSQNDLVYNSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGP
KELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQ
QLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTG
SQATMDERNRQIAEIGASLIKHW
>resfam_S19_tetX|FEATURES|resfam|tetracycline|tetX|antibiotic inactivation|1
MIKKILVIGAGIAGTAVCYWLRRFGFYPVLIEKSACIRKGGQGLDIRGVAIDIVKKMVIY
EQICKMRTQVECGRYVDVVGKTLHEEKGEKFAFRQDEDVEILRGDLIEILMKTIDDVPCH
FNQSIDSIEQNDDDVIVYFKDARVEHYDLIIGADGIHSSIRRMVFDKDEYRLVNLAEAYF
SIFSIPNYLNLSHTEVQCETNEKLVSITSDKDPKTAQVAFMFRSQHVWNNLRDEHEQMQF
LRDIFHDFGWEAQKILELMPNSHDFYFDSVTQVKMRSWTKGQVALVGDASYSASPLSGQG
NNLALVGAYILAGELKAAEGNYKLAFNRYNELLHPFVEANQQLGAWVSESFLVPDAVSKE
VAEERSNRILQKVQIISNAIKLPEYE
>2XDO_A|FEATURES|NCBI|tetracycline|tetX|antibiotic inactivation|1
MGSSHHHHHHSSGLVPRGSHMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDND
REARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVKPENRF
DNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGG
MSKVRKFVTDTEVEETGTFNIQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNN
GALHFGISFKTPDEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIHTTLSFVGLATR
IFPLEKPWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLVDALILSDNLADGKFNSIEEAV
KNYEQQMFIYGKEAQEESTQNEIEMFKPDFTFQQLLNV
>AAR29973.1|FEATURES|resfam|tetracycline|tetW|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDALLEKYIAGEPISQEKLAREEQRRVQEASLFPVYHGSAKKGLGIQPLMDAVTGLFQP
IGEQGSATLCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILPSDSVRLNDVLGDQTRLPRKRWREAPLPMLRTTIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKIETVVKEPTVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFTLYAPQEYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGQ
SVCLTELKGYQAAVGQPVIQPRRPNNRLDKVRHMFQKVM
>YP_001084779.1|FEATURES|resfam|multidrug|adeB|antibiotic efflux|0
MNISATYPGATAKTINDSVVTLIERELSGVKNLLYYSATTDTSGTAEITATFKPGTDVEM
AQVDVQNKIKAVEARLPQVVRQQGLQVEASSSGFLMLVGINSPNNQYSEVDLSDYLVRNV
VEELKRVEGVGKVQSFGAEKAMRIWVDPNKLVSYGLSISDVNNAIRENNVEIAPGRLGDL
PAEKGQLITIPLSAQGQLSSLEQFKNISLKSKTNGSVIKLSDVANVEIGSQAYNFAILEN
GKPATAAAIQLSPGANAVKTAEGVRAKIEELKLNLPEGMEFSIPYDTAPFVKISIEKVIH
TLLEAMVLVFIVMYLFLHNVRYTLIPAIVAPIALLGTFTVMLLAGFSINVLTMFGMVLAI
GIIVDDAIVVVENVERIMATEGLNPKDATSKAMKEITSPIIGITLVLAAVFLPMAFASGS
VGVIYKQFTLTMSVSILFSALLALILTPALCATILKPIDGHHQKKGFFAWFDRSFDKVTK
KYELMLLKIIKHTVPMMVIFLVITGITFAGMKYWPTAFMPEEDQGWFMTSFQLPSDATAE
RTRNVVNQFENNLKDNPDVKSNTTILGWGFSGAGQNVAVAFTTLKDFKERTSSASKMTSA
VNTSMANSTEGETMAVLPPAIDELGTFSGFSLRLQDRANLGMPALLAAQDELMAMAAKNK
KFYMVWNEGLPQGDNISLKIDREKLSALGVKFSDVSDIISTSMGSMYINDFPNQGRMQQV
IVQVEAKSRMQLKDILNLKVMGSSGQLVSLSEVVTPQWNKAPQQYNRYNGRPSLSIAGIP
NFDTSSGEAMREMEQLIAKLPKGIGYEWTGISLQEKQSESQMAFLLGLSMLVVFLVLAAL
YESWAIPLSVMLVVPLGIFGAIIAIMSRGLMNDVFFKIGLITIIGLSAKNAILIVEFAKM
LKEEGMSLIEATVAAAKLRLRPILMTSLAFTCGVIPLVIASGASSETQHALGTGVFGGMI
SATILAIFFVPVFFIFILGAVEKLFSSKKKISS
>WP_000046678.1|FEATURES|resfam|multidrug|adeJ|antibiotic efflux|0
MAQFFIHRPIFAWVIALVIMLAGILTLTKMPIAQYPTIAPPTVTIAATYPGASAETVENT
VTQIIEQQMNGLDGLRYISSNSAGNGQASIQLNFEQGVDPDIAQVQVQNKLQSATALLPE
DVQRQGVTVTKSGASFLQVIAFYSPDNNLSDSDIKDYVNSSIKEPLSRVAGVGEVQVFGG
SYAMRIWLDPAKLTSYQLTPSDIATALQAQNSQVAVGQLGGAPAVQGQVLNATVNAQSLL
QTPEQFKNIFLKNTASGAEVRLKDVARVELGSDNYQFDSKFNGKPAAGLAIKIATGANAL
DTAEAVEQRLSELRKNYPTGLADKLAYDTTPFIRLSIESVVHTLIEAVILVFIVMFLFLQ
NWRATIIPTLAVPVVVLGTFAVINIFGFSINTLTMFAMVLAIGLLVDDAIVVVENVERVM
SEDHTDPVTATSRSMQQISGALVGITSVLTAVFVPMAFFGGTTGVIYRQFSITLVTAMVL
SLIVALTFTPALCATILKQHDPNKEPSNNIFARFFRSFNNGFDRMSHSYQNGVSRMLKGK
IFSGVLYAVVVALLVFLFQKLPSSFLPEEDQGVVMTLVQLPPNATLDRTGKVIDTMTNFF
MNEKDTVESIFTVSGFSFTGVGQNAGIGFVKLKDWSKRTTPETQIGSLIQRGMALNMIIK
DASYVMPLQLPAMPELGVTAGFNLQLKDSSGQGHEKLIAARNTILGLASQDKRLVGVRPN
GQEDTPQYQINVDQAQAGAMGVSIAEINNTMRIAWGGSYINDFVDRGRVKKVYVQGDAGS
RMMPEDLNKWYVRNNKGEMVPFSAFATGEWTYGSPRLERYNGVSSVNIQGTPAPGVSSGD
AMKAMEEIIGKLPSMGLQGFDYEWTGLSLEERESGAQAPFLYALSLLIVFLCLAALYESW
SIPFSVLLVVPLGVIGAIVLTYLGMIIKGDPNLSNNIYFQVAIIAVIGLSAKNAILIVEF
AKELQEKGEDLLDATLHAAKMRLRPIIMTTLAFGFGVLPLALSTGAGAGSQHSVGFGVLG
GVLSATFLGIFFIPVFYVWIRSIFKYKPKTINTQEHKS
>WP_050976143.1|FEATURES|resfam|multidrug|oprM|antibiotic efflux|0
MRPVVFGLALTGVAACSLAPPYELPALPVESRYPADAPVAPAAQRAADTSWQDYFADPAL
RRLIGQALDNSRDLRAAVLRVEEARAAFGIRRADRFPTVGLGFEGVRGRTPADLSITGEA
VTSGQYQMGISLASWELDLWGRVRSLEGAALEEFLATEAARRAVTVSVVAQVADAYLTLR
ELDERIVLAQRTIDTRQESFRIFSRRVEVGATSRLDLAQVETLLTQAQALGAQLEQARAL
QAHALAVLVGAPLDLPAAATRLDDDLILHELDAGLPSELLTGRPDIVAAEHRLKAAHASI
GAARAAFFPRIALTASAGSASAALDGLFEPGSGAWRFAPTISLPIFDAGRNRAGLDLAEV
RRDLAVASYEKTVQQAFREVADALAARHWLEAQLGIQRAALATQVERARLAKLRYDNGAA
RYLEVLDAQRDLLAAEQQVVQTRRALLSSRVALYAALGGGAQEPERTPR
>WP_000010517.1|FEATURES|resfam|multidrug|smeF|antibiotic efflux|0
MSFSMTKLSVALLLTSSLVGCAAVVKTPYQAPAVQVPGSFQYDKAKAKTASVEQYSDHWW
TLFGDAQLNQLVTNVLERNSDLAVAGITLKQARLQADLTANKQGLRTSSSVSTGHSFDLN
SGDDSAKGLSMSAGVSYELDLFGKLARQTEASKWEALATEQDLQATGQSLIATTAKLYWQ
LGYLNERYATAQQSLATSQKLYQLVQTQYKAGAVSGLDLTQAEQSVQSQKASLSQIEQQL
VETRTAIAVLLHEPVQQLNIQEPQRLPRTALPAIGAGLPADILSRRPDLQAAELRLRKAL
ATKDATKASYYPSISLTSSLGSSSTSLTELLRNPALTLGASLSLPFLQYNDMKKDIAISN
LDYEKAIIQYRQTLYQAFADVENALSSRTELDKQVAIQERNVELAEKTERLTEVRYRYGA
VALKTLLDAQQTTRTARLSLVETKQSQYNAYVTLMQALGGSPVKELPQ
>WP_011764345.1|FEATURES|resfam|multidrug|oprM|antibiotic efflux|0
MTASVARLRLAPVLLAALVAGCAFTEPVARPDQPLPAQWTEQPGPAAATPLPDTWWQSFG
SPALDALVAEALVASPDLQVQAERVLQAELALRQTRASLFPWLTLDADSGWRRADAGDRG
ASTVTETKTTSLGLSASYEVDLWGRVAANVGSARASLNATRYDRDSVRLSLAASVATTYF
QLLTLQERLEIARQNLAIAERVLRVVEARYRNGAASALEVSQQRTTVLTQRAAIEPLEVS
VRQTRSALAILLGRNPQDAAPEFERLEALAIPTVTPGLPVELLLRRPDLASVEASLAAAS
ADIAAARAALLPSISLSAGGGVASSLLLSLADPGTTVSLSASLVQTIFDGGRLQAAVDIA
RSRQRELLESYRSAIITALKEVEDALGNASRDANQEAAQREILAEAQRALRLAELRYREG
AADLLTVLDAQRTLFSAQDQLAQLRQARLTDAVGLYKALGGGWRAENSMAAGG
>WP_011763981.1|FEATURES|resfam|multidrug|oprM|antibiotic efflux|0
MPLKTLAVALAAASLGACSTLAPDYERPAAPVAAAWPAEPAQPAAGTPSADAVAWRSFFA
DERLRQVVDLALANNRDLRVSALNIERARALYQIQRAELVPWIGVGGGQSAQRLPADLTQ
RGEPTISRQYSATVGFSSYELDFFGRIRSLRDAALEQYLATEDARRSAQISLVAEAANAW
LTLAADRERLDLARRTYETQQQSYELTKKSFDFGAVSAIDLRQAQTARESARADLAAYTT
QVARDINALNLVAGAAVPDELLPTALTDKVSAVGDLPAGLPSEVLVSRPDILAAERQLRA
AYANIGAARAAFFPSITLTAAAGTASASLEGLFKAGSGTWSFAPQINLPIFQGGRLLANL
QVAKVDREIAVADYEKAIQSAFREVADALAERANVGEELDARRALVEATAETYRLSEARY
RSGVDSYLGLLDAQRTLYSAEQGLISVRLADAANRVALYRVLGGGAQ
>YP_001706328.1|FEATURES|resfam|multidrug|adeK|antibiotic efflux|0
MMQKVWSISGRSIAVSALALALAACQSMRGPEPVVKTDIPQSYAYNSASGTSIAEQGYKQ
FFADPRLLEVIDLALANNRDLRTATLNIERAQQQYHITQNNQLPTIGASGSAIRQVSQSR
DPNNPYSTYQVGLGVTAYELDFWGRVRSLKDAALDSYLATQSARDSTQISLISQVAQAWL
NYSFATANLRLAEQTLKAQLDSYNLNKKRFDVGIDSEVPLRQAQISVETARNDVANYKTQ
IAQAQNLLNLLVGQPVPQNLLPTQPVKRIAQQNVFTAGLPSDLLNNRPDVKAAEYNLSAA
GANIGAAKARLFPTISLTGSAGYASTDLSDLFKSGGFVWSVGPSLDLPIFDWGTRRANVK
ISETDQKIALSDYEKSVQSAFREVNDALATRANIGERLTAQQRLVEATNRNYTLSNARFR
AGIDSYLTVLDAQRSSYAAEQGLLLLQQANLNNQIELYKTLGGGLKANTSDTVVHQPSSA
ELKKQ
>WP_001174793.1|FEATURES|resfam|multidrug|adeK|antibiotic efflux|0
MMQKVWSISGRSIAVSALALALAACQSMRGPEPVVKTDIPQSYAYNSASGTSIAEQGYKQ
FFADPRLLEVIDLALANNRDLRTATLNIERAQQQYQITQNNQLPTIGASGSAIRQVSQSR
DPNNPYSTYQVGLGVTAYELDFWGRVRSLKDAALDSYLATQSARDSTQISLISQVAQAWL
NYSFATANLRLAEQTLKAQLDSYNLNKKRFDVGIDSEVPLRQAQISVETARNDVANYKTQ
IAQAQNLLNLLVGQPVPQNLLPTQPVKRIAQQNVFTAGLPSDLLNNRPDVKAAEYNLSAA
GANIGAAKARLFPTISLTGSAGYASTDLSDLFKSGGFVWSVGPSLDLPIFDWGTRRANVK
ISETDQKIALSDYEKSVQSAFREVNDALATRANIGERLTAQQRLVEATNRNYTLSNARFR
AGIDSYLTVLDAQRSSYAAEQGLLLLQQANLNNQIELYKTLGGGLKANTSDTVVHQPSSA
ELKKQ
>YP_001084783.1|FEATURES|resfam|multidrug|adeS|antibiotic efflux|0
MRLAKRFIVPINFLAEAAKKISHGDLSARAYDNRIHSAEMSELLYNFNDMAQKLEVSVKN
AQVWNAAIAHELRTPITILQGRLQGIIDGVFKLDEVLFKSLLNQVEGLSHLVEDLRTLSL
VENQQLRLNYELFDFKAVVEKVLKAFEDRLDQAKLVPELDLTSTPVYCDRRRIEQVLIAL
IDNAIRYSNAGKLKISSEVVSQNWILKIEDEGPGIATEFQDDLYKPFFRLEESRNKEFGG
TGLGLAVVHAIIVALKGTIQYSNQGSKSVFTIKISMGHEEIG
>WP_000837449.1|FEATURES|resfam|multidrug|adeS|antibiotic efflux|0
MKSKLGISKQLFIALTIVNLSVTLFSIVLGYIIYNYAIEKGWISLSSFQQEDWTSFHFVD
WIWLATVIFCGCIISLVIGMRLAKRFIVPINFLVEAAKKISHGDLSARAYDNRIHSAEMS
ELLYNFNDMAQKLEVSVKNAQVWNAAIAHELRTPITILQGRLQGIIDGVFKPDEVLFKSL
LNQVEGLSHLVEDLRTLSLVENQQLRLNYELFDLKAVVEKVLKAFEDRLDQAKLVPELDL
TSTPVYCDRRRIEQVLIALIDNAIRYSNAGKLKISSEVVADNWILKIEDEGPGIATEFRD
DLFKPFFRLEESRNKEFGGTGLGLAVVHAIIVALKGTIQYSNQGSKSVFTIKISMGHEEM
G
>WP_000837444.1|FEATURES|resfam|multidrug|adeS|antibiotic efflux|0
MKSKLGISKQLFIALTIVNLSVTLFSIVLGYIIYNYAIEKGWISLSSFQQEDWTSFHFVD
WIWLATVIFCGCIISLVIGMRLAKRFIVPINFLAEAAKKISHGDLSARAYDNRIHSAEMS
ELLYNFNDMAQKLEVSVKNAQVWNAAIAHELRTPITILQGRLQGIIDGVFKPDEVLFKSL
LNQVEGLSHLVEDLRTLSLVENQQLRLNYELFDLKAVVEKVLKAFEDRLDQAKLVPELDL
TSTPVYCDRRRIEQVLIALIDNAIRYSNAGKLKISSEVVADNWILKIEDEGPGIATEFRD
DLFKPFFRLEESRNKEFGGTGLGLAVVHAIIVALKGTIQYSNQGSKSVFTIKISMGHEEM
G
>WP_000680574.1|FEATURES|resfam|multidrug|smeR|antibiotic efflux|0
MKHIMLVEDEVELAHLVRDYLEAAGFEVSMFHDGQDAYTNFQQRKPNLMILDLMVPRMDG
LTICRKVREQSDLPIIMVTARTEEIDRVLGLNMGADDYVCKPFSPKELVARVQAVLRRLE
RKAEPEQNDSFRIDKAQQRIWYQQKSLSLTPTEFRLLELFLEHVGQVYSRAQLLDHINPD
SFDVADRVIDSHIKNLRRKITEVAETGNRHEWIQAVYGVGYRFEYPEE
>YP_001706192.1|FEATURES|resfam|multidrug|smeR|antibiotic efflux|0
MKHIMLVEDEVELAHLVCDYLEAAGFEVSMFHDGQDAYTSFQQRKPNLMILDLMVPRMDG
LTICRKVREQSDLPIIMVTARTEEIDRVLGLNMGADDYVCKPFSPKELVARVQAVLRRLE
RKAEPEQNDSFRIDKAQQRIWYQQKSLSLTPTEFRLLELFLEHVGQVYSRAQLLDHINPD
SFDVADRVIDSHIKNLRRKITEVAETGNRHEWIQAVYGVGYRFEYPEE
>NP_310914.1|FEATURES|resfam|multidrug|baeR|antibiotic efflux|0
MTELPIDENTPRILIVEDEPKLGQLLIDYLRAASYAPTLISHGDQVLSYVRQTPPDLILL
DLMLPGTDGLTLCREIRRFSDIPIVMVTAKIEEIDRLLGLEIGADDYICKPYSPREVVAR
VKTILRRCKPQRELQQQDAESPLIIDEGRFQASWRGKMLDLTPAEFRLLKTLSHEPGKVF
SREQLLNHLYDDYRVVTDRTIDSHIKNLRRKLESLDAEQSFIRAVYGVGYRWEADACRIV
>WP_012300504.1|FEATURES|resfam|multidrug|smeS|antibiotic efflux|0
MNVLRVPIALRLFLTVLLTTLLIATASLSVLHWTMQKNFAKYVADVEMQKLDRLITNLGN
VYTVYHDWGNAIQAQILQIEGTAAPDDYDRLSQWWLRRQYDIAIQQHSFDEHTLINISPD
AGTVNKNSIFSDEELRTLEQNLPSEYQPFEGLRFPLSANQFRPSDDKNKSKKGSLKDIET
QNGKKRFIALPDRLGLSSRLSLYDAKHQFVVGEPPSSDQMSYRPIMVNSQVVGYLGLKPV
LDKEDALSINFFSNQKRYLLLIYALTLLSSLVAALLMATYFKKPIQRLLNATNELTKGNY
QHQVVIKRNDELGDLSTQLNHLAEILHQHEESRRQWVADTSHELKTPLAVLQAQIEAMQD
GIRKATPEHLDAMMRQVSSLKKLTQDLADLAQADAQQLKCYLSSVNPWEVILQEVENFRP
KLEQAGLEIEVEGEGASLLLDRDRFKQIIVNLIGNSIRYTETGGKIHIHTNQTSQEWTLY
VDDSPFGLSDEQLSRLGERFYRVDDSRTRSTGGTGLGLALSCKIAQALGGTLSFEHSPLG
GLRCVLTFKKQS
>YP_001706191.1|FEATURES|resfam|multidrug|smeS|antibiotic efflux|0
MNVLRVPIALRLFLTVLLTTLLIATASLSVLHWTMQKNFAKYVADVEMQKLDRLITNLGN
VYTVYHDWGNAIQAQILQIEGTAAPDDYDRLSQWWLRRQYDIAIQQHSFDEHTLINISPD
AGTVNKNSIFSDEELRTLEQNLPSEYQPFEGLRFPLSANQFRPSDDKNKSKKGSLKDIET
QNGKKRFIALPDRLGLSSRLSLYDAKHQFVVGEPPSSDQMSNRPIMVNSQVVGYLGLKPV
LDKEDALSINFFSNQKRYLLLIYALTLLSSLVAALLMATYFKKLIQRLLNATNELTKGNY
QHQVVIKRNDELGDLSTQLNHLAEILHQHEESRRQWVADTSHELKTPLAVLQAQIEAMQD
GIRKATPEHLDAMMRQVSSLKKLTQDLADLAQADAQQLKCYLSSVNPWEVILQEVENFRP
KLEQAGLEIEVEGEGASLLLDRDRFKQIIVNLIGNSIRYTETGGKIHIHTNQTPQEWTLY
VDDSPFGLSDEQLSRLGERFYRVDDSRTRSTGGTGLGLALSCKIAQALGGTLSFEHSPLG
GLRCVLTFKKQS
>WP_001284653.1|FEATURES|resfam|beta_lactam|mecI|antibiotic target replacement|1
MANKQVEISMAEWDVMNIIWDKKSVSANEIVVEIQKYKEVSDKTIRTLITRLYKKEIIKR
YKSENIYFYSSNIKEDDIKMKTAKTFLNKLYGGDMKSLVLNFAKNEELNNKEIEELRDIL
NDISKK
>WP_001096377.1|FEATURES|resfam|beta_lactam|mecR1|antibiotic target replacement|1
MAKLLIMSIVSFCFIFLLLLFFRYILKRYFNYMLNYKVWYLTLLAGLIPFIPIKFSLFKF
NNVNNQAPTVESKSHDLNHNINTTKPIQEFTTDIHKFNWDSIDNICTVVWIVLVIILSFK
FLKSLLYLKYLKKQSLYLNENEKNKVDTILFNHQYKKNIVIRKAETIQSPITFWYGKYII
LIPSSYFKSVIDKRLKYIILHEYAHAKNRDTLHLIIFNIFSIIMSYNPLVHIVKRKIIHD
NEVEADRFVLNNINKNEFKTYAESIMDSVLNVPFFNKNILSHSFNGKKSLLKRRLINIKE
ANLKKQSKLILIFICIFTFLLMVIQSQFLMGQSITDYNYKKPLHNDYQILDKSKIFGSNS
GSFVMYSMKKDKYYIYNEKESRKRYSPNSTYKIYLAMFGLDRHIINDENSRMSWNHKHYP
FDAWNKEQDLNTAMQNSVNWYFERISDQIPKNYTATQLKQLNYGNKNLGSYKSYWMEDSL
KISNLEQVIVFKNMMEQNNHFSKKAKNQLSSSLLIKKNEKYELYGKTGTGIVNGKYNNGW
FVGYVITNHDKYYFATHLSDGKPSGKNAELISEKILKEMGVLNGQ
>YP_001715978.1|FEATURES|resfam|beta_lactam|mecR1|antibiotic target replacement|1
MAKLLIMSVVSFCFIFLLLVFFRYILKRYFNYSLNYKVWYLTMLAGLIPFIPIKFSFIKF
NNVNNQAPTVESKSHDLNHNINTTKPIQEFTTDIHKFNWDSIDNICTVIWIVLVIILSFK
FLKALLYLKYLKKQSLYLNENEKNKIDTILFNHQYKKNIVIRKAEAIQSPITFWYGKYII
LIPSSYFKSVIDKRLKYIILHEYAHAKNRDTLHLIIFNIFSIIMSYNPLVHIVKRKIIHD
NEVEADRFVLNNINKNEFKTYAESIMDSVLKTPFSNKNILSHSFNGKKSLLKSRLINIKE
ADLKKQSKLILIFICIFTFFIMIIQSQFLMGQSLTDYNYKKPLQSDYQILDESKNFGSNS
GSFVMYSMKKDKYYIYNEKESRKRYSPDSTYKIYLALFGLDRHIISDKNSRMSWNHKHYL
FESWNKEQDLNTAMQNSVNWYFERISNQIPKNYTAAQLKQLNYGNENLGSYKSYWMEDSL
KISNLEQVIVFKNMMEQNNHFSKKAKNQLSSSLLIKKNEKYELYGKTGTGIVNGKYNNGW
FVGYVITNHDKYYFATHLSDGNPSGKNAELISEKILKGMGVLNDQ
>WP_001096385.1|FEATURES|resfam|beta_lactam|mecR1|antibiotic target replacement|1
MAKLLIMSVVSFCFIFLLLVFFRYILKRYFNYSLNYKVWYLTVLAGLIPFIPIKFSFIKF
NNVNNQAPTVESKSHDLNHNIITTKPVQEFATDIHKFNWDSIDNICTVIWIVLVIILSFK
FLKALLYLKYLKKQSLYLNENEKNKIDTILFNHQYKKNIVIRKAEAIQSPITFWYGKYII
LIPSSYFKSVIDKRLKYIILHEYAHAKNRDTLHLIIFNIFSIIMSYNPLVHIVKRKIIHD
NEVEADRFVLNNINKNEFKTYAESIMDSVLKTSFFNKNILSHSFNGKKSLLKNRLINIKE
ADLKKQSKLILIFICIFTFFIMIIQSQFLMGQSLTDYNYKKPLQSDYQILDESKNFGSNS
GSFVMYSMKKDKYYIYNEKESRKRYSPDSTYKIYLALFGLDRHIISDKNSRMSWNHKHYL
FESWNKEQDLNTAMQNSVNWYFERISNQIPKNYTAAQLKQLNYGNENLGSYKSYWMEDSL
KISNLEQVIVFKNMMEQNNHFSKKAKNQLSSSLLIKKNEKYELYGKTGTGIVNGKYNNGW
FVGYVITNHDKYYFATHLSDGNPSGKNAELISEKILKGMGVLNGQ
>NP_932192.1|FEATURES|resfam|beta_lactam|mecR1|antibiotic target replacement|1
MLVFFRYILKRYFNYSLNYKVWYLTVLAGLIPFIPIKFSFIKFNNVNNQSPTVESRSHDL
NHNINTTKPVQEFTTDIHKFNWDSIDNICTVIWIVLVIILSFKFLKSLLYLKYLKRQSLY
LNENEKNKIDTILFNHQYKKNIVIRKAETIQSPITFWYGKYIILIPSSYFKSVIDKRLKY
IILHEYAHAKNRDTLHLIIFNIFSIVMSYNPLIHIVKRKIIHDNEVEADRFVLNNINKNE
FKTYAESIMDSVLNIPFFNKNILSHSFNGKKSLLKRRLINIKEANLKKQSKLIPIFICIF
TFLLMVIQSQFLMGQSITDYNYKKPLQNDHQILDESKNFGSNSGSFVMYSMKKDKYYIYN
EKESRKRYSPDSTYKIYLAMFGLDHHIISDKNSRMSWNHKHYPFESWNKEQDLNTAMQNS
VNWYFERISNQIPKNYTAAQLKQLNYGNENLGSYKSYWMEDSLKISNLEQVIVFKNMMEQ
NNHFSKKAKNQLSSSLLIKKNEKYELYGNTGTGIVNGKYNNGWFVGYVITNHDKYYFATH
LSDGKPSGKNAELISEKILKEMGVLNGQ
>NP_878024.1|FEATURES|resfam|beta_lactam|mecR1|antibiotic target replacement|1
MAKLLIMSIVSFCFIFLLLLFFRYILKRYFNYMLNYKVWYLTLLAGLIPFIPIKFSLFKF
NNVNNQAPTVESKSHDLNHNINTTKPIQEFTTDIHKFNWDSIDNICTVIWIVLVIILSFK
FLKALLYLKYLKKQSLYLNENEKNKIDTILFNHQYKKNIVIRKAETIQSPITFWYGKYII
LIPSSYFKSVIDKRLKYIILHEYAHAKNRDTLHLIIFNIFSIIMSYNPLVHIVKRKIIHD
NEVEADRFVLNNINKNEFKTYAESIMDSVLNVPFFNKNILSHSFNGKKSLLKRRLINIKE
ANLKKQSKLILIFICIFTFLLMVIQSQFLMGQSITDYNYKKPLHNDYQILDKSKIFGSNS
GSFVMYSMKKDKYYIYNEKESRKRYSPNSTYKIYLAMFGLDRHIINDENSRMSWNHKHYP
FDAWNKEQDLNTAMQNSVNWYFERISDQIPKNYTATQLKQLNYGNKNLGSYKSYWMEDSL
KISNLEQVIVFKNMMEQNNHFSKKAKNQLSSSLLIKKNEKYELYGKTGTGIVNGKYNNGW
FVGYVITNHDKYYFATHLSDGKPSGKNAELISEKILKEMGVLNGQ
>WP_001096389.1|FEATURES|resfam|beta_lactam|mecR1|antibiotic target replacement|1
MAKLLITSVVSFCFIFLLLVFFKYILKRYFNYSLNYKVWYLTVLAGLIPFIPIKFSFIKF
NNVNNQAPTVESKSHDLNHNINTTKPIQEFTTDIHKFNWDSIDNICTVVWIVLVIILSFK
FLKSLLYLKYLKKQSLYLNENEKNKVDTILFNHQYKKNIVIRKAETIQSPITFWYGKYII
LIPSSYFKSVIDKRLKYIILHEYAHAKNRDTLHLIIFNIFSIIMSYNPLVHIVKRKIIHD
NEVEADRFVLNNINKNEFKTYAESIMDSVLKTPFSNKNILSHSFNGKKSLLKSRLINIKE
ADLKKQSKLILIFICIFTFFIMIIQSQFLMGQSLTDYNYKKPLQSDYQILDESKNFGSNS
GSFVMYSMKKDKYYIYNEKESRKRYSPDSTYKIYLALFGLDRHIISDKNSRMSWNHKHYL
FESWNKEQDLNTAMQNSVNWYFERISNQIPKNYTAAQLKQLNYGNENLGSYKSYWMEDSL
KISNLEQVIVFKNMMEQNNHFSKKAKNQLSSSLLIKKNEKYELYGKTGTGIVNGKYNNGW
FVGYVITNHDKYYFATHLSDGNPSGKNAELISEKILKGMGVLNDQ
>YP_536856.1|FEATURES|resfam|beta_lactam|mecR1|antibiotic target replacement|1
MAKLLIMSVVSFCFIFLLLVFFRYILKRYFNYSLNYKVWYLTMLAGLIPFIPIKFSFIKF
NNVNNQAPTVESKSHDLNHNINTTKPIQEFTTDIHKFNWDSIDNICTVIWIVLVIILRFK
FLKALLYLKYLKKQSLYLNENEKNKIDTILFNHQYKKNIVIRKAEAIQSPITFWYGKYII
LIPSSYFKSVIDKRLKYIILHEYAHAKNRDTLHLIIFNIFSIIMSYNPLVHIVKRKIIHD
NEVEADRFVLNNINKNEFKTYAESIMDSVLKTPFSNKNILSHSFNGKKSLLKSRLINIKE
ADLKKQSKLILIFICIFTFFIMIIQSQFLMGQSLTDYNYKKPLQSDYQILDESKNFGSNS
GSFVMYSMKKDKYYIYNEKESRKRYSPDSTYKIYLALFGLDRHIISDKNSRMSWNHKHYL
FESWNKEQDLNTAMQNSVNWYFERISNQIPKNYTAAQLKQLNYGNENLGSYKSYWMEDSL
KISNLEQVIVFKNMMEQNNHFSKKAKNQLSSSLLIKKNEKYELYGKTGTGIVNGKYNNGW
FVGYVITNHDKYYFATHLSDGNPSGKNAELISEKILKGMGVLNDQ
>WP_001140999.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|lmrB|antibiotic efflux|0
MAKVELTTRRRNFIVAVMLISAFVAILNQTLLNTALPSIMRELNINESTSQWLVTGFMLV
NGVMIPLTAYLMDRIKTRPLYLAAMGTFLLGSIVAALAPNFGVLMLARVIQAMGAGVLMP
LMQFTLFTLFSKEHRGFAMGLAGLVIQFAPAIGPTVTGLIIDQASWRVPFIIIVGIAILA
FVFGLVSISSYNEVKYTKLDKRSVMYSTIGFGLMLYAFSSAGDLGFTSPIVIGALILSMV
IIYLFIRRQFNITNALLNLRVFKNRTFALCTISSMIIMMSMVGPALLIPLYVQNSLSLSA
LLSGLVIMPGAIINGIMSVFTGKFYDKYGPRPLIYTGFTILTITTIMLCFLHTDTSYTYL
IVVYAIRMFSVSLLMMPINTTGINSLRNEEISHGTAIMNFGRVMAGSLGTALMVTLMSFG
AKIFLSTSPSHLTATEIKQQSIAIGVDISFAFVAVLVMAAYVIALFIREPKEIESNRRKF
>WP_000213874.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|lmrB|antibiotic efflux|0
MTTTFIISYIILALIIVGVINLFLIRSRKKGKRQQKEQQFTTRQSNQSKFKASDLDKTTD
QSTQRMTHEELRVDNQDDHSQVSLNGYTKGSEKDQEAFTNNKDEEAVAAKNPESEEYKVN
EKIKKEHKNFIFGEGVSRGKILAALLFGMFIAILNQTLLNVALPKINTEFNISASTGQWL
MTGFMLVNGILIPITAYLFNKYSYRKLFLVALVLFTIGSLICAISMNFPIMMVGRVLQAI
GAGVLMPLGSIVIITIYPPEKRGAAMGTMGIAMILAPAIGPTLSGYIVQNYHWNVMFYGM
FIIGIIAILIGFVWFKLYQYTTNPKADIPGIIFSTIGFGALLYGFSEAGNKGWGSVEIET
MFAIGIIFIILFVIRELRMKSPMLNLEVLKFPTFTLTTIINMVVMLSLYGGMILLPIYLQ
NLRGFSALDSGLLLLPGSLIMGLLGPFAGKLLDTIGLKPLAIFGIAVMTYATWELTKLNM
DTPYMTIMGIYVLRSFGMAFIMMPMVTAAINALPGRLASHGNAFLNTMRQLAGSIGTAIL
VTVMTTQTTQHLSAFGEELDKTNPVVQDHMRELASQYGGQEGAMKVLLQFVNKLATVEGI
NDAFIVATIFSIIALILCLFLQSNKKAKATAQKLDADNSINHE
>WP_072498116.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|lmrB|antibiotic efflux|0
MGGFFGLLNETLLVTALPSIMKDFEISYTQVQWLTTAFLLTNGIVIPLSALVIQRYTTRQ
VFLVGISIFFLGTLLGGLSPHFATLLVARIIQALGAGIMMPLMMTTILDVFQPHERGKYM
GIFGLVIGLAPAIGPTLSGYLVEYFNWRSLFHVVAPIAAVTFLIGFKTIKNVGTTIKVPI
DFISVIFSVLGFGGLLYGTSSISEKGFDNPIVLVSMIGGVVLVALFVLRQYRLSTPLLNF
AVFKNKQFTVGIIIMGVTMVSMIGSETILPIFVQNLLHRSALDSGLTLLPGAIVMAFMSM
TSGALYEKFGPRNLALVGMAIVVITTAYFVVMDEQTSTIMLATVYAIRMVGIALGLIPVM
THTMNQLKPEMNAHGSSMTNTVQQIAGSIGTAALITILSHASKNFSPTMSDYNGMNKIDM
MNQIKVDTMLHGYHAGFLFALLITVVSFFCSFMLQGKKKEVDSRQ
>WP_001140995.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|lmrB|antibiotic efflux|0
MAKVELTTRRRNFIVAVMLISAFVAILNQTLLNTALPSIMRELNINESTSQWLVTGFMLV
NGVMIPLTAYLMDRIKTRPLYLAAMGTFLLGSIVAALAPNFGVLMLARVIQAMGAGVLMP
LMQFTLFTLFSKEHRGFAMGLAGLVIQFAPAIGPTATGLIIDQASWRVPFIIILGIAILA
FVFGLVSISSYNEVKYTKLDKRSVMYSTIGFGLMLYAFSSAGDLGFTSPIVIGALILSMV
IIYLFIRRQFNITNALLNLRVFKNRTFALCTISSMIIMMSMVGPALLIPLYVQNSLSLSA
LLSGLVIMPGAIINGIMSVFTGKFYDKYGPRPLIYTGFTILTITTIMLCFLHTDTSYTYL
IVVYAIRMFSVSLLMMPINTTGINSLRNEEISHGTAIMNFGRVMAGSLGTALMVTLMSFG
AKIFLSTSPSHLTATEIKQQSIAIGVDISFAFVAVLVMAAYVIALFIREPKEIESNRRKF
>WP_001141007.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|lmrB|antibiotic efflux|0
MMAKVELTTRRRNFIVAVMLISAFVAILNQTLLNTALPSIMRELNINESTSQWLVTGFML
VNGVMIPLTAYLMDRIKTRPLYLAAMGTFLLGSIVAALAPNFGVLMLARVIQAMGAGVLM
PLMQFTLFTLFSKEHRGFAMGLAGLVIQFAPAIGPTVTGLIIDQASWRVPFIIIVGIALV
AFVFGLVSISSYNEVKYTKLDKRSVMYSTIGFGLMLYAFSSAGDLGFTSPIVIGALIISM
VIIYLFIRRQFNITNVLLNLRVFKNRTFALCTISSMIIMMSMVGPALLIPLYVQNSLSLS
ALLSGLVIMPGAIINGIMSVFTGKFYDKYGPRPLIYTGFTILTITTIMLCFLHTDTSYTY
LIVVYAIRMFSVSLLMMPINTTGINSLRNEEISHGTAIMNFGRVMAGSLGTALMVTLMSF
GAKIFLSTSPSHLTATEIKQQSIAIGVDISFAFVAVLVMAAYVIALFIREPKEIESNRRK
F
>WP_000213885.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|lmrB|antibiotic efflux|0
MTTTFIISYIILALIIVGVINLFLIRSRKKGKRQQKEQQFTTRQSNQSKFKASDLDKTTD
QSTQRMTHEELRVDNQDDHSQVSLNGYTKGSEKDQEAFTNNNGEEAVAAKNPESEEYKVN
EKIKKEHKNFIFGEGVSRGKILAALLFGMFIAILNQTLLNVALPKINTEFNISASTGQWL
MTGFMLVNGILIPITAYLFNKYSYRKLFLVALVLFTIGSLICAISMNFPIMMVGRVLQAI
GAGVLMPLGSIVIITIYPPEKRGAAMGTMGIAMILAPAIGPTLSGYIVQNYHWNVMFYGM
FIIGIIAILVGFVWFKLYQYTTNPKADIPGIIFSTIGFGALLYGFSEAGNKGWGSVEIET
MFAIGIIFIILFVIRELRMKSPMLNLEVLKFPTFTLTTIINMVVMLSLYGGMILLPIYLQ
NLRGFSALDSGLLLLPGSLIMGLLGPFAGKLLDTIGLKPLAIFGIAVMTYATWELTKLNM
DTPYMTIMGIYVLRSFGMAFIMMPMVTAAINALPGRLASHGNAFLNTMRQLAGSIGTAIL
VTVMTTQTTQHLSAFGEELDKTNPVVQDHMRELASQYGGQEGAMKVLLQFVNKLATVEGI
NDAFIVATIFSIIALILCLFLQSNKKAKATAQKLEASSNNNHE
>WP_072416042.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|lmrB|antibiotic efflux|0
MSKKQKLTMIITMLMGGFFGLLNETLLVTALPSIMKDFEISYTQVQWLTTAFLLTNGIVI
PLSALVIQRYTTRQVFLVGISIFFLGTLLGGLSPHFATLLVARIIQALGAGIMMPLMMTT
ILDVFQPHERGKYMGIFGLVIGLAPAIGPTLSGYLVEYLNWRSLFHVVAPIAAVTFLIGF
KTIKNVGTTIKVPIDFISVIFSVLGFGGLLYGTSSISEKGFDNPIVLVSMIGGVVLVALF
VLRQYRLSTPLLNFAVFKNKQFTVGIIIMGVTMVSMIGSETILPIFVQNLLHRSALDSGL
TLLPGAIVMAFMSMTSGALYEKFGPRKLALVGMAIVVITTAYFVVMDEQTSTIMLATVYA
IRMVGIALGLIPVMTHTMNQLKPEMNAHGSSMTNTVQQIAGSIGTAALITILSHASKNFS
PTMSDYNGMNKIDMMNQIKVDTMLHGYHAGFLFALLITVVSFFCSFMLQGKKKEVDSRQ
>WP_000128093.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|LmrB|antibiotic efflux|0
MTAYPSIMKDFEISYTQVQWLTTAFLLTNGIVIPLSALVIQRYTTRQVFLVGISIFFLGT
LLGGLSPHFATLLVARIIQALGAGIMMPLMMTTILDVFQPHERGKYMGIFGLVIGLAPAI
GPTLSGYLVEYFNWRSLFHVVAPIAAVTFLIGFKTIKNVGTTIKVPIDFISVIFSVLGFG
GLLYGTSSISEKGFDNPIVLVSMIGGVVLVALFVLRQYRLSTPLLNFAVFKNKQFTVGII
IMGVTMVSMIGSETILPIFVQNLLHRSALDSGLTLLPGAIVMAFMSMTSGALYEKFGPRN
LALVGMAIVVITTAYFVVMDEQTSTIMLATVYAIRMVGIALGLIPVMTHTMNQLKPEMNA
HGSSMTNTVQQIAGSIGTAALITILSHASKNFSPTMSDYNGMNKIDMMNQIKVDTMLHGY
HAGFLFALLITVVSFFCSFMLQGKKKEVDSRQ
>WP_000857095.1|FEATURES|resfam|multidrug|emrB|antibiotic efflux|0
MKTQTPFAELSGGRLLLAAFVIALSNFMVVLDTTIANVSVPHITGNLAVSSTQGTWVVTS
YAVAEAICVPLTGWLAGRFGTVRVFIFGLIGFTVFSFLCGLATSLEMLVFFRIGQGLCGG
PLMPLSQTLLMRIFPQEKHAQAMGLWAMTTVVGPILGPILGGLISDNLSWHWIFFINLPV
GIVCVLAAMRLLRVAETETISLRIDTVGLGLLILWIGALQLMLDLGHERDWFNSTSIVVL
ALTAAIGFVVFLIWELTDKHPVVDVKVFRHRGFAISVLALSLGFGAFFGSIVLIPQWLQM
NLSYTATWAGYLTATMGFGSLTMSPIVAKLSTKHDPRALASFGLILLGIVTLMRAFWTTD
ADFMALAWPQILQGFAVPFFFIPLSNIALGSVLQQEIASAAGLMNFLRTMAGAIGASIAV
TVWDDHAKVARSEMVSNLHTTEVQNTLLQNGFTADSTLGIISNLVDKEAITMSANHVFLL
FAIVFVFAGLVIWLCPKPKQVSGMPSH
>AAK47485.1|FEATURES|resfam|qa_compound|Qac|antibiotic efflux|0
MIYLYLLCAIFAEVVATSLLKSTEGFTRLWPTVGCLVGYGIAFALLALSISHGMQTDVAY
ALWSAIGTAAIVLVAVLFLGSPISVMKVVGVGLIVVGVVTLNLAGAH
>WP_003689303.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|macA|antibiotic efflux|0
MAKMMKWSAVAAVAAAAVWGGWHYLKPEPQASYITETVRRGGISRTVSATGEISPSNLVS
VGAQASGQIKKLYVKLGQQVKKGDLIAEINSTTQTNTLDMEKSKLETYQAKLVSAQIALG
SAEKKYKRQAALWKDDATSKEDLESAQDALAAAKANVAELKALIRQSKISINTAESDLGY
TRITATMDGTVVAIPVEEGQTVNAAQSTPTIVQLANLDMMLNKMQIAEGDITKVKAGQDI
SFTILSEPDTPIKAKLDSVDPGLTTMSSGGYNSSTDTASNAVYYYARSFVPNPDGKLATG
MTTQNTVEIDGVKNVLLIPSLTVKNRGGKAFVRVLGADGKAAEREIRTGMRDSMNTEVKS
GLKEGDKVVISEITAAEQQESGERALGGPPRR
>WP_001124213.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|macA|antibiotic efflux|0
MPKIKPIKLVIIVVCIAIIAVLAWKFLKPKQQQPQYITAEVTRGDIENNVLATGTLDATK
LISVGAQVSGQVKKMYVQLGDQVKQGQLIAQIDSTTQENSLKTSDANIKNLEAQRLQQIA
SLNEKQLEYRRQQQMYAQDATPRADLESAEAAYKTAQAQVKALDAQIESAKITRSTAQTN
IGYTRIVAPTDGTVVAIVTEEGQTVNANQSAPTIVKIAKLQNMTIKAQVSEADIMKVEKG
QQVYFTTLGDETKRYATLRQIEPAPDSISSESNSTTSSTTSSAVYYNALFDVPNTDGKLR
IDMTAQVYIVLNSAKNALLVPSSALSSKQFSGQRKQGQSADKASSTPSAERKHQGNGVRL
ERLNLTPEQKQLIEQGKATLSVVRVLQADGTTKPTQILVGINNRVNAQVLAGLKQGDQVV
IADSSENSAASANSGNNRRRGPMGM
>WP_041642270.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|macA|antibiotic efflux|0
MFGNGDPTALYQFATVSRGDIEDVVTATGTLQPREYVDVGAQVSGQLKKIHVEVGSLVKN
GDLLGEIDSTVYLSKVDASRAQLRNLRAQLKEREAQVALAQVQFKRQTALMAEDATTTET
LQTAEATLKSAEAQLEALRAQIEQYESTLRGDEANLQYARIMSPMTGTVVSITARQGQTL
NTNQSAPTILRVADLTTMTVQTQVSEADVSRLKLGMAAYFTTLGGHGKRWYGKLDKIEPT
PTVTNNVVLYNALFDVPNDDNLLMTQMTAQVFFIVAQAKDVLQIPLAAVSQGARGPRAGA
QPAAGGAPAGAARGNGPRRATVKVLRADNTLEEREVQIGVSNRVQAQVLDGLQEGERVVT
GLLSAPAPAASTTSNRQGPPPRL
>NP_308991.2|FEATURES|resfam|macrolide-lincosamide-streptogramin|macA|antibiotic efflux|0
MKKRKTVKKRYVIALVIVIAGLITLWRILNAPVPTYQTLIVRPGDLQQSVLATGKLDALR
KVDVGAQVSGQLKTLSVAIGDKVKKDQLLGVIDPEQAENQIKEVEATLMELRAQRQQAEA
ELKLARVTYSRQQRLAQTQAVSLQDLDTAATEMAVKQAQIGTIDAQIKRNQASLDTAKTN
LDYTRIVAPMAGEVTQITTLQGQTVIAAQQAPNILTLADMSTMLVKAQVSEADVIHLKPG
QKAWFTVLGDPLTRYEGQIKDVLPTPEKVNDAIFYYARFEVPNPNGLLRLDMTAQVHIQL
TDVKNVLTIPLSALGDPVGDNRYKVKLLRNGETREREVTIGARNDTDVEIVKGLEAGDEV
VIGEAKPGAAQ
>WP_011764346.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MKREAFSPSASSTGAGTPLIELAGITRSFRNGEIETRVLHGIDLTIYPGEFVAIVGASGS
GKSTLMNILGCLDRPSSGTYRFMGEDVAGFDRDELARLRREAFGFVFQSYNLLGGASARE
NVEVPAVYSGMPPAERHARAEQLLASLGLGERSHHRPSQLSGGQQQRVSIARALMNGGRI
ILADEPTGALDSRSGEEVMKLLRQLSAEGHTIILITHAREVAEMAQRIIEIRDGHIVADP
GPSKPQGPEPDFAPHVDRTSSMSDLVEATRTALRALRANLFRSALTLLGIVIGVASVIAM
LAIGDGAKAKVVDQISAMGTNLLTVRPGAPNQRGRETTATLVIEDVRAIAELPNVLASVP
EQSASVTLRADNTDQRTTANATSWNYGVARNWPVASGTFFSAEDEARYATVAVLGQTTAG
ALFPGVDPIGQYVLVNNIPFQVIGVMSPKGATPWGQDQDDIVFVPFTTGSLRVTGQRYLR
NVTVAVEDVSRIDATQNEVSQLLLARHGVEDFQIRNMASVIDTVSATQNTLTILLGTVAA
ISLLVGGIGVMNIMLVSVTERTREIGIRMATGARMKNILQQFLIEALVVSALGGLIGVAV
GLGTAAVIALFDTPIKYSLLPVVLAFGCAFATGLVFGYLPARKAARLDPVVALASE
>WP_011764568.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MAQIELSGIERVFTLGDSQVHALRDVSLEIEAGEYVAVMGPSGSGKSTLLNLLGLLDRPD
AGHYRLEGRDVTTLSADEQAQVRRNRIGFVFQSFHLVPRLTAAENIALPLMLAGLAPAER
QARVGRALKDFGLETRADHRPDELSGGQRQRVAIARATIMQPAMLLADEPTGNLDRHTGQ
EVTELLEALNAAGTTLIVVTHDPAMGNRARRRLMMEDGMLRQDLRDGTPAPTGTP
>WP_000165905.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MTKQALLEVSNLVREFPAGESTIQILKGIDLTIYEGELVAIVGQSGSGKSTLMNILGCLD
RPTSGSYKVNGQETGKLEPDQLAQLRREYFGFIFQRYHLLGDLSAEGNVEVPAVYAGVTP
ADRKQRATALLTELGLGTKTQNRPSQLSGGQQQRVSIARALMNGGDVILADEPTGALDSH
SGVEVMRILRELNAAGHTIILVTHDMQVAKNATRIIEISDGEIISDRPNVPDQSLEEVKS
DPDAAPALQNKQKKGKSISAWRSTLDRLSEAFQMALLSMNAHRMRTFLTMLGIIIGIASV
VTVVALGNGSQQQILSNISSLGTNTITVFQGRGFGDNSKTANFKTLVPADADALMTQPYV
SAVSPMVSTSKTMRYQQNEANATINGVSNDYFDVKGLVFKDGQTFDQRSVRDRSQDVVID
TNTQKQFFSDGTNPIGQVVLLGSVPARIIGIVEPQTSGMGSDDTLNVYMPYTTVMSRMLG
QAHVRNIVVRINDKYSTSAAENAIVNLLTQRHGAQDIFTMNSDSIRQTIEKTTSTMTLLV
SAIAVISLVVGGIGVMNIMLVSVTERTQEIGVRMAVGARQSDILQQFLIEAILVCLIGGV
LGVLLSLGLGQLINKFAGGNFAVAYSTTSIVAAFVCSTLIGVVFGFLPAKNAAKLDPVAA
LSRE
>WP_000323365.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MAYIEMKHCYKRYQVGDTEIVANRDVNFEIEKGELVIILGASGAGKSTVLNLLGGMDTND
EGEIWIDGVNIADYSSHQRTNYRRNDVGFVFQFYNLVSNLTAKENVELASEIVTDALNPD
QVLTDVGLAHRLNNFPAQLSGGEQQRVSIARAVAKNPKILLCDEPTGALDYQTGKQVLKI
LQDMSRQKGATVIIVTHNGALAPIADRVIHMHDASVKDVVLNQHPQDIDSLEY
>WP_000811482.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MKQLISLKNIFRSYRNGDQELQVLKNINLEVNEGEFVAIMGPSGSGKSTLMNTIGMLDTP
TSGEYYLEGQEVAGLGEKQLAKVRNQQIGFVFQQFFLLSKLNALQNVELPLIYAGVSSSK
RRKLAEEYLDKVELTERSHHLPSELSGGQKQRVAIARALVNNPSIILADEPTGALDTKTG
NQIMQLLVDLNKEGKTIIMVTHEPEIAAYAKRQIVIRDGVISSDSAQLGKEEN
>WP_011764567.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MSPRDTLRFAAGAAFGYPLRTALMVLAMAIGVAAVVVLTALGDGARRYVVGEFASLGANL
IIVLPGRNETGGVNAGSFVTSTPRDLTVADASALLRAPLAARMAPLSVGNSEIAVGGKLR
EVMVLGTSADYLDIRHYSLSQGRFLPREDLNRAGAVAVIGDKLREELFGNEPAVGRMVRV
GDTRLRIIGVMARGAQGLGLNTDELVIVPVATALAMFNTNTLFRIMVEARSREALGPAQK
QMEDILRARHDGELDVTLITQDAVLGTFDRILGALTMAVAGIAAISLAVAGILVMNVMLV
AVTQRTGEIGLLKALGASARTIRLAFLTEAALLSLAGALVGYGLGQLGAWAIRLTWPVLP
AWPPDWAVVAGLGTALGTGLLFGVLPARRAARLDPVQALAKR
>WP_000571330.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MIELKNITKTIGGKVILDNLSLRIDQGDLVAIVGKSGSGKSTLLNLLGLIDGDYSGRYEI
FGQTNLAVNSAKSQTIIREHISYLFQNFALIDDETVEYNLMLALKYVKLPKKDKLKKVEE
ILERVGLSATLHQRVSELSGGEQQRIAVARAILKPSQLILADEPTGSLDPENRDLVLKFL
LEMNREGKTVIIVTHDAYVAQQCHRVIELGEGK
>WP_011764566.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|M621_20535|antibiotic efflux|0
MLWRDFLQLALRSLTAHRLRSFLTLLGIGVGIAAVILLTSIGEGLHRFVLQEFTQFGTNI
IKVTPGKTGARGGPPGLPSTTRELTLDDAAALARAPYVTGITPTVSGNSEVRANGRVRRT
FIMGAGAQMQQVFSMRVKSGRFLPPDDAAHARAFVVLGATLKRELFGNANALGERLQIGG
ERYRVIGVMESKGQFLGIDLDDAAYIPAARALALYNRDGLMEINVTYNEGVSAARAAAEV
RKVMRARHGREDFTLTTQEDMLATLSNILGILTAAVGALGGISLLVGGVGIVTIMTIAVA
ERTAEIGLLVALGARRTTILGLFLGEAVALAAIGGAVGLAVGAGLAQLVGLAVPALPVST
PWRFVAIAEALAVLIGLTAGVLPARRAARLDPVEALRAQ
>YP_001708126.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MTKQALLEVSNLVREFPAGESTIQILKGIDLTIYEGELVAIVGQSGSGKSTLMNILGCLD
RPTSGSYKVNGQETGKLEPDQLAQLRREYFGFIFQRYHLLGDLSAEGNVEVPAVYAGVTP
ADRKQRATALLTELGLGTKTQNRPSQLSGGQQQRVSIARALMNGGDVILADEPTGALDSH
SGVEVMRILRELNAAGHTIILVTHDMQVAKNATRIIEISDGEIISDRPNVPDQSLEEVKS
DPDAAPALQNKQKKGKSISAWRSTLDRLSEAFQMALLSMNAHRMRTFLTMLGIIIGIASV
VTVVALGNGSQQQILSNISSLGTNTITVFQGRGFGDNSKTANFKTLVPADADALMTQPYV
SAVSPMVSTSKTMRSQQNEANATINGVSNDYFDVKGLVFKDGQTFDQRSVRDRSQDVVID
TNTQKQFFSDGTNPIGQVVLLGSVPARIIGIVEPQTSGMGSDDTLNVYMPYTTVMSRMLG
QAHVRNIVVRINDKYSTSAAENAIVNLLTQRHGAQDIFTMNSDSIRQTIEKTTSTMTLLV
SAIAVISLVVGGIGVMNIMLVSVTERTQEIGVRMAVGARQSDILQQFLIEAILVCLIGGV
LGVLLSLGLGQLINKFAGGNFAVAYSTTSIVAAFVCSTLIGVVFGFLPAKNAAKLDPVAA
LSRE
>WP_001347297.1|FEATURES|NCBI|multidrug|marA|antibiotic efflux|0
MTMSRRNTDAITIHSILDWIEDNLESPLSMEKVSERSGYSKWHLQRMFKKETGHSLGQYI
RSRKMTEIAQKLKESNEPILYLAERYGFESQQTLTRTFKNYFDVPPHKYRMTNMQGESRF
LHPLNHYNS
>CBZ41941.1|FEATURES|resfam|beta_lactam|mecR1|antibiotic target replacement|1
MLQQFLIMSIISSIMTLLLIMIVRIICIKYFKAQLNHKVWLLVVLSIFLPLIPINNLLQL
NIPGILSSDMISHSSKSINHNLSNENTNLTKDLALDIQHHEMPFILIILLVVWFIGLIFF
SFKFISAIKQIAFIKDLSIRSPILDNQLKKCINDLNIKEKSIAIIHVDEVENPMVFWLGK
YYIVLPTNIMDMMEEEEIDYIISHELIHIKNKDLWGNYIFTIFTSIVWFNPALHLAKKLF
NIDCEISCDNQVLTKLSQSNHTSYGKAILKCWAIQKQSVNNFAAKYLLGTQSNLKSRIVN
VSKFKNTRNRKWKFLPYVVLSVLILLQGLMVSDHSDKNEYTDDIKYTNLKGLGSHFSGFK
GSFVLYDNQKKEYFLYNEKESRKRYTPDSTYKPYLALIGFDKNVMSLNNTEQKWNGNENV
FKEWNQNQNLSSAMRYSVNWYFENIDRSIKNKDLKNYISELQYGNENISGSKNYWNESSL
KISAIEQVKLLMKIDNQQLKFDENYINAVKDSITLKKANQYRYLGKTGTGIINGKETNGW
FIGTIEKNGKSYYFATHLDGKNNASGKKAKDISEKILEEMELMQ
>WP_001549960.1|FEATURES|resfam|beta_lactam|mecR1|antibiotic target replacement|1
MLSSFLMLSIISSLLTICVIFLVRMLYIKYTQNIMSHKIWLLVLVSTLIPLIPFYKISNF
TFSKDMMNRNVSDTTSSVSHMLDGQQSSVTKDLAINVNQFETSNITYMILLIWVFGSLLC
LFYMIKAFRQIDVIKSSSLESSYLNERLKVCQSKMQFYKKHITISYSSNIDNPMVFGLVK
SQIVLPTVVVETMNDKEIEYIILHELSHVKSHDLIFNQLYVVFKMIFWFNPALYISKTMM
DNDCEKVCDRNVLKILNRHEHIRYGESILKCSILKSQHINNVAAQYLLGFNSNIKERVKY
IALYDSMPKPNRNKRIVAYIVCSISSFT
>WP_001071135.1|FEATURES|resfam|peptide|mprF|antibiotic target alteration|0
MNQEVKNKIFSILKITFATALFIFVAITLYRELSGINFKDTLVEFSKINRMSLVLLFIGG
GASLVILSMYDVILSRALKMDISLGKVLRVSYIINALNAIVGFGGFIGAGVRAMVYKNYT
HDKKKLVHFISLILISMLTGLSLLSLLIVFHVFDASLILDKITWVRWVLYVVSFFLPLFI
IYSMVRPPDKNNRFVGLYCTLVSCVEWLAAAVVLYFCGVIVDAHVSFMSFIAIFIIAALS
GLVSFIPGGFGAFDLVVLLGFKTLGVPEEKVLLMLLLYRFAYYFVPVIIALILSSFEFGT
SAKKYIEGSKYFIPAKDVTSFLMSYQKDIIAKIPSLSLAILVFFTSMIFFVNNLTIVYDA
LYDGNHLTYYILLAIHTSACLLLLLNVVGIYKQSRRAIIFAMISILLITVATFFTYASYI
LITWLAIIFVLLIVAFRRARRLKRPVRMRNIVAMLLFSLFILYVNHIFIAGTLYALDIYT
IEMHTSVLRYYFWLTILIIAIIIGMIAWLFDYQFSKVRISSKIEDCEEIINQYGGNYLSH
LIYSGDKQFFTNENKTAFLMYRYKASSLVVLGDPLGDENAFDELLEAFYNYAEYLGYDVI
FYQVTDQHMPLYHNFGNQFFKLGEEAIIDLTQFSTSGKKRRGFRATLNKFDELNISFEII
EPPFSTEFINELQHVSDLWLDNRQEMHFSVGEFNEEYLSKAPIGVMRNEENEVIAFCSLM
PTYFNDAISVDLIRWLPELDLPLMDGLYLHMLLWSKEQGYTKFNMGMATLSNVGQLHYSY
LRERLAGRVFEHFNGLYRFQGLRRYKSKYNPNWEPRFLVYRKDNSLWESLSKVMRVIRHK
>YP_188509.1|FEATURES|NCBI|peptide|mprF|antibiotic target alteration|0
MTQELKSKLLSFFKFIFATALFIFVIFTLYRELSHINFKETFIQFGKINRLWLVLLFAGG
GLSLILLSLYDIILVKALKLKMPLIRVFRVSYIINALNSIIGFGGFIGAGVRAFVYKNYT
NDTKKLVQYISIILVSMLTGLSLLSILVVLRIFNASHMIDEISWVRWILYIVALFLPIFI
FYTVARPVDRNNRYMGVYCTVVSCVEWMAAATVLYFAALIVDIHISFMTFVGIFVIAALS
GLVSFIPGGFGAFDLVVLLGLKSLGISEEKILLALVLYRFAYYFVPVMIALILSSFEFGN
TAKKYLDNSKYFIPVKDFTSFLRSYQKDILAKVPSFSLAILIFLTSIIFFINNLTIVYDG
LYDGNHFAYYIALAIQTSACLLLILNVRGIYKGSRRAIIYAFISIILIASATIYTYASFL
LLSWLIIIFVLLILAYQRAQVLKRPLRFKKLAFMLLLSIFILYLNHILISGTLYALDVYH
IEIDTSLLRYYFWMTIVIIMLLVGVIAWLFDYKYKRPHHSIDLTLCDAIIQKYGGNYLSH
LVYSGDKDCFFNENKDSFIMYRYKSNALVVLGDPIGNTKSFESLLEAFYQFAEYQGYEII
FYQISDQYMPLYHNFGNQFFKLGEEAIIDLTTFTTSGKKRRGFRATLNKFDDLNINFEII
EPPFTQDFFDELKFVSDKWLDGRSEMHFSVGQFTQTYLSKAPIGVMRDHSGKMIAFCSLM
PTYSNNAISVDLIRWLPELDLPLMDGLYLHMLLWSKEKGYKAFNMGMATLSNVGQLHYSY
LRERMAGRVFEHFNGLYRFQGLRRYKEKYSPNWEPRFLVYQKHYSLWESMLKVMRVIRHK
>NP_309628.1|FEATURES|resfam|multidrug|phoQ|antibiotic target alteration|0
MKKLLRLFFPLSLRVRFLLATAAVVLVLSLAYGMVALIGYSVSFDKTTFRLLRGESNLFY
TLAKWENNKLHVELPENIDKQSPTMTLIYDENGQLLWAQRDVPWLMKMIQPDWLKSNGFH
EIEADVNDTSLLLSGDHSIQQQLQEVREDDDDAEMTHSVAVNVYPATSRMPKLTIVVVDT
IPVELKSSYMVWSWFIYVLSANLLLVIPLLWVAAWWSLRPIEALAKEVRELEEHNRELLN
PATTRELTSLVRNLNRLLKSERERYDKYRTTLTDLTHSLKTPLAVLQSTLRSLRSEKMSV
SDAEPVMLEQISRISQQIGYYLHRASMHGGTLLSRELHPVAPLLDNLTSALNKVYQRKGV
NISLDISPEISFVGEQNDFVEVMGNVLDNACKYCLEFVEISARQTDEHLYIVVEDDGPGI
PLSKREVIFDRGQRVDTLRPGQGVGLAVAREITKQYEGKIVAGESMLGGARMEVIFGRQH
STPKDE
>WP_006177023.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
MMNQRAEGERNMTISAQVIDTIVEWIDDNLHQPLRIEEIARHAGYSKWHLQRLFMQYKGK
SLGRYIRERKLLLAARDLRESDERVYDICLRYGFDSQQTFTRIFTRTFHQPPGAYRKENH
TRAH
>P55922.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
MTISAQVIDTIVEWIDDNLHQPLRIEDIARHAGYSKWHLQRLFLQYKGESLGRYIRERKL
LLAARDLRESDERVYEICLRYGFESQQTFTRIFTRTFHQPPGAYRKENHSRTH
>NP_671020.1|FEATURES|NCBI|multidrug|robA|antibiotic efflux|0
MDQASIIRDLLSWLESHLDQPLALDNVAAKAGYSKWHLQRMFKDVTGNAIGAYIRARRLS
KAAVALRLTSRPILDIALQYRFDSQQTFTRAFKKQFAQTPALYRRAEDWHSSGICPPIRL
GTYTLPQPEFITLPEQHLVGITQSYSCTLEQISTHRAELRLHFWQQYLGDADQLPPVLYG
LHHSRPNPEKDDEQEIFYTTAIEPQHIPCNVPEGQPVILQGGEYVQFSYDGPLDGLQNFI
LTLYGTILPQLALIRRRGYDIERFYPQGRPKDGPPATLKCDYFIPIRR
>WP_006177022.1|FEATURES|NCBI|tetracycline|tet37|antibiotic inactivation|0
MKKPLFICVVFVMIIASAASLPFVLNAGFGQPPQGDQLSGLQASPQYRDGAFHNALPTPG
YNGDKNMLVAMWEFLTKKTENARPAQPLPLVNTDLASLPLAQDTLVWLGHSSWYLQLAGK
RILIDPVLGNYAAPFSFLNKAFEGDYPWRAASMPEIDLLIISHDHYDHLDYATIKALLPK
VKRVVTPLGVGSHLRYWGMDPTIIDERDWNQSVRISEALTVHVLPARHFSGRGIKRNQTL
WGSFMFVTPEQKVYYSGDSGYGPHFRDIGEQFGAVDLAIMENGQYDQDWKYIHMLPDETA
QAAADLNAKAVVPGHNGRFVLAKHTWNDPLIQLAKASRDKGYRLLTPELGEPVRVNDTAQ
QFRPWWE
>WP_006809718.1|FEATURES|NCBI|tetracycline|tet37|antibiotic inactivation|0
MKKPLFICVVLVMIIASAASLPFVLNAGFGQPPQGAQLSEVEASPHYRDGQFHNTLPTPG
FTGQQNMLVAWWQFLTRKTENARPAQPLPLVKTDLASLSPDQDTLVWLGHSSWYMQLAGK
RILIDPVLSNYAAPFSFLNKAFAGEYPWRAESMPEIDLLIISHDHYDHLDYATIKALLPK
VKRVVTPLGVGSHLRYWGMSQDIIDERDWNQSVHISDALTVHVLPARHFSGRGIKRNQTL
WGSFMFVTPERKVYYSGDSGYGPHFKSIGEQFGGVDLAIMENGQYDQDWKYIHMHPAETA
QASADLNAKAVVPGHNGRFVLAKHTWNDPLIQLAKASKDKNYRLLTPELGEPVRVSDSTQ
QFREWWE
>1613275A|FEATURES|NCBI|beta_lactam|romA|antibiotic inactivation|0
MKKTLFICVVFVMIIASAASLPFVLNAGFGQPPQGAQLTEVEASPHYYEGKFHNTLPTPG
FTGQQNMLVAWWQFLTRKTENARPAQPLPLVKTDLASLPLEQDTLVWLGHSSWYLQLAGK
RILIDPVLGNYAAPFSFLNKAFAGEYPWRAASMPEIDLLIISHDHYDHLDYATIRALLPK
VKRVVTPLGVGSHLRYWGMKPEIIDERDWNQSVHISDALTVHLLPARHFSGRGIKRDQTL
WGSFMFVTPEQKIYYSGDSGYGPHFKAIGEQFGDVDLAIMENGQYDQDWKYIHMLPEETA
QASVDLNAKAVVPGHNGRFVLAKHTWNDPLIQLAKASKDKNYRLLTPELGEPVRVSDTTQ
TFRQWWE
>WP_011766345.1|FEATURES|resfam|multidrug|golS|antibiotic efflux|0
MSLDIAEVARQSGVPASTLRYYEEKGLIAALGRQGQRRVFADGVLERLALIALGRASGFS
LDEIAAMFAPDGGLQIDRALLRRRADELDQRIRQLSAMRDGLRHAAQCSAPSHLECPTFR
RILRAAAIGALGPRPRQTPRRPGAT
>YP_001083264.1|FEATURES|resfam|multidrug|golS|antibiotic efflux|0
MDIGEVAKKAKVTTATLRFYEEKGLIKSIGRQGLRRQYGKQVIDQLALIALGRAAGFSLN
EIATMFGQDGKPDLDRQKLKDKAEQLEQMAKRLHFISQGLEHAAVCPAENHMECPTFQKF
LKAAIAGEYQPTKL
>WP_000351003.1|FEATURES|resfam|multidrug|golS|antibiotic efflux|0
MDIGEVSKKAKVTTATLRFYEEKGLIKSIGRQGLRRQYGKQVIDQLALIALGRAAGFSLN
EVATMFRQDGKPDLDRQKLKDKAEQLEQMAKRLHFISQGLEHAAVCPAENHMECPTFQKF
LKAAIAGEYQPTKL
>WP_000004112.1|FEATURES|resfam|multidrug|golS|antibiotic efflux|0
MLTVGEVAKRSGVAVSTLHFYESKGLIKSIRTNGNQRRFTLVVLRYIAIIKIAQKVGIPL
DEIKQALSKYPMGSKLTAQQWKELSLDWRKNLDERIQKLTRLRDEMDWCIGCGCLSLEQC
PLRNPNDVLGQEGAGPRILERP
>WP_001985623.1|FEATURES|resfam|triclosan|OpmH|antibiotic efflux|0
MKIKLMLVAGLWSFTSSSFALDLVETYERAKLNDPTWQANQQQFEADQLNLGLATGALLP
TVTLSGNITRNRQTVKRSNFPGVDQEGLSDALVSNTSTTKQATLSARQPLFRMDAWEGYK
QVKTSVALSEITLRLQKQDHVLNVAEAYFNVLRQQALTAAYLQEEKALLEQLNMMNAKLK
EGLVARSDVSEANAQYQNARANRIATNVQLLLAQEQLTEYIGPYQDKLAVLRSDFIFQKP
YPAQLDEWLGLAQQQNLKIQQARLQKRYAEDQRRVEKAALYPQIDAVASYGYTKQTPETL
ISTDGKFDQVGVEMNWNLFNGGRTRTSIKKASVELNKAQAQLDAAIRRANVDVKSAFMQV
DTDRAKLEARKAAMDSSALVSQASKASYNEGLKSMVDVLLAQRNAFSAKQDYLNAQYDYL
LNVLRLKAAVGQLGEKDLVELNSWLTYQ
>YP_001708355.1|FEATURES|resfam|triclosan|OpmH|antibiotic efflux|0
MKIKLMLVAGLWSFTSSSFALDLVETYERAKLNDPTWQANQQQFEADQLNLGLATGALLP
TVTLSGNITRNRQTVKRSNFPGVDQEGLSDALVSNTSTTKQATLSARQPLFRMDAWEGYK
QVKTSVALSEITLKLQKQDHVLNVAEAYFNVLRQQALTAAYLQEEKALLEQLNMMNAKLK
EGLVARSDVSEANAQYQNARANRIATNVQLLLAQEQLSEYIGPYQDKLAVLRSDFIFQKP
YPAQLDEWLGLTQQQNLKIQQARLQKRYAEDQRRVEKAALYPQIDAVASYGYTKQTPETL
ISTDGKFDQVGVEMNWNLFNGGRTRTSIKKASVELNKAQAQLDAAIRRANVDVKSAFMQV
DTDRAKLEARKAAMDSSALVSQASKASYNEGLKSMVDVLLAQRNAFSAKQDYLNAQYDYL
LNVLRLKAAVGQLGEKDLVELNSWLTYQ
>WP_011764584.1|FEATURES|resfam|multidrug|TolC|antibiotic efflux|0
MKRSLAAKLFAAGLAAAFGAPAAAADLLQTYRDALANDARYAAARAERDAGMERVVQARA
GLLPNLTASASTAYNDGEARTSAVSVDRRYNSNGYAVQLTQPLFRWQNWVQYKQGELQTA
LAETQFGQARQDLILRVAEAYFNVLNAQDALDAVVQLRTAAAEQLELARRSFEVGTVTIT
DVHEAQSRYDLASAQEIAARNDLDVQRQTLAQIIGREPDPLAPLRAGVELQRPQPDSIAD
WVGAAEQGSFGVQGQQLNREIAAREVERARAGHLPTLDLVASRGLNQRPSITTERSEASS
IGLQLNVPLYQGGAVSSRERETAALKLKADADLEDARRGAALAARQSYLGVTSGLAQIRA
LEAARISSASALEANRLGYEVGVRINIDVLNAQTQLADTQQRLARARYDTLLAQLRLKAA
AGTLGDEDVQAINALLAP
>WP_000677758.1|FEATURES|resfam|multidrug|TolC|antibiotic efflux|0
MKGMKPFNTRFLTLRHALYLGVLLVSNTHAMTLDEALSASLRHESQLEVSRLSVNQSTAM
LEQAKQRDGLKVNLVGQLDYERINTPSHVLFPTEGNRKGRSLQLQADYPIYTSGRHRLGI
DIAESQLSAQHQGLSDQRSETILNTVMVYTDVLKKKAILELRQKTMANLQRSLYESKRRF
DVGMITRADLAQVLAQVAQGQADITQAQSNLTVSEAQFYQVTGITPDNLVPINQLPTIPA
NLDEILAQTKNHPALMRAKYEKQAAEKQYALTKRELWPTVMLTSRAGKQDEASYIGSESN
NYMVGVQLNVPLYDDGLNRANVKKAQADIDLAAQKIRSLELDLNKRTRTTYAQLQTIRQN
KDALANAIEAASIAFVYTRKEFDVGTKTTFDLLNTEQKLLDAQTQKTVNDQDEVVFVYQL
LDQMGRLNNLVPMQTAQQVNNE
>AAF71277.2|FEATURES|resfam|glycopeptide|vanRG|antibiotic target alteration|0
MRDPICIADDDRESADIMELHLERTVMKSINLTMDRCRRCAESEKMDLAMLDVMLPDVEG
FHICQKIREGYFDPTIMRTAKEEDADKNTGLTIGADDYITKPFIPVEVAAGVKTQLRRHV
GYNNAAAIDKEHVLVTEYDINGLVLHENTHKCTPYGKAVTLTPIEFSVLCDQCENQGKQR
FLQRMIKAIVWGEKFLDNNNTVMAHIGRLREKLKEPARNPKFIKTVWGVGYTIEE
>AAM80541.1|FEATURES|resfam|glycopeptide|vanRO|antibiotic target alteration|0
MRVLIVEDELYMAEAIRDGLRLEAIAADIAGDGDTALELLSVNAYDIAVLDRDIPGPSGD
EVAERIVATGSGMPILMLTAADRLDDKASGFQLGADDYLTKPFELRELILRIRALDRRRA
HIRPPVREIAGLRLDPFRREVYRDDRYIALTRKQFAVLEVLVAAEGGVVSAEELLERAWD
ENADSFTNAVRITVSALRKRLGEPQIIATVPGVGYRIATPTDIRREGDAGA
>CAG25752.1|FEATURES|resfam|glycopeptide|vanRO|antibiotic target alteration|0
MRVLIVEDEPYLAEAIRDGLRLEAIAADTAGNGDTALELLSLNTYDIAVLDRDIPGPSGD
EIAKRIVASGSGLPILMLTAADRLDDKITGFELGADDYLTKPFELRELVLRLRALDRRRA
HNRPPVLEIAGLRLNPFRREVYRDDRYIALTRKQFAVLEVLVSADGGVVSAEELLERAWD
KNADPFTNAVRITVSALRKRLGEPWIITTVAGVGYRIGAAPGAGR
>CAG15006.1|FEATURES|resfam|glycopeptide|vanSO|antibiotic target alteration|0
MDRAPGLSVRLKLTLSYAGFLMLAGASLLATVWVYLLRGLPDTAMSSRGLVPIKTIVLHA
FAPATAGVLLFLLVFGLLGGWLLAGRMLAPLTRITEATRMAANGSLSHRIELDGRKDEFR
ELADAFDIMLTRLEAHIAEHQRFAANASHELRTPLAITKTLLDVARTDPARSTHELIGRL
HTVNTRAIDLTEALLLLSRADRRSFKREYVDLSLNVEEAIETLLPLAEKHGVTIEASGDI
TPTVGSRALLLQMTINLLHNAIVHNVAEERIVWVTTSVHPKSVTLTVENTGEQLSAQLVS
TLTEPFQRGTERIHHDHAGVGLGLAIVKSIAHAHDGTLTTAPRAGGGLHVTVQLPAATTP
PRN
>AAM80542.1|FEATURES|resfam|glycopeptide|vanSO|antibiotic target alteration|0
MRVHRAPGMSVRLKFTLSYAGFVMLAGTLMLVTVWVYLLRGLPDAASSPNGLVPVRAIVL
HAYAPATAVVLALLLVFGLLGGWLLAGRMLAPLTRITDATRTAANGSLSHRIELEGRKDE
FRELADAFDTMLARLEAHVAEQRRFAATASHELRTPLAITKALLEVTINGPGRDLGELIG
RLHNVNARAIDLTEALLLLSRADQRSFTREPVDLSLNVEEAVETLLPLAEKHGVAIEASG
DITPAMGSRALLLQLTVNLIHNAIVHNLHGRGIVRVTTGIESGSVTLSVENTGEVLPAQL
VSTLTEPFRRGTERIRQDHAGVGLGLAIVKSITEAHDGTLTIVPRPGGGLQVTVRLPAAP
PPETLNR
>CAG25751.1|FEATURES|resfam|glycopeptide|vanSO|antibiotic target alteration|0
MDRAAGMSVRLKLTLSYACFLVLAGVLLLASVWLFLLRDVPDVLAKPPPGGVLERSVLVR
NFLPAAGSVLFFLLLFGLLGGWILAGRMLAPLTRITDAARMAANGSLSHRIRLEGTEDEF
RELADAFDAMLARLEAHVAAQRRFAANASHELRTPLAITQALLEVARNDPAKDPLLVFDR
LHAVNARAIDLTEALLVLSRADQRAFTREPVDLSLLVEEAIETLLPIAEKRRVVIIASGH
ISRVVGSATLLLQ
>AAV68179.1|FEATURES|resfam|glycopeptide|vanSE|antibiotic target alteration|1
MKNNLTVQITKKYFYTMIIITTILVILPLVAKMFLSLRVWQGTEFFYPILYILNRSLGVW
LIVTPLFIWLIVTYMFFRKMISYLEEMIVATKSLIETPNEKIVLRVELAEFENEINHIRI
DSLENKKMAEEAGKKRDDLLTYLAHDLRTPLTSIIGYISLLQNEQTYLELDSTKRKNYID
IISDKANRLEHLLNDFFEIAKTGKSREEVYKEEVDLSLMLSQISSEFLPLLDEKKLEWDF
KIEPNVFVQLNINKFERVLDNLIRNAISFAQ
>AAD02118.1|FEATURES|resfam|glycopeptide|vanXO|antibiotic target alteration|1
MKPTESMTDGFVFADDLVPGLRWDAKYATWDNFTGKPVDGYLVNRIVGTKALCAALERAR
DEAASLGFGLLLWDGYRPQRAVDCFLRWSQQPEDGRTKSRHYPNIARAEMFEKGYVAARS
GHSRGSTVDLTLYDLATNELVPMGGDHDLMDPVSHHGAQGLAPVEARNRQHLRSVMESCG
FKAYEYEWWHYTLADEPYPDTYFDFPIM
>AAK45103.1|FEATURES|resfam|glycopeptide|vanXA|antibiotic target alteration|0
MSAGRWSESPSATSWPVRPVNTTTPSGPVPPVSEAARAAGLVDVRGVVPDAAIDLRYATA
NNFTGTQLYPPGARCLVHESMAEGLAAAAAVLRPHGQVLVFWDCYRPHDVQVRMFDVVPN
PAWVARPGKYAHSHEAGRSVDVTFASAQRQCPSVRRSGELCLADMGTDFDDFSSRATAFA
TQGVSAEAQANRAHLRAAMQAGGLTVYSGEWWHFDGPGAGVDRPILEVPVD
>ADO66792.1|FEATURES|NCBI|glycopeptide|vanYA|antibiotic target alteration|1
MKMKKLFFLLLLLFLIYLGYDYVNEALFSQEKVEFQNYDQNPKEHLENSGTSENTQEKTI
TEEQVYQGNLLLINSKYPVRQESVKSDIVNLSKHDELINGYGLLDSNIYMSKEIAQKFSE
MVNDAVKGGVSHFIINSGYRDFDEQSVLYQEMGAEYALPAGYSEHNSGLSLDVGSSLTKM
ERAPEGKWIEENAWKYGFILRYPEDKTELTGIQYEPWHIRYVGLPHSAIMKEKNFVLEEY
MDYLKEEKTISVSVNGEKYEIFYYPVTKNTTIHVPTNLRYEISGNNIDGVIVTVFPGSTH
TNSRR
>AAA26657.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|MsrA|antibiotic target protection|0
MLTQVRFQIPYGKNIALVGANGVGKTTLLEAIYHQIEGIDCSPKVQMAYYRQLAYEDMRD
VSLLQYLMDETDSSESFSRAILNNLGLNEALERSCNVLSGGERTKLSLAVLFSTKANMLI
LDEPTNFLDIKTLEALEMFMNKYPGIILFTSHDTRFVKHVSDKKWELTGQSIHDIT
>CAA54269.1|FEATURES|NCBI|chloramphenicol|ND00_04320|antibiotic inactivation|1
MFRAMRPKRHELPTDESVGILKRMTNGTLALHGDGDYPYAVPVSYVYSDGRIYFHTATQG
HKVDALMRNDKVSFCVVEQDDVKSAEFTTYFRSVIPFGRARILTDETENGAALQLLADKY
SSGMPGLEAVIAKGFRHLLMVEIDIEHLTGKESIELVREKNDM
>AAA26034.1|FEATURES|NCBI|tetracycline|tetK|antibiotic efflux|1
MFSLYKKFKGLFYSVLFWLCILSFFSVLNEMVLNVSLPDIANHFNTTPGITNWVNTAYML
TFSIGTAVYGKLSDYINIKKLLIIGISLSCLGSLIAFIGHNHFFILIFGRLVQGVGSAAF
PSLIMVVVARNITRKKQGKAFGFIGSIVALGEGLGPSIGGIIAHYIHWSYLLILPMITIV
TIPFLIKVMVPGKSTKNTLDIVGIVLMSISIICFMLFTTNYNWTFLILFTIFFVIFIKHI
SRVSNPFINPKLGKNIPFMLGLFSGWANIFYSSWFYINGALYDENYLSCKCSDNR
>CAA25445.1|FEATURES|NCBI|trimethoprim|dfrA1|antibiotic target replacement|1
MKLSLMVAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYA
VVTRSSFTSDNENVLIFPSIKDALTNLKKITDHVIVSGGGEIYKSLIDQVDTLHISTIDI
EPEGDVYFPEIPSNFRPVFTQDFASNINYSYQIWQKG
>CAB41447.1|FEATURES|NCBI|trimethoprim|dfrA1|antibiotic target replacement|1
MKLSLMVAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYA
VVTRPSFTSDNENVVIFPSIKDALTNLKKITDHVIVSGGGEIYKSLIDQVDTLHISTIDI
EPEGDVYFPEIPSNFRPVFTQDFASNINYSYQIWQKG
>AAD51057.1|FEATURES|NCBI|glycopeptide|vanSD|antibiotic target alteration|1
MKNRNKTSHEDDYLLFKNRLSVKILLMMVYSILIIAGVYLFILKDNFANVVVAILDSFIY
HDRDEAVAVYLRTFKAYEIWLFLIAVMGVFFMIFRRYLDSISKYFKEINRGIDTLVNEDA
NDIGLPPELASTERKINSIRHTLTKRKTDAELAEQRKNDLVMYLAHDLKTPLSSVIGYLN
LLRDENQISEELREKYLSISLDKAERLEELINEFFEITRFNLSTSRLCTAKSI
>AAG44836.1|FEATURES|NCBI|beta_lactam|penP|antibiotic inactivation|1
MTFSALPFRRADRRRLLAAALAACALTLTAACDSGTVTVPVTDSVTTSAVADPRFAELET
TSGARLGVFAVDTGSGRTVAHRADERFPMASTFKGLACGALLREHPLSTGYFDQVIHYSA
AELVEYSPVTETRVETGMTVRELCDAAITVSDNTAGNQLLKLLGGPEGFTASLRSLGDAT
SRLDRWETDLNTAIPGDERDTTTPAALAADYRALVVGDVLGAPERDQLKAWLVANTTGAT
RIRAGLPADWTVGDKTGSPAYGSALDVAVAWPPGRAPIVIAVLSTKSEQDAEPDNALLAE
ATRVVVDALG
>CAC20135.1|FEATURES|NCBI|tetracycline|tetE|antibiotic efflux|1
VMMALVIIFLDAMGIGIIMPVLPALLREFVGKANVAENYGVLLALYAMMQVIFAPLLGRW
SDRIGRRPVLLLSLLGATLDYALMATASVVWVLYLGRLIAGITGATGAVAASTIADVTPE
ESRTHWFGMMGACFGGGMIAGPVIGGFAGQLSVQAPFMFAAAINGLAFLVSLFILHETHN
ANQVSDELKNETINETTSSIREMISPLSGLLVVFFIIQLIGQIPATLWVLFGEERFAWDG
VMVGVSLAVFGLTHALFQGLAAGFIAKHLGERKAIAVGILADGCGLFLLAVFTQSWMVCP
VLLLLACGGITLPALQGIISVRVGQVAQGQLQGVLTSLTHLTAVIGPLVFAFLYSATRET
WNGWVWIIGCGLYVVALIILRFFHPGRVIHPINKSDVQ
>AAK50437.1|FEATURES|NCBI|fosfomycin|fosX|antibiotic inactivation|1
MTTFLCDGLGAREVYDSAGHNYSLSREKFFVLGGVWLAAMEGVPPSERSYQHVAFRVSES
DLAVYQARLGSLGVEIRPPRPRVNGEGLSLYFYDFDNHLFELHTGTLEQRLARYGAGR
>CAD11597.1|FEATURES|NCBI|trimethoprim|dfrA7|antibiotic target replacement|1
MKISLISATSENGVIGNGPDLPWSAKGEQLLFKALTYNQWLLVGRKTFDSMGVLPNRKYA
VVSRKGISSSNENVLVFPSIEIALQELSKITDHLYVSGGGQIYNSLIEKADIIHLSTVHV
EVEGDINFPKIPENFNLVFEQFFLSNIITHIRFGKKANKSFQHQPALLGQFLSRGFMVFC
AKVFHKTTT
>CAD56147.1|FEATURES|NCBI|bacitracin|uppP|antibiotic inactivation|1
MFREMRRKRQQLSAEESIAILERMTNGVLALHGDEGYPYAVPVSYVYADGKIYFHSAMKG
HKVDAIMRNERVSFCVVERDDVCPGEFTTYFRSVVLFGKTRILTEEAEKLAALSLLADKY
SPGEPGKDAEIAKGFNLLMVEIAVEHMTGKEA
>AAO42741.1|FEATURES|NCBI|tetracycline|fusA|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDALLEKYIAGEPISQEKLAREEQRRVQEASLFPVYHGSAKKGLGIQPLMDAVTGLFQP
IGEQGSATLCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILPSDSVRLNDVLGDQTRLPRKRWREAPLPMLRTTIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKIETVVKEPTVIY
MERPLKAASHTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFNKLA
>AAP46576.1|FEATURES|NCBI|beta_lactam|pbp2b|antibiotic target alteration|0
MLIKSEYKPRMLPKEEQVKKPMTSNGRISFVLMAIAVLFAGLIARGLYLQTVTYNFLKEQ
GDNRIVRTQTLPATRGTVSDRNGAVLALSAPTESLFAVPKEMKEMPSAAQLERLSELVDV
PVDVLRNKLEQKGKSFIWIKRQLDPKVAEEVKALGLENFVFEKELKRHYPMGNLFAHVIG
FTDIDGKGQEGLELSLEDSLHAEEGAEVVLRDREGNIVDSLDSPRNKAPQNGKDIILSLD
QRIQTLAYEELNKAVEYHQAKAGTVVVLDARTGEILALVNTPAYEPNKPGQADSEQRRNR
AVTDMIEPGSAMKPFTIAKALDSGKVDATDTFNTLPYKIGPATVQDTHVYPTLDVRGIMQ
KSSNVGTSKLSAMFTPKEMYDFYHDLGVGVRMHSGFPGETAGLLRSWRRWQKIEQATMSF
GYGLQLSLLQLARAYTVLTHDGELLPVSFEKQAVAPKGKRVIKASTAKKVRELMVSVTEP
GGTGTAGAVDGFDVGAKTGTARKLVNGRYVDNKHVATFIGFAPAKNPRVIVAVTIDEPTA
NGYYGGVVTGPPFKKIMGGSLNILGVSPTKPLTAAAVKTPS
>AAR37058.1|FEATURES|NCBI|glycopeptide|vanYD|antibiotic target alteration|0
MERQNNNENQYGRNRRKDKRRKLFFLQSSMCHARSAHSLCNFWSCVFSERE
>AAS76623.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|Erm(39)|antibiotic target alteration|1
MSSKNQGRHEHGQNFLCDRRVVADIVKIVSHTTGSIVEIGAGDGALTVPMQRLGRPLTAI
EIDRRRAERLARRTTAHVVTADFLRYRLPPTEHVVVGNLPFHLTTAILRRLLHSPAWTDA
VLLMQWEVARRRAAVGGATMMTAQWWPWFEFGLARKVSADAFRPRPSVDAGLLTITRRRE
PLIDGADRRRYQALVHAVFTGRGRGVAQIVGPRVPRHWLRHNGITPSALPRDLTAAQWAA
LFEVTSEAKRC
>AAS87023.1|FEATURES|NCBI|beta_lactam|blaPLA2a|antibiotic inactivation|1
MRQYRFALLPLLAALALPGWAHQATVTTVKQAESQLQGRVGYAELDLASGQLLAGYRSDE
RFPMMSTFKVLLCGAVLSRVDAGEEQLDRRIHYRQQDLVEYSPVTEKHLTDGLTVGELCA
AAITLSDNTAANLLLTTLGGPQGLTSFLRHSGDQTSRLDRWETELNEARPGDVRDTTTPQ
AMARTLRNLLTGRVLSSASQQQLQRWMVEDKVAGPLLRSVLPAGWFIADKTGAGNRGSRG
IIAALGPDGKAARIVVIYLTGTPAAMDERNKQIAAIGATLVTHWSADENRP
>ABD22979.1|FEATURES|NCBI|fosfomycin|FosX|antibiotic inactivation|1
MGILGISHLTFVVRDVERTARLVCEGLGAEEVYDSKAKNFSLSREKFFLLGGVWLAFMEG
VPSERSYRHVAFEVTEEEIARYEASLRNLGVEVREPRPRVAGEGLSLYFYDYDNNLFELH
AGTLAQRLERYTQ
>ABD98019.1|FEATURES|NCBI|tetracycline|tetS|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYSSGRIKELGSVDSGTTKTDTMFLERQRGITIQTAI
TSFQRENVKVNIVDTPGHMDFLADVYRSLSVLDGAILLISAKDGVQSQTRILFHALRKMN
IPIIFFINKIDQNGINLPDVYQDIKDKLSDDIIIKQTVNLNLKPYVIDYTEPEQWETVIV
GNDYLLEKYTIGKTLNIAELEKEENERIQSCSLYPVYHGSAKNNIGIKQLIEVITSKLFS
PTQLNSDKLCGNVFKVEYSDDGQRLVYVRLYSGTLHLRDSVNISEKEKIKVTEMYTSING
ELRQIDKAEPGEIIILKNELLKLNNVLGDKKRLPHREILENPLPMLQTTIEPCKSVQREK
LLDALFEISDSDPLLQYYVDTVTHEIVLSFLGEVQMEVTCTLIQEKYHIEIETRKPTVIY
MERPLKKSEFTIDIEVPPNPFWASIGLSVTPLPLGSGIQYESLVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWKLTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQAFRKSGTELLEPYL
SFEIYVPQEYLSRAYNDASKYCANILNTKLKGNEVILIGEIPARCIQEYRNSLTFFTNGR
SVCLTELKGYQVTNIKSAFQPRRPNNRIDKVRHMFNKINLH
>EAT07996.1|FEATURES|NCBI|beta_lactam|BEL-1|antibiotic inactivation|1
MKIVTALGALALLAAPASAADRQKTPAQEPAPTGNLDNLMPAAPRYLVPQSALEQVRNPK
EIEEETGGRLGVALVDRQGALLLGFNRDERFAMCSTFKAPLAAAVLTGADGGKFGLEGTI
PFGKEDVLDYAPVVKKNLKRGRMSMEELARAAVEVSDNSAANLLLPMLGGPEGLTAFMRV
HGDDVTRLDRTEPALNENAEGDPRDTTTPAAMAGLMARLFFRDLKAESADRLRAWFNASS
TGDKRIKAGLPEGWTSGSKTGSCGTAYNDVALVKSPTGEEYILAIYLDRPTIDAKKAEAA
IAEAARAALNFVGQARKSGLE
>ABN79416.1|FEATURES|NCBI|tetracycline|tetW|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLAVLDGAISVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDKLLEKYIAGEPISREKLVREEQRRVQDASLFPVYYGSAKKGLGIQPLMDAVTGLFQP
IGEQGSAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILADDTLKLNDILGNEKLLPHKTRIDNPMPLLRTTVEPQKPEQREA
LLNALAEIADTDPLLHFDIDTVTHEIMLSFLGKVQLEVICSLLEEKYHVGVAMKEPSVIY
LERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTNFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>CAM97383.1|FEATURES|NCBI|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDKLLEKYIAGEPISREKLVREEQRRVQDASLFPVYYGSAKKGLGIQPLMDAVTGLFQP
IGEQGSAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILADDTLKLNDILGNEKLLPHKTRIDNPMPLLRTTVEPQKPEQREA
LLNALAEIADTDPLLHFDIDTVTHEIMLSFLGKVQLEVICSLLEEKYHVGVAMKEPSVIY
LERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTNFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>CAP09892.1|FEATURES|NCBI|tetracycline|tetW|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDKLLEKYIAGEPISREKLVREEQRRVQDASLFPVYYGSAKKGLGIQPLMDAVTGLFQP
IGEQGSAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILPSDSVRLSDVLGDPTRLPRKRWREDPLPMLRTSIAPKTAAQRER
LLNALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPTVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFTLYAPREYLSRAYHDAPKYCATIETVQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGQ
SVCLTELKGYQAAVGKPVIQPRRPNNRLD
>CAP09893.1|FEATURES|NCBI|tetracycline|tetW|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDKLLGKYIAGEPISREKLVREEQRRVQDASLFPVYYGSAKKGLGIQPLMDAVTGLFQP
IGEQGSAALCGRVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILPSDSVRLNDVLGDPTRLPRKRWREDPLPMLRTSIAPKTAAQRER
LLNALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPTVIY
MERPLKAASRTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFTLYAPREYLSRAYHDAPKYCATIETVQVKKDEVVFTGEIPARRIQAYRTDLAFYTNGQ
SVCLTELKGYQAAVGKPVIQPRRPNNRLD
>CAP09894.1|FEATURES|NCBI|tetracycline|tetW|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDKLLEKYIAGEPISREKLAREEQRRVQDASLFPVYYGSAKKGLGIQPLMDAVTGLFQP
IGEQGSAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILPSDSVRLNDVLGDPTRLPRKRWREDPLPMLRTSIAPKTAAQRAR
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPTVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLPPGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFTLYAPREYLSRAYHDAPKYCATIETVQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGQ
SVCLTELKGYQAAVGKPVIQPRRPNNRLD
>CAP09895.1|FEATURES|NCBI|tetracycline|tetW|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDKLLEKYIAGEPISREKLVREEQRRVQDASLFPVYYGSAKKGLGIQPLMDAVTGLFQP
IGEQGSAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILPSDSVRLNDVLGDPTRLPRKRWREDPLPMLRTSIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPTVIY
IERPLKAASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFTLYAPREYLSRAYHDAPKYCATIETVQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGQ
SVCLTELKGYQAAVGKPVIQPRRPNNRLD
>CAP09896.1|FEATURES|NCBI|tetracycline|tetW|antibiotic target protection|1
MKIINLGIPAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDKLLEKYIAGEPISREKLVREEQRRVQDASLFPVYYGSAKKGLGIQPLMDAVTGLFQP
IGEQGSAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILPSDSVRLNDVLGDPTRLPRKRRREDPLPMLRTSIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPTVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFTLYAPREYLSRAYHDAPKYCATIETVQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGQ
SVCLTELKGYQAAVGKPVIQPRRPNNRLD
>ACF06164.1|FEATURES|NCBI|sulfonamide|sul1|antibiotic target replacement|1
MEVAAEADAMVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHP
DARPVSPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPAL
YPDIAEADCRLVVMHSAQRDGIATRTGHLRLEDALDEIVRFFEARVSALRRSGVAADRLI
LDPGMGFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASL
AAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA
>ACI16367.1|FEATURES|NCBI|multidrug|qepA|antibiotic efflux|1
MSATLHDTAADRRKATRREWIGLAVVALPCLVYAMDLTVLNLALPVLSRELQPSSAQLLW
ILDIYGFFVAGFLITMGTLGDRIGRRRLLLIGAAFFAFASVLAALADTAALLIAARALLG
LAGATIAPSTMALVRNMFHDPRQRQFAIGVWIAAFSLGSAIGPLVGGVLLEFFHWGAVFW
LNVPVMLLTLALGPRFLPEYRDPDAGHLDLASVLLSLAAVLLTIYGLKQLAEHGAGLASM
AALLAGLAVGALFLRRQGHIAYPLLDLRLFAHAPFRAALAAYALAALAMFGVYIFMTQYL
QLVLGLSPLQAGLATLPWSLCFVIGSLLSPQLAARWPAARILVVGLSAAAFGFAVLGLGQ
GLWWLVPATIVMGLGLAPVFTIGNEIIITSAPSERAGAASALSETVSEFSGALGIALFGS
VGLVVYRQALTSAALPGLPADALQAAGASLGGAVHLADTLPAWQGAALLAAARAGFTDAL
QATAWAGAVLVLVAAGLVARLLRKRPTLASG
>CAT00035.1|FEATURES|NCBI|trimethoprim|dfrA5|antibiotic target replacement|1
MKISLMAAKARNGVIGCGSDIPWNAKGEQLLFKAITYNQWLLVGRKTFEAMGALPNRKYA
VVSRSGSVATNDDMVVFPSIEAAMGKLKTLTNHVVVSGGGEIYKSLIAHADTLHISTIDS
EPEGNVFFPEIPKDFNVVFEQEFHSNINYRYQIWQRG
>CAQ58207.1|FEATURES|NCBI|tetracycline|tetW|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDKLLEKYIAGEPISREKLVREEQRRVQDASLFPVYYGSAKKGLGIQPLMDAVTGLFQP
IGEQGSAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILADDTLKLNDILGNEKLLPHKTRIDNPMPLLRTTVEPQKPEQREA
LLNALAEIADTDPLLHFDIDTVTHEIMLSFLGKVQLEVICSLLEEKYHVGVAMKEPSVIY
LERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTNFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>ACM41518.1|FEATURES|NCBI|trimethoprim|dfrA5|antibiotic target replacement|1
MKISLMAAKARNGVIGCGSDIPWNAKGEQLLFKAITYNQWLLVGRKTFEAMGALPNRKYA
VVSRSGSVATNDDVVVFPSIEAAMRELKTLTNHVVVSGGGEIYKSLIAHADTLHISTIDS
EPEGNVFFPEIPKEFNVVFEQEFHSNINYRYQIWQRG
>ACO54027.1|FEATURES|NCBI|sulfonamide|sul1|antibiotic target replacement|1
MGLCRYGAHNCCLFARPIPIVEVAAEADAMVTVFGILNLTEDSFFDESRRLDPAGAVTAA
IEMLRVGSDVVDVGPAASHPDARPVSPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRY
ALKRGVGYLNDIQGFPDPALYPDIAEADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVR
FFEARVSALRRSGVAADRLILDPGLGFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSR
KSFLGATVGLPVKDLGPASLAAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRDA
RDRGLDHA
>ACR40098.1|FEATURES|NCBI|chloramphenicol|nimI|antibiotic inactivation|1
MFREMRRKRQQLSDAESVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKG
HKVDAIRGCDKASFCVIEQDEVHGEEYTTYFRSVIAFGRIRILEDETERMAAARLLGDRY
HPHHEEALGRELAKSFSHMLVICLDIEHMTGK
>ACR40099.1|FEATURES|NCBI|nitroimidazole|nimI|antibiotic inactivation|1
MFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKG
HKVDAIRGCDKASFCVIEQDEVHGEEYTTYFRSVIAFGRIRILEDEAERMAAARLLGDRY
HPHHEEALGRELAKSFGHMLVICLDIEHMTGK
>ACR40101.1|FEATURES|NCBI|chloramphenicol|ND00_04320|antibiotic inactivation|1
MFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKG
HKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVVAFGRIRILEDEAERMAAARLLGDRY
HPHHEEALGRELAKSFSHMLVICLDIEHMTGK
>ACR40102.1|FEATURES|NCBI|chloramphenicol|ND00_04320|antibiotic inactivation|1
MFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKG
HKVDAIRGCDKASFCVIEQDEVHGEEYTTYFRSVVAFGRIRILEDEAERMAAARLLGDRY
HPHHEEALGRELAKSFSHMLVICLDIEHMTGK
>ACR40104.1|FEATURES|NCBI|chloramphenicol|ND00_04320|antibiotic inactivation|1
MFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKG
HKVDAIRGCDKASFCVIEQDEVHGEEYTTYFRSVIAFGRIRILEDETERMAAARLLGDRY
HPHHEEALGRELAKSFSHMLVICLDIEHMTGKEA
>ACZ52983.1|FEATURES|NCBI|trimethoprim|dfrA17|antibiotic target replacement|1
MKISLISAVSENGVIGSGPDIPWSAKGEQLIFKALTYNQWLLVGRKTFDSMGVLPNRKYA
VVSKNGISGSNENVLVFPSIENALQELSKITDHVYISGGGQIYESLIEKADIIHLSTIHV
EVEGDIKFPILPEGFNLVFEQFFVSNINYTYQIWKKG
>CBL13258.1|FEATURES|NCBI|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMK
IPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMCVPTNG
EIVPADHACPGEIVILADDTLKLNDILGNEKLLPHKTRIDNPMPLLRTTVEPQKPEQREA
LLNALAEIADTDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>BAI97006.1|FEATURES|NCBI|beta_lactam|BEL-1|antibiotic inactivation|1
MSLPRRLIFAALLLAAPAAAQQEAPRQSLLPPPPRYMVSESAMKSVRNPKEIETESGGRL
GVALVDGKGALILGFNRDERFAMCSTFKAPLAAAVLAGAEGGKFGLEGQISFAKADLLDY
APVVRKNVKRGRMSMEELAAAAVEVSDNSAANLLLPMVGGPEGLTRFIRAHGDMVTRLDR
NEPSLNENAEGDERDTTSPAAMAGLMGRLIFRDLAPESAGKLRGWLNASTTGANRIKAGL
PKGWISGSKTGSCGTAYNDVALVKAPSGEEYILAIYLDRPTVDAKAAEAAIAETARAALD
FVDKAQKTGLE
>ADH06626.1|FEATURES|NCBI|fosfomycin|FosB|antibiotic inactivation|1
MLRGINHICFSVSNLENSIMFYEKVLEGELLVKGRKLAYFNICGVWIALNEETHIPRNEI
HQSYTHIAFSVEKEDFKCLIQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGT
LQDRLNYYRDEKPHMTFY
>ADK91600.1|FEATURES|NCBI|tetracycline|tetM|antibiotic target protection|1
MEEIKLKIINIGILAHVDAGKTTLTESLLYSSGAITELGSVDKGTTRTDNTLLERQRGIT
IQTGITSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHA
LRKIGIPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQW
DTVIEGNDDLLEKYMSGKSLEALELEQEESIRFQNCSLFPLYHGSAKSNIGIDNLIEVIT
NKFYSSTHRGPSELCGNVFKIEYTKKRQRLAYIRLYSGVLHLRDSVRVSEKEKIKVTEMY
TSINGELCKIDRAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIENPHPLLQTTVEPSKP
EQREMLLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKE
PTVIYMERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQN
AVMEGIRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTEL
LEPYLSFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPDRCIQEYRSDLTF
FTNGRSVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>ADN51953.1|FEATURES|NCBI|tetracycline|tetL|antibiotic efflux|1
MNTSYSQSNLRHNQILIWLCVLSFFSVLNEMVLNVSLPDIANDFNKSPASTSWVNTAFML
TFSIGTALYGKLSDQLGIKRLLLFGIIINCFGSVIGFVGHSFFPILILARFIQGAGAAAF
PALVMVVVARYIPKENRGKAFGLIGSIVAMGEGIGPAIGGMIAHFIHWSYLLLIPMMTII
TVPFLIKLLKKEVRIKGHFDIVGIILMSVGIVFFMLFTTSYNISFLIISILSFLIFVKHI
RKVTEPFVEPALGKNISFIIGVLCGGLIFGTVAGFIYMVPYMMKDVHQLSTAAIGSVIIF
PGTMSVIIFGYIGGLLVDRKGPLYVLTIGVTFLSVSFLIAAFFLEVTPWLLTIILVFVFG
GLSFTKTVISTIVSSSLKQKEAGAGMSLLNFTSFLSEGIGIAIVGGLLSVRLLNQKLLPM
DLDQSTYLYSNMLFLFTGVVVTSWLITLNVYKRRQIQFKS
>YP_003084339.2|FEATURES|NCBI|macrolide-lincosamide-streptogramin|VgaA|antibiotic target protection|1
MVLLEAKNIKHYIKDRLLLKIDELKIEHNDRIGLVGVNGSGKTTLLNILAEKFIPDEGTI
TPYAQSEILPQLKKTDAAKSGGEITQEYIQQTLNSAPALLLADEPTTNLDTDHIEWVEKK
LKRWQGAFVLVSHDREFLDALCSVIWELEDGEITEYKGNYSDYLKQKEVEKQQQQSTYEK
YEKEKKQLEKAIQLKEEKAQRATKKPKNLSASERRIKGSKPYFAKKQKKLHKTAGALETR
VEKLEKVEKIKDQPPIKMDLPNERNLKNRVIIRVEDLEGLVPKQLLWKKATFQIYGGDKL
AIIGPNGSGKTTLVKKIITQENGVTISPSVKIGYFSQNLMTLDVNKSILENVQNSSKQEE
SLIRTVLARMHFFDEDVYKPVHVLSGGERVKVALTKLLVSDINTLVLDEPTNYLDTEALK
ALENLLNEYTGSIIFVSHDRTFTENIATRILEIRNKKIEIFDGTYQQFKNRSTKKERDFQ
QEEQLLLDTKISEVLSRLSMEPSQALEKEFQNLLKEKSKLKE
>CAQ53849.2|FEATURES|NCBI|trimethoprim|dfrA5|antibiotic target replacement|1
MKVSLMAARARNGVIGCGPHIPWSAKGEQLLFKALTYNQWLLVGRKTFESMGALPNRKYA
VVTRSAWTANNDNVVVFPSIEEAMGGLAKLNGHVIVSGGGEIYRETLPMASTLHVSTIDI
EPEGDVFFPNIPNFFEVVFEQHFSSNINYCYQIWKKG
>AEG48329.1|FEATURES|NCBI|beta_lactam|BEL-1|antibiotic inactivation|1
MPRRLLLAALLLAGPASAQQEAPRQSLLPPPPRYMVSESAMKSVRNPKEIESESGGRLGV
ALVDSKGALILGFNRDERFAMCSTFKAPLAAAVLSGAEGNKFGLEGQIGFTKADLLDHAP
VVKKNARRGRMSMEELAAAAVEVSDNSAANLLLPMIGGPEGFTRYVRAHGDNVTRLDRTE
PALNENAEGDERDTTSPAAMAGLMRRLIFTDLKPESAARLRGWLNASTTGGNRIKAGLPK
DWTSGSKTGTCGTAYNDVALVKAPSGEEYILAIYLDRPTVDAKAAEAAIAETARAALDFV
GKAQKTGLE
>BAK53071.1|FEATURES|NCBI|beta_lactam|mecC|antibiotic target replacement|1
MMKKIKIVPLILIVVVVGFGIYFYASKDKEINNTIDAIEDKNFKQVYKDSSYISKSDNGE
VEMTERPIKIYNSLGVKDINIQDRKIKKVSKNKKRVDAQYKIKTNYGNIDRNVQFNFVKE
DGMWKLDWDHSVIIPGMQKDQSIHIENLKSERGKILDRNNVELANTGTAYEIGIVPKNVS
KKDYKAIAKELSISEDYIKQQMDQNWVQDDTFVPLKTVKKMDEYLSDFAKKFHLTTNETE
SRNYPLGKATSHLLGYVGPINSEELKQKEYKGYKDDAVIGKKGLEKLYDKKLQHEDGYRV
TIVDDNSNTIAHTLIEKKKKDGKDIQLTIDAKVQKSIYNNMKNDYGSGTAIHPQTGELLA
LVSTPSYDVYPFMYGMSNEEYNKLTEDKKEPLLNKFQITTSPGSTQKILTAMIGLNNKTL
DDKTSYKIDGKGWQKDKSWGGYNVTRYEVVNGNIDLKQAIESSDNIFFARVALELGSKKF
EKGMKKLGVGEDIPSDYPFYNAQISNKNLDNEILLADSGYGQGEILINPVQILSIYSALE
NNGNINAPHLLKDTKNKVWKKNIISKENINLLTDGMQQVVNKTHKEDIYRSYANLIGKSG
TAELKMKQGETGRQIGWFISYDKDNPNMMMAINVKDVQDKGMASYNAKISGKVYDELYEN
GNKKYDIDE
>BAK53145.1|FEATURES|NCBI|beta_lactam|mecC|antibiotic target replacement|1
MMKKIKIVPLILIVVVVGFGIYFYASKDKEINNTIDAIEDKNFKQVYKDSSYISKSDNGE
VEMTERPIKIYNSLGVKDINIQDRKIKKVSKNKKRVDAQYKIKTNYGNIDRNVQFNFVKE
DGMWKLDWDHSVIIPGMQKDQSIHIENLKSERGKILDRNNVELANTGTAYEIGIVPKNVS
KKDYKAIAKELSISEDYIKQQMDQNWVQDDTFVPLKTVKKMDEYLSDFAKKFHLTTNETE
SRNYPLEKATSHLLGYVGPINSEELKQKEYKGYKDDAVIGKKGLEKLYDKKLQHEDGYRV
TIVDDNSNTIAHTLIEKKKKDGKDIQLTIDAKVQKSIYNNMKNDYGSGTAIHPQTGELLA
LVSTPSYDVYPFMYGMSNEEYNKLTEDKKEPLLNKFQITTSPGSTQKILTAMIGLNNKTL
DDKTSYKIDGKGWQKDKSWGGYNVTRYEVVNGNIDLKQAIESSDNIFFARVALELGSKKF
EKGMKKLGVGEDIPSDYPFYNAQISNKNLDNEILLADSGYGQGEILINPVQILSIYSALE
NNGNINAPHLLKDTKNKVWKKNIISKENINLLTDGMQQVVNKTHKEDIYRSYANLIGKSG
TAELKMKQGETGRQIGWFISYDKDNPNMMMAINVKDVQDKGMASYNAKISGKVYDELYEN
GNKKYDIDE
>EIA84095.1|FEATURES|NCBI|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMK
IPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMCIPSNG
EIVPADHACPGEIVILADDTLKLNDILGNEKLLPHKTRIDNPMPLLRTTVEPQKPEQREA
LLNALAEIADTDPLLHFDIDTVTHEIMLSFLGNVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTCFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>AFJ38137.1|FEATURES|NCBI|fosfomycin|fosX|antibiotic inactivation|1
MKGISHITFIVRDLNRMAALLCEGLGAREVYDSSNQNFSLSREKFFVLGSTWLAAMEGEP
PAERSYQHVAFAVSETDLPAYQARLEALGVEIRPPRSRVDGEGLSLYFYDFDNHLFELHS
GTLEQRLVRYQAGR
>AFK31665.1|FEATURES|NCBI|tetracycline|tet32|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLTEAYRALSVLDGAVLVISAKDGVQAQTRILFHALQKMN
IPTIIFINKIDQNGIDLQRVYQSIKDKLTSDMIVMQEVSLSPQISMTDISDLDKWDMIIS
GSDELLERYVAEDSLDIQELQYEKCKRTRCCSLFPVYHGSAKDNLGTEKLIEAITETFIT
ETDDIQSELCGYVFKVEYTERKKRLSYLRLYHGTLHLRDTLLLSKKEKIKITEMCIPSNG
EIVPADHACPGEIVILADDTLKLNDILGNEKLLPHKTWIDNPMPLLRTTVEPQKPEQREA
LLNALAEIADTDPLLHFDIDTVTHEIMLSFLGKVQLEVICSLLEEKYHVGVAMKEPSVIY
LERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>AFK31669.1|FEATURES|NCBI|tetracycline|tetW|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAEPGSVDKGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDKLLEKYIAGEPISREKLVREEQRRVQDASLFPVYYGSAKKGLGIQPLMDAVTGLFQP
IGEQGSAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILADDTLKLNDILGNEKLLPHKTRIDNPMPLLRTTVEPQKPEQREA
LLNALAEIADTDPLLHFDIDTVTHEIMLSFLGKVQLEVICSLLEEKYHVGVAMKEPSVIY
LERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTNFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>EJY24646.1|FEATURES|NCBI|multidrug|salA|antibiotic target protection|1
MSKATFAIASTNAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKT
TLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDM
ENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADDKKPI
SEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRM
FLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFR
YKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTP
LAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMDGVAALSGDFKFGYNVEISYFDQQLAQI
SGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKR
TNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFV
QSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQ
YDEELERLNKIISEPNNSSDYMVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM
>WP_004207704.1|FEATURES|NCBI|beta_lactam|BEL-1|antibiotic inactivation|1
MALRKSLSLAALTACLVVTLPLSAAPKKKAPAKKAEEVPTLPTLMPPAPRYLVPQSALTS
VRNPKEIEEETGGRMGIALVDREGALILGFNRDDRFAMCSTFKAPLAAAVLIGAQGGKFG
LEGEIPFTKDDILDYAPVVKKNKKRGRMSMAELAEAAVEVSDNSAANLLLPMLGGPEGLT
SFIRAHGDKITRLDRIEPELNENVAGDPRDTTSPAAMAGLMGRLLFRDMQAADADRLRGW
LNASTTGDKRIKAGLPEGWTSGSKTGSCGTAYNDVALVKSPAGEEYILAIYLDRPTVDDK
KAEAAIAEAAHSALEFVSKAQKSGLD
>WP_004657207.1|FEATURES|NCBI|beta_lactam|F895_00180|antibiotic inactivation|1
MIMSKKLTCLALFTAIFFAIPMAACQSFSQQKQQLSTQKNEQQQISSLFQSAQTSGVLVI
YDGKKIQSYGNDLDRAEQRYIPASTFKMLNALIGIQHHKTTPDEVFKWDGKKRAFSSWEK
DLTLAEAMQASAVPVYQELARRIGLELMTREVKRVGYGNKNIGTQVDNFWLVGPLKITPV
EEVRFAYALAKQKLPFDQPTQQQVKAMLLVDQIQGTKIYAKSGWGMDVSPQVGWWTGWIE
QPNGKITAFSLNMQMSQPEHADARKAIVYQALQQLGLLAH
>WP_004683508.1|FEATURES|NCBI|beta_lactam|F889_02977|antibiotic inactivation|1
MPKILKHLGLCASVMIGLTLLGCQNLQAPTQSAVSKKHDQTEIASLFQHAQTVGVFVTYD
GQTLQEYGNALSRSNTAYIPASTFKMLNALIGIQHHKSSPNEVFKWDGKKRAFASWEKDL
TLAEAMQASAVPVYQELARRIGLELMANEVKRVGFGNAEIGTQVDDFWLVGPLKITPVEE
VKFAYALAHKQLTFDQSVQEQVKQMVLVDEVKGTKIYAKSGWGMDVTPQVGWWTGWIEQP
NGQVIAFSLNMQINNSKQGDARKAIVYQALQQLKLLETQ
>WP_004725235.1|FEATURES|NCBI|beta_lactam|OXA-355|antibiotic inactivation|1
MSNNLFKFKIKSSVLIILSSVAFSGCVSNANLHDPASSQRTSEIPLLFNYAQTQAVFVTY
DGTQFKRYGNDLNRAKTAYIPASTFKMLNALIGLQHAKATNTEVFKWNGEKRSFPAWEKD
MTLAQAMQASAVPVYQELARRIGLDLMSQEVKRVGFGNTQIGQQVDNFWLVGPLKITPEQ
EAKFAYQLAKKTLPFDDAVQQQVKDMLYVERRGDSKLYAKSGWGMDVEPQVGWYTGWIEQ
PNGQITAFALNMHMQTGDDPAERKQLTLSILDKLGLFFYLR
>WP_004776204.1|FEATURES|NCBI|beta_lactam|F895_00180|antibiotic inactivation|1
MSKKLKLLALCATVISAATLVGCQNIQSQAQPLVLKKQAQDQIATAFENIQTTGVLVTYD
GKNFQRYGNDLSRADQRYIPASTFKMLNALIGIQHHKTSPNEVFKWDGQKRAFRSWEQDL
TLAEAMQASAVPVYQELARRIGLELMASEVKRVGYGNQNIGTQFDNFWLVGPLEITPVEE
VKFAYALAKQQLPFAPSTQQQVRDMLLIENVQGTRIYAKSGWGMDVNPQVGWWTGWVEQP
NGQITAFSLNMEMKKAEHADARKAIVYQALQQLGLLPQ
>WP_004816501.1|FEATURES|NCBI|beta_lactam|OXA-355|antibiotic inactivation|1
MSNYRFKSKIKSSVLIILSSVAFSGCVSNANLHDPASSQRTSEIPLLFNYAQTQAVFVTY
DGTQFKRYGNDLNRAKTAYIPASTFKMLNALIGLQHAKATNTEVFKWNGEKRSFPAWEKD
MTLAQAMQASAVPVYQELARRIGLDLMSKEVKRVGFGNTQIGQQVDNFWLVGPLKITPEQ
EAKFAFQLANKTLPFDDAVQQQVKDMLYVERRGDSKLYAKSGWGMDVEPQVGWYTGWVEQ
PNGQITAFALNMHMQTGDDPAERKQLTLSILDKLGLFFYLR
>WP_004867933.1|FEATURES|NCBI|beta_lactam|OXA-229|antibiotic inactivation|1
MNKKLNLALLCFLSILCAACQSNQQLSANSHTENHNTRAAEISLLFDEMHTQAVFVTYDG
QHFQSYGNALQRADTAYVPASTFKMLNALIGLQNHKATNTEVFKWDGQKRAMSIWEKDMT
LSDAMKVSAVPVYQELARRIGLDLMQKEVTRVRYGNTDIGTVVDRFWLDGPLKITPKQEA
QFAYQLATQQLPFDQNVQSQVKDMLYVESRGQSKLFAKSGLSMKNGQPDIGWYTGWVEQA
DGKIVAFSINMQMVQGLDVNSRQQATLDILDKLGIFFYL
>WP_004878009.1|FEATURES|NCBI|beta_lactam|F895_00180|antibiotic inactivation|1
MRKKFKVALLCSSLCLSLGLVACHSLNSELQIAEQQKQQQKISKLFVNAKTEGVFVTYDG
QKIHEYGNALNRAQTSYIPASTFKMLNALIGIQHHKTTPNEVFKWNGEKRRFKSWEKDLT
LTEAIQASAVPIYQELARRIGLDLMASEVKRIGFGNSDIGNQVDNFWLVGPLKITPIQEV
RFTYALANEQLAFDIPVQQQVKQMLLVDQMNGTKVYAKSGWGMDVEPQVGWWTGWVEQPN
GKVTAFSLNMEMNKTEHVEARKTIVYEALQQLGLI
>WP_005011312.1|FEATURES|NCBI|beta_lactam|OXA-331|antibiotic inactivation|1
MNPFTKYCAILCPIIFLGACTISPFSHDQAHSAHASQLTDAATIRNLFNQANVQGVILIK
SGNDLQAYGNAIQRADQPFIPASTFKMLNALIGIEHNKTSPDEVFKWNGEKRSFPAWEKD
LTLAQAMTASAVPVYQELAHRIGLELMQNEVKRVQFGNGDIGAQVDNFWLMGPLKITPRQ
EVQFADQLSHLQLPFRKSTQQQVIQMLFIEQIGSKALYAKSGWGMDVEPQVGWYTGWVED
AQGKTTAFSLNLEMDQSTPASLRKELVISSLKQLKIL
>WP_005201559.1|FEATURES|NCBI|beta_lactam|F895_00180|antibiotic inactivation|1
MMMSKKLKCLAFFTAIFFAIPMTACQSFSQQKQQLSTQKNEQQQISSLFQSAQTSGVLVI
YDGKKIQSYGNDLDRAEQRYIPASTFKMLNALIGIQHHKTTPDEMFKWDGKKRAFSSWEK
DLTLAEAMQASAVPVYQELARRIGLELMTREVKRVGYGNKNIGTQVDNFWLVGPLKITPV
EEVRFAYALAKQKLPFDQSTQQQVKGMLLIDEVQGTKIYAKSGWGMDVSPQVGWWTGWIE
QANGKITAFSLNMEMSRPEHAEARKAIVYQALQQLDLLAN
>WP_005209448.1|FEATURES|NCBI|beta_lactam|F895_00180|antibiotic inactivation|1
MSKKLKMLTLSISMMLGLPLMACQSFSQQKQQIMTQESEQQQIASLFQNAQTSGVLVIYD
GKKIQKFGNDVHRADQRYIPASTFKMLNALIGIQHHKTTPKEVFKWDGQKRAFSSWEKDL
TLAEAMQASAVPVYQELARRIGLELMTREVKRVGYGNKNIGTQVDNFWLVGPLKITPVEE
VRFAYALAKQKLPFDQSTQQQVKGMLLIDEVQGTKIYAKSGWGMDVSPQVGWWTGWIEQA
NGKVTAFSLNMEMSRPEHAEARKAIVYQALQQLDLLAN
>WP_005227858.1|FEATURES|NCBI|beta_lactam|F889_02977|antibiotic inactivation|1
MLFNFIVMPKKLKLLVLSVVVMPSIILLGCQNIQPHVQTLVTQKQTEDQIATAFENIQTS
GVLVTYDGKAIQKYGNALNRANQRYIPASTFKMLNALIGIQHHKTSPNEVFKWDGQKRVF
TSWEKDLTLAEAMQASAVPVYQELARRIGLELMASEVKRVGYGNQSIGTQVDNFWLVGPL
EITPVEEVKFAYALAKKQLAFDSSTQQQVKDMLLIEDIQGTKIYAKSGWGMDVKPQVGWW
TGWVEQPNGQVTAFSLNMEMKKAAHAEARKAIVYQALQQLGLLPQ
>WP_005260134.1|FEATURES|NCBI|beta_lactam|F895_00180|antibiotic inactivation|1
MSKKLKLLALCATVISAATLVGCQNIQSQAQPLVLKKQTQDQIATAFENIQTTGVLVTYD
GKNFQKYGNDLSRADQRYIPASTFKMLNALIGIQHHKTSPNEVFKWDGQKRAFRSWEKDL
TLAEGMQASAVPVYQELARRIGLELMASEVKRVGYGNQNIGAQVDNFWLVGPLEITPVEE
VKFAYALAKQQLPFDPSTQQQVRDMLLIENVQGTRIYAKSGWGMDVNPQVGWWTGWIEQT
NGQITAFSLNMEMKKAEHADARKAIVYQALQQLGLLPQ
>WP_005282462.1|FEATURES|NCBI|beta_lactam|F889_02977|antibiotic inactivation|1
MLFNFIVMPKKLKLLALSVVVMPSIILLGCQNIQPHVQALVTQKQTEDQIATAFENIQTS
GVLVTYDGKAIQKYGNALNRADQRYIPASTFKMLNALIGIQHHKTSPNEVFKWDGQKRAF
TSWEKDLTLAEAMQASAVPVYQELARRIGLELMASEVKRVGYGNQSIGTQVDNFWLVGPL
EITPVEEVKFAYALAKKQLAFDSSTQQQVKDMLLIEDIQGTKIYAKSGWGMDVKPQVGWW
TGWVEQPNGQVTAFSLNMEMKKAAHAEARKAIVYQALQQLGLLPQ
>WP_005317413.1|FEATURES|NCBI|beta_lactam|F895_00180|antibiotic inactivation|1
MMMSKKLKCLAFFTAIFFAIPMTACQSFSQQKQQLSTQKNEQQQISSLFQSAQTNGVLVI
YDGKKIQKFGNDLDRAEQRYIPASTFKMLNALIGIQHHKTTPDEVFKWDGKKRAFSSWEK
DLTLAEAMQASAVPVYQELARRIGLELMTREVKRVGYGNKNIGTQVDNFWLVGPLKITPI
EEVRFAYALAKQKLPFDQPTQQQVKAMLLVDQIQGTKIYAKSGWGMDVSPQVGWWTGWIE
QPNGKITAFSLNMQMSQPEHADARKVIVYQALQELGLLAH
>WP_005812825.1|FEATURES|resfinder|nitroimidazole|nimJ|antibiotic inactivation|1
MNEFREMRRKRQQLSEEESIAILQKATAGTLALLGDNDYPYAVPISYVYADGRLYFHSAL
SGHKVDAIRKCDKASFCVIEQDEVHPEKYTTFFRSVIAFGRIHIIEDETEKLETARMLVN
RYNPNQEEALQKELENGLSRMLMIRFDIEHLTGKEAIELVRRHQK
>WP_007708339.1|FEATURES|NCBI|beta_lactam|BEL-1|antibiotic inactivation|1
MAVRKSLSFAALTACLLVAMPLSAAPKKKAPAKKAEDVPVLPTQLPPAPRYLVPQSALTS
VRNPKEIEEETGGRMGIALVDRDGALILGFNRDDRFAMCSTFKAPLAAAVLIGAEGGKFG
LDGEIPFTKDDILDYAPVVKKNRKRGRMSMAELAQAAVEVSDNSAANLLLPMLGGPEGLT
AFMRAHGDKITRLDRNEPALNENIEGDGRDTTSPAAMAGLMSRLLFRDMQAADADRLRGW
LNASTTGDKRIKAGLPEGWTSGSKTGSCGTAYNDVALVKAPSGEEYILAIYLDRPTVDQK
AAEAAIAEAAHSALEFVSKAKKSGLD
>AGV79342.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Ie-APH(2'')-Ia|antibiotic inactivation|1
MEIVQDKIRIRTLTNDDFPLMLKWLTDDRVLEFYGGRDKKYTLESLKEHYTEKWEDEVFR
VIIEYDNVPIGYGQVYKMYDELYSDYHYPKTNEIVYGMDQFIGEPEYWSKGIGSKYTKMI
FEFLKKERNANAVILDPHKNNPRAIRSYQKSGFRIIEDLPEHELHEGKKEDCYLMEYRYD
DNVTNVKAMKYLIEHYFEDFKVESIKVIGSGYDSVAYLVNGEYIFKTKFSANKKKGYEKE
KAIYDFLNQRLNTNIKIPNVKYSYFSDNISILGYKEIKGTFLTPEIYFALSKEKQELLKQ
DIAMFLRQMHDLDYSEISLYTIDNKQNVLEEYQLLKDTIYDSLTDIEKQYVEDFMQRLHS
TTIFDGKKCLCHNDFSCNHLLLDDENRLCGVIDFGDSGIIDEYCDFIYLLEDSEEEIGVS
FGEDILRLYGNIDISKAKEYQDVVEQYYPIETIVYGIKNNRPDFIEKGRKEIYIRTRKDE
KLRK
>AGV79344.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Ie-APH(2'')-Ia|antibiotic inactivation|1
MDIKKIIEEKCKIVVDSIKLIGEGYDSKAYIVNNEYVFKIKFSANKKKGYEKEKAIYDFL
NKKLNTTINIPNIEYSYISDDISILGYKEIKGTFLTPEIYFTLSKEKQDLLKQDIAMFLK
QMHNLDYSEISSYTIDNKQNVLEEYQLLKETIYDSFTDIEKQYVENFMQILHNTTIFDGR
KCLCHNDFSCNHLLLDDNRLVGVIDFGDSGIIDEYCDFIYLLEDSKEEIGVSFGEDILRL
YGNIDISKAKEYQDVVEQYYPIETIVYGIKNNKPDFIEKGRKEIYIRTHKEEKLRK
>BAO48025.1|FEATURES|NCBI|fosfomycin|fosX|antibiotic inactivation|1
MEGISHITLIVRDLSRMTTFLCDGLGAREVYDSAGHNYSLSREKFFVLGGVWLAAMEGVP
PSERSYQHVAFRVSESDLAVYQARLGSLGVEIRPPRPRVNGEGLSLYFYDFDNHLFELHT
GTLEQRLARYGAGR
>AHU60294.1|FEATURES|NCBI|multidrug|smeR|antibiotic efflux|0
MRPRRSMLFIPGANAAMLSTSFVYGADAVMFDLEDAVALREKDTARLLVHHALQHPFYQD
VEKVVRINPLNTPFGLADLEAVVRGGADIVRLPKTDSKNDVLELEAQVERIERECGREVG
STRLMAAIESAKGVVNAVDIATSSPRMVAIALAAFDYVMDMGTSRGDGTELFYARCAVLH
AARVAGIAAYDVVWSDINNEEGFLKEVQLAKGLGFNGKSLVNPRQIELLHQAYSPTRKEV
EHAYEVIAAAEEAESRGLGVVSLNGKMIDGPIIDHARKVVALSASGIRD
>WP_025577435.1|FEATURES|NCBI|beta_lactam|CARB-18|antibiotic inactivation|1
MKKLFLLVGLMVCSTVSYASKLNEDISLIEKQTSGRIGVSVWDTQTDERWDYRGDERFPL
MSTFKTLACATMLSDMDSGKLNKNATAKIDERNIVVWSPVMDKLAGQNTRIEHACEAAML
MSDNTAANLVLNEIGGPKAVTLFLRSIGDKTTRLDRLEPRLNEAKPGDKRDTTTPNAMVN
TLHTLMEDNALSYESRTQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGNYGSRGISAM
IWKDNYKPVYISIYVTDTDLSLQARDQLIAQISQLILEHYKES
>WP_028086456.1|FEATURES|NCBI|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMK
IPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMCIPSNG
EIVPADHACPGEIVILADDTLKLNDILGNEKLLPHKTWIDNPMPLLRTTVEPQKPEQREA
LLNALAEIADTDPLLHFDIDTVTHEIMLSFLGKVQLEVICSLLEEKYHVGVAMKEPSVIY
LERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>WP_031841337.1|FEATURES|NCBI|beta_lactam|CARB-18|antibiotic inactivation|1
MKKLFLLVGLMVCSTVSYASKLNEDISLIEKQTSGRIGVSVWDTQTDERWDYRGDERFPL
MSTFKTLACATMLSDMDSGKLNKNATAKIDESNIVVWSPVMDKLAGQSTRIEHACEAAML
MSDNTAANLVLNEIGGPKAVTLFLRSIGDKATRLDRLEPRLNEAKPGDKRDTTTPNAMVN
TLHTLMEDNALSYESRTQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGNYGSRGISAM
IWKDNYKPVYISIYVTDTDLSLQARDQLIAQISQLILEHYKES
>AJC94664.1|FEATURES|NCBI|beta_lactam|OXA-184|antibiotic inactivation|1
MKKIFLLFGLFCSFALANENLKDLFKDYNESGVFIAYDGKNYYSNDFKKANKRILPASTF
KIFNALIALNEGVVKDTNEIFYHYKGEKVFLPSWKNNANLALAMQRSQLPAYKELARKIG
LEKMQKNLNKLNYGNQKISKIDEFWIDDSLQISLKEQATLLFKLANLTLDYPKHIQEEVI
NIIKLKENDHYELFAKTGWGLRQYGQIVGFIKSKKSDKIYAFALNMNISDFNKLYLREEI
VQLYLDQL
>AJE61443.1|FEATURES|NCBI|beta_lactam|NDM-4|antibiotic inactivation|1
MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQ
HTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTH
AHQDKMGGMDALHAAGIATYANALSNQLAPQEGVVAAQHSLTFAANGWVEPATAPNFGPL
KVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAF
PKASMIVMSHSAPDSRAAITHTARMADKLR
>AJO67548.1|FEATURES|NCBI|tetracycline|tetD|antibiotic efflux|1
MNKFAITALTITALDAMGIGLIMPVLPALLREYVSIEHLANHYGILLALYAIMQVFFAPL
LGRWSDKFGRRPILLISLAGAALDYTLLALSSSLWMLYLGRLASGITGATGAVAASVIAD
HTQPQQRTKWFGRLGAAFGVGLIAGPAIGGFAGQLSPHLPFVIAAVLNACSFVVIWVIFK
DQRKAVIQDAQHGDQPSPIPFMQIIKPIIQLLFVFFMAQLIGQIPATTWVLFTEGRFQWD
SMQVGLSLAGLGVMHALFQAFVAGAIAKKFNEKVTIIVGFALDGSAFIILSLLAEGWLIY
PTLILLAGGSIALPALQSLMSAQVNQANQGKLQGVLVSLTNATGVIGPLLFSVIFGQTLT
MWDGWVWVIGAIMYVFLIVFILSFYRSSRPTIKQQTDN
>KLE07522.1|FEATURES|NCBI|beta_lactam|OXA-198|antibiotic inactivation|1
MNKKIKLIFILIFSINLFANDVELENLFKKYQVEGTLVLESLNTKKVDIYNEKRANTSFS
PASTFKIPNTLIALNEGVVNKDSIIVWDKKVREFDAWNKDQTLQSAFKSSCVWCYKEFAS
KIGVEKYSKYLKELNYGNKTIGKDVTDFWLDESLRITAFEEIRFLKQLQANNLAFKQEDI
NLLKELMIDEKSENYVVRAKTGWEGKYGWYVGYVETKNDVWFFALNIDTKTKEDLAKRKA
LTLEALKTKGIIN
>KLE13731.1|FEATURES|NCBI|beta_lactam|OXA-198|antibiotic inactivation|1
MNKKIKLIFILIFSINLFANDVELENLFKKYQVEGTLVLESLNTKKVDIYNEKRANTSFS
PASTFKIPNTLIALNEGVVNKDSIIVWDKKVREFDAWNKDQTLQSAFKSSCVWCYKEFAS
KIGVEKYKKYLKELNYGNKTIGKDVTDFWLDESLRITAFEEIRFLKQLQANNLAFKQEDI
NLLKELMIDEKSENYVVRAKTGWEGKYGWYVGYVETKNDVWFFALNIDTKTKEDLAKRKA
LTLEALKTKGIID
>AKI29907.1|FEATURES|NCBI|beta_lactam|OXA-184|antibiotic inactivation|1
MRNFIVFILFLNIAIGEDKILGNFFKDCNTSGTFIVFDGKNYASNDFQRAKQAFSPASTF
KIFNALIALDNGVVRDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIG
LKTMQEGLNKLSYGNTKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVK
EIILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTENKILSFALNIDIKDIKNIKIREELL
EKYLAIITN
>AKI29908.1|FEATURES|NCBI|beta_lactam|OXA-184|antibiotic inactivation|1
MRNFIVFILFLNIAIGEDKILGNFFKDCNTSGTFIVFDGKNYASNDFKRAKQAFSPASTF
KIFNALIALDNGVVRDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIG
LKTMQESLNKLSYGNAKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKIQEEVK
EIILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTENKILSFALNVDIKDIKNIKIREELL
NKYLANFFNNNRIKSFY
>AKI29909.1|FEATURES|NCBI|beta_lactam|OXA-184|antibiotic inactivation|1
MKKIILFLWILNFAFGQDKILEDFFKDYNTSGTFIIFDGKNYASNDFQRAKQTFSPASTF
KIFNALIALDNGVVKDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIG
LKTMQESLNKLSYGNAKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSNKSQEEVK
KLLLFKENKIQKIYAKTGFNDNINLAWIVGFVKTKNKILSFALNVDIKDIKNIKIREELL
EKYIYSLN
>AKI29910.1|FEATURES|NCBI|beta_lactam|OXA-184|antibiotic inactivation|1
MKKIILFLWILNFAFGQDKILEDFFKDYNTSGIFIIFDGKNYASNDFQRAKQTFSPASTF
KIFNALIALDNGVVKDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIG
LKTMQESLNKLSYGNAKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVK
KLLLFKENKIQKIYAKTGFNDNINLAWIVGFVKTKNKILSFALNVDIKHIKNIKIREELL
EKYLAIITN
>AKI29912.1|FEATURES|NCBI|beta_lactam|OXA-184|antibiotic inactivation|1
MKKILLLFSLFYSFALANDKLKDFFKDYNTSGVFITFDGKHYASNDFKRAKEPFSPASTF
KIFNALIALDNGVVKDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIG
LKTMQESLNKLSYGNAKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVK
KIILFKEDKIQKIYAKTGFNDGINLAWIVGFIESKNKILSFALNVDIKDIKNIKIREELL
EKYIYSLN
>AKI29913.1|FEATURES|NCBI|beta_lactam|OXA-184|antibiotic inactivation|1
MKKILLLFSLFYSFALANDKLKDFFKDYNTSGVFITFDGKHYASNNFKRAKEPFSPASTF
KIFNALIALDNGVVKDTKEIFYHYKGEKVFLPSWKQDASLRSAIKRSQVPAFKELARKIG
LKTMQESLNKLSYGNTKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVK
KIILFKEDKIQKIYAKTGFNDGINLAWIVGFIESKNKILSFALNVDIKNIKNLKIREELL
EKYIYSLN
>AKI82195.1|FEATURES|NCBI|quinolone|QnrB3|antibiotic target protection|1
MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGGKFSRAM
LKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>AKO62869.1|FEATURES|NCBI|quinolone|QnrB17|antibiotic target protection|1
MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGTDFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>AKO62870.1|FEATURES|NCBI|quinolone|QnrB13|antibiotic target protection|1
MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRSVDLQGVKLDNYQASLLMERLGIAIIG
>AKO62872.1|FEATURES|NCBI|quinolone|QnrB16|antibiotic target protection|1
MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNASALDIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG
>AKQ05891.1|FEATURES|NCBI|tetracycline|tetX|antibiotic inactivation|1
MRCHFRCNLALPLLVFLNLSRAIKDYQTMSSINNILVIGAGIAGPSVCYWLKRFGFSPVL
IEKSANLRKGGHALDVRGVAIDLVKRMGIYEKIGNRRTQVEFGRYMDTQGNILHEEKGER
FCYREGEDVEITRGDLVEILIDAIEGVPCYLNQSIDSIKQRDGDVAVRFKDGKIEYYDLI
IGADGLHSTTRRMVFDKDEYQLTNLGAYFSVFSIPNYLNLNHTEIQFEANQKLISMTSDK
NPKMAEVAFMFRVQNVLNNRRDENEQKRFLRDTFQGFGWETSKILELMSDSDDFYFDSVS
QVKMKSWTKGRVALLGDAGYCASPISGQGNNLALVGAYVLAGELKQASDNYHQAFNRYNE
LLHPFIEANQKLGVLVNESFLVQDEVSKEVAEERSNKIMEEVKIVSNMISLPDYE
>AKQ05892.1|FEATURES|NCBI|tetracycline|tetX|antibiotic inactivation|1
MTFLFKEFKGVFKMKKVLVVGAGVAGLAVCYWLKEFGFSPTLIEKSNALRKGGYGVDIFG
IAVDIAKKMSVYEKICAMRTQLEHGFYVNADGHTLVEEQGEKFGFRQGEEVEILREDLIE
ILKQAIKDIPCHFNQRIKRIKQDGKHVEVTFKDNKTENYDLVIGADGVHSTTRAFTFDKE
EYDLIDFGCYSAIFSLPNYLKLRQSEIAFDANQKFISVSSDKNPTIALASLMFHSNRGDN
IRNEKDQKSFFKDAFIDLGWETNNLLQYMEESNDFYFDVATQIKMKSWTKGRIALVGDSG
YCSTALSGQGTTTALVGAYILAGELKAANGNHITAFERYNMLLHPFVEANQELGAWINET
FLLEDAVSKEAVEARTDNIIKKISAISNVIKLPEYSAYK
>AKQ05893.1|FEATURES|NCBI|tetracycline|tetX|antibiotic inactivation|1
MSAINKILVIGAGIAGPTVCYWLKRFGFSPTLIERSSKIRKGGQGLDVRGVAIDIVKRMG
IYEKICNMRTQVELGRYVDARGNILHEEKGERFAFRQGEDVEINRGDLVEILIQTIEGVP
CHFNQWIDGIKQSDNDVEVQFKDGRTEHYGLVIGADGLHSKTRRMVFNEDEYKLTNLGLY
FSVFSIPNYLNLNHTEVQFEANQKLISLTSDKNPKMAEAAFCFRTQNVLNNIRDENEQQK
FLRDTFQDFGWETSKILELMSDSDNFYFDSVTQVEMKSWTKGRVALLGDAGYSASPISGQ
GNNLALVGAYVFAGELKQAGGNYHRAFSRYNELLHSFVEANQKLGILVNESTLVYGEVSQ
EVAEERSNKIMQEVEIAANMISLPNYE
>AKQ05895.1|FEATURES|NCBI|tetracycline|tetX|antibiotic inactivation|1
MPIINKILVIGAGIAGPAVCYWLRRFGFSPILVERCANLRKGGHAVDIRGVAIDLAKSMG
IYKKICNMRTQVELGRYVDAEGNILHEEKGERFGFREGDDIEILRGDLVQILIDAMGDVP
CHFNQWVESIKQRDNDVEVQFKDGRTELYDLVIGADGLHSTTRRMVFDKDEYKLTNLGAY
FSAFSIPNYLNLNHTDVQFEANQKLISMASDKNPKIAITGFCFRAQNVLNNLRDENEQRR
FLRDTFQDFGWETSKILELMSDSNDFYFDSFTQVKMKSWTKGRVALVGDAGYCASPFPGQ
GSNQALVGAYIFAGELKQAEGNYHRAFNRYNELLQPFVEANQKFGVLVNESFLVRDEVSK
EVAEERSNKIMQEIKIVSNMISLPNYE
>AKQ05896.1|FEATURES|NCBI|tetracycline|tetX|antibiotic inactivation|1
MSNVNKILVIGAGIAGPAACYWLRRFGFSPVLVERSASLRKGGHALDVRGVAIDLVKRMG
IYQKIYNMRTQLEFGRHVDPEGNTLHEEKGERFGFREGQDVEIIRSDLVEILIDSIEGVP
LQFNQTIESVKQTDAVVEVQFKDGRTEHFDLVIGADGLHSTTRRIVFDKHEYKLNDLGAY
FSVFSIPNYLNLNNTEVQCEANQKLLSITSDKNRKMAEVAFSFRGQNVLNNVRDESEQRR
VLRDTFQDFGWEAPRILELMSDSDDFYSDSFTQVIMKSWTKGRVALLGDAAYSASPISGQ
GNNLALVGAYVLAGELKQAGGNYKRAFDRYNEILRPFIEANQKLGVLVNESFLVRDEVSK
EVAEERSNNIMEQVKIASNMIVLQDYANPH
>AKQ05897.1|FEATURES|NCBI|tetracycline|tetX|antibiotic inactivation|1
MSTINKILVIGAGIAGPAVCYWLRRFGFSPVLIEKFANIRKEGQALDFRGVAIDIVKGMN
IYEKMCNMHKQLEVGRYVDTEGNTLHEERGERFCFRQGEDVEIARGDFAEILTGAIEGIP
CHFNQVIDSIKQSDDDVKVQFNDGRVEHYDLVIGADGIYSTTRGMVFDKDEYKLVNLGVC
FGVFSILNYLNLSHTEVQCEANQKLISIWSHKNPKMAEVAFVFRTQNVLNNIRNKNEQQQ
LLRDAFQDFGWEASKILELMTGSDDFYFDSATQVKMKSWTKGRVALLGDAGYSASPLSGQ
GNYLALVGAYIFAGELKKADGNYTRAFSRYNELLHPLVEACHKLGVLVSESFLVPDEVSK
EVAEERSNKILQEVKIVSNMISLPEYE
>AKQ05898.1|FEATURES|NCBI|tetracycline|tetX|antibiotic inactivation|1
MSTIKKILVIGAGIAGTAVCYWLRRFGFYPVLIEKSACIRKGGQGLDIRGVAIDIVKKMV
IYEQICKMRTQVECGRYVDVVGKTLHEEKGEKFAFRQDEDVEILRGDLIEILMKTIDDVP
CHFNQSIDSIEQNDDDVIVYFKDARVEHYDLIIGADGIHSSIRRMVFDKDEYRLVNLAEA
YFSIFSIPNYLNLSHTEVQCETNEKLVSITSDKDPKTAQVAFMFRSQHVWNNLRDEHEQM
QFLRDIFHDFGWEAQKILELMPNSHDFYFDSVTQVKMRSWTKGQVALVGDASYSASPLSG
QGNNLALVGAYILAGELKAAEGNYRLAFNRYNELLHPFVEANQQLGAWVSESFLVPDAVS
KEVAEERSNRILQKVQIISNAIKLPEYE
>AKQ05899.1|FEATURES|NCBI|tetracycline|tetX|antibiotic inactivation|1
MPHTKKILVIGASIAGPALCYWLNHYGFQPTLVEKNQSTRKGGYAIDLRGIAVDVAKQMG
IYDSVCAMRTSLQCVRYVDAAGNLLFEEHGEKGGFRQGDEVEIVRGDLVDILMKTITDIP
CFYDHAIESLTQHDDHVTVQFKNGKTENYDLVIAADGLHSATRRMVFSKDDYHLRNLGCY
ISVFSIPNYLQLDHCETLLEAKQKLVSITSDKDSTKAFAGFMFRSSNSPNYIRDEASQKD
FLRENFTNHGWESNKLLSLMNDANDFYFDAIMQVKMKDWTKGRIALVGDAGYTPSPLSGQ
GTSLALVGAYILAGELKTATDHVAAFARYNELLKPYVEANQAFGVWVSESFLADEPLSAE
QAEERNNIVLGIMKKATHAIELPEY
>ALA99185.1|FEATURES|NCBI|beta_lactam|OXA-62|antibiotic inactivation|1
MNTIISRRWRAGLWRRLVGAVVLPATLAATPAAYAADVPKAAPGRITERADWGKLFTAEG
VKGTIVVLDARTQTYQAYDAARAEKRMSPASTYKIFNSLLALDSGALDNERAIIPWDGKP
RRIKNWNAAMDLRTAFRVSCLPCYQVVSHKIGRRYAQAKLNEVGYGNRTIGGAPDAYWVD
DSLQISAREQVDFLQRLARGTLPFSARSQDIVRQMSIVEATPDYVLHGKTGWFVDKKPDI
GWWVGWIERDGNIASVAINIDMLSEADAPKRARIVKSVLKDLKLI
>ALA99186.1|FEATURES|NCBI|beta_lactam|OXA-62|antibiotic inactivation|1
MNTIISRRWRAGLWRRLVGAVVLPATLAATPAAYAADVPKAAPGRITERADWGKLFAAEG
VKGTIVVLDARTQTYQAYDAARAGKRMSPASTYKIFNSLLALDSGALDNERAIIPWDGKP
RRIKNWNAAMDLRTAFRVSCLPCYQVVSHKIGRQYAQAKLNEVGYGNRTIGGAPDAYWVD
DSLQISAREQVDFVQRLARGTLPFSARSQDIVRQMSIVEATPDYVLHGKTGWFVDKKPDI
GWWVGWIERDGNITSVAINIDMLSEADAPKRARIVKAVLKDLKLI
>ALA99187.1|FEATURES|NCBI|beta_lactam|OXA-62|antibiotic inactivation|1
MKKIISRWRRGVFGLRVALAVVSPMVFAVPAHATEAAGGAAGTKAAAVHMKERADWGKFF
DAEGVKGTIVVLDGRTQTYQAFDTARAERRMSPASTYKIFNSLLALESGALDNEREIIPW
DGKPRRGKYWNAAMDLRTAFRVSCLPCYQVVSHKIARQFAQSKLNEAGYGNHTIGRAADA
YWVDDSLQISAREQVDFLQRLARGTLPFSARSQDIVRQISIVEANPDYVLHGKTGWFVDK
KPDIGWWVGWIERDGNITSVALNIDLKDDADAPKRARIVRAVLSSLQLI
>ALA99188.1|FEATURES|NCBI|beta_lactam|OXA-62|antibiotic inactivation|1
MKRILSHWCRAAVVLRLASAVVAHGLLPSPAHALELSRASAAAAPSVAAPVHVTERADWG
KFFAAENVKGTVVVLDGKTQTYQAYDSARAERRMSPASTYKIFNSLLALESGALDNERET
IPWDGKPRRIKAWNAELNLRDAFRVSCYPCYQVVSHKIPRAYAQAKLDAVGYGNRTIGRV
NDTYWVDDSLQISAREQVDFLQRLARGTLPFSARSQDIVRQISIVEANADYVLHGKTGWF
VDKKPDIGWWVGWLERDGNLTMIALNIDMNGDADGPKRARIVREVLKNLKLI
>ALA99189.1|FEATURES|NCBI|beta_lactam|OXA-62|antibiotic inactivation|1
MKRILSRWRRAAVVLRLASAVVAHGLLPSPAHALELSRASAAAAPSVAAPVHVTERADWG
KFFAAENVKGTVVVLDGKTQTYQAYDSARAERRMSPASTYKIFNSLLALESGALDNERET
IPWDGKPRRIKAWNAELNLRDAFRVSCYPCYQVVSHKIPRAYAQAKLDAVGYGNRTIGRV
NDTYWVDDSLQISAREQVDFLQRLARGTLPFSARSQDIVRQISIVEANADYVLHGKTGWF
VEKKPDIGWWVGWLERDGNLTMIALNIDMNGDADGPKRARIVREVLKNLKLI
>ALA99190.1|FEATURES|NCBI|beta_lactam|OXA-62|antibiotic inactivation|1
MKKTFSRWRRGALVLRILGALASPVVFATPGHAAEPVRPPSVHITERADWGKYFADEGVK
GTVVVLDGRTQTYQAYDAARAERRLSPASTYKIFNSLLALESGAIDNEREVIPWDGKPRS
MKAWNAALNLRDAFRVSCLPCYQILSHKIPRQYAQAKLNEVGYGNRTIGHAADTYWVDDS
LQISAREQVDFLQRLAKGTLPFSARSQDIVRNISIVEANADYVLHGKTGWFTDKKPDIGW
WVGWLERDGNLTMIALNIDIQSDADGPKRVRIVRSVLKDLKLI
>ALA99191.1|FEATURES|NCBI|beta_lactam|OXA-62|antibiotic inactivation|1
MMMLSRWRRSAVVLRIAAALLSPLAVAIPAHADAIANAANAVAPKIVERADWGKYFDAEG
AKGTIIVLDGRTGGYQAYDSTRANQRMSPASTYKIFNSLLALESGALDNEREIIPWDGKP
RSMKRWNAAMNLRDAFRVSCLPCYQVVSRKIARTYAQGKLDAVGYGNHTIGSAADAYWVD
NSLQISAREQVVFLQRLARGQLPFSARTQDIVRQISIAEANMDYVLHGKTGWYVDGKHDI
GWWVGWIERDGNITTVALNMDMRSDADAPKRARIARAVLKDLKLI
>ALA99192.1|FEATURES|NCBI|beta_lactam|OXA-62|antibiotic inactivation|1
MKKTLSRWRRGALALRLLGALASPVVFAMPGHAAEPAHSSAVRIAERADWGKYFADEGVK
GTVIVLDGRTQTYQAYDAARAERRMSPASTYKIFNSLLALESGALDNEREVIPWDGKPRR
VKAWNAALDLRNAFRVSCLPCYQVVSHKIPRQYAQAKLNEAGYGNRTIGRAAHAYWIDDS
LQISAREQVDFLQRLATGTLPFSARSQDIVRNISIVEANVDYVLHGKTGWFTEKKPDIGW
WVGWLERDGNLTMIALNIDIQTDADAPKRARIVRNVLKDLKLI
>ALA99193.1|FEATURES|NCBI|beta_lactam|OXA-62|antibiotic inactivation|1
MKKTLSRWRRGALALRLLGALASPVVFAMPGHAAEPAHSSAVRIAERADWGKYFADEGVK
GTVIVLDGRTQTYQAYDAARAERRMSPASTYKIFNSLLALESGALDNEREVIPWDGKPRR
VKAWNAALDLRNAFRVSCLPCYQVVSHKIPRQYAQAKLNEAGYGNRTIGRAAHAYWIDDS
LQISAREQVDFLQRLATGALPFSARSQDIVRNISIVEANVDYVLHGKTGWFTEKKPDIGW
WVGWLERDGNLTMIALNIDIQTDADAPKRARIVRNVLKDLKLI
>ALI92811.1|FEATURES|NCBI|multidrug|salA|antibiotic target protection|1
MSEATFAIASTYAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKT
TLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDM
ENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADDKKPI
SEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRM
FLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFR
YKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTP
LAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMDGVAALSGDFKFGYNVEISYFDQQLAQI
SGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKR
TNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFV
QSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQ
YDEELERLNKIISEPNNSSDYIVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM
>KPU95363.1|FEATURES|NCBI|bacitracin|uppP|antibiotic efflux|0
MTLSDMWNIGLMQGFAGLSLFAVLLLMGLGLAIIFGQMGVINMAHGEFMTIGAYSVFLAA
QVTEHLAPAFMPYYFPISIALAFVFAFIVGWLVEWALIRHLYKRPLDTLLATWGVSLGLQ
QIFRTFIGPKEVSPTLPEWLMGSWTPHEGLDIPINGMFVLVLTALVTGGVLIALHRSRWG
LRVRATVANRTMANATGIDTKKTDRLTFAIGCGIAGVAGAAFTTIGSTGPTSGSLYIVDA
FLVVTFGGAASLLGTVVSAFGIAQTQSVSEFFMTGSMAKVLTLSLIVLILMMRPQGLFAV
KVRR
>ALM24139.1|FEATURES|NCBI|fosfomycin|FosB3|antibiotic inactivation|1
MIKGINHITYSVSNIAKSIEFYRDILGADILVESETSAYFNLGGIWLALNEEKNIPRSEI
KYSYTHIAFTISDNDFEDWYIWLKENEVNILEGRDRDIRDKKSIYFTDLDGHKLELHTGS
LEDRLSYYKEAKPHMNFYI
>ALM24145.1|FEATURES|NCBI|fosfomycin|FosB3|antibiotic inactivation|1
MIKGINHITYSVSNIAKSIEFYRDILGADILVESETSAYFNLGDIWLALNEEKNIPRSEI
KYSYTHIAFTISDNDFEDWYIWLKENEVNILEGRDRDIRDKKSIYFTDLDGHKLELHTGS
LEDRLNYYKEAKPHMNFYI
>ALN12426.1|FEATURES|NCBI|fosfomycin|FosB3|antibiotic inactivation|1
MIKGINHITYSVSNIAKSIEFYRDILEADILVESETSAYFNLGGIWLALNEEKNIPRSEI
KYSYTHIAFTISDNDFEDWYNWLKENEVNILEGRDRDIRDKKSIYFTDLDGHKLELHTGS
LEDRLSYYKEAKPHMNFYI
>ALV83428.1|FEATURES|NCBI|multidrug|salA|antibiotic target protection|1
MSEATFAIASTYAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKT
TLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDM
EKKMKQLIDKMENQWDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADDKKPI
SEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRM
FLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFR
YKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSVSELVIGYDTP
LAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMDGASALSGDFKFGYNVEISYFDQQLAQI
SGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKR
TNVLILDEPTNHMDIIGKENLENILCSYKGTIIFVSHDRYFTNKIADRLLVFDKDGVEFV
ESTYGEYEKKRLNSEKPFNYINVEKKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQ
YDEELERLNKIISQPNNSSDYIVLTELQKSIDEVKRCQGIYFNEWEQLMGELEVM
>AMM74551.1|FEATURES|NCBI|multidrug|salA|antibiotic target protection|1
MSKATFAIASTNAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKT
TLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDM
ENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADDKKPI
SEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRM
FLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFR
YKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTP
LAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMGGVAALSGDFKFGYNVEISYFDQQLAQI
SGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKR
PNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFV
QSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQ
YDEELERLNKIISEPNNSSDYIVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM
>AMM74583.1|FEATURES|NCBI|multidrug|salA|antibiotic target protection|1
MSKATFAIASTNAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKT
TLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRKVFKTLIDM
ENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADDKKPI
SEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRM
FLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFR
YKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTP
LAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMGGVAALSGDFKFGYNVEISYFDQQLAQI
SGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKR
TNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFV
QSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQ
YDEELERLNKIISEPNNSSDYIVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM
>AMM74625.1|FEATURES|NCBI|multidrug|salA|antibiotic target protection|1
MSEATFAIASTNAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKT
TLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDM
ENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADDKKPI
SEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRM
FLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFR
YKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTP
LAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMGGVAALSGDFKFGYNVEISYFDQQLAQI
SGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKR
TNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFV
QSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQ
YDEELERLNKIISEPNNSSDYMVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM
>AMM74643.1|FEATURES|NCBI|multidrug|salA|antibiotic target protection|1
MSKATFAIASTNAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKT
TLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDM
ENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADDKKPI
SEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRM
FLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFR
YKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTP
LAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMDGVAALSGDFKFGYNVEISYFDQQLAQI
SGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKR
TNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFV
QSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQ
YDEELERLNKIISEPNNSSDYIVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM
>AMM74658.1|FEATURES|NCBI|multidrug|salA|antibiotic target protection|1
MSEATFAIASTNAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKT
TLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDM
ENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADDKKPI
SEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRM
FLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFR
YKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTP
LAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMDGVAALSGDFKFGYNVEISYFDQQLAQI
SGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKR
TNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFV
QSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQ
YDEELERLNKIISEPNNSSDYIVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM
>AMP42440.1|FEATURES|NCBI|tetracycline|tetD|antibiotic efflux|1
MNKFAITALTITALDAMGIGLIMPVLPTLLREYVSAENLANHYGILLALYAIMQVFFAPL
LGKWSDKFGRRPILLLSLAGAAVDYTLLALSSSLWMLYVGRLISGVTGATGAVAASVIAD
NTASQERTKWFGRLGAAFGIGLIAGPAIGGFTGQFSAHLPFIIAAILNALSFLVIMLIFK
DNKIKNTEKNTTETAENSRPFLQVIKPVILLLFIFFMTQMIGQIPATTWVLFTEHRFQWG
SMEVGLSLAGLGIMHALFQAFVAGAIAKKFNEKVTIIVGFVVDGAAFIILSLLTKGWMIY
PTLILLAGGSIALPALQGLMSAQVNQTNQGKLQGVLVSLTNTTGVIGPLLFSFIFGQTLA
SWDGWIWMIGAIMYVLLIVFILSFYRSTKKIVKIAKLPAS
>AMR98919.1|FEATURES|NCBI|beta_lactam|OXA-184|antibiotic inactivation|1
MKKIFLLFGLFCSFALANENLKDLFKDYNESGVFIAYDGKNYYSNDFKKANKRILPASTF
KIFNALIALNEDVVKDTNEIFYHYKGEKVFLPSWKNNANLALAMQRSQLPAYKELARKIG
LEKMQKNLNKLNYGNQKISKIDEFWIDDSLQISLKEQATLLFKLANLTLDYPKHIQEEVI
NIIKLKENDHYELFAKTGWGLRQYGQIVGFIKSKKSDKIYAFALNMNISDFNKLYLREEI
VQLYLDQL
>AND62509.1|FEATURES|NCBI|quinolone|QnrD2|antibiotic target protection|1
MEKHFINEKFSRDQFTGNRVKNIAFSNCDFSGVDLTDTEFVDCSFYDRNSLVGCDFNRAK
LKNASFKSCDLSMSNFKNISALGLEISECLAQGVDFRGANFMNMITTRSWFCSAYITKTN
LSYANFSRVILEKCELWENRWNGTVITGAVFRGSDLSCGEFSSFDWSLADFTGCDLTGGV
LGELDARRTNLDGVKLDGEQALQLVESLGVIVHR
>ANJ15621.1|FEATURES|NCBI|polymyxin|MCR-1|antibiotic target alteration|1
MMQHTSVWYRRSVSPFVLVASVAVFLTATANLTFFDKVSQTYPIADNLGFVLTIAVVLFG
AMLLITTLLSSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNALQTDQAETKDL
LNAAFIMRIIGLGVLPSLLVAFVKVDYPTWGKGLMRRLGLIVASLALILLPVVAFSSHYA
SFFRVHKPLRSYVNPIMPIYSVGKLASIEYKKASAPKDTIYHAKDAVQATKPDMRKPRLV
VFVVGETARADHVSFNGYERDTFPQLAKIDGVTNFSNVTSCGTSTAYSVPCMFSYLGADE
YDVDTAKYQENVLDTLDRLGVSILWRDNNSDSKGVMDKLPKAQFADYKSATNNAICNTNP
YNECRDVGMLVGLDDFVAANNGKDMLIMLHQMGNHGPAYFKRYDEKFAKFTPVCEGNELA
KCEHQSLINAYDNALLATDDFIAQSIQWLQTHSNAYDVSMLYVSDHGESLGENGVYLHGM
PNAFAPKEQRSVPAFFWTDKQTGITPMATDTVLTHDAITPTLLKLFDVTADKVKDRTAFI
R
>AOE23833.1|FEATURES|NCBI|quinolone|QnrB19|antibiotic target protection|1
MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDSYRASLLMERLGIAVIG
>AOE23835.1|FEATURES|NCBI|quinolone|QnrB19|antibiotic target protection|1
MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNVTALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDSYRASLLMERLGIAVIG
>AON96411.1|FEATURES|NCBI|multidrug|salA|antibiotic target protection|1
MSKATFAIASTNAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKT
TLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDM
ENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADDKKPI
SEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRM
FLNRIVDKVYEIEWGKTKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFR
YKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTP
LAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMGGVAALSGDFKFGYNVEISYFDQQLAQI
SGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKR
TNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFV
QSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQ
YDEELERLNKIISEPNNSSDYIVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM
>AON96413.1|FEATURES|NCBI|multidrug|salA|antibiotic target protection|1
MSEATFAIASTNAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKT
TLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDM
ENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADDKKPI
SEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRM
FLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFR
YKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTP
LAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMGGVAALSGDFKFGYNVEISYFDQQLAQI
SGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKR
TNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFV
QSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQ
YDEELERLNKIISEPNNSSDYIVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM
>AON96416.1|FEATURES|NCBI|multidrug|salA|antibiotic target protection|1
MSEATFAIASTYAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKT
TLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDM
ENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADDKKPI
SEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRM
FLNRIVNKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFR
YKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTP
LAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMDGVAALSGDFKFGYNVEISYFDQQLAQI
SGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKR
TNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFV
QSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQ
YDEELERLNKIISEPNNSSDYMVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM
>AON96418.1|FEATURES|NCBI|multidrug|salA|antibiotic target protection|1
MSKATFAIASTNAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKT
TLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRKVFKTLIDM
ENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADDKKPI
SEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRM
FLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFR
YKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTP
LAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMGGVAALSGDFKFGYNVEISYFDQQLAQI
SGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKR
PNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFV
QSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQ
YDEELERLNKIISEPNNSSDYIVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM
>AON96419.1|FEATURES|NCBI|multidrug|salA|antibiotic target protection|1
MSKATFAIASTNAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKT
TLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESRSMVDEVRTVFKTLIDM
ENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADDKKPI
SEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRM
FLNRIVDKVYEIEWGKTKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFR
YKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTP
LAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMGGVAALSGDFKFGYNVEISYFDQQLAQI
SGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKR
TNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFV
QSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQ
YDEELERLNKIISEPNNSSDYIVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM
>APM84488.1|FEATURES|NCBI|polymyxin|MCR-1|antibiotic target alteration|1
MMQHTSVWYRRSVSPFVLVASVAVFLTATANLTFFDKISQTYPIADNLGFVLTIAVVLFG
AMLLITTLLSSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNALQTDQAETKDL
LNAAFIMRIIGLGVLPSLLVAFVKVDYPTWGKGLMRRLGLIVASLALILLPVVAFSSHYA
SFFRVHKPLRSYVNPIMPIYSVGKLASIEYKKASAPKDTIYHAKDAVQATKPDMRKPRLV
VFVVGETARADHVSFNGYERDTFPQLAKIDGVTNFSNVTSCGTSTAYSVPCMFSYLGADE
YDVDTAKYQENVLDTLDRLGVSILWRDNNSDSKGVMDKLPKAQFADYKSATNNAICNTNP
YNECRDVGMLVGLDDFVAANNGKDMLIMLHQMGNHGPAYFKRYDEKFAKFTPVCEGNELA
KCEHQSLINAYDNALLATDDFIAQSIQWLQTYSNAYDVSMLYVSDHGESLGENGVYLHGM
PNAFAPKEQRSVPAFFWTDKQTGITPMATDTVLTHDAITPTLLKLFDVTADKVKDRTAFI
R
>APM87143.1|FEATURES|NCBI|polymyxin|MCR-1|antibiotic target alteration|1
MMQHTSVWYRRSVSPFVLVASVAVFLTATANLTFFDKISQTYPIADNLGFVLTIAVVLFG
AMLLITTLLSSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNALQTDQAETKDL
LNAAFIMRIIGLGVLPSLLVAFVKVDYPTWGKGLMRRLGLIVASLALILLPVVAFSSHYA
SFFRVHKPLRSYVNPIMPIYSVGKLASIEYKKASAPKDTIYHAKDAVQATKPDMRKPRLV
VFVVGETARADHVSFNGYERDTFPQLAKIDGVTNFSNVTSCGTSTAYSVPCMFSYLGADE
YDVDTAKYQENVLDTLDRLGVSILWRDNNSDSKGVMDKLPKAQFADYKSATNNAICNTNP
YNECRDVGMLVGLDDFVAANNGKDMLIMLHQMGNHGPAYFKRYDEKFAKFTPVCEGNELA
KCEHQSLINAYDNALLATDNFIAQSIQWLQTHSNAYDVSMLYVSDHGESLGENGVYLHGM
PNAFAPKEQRSVPAFFWTDKQTGITPMATDTVLTHDAITPTLLKLFDVTADKVKDRTAFI
R
>APZ75411.1|FEATURES|NCBI|beta_lactam|NDM-1|antibiotic inactivation|1
MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDQRFGDLVFRQLA
PNVWQHTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVAL
AVVTHAHQDKMGGMDALHAAGIATYANALSNQLAPQEGMVAAQHSLTFAANGWVEPATAP
NFGPLKVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARA
FGAAFPKASMIVMSHSAPDSRAAITHTARMADKLR
>AQK48217.1|FEATURES|NCBI|polymyxin|MCR-1|antibiotic target alteration|1
MMQHTSVWYRRSVSPFVLVASVAVFLTATANLTFFDKISQTYPIADNLGFVLTIAVVLFG
AMLLITTLLSSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNALQTDQAETKDL
LNAAFIMRIIGLGVLPSLLVAFVKVDYPTWGKGLMRRLGLIVASLALILLPVVAFSSHYA
SFFRVHKPLRSYVNPIMPIYSVGKLASIEYKKASAPKDTIYHAKDAVQATKPDMRKPRLV
VFVVGETARADHVSFNGYERDTFPQLAKIDGVTNFSNVTSCGTSTAYSVPCMFSYLGADE
YDVDTAKYQENVLDTLDRLGVSILWRDNNSDSKGVMDKLPKAQFADYKSATNNAICNTNP
YNECRDVGMLVGLDDFVAANNGKDMLIMLHQMGNHGPAYFKRYDEKFAKFTPVCEGNELA
KCEHQSLINAYDNALLATDDFIAQSIQWLQTHSNAYDVSMLYVSDHGESLGENGVYLHGM
PNAFAPKEQRSVPAFFWTDKQTGITPMATDTVLTHDAITPTLLKLFDVTADKVKDHTAFI
R
>AQM56008.1|FEATURES|NCBI|multidrug|qepA|antibiotic efflux|1
MSATLHDTAADRRKATRREWIGLAVVALPCLVYAMDLTVLNLALPVLSRELQPSSAQLLW
ILDIYGFFVAGFLITMGTLGDRIGRRRLLLIGAALFAFASVLAALADTAALLIAARALLG
LAGATIAPSTMALIRNMFHDPRQRQFAIGVWIAAFSLGSAIGPLVGGVLLEFFHWGAVFW
LNVPVMLLTLALGPRFLPEYRDPDAGHLDLASVLLSLAAVLLTIYGLKQLAEHGAGLASM
AALLAGLAVGALFLRRQGHIAYPLLDLRLFAHAPFRAALAAYALAALAMFGVYIFMTQYL
QLVLGLSPLQAGLATLPWSLCFVIGSLLSPQLAARWPAARILVVGLSAAAFGFAVLGLGQ
GLWWLVPATIVMGLGLAPVFTIGNEIIITSAPSERAGAASALSETVSEFSGALGIALFGS
VGLVVYRQALTSAALPGLPADALQAAGASLGGAVHLADTLPAWQGAALLAAARAGFTDAL
QATAWAGAVLVLVAAGLVARLLRKRPALASG
>AQM75611.1|FEATURES|NCBI|multidrug|cfr|antibiotic target alteration|1
MSKYKKMKQLIADMRLPEYRYKQLLDAVFLQGIMRFEDMKLLPKTLREKLVEQFGETVVE
IKAIHHEKSMQTDKVLFELSDGNRVETVGLFYKEGWNSFCISSQSGCGFGCKFCATGTLG
LRRNLTVDEITDQILYFMQQGCSINSISFMGMGEPFANPQVFEALHDLTAPELFGLSKRR
ITISTIGIVPGIQKLTREYPQVNLAYSLHAPTDRLRETLMPITKTYPLGQVLDTLDQHIR
QTNRKVFLAYIMLKDVNDSDRHAEQLTKLLFKHKKYLPLYHLDLIPYNQTTVTETMVPSS
HTRIKAFCRIIHNAGISINIRTQFGSDINAACGQLAGAYRDDQKQGERTMSARDVKSFGE
EVCEYGFYNQGAMRSTNSS
>AQQ11622.1|FEATURES|NCBI|polymyxin|MCR-1|antibiotic target alteration|1
MMQHTSVWYRRSVSPFVLVASVAVFLTATANLTFFDKISQTYPIADNLGFVLTIAVVLFG
AMLLITTLLSSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNALQTDQAETKDL
LNAAFIMRIIGLGVLPSLLVAFVKVDYPTWGKGLMRRLGLIVASLALILLPVVAFSSHYA
SFFRVHKPLRSYVNPIMPIYSVGKLASIEYKKASTPKDTIYHAKDAVQATKPDMRKPRLV
VFVVGETARADHVSFNGYERDTFPQLAKIDGVTNFSNVTSCGTSTAYSVPCMFSYLGADE
YDVDTAKYQENVLDTLDRLGVSILWRDNNSDSKGVMDKLPKAQFADYKSATNNAICNTNP
YNECRDVGMLVGLDDFVAANNGKDMLIMLHQMGNHGPAYFKRYDEKFAKFTPVCEGNELA
KCEHQSLINAYDNALLATDDFIAQSIQWLQTHSNAYDVSMLYVSDHGESLGENGVYLHGM
PNAFAPKEQRSVPAFFWTDKQTGITPMATDTVLTHDAITPTLLKLFDVTADKVKDRTAFI
R
>WP_078254299.1|FEATURES|NCBI|polymyxin|MCR-1|antibiotic target alteration|1
MTSQHSWYRYSINPFVLMGLVALFLAATANLTFFEKAMAVYPVSDNLGFIISMAVALMGA
MLLIVVLLSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNAMQTDQAESKDLMN
LAFFVRIIGLGVLPSVLVAFAKVNYPTWGKGLIQRAMTWGVSLVLLLVPIGLFSSQYASF
FRVHKPVRFYINPITPIYSVGKLASIEYKKATAPTDTIYHAKDAVQTTKPSERKPRLVVF
VVGETARADHVQFNGYGRETFPQLAKVDGLANFSQVTSCGTSTAYSVPCMFSYLGQDDYD
VDTAKYQENVLDTLDRLGVDILWRDNNSDSKGVMDKLPTTQYFDYKSATNNTICNTNPFN
ECRDVGMLVGLDDYVSANNGKDMLIMLHQMGNHGPAYFKRYDEQFAKFTPVCEGNELAKC
EHQSLINAYDNALLATDDFIAKSIDWLKTHEANYDVAMLYVSDHGESLGENGVYLHGMPN
AFAPKEQRAVPAFFWSNNTTFKPTASDTVLTHDAITPTLLKLFDVTADKVKDRTAFIQ
>AQY61516.1|FEATURES|NCBI|polymyxin|MCR-1|antibiotic target alteration|1
MMRHTSVWYRRSVSPFVLVASVAVFLTATANLTFFDKISQTYPIADNLGFVLTIAVVLFG
AMLLITTLLSSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNALQTDQAETKDL
LNAAFIMRIIGLGVLPSLLVAFVKVDYPTWGKGLMRRLGLIVASLALILLPVVAFSSHYA
SFFRVHKPLRSYVNPIMPIYSVGKLASIEYKKASAPKDTIYHAKDAVQATKPDMRKPRLV
VFVVGETARADHVSFNGYERDTFPQLAKIDGVTNFSNVTSCGTSTAYSVPCMFSYLGADE
YDVDTAKYQENVLDTLDRLGVSILWRDNNSDSKGVMDKLPKAQFADYKSATNNAICNTNP
YNECRDVGMLVGLDDFVAANNGKDMLIMLHQMGNHGPAYFKRYDEKFAKFTPVCEGNELA
KCEHQSLINAYDNALLATDDFIAQSIQWLQTHSNAYDVSMLYVSDHGESLGENGVYLHGM
PNAFAPKEQRSVPAFFWTDKQTGITPMATDTVLTHDAITPTLLKLFDVTADKVKDRTAFI
R
>ARB18025.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MFREMRRKRQLLPTEESITILEKMTNGTLALHGDNGYPYAVPVSYVYADGKIYFHSAVKG
HKVDAILRNNKVSFCVVEQDDVKPAEFTTYFRSVIAFGKARILADEGEKQLAFRLLADKY
SHGEVGMEAEIAKGFNHLLMVEIMVEHMTGKEA
>ARO85965.1|FEATURES|NCBI|beta_lactam|B224_5390|antibiotic inactivation|1
MSRILLSSLLAAGLFCSLPASAATGCMLFADGSGKPFSAQGDCASQLPPASTFKIPLALM
GYDSGFLVDEQLPALPFKAGDPDFLPEWKQTTTPSRWMTYSVIWYSQRLTEWLGAARFQQ
YVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPQEQARFLGKLVSGKLPVSAQTLQHT
ANILRQPDIDGWQIHGKTGTGYPKLLDGSLDRDQQIGWFVGWASKQDQKLIFVHTVIQKP
GKQFASLRAREEVFAALPEQLKKL
>ASK49940.1|FEATURES|NCBI|polymyxin|MCR-1|antibiotic target alteration|1
MVQHTSVWYRCSVSPFVLVASVSVFLTATANLTFFDKISQTYPIADNLGFVLTIAVVLFG
AMLLITTLLSSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNALQTDQAETKDL
LNAAFIMRIIGLGVLPSLLVAFVKVDYPTWGKGLVRRLGLIVASLALILLPVVAFSSHYA
SFFRVHKPLRSYVNPIMPIYSVGKLASIEYKKASAPKDTIYHAKDAVQATKPDTRKPRLV
VFVVGETARADHVSFNGYERDTFPQLAKIDGVTNFSNVTSCGTSTAYSVPCMFSYLGADE
YDVDTAKYQENVLDTLDRLGVSILWRDNNSDSKGVMDKLPKAQFADYKSATNNTICNTNP
YNECRDVGMLVGLDDFVAANNGKDMLIMLHQMGNHGPAYFKRYDEKFAKFTPVCEGNELA
KCEHQSLINAYDNALLATDDFITQSIQWLQTHSNAYDVSMLYVSDHGESLGENGVYLHGM
PNAFAPKEQRSVPAFFWTDKQTGITPMATDTVLTHDAITPTLLKLFDVTADKVKDRTAFI
R
>ASK49942.1|FEATURES|NCBI|polymyxin|MCR-1|antibiotic target alteration|1
MTQHSPWYRRPVNPYLLMSVVALFLSATANLTFFDKITNTYPMAQNAGFVISTALVLFGA
MLLITVLLSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNALQTDQAESKDLMN
MAFFVRIIGLGVLPSILVAWVKVDYPTLGKSLIQRAMTWGVAVVMALVPILAFSSHYASF
FREHKPLRSYVNPVMPIYSVGKLASIEYKKATAPKDTIYHAKDAVQTTTPAERKPRLVVF
VVGETARADHVQFNGYSRETFPQLAKIDNLANFSQVTSCGTSTAYSVPCMFSYLGQDDYD
VDTAKYQENVLDTLDRLGVGILWRDNNSDSKGVMDKLPASQYFDYKSATNNTICNTNPYN
ECRDVGMLVGLDDYVSTNQGKDMLIMLHQMGNHGPAYFKRYDEQFAKYTPVCEGNELAKC
EHQSLINAYDNALLATDDFIAKSIDWLKTHQANYDVAMLYVSDHGESLGENGVYLHGMPN
AFAPKEQRAVPAFFWSNNPSFTPTASDTVLTHDAITPTLLKLFDVTADKVKDRTAFIR
>WP_094315354.1|FEATURES|NCBI|polymyxin|eptA|antibiotic target alteration|1
MPSLIKIKIVPLMFFLALYFAFMLNWRGVLHFYEILYKLEDFKFGFAISLPILLVAALNF
VFVPFSIRYLIKPFFALLIALSAIVSYTMMKYRVLFDQNMIQNIFETNQNEALAYLSLPI
IVWVTIAGFIPAILLFFVEIEYEEKWFKGILTRALSMFASLIVIAVIAALYYQDYVSVGR
NNSNLQREIVPANFVNSTVKYVYNRYLAEPIPFTTLGDDAKRDTNQSKPTLMFLVVGETA
RGKNFSMNGYEKDTNPFTSKSGGVISFNDVRSCGTATAVSVPCMFSNMGRKEFDDNRARN
SEGLLDVLQKTGISIFWKENDGGCKGVCDRVPNIEIEPKDHPKFCDKNTCYDEVVLQDLD
SEIAQMKGDKLVGFHLIGSHGPTYYKRYPDAHRQFTPDCPRSDIENCTDEELTNTYDNTI
RYTDFVIGEMIAKLKTYEDKYNTALLYVSDHGESLGALGLYLHGTPYQFAPDDQTRVPMQ
VWMSPGFIKEKGVDMACLQQKAADTRYSHDNIFSSVLGIWDVKTSVYEKGLDIFSQCRNV
Q
>ATM29809.1|FEATURES|NCBI|polymyxin|MCR-1|antibiotic target alteration|1
MMQHTSVVWYRRSVSPFVLVASVAVFLTATANLTFFDKISQTYPIADNLGFVLTIAVVLF
GAMLLITTLLSSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNALQTDQAETKD
LLNAAFIMRIIGLGVLPSLLVAFVKVDYPTWGKGLMRRLGLIVASLALILLPVVAFSSHY
ASFFRVHKPLRSYVNPIMPIYSVGKLASIEYKKASAPKDTIYHAKDAVQATKPDMRKPRL
VVFVVGETARADHVSFNGYERDTFPQLAKIDGVTNFSNVTSCGTSTAYSVPCMFSYLGAD
EYDVDTAKYQENVLDTLDRLGVSILWRDNNSDSKGVMDKLPKAQFADYKSATNNAICNTN
PYNECRDVGMLVGLDDFVAANNGKDMLIMLHQMGNHGPAYFKRYDEKFAKFTPVCEGNEL
AKCEHQSLINAYDNALLATDDFIAQSIQWLQTHSNAYDVSMLYVSDHGESLGENGVYLHG
MPNAFAPKEQRSVPAFFWTDKQTGITPMATDTVLTHDAITPTLLKLFDVTADKVKDRTAF
IR
>ATP60693.1|FEATURES|NCBI|polymyxin|eptA|antibiotic target alteration|1
MPSLIKIKIVPLMFFLALYFAFVLNWRGVLHFYEILYKLEDFKFGFAISLPILLVAALNF
VFVPFSIRYLIKPFFALLIALSAIVSYTMMKYRVLFDQNMIQNIFETNQNEALAYLSLPI
IVWVTIAGFIPAILLFFVEIEYEEKWFKGILTRALSMFASLIVIAVIAALYYQDYVSVGR
NNSNLQREIVPANFVNSTVKYVYNRYLAEPIPFTTLGDDAKRDTNQSKPTLMFLVVGETA
RGKNFSMNGYEKDTNPFTSKSGGVISFNDVRSCGTATAVSVPCMFSNMGRKEFDDNRARN
SEGLLDVLQKTGISIFWKENDGGCKGVCDRVPNIEIEPKDHPKFCDKNTCYDEVVLQDLD
SEIAQMKGDKLVGFHLIGSHGPTYYKRYPDAHRQFTPDCPRSDIENCTDEELTNTYDNTI
RYTDFVIGEMIAKLKTYEDKYNTALLYVSDHGESLGELGLYLHGTPYQFAPDDQTRVPMQ
VWMSPGFIKEKGVDMACLQQKAADTRYSHDNIFSSVLGIWDVKTSVYEKGLDIFSQCRNV
Q
>ATQ63392.1|FEATURES|NCBI|polymyxin|eptA|antibiotic target alteration|1
MPSLIKIKIVPLMFFLALYFAFMLNWRGVLHFYEILYKLEDFKFGFAISLPILLVAALNF
VFVPFSIRYLIKPFFALLIALSAIVSYTMMKYRVLFDQNMIQNIFETNQNEALAYLSLPI
IGWVTIAGFIPAILLFFVEIEYEEKWFKGILTRALSMFASLIVIAVIAALYYQDYVSVGR
NNSNLQREIVPANFVNSTVKYVYNRYLAEPIPFTTLGDDAKRDTNQSKPTLMFLVVGETA
RGKNFSMNGYEKDTNPFTSKSGGVISFNDVRSCGTATAVSVPCMFSNMGRKEFDDNLARN
SEGLLDVLQKTGVSIFWKENDGGCKGVCDRVPNIEIKPKDYPKFCDKNTCYDEVVLQELD
SEIAQMKGDKLVGFHLIGSHGPTYYKRYPDAHRQFTPDCPRSDIENCTDEELTNTYDNTI
RYTDFVIGEMIAKLKTYEDKYNTALLYVSDHGESLGALGLYLHGTPYKFAPDDQTRVPMQ
VWMSPGFTKEKGVDMACLQQKAADTRYSHDNIFSSVLGIWDVKTSVYEKGLDIFSQCRNV
Q
>ATU31384.1|FEATURES|NCBI|quinolone|QnrA3|antibiotic target protection|1
MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFS
YADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYIS
GCNLAYANLSGQCLEKCELFENNWSNANLSGASLMDSDLSRGTFSRDCWQQVNLRGCDLT
FADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD
>ABC17630.3|FEATURES|NCBI|quinolone|QnrB4|antibiotic target protection|1
MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAN
LKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSE
LGDLDIRGVDLQGVKLDSYQASLLLERLGIAVMG
>AEL00452.2|FEATURES|NCBI|quinolone|QnrB34|antibiotic target protection|1
MTLALVGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAI
LKDAIFKSCDLSMAGFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSE
LGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG
>AUE22029.1|FEATURES|NCBI|polymyxin|eptA|antibiotic target alteration|1
MISRFKTLSVNQFTFITALFYVAIFNLPLFGIVRKGIEKQPEVDPLFIASMPLFLTFALS
FLFSIFTVKYLLKPFFIVLTLLSSSVFFAAYQYNVVFDYGMIENTFQTHPAEALMYVNLA
SITNLLLTGLLPSYLIYKADIHYQPFFKELLHKLAFMLLMFVGIGIVAFFYYQDYAAFVR
NNSELRRYIVPTYFVSSASKYLNEHYLQTPMEYQQLGLDAKNASRNPNTKPNLLVVVVGE
TARSMSYQYYGYNKPTNAHTQNQGLIAFNDTSSCGTATAVSLPCMFSRMGRADYDPRRAN
AQDTVIDVLSHSGIKVQWFDNDSGCKGVCDRVENLTIDLKSDPKLCSGQYCFDQVLLNKL
DKILAVAPSQDTVIFLHIIGSHGPTYYLRYPPEHRKFIPDCPRSDIQNCSQEELINTYDN
TILYTDFILSEVVNKLKGKQDMFDTAMLYLSDHGESLGEKGMYLHGAPYSIAPKEQTSVP
MLAWVSNDFSQDNQLNMTCVAQRAEQGGFSHDNLFDSLLGLMNVKTTVYQSQLDIFAPCR
>BBB21811.1|FEATURES|NCBI|polymyxin|MCR-1|antibiotic target alteration|1
MMHHTSVWYRRSVSPFVLVASVAVFLTATANLTFFDKISQTYPIADNLGFVLTIAVVLFG
AMLLITTLLSSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNALQTDQAETKDL
LNAAFIMRIIGLGVLPSLLVAFVKVDYPTWGKGLMRRLGLIVASLALILLPVVAFSSHYA
SFFRVHKPLRSYVNPIMPIYSVGKLASIEYKKASAPKDTIYHAKDAVQATKPDMRKPRLV
VFVVGETARADHVSFNGYERDTFPQLAKIDGVTNFSNVTSCGTSTAYSVPCMFSYLGADE
YDVDTAKYQENVLDTLDRLGVSILWRDNNSDSKGVMDKLPKAQFADYKSATNNAICNTNP
YNECRDVGMLVGLDDFVAANNGKDMLIMLHQMGNHGPAYFKRYDEKFAKFTPVCEGNELA
KCEHQSLINAYDNALLATDDFIAQSIQWLQTHSNAYDVSMLYVSDHGESLGENGVYLHGM
PNAFAPKEQRSVPAFFWTDKQTGITPMATDTVLTHDAITPTLLKLFDVTADKVKDRTAFI
R
>AUN87920.1|FEATURES|NCBI|polymyxin|eptA|antibiotic target alteration|1
MPSLIKIKIVPLMFFLALYFAFMLNWRGVLHFYEILYKLEDFKFGFAISLPILLVAALNF
VFVPFSIRYLIKPFFALLIALSAIVSYTMMKYRVLFDQNMIQNIFETNQNEALAYLSLPI
IVWVTIAGFIPAILLFFVEIEYEEKWFKGILTRALSMFASLIVIAVIAALYYQDYVSVGR
NNSNLQREIVPANFVNSTVKYVYNRYLAEPIPFTTLGDDAKRDTNQSKPTLMFLVVGETA
RGKNFSMNGYEKDTNPFTSKSGGVISFNDVRSCGTATAVSVPCMFSNMGRKEFDDNRARN
SEGLLDVLQKTGISIFWKENDGGCKGVCDRVPNIEIEPKDHPKFCDKNTCYDEVVLQDLD
SEIAQMKGDKLVVFHLIGSHGPTYYKRYPDAHRQFTPDCPRSDIENCTDEELTNTYDNTI
RYTDFVIGEMIAKLKTYEDKYNTALLYVSDHGESLGALGLYLHGTPYTFAPDDQTRVPMQ
VWMSPGFTKEKGVDMACLQQKAADTRYSHDNIFSSVLGIWDVKTSVYEKGLDIFSQCRNV
Q
>AUR80098.1|FEATURES|NCBI|polymyxin|eptA|antibiotic target alteration|1
MRITLGVMKVNLLLVLFFALVLNWPFFLRFYSVISGLEHVRAGFVISVPLVLLAALNAVF
IPFTFRWLLKPFFSLLILTGSIVSYAMLKYGVIFDASMIQNIVETNNSEATSYLNVPVVL
WFLLTGVLPMVVLWSLKVRYPANWYKGLAIRAGALAFSLLFVGGVAALYYQDYVSIGRNH
RILGKQIVPANYVNGIYKYARDVVFATPIPYQPLGTDAKVVAKGDKPTLMFLVVGETARG
KNFSMNGYEKETNPFTSQAGGVISFKDVRSCGTATAVSVPCMFSNMGRKEFDDNRARNSE
GLLDVLQRSGVSIFWKENDGGCKGVCDRVPNIEIKPKDHPQFCDKNTCYDEVVLQNLDDE
VAQMKGDKLVGFHLIGSHRPPYHQRYPDKPPPFVPDCPRSDIENCSDEELVNTYDNTIRY
TDFVIAEMITKLKKYEDKYNTALIYLSDHGESLGAMGLYLHGTPYKFAPDDQTRVPMQVW
MSPGFAKEKGMDLNCLQQKAADNRYSHDNLFSSVLGIWDVSTAVYDKQLDIFSQCRTVQ
>ASK38392.2|FEATURES|NCBI|polymyxin|MCR-1|antibiotic target alteration|1
MMQHTSVWYRRSVSPFVLVASVAVFLTATANLTFFDKISQTYPIADNLGFVLTIAVVLFG
AMLLITTLLSSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNALQTDQAETKDL
LNAAFIMRIIGLGVLPSLLVAFVKVDYPTWGKGLMRRLGLIVASLALILLPVVAFSSHYA
SFFRVHKPLRSYVNPIMPIYSVGKLASIEYKKASAPKDTIYHAKDAVQATKPDMRKPRLV
VFVVGETARADHVSFNGYERDTFPQLAKIDGVTNFSNVTSCGTSTAYSVPCMFSYLGADE
YDVDTAKYQENVLDTLDRLGVSILWRDNNSDSKGVMDKLPKAQFADYKSATNNAICNTNP
YNECRDVGMLVGLDDFVAANNGKDMLIMLHQMGNHGPAYFKRYDEKFAKFTPACEGNELA
KCEHQSLINAYDNALLATDDFIAQSIQWLQTHSNAYDVSMLYVSDHGESLGENGVYLHGM
PNAFAPKEQRSVPAFFWTDKQTGITPMATDTVLTHDAITPTLLKLFDVTADKVKDRTAFI
R
>AVM85875.1|FEATURES|NCBI|polymyxin|PmrC|antibiotic target alteration|1
MRLSAFITFLKMRPQVRTEFLTLFISLVFTLLCNGVFWNALLAGRDSLTSGTWLMLLCTG
LLITGLQWLLLLLVATRWSVKPLLILLAVMTPAAVYFMRNYGVYLDKAMLRNLMETDVRE
ASELLQWRMLPYLLVAAVSVWWIARVRVLRTGWKQAVMMRSACLAGALAMISMGLWPVMD
VLIPTLRENKPLRYLITPANYVISGIRVLTEQASSSADEAREVVAADAHRGPQQGRRPRA
LVLVVGETVRAANWGLSGYERQTTPELAARDVINFSDVTSCGTDTATSLPCMFSLNGRRD
YDERQIRRRESVLHVLNRSDVNILWRDNQSGCKGVCDGLPFENLSSAGHPTLCHGERCLD
EILLEGLAEKITTSRSDMLIVLHMLGNHGPAYFQRYPASYRRWSPTCDTTDLASCSHEAL
VNTYDNAVLYTDHVLARTIDLLSGIRSHDTALLYVSDHGESLGEKGLYLHGIPYVIAPDE
QIKVPMIWWQSSQVYADQACMQTHASRAPVSHDHLFHTLLGMFDVKTAAYTPELDLLATC
RKGQPQ
>ALMH01000001_optrA_18|FEATURES|resfinder|multidrug|salA|antibiotic target protection|1
LSEATFAIASTNAKEDMKMQYKIINGAVYYDGNMVLENIDIEINDNEKIAIVGRNGCGKT
TLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDM
ENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADDKKPI
SEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRM
FLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFR
YKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTP
LAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMDGVAALSGDFKFGYNVEISYFDQQLAQI
SGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKR
TNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFV
QSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQ
YDEELERLNKIISEPNNSSDYIVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM
>ALMN01000021_optrA_19|FEATURES|resfinder|multidrug|salA|antibiotic target protection|1
LSEATFAIASTYAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKT
TLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDM
ENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADDKKPI
SEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRM
FLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFR
YKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTP
LAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMGGVAALSGDFKFGYNVEISYFDQQLAQI
SGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKR
TNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFV
QSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQ
YDEELERLNKIISEPNNSSDYIVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM
>ALMZ01000078_optrA_20|FEATURES|resfinder|multidrug|salA|antibiotic target protection|1
LSKATFAIASTNAKEDMKMQYKIINGAVYYDGNMVLENIDIEINDNEKIAIVGRNGCGKT
TLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDM
ENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADDKKPI
SEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRM
FLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFR
YKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTP
LAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMDGVAALSGDFKFGYNVEISYFDQQLAQI
SGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKR
TNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFV
QSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQ
YDEELERLNKIISEPNNSSDYIVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM
>DQ993182_1|FEATURES|resfinder|trimethoprim|dfrB7|antibiotic target replacement|0
MDQSSKEVSSPATDQFALPFRATFGLGDRVRKKSGAAWQGQVVGWYSTKLTPEGYAVESE
SHPGSVQIYPVAALERVA
>CAH16951.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|0
MGVLNVTSDSFYDGGKYLSVDRACDQALKLIACGADLIDIGGESTKPGAPPVPLDVELSR
VLPVIKQLRALADVCISIDTNKPEVMEAAIDAGANVINDVYALRRDGALNVAAQLDVPVC
LMHMKGEPRTMQENPSYPEGIMKELQHFFEERIDKCQKAGLNKNKLILDPGFGFGKRIKD
NLKLIYHLNELRSFGLPILLGVSRKSTIGAVLNNEVEQRLIGSITLGIYAALKGTAIIRT
HDVDETNQALTMINAIYQAAKEIS
>WP_000918666.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MAGQVVQYGRHRKRRNYARISEVLELPNLIEIQTKSYEWFLREGLIEMFRDISPIEDFTG
NLSLEFVDYRLGEPKYDLEESKNRDATYAAPLRVKVRLIIKETGEVKEQEVFMGDFPLMT
DTGTFVINGAERVIVSQLVRSPSVYFNEKIDKNGRENYDATIIPNRGAWLEYETDAKDVV
YVRIDRTRKLPLTVLLRALGFSSDQEIVDLLGDNEYLRNTLEKDGTENTEQALLEIYERL
RPGEPPTVENAKSLLYSRFFDPKRYDLASVGRYKTNKKLHLKHRLFNQKLAEPIVNTETG
EIVVEEGTVLDRRKIDEIMDVLESNANSEVFELHGSVIDEPVEIQSIKVYVPNDDEGRTT
TVIGNAFPDSEVKCITPADIIASMSYFFNLLSGIGYTDDIDHLGNRRLRSVGELLQNQFR
IGLSRMERVVRERMSIQDTESITPQQLINIRPVIASIKEFFGSSQLSQFMDQANPLAELT
HKRRLSALGPGGLTRERAQMEVRDVHYSHYGRMCPIETPEGPNIGLINSLSSYARVNEFG
FIETPYRKVDLDTHAITDQIDYLTADEEDSYVVAQANSKLDENGRFMDDEVVCRFRGNNT
VMAKEKMDYMDVSPKQVVSAATACIPFLENDDSNRALMGANMQRQAVPLMNPEAPFVGTG
MEHVAARDSGAAITAKHRGRVEHVESNEILVRRLVEENGVEHEGELDRYPLAKFKRSNSG
TCYNQRPIVAVGDVVEYNEILADGPSMELGEMALGRNVVVGFMTWDGYNYEDAVIMSERL
VKDDVYTSIHIEEYESEARDTKLGPEEITRDIPNVSESALKNLDDRGIVYIGAEVKDGDI
LVGKVTPKGVTELTAEERLLHAIFGEKAREVRDTSLRVPHGAGGIVLDVKVFNREEGDDT
LSPGVNQLVRVYIVQKRKIHVGDKMCGRHGNKGVISKIVPEEDMPYLPDGRPIDIMLNPL
GVPSRMNIGQVLELHLGMAAKNLGIHVASPVFDGANDDDVWSTIEEAGMARDGKTVLYDG
RTGEPFDNRISVGVMYMLKLAHMVDDKLHARSTGPYSLVTQQPLGGKAQFGGQRFGEMEV
WALEAYGAAYTLQEILTYKSDDTVGRVKTYEAIVKGENISRPSVPESFRVLMKELQSLGL
DVKVMDEQDNEIEMTDVDDDDVVEHKVDLQQNDAPETQKEVTD
>CAJ66881.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MPHPVTIGKRTRMSFSKIKEIADVPNLIEIQVDSYEWFLKEGLKEVFDDISPIEDYTGNL
ILEFVDYSLDDKPKYDIEECKERDATYCAPLKVKVRLINKETGEIKEQEVFMGDFPLMTE
RGTFVINGAERVIVSQLVRSPGVYYAEERDKTGKRLISSTVIPNRGAWLEYETDSNDVIS
VRVDRTRKQPVTVLLRALGIGTDAEIIDLLGEDERLSATLEKDNTKTVEEGLVEIYKKLR
PGEPPTVESASSLLNALFFDPKRYDLAKVGRYKFNKKLALCYRIMNKISAEDIINPETGE
VFVKAGEKISYDLAKAIQNAGINVVNLLMDDDKKVRVIGNNFVDIKSHIDFDIDDLNIKE
KVHYPTLKEILDGYSDEEEIKEAIKSRIKELIPKHILLDDIIASISYEFNIFYNIGNIDD
IDHLGNRRIRSVGELLQNQVRIGLSRMERVIKERMTVQDMEAITPQALVNIRPVSAAIKE
FFGSSQLSQFMDQTNPLSELTHKRRLSALGPGGLSRERAGFEVRDVHHSHYGRMCPIETP
EGPNIGLINSLGTYAKINEFGFIESPYRKFDKETSTVTDEIHYLTADEEDLFVRAQANEP
LTEDGKFVNHRVVCRTVNGAVEMVPESRVDYMDISPKQVVSVATAMIPFLENDDANRALM
GANMQRQAVPLVRREAPIIGTGIEYRAAKDSGAVVVARNSGIAERVTADEIIIKREDGNR
DRYNLLKFKRSNSGTCINQTPIINKGDQIIKGDVIADGPATDLGEVALGRNCLIAFMTWE
GYNYEDAILINERLVKEDRLSTIHIEEYECEARDTKLGPEEITRDIPNVGDSAIKNLDDR
GIIRIGAEVDSGDILVGKVTPKGETELTAEERLLRAIFGEKAREVRDTSLKVPHGESGII
VDVKVFTRENGDDLSPGVNELVRCYIAKKRKIKVGDKMAGRHGNKGVISRVLPEEDMPFM
ENGTPLDIILNPQGIPSRMNIGQVLEVHLGLAAKTLGWYVATSVFDGANEYDIMDALEEA
GYPRDGKLTLYDGRTGESFDNRITVGYMYYLKLHHLVDEKLHARSTGPYSLVTQQPLGGK
AQFGGQRFGEMEVWALEAYGAAHILQEILTVKSDDVVGRVRTYEAIVKGENIPEPGIPES
FKVLIKELQSLCLDVKVLTDEDQEIEVRESVDEDDTIGEFELDVVNHMGEVEESNIIEEI
EDDFAENAEDEDIENLEEFTEDDLFEEEIDFDSDDFDM
>ACQ59476.1|FEATURES|megares|elfamycin|tufab|antibiotic target alteration|0
MRGHLKSHLNPYLEGQLMSKEKFERTKPHVNVGTIGHVDHGKTTLTAAICTVLAKVYGGK
ARDFASIDNAPEERERGITINTSHVEYDTPNRHYAHVDCPGHADYVKNMITGAAQMDGGI
LVVAATDGPMPQTREHILLGRQVGIPYIIVFMNKCDMVDDEELLELVEMEVRELLSEYDF
PGDDLPVIQGSALGALNGEAQWEAKIVELAEALDTYIPEPERAVDMAFLMPIEDVFSIQG
RGTVVTGRIERGILKVGDEVAIVGIKETVKTTCTGVEMFRKLLDEGRAGENVGALLRGTK
REEVERGQVLAKPGSITPHTKFESEVYVLSKDEGGRHTPFFKGYRPQFYFRTTDVTGSIE
LPEGVEMVMPGDNVKMVVDLIAPIAMDEGLRFAIREGGRTVGAGVVAKIIA
